PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Feng, H; Xiong, XJ; Chen, Z; Xu, QY; Zhang, ZW; Feng, JG; Wu, YN				Feng, Hua; Xiong, Xiujuan; Chen, Zhuo; Xu, Qunying; Zhang, Zhongwei; Feng, Jiangao; Wu, Yongning			Prevalence and factors for food allergy in different populations from different regions: A protocol for a systematic review and meta-analysis	PLOS ONE			English	Review							RISK-FACTORS; PEANUT ALLERGY; EPIDEMIOLOGY; CHILDREN; INFANTS; UPDATE	Background To determine the prevalence of food allergy (FA) and factors associated with these occurrences in different populations from different regions. Materials and methods The literature search will be conducted via Pubmed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Vip and Wanfang databases. Ratio rate (RR), odds ratio (OR) and 95% confidence intervals (CIs) will be adopted to evaluate prevalence and factors for FA in different populations from different regions. When the heterogeneity is small (I-2<50%), the fixed effect model will be analyzed, otherwise, random effects model analysis will be performed. When the heterogeneity is large (I-2 >= 50%), Meta regression will be used to explore the sources of inter-study heterogeneity. When the heterogeneity is large (I-2 >= 50%) and the results are statistically significant (P<0.05), subgroup analysis will be analyzed based on age, gender, race/region, literature quality and other factors. Funnel plots will be used to reflect reporting bias and the Begg's test will be used to test the symmetry of the funnel plots. When publication bias occurs, "cut-and-fill" method will be adopted to adjust publication bias. And sensitivity analysis will be performed for all outcome indicators. Discussion This meta-analysis will evaluate the prevalence of FA and factors associated with these occurrences in different populations from different regions on the basis of existing evidences. Our study may be crucial to analyze similarities and differences regarding FA between different individuals from diverse regions and eventually define preventive or diagnostic approaches specifically tailored to certain populations and regions. Systematic review registration OSF registration number: 10.17605/OSF.IO/VQXU9	[Feng, Hua; Chen, Zhuo; Wu, Yongning] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang, Jiangxi, Peoples R China; [Feng, Hua; Xu, Qunying; Zhang, Zhongwei; Feng, Jiangao] Nanchang Univ, Sch Publ Hlth, Nanchang, Jiangxi, Peoples R China; [Xiong, Xiujuan] Nanchang Univ, Dept Pathol, Basic Med Coll, Nanchang, Jiangxi, Peoples R China; [Wu, Yongning] Chinese Acad Med Sci, NHC Key Lab Food Safety Risk Assessment, Med Sci Res Unit 2019URU104, China Natl Ctr Food Safety Risk Assessment, Beijing, Peoples R China	Nanchang University; Nanchang University; Nanchang University; Chinese Academy of Medical Sciences - Peking Union Medical College	Wu, YN (corresponding author), Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang, Jiangxi, Peoples R China.; Wu, YN (corresponding author), Chinese Acad Med Sci, NHC Key Lab Food Safety Risk Assessment, Med Sci Res Unit 2019URU104, China Natl Ctr Food Safety Risk Assessment, Beijing, Peoples R China.	wuyongning123@outlook.com			CAMS Innovation Fund for Medical Science [CIFMS 2019-I2M-5024]	CAMS Innovation Fund for Medical Science	This is supported by CAMS Innovation Fund for Medical Science (CIFMS 2019-I2M-5024). The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KJ, 2012, IMMUNOL ALLERGY CLIN, V32, P35, DOI 10.1016/j.iac.2011.11.008; [Anonymous], 2016, FINDING PATH SAFETY; Burks AW, 2012, J ALLERGY CLIN IMMUN, V129, P906, DOI 10.1016/j.jaci.2012.02.001; Ebert CS, 2011, OTOLARYNG CLIN N AM, V44, P537, DOI 10.1016/j.otc.2011.03.001; Hu Y, 2010, PEDIATR INT, V52, P820, DOI 10.1111/j.1442-200X.2010.03166.x; Jackson K, 2013, BFI FILM CLASSICS, P1, DOI 10.1007/978-1-84457-702-6; Johansson SGO, 2001, ALLERGY, V56, P813, DOI 10.1034/j.1398-9995.2001.t01-1-00001.x; Keet CA, 2012, J ALLERGY CLIN IMMUN, V129, P169, DOI 10.1016/j.jaci.2011.10.002; Koplin JJ, 2014, ALLERGY, V69, P1639, DOI 10.1111/all.12487; Koplin JJ, 2012, ALLERGY, V67, P1415, DOI 10.1111/all.12015; Kotz D, 2011, J ALLERGY CLIN IMMUN, V127, P623, DOI 10.1016/j.jaci.2010.11.021; Kusunoki T, 2012, PEDIAT ALLERG IMM-UK, V23, P250, DOI 10.1111/j.1399-3038.2011.01246.x; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lack G, 2012, J ALLERGY CLIN IMMUN, V129, P1187, DOI 10.1016/j.jaci.2012.02.036; Loke P, 2016, J ALLERGY CLIN IMMUN, V138, P529, DOI 10.1016/j.jaci.2016.02.014; Masilamani M, 2012, IMMUNOL ALLERGY CLIN, V32, P11, DOI 10.1016/j.iac.2011.12.003; Meltzer EO, 2009, J ALLERGY CLIN IMMUN, V124, pS43, DOI 10.1016/j.jaci.2009.05.013; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127, P668, DOI 10.1016/j.jaci.2011.01.039; Prescott S, 2011, PEDIAT ALLERG IMM-UK, V22, P155, DOI 10.1111/j.1399-3038.2011.01145.x; Salo PM, 2014, J ALLERGY CLIN IMMUN, V134, P350, DOI 10.1016/j.jaci.2013.12.1071; Sampson HA, 2005, ALLERGY, V60, P19, DOI 10.1111/j.1398-9995.2005.00853.x; Sasaki M, 2018, J ALLER CL IMM-PRACT, V6, P496, DOI 10.1016/j.jaip.2017.12.011; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Venter C, 2010, ALLERGY, V65, P103, DOI 10.1111/j.1398-9995.2009.02176.x	24	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261092	10.1371/journal.pone.0261092	http://dx.doi.org/10.1371/journal.pone.0261092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905577	Green Published, gold			2022-12-26	WOS:000754615500019
J	Ramzan, M; Dawar, A; Saeed, A; Kumam, P; Watthayu, W; Kumam, W				Ramzan, Muhammad; Dawar, Abdullah; Saeed, Anwar; Kumam, Poom; Watthayu, Wiboonsak; Kumam, Wiyada			Heat transfer analysis of the mixed convective flow of magnetohydrodynamic hybrid nanofluid past a stretching sheet with velocity and thermal slip conditions	PLOS ONE			English	Article							NUMERICAL-SIMULATION; MHD FLOW; FLUID	The present study is related to the analytical investigation of the magnetohydrodynamic flow of Ag - MgO/ water hybrid nanoliquid with slip conditions via an extending surface. The thermal radiation and Joule heating effects are incorporated within the existing hybrid nanofluid model. The system of higher-order partial differential equations is converted to the nonlinear system of ordinary differential equations by interpreting the similarity transformations. With the implementation of a strong analytical method called HAM, the solution of resulting higher-order ordinary differential equations is obtained. The results of the skin friction coefficient, Nusselt number, velocity profile, and temperature profile of the hybrid nanofluid for varying different flow parameters are attained in the form of graphs and tables. Some important outcomes showed that the Nusselt number and skin friction are increased with the enhancement in Eckert number, stretching parameter, heat generation parameter and radiation parameter for both slip and no-slip conditions. The thermal profile of the hybrid nanofluid is higher for suction effect but lower for Eckert number, stretching parameter, magnetic field, heat generation and radiation parameter. For both slip and no-slip conditions, the hybrid nanofluid velocity shows an upward trend for both the stretching and mixed convection parameters.	[Ramzan, Muhammad; Kumam, Poom; Watthayu, Wiboonsak] King Mongkuts Univ Technol Thonburi KMUTT, Dept Math, KMUTT Fixed Point Res Lab, Room SCL Fixed Point Lab 802,Fac Sci, Bangkok, Thailand; [Ramzan, Muhammad; Saeed, Anwar; Kumam, Poom; Watthayu, Wiboonsak] King Mongkuts Univ Technol Thonburi KMUTT, Ctr Excellence Theoret & Computat Sci TaCS CoE, Fac Sci, Sci Lab Bldg, Bangkok, Thailand; [Dawar, Abdullah] Abdul Wali Khan Univ, Dept Math, Mardan, Pakistan; [Kumam, Poom] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Kumam, Wiyada] Rajamangala Univ Technol Thanyaburi, Fac Sci & Technol, Dept Math & Comp Sci, Program Appl Stat,Appl Math Sci & Engn Res Unit A, Pathum Thani, Thailand	King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi; Abdul Wali Khan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Rajamangala University of Technology Thanyaburi	Kumam, P (corresponding author), King Mongkuts Univ Technol Thonburi KMUTT, Dept Math, KMUTT Fixed Point Res Lab, Room SCL Fixed Point Lab 802,Fac Sci, Bangkok, Thailand.; Kumam, P (corresponding author), King Mongkuts Univ Technol Thonburi KMUTT, Ctr Excellence Theoret & Computat Sci TaCS CoE, Fac Sci, Sci Lab Bldg, Bangkok, Thailand.; Kumam, P (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	poom.kum@kmutt.ac.th	Dawar, Abdullah/W-1870-2018; Saeed, Anwar/ABB-5007-2021; Kumam, Poom/E-7122-2011	Dawar, Abdullah/0000-0001-9073-7556; Saeed, Anwar/0000-0003-1566-6457; Kumam, Poom/0000-0002-5463-4581	Center of Excellence in Theoretical and Computational Science (TaCSCoE), KMUTT; Thailand Science Research and Innovation (TSRI) Basic Research Fund: Fiscal year 2021 [64A306000005]	Center of Excellence in Theoretical and Computational Science (TaCSCoE), KMUTT; Thailand Science Research and Innovation (TSRI) Basic Research Fund: Fiscal year 2021	The authors acknowledge the financial support provided by the Center of Excellence in Theoretical and Computational Science (TaCSCoE), KMUTT. Moreover, this research project is supported by Thailand Science Research and Innovation (TSRI) Basic Research Fund: Fiscal year 2021 under project number 64A306000005".	Abu Bakar S, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9080878; Ahmad F, 2021, CASE STUD THERM ENG, V27, DOI 10.1016/j.csite.2021.101257; Akbari OA, 2017, PHYSICA E, V86, P68, DOI 10.1016/j.physe.2016.10.013; Al-Hanaya AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65278-5; Alaidrous AA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71543-4; Alhussain ZA, 2022, ARAB J SCI ENG, V47, P1087, DOI 10.1007/s13369-021-06067-8; Ashwinkumar GP, 2021, INT COMMUN HEAT MASS, V127, DOI 10.1016/j.icheatmasstransfer.2021.105563; Ashwinkumar GP, 2021, HEAT TRANSF, V50, P1679, DOI 10.1002/htj.21947; Aziz A, 2020, AIP ADV, V10, DOI 10.1063/1.5129569; Chalavadi S., HEAT TRANSF; El-Dabe NTM, 2021, ARCH APPL MECH, V91, P1067, DOI 10.1007/s00419-020-01810-3; Gupta S, 2020, SN APPL SCI, V2, DOI 10.1007/s42452-020-1995-x; Hafeez A, 2022, APPL NANOSCI, V12, P265, DOI 10.1007/s13204-020-01600-x; Hashim, 2020, NEURAL COMPUT APPL, V32, P3253, DOI 10.1007/s00521-019-04100-4; Hayat T, 2021, INT COMMUN HEAT MASS, V120, DOI 10.1016/j.icheatmasstransfer.2020.104965; Idowu A.S., ARAB J BASIC APPL SC, V27, P149, DOI DOI 10.1080/25765299.2020.1746017; Islam S, 2020, AIP ADV, V10, DOI 10.1063/1.5145298; Jain S, 2021, INT J COMPUT METH EN, V22, P32, DOI 10.1080/15502287.2020.1846096; Kazemi MA, 2020, SN APPL SCI, V2, DOI 10.1007/s42452-020-03567-4; Kempannagari AK, 2020, HEAT TRANSF, V49, P3575, DOI 10.1002/htj.21789; Khan A, 2020, INT COMMUN HEAT MASS, V119, DOI 10.1016/j.icheatmasstransfer.104979; Khan MI, 2020, ALEX ENG J, V59, P1761, DOI 10.1016/j.aej.2020.04.042; Khashi'ie NS, 2020, ALEX ENG J, V59, P1787, DOI 10.1016/j.aej.2020.04.048; Kotha G, 2020, EUR PHYS J PLUS, V135, DOI 10.1140/epjp/s13360-020-00606-2; Kumar A, 2020, PHYSICA A, V551, DOI 10.1016/j.physa.2019.123972; Kumar KA, 2020, J THERM ANAL CALORIM, V139, P3661, DOI 10.1007/s10973-019-08694-8; Kumar KA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51242-5; Kumar KA, 2018, ALEX ENG J, V57, P435, DOI 10.1016/j.aej.2016.11.013; Liao S., 2012, HOMOTOPY ANAL METHOD, P153; Lund LA, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12020276; Ma Y, 2019, INT J HEAT MASS TRAN, V137, P714, DOI 10.1016/j.ijheatmasstransfer.2019.03.169; Mabood F, 2021, J THERM ANAL CALORIM, V146, P227, DOI 10.1007/s10973-020-09943-x; Mahabaleshwar US, 2020, THERM SCI ENG PROG, V16, DOI 10.1016/j.tsep.2019.100459; Mukhtar T, 2020, NUMER METH PART D E, DOI 10.1002/num.22643; Ramadevi B, 2019, PRAMANA-J PHYS, V93, DOI 10.1007/s12043-019-1847-7; Roy NC, 2020, EUR PHYS J PLUS, V135, DOI 10.1140/epjp/s13360-020-00788-9; Samrat S.P., 2021, P I MECH ENG PART J; Shoaib M, 2021, ALEX ENG J, V60, P3605, DOI 10.1016/j.aej.2021.02.015; Shoaib M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75254-8; Sreedevi P, 2021, WAVE RANDOM COMPLEX, DOI 10.1080/17455030.2021.1968537; Tlili I, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63708-y; Tlili I, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61215-8; Uddin I, 2021, J THERM ANAL CALORIM, V145, P495, DOI 10.1007/s10973-020-09574-2; Rasheed HU, 2021, COATINGS, V11, DOI 10.3390/coatings11030353; Ramudu ACV, 2020, HEAT TRANSF, V49, P5020, DOI 10.1002/htj.21865; Wahid NS, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9010030; Waini I, 2020, APPL MATH MECH-ENGL, V41, P507, DOI 10.1007/s10483-020-2584-7; Waqas H, 2020, MATH COMPUT SIMULAT, V178, P166, DOI 10.1016/j.matcom.2020.05.030; Xiong QG, 2020, J THERM ANAL CALORIM, V139, P2601, DOI 10.1007/s10973-019-08757-w; Yashkun U, 2021, INT J NUMER METHOD H, V31, P1930, DOI 10.1108/HFF-07-2020-0423; Zainal NA, 2021, NEURAL COMPUT APPL, V33, P11285, DOI 10.1007/s00521-020-05645-5	51	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0260854	10.1371/journal.pone.0260854	http://dx.doi.org/10.1371/journal.pone.0260854			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905556	Green Published, gold			2022-12-26	WOS:000754615500016
J	Al Mamun, MA; Nihad, SAI; Sarkar, MAR; Aziz, MA; Qayum, MA; Ahmed, R; Rahman, NMF; Hossain, MI; Kabir, MS				Al Mamun, Md. Abdullah; Nihad, Sheikh Arafat Islam; Sarkar, Md. Abdur Rouf; Aziz, Md. Abdullah; Qayum, Md. Abdul; Ahmed, Rokib; Rahman, Niaz Md Farhat; Hossain, Md. Ismail; Kabir, Md. Shahjahan			Growth and trend analysis of area, production and yield of rice: A scenario of rice security in Bangladesh	PLOS ONE			English	Article								Bangladesh positioned as third rice producing country in the world. In Bangladesh, regional growth and trend in rice production determinants, disparities and similarities of rice production environments are highly desirable. In this study, the secondary time series data of area, production, and yield of rice from 1969-70 to 2019-20 were used to investigate the growth and trend by periodic, regional, seasonal and total basis. Quality checking, trend fitting, and classification analysis were performed by the Durbin-Watson test, Exponential growth model, Cochrane-Orcutt iteration method and clustering method. The production contribution to the national rice production of Boro rice is increasing at 0.97% per year, where Aus and Aman season production contribution significantly decreased by 0.48% and 0.49% per year. Among the regions, Mymensingh, Rangpur, Bogura, Jashore, Rajshahi, and Chattogram contributed the most i.e., 13.9%, 9.8%, 8.6%, 8.6%, 8.2%, and 8.0%, respectively. Nationally, the area of Aus and Aman had a decreasing trend with a -3.63% and -0.16% per year, respectively. But, in the recent period (Period III) increasing trend was observed in the most regions. The Boro cultivation area is increasing with a rate of 3.57% per year during 1984-85 to 2019-20. High yielding variety adoption rate has increased over the period and in recent years it has found 72% for Aus, 73.5% for Aman, and 98.4% for Boro season. As a result, the yield of the Aus, Aman, and Boro seasons has been found increasing growth for most of the regions. We have identified different cluster regions in different seasons, indicating high dissimilarities among the rice production regions in Bangladesh. The region-wise actionable plan should be taken to rapidly adopt new varieties, management technologies and extension activities in lower contributor regions to improve productivity. Cluster-wise, policy strategies should be implemented for top and less contributor regions to ensure rice security of Bangladesh.	[Al Mamun, Md. Abdullah; Aziz, Md. Abdullah; Qayum, Md. Abdul; Ahmed, Rokib; Rahman, Niaz Md Farhat; Hossain, Md. Ismail] Bangladesh Rice Res Inst, Agr Stat Div, Gazipur, Bangladesh; [Nihad, Sheikh Arafat Islam] Bangladesh Rice Res Inst, Plant Pathol Div, Gazipur, Bangladesh; [Sarkar, Md. Abdur Rouf] Bangladesh Rice Res Inst, Agr Econ Div, Gazipur, Bangladesh; [Kabir, Md. Shahjahan] Bangladesh Rice Res Inst, Gazipur, Bangladesh	Bangladesh Rice Research Institute (BRRI); Bangladesh Rice Research Institute (BRRI); Bangladesh Rice Research Institute (BRRI); Bangladesh Rice Research Institute (BRRI)	Al Mamun, MA (corresponding author), Bangladesh Rice Res Inst, Agr Stat Div, Gazipur, Bangladesh.	mamunru4777@gmail.com	Sarkar, Md Abdur Rouf/C-3769-2014	Sarkar, Md Abdur Rouf/0000-0002-5926-3863; Aziz, Md. Abdullah/0000-0003-1662-6430; Al Mamun, Md. Abdullah/0000-0001-7535-1743; Nihad, Sheikh Arafat Islam/0000-0003-1959-2619				Alam MZ, 2017, J FOOD QUALITY, DOI 10.1155/2017/2045157; Alam MS., 2010, AGRICULTURISTS, V8, P88, DOI [10.3329/agric.v8i2.7582, DOI 10.3329/AGRIC.V8I2.7582]; Barua R., 2017, SCI AGR, V17, P112, DOI [10.15192/PSCP.SA.2017, DOI 10.15192/PSCP.SA.2017]; BBS (Bangladesh Bureau of Statistics), 2007, YB AGR STAT BANGL; BBS (Bangladesh Bureau of Statistics), 2020, YB AGR STAT BANGL; Biswas A., 2020, BANGLADESH RICE J, DOI [10.3329/brj.v23i1.46082, DOI 10.3329/BRJ.V23I1.46082]; CEGIS, 2012, MAST PLAN HAOR AR MA, VII, P73; Chanda SC., 2019, ASIAN J CROP SOIL SC, DOI [10.18801/ajcsp.010119.02, DOI 10.18801/AJCSP.010119.02]; COCHRANE D, 1949, J AM STAT ASSOC, V44, P32, DOI 10.2307/2280349; Douglas C., 2012, INTRO LINEAR REGRESS; DURBIN J, 1951, BIOMETRIKA, V38, P159, DOI 10.1093/biomet/38.1-2.159; Fatema K., 2011, BANGLADESH J AGR EC; Finger R, 2010, FOOD POLICY, V35, P175, DOI 10.1016/j.foodpol.2009.11.004; Haque SA, 2006, PAK J BOT, V38, P1359; Huth R, 2005, INT J CLIMATOL, V25, P469, DOI 10.1002/joc.1146; Islam SM., 2019, DESALINATION CHALLEN, DOI [DOI 10.5772/INTECHOPEN.85919, 10.5772/intechopen.85919]; Kabir MMM, 2014, PHILIPP AGRIC SCI, V97, P347; Kabir MJ., 2021, BANGLADESH RICE J, V25, P101, DOI [10.3329/brj.v25i1.55182, DOI 10.3329/BRJ.V25I1.55182]; Kabir MJ, 2020, IMPACT SUPER CYCLONE; Kabir MS., 2020, RICE J, V24, P1; Kannan S, 2011, STOCH ENV RES RISK A, V25, P457, DOI 10.1007/s00477-010-0415-y; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Mainuddin M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250897; Mondal MK, 2001, AGR WATER MANAGE, V47, P9, DOI 10.1016/S0378-3774(00)00098-6; Nasim M., 2017, DISTRIBUTION CROPS C, V21, P1; Nasim M., 2021, BANGLADESH RICE J, V25, P89, DOI [10.3329/BRJ.V25I1.55181, DOI 10.3329/BRJ.V25I1.55181]; Nihad SAI, 2021, CURR PLANT BIOL, V25, DOI 10.1016/j.cpb.2020.100194; Rabbi S., 2020, BANGLADESH RICE J, V24, P67, DOI [10.3329/BRJ.V24I2.53449, DOI 10.3329/BRJ.V24I2.53449]; Rahman M. C., 2021, Journal of the Bangladesh Agricultural University, V19, P243, DOI 10.5455/JBAU.53297; Rahman MS., 2020, BANGLADESH RISE J, V24, P83, DOI [10.3329/BRJ.V24I2.53450, DOI 10.3329/BRJ.V24I2.53450, 10.3329/brj.v24i2.53450]; Salam MU, 2019, ADVANCES IN RICE RESEARCH FOR ABIOTIC STRESS TOLERANCE, P895, DOI 10.1016/B978-0-12-814332-2.00044-7; Sarker BC., 2019, J INDIAN SOC COAST A, V37, P51; Shelley I.J., 2016, J INT COOP AGR DEV, V14, P20, DOI [10.50907/jicad.14.0_20, DOI 10.50907/JICAD.14.0_20, DOI 10.18999/JOUICA.14.20]; Uddin M. T., 2018, Agriculture and Food Security, V7, DOI 10.1186/s40066-018-0167-3; USDA (United State of Department of Agriculture), 2020, WORLD BEEF PRODUCTIO; Wilks DS, 2019, STATISTICAL METHODS IN THE ATMOSPHERIC SCIENCES, 4TH EDITION, P1, DOI 10.1016/C2017-0-03921-6	36	8	8	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0261128	10.1371/journal.pone.0261128	http://dx.doi.org/10.1371/journal.pone.0261128			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890444	Green Published, gold			2022-12-26	WOS:000747293600028
J	Tsega, SS; Yazew, BG; Mekonnen, K				Tsega, Sintayehu Simie; Yazew, Birhaneselassie Gebeyehu; Mekonnen, Kennean			Sleep quality and associated factors among adult patients with epilepsy attending follow-up care at referral hospitals in Amhara region, Ethiopia	PLOS ONE			English	Article							JUVENILE MYOCLONIC EPILEPSY; QUESTIONNAIRE; DISTURBANCES; INSOMNIA; DEATH	Background Globally, epilepsy is the commonest neurological disorder in adults. It has significant health and economic consequences to the affected individuals and the family. There is ample evidence that epileptic patients are at increased risk of poor sleep quality than the general population. However, there is limited evidence on sleep quality among epileptic patients and associated factors in Ethiopia. Therefore, this study investigated the prevalence of poor sleep quality and associated factors among adult patients with epilepsy. Method Institutional based cross-sectional study was conducted among adult epileptic patients attending follow-up care at referral hospitals in the Amhara region. A total of 575 epileptic patients were recruited using a stratified systematic random sampling technique. An interviewer-administered semi-structured questionnaire and record review were used for data collection. To assess sleep quality the pretested Pittsburgh Sleep Quality Index (PSQI) tool was used. A binary logistic regression model was used to assess factors associated with poor sleep quality. Variables with a p-value less than 0.2 in the bivariable binary logistic regression analysis were considered for the multivariable binary logistic regression analysis. In the multivariable binary logistic regression analysis, the Adjusted Odds Ratio (AOR) with the 95% Confidence Interval (CI) were reported to declare the statistical significance and strength of association. Model fitness was assessed using the Hosmer-Lemeshow test and was adequate (p>0.05). Multicollinearity of the independent variables was assessed using the Variance Inflation Factor (VIF) and the mean VIF was less than 10. Results A total of 565 participants were enrolled in the study with a response rate of 98.3%. The prevalence of poor sleep quality among adult epileptic patients was 68.8% [95% CI: 64.8%, 72.5%]. In the multivariable binary logistic regression, being unable to read and write [AOR = 3.16, 95%CI: 1.53, 6.51], taking polytherapy treatment [AOR = 2.10, 95% CI: 1.37, 3.21], poor medication adherence [AOR = 2.53, 95%CI: 1.02, 6.23] and having poor support [AOR = 2.72, 95%CI: 1.53, 4.82] and moderate social support [AOR = 1.89, 95%CI: 1.05, 3.41] were significantly associated with higher odds of poor sleep quality. Conclusion and recommendation Poor sleep quality is a major public health concern in Ethiopia. The patient's level of education, number of medication use, medication adherence, and social support were found significant predictors of poor sleep quality. These findings highlight improving medication adherence and social support are effective strategies to improve the sleep quality of epileptic patients. Besides, it is better to give special emphasis to those epileptic patients with a low level of education and taking polytherapy to enhance sleep quality.	[Tsega, Sintayehu Simie; Yazew, Birhaneselassie Gebeyehu] Univ Gondar, Sch Nursing, Dept Med Nursing, Coll Med & Hlth Sci, Gondar, Ethiopia; [Mekonnen, Kennean] Univ Gondar, Sch Nursing, Dept Emergency & Crit Care, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar	Tsega, SS (corresponding author), Univ Gondar, Sch Nursing, Dept Med Nursing, Coll Med & Hlth Sci, Gondar, Ethiopia.	simies952@gmail.com			University of Gondar College of Medicine and Health sciences	University of Gondar College of Medicine and Health sciences	The University of Gondar College of Medicine and Health sciences was the funding source for this study. It was funding for data collection and we acknowledge it.	Adem K, 2020, PSYCHIAT J, V2020; Allers K, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0494-y; Alsaadi T, 2017, SEIZURE-EUR J EPILEP, V53, P13, DOI 10.1016/j.seizure.2017.10.017; Argaw B.A., 2017, WIDER WORKING PAPER; Basu S, 2019, TZU CHI MED J, V31, P73, DOI 10.4103/tcmj.tcmj_177_18; Brown, 2002, SHIKEN JALT TESTING, V6, P17; Catalao R, 2018, IMPLEMENTING INTEGRA, V18, P1, DOI [10.1186/s12913-018-3190-y, DOI 10.1186/S12913-018-3190-Y]; Chen N.-C., 2011, SLEEP QUALITY DAYTIM, V20, P249; Cho S, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-213; Cilliler AE, 2020, EPILEPSY BEHAV, V102, DOI 10.1016/j.yebeh.2019.106661; Dalgard O., 2009, SOCIAL SUPPORT CONSE; Dede HO, 2019, NEUROLOGIST, V24, P170, DOI 10.1097/NRL.0000000000000254; Fanta T, 2015, PREVALENCE FACTORS A; Friedman D, 2014, EPILEPSY BEHAV, V35, P13, DOI 10.1016/j.yebeh.2014.03.022; Giorelli A.S., 2013, EXCESSIVE DAYTIME SL; Im HJ, 2016, EPILEPSY BEHAV, V57, P55, DOI 10.1016/j.yebeh.2016.01.022; Itani O, 2017, SLEEP MED, V32, P246, DOI 10.1016/j.sleep.2016.08.006; Klobucnikova K, 2014, NEUROENDOCRINOL LETT, V35, P405; Kofie CD, 2015, QUALITY LIFE PATIENT; Komolafe MA, 2015, ANN AFR MED, V14, P103, DOI 10.4103/1596-3519.149880; Krishnan P, 2012, EPILEPSY BEHAV, V23, P305, DOI 10.1016/j.yebeh.2011.12.018; Manni R, 2013, SUBJECTIVE SLEEP QUA, V14, pe196; Mbuba CK, 2012, EPILEPSY BEHAV, V24, P81, DOI 10.1016/j.yebeh.2012.02.019; Miano S.J.S.N.A.C.G.t.B., 2020, SLEEP SEIZURE DISORD, V11, P169; Neves GSL, 2016, REV BRASILEIRA NEURO, V51; Ohayon M, 2017, SLEEP HEALTH, V3, P6, DOI 10.1016/j.sleh.2016.11.006; Ohayon MM, 2019, SLEEP HEALTH, V5, P5, DOI 10.1016/j.sleh.2018.10.003; Planas-Ballve A, 2020, INSOMNIO POBRE CALID; Reda AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016049; Roshan S, 2017, SEIZURE-EUR J EPILEP, V50, P194, DOI 10.1016/j.seizure.2017.06.021; Short MA, 2015, SLEEP MED, V16, P987, DOI 10.1016/j.sleep.2015.03.007; Shvarts Vladimir, 2013, Epilepsy Res Treat, V2013, P670682, DOI 10.1155/2013/670682; Singh A, 2016, NEUROL CLIN, V34, P837, DOI 10.1016/j.ncl.2016.06.015; Stauder M, 2020, EPILEPSY BEHAV, V112, DOI 10.1016/j.yebeh.2020.107450; Sudbrack-Oliveira P, 2019, SLEEP MED, V53, P22, DOI 10.1016/j.sleep.2018.09.004; Tesema MT, 2018, INT J EDUC DEV, V60, P51, DOI 10.1016/j.ijedudev.2017.10.023; Trinka E, 2019, EPILEPSIA, V60, P7, DOI 10.1111/epi.14458; Turaga S, 2016, OBSERVATIONAL STUDY, V1, P20; Unterberger I, 2015, SLEEP MED, V16, P237, DOI 10.1016/j.sleep.2014.09.021; Vendrame M, 2013, J CLIN SLEEP MED, V9, P141, DOI 10.5664/jcsm.2410; Wagner R.G, 2016, HLTH CARE UTILIZATIO, V16, P1, DOI [10.1186/s12913-016-1460-0, DOI 10.1186/S12913-016-1460-0]; Winsor AA, 2021, SLEEP MED REV, V57, DOI 10.1016/j.smrv.2021.101416; Xu X, 2006, EPILEPSIA, V47, P1176, DOI 10.1111/j.1528-1167.2006.00591.x; Xu Y, 2020, CLIN NEUROL NEUROSUR, V195, DOI 10.1016/j.clineuro.2020.105963	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0261386	10.1371/journal.pone.0261386	http://dx.doi.org/10.1371/journal.pone.0261386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890425	Green Published, gold			2022-12-26	WOS:000747293600046
J	Hachim, IY; Hachim, MY; Hannawi, H; Bin Naeem, K; Salah, A; Hannawi, S				Hachim, Ibrahim Y.; Hachim, Mahmood Y.; Hannawi, Haifa; Bin Naeem, Kashif; Salah, Abdulla; Hannawi, Suad			The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study	PLOS ONE			English	Article							DISEASE 2019 COVID-19; LACTATE-DEHYDROGENASE; MORTALITY; INFECTION; SEVERITY	Several reports highlighted the central role of inflammation in the pathogenesis of corona virus disease-19 (COVID-19) disease. Also, the hyper-inflammatory response that is triggered by severe acute respiratory syndrom-Covid-2 (SARS-CoV-2) infection was believed to play an essential role in disease severity and adverse clinical course. For that reason, the classical inflammatory markers were proposed as a possible indicator for COVID-19 severity. However, an extensive analysis of the predictive value of inflammatory biomarkers in large patients' cohorts is still limited and critically needed. In this study we investigated the predictive value of the classical inflammatory biomarkers in a patient cohort consists of 541 COVID-19 patients admitted to Al Kuwait Hospital, Dubai, UAE. A detailed analysis of the association between the essential inflammatory markers and clinical characteristics as well as clinical outcome of the patients were made. In addition, the correlation between those markers and a wide range of laboratory biomarkers and incidence of acute organs injury were investigated. Our results showed a significant elevation of many inflammatory markers including white cell count (WBC) count, neutrophils count, C-reactive protein (CRP), D-Dimer, ferritin, procalcitonin (PCT), and lactate dehydrogenase (LDH) levels in patients with more severe illness. Also, our results highlighted that higher levels of those markers can predict worse patient outcome including the need of ventilation, intensive care unit (ICU) admission, multiple organs dysfunction as well as death. In addition, Our results showed that the presence of lymphopenia and lower absolute lymphocyte count (ALC) at the time of admission were associated with severe to critical COVID-19 illness (P<0.0001), presence of acute respiratory distress syndrome (ARDS) (P<0.0001) and the need for ventilation and ICU admission., Moreover, our results showed a strong association between lower ALC count and multiple organs dysfunction and patient's death (P<0.0001). In conclusion, our results highlighted the possible use of classical inflammatory biomarkers at time of admission as a potential predictive marker for more severe clinical course in COVID-19 patients that might need more aggressive therapeutic approach including the need of ventilators and ICU admission. The presence of such predictive markers might improve patient's stratification and help in the direction of the available resources to patients in need, which in turn help in improving our response to the disease pandemic.	[Hachim, Ibrahim Y.] Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates; [Hachim, Ibrahim Y.] Univ Sharjah, Coll Med, Sharjah, U Arab Emirates; [Hachim, Mahmood Y.] Mohammed bin Rashid Univ Med & Hlth Sci, Coll Med, Dubai, U Arab Emirates; [Hannawi, Haifa] Mohammed bin Rashid Univ Med & Hlth Sci, Dubai, U Arab Emirates; [Hannawi, Haifa; Bin Naeem, Kashif; Hannawi, Suad] Minist Hlth & Prevent MOHAP, Dubai, U Arab Emirates; [Salah, Abdulla] Gulf Med Univ, Ajman, U Arab Emirates	University of Sharjah; University of Sharjah	Hannawi, S (corresponding author), Minist Hlth & Prevent MOHAP, Dubai, U Arab Emirates.	suad1@ausdoctors.net		Hachim, Ibrahim Y./0000-0001-6438-9455	COVID-19 research grant, University of Sharjah, UAE [CoV19-0303]	COVID-19 research grant, University of Sharjah, UAE	Dr. Ibrahim Y. Hachim is supported by COVID-19 research grant (CoV19-0303), University of Sharjah, UAE.	Adam SS, 2009, BLOOD, V113, P2878, DOI 10.1182/blood-2008-06-165845; Al Heialy S, 2021, SAUDI J BIOL SCI, V28, P1445, DOI 10.1016/j.sjbs.2020.11.081; Ali N, 2020, J MED VIROL, V92, P2409, DOI 10.1002/jmv.26097; Bartziokas K, 2021, MED CLIN-BARCELONA, V156, P37, DOI 10.1016/j.medcli.2020.07.043; Bi XJ, 2020, PLATELETS, V31, P674, DOI 10.1080/09537104.2020.1760230; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Duffy CR, 2020, OBSTET GYNECOL, V136, P229, DOI 10.1097/AOG.0000000000003984; Force T R, 1998, Respir Care Clin N Am, V4, P665; Gao Y, 2020, J MED VIROL, V92, P791, DOI 10.1002/jmv.25770; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hachim Ibrahim Y, 2021, Oman Med J, V36, pe221, DOI 10.5001/omj.2020.92; Hachim MY, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.585003; Halaby R, 2015, J THROMB THROMBOLYS, V39, P55, DOI 10.1007/s11239-014-1101-6; Hannawi S, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.632965; He XK, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81300-w; He ZP, 2005, INT J INFECT DIS, V9, P323, DOI 10.1016/j.ijid.2004.07.014; Henry BM, 2020, AM J EMERG MED, V38, P1722, DOI 10.1016/j.ajem.2020.05.073; Herold T, 2020, J ALLERGY CLIN IMMUN, V146, P128, DOI 10.1016/j.jaci.2020.05.008; Huang I, 2020, THER ADV RESPIR DIS, V14, DOI 10.1177/1753466620937175; Huang I, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00453-4; Ji P, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000023315; Kutsuna Satoshi, 2020, Glob Health Med, V2, P78, DOI 10.35772/ghm.2020.01031; Li C, 2020, AGING-US, V12, P15670, DOI 10.18632/aging.103770; Li TS, 2004, J INFECT DIS, V189, P648, DOI 10.1086/381535; Lin L, 2020, EMERG MICROBES INFEC, V9, P727, DOI 10.1080/22221751.2020.1746199; Lippi G, 2020, CLIN CHIM ACTA, V505, P190, DOI 10.1016/j.cca.2020.03.004; Lippi G, 2018, CLIN CHEM LAB MED, V56, P1193, DOI 10.1515/cclm-2018-0312; Liu BM, 2021, CYTOKINE, V142, DOI 10.1016/j.cyto.2021.155478; Liu Chun-Yu, 2005, J Chin Med Assoc, V68, P110, DOI 10.1016/S1726-4901(09)70231-X; Luo XM, 2020, CLIN INFECT DIS, V71, P2174, DOI 10.1093/cid/ciaa641; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P1271, DOI 10.4161/cc.10.8.15330; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Naeem KB, 2020, SAUDI MED J, V41, P1204, DOI 10.15537/smj.2020.11.25466; Poggiali E, 2020, CLIN CHIM ACTA, V509, P135, DOI 10.1016/j.cca.2020.06.012; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Smilowitz Nathaniel R, 2021, Eur Heart J, V42, P2270, DOI 10.1093/eurheartj/ehaa1103; Sugiyama M, 2021, GENE, V766, DOI 10.1016/j.gene.2020.145145; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Vabret N, 2020, NAT REV IMMUNOL, V20, P338, DOI 10.1038/s41577-020-0319-0; Wagner J, 2020, INT J LAB HEMATOL, V42, P761, DOI 10.1111/ijlh.13288; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Yang YM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10402-1; Zeng FR, 2020, INT J INFECT DIS, V96, P467, DOI 10.1016/j.ijid.2020.05.055; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zhang JJY, 2020, CLIN INFECT DIS, V71, P2199, DOI 10.1093/cid/ciaa576; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu FY, 2021, ANN HEPATOL, V24, DOI 10.1016/j.aohep.2021.100348; Zhu YQ, 2020, QUANT IMAG MED SURG, V10, P1045, DOI 10.21037/qims.2020.04.11	55	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260537	10.1371/journal.pone.0260537	http://dx.doi.org/10.1371/journal.pone.0260537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855832	Green Published, gold			2022-12-26	WOS:000735299000068
J	Ozgencil, M; Barwell, J; Tischkowitz, M; Izatt, L; Kesterton, I; Simpson, M; Sharpe, P; de Sepulveda, P; Voisset, E; Solomon, E				Ozgencil, Meryem; Barwell, Julian; Tischkowitz, Marc; Izatt, Louise; Kesterton, Ian; Simpson, Michael; Sharpe, Paul; de Sepulveda, Paulo; Voisset, Edwige; Solomon, Ellen			Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; TRANSCRIPTIONAL ACTIVATION; ATAXIA-TELANGIECTASIA; MISSENSE MUTATIONS; TP53 MUTATIONS; HISTONE H2AX; CANCER; RADIOSENSITIVITY; DIFFERENTIATION; PROPAGATION	Establishing a universally applicable protocol to assess the impact of BRCA1 variants of uncertain significance (VUS) expression is a problem which has yet to be resolved despite major progresses have been made. The numerous difficulties which must be overcome include the choices of cellular models and functional assays. We hypothesised that the use of induced pluripotent stem (iPS) cells might facilitate the standardisation of protocols for classification, and could better model the disease process. We generated eight iPS cell lines from patient samples expressing either BRCA1 pathogenic variants, non-pathogenic variants, or BRCA1 VUSs. The impact of these variants on DNA damage repair was examined using a ?H2AX foci formation assay, a Homologous Repair (HR) reporter assay, and a chromosome abnormality assay. Finally, all lines were tested for their ability to differentiate into mammary lineages in vitro. While the results obtained from the two BRCA1 pathogenic variants were consistent with published data, some other variants exhibited differences. The most striking of these was the BRCA1 variant Y856H (classified as benign), which was unexpectedly found to present a faulty HR repair pathway, a finding linked to the presence of an additional variant in the ATM gene. Finally, all lines were able to differentiate first into mammospheres, and then into more advanced mammary lineages expressing luminal- or basal-specific markers. This study stresses that BRCA1 genetic analysis alone is insufficient to establish a reliable and functional classification for assessment of clinical risk, and that it cannot be performed without considering the other genetic aberrations which may be present in patients. The study also provides promising opportunities for elucidating the physiopathology and clinical evolution of breast cancer, by using iPS cells.	[Ozgencil, Meryem; Simpson, Michael; Voisset, Edwige; Solomon, Ellen] Kings Coll London, Fac Life Sci & Med, Dept Med & Mol Genet, London, England; [Barwell, Julian] Univ Leicester, Dept Genet & Genome Biol, Leicester, Leics, England; [Tischkowitz, Marc] Univ Cambridge, Natl Inst Hlth Res, Dept Med Genet, Cambridge Biomed Res Ctr, Cambridge, England; [Izatt, Louise] Guys & St Thomas NHS Fdn Trust, Clin Genet, London, England; [Kesterton, Ian] Guys & St Thomas NHS Fdn Trust, Guys Hosp, Cytogenet Lab, Viapath Analyt, London, England; [Sharpe, Paul] Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London, England; [de Sepulveda, Paulo] Aix Marseille Univ, Inst Paoli Calmettes, Signaling Hematopoiesis & Mech Oncogenesis Lab, NSERM,CNRS,CRCM, Marseille, France; [Ozgencil, Meryem] Queen Mary Univ London, Ctr Canc Cell & Mol Biol, John Vane Ctr, Barts Canc Inst, Charterhouse Sq, London, England	University of London; King's College London; University of Leicester; University of Cambridge; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); University of London; Queen Mary University London	Voisset, E; Solomon, E (corresponding author), Kings Coll London, Fac Life Sci & Med, Dept Med & Mol Genet, London, England.	edwige.voisset@inserm.fr; ellen.solomon@kcl.ac.uk	Voisset, Edwige/GSE-5113-2022; De sepulveda, paulo/K-6043-2015; Simpson, Michael/F-4737-2011	Voisset, Edwige/0000-0002-0943-4847; De sepulveda, paulo/0000-0001-8295-5414; Simpson, Michael/0000-0002-8539-8753	European Union Scholarship Programme; Breast Cancer Now [2015NovPR609]; Blood Cancer UK [13043]; King's College London; National Institute for Health Research (NIHR) Biomedical Research Centre, based at Guy's and St. Thomas' NHS Foundation Trust	European Union Scholarship Programme; Breast Cancer Now; Blood Cancer UK; King's College London(General Electric); National Institute for Health Research (NIHR) Biomedical Research Centre, based at Guy's and St. Thomas' NHS Foundation Trust	This work was supported by a European Union Scholarship Programme, by a pilot grant from Breast Cancer Now (2015NovPR609), by a specialist program grant from Blood Cancer UK (13043; previously called Bloodwise) and King's College London. All BRC facilities were funded by the National Institute for Health Research (NIHR) Biomedical Research Centre, based at Guy's and St. Thomas' NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus L, 2019, NAT GENET, V51, P1450, DOI 10.1038/s41588-019-0507-7; Barwell J, 2007, INT J CANCER, V121, P1631, DOI 10.1002/ijc.22915; Bourton EC, 2012, CYTOM PART A, V81A, P130, DOI 10.1002/cyto.a.21171; Bouwman P, 2013, CANCER DISCOV, V3, P1142, DOI 10.1158/2159-8290.CD-13-0094; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Broeks A, 1998, HUM MUTAT, V12, P330, DOI 10.1002/(SICI)1098-1004(1998)12:5<330::AID-HUMU6>3.0.CO;2-H; Buchholz TA, 2002, INT J CANCER, V97, P557, DOI 10.1002/ijc.10109; Burga LN, 2009, CANCER RES, V69, P1273, DOI 10.1158/0008-5472.CAN-08-2954; Caputo SM, 2021, AM J HUM GENET, V108, P1907, DOI 10.1016/j.ajhg.2021.09.003; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen CC, 2018, ANNU REV CANC BIOL, V2, P313, DOI 10.1146/annurev-cancerbio-030617-050502; Cochran RL, 2015, ONCOTARGET, V6, P25240, DOI 10.18632/oncotarget.4595; Devito L, 2016, STEM CELL RES, V16, P184, DOI 10.1016/j.scr.2015.12.034; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Ernestos B, 2010, INT J RADIAT ONCOL, V76, P1199, DOI 10.1016/j.ijrobp.2009.10.020; Figlioli G, 2020, CANCERS, V12, DOI 10.3390/cancers12020292; Findlay GM, 2018, NATURE, V562, P217, DOI 10.1038/s41586-018-0461-z; Fleming MA, 2003, P NATL ACAD SCI USA, V100, P1151, DOI 10.1073/pnas.0237285100; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Greenblatt MS, 2001, CANCER RES, V61, P4092; Grey W, 2018, BBA-MOL CELL RES, V1865, P105, DOI 10.1016/j.bbamcr.2017.09.009; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Halevy T, 2014, J CLIN MED, V3, P1146, DOI 10.3390/jcm3041146; Hayes F, 2000, CANCER RES, V60, P2411; Holstege H, 2009, CANCER RES, V69, P3625, DOI 10.1158/0008-5472.CAN-08-3426; Humphrey JS, 1997, P NATL ACAD SCI USA, V94, P5820, DOI 10.1073/pnas.94.11.5820; Ilic D, 2012, CYTOTHERAPY, V14, P122, DOI 10.3109/14653249.2011.623692; Kechin AA, 2018, B EXP BIOL MED+, V165, P94, DOI 10.1007/s10517-018-4107-9; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kotsopoulos J, 2007, BRIT J CANCER, V96, P118, DOI 10.1038/sj.bjc.6603528; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Lee DF, 2015, CELL, V161, P240, DOI 10.1016/j.cell.2015.02.045; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li HY, 2020, GENET MED, V22, P701, DOI 10.1038/s41436-019-0729-1; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lovelock PK, 2006, J MED GENET, V43, P74, DOI 10.1136/jmg.2005.033258; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Mariotti LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079541; Maxwell KN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00388-9; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Navarro AM, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-017-0009-2; Nieuwenhuis B, 2002, INT J RADIAT BIOL, V78, P285, DOI 10.1080/09553000110097974; Parsons MT, 2019, HUM MUTAT, V40, P1557, DOI 10.1002/humu.23818; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Qu Y, 2017, STEM CELL REP, V8, P205, DOI 10.1016/j.stemcr.2016.12.023; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Semmler L, 2019, J BREAST CANCER, V22, P1, DOI 10.4048/jbc.2019.22.e6; Sharma B, 2018, CURR PROB CANCER, V42, P189, DOI 10.1016/j.currproblcancer.2018.01.001; Silva TP, 2021, STEM CELL RES, V52, DOI 10.1016/j.scr.2021.102242; Soyombo AA, 2013, STEM CELL REP, V1, P336, DOI 10.1016/j.stemcr.2013.08.004; Stirparo GG, 2021, CELL STEM CELL, V28, P164, DOI 10.1016/j.stem.2020.11.014; Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943; Susanto E, 2020, P NATL ACAD SCI USA, V117, P20127, DOI 10.1073/pnas.1920521117; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Toh GT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002024; Toland AE, 2017, J MED GENET, V54, P721, DOI 10.1136/jmedgenet-2017-104707; Vaclova T, 2015, BREAST CANCER RES TR, V152, P271, DOI 10.1007/s10549-015-3459-3; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; Verhagen MMM, 2012, HUM MUTAT, V33, P561, DOI 10.1002/humu.22016; Vignard J, 2013, RADIOTHER ONCOL, V108, P362, DOI 10.1016/j.radonc.2013.06.013; Voisset E, 2018, BLOOD, V131, P636, DOI 10.1182/blood-2017-07-794784; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507	68	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260852	10.1371/journal.pone.0260852	http://dx.doi.org/10.1371/journal.pone.0260852			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855882	Green Published, gold			2022-12-26	WOS:000735299000140
J	Rad, I; Stahlberg, R; Kung, K; Pollack, GH				Rad, Iman; Stahlberg, Rainer; Kung, Kurt; Pollack, Gerald H.			Low frequency weak electric fields can induce structural changes in water	PLOS ONE			English	Article							CONTACT; ENERGY; LIQUID	Low frequency electric fields were exposed to various water samples using platinum electrodes mounted near the water surface. Responses were monitored using a spectro-radiometer and a contact-angle goniometer. Treatment of DI (deionized), EZ (Exclusion Zone), and bulk water with certain electromagnetic frequencies resulted in a drop of radiance persisting for at least half an hour. Compared to DI water, however, samples of EZ and bulk water showed lesser radiance drop. Contact-angle goniometric results confirmed that when treated with alternating electric fields (E = 600 +/- 150 V/m, f = 7.8 and 1000 Hz), droplets of EZ and bulk water acquired different charges. The applied electric field interacted with EZ water only when electrodes were installed above the chamber, but not beneath. Further, when DI water interacted with an electric field applied from above (E = 600 +/- 150 V/m, f = 75 Hz), its radiance profile became similar to that of EZ water. Putting these last two findings together, one can say that application of an electric field on DI water from above (E = 600 +/- 150 V/m, f = 7.8 to 75 Hz) may induce a molecular ordering in DI water similar to that of EZ water.	[Rad, Iman; Stahlberg, Rainer; Kung, Kurt; Pollack, Gerald H.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Rad, Iman] Stem Cell Technol Res Ctr, Tehran, Iran	University of Washington; University of Washington Seattle	Rad, I (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.; Rad, I (corresponding author), Stem Cell Technol Res Ctr, Tehran, Iran.	radi@u.washington.edu			software AG foundation (SAGST) Foundation	software AG foundation (SAGST) Foundation	We were financially supported through a grant from the software AG foundation (SAGST) Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavijeh MS, 2021, J MECH SCI TECHNOL, V35, P1319, DOI 10.1007/s12206-020-1242-9; Alavijeh MS, 2021, J MECH SCI TECHNOL, V35, P815, DOI 10.1007/s12206-021-0143-x; Alinezhad-Bermi S, 2021, IN VITRO CELL DEV-AN, V57, P290, DOI 10.1007/s11626-020-00430-z; Chai BH, 2009, J PHYS CHEM B, V113, P13953, DOI 10.1021/jp908163w; Choi EM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.085701; Elia V, 2018, J MOL LIQ, V268, P598, DOI 10.1016/j.molliq.2018.07.045; Fuchs EC., 2019, RAMAN SPECTROSCOPY S, V52; Fuchs EC., 2021, ELECT INDUCED LIQUID, V13, P602; Ismail MF, 2021, MATER CHEM PHYS, V258, DOI 10.1016/j.matchemphys.2020.123933; Janssens-Maenhout GGA, 2003, J COLLOID INTERF SCI, V257, P141, DOI 10.1016/S0021-9797(02)00026-7; Lamour G, 2010, J CHEM EDUC, V87, P1403, DOI 10.1021/ed100468u; Mensink LIS, 2021, SOFT MATTER, V17, P1368, DOI 10.1039/d0sm00156b; Montagnier L, 2017, WATER-SUI, V9, DOI 10.3390/w9050339; Nazari H, 2020, MOL CELL BIOCHEM, V470, P29, DOI 10.1007/s11010-020-03742-6; Pollack GH., 2010, GOOGLE PATENTS; Rad I, 2018, J ALTERN COMPLEM MED, V24, P431, DOI 10.1089/acm.2017.0280; Rad I, 2018, J PHYS CHEM B, V122, P7711, DOI 10.1021/acs.jpcb.7b12689; Rad I, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/016004; Rodriguez-Camacho J., 2021, 2020 28 EUR SIGN PRO; Rohani M, 2013, LANGMUIR, V29, P6556, DOI 10.1021/la4001945; Schmit JD, 2021, TRENDS BIOCHEM SCI, V46, P525, DOI 10.1016/j.tibs.2020.12.011; Stahlberg R, 2019, INDIAN J PHYS, V93, P221, DOI 10.1007/s12648-018-1265-6; Walsh T, 2017, PHYS TEACH, V55, P316, DOI 10.1119/1.4981047; Wexler AD, 2016, PHYS CHEM CHEM PHYS, V18, P16281, DOI 10.1039/c5cp07218b; Yoo H, 2011, J PHYS CHEM LETT, V2, P532, DOI 10.1021/jz200057g; Zasetsky AY, 2004, J CHEM PHYS, V121, P6941, DOI 10.1063/1.1787494	26	1	1	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260967	10.1371/journal.pone.0260967	http://dx.doi.org/10.1371/journal.pone.0260967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855917	Green Published, gold			2022-12-26	WOS:000735299000159
J	Weiss, A; Touret, F; Baronti, C; Gilles, M; Hoen, B; Nougairede, A; de Lamballerie, X; Sommer, MOA				Weiss, Anne; Touret, Franck; Baronti, Cecile; Gilles, Magali; Hoen, Bruno; Nougairede, Antoine; de Lamballerie, Xavier; Sommer, Morten O. A.			Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2)	PLOS ONE			English	Article								SARS-CoV-2 variants are emerging with potential increased transmissibility highlighting the great unmet medical need for new therapies. Niclosamide is a potent anti-SARS-CoV-2 agent that has advanced in clinical development. We validate the potent antiviral efficacy of niclosamide in a SARS-CoV-2 human airway model. Furthermore, niclosamide remains its potency against the D614G, Alpha (B.1.1.7), Beta (B.1.351), and Delta (B.1.617.2) variants. Our data further support the potent anti-SARS-CoV-2 properties of niclosamide and highlights its great potential as a therapeutic agent for COVID-19.	[Weiss, Anne] UNION Therapeut Res Serv, Hellerup, Denmark; [Weiss, Anne; Sommer, Morten O. A.] Tech Univ Denmark, Novo Nordisk Ctr Biosustainabil, Lyngby, Denmark; [Touret, Franck; Baronti, Cecile; Gilles, Magali; Nougairede, Antoine; de Lamballerie, Xavier] Aix Marseille Univ, Unite Virus Emergents UVE, IHU Mediterranee Infect, Inserm 1207,IRD 190, Marseille, France; [Hoen, Bruno] Inst Pasteur, Paris, France; [Sommer, Morten O. A.] UNION Therapeut, Hellerup, Denmark	Technical University of Denmark; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sommer, MOA (corresponding author), Tech Univ Denmark, Novo Nordisk Ctr Biosustainabil, Lyngby, Denmark.; de Lamballerie, X (corresponding author), Aix Marseille Univ, Unite Virus Emergents UVE, IHU Mediterranee Infect, Inserm 1207,IRD 190, Marseille, France.; Sommer, MOA (corresponding author), UNION Therapeut, Hellerup, Denmark.	xavier.de-lamballerie@univ-amu.fr; morten.sommer@uniontherapeutics.com	Touret, Franck/ABD-3236-2020	Touret, Franck/0000-0002-4734-2249; Sommer, Morten Otto Alexander/0000-0003-4005-5674; baronti, cecile/0000-0002-2319-9484; Weiss, Anne/0000-0002-1738-0519	Innovationsfonden Denmark [0208-00081, 0153-00209]; Novo Nordisk Foundation under NFF [NNF20CC0035580]	Innovationsfonden Denmark; Novo Nordisk Foundation under NFF	We are thankful for the support of Innovationsfonden Denmark under the grant number: 0208-00081 and 0153-00209 (receiver: AW, MOAS; https://innovationsfonden.dk) and The Novo Nordisk Foundation under NFF grant number: NNF20CC0035580 (receiver: MOAS; https://novonordiskfonden.dk).The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.	[Anonymous], JOHNSON JOHNSON ANNO; Backer V, 2021, LANCET REG HEALTH-EU, V4, DOI 10.1016/j.lanepe.2021.100084; Boda B, 2018, ANTIVIR RES, V156, P72, DOI 10.1016/j.antiviral.2018.06.007; Braga L, 2021, NATURE, V594, P88, DOI 10.1038/s41586-021-03491-6; Brunaugh AD., 2020, BROAD SPECTRUM PATIE; Campbell F, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.24.2100509; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Delang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31819; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Essaidi-Laziosi M, 2018, J ALLERGY CLIN IMMUN, V141, P2074, DOI 10.1016/j.jaci.2017.07.018; Gassen NC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24007-w; Graham B.S., 2021, NATURE, DOI [10.1101/2021.01.25.428137, DOI 10.1038/S41586-021-03398-2]; Jeon S, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00819-20; Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976; Lamers M. M., 2021, HUMAN ORGANOID SYSTE, DOI [10.1101/2021.05.03.441080, DOI 10.1101/2021.05.03.441080]; Lee J., 2021, 438540 BIORXIV, DOI [10.1101/2021.04.06.438540, DOI 10.1101/2021.04.06.438540]; Lee S, 2020, EMERG MICROBES INFEC, V9, P2169, DOI 10.1080/22221751.2020.1827985; Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214; Pearson C. A. B., ESTIMATES SEVERITY T, DOI DOI 10.1038/s41423-021-00641-8; Pizzorno A, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100059; Sheahan TP, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb5883; Touret F, 2021, ANTIVIR RES, V193, DOI 10.1016/j.antiviral.2021.105137; Touret F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70143-6; Shi Pei-Yong, 2021, Res Sq, DOI [10.1101/2021.01.07.425740, 10.21203/rs.3.rs-143532/v1]; Xu JM, 2020, ACS INFECT DIS, V6, P909, DOI 10.1021/acsinfecdis.0c00052	27	8	8	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260958	10.1371/journal.pone.0260958	http://dx.doi.org/10.1371/journal.pone.0260958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855904	Green Published, gold			2022-12-26	WOS:000735299000156
J	Zhang, YJ; Zhang, YX; Ai, B; Gong, JJ; Li, YC; Yu, SY; Cai, XY; Zhang, L				Zhang, Yujie; Zhang, Yuxin; Ai, Bo; Gong, Juejun; Li, Yichen; Yu, Shiying; Cai, Xiuyu; Zhang, Li			GTF2E2 is a novel biomarker for recurrence after surgery and promotes progression of esophageal squamous cell carcinoma via miR-139-5p/GTF2E2/FUS axis	ONCOGENE			English	Article							TRANSCRIPTION; EXPRESSION; TFIIE; MUTATIONS; MICRORNAS; COMPLEX	Esophageal squamous cell carcinoma (ESCC) is one of the most lethal gastrointestinal malignancies with high mortality. Recurrence develops within only a few years after curative resection and perioperative adjuvant therapy in 30-50% of these patients. Therefore, it is essential to identify postoperative recurrence biomarkers to facilitate selecting the following surveillance and therapeutic strategies. The general transcription factor IIE subunit beta (GTF2E2) is crucial for physiological and pathological functions, but its roles in the aggression and recurrence of ESCC remain ambiguous. In this study, we found that GTF2E2 was highly expressed in ESCC samples, and elevated GTF2E2 expression predicted early recurrence after surgery for ESCC patients. High expression of GTF2E2 associated with more aggressive clinic features and poor prognosis. GTF2E2 promoted the proliferation and mobility of ESCC cells in vitro and in vivo. We further revealed that miR-139-5p repressed GTF2E2 expression by downregulating its mRNA through binding with Argonaute 2 (Ago2). Rescue assays suggested that miR-139-5p affected GTF2E2-mediated ESCC progression. Moreover, GTF2E2 positively interacted with FUS promoter and regulated FUS expression, and the phenotype changes caused by GTF2E2 manipulation were recovered by rescuing FUS expression in ESCC cells. Additionally, we demonstrated that GTF2E2 promotes ESCC cells progression via activation of the AKT/ERK/mTOR pathway. In conclusion, GTF2E2 may serve as a novel biomarker for recurrence after surgery and a potential therapeutic target for ESCC patients, and it promotes ESCC progression via miR-139-5p/GTF2E2/FUS axis.	[Zhang, Yujie; Gong, Juejun; Li, Yichen; Yu, Shiying; Zhang, Li] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Zhang, Yuxin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Ai, Bo] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Thorac Surg Ctr, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Cai, Xiuyu] Sun Yet Sen Univ, Collaborat Innovat Ctr Canc Med, Dept VIP Inpatient, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; State Key Lab Oncology South China; Sun Yat Sen University	Yu, SY; Zhang, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.; Cai, XY (corresponding author), Sun Yet Sen Univ, Collaborat Innovat Ctr Canc Med, Dept VIP Inpatient, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China.	syyu_qh@163.com; caixy_84@outlook.com; luzigang@163.com	yuxin, Zhang/GNH-2283-2022	zhang, yujie/0000-0002-9109-3171; Cai, Xiuyu/0000-0002-5251-9272	National Science Foundation of China [81572934, 82172825]; Chinese Society of Clinical Oncology Foundation [Y-BMS2019070]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Society of Clinical Oncology Foundation	This work was supported by the National Science Foundation of China (No. 81572934, 82172825) and Chinese Society of Clinical Oncology Foundation (No. Y-BMS2019070).	Baiu Ioana, 2020, JAMA, V324, P1580, DOI 10.1001/jama.2020.2101; Bakir B, 2020, TRENDS CELL BIOL, V30, P764, DOI 10.1016/j.tcb.2020.07.003; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi GS, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-01878-z; Borggreve AS, 2018, ANN NY ACAD SCI, V1434, P192, DOI 10.1111/nyas.13677; Compe E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10131-1; Davies AR, 2014, J SURG ONCOL, V109, P459, DOI 10.1002/jso.23511; Dhar SK, 2014, ANTIOXID REDOX SIGN, V20, P1550, DOI 10.1089/ars.2012.4984; Ding ZY, 2014, HEPATOLOGY, V60, P1620, DOI 10.1002/hep.27273; Du F, 2020, THERANOSTICS, V10, P7335, DOI 10.7150/thno.45971; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Dziuba N, 2012, AIDS RES HUM RETROV, V28, P1329, DOI 10.1089/aid.2011.0358; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Feng Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2028-9; Gao L, 2019, CELL DEATH DIS, V10, DOI [10.1038/s41419-019-1971, 10.1038/s41419-019-1971-9]; Hamai Y, 2018, WORLD J SURG, V42, P2190, DOI 10.1007/s00268-017-4430-8; Hua SN, 2018, ONCOGENE, V37, P1624, DOI 10.1038/s41388-017-0057-3; Jiao WP, 2019, DIGEST LIVER DIS, V51, P149, DOI 10.1016/j.dld.2018.07.017; Kakeji Y, 2021, ESOPHAGUS-TOKYO, V18, P25, DOI 10.1007/s10388-020-00782-1; Kuschal C, 2016, AM J HUM GENET, V98, P627, DOI 10.1016/j.ajhg.2016.02.008; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Liu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077068; Liu SX, 2021, J CELL PHYSIOL, V236, P79, DOI 10.1002/jcp.29481; LoRusso PM, 2016, J CLIN ONCOL, V34, P3803, DOI 10.1200/JCO.2014.59.0018; Lu TX, 2018, J ALLERGY CLIN IMMUN, V141, P1202, DOI 10.1016/j.jaci.2017.08.034; Mariette C, 2003, CANCER-AM CANCER SOC, V97, P1616, DOI 10.1002/cncr.11228; Miwa K, 2016, J MOL BIOL, V428, P4258, DOI 10.1016/j.jmb.2016.09.008; Montero-Conde C, 2020, INT J CANCER, V146, P521, DOI 10.1002/ijc.32622; Ni WJ, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6622-0; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Roskoski R, 2019, PHARMACOL RES, V142, P151, DOI 10.1016/j.phrs.2019.01.039; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Tang S, 2021, CANCER IMAGING, V21, DOI 10.1186/s40644-021-00407-5; Thei AF, 2019, AM J HUM GENET, V105, P434, DOI 10.1016/j.ajhg.2019.06.017; Theil AF, 2017, HUM MOL GENET, V26, P4689, DOI 10.1093/hmg/ddx351; Wang ZJ, 2020, J ONCOL, V2020, DOI 10.1155/2020/8813800; Wei WQ, 2020, LANCET ONCOL, V21, pE342, DOI 10.1016/S1470-2045(20)30073-5; Wen J, 2021, ANN SURG, V273, P523, DOI 10.1097/SLA.0000000000003369; Wu Q, 2020, CANCER BIOL THER, V21, P17, DOI 10.1080/15384047.2019.1647050; Yang H, 2018, J CLIN ONCOL, V36, P2796, DOI 10.1200/JCO.2018.79.1483; Yang LW, 2020, WORLD NEUROSURG, V138, pE492, DOI 10.1016/j.wneu.2020.02.159; Yang M, 2013, ONCOL REP, V29, P169, DOI 10.3892/or.2012.2105; Yang S, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00981-4; Yang YM, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00323-3; Zhu ZJ, 2011, ANN THORAC SURG, V91, P1502, DOI 10.1016/j.athoracsur.2011.01.007	46	0	0	1	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2022	41	6					782	796		10.1038/s41388-021-02122-8	http://dx.doi.org/10.1038/s41388-021-02122-8		DEC 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YT5VS	34853466	hybrid, Green Published			2022-12-26	WOS:000724661100001
J	Cai, D; Brickey, WJ; Ting, JP; Sad, S				Cai, David; Brickey, Willie June; Ting, Jenny P.; Sad, Subash			Isolates of Salmonella typhimurium circumvent NLRP3 inflammasome recognition in macrophages during the chronic phase of infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; T-CELL RESPONSE; III SECRETION; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR PROLIFERATION; PSEUDOMONAS-AERUGINOSA; PATHOGENICITY ISLAND; CYSTIC-FIBROSIS; HOST-DEFENSE; IFN-GAMMA	Inflammasome signaling results in cell death and release of cytokines from the IL-1 family, which facilitates control over an infection. However, some pathogens such as Salmonella typhimurium (ST) activate various innate immune signaling pathways, including inflammasomes, yet evade these cell death mechanisms, resulting in a chronic infection. Here we investigated inflammasome signaling induced by acute and chronic isolates of ST obtained from different organs. We show that ST isolated from infected mice during the acute phase displays an increased potential to activate inflammasome signaling, which then undergoes a protracted decline during the chronic phase of infection. This decline in inflammasome signaling was associated with reduced expression of virulence factors, including flagella and the Salmonella pathogenicity island I genes. This reduction in cell death of macrophages induced by chronic isolates had the greatest impact on the NLRP3 inflammasome, which correlated with a reduction in caspase-1 activation. Furthermore, rapid cell death induced by Casp-1/11 by ST in macrophages limited the subsequent activation of cell death cascade proteins Casp-8, RipK1, RipK3, and MLKL to prevent the activation of alternative forms of cell death. We observed that the lack of the ability to induce cell death conferred a competitive fitness advantage to ST only during the acute phase of infection. Finally, we show that the chronic isolates displayed a significant attenuation in their ability to infect mice through the oral route. These results reveal that ST adapts during chronic infection by circumventing inflammasome recognition to promote the survival of both the host and the pathogen.	[Cai, David; Sad, Subash] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Brickey, Willie June; Ting, Jenny P.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Sad, Subash] Univ Ottawa, Ctr Infect Immun & Inflammat CI3, Ottawa, ON, Canada	University of Ottawa; University of North Carolina; University of North Carolina Chapel Hill; University of Ottawa	Sad, S (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Sad, S (corresponding author), Univ Ottawa, Ctr Infect Immun & Inflammat CI3, Ottawa, ON, Canada.	Subash.sad@uottawa.ca		Brickey, Willie June/0000-0002-6503-539X; Cai, David/0000-0002-6867-1682	University of Ottawa Centre for Infection, Immunity, and Inflammation (CI3)	University of Ottawa Centre for Infection, Immunity, and Inflammation (CI3)	D. C. was supported by a scholarship from the University of Ottawa Centre for Infection, Immunity, and Inflammation (CI3).	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Apel D, 2008, BBA-BIOMEMBRANES, V1778, P1851, DOI 10.1016/j.bbamem.2007.07.005; Arpaia N, 2011, CELL, V144, P675, DOI 10.1016/j.cell.2011.01.031; Baishya J, 2019, NPJ BIOFILMS MICROBI, V5, DOI 10.1038/s41522-019-0089-2; Bergeron JR, 2016, PEERJ, V4, DOI 10.7717/peerj.1718; Bierschenk D, 2019, J LEUKOCYTE BIOL, V105, P401, DOI 10.1002/JLB.MA0318-112RR; BLISKA JB, 1993, CELL, V73, P903, DOI 10.1016/0092-8674(93)90270-Z; Brown DE, 2013, VET PATHOL, V50, P867, DOI 10.1177/0300985813478213; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Caruso AM, 1999, J IMMUNOL, V162, P5407; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Cummings LA, 2006, MOL MICROBIOL, V61, P795, DOI 10.1111/j.1365-2958.2006.05271.x; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Deretic V, 1999, MOL MICROBIOL, V31, P1603, DOI 10.1046/j.1365-2958.1999.01279.x; Diepold A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0020; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Doerflinger M, 2020, IMMUNITY, V53, P533, DOI 10.1016/j.immuni.2020.07.004; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fernandez-Moreira E, 2006, INFECT IMMUN, V74, P3285, DOI 10.1128/IAI.01382-05; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gong T, 2018, TRENDS IMMUNOL, V39, P393, DOI 10.1016/j.it.2018.01.009; Gonzalez-Escobedo G, 2013, INFECT IMMUN, V81, P2920, DOI 10.1128/IAI.00258-13; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Gram AM, 2021, J IMMUNOL, V206, P631, DOI 10.4049/jimmunol.2000382; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; Gunn JS, 2014, TRENDS MICROBIOL, V22, P648, DOI 10.1016/j.tim.2014.06.007; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hausmann A, 2020, MUCOSAL IMMUNOL, V13, P530, DOI 10.1038/s41385-019-0247-0; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Huus KE, 2016, J IMMUNOL, V196, P3097, DOI 10.4049/jimmunol.1501642; Jain M, 2008, TRANSL RES, V152, P257, DOI 10.1016/j.trsl.2008.10.003; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lindgren SW, 1996, P NATL ACAD SCI USA, V93, P4197, DOI 10.1073/pnas.93.9.4197; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Luu RA, 2006, J IMMUNOL, V177, P1516, DOI 10.4049/jimmunol.177.3.1516; Macnab RM, 2004, BBA-MOL CELL RES, V1694, P207, DOI 10.1016/j.bbamcr.2004.04.005; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; McComb S, 2014, P NATL ACAD SCI USA, V111, pE3206, DOI 10.1073/pnas.1407068111; Medzhitov R, 2000, SEMIN IMMUNOL, V12, P185, DOI 10.1006/smim.2000.0230; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Morimoto YV, 2014, MOL MICROBIOL, V91, P1214, DOI 10.1111/mmi.12529; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nguyen T, 2013, PLACENTA, V34, P765, DOI 10.1016/j.placenta.2013.06.003; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Patel R, 2016, IMMUNOL CELL BIOL, V94, P378, DOI 10.1038/icb.2015.98; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qu Y, 2016, J EXP MED, V213, P877, DOI 10.1084/jem.20132234; Rappuoli R, 2011, NATURE, V473, P463, DOI 10.1038/nature10124; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Rogerson BJ, 2006, IMMUNOLOGY, V118, P195, DOI 10.1111/j.1365-2567.2006.02355.x; Roy MF, 2006, GENES IMMUN, V7, P655, DOI 10.1038/sj.gene.6364344; Sadh S, 2020, J IMMUNOL METHODS, V481, DOI 10.1016/j.jim.2020.112788; SAGE Working Group on Typhoid Vaccines WHO Secretariat, 2017, BACKGR PAP SAGE TYPH; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Shutinoski B, 2016, CELL DEATH DIFFER, V23, P1628, DOI 10.1038/cdd.2016.51; Shutinoski B, 2020, MICROBES INFECT, V22, P40, DOI 10.1016/j.micinf.2019.08.002; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Srikanth CV, 2007, IMMUNOL RES, V37, P61, DOI 10.1007/BF02686090; Srinivasan A, 2004, J IMMUNOL, V173, P4091, DOI 10.4049/jimmunol.173.6.4091; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Storek KM, 2015, IMMUNOL REV, V265, P112, DOI 10.1111/imr.12289; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Tzelepis F, 2012, CELL REP, V2, P1710, DOI 10.1016/j.celrep.2012.10.024; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; van Faassen H, 2004, J IMMUNOL, V172, P3491, DOI 10.4049/jimmunol.172.6.3491; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Wain J, 2002, LANCET INFECT DIS, V2, P163, DOI 10.1016/S1473-3099(02)00225-6; Zhao YH, 2011, FEMS IMMUNOL MED MIC, V61, P76, DOI 10.1111/j.1574-695X.2010.00750.x; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7	94	0	0	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101461	10.1016/j.jbc.2021.101461	http://dx.doi.org/10.1016/j.jbc.2021.101461			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP0ZE	34864057	Green Published, gold			2022-12-26	WOS:000748357700007
J	Wagner, BM; Robinson, JW; Healy, CL; Gauthier, M; Dickey, DM; Yee, SP; Osborn, JW; O'Connell, TD; Potter, LR				Wagner, Brandon M.; Robinson, Jerid W.; Healy, Chastity L.; Gauthier, Madeline; Dickey, Deborah M.; Yee, Siu-Pok; Osborn, John W.; O'Connell, Timothy D.; Potter, Lincoln R.			Guanylyl cyclase-A phosphorylation decreases cardiac hypertrophy and improves systolic function in male, but not female, mice	FASEB JOURNAL			English	Article						cardiac hypertrophy; extracellular-regulated kinase; guanylyl cyclase; hypertension; natriuretic peptide	NATRIURETIC-PEPTIDE RECEPTOR; ACTIVATED PROTEIN-KINASE; CARDIOMYOCYTE HYPERTROPHY; HOMOLOGY DOMAIN; OOCYTE MEIOSIS; BLOOD-PRESSURE; CGMP; DEPHOSPHORYLATION; LACKING; HYPERTENSION	Atrial natriuretic peptide (NP) and BNP increase cGMP, which reduces blood pressure and cardiac hypertrophy by activating guanylyl cyclase (GC)-A, also known as NPR-A or Npr1. Although GC-A is highly phosphorylated, and dephosphorylation inactivates the enzyme, the significance of GC-A phosphorylation to heart structure and function remains unknown. To identify in vivo processes that are regulated by GC-A phosphorylation, we substituted glutamates for known phosphorylation sites to make GC-A(8E/8E) mice that express an enzyme that cannot be inactivated by dephosphorylation. GC-A activity, but not protein, was increased in heart and kidney membranes from GC-A(8E/8E) mice. Activities were threefold higher in female compared to male cardiac ventricles. Plasma cGMP and testosterone were elevated in male and female GC-A(8E/8E) mice, but aldosterone was only increased in mutant male mice. Plasma and urinary creatinine concentrations were decreased and increased, respectively, but blood pressure and heart rate were unchanged in male GC-A(8E/8E) mice. Heart weight to body weight ratios for GC-A(8E/8E) male, but not female, mice were 12% lower with a 14% reduction in cardiomyocyte cross-sectional area. Subcutaneous injection of fsANP, a long-lived ANP analog, increased plasma cGMP and decreased aldosterone in male GC-A(WT/WT) and GC-A(8E/8E) mice at 15 min, but only GC-A(8E/8E) mice had elevated levels of plasma cGMP and aldosterone at 60 min. fsANP reduced ventricular ERK1/2 phosphorylation to a greater extent and for a longer time in the male mutant compared to WT mice. Finally, ejection fractions were increased in male but not female hearts from GC-A(8E/8E) mice. We conclude that increased phosphorylation-dependent GC-A activity decreases cardiac ERK activity, which results in smaller male hearts with improved systolic function.	[Wagner, Brandon M.; Healy, Chastity L.; Gauthier, Madeline; O'Connell, Timothy D.; Potter, Lincoln R.] Univ Minnesota, Med Sch, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Robinson, Jerid W.; Dickey, Deborah M.; Potter, Lincoln R.] Univ Minnesota, Med Sch, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Yee, Siu-Pok] Univ Connecticut, Dept Cell Biol, Hlth Ctr, Farmington, CT USA; [Osborn, John W.] Univ Minnesota, Med Sch, Dept Surg, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Connecticut; University of Minnesota System; University of Minnesota Twin Cities	O'Connell, TD; Potter, LR (corresponding author), Univ Minnesota, Med Sch, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.; Potter, LR (corresponding author), Univ Minnesota, Med Sch, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	tdoconne@umn.edu; potter@umn.edu		Wagner, Brandon/0000-0001-9162-3032	National Institutes of Health [R01GM098309]; University of Minnesota Foundation Bridge Grant; University of Minnesota-Mayo Clinic Partnership Grant; University of Minnesota Academic Health Center Faculty Research and Development Grant; Fund for Science and the Hormone Receptor Lund; NIH [R01tIL130099, R0111L152215];  [NIHT32DK007203]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Foundation Bridge Grant; University of Minnesota-Mayo Clinic Partnership Grant; University of Minnesota Academic Health Center Faculty Research and Development Grant; Fund for Science and the Hormone Receptor Lund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This work was supported by the National Institutes of Health Grant R01GM098309, a University of Minnesota Foundation Bridge Grant, a University of Minnesota-Mayo Clinic Partnership Grant, a University of Minnesota Academic Health Center Faculty Research and Development Grant, and Grants from the Fund for Science and the Hormone Receptor Lund to LRP. NIHT32DK007203 Grant supported JWR. NIH R01tIL130099 and NIH R0111L152215 to TDO also funded portions of this work	Abbey SE, 2002, J BIOL CHEM, V277, P42423, DOI 10.1074/jbc.M206686200; Asirvatham-Jeyaraj N, 2021, HYPERTENSION, V77, P519, DOI 10.1161/HYPERTENSIONAHA.119.14069; Babiker FA, 2004, CIRCULATION, V109, P269, DOI 10.1161/01.CIR.0000105682.85732.BD; Bereta G, 2010, J BIOL CHEM, V285, P1899, DOI 10.1074/jbc.M109.061713; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Chen Y, 2020, AM J PHYSIOL-REG I, V318, pR669, DOI 10.1152/ajpregu.00354.2019; Chen Y, 2020, CARDIOVASC DRUG THER, V34, P3, DOI 10.1007/s10557-020-06936-8; Coue M, 2015, DIABETES, V64, P4033, DOI 10.2337/db15-0305; Dickey DM, 2009, J BIOL CHEM, V284, P19196, DOI 10.1074/jbc.M109.010777; DOMINO SE, 1991, METHOD ENZYMOL, V195, P345; Edmund AB, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau5378; Egbert JR, 2014, DEVELOPMENT, V141, P3594, DOI 10.1242/dev.112219; HANEDA M, 1991, KIDNEY INT, V40, P188, DOI 10.1038/ki.1991.199; Hayashi D, 2004, BIOCHEM BIOPH RES CO, V322, P310, DOI 10.1016/j.bbrc.2004.07.119; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Hofmann F, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0690-1; Holtwick R, 2003, J CLIN INVEST, V111, P1399, DOI 10.1172/JCI200317061; HORI R, 1985, BIOCHEM BIOPH RES CO, V129, P773, DOI 10.1016/0006-291X(85)91959-X; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Jaffe LA, 2017, ANNU REV PHYSIOL, V79, P237, DOI 10.1146/annurev-physiol-022516-034102; John SWM, 1996, AM J PHYSIOL-REG I, V271, pR109, DOI 10.1152/ajpregu.1996.271.1.R109; Joubert S, 2001, BIOCHEMISTRY-US, V40, P11096, DOI 10.1021/bi010580s; Kehat I, 2010, ANN NY ACAD SCI, V1188, P96, DOI 10.1111/j.1749-6632.2009.05088.x; Keppler A, 2007, KIDNEY INT, V71, P74, DOI 10.1038/sj.ki.5001988; Kishimoto I, 2001, P NATL ACAD SCI USA, V98, P2703, DOI 10.1073/pnas.051625598; Kishimoto I, 1996, P NATL ACAD SCI USA, V93, P6215, DOI 10.1073/pnas.93.12.6215; Knowles JW, 2001, J CLIN INVEST, V107, P975, DOI 10.1172/JCI11273; KOLLER KJ, 1993, J BIOL CHEM, V268, P5997; Kuhn M, 2016, PHYSIOL REV, V96, P751, DOI 10.1152/physrev.00022.2015; Lee DI, 2015, NATURE, V519, P472, DOI 10.1038/nature14332; Li YH, 2004, ENDOCRINOLOGY, V145, P951, DOI 10.1210/en.2003-0816; Li YH, 2002, CIRCULATION, V106, P1722, DOI 10.1161/01.CIR.0000029923.57048.61; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Lopez MJ, 1997, J BIOL CHEM, V272, P23064, DOI 10.1074/jbc.272.37.23064; LOPEZ MJ, 1995, NATURE, V378, P65, DOI 10.1038/378065a0; Lukowski R, 2010, P NATL ACAD SCI USA, V107, P5646, DOI 10.1073/pnas.1001360107; MARINGREZ M, 1986, NATURE, V324, P473, DOI 10.1038/324473a0; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Miyashita K, 2009, DIABETES, V58, P2880, DOI 10.2337/db09-0393; Nakamura M, 2018, NAT REV CARDIOL, V15, P387, DOI 10.1038/s41569-018-0007-y; NUSHIRO N, 1987, TOHOKU J EXP MED, V152, P301, DOI 10.1620/tjem.152.301; O'Connell TD, 2006, J CLIN INVEST, V116, P1005, DOI 10.1172/JCI22811; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Oliver PM, 1998, P NATL ACAD SCI USA, V95, P2547, DOI 10.1073/pnas.95.5.2547; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Otani K, 2020, CIRCULATION, V141, P571, DOI 10.1161/CIRCULATIONAHA.119.039761; Otto NM, 2017, MOL PHARMACOL, V92, P67, DOI 10.1124/mol.116.107995; Pandey KN, 1999, ENDOCRINOLOGY, V140, P5112, DOI 10.1210/en.140.11.5112; Pandey KN, 2000, BIOCHEM BIOPH RES CO, V271, P374, DOI 10.1006/bbrc.2000.2627; Patrucco E, 2014, P NATL ACAD SCI USA, V111, P12925, DOI 10.1073/pnas.1414364111; Pichlo M, 2014, J CELL BIOL, V206, P541, DOI 10.1083/jcb.201402027; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Potter LR, 1998, J BIOL CHEM, V273, P15533, DOI 10.1074/jbc.273.25.15533; POTTER LR, 1992, J BIOL CHEM, V267, P14531; Potter LR, 1998, BIOCHEMISTRY-US, V37, P2422, DOI 10.1021/bi972303k; POTTER LR, 1994, J BIOL CHEM, V269, P14636; Potter LR, 1999, MOL BIOL CELL, V10, P1811, DOI 10.1091/mbc.10.6.1811; Potter LR, 1998, MOL CELL BIOL, V18, P2164, DOI 10.1128/MCB.18.4.2164; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Robinson JW, 2020, BONE, V135, DOI 10.1016/j.bone.2020.115320; Robinson JW, 2017, CELL SIGNAL, V40, P222, DOI 10.1016/j.cellsig.2017.09.021; Robinson JW, 2012, DEV BIOL, V366, P308, DOI 10.1016/j.ydbio.2012.04.019; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Schewe J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13033-4; Schroter J, 2010, FEBS J, V277, P2440, DOI 10.1111/j.1742-4658.2010.07658.x; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; Scott NJA, 2009, BBA-MOL BASIS DIS, V1792, P1175, DOI 10.1016/j.bbadis.2009.09.009; Shuhaibar LC, 2017, ELIFE, V6, DOI 10.7554/eLife.31343; Shuhaibar LC, 2016, DEV BIOL, V409, P194, DOI 10.1016/j.ydbio.2015.10.025; Shuhaibar LC, 2015, P NATL ACAD SCI USA, V112, P5527, DOI 10.1073/pnas.1423598112; Silberbach M, 1999, J BIOL CHEM, V274, P24858, DOI 10.1074/jbc.274.35.24858; SMITH JB, 1987, AM J PHYSIOL, V253, pC147, DOI 10.1152/ajpcell.1987.253.1.C147; Suda M, 1998, P NATL ACAD SCI USA, V95, P2337, DOI 10.1073/pnas.95.5.2337; SUGIMOTO T, 1993, BIOCHEM BIOPH RES CO, V195, P72, DOI 10.1006/bbrc.1993.2011; Suhasini M, 1998, MOL CELL BIOL, V18, P6983, DOI 10.1128/MCB.18.12.6983; Tamura N, 2000, P NATL ACAD SCI USA, V97, P4239, DOI 10.1073/pnas.070371497; Tsai EJ, 2009, PHARMACOL THERAPEUT, V122, P216, DOI 10.1016/j.pharmthera.2009.02.009; Ueyama T, 2000, J MOL CELL CARDIOL, V32, P947, DOI 10.1006/jmcc.2000.1135; van Eickels M, 2001, CIRCULATION, V104, P1419, DOI 10.1161/hc3601.095577; Vellaichamy E, 2014, ENDOCRINOLOGY, V155, P1045, DOI 10.1210/en.2013-1416; Wagner BM, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.147832; Yan ZP, 2021, CARDIOL J, V28, P473, DOI 10.5603/CJ.a2020.0061; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yoder AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036747; Yoder AR, 2010, BIOCHEMISTRY-US, V49, P10137, DOI 10.1021/bi101700e	85	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22069	10.1096/fj.202100600RRR	http://dx.doi.org/10.1096/fj.202100600RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34859913				2022-12-26	WOS:000734992000049
J	Banerjee, S; Kumar, P; Srivastava, S; Banerjee, A				Banerjee, Snigdha; Kumar, Pradeep; Srivastava, Shobhit; Banerjee, Adrita			Association of anthropometric measures of obesity and physical activity with cardiovascular diseases among older adults: Evidence from a cross-sectional survey, 2017-18	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; RISK-FACTORS; PROSPECTIVE COHORT; GLOBAL BURDEN; INDIA; MORTALITY; HEALTH; MEN; PREVENTION	Background With the increase in elderly population, the risk of cardiovascular diseases (CVD) among Indian older adults is also increasing. The present paper tries to assess how different anthropometric measures of obesity and physical activity affects cardiovascular disease risk among older adults in India. Methods The data from Longitudinal Ageing Study in India (LASI) has been used. The total sample size for the present study is 31,464 older adults aged 60 years and above. Chi-square test and binary logistic regression has been used to measure the association of obesity measures and CVD prevalence. Results About 35.2% (n = 11,058) of the older adults suffered from CVD. Moreover, 22.2% (n = 6,217) of the older adults were obese/overweight, 23.7% (n = 6,651) had high risk waist circumference and 77.0% (n = 21,593) had high risk waist-Hip ratio. The likelihood of CVD was 60%, 50%, and 34% significantly higher among older adults who were obese/overweight [Adjusted odds ratio (AOR): 1.60; CI: 1.48-1.72], had high risk waist circumference [AOR: 1.50; CI: 1.39-1.62] and high risk waist-Hip ratio [AOR: 1.34; CI: 1.25-1.44], respectively compared to older adults with normal BMI and those who do not have a high risk waist circumference and high risk waist hip ratio. Moreover, older adults who never did physical activity had 22 per cent higher risk of CVD than those who did frequent [AOR: 1.22; CI: 1.13-1.32] physical activity. Conclusion The burden of overweight and obesity along with physical inactivity increases the risk of CVD in older adults. These findings highlight the urgent need for framing direct and indirect strategies to control obesity in order to reduce the burden of CVD among older adults in India.	[Banerjee, Snigdha; Banerjee, Adrita] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Kumar, Pradeep] India Habitat Ctr, Populat Council, India Country Off, New Delhi, India; [Srivastava, Shobhit] MAMTA Hlth Inst Mother & Child, Res & Innovat, New Delhi, India	International Institute for Population Sciences	Banerjee, A (corresponding author), Int Inst Populat Sci, Mumbai, Maharashtra, India.	adrita.banerjee@yahoo.co.in	Kumar, Pradeep/AAN-9128-2021; Srivastava, Shobhit/AAI-1811-2021; Kumar, Pradeep/GQV-5790-2022	Kumar, Pradeep/0000-0003-4259-820X; Srivastava, Shobhit/0000-0002-7138-4916; 				Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Arokiasamy P, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015571640; Basu S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001480; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Boateng GO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186947; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Canoy D, 2007, CIRCULATION, V116, P2933, DOI 10.1161/CIRCULATIONAHA.106.673756; Celermajer DS, 2012, J AM COLL CARDIOL, V60, P1207, DOI 10.1016/j.jacc.2012.03.074; Chauhan S., INT J SCI RES PUBL, V3; Chauhan S, 2021, J SUBST USE, V26, P524, DOI 10.1080/14659891.2020.1851411; Chomistek AK, 2015, J AM COLL CARDIOL, V65, P43, DOI 10.1016/j.jacc.2014.10.024; Eckel RH, 2004, CIRCULATION, V110, P2968, DOI 10.1161/01.CIR.0000140086.88453.9A; Erlichman J, 2002, Obes Rev, V3, P257, DOI 10.1046/j.1467-789X.2002.00077.x; Fan HM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21521; Fauziana R, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0297-z; Ferri CP, 2011, J NEUROL NEUROSUR PS, V82, P1074, DOI 10.1136/jnnp.2010.234153; Gaziano TA, 2005, CIRCULATION, V112, P3547, DOI 10.1161/CIRCULATIONAHA.105.591792; Gelber RP, 2008, J AM COLL CARDIOL, V52, P605, DOI 10.1016/j.jacc.2008.03.066; Ghosh A, 2003, ASIA PAC J CLIN NUTR, V12, P166; Goran MI, 2003, J CLIN ENDOCR METAB, V88, P1417, DOI 10.1210/jc.2002-021442; Guasch-Ferre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043275; Hu G, 2005, INT J OBESITY, V29, P894, DOI 10.1038/sj.ijo.0802870; International Institute for Population Sciences (IIPS) and NPHCE MoHFW, 2020, LONG AG STUD IND LAS; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Juonala M., NEW ENGL J MED; Kastor A, 2016, AGEING INT, V41, P178, DOI 10.1007/s12126-016-9241-y; King J.E., 2008, OSBORNE J BEST PRACT, V25, P358, DOI DOI 10.4135/9781412995627.D29; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Litwin SE, 2008, J AM COLL CARDIOL, V52, P616, DOI 10.1016/j.jacc.2008.05.017; Mchugh ML, BIOCHEM MEDICA; McKenna SP, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-86; Michalakis K, 2013, METABOLISM, V62, P1341, DOI 10.1016/j.metabol.2013.05.019; Muhammad T, 2021, BMC GERIATR, V21, DOI 10.1186/s12877-021-02027-x; Nguyen HN, 2013, CIRC J, V77, P2851, DOI 10.1253/circj.CJ-13-1292; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Pandey RM, 2013, INT J CARDIOL, V163, P157, DOI 10.1016/j.ijcard.2011.06.008; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; Prabhakaran D, 2018, J AM COLL CARDIOL, V72, P79, DOI 10.1016/j.jacc.2018.04.042; Prabhakaran D, 2016, CIRCULATION, V133, P1605, DOI 10.1161/CIRCULATIONAHA.114.008729; Rastogi T, 2004, INT J EPIDEMIOL, V33, P759, DOI 10.1093/ije/dyh042; Reddy KS, 1998, CIRCULATION, V97, P596; Ruan Y, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5653-9; Schooling CM, 2006, ARCH INTERN MED, V166, P1498, DOI 10.1001/archinte.166.14.1498; Selvamani Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193979; Shah B, 2010, INDIAN J MED RES, V132, P634; Srivastava S, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10601-6; Srivastava S, 2021, AGEING INT, V46, P200, DOI 10.1007/s12126-020-09382-x; Srivastava S, 2020, SSM-POPUL HLTH, V10, DOI 10.1016/j.ssmph.2020.100557; StataCorp, 2015, STAT STAT SOFTW REL; Tharkar S, 2010, HEART ASIA, V2, P145, DOI 10.1136/ha.2009.000950; Troutman-Jordan M, 2020, GERIATR NURS, V41, P846, DOI 10.1016/j.gerinurse.2020.05.010; WHO, WHO TECHN REP SER; Wildman RP, 2003, HYPERTENSION, V42, P468, DOI 10.1161/01.HYP.0000090360.78539.CD; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; World Health Organization, 2007, PREV CARD DIS GUID A; World Health Organization, 2011, GLOBAL ATLAS CARDIOV; Yadav S, 2014, GLOBAL HEALTH ACTION, V7, P84, DOI 10.3402/gha.v7.23248; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zacharias A, 2011, WORLD DEV, V39, P1820, DOI 10.1016/j.worlddev.2011.04.026; Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005; Zhang J, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-036664; Zou ZY, 2020, CIRCULATION, V141, P790, DOI 10.1161/CIRCULATIONAHA.119.042864	63	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0260148	10.1371/journal.pone.0260148	http://dx.doi.org/10.1371/journal.pone.0260148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY5KW	34910748	gold, Green Published			2022-12-26	WOS:000754828900012
J	Brown, JW; Das, KK; Kalas, V; Das, KM; Mills, JC				Brown, Jeffrey W.; Das, Koushik K.; Kalas, Vasilios; Das, Kiron M.; Mills, Jason C.			mAb Das-1 recognizes 3'-Sulfated Lewis A/C, which is aberrantly expressed during metaplastic and oncogenic transformation of several gastrointestinal Epithelia	PLOS ONE			English	Article							NEUTROPHIL-ACTIVATING PROTEIN; METACHRONOUS GASTRIC-CANCER; BLOOD-GROUP LEWIS(A); HELICOBACTER-PYLORI; INTESTINAL METAPLASIA; MONOCLONAL-ANTIBODY; L-SELECTIN; SULFATED OLIGOSACCHARIDES; HUMAN-COLON; LIGAND	Introduction Multiple previous studies have shown the monoclonal antibody Das-1 (formerly called 7E(12)H(12)) is specifically reactive towards metaplastic and carcinomatous lesions in multiple organs of the gastrointestinal system (e.g. Barrett's esophagus, intestinal-type metaplasia of the stomach, gastric adenocarcinoma, high-grade pancreatic intraepithelial neoplasm, and pancreatic ductal adenocarcinoma) as well as in other organs (bladder and lung carcinomas). Beyond being a useful biomarker in tissue, mAb Das-1 has recently proven to be more accurate than current paradigms for identifying cysts harboring advanced neoplasia. Though this antibody has been used extensively for clinical, basic science, and translational applications for decades, its epitope has remained elusive. Methods In this study, we chemically deglycosylated a standard source of antigen, which resulted in near complete loss of the signal as measured by western blot analysis. The epitope recognized by mAb Das-1 was determined by affinity to a comprehensive glycan array and validated by inhibition of a direct ELISA. Results The epitope recognized by mAb Das-1 is 3'-Sulfo-Lewis A/C (3'-Sulfo-Le(A/C)). 3'-Sulfo-Le(A/C) is broadly reexpressed across numerous GI epithelia and elsewhere during metaplastic and carcinomatous transformation. Discussion 3'-Sulfo-Le(A/C) is a clinically important antigen that can be detected both intracellularly in tissue using immunohistochemistry and extracellularly in cyst fluid and serum by ELISA. The results open new avenues for tumorigenic risk stratification of various gastrointestinal lesions.	[Brown, Jeffrey W.; Das, Koushik K.; Mills, Jason C.] Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA; [Kalas, Vasilios] Washington Univ, Sch Med, St Louis, MO USA; [Kalas, Vasilios] Northwestern Univ, Phys Scientist Training Program, Dept Med, McGaw Med Ctr, Chicago, IL 60611 USA; [Das, Kiron M.] Rutgers Robert Wood Johnson Med Sch, Div Gastroenterol, New Brunswick, NJ USA; [Mills, Jason C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Mills, Jason C.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Mills, Jason C.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Washington University (WUSTL); Washington University (WUSTL); Northwestern University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Washington University (WUSTL); Washington University (WUSTL); Baylor College of Medicine	Brown, JW; Mills, JC (corresponding author), Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA.; Mills, JC (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Mills, JC (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.; Mills, JC (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	brownjw@wustl.edu; jason.mills@bcm.edu	Mills, Jason/AAA-6688-2021; Brown, Jeffrey Wade/ABA-7141-2021	Mills, Jason/0000-0002-0402-4662; Brown, Jeffrey Wade/0000-0002-3992-9613	Department of Defense, through the PRCRP program [W81XWH-20-1-0630]; NIH [T32 DK007130-42]; Digestive Disease Research Core Centers Pilot and Feasibility Grant [P30 DK052574]; American Gastroenterological Association [AGA2021-5101]; National Institute of Diabetes and Digestive and Kidney Diseases [R21 AI156236, R21 DK111369, R01 DK094989, R01 DK105129, R01 DK110406, P30 DK056338, R01 DK47673, R01 DK63618]; Doris Duke Charitable Foundation; Fund to Retain Clinical Scientists; Alvin J. Siteman Cancer Center-Barnes Jewish Foundation Cancer Frontier Fund; National Institutes of Health National Cancer Institute [P30 CA09182, R01 CA239645, R01 CA246208]; BETRNet [U54 CA163060]; Medical Scientist Training Program Training grant [T32 GM07200];  [R24 GM098791];  [R24 GM137763];  [P41 GM103694]	Department of Defense, through the PRCRP program(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Disease Research Core Centers Pilot and Feasibility Grant; American Gastroenterological Association; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Fund to Retain Clinical Scientists; Alvin J. Siteman Cancer Center-Barnes Jewish Foundation Cancer Frontier Fund; National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BETRNet; Medical Scientist Training Program Training grant; ; ; 	This study received support from the following sources: JWB is supported by the Department of Defense, through the PRCRP program under Award No. W81XWH-20-1-0630, NIH T32 DK007130-42, the Digestive Disease Research Core Centers Pilot and Feasibility Grant as part of P30 DK052574, the American Gastroenterological Association AGA2021-5101, the National Institute of Diabetes and Digestive and Kidney Diseases R21 AI156236, and the Doris Duke Charitable Foundation, Fund to Retain Clinical Scientists. JCM is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (R21 DK111369, R01 DK094989, R01 DK105129, R01 DK110406, P30 DK056338), the Alvin J. Siteman Cancer Center-Barnes Jewish Foundation Cancer Frontier Fund, The National Institutes of Health National Cancer Institute (P30 CA09182, R01 CA239645, R01 CA246208), and the BETRNet (U54 CA163060). The National Center for Functional Glycomics Glycan Array resource and much appreciated assistance with the analysis was supported by R24 GM098791, R24 GM137763, and P41 GM103694. VK was supported by the Medical Scientist Training Program Training grant T32 GM07200. Development of mAb Das-1 was supported in part by National Institute of Diabetes and Digestive and Kidney Diseases research grants R01 DK47673 and R01 DK63618, awarded to KMD.	Azuma N, 2000, J GASTROENTEROL, V35, P583, DOI 10.1007/s005350070057; Badve S, 2000, PATHOBIOLOGY, V68, P76, DOI 10.1159/000028117; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bloem K, 2014, IMMUNOL LETT, V158, P33, DOI 10.1016/j.imlet.2013.11.007; Bodger K, 2003, J CLIN PATHOL, V56, P703, DOI 10.1136/jcp.56.9.703; Brown JW, 2021, GASTROENTEROLOGY, V160, pS71; Brown JW, 2019, GASTROENTEROLOGY, V156, pS82; Capon C, 1997, J BIOL CHEM, V272, P31957, DOI 10.1074/jbc.272.51.31957; CORREA P, 1992, CANCER RES, V52, P6735; DAS KM, 1990, GASTROENTEROLOGY, V98, P464, DOI 10.1016/0016-5085(90)90839-S; DAS KM, 1994, ANN INTERN MED, V120, P753, DOI 10.7326/0003-4819-120-9-199405010-00006; Das KK, 2021, HUM PATHOL, V111, P36, DOI 10.1016/j.humpath.2021.01.003; Das KK, 2019, GASTROENTEROLOGY, V157, P720, DOI 10.1053/j.gastro.2019.05.014; Das KK, 2014, GUT, V63, P1627, DOI 10.1136/gutjnl-2013-306219; de Vries AC, 2008, GASTROENTEROLOGY, V134, P945, DOI 10.1053/j.gastro.2008.01.071; DeMeester SR, 2002, AM J GASTROENTEROL, V97, P2514; Deshpande CG, 2002, PATHOBIOLOGY, V70, P343, DOI 10.1159/000071274; EVANS DJ, 1995, INFECT IMMUN, V63, P2213, DOI 10.1128/IAI.63.6.2213-2220.1995; Feng XS, 2013, EXP THER MED, V5, P1555, DOI 10.3892/etm.2013.1038; FILIPE MI, 1985, GUT, V26, P1319, DOI 10.1136/gut.26.12.1319; Galustian C, 1997, BIOCHEMISTRY-US, V36, P5260, DOI 10.1021/bi962887a; Galustian C, 2002, IMMUNOLOGY, V105, P350, DOI 10.1046/j.1365-2567.2002.01369.x; Galustian C, 1999, J BIOL CHEM, V274, P18213, DOI 10.1074/jbc.274.26.18213; GERSTEN KM, 1995, J BIOL CHEM, V270, P25047, DOI 10.1074/jbc.270.42.25047; Goldenring JR, 2018, J PATHOL, V245, P132, DOI 10.1002/path.5066; Hahn HP, 2009, AM J SURG PATHOL, V33, P1006, DOI 10.1097/PAS.0b013e31819f57e9; HAKKINEN I, 1969, ANN SURG, V169, P277, DOI 10.1097/00000658-196902000-00016; Heidarian Amin, 2021, J Am Soc Cytopathol, V10, P249, DOI 10.1016/j.jasc.2021.01.002; Issa SMA, 2011, ELECTROPHORESIS, V32, P3554, DOI 10.1002/elps.201100374; JASS JR, 1979, HISTOPATHOLOGY, V3, P191, DOI 10.1111/j.1365-2559.1979.tb02996.x; Kawanaka M, 2016, BRIT J CANCER, V114, P21, DOI 10.1038/bjc.2015.418; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Loveless RW, 1998, GLYCOBIOLOGY, V8, P1237, DOI 10.1093/glycob/8.12.1237; McKitrick TR, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02199-7; Mirza ZK, 2003, GUT, V52, P807, DOI 10.1136/gut.52.6.807; Namavar F, 1998, INFECT IMMUN, V66, P444, DOI 10.1128/IAI.66.2.444-447.1998; O'Connell FP, 2005, ARCH PATHOL LAB MED, V129, P338; Onuma EK, 2001, AM J GASTROENTEROL, V96, P2480; Ota H, 1998, HUM PATHOL, V29, P846, DOI 10.1016/S0046-8177(98)90455-5; Pantuck AJ, 1998, BRIT J UROL, V82, P426; Pantuck AJ, 1997, J UROLOGY, V158, P1722, DOI 10.1016/S0022-5347(01)64109-0; Piazuelo MB, 2004, MODERN PATHOL, V17, P62, DOI 10.1038/modpathol.3800016; Saenz JB, 2019, GASTROENTEROLOGY, V156, P160, DOI 10.1053/j.gastro.2018.09.050; Saenz JB, 2018, NAT REV GASTRO HEPAT, V15, P257, DOI 10.1038/nrgastro.2018.5; Satin B, 2000, J EXP MED, V191, P1467, DOI 10.1084/jem.191.9.1467; Shah SC, 2020, GASTROENTEROLOGY, V158, P745, DOI 10.1053/j.gastro.2019.12.004; Tanaka-Okamoto M, 2017, GLYCOBIOLOGY, V27, P400, DOI 10.1093/glycob/cww133; Tang HY, 2016, CELL MOL GASTROENTER, V2, P210, DOI 10.1016/j.jcmgh.2015.12.003; Teal E, 2020, AM J PHYSIOL-CELL PH, V319, pC947, DOI 10.1152/ajpcell.00415.2019; Teneberg S, 1997, J BIOL CHEM, V272, P19067, DOI 10.1074/jbc.272.30.19067; Veerman ECI, 1997, GLYCOBIOLOGY, V7, P737, DOI 10.1093/glycob/7.6.737; Watari J, 2012, INT J CANCER, V130, P2349, DOI 10.1002/ijc.26275; YUEN CT, 1994, J BIOL CHEM, V269, P1595; YUEN CT, 1992, BIOCHEMISTRY-US, V31, P9126, DOI 10.1021/bi00153a003; Zheng J, 2009, CLIN CHIM ACTA, V405, P119, DOI 10.1016/j.cca.2009.04.017	55	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0261082	10.1371/journal.pone.0261082	http://dx.doi.org/10.1371/journal.pone.0261082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910746	Green Published, gold			2022-12-26	WOS:000754828900034
J	Lee, Y; Shin, J; Kim, Y; Kim, DS				Lee, Yujin; Shin, Jihye; Kim, Yujeong; Kim, Dong-Sook			Consumption of single products versus fixed-dose combination medicines for hypertension and hyperlipidemia during 2015-2019 in South Korea	PLOS ONE			English	Article							2017 AMERICAN-COLLEGE; HIGH BLOOD-PRESSURE; ANTIHYPERTENSIVE DRUGS; GUIDELINE; TRENDS	Background Fixed-dose combinations can simplify prescribing, and numerous combination products exist for hypertension and dyslipidemia in South Korea. This study's aim was to compare trends in the consumption of single products versus fixed-dose combinations for hypertension and hyperlipidemia. Methods and findings We analyzed the Korean national health insurance claims database from January 2015 through December 2019. Consumption of medicines was calculated using the defined daily dose per 1,000 inhabitants per day (DIDs) and expenditures over time. During 2015-2019, the use of antihypertensive drugs increased with an annual growth rate (AGR) of 0.9% for single products and with an AGR of 35.6% for fixed-dose combinations. A notable increase was observed for antihyperlipidemic combination drugs with an AGR of 268.1% compared to single products with 35.7%. For older adults (65+ years), the consumption of drugs for hypertension and hyperlipidemia was 3-4.5 and about 3 times higher, respectively, than in adults aged 20-64 years, and a sharp increase was found in antihyperlipidemic fixed-dose combinations among older adults. A large increase was seen for C09 (agents acting on the renin-angiotensin system) with an AGR of 36.5%, especially C09DB (angiotensin II receptor blockers + calcium channel blockers) was widely used and steeply increased with 114.2%. For antihyperlipidemic drugs, C10AA (HMG CoA reductase inhibitors) accounted for a large share and sharply increased, with 52.1 DIDs in 2019 and with an AGR of 78.4%, whereas C10BA (combinations of various lipid modifying agents) increased 9.6 times from 2.9 DIDs (96 million USD) in 2015 to 27.7 DIDs (912 million USD) in 2019. Conclusion The findings of increased consumption and drug spending among older adults underscores the need for real-world evidence about health outcomes of fixed-dose combinations in this population.	[Lee, Yujin; Shin, Jihye; Kim, Yujeong; Kim, Dong-Sook] Hlth Insurance Review & Assessment Serv HIRA, Dept Res, Wonju, South Korea		Kim, DS (corresponding author), Hlth Insurance Review & Assessment Serv HIRA, Dept Res, Wonju, South Korea.	sttone@hanmail.net		Kim, Yujeong/0000-0002-4838-7289; Kim, Dong-Sook/0000-0003-2372-1807				An JJ, 2020, CURR HYPERTENS REP, V22, DOI 10.1007/s11906-020-01109-2; [Anonymous], 2020, OECD HLTH STAT 2020; [Anonymous], 2019, GUIDELINES MANAGEMEN; Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.009, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.010]; Du LP, 2018, J CLIN HYPERTENS, V20, P902, DOI 10.1111/jch.13272; HIRA, 2020, NATL HLTH INSURANCE; HIRA (Annual), NATL HLTH INSURANCE; Huang LY, 2013, EUR REV MED PHARMACO, V17, P410; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kawalec P, 2018, ARCH MED SCI, V14, P1125, DOI 10.5114/aoms.2018.77561; KCDC, 2020, 2018 NAT HLTH NUTR E; KSoLA, 2018, KOR GUID MAN DYSL; Kucan M, 2018, CLIN THER, V40, P1159, DOI 10.1016/j.clinthera.2018.05.018; Malo S, 2019, EXPERT REV PHARM OUT, V19, P463, DOI 10.1080/14737167.2019.1567338; OECD, PHARM MARK OECD STAT; Pettersson B, 2012, HEALTH POLICY, V104, P84, DOI 10.1016/j.healthpol.2011.10.010; Soboleva MS, 2020, CLINICOECONOMIC OUTC, V12, P265, DOI 10.2147/CEOR.S251721; Sundboll J, 2017, AM J CARDIOL, V120, P2193, DOI 10.1016/j.amjcard.2017.08.042; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; Whelton PK, 2018, JAMA-J AM MED ASSOC, V320, P1749, DOI 10.1001/jama.2018.16755; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]; Whelton PK, 2018, JAMA CARDIOL, V3, P352, DOI 10.1001/jamacardio.2018.0005; WHOCC, 2020, AN THER CHEM ATC DEF; Xu HM, 2015, INT J CLIN PHARM TH, V53, P430, DOI 10.5414/CP202243	24	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0259467	10.1371/journal.pone.0259467	http://dx.doi.org/10.1371/journal.pone.0259467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910724	Green Published, gold			2022-12-26	WOS:000754828900007
J	Bitty-Anderson, AM; Ferre, V; Gbeasor-Komlanvi, FA; Tchankoni, MK; Sadio, A; Salou, M; Descamps, D; Dagnra, CA; Charpentier, C; Ekouevi, DK; Coffie, PA				Bitty-Anderson, Alexandra M.; Ferre, Valentine; Gbeasor-Komlanvi, Fifonsi A.; Tchankoni, Martin Kouame; Sadio, Arnold; Salou, Mounerou; Descamps, Diane; Dagnra, Claver A.; Charpentier, Charlotte; Ekouevi, Didier K.; Coffie, Patrick A.			Prevalence of hepatitis B and C among female sex workers in Togo, West Africa	PLOS ONE			English	Article							VACCINATION; VIRUS; HIV; PEOPLE	Background Hepatitis B and C are endemic in sub-Saharan Africa, with prevalence among the highest in the World. However, several challenges impede the progression towards the elimination of viral hepatitis by 2030 as suggested by the World Health Organization Global health sector strategy on viral hepatitis, including the lack of knowledge on the scale of this epidemic in the region. The aim of this study was to estimate the prevalence of hepatitis B and C among female sex workers (FSW) in Togo. Methods This ancillary study from a national cross-sectional bio-behavioral study was conducted in 2017 using a respondent-driven sampling (RDS) method, in eight towns of Togo among FSW. Socio-demographic, behavioral and sexual characteristics were assessed using a standardized questionnaire. Blood samples were collected for HIV, hepatitis B and C serological testing. Data were analyzed using descriptive analysis and a logistic regression model. Results Out of the 1,036 FSW recruited for this study, biological analyses for viral hepatitis were completed for 769 of them. The median age was 26 years [IQR: 22-33] and 49.8% (n = 383) had attained secondary school. The prevalence of hepatitis B was 9.9% [95% CI: (7.9-12.2)] and the prevalence of hepatitis C was 5.3% [95% CI: (3.9-7.2)]. Higher hepatitis B and C prevalence was associated with recruitment out of Lome (aOR: 6.63; 95%CI: 3.51-13.40, p <0.001 and OR: 2.82; 95% CI: [1.37-5.99]; p<0.001, respectively) and, for hepatitis B, with never using condoms for vaginal intercourse (OR: 3.14; 95%CI: [1.02-8.71]; p<0.05). Conclusions Results from this study reveals high prevalence of hepatitis B and C among FSW in Togo and an opportunity for advocacy toward the introduction of immunizations and treatment in this population.	[Bitty-Anderson, Alexandra M.; Coffie, Patrick A.] CHU Treichville, Programme PACCI, Site ANRS Cote Ivoire, Abidjan, Cote Ivoire; [Bitty-Anderson, Alexandra M.; Ekouevi, Didier K.] Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res, U1219,ISPED, Bordeaux, France; [Ferre, Valentine; Descamps, Diane; Charpentier, Charlotte] Univ Paris, INSERM, UMR 1137, IAME, Paris, France; [Ferre, Valentine; Descamps, Diane] Hop Bichat Claude Bernard, AP HP, Lab Virol, Paris, France; [Gbeasor-Komlanvi, Fifonsi A.; Ekouevi, Didier K.] Univ Lome, Fac Sci Sante, Dept Sante Publ, Lome, Togo; [Gbeasor-Komlanvi, Fifonsi A.; Tchankoni, Martin Kouame; Sadio, Arnold; Ekouevi, Didier K.] CARESP, Lome, Togo; [Salou, Mounerou; Dagnra, Claver A.] Univ Lome, Dept Sci Fondamentales, Lab Biol Mol, Lome, Togo; [Dagnra, Claver A.] Programme Natl Lutte VIH Sida Hepatites Virales &, Lome, Togo; [Ekouevi, Didier K.] Univ Bordeaux, Inst Sante Publ Epidemiol Dev ISPED, Bordeaux, France; [Coffie, Patrick A.] Univ Felix Houphouet Boigny, UFR Sci Med, Dept Dermatol & Infectiol, Abidjan, Cote Ivoire; [Coffie, Patrick A.] CHU Treichville, Serv Malad Infectieuses & Trop, Abidjan, Cote Ivoire	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite de Bordeaux	Ekouevi, DK (corresponding author), Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res, U1219,ISPED, Bordeaux, France.; Ekouevi, DK (corresponding author), Univ Lome, Fac Sci Sante, Dept Sante Publ, Lome, Togo.; Ekouevi, DK (corresponding author), CARESP, Lome, Togo.; Ekouevi, DK (corresponding author), Univ Bordeaux, Inst Sante Publ Epidemiol Dev ISPED, Bordeaux, France.	didier.ekouevi@gmail.com	Ferré, Valentine/GNP-2900-2022	TCHANKONI, Martin Kouame/0000-0001-9873-3293	African Center for Research in Epidemiology and Public health; Togo National HIV and STI Control Program	African Center for Research in Epidemiology and Public health; Togo National HIV and STI Control Program	This work was funded by the "African Center for Research in Epidemiology and Public health" and the Togo National HIV and STI Control Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abara WE, 2017, ANN INTERN MED, V167, P794, DOI 10.7326/M17-1106; Agyeman AA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1708-7; Amon J, GUIDELINES REPEATED, V358; [Anonymous], 2017, GLOB HEP REP 2017, P2017; Baars JE, 2009, WOMEN HEALTH ISS, V19, P61, DOI 10.1016/j.whi.2008.09.002; Babor TF., ALCOHOL USE DISORDER, P41; Bigna JJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015748; Bitty-Anderson AM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-028934; Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003; Carneiro LM, 2014, J PUBLIC HEALTH MAN, V20, P662, DOI 10.1097/PHH.0000000000000048; Catherine FX, 2017, HUM VACC IMMUNOTHER, V13, P1304, DOI 10.1080/21645515.2016.1277844; Centers for Disease Control and Prevention (CDC), 2005, 54 CDCP, V54, P2005; Coffie PA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2568-5; Conseil National de Lutte contre le sida et les infections sexuellement transmissibles Republique du Togo, 2015, EST TAILL CART SIT H; Degenhardt L, 2017, LANCET GLOB HEALTH, V5, pE1192, DOI 10.1016/S2214-109X(17)30375-3; Ekouevi DK, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05574-7; Ekouevi DK, 2018, J PUBLIC HEALTH AFR, V9, P100, DOI 10.4081/jphia.2018.871; Farooq PD, 2019, CURR HIV-AIDS REP, V16, P395, DOI 10.1007/s11904-019-00461-6; Ferre VM, 2019, CLIN INFECT DIS, V69, P1019, DOI 10.1093/cid/ciy1012; Forbi JC, 2008, REV INST MED TROP SP, V50, P219, DOI 10.1590/S0036-46652008000400006; Global Adult Tobacco Survey Collaborative Group, 2011, TOB QUEST SURV SUBS; Halatoko WA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4134-x; Hongjaisee S, 2020, INT J INFECT DIS, V100, P247, DOI 10.1016/j.ijid.2020.09.004; Jaquet A, 2017, LIVER INT, V37, P1116, DOI 10.1111/liv.13484; Jepkemei KB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233727; Joint United Nations Programme on HIV/AIDS (UNAIDS), TOGO; Kolou M, 2018, J RECHERCHE SCI LOME, V20, P225; Lafort Y, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3305-5; Laurent C, 2001, INT J EPIDEMIOL, V30, P872, DOI 10.1093/ije/30.4.872; Mawuli LA., 2018, J LIVER RES DISORD T, V4, DOI [10.15406/jlrdt.2018.04.00112, DOI 10.15406/JLRDT.2018.04.00112]; Mora N, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1584-1; Mutagoma M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2625-0; Niama FR, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0189-5; Patassi A A, 2016, SAMJ, S. Afr. med. j., V106, P634, DOI [10.7196/samj.2016.v106i6.10312, 10.7196/SAMJ.2016.v106i6.10312]; Ranjan A, 2019, INT J INFECT DIS, V87, P170, DOI 10.1016/j.ijid.2019.07.032; Rao VB, 2015, LANCET INFECT DIS, V15, P819, DOI 10.1016/S1473-3099(15)00006-7; Sadio AJ, 2019, MED SANTE TROP, V29, P294, DOI 10.1684/mst.2019.0922; Scheibe A, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05359-y; Teclessou JN, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.191.11285; WHO, 2015, WHO GUID PREV CAR TR; World Health Organization. Regional Office for Africa, 2017, END HEP 2030 PREV CA; World Health Organization (WHO), HEP B FACT SHEET	42	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0259891	10.1371/journal.pone.0259891	http://dx.doi.org/10.1371/journal.pone.0259891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890388	Green Published, gold			2022-12-26	WOS:000747293600006
J	Egbenyah, F; Udofia, EA; Ayivor, J; Osei, MM; Tetteh, J; Tetteh-Quarcoo, PB; Sampane-Donkor, E				Egbenyah, Fredrick; Udofia, Emilia Asuquo; Ayivor, Jesse; Osei, Mary-Magdalene; Tetteh, John; Tetteh-Quarcoo, Patience B.; Sampane-Donkor, Eric			Disposal habits and microbial load of solid medical waste in sub-district healthcare facilities and households in Yilo-Krobo municipality, Ghana	PLOS ONE			English	Article							MANAGEMENT; ESCHERICHIA; RESISTANCE; EMISSIONS; HOSPITALS; URBAN	The study aimed to assess disposal practices and quantify the microbial load present in SMW from ten sub-district level healthcare facilities and 385 households in Yilo Krobo municipality, Ghana. Disposal of solid medical waste (SMW) was assessed by questionnaire-based surveys, unstructured interviews and field observations. Microbiological analysis identified species and counts of bacteria present in SMW from both sources. Sociodemographic factors influencing the method of SMW disposal in households were evaluated using logistic regression analysis, with statistical significance set at p<0.05. Open burning (29%), burying (25%) and disposal at a dumpsite (49%) were common methods used by households to discard SMW. SMW disposal at a dumpsite was associated with age of respondents in households. Older people (50+ years) were three times more likely to place SMW in household waste later discarded at a dumpsite, compared to younger persons (20-30 years) [a0R, 95%CI = 3.37, 1.41-8.02]. In sub-district level healthcare facilities, open burning and burying were the most common methods used. Bacillus subtilis, Klebsiella pneumonia, Pseudomonas aeruginosa, Clostridium tetani, Enterococcus faecalis, Acinetobacter spp. Escherichia coli, Bacillus cereus and Enterococcus faecium) were bacteria identified in SMW recovered from both the healthcare facilities and the households. Klebsiella pneumoniae, Acinetobacter spp. and Clostridium tetani were found exclusively in untreated SMW generated in the healthcare facilities. Bacillus spp. and Pseudomonas spp. were found in one sample of treated SMW. The microbial load in SMW from healthcare facilities and households ranged from 0.036 x 10(3)cfc/mg to 0.167 x 10(3) cfc/mg and from 0.118 x 10(3)cfc/mg to 0.125 x 10(3)cfc/mg respectively. This highlights the need for institutionalizing appropriate treatment methods in sub-district level facilities or strengthening the linkages with higher level facilities to ensure regular and adequate treatment of SMW. Public guidance on management of SMW generated in households which is context specific should also be provided.	[Egbenyah, Fredrick; Ayivor, Jesse] Univ Ghana, Coll Basic & Appl Sci, Inst Environm & Sanitat Studies, Legon, Accra, Ghana; [Udofia, Emilia Asuquo; Tetteh, John] Univ Ghana, Coll Hlth Sci, Sch Med, Dept Community Hlth, Korle Bu, Accra, Ghana; [Osei, Mary-Magdalene; Tetteh-Quarcoo, Patience B.; Sampane-Donkor, Eric] Univ Ghana, Coll Hlth Sci, Sch Med, Dept Med Microbiol, Korle Bu, Accra, Ghana	University of Ghana; University of Ghana; University of Ghana	Udofia, EA (corresponding author), Univ Ghana, Coll Hlth Sci, Sch Med, Dept Community Hlth, Korle Bu, Accra, Ghana.	eudofia@ug.edu.gh	Tetteh, John/AEU-3066-2022; Udofia, Emilia Asuquo/AAQ-6729-2020	Tetteh, John/0000-0002-1986-4103; Udofia, Emilia Asuquo/0000-0002-7279-1839				Adu RO, 2020, J ENVIRON PUBLIC HEA, V2020, DOI 10.1155/2020/2934296; Al-Khatib IA, 2009, WASTE MANAGE, V29, P2398, DOI 10.1016/j.wasman.2009.03.014; Alwabr G.M, 2016, CURRENT LIFE SCI, V2, P67, DOI [10.5281/zenodo.57550, DOI 10.5281/ZENODO.57550]; Anitha J., 2012, INT J PHARM PHARM SC, V4, P386; Apurva P., 2010, ASIAN J EXP BIOL SCI, V1, P337; Asante B., 2013, INT J SCI TECHNOLOGY, V3, P106; Auta A, 2011, J PHARMACOL PHARMACO, V2, P195, DOI 10.4103/0976-500X.83290; Blanch AR, 2003, J APPL MICROBIOL, V94, P994, DOI 10.1046/j.1365-2672.2003.01919.x; Blenkharn JI, 2007, PUBLIC HEALTH, V121, P540, DOI 10.1016/j.puhe.2006.12.005; CDC, 2021, FACT AFF EFF DIS STE; Chartier Y, 2014, SAFE MANAGEMENT WAST, V1, P3; Coker A, 2009, WASTE MANAGE, V29, P804, DOI 10.1016/j.wasman.2008.06.040; Crawford SE., 2008, PEDIAT RESP MED, VSecond edition, P501; DROFFNER ML, 1991, J MICROBIOL METH, V14, P201, DOI 10.1016/0167-7012(91)90024-K; Fuentefria AM, 2008, J BASIC MICROB, V48, P25, DOI 10.1002/jobm.200700143; Gullett BK, 2001, CHEMOSPHERE, V43, P721, DOI 10.1016/S0045-6535(00)00425-2; Hedman B, 2005, ENVIRON SCI TECHNOL, V39, P8790, DOI 10.1021/es051117w; Hyun M, 2019, INFECT CHEMOTHER, V51, P130, DOI 10.3947/ic.2019.51.2.130; Igbinomwanhia DI., 2011, INT J GEOTECH ENV, V1, P128; Insa E, 2010, RESOUR CONSERV RECY, V54, P1048, DOI 10.1016/j.resconrec.2010.06.005; Ishtiaq Osama, 2012, J Infect Public Health, V5, P182, DOI 10.1016/j.jiph.2012.02.002; Javid Manzoor, 2019, Environmental Claims Journal, V31, P311, DOI 10.1080/10406026.2019.1619265; Johansson E, 2000, ACTA CRYSTALLOGR D, V56, P662, DOI 10.1107/S0907444900003735; Lubasi-Kapijimpanga BI., MEDICAL WASTE REPORT; Manowan V., 2009, THESIS G WASHINGTON, P1; Mehrad B, 2015, CHEST, V147, P1413, DOI 10.1378/chest.14-2171; Mohamed S, 2018, 2018 CONFERENCE ON INFORMATION COMMUNICATIONS TECHNOLOGY AND SOCIETY (ICTAS); Nascimento TC, 2009, REV SOC BRAS MED TRO, V42, P415, DOI 10.1590/S0037-86822009000400011; Nemathaga F, 2008, WASTE MANAGE, V28, P1236, DOI 10.1016/j.wasman.2007.03.033; Osagie RN, 2016, INT J PUBLIC HLTH SC, V5, P51; Oyeleke SB, 2009, AFR J BIOTECHNOL, V8, P1253; Park H, 2009, J ENVIRON SCI HEAL A, V44, P995, DOI 10.1080/10934520902996898; Phorano O., 2005, BOTSWANA NOTES RECOR, V37, P161; Pruss-Ustun A., 1999, SAFE MANAGEMENT WAST; Raghavendra HL, IJRSI, V4, P2321; Saini Savita, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P986; Sasu S, 2012, WASTE MANAGE RES, V30, P625, DOI 10.1177/0734242X11423286; Sridhar M, 2003, P 3 INT C ENV HLTH, P512; Tang JE, 2009, J APPL PHYSIOL, V107, P987, DOI 10.1152/japplphysiol.00076.2009; Tumeo E, 2008, INT J HYG ENVIR HEAL, V211, P200, DOI 10.1016/j.ijheh.2007.02.010; Udofia EA, 2018, AJEST, P534, DOI [10.4236/jep.2018.913081, DOI 10.4236/JEP.2018.913081]; Vogler Sabine, 2014, J Pharm Policy Pract, V7, P6, DOI 10.1186/2052-3211-7-6; World Health Organization (WHO), 2005, MAN SOL HLTH CAR WAS; Zhou Z, 2014, ENVIRON SCI TECHNOL, V48, P1343, DOI 10.1021/es404185m	44	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0261211	10.1371/journal.pone.0261211	http://dx.doi.org/10.1371/journal.pone.0261211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890437	gold, Green Published			2022-12-26	WOS:000747293600036
J	Pagnone, A; Koch, F; Pausch, F; Trimborn, S				Pagnone, Anna; Koch, Florian; Pausch, Franziska; Trimborn, Scarlett			The Southern Ocean diatom Pseudo-nitzschia subcurvata flourished better under simulated glacial than interglacial ocean conditions: Combined effects of CO2 and iron	PLOS ONE			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; PHYTOPLANKTON COMMUNITY STRUCTURE; CARBON ACQUISITION; BIOGENIC SILICA; PHOTOSYSTEM-II; TRACE-METALS; LIMITATION; LIGHT; COASTAL; NITROGEN	The 'Iron Hypothesis' suggests a fertilization of the Southern Ocean by increased dust deposition in glacial times. This promoted high primary productivity and contributed to lower atmospheric pCO(2). In this study, the diatom Pseudo-nitzschia subcurvata, known to form prominent blooms in the Southern Ocean, was grown under simulated glacial and interglacial climatic conditions to understand how iron (Fe) availability (no Fe or Fe addition) in conjunction with different pCO(2) levels (190 and 290 mu atm) influences growth, particulate organic carbon (POC) production and photophysiology. Under both glacial and interglacial conditions, the diatom grew with similar rates. In comparison, glacial conditions (190 mu atm pCO(2) and Fe input) favored POC production by P. subcurvata while under interglacial conditions (290 mu atm pCO(2) and Fe deficiency) POC production was reduced, indicating a negative effect caused by higher pCO(2) and low Fe availability. Under interglacial conditions, the diatom had, however, thicker silica shells. Overall, our results show that the combination of higher Fe availability with low pCO(2), present during the glacial ocean, was beneficial for the diatom P. subcurvata, thus contributing more to primary production during glacial compared to interglacial times. Under the interglacial ocean conditions, on the other hand, the diatom could have contributed to higher carbon export due to its higher degree of silicification.	[Pagnone, Anna; Koch, Florian; Pausch, Franziska; Trimborn, Scarlett] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, EcoTrace, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Koch, F (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, EcoTrace, Bremerhaven, Germany.	florian.koch@awi.de		Koch, Florian/0000-0001-7107-4160; Trimborn, Scarlett/0000-0003-1434-9927; Pausch, Franziska/0000-0002-4207-1304; Pagnone, Anna/0000-0001-9750-0711	German Federal Ministry of Education and Research (BMBF) as Research for Sustainability initiative (FONA) [FKZ: 01LP1505C]; Helmholtz Association (HGF Young Investigators Group EcoTrace) [VH-NG-901]	German Federal Ministry of Education and Research (BMBF) as Research for Sustainability initiative (FONA)(Federal Ministry of Education & Research (BMBF)); Helmholtz Association (HGF Young Investigators Group EcoTrace)	AP was supported by German Federal Ministry of Education and Research (BMBF) as Research for Sustainability initiative (FONA); www.fona.de through Palmod project (FKZ: 01LP1505C). ST, FK and FP were funded by the Helmholtz Association (HGF Young Investigators Group EcoTrace, VH-NG-901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani S, 2016, GEOPHYS RES LETT, V43, P3944, DOI 10.1002/2016GL067911; Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Anderson RF, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0054; Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; BILGER W, 1991, PLANTA, V184, P226, DOI [10.1007/BF01102422, 10.1007/BF00197951]; Boelen P, 2011, J EXP MAR BIOL ECOL, V406, P38, DOI 10.1016/j.jembe.2011.06.012; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyle E, 1998, NATURE, V393, P733, DOI 10.1038/31585; Brewer P.G., 1986, CHANGING CARBON CYCL, P348, DOI 10.1007/978-1-4757-1915-4_18; BRZEZINSKI MA, 1995, DEEP-SEA RES PT I, V42, P1215, DOI 10.1016/0967-0637(95)93592-3; Bucciarelli E, 2010, BIOGEOSCIENCES, V7, P657, DOI 10.5194/bg-7-657-2010; Buesseler KO, 2001, DEEP-SEA RES PT II, V48, P4275, DOI 10.1016/S0967-0645(01)00089-3; Cutter G.A., 2017, SAMPLING SAMPLE HAND, P139, DOI [10.25607/OBP-2, DOI 10.25607/OBP-2]; Davey M, 2001, J PHYCOL, V37, P987, DOI 10.1046/j.1529-8817.2001.99169.x; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; DEBAAR HJW, 1995, NATURE, V373, P412, DOI 10.1038/373412a0; Diatoms SmetacekV., 1999, PROTIST, DOI [10.1016/S1434-4610(99)70006-4, DOI 10.1016/S1434-4610(99)70006-4]; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Feng Y, 2010, DEEP-SEA RES PT I, V57, P368, DOI 10.1016/j.dsr.2009.10.013; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gerringa LJA, 2000, MAR CHEM, V68, P335, DOI 10.1016/S0304-4203(99)00092-4; GRAN G, 1952, ANALYST, V77, P661, DOI 10.1039/an9527700661; GREENE RM, 1992, PLANT PHYSIOL, V100, P565, DOI 10.1104/pp.100.2.565; GREENE RM, 1991, LIMNOL OCEANOGR, V36, P1772, DOI 10.4319/lo.1991.36.8.1772; Gruber N, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003349; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hasle GR, 1964, SKRIFTER UTGITT NORS; Hathorne EC, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003907; Hauck J, 2018, GLOBAL BIOGEOCHEM CY, V32, P1556, DOI 10.1029/2018GB005977; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hoffmann LJ, 2007, BIOGEOSCIENCES, V4, P569, DOI 10.5194/bg-4-569-2007; Hoogstraten A, 2012, J PHYCOL, V48, P559, DOI 10.1111/j.1529-8817.2012.01148.x; Hoppe CJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079890; HUDSON RJM, 1990, LIMNOL OCEANOGR, V35, P1002, DOI 10.4319/lo.1990.35.5.1002; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; King AL, 2015, MAR ECOL PROG SER, V537, P59, DOI 10.3354/meps11458; Koch F, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00514; Koch F, 2019, LIMNOL OCEANOGR, V64, P357, DOI 10.1002/lno.11045; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Koroleff F., 1983, METHODS SEAWATER ANA, P174; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; Lambert F, 2015, GEOPHYS RES LETT, V42, P6014, DOI 10.1002/2015GL064250; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; Marchetti A, 2005, THESIS U BRIT COL; Marchetti A, 2007, LIMNOL OCEANOGR, V52, P2270, DOI 10.4319/lo.2007.52.5.2270; Marchetti A, 2006, LIMNOL OCEANOGR, V51, P2092, DOI 10.4319/lo.2006.51.5.2092; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Martinez-Garcia A, 2014, SCIENCE, V343, P1347, DOI 10.1126/science.1246848; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; Mayr C, 2013, GEOLOGY, V41, P831, DOI 10.1130/G34335.1; McKay RML, 1997, PLANT PHYSIOL, V114, P615, DOI 10.1104/pp.114.2.615; MEHLER AH, 1951, ARCH BIOCHEM BIOPHYS, V33, P65, DOI 10.1016/0003-9861(51)90082-3; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Milligan AJ, 2000, J PHYCOL, V36, P78, DOI 10.1046/j.1529-8817.2000.99013.x; Moore JK, 2006, TELLUS B, V58, P560, DOI 10.1111/j.1600-0889.2006.00209.x; MOREL FMM, 1991, LIMNOL OCEANOGR, V36, P1742, DOI 10.4319/lo.1991.36.8.1742; Muglia J, 2018, EARTH PLANET SC LETT, V496, P47, DOI 10.1016/j.epsl.2018.05.038; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nunn BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075653; Oxborough K, 2012, LIMNOL OCEANOGR-METH, V10, P142, DOI 10.4319/lom.2012.10.142; Petrou K, 2014, MAR BIOL, V161, P925, DOI 10.1007/s00227-014-2392-z; Prasil O, 1996, PHOTOSYNTH RES, V48, P395, DOI 10.1007/BF00029472; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; Raven JA, 1999, PLANT CELL ENVIRON, V22, P741, DOI 10.1046/j.1365-3040.1999.00419.x; Reinfelder JR, 2012, MAR ECOL PROG SER, V466, P57, DOI 10.3354/meps09905; Ryan-Keogh TJ, 2012, J PHYCOL, V48, P145, DOI 10.1111/j.1529-8817.2011.01092.x; Schuback N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133235; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Smetacek V, 2018, PROTIST, V169, P791, DOI 10.1016/j.protis.2018.08.004; Smetacek V, 2012, NATURE, V487, P313, DOI 10.1038/nature11229; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Stoll MHC, 2001, ANAL CHEM, V73, P4111, DOI 10.1021/ac010303r; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Strzepek RF, 2019, P NATL ACAD SCI USA, V116, P4388, DOI 10.1073/pnas.1810886116; Strzepek RF, 2012, LIMNOL OCEANOGR, V57, P1182, DOI 10.4319/lo.2012.57.4.1182; Strzepek RF, 2011, LIMNOL OCEANOGR, V56, P1983, DOI 10.4319/lo.2011.56.6.1983; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Suggett DJ, 2004, LIMNOL OCEANOGR-METH, V2, P316, DOI 10.4319/lom.2004.2.316; Sugie K, 2008, J PLANKTON RES, V30, P1245, DOI 10.1093/plankt/fbn080; Sugie K, 2013, J PHYCOL, V49, P475, DOI 10.1111/jpy.12054; Sun J, 2011, LIMNOL OCEANOGR, V56, P829, DOI 10.4319/lo.2011.56.3.0829; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Sunda WG, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00204; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; Timmermans KR, 2004, LIMNOL OCEANOGR, V49, P2141, DOI 10.4319/lo.2004.49.6.2141; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Trimborn S, 2008, PHYSIOL PLANTARUM, V133, P92, DOI 10.1111/j.1399-3054.2007.01038.x; Trimborn S, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00167; Trimborn S, 2017, MAR ECOL PROG SER, V578, P35, DOI 10.3354/meps12250; Trimborn S, 2015, DEEP-SEA RES PT I, V98, P115, DOI 10.1016/j.dsr.2014.12.010; Trimborn S, 2014, J EXP MAR BIOL ECOL, V451, P44, DOI 10.1016/j.jembe.2013.11.001; Trimborn S, 2013, LIMNOL OCEANOGR, V58, P997, DOI 10.4319/lo.2013.58.3.0997; Utermohl H., 1958, SIL COMMUN 1953 1996, V9, P1, DOI [10.1080/05384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; van Heuven S., 2011, ORNLCDIAC105B, DOI [10.3334/CDIAC/otg.CO2SYS_MATLAB_v1.1, DOI 10.3334/CDIAC/OTG.CO2SYS_MATLAB_V1.1]; van Leeuwe MA, 2014, J PHYCOL, V50, P1070, DOI 10.1111/jpy.12238; Wagener T, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002984; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183; Zhu Z, 2017, BIOGEOSCIENCES, V14, P5281, DOI 10.5194/bg-14-5281-2017	107	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0260649	10.1371/journal.pone.0260649	http://dx.doi.org/10.1371/journal.pone.0260649			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890411	gold, Green Published			2022-12-26	WOS:000747293600015
J	Endo, N; Ito, T; Watanabe, K; Nakazawa, K				Endo, Nozomi; Ito, Takayuki; Watanabe, Katsumi; Nakazawa, Kimitaka			Enhancement of loudness discrimination acuity for self-generated sound is independent of musical experience	PLOS ONE			English	Article							SPEECH; ATTENUATION; PLASTICITY; RECALIBRATION; PERCEPTION	Musicians tend to have better auditory and motor performance than non-musicians because of their extensive musical experience. In a previous study, we established that loudness discrimination acuity is enhanced when sound is produced by a precise force generation task. In this study, we compared the enhancement effect between experienced pianists and non-musicians. Without the force generation task, loudness discrimination acuity was better in pianists than non-musicians in the condition. However, the force generation task enhanced loudness discrimination acuity similarly in both pianists and non-musicians. The reaction time was also reduced with the force control task, but only in the non-musician group. The results suggest that the enhancement of loudness discrimination acuity with the precise force generation task is independent of musical experience and is, therefore, a fundamental function in auditory-motor interaction.	[Endo, Nozomi; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Endo, Nozomi] Japan Soc Promot Sci, Tokyo, Japan; [Ito, Takayuki] Univ Grenoble Alpes, CNRS, Grenoble INP, GIPSA Lab, Grenoble, France; [Ito, Takayuki] Haskins Labs Inc, New Haven, CT USA; [Watanabe, Katsumi] Waseda Univ, Fac Sci & Engn, Tokyo, Japan; [Watanabe, Katsumi] Univ New South Wales, Fac Arts Design & Architecture, Sydney, NSW, Australia	University of Tokyo; Japan Society for the Promotion of Science; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Yale University; Haskins Laboratories; Waseda University; University of New South Wales Sydney	Nakazawa, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.	nakazawa@idaten.c.u-tokyo.ac.jp		Ito, Takayuki/0000-0002-3265-360X; Watanabe, Katsumi/0000-0003-1282-9994; Nakazawa, Kimitaka/0000-0001-5483-8659	JSPS KAKENHI [20J14743, 17H00753, 17H06344, 18H04082]; Tateishi Science and Technology Promotion Foundation [2197001]; National Institute on Deafness and Other Communication Disorders [R01-DC017439]; JST Moonshot RD [JPMJMS2012]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tateishi Science and Technology Promotion Foundation; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); JST Moonshot RD	This study was jointly supported by research grants from JSPS KAKENHI (20J14743) and Tateishi Science and Technology Promotion Foundation Grant 2197001 awarded to N.E.; the National Institute on Deafness and Other Communication Disorders Grant R01-DC017439 awarded to T.I.; JSPS KAKENHI (17H00753 and 17H06344 to K.W.; 18H04082 to K.N.); JST Moonshot R&D (JPMJMS2012) to K.W. and K.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Samira, 2011, Seminars in Hearing, V32, P129, DOI 10.1055/s-0031-1277234; Bianchi F, 2016, JARO-J ASSOC RES OTO, V17, P69, DOI 10.1007/s10162-015-0548-2; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Endo N, 2021, EXP BRAIN RES, V239, P1141, DOI 10.1007/s00221-020-05993-7; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Fujisaki W, 2010, P ROY SOC B-BIOL SCI, V277, P2281, DOI 10.1098/rspb.2010.0243; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Hirano M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd2558; Hirano M, 2020, CEREB CORTEX, V30, P1148, DOI 10.1093/cercor/bhz154; Horvath J, 2015, BRAIN RES, V1626, P54, DOI 10.1016/j.brainres.2015.03.038; Hosoda M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37632; Ito T, 2009, P NATL ACAD SCI USA, V106, P1245, DOI 10.1073/pnas.0810063106; Kaiser J, 2018, EUR J NEUROSCI, V47, P1303, DOI 10.1111/ejn.13931; Kishon-Rabin Liat, 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P125; Kleiner M, 2007, PERCEPTION, V36, P14; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Libesman S, 2020, J COGNITIVE NEUROSCI, V32, P426, DOI 10.1162/jocn_a_01486; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Menning H, 2000, NEUROREPORT, V11, P817, DOI 10.1097/00001756-200003200-00032; Myers JC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58447-z; Nasir SM, 2009, P NATL ACAD SCI USA, V106, P20470, DOI 10.1073/pnas.0907032106; Ohashi H, 2019, J NEUROPHYSIOL, V122, P2076, DOI 10.1152/jn.00028.2019; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Ragert P, 2004, EUR J NEUROSCI, V19, P473, DOI 10.1111/j.0953-816X.2003.03142.x; Repp BH, 2007, PSYCHOL SCI, V18, P6, DOI 10.1111/j.1467-9280.2007.01839.x; ROSENBLUM LD, 1991, J EXP PSYCHOL HUMAN, V17, P976, DOI 10.1037/0096-1523.17.4.976; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Takeshima Y, 2013, ATTEN PERCEPT PSYCHO, V75, P501, DOI 10.3758/s13414-012-0403-z; Toida K, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00688; Trudeau-Fisette P, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00344; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Weiss C, 2012, CONSCIOUS COGN, V21, P1654, DOI 10.1016/j.concog.2012.08.010; Weiss C, 2011, COGNITION, V121, P207, DOI 10.1016/j.cognition.2011.06.011; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260859	10.1371/journal.pone.0260859	http://dx.doi.org/10.1371/journal.pone.0260859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874970	Green Published, gold			2022-12-26	WOS:000753617500038
J	Zhang, Y; Yuan, Y				Zhang, Yi; Yuan, Yi			International trade and finance exploration using network model of computer trade platform	PLOS ONE			English	Article							ALGORITHM; MACHINE; ERROR; SPACE	International trade becomes increasingly frequent with the deepening of economic globalization. In order to ensure the stable and rapid development of international trade and finance, it is particularly crucial to predict the sales trend of foreign trade goods in advance through the network model of computer trade platform. To optimize the accuracy of sales forecasts for foreign trade goods, under the background of "Internet plus foreign trade", the controllable relevance big data mining of foreign trade goods sales, personalized prediction mechanism, intelligent prediction algorithm, improved distributed quantitative and centralized qualitative calculation are taken as the premise to design dynamic prediction model on export sales based on controllable relevance big data of cross border e-commerce (DPMES). Moreover, after the related experiments and comparative discussions, the forecast error ratios from the first quarter to the fourth quarter are 2.3%, 2.1%, 2.4% and 2.4% respectively, which are also within the acceptable range. The experimental results show that the design combines the advantages of openness and extensibility of Internet plus with dynamic prediction of big data, and achieves the wisdom, quantitative and qualitative prediction of the volume of goods sold under the background of "Internet plus foreign trade", which is controlled by the relevant data of foreign trade. The overall performance of this design is stronger than the previous models, has better dynamic evolution and high practical significance, and is of great significance in the development of international trade and finance.	[Zhang, Yi] XIAN Univ Finance & Econ, Sch Management, Xian, Shaanxi, Peoples R China; [Yuan, Yi] XIAN Univ Finance & Econ, Sch Business, Xian, Shaanxi, Peoples R China	Xi'an University of Finance & Economics; Xi'an University of Finance & Economics	Zhang, Y (corresponding author), XIAN Univ Finance & Econ, Sch Management, Xian, Shaanxi, Peoples R China.	zhangyi7978@xaufe.edu.cn			National Social Science Foundation of China [20BJL068]; Key Research Base Project of Philosophy and Social Sciences of Shaanxi Education Department [20JZ054]; Soft Science Project of Shaanxi Provincial Department of Science and Technology Research on Financial Service Innovation Capability of Shaanxi Free Trade Zone under Background of "One Belt One Road" [2020KRM114]	National Social Science Foundation of China; Key Research Base Project of Philosophy and Social Sciences of Shaanxi Education Department; Soft Science Project of Shaanxi Provincial Department of Science and Technology Research on Financial Service Innovation Capability of Shaanxi Free Trade Zone under Background of "One Belt One Road"	The National Social Science Foundation of China (grant number 20BJL068), Key Research Base Project of Philosophy and Social Sciences of Shaanxi Education Department (grant number 20JZ054); Soft Science Project of Shaanxi Provincial Department of Science and Technology Research on Financial Service Innovation Capability of Shaanxi Free Trade Zone under Background of "One Belt One Road" (2020KRM114. The funders played an important role in assisting in the study design, data collection, decision making for publication, and manuscript preparation.	Abdel-Hamid NB, 2018, J GRID COMPUT, V16, P607, DOI 10.1007/s10723-018-9465-z; Algarni M, 2017, INT J FATIGUE, V96, P162, DOI 10.1016/j.ijfatigue.2016.11.033; Bal VH, 2017, J AUTISM DEV DISORD, V47, P2938, DOI 10.1007/s10803-017-3204-3; Boyd MP, 2019, LINGUIST EDUC, V50, P25, DOI 10.1016/j.linged.2019.03.002; Chiou R, 2018, CORTEX, V103, P100, DOI 10.1016/j.cortex.2018.02.018; Feng KX, 2019, ENG STRUCT, V181, P605, DOI 10.1016/j.engstruct.2018.12.039; Frigola J, 2017, NAT GENET, V49, P1684, DOI 10.1038/ng.3991; Gao J, 2019, FUTURE GENER COMP SY, V99, P508, DOI 10.1016/j.future.2019.04.048; Huo J, 2018, APPL OPTICS, V57, P3306, DOI 10.1364/AO.57.003306; Li LC, 2019, KNOWL-BASED SYST, V172, P1, DOI 10.1016/j.knosys.2019.01.015; Li XY, 2021, NEUROCOMPUTING, V421, P285; Liu Y, 2019, JAMA-J AM MED ASSOC, V322, P1806, DOI 10.1001/jama.2019.16489; Lv ZH, 2020, IEEE T IND INFORM, V16, P2566, DOI 10.1109/TII.2019.2916689; Ma C, 2020, NEUROCOMPUTING, V401, P327, DOI 10.1016/j.neucom.2020.03.078; Menaga D, 2022, EVOL INTELL, V15, P1487, DOI 10.1007/s12065-021-00576-z; Menaga D, 2018, IET INFORM SECUR, V12, P332, DOI 10.1049/iet-ifs.2017.0634; Niu Y., 2021, INF PROCESS MANAG, V58, P102725; Pan JS, 2018, J INTERNET TECHNOL, V19, P1111, DOI 10.3966/160792642018081904014; Shirokov ME, 2020, LOBACHEVSKII J MATH, V41, P714, DOI 10.1134/S199508022004023X; Trifonov P, 2020, IEEE T COMMUN, V68, P6714, DOI 10.1109/TCOMM.2020.3018781; van der Heide LM, 2020, COMPUT OPER RES, V114, DOI 10.1016/j.cor.2019.104828; Vandekerckhove K, 2018, AAPS J, V20, DOI 10.1208/s12248-018-0230-9; Wang TF, 2020, SOFT COMPUT, V24, P919, DOI 10.1007/s00500-019-04612-0; Wang Y, 2020, IND MARKET MANAG, V89, P72, DOI 10.1016/j.indmarman.2019.09.004; Wu XJ, 2019, NEURAL COMPUT APPL, V31, P4685, DOI 10.1007/s00521-018-3509-y	25	1	1	8	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0260883	10.1371/journal.pone.0260883	http://dx.doi.org/10.1371/journal.pone.0260883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY3JJ	34860849	Green Published, gold			2022-12-26	WOS:000754686900010
J	Kentour, M; Lu, J				Kentour, Mohamed; Lu, Joan			An investigation into the deep learning approach in sentimental analysis using graph-based theories	PLOS ONE			English	Article							NEURAL-NETWORKS; BACKPROPAGATION	Sentiment analysis is a branch of natural language analytics that aims to correlate what is expressed which comes normally within unstructured format with what is believed and learnt. Several attempts have tried to address this gap (i.e., Naive Bayes, RNN, LSTM, word embedding, etc.), even though the deep learning models achieved high performance, their generative process remains a "black-box" and not fully disclosed due to the high dimensional feature and the non-deterministic weights assignment. Meanwhile, graphs are becoming more popular when modeling complex systems while being traceable and understood. Here, we reveal that a good trade-off transparency and efficiency could be achieved with a Deep Neural Network by exploring the Credit Assignment Paths theory. To this end, we propose a novel algorithm which alleviates the features' extraction mechanism and attributes an importance level of selected neurons by applying a deterministic edge/node embeddings with attention scores on the input unit and backward path respectively. We experiment on the Twitter Health News dataset were the model has been extended to approach different approximations (tweet/aspect and tweets' source levels, frequency, polarity/subjectivity), it was also transparent and traceable. Moreover, results of comparing with four recent models on same data corpus for tweets analysis showed a rapid convergence with an overall accuracy of approximate to 83% and 94% of correctly identified true positive sentiments. Therefore, weights can be ideally assigned to specific active features by following the proposed method. As opposite to other compared works, the inferred features are conditioned through the users' preferences (i.e., frequency degree) and via the activation's derivatives (i.e., reject feature if not scored). Future direction will address the inductive aspect of graph embeddings to include dynamic graph structures and expand the model resiliency by considering other datasets like SemEval task7, covid-19 tweets, etc.	[Kentour, Mohamed; Lu, Joan] Univ Huddersfield, Sch Comp & Engn, Huddersfield, W Yorkshire, England	University of Huddersfield	Kentour, M (corresponding author), Univ Huddersfield, Sch Comp & Engn, Huddersfield, W Yorkshire, England.	mohamed.kentour@hud.ac.uk		Lu, Joan/0000-0002-0585-2806; , mohamed/0000-0002-7197-7869				Abualigah L., 2020, STUDIES COMPUTATIONA, P129, DOI [10.1007/978-3-030-34614-0_7, DOI 10.1007/978-3-030-34614-0_7]; Agarwal Ayush, 2019, 2019 4th International Conference on Big Data, Cloud Computing, Data Science & Engineering (BCD), P19, DOI 10.1109/BCD.2019.8885108; Ahmad M, 2018, INT J ADV COMPUT SC, V9, P182; Ahn H, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10061959; Alazab M., 2020, MULTIDIRECTIONAL LST, V8, DOI [10.1109/ACCESS.2020.2991067, DOI 10.1109/ACCESS.2020.2991067]; Amara S, 2020, INT CONF ADVAN COMPU, P105, DOI 10.1109/ICACCS48705.2020.9074360; Aravantino V., 2018, ARXIV181206744CSLG; Arora R., ARXIV161101491V6CSLG; Arulmurugan R, 2019, CLUSTER COMPUT, V22, P1199, DOI 10.1007/s10586-017-1200-1; Ashokkumar P, 2021, ACM T ASIAN LOW-RESO, V20, DOI 10.1145/3425781; Asif M, 2020, TELEMAT INFORM, V48, DOI 10.1016/j.tele.2020.101345; Bijari K, 2020, EXPERT SYST APPL, V144, DOI 10.1016/j.eswa.2019.113090; Chen FH, 2018, IEEE T MULTIMEDIA, V20, P997, DOI 10.1109/TMM.2017.2757769; Chen H., ARXIV190904225V4CSCL; Chen LC, 2020, SOFT COMPUT, V24, P8187, DOI 10.1007/s00500-019-04402-8; Cirqueira D, 2020, PROCEEDINGS OF THE 4TH INTERNATIONAL CONFERENCE ON COMPUTER-HUMAN INTERACTION RESEARCH AND APPLICATIONS (CHIRA), P319, DOI 10.5220/0010215303190328; Clark EM., 2018, ARXIV180509959V1CSCL; Cunliffe E, 2018, ANTIQUITY, V92, P1094, DOI 10.15184/aqy.2018.134; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Dong X., 2019, ARXIV190706572V1CSLG; Dube S., 2018, ARXIVABS180100634; El-Affendi MA, 2021, IEEE ACCESS, V9, P7508, DOI 10.1109/ACCESS.2021.3049626; Elbattah M, 2021, HEALTHINF: PROCEEDINGS OF THE 14TH INTERNATIONAL JOINT CONFERENCE ON BIOMEDICAL ENGINEERING SYSTEMS AND TECHNOLOGIES - VOL. 5: HEALTHINF, P825, DOI 10.5220/0010414508250832; Goyal Anirudh, 2017, ARXIV171104755; Greff K, 2017, IEEE T NEUR NET LEAR, V28, P2222, DOI 10.1109/TNNLS.2016.2582924; Gu Y., 2014, J LANGUAGE TECHNOLOG, V29, P79; Guo Y, 2020, NEURAL NETWORKS, V126, P250, DOI 10.1016/j.neunet.2020.03.001; Hamilton WL, 2017, ADV NEUR IN, V30; Haque TU, 2018, 2018 IEEE INT C INNO, P1; Hassan Saif., 2013, CEUR WORKSH P, P1096; Hatami N., 2017, ARXIV171000886V2CSCV, DOI [10.1371/journal.pone.0178410, DOI 10.1371/JOURNAL.PONE.0178410]; Hoefler T., 2021, J MACH LEARN RES, V22, P1; Huang YK, 2020, KNOWL-BASED SYST, V204, DOI 10.1016/j.knosys.2020.106202; Islam MA, 2020, IEEE T FUZZY SYST, V28, P1291, DOI 10.1109/TFUZZ.2019.2917124; Ivakhnenko A., 1965, CYBERNETIC PREDICTIN; Jiang KY, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2198-y; Karami A., 2017, INT J FUZZY SYST, V1, P1; Karami A., 2017, PROC ASS INF SCI TEC, V54, P357, DOI [DOI 10.1002/PRA2.2017.14505401039, 10.1002/pra2.2017.14505401039]; Karami A, 2020, IEEE ACCESS, V8, P67698, DOI 10.1109/ACCESS.2020.2983656; Kim B, 2020, DECIS SUPPORT SYST, V134, DOI 10.1016/j.dss.2020.113302; Kojima R, 2020, J CHEMINFORMATICS, V12, DOI 10.1186/s13321-020-00435-6; Kolajo T., 2018, FUDMA J SCI FJS, V2, P14; Kowsari K, 2019, INFORMATION, V10, DOI 10.3390/info10040150; Kraus M, 2019, EXPERT SYST APPL, V118, P65, DOI 10.1016/j.eswa.2018.10.002; Kumar S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45605-1; Li B, 2019, INT CONF ACOUST SPEE, P7550, DOI 10.1109/ICASSP.2019.8683812; Lillicrap TP, 2019, CURR OPIN NEUROBIOL, V55, P82, DOI 10.1016/j.conb.2019.01.011; Liu YH., 2020, SOLUTION TEMPORAL CR, DOI [10.1101/2020.11.22.393504, DOI 10.1101/2020.11.22.393504]; Maas A. L., 2011, P 49 ANN M ASS COMP, P142; Man, 2014, P 8 INT WORKSH SEM E, P54, DOI DOI 10.3115/V1/S14-2007; Mantyla MV, 2018, COMPUT SCI REV, V27, P16, DOI 10.1016/j.cosrev.2017.10.002; Masud M, 2020, COMPUT COMMUN, V152, P215, DOI 10.1016/j.comcom.2020.01.050; Matalon Y, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86510-w; Minsky M., 1963, COMPUT THOUGHT, P406; Namdar K., 2020, ARXIV200604836CSLG; Pandeya YR, 2021, MULTIMED TOOLS APPL, V80, P2887, DOI 10.1007/s11042-020-08836-3; PRXJJU, 2021, ANAL VIDHYA, DOI [10.1021/acsomega.1c01314, DOI 10.1021/ACSOMEGA.1C01314]; Rajput N.K., 2020, 200403925CS ARXIV; Rambocas M, 2018, J RES INTERACT MARK, V12, P146, DOI 10.1108/JRIM-05-2017-0030; Rao GZ, 2018, NEUROCOMPUTING, V308, P49, DOI 10.1016/j.neucom.2018.04.045; Ren ZY, 2020, IEEE ACCESS, V8, P93464, DOI 10.1109/ACCESS.2020.2995211; Richards BA, 2019, NAT NEUROSCI, V22, P1761, DOI 10.1038/s41593-019-0520-2; Rios N, 2018, INFORM SOFTWARE TECH, V102, P117, DOI 10.1016/j.infsof.2018.05.010; Chagas BNR, 2018, 2018 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE (WI 2018), P452, DOI 10.1109/WI.2018.00-53; Rozanska A, 2019, IFAC PAPERSONLINE, V52, P411, DOI 10.1016/j.ifacol.2019.12.696; Rudin C, 2019, NAT MACH INTELL, V1, P206, DOI 10.1038/s42256-019-0048-x; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Seo D, 2020, IEEE ACCESS, V8, P8572, DOI 10.1109/ACCESS.2019.2963055; Shankar GS, 2020, WIREL COMMUN MOB COM, V2020, DOI 10.1155/2020/8879054; She LB, 2017, PROCEEDINGS OF THE 55TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2017), VOL 1, P1634, DOI 10.18653/v1/P17-1150; Shmidhuber J., 2014, IDSIA0314; Siemonsma PC, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0859-3; Singh A, 2020, J IMAGING, V6, DOI 10.3390/jimaging6060052; Smith RC, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11520; Song M, 2019, INFORM PROCESS MANAG, V56, P637, DOI 10.1016/j.ipm.2018.12.005; Sun JM, 2019, IEEE IJCNN; Thelwall M, 2018, ONLINE INFORM REV, V42, P343, DOI 10.1108/OIR-05-2017-0153; Torres A.D., 2018, COMPUTATIONAL INTELL, P61; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Velickovic P., 2017, INT C LEARN REPR VAN; Violos J., 2016, WIMS, P22; Vora S., 2019, INT J COMPUTATIONAL, V2; Vyas V., SENTIMENT ANAL KNOWL, P15; Waheeb SA, 2020, INFORMATION, V11, DOI 10.3390/info11050281; Wang XZ, 2019, COMPUTING, V101, P587, DOI 10.1007/s00607-018-00699-9; Weber T, 2019, PR MACH LEARN RES, V89; Wu YH, 2016, ADV NEUR IN, V29; Xue W, 2017, IJCNLP, P151; Yang F, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10072361; Yang J, 2021, ENG APPL ARTIF INTEL, V97, DOI 10.1016/j.engappai.2020.104048; Yang K, 2021, TSINGHUA SCI TECHNOL, V26, P208, DOI 10.26599/TST.2019.9010059; Yang ZX, 2020, KNOWL-BASED SYST, V204, DOI 10.1016/j.knosys.2020.106194; Yin Y., P 2017 C EMP METH NA, P2044; You QZ, 2016, MM'16: PROCEEDINGS OF THE 2016 ACM MULTIMEDIA CONFERENCE, P1008, DOI 10.1145/2964284.2964288; Yuan H, 2020, KDD '20: PROCEEDINGS OF THE 26TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P430, DOI 10.1145/3394486.3403085; Yuan Hao, 2020, P 8 INT C LEARN REPR; Yue X, 2020, BIOINFORMATICS, V36, P1241, DOI 10.1093/bioinformatics/btz718; Zadeh Amir, 2016, ARXIV160606259; Zhang W, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2220-4; Zhao PL, 2020, KNOWL-BASED SYST, V193, DOI 10.1016/j.knosys.2019.105443; Zhou ZP, 2017, ACS CENTRAL SCI, V3, P1337, DOI 10.1021/acscentsci.7b00492; Zhu J., 2020, INTERPRETING BASIS P; Zhu Q., 2020, ARXIV200905204V1CSLG; Zunic A, 2020, JMIR MED INF, V8, P34, DOI 10.2196/16023	104	1	1	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260761	10.1371/journal.pone.0260761	http://dx.doi.org/10.1371/journal.pone.0260761			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855856	gold, Green Published			2022-12-26	WOS:000735299000114
J	Padlo, T; Strus, P; Gil, A				Padlo, Tomasz; Strus, Pawel; Gil, Agnieszka			Danube as a symbol of Europe. Perception of the river from varied geographical perspectives	PLOS ONE			English	Article							COGNITIVE MAPS; REPRESENTATIONS; DISTORTIONS; WORLD; WATER	The Danube is promoted as a pan-European river, what can be justified for instance by the vast range of its drainage basin, covering 19 countries on both sides of the historical border diving Eastern and Western Europe. Differentiation of imaginations of Danube course from the perspective of 7 European cities, based on research covering 1577 respondents, conducted between 2005-2007 and 2016-2018 has been presented in the paper. Maps presenting the generalized imagination of river course have been generated for each city. It has been proved that in spite of substantial political, economical and symbolical importance of this river for big part of Europe, the course of Danube remains unknown for inhabitants of its Western part, in parallel to more correct recognition of the river by students from Eastern Europe. It has been shown that the perception does not change despite the progressing integration processes.	[Padlo, Tomasz; Strus, Pawel; Gil, Agnieszka] Pedag Univ Krakow, Inst Geog, Krakow, Poland	Pedagogical University of Cracow	Padlo, T (corresponding author), Pedag Univ Krakow, Inst Geog, Krakow, Poland.	tomasz.padlo@up.krakow.pl		Padlo, Tomasz/0000-0002-7502-6809; Gil, Agnieszka/0000-0002-4101-181X				Agh A., 2011, KOSSUTH KIADO; Angiel J, 2008, MISC GEOGR, V13, P299; Angiel J, 2015, SUSTAIN DEV, V23, P188, DOI 10.1002/sd.1586; Apostolopoulou E, 2011, PROCD SOC BEHV, V19, P443, DOI 10.1016/j.sbspro.2011.05.152; Bell S., 2011, UNDERSTANDING PROCES, P1; BLADES M, 1990, J ENVIRON PSYCHOL, V10, P327, DOI 10.1016/S0272-4944(05)80032-5; Boschmann EE, 2014, PROF GEOGR, V66, P236, DOI 10.1080/00330124.2013.781490; Brix E, 2018, HERITO, V31, P10; Busek E, 2010, EAST J EUR STUD, V1, P9; Canetti Elias., 1979, CONSCIENCE WORDS ESS; Cattell David T., 1960, AM SLAVIC E EUROPEAN, V19, P380; Cauvin C, 1999, CYBERGEO EUROPEAN J, V72; Chase W.G., 1982, ACQUISITION SYMBOLIC, P391, DOI [10.1007/978-1-4613-3724-9_43, DOI 10.1007/978-1-4613-3724-9, DOI 10.1038/s41598-020-62877-0]; Dermendijeva S., 2011, SERIA GEOGRAFIE, P14; Didelon C, 2011, MENTAL MAPS STUDENTS; Didelon C, 2011, CARTOGR J, V48, P100, DOI 10.1179/1743277411Y.0000000009; East WG, 1932, ECONOMICA, P321, DOI 10.2307/2548593; Friedman A, 2000, J EXP PSYCHOL GEN, V129, P193, DOI 10.1037/0096-3445.129.2.193; Gieseking JJ, 2013, QUAL INQ, V19, P712, DOI 10.1177/1077800413500926; Gobster PH, 2004, LANDSCAPE URBAN PLAN, V68, P147, DOI 10.1016/S0169-2046(03)00162-2; Golledge RG, 2003, AUST GEOGR STUD, V41, P117, DOI 10.1111/1467-8470.00199; GOULD PR, 1968, REG STUD, V2, P161, DOI 10.1080/09595236800185171; Hatlova K, 2020, ISPRS INT J GEO-INF, V9, DOI 10.3390/ijgi9040271; Hayden D., 1997, POWER PLACE URBAN LA; Istomin KV, 2020, SIBIRICA, V19, P1, DOI 10.3167/sib.2020.190202; Istomin KV, 2009, CURR ANTHROPOL, V50, P29, DOI 10.1086/595624; Kaplan S., 2015, IMAGE ENV, P63; Kiss CG, 2018, HERITO, V31, P56; Kitchin R, 2002, IB TAURIS; Kitchin R., 2000, COGNITIVE MAPPING PR; KITCHIN RM, 1994, J ENVIRON PSYCHOL, V14, P1, DOI 10.1016/S0272-4944(05)80194-X; Koev K, 2013, J DANUBIAN STUDIES R, V3; Krueger P, 2010, RACE ETHNIC EDUC-UK, V13, P383, DOI 10.1080/13613324.2010.500846; LLOYD R, 1987, ANN ASSOC AM GEOGR, V77, P191, DOI 10.1111/j.1467-8306.1987.tb00153.x; Lynch K., 1982, IMAGEN CITY; Magris C, 1989, PATRICK CREAGH; Moles A., 1978, PSYCHOL ESPACE CASTE; Niescioruk K, 2016, CARTOGR J, V53, P186, DOI 10.1080/00087041.2015.1108064; PACIONE M, 1976, REG STUD, V10, P275, DOI 10.1080/09595237600185281; Padlo T., 2015, NATIONS STEREOTYPES, V25, P172; Padlo T., 2013, POSTRZEGANIE EUROPY; Pantovic M., 2013, European Researcher, V59, P2295; Polonsky F, 2010, J MAPS, V6, P311, DOI 10.4113/jom.2010.1083; Popper O, 1943, GEOGR J, V102, P240, DOI 10.2307/1789134; SAARINEN TF, 1995, PROF GEOGR, V47, P196, DOI 10.1111/j.0033-0124.1995.00196.x; Saarinen TF, 1987, DISCUSSION PAPER SER, P87; SHERMAN RC, 1979, ENVIRON BEHAV, V11, P209, DOI 10.1177/0013916579112004; Silverman B.W., 1986, DENSITY ESTIMATION S; SMITH DG, 1995, NEW ZEAL J MAR FRESH, V29, P29, DOI 10.1080/00288330.1995.9516637; Taylor Y, 2007, YORK STUD WOMEN MEN, P1, DOI 10.1057/9780230592384; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Tu Huynh N., 2007, CARTOGRAPHICA INT J, V42, P285, DOI [DOI 10.3138/CARTO.42.4.285, 10.3138/carto.42.4.285]; TVERSKY B, 1981, COGNITIVE PSYCHOL, V13, P407, DOI 10.1016/0010-0285(81)90016-5; Ungureanu M-R, 2019, DONAURAUM, V59, P159; Waller D. E., 2013, HDB SPATIAL COGNITIO, DOI 10.1037/13936-000; Wiegand P, 1995, INT RES GEOGR ENVIRO, V4, P19, DOI [10.1080/10382046.1995.9964956, DOI 10.1080/10382046.1995.9964956]; Wright JK, 1947, ANN ASSOC AM GEOGR, V37, P1; Yamashita S, 2002, LANDSCAPE URBAN PLAN, V62, P3, DOI 10.1016/S0169-2046(02)00093-2	58	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260848	10.1371/journal.pone.0260848	http://dx.doi.org/10.1371/journal.pone.0260848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855880	Green Published, gold			2022-12-26	WOS:000735299000138
J	Page, EC; Heatley, SL; Eadie, LN; McClure, BJ; de Bock, CE; Omari, S; Yeung, DT; Hughes, TP; Thomas, PQ; White, DL				Page, Elyse C.; Heatley, Susan L.; Eadie, Laura N.; McClure, Barbara J.; de Bock, Charles E.; Omari, Sofia; Yeung, David T.; Hughes, Timothy P.; Thomas, Paul Q.; White, Deborah L.			HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort	ONCOGENE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MURINE XENOGRAFT MODELS; CHILDREN; TRANSCRIPTION; INHIBITION; PI3K/MTOR; TRANSFORMATION; ACTIVATION; EXPRESSION; MUTATIONS	The genetic basis of the predisposition for Down Syndrome (DS) patients to develop cytokine receptor-like factor 2 rearranged (CRLF2r) acute lymphoblastic leukemia (ALL) is currently unknown. Genes located on chromosome 21 and expressed in hematopoietic cells are likely candidates for investigation of CRLF2r DS-ALL pathogenesis. We explored the high-mobility group nucleosome-binding protein 1 (HMGN1), located in the DS critical region, in an inducible CRISPR/Cas9 knockout (KO) xenograft model to assess the effect of HMGN1 loss of function on the leukemic burden. We demonstrated HMGN1 KO-mitigated leukemic phenotypes including hepatosplenomegaly, thrombocytopenia, and anemia, commonly observed in leukemia patients, and significantly increased survival in vivo. HMGN1 overexpression in murine stem cells and Ba/F3 cells in vitro, in combination with P2RY8-CRLF2, resulted in cytokine-independent transformation and upregulation of cell signaling pathways associated with leukemic development. Finally, in vitro screening demonstrated successful targeting of P2RY8-CRLF2 and HMGN1 co-expressing cell lines and patient samples with fedratinib (JAK2 inhibitor), and GSK-J4 (demethylase inhibitor) in combination. Together, these data provide critical insight into the development and persistence of CRLF2r DS-ALL and identify HMGN1 as a potential therapeutic target to improve outcomes and reduce toxicity in this high-risk cohort of young patients.	[Page, Elyse C.; Heatley, Susan L.; Eadie, Laura N.; McClure, Barbara J.; Yeung, David T.; Hughes, Timothy P.; White, Deborah L.] South Australian Hlth & Med Res Inst, Canc Program, Precis Med Theme, Adelaide, SA, Australia; [Page, Elyse C.; White, Deborah L.] Univ Adelaide, Fac Sci, Adelaide, SA, Australia; [Heatley, Susan L.; Eadie, Laura N.; McClure, Barbara J.; Yeung, David T.; Hughes, Timothy P.; Thomas, Paul Q.; White, Deborah L.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Page, Elyse C.; White, Deborah L.] Australian & New Zealand Childrens Haematol Oncol, Sydney, NSW, Australia; [de Bock, Charles E.; Omari, Sofia] UNSW Sydney, Lowy Canc Res Ctr, Childrens Canc Inst, Sydney, NSW, Australia; [de Bock, Charles E.; Omari, Sofia] UNSW Sydney, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Yeung, David T.; Hughes, Timothy P.; White, Deborah L.] Australasian Leukaemia & Lymphoma Grp, Melbourne, Vic, Australia; [Yeung, David T.; Hughes, Timothy P.] Royal Adelaide Hosp, Dept Haematol, Adelaide, SA, Australia; [Yeung, David T.; Hughes, Timothy P.] SA Pathol, Adelaide, SA, Australia; [Yeung, David T.] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Thomas, Paul Q.] South Australian Hlth & Med Res Inst, Gene Editing Program, Precis Med Theme, Adelaide, SA, Australia; [White, Deborah L.] Australian Genom Hlth Alliance AGHA, Sydney, NSW, Australia	South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; University of Adelaide; Children's Cancer Institute; University of New South Wales Sydney; University of New South Wales Sydney; Royal Adelaide Hospital; SA Pathology; University of South Australia; South Australian Health & Medical Research Institute (SAHMRI)	White, DL (corresponding author), South Australian Hlth & Med Res Inst, Canc Program, Precis Med Theme, Adelaide, SA, Australia.; White, DL (corresponding author), Univ Adelaide, Fac Sci, Adelaide, SA, Australia.; White, DL (corresponding author), Univ Adelaide, Discipline Med, Adelaide, SA, Australia.; White, DL (corresponding author), Australian & New Zealand Childrens Haematol Oncol, Sydney, NSW, Australia.; White, DL (corresponding author), Australasian Leukaemia & Lymphoma Grp, Melbourne, Vic, Australia.; White, DL (corresponding author), Australian Genom Hlth Alliance AGHA, Sydney, NSW, Australia.	Deborah.white@sahmri.com	Heatley, Susan/AGP-2179-2022; de Bock, Charles/H-7699-2019	de Bock, Charles/0000-0001-5182-8535; Heatley, Susan/0000-0001-7497-6477; White, Deborah/0000-0003-4844-333X; McClure, Barbara/0000-0002-5201-4127; Omari, Sofia/0000-0003-0345-5601	Detmold Hoopman Group; Australian Cancer Research Foundation; Australian Government through the Zero Childhood Cancer Program; NHMRC; Beat Cancer; RTP University of Adelaide scholarship	Detmold Hoopman Group; Australian Cancer Research Foundation; Australian Government through the Zero Childhood Cancer Program; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Beat Cancer; RTP University of Adelaide scholarship	Flow cytometry analysis and cell sorting were performed at the South Australian Health Medical Research Institute (SAHMRI) in the ACRF Cellular Imaging and Cytometry Core Facility. The Facility is generously supported by the Detmold Hoopman Group, Australian Cancer Research Foundation, and the Australian Government through the Zero Childhood Cancer Program. Animal models were performed in the Bioresources Core Facility at SAHMRI and we would like to acknowledge the technical support provided. The authors acknowledge the facilities and scientific and technical assistance of the National Imaging Facility, a National Collaborative Research Infrastructure Strategy (NCRIS) capability, at the Preclinical Imaging and Research Laboratories/Bioresources, South Australian Health and Medical Research Institute. This study has been performed as partial fulfillment of the requirement for a Ph.D. degree from the University of Adelaide Faculty of Sciences for E.C.P. Funding for this study was provided by NHMRC, Beat Cancer, and L.F.A. E.C.P. was supported by an RTP University of Adelaide scholarship.	Adikusuma F, 2018, NATURE, V560, pE8, DOI 10.1038/s41586-018-0380-z; Antonarakis SE, 2017, NAT REV GENET, V18, P147, DOI 10.1038/nrg.2016.154; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Buitenkamp TD, 2012, LEUKEMIA, V26, P2204, DOI 10.1038/leu.2012.84; Buitenkamp TD, 2014, BLOOD, V123, P70, DOI 10.1182/blood-2013-06-509463; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P431, DOI 10.1016/S0968-0004(01)01855-2; Cabal-Hierro L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15221-z; Caruso C, 2019, CANCER DISCOV, V9, P1332, DOI 10.1158/2159-8290.CD-NB2019-102; Catez F, 2002, EMBO REP, V3, P760, DOI 10.1093/embo-reports/kvf156; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Figueroa ME, 2013, J CLIN INVEST, V123, P3099, DOI 10.1172/JCI66203; Ghosh S, 2009, AM J MED GENET A, V149A, P1415, DOI 10.1002/ajmg.a.32932; Gozgit JM, 2008, J BIOL CHEM, V283, P32334, DOI 10.1074/jbc.M803813200; Hama A, 2008, BRIT J HAEMATOL, V140, P552, DOI 10.1111/j.1365-2141.2007.06971.x; Heerema NA, 2007, GENE CHROMOSOME CANC, V46, P684, DOI 10.1002/gcc.20451; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; Hurtz C, 2020, J CLIN INVEST, V130, P3637, DOI 10.1172/JCI134424; Izraeli S, 2014, BLOOD, V123, P35, DOI 10.1182/blood-2013-07-453480; Lane AA, 2014, NAT GENET, V46, P618, DOI 10.1038/ng.2949; Lee P, 2016, LEUKEMIA, V30, P1816, DOI 10.1038/leu.2016.164; Li Q, 2018, ONCOL LETT, V15, P4517, DOI 10.3892/ol.2018.7898; Li WP, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0761-2; Li YN, 2018, J CANCER RES CLIN, V144, P1065, DOI 10.1007/s00432-018-2631-7; Lim JH, 2004, MOL CELL, V15, P573, DOI 10.1016/j.molcel.2004.08.006; Maude SL, 2015, BLOOD, V125, P1759, DOI 10.1182/blood-2014-06-580480; Meyr F, 2013, BRIT J HAEMATOL, V162, P98, DOI 10.1111/bjh.12348; Mowery CT, 2018, CELL REP, V25, P1898, DOI 10.1016/j.celrep.2018.10.061; Mullally A, 2020, BLOOD ADV, V4, P1792, DOI 10.1182/bloodadvances.2019000954; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Page EC, 2018, CANCER LETT, V432, P69, DOI 10.1016/j.canlet.2018.05.045; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Roberts I, 2014, BRIT J HAEMATOL, V167, P587, DOI 10.1111/bjh.13096; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Rochman M, 2011, NUCLEIC ACIDS RES, V39, P4076, DOI 10.1093/nar/gkq1343; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Sandhofer N, 2015, LEUKEMIA, V29, P828, DOI 10.1038/leu.2014.305; Tasian SK, 2017, BLOOD, V129, P177, DOI 10.1182/blood-2016-05-707653; Tasian SK, 2012, BLOOD, V120, P833, DOI 10.1182/blood-2011-12-389932; Tasian Sarah K., 2011, Critical Reviews in Oncogenesis, V16, P13; Vesely C, 2017, LEUKEMIA, V31, P1491, DOI 10.1038/leu.2016.365; Whitlock JA, 2006, BRIT J HAEMATOL, V135, P595, DOI 10.1111/j.1365-2141.2006.06337.x; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107; Zhu N, 2007, MOL CELL BIOL, V27, P8859, DOI 10.1128/MCB.01724-07	45	2	2	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2022	41	6					797	808		10.1038/s41388-021-02126-4	http://dx.doi.org/10.1038/s41388-021-02126-4		DEC 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YT5VS	34857887				2022-12-26	WOS:000725389500001
J	Witt, VD; Baur, G; Ecke, J; Kirchner, A; Hauptmann, B				Witt, Victoria Dorothea; Baur, Gabriel; Ecke, Jule; Kirchner, Anja; Hauptmann, Bjoern			Parkinson's patients situation during the SARS CoV-2 pandemic and their interest in telemedicine A cross-sectional study	PLOS ONE			English	Article							QUALITY-OF-LIFE; DISEASE; IMPACT; CARE	Background During the SARS CoV-2 pandemic, telemedicine experienced an enormous boom. Also, for Parkinson's patients there are upcoming alternatives to regular care. Objective The aim of the present study was to interview Parkinson's patients under the impression of the first lockdown in Germany about their health care situation, but especially about the use of and attitudes towards videotherapy and -consultation. Methods Northern German members of the German Parkinson Association were mailed a 16-item questionnaire including demographic questions on a one-time basis. The voluntary participants answered regarding their health care situation during the first German SARS CoV-2 lockdown, as well as attitudes towards videotherapy/-consultations. Results The 332 (of 974 questionnaires) responding evaluated their care situation predominantly (58.7%) unchanged during lockdown. There was hardly any previous experience in the areas of videotherapy and -consultations (15.4% and 3%, respectively), but at the same time mostly imaginability of implementation (54.2% and 56%, respectively) and the belief that they could motivate themselves to do so (51.8%). A total of 69% welcomed technical support for the implementation of videotherapy. Conclusion In principle, there seems to be both, a need and an interest in telematics in healthcare such as videotherapy and video consultations, even if further barriers such as technical implementation need to be addressed. An expansion of telemedical services and infrastructure seems desirable not only in the pandemic situation, but also in the long term against the backdrop of demographic change, especially in an area like Schleswig-Holstein. Further studies are needed.	[Witt, Victoria Dorothea] Psychiat Ctr Rickling, Rickling, Germany; [Witt, Victoria Dorothea; Baur, Gabriel; Hauptmann, Bjoern] MSH Med Sch Hamburg, Hamburg, Germany; [Ecke, Jule; Kirchner, Anja; Hauptmann, Bjoern] Segeberger Kliniken, Neurol Ctr, Bad Segeberg, Germany	Segeberger Kliniken Group	Witt, VD (corresponding author), Psychiat Ctr Rickling, Rickling, Germany.; Witt, VD; Hauptmann, B (corresponding author), MSH Med Sch Hamburg, Hamburg, Germany.; Hauptmann, B (corresponding author), Segeberger Kliniken, Neurol Ctr, Bad Segeberg, Germany.	V.D.Witt@gmail.com; bjoern.hauptmann@segebergerkliniken.de		Witt, Victoria Dorothea/0000-0002-0084-3054	'Versorgungssicherungsfonds' (care protection fund) by the federal state of Schleswig-Holstein (Germany)	'Versorgungssicherungsfonds' (care protection fund) by the federal state of Schleswig-Holstein (Germany)	V.D.W., J.E. and A.K. are supported by the 'Versorgungssicherungsfonds' (care protection fund) by the federal state of Schleswig-Holstein (Germany). The funder did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achey M, 2014, MOVEMENT DISORD, V29, P871, DOI 10.1002/mds.25903; [Anonymous], IBM SPSS STAT VERS 2; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Ascherio A, 2016, LANCET NEUROL, V15, P1255, DOI 10.1016/S1474-4422(16)30230-7; Bashiri M, 2016, TELEMED E-HEALTH, V22, P514, DOI 10.1089/tmj.2015.0112; Bitzer EM, 2021, BUNDESGESUNDHEITSBLA, V64, P277, DOI 10.1007/s00103-021-03282-4; Bloem BR, 2020, JAMA NEUROL, V77, P927, DOI 10.1001/jamaneurol.2020.1452; Boender TS, 2020, EPIDEMIOLOGISCHES B, V27, P3; Bombaci A, 2021, NEUROL SCI, V42, P9, DOI 10.1007/s10072-020-04783-x; Braczynski AK, 2021, J PARKINSON DIS, V11, P833, DOI 10.3233/JPD-202513; Brigo F, 2021, THER ADV CHRONIC DIS, V12, DOI 10.1177/20406223211029616; Chapuis S, 2005, MOVEMENT DISORD, V20, P224, DOI 10.1002/mds.20279; Chen YY, 2020, J TELEMED TELECARE, V26, P3, DOI 10.1177/1357633X18792805; Chirra M, 2019, TELEMED E-HEALTH, V25, P541, DOI 10.1089/tmj.2018.0101; Dorsey ER, 2018, J PARKINSON DIS, V8, pS3, DOI 10.3233/JPD-181474; Erro R, 2016, EUR J NEUROL, V23, P1673, DOI 10.1111/ene.13106; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Ertelt D, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-42; Garg D, 2020, ANN INDIAN ACAD NEUR, V23, pS24, DOI 10.4103/aian.AIAN_295_20; Haser I, 2008, KLIN, V37, P9, DOI [10.1055/S-2008-1052288, DOI 10.1055/S-2008-1052288]; Helmich RC, 2020, J PARKINSON DIS, V10, P351, DOI 10.3233/JPD-202038; Jorzig A., 2020, DIGITALISIERUNG GESU, P23; Kantor D, 2018, NEUROL THER, V7, P23, DOI 10.1007/s40120-017-0087-3; Karlsen KH, 2000, J NEUROL NEUROSUR PS, V69, P584, DOI 10.1136/jnnp.69.5.584; Keesara S, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005835; Lauze M, 2016, J PARKINSON DIS, V6, P685, DOI 10.3233/JPD-160790; Lavorgna L, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00583; Mammen JR, 2018, TELEMED E-HEALTH, V24, P255, DOI 10.1089/tmj.2017.0119; Masroor S, 2020, J CARDIAC SURG, V35, P1345, DOI 10.1111/jocs.14638; Miele G, 2020, TELEMED E-HEALTH, V26, P1533, DOI 10.1089/tmj.2020.0184; Pedrosa AL, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.566212; Ricciardi D, 2021, NEUROL SCI, V42, P4889, DOI 10.1007/s10072-021-05566-8; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Saboorizadeh N., 2019, FRONT HEAL INFORMATI, V8, P23, DOI [10.30699/fhi.v8i1.158, DOI 10.30699/FHI.V8I1.158]; Smith AC, 2009, MED J AUSTRALIA, V190, P15, DOI 10.5694/j.1326-5377.2009.tb02255.x; Spear KL, 2019, J PARKINSON DIS, V9, P401, DOI 10.3233/JPD-181557; Subramanian I, 2020, MOV DISORD CLIN PRAC, V7, P739, DOI 10.1002/mdc3.12994; Wosik J, 2020, J AM MED INFORM ASSN, V27, P957, DOI 10.1093/jamia/ocaa067	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260317	10.1371/journal.pone.0260317	http://dx.doi.org/10.1371/journal.pone.0260317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855794	gold, Green Published			2022-12-26	WOS:000735299000043
J	Bayeh, AB; Abegaz, BA				Bayeh, Agegnehu Berie; Abegaz, Belta Asnakew			The role of sigmoid colon anatomic dimensions in the development of sigmoid volvulus, North-Western Ethiopia	PLOS ONE			English	Article							INTESTINAL VOLVULUS; MANAGEMENT	Introduction Sigmoid colon anatomic dimensions have been studied to have roles in the occurrence of sigmoid volvulus; however, these studies are few in number and failed to control the confounding effect of acute sigmoid obstruction on the anatomic dimensions. The main objective of this study was to assess the role of sigmoid colon anatomic dimensions in the development of sigmoid volvulus controlling the effect of acute sigmoid obstruction on the anatomic dimensions. Materials and methods The study was carried out from Dec, 2019 to April, 2021 at Tibebe Ghion Specialized Hospital and Felege Hiwot Comprehensive Specialized Hospital, two referral hospitals in Bahir Dar city, North-Western Ethiopia to compare sigmoid anatomic dimensions among three independent groups of participants: patients with no history of sigmoid volvulus (I), those for whom elective surgery was done after non-surgical detorsion of sigmoid volvulus (II), and patients for whom emergency surgery was done for sigmoid volvulus (III). The anatomic dimensions were compared using fixed effects one-way ANOVA or Kruskal-Wallis H test at p-value <= .05 (two-sided) and Tukey method or Dunn-Bonferroni's test was used for post-hoc comparisons. Results A total of 66 consecutive eligible patients (22 for each of the three groups) were included and analyzed in the study. The means of anatomic dimensions (in cm) for groups (I, II, III) were: sigmoid colon length-SCL (35.91, 71.07, 80.86), meso-sigmoid height-MSH (17.11, 26.52, 28.86), meso-sigmoid maximal width-MSMW (9.70, 14.89,16.80), and meso-sigmoid root width-MSRW (8.34, 7.48, 8.11). SCL, MSH, MSMW, MSH/MSRW, and MSMW/MSRW were found to be statistically significantly different in patients with sigmoid volvulus. MSRW and MSH/MSMW were not different between the study groups. Conclusion A long sigmoid colon with long and wide mesentery, but with a constant base is highly likely to predispose individuals to sigmoid volvulus.	[Bayeh, Agegnehu Berie] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Gen Surg, Bahir Dar, Amhara Regional, Ethiopia; [Abegaz, Belta Asnakew] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Biomed Sci, Bahir Dar, Amhara Regional, Ethiopia	Bahir Dar University; Bahir Dar University	Bayeh, AB (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Gen Surg, Bahir Dar, Amhara Regional, Ethiopia.	agegnehuberie@gmail.com		Bayeh, Agegnehu/0000-0002-2638-7229				Akinkuotu A, 2011, CLIN ANAT, V24, P634, DOI 10.1002/ca.21131; Ali MK, 1998, ETHIOPIAN MED J, V36, P47; ANDERSEN DA, 1956, BRIT J SURG, V44, P132, DOI 10.1002/bjs.18004418404; ASBUN HJ, 1992, DIS COLON RECTUM, V35, P350, DOI 10.1007/BF02048112; Atamanalp SS, 2011, TURK J MED SCI, V41, P377, DOI 10.3906/sag-1011-3; Bhatnagar BNS, 2004, CLIN ANAT, V17, P236, DOI 10.1002/ca.10204; Bouchagier K., 2008, IJSM, V4, P88, DOI [10.5455/ijsm.sigmoid-volvulus-formation-anatomy, DOI 10.5455/IJSM.SIGMOID-VOLVULUS-FORMATION-ANATOMY]; Brothwell D., 1967, DIS ANTIQUITY SURVEY, P766; Chalya PL, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0001-1; Ertem M., 1995, Bulletin de l'Association des Anatomistes, V79, P5; Lal Sunil K, 2006, Gastrointest Endosc Clin N Am, V16, P175, DOI 10.1016/j.giec.2006.01.010; Madiba TE, 2008, SURG RADIOL ANAT, V30, P409, DOI 10.1007/s00276-008-0344-3; Mulugeta GA, 2019, BMC SURG, V19, DOI 10.1186/s12893-019-0561-1; Nuhu A, 2010, ANN AFR MED, V9, P86, DOI 10.4103/1596-3519.64747; PERRY EG, 1983, AUST NZ J SURG, V53, P483; Raimondo D, 2020, J GYNECOL OBSTET HUM, V49, DOI 10.1016/j.jogoh.2020.101697; SAIDI F, 1969, GUT, V10, P838, DOI 10.1136/gut.10.10.838; Saidi H., 2007, ANN AFR SURG, V1, P56; Swenson BR, 2012, DIS COLON RECTUM, V55, P444, DOI 10.1097/DCR.0b013e3182404b3d; TEGEGNE A, 1995, TROP GEOGR MED, V47, P212; UDEZUE NO, 1990, DIS COLON RECTUM, V33, P647, DOI 10.1007/BF02150738; VAEZZADEH K, 1970, ANN SURG, V172, P1027, DOI 10.1097/00000658-197012000-00016; WERTKIN MG, 1978, DIS COLON RECTUM, V21, P40, DOI 10.1007/BF02586545	23	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260708	10.1371/journal.pone.0260708	http://dx.doi.org/10.1371/journal.pone.0260708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851992	gold, Green Published			2022-12-26	WOS:000755762900057
J	Chellappa, SL; Engen, PA; Naqib, A; Qian, JY; Vujovic, N; Rahman, N; Green, SJ; Garaulet, M; Keshavarzian, A; Scheer, FAJL				Chellappa, Sarah L.; Engen, Phillip A.; Naqib, Ankur; Qian, Jingyi; Vujovic, Nina; Rahman, Nishath; Green, Stefan J.; Garaulet, Marta; Keshavarzian, Ali; Scheer, Frank A. J. L.			Proof-of-principle demonstration of endogenous circadian system and circadian misalignment effects on human oral microbiota	FASEB JOURNAL			English	Article						circadian misalignment; circadian rhythms; functional pathways; microbiota; shift work	NIGHT-SHIFT WORK; IMPACT; RISK; CELL; OSCILLATIONS; METABOLISM; DIVERSITY; BACTERIAL; DISEASE; HEALTH	Circadian misalignment-the misalignment between the central circadian "clock" and behavioral and environmental cycles (including sleep/wake, fasting/eating, dark/light)-results in adverse cardiovascular and metabolic effects. Potential underlying mechanisms for these adverse effects include alterations in the orogastrointestinal microbiota. However, it remains unknown whether human oral microbiota has endogenous circadian rhythms (i.e., independent of sleep/wake, fasting/eating, and dark/light cycles) and whether circadian misalignment influences oral microbiota community composition. Healthy young individuals [27.3 +/- 2.3 years (18-35 years), 4 men and 2 women, body-mass index range: 18-28 kg/m(2)] were enrolled in a stringently controlled 14-day circadian laboratory protocol. This included a 32-h constant routine (CR) protocol (endogenous circadian baseline assessment), a forced desynchrony protocol with four 28-h "days" under similar to 3 lx to induce circadian misalignment, and a post-misalignment 40-h CR protocol. Microbiota assessments were performed on saliva samples collected every 4 h throughout both CR protocols. Total DNA was extracted and processed using high-throughput 16S ribosomal RNA gene amplicon sequencing. The relative abundance of specific oral microbiota populations, i.e., one of the five dominant phyla, and three of the fourteen dominant genera, exhibited significant endogenous circadian rhythms. Importantly, circadian misalignment dramatically altered the oral microbiota landscape, such that four of the five dominant phyla and eight of the fourteen dominant genera exhibited significant circadian misalignment effects. Moreover, circadian misalignment significantly affected the metagenome functional content of oral microbiota (inferred gene content analysis), as indicated by changes in specific functional pathways associated with metabolic control and immunity. Collectively, our proof-of-concept study provides evidence for endogenous circadian rhythms in human oral microbiota and show that even relatively short-term experimental circadian misalignment can dramatically affect microbiota community composition and functional pathways involved in metabolism and immune function. These proof-of-principle findings have translational relevance to individuals typically exposed to circadian misalignment, including night shift workers and frequent flyers.	[Chellappa, Sarah L.; Qian, Jingyi; Vujovic, Nina; Rahman, Nishath; Scheer, Frank A. J. L.] Brigham & Womens Hosp, Dept Med, Div Sleep & Circadian Disorders, Med Chronobiol Program, 75 Francis St, Boston, MA 02115 USA; [Chellappa, Sarah L.; Qian, Jingyi; Vujovic, Nina; Rahman, Nishath; Scheer, Frank A. J. L.] Brigham & Womens Hosp, Dept Neurol, Div Sleep & Circadian Disorders, Med Chronobiol Program, 75 Francis St, Boston, MA 02115 USA; [Chellappa, Sarah L.; Qian, Jingyi; Vujovic, Nina; Scheer, Frank A. J. L.] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA; [Chellappa, Sarah L.] Univ Cologne, Fac Med, Dept Nucl Med, Cologne, Germany; [Chellappa, Sarah L.] Univ Cologne, Univ Hosp Cologne, Cologne, Germany; [Engen, Phillip A.; Naqib, Ankur; Keshavarzian, Ali] Rush Univ, Rush Med Coll, Rush Ctr Integrated Microbiome & Chronobiol Res, Med Ctr, Chicago, IL 60612 USA; [Green, Stefan J.] Rush Univ, Genom & Microbiome Core Facil, Med Ctr, Chicago, IL 60612 USA; [Garaulet, Marta] Univ Murcia, Dept Physiol, Reg Campus Int Excellence, Murcia, Spain; [Garaulet, Marta] Univ Clin Hosp, Biomed Res Inst Murcia, IMIB Arrixaca UMU, Murcia, Spain; [Keshavarzian, Ali] Rush Univ, Dept Physiol, Med Ctr, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Dept Med, Med Ctr, Chicago, IL 60612 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Cologne; University of Cologne; Rush University; Rush University; University of Murcia; Rush University; Rush University	Chellappa, SL; Scheer, FAJL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Sleep & Circadian Disorders, Med Chronobiol Program, 75 Francis St, Boston, MA 02115 USA.; Chellappa, SL; Scheer, FAJL (corresponding author), Brigham & Womens Hosp, Dept Neurol, Div Sleep & Circadian Disorders, Med Chronobiol Program, 75 Francis St, Boston, MA 02115 USA.	sarah.chellappa@outlook.com; fscheer@bwh.harvard.edu	Scheer, Frank A.J.L./C-2795-2012	Scheer, Frank A.J.L./0000-0002-2014-7582; Naqib, Ankur/0000-0003-0832-5646; Garaulet, Marta/0000-0002-4066-3509; Green, Stefan/0000-0003-2781-359X; Chellappa, Sarah L./0000-0002-6190-464X	NIH [R01H1.118601, 1UL1TR001102, K 991-11, 148500, R0 1 DK 099512, R01DK102696, R01H1.140574, R01DK105072]; American Diabetes Association [111-17-PDF-103]; Spanish Government of Investigation,Development and Innovation [SAE2017-84135-R]; Seneca Foundation [20795/FI/18]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Spanish Government of Investigation,Development and Innovation; Seneca Foundation(Fundacion Seneca)	NIH, Grant/Award Number: RO1H1.118601, 1UL1TR001102, K 991-11,148500, RO 1 DK 099512, R01DK102696, RO1H1.140574 and RO1DK105072; American Diabetes Association, Grant/Award Number 111-17-PDF-103; The Spanish Government of Investigation,Development and Innovation, Grant/ Award Number: SAE2017-84135-R; Seneca Foundation, Grant/Award Number: 20795/FI/18	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Abranches J, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.GPP3-0042-2018; [Anonymous], [No title captured], DOI [10.1126/science.284.5423.2177, DOI 10.1126/SCIENCE.284.5423.2177]; Atarashi K, 2017, SCIENCE, V358, P359, DOI 10.1126/science.aan4526; Bishehsari F, 2021, TRANSL RES, V231, P113, DOI 10.1016/j.trsl.2020.11.007; Butler TD, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01783; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caricilli Andrea Moro, 2014, World J Gastrointest Pathophysiol, V5, P18, DOI 10.4291/wjgp.v5.i1.18; Collado MC, 2018, FASEB J, V32, P2060, DOI 10.1096/fj.201700697RR; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Curtis MA, 2011, CELL HOST MICROBE, V10, P302, DOI 10.1016/j.chom.2011.09.008; Deaver JA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00737; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Flores R, 2012, EUR J CLIN INVEST, V42, P848, DOI 10.1111/j.1365-2362.2012.02660.x; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; GREENHOUSE JB, 1987, STAT MED, V6, P167, DOI 10.1002/sim.4780060209; Grimaldi D, 2016, HYPERTENSION, V68, P243, DOI 10.1161/HYPERTENSIONAHA.115.06847; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Jorge C., 2019, 6 EUR WORK COND SURV; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Karpinski TM, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010020; Kreth J, 2009, DNA CELL BIOL, V28, P397, DOI 10.1089/dna.2009.0868; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Leproult R, 2014, DIABETES, V63, P1860, DOI 10.2337/db13-1546; Liang X, 2015, P NATL ACAD SCI USA, V112, P10479, DOI 10.1073/pnas.1501305112; Liu QY, 2018, INT J EPIDEMIOL, V47, P1956, DOI 10.1093/ije/dyy079; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; Morris CJ, 2016, P NATL ACAD SCI USA, V113, pE1402, DOI 10.1073/pnas.1516953113; Morris CJ, 2015, P NATL ACAD SCI USA, V112, pE2225, DOI 10.1073/pnas.1418955112; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Naqib A, 2018, METHODS MOL BIOL, V1783, P149, DOI 10.1007/978-1-4939-7834-2_7; NHIS. 2010 National Health Interview Survey, PUBL US DAT FIL DOC; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Qian JY, 2016, TRENDS ENDOCRIN MET, V27, P282, DOI 10.1016/j.tem.2016.03.005; Rizzatti G, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9351507; ROZA AM, 1984, AM J CLIN NUTR, V40, P168, DOI 10.1093/ajcn/40.1.168; Sarkar A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81420-3; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Shigi N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00067; Skapenko A, 2005, ARTHRITIS RES THER, V7, pS4, DOI 10.1186/ar1703; Skarke C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17362-6; Spalding MD, 2010, MICROBIOL MOL BIOL R, V74, P200, DOI 10.1128/MMBR.00008-10; Takayasu L, 2017, DNA RES, V24, P261, DOI 10.1093/dnares/dsx001; Terlecky Stanley R, 2012, World J Biol Chem, V3, P93, DOI 10.4331/wjbc.v3.i5.93; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; Tsay, 1993, HIERARCHICAL MODEL S; Vetter C, 2018, DIABETES CARE, V41, P762, DOI 10.2337/dc17-1933; Vetter C, 2016, JAMA-J AM MED ASSOC, V315, P1726, DOI 10.1001/jama.2016.4454; Voigt RM, 2016, INT REV NEUROBIOL, V131, P193, DOI 10.1016/bs.irn.2016.07.002; Voigt RM, 2016, ALCOHOL CLIN EXP RES, V40, P335, DOI 10.1111/acer.12943; Voigt RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097500; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Waterhouse J, 2007, LANCET, V369, P1117, DOI 10.1016/S0140-6736(07)60529-7; Wefers J, 2018, P NATL ACAD SCI USA, V115, P7789, DOI 10.1073/pnas.1722295115; Wright KP, 2015, BRAIN BEHAV IMMUN, V47, P24, DOI 10.1016/j.bbi.2015.01.004; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Yang R, 2010, BIOINFORMATICS, V26, pi168, DOI 10.1093/bioinformatics/btq189; Zarrinpar A, 2014, CELL METAB, V20, P1006, DOI 10.1016/j.cmet.2014.11.008; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhao HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11779-9; Zhao JF, 2018, DIGEST LIVER DIS, V50, P1195, DOI 10.1016/j.dld.2018.04.016	70	4	4	7	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22043	10.1096/fj.202101153R	http://dx.doi.org/10.1096/fj.202101153R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34861073	Green Accepted			2022-12-26	WOS:000734992000027
J	Stavroulaki, EM; Suchodolski, JS; Pilla, R; Fosgate, GT; Sung, CH; Lidbury, JA; Steiner, JM; Xenoulis, PG				Stavroulaki, Evangelia M.; Suchodolski, Jan S.; Pilla, Rachel; Fosgate, Geoffrey T.; Sung, Chi-Hsuan; Lidbury, Jonathan A.; Steiner, Jorg M.; Xenoulis, Panagiotis G.			Short- and long-term effects of amoxicillin/clavulanic acid or doxycycline on the gastrointestinal microbiome of growing cats	PLOS ONE			English	Article							GUT MICROBIOTA; FECAL MICROBIOTA; ANTIBIOTIC EXPOSURE; WEIGHT-GAIN; DOGS; DISEASE; HEALTHY; DYSBIOSIS; IMMUNITY; RNA	Antibiotic treatment in early life influences gastrointestinal (GI) microbial composition and function. In humans, the resultant intestinal dysbiosis is associated with an increased risk for certain diseases later in life. The objective of this study was to determine the temporal effects of antibiotic treatment on the GI microbiome of young cats. Fecal samples were collected from cats randomly allocated to receive either amoxicillin/clavulanic acid (20 mg/kg q12h) for 20 days (AMC group; 15 cats) or doxycycline (10 mg/kg q24h) for 28 days (DOX group;15 cats) as part of the standard treatment of upper respiratory tract infection. In addition, feces were collected from healthy control cats (CON group;15 cats). All cats were approximately two months of age at enrolment. Samples were collected on days 0 (baseline), 20 or 28 (AMC and DOX, respectively; last day of treatment), 60, 120, and 300. DNA was extracted and sequencing of the 16S rRNA gene and qPCR assays were performed. Fecal microbial composition was different on the last day of treatment for AMC cats, and 1 month after the end of antibiotic treatment for DOX cats, compared to CON cats. Species richness was significantly greater in DOX cats compared to CON cats on the last day of treatment. Abundance of Enterobacteriales was increased, and that of Erysipelotrichi was decreased in cats of the AMC group on the last day of treatment compared to CON cats. The abundance of the phylum Proteobacteria was increased in cats of the DOX group on days 60 and 120 compared to cats of the CON group. Only minor differences in abundances between the treatment groups and the control group were present on day 300. Both antibiotics appear to delay the developmental progression of the microbiome, and this effect is more profound during treatment with amoxicillin/clavulanic acid and one month after treatment with doxycycline. Future studies are required to determine if these changes influence microbiome function and whether they have possible effects on disease susceptibility in cats.	[Stavroulaki, Evangelia M.; Xenoulis, Panagiotis G.] Univ Thessaly, Fac Vet Sci, Clin Med, Kardhitsa, Greece; [Suchodolski, Jan S.; Pilla, Rachel; Sung, Chi-Hsuan; Lidbury, Jonathan A.; Steiner, Jorg M.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Gastrointestinal Lab, College Stn, TX USA; [Fosgate, Geoffrey T.] Univ Pretoria, Dept Prod Anim Studies, Onderstepoort, South Africa	University of Thessaly; Texas A&M University System; Texas A&M University College Station; University of Pretoria	Stavroulaki, EM (corresponding author), Univ Thessaly, Fac Vet Sci, Clin Med, Kardhitsa, Greece.	evangelia.stavroulaki@gmail.com	Fosgate, Geoffrey T/N-8700-2014	Fosgate, Geoffrey T/0000-0002-9432-0042	Miller Trust Award of the Winn Feline Foundation [MT18- 003]	Miller Trust Award of the Winn Feline Foundation	The study was funded by the Miller Trust Award of the Winn Feline Foundation (MT18- 003; JSS, PGX, JMS, EMS). The URL of the funder's website is https://everycat.org/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles SR, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0187-9; Abu-Sbeih H, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0714-x; Agyepong N, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0324-2; Alessandri G, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.02875-19; AlShawaqfeh MK, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix136; Angelakis E, 2017, MICROB PATHOGENESIS, V106, P162, DOI 10.1016/j.micpath.2016.11.002; Angelakis E, 2014, ANTIMICROB AGENTS CH, V58, P3342, DOI 10.1128/AAC.02437-14; [Anonymous], 2020, J FELINE MED SURG, V22, P813, DOI 10.1177/1098612X20941784; Apprill A, 2015, AQUAT MICROB ECOL, V75, P129, DOI 10.3354/ame01753; Aversa Z, 2021, MAYO CLIN PROC, V96, P66, DOI 10.1016/j.mayocp.2020.07.019; Baars Annemarie, 2015, Microorganisms, V3, P641, DOI 10.3390/microorganisms3040641; Becker E, 2017, INT J ANTIMICROB AG, V50, P342, DOI 10.1016/j.ijantimicag.2017.03.017; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bermingham EN, 2013, MICROBIOLOGYOPEN, V2, P173, DOI 10.1002/mbo3.60; Blake AB, 2020, J VET INTERN MED, V34, P2345, DOI 10.1111/jvim.15928; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Boynton Felicia D Duke, 2017, BMC Res Notes, V10, P644, DOI 10.1186/s13104-017-2960-7; Bresciani F, 2018, J VET INTERN MED, V32, P1903, DOI 10.1111/jvim.15227; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Candon S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125448; Costantini L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122645; Deusch O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144881; Deusch O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101021; Di Caprio R, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/329418; Dogra S, 2015, MBIO, V6, DOI 10.1128/mBio.02419-14; Elvers KT, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035677; Ferrer M, 2017, BIOCHEM PHARMACOL, V134, P114, DOI 10.1016/j.bcp.2016.09.007; Galla S, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014373; Gasparrini AJ, 2019, NAT MICROBIOL, V4, P2285, DOI 10.1038/s41564-019-0550-2; Gendrin M, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw074; Graversen KB, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00496; Gronvold AMR, 2010, FEMS MICROBIOL ECOL, V71, P313, DOI 10.1111/j.1574-6941.2009.00808.x; Guard BC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175718; Hoehne SN, 2017, VET PATHOL, V54, P234, DOI 10.1177/0300985816664792; Hooda S, 2013, BRIT J NUTR, V109, P1637, DOI 10.1017/S0007114512003479; Hornef MW, 2020, IMMUNOLOGY, V159, P15, DOI 10.1111/imm.13149; Igarashi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107909; Inness VL, 2007, J ANIM PHYSIOL AN N, V91, P48, DOI 10.1111/j.1439-0396.2006.00640.x; Janeczko S, 2008, VET MICROBIOL, V128, P178, DOI 10.1016/j.vetmic.2007.10.014; Jess T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48065-9; Jung JY, 2018, ANAEROBE, V49, P85, DOI 10.1016/j.anaerobe.2017.12.011; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Kabbani TA, 2017, GUT MICROBES, V8, P17, DOI 10.1080/19490976.2016.1267890; Kalenyak K, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fix173; Kaur H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01365; Koo H, 2019, NPJ BIOFILMS MICROBI, V5, DOI 10.1038/s41522-019-0103-8; Korpela K, 2020, PEDIATR RES, V88, P438, DOI 10.1038/s41390-020-0761-5; Laflamme D, 1997, FELINE PRACT, V25, P13; Laflamme DP, 2012, J FELINE MED SURG, V14, P669, DOI 10.1177/1098612X12446906; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Lange K, 2016, DIGEST DIS, V34, P260, DOI 10.1159/000443360; Lappin MR, 2017, J VET INTERN MED, V31, P279, DOI 10.1111/jvim.14627; Levy M, 2017, NAT REV IMMUNOL, V17, P219, DOI 10.1038/nri.2017.7; Li QH, 2021, MSYSTEMS, V6, DOI 10.1128/mSystems.00111-21; Liu L, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01213; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lyu Y, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01661; MacPherson CW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29229-5; Manchester AC, 2019, J VET INTERN MED, V33, P2605, DOI 10.1111/jvim.15635; Milani C, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00036-17; Minamoto Y, 2015, GUT MICROBES, V6, P33, DOI 10.1080/19490976.2014.997612; Modi SR, 2014, J CLIN INVEST, V124, P4212, DOI 10.1172/JCI72333; Mohr KI, 2016, CURR TOP MICROBIOL, V398, P237, DOI 10.1007/82_2016_499; Moon CD, 2018, MICROBIOLOGYOPEN, V7, DOI 10.1002/mbo3.677; Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002; Mulder M, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1791677; Neuman H, 2018, FEMS MICROBIOL REV, V42, P489, DOI 10.1093/femsre/fuy018; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Oliphant K, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0704-8; Ortqvist AK, 2019, GUT, V68, P218, DOI 10.1136/gutjnl-2017-314352; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Venegas DP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00277; Patrick DM, 2020, LANCET RESP MED, V8, P1094, DOI 10.1016/S2213-2600(20)30052-7; Pilla R, 2020, J VET INTERN MED, V34, P1853, DOI 10.1111/jvim.15871; Pilla R, 2020, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00498; Ramadan Z, 2014, J VET INTERN MED, V28, P59, DOI 10.1111/jvim.12261; Ritchie LE, 2010, VET MICROBIOL, V144, P140, DOI 10.1016/j.vetmic.2009.12.045; Schmidt M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201279; Shao XQ, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00170; Soontararak S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220522; Stinson LF, 2020, J DEV ORIG HLTH DIS, V11, P201, DOI 10.1017/S2040174419000588; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Suchodolski JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127378; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Sykes JE, 2014, VET CLIN N AM-SMALL, V44, P331, DOI 10.1016/j.cvsm.2013.10.005; Tanaka S, 2009, FEMS IMMUNOL MED MIC, V56, P80, DOI 10.1111/j.1574-695X.2009.00553.x; Tauchi H, 2019, BENEF MICROBES, V10, P641, DOI 10.3920/BM2019.0003; Tierney BT, 2019, CELL HOST MICROBE, V26, P283, DOI 10.1016/j.chom.2019.07.008; Tizard IR, 2018, VET CLIN N AM-SMALL, V48, P307, DOI 10.1016/j.cvsm.2017.10.008; Torres-Henderson C, 2017, TOP COMPANION ANIM M, V32, P104, DOI 10.1053/j.tcam.2017.11.002; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ungaro R, 2014, AM J GASTROENTEROL, V109, P1728, DOI 10.1038/ajg.2014.246; Vangay P, 2015, CELL HOST MICROBE, V17, P553, DOI 10.1016/j.chom.2015.04.006; Watson VE, 2019, VET MICROBIOL, V231, P197, DOI 10.1016/j.vetmic.2019.03.020; WHITE AR, 1985, J ANTIMICROB CHEMOTH, V15, P227, DOI 10.1093/jac/15.suppl_A.227; Whittemore JC, 2019, GUT MICROBES, V10, P521, DOI 10.1080/19490976.2018.1560754; Whittemore JC, 2018, PEERJ, V6, DOI 10.7717/peerj.5130; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x; Yang YT, 2021, POL J MICROBIOL, V70, P33, DOI 10.33073/pjm-2021-001; Young WN, 2016, SCI REP-UK, V6, DOI 10.1038/srep34668; Zaura E, 2015, MBIO, V6, DOI 10.1128/mBio.01693-15; Zhang JH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52632-5	105	4	4	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0253031	10.1371/journal.pone.0253031	http://dx.doi.org/10.1371/journal.pone.0253031			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910719	gold, Green Submitted, Green Published			2022-12-26	WOS:000754828900004
J	Wang, SB; Li, TW; Li, DD; Cheng, H				Wang, Sibo; Li, Tingwei; Li, Dongdong; Cheng, Hong			Contributions of park constructions to residents' demands of ecosystem services consumption: A case study of urban public parks in Beijing	PLOS ONE			English	Article							GREEN SPACES; MICROCLIMATE; HEALTH; MOTIVATION; VISITORS	Urban public parks can provide convenience for residents to get close to nature and provide places for daily ecosystem services. It is of practical and theoretical significance to choose urban public parks as the entry point to explore the changing trends and supply paths of urban residents' daily ecosystem service consumption. Based on the government 's research? of urban public parks in Beijing from 1993 to 2018, this study explores the residents' ecosystem services consumption demands and the contributions of park constructions to these demands. The results show that: (1) in the past 25 years, the frequency, duration, participation rate, and evaluation of people's daily ecosystem service consumption have increased significantly. In other words, the ecosystem services demands are increasing. (2) different constructions of a park have distinct contributions to the increasing demands of ecosystem service consumption. The contributions from constructions of the natural landscape and the infrastructure have been in decline since 1993, yet they contribute the most to the demands of residents' ecosystem services consumption until 2018. The contributions made by constructions of management and maintenance, and transportation around urban public parks have been on the rise and the significant points occurring after the 2008 Olympic Games. Our research proposes a method to determine the relation between the demands of residents' ecosystem services consumption and the contributions of park constructions to these demands, which has significant implications for optimizing the constructions of urban public parks to better meet the demands of ecosystem services consumption.	[Wang, Sibo] Res Inst Ecocivilizat CASS, Beijing 100028, Peoples R China; [Li, Tingwei; Cheng, Hong] Beijing E Hualu Informat Technol Co Ltd, Dept Data Res, Beijing 100430, Peoples R China; [Li, Dongdong] North China Univ Technol, Dept Marxism, Beijing 100144, Peoples R China	North China University of Technology	Li, TW (corresponding author), Beijing E Hualu Informat Technol Co Ltd, Dept Data Res, Beijing 100430, Peoples R China.	1046332069@qq.com			Major Program of National Social Science Fund [2016MZD023]; National Social Science Found Youth Project [15CGL039]; National Statistical Science Research Project [2021LY069]; National Key Research and Development Program of China [2018YFB1601600]	Major Program of National Social Science Fund; National Social Science Found Youth Project; National Statistical Science Research Project; National Key Research and Development Program of China	This research was funded by Major Program of National Social Science Fund (2016MZD023), National Social Science Found Youth Project (15CGL039), National Statistical Science Research Project (2021LY069), and National Key Research and Development Program of China (2018YFB1601600). Wang received the former three awards (2016MZD023, 15CGL039, 2021LY069) and Cheng received the fourth award (2018YFB1601600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahabadi A, 2017, CHEMOSPHERE, V172, P459, DOI 10.1016/j.chemosphere.2017.01.045; Andreucci MB, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11226425; Artmann M, 2017, URBAN FOR URBAN GREE, V27, P203, DOI 10.1016/j.ufug.2017.08.007; Bedimo-Rung AL, 2005, AM J PREV MED, V28, P159, DOI 10.1016/j.amepre.2004.10.024; Bolund P, 1999, ECOL ECON, V29, P293, DOI 10.1016/S0921-8009(99)00013-0; Chiesura A, 2004, LANDSCAPE URBAN PLAN, V68, P129, DOI 10.1016/j.landurbplan.2003.08.003; Du W.G., 2018, FORESTRY SCI, V54, P155; Engstrom G, 2017, ECOL SOC, V22, DOI 10.5751/ES-09365-220221; Hung K., 2006, Leisure Studies, V25, P291, DOI 10.1080/02614360500409810; Irvine KN, 2013, INT J ENV RES PUB HE, V10, P417, DOI 10.3390/ijerph10010417; Jun Y., 2018, SCI TOTAL ENVIRON, P639; Kamri T, 2013, PROCD SOC BEHV, V101, P495, DOI 10.1016/j.sbspro.2013.07.223; Kemperman ADAM, 2006, LEISURE SCI, V28, P57, DOI 10.1080/01490400500332710; Kibria ASMG, 2017, ECOSYST SERV, V26, P27, DOI 10.1016/j.ecoser.2017.05.008; Lee ACK, 2011, J PUBLIC HEALTH-UK, V33, P212, DOI 10.1093/pubmed/fdq068; Lee YCh LiaoPT., 2021, ECOL MODEL, V439; Liang H, 2014, J FORESTRY RES, V25, P847, DOI 10.1007/s11676-014-0475-9; Lin BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087422; Lindsey G, 2001, PROF GEOGR, V53, P332, DOI 10.1111/0033-0124.00288; Martin-Lopez B, 2017, LAND USE POLICY, V66, P90, DOI 10.1016/j.landusepol.2017.04.040; McCormack GR, 2010, HEALTH PLACE, V16, P712, DOI 10.1016/j.healthplace.2010.03.003; Mullaney Jennifer., 2014, LANDSCAPE URBAN PLAN; Norris C, 2012, J APPL ECOL, V49, P562, DOI 10.1111/j.1365-2664.2011.02084.x; Regina L., 2017, ECOSPHERE, V8; Russo A., 2019, Advances in Horticultural Science, V33, P605, DOI 10.13128/ahsc-8230; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Sodoudi S, 2018, URBAN FOR URBAN GREE, V34, P85, DOI 10.1016/j.ufug.2018.06.002; Sutton PC, 2019, LAND-BASEL, V8, DOI 10.3390/land8040054; Takacs A, 2016, PROCEDIA ENVIRON SCI, V32, P97, DOI 10.1016/j.proenv.2016.03.015; Talen E, 2010, J URBAN DES, V15, P473, DOI 10.1080/13574809.2010.502335; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Vanwalleghem T, 2009, ECOSYSTEMS, V12, P1158, DOI 10.1007/s10021-009-9281-1; Verburg PH, 1999, GLOBAL ENVIRON CHANG, V9, P303, DOI 10.1016/S0959-3780(99)00175-2; Wang X., 2017, CHINESE LANDSCAPE AR, V33, P14; Wright DR, 2015, SOC NATUR RESOUR, V28, P1013, DOI 10.1080/08941920.2015.1054976; Wright Wendel HeatherE., 2012, LANDSCAPE URBAN PLAN, DOI [10.1016/j.landurbplan.2012.01.011, DOI 10.1016/J.LANDURBPLAN.2012.01.011]; Xuliang Zhang., 2013, NRC RES PRESS, V89; Zhang H., 2017, CHINESE LANDSCAPE AR, P18	38	1	1	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0259661	10.1371/journal.pone.0259661	http://dx.doi.org/10.1371/journal.pone.0259661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY5KW	34910723	Green Published, gold			2022-12-26	WOS:000754828900008
J	Rasmussen, G; Smultea, M; Cloutier, T; Giordano, A; Kaplin, B; Willey, L				Rasmussen, Gregory; Smultea, Mari; Cloutier, Tammy; Giordano, Anthony; Kaplin, Beth; Willey, Lisabeth			Quantitative photogrammetric methodology for measuring mammalian belly score in the painted dog	PLOS ONE			English	Article							HWANGE NATIONAL-PARK; BODY CONDITION; LYCAON-PICTUS; PACK SIZE; AFRICAN; POPULATION; DOMINANCE; LIONS; TRAP; HERBIVORES	The use of "belly scoring" can offer a novel, non-invasive objective management tool to gauge food intake between individuals, groups, and populations, and thus, population fitness. As food availability is increasingly affected by predation, ecological competition, climate change, habitat modification, and other human activities, an accurate belly scoring tool can facilitate comparisons among wildlife populations, serving as an early warning indicator of threats to wildlife population health and potential population collapse. In social species, belly scores can also be a tool to understand social behavior and ranking. We developed and applied the first rigorous quantitative photogrammetric methodology to measure belly scores of wild painted dogs (Lycaon pictus). Our methodology involves: (1) Rigorous selection of photographs of the dorso/lateral profile of individuals at a right angle to the camera, (2) photogrammetrically measuring belly chord length and "belly drop" in pixels, (3) adjusting belly chord length as a departure from a standardized leg angle, and (4) converting pixel measurements to ratios to eliminate the need to introduce distance from the camera. To highlight a practical application, this belly score method was applied to 631 suitable photographs of 15 painted dog packs that included 186 individuals, all collected between 2004-2015 from allopatric painted dog populations in and around Hwange (n = 462) and Mana Pools National Parks (n = 169) in Zimbabwe. Variation in mean belly scores exhibited a cyclical pattern throughout the year, corresponding to biologically significant patterns to include denning demand and prey availability. Our results show significant differences between belly scores of the two different populations we assessed, thus highlighting food stress in the Hwange population. In the face of growing direct and indirect anthropogenic disturbances, this standardised methodology can provide a rapid, species-specific non-invasive management tool that can be applied across studies to rapidly detect emergent threats.	[Rasmussen, Gregory] Painted Dog Res Trust, Victoria Falls, Zimbabwe; [Smultea, Mari; Cloutier, Tammy] Smultea Environm Sci, Preston, WA USA; [Cloutier, Tammy; Willey, Lisabeth] Antioch Univ New England, Keene, New Hampshire, England; [Giordano, Anthony] SPECIES Soc Preservat Endangered Carnivores & Int, Ventura, CA USA; [Kaplin, Beth] Univ Rwanda, Kigali, Rwanda	University of Rwanda	Rasmussen, G (corresponding author), Painted Dog Res Trust, Victoria Falls, Zimbabwe.	greg@painteddogresearch.org		Cloutier, Tammy/0000-0001-8273-286X				Barrickman NL, 2015, AM J PRIMATOL, V77, P823, DOI 10.1002/ajp.22416; Betram B.C.R., 1975, East African Wildlife Journal, V13, P141; Buettner UK, 2007, J ZOOL, V272, P10, DOI 10.1111/j.1469-7998.2006.00240.x; CARO TM, 1987, BEHAV ECOL SOCIOBIOL, V20, P351, DOI 10.1007/BF00300681; Chamaille-Jammes S, 2007, J TROP ECOL, V23, P725, DOI 10.1017/S0266467407004531; CHILDES SL, 1988, BIOL CONSERV, V44, P301, DOI 10.1016/0006-3207(88)90022-5; Cloutier TL, 2021, HUM DIMENS WILDL, V26, P481, DOI 10.1080/10871209.2020.1849873; Courchamp F, 2002, BEHAV ECOL, V13, P20, DOI 10.1093/beheco/13.1.20; Courchamp F, 2001, ANIM CONSERV, V4, P169, DOI 10.1017/S1367943001001196; Creel S, 2001, CONSERV BIOL, V15, P271, DOI 10.1046/j.1523-1739.2001.99534.x; Croes B, 2012, CANID NEWS, P15; Cui S, 2020, J ZOOL, V312, P12, DOI 10.1111/jzo.12788; CUMMING DHM, 1982, ECOL STUD, V42, P217; Dauwalter DC, 2009, T AM FISH SOC, V138, P38, DOI 10.1577/T07-154.1; Davies-Mostert H T, 2010, BASELINE RESULTS 5 T; DelGiudice GD, 2011, J WILDLIFE DIS, V47, P30, DOI 10.7589/0090-3558-47.1.30; Dudley JP, 2001, AFR J ECOL, V39, P187, DOI 10.1046/j.0141-6707.2000.00297.x; Dunham KM, 2013, AFR J ECOL, V51, P431, DOI 10.1111/aje.12052; Edwards CTT., 2018, PLOS ONE, V8; FANSHAWE J H, 1991, Oryx, V25, P137; Fearnbach H, 2018, ENDANGER SPECIES RES, V35, P175, DOI 10.3354/esr00883; Fearnbach Holly, 2011, Endangered Species Research, V13, P173, DOI 10.3354/esr00330; Fernando Prithiviraj, 2009, Gajah, V31, P29; Frame GW., 1977, WILDLIFE NEWS, V12, P2; Gaidet-Drapier N, 2006, BIODIVERS CONSERV, V15, P735, DOI 10.1007/s10531-004-1063-7; Giles SL, 2015, APPL ANIM BEHAV SCI, V166, P71, DOI 10.1016/j.applanim.2015.02.019; Gonzalez LF, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010097; Green SE, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10010132; Hing S, 2016, WILDLIFE RES, V43, P51, DOI 10.1071/WR15183; IBM Corp, 2019, IBM SPSS STAT WINDOW; Knobel DL, 2002, J WILDLIFE DIS, V38, P352, DOI 10.7589/0090-3558-38.2.352; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lane EP, 2014, EUR J WILDLIFE RES, V60, P599, DOI 10.1007/s10344-014-0824-1; Lehmann MB, 2008, S AFR J WILDL RES, V38, P66, DOI 10.3957/0379-4369-38.1.66; Lehmann MB, 2008, AFR ZOOL, V43, P230, DOI 10.3377/1562-7020-43.2.230; MADDOCK AH, 1994, BIOL CONSERV, V67, P57, DOI 10.1016/0006-3207(94)90009-4; Marnewick K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086265; Marsden CD, 2012, MOL ECOL, V21, P1379, DOI 10.1111/j.1365-294X.2012.05477.x; Mech LD, 1999, CAN J ZOOL, V77, P1196, DOI 10.1139/cjz-77-8-1196; Meyer CFJ, 2010, BIOL CONSERV, V143, P2797, DOI 10.1016/j.biocon.2010.07.029; Miller CA, 2012, MAR ECOL PROG SER, V459, P135, DOI 10.3354/meps09675; Mills M. G. L., 1995, Koedoe, V38, P95; Monks NJ, 2008, DEMOGRAPHY POPULATIO; Mott CL, 2010, WILDLIFE BIOL, V16, P93, DOI 10.2981/09-010; Muneza AB, 2019, J WILDLIFE DIS, V55, P770, DOI 10.7589/2018-06-149; Packer C., 1986, P429; Perez-Flores J, 2016, TROP CONSERV SCI, V9, DOI 10.1177/1940082916676128; Perryman Wayne L., 2002, Journal of Cetacean Research and Management, V4, P155; Range Wide Conservation Program for Cheetah & African Wild Dogs (RWCP), 2019, RANG WID; Rasmussen G., 2009, THESIS U OXFORD UK; Rasmussen GSA, 2008, AM NAT, V172, P508, DOI 10.1086/590965; Rasmussen GSA, 1999, BIOL CONSERV, V88, P133, DOI 10.1016/S0006-3207(98)00006-8; Schiffmann C, 2017, J ZOO AQUAR RES, V5, P1; Shirane Y, 2020, PEERJ, V8, DOI 10.7717/peerj.9982; Shrader AM, 2006, S AFR J WILDL RES, V36, P1; Shumba T, 2018, AFR J WILDL RES, V48, DOI 10.3957/056.048.013002; Smiley RA, 2020, WILDLIFE SOC B, V44, P208, DOI 10.1002/wsb.1070; Tarugara A, 2019, PEERJ, V7, DOI 10.7717/peerj.7630; TILSON RL, 1984, ANIM BEHAV, V32, P715, DOI 10.1016/S0003-3472(84)80147-5; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; van der Meer E, 2014, ORYX, V48, P285, DOI 10.1017/S0030605312001366; van der Meer E, 2014, AFR J ECOL, V52, P69, DOI 10.1111/aje.12092; Wilkinson I., 1995, 19941995 WILD UNPUB; Willisch CS, 2013, MAMM BIOL, V78, P351, DOI 10.1016/j.mambio.2013.02.004; Woodroffe R, 2017, J ANIM ECOL, V86, P1329, DOI 10.1111/1365-2656.12719; Woodroffe Rosie, 1997, P58; Zielke L, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8100163; Zimbabwe Parks and Wildlife Management Authority (ZPWMA), 2017, MAN POOLS	68	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261171	10.1371/journal.pone.0261171	http://dx.doi.org/10.1371/journal.pone.0261171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905569	gold, Green Published			2022-12-26	WOS:000754615500025
J	Flower, J; Estep, A; James, K; Ramdeen, R; Runge, CA; Thomas, L; Lester, SE				Flower, Jason; Estep, Andy; James, Keinan; Ramdeen, Robin; Runge, Claire A.; Thomas, Lennon; Lester, Sarah E.			An experimental evaluation of the effect of escape gaps on the quantity, diversity, and size of fish caught in traps in Montserrat	PLOS ONE			English	Article							RESOURCE USERS; REEF FISHES; MANAGEMENT; SUSTAINABILITY; SELECTIVITY; BYCATCH	Coral reef fisheries are vital to the livelihoods of millions of people worldwide but are challenging to manage due to the high diversity of fish species that are harvested and the multiple types of fishing gear that are used. Fish traps are a commonly used gear in reef fisheries in the Caribbean and other regions, but they have poor selectivity and frequently capture juvenile fish, impacting the sustainability of the fishery. One option for managing trap fisheries is the addition of escape gaps, which allow small fish to escape. We compared catches of traps with and without two 2.5 cm (1 inch) escape gaps on the Caribbean island of Montserrat. No significant differences were found in the mean fish length, total fish biomass, number of fish, fish species richness, and Shannon diversity index between hauls of the two trap designs, though traps with escape gaps did catch larger proportions of wider-bodied fish and smaller proportions of narrow-bodied fish. Furthermore, traps with gaps caught a smaller proportion of small-sized fish and fewer immature fish (though differences were not statistically significant). Linear mixed effect models predict that soak time (the length of time between trap hauls) increases the mean catch length, total catch biomass and total number of species in the catch. The relatively modest evidence for the effect of the gaps on catch may be explained by the long soak times used, which could have allowed most smaller-sized fish to escape or be consumed by larger individuals before hauling in both traps with and without escape gaps. Despite the small differences detected in this study, escape gaps may still offer one of the best options for improving sustainability of catches from fish traps, but larger escape gaps should be tested with varying soak times to determine optimum escape gap size.	[Flower, Jason; Thomas, Lennon] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Flower, Jason; Thomas, Lennon] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Flower, Jason; Thomas, Lennon] Univ Calif Santa Barbara, Environm Market Solut Lab, Santa Barbara, CA 93106 USA; [Estep, Andy; Ramdeen, Robin] Waitt Inst, La Jolla, CA USA; [James, Keinan] Minist Educ Youth Affairs & Sports, Youth Apprenticeship Program, Brades, Montserrat; [Runge, Claire A.] Univ Queensland, Sch Earth & Environm Sci, St Lucia, Qld, Australia; [Lester, Sarah E.] Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Queensland; State University System of Florida; Florida State University	Flower, J (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.; Flower, J (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.; Flower, J (corresponding author), Univ Calif Santa Barbara, Environm Market Solut Lab, Santa Barbara, CA 93106 USA.	jflower@ucsb.edu	Flower, Jason/W-7656-2019	Flower, Jason/0000-0002-6731-8182	Waitt Foundation	Waitt Foundation	This project was funded by the Waitt Foundation, https://www.waittfoundation.org/.The Waitt Institute provided staff and resources to conduct the study, but they played no role in the study design, analysis, or decision to publish.	Ault JS, 2008, ENVIRON CONSERV, V35, P221, DOI 10.1017/S0376892908005043; Bacheler NM, 2013, ICES J MAR SCI, V70, P873, DOI 10.1093/icesjms/fst062; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beliaeff B., 1992, P 41 GULF CAR FISH I, P150; Bohnsack J.A., 1989, MAR FISH REV, V51, P36; Brown CJ, 2016, ECOLOGY, V97, P2447, DOI 10.1002/ecy.1463; Condy M, 2015, AQUAT CONSERV, V25, P396, DOI 10.1002/aqc.2482; CRFM, 2014, 10 ANN CRFM SCI M KI, V1; DeMartini Edward E., 2015, P135; Dulvy N., 2009, NAT CLIM CHANGE, V1, P68, DOI [10.1038/climate.2009.52, DOI 10.1038/CLIMATE.2009.52]; Estep A., 2018, MARINE SCI ASSESSMEN, P123; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Garrison VH, 1998, REV BIOL TROP, V46, P41; Gomes I, 2014, AQUAT CONSERV, V24, P680, DOI 10.1002/aqc.2389; Harrison XA, 2018, PEERJ, V6, DOI 10.7717/peerj.4794; Hawkins JP, 2007, AQUAT CONSERV, V17, P111, DOI 10.1002/aqc.784; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Hoegh-Guldberg O, 2019, REG STUD MAR SCI, V30, DOI 10.1016/j.rsma.2019.100699; Jimenez AR., 1996, P 44 GULF CAR FISH I; Johnson AE, 2010, MAR ECOL PROG SER, V415, P201, DOI 10.3354/meps08762; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Ludecke D., 2021, **DATA OBJECT**, DOI 10.5281/zenodo.2400856; Mahon R, 2001, FISH FISH, V2, P356, DOI 10.1046/j.1467-2960.2001.00054.x; Mbaru EK, 2013, FISH RES, V148, P90, DOI 10.1016/j.fishres.2013.08.011; McClanahan TR, 2018, CONSERV BIOL, V32, P159, DOI 10.1111/cobi.12980; McClanahan TR, 2008, ENVIRON CONSERV, V35, P340, DOI 10.1017/S0376892908005250; McClanahan TR, 2005, FISHERIES MANAG ECOL, V12, P105, DOI 10.1111/j.1365-2400.2004.00431.x; McClanahan TR, 2004, FISHERIES MANAG ECOL, V11, P51, DOI 10.1111/j.1365-2400.2004.00358.x; MILLER RJ, 1987, B MAR SCI, V40, P484; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Munro JL., 2003, P 54 GULF CAR FISH I; Munro JL., 1971, P 23 GULF CAR FISH I, P184; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; NOAA, 2015, REP IMP GHOST FISH V, P25; Ponteen A., 2014, MONTSERRAT NATL FISH; R Core Team, 2021, R LANGUAGE ENV STAT; Renchen GF, 2012, J FISH BIOL, V81, P1611, DOI 10.1111/j.1095-8649.2012.03418.x; Robertson D.R., 2019, SHOREFISHES GREATER; Rogers A, 2018, J APPL ECOL, V55, P1041, DOI 10.1111/1365-2664.13051; Rogers A, 2014, CURR BIOL, V24, P1000, DOI 10.1016/j.cub.2014.03.026; Sandin SA, 2008, CARIBB J SCI, V44, P137; Sary Z, 1997, MAR ECOL PROG SER, V154, P107, DOI 10.3354/meps154107; Scheld AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19671; Selliah N., 2001, P 52 GULF CAR FISH I, P634; Sheridan P., 2005, Proceedings of the Gulf and Caribbean Fisheries Institute, V56, P511; Solt F., 2018, DOTWHISKER DOT AND W; Sustainable Fisheries Group, 2016, ASS MONTS FISH, P35; Teh LSL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065397; Warton DI, 2016, METHODS ECOL EVOL, V7, P882, DOI 10.1111/2041-210X.12552; Williams SM, 2015, J BIOGEOGR, V42, P1327, DOI 10.1111/jbi.12509	51	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0261119	10.1371/journal.pone.0261119	http://dx.doi.org/10.1371/journal.pone.0261119			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890426	gold, Green Published			2022-12-26	WOS:000747293600027
J	Li, ZM; Fu, W; Udimal, TB; Luo, MC; Chen, JC				Li, Zhongming; Fu, Wei; Udimal, Thomas Bilaliib; Luo, Mingcan; Chen, Jiancheng			The measurement of competitiveness of forest green food industry in Yunnan Province	PLOS ONE			English	Article							ORGANIC FOOD; CONSUMPTION; KNOWLEDGE; PURCHASE	Improvement in living standards has led to the development and utilization of forest green foods. The study seeks to examine the foundation and potential of forest green food industry in Yunnan Province. By constructing the industrial competitive advantage model, this paper measured and analyzed the competitiveness of forest green food industry in Yunnan Province from 2016 to 2020 by using fuzzy evaluation method and AHP. The conclusions were as follows: (1) The competitiveness of forest green food industry in Yunnan Province was at a medium level with competitiveness index of 83.98. (2) The competitive advantage of forest green food industry in Yunnan Province mainly depended on key factors such as natural endowment and education level. The area is however not having comparative advantage in general factors and important factors. Therefore, there is the need to put in place measures to realise the full potential of forest green food industry in the area by providing players in the sector with requisite skills.	[Li, Zhongming; Fu, Wei; Udimal, Thomas Bilaliib; Luo, Mingcan] Southwest Forestry Univ, Sch Econ & Management, Kunming, Yunnan, Peoples R China; [Chen, Jiancheng] Beijing Forestry Univ, Sch Econ & Management, Beijing, Peoples R China	Southwest Forestry University - China; Beijing Forestry University	Fu, W (corresponding author), Southwest Forestry Univ, Sch Econ & Management, Kunming, Yunnan, Peoples R China.	fuweiynlzd@163.com		Li, ZhongMing/0000-0002-1096-022X	Major Project of Philosophy and Social Sciences in Yunnan Province [174212]; Planning Office of Philosophy and Social Sciences of Yunnan Province	Major Project of Philosophy and Social Sciences in Yunnan Province; Planning Office of Philosophy and Social Sciences of Yunnan Province	This study was supported by Major Project of Philosophy and Social Sciences in Yunnan Province(Grant no. 174212) from Planning Office of Philosophy and Social Sciences of Yunnan Province (http://www.ynpopss.gov.cn/).The funder had a role in preparation of the manuscript.	Bose P, 2019, EUROPEAN I FOOD LAW; Brantsaeter AL, 2017, ANNU REV PUBL HEALTH, V38, P295, DOI 10.1146/annurev-publhealth-031816-044437; Claro DP, 2004, J BUS IND MARK, V19, P405, DOI 10.1108/08858620410556345; Czerepko J., 2016, GOVERNANCE ECOLOGY, V12, P215; DEYOUNG R, 1985, J ENVIRON SYST, V15, P281, DOI 10.2190/3FWV-4WM0-R6MC-2URB; Dholakia Jalpa, 2012, Journal of Human Ecology, V37, P221; Fu W, 2020, PHYS CHEM EARTH, V120, DOI 10.1016/j.pce.2020.102904; Fungo R, 2016, APPETITE, V97, P176, DOI 10.1016/j.appet.2015.12.005; Hsieh MF, 2012, AM J AGR ECON, V94, P307, DOI 10.1093/ajae/aar100; Iqbal M, 1995, TRADE RESTRICTIONS A; Kahl J, 2012, J SCI FOOD AGR, V92, P2751, DOI 10.1002/jsfa.5888; Kaminska N., 2016, Agronomy Research, V14, P67; King F.H., 1911, FARMERS FORTY CENTUR; [刘庆博 Liu Qingbo], 2013, [西北林学院学报, Journal of Northwest Forestry College], V28, P265; Nischalke SM, 2017, MT RES DEV, V37, P254, DOI 10.1659/MRD-JOURNAL-D-16-00096.1; Norikane A., 2009, LEISA Magazine, V25, P10; Nytofte JLS, 2019, URBAN FOR URBAN GREE, V45, DOI 10.1016/j.ufug.2019.04.009; Odebode Stella O., 2005, Journal of Food Agriculture & Environment, V3, P138; Raynolds LT, 2004, WORLD DEV, V32, P725, DOI 10.1016/j.worlddev.2003.11.008; Rowland D, 2017, ENVIRON CONSERV, V44, P102, DOI 10.1017/S0376892916000151; Shaheen MAR, 2013, J FOOD AGRIC ENVIRON, V11, P231; Singer H, 2018, TURK J AGRIC FOR, V42, P364, DOI 10.3906/tar-1801-138; Song XD, 2020, INT J INTELLIGENT IN, V9, P184; Sudarmalik, 2014, MANUJ HUTAN TROPIKA, V20, P159, DOI 10.7226/jtfm.20.3.159; Sun CZ, 2021, FRONT ENV SCI-SWITZ, V9, DOI 10.3389/fenvs.2021.665990; Thorsoe MH, 2015, J AGR ENVIRON ETHIC, V28, P767, DOI 10.1007/s10806-015-9559-6; Tokarczyk J, 2006, FOREST PROD J, V56, P4; Vietoris V, 2016, POL J FOOD NUTR SCI, V66, P139, DOI 10.1515/pjfns-2015-0028; [王德章 WANG De-zhang], 2009, [中国工业经济, China Industrial Economy], P67; [王德章 Wang Dezhang], 2006, [中国工业经济, China Industrial Economy], P32; Wang JM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134676; Wang YZ., 2009, ISSUES FORESTRY EC, V29, P438; Wu JG, 2013, LANDSCAPE ECOL, V28, P999, DOI 10.1007/s10980-013-9894-9; Yin SJ, 2010, J SCI FOOD AGR, V90, P1361, DOI 10.1002/jsfa.3936; Yu XH, 2014, FOOD POLICY, V45, P80, DOI 10.1016/j.foodpol.2014.01.003; Zhai XJ., 2019, FORESTRY EC, V41, P80; Zheng DS., 2019, ISSUES FORESTRY EC, V39, P621; Zhou RG, 2017, WORK, V56, P21, DOI 10.3233/WOR-162473	38	3	3	11	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0261133	10.1371/journal.pone.0261133	http://dx.doi.org/10.1371/journal.pone.0261133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890443	gold, Green Published			2022-12-26	WOS:000747293600029
J	Basten, MGJ; Van Wees, DA; Matser, A; Boyd, A; Rozhnova, G; Den Daas, C; Kretzschmar, MEE; Heijne, JCM				Basten, Maartje G. J.; van Wees, Daphne A.; Matser, Amy; Boyd, Anders; Rozhnova, Ganna; den Daas, Chantal; Kretzschmar, Mirjam E. E.; Heijne, Janneke C. M.			Time for change: Transitions between HIV risk levels and determinants of behavior change in men who have sex with men	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; UNITED-STATES; PREDICTORS; MSM; PREVENTION; TRENDS	As individual sexual behavior is variable over time, the timing of interventions might be vital to reducing HIV transmission. We aimed to investigate transitions between HIV risk levels among men who have sex with men (MSM), and identify determinants associated with behavior change. Participants in a longitudinal cohort study among HIV-negative MSM (Amsterdam Cohort Studies) completed questionnaires about their sexual behavior during biannual visits (2008-2017). Visits were assigned to different HIV risk levels, based on latent classes of behavior. We modelled transitions between risk levels, and identified determinants associated with these transitions at the visit preceding the transition using multi-state Markov models. Based on 7,865 visits of 767 participants, we classified three risk levels: low (73% of visits), medium (22%), and high risk (5%). For MSM at low risk, the six-month probability of increasing risk was 0.11. For MSM at medium risk, the probability of increasing to high risk was 0.08, while the probability of decreasing to low risk was 0.33. For MSM at high risk, the probability of decreasing risk was 0.43. Chemsex, erection stimulants and poppers, high HIV risk perception, and recent STI diagnosis were associated with increased risk at the next visit. High HIV risk perception and young age were associated with decreasing risk. Although the majority of MSM showed no behavior change, a considerable proportion increased HIV risk. Determinants associated with behavior change may help to identify MSM who are likely to increase risk in the near future and target interventions at these individuals, thereby reducing HIV transmission.	[Basten, Maartje G. J.; van Wees, Daphne A.; Rozhnova, Ganna; Kretzschmar, Mirjam E. E.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Basten, Maartje G. J.; van Wees, Daphne A.; Matser, Amy; Boyd, Anders] Publ Hlth Serv Amsterdam, Dept Infect Dis Res & Prevent, Amsterdam, Netherlands; [Boyd, Anders] Stichting HIV Monitoring, Amsterdam, Netherlands; [Rozhnova, Ganna] Univ Lisbon, Fac Ciencias, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal; [den Daas, Chantal; Heijne, Janneke C. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [den Daas, Chantal] Inst Appl Hlth Sci, Aberdeen Hlth Psychol Grp, Aberdeen, Scotland	Utrecht University; Utrecht University Medical Center; Public Health Service Amsterdam; BIOISI; Universidade de Lisboa; Netherlands National Institute for Public Health & the Environment; University of Aberdeen	Basten, MGJ (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.; Basten, MGJ (corresponding author), Publ Hlth Serv Amsterdam, Dept Infect Dis Res & Prevent, Amsterdam, Netherlands.	M.G.J.Basten-3@umcutrecht.nl	Boyd, Anders/GLQ-8906-2022; van Wees, Daphne/J-6536-2018	Boyd, Anders/0000-0001-9512-8928; den Daas, Chantal/0000-0003-0955-3691; Matser, Amy/0000-0003-4291-1905; van Wees, Daphne/0000-0002-6562-7029; Rozhnova, Ganna/0000-0002-6725-7359; Kretzschmar, Mirjam/0000-0002-4394-7697	Netherlands Organisation for Health Research and Development ZonMw grant [522004009]	Netherlands Organisation for Health Research and Development ZonMw grant	This project was funded by the Netherlands Organisation for Health Research and Development ZonMw grant 522004009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basten M, 2021, AIDS BEHAV, V25, P1800, DOI 10.1007/s10461-020-03109-4; Basten M, 2018, AIDS, V32, P1185, DOI 10.1097/QAD.0000000000001803; BLOWER SM, 1995, EPIDEMIOLOGY, V6, P238, DOI 10.1097/00001648-199505000-00008; Burns DN, 2014, AIDS RES HUM RETROV, V30, P217, DOI [10.1089/aid.2013.0274, 10.1089/AID.2013.0274]; Champenois K, 2018, AIDS, V32, P1871, DOI 10.1097/QAD.0000000000001916; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Coyer L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205663; Datta J, 2019, SEX HEALTH, V16, P18, DOI 10.1071/SH18025; den Daas C, 2019, SURVEY MANNEN SEKSUA; Hess KL, 2017, AIDS BEHAV, V21, P2811, DOI 10.1007/s10461-017-1799-1; Holtz TH, 2015, ARCH SEX BEHAV, V44, P341, DOI 10.1007/s10508-014-0427-7; Hoornenborg E, 2019, LANCET HIV, V6, pE447, DOI 10.1016/S2352-3018(19)30136-5; Hoornenborg E, 2018, AIDS, V32, P1527, DOI [10.1097/QAD.0000000000001874, 10.1097/qad.0000000000001874]; Hoornenborg E, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25105; Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9; Kaplan D, 2008, DEV PSYCHOL, V44, P457, DOI 10.1037/0012-1649.44.2.457; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Nichols BE, 2016, LANCET INFECT DIS, V16, P1423, DOI 10.1016/S1473-3099(16)30311-5; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Ostrow DG, 2008, AIDS BEHAV, V12, P127, DOI 10.1007/s10461-007-9223-x; Paz-Bailey G, 2016, AIDS, V30, P1985, DOI 10.1097/QAD.0000000000001139; Pines HA, 2014, JAIDS-J ACQ IMM DEF, V65, P579, DOI 10.1097/QAI.0000000000000101; Prestage G, 2019, JAIDS-J ACQ IMM DEF, V81, P52, DOI 10.1097/QAI.0000000000001976; RCore Team, 2020, R LANG ENV STAT COMP; Romero-Severson Ethan O, 2012, Stat Commun Infect Dis, V4; Rozhnova G, 2018, AIDS, V32, P2615, DOI [10.1097/QAD.0000000000002050, 10.1097/qad.0000000000002050]; Staritsky LE, 2020, SEXUALLY TRANSMITTED; StataCorp, 2017, STAT REL 15 STAT SOF, DOI DOI 10.2307/2234838; Stromdahl S, 2015, EUROSURVEILLANCE, V20, P36, DOI 10.2807/1560-7917.ES2015.20.15.21096; Underhill K, 2018, ARCH SEX BEHAV, V47, P2109, DOI 10.1007/s10508-017-1100-8; van Bilsen WPH, 2020, AIDS, V34, P301, DOI 10.1097/QAD.0000000000002417; Van Empelen P, 2011, SCHORER MONITOR 2011; van Sighem A, 2019, MONITORING REPORT 20; van Wees DA, 2020, PREV MED, V139, DOI 10.1016/j.ypmed.2020.106200; VANGRIENSVEN GJP, 1989, BMJ-BRIT MED J, V298, P218, DOI 10.1136/bmj.298.6668.218; Wong CF, 2013, AM J COMMUN PSYCHOL, V51, P439, DOI 10.1007/s10464-012-9562-2; Zhang X., 2012, STAT COMMUN INFECT D, V4, DOI [10.1515/1948-4690.1041, DOI 10.1515/1948-4690.1041]	37	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0259913	10.1371/journal.pone.0259913	http://dx.doi.org/10.1371/journal.pone.0259913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY8LQ	34882698	Green Published, gold			2022-12-26	WOS:000755037200014
J	Choi, SS; Choi, H; Baek, IC; Park, SA; Park, JS; Kim, TG; Jeun, SS; Ahn, S				Choi, Sang-Soo; Choi, Haeyoun; Baek, In-Cheol; Park, Soon A.; Park, Jae-Sung; Kim, Tai-Gyu; Jeun, Sin-Soo; Ahn, Stephen			HLA polymorphisms and risk of glioblastoma in Koreans	PLOS ONE			English	Article							ADJUVANT TEMOZOLOMIDE; BRAIN GLIOMA; CANCER; RADIOTHERAPY; ASSOCIATION; CONCOMITANT; FREQUENCY; ADULTS	Purpose Immune responses for cancer cells can be altered according to genetic variation of human leukocyte antigen (HLA). Association of HLA polymorphism with risk of various cancer types is well known. However, the association between HLA and glioblastoma (GBM) remains uncertain. We sought to evaluate the association of HLA polymorphism with risk of GBM development in Koreans. Materials and methods A case-control study was performed to identify the odds ratios (OR) of HLA class I and II genes for GBM. The control group consisted of 142 healthy Korean volunteers, and the GBM group was 80 patients with newly diagnosed GBM at our institution. HLA class I (-A, -B, and-C) and class II (-DR, -DQ, and-DP) genotyping was performed by high-resolution polymerase chain reaction (PCR)-sequence-based typing (PCR-SBT) methods. Results There were significantly decreased frequencies of HLA-A*26:02 (OR 0.22 CI 0.05-0.98), HLA-C*08:01 (OR 0.29 CI 0.10-0.87), and HLA-DRB1*08:03 (OR 0.32 CI 0.11-0.98), while there was significantly increased frequency of HLA-C*04:01 (OR 2.29 CI 1.05-4.97). In analysis of haplotypes, the frequency of DRB1*14:05-DQB1*05:03 was significantly decreased (OR 0.22 CI 0.05-0.98). Conclusion This study suggests that genetic variations of HLA may affect GBM development in Koreans. Further investigations with larger sample sizes are needed to delineate any potential role of the HLA polymorphisms in the pathogenesis of GBM development.	[Choi, Sang-Soo; Park, Jae-Sung; Jeun, Sin-Soo; Ahn, Stephen] Catholic Univ Korea, Coll Med, Dept Neurosurg, Seoul St Marys Hosp, Seoul, South Korea; [Choi, Haeyoun; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea; [Baek, In-Cheol] Catholic Univ Korea, Coll Med, Catholic Hematopoiet Stem Cell Bank, Seoul, South Korea; [Park, Soon A.; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Ahn, S (corresponding author), Catholic Univ Korea, Coll Med, Dept Neurosurg, Seoul St Marys Hosp, Seoul, South Korea.	nsstp@catholic.ac.kr	Ahn, Stephen/AAB-6150-2021	Ahn, Stephen/0000-0002-6854-1597; Baek, In-Cheol/0000-0003-3630-3364	Basic Science Research Program through the National research Foundation of Korea (NRF) - Ministry of Education [NRF-2020R1I1A1A01072972]; Bio and Medical Technology Development Program of the NRF - Ministry of Science and ICT at South Korea [NRF-2020M3A9E8024875]	Basic Science Research Program through the National research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of Korea); Bio and Medical Technology Development Program of the NRF - Ministry of Science and ICT at South Korea	This research was supported by Basic Science Research Program through the National research Foundation of Korea (NRF) funded by the Ministry of Education (NRF2020R1I1A1A01072972) and the Bio and Medical Technology Development Program of the NRF funded by the Ministry of Science and ICT (NRF2020M3A9E8024875) at South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassig BA, 2011, J NEUROIMMUNOL, V233, P185, DOI 10.1016/j.jneuroim.2010.11.005; Carey BS, 2019, INT J IMMUNOGENET, V46, P307, DOI 10.1111/iji.12443; Dendrou CA, 2018, NAT REV IMMUNOL, V18, P325, DOI 10.1038/nri.2017.143; Disney-Hogg L, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1027-5; Fletcher LB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174457; Garrido F, 2019, IMMUNOLOGY, V158, P255, DOI 10.1111/imm.13114; Garrido F, 2019, ADV EXP MED BIOL, V1151, P79, DOI 10.1007/978-3-030-17864-2_3; Guerini FR, 2006, J NEURO-ONCOL, V77, P213, DOI 10.1007/s11060-005-9032-x; Han S, 2017, CANCER IMMUNOL IMMUN, V66, P1265, DOI 10.1007/s00262-017-2018-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kamiza AB, 2020, CANCER EPIDEMIOL, V67, DOI 10.1016/j.canep.2020.101748; Kim HJ, 2014, INT J SURG, V12, P815, DOI 10.1016/j.ijsu.2014.06.012; La Torre D, 2009, NEUROSURGERY, V64, P1082, DOI 10.1227/01.NEU.0000345946.35786.92; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Li YF, 2019, J CANCER, V10, P4731, DOI 10.7150/jca.33566; Machulla HKG, 2001, J NEURO-ONCOL, V52, P253, DOI 10.1023/A:1010612327647; Ostrom QT, 2019, NEURO-ONCOLOGY, V21, P1357, DOI 10.1093/neuonc/noz123; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Pouchieu C, 2018, J NEURO-ONCOL, V138, P271, DOI 10.1007/s11060-018-2816-6; Probst CM, 2000, HUM BIOL, V72, P597; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Shin DH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216941; Song W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007157; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tang JM, 2005, CANCER EPIDEM BIOMAR, V14, P2040, DOI 10.1158/1055-9965.EPI-05-0136; Wiemels JL, 2002, INT J CANCER, V98, P609, DOI 10.1002/ijc.10239; Yang HM, 2016, TUMOR BIOL, V37, P7119, DOI 10.1007/s13277-016-5051-9; Yoon J, 2015, ACTA HAEMATOL-BASEL, V133, P164, DOI 10.1159/000365436; Zhang CA, 2017, J NEURO-ONCOL, V135, P237, DOI 10.1007/s11060-017-2569-7	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260618	10.1371/journal.pone.0260618	http://dx.doi.org/10.1371/journal.pone.0260618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882724	Green Published, gold			2022-12-26	WOS:000755037200033
J	Soto-Moreno, EJ; Balboula, A; Spinka, C; Rivera, RM				Soto-Moreno, Edgar Joel; Balboula, Ahmed; Spinka, Christine; Rivera, Rocio Melissa			Serum supplementation during bovine embryo culture affects their development and proliferation through macroautophagy and endoplasmic reticulum stress regulation	PLOS ONE			English	Article							IN-VITRO MATURATION; MESSENGER-RNA; CELL-SURVIVAL; AUTOPHAGY; MTOR; PATHWAY; OOCYTES; ABSENCE; QUALITY; GROWTH	Serum supplementation during bovine embryo culture has been demonstrated to promote cell proliferation and preimplantation embryo development. However, these desirable outcomes, have been associated with gene expression alterations of pathways involved in macroautophagy, growth, and development at the blastocyst stage, as well as with developmental anomalies such as fetal overgrowth and placental malformations. In order to start dissecting the molecular pathways by which serum supplementation of the culture medium during the preimplantation stage promotes developmental abnormalities, we examined blastocyst morphometry, inner cell mass and trophectoderm cell allocations, macroautophagy, and endoplasmic reticulum stress. On day 5 post-insemination, > 16 cells embryos were selected and cultured in medium containing 10% serum or left as controls. Embryo diameter, inner cell mass and trophectoderm cell number, and macroautophagy were measured on day 8 blastocysts (BL) and expanded blastocysts (XBL). On day 5 and day 8, we assessed transcript level of the ER stress markers HSPA5, ATF4, MTHFD2, and SHMT2 as well as XBP1 splicing (a marker of the unfolded protein response). Serum increased diameter and proliferation of embryos when compared to the no-serum group. In addition, serum increased macroautophagy of BL when compared to controls, while the opposite was true for XBL. None of the genes analyzed was differentially expressed at any stage, except that serum decreased HSPA5 in day 5 > 16 cells stage embryos. XBP1 splicing was decreased in BL when compared to XBL, but only in the serum group. Our data suggest that serum rescues delayed embryos by alleviating endoplasmic reticulum stress and promotes development of advanced embryos by decreasing macroautophagy.	[Soto-Moreno, Edgar Joel; Balboula, Ahmed; Rivera, Rocio Melissa] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Spinka, Christine] Univ Missouri, Coll Agr Food & Nat Resources, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Rivera, RM (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	riverarm@missouri.edu		Soto-Moreno, Edgar J./0000-0002-1925-2940; Rivera, Rocio Melissa/0000-0002-9832-9618	United States Department of Agriculture Agriculture and Food Research Initiative (USDAAFRI) [2018-67015-27598]; National Institute of HealthInitiative for Maximizing Student Development (NIH-IMSD) [GM056901]	United States Department of Agriculture Agriculture and Food Research Initiative (USDAAFRI)(United States Department of Agriculture (USDA)); National Institute of HealthInitiative for Maximizing Student Development (NIH-IMSD)	This research was partially funded by the United States Department of AgricultureAgriculture and Food Research Initiative (USDAAFRI), grant 2018-67015-27598, PI: RMR. EJSM is funded by the National Institute of HealthInitiative for Maximizing Student Development (NIH-IMSD) T32 Fellowship, R25 grant GM056901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, MOL REPROD DEV, V61, P57, DOI 10.1002/mrd.1131; Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Adjibade P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14262-7; Ali A, 2002, BIOL REPROD, V66, P901, DOI 10.1095/biolreprod66.4.901; Annes K., 2017, Brazilian Journal of Veterinary Research and Animal Science, V54, P209, DOI 10.11606/issn.1678-4456.bjvras.2017.107721; Azari Dolatabad N, 2019, INDIVIDUAL SERUM FRE, P685; Baker M, 2016, NATURE, V537, P433, DOI 10.1038/537433a; Bond P, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0118-y; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Brunner D, 2010, ALTEX-ALTERN ANIM EX, V27, P53; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Chanson A, 2001, J ASSIST REPROD GEN, V18, P97, DOI 10.1023/A:1026534725483; Chen ZY, 2015, P NATL ACAD SCI USA, V112, P4618, DOI 10.1073/pnas.1422088112; Chen ZY, 2013, EPIGENETICS-US, V8, P591, DOI 10.4161/epi.24655; Daigneault BW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25964-x; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Dobrinsky JR, 1996, BIOL REPROD, V55, P1069, DOI 10.1095/biolreprod55.5.1069; Ynsaurralde-Rivolta AE, 2020, THERIOGENOLOGY, V148, P140, DOI 10.1016/j.theriogenology.2020.02.045; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Farin PW, 2001, THERIOGENOLOGY, V55, P151, DOI 10.1016/S0093-691X(00)00452-0; George F, 2008, THERIOGENOLOGY, V69, P612, DOI 10.1016/j.theriogenology.2007.11.008; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Heras S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2393-z; Hetz C, 2020, NAT REV MOL CELL BIO, V21, P421, DOI 10.1038/s41580-020-0250-z; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Krebs M, 2007, DIABETES, V56, P1600, DOI 10.2337/db06-1016; Latorraca LB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69939-3; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Pramanik J, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0589-3; Racek T, 2008, J BIOL CHEM, V283, P34305, DOI 10.1074/jbc.M803925200; Reich S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16747-y; Rivera RM, 2000, J DAIRY SCI, V83, P305, DOI 10.3168/jds.S0022-0302(00)74879-X; Rizos D, 2003, BIOL REPROD, V68, P236, DOI 10.1095/biolreprod.102.007799; RORIE RW, 1994, THERIOGENOLOGY, V42, P397, DOI 10.1016/0093-691X(94)90678-C; Rozpedek W, 2016, CURR MOL MED, V16, P533, DOI 10.2174/1566524016666160523143937; Sabatini DM, 2017, P NATL ACAD SCI USA, V114, P11818, DOI 10.1073/pnas.1716173114; Sakurai N, 2016, CELL REPROGRAM, V18, P309, DOI 10.1089/cell.2015.0081; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shaheen A, 2018, CELL STRESS CHAPERON, V23, P797, DOI 10.1007/s12192-018-0905-2; Sharma A, 2015, THERIOGENOLOGY, V84, P200, DOI 10.1016/j.theriogenology.2015.03.009; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Song BS, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.097949; Sovernigo TC, 2017, REPROD DOMEST ANIM, V52, P561, DOI 10.1111/rda.12946; Spricigo JFW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130164; Stoecklein KS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0243727; Thompson JG, 1998, THERIOGENOLOGY, V49, P1239, DOI 10.1016/S0093-691X(98)00071-5; Tsukamoto S, 2018, J REPROD DEVELOP, V64, P217, DOI 10.1262/jrd.2018-039; Viana J., 2020, EMBRYO TECHNOLOGY NE, V38, P7; Vincenz-Donnelly L, 2017, FREE RADICAL BIO MED, V108, P383, DOI 10.1016/j.freeradbiomed.2017.03.031; Wu J, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0935-8; Wydooghe E, 2014, REPROD FERT DEVELOP, V26, P717, DOI 10.1071/RD13043; Yoon SB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219978; YOUNIS AI, 1989, GAMETE RES, V23, P189, DOI 10.1002/mrd.1120230206; Zhang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040433; Zhang Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196785	65	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260123	10.1371/journal.pone.0260123	http://dx.doi.org/10.1371/journal.pone.0260123			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882691	gold, Green Published			2022-12-26	WOS:000755037200021
J	Park, MS; Lee, S; Ahn, T; Kim, D; Jung, MH; Choi, JH; Han, S; Ryu, KH; Kim, EJ				Park, Myung Soo; Lee, Sunki; Ahn, Taehoon; Kim, Doyoung; Jung, Mi-Hyang; Choi, Jae Hyuk; Han, Seongwoo; Ryu, Kyu Hyung; Kim, Eung Ju			Current status of cardiac rehabilitation among representative hospitals treating acute myocardial infarction in South Korea	PLOS ONE			English	Article							HEART-DISEASE; UPDATE; PARTICIPATION; SERVICES; FAILURE	Cardiac rehabilitation services are mostly underutilized despite the documentation of substantial morbidity and mortality benefits of cardiac rehabilitation post-acute myocardial infarction. To assess the implementation rate and barriers to cardiac rehabilitation in hospitals dealing with acute myocardial infarction in South Korea, between May and July 2016, questionnaires were emailed to cardiology directors of 93 hospitals in South Korea; all hospitals were certified institutes for coronary interventions. The questionnaires included 16 questions on the hospital type, cardiology practice, and implementation of cardiac rehabilitation. The obtained data were categorized into two groups based on the type of the hospital (secondary or tertiary) and statistically analysed. Of the 72 hospitals that responded (response rate of 77%), 39 (54%) were tertiary medical centers and 33 (46%) were secondary medical centers. All hospitals treated acute myocardial infarction patients and performed emergency percutaneous coronary intervention; 79% (57/72) of the hospitals performed coronary artery bypass grafting. However, the rate of implementation of cardiac rehabilitation was low overall (28%, 20/72 hospitals) and even lower in secondary medical centers (12%, 4/33 hospitals) than in tertiary centers (41%, 16/39 hospitals, p = 0.002). The major barriers to cardiac rehabilitation included the lack of staff (59%) and lack of space (33%). In contrast to the wide availability of acute-phase invasive treatment for AMI, the overall implementation of cardiac rehabilitation is extremely poor in South Korea. Considering the established benefits of cardiac rehabilitation in patients with acute myocardial infarction, more administrative support, such as increasing the fee for cardiac rehabilitation services by an appropriate level of health insurance coverage should be warranted.	[Park, Myung Soo; Lee, Sunki; Kim, Doyoung; Jung, Mi-Hyang; Choi, Jae Hyuk; Han, Seongwoo; Ryu, Kyu Hyung] Hallym Univ, Dept Cardiol, Dongtan Sacred Hosp, Hwaseong, South Korea; [Ahn, Taehoon] Korea Univ, Dept Cardiol, Anam Hosp, Seoul, South Korea; [Kim, Eung Ju] Korea Univ, Dept Cardiol, Guro Hosp, Seoul, South Korea	Hallym University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, EJ (corresponding author), Korea Univ, Dept Cardiol, Guro Hosp, Seoul, South Korea.	withnoel@empal.com	안, 태훈/GON-9067-2022	안, 태훈/0000-0003-1544-1784; Kim, Eung Ju/0000-0003-2322-6267; Jung, Mi-Hyang/0000-0003-0224-5178; Park, Myung Soo/0000-0002-8352-5069				ADES PA, 1992, ARCH INTERN MED, V152, P1033, DOI 10.1001/archinte.152.5.1033; Ding RJ, 2017, ADV EXP MED BIOL, V1000, P31, DOI 10.1007/978-981-10-4304-8_3; Europa WRf, 1992, NEEDS ACT PRI CARD R; Francis T, 2019, CAN J CARDIOL, V35, P352, DOI 10.1016/j.cjca.2018.11.013; Giannuzzi P, 2003, Eur J Cardiovasc Prev Rehabil, V10, P319, DOI 10.1097/01.hjr.0000086303.28200.50; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Goto Y, 2007, CIRC J, V71, P173, DOI 10.1253/circj.71.173; Goto Y, 2014, PROG CARDIOVASC DIS, V56, P557, DOI 10.1016/j.pcad.2013.12.001; Jeon B, 2013, HEALTH POLICY, V113, P69, DOI 10.1016/j.healthpol.2013.05.007; Kim C, 2010, ANN REHABIL MED-ARM, V34, P491; Kim Chul LJW., PUBL HLTH WEEKL REP, V13; Kim H, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7439-0; Kim SH, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e262; Korenfeld Y, 2009, AM HEART J, V158, P480, DOI 10.1016/j.ahj.2009.06.020; Lavin D, 2005, IRISH J MED SCI, V174, P33, DOI 10.1007/BF03168979; Lee SW, 2015, KOREAN CIRC J, V45, P202, DOI 10.4070/kcj.2015.45.3.202; McMahon SR, 2017, TRENDS CARDIOVAS MED, V27, P420, DOI 10.1016/j.tcm.2017.02.005; Olsen SJS, 2018, EUR J CARDIOVASC NUR, V17, P273, DOI 10.1177/1474515117737766; Pesah E, 2019, HEART, V105, P1806, DOI 10.1136/heartjnl-2018-314486; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Reiss N., 2019, THORAC CARDIOV SURG; Ribeiro F, 2020, ARQ BRAS CARDIOL, V114, P708, DOI 10.36660/abc.20200157; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Servey JT, 2016, AM FAM PHYSICIAN, V94, P37; Suaya JA, 2009, J AM COLL CARDIOL, V54, P25, DOI 10.1016/j.jacc.2009.01.078; Sukul D, 2019, J AM COLL CARDIOL, V73, P3148, DOI 10.1016/j.jacc.2019.03.515; Thomas RJ, 2010, CIRCULATION, V122, P1342, DOI 10.1161/CIR.0b013e3181f5185b; Turk-Adawi K, 2014, NAT REV CARDIOL, V11, P586, DOI 10.1038/nrcardio.2014.98; Turk-Adawi KI, 2015, HEART LUNG CIRC, V24, P510, DOI 10.1016/j.hlc.2014.11.013; van Engen-Verheul M, 2013, EUR J PREV CARDIOL, V20, P349, DOI 10.1177/2047487312439497	30	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0261072	10.1371/journal.pone.0261072	http://dx.doi.org/10.1371/journal.pone.0261072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879117	Green Published, gold			2022-12-26	WOS:000754625200048
J	Agback, T; Dominguez, F; Frolov, I; Frolova, EI; Agback, P				Agback, Tatiana; Dominguez, Francisco; Frolov, Ilya; Frolova, Elena I.; Agback, Peter			H-1, C-13 and N-15 resonance assignment of the SARS-CoV-2 full-length nsp1 protein and its mutants reveals its unique secondary structure features in solution	PLOS ONE			English	Article							HOST GENE-EXPRESSION; NONSTRUCTURAL PROTEIN-1; PATHOGENICITY FACTOR; NMR-SPECTROSCOPY; RATIONAL DESIGN; RNA-SYNTHESIS; CORONAVIRUS; REPLICATION; MUTAGENESIS; BACKBONE	Structural characterization of the SARS-CoV-2 full length nsp1 protein will be an essential tool for developing new target-directed antiviral drugs against SARS-CoV-2 and for further understanding of intra- and intermolecular interactions of this protein. As a first step in the NMR studies of the protein, we report the H-1, C-13 and N-15 resonance backbone assignment as well as the C beta of the apo form of the full-lengthSARS-CoV-2 nsp1 including the folded domain together with the flaking N- and C- terminal intrinsically disordered fragments. The 19.8 kD protein was characterized by high-resolution NMR. Validation of assignment have been done by using two different mutants, H81P and K129E/D48E as well as by amino acid specific experiments. According to the obtained assignment, the secondary structure of the folded domain in solution was almost identical to its previously published X-ray structure as well as another published secondary structure obtained by NMR, but some discrepancies have been detected. In the solution SARS-CoV-2 nsp1 exhibited disordered, flexible N- and C-termini with different dynamic characteristics. The short peptide in the beginning of the disordered C-terminal domain adopted two different conformations distinguishable on the NMR time scale. We propose that the disordered and folded nsp1 domains are not fully independent units but are rather involved in intramolecular interactions. Studies of the structure and dynamics of the SARS-CoV-2 mutant in solution are on-going and will provide important insights into the molecular mechanisms underlying these interactions.	[Agback, Tatiana; Agback, Peter] Swedish Univ Agr Sci, Dept Mol Sci, Uppsala, Sweden; [Dominguez, Francisco; Frolov, Ilya; Frolova, Elena I.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL USA	Swedish University of Agricultural Sciences; University of Alabama System; University of Alabama Birmingham	Agback, P (corresponding author), Swedish Univ Agr Sci, Dept Mol Sci, Uppsala, Sweden.	peter.agback@slu.se		Agback, Peter/0000-0003-2226-0746	Swedish Foundation for Strategic Research [ITM170218]; Public Health Service [R21AI146969]; UAB Research Acceleration Funds	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); UAB Research Acceleration Funds	This work was supported by Swedish Foundation for Strategic Research grant ITM170218 to P.A. (https://strategiska.se/), Public Health Service grant R21AI146969 to I.F. (https://www.niaid.nih.gov/) and UAB Research Acceleration Funds to E.F. and I.F. (https://www.uab.edu/home/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agback P, 2020, MOLECULES, V25, DOI 10.3390/molecules25245824; Almeida MS, 2007, J VIROL, V81, P3151, DOI 10.1128/JVI.01939-06; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bermel W, 2005, ANGEW CHEM INT EDIT, V44, P3089, DOI 10.1002/anie.200461794; Bermel W, 2005, J MAGN RESON, V172, P324, DOI 10.1016/j.jmr.2004.11.005; Brockway SM, 2005, VIROLOGY, V340, P209, DOI 10.1016/j.virol.2005.06.035; Eckerle LD, 2006, ADV EXP MED BIOL, V581, P55; Enjuanes L, 2006, ANNU REV MICROBIOL, V60, P211, DOI 10.1146/annurev.micro.60.080805.142157; Gomez GN, 2019, BIOCHEM CELL BIOL, V97, P758, DOI 10.1139/bcb-2018-0394; Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433; Jimenez-Guardeno JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005215; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Lapointe CP, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017715118; Lin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061166; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lokugamage KG, 2012, J VIROL, V86, P13598, DOI 10.1128/JVI.01958-12; Markley JL, 1998, EUR J BIOCHEM, V256, P1, DOI 10.1046/j.1432-1327.1998.2560001.x; Nakagawa K, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020300; Nakagawa K, 2018, J VIROL, V92, DOI 10.1128/JVI.01157-18; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schubert K, 2020, NAT STRUCT MOL BIOL, V27, P959, DOI 10.1038/s41594-020-0511-8; Semper C, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2020.101903; Semper C, 2020, PROTEIN SCI, V29, P758, DOI 10.1002/pro.3815; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shen Z, 2021, J GEN VIROL, V102, DOI 10.1099/jgv.0.001513; Sola I, 2015, ANNU REV VIROL, V2, P265, DOI 10.1146/annurev-virology-100114-055218; Tanaka T, 2012, J VIROL, V86, P11128, DOI 10.1128/JVI.01700-12; Thoms M, 2020, SCIENCE, V369, P1249, DOI 10.1126/science.abc8665; Tidu A, 2021, RNA, V27, P253, DOI 10.1261/rna.078121.120; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang Y, 2021, BIOMOL NMR ASSIGN, V15, P287, DOI 10.1007/s12104-021-10019-6; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yuan S, 2020, MOL CELL, V80, P1055, DOI 10.1016/j.molcel.2020.10.034; Zhang K, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe7386; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109	46	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0251834	10.1371/journal.pone.0251834	http://dx.doi.org/10.1371/journal.pone.0251834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874953	Green Submitted, Green Published, gold			2022-12-26	WOS:000753617500001
J	Jiang, W; Fu, XL; Wu, WL				Jiang, Wei; Fu, Xiaoli; Wu, Weiliang			Gene mining, codon optimization and analysis of binding mechanism of an aldo-keto reductase with high activity, better substrate specificity and excellent solvent tolerance	PLOS ONE			English	Article							CHIRAL ALCOHOLS; PURIFICATION; CLONING	The biosynthesis of chiral alcohols has important value and high attention. Aldo-keto reductases (AKRs) mediated reduction of prochiral carbonyl compounds is an interesting way of synthesizing single enantiomers of chiral alcohols due to the high enantio-, chemo- and regioselectivity of the enzymes. However, relatively little research has been done on characterization and apply of AKRs to asymmetric synthesis of chiral alcohols. In this study, the AKR from Candida tropicalis MYA-3404 (C. tropicalis MYA-3404), was mined and characterized. The AKR shown wider optimum temperature and pH. The AKR exhibited varying degrees of catalytic activity for different substrates, suggesting that the AKR can catalyze a variety of substrates. It is worth mentioning that the AKR could catalytic reduction of keto compounds with benzene rings, such as cetophenone and phenoxyacetone. The AKR exhibited activity on N,N-dimethyl-3-keto-3-(2-thienyl)-1-propanamine (DKTP), a key intermediate for biosynthesis of the antidepressant drug duloxetine. Besides, the AKR still has high activity whether in a reaction system containing 10%-30% V/V organic solvent. What's more, the AKR showed the strongest stability in six common organic solvents, DMSO, acetonitrile, ethyl acetate, isopropanol, ethanol, and methanol. And, it retains more that 70% enzyme activity after 6 hours, suggesting that the AKR has strong solvent tolerance. Furthermore, the protein sequences of the AKR and its homology were compared, and a 3D model of the AKR docking with coenzyme NADPH were constructed. And the important catalytic and binding sites were identified to explore the binding mechanism of the enzyme and its coenzyme. These properties, predominant organic solvents resistance and extensive substrate spectrum, of the AKR making it has potential applications in the pharmaceutical field.	[Jiang, Wei; Fu, Xiaoli; Wu, Weiliang] Huaqiao Univ, Coll Chem Engn, Xiamen, Peoples R China	Huaqiao University	Jiang, W (corresponding author), Huaqiao Univ, Coll Chem Engn, Xiamen, Peoples R China.	wjiang@hqu.edu.cn		Jiang, Wei/0000-0002-8194-6003	Natural Science Foundation of China [21808073]; Natural Science Foundation of Fujian Province, China [2021J05058]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province)	The work was supported by the Natural Science Foundation of China (No. 21808073)and the Natural Science Foundation of Fujian Province, China (No. 2021J05058), and they mainly provide funding for research.	Abdur-Rashid K, 2001, J AM CHEM SOC, V123, P7473, DOI 10.1021/ja015902u; Agrawal C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137744; Asako H, 2005, APPL ENVIRON MICROB, V71, P1101, DOI 10.1128/AEM.71.2.1101-1104.2005; Asako H, 1997, APPL ENVIRON MICROB, V63, P1428, DOI 10.1128/AEM.63.4.1428-1433.1997; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bollinger A, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.00106-20; Cai S, 2019, ORG LETT, V21, P4411, DOI 10.1021/acs.orglett.9b00950; Cao C, 2013, BIOCHEM ENG J, V76, P13, DOI 10.1016/j.bej.2013.04.005; Choi YH, 2010, APPL MICROBIOL BIOT, V87, P185, DOI 10.1007/s00253-010-2442-5; Colak NS, 2021, SYNTHETIC COMMUN, V51, P2305, DOI 10.1080/00397911.2021.1931337; Drury JE, 2007, ENZYMOLOGY MOL BIOL, P184; Jiang W, 2020, APPL BIOCHEM BIOTECH, V190, P18, DOI 10.1007/s12010-019-03091-1; Kim T, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03172-16; Knadler MP, 2011, CLIN PHARMACOKINET, V50, P281, DOI 10.2165/11539240-000000000-00000; Lee MS, 2020, ACS SYNTH BIOL, V9, P1951, DOI 10.1021/acssynbio.0c00267; Liang C, 2018, BIORESOUR BIOPROCESS, V5, DOI 10.1186/s40643-018-0220-x; Liao K, 2021, ANGEW CHEM INT EDIT, V60, P8488, DOI 10.1002/anie.202016286; Luo X, 2016, J BIOTECHNOL, V224, P20, DOI 10.1016/j.jbiotec.2016.03.008; Luo X, 2015, ENZYME MICROB TECH, V77, P68, DOI 10.1016/j.enzmictec.2015.06.004; Ma YH, 2013, BIOTECHNOL LETT, V35, P757, DOI 10.1007/s10529-013-1141-6; Maji R, 2019, CHEM-EUR J, V25, P4452, DOI 10.1002/chem.201806068; Marcyk PT, 2019, ANGEW CHEM INT EDIT, V58, P1727, DOI 10.1002/anie.201812894; McFadden CF, 1996, LANGMUIR, V12, P2483, DOI 10.1021/la950348l; Ni Y, 2011, APPL MICROBIOL BIOT, V89, P1111, DOI 10.1007/s00253-010-2941-4; Penning TM, 2015, CHEM-BIOL INTERACT, V234, P236, DOI 10.1016/j.cbi.2014.09.024; Shi Lizhen., 2017, B FERMENTATION SCI T, V046, P198; Soni P, 2005, APPL MICROBIOL BIOT, V67, P771, DOI 10.1007/s00253-004-1870-5; Wang CF, 2016, ANESTH ANALG, V122, P719, DOI 10.1213/ANE.0000000000001086; Wang JW, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21600-x; Wang K, 2020, ANGEW CHEM INT EDIT, V59, P11408, DOI 10.1002/anie.202003104; Wojaczynska E, 2020, CHEM REV, V120, P4578, DOI 10.1021/acs.chemrev.0c00002; Woodley JM, 2008, TRENDS BIOTECHNOL, V26, P321, DOI 10.1016/j.tibtech.2008.03.004; Xiang M, 2021, J AM CHEM SOC, V143, P2838, DOI 10.1021/jacs.0c12242; Zheng GW, 2017, ACS CATAL, V7, P7174, DOI 10.1021/acscatal.7b01933; Zhou MX, 2021, ANGEW CHEM INT EDIT, V60, P1641, DOI 10.1002/anie.202012445; Zhu FC, 2020, J BIOTECHNOL, V309, P68, DOI 10.1016/j.jbiotec.2019.12.014; Zhu T, 2020, INT J BIOL MACROMOL, V159, P622, DOI 10.1016/j.ijbiomac.2020.05.021	37	0	0	8	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260787	10.1371/journal.pone.0260787	http://dx.doi.org/10.1371/journal.pone.0260787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855894	gold, Green Published			2022-12-26	WOS:000735299000122
J	Kamanga, J; Stankevitz, K; Martinez, A; Chiegil, R; Nyirenda, L; Mulenga, F; Chen, M; Mpofu, M; Lubasi, S; Bateganya, M				Kamanga, Joseph; Stankevitz, Kayla; Martinez, Andres; Chiegil, Robert; Nyirenda, Lameck; Mulenga, Florence; Chen, Mario; Mpofu, Mulamuli; Lubasi, Sam; Bateganya, Moses			Improved HIV case finding among key populations after differentiated data driven community testing approaches in Zambia	PLOS ONE			English	Article							SOCIAL NETWORKS	Introduction Open Doors, an HIV prevention project targeting key populations in Zambia, recorded low HIV positivity rates (9%) among HIV testing clients, compared to national adult prevalence (12.3%), suggesting case finding efficiency could be improved. To close this gap, they undertook a series of targeted programmatic and management interventions. We share the outcomes of these interventions, specifically changes in testing volume, HIV positivity rate, and total numbers of key populations living with HIV identified. Methods The project implemented a range of interventions to improve HIV case finding using a Total Quality Leadership and Accountability (TQLA) approach. We analyzed program data for key populations who received HIV testing six months before the interventions (October 2017-March 2018) and 12 months after (April 2018-March 2019). Interrupted time series analysis was used to evaluate the impact on HIV positivity and total case finding and trends in positivity and case finding over time, before and after the interventions. Results While the monthly average number of HIV tests performed increased by only 14% post-intervention, the monthly average number of HIV positive individuals identified increased by 290%. The average HIV positivity rate rose from 9.7% to 32.4%. Positivity rates and case finding remained significantly higher in all post-intervention months. Similar trends were observed among FSW and MSM. Conclusions The Open Doors project was able to reach large numbers of previously undiagnosed key populations by implementing a targeted managerial and technical intervention, resulting in a significant increase in the HIV positivity rate sustained over 12 months. These results demonstrate that differentiated, data-driven approaches can help close the 95-95-95 gaps among key populations.	[Kamanga, Joseph; Nyirenda, Lameck; Mulenga, Florence; Lubasi, Sam] FHI 360, Lusaka, Zambia; [Stankevitz, Kayla; Martinez, Andres; Chiegil, Robert; Chen, Mario; Bateganya, Moses] FHI 360, Durham, NC 27701 USA; [Mpofu, Mulamuli] FHI 360, Gaborone, Botswana	FHI 360	Stankevitz, K (corresponding author), FHI 360, Durham, NC 27701 USA.	kstankevitz@fhi360.org		Stankevitz, Kayla/0000-0002-9779-7014	United States Agency for International Development (USAID); U.S. President's Emergency Plan for AIDS Relief (PEPFAR); USAID	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USAID(United States Agency for International Development (USAID))	This work is made possible by the support of the American People through the United States Agency for International Development (USAID) and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Financial assistance was provided by USAID to FHI 360. The contents of this report are the sole responsibility of FHI 360 and do not necessarily reflect the views of USAID, PEPFAR, or the United States Government. The funder provided support in the form of some portion of salaries for authors JK, KS, AM, RC, LN, FM, MC, MM, SL, MB; but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2017, NAT ADIS STRAT FRAM; [Anonymous], 2019, TOT QUAL LEAD ACC; [Anonymous], 2017, ZAMB POPULATION BASE; Aqil A, 2009, HEALTH POLICY PLANN, V24, P217, DOI 10.1093/heapol/czp010; Bertozzi SM, 2008, LANCET, V372, P831, DOI 10.1016/S0140-6736(08)60889-2; Cowan FM, 2019, CURR OPIN HIV AIDS, V14, P401, DOI 10.1097/COH.0000000000000562; De Cock KM, 2019, AIDS, V33, P349, DOI [10.1097/qad.0000000000002096, 10.1097/QAD.0000000000002096]; Doshi RH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201352; Girault P, 2015, AIDS BEHAV, V19, P1990, DOI 10.1007/s10461-015-1069-z; Hensen B, 2014, AIDS, V28, P2133, DOI 10.1097/QAD.0000000000000395; ICAP, 2017, APPR STRAT HIV TEST; Kim YM, 2012, PSYCHOL HEALTH MED, V17, P213, DOI 10.1080/13548506.2011.592844; Kimbrough LW, 2009, AM J PUBLIC HEALTH, V99, P1093, DOI 10.2105/AJPH.2008.139329; Lillie TA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213743; Linden A, 2017, STATA J, V17, P73, DOI 10.1177/1536867X1701700105; Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208; Macdonald V, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21658; Mahachi N, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25321; Marsh K, 2019, AIDS, V33, pS213, DOI 10.1097/QAD.0000000000002355; Muhula S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3033-x; Mwango LK, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25520; Nash SG, 2017, HIV TESTING ENGLAND; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; Nicol E, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2641-1; PEPFAR, 2020, PEPFAR MON EV REP IN; PEPFAR, 2019, PEPFAR ZAMB COUNTR O; Pines HA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010388; Reh FJ., 2017, UNDERSTANDING PARETO; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; StataCorp, 2017, STAT REL 15 STAT SOF, DOI DOI 10.2307/2234838; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; UNAIDS, 2019, UNAIDS SPEC AN; UNAIDS, 2017, FAST TRACK COMM END; UNDP, 2019, ZAMB REM LEG POL BAR; Wheeler T, 2015, JAIDS-J ACQ IMM DEF, V68, pS69, DOI 10.1097/QAI.0000000000000534; WHO, 2008, FRAM STAND COUNTR HL, V2; World Health Organization (WHO), 2017, US UN PAT ID PERSON	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0258573	10.1371/journal.pone.0258573	http://dx.doi.org/10.1371/journal.pone.0258573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855752	gold, Green Published			2022-12-26	WOS:000735299000008
J	Yang, Y; Chen, YP; Cai, JM; Liu, XB; Huang, GX				Yang, Yang; Chen, Yipeng; Cai, Jimiao; Liu, Xianbao; Huang, Guixiu			Antifungal activity of volatile compounds generated by endophytic fungi Sarocladium brachiariae HND5 against Fusarium oxysporum f. sp. cubense	PLOS ONE			English	Article							ORGANIC-COMPOUNDS; OXIDATIVE STRESS; ESSENTIAL OIL; CELL-WALL; WILT; BANANA; CHLOROPICRIN; ASPERGILLUS; ACID; PATHOGENESIS	The soil-born filamentous fungal pathogen Fusarium oxysporum f. sp. cubense (FOC), which causes vascular wilt disease in banana plants, is one of the most economically important Fusarium species. Biocontrol using endophytic microorganisms is among the most effective methods for controlling banana Fusarium wilt. In this study, volatile organic compounds (VOCs) showed strong antifungal activity against FOC. Seventeen compounds were identified from the VOCs produced by endophytic fungi Sarocladium brachiariae HND5, and three (2-methoxy-4-vinylphenol, 3,4-dimethoxystyrol and caryophyllene) showed antifungal activity against FOC with 50% effective concentrations of 36, 60 and 2900 mu L/L headspace, respectively. Transmission electron microscopy (TEM) and double fluorescence staining revealed that 2-methoxy-4-vinylphenol and 3,4-dimethoxystyrol damaged the plasma membranes, resulting in cell death. 3,4-dimethoxystyrol also could induce expression of chitin synthases genes and altered the cell walls of FOC hyphae. Dichloro-dihydro-fluorescein diacetate staining indicated the caryophyllene induced accumulation of reactive oxygen species (ROS) in FOC hyphae. FOC secondary metabolism also responded to active VOC challenge by producing less fusaric acid and expressions of genes related to fusaric acid production were interrupted at sublethal concentrations. These findings indicate the potential of S. brachiariae HND5 as a biocontrol agent against FOC and the antifungal VOCs as fumigants.	[Yang, Yang; Chen, Yipeng; Cai, Jimiao; Liu, Xianbao; Huang, Guixiu] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou, Hainan, Peoples R China; [Yang, Yang; Chen, Yipeng; Cai, Jimiao; Liu, Xianbao; Huang, Guixiu] Minist Agr & Rural Affairs, Key Lab Integrated Pest Management Trop Grops, Beijing, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Huang, GX (corresponding author), Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou, Hainan, Peoples R China.; Huang, GX (corresponding author), Minist Agr & Rural Affairs, Key Lab Integrated Pest Management Trop Grops, Beijing, Peoples R China.	hgxiu@catas.cn			Hainan Provincial Natural Science Foundation of China [319QN268]	Hainan Provincial Natural Science Foundation of China	YY is founded by Hainan Provincial Natural Science Foundation of China [Grant 319QN268]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akila R, 2011, BIOL CONTROL, V57, P175, DOI 10.1016/j.biocontrol.2011.02.010; Alpha CJ, 2015, APPL ENVIRON MICROB, V81, P1147, DOI 10.1128/AEM.03294-14; Arita N, 2020, FEBS J, V287, P3427, DOI 10.1111/febs.15211; Bacon CW, 1996, APPL ENVIRON MICROB, V62, P4039, DOI 10.1128/AEM.62.11.4039-4043.1996; Boukaew S, 2013, BIOCONTROL, V58, P471, DOI 10.1007/s10526-013-9510-6; Bubici G, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00616; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Chalfoun NR, 2013, J BIOL CHEM, V288, P14098, DOI 10.1074/jbc.M112.429423; Crutcher FK, 2015, MICROBIOL-SGM, V161, P875, DOI 10.1099/mic.0.000043; Dichtl K, 2010, MOL MICROBIOL, V76, P1191, DOI 10.1111/j.1365-2958.2010.07170.x; Ding ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122634; Gilreath JP, 2005, CROP PROT, V24, P779, DOI 10.1016/j.cropro.2005.01.002; Giraldo A, 2015, PERSOONIA, V34, P10, DOI 10.3767/003158515X685364; Gong AD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01091; Gong AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116871; Gonzalez-Rompinelli EM, 2013, FOOD CONTROL, V33, P440, DOI 10.1016/j.foodcont.2013.03.026; Grunewaldt-Stocker G, 2007, PLANT ROOT, V1, P46, DOI 10.3117/plantroot.1.46; Gu Q, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/aem.01075-17, 10.1128/AEM.01075-17]; Guo Y, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00891; Hael-Conrad V, 2015, PLANT SCI, V241, P120, DOI 10.1016/j.plantsci.2015.09.025; Hai Y, 2020, J AM CHEM SOC, V142, P19668, DOI 10.1021/jacs.0c09352; Heslop-Harrison JS, 2007, ANN BOT-LONDON, V100, P1073, DOI 10.1093/aob/mcm191; Ho YN, 2015, PLANT SOIL, V387, P295, DOI 10.1007/s11104-014-2297-0; Hutchinson CM, 2000, PEST MANAG SCI, V56, P413, DOI 10.1002/(SICI)1526-4998(200005)56:5<413::AID-PS140>3.0.CO;2-J; Hwang SC, 2004, PLANT DIS, V88, P580, DOI 10.1094/PDIS.2004.88.6.580; Hyde KD, 2008, FUNGAL DIVERS, V33, P163; Janaki T., 2017, INT J PHARM PHARM SC, V9, P78; Jeong JB, 2011, ARCH PHARM RES, V34, P2109, DOI 10.1007/s12272-011-1214-9; KAMINSKI E, 1974, APPL MICROBIOL, V27, P1001, DOI 10.1128/AEM.27.6.1001-1004.1974; Karlshoj K, 2005, J AGR FOOD CHEM, V53, P708, DOI 10.1021/jf0485887; Korpi A, 2009, CRIT REV TOXICOL, V39, P139, DOI [10.1080/10408440802291497, 10.1080/10408440802291497 ]; Li CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070226; Li QL, 2010, POSTHARVEST BIOL TEC, V58, P157, DOI 10.1016/j.postharvbio.2010.06.003; Liu SW, 2020, NEW PHYTOL, V225, P913, DOI 10.1111/nph.16193; Liu XB, 2017, MYCOSPHERE, V8, P827, DOI 10.5943/mycosphere/8/7/2; Liu XB, 2010, PLANT DIS, V94, P916, DOI 10.1094/PDIS-94-7-0916A; Liu YP, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0690-x; Liu ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34975; LYONS PC, 1990, PLANT PHYSIOL, V92, P726, DOI 10.1104/pp.92.3.726; Madrid MP, 2003, MOL MICROBIOL, V47, P257, DOI 10.1046/j.1365-2958.2003.03299.x; Medina-Romero YM, 2017, APPL MICROBIOL BIOT, V101, P8209, DOI 10.1007/s00253-017-8542-8; Martin-Urdiroz M, 2008, EUKARYOT CELL, V7, P112, DOI 10.1128/EC.00347-07; Minerdi D, 2009, ENVIRON MICROBIOL, V11, P844, DOI 10.1111/j.1462-2920.2008.01805.x; Minuto A, 2006, CROP PROT, V25, P1244, DOI 10.1016/j.cropro.2006.03.017; Nel B, 2007, CROP PROT, V26, P697, DOI 10.1016/j.cropro.2006.06.008; Pagans E, 2006, J HAZARD MATER, V131, P179, DOI 10.1016/j.jhazmat.2005.09.017; Pegg KG, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01395; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; Porter James K., 1995, Natural Toxins, V3, P91, DOI 10.1002/nt.2620030206; Potshangbam M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00325; Qi XZ, 2013, PHYSIOL MOL PLANT P, V84, P76, DOI 10.1016/j.pmpp.2013.07.007; Raza W, 2015, BIOL CONTROL, V80, P89, DOI 10.1016/j.biocontrol.2014.09.004; Schalchli H., 2015, CRIT REV BIOTECHNOL, V8, P1; Schoffelmeer EAM, 1999, FUNGAL GENET BIOL, V27, P275, DOI 10.1006/fgbi.1999.1153; Stinson M, 2003, PLANT SCI, V165, P913, DOI 10.1016/S0168-9452(03)00299-1; Stone JK, 2000, BOOK SOIL P, P3; Stoppacher N, 2010, J MICROBIOL METH, V81, P187, DOI 10.1016/j.mimet.2010.03.011; Strobel GA, 1997, PLANT SCI, V128, P97, DOI 10.1016/S0168-9452(97)00131-3; Tahir HAS, 2017, SCI REP-UK, V7, DOI 10.1038/srep40481; Voda K, 2004, J MOL MODEL, V10, P76, DOI 10.1007/s00894-003-0174-5; Vukovic N, 2008, J SERB CHEM SOC, V73, P299, DOI 10.2298/JSC0803299V; Wicklow DT, 2005, MYCOL RES, V109, P610, DOI 10.1017/S0953756205002820; WILKINS K, 1995, CHEMOSPHERE, V31, P3225, DOI 10.1016/0045-6535(95)00184-A; Wu YC, 2015, J BASIC MICROB, V55, P1104, DOI 10.1002/jobm.201400906; Xie HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117980; Yang Y, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6095-1; Yeh YH, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-25; Yuan ZL, 2012, CRIT REV BIOTECHNOL, V32, P363, DOI 10.3109/07388551.2011.651429	68	3	3	8	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260747	10.1371/journal.pone.0260747	http://dx.doi.org/10.1371/journal.pone.0260747			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855862	gold, Green Published			2022-12-26	WOS:000735299000110
J	Zaabaar, E; Kyei, S; Brew, MAAP; Boadi-Kusi, SB; Assiamah, F; Asiedu, K				Zaabaar, Ebenezer; Kyei, Samuel; Brew, Maame Ama Amamoah Parkson; Boadi-Kusi, Samuel Bert; Assiamah, Frank; Asiedu, Kofi			The utility of measures of anterior segment parameters of a Pentacam Scheimpflug tomographer in discriminating high myopic astigmatism from keratoconus	PLOS ONE			English	Article							POSTERIOR CORNEAL ELEVATION; EYES; INDEXES	The study aimed to evaluate and compare anterior segment parameters between keratoconic eyes and eyes with high myopic astigmatism using Pentacam Scheimpflug tomography. This was a retrospective cross-sectional study that included sixty keratoconic eyes (thirty-two persons) and seventy-three eyes (forty-six persons) with high myopic astigmatism with mean ages 24.72 +/- 11.65years and 26.60 +/- 10.69years, respectively. Twenty-three parameters from the topographic map and fifteen parameters from the Belin-Ambrosio enhanced ectasia display map of the printouts of a Scheimpflug principle-based Pentacam tomographer were evaluated for their diagnostic accuracy using Receiver Operating Characteristic (ROC) curve. All parameters except cornea volume, anterior chamber volume, and anterior chamber angle indicated a significant difference between high myopic astigmatism and keratoconic eyes. The area under the receiver operating characteristic (AUROC) of eighteen Pentacam parameters was excellent (0.9-1.0) in discriminating keratoconus from high myopic astigmatism, out of which four {anterior minimum sagittal curvature (ant. Rmin), posterior minimum sagittal curvature (post. Rmin), maximum Ambrosio relational thickness (ART max) and total deviation value (D)} indicated excellent (>90%) sensitivity and specificity in addition to the excellent AUROC values. Topographic and Belin-Ambrosio enhanced ectasia display (BAD) maps of a Scheimpflug principle-based Pentacam tomographer are useful in enhancing the diagnosis of keratoconus and may also provide valuable information in effectively screening for keratoconus cases among refractive surgery candidates with high myopic astigmatism.	[Zaabaar, Ebenezer; Kyei, Samuel; Boadi-Kusi, Samuel Bert] Univ Cape Coast, Coll Hlth & Allied Sci, Sch Allied Hlth Sci, Dept Optometry & Vis Sci, Cape Coast, Ghana; [Brew, Maame Ama Amamoah Parkson] Univ Cape Coast, Coll Hlth & Allied Sci, Sch Allied Hlth Sci, Dept Imaging Technol & Sonog, Cape Coast, Ghana; [Assiamah, Frank] Korle Bu Teaching Hosp, Eye Dept, Accra, Ghana; [Asiedu, Kofi] Cosmopolitan Med Ctr, Eye Clin, Dworwulu, Accra, Ghana	University of Cape Coast; University of Cape Coast	Kyei, S (corresponding author), Univ Cape Coast, Coll Hlth & Allied Sci, Sch Allied Hlth Sci, Dept Optometry & Vis Sci, Cape Coast, Ghana.	skyei@ucc.edu.gh	Kyei, Samuel/ABD-5389-2020; Asiedu, Kofi/AAC-9855-2019	Kyei, Samuel/0000-0003-2568-8246; 				Ambrosio R, 2019, SEMIN OPHTHALMOL, V34, P66, DOI 10.1080/08820538.2019.1569075; Ambrosio R., 2013, CURR OPHTHALMOL REP, V1, P28; Ambrosio R, 2011, J REFRACT SURG, V27, P753, DOI 10.3928/1081597X-20110721-01; Arora R, 2019, INDIAN J OPHTHALMOL, V67, P551, DOI 10.4103/ijo.IJO_1496_18; BROOKS AMV, 1984, AUST J OPHTHALMOL, V12, P317, DOI 10.1111/j.1442-9071.1984.tb01175.x; Cavas-Martinez F, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0036-8; Chan TCY, 2018, BRIT J OPHTHALMOL, V102, P42, DOI 10.1136/bjophthalmol-2017-310355; Doctor K, 2020, INDIAN J OPHTHALMOL, V68, P2732, DOI 10.4103/ijo.IJO_2111_20; Fam HB, 2006, J CATARACT REFR SURG, V32, P1281, DOI 10.1016/j.jcrs.2006.02.060; Fuest M., 2019, SCI REP-UK, V9, P1; GROSVENOR T, 1991, OPTOMETRY VISION SCI, V68, P204, DOI 10.1097/00006324-199103000-00008; Hashemi H, 2019, EYE CONTACT LENS, V45, P46, DOI 10.1097/ICL.0000000000000531; Hosseini SMA, 2014, CONTACT LENS ANTERIO, V37, P26, DOI 10.1016/j.clae.2013.07.007; Kahuam-Lopez N, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012946.pub2; Kamiya K, 2014, BRIT J OPHTHALMOL, V98, P459, DOI 10.1136/bjophthalmol-2013-304132; Katsanevaki VJ, 2007, BRIT MED BULL, V83, P325, DOI 10.1093/bmb/ldm015; Kovacs I, 2016, J CATARACT REFR SURG, V42, P275, DOI 10.1016/j.jcrs.2015.09.020; LEWYCKYJ M, 1991, INVEST OPHTH VIS SCI, V32, P778; MCNEIL BJ, 1984, MED DECIS MAKING, V4, P137, DOI 10.1177/0272989X8400400203; Mihaltz K, 2009, CORNEA, V28, P976, DOI 10.1097/ICO.0b013e31819e34de; Muftuoglu O, 2013, J CATARACT REFR SURG, V39, P1348, DOI 10.1016/j.jcrs.2013.03.023; Omar IAN, 2019, CLIN OPHTHALMOL, V13, P1909, DOI 10.2147/OPTH.S225326; Orucoglu F, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/925414; Pahuja N, 2016, INVEST OPHTH VIS SCI, V57, P5372, DOI 10.1167/iovs.16-19677; Sakarya Y, 2000, J CATARACT REFR SURG, V26, P307, DOI 10.1016/S0886-3350(00)00349-7; Schlegel Z, 2008, J CATARACT REFR SURG, V34, P789, DOI 10.1016/j.jcrs.2007.12.036; Sedaghat MR, 2018, CORNEA, V37, P1025, DOI 10.1097/ICO.0000000000001639; Touzeau O, 2004, J FR OPHTALMOL, V27, P765, DOI 10.1016/S0181-5512(04)96211-0; TUFT SJ, 1992, BRIT J OPHTHALMOL, V76, P642, DOI 10.1136/bjo.76.11.642; Ucakhan OO, 2011, J CATARACT REFR SURG, V37, P1116, DOI 10.1016/j.jcrs.2010.12.049; Wahba SS, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6392472; Weale RA, 2003, SURV OPHTHALMOL, V48, P515, DOI 10.1016/S0039-6257(03)00086-9; Zhao WX, 2020, J OPHTHALMOL, V2020, DOI 10.1155/2020/5291485	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260648	10.1371/journal.pone.0260648	http://dx.doi.org/10.1371/journal.pone.0260648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855828	gold, Green Published			2022-12-26	WOS:000735299000084
J	Kaplan, N; Liu, M; Wang, JY; Yang, WD; Fiolek, E; Peng, H; Lavker, RM				Kaplan, Nihal; Liu, Min; Wang, Junyi; Yang, Wending; Fiolek, Elaina; Peng, Han; Lavker, Robert M.			Eph signaling is regulated by miRNA-210: Implications for corneal epithelial repair	FASEB JOURNAL			English	Article						corneal epithelium; Eph; ephrin signaling; F-actin; microRNAs; migration; wound repair	STEM-CELLS; EPIDERMAL DIFFERENTIATION; GENE-EXPRESSION; RECEPTOR; MACROPINOCYTOSIS; MICRORNAS; MIGRATION; AUTOPHAGY; MIR-210; TARGETS	A distinct boundary exists between the progenitor cells in the basal limbal epithelium and the more differentiated corneal epithelial basal cells. We have shown that reciprocal expression patterns of EphA2 and Ephrin-A1 are likely to contribute to normal limbal-corneal epithelial compartmentalization as well as play a role in response to injury. How this signaling axis is regulated remains unclear. We have demonstrated that microRNAs (miRNAs) play critical roles in corneal epithelial wound healing and several miRNAs (e.g. miR-210) have been predicted to target ephrins. Previous expression profiling experiments demonstrated that miR-210 is prominently expressed in corneal epithelial cells. RNA-seq data acquired from miR-210-depleted HCECs showed up-regulation of genes involved in cellular migration. In addition, miR-210 is decreased after corneal injury while EphA2 is increased. Moreover, antago-210-treated HCECs markedly enhanced wound closure in a scratch wound assay. Antago-210 treatment resulted in increased EphA2 protein levels as well as pS897-EphA2, the pro-migratory form of EphA2. As expected, Ephrin-A1 levels were reduced, while levels of a well-known target of miR-210, Ephrin-A3, were increased by antago-210 treatment. The increase in migration with antago-210 could be inhibited by Ephrin-A1 overexpression, Ephrin-A1-Fc treatment or siRNA depletion of EphA2. However, depletion of Ephrin-A3 did not have effects on the antago-210-induced increase in migration. In addition, Ephrin-A1 overexpression and siEphA2 dampened EGFR signaling, which is increased by antago-210. Our data clearly demonstrate a link between miR-210 and EphA2/Ephrin-A1 signaling that regulates, in part, corneal epithelial migration. This interaction might potentially control the limbal-corneal epithelial boundary.	[Kaplan, Nihal; Liu, Min; Wang, Junyi; Yang, Wending; Fiolek, Elaina; Peng, Han; Lavker, Robert M.] Northwestern Univ, Dept Dermatol, 303 East Chicago Ave,Ward 9-124, Chicago, IL 60611 USA; [Wang, Junyi] Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Ophthalmol & Visual Sci Key Lab PLA, Beijing, Peoples R China	Northwestern University; Chinese People's Liberation Army General Hospital	Lavker, RM (corresponding author), Northwestern Univ, Dept Dermatol, 303 East Chicago Ave,Ward 9-124, Chicago, IL 60611 USA.; Peng, H (corresponding author), Northwestern Univ, Dept Dermatol, 303 East Chicago Ave,Ward 9-120, Chicago, IL 60611 USA.	han-peng@northwestern.edu; r-lavker@northwestern.edu	wang, junyi/GYA-3213-2022	Peng, Han/0000-0002-1105-8254	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR075049]; NCI [CCSG P30 CA060553]; NIH [1S100 D021704 -01]; National Institutes of Health [EY028560, EY019463, EY032922]; Dermatology Foundation; Eversight research grant	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; Eversight research grant	The NU-SODRC Skin Tissue Engineering and Morphology Core facility assisted in morphologic analysis. The NUSBDRC Is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR075049. Imaging work was performed at the Northwestern University Center for Advanced Microscopy generously supported by NCI CCSG P30 CA060553 awarded to the Robert I I Lurie Comprehensive Cancer Center. high content imaging was performed on the Nikon Biostation CT system purchased with the support of NIH 1S100 D021704 -01. This research is supported by National Institutes of lealth Grants EY028560 and EY019463 (to R.M.I,.), and EY032922 (to Ht.); a Dermatology Foundation research grant and Career Development Award (to H.P.); and an Eversight research grant (to H.P.).	Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bhattacharya S, 2019, STEM CELLS, V37, P417, DOI 10.1002/stem.2959; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Cakmak H, 2018, CUTAN OCUL TOXICOL, V37, P191, DOI 10.1080/15569527.2017.1375943; Dallas A, 2019, TISSUE ENG PT A, V25, P44, DOI [10.1089/ten.TEA.2017.0484, 10.1089/ten.tea.2017.0484]; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Funari VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084425; Genander M, 2012, CELL ADHES MIGR, V6, P126, DOI 10.4161/cam.18932; Genander M, 2010, CURR OPIN CELL BIOL, V22, P611, DOI 10.1016/j.ceb.2010.08.005; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Kaplan N, 2020, FASEB J, V34, P525, DOI 10.1096/fj.201901512R; Kaplan N, 2018, INVEST OPHTH VIS SCI, V59, P393, DOI 10.1167/iovs.17-22941; Kaplan N, 2012, INVEST OPHTH VIS SCI, V53, P936, DOI 10.1167/iovs.11-8685; Kojima T, 2007, CORNEA, V26, P569, DOI 10.1097/ICO.0b013e3180335526; Kulkarni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03449-7; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Lavker Robert M., 2009, Human Genomics, V3, P332; Lee SKW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021249; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin S, 2012, SEMIN CELL DEV BIOL, V23, P92, DOI 10.1016/j.semcdb.2011.10.017; Lin S, 2010, MOL BIOL CELL, V21, P3902, DOI 10.1091/mbc.E10-03-0242; Liu YM, 2019, INVEST OPHTH VIS SCI, V60, P2925, DOI 10.1167/iovs.19-26663; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Mohamed AM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002513; Narayanan S, 2005, EXP EYE RES, V80, P175, DOI 10.1016/j.exer.2004.08.027; Pajoohesh-Ganji A, 2005, BIOL CELL, V97, P265, DOI 10.1042/BC20040114; Park JK, 2017, FASEB J, V31, P257, DOI 10.1096/fj.201600746R; Park JK, 2016, J CELL BIOL, V215, P667, DOI 10.1083/jcb.201604032; Park JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134853; Peng H, 2017, AUTOPHAGY, V13, P975, DOI 10.1080/15548627.2017.1287658; Peng H, 2017, INVEST OPHTH VIS SCI, V58, P416, DOI 10.1167/iovs.16-21111; Peng H, 2015, STEM CELLS, V33, P1642, DOI 10.1002/stem.1962; Peng H, 2013, INVEST OPHTH VIS SCI, V54, P2781, DOI 10.1167/iovs.12-11512; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; Peng H, 2012, FASEB J, V26, P3140, DOI 10.1096/fj.11-198515; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Ryan D, 2006, MOL VIS, V12, P1175; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Stepp MA, 2005, OCUL SURF, V3, P15, DOI 10.1016/S1542-0124(12)70119-2; Swamynathan SK, 2008, INVEST OPHTH VIS SCI, V49, P3360, DOI 10.1167/iovs.08-1811; Teng YF, 2015, FUNCT INTEGR GENOMIC, V15, P277, DOI 10.1007/s10142-014-0417-9; Tseng SCG, 2016, OCUL SURF, V14, P100, DOI 10.1016/j.jtos.2015.12.002; Ventrella R, 2018, J INVEST DERMATOL, V138, P2133, DOI 10.1016/j.jid.2018.04.011; Ventrella R, 2017, EXP CELL RES, V358, P58, DOI 10.1016/j.yexcr.2017.03.024; Wang JY, 2020, ADV THER-GERMANY, V3, DOI 10.1002/adtp.202000138; Weigelt CM, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800149; White BEP, 2014, CELL ADHES MIGR, V8, P327, DOI 10.4161/19336918.2014.970012; Winkler MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114692; Wykosky J, 2007, MOL CANCER THER, V6, P3208, DOI 10.1158/1535-7163.MCT-07-0200; Yang NY, 2011, CELL SIGNAL, V23, P201, DOI 10.1016/j.cellsig.2010.09.004; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Zaccagnini G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09763-4	58	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22076	10.1096/fj.202101423R	http://dx.doi.org/10.1096/fj.202101423R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34856019				2022-12-26	WOS:000734992000044
J	Saleem, H; Ashfaq, UA; Nadeem, H; Zubair, M; Siddique, MH; Rasul, I				Saleem, Hira; Ashfaq, Usman Ali; Nadeem, Habibullah; Zubair, Muhammad; Siddique, Muhammad Hussnain; Rasul, Ijaz			Subtractive genomics and molecular docking approach to identify drug targets against Stenotrophomonas maltophilia	PLOS ONE			English	Article							PROTEIN STRUCTURES	Stenotrophomonas maltophilia is a multidrug resistant pathogen associated with high mortality and morbidity in patients having compromised immunity. The efflux systems of S. maltophilia include SmeABC and SmeDEF proteins, which assist in acquisition of multiple-drug-resistance. In this study, proteome based mapping was utilized to find out the potential drug targets for S. maltophilia strain k279a. Various tools of computational biology were applied to remove the human-specific homologous and pathogen-specific paralogous sequences from the bacterial proteome. The CD-HIT analysis selected 4315 proteins from total proteome count of 4365 proteins. Geptop identified 407 essential proteins, while the BlastP revealed approximately 85 non-homologous proteins in the human genome. Moreover, metabolic pathway and subcellular location analysis were performed for essential bacterial genes, to describe their role in various cellular processes. Only two essential proteins (Acyl-[acyl-carrier-protein]-UDP-N acetyl glucosamine O-acyltransferase and D-alanine-D-alanine ligase) as candidate for potent targets were found in proteome of the pathogen, in order to design new drugs. An online tool, Swiss model was employed to model the 3D structures of both target proteins. A library of 5000 phytochemicals was docked against those proteins through the molecular operating environment (MOE). That resulted in to eight inhibitors for both proteins i.e. enterodiol, aloin, ononin and rhinacanthinF for the Acyl-[acyl-carrier-protein]-UDP-N acetyl glucosamine O-acyltransferase, and rhazin, alkannin beta, aloesin and ancistrocladine for the D-alanine-D-alanine ligase. Finally the ADMET was done through ADMETsar. This study supported the development of natural as well as cost-effective drugs against S. maltophilia. These inhibitors displayed the effective binding interactions and safe drug profiles. However, further in vivo and in vitro validation experiment might be performed to check their drug effectiveness, biocompatibility and their role as effective inhibitors.	[Saleem, Hira; Ashfaq, Usman Ali; Nadeem, Habibullah; Zubair, Muhammad; Siddique, Muhammad Hussnain; Rasul, Ijaz] Univ Faisalabad, Dept Bioinformat & Biotechnol, Govt Coll, Faisalabad, Pakistan	Government College University Faisalabad	Rasul, I (corresponding author), Univ Faisalabad, Dept Bioinformat & Biotechnol, Govt Coll, Faisalabad, Pakistan.	ijazrasul@gcuf.edu.pk	Ashfaq, Usman A/D-7792-2013; Zubair, Muhammad/HGA-4479-2022	Ashfaq, Usman A/0000-0002-5495-805X; Zubair, Muhammad/0000-0003-4534-0968; Siddique, Muhammad Hussnain/0000-0003-3700-0509				Abuthakir MHS, 2020, CURR MICROBIOL, V77, P2953, DOI 10.1007/s00284-020-02114-z; Adki KM, 2020, CHEM BIODIVERS, V17, DOI 10.1002/cbdv.202000422; Ahmad S, 2019, INTERDISCIP SCI, V11, P508, DOI 10.1007/s12539-018-0299-y; [Anonymous], 2016, MOL OP ENV MOE; Asalone KC, 2019, JOVE-J VIS EXP, DOI 10.3791/58877; Banerjee P, 2018, NUCLEIC ACIDS RES, V46, pW257, DOI 10.1093/nar/gky318; Barh D, 2011, DRUG DEVELOP RES, V72, P162, DOI 10.1002/ddr.20413; Birzele F, 2006, BIOINFORMATICS, V22, P2628, DOI 10.1093/bioinformatics/btl453; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Brooke JS, 2014, EXPERT REV ANTI-INFE, V12, P1, DOI 10.1586/14787210.2014.864553; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Chakrabarty RP, 2020, MICROB PATHOGENESIS, V149, DOI 10.1016/j.micpath.2020.104293; Chandela R, 2022, COMB CHEM HIGH T SCR, V25, P123, DOI 10.2174/1871520620666201123094330; Chang YT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00893; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Desale V.J, 2020, CURR COMPUT-AID DRUG; Garcia-Jacas CR, 2019, CHEM RES TOXICOL, V32, P1178, DOI 10.1021/acs.chemrestox.9b00011; HEDIGER MA, 1989, P NATL ACAD SCI USA, V86, P5748, DOI 10.1073/pnas.86.15.5748; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hossain T, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3783714; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kaur H, 2021, MICROB PATHOGENESIS, V152, DOI 10.1016/j.micpath.2020.104608; Koutsouleris N, 2021, JAMA PSYCHIAT, V78, P195, DOI 10.1001/jamapsychiatry.2020.3604; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kryshtafovych A, 2019, PROTEINS, V87, P1011, DOI 10.1002/prot.25823; Lakshmi P, 2020, ALGO INTELL SY, P11, DOI 10.1007/978-981-15-2445-5_2; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin XQ, 2020, MOLECULES, V25, DOI 10.3390/molecules25061375; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Mondal Shakhinur Islam, 2015, Adv Appl Bioinform Chem, V8, P49, DOI 10.2147/AABC.S88522; Nseir S, 2006, CRIT CARE, V10, DOI 10.1186/cc5063; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinzi L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184331; Rodriguez-R LM, 2020, ENVIRON MICROBIOL, V22, P3394, DOI 10.1111/1462-2920.15112; Samonis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037375; Sanchez MB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00658; Shahid F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103644; Studer G, 2020, BIOINFORMATICS, V36, P1765, DOI 10.1093/bioinformatics/btz828; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wright GD, 2011, CHEM COMMUN, V47, P4055, DOI 10.1039/c0cc05111j; Yang HB, 2019, BIOINFORMATICS, V35, P1067, DOI 10.1093/bioinformatics/bty707; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024; Zhu H, 2020, ANNU REV PHARMACOL, V60, P573, DOI 10.1146/annurev-pharmtox-010919-023324	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0261111	10.1371/journal.pone.0261111	http://dx.doi.org/10.1371/journal.pone.0261111			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910751	Green Published, gold			2022-12-26	WOS:000754828900035
J	Marino, YA; Bayman, P; Sabat, AM				Marino, Yobana A.; Bayman, Paul; Sabat, Alberto M.			Demography and perturbation analyses of the coffee berry borer Hypothenemus hampei (Coleoptera: Curculionidae): Implications for management	PLOS ONE			English	Article							BEAUVERIA-BASSIANA; METARHIZIUM-ANISOPLIAE; FERRARI COLEOPTERA; LIFE-HISTORY; BIOLOGICAL-CONTROL; ANT PREDATION; POPULATION; SCOLYTIDAE; SENSITIVITY; HYMENOPTERA	The coffee berry borer (CBB) Hypothenemus hampei Ferrari is the most serious pest of coffee worldwide. Management of the CBB is extremely difficult because its entire life cycle occurs inside the fruit, where it is well protected. Knowing which life stages contribute most to population growth, would shed light on the population dynamics of this pest and help to improve CBB management programs. Two staged-classified matrices were constructed for CBB populations reared in the lab on artificial diets and CBB populations from artificial infestations in the field. Matrices were used to determine demographic parameters, to conduct elasticity analyses, and to perform prospective perturbation analysis. Higher values of the intrinsic rate of natural increase (r(m)) and population growth rate (lambda): were observed for CBB populations growing in the lab than in the field (r(m): 0.058, lambda: 1.74 lab; r(m): 0.053, lambda: 1.32 field). Sensitivity values for both CBB populations were highest for the transitions from larva to pupa (G(2): 0.316 lab, 0.352 field), transition from pupa to juvenile (G(3): 0.345 lab, 0.515 field) and survival of adult females (P-5: 0.324 lab, 0.389 field); these three vital rates can be important targets for CBB management. Prospective perturbation analyses indicated that an effective management for the CBB should consider multiple developmental stages; perturbations of >90% for each transition are necessary to reduce lambda to <1. However, when the three vital rates with highest sensitivity are impacted at the same time, the percentage of perturbation is reduced to 25% for each transition; with these reductions in survival of larvae, pupae and adult females the value of lambda was reduced from 1.32 to 0.96. Management programs for CBB should be focused on the use of biological and cultural measures that are known to affect these three important targets.	[Marino, Yobana A.; Bayman, Paul; Sabat, Alberto M.] Univ Puerto Rico Rio Piedras, Dept Biol, San Juan, PR 00925 USA	University of Puerto Rico; University of Puerto Rico Rio Piedras	Marino, YA (corresponding author), Univ Puerto Rico Rio Piedras, Dept Biol, San Juan, PR 00925 USA.	yandreamarinoc@gmail.com			USDA [58-1245-4-082, 58-1245-4-083]; Puerto Rico Science and Technology Research Trust [ARG 2022-00042]	USDA(United States Department of Agriculture (USDA)); Puerto Rico Science and Technology Research Trust	USDA Specific Cooperative Agreements 58-1245-4-082 and 58-1245-4-083. Puerto Rico Science and Technology Research Trust, grant ARG 2022-00042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD GB, 1989, J INVERTEBR PATHOL, V54, P45, DOI 10.1016/0022-2011(89)90138-9; Aristizabal LF, 2017, INSECTS, V8, DOI 10.3390/insects8040123; Armbrecht I, 2007, ENTOMOL EXP APPL, V124, P261, DOI 10.1111/j.1570-7458.2007.00574.x; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; BAKER PS, 1992, J APPL ECOL, V29, P656, DOI 10.2307/2404473; Bayman P, 2021, BIOL CONTROL, V155, DOI 10.1016/j.biocontrol.2021.104533; Benavides P, 2003, P 1 INT S BIOL CONTR; Benavides P., 2012, CENICAFE, V46, P1; Benavides P., 2012, INSECTICIDES ADV INT, P512; Benton TG, 1999, TRENDS ECOL EVOL, V14, P467, DOI 10.1016/S0169-5347(99)01724-3; Bergamin J., 1943, ARQ INST BIOL [SAO PAULO], V14, P31; BRUN LO, 1994, B ENTOMOL RES, V84, P175, DOI 10.1017/S0007485300039651; Bustillo A.E., 1998, MANEJO INTEGRADO BRO; BUSTILLO ALEX E., 2002, Neotrop. entomol., V31, P635, DOI 10.1590/S1519-566X2002000400018; Carslake D, 2009, ECOLOGY, V90, P3258, DOI 10.1890/08-1188.1; Castillo A, 2002, J INVERTEBR PATHOL, V79, P199, DOI 10.1016/S0022-2011(02)00024-1; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2000, ECOLOGY, V81, P619, DOI 10.2307/177364; CASWELL H, 1978, THEOR POPUL BIOL, V14, P215, DOI 10.1016/0040-5809(78)90025-4; Caswell H., 2015, DEMOGR RES, V33, P801, DOI DOI 10.4054/DEMRES.2015.33.28; Caswell H, 2019, SENSITIVITY ANAL MAT, DOI 10.1007/978-3-030-10534-1; Caswell H, 2012, THEOR POPUL BIOL, V82, P329, DOI 10.1016/j.tpb.2012.03.008; Constantino LM, 2011, REV COLOMB ENTOMOL, V37, P173; Cruz LP, 2006, APPL MICROBIOL BIOT, V71, P918, DOI 10.1007/s00253-005-0218-0; Damon A, 2000, B ENTOMOL RES, V90, P453, DOI 10.1017/S0007485300000584; De la Rosa W, 2000, J ECON ENTOMOL, V93, P1409, DOI 10.1603/0022-0493-93.5.1409; De la Rosa-Reyes W, 1995, ENTOMOPHAGA, V40, P403, DOI 10.1007/BF02373728; de Souza RA., 2020, INT J ADV ENG RES SC, V7; FAO (Food and Agriculture Organization of the United Nations), 2015, STAT COFF PAC; Fernández Silvestre, 2007, Bioagro, V19, P35; Follett PA, 2016, BIOL CONTROL, V101, P152, DOI 10.1016/j.biocontrol.2016.07.002; Gallardo F., 2015, MANEJO INTEGRADO BRO; Gallardo-Covas F, 2010, J AGR U PUERTO RICO, V94, P195; Gallego Ropero M. C., 2005, Manejo Integrado de Plagas y Agroecologia, P32; Gomez J, 2015, ANN ENTOMOL SOC AM, V108, P311, DOI 10.1093/aesa/sav009; Gonthier DJ, 2013, BIOCONTROL, V58, P815, DOI 10.1007/s10526-013-9541-z; Hamilton LJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218321; Hollingsworth R, 2020, FRONT SUSTAIN FOOD S, V4, DOI 10.3389/fsufs.2020.00022; Infante F, 2005, BIOCONTROL, V50, P259, DOI 10.1007/s10526-004-1115-7; Jaramillo J, 2006, B ENTOMOL RES, V96, P223, DOI 10.1079/BER2006434; Jaramillo J, 2005, B ENTOMOL RES, V95, P467, DOI 10.1079/BER2005378; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Johnson MA, 2019, J ECON ENTOMOL, V112, P2833, DOI 10.1093/jee/toz219; Laiton LA, 2018, REV COLOMB ENTOMOL, V44, P200, DOI 10.25100/socolen.v44i2.7319; Lapointe SL, 2008, J INSECT PHYSIOL, V54, P1157, DOI 10.1016/j.jinsphys.2008.04.020; Lauziere I, 2001, BIOL CONTROL, V21, P128, DOI 10.1006/bcon.2000.0909; Leather Simon R., 1995, P143; Marino YA, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iew125; Marino YA, 2017, INSECTS, V8, DOI 10.3390/insects8010008; Marino YA, 2016, AGR ECOSYST ENVIRON, V222, P258, DOI 10.1016/j.agee.2015.12.031; Mbang J., 2012, AFRICAN CROP SCI J, P443; Monzon AJ, 2008, J INVERTEBR PATHOL, V97, P134, DOI 10.1016/j.jip.2007.07.008; Morris JR, 2016, AGR ECOSYST ENVIRON, V233, P224, DOI 10.1016/j.agee.2016.09.018; Newson J., 2020, CONSERVATION BIOCONT; OHMART CP, 1985, OECOLOGIA, V68, P41, DOI 10.1007/BF00379471; Pava-Ripoll M, 2008, J INVERTEBR PATHOL, V99, P220, DOI 10.1016/j.jip.2008.05.004; Portilla M., 1999, CENICAFE, V50, P24; Portilla M., 2014, MASS PRODUCTION BENE, P241, DOI DOI 10.1016/B978-0-12-391453-8.00008-X; Portilla M., 2008, SISTEMAS AGROECOLOGI, P9; Portilla Maribel, 2000, Revista Colombiana de Entomologia, V26, P99; Portilla Maribel, 2000, Revista Colombiana de Entomologia, V26, P31; Portilla Maribel, 1999, Revista Colombiana de Entomologia, V25, P57; Portilla R., 2006, CENICAFE, V57, P37; Purevsuren B, 2001, J THERM ANAL CALORIM, V66, P743, DOI 10.1023/A:1013135920477; R Core Team, 2021, R LANG ENV STAT; Rice RA, 1999, GEOGR REV, V89, P554, DOI 10.2307/216102; Rizzuto M., 2014, VISION GERENCIAL, V2, P291; Ruiz L., 1996, CENICAFE, V47, P77; Ruiz-Cardenas R, 2010, SCI AGR, V67, P658, DOI 10.1590/S0103-90162010000600007; Sadeghian S., 2007, CENICAFE, V57, P251; Serrato-Diaz LM, 2020, PHYTOPATHOLOGY, V110, P1541, DOI 10.1094/PHYTO-02-20-0057-R; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Hector IT, 2006, REV COLOMB ENTOMOL, V32, P39; Vandermeer JH., 2002, TROPICAL AGROECOSYST; Varon E., 2004, REV MANEJO INTEGRADO, V73, P42; Vega F.E., 2015, BARK BEETLES BIOL EC, P427, DOI DOI 10.1016/B978-0-12-417156-5.00011-3; Vega FE, 1999, AFR ENTOMOL, V7, P243; Vega Fernando E., 2009, Terrestrial Arthropod Reviews, V2, P129; Romero JV, 2007, REV COLOMB ENTOMOL, V33, P10; Wraight SP, 2018, J INVERTEBR PATHOL, V156, P54, DOI 10.1016/j.jip.2018.07.008	81	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0260499	10.1371/journal.pone.0260499	http://dx.doi.org/10.1371/journal.pone.0260499			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905539	gold, Green Published			2022-12-26	WOS:000754615500006
J	Yang, ZB; Song, JE; Gao, SX; Wang, H; Du, YF; Lin, QY				Yang, Zhangbo; Song, Jingen; Gao, Shanxing; Wang, Hui; Du, Yingfei; Lin, Qiuyue			Contact network analysis of Covid-19 in tourist areas-Based on 333 confirmed cases in China	PLOS ONE			English	Article							TRANSMISSION; OUTBREAK; WEB	The spread of infectious diseases is highly related to the structure of human networks. Analyzing the contact network of patients can help clarify the path of virus transmission. Based on confirmed cases of COVID-19 in two major tourist provinces in southern China (Hainan and Yunnan), this study analyzed the epidemiological characteristics and dynamic contact network structure of patients in these two places. Results show that: (1) There are more female patients than males in these two districts and most are imported cases, with an average age of 45 years. Medical measures were given in less than 3 days after symptoms appeared. (2) The whole contact network of the two areas is disconnected. There are a small number of transmission chains in the network. The average values of degree centrality, betweenness centrality, and PageRank index are small. Few patients have a relatively high contact number. There is no superspreader in the network.	[Yang, Zhangbo; Song, Jingen; Lin, Qiuyue] Xi An Jiao Tong Univ, Sch Humanities & Social Sci, Xian, Peoples R China; [Yang, Zhangbo] Xi An Jiao Tong Univ, Inst Empir Social Sci Res, Xian, Peoples R China; [Gao, Shanxing; Wang, Hui] Xi An Jiao Tong Univ, Sch Management, Xian, Peoples R China; [Du, Yingfei] Nankai Univ, Zhou Enlai Sch Govt, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Nankai University	Wang, H (corresponding author), Xi An Jiao Tong Univ, Sch Management, Xian, Peoples R China.	whh609@163.com			National Natural Science Foundation of China [71902155]; National Philosophy and Social Sciences Foundation of China [20VYJ052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Philosophy and Social Sciences Foundation of China	This research was supported by National Natural Science Foundation of China (Grant No. 71902155) and National Philosophy and Social Sciences Foundation of China (Grant No. 20VYJ052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; [Anonymous], 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)30183-5; Azad S, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa130; Azimi P, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015482118; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Easley D, 2010, NETWORKS CROWDS MARK; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Jia JSS, 2020, NATURE, V582, P389, DOI [10.1038/s41586-020-2284-y, 10.1109/LGRS.2020.3028443]; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Marvel S.A., 2013, ARXIV PREPRINT ARXIV; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Morawska L, 2020, ENVIRON INT, V142, DOI 10.1016/j.envint.2020.105832; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272; Prather KA, 2020, SCIENCE, V370, P303, DOI 10.1126/science.abf0521; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; WHO, 2019, REP WHO CHIN JOINT M; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	25	1	1	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261335	10.1371/journal.pone.0261335	http://dx.doi.org/10.1371/journal.pone.0261335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905566	gold, Green Published			2022-12-26	WOS:000754615500036
J	Kramer, KJ; Ottum, S; Gonullu, D; Bell, C; Ozbeki, H; Berman, JM; Recanati, MA				Kramer, Katherine J.; Ottum, Sarah; Gonullu, Damla; Bell, Capricia; Ozbeki, Hanna; Berman, Jay M.; Recanati, Maurice-Andre			Reoperation rates for recurrence of fibroids after abdominal myomectomy in women with large uterus	PLOS ONE			English	Article							TRANSFORMING GROWTH FACTOR-BETA-3; UTERINE FIBROIDS; LAPAROSCOPIC MYOMECTOMY; LEIOMYOMA; MYOMA; MANAGEMENT; ULTRASOUND; EXPRESSION; RISK; GENE	Background The population of women undergoing abdominal myomectomy for symptomatic large fibroid uterus is unique. We seek to characterize the timing, risk factors as well as the presenting symptoms which led patients to undergo repeat surgery in this patient population. Methods and findings We followed 592 patients who underwent an abdominal myomectomy from March 1998 to June 2010 at St. Vincent's Catholic Medical Center and presented later during the study period with a recurrence of symptoms attributable to a reemergence of fibroids and who chose to undergo repeat surgical management. Twelve percent of patients exhibited symptoms of fibroid uterus which led to reoperation within the study period. The mean age at repeat surgery was 44.1 0.6 years old (n = 69) and the mean time between operations was 7.9 +/- 0.3 years. Presentation was variable but included bleeding, pain and infertility. Patients presented for surgery with a significantly smaller sized uterus than at their initial surgery. Timing between surgeries correlated with age at initial surgery and uterine size but race, number of fibroids, aggregate weight of fibroids removed, operative time or blood loss at the initial surgery did not correlate. Data is suggestive that intraperitoneal triamcinolone may reduce reoperation rates but not timing of recurrence. Conclusion These results may help in counseling patients, particularly younger women, on the risks of fibroid recurrence necessitating repeat surgery. Further research is necessary to assess if triamcinolone can alter fibroid reurrence in patients who undergo uterus sparing procedures.	[Kramer, Katherine J.] St Vincents Med Ctr Manhattan, Dept Obstet & Gynecol, New York, NY USA; [Ottum, Sarah] Univ Cincinnati, Dept Obstet & Gynecol, Cincinnati, OH USA; [Gonullu, Damla; Berman, Jay M.; Recanati, Maurice-Andre] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Bell, Capricia] Wayne State Univ, Sch Med, Detroit, MI USA; [Ozbeki, Hanna] George Washington Univ, Milken Inst Publ Hlth, Washington, DC USA; [Recanati, Maurice-Andre] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA	University System of Ohio; University of Cincinnati; Wayne State University; Wayne State University; George Washington University; Wayne State University	Recanati, MA (corresponding author), Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA.; Recanati, MA (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA.	marecanati@wayne.edu			NIH-Women's Reproductive Health Research Career Development Award [K-12HD001254]	NIH-Women's Reproductive Health Research Career Development Award	This research was supported under NIH-Women's Reproductive Health Research Career Development Award (K-12HD001254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arici A, 2000, FERTIL STERIL, V73, P1006, DOI 10.1016/S0015-0282(00)00418-0; Bulun SE, 2013, NEW ENGL J MED, V369, P1344, DOI 10.1056/NEJMra1209993; Cardozo ER, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2011.12.002, 10.1016/j.ajog.2012.08.020]; CARLSON KJ, 1994, OBSTET GYNECOL, V83, P566, DOI 10.1097/00006250-199404000-00013; Dean J, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0766-6; Fauconnier A, 2000, HUM REPROD UPDATE, V6, P595, DOI 10.1093/humupd/6.6.595; FEDELE L, 1995, HUM REPROD, V10, P1795, DOI 10.1093/oxfordjournals.humrep.a136176; FRIEDMAN AJ, 1988, FERTIL STERIL, V49, P404; Grigorieva V, 2003, FERTIL STERIL, V79, P1194, DOI 10.1016/S0015-0282(03)00175-4; Grygielko ET, 2005, J PHARMACOL EXP THER, V313, P943, DOI 10.1124/jpet.104.082099; Jirecek S, 2004, FERTIL STERIL, V81, P132, DOI 10.1016/j.fertnstert.2003.06.009; Joseph DS, 2010, FERTIL STERIL, V93, P1500, DOI 10.1016/j.fertnstert.2009.01.081; Kotani Y, 2018, J OBSTET GYNAECOL RE, V44, P298, DOI 10.1111/jog.13519; Lee BS, 2001, J CLIN ENDOCR METAB, V86, P913, DOI 10.1210/jc.86.2.913; Levine DJ, 2013, J MINIM INVAS GYN, V20, P770, DOI 10.1016/j.jmig.2013.04.015; LINDER D, 1965, SCIENCE, V150, P67, DOI 10.1126/science.150.3692.67; Liu JH, 2018, OBSTET GYNECOL, V132, P1241, DOI 10.1097/AOG.0000000000002942; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Marjoribanks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003855.pub2; Murji A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010770.pub2; Nezhat FR, 1998, J AM ASSOC GYN LAP, V5, P237, DOI 10.1016/S1074-3804(98)80025-X; Nishiyama S, 2006, GYNECOL OBSTET INVES, V61, P155, DOI 10.1159/000090628; Obed JY, 2011, ARCH GYNECOL OBSTET, V283, P311, DOI 10.1007/s00404-010-1355-y; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036935; Parker WH, 2007, FERTIL STERIL, V88, P255, DOI 10.1016/j.fertnstert.2007.06.044; Reed SD, 2006, J WOMENS HEALTH, V15, P1046, DOI 10.1089/jwh.2006.15.1046; Rossetti A, 2001, HUM REPROD, V16, P770, DOI 10.1093/humrep/16.4.770; Shiota M, 2012, GYNECOL MINIM INVASI, V1, P34, DOI 10.1016/j.gmit.2012.08.003; Singh SS, 2015, CURR MED RES OPIN, V31, P1, DOI 10.1185/03007995.2014.982246; Steinauer J, 2004, OBSTET GYNECOL, V103, P1331, DOI 10.1097/01.AOG.0000127622.63269.8b; Stewart EA, 2017, BJOG-INT J OBSTET GY, V124, P1501, DOI 10.1111/1471-0528.14640; Stewart EA, 2013, J WOMENS HEALTH, V22, P807, DOI 10.1089/jwh.2013.4334; Tanwar PS, 2009, BIOL REPROD, V81, P545, DOI 10.1095/biolreprod.108.075648; Teo UL, 2020, J OBSTET GYNAECOL, V40, P673, DOI 10.1080/01443615.2019.1647520; Varelas FK, 2007, OBSTET GYNECOL, V110, P643, DOI 10.1097/01.AOG.0000279151.20878.60; Venkatachalam S, 2004, J Obstet Gynaecol, V24, P798; Vilos GA, 2015, J OBSTET GYNAECOL CA, V37, P157, DOI 10.1016/S1701-2163(15)30338-8; West S, 2006, FERTIL STERIL, V85, P36, DOI 10.1016/j.fertnstert.2005.05.073; Yoo EH, 2007, J MINIM INVAS GYN, V14, P690, DOI 10.1016/j.jmig.2007.06.003	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0261085	10.1371/journal.pone.0261085	http://dx.doi.org/10.1371/journal.pone.0261085			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882735	gold, Green Published			2022-12-26	WOS:000755037200058
J	Kristo, K; Manteghi, R; Ibrahim, YHEY; Ungor, D; Csapo, E; Berkesi, D; Konya, Z; Csoka, I				Kristo, Katalin; Manteghi, Reihaneh; Ibrahim, Yousif H-E Y.; Ungor, Ditta; Csapo, Edit; Berkesi, Daniel; Konya, Zoltan; Csoka, Ildiko			Optimization of layering technique and secondary structure analysis during the formulation of nanoparticles containing lysozyme by quality by design approach	PLOS ONE			English	Article							CHITOSAN NANOPARTICLES; RELEASE; DRUG	In our study, core-shell nanoparticles containing lysozyme were formulated with precipitation and layering self-assembly. Factorial design (DoE) was applied by setting the process parameters during the preparation with Quality by Design (QbD) approach. The factors were the concentration of lysozyme and sodium alginate, and pH. Our aim was to understand the effect of process parameters through the determination of mathematical equations, based on which the optimization parameters can be predicted under different process parameters. The optimization parameters were encapsulation efficiency, particle size, enzyme activity and the amount of alpha-helix structure. The nanoparticles were analysed with transmission electron microscopy (TEM), Fourier-transform infrared spectroscopy (FTIR) and circular dichroism (CD) spectroscopy. Based on our results, we found that pH was the most important factor and pH 10 was recommended during the formulation. Enzyme activity and alpha-helix content correlated with each other very well, and particle size and encapsulation efficiency also showed very good correlation with each other. The results of the alpha-helix content of FTIR and CD measurements were very similar for the precipitated lysozyme due to the solid state of lysozyme. The mixing time had the best influence on the encapsulation efficiency and the particle size, which leads to the conclusion that a mixing time of 1 h is recommended. The novelty in our study is the presentation of a mathematical model with which the secondary structure of the protein and other optimization parameters can be controlled in the future during development of nanoparticle based on the process parameters.	[Kristo, Katalin; Manteghi, Reihaneh; Ibrahim, Yousif H-E Y.; Csoka, Ildiko] Univ Szeged, Inst Pharmaceut Technol & Regulatory Affairs, Szeged, Hungary; [Ungor, Ditta; Csapo, Edit] Univ Szeged, Interdisciplinary Excellence Ctr, Dept Phys Chem & Mat Sci, MTA SZTE Lendulet Momentum Noble Met Nanostruct R, Szeged, Hungary; [Csapo, Edit] Univ Szeged, Dept Med Chem, MTA SZTE Biomimet Syst Res Grp, Szeged, Hungary; [Berkesi, Daniel; Konya, Zoltan] Univ Szeged, Dept Appl & Environm Chem, Szeged, Hungary	Szeged University; Szeged University; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Szeged University; Szeged University	Kristo, K (corresponding author), Univ Szeged, Inst Pharmaceut Technol & Regulatory Affairs, Szeged, Hungary.	kristo.katalin@szte.hu	Csapó, Edit/AAS-4639-2020; Konya, Zoltan/C-2492-2009	Csapó, Edit/0000-0002-6980-9524; Konya, Zoltan/0000-0002-9406-8596; Ibrahim, Yousif H-E. Y./0000-0002-3049-9776; Ungor, Ditta/0000-0002-7659-0428	University of Szeged [5264]	University of Szeged(European Commission)	The publication was supported by The University of Szeged Open Access Fund (Fund Ref, Grant No. 5264). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, MUCOSAL IMMUNITY INV; Ben Amara C, 2016, FOOD RES INT, V89, P272, DOI 10.1016/j.foodres.2016.08.015; DeFrates K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061717; Deng QY, 2006, PHARM BIOL, V44, P336, DOI 10.1080/13880200600746246; Donatan S, 2016, ACS APPL MATER INTER, V8, P14284, DOI 10.1021/acsami.6b03492; Epaud R, 2019, RESPIR MED RES-FRANC, V76, P22, DOI 10.1016/j.resmer.2019.07.005; Estey T, 2006, J PHARM SCI-US, V95, P1626, DOI 10.1002/jps.20625; Fan YF, 2006, INT J PHARMACEUT, V324, P158, DOI 10.1016/j.ijpharm.2006.05.062; Guan YF, 2019, FOOD CHEM, V286, P483, DOI 10.1016/j.foodchem.2019.02.023; Ibrahim YHEY, 2020, DARU, V28, P403, DOI 10.1007/s40199-019-00316-w; Knubovets T, 1999, P NATL ACAD SCI USA, V96, P1262, DOI 10.1073/pnas.96.4.1262; Komorek P, 2020, BIOELECTROCHEMISTRY, V135, DOI 10.1016/j.bioelechem.2020.107582; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Kristo K, 2020, INT J PHARMACEUT, V573, DOI 10.1016/j.ijpharm.2019.118825; Lin CC, 2019, J ALLOY COMPD, V775, P419, DOI 10.1016/j.jallcom.2018.09.187; Marudova M, 2016, BULG CHEM COMMUN, V48, P468; Pallagi E, 2018, EUR J PHARM SCI, V122, P160, DOI 10.1016/j.ejps.2018.07.003; Perez C, 2000, BIOTECHNOL LETT, V22, P1899, DOI 10.1023/A:1005645810247; Santos AC, 2019, COLLOID SURFACE B, V180, P127, DOI 10.1016/j.colsurfb.2019.04.030; Sarkar S, 2020, INT J BIOL MACROMOL, V151, P467, DOI 10.1016/j.ijbiomac.2020.02.179; Schneider G, 2008, LANGMUIR, V24, P1778, DOI 10.1021/la7021837; Sepulveda-Rivas S, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11030103; Suo ZL, 2018, RSC ADV, V8, P4742, DOI 10.1039/c7ra12890h; Szigeti K, 2008, BBA-PROTEINS PROTEOM, V1784, P1965, DOI 10.1016/j.bbapap.2008.08.015; Varga N, 2014, COLLOID SURFACE B, V123, P616, DOI 10.1016/j.colsurfb.2014.10.005; Gonzalez-Aramundiz JV, 2018, MOL PHARMACEUT, V15, P5653, DOI 10.1021/acs.molpharmaceut.8b00852; Vonhoff S, 2010, J PHARMACEUT BIOMED, V51, P39, DOI 10.1016/j.jpba.2009.07.031; Wang F, 2020, COLLOID SURFACE B, V190, DOI 10.1016/j.colsurfb.2020.110925; Wang GY, 2020, MATER TODAY BIO, V6, DOI 10.1016/j.mtbio.2020.100055; Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499; Wu TT, 2017, CARBOHYD POLYM, V155, P192, DOI 10.1016/j.carbpol.2016.08.076; Xu W, 2015, FOOD RES INT, V71, P83, DOI 10.1016/j.foodres.2015.02.007; Yada T, 2004, COMP BIOCHEM PHYS C, V139, P57, DOI 10.1016/j.cca.2004.09.003; Yang HY, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.024; Zhang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119766	35	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260603	10.1371/journal.pone.0260603	http://dx.doi.org/10.1371/journal.pone.0260603			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882727	Green Accepted, Green Published, gold			2022-12-26	WOS:000755037200030
J	Richardson, S; Iles, A; Rotchell, JM; Charlson, T; Hanson, A; Lorch, M; Pamme, N				Richardson, Samantha; Iles, Alexander; Rotchell, Jeanette M.; Charlson, Tim; Hanson, Annabel; Lorch, Mark; Pamme, Nicole			Citizen-led sampling to monitor phosphate levels in freshwater environments using a simple paper microfluidic device	PLOS ONE			English	Article							MARINE EUTROPHICATION; IN-SITU; PHOSPHORUS; FUTURE; NUTRIENTS; MOLYBDATE	Contamination of waterways is of increasing concern, with recent studies demonstrating elevated levels of antibiotics, antidepressants, household, agricultural and industrial chemicals in freshwater systems. Thus, there is a growing demand for methods to rapidly and conveniently monitor contaminants in waterways. Here we demonstrate how a combination of paper microfluidic devices and handheld mobile technology can be used by citizen scientists to carry out a sustained water monitoring campaign. We have developed a paper-based analytical device and a 3 minute sampling workflow that requires no more than a container, a test device and a smartphone app. The contaminant measured in these pilots are phosphates, detectable down to 3 mg L-1. Together these allow volunteers to successfully carry out cost-effective, high frequency, phosphate monitoring over an extended geographies and periods.	[Richardson, Samantha; Iles, Alexander; Lorch, Mark; Pamme, Nicole] Univ Hull, Dept Chem & Biochem, Kingston Upon Hull, N Humberside, England; [Rotchell, Jeanette M.] Univ Hull, Dept Biol & Marine Sci, Kingston Upon Hull, N Humberside, England; [Charlson, Tim] Pocklington Canal Amen Soc, Pocklington, England; [Hanson, Annabel] East Riding Yorkshire Council, Beverley, England	University of Hull; University of Hull	Lorch, M (corresponding author), Univ Hull, Dept Chem & Biochem, Kingston Upon Hull, N Humberside, England.	M.Lorch@hull.ac.uk		Iles, Alexander/0000-0003-0837-6160	Interreg VB North Sea Region Programme, European Regional Development Fund	Interreg VB North Sea Region Programme, European Regional Development Fund	JR, NP, ML, AI, SR, Interreg VB North Sea Region Programme, European Regional Development Fund.	Albaiges J, 2008, INT J ENVIRON AN CH, V88, P598; Almeida MIGS, 2018, TALANTA, V177, P176, DOI 10.1016/j.talanta.2017.08.072; Altenburger R, 2019, ENVIRON SCI EUR, V31, DOI 10.1186/s12302-019-0193-1; [Anonymous], 1999, STANDARD METHODS EXA, P252; [Anonymous], 2018, UK ENV AGENCY WATER; Arle J, 2016, WATER-SUI, V8, DOI 10.3390/w8060217; Behmel S, 2016, SCI TOTAL ENVIRON, V571, P1312, DOI 10.1016/j.scitotenv.2016.06.235; Bochet CG, 2009, DALTON T, P5127, DOI 10.1039/b904101j; BOLTZ DF, 1947, ANAL CHEM, V19, P873, DOI 10.1021/ac60011a019; BOSTROM B, 1988, HYDROBIOLOGIA, V170, P133, DOI 10.1007/BF00024902; Boyd CE., 2015, WATER QUALITY INTRO; CROUCH SR, 1967, ANAL CHEM, V39, P1084, DOI 10.1021/ac60254a027; DRUMMOND L, 1995, ANAL CHIM ACTA, V302, P69, DOI 10.1016/0003-2670(94)00429-P; Duffy G, 2017, ANALYST, V142, P4355, DOI [10.1039/C7AN00840F, 10.1039/c7an00840f]; Edwards GP, 1965, J AM WATER WORKS ASS, V57, P917, DOI DOI 10.1002/J.1551-8833.1965.TB01479.X; GOING JE, 1974, ANAL CHIM ACTA, V70, P95, DOI 10.1016/S0003-2670(01)82914-7; Goulder R.., 2014, J RAILWAY CANAL HIST, P139; GUPTA PK, 1981, MICROCHEM J, V26, P32, DOI 10.1016/0026-265X(81)90005-9; HARDING LW, 1994, MAR ECOL PROG SER, V104, P267, DOI 10.3354/meps104267; HARWOOD JE, 1969, WATER RES, V3, P417, DOI 10.1016/0043-1354(69)90003-7; Ho CK, 2005, SENSORS-BASEL, V5, P4, DOI 10.3390/s5010004; Huang YB, 2013, GREEN CHEM, V15, P1095, DOI 10.1039/c3gc40136g; Jayawardane BM, 2012, TALANTA, V100, P454, DOI 10.1016/j.talanta.2012.08.021; Keggin JF, 1934, P R SOC LOND A-CONTA, V144, P0075, DOI 10.1098/rspa.1934.0035; Lu Y, 2009, ELECTROPHORESIS, V30, P1497, DOI 10.1002/elps.200800563; Meredith NA, 2016, ANALYST, V141, P1874, DOI 10.1039/c5an02572a; Muller A, 2000, ACCOUNTS CHEM RES, V33, P2, DOI 10.1021/ar9601510; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nagul EA, 2015, ANAL CHIM ACTA, V890, P60, DOI 10.1016/j.aca.2015.07.030; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; Prien RD, 2007, MAR CHEM, V107, P422, DOI 10.1016/j.marchem.2007.01.014; Quevauviller PP., 2011, CHEM MARINE MONITORI; Rosenberg R, 1990, AMBIO, V19, P102; Smil V, 2000, ANNU REV ENERG ENV, V25, P53, DOI 10.1146/annurev.energy.25.1.53; Smith VH, 1998, SUCCESSES, LIMITATIONS, AND FRONTIERS IN ECOSYSTEM SCIENCE, P7; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Strobl RO, 2008, J ENVIRON MANAGE, V87, P639, DOI 10.1016/j.jenvman.2007.03.001; Tenda K, 2016, MICROMACHINES-BASEL, V7, DOI 10.3390/mi7050080; TRUESDALE VW, 1975, ANALYST, V100, P203, DOI 10.1039/an9750000203; UK Environment agency, STAT ENV WAT QUAL 20; Wade AJ, 2012, HYDROL EARTH SYST SC, V16, P4323, DOI 10.5194/hess-16-4323-2012; WELCH EB, 1977, J WATER POLLUT CON F, V49, P1218; Zhang JZ, 1999, TALANTA, V49, P293, DOI 10.1016/S0039-9140(98)00377-4	43	1	1	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260102	10.1371/journal.pone.0260102	http://dx.doi.org/10.1371/journal.pone.0260102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882681	gold, Green Published			2022-12-26	WOS:000755037200020
J	Untracht, GR; Matos, RS; Dikaios, N; Bapir, M; Durrani, AK; Butsabong, T; Campagnolo, P; Sampson, DD; Heiss, C; Sampson, DM				Untracht, Gavrielle R.; Matos, Rolando S.; Dikaios, Nikolaos; Bapir, Mariam; Durrani, Abdullah K.; Butsabong, Teemapron; Campagnolo, Paola; Sampson, David D.; Heiss, Christian; Sampson, Danuta M.			OCTAVA: An open-source toolbox for quantitative analysis of optical coherence tomography angiography images	PLOS ONE			English	Article							VESSEL DENSITY; SEGMENTATION; ENHANCEMENT; MICROCIRCULATION; REPEATABILITY; SKIN	Optical coherence tomography angiography (OCTA) performs non-invasive visualization and characterization of microvasculature in research and clinical applications mainly in ophthalmology and dermatology. A wide variety of instruments, imaging protocols, processing methods and metrics have been used to describe the microvasculature, such that comparing different study outcomes is currently not feasible. With the goal of contributing to standardization of OCTA data analysis, we report a user-friendly, open-source toolbox, OCTAVA (OCTA Vascular Analyzer), to automate the pre-processing, segmentation, and quantitative analysis of en face OCTA maximum intensity projection images in a standardized workflow. We present each analysis step, including optimization of filtering and choice of segmentation algorithm, and definition of metrics. We perform quantitative analysis of OCTA images from different commercial and non-commercial instruments and samples and show OCTAVA can accurately and reproducibly determine metrics for characterization of microvasculature. Wide adoption could enable studies and aggregation of data on a scale sufficient to develop reliable microvascular biomarkers for early detection, and to guide treatment, of microvascular disease.	[Untracht, Gavrielle R.] Univ Western Australia, Sch Elect Elect & Comp Engn, Opt Biomed Engn Lab, Perth, WA, Australia; [Untracht, Gavrielle R.; Durrani, Abdullah K.; Sampson, David D.] Univ Surrey, Sch Phys, Adv Technol Inst, Surrey Biophoton, Guildford, Surrey, England; [Untracht, Gavrielle R.; Durrani, Abdullah K.; Sampson, David D.; Sampson, Danuta M.] Univ Surrey, Sch Biosci & Med, Guildford, Surrey, England; [Matos, Rolando S.; Bapir, Mariam; Butsabong, Teemapron; Campagnolo, Paola; Heiss, Christian; Sampson, Danuta M.] Univ Surrey, Dept Biochem Sci, Guildford, Surrey, England; [Matos, Rolando S.; Bapir, Mariam; Butsabong, Teemapron; Campagnolo, Paola; Heiss, Christian; Sampson, Danuta M.] Univ Surrey, Sch Biosci & Med, Dept Clin & Expt Med, Guildford, Surrey, England; [Dikaios, Nikolaos] Acad Athens, Math Res Ctr, Athens, Greece; [Heiss, Christian] East Surrey Hosp, Surrey & Sussex Healthcare NHS Trust, Redhill, Surrey, England; [Sampson, Danuta M.] Univ Surrey, Ctr Vis Speech & Signal Proc, Surrey Biophoton, Guildford, Surrey, England	University of Western Australia; University of Surrey; University of Surrey; University of Surrey; University of Surrey; Academy of Athens; East Surrey Hospital; University of Surrey	Untracht, GR (corresponding author), Univ Western Australia, Sch Elect Elect & Comp Engn, Opt Biomed Engn Lab, Perth, WA, Australia.; Untracht, GR (corresponding author), Univ Surrey, Sch Phys, Adv Technol Inst, Surrey Biophoton, Guildford, Surrey, England.; Untracht, GR (corresponding author), Univ Surrey, Sch Biosci & Med, Guildford, Surrey, England.	gavuntracht@gmail.com	Dikaios, Nikolaos/F-5868-2011; Campagnolo, Paola/F-7149-2015; Sampson, David/ABC-5579-2020; Sampson, Danuta M/A-5873-2016	Dikaios, Nikolaos/0000-0001-9865-0260; Campagnolo, Paola/0000-0002-8957-3969; Sampson, David/0000-0001-6724-3873; Heiss, Christian/0000-0002-3212-8995; Matos, Rolando/0000-0003-2460-1268; Bapir, Mariam/0000-0003-4852-9096; Sampson, Danuta M/0000-0003-4737-6606; Untracht, Gavrielle/0000-0001-6334-0625	IPRS (University of Western Australia); Rank Prize Covid-19 response fund; Doctoral College studentship award (University of Surrey); Higher Education Innovation; Industrial Strategy Internal Funding (University of Surrey)	IPRS (University of Western Australia); Rank Prize Covid-19 response fund; Doctoral College studentship award (University of Surrey); Higher Education Innovation; Industrial Strategy Internal Funding (University of Surrey)	GRU received funding from the IPRS (University of Western Australia) and the Rank Prize Covid-19 response fund. RSM and AKD are supported by the Doctoral College studentship award (University of Surrey). CH and DMS received funding from the Higher Education Innovation Funding, Industrial Strategy Internal Funding (University of Surrey). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla M, 2015, 2015 SCIENCE AND INFORMATION CONFERENCE (SAI), P687, DOI 10.1109/SAI.2015.7237216; Aja-Fernandez S, 2015, KNOWL-BASED SYST, V83, P1, DOI 10.1016/j.knosys.2015.02.029; Alam M, 2019, BIOMED OPT EXPRESS, V10, P2055, DOI 10.1364/BOE.10.002055; Alam MN, 2021, QUANT IMAG MED SURG, V11, P1102, DOI 10.21037/qims-20-557; Argarini R, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001479; Baran U, 2016, SKIN RES TECHNOL, V22, P238, DOI 10.1111/srt.12255; Beckman JA, 2019, CIRCULATION, V140, P449, DOI 10.1161/CIRCULATIONAHA.119.040672; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; Borrelli E, 2020, OPHTHALMOL THER, V9, P697, DOI 10.1007/s40123-020-00286-2; Bukowska DM, 2013, OPT EXPRESS, V21, P24025, DOI 10.1364/OE.21.024025; Byers RA, 2018, BIOMED OPT EXPRESS, V9, P2001, DOI 10.1364/BOE.9.002001; Carpentier G., 2012, IMAGEJ NEWS, V5; Carter HH, 2016, J APPL PHYSIOL, V121, P965, DOI 10.1152/japplphysiol.00918.2015; Casper MJ, 2020, LASER SURG MED, V52, P653, DOI 10.1002/lsm.23188; Casper M, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.4.046005; Chan FHY, 1998, IEEE T IMAGE PROCESS, V7, P468, DOI 10.1109/83.661196; Chapman BE, 2005, MED IMAGE ANAL, V9, P191, DOI 10.1016/j.media.2004.08.001; Chen CL, 2017, BIOMED OPT EXPRESS, V8, P1056, DOI 10.1364/BOE.8.001056; Chu ZD, 2019, AM J OPHTHALMOL, V208, P111, DOI 10.1016/j.ajo.2019.07.003; Chu ZD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34826-5; Chu ZD, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.6.066008; Corliss BA, 2020, MICROCIRCULATION, V27, DOI 10.1111/micc.12618; Corliss BA, 2019, MICROCIRCULATION, V26, DOI 10.1111/micc.12520; Corvi F, 2018, AM J OPHTHALMOL, V186, P25, DOI 10.1016/j.ajo.2017.11.011; Dash S, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0217-0; Di Antonio L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243074; Dolezyczek H, 2020, BIOMED OPT EXPRESS, V11, P5003, DOI 10.1364/BOE.400723; Drexler W, 2008, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-540-77550-8; Eriksson S, 2014, MED DEVICES-EVID RES, V7, P445, DOI 10.2147/MDER.S51426; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Garrioch R, 2012, OPTOMETRY VISION SCI, V89, P632, DOI 10.1097/OPX.0b013e3182540562; Gong PJ, 2020, J BIOMED OPT, V25, DOI 10.1117/1.JBO.25.9.095004; Gong PJ, 2020, J BIOPHOTONICS, V13, DOI 10.1002/jbio.202000007; Hansen C, 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0240111, 10.1371/jouranl.pone.0240111]; Hennersperger C, 2015, IEEE T MED IMAGING, V34, P13, DOI 10.1109/TMI.2014.2340912; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hiner MC, 2017, BIOINFORMATICS, V33, P629, DOI 10.1093/bioinformatics/btw681; Hojati S, 2020, SOFTWAREX, V12, DOI 10.1016/j.softx.2020.100510; Hormel TT, 2018, BIOMED OPT EXPRESS, V9, P6412, DOI 10.1364/BOE.9.006412; Hua R, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/5498125; Kallab M, 2021, AM J PHYSIOL-HEART C, V320, pH23, DOI 10.1152/ajpheart.00495.2020; Kashani A.H., 2019, AUTOMATED 3D ANAL FR BIORXIV2019655175, DOI [DOI 10.1101/655175, 10.1101/655175]; Kraker JA, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.11.7; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Leontidis G, 2016, COMPUT BIOL MED, V72, P65, DOI 10.1016/j.compbiomed.2016.03.006; Liew YM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.061213; Likas A, 2003, PATTERN RECOGN, V36, P451, DOI 10.1016/S0031-3203(02)00060-2; Longo A, 2020, PHOTOACOUSTICS, V20, DOI 10.1016/j.pacs.2020.100200; Ma YH, 2021, IEEE T MED IMAGING, V40, P928, DOI 10.1109/TMI.2020.3042802; Masters BR, 2004, ANNU REV BIOMED ENG, V6, P427, DOI 10.1146/annurev.bioeng.6.040803.140100; Mehta N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72358-z; Mehta N, 2019, AM J OPHTHALMOL, V205, P54, DOI 10.1016/j.ajo.2019.03.008; Meiburger KM, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201900131; Meleppat RK, 2019, PROC SPIE, V10858, DOI 10.1117/12.2511044; Men SJ, 2017, SKIN RES TECHNOL, V23, P607, DOI 10.1111/srt.12379; Men SJ, 2018, LASER SURG MED, V50, P908, DOI 10.1002/lsm.22944; Munk MR, 2021, OPHTHALMOL RETINA, V5, P981, DOI 10.1016/j.oret.2020.12.022; Neubauer-Geryk J, 2019, POSTEP DERM ALERGOL, V36, P247, DOI 10.5114/ada.2019.83656; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; Pries AR, 2017, EUR HEART J, V38, P478, DOI 10.1093/eurheartj/ehv760; Rabiolo A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205773; Rabiolo A, 2018, INVEST OPHTH VIS SCI, V59, P231, DOI 10.1167/iovs.17-22359; Reif R, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/509783; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sampson DM, 2017, INVEST OPHTH VIS SCI, V58, P3065, DOI 10.1167/iovs.17-21551; Seaman ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020807; Seidelmann SB, 2016, CIRCULATION, V134, P1328, DOI 10.1161/CIRCULATIONAHA.116.023425; Si P, 2018, ACS NANO, V12, P11986, DOI 10.1021/acsnano.8b03862; Spaide RF, 2018, PROG RETIN EYE RES, V64, P1, DOI 10.1016/j.preteyeres.2017.11.003; Stefan S, 2020, BIOMED OPT EXPRESS, V11, P7325, DOI 10.1364/BOE.405763; Taibouni K, 2019, COMPUT BIOL MED, V114, DOI 10.1016/j.compbiomed.2019.103450; Tan BY, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3246; Terheyden JH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230260; Tingelhoff K, 2008, EUR ARCH OTO-RHINO-L, V265, P1061, DOI 10.1007/s00405-008-0594-z; Ulrich M, 2016, DERMATOLOGY, V232, P298, DOI 10.1159/000444706; Welzel J, 1997, J AM ACAD DERMATOL, V37, P958, DOI 10.1016/S0190-9622(97)70072-0; Zhao HX, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.4.046006; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	79	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0261052	10.1371/journal.pone.0261052	http://dx.doi.org/10.1371/journal.pone.0261052			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882760	Green Submitted, Green Published, gold			2022-12-26	WOS:000755037200056
J	Wei, JJ; Long, KJ; Gu, J; Zhou, ZC; Li, S				Wei, Junjun; Long, Kejun; Gu, Jian; Zhou, Zhengchuan; Li, Shun			Freeway ramp metering based on PSO-PID control	PLOS ONE			English	Article							TIME; MODEL	Ramp metering on freeway is one of the effective methods to alleviate traffic congestion. This paper advances the field of freeway ramp metering by introducing an application to the on-ramp, capitalizing on the macro traffic follow theory and improved the freeway traffic flow. The Particle Swarm Optimization (PSO) based on Proportional Integral Derivative (PID) controller is further developed to single ramp metering as well as to optimize the PID parameters. The approach is applied to a case study of the Changyi Freeway(G5513) in Hunan, China. The simulation is conducted by applying the actual profile traffic data to PID controller to adjust the entering traffic flow on the freeway on-ramp. The results show that the PSO-PID controller tends to converge in about 80 minutes, and the density tends to be stable after 240 iterations. The system has smaller oscillation, more accurate adjustment of ramp regulation rate, and more ideal expected traffic flow density. The traffic congestion on mainline is effectively slowed down, traffic efficiency is improved, and travel time and cost are reduced. The nonlinear processing ability of PSO-PID controller overcomes the defects of the traditional manual closing ramp, and can be successfully applied in the field of intelligent ramp metering.	[Wei, Junjun; Long, Kejun; Gu, Jian; Zhou, Zhengchuan; Li, Shun] Changsha Univ Sci & Technol, Sch Traff & Transportat Engn, Changsha, Peoples R China; [Long, Kejun; Gu, Jian] Changsha Univ Sci & Technol, Hunan Key Lab Smart Roadway & Cooperat Vehicle In, Changsha, Peoples R China	Changsha University of Science & Technology; Changsha University of Science & Technology	Long, KJ (corresponding author), Changsha Univ Sci & Technol, Sch Traff & Transportat Engn, Changsha, Peoples R China.; Long, KJ (corresponding author), Changsha Univ Sci & Technol, Hunan Key Lab Smart Roadway & Cooperat Vehicle In, Changsha, Peoples R China.	longkejun@csust.edu.cn		, Kejun/0000-0001-5968-1865	National Natural Science Foundation of China [51678076]; National Key Research and Development Program of China [2018YFB1600905-4]; Hunan provincial key research and development program [2019SK2171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Hunan provincial key research and development program	LONG Kejun has received the National Natural Science Foundation of China under Grant 51678076, the National Key Research and Development Program of China under Grant 2018YFB1600905-4, Hunan provincial key research and development program under Grant 2019SK2171.	Bellemans T, 2006, CONTROL ENG PRACT, V14, P757, DOI 10.1016/j.conengprac.2005.03.010; Bellemans T., 2006, INTELLIGENT TRANSPOR, P406; Belletti F, 2018, IEEE T INTELL TRANSP, V19, P1198, DOI 10.1109/TITS.2017.2725912; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Dong BW, 2018, J ADV TRANSPORT, DOI 10.1155/2018/2702360; Fares A., 2015, PROGR SYSTEMS ENG; Fares A, 2014, IEEE INT CONF CON AU, P1226, DOI 10.1109/ICCA.2014.6871097; Gao K, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19092059; Gokasar I., 2013, ADV DYNAMIC NETWORK; Ivanjko E, 2015, CYBERN INF TECHNOL, V15, P88, DOI 10.1515/cait-2015-0019; Jeon S, 2016, IEICE T FUND ELECTR, VE99A, P1843, DOI 10.1587/transfun.E99.A.1843; Kotsialos A, 2002, TRANSPORT RES C-EMER, V10, P65, DOI 10.1016/S0968-090X(01)00005-5; Kotsialos A., 2001, NETW SPAT ECON, P179; [梁新荣 Liang Xinrong], 2005, [计算机工程与应用, Computer Engineering and Application], V41, P111; Liu J C., 1994, WORKSH PAR DISTR REA; Long KJ, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9010104; Long KJ, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10124359; Meshkat A, 2015, IET INTELL TRANSP SY, V9, P639, DOI 10.1049/iet-its.2014.0207; Paesani, 1997, ITS AM 7 ANN M EXP M; Papageorgiou M, 2002, IEEE T INTELL TRANSP, V3, P271, DOI 10.1109/TITS.2002.806803; PAPAGEORGIOU M, 1980, TRANSPORT RES B-METH, V14, P349, DOI 10.1016/0191-2615(80)90015-6; Papageorgiou M, 1991, INT C ROAD TRAFF CON, P194; Papamichail I, 2010, TRANSPORT RES C-EMER, V18, P311, DOI 10.1016/j.trc.2008.11.002; Papamichail I, 2010, TRANSPORT RES REC, P10, DOI 10.3141/2178-02; Ren L, 2006, TRAFFIC STANDARDIZAT, P146; Smaragdis E, 2004, TRANSPORT RES B-METH, V38, P251, DOI 10.1016/S0191-2615(03)00012-2; STEPHANEDES YJ, 1994, IEE CONF PUBL, P181; Taylor C, 1998, TRANSPORT RES REC, P10, DOI 10.3141/1634-02; Wattleworth J A., 1965, HRB REC, V89, P1; Wu W, 2021, NETW SPAT ECON, V21, P513, DOI 10.1007/s11067-021-09538-5; Wu W, 2020, TRANSPORT RES E-LOG, V134, DOI 10.1016/j.tre.2020.101855; Zeng Ai-guo, 2007, Computer Engineering and Applications, V43, P189; Zhang HM, 1997, TRANSPORT RES C-EMER, V5, P273, DOI 10.1016/S0968-090X(97)00019-3; Zhao J, 2020, TRANSPORT RES B-METH, V138, P1, DOI 10.1016/j.trb.2020.04.001; Zhao J, 2017, COMPUT-AIDED CIV INF, V32, P674, DOI 10.1111/mice.12281; Zhao J, 2016, TRANSPORTMETRICA A, V12, P413, DOI 10.1080/23249935.2016.1146927; Zheng Jianhu, 2006, Computer Measurement & Control, V14, P196	38	2	2	9	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260977	10.1371/journal.pone.0260977	http://dx.doi.org/10.1371/journal.pone.0260977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882717	Green Published, gold			2022-12-26	WOS:000755037200049
J	Astarita, JL; Keerthivasan, S; Husain, B; Senbabaoglu, Y; Verschueren, E; Gierke, S; Pham, VC; Peterson, SM; Chalouni, C; Pierce, AA; Lill, JR; Gonzalez, LC; Martinez-Martin, N; Turley, SJ				Astarita, Jillian L.; Keerthivasan, Shilpa; Husain, Bushra; Senbabaoglu, Yasin; Verschueren, Erik; Gierke, Sarah; Pham, Victoria C.; Peterson, Sean M.; Chalouni, Cecile; Pierce, Andrew A.; Lill, Jennie R.; Gonzalez, Lino C.; Martinez-Martin, Nadia; Turley, Shannon J.			The neutrophil protein CD177 is a novel PDPN receptor that regulates human cancer-associated fibroblast physiology	PLOS ONE			English	Article							PREDICTS POOR-PROGNOSIS; MATRIX STIFFNESS; PODOPLANIN; CELLS; EXPRESSION; PHOSPHORYLATION; PLATFORM; IMPACT; TARGET; STAT3	The cancer-associated fibroblast (CAF) marker podoplanin (PDPN) is generally correlated with poor clinical outcomes in cancer patients and thus represents a promising therapeutic target. Despite its biomedical relevance, basic aspects of PDPN biology such as its cellular functions and cell surface ligands remain poorly uncharacterized, thus challenging drug development. Here, we utilize a high throughput platform to elucidate the PDPN cell surface interactome, and uncover the neutrophil protein CD177 as a new binding partner. Quantitative proteomics analysis of the CAF phosphoproteome reveals a role for PDPN in cell signaling, growth and actomyosin contractility, among other processes. Moreover, cellular assays demonstrate that CD177 is a functional antagonist, recapitulating the phenotype observed in PDPN-deficient CAFs. In sum, starting from the unbiased elucidation of the PDPN co-receptome, our work provides insights into PDPN functions and reveals the PDPN/CD177 axis as a possible modulator of fibroblast physiology in the tumor microenvironment.	[Astarita, Jillian L.; Keerthivasan, Shilpa; Turley, Shannon J.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA; [Husain, Bushra; Verschueren, Erik; Pham, Victoria C.; Peterson, Sean M.; Lill, Jennie R.; Gonzalez, Lino C.; Martinez-Martin, Nadia] Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA 94080 USA; [Senbabaoglu, Yasin] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Gierke, Sarah; Chalouni, Cecile] Genentech Inc, Ctr Adv Light Microscopy, San Francisco, CA 94080 USA; [Pierce, Andrew A.] Genentech Inc, Dept Pathol Res, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Turley, SJ (corresponding author), Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA.; Martinez-Martin, N (corresponding author), Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA 94080 USA.	mrtn.nm32@gmail.com; turley.shannon@gene.com		Pierce, Andrew/0000-0002-2692-4514; Astarita, Jillian/0000-0002-7615-1839				Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bito T, 2012, J DERMATOL SCI, V68, P3, DOI 10.1016/j.jdermsci.2012.06.006; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Chen XM, 2019, NAT REV DRUG DISCOV, V18, P99, DOI 10.1038/s41573-018-0004-1; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; Cremasco V, 2018, CANCER IMMUNOL RES, V6, P1472, DOI 10.1158/2326-6066.CIR-18-0098; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Deka J, 2010, CANCER RES, V70, P6619, DOI 10.1158/0008-5472.CAN-10-0148; Dominguez CX, 2020, CANCER DISCOV, V10, P232, DOI 10.1158/2159-8290.CD-19-0644; El-Mohri H, 2017, MAT SCI ENG C-MATER, V74, P146, DOI 10.1016/j.msec.2017.02.001; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Hazan-Halevy I, 2010, BLOOD, V115, P2852, DOI 10.1182/blood-2009-10-230060; Hoshino A, 2011, CANCER RES, V71, P4769, DOI 10.1158/0008-5472.CAN-10-3228; Husain B, 2019, MOL CELL PROTEOMICS, V18, P2310, DOI 10.1074/mcp.TIR119.001433; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kollmannsberger P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao4881; Krishnan H, 2018, CANCER SCI, V109, P1292, DOI 10.1111/cas.13580; Krishnan H, 2013, J BIOL CHEM, V288, P12215, DOI 10.1074/jbc.C112.446823; Kwon M, 2014, EXPERT OPIN THER TAR, V18, P1435, DOI 10.1517/14728222.2014.957181; Lopez-Garcia C, 2017, CANCER CELL, V31, P79, DOI 10.1016/j.ccell.2016.11.001; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Martinez VG, 2019, CELL REP, V29, P2810, DOI 10.1016/j.celrep.2019.10.103; Martinez-Martin N, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/2197615; Park YL, 2016, ONCOTARGET, V7, P72229, DOI 10.18632/oncotarget.12664; Peranzoni E, 2013, CELL MOL LIFE SCI, V70, P4431, DOI 10.1007/s00018-013-1339-8; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Ramani SR, 2012, ANAL BIOCHEM, V420, P127, DOI 10.1016/j.ab.2011.09.017; Retzbach EP, 2018, ORAL ONCOL, V78, P126, DOI 10.1016/j.oraloncology.2018.01.011; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Schwager SC, 2019, AM J PHYSIOL-CELL PH, V317, pC82, DOI 10.1152/ajpcell.00418.2018; Shindo K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-168; Stroncek DF, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-36; Suzuki J, 2021, LUNG CANCER, V153, P1, DOI 10.1016/j.lungcan.2020.12.020; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Taylor AM, 2018, CANCER CELL, V33, P676, DOI 10.1016/j.ccell.2018.03.007; Turley SJ, 2015, NAT REV IMMUNOL, V15, P669, DOI 10.1038/nri3902; Verschueren E, 2020, CELL, V182, P329, DOI 10.1016/j.cell.2020.06.007; Wakahara R, 2012, GENES CELLS, V17, P132, DOI 10.1111/j.1365-2443.2011.01575.x; Wright GJ, 2010, BIOCHEM SOC T, V38, P919, DOI 10.1042/BST0380919; Zhou X, 2016, PROTEIN CELL, V7, P548, DOI 10.1007/s13238-016-0288-z	46	4	4	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260800	10.1371/journal.pone.0260800	http://dx.doi.org/10.1371/journal.pone.0260800			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879110	Green Published, gold			2022-12-26	WOS:000754625200029
J	Colomer-Perez, N; Useche, SA				Colomer-Perez, Natura; Useche, Sergio A.			Self-care appraisal in nursing assistant students: Adaptation, validation and psychometric properties of the Spanish ASAS	PLOS ONE			English	Article							AGENCY-SCALE; COEFFICIENT ALPHA; COMPOSITE RELIABILITY; OLDER-PEOPLE; MODEL; HEALTH; NURSES; BEHAVIORS; VALIDITY; ABILITY	The core implication of nursing professionals' labor is promoting self-care and foster well-being among healthcare service users. The beginning of the healing process starts with the provider, and self-care habits are needed to positively impact on patients' care outcomes at different spheres. Overall, current literature supports the idea that nurses' personal self-care should be a necessary skill to be expected in their professional role. In this regard, the Appraisal of Self-care Agency Scale (ASAS) is a worldwide known instrument aimed at assessing the ability to engage in self-care. However, it has never been tested in the Spanish context before, and much less in nursing practitioners or apprentices. The aim of this study was to translate, adapt and validate the ASAS for Spanish nursing apprentices, assessing its dimensionality, psychometric properties and convergent validity by means of the Sense of Coherence (SOC-13) questionnaire. Methods: Data were collected from a random sample of 921 Certificated Nursing Assistant (CNA) Spanish students and was analyzed trough confirmatory factor analyses via structural equation models. The core ASAS construct and its subscales were correlated with the SOC-13 scores. Results: Fair psychometric properties for the questionnaire were set. Also, SEM models endorse the validity and reliability of the four-factor dimensionality of the Spanish adaptation of the ASAS, whose associations to SOC scores were coherent and significant. Conclusion: This study allowed to establish that the Spanish version of the ASAS might be a useful tool for addressing self-care-related issues among nursing apprentices, a key population for promoting both their own and patients' health and welfare through healthy and care-related behaviors.	[Colomer-Perez, Natura] Univ Valencia, Fac Nursing & Chiropody, Dept Nursing, Valencia, Spain; [Useche, Sergio A.] Univ Valencia, Fac Psychol, Valencia, Spain	University of Valencia; University of Valencia	Colomer-Perez, N (corresponding author), Univ Valencia, Fac Nursing & Chiropody, Dept Nursing, Valencia, Spain.	natura.colomer@uv.es	Useche, Sergio A./O-7552-2014; Colomer, Natura/AAU-2968-2021	Useche, Sergio A./0000-0002-5099-4627; Colomer, Natura/0000-0002-5973-9876				Ageborg Maria, 2005, Hemodial Int, V9 Suppl 1, pS8, DOI 10.1111/j.1542-4758.2005.01164.x; Alhambra-Borras T, 2017, SPAN J PSYCHOL, V20, DOI 10.1017/sjp.2017.52; Ashcraft PF, 2018, NURS EDUC, V43, P140, DOI 10.1097/NNE.0000000000000450; Basak T, 2015, REHABIL NURS, V40, P60, DOI 10.1002/rnj.153; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; Callaghan DM, 2003, NURS SCI QUART, V16, P247, DOI 10.1177/0894318403016003016; Canty-Mitchell J, 2001, J Child Adolesc Psychiatr Nurs, V14, P18, DOI 10.1111/j.1744-6171.2001.tb00285.x; Ciftci B, 2015, ARCH PSYCHIAT NURS, V29, P372, DOI 10.1016/j.apnu.2015.06.007; Cocchieri A, 2015, EUR J CARDIOVASC NUR, V14, P126, DOI 10.1177/1474515113518443; Colomer-Perez N, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16245042; Crane PJ, 2016, AORN J, V104, P386, DOI 10.1016/j.aorn.2016.09.007; Dale B, 2011, NORDISK SYGEPLEJEFOR, V1, P219; Damasio BF, 2013, CAD SAUDE PUBLICA, V29, P2071, DOI 10.1590/0102-311X00165312; Denyes MJ, 2001, NURS SCI QUART, V14, P48, DOI 10.1177/089431840101400113; Evers GC, 1986, NEW FRONTIERS NURSIN, P130; EVERS GCM, 1993, INT J NURS STUD, V30, P331, DOI 10.1016/0020-7489(93)90105-4; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernández Alba Rosa, 2011, av.enferm., V29, P30; Fex A, 2012, J ADV NURS, V68, P806, DOI 10.1111/j.1365-2648.2011.05781.x; Finney SJ, 2006, QUANT METH EDUC BEHA, P269; Fok May S M, 2002, Contemp Nurse, V12, P124; Foureur M, 2013, CONTEMP NURSE, V45, P114, DOI 10.5172/conu.2013.45.1.114; Gallegos C., 1998, DESARROLLO CIENTIFIC, V6, P260; GAST HL, 1989, ADV NURS SCI, V12, P26, DOI 10.1097/00012272-198910000-00006; Goransson C, 2020, SCAND J CARING SCI, V34, P772, DOI 10.1111/scs.12782; Stacciarini TSG, 2017, REV LAT-AM ENFERM, V25, DOI 10.1590/1518-8345.1378.2856; Guo LN, 2017, WESTERN J NURS RES, V39, P1459, DOI 10.1177/0193945916672821; Hicks M, 2008, J NURS SCHOLARSHIP, V40, P349, DOI 10.1111/j.1547-5069.2008.00249.x; Jones PS, 2001, NURS RES, V50, P300, DOI 10.1097/00006199-200109000-00008; Karasu F, 2020, APPL NURS RES, V51, DOI 10.1016/j.apnr.2019.151208; Krampe H, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02953-x; Kusnanto K, 2018, J TAIBAH UNIV MED SC, V13, P472, DOI 10.1016/j.jtumed.2018.07.002; Letvak Susan, 2013, Nurs Adm Q, V37, P295, DOI 10.1097/NAQ.0b013e3182a2f99a; LORENSEN M, 1993, INT J NURS STUD, V30, P15, DOI 10.1016/0020-7489(93)90089-D; Manrique-Abril F, 2009, AQUICHAN, V9, P222; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; McSharry Patsy, 2017, Nurs Stand, V31, P51, DOI 10.7748/ns.2017.e10588; Mellor P, 2017, CONTEMP NURSE, V53, P390, DOI 10.1080/10376178.2017.1348903; Moore J B, 1993, Sch Inq Nurs Pract, V7, P199; Nevins CM, 2016, J HOLIST NURS, V34, P185, DOI 10.1177/0898010115596432; Nursing Development Conference Group, 1973, CONC FORM NURS PROC; Orem D.E., 1995, NURSING CONCEPTS PRA, V(5.); Orem DE, 2011, NURS SCI QUART, V24, P35, DOI 10.1177/0894318410389061; Oren B, 2014, J RENAL CARE, V40, P266, DOI 10.1111/jorc.12098; Padilla MA, 2016, EDUC PSYCHOL MEAS, V76, P436, DOI 10.1177/0013164415593776; Peterson RA, 2013, J APPL PSYCHOL, V98, P194, DOI 10.1037/a0030767; Raykov T, 2001, APPL PSYCH MEAS, V25, P69, DOI 10.1177/01466216010251005; Raykov T, 1998, APPL PSYCH MEAS, V22, P375, DOI 10.1177/014662169802200407; Raykov T., 2011, INTRO PSYCHOMETRIC T; Saeidzadeh S, 2016, J CLIN NURS, V25, P3311, DOI 10.1111/jocn.13396; Shi DX, 2019, EDUC PSYCHOL MEAS, V79, P310, DOI 10.1177/0013164418783530; Slusher I L, 1999, Issues Compr Pediatr Nurs, V22, P49, DOI 10.1080/014608699265383; Soderhamn O, 1996, SCAND J CARING SCI, V10, P3; Soderhamn O., 2001, J NURS THEORY, V10, P5; Soderhamn U, 2008, EUR J CLIN NUTR, V62, P96, DOI 10.1038/sj.ejcn.1602691; Sonninen AL., 1997, THESIS KUOPIO U, DOI [10.1016/s0887-8994(96)00315-3, DOI 10.1016/S0887-8994(96)00315-3]; Sousa V.D., 2002, ONLINE BRAZ J NURS, V1, P3, DOI [DOI 10.17665/1676-4285.20024811, 10.17665/1676-4285.20024811]; Sousa VD, 2008, DIABETES EDUCATOR, V34, P98, DOI 10.1177/0145721707311955; Sousa VD, 2010, J EVAL CLIN PRACT, V16, P1031, DOI 10.1111/j.1365-2753.2009.01242.x; Sundsli K, 2013, CLIN INTERV AGING, V8, P123, DOI 10.2147/CIA.S39689; Sundsli K, 2012, J MULTIDISCIP HEALTH, V5, P85, DOI 10.2147/JMDH.S29388; Tanimura C, 2019, YONAGO ACTA MED, V62, P137, DOI 10.33160/yam.2019.03.019; Ullman JB., 1996, STRUCT EQU MODELING, V5th, P676; van Achterberg T, 1991, Scand J Caring Sci, V5, P101; Velandia-Arias Anita, 2009, Rev. salud pública, V11, P538; Vinje H.F., 2017, HDB SALUTOGENESIS, P307, DOI DOI 10.1007/978-3-319-04600-6; Waki S, 2016, JPN J NURS SCI, V13, P478, DOI 10.1111/jjns.12127; Wang Hsiu-Hung, 2000, Kaohsiung Journal of Medical Sciences, V16, P459; WHETSTONE WR, 1989, J ADV NURS, V14, P962, DOI 10.1111/j.1365-2648.1989.tb01484.x; While AE, 2015, LONDON J PRIM CARE, V7, P112, DOI 10.1080/17571472.2015.1113716; Wolf D, 2008, J NURS ADMIN, V38, P532, DOI 10.1097/NNA.0b013e31818ebf4f; Wong CL, 2015, J NURS SCHOLARSHIP, V47, P219, DOI 10.1111/jnu.12134	74	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260827	10.1371/journal.pone.0260827	http://dx.doi.org/10.1371/journal.pone.0260827			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY2LS	34879084	Green Published, gold			2022-12-26	WOS:000754625200031
J	Singini, MG; Sitas, F; Bradshaw, D; Chen, WC; Motlhale, M; Kamiza, AB; de Villiers, CB; Lewis, CM; Mathew, CG; Waterboer, T; Newton, R; Muchengeti, M; Singh, E				Singini, Mwiza Gideon; Sitas, Freddy; Bradshaw, Debbie; Chen, Wenlong Carl; Motlhale, Melitah; Kamiza, Abram Bunya; de Villiers, Chantal Babb; Lewis, Cathryn M.; Mathew, Christopher G.; Waterboer, Tim; Newton, Robert; Muchengeti, Mazvita; Singh, Elvira			Ranking lifestyle risk factors for cervical cancer among Black women: A case-control study from Johannesburg, South Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS; COLLABORATIVE REANALYSIS; NATURAL-HISTORY; INDIVIDUAL DATA; HIV-INFECTION; SMOKING; POPULATION; COFACTORS; SPECTRUM	Background Aside from human papillomavirus (HPV), the role of other risk factors in cervical cancer such as age, education, parity, sexual partners, smoking and human immunodeficiency virus (HIV) have been described but never ranked in order of priority. We evaluated the contribution of several known lifestyle co-risk factors for cervical cancer among black South African women. Methods We used participant data from the Johannesburg Cancer Study, a case-control study of women recruited mainly at Charlotte Maxeke Johannesburg Academic Hospital between 1995 and 2016. A total of 3,450 women in the study had invasive cervical cancers, 95% of which were squamous cell carcinoma. Controls were 5,709 women with cancers unrelated to exposures of interest. Unconditional logistic regression models were used to calculate adjusted odds ratios (ORadj) and 95% confidence intervals (CI). We ranked these risk factors by their population attributable fractions (PAF), which take the local prevalence of exposure among the cases and risk into account. Results Cervical cancer in decreasing order of priority was associated with (1) being HIV positive (ORadj = 2.83, 95% CI = 2.53-3.14, PAF = 17.6%), (2) lower educational attainment (ORadj = 1.60, 95% CI = 1.44-1.77, PAF = 16.2%), (3) higher parity (3+ children vs 2-1 children (ORadj = 1.25, 95% CI = 1.07-1.46, PAF = 12.6%), (4) hormonal contraceptive use (ORadj = 1.48, 95% CI = 1.24-1.77, PAF = 8.9%), (5) heavy alcohol consumption (ORadj = 1.44, 95% CI = 1.15-1.81, PAF = 5.6%), (6) current smoking (ORadj = 1.64, 95% CI = 1.41-1.91, PAF = 5.1%), and (7) rural residence (ORadj = 1.60, 95% CI = 1.44-1.77, PAF = 4.4%). Conclunsion This rank order of risks could be used to target educational messaging and appropriate interventions for cervical cancer prevention in South African women.	[Singini, Mwiza Gideon; Chen, Wenlong Carl; Motlhale, Melitah; Muchengeti, Mazvita; Singh, Elvira] Natl Canc Registry, Natl Hlth Lab Serv, Johannesburg, South Africa; [Singini, Mwiza Gideon; Motlhale, Melitah; Muchengeti, Mazvita; Singh, Elvira] Univ Witwatersrand, Sch Publ Hlth, Div Epidemiol & Biostat, Fac Hlth Sci, Johannesburg, South Africa; [Sitas, Freddy; Bradshaw, Debbie] South African Med Res Council, Burden Dis Res Unit, Cape Town, South Africa; [Sitas, Freddy] Univ New South Wales Sydney, Sch Publ Hlth & Community Med, Ctr Primary Hlth Care & Equity, Sydney, Australia; [Sitas, Freddy] Univ Sydney, Sch Publ Hlth, Menzies Ctr Hlth Policy, Sydney, Australia; [Chen, Wenlong Carl] Univ Witwatersrand, Fac Hlth Sci, Sydney Brenner Inst Mol Biosci, Johannesburg, South Africa; [de Villiers, Chantal Babb] Univ Witwatersrand, Sch Pathol, Div Human Genet, Fac Hlth Sci, Johannesburg, South Africa; [Lewis, Cathryn M.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Social Genet & Dev Psychiat Ctr, London, England; [Lewis, Cathryn M.; Mathew, Christopher G.] Kings Coll London, Dept Med & Mol Genet, Fac Life Sci & Med, London, England; [Waterboer, Tim] German Canc Res Ctr, Div Infect & Canc Epidemiol, Heidelberg, Germany; [Newton, Robert] MRC, UVRI, Entebbe, Uganda; [Newton, Robert] LSHTM, Uganda Res Unit, Entebbe, Uganda; [Newton, Robert; Muchengeti, Mazvita] Univ York, York, N Yorkshire, England; [Muchengeti, Mazvita] Stellenbosch Univ, South African DSINRF Ctr Excellence Epidemiol Mod, Stellenbosch, South Africa	National Health Laboratory Service; University of Witwatersrand; South African Medical Research Council; University of New South Wales Sydney; University of Sydney; University of Witwatersrand; University of Witwatersrand; University of London; King's College London; University of London; King's College London; Helmholtz Association; German Cancer Research Center (DKFZ); University of York - UK; Stellenbosch University	Singh, E (corresponding author), Natl Canc Registry, Natl Hlth Lab Serv, Johannesburg, South Africa.; Singh, E (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Div Epidemiol & Biostat, Fac Hlth Sci, Johannesburg, South Africa.	elviras@nicd.ac.za	Chen, Wenlong/ABA-6218-2020; Singh, Elvira/O-4442-2018; MOTLHALE, MELITAH/U-2490-2018; Lewis, Cathryn/A-5225-2010; Mathew, Christopher George/G-3434-2015	Chen, Wenlong/0000-0002-3248-4906; Sitas, Freddy/0000-0001-9679-1481; Singh, Elvira/0000-0003-1259-2122; MOTLHALE, MELITAH/0000-0003-4703-7057; Lewis, Cathryn/0000-0002-8249-8476; Singini, Mwiza Gideon/0000-0002-2897-1728; Mathew, Christopher George/0000-0003-4178-1838				Appleby P, 2006, INT J CANCER, V119, P1108, DOI 10.1002/ijc.21953; Appleby P, 2009, CANCER EPIDEM BIOMAR; Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Azimi SS, 2015, J RES HEALTH SCI, V15, P22; BOSCH FX, 1992, INT J CANCER, V52, P750, DOI 10.1002/ijc.2910520514; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; BRINTON LA, 1989, AM J EPIDEMIOL, V130, P486, DOI 10.1093/oxfordjournals.aje.a115362; Castellsague X, 2002, VIRUS RES, V89, P191, DOI 10.1016/S0168-1702(02)00188-0; CDC, 2020, DRINK TOO MUCH ALC C; Chen WC, 2020, CANCER EPIDEMIOL, V65, DOI 10.1016/j.canep.2020.101701; Chiaffarino F., 2001, CANCER EPIDEM BIOMAR, V10, P899; de Sanjose S, 2018, BEST PRACT RES CL OB, V47, P2, DOI 10.1016/j.bpobgyn.2017.08.015; HERRERO R, 1990, INT J CANCER, V46, P5, DOI 10.1002/ijc.2910460103; HERRERO R, 1989, JNCI-J NATL CANCER I, V81, P205, DOI 10.1093/jnci/81.3.205; Hildesheim A, 2001, BRIT J CANCER, V84, P1219, DOI 10.1054/bjoc.2001.1779; Holmes RS, 2009, CANCER EPIDEM BIOMAR, V18, P2442, DOI 10.1158/1055-9965.EPI-08-0956; IARC, 2012, BIOL AG REV HUM CARC; IARC Working Group, 2012, IARC MONOGRAPHS EVAL, V100E, P46; Jensen KE, 2013, BRIT J CANCER, V108, P234, DOI 10.1038/bjc.2012.513; Lazcano-Ponce E, 2008, CANCER EPIDEM BIOMAR, V17, P2808, DOI 10.1158/1055-9965.EPI-07-2659; Lee CH, 2008, INT J CANCER, V122, P1347, DOI 10.1002/ijc.23264; LICCIARDONE JC, 1989, INT J EPIDEMIOL, V18, P533, DOI 10.1093/ije/18.3.533; LINET MS, 1987, AM J EPIDEMIOL, V125, P1; Liu Zhi-Chang, 2015, Asian Pac J Cancer Prev, V16, P3893; Louie KS, 2011, CANCER EPIDEM BIOMAR, V20, P1379, DOI 10.1158/1055-9965.EPI-11-0284; Mabaso M, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1055-6; Mandelblatt JS, 1999, CANCER EPIDEM BIOMAR, V8, P97; Mbulaiteye SM, 2006, INT J CANCER, V118, P985, DOI 10.1002/ijc.21443; Mbulawa ZZA, 2012, J INFECT DIS, V206, P15, DOI 10.1093/infdis/jis299; Mouw T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003639; Munoz N, 2002, LANCET, V359, P1093, DOI 10.1016/S0140-6736(02)08151-5; National Department of Health Statistics South Africa South African Medical Research Council & ICF, 2019, S AFR DEM HLTH SURV; NCR_SA, 2017, CANC S AFR 2017 FULL; PARAZZINI F, 1990, INT J EPIDEMIOL, V19, P539, DOI 10.1093/ije/19.3.539; Roura E, 2014, INT J CANCER, V135, P453, DOI 10.1002/ijc.28666; Senaviratna N. A. M. R., 2019, ASIAN J PROBAB STAT, V5, P1, DOI [10.9734/ajpas/2019/v5i230132, DOI 10.9734/AJPAS/2019/V5I230132]; Sitas F, 2000, INT J CANCER, V88, P489, DOI 10.1002/1097-0215(20001101)88:3&lt;489::AID-IJC25&gt;3.0.CO;2-Q; Sitas Freddy, 2007, Infect Agent Cancer, V2, P6, DOI 10.1186/1750-9378-2-6; SMITH AH, 1988, INT J EPIDEMIOL, V17, P298, DOI 10.1093/ije/17.2.298; Stein L, 2008, BRIT J CANCER, V98, P1586, DOI 10.1038/sj.bjc.6604303; Stein L, 2008, INT J CANCER, V122, P2260, DOI 10.1002/ijc.23391; Syrjanen K, 2011, INT J STD AIDS, V22, P263, DOI 10.1258/ijsa.2009.009280; Tadesse SK, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0231-0; Thygesen LC, 2009, ALCOHOL ALCOHOLISM, V44, P387, DOI 10.1093/alcalc/agp034; Urban M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001182; Vhuromu E. N., 2018, The Open Public Health Journal, V11, P451, DOI 10.2174/1874944501811010451; Weiderpass E, 2001, CANC EPIDEMIOL PREV, V10; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	49	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260319	10.1371/journal.pone.0260319	http://dx.doi.org/10.1371/journal.pone.0260319			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879064	Green Published, Green Accepted, gold			2022-12-26	WOS:000754625200013
J	Chang, YY; Lin, HJ; Hsiao, LC; Lin, YF; Chang, CS; Liu, DZ				Chang, Yao-Yuan; Lin, Hung-Jun; Hsiao, Ling-Chi; Lin, Yu-Feng; Chang, Chih-Sheng; Liu, Der-Zen			Reduction of breast tumor drug resistance by 2,3,5,4'-tetrahydroxystilbene for exhibition synergic chemotherapeutic effect	PLOS ONE			English	Article							P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; ADENOVIRAL DELIVERY; BLADDER-CANCER; RESVERATROL; CELLS; DOXORUBICIN; COMBINATION; INHIBITION; EXPRESSION	Chemotherapy drugs have limited efficacy in breast cancer due to multidrug resistance generated by cancer cells against anticancer drugs. In this study, we developed a novel derivative, 2, 3, 5, 4'-tetrahydroxystilbene (TG1) by modifying 2, 3, 5, 4'-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG). In-vivo zebrafish embryo tests revealed that TG1 showed low toxicity. The equitoxic combination of DOX or DTX with TG1 in MCF-7/Adr reduced the IC50 of DOX or DTX, and the combination index (CI) showed strong synergistic effects in the 1:3 molar ratio of DTX: TG1 and 1:5 molar ratio of DOX: TG1. Moreover, fluorescence images confirmed the cellular uptake of DOX when combined with TG1 in MCF-7/Adr. Western blotting analysis indicated downregulation of p-glycoprotein (P-gp) after MCF-7/Adr treated with TG1. In conclusion, the combined therapy of DTX or DOX and TG1 increases drug efficacy via suppressing the p-glycoprotein efflux pump. These results suggest that TG1 may have potential use for breast cancer patients, especially those with multidrug resistance.	[Chang, Yao-Yuan; Lin, Hung-Jun; Hsiao, Ling-Chi; Liu, Der-Zen] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, Taipei, Taiwan; [Lin, Yu-Feng] Natl Taiwan Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Chang, Chih-Sheng] Natl Chiayi Univ, Dept Hort Sci, Chiayi, Taiwan; [Liu, Der-Zen] Med & Pharmaceut Ind Technol & Dev Ctr, New Taipei, Taiwan	Taipei Medical University; National Taiwan University; National Taiwan University Hospital; National Chiayi University	Liu, DZ (corresponding author), Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, Taipei, Taiwan.; Chang, CS (corresponding author), Natl Chiayi Univ, Dept Hort Sci, Chiayi, Taiwan.; Liu, DZ (corresponding author), Med & Pharmaceut Ind Technol & Dev Ctr, New Taipei, Taiwan.	changcs200@yahoo.com.tw; tonyliu@tmu.edu.tw			Ministry of Science and Technology, Taiwan [MOST105-2221-E-038-003-MY3, MOST107-2314-B-038-033-MY3]; Agricultural Technology Research Institute (TW) [10710025]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Agricultural Technology Research Institute (TW)	The list of funders were - Ministry of Science and Technology, Taiwan, MOST105-2221-E-038-003-MY3 for Der-Zen Liu - Ministry of Science and Technology, Taiwan, MOST107-2314-B-038-033-MY3 for Der-Zen Liu - Agricultural Technology Research Institute (TW), 10710025 for Hung-Jun Lin And the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abd AM, 2011, CELL PROLIFERAT, V44, P591, DOI 10.1111/j.1365-2184.2011.00783.x; Al-Thani HF, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14070625; Alfarouk KO, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0221-1; Bao LL, 2012, AM J PATHOL, V180, P2490, DOI 10.1016/j.ajpath.2012.02.024; Chen T, 2015, CANCER BIOL THER, V16, P106, DOI 10.4161/15384047.2014.987062; Cho CJ, 2019, ONCOL LETT, V18, P6869, DOI 10.3892/ol.2019.11023; Choi JS, 2009, PHARMAZIE, V64, P49, DOI 10.1691/ph.2008.8683; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Clarke R, 2005, SEMIN ONCOL, V32, pS9, DOI 10.1053/j.seminoncol.2005.09.009; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Fletcher JI, 2016, DRUG RESIST UPDATE, V26, P1, DOI 10.1016/j.drup.2016.03.001; Funato T, 2005, METH MOLEC MED, V106, P215; Galmarini Carlos Maria, 2003, Curr Opin Investig Drugs, V4, P1416; GERMANN UA, 1995, J NATL CANCER I, V87, P1573, DOI 10.1093/jnci/87.21.1573; Ghoncheh Mahshid, 2016, Asian Pac J Cancer Prev, V17, P43; Guo X, 2019, ASIAN J PHARM SCI, V14, P78, DOI 10.1016/j.ajps.2018.03.002; Hayashi N, 2018, CLIN BREAST CANCER, V18, pE219, DOI 10.1016/j.clbc.2017.09.013; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang F, 2014, EXP THER MED, V7, P1611, DOI 10.3892/etm.2014.1662; Huesker M, 2002, HEPATOLOGY, V36, P874, DOI 10.1053/jhep.2002.35619; Hutchinson L, 2010, NAT REV CLIN ONCOL, V7, P669, DOI 10.1038/nrclinonc.2010.192; Ivanova L, 2018, TOXICOL LETT, V284, P21, DOI 10.1016/j.toxlet.2017.11.021; Junco JJ, 2013, MOL CANCER RES, V11, P1521, DOI 10.1158/1541-7786.MCR-13-0237; Kaszubiak A, 2007, INT J ONCOL, V31, P419; Khan NAJ, 2021, MED ONCOL, V38, DOI 10.1007/s12032-021-01486-x; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; Lee SH, 2021, NUTR RES PRACT, V15, P12, DOI 10.4162/nrp.2021.15.1.12; Li YG, 2012, BIOCHEM BIOPH RES CO, V422, P85, DOI 10.1016/j.bbrc.2012.04.110; Maier-Salamon A, 2006, PHARM RES-DORDR, V23, P2107, DOI 10.1007/s11095-006-9060-z; Marques SM, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9040357; Muley H, 2020, BIOCHEM PHARMACOL, V177, DOI 10.1016/j.bcp.2020.113959; Murray S, 2012, CANCER TREAT REV, V38, P890, DOI 10.1016/j.ctrv.2012.02.011; Pawlowski KM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-119; Pradines Bruno, 2005, Current Drug Targets - Infectious Disorders, V5, P411; Schroeter A, 2014, MOLECULES, V19, P20054, DOI 10.3390/molecules191220054; Seretny M, 2014, PAIN, V155, P2461, DOI 10.1016/j.pain.2014.09.020; Tsai PW, 2018, MOLECULES, V23, DOI 10.3390/molecules23030571; Tshering G, 2021, COMP BIOCHEM PHYS C, V239, DOI 10.1016/j.cbpc.2020.108869; Wang SS, 2017, MOL MED REP, V15, P1179, DOI 10.3892/mmr.2017.6111; Wang X, 2019, CANCER DRUG RESIST, V2, P141, DOI 10.20517/cdr.2019.10; Wang ZY, 2015, TUMOR BIOL, V36, P9499, DOI 10.1007/s13277-015-3636-3; Xu JH, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0487-8; Xue CJ, 2016, TUMOR BIOL, V37, P8587, DOI 10.1007/s13277-015-4478-8	44	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260533	10.1371/journal.pone.0260533	http://dx.doi.org/10.1371/journal.pone.0260533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874967	gold, Green Published			2022-12-26	WOS:000753617500029
J	van Gestel, LC; Adriaanse, MA; de Ridder, DTD				van Gestel, Laurens C.; Adriaanse, Marieke A.; de Ridder, Denise T. D.			Who accepts nudges? nudge acceptability from a self-regulation perspective	PLOS ONE			English	Article							STRATEGIES; ATTITUDES; POLICIES	Background Public acceptability of nudging is receiving increasingly more attention, but studies remain limited to evaluations of aspects of the nudge itself or (inferred intentions) of the nudger. Yet, it is important to investigate which individuals are likely to accept nudges, as those who are supposed to benefit from the implementation should not oppose it. The main objective of this study was to integrate research on self-regulation and nudging, and to examine acceptability of nudges as a function of self-regulation capacity and motivation. Method Participants (N = 301) filled in questionnaires about several components of self-regulation capacity (self-control, proactive coping competence, self-efficacy, perceived control and perceived difficulty) and motivation (autonomous motivation and controlled motivation). To evaluate nudge acceptability, we used three vignettes describing three types of nudges (default, portion size, and rearrangement) that stimulated either a pro-self behavior (healthy eating) or pro-social behavior (sustainable eating) and asked participants to rate the nudges on (aspects of) acceptability. Results Results revealed that there were substantial differences in acceptability between the three types of nudges, such that the default nudge was seen as less acceptable and the rearrangement nudge as most acceptable. The behavior that was stimulated did not affect acceptability, even though the nudges that targeted healthy eating were seen as more pro-self than the nudges targeting sustainable eating. From all self-regulation components, autonomous motivation was the only measure that was consistently associated with nudge acceptability across the three nudges. For self-regulatory capacity, only some elements were occasionally related to acceptability for some nudges. Conclusion The current study thus shows that people are more inclined to accept nudges that target behaviors that they are autonomously motivated for, while people do not meaningfully base their judgments of acceptability on self-regulatory capacity.	[van Gestel, Laurens C.; Adriaanse, Marieke A.; de Ridder, Denise T. D.] Univ Utrecht, Dept Social Hlth & Org Psychol, Utrecht, Netherlands	Utrecht University	van Gestel, LC (corresponding author), Univ Utrecht, Dept Social Hlth & Org Psychol, Utrecht, Netherlands.	l.c.vangestel@uu.nl	van Gestel, Laurens/GQI-2264-2022; Adriaanse, Marieke/AFQ-8371-2022	Adriaanse, Marieke/0000-0002-2218-4723; van Gestel, Laurens/0000-0002-2461-4301	Netherlands Organization for Health Research and Development under ZonMW [91215012]	Netherlands Organization for Health Research and Development under ZonMW	This work is supported by the Netherlands Organization for Health Research and Development under ZonMW Grant 91215012 (www.zonmw.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspinwall LG, 1997, PSYCHOL BULL, V121, P417, DOI 10.1037//0033-2909.121.3.417; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Bang HM, 2020, BEHAV PUBLIC POLICY, V4, P50, DOI 10.1017/bpp.2018.1; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Blekesaune M, 2003, EUR SOCIOL REV, V19, P415, DOI 10.1093/esr/19.5.415; Bode C, 2008, PSYCHOL GEZONDH, V36, P81, DOI 10.1007/BF03077476; Brehm S.S., 1981, PSYCHOL REACTANCE, DOI DOI 10.1016/B978-0-12-129840-1.50005-3; Cadario R, 2020, MARKET SCI, V39, P465, DOI 10.1287/mksc.2018.1128; Cadario R, 2019, FOOD POLICY, V85, P1, DOI 10.1016/j.foodpol.2019.04.002; de Ridder D, 2022, PERSPECT PSYCHOL SCI, V17, P346, DOI 10.1177/1745691621995183; de Ridder DTD, 2012, PERS SOC PSYCHOL REV, V16, P76, DOI 10.1177/1088868311418749; Diepeveen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-756; Duckworth AL, 2018, PSYCHOL SCI PUBL INT, V19, P102, DOI 10.1177/1529100618821893; Duckworth AL, 2016, PERSPECT PSYCHOL SCI, V11, P35, DOI 10.1177/1745691615623247; Evers C, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6097-y; Fogg B.J., 2009, P 4 INT C PERS TECHN, V40, P7, DOI [DOI 10.1145/1541948.1541999, 10.1145/1541948.1541999]; Gillebaart M, 2015, SOC PERSONAL PSYCHOL, V9, P88, DOI 10.1111/spc3.12160; Grimm P, 2022, WILEY INT ENCY MARKE, DOI [10.1002/9781444316568.WIEM02057, DOI 10.1002/9781444316568.WIEM02057, 10.1002/9781444316568.wiem02057]; Hagman W, 2015, REV PHILOS PSYCHOL, V6, P439, DOI 10.1007/s13164-015-0263-2; Hansen PG, 2021, J PUBLIC HEALTH-UK, V43, P392, DOI 10.1093/pubmed/fdz154; Jung JY, 2016, JUDGM DECIS MAK, V11, P62; Kroese FM, 2016, J PUBLIC HEALTH-UK, V38, pE133, DOI 10.1093/pubmed/fdv096; Leonard TC, 2008, CONST POLITICAL ECON, V19, P356, DOI 10.1007/s10602-008-9056-2; Levesque CS, 2007, HEALTH EDUC RES, V22, P691, DOI 10.1093/her/cyl148; Loibl C, 2018, J CONSUM AFF, V52, P655, DOI 10.1111/joca.12181; Luszczynska A., 2020, HDB BEHAV CHANGE, P333, DOI [10.1017/97811086773180.023, DOI 10.1017/97811086773180.023]; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Nichols AL, 2008, J GEN PSYCHOL, V135, P151, DOI 10.3200/GENP.135.2.151-166; Nordgren LF, 2009, PSYCHOL SCI, V20, P1523, DOI 10.1111/j.1467-9280.2009.02468.x; Pechey R, 2014, SOC SCI MED, V113, P104, DOI 10.1016/j.socscimed.2014.05.010; Petrescu DC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155995; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Reijula S, 2022, BEHAV PUBLIC POLICY, V6, P119, DOI 10.1017/bpp.2020.5; Reisch LA, 2016, JUDGM DECIS MAK, V11, P310; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schroeder J, 2017, J EXP PSYCHOL GEN, V146, P1106, DOI 10.1037/xge0000320; Sunstein CR, 2018, REGUL GOV, V12, P3, DOI 10.1111/rego.12161; Szaszi B, 2018, J BEHAV DECIS MAKING, V31, P355, DOI 10.1002/bdm.2035; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Tannenbaum D, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0130; Van Gestel LC, 2018, PSYCHOL HEALTH, V33, P800, DOI 10.1080/08870446.2017.1416116; Van Gestel L.C., 2020, COMPREH RESULTS SOC, V0, P1, DOI [10.1080/23743603.2020.1808456, DOI 10.1080/23743603.2020.1808456]; Van Gestel LC, 2021, MOTIV SCI, V7, P319, DOI 10.1037/mot0000230; Vohs KD, 2004, HDB SELF REGULATION, P1; Wachner J, EFFECT NUDGES AUTONO; Wachner J., 2020, COMPREHENSIVE RESULT, P1, DOI [10.1080/23743603.2020.1808782, DOI 10.1080/23743603.2020.1808782]; Wachner J, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.607894	47	4	4	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0260531	10.1371/journal.pone.0260531	http://dx.doi.org/10.1371/journal.pone.0260531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY3JJ	34860843	Green Published, gold			2022-12-26	WOS:000754686900005
J	Ezinne, NE; Ojukwu, CS; Ekemiri, KK; Akano, OF; Ekure, E; Osuagwu, UL				Ezinne, Ngozika E.; Ojukwu, Chukwuebuka S.; Ekemiri, Kingsley K.; Akano, Obinna F.; Ekure, Edgar; Osuagwu, Uchechukwu Levi			Prevalence and clinical profile of glaucoma patients in rural Nigeria-A hospital based study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CROSS-SECTIONAL SURVEY; INTRAOCULAR-PRESSURE; AFRICAN POPULATION; VISUAL IMPAIRMENT; RISK-FACTORS; PATTERN; BURDEN; STATE	Purpose To determine the prevalence and clinical presentation of participants with glaucoma attending a public eye care facility in Nigeria. Method Hospital based retrospective study of glaucoma participants aged 50 years and above seen over a 5-year period. Descriptive statistics summarized the demographic, clinical characteristics and treatment of the participants and determined the association of variables with gender and age. Prevalence of the glaucoma by type, and their 95% confidence intervals (CI) were also calculated. Result Of the 5482 case files that were reviewed, 995 (18.15%, 95% Cl 17.15-19.19%) had glaucoma particularly primary open angle glaucoma (11.55%, 95%CI 10.73-12.42%) and were mostly females (564, 56.7%) aged 69 12 years (range, 50-103 years). In contrast to other glaucoma types, the prevalence of primary angle closure glaucoma (3.68, 95%CI 3.22-4.22) increased by 15% over 5 years. The mean intraocular pressure ranged from 15-50 mmHg but higher in females than males (27.8 +/- 6.1mmHg versus 26.6 +/- 6.0 mmHg, P < 0.05) who had comparable VA (0.58 +/- 0.4 Log MAR) and cup-disc ratios (P > 0.05). On presentation, the glaucoma hemi field test (GHFT) was outside the normal limits in 45.5% and 54.5% of males and females, respectively. The type of visual field defect was associated with glaucoma type (P = 0.047). Arcuate scotoma was most common (35.5%) across glaucoma types, paracentral scotoma more common in Secondary glaucoma while Seidel scotoma was highest in NTG (19.3%). Beta-blocker was the mainstay of management (42.2%) but more likely to be prescribed to males while more females received carbonic anhydrase inhibitors. Conclusions The high prevalence of glaucoma in older people remains a public health problem in Nigeria. The fact that about half of the participants presented with visual field defect suggests there is a need for public health messages to emphasize on early glaucoma screening, detection and management.	[Ezinne, Ngozika E.; Ekemiri, Kingsley K.] Univ West Indies, Dept Clin Surg Sci, Optometry Unit, St Augustine Campus, St Augustine, Trinidad Tobago; [Ezinne, Ngozika E.; Ojukwu, Chukwuebuka S.] Madonna Univ, Dept Optometry, Elele Campus, Okija, Nigeria; [Ojukwu, Chukwuebuka S.] Oxford Brookes Univ, Dept Publ Hlth, Oxford, England; [Akano, Obinna F.] Eye Optometry, New York, NY USA; [Ekure, Edgar] Salus Univ, Dept Biomed, Elkins Pk, PA USA; [Osuagwu, Uchechukwu Levi] Western Sydney Univ, Sch Med, Translat Hlth Res Inst THRI, Campbelltown, NSW, Australia; [Osuagwu, Uchechukwu Levi] Univ KwaZulu Natal, African Vis Res Inst, Discipline Optometry, Durban, South Africa	University West Indies Mona Jamaica; University West Indies Saint Augustine; Oxford Brookes University; University of Sydney; Western Sydney University; University of Kwazulu Natal	Osuagwu, UL (corresponding author), Western Sydney Univ, Sch Med, Translat Hlth Res Inst THRI, Campbelltown, NSW, Australia.; Osuagwu, UL (corresponding author), Univ KwaZulu Natal, African Vis Res Inst, Discipline Optometry, Durban, South Africa.	l.osuagwu@westernsydney.edu.au	Ekemiri, Kingsley/J-3659-2018; osuagwu, Uchechukwu Levi/K-5236-2015	Ekemiri, Kingsley/0000-0003-3881-7502; osuagwu, Uchechukwu Levi/0000-0002-1727-6914; Ezinne, Ngozika/0000-0003-3138-0213				Abdu L, 2002, Niger J Med, V11, P108; Abdull MM, 2009, INVEST OPHTH VIS SCI, V50, P4114, DOI 10.1167/iovs.09-3507; Adio AO, 2012, CLIN OPHTHALMOL, V6, P2023, DOI 10.2147/OPTH.S37145; Agarwal R, 2009, INDIAN J OPHTHALMOL, V57, P257, DOI 10.4103/0301-4738.53049; Al Obeidan SA, 2011, SAUDI J OPHTHALMOL, V25, P373, DOI 10.1016/j.sjopt.2011.09.001; Alemu AM, 2009, INT J OPHTHALMOL-CHI, V2, P168; [Anonymous], STAT GLANC NIG; Asana UE., 2013, ARCH INT SURG, V3, P23, DOI [10.4103/2278-9596.117140, DOI 10.4103/2278-9596.117140]; Ashaye A, 2013, INVEST OPHTH VIS SCI, V54, P7410, DOI 10.1167/iovs.13-12698; Bastawrous A, 2014, TROP MED INT HEALTH, V19, P600, DOI 10.1111/tmi.12276; Budenz DL, 2013, JAMA OPHTHALMOL, V131, P651, DOI 10.1001/jamaophthalmol.2013.1686; Buhrmann RR, 2000, INVEST OPHTH VIS SCI, V41, P40; Cho HK, 2014, SURV OPHTHALMOL, V59, P434, DOI 10.1016/j.survophthal.2013.09.003; Duke Roseline, 2013, J Curr Glaucoma Pract, V7, P6, DOI 10.5005/jp-journals-10008-1129; Ekwerekwu Chimdi M, 2002, West Afr J Med, V21, P200; Enock Malachi Epo, 2010, J Ophthalmic Vis Res, V5, P87; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gyasi M E, 2014, Ghana Med J, V48, P143, DOI 10.4314/gmj.v48i3.4; Hashemi H, 2019, J CURR OPHTHALMOL, V31, P366, DOI 10.1016/j.joco.2018.05.003; Holladay JT, 2004, J CATARACT REFR SURG, V30, P287, DOI 10.1016/j.jcrs.2004.01.014; Ibrahim N, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0831-2; Isawumi MA, 2014, MIDDLE EAST AFR J OP, V21, P165, DOI 10.4103/0974-9233.129769; Kapetanakis VV, 2016, BRIT J OPHTHALMOL, V100, P86, DOI 10.1136/bjophthalmol-2015-307223; Khandekar R, 2019, SAUDI J OPHTHALMOL, V33, P332, DOI 10.1016/j.sjopt.2019.02.006; Kim MJ, 2014, CLIN EXP OPHTHALMOL, V42, P825, DOI 10.1111/ceo.12347; Kizor-Akaraiwe NN, 2016, BMJ OPEN OPHTHALMOL, V1, DOI 10.1136/bmjophth-2016-000018; Komolafe O O, 2013, Middle East Afr J Ophthalmol, V20, P163, DOI 10.4103/0974-9233.110609; Kreft D, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6935-6; Kyari F, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0264-7; Kyari F, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0160-6; Kyari F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1299; Kyei S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245486; Lafuma A, 2007, CURR MED RES OPIN, V23, P3009, DOI 10.1185/030079907X242836; Lee DA, 2005, AM J HEALTH-SYST PH, V62, P691, DOI 10.1093/ajhp/62.7.691; Lee YR, 2012, INVEST OPHTH VIS SCI, V53, P881, DOI 10.1167/iovs.11-7846; Liang YB, 2011, INVEST OPHTH VIS SCI, V52, P8672, DOI 10.1167/iovs.11-7480; Mbadugha CA, 2014, SCI REP-UK, V4, DOI 10.1038/srep07585; Murdoch I E, 2001, Afr J Med Med Sci, V30, P337; Nelson-Ayifah D, 2020, AFR VIS EYE HEALTH J, V79, DOI 10.4102/aveh.v79i1.521; Ntim-Amponsah CT, 2004, EYE, V18, P491, DOI 10.1038/sj.eye.6700674; Ocansey S, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1528-x; Olawoye O., 2015, NIGER J OPHTHALMOL, V22, P11, DOI [10.4103/0189-9171.142747, DOI 10.4103/0189-9171.142747]; Omoti AE, 2006, TROP DOCT, V36, P97, DOI 10.1258/004947506776593323; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rotchford AP, 2003, OPHTHALMOLOGY, V110, P376, DOI 10.1016/S0161-6420(02)01568-3; Rotchford AP, 2002, ARCH OPHTHALMOL-CHIC, V120, P471, DOI 10.1001/archopht.120.4.471; Schulze-Bonsel K, 2006, INVEST OPHTH VIS SCI, V47, P1236, DOI 10.1167/iovs.05-0981; Seo SJ, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/1690256; Steinmetz JD, 2021, LANCET GLOB HEALTH, V9, pE144, DOI 10.1016/S2214-109X(20)30489-7; Sun J, 2012, EYE, V26, P283, DOI 10.1038/eye.2011.243; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Usifoh SF., 2014, J PHARM BIORES, V11, P22, DOI [10.4314/jpb.v11i1.4, DOI 10.4314/JPB.V11I1.4]; Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309; Yamamoto S, 2014, OPHTHALMOLOGY, V121, P1558, DOI 10.1016/j.ophtha.2014.03.003; Yoon Kyung Chul, 2015, Korean J Ophthalmol, V29, P359, DOI 10.3341/kjo.2015.29.6.359; Zhang N, 2021, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.624179; Zhao Y, 2015, INDIAN J OPHTHALMOL, V63, P825, DOI 10.4103/0301-4738.171963	59	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260965	10.1371/journal.pone.0260965	http://dx.doi.org/10.1371/journal.pone.0260965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855905	gold, Green Published			2022-12-26	WOS:000735299000158
J	Kose, J; Lenz, C; Akuno, J; Kiiru, F; Odionyi, JJ; Otieno-Masaba, R; Okoth, EA; Woelk, G; Leselewa, S; Fraaij, PL; Rakhmanina, N				Kose, Judith; Lenz, Cosima; Akuno, Job; Kiiru, Fred; Odionyi, Justine Jelagat; Otieno-Masaba, Rose; Okoth, Elizabeth A.; Woelk, Godfrey; Leselewa, Solomon; Fraaij, Pieter Leendert; Rakhmanina, Natella			Supporting adolescents living with HIV within boarding schools in Kenya	PLOS ONE			English	Article							HEALTH; EDUCATION; ASTHMA; IMPACT	Adolescents and youth living with HIV (AYLHIV) are a uniquely vulnerable population facing challenges around adherence, disclosure of HIV status and stigma. Providing school-based support for AYLHIV offers an opportunity to optimize their health and wellbeing. The purpose of this study was to evaluate the feasibility of school-based supportive interventions for AYLHIV in Kenya. From 2016-2019, with funding from ViiV Healthcare, the Elizabeth Glaser Pediatric AIDS Foundation implemented the innovative Red Carpet Program (RCP) for AYLHIV in participating public healthcare facilities and boarding schools in Homa Bay and Turkana Counties in Kenya. In this analysis, we report the implementation of the school-based interventions for AYLHIV in schools, which included: a) capacity building for overall in-school HIV, stigma and sexual and reproductive health education; b) HIV care and treatment support; c) bi-directional linkages with healthcare facilities; and d) psychosocial support (PSS). Overall, 561 school staff and 476 school adolescent health advocates received training to facilitate supportive environments for AYLHIV and school-wide education on HIV, stigma, and sexual and reproductive health. All 87 boarding schools inter-linked to 66 regional healthcare facilities to support care and treatment of AYLHIV. Across all RCP schools, 546 AYLHIV had their HIV status disclosed to school staff and received supportive care within schools, including treatment literacy and adherence counselling, confidential storage and access to HIV medications. School-based interventions to optimize care and treatment support for AYLHIV are feasible and contribute to advancing sexual and reproductive health within schools.	[Kose, Judith] Elizabeth Glaser Pediat AIDS Fdn, Tech Strategy & Innovat, Nairobi, Kenya; [Kose, Judith] Erasmus Univ, Dept Virosci, Erasmus MC, Rotterdam, Netherlands; [Lenz, Cosima; Rakhmanina, Natella] Elizabeth Glaser Pediat AIDS Fdn, Tech Strategy & Innovat, Washington, DC USA; [Akuno, Job; Odionyi, Justine Jelagat; Otieno-Masaba, Rose; Okoth, Elizabeth A.] Elizabeth Glaser Pediat AIDS Fdn, Country Program, Nairobi, Kenya; [Kiiru, Fred] Minist Educ, Nyanza Region, Homa Bay County, Kenya; [Woelk, Godfrey] Elizabeth Glaser Pediat AIDS Fdn, Res Dept, Washington, DC USA; [Leselewa, Solomon] Teachers Serv Commiss, Nyanza Region, Homa Bay County, Kenya; [Fraaij, Pieter Leendert] Erasmus MC Sophia Erasmus Univ, Pediat Infect Dis Div, Rotterdam, Netherlands; [Rakhmanina, Natella] George Washington Univ, Washington, DC USA; [Rakhmanina, Natella] Childrens Natl Hosp, Washington, DC USA; [Kose, Judith] Ariel House, Nairobi, Kenya	Erasmus University Rotterdam; Erasmus MC; George Washington University; Children's National Health System	Kose, J (corresponding author), Elizabeth Glaser Pediat AIDS Fdn, Tech Strategy & Innovat, Nairobi, Kenya.; Kose, J (corresponding author), Erasmus Univ, Dept Virosci, Erasmus MC, Rotterdam, Netherlands.; Kose, J (corresponding author), Ariel House, Nairobi, Kenya.	jkose@pedaids.org		Lenz, Cosima/0000-0001-8041-6943	United States Government (USG); ViiV Healthcare UK Ltd, London, UK; ELMA Philanthropies; Positive Action for Adolescents Programme by ViiV Healthcare UK Ltd, London, UK under the Positive Action for Adolescents Program	United States Government (USG); ViiV Healthcare UK Ltd, London, UK; ELMA Philanthropies; Positive Action for Adolescents Programme by ViiV Healthcare UK Ltd, London, UK under the Positive Action for Adolescents Program	This work was supported with funding by a grant from the Positive Action for Adolescents Programme by ViiV Healthcare UK Ltd, London, UK under the Positive Action for Adolescents Program. EGPAF's adolescent and youth-focused programs in Kenya are supported by funding from United States Government (USG), ELMA Philanthropies, and ViiV Healthcare UK Ltd, London, UK. The funder did not participate in the implementation of the program or interpretation of the results as presented in this manuscript. The results do not necessarily represent the views of the funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2854-y; Baxen J, 2015, INT J EDUC DEV, V41, P237, DOI 10.1016/j.ijedudev.2014.11.002; Bruzzese JM, 2008, FAM PROCESS, V47, P95, DOI 10.1111/j.1545-5300.2008.00241.x; Cho H, 2018, J ADOLESCENT HEALTH, V62, P44, DOI 10.1016/j.jadohealth.2017.07.015; Coffman JM, 2009, PEDIATRICS, V124, P729, DOI 10.1542/peds.2008-2085; Enane LA, 2020, AIDS CARE, V32, P104, DOI 10.1080/09540121.2019.1668530; Fonner VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089692; Gregson S, 2007, P NATL ACAD SCI USA, V104, P14586, DOI 10.1073/pnas.0611540104; Hale DR, 2018, J EPIDEMIOL COMMUN H, V72, P465, DOI 10.1136/jech-2017-209605; Halia Access Network, 2018, ED FACT SHEET KEN; IAS WHO CIPHER, PRI RES QUEST ADOL H; Inzaule SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167492; Kimera E, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-0980-1; Luseno WK, 2017, AJAR-AFR J AIDS RES, V16, P241, DOI 10.2989/16085906.2017.1365089; Madiba S, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9623159; Madiba S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1746-x; Mason-Jones AJ, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-49; Mburu G, 2014, CHILD YOUTH SERV REV, V45, P9, DOI 10.1016/j.childyouth.2014.03.033; Michielsen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-729; Mirzazadeh A, 2018, PREV SCI, V19, P490, DOI 10.1007/s11121-017-0830-0; Mudege N. N., 2009, FORMATIVE EVALUATION; Mutumba M, 2015, AIDS PATIENT CARE ST, V29, P86, DOI 10.1089/apc.2014.0222; Mutwa PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060073; Nabors LA., 2010, J CHILD SERV, V3, P175; Nabukeera-Barungi N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1265-5; NASCOP, 2020, ESTIM; National AIDS and STI Control Program (NASCOP), 2014, ADOL PACK CAR KEN HL; National AIDS and STI Control Programme (NASCOP), 2020, PREL KENPHIA 2018 RE; Neil AL, 2009, CLIN PSYCHOL REV, V29, P208, DOI 10.1016/j.cpr.2009.01.002; Odionyi JJ, 2017, DEBATE SCH BASED SER; Oduor A, 2017, STANDARD DIGITAL; Roeser RW, 2000, ELEM SCHOOL J, V100, P443, DOI 10.1086/499650; Ruria EC, 2017, AIDS, V31, pS253, DOI 10.1097/QAD.0000000000001538; Sani AS, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3715-4; Smith G., 2003, SEX ED, V3, P1, DOI [10.1080/1468181032000052126, DOI 10.1080/1468181032000052126]; Toska E, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6580-0; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; WHO, SCH HLTH SERV; Wolf HT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1154	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260278	10.1371/journal.pone.0260278	http://dx.doi.org/10.1371/journal.pone.0260278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855779	gold, Green Published			2022-12-26	WOS:000735299000040
J	Adeyemi, OJ; Gill, TL; Paul, R; Huber, LB				Adeyemi, Oluwaseun John; Gill, Tasha Leimomi; Paul, Rajib; Huber, Larissa Brunner			Evaluating the association of self-reported psychological distress and self-rated health on survival times among women with breast cancer in the U.S	PLOS ONE			English	Article							MULTIPLE IMPUTATION; IMMUNE-SYSTEM; DNA-DAMAGE; STRESS; MORTALITY; DEPRESSION; METAANALYSIS; OBESITY	Background Psychological distress and self-rated health status may create additional complexities in patients already diagnosed with breast cancer. This study aims to assess the association of self-report-based assessment of psychological distress and self-rated health on survival times among women with breast cancer diagnoses. Methods Seventeen-year data from the Integrated Public Use Microdata Series-National Health Interview Survey (IPUMS-NHIS) were pooled and analyzed. Women who were aged 30 to 64 years old, with breast cancer diagnosis were selected (n = 2,819). The outcome variable was time to death. The independent variables were self-reported assessment of psychological distress and self-rated health. Psychological distress was defined using the Kessler-6 scale while self-rated health was measured on a 3-point Likert scale: Poor, Fair, and Good-to-Excellent (referred to as good for brevity). We computed unadjusted and adjusted hazard ratios (HR) using Cox-Proportional Hazard regression models with sociodemographic characteristics and measures of health care access used as potential confounders. Significance was set at alpha = 0.05. Results Women with breast cancer assessed as having psychological distress had 46% (Adjusted HR: 1.46; 95% CI: 1.02-2.09) increased risks of mortality. Also, women who rated their health as poor or fair had a significantly elevated mortality risk (Poor Health: Adjusted HR: 3.05; 95% CI: 2.61-4.69; Fair Health: Adjusted HR: 1.83; 95% CI: 1.43-2.35) as compared to women with good health status. Conclusions Self-reported psychological distress and fair and poor self-rated health are associated with reduced survival times among women with breast cancer diagnoses.	[Adeyemi, Oluwaseun John; Gill, Tasha Leimomi; Paul, Rajib; Huber, Larissa Brunner] Univ Edinburgh, Dept Trauma & Orthopaed, Edinburgh, Midlothian, Scotland; [Adeyemi, Oluwaseun John] Univ North Carolina Charlotte, Dept Publ Hlth Sci, Charlotte, NC 28223 USA	University of Edinburgh; University of North Carolina; University of North Carolina Charlotte	Adeyemi, OJ (corresponding author), Univ Edinburgh, Dept Trauma & Orthopaed, Edinburgh, Midlothian, Scotland.; Adeyemi, OJ (corresponding author), Univ North Carolina Charlotte, Dept Publ Hlth Sci, Charlotte, NC 28223 USA.	oadeyemi@uncc.edu	Adeyemi, Oluwaseun/GRY-2030-2022	Gill, Tasha/0000-0002-8322-5314; Adeyemi, Oluwaseun/0000-0002-7287-970X				Alagizy HA, 2020, MIDDLE EAST CURR PSY, V27, DOI 10.1186/s43045-020-00036-x; American Cancer Society, 2021, COMM IS BREAST CANC; [Anonymous], 2018, IPUMS Health Surveys: National Health Interview Survey, [Internet], DOI 10.18128/D070.V6.3; Araujo RV, 2019, REV ESC ENFERM USP, V53, DOI [10.1590/S1980-220X2018031303529, 10.1590/s1980-220x2018031303529]; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Benyamini Y, 1999, RES AGING, V21, P392, DOI 10.1177/0164027599213002; Brandt A, 2008, ANN ONCOL, V19, P2084, DOI 10.1093/annonc/mdn527; Bulun SE, 2012, TRENDS ENDOCRIN MET, V23, P83, DOI 10.1016/j.tem.2011.10.003; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; Centers for Disease Control and Prevention, 2018, BRFSS COMB LANDL CEL; Centers for Disease Control and Prevention, 2021, BREAST CANC STAT DIV; Cleary MP, 2009, ENDOCRINOLOGY, V150, P2537, DOI 10.1210/en.2009-0070; Cohen S., 1994, MEASURING STRESS GUI, V10, P1; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Connolly BS, 2002, NUTR CANCER, V44, P127, DOI 10.1207/S15327914NC4402_02; Crosswell AD, 2020, HEALTH PSYCHOL OPEN, V7, DOI 10.1177/2055102920933072; Cvetkovic J, 2016, PSYCHIAT RES, V240, P343, DOI 10.1016/j.psychres.2016.04.048; Dauchy S, 2013, EJC Suppl, V11, P205, DOI 10.1016/j.ejcsup.2013.07.006; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Eng JA, 2015, J AM GERIATR SOC, V63, P757, DOI 10.1111/jgs.13340; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Flint MS, 2007, PSYCHONEUROENDOCRINO, V32, P470, DOI 10.1016/j.psyneuen.2007.02.013; Franke GH, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-016-0283-3; Gidron Y, 2006, BIOL PSYCHOL, V72, P291, DOI 10.1016/j.biopsycho.2005.11.011; Gilbar O, 1996, GEN HOSP PSYCHIAT, V18, P266, DOI 10.1016/0163-8343(96)00023-0; Goldman R., 2020, BREAST CANCER-TOKYO; Hamer M, 2009, J PSYCHOSOM RES, V66, P255, DOI 10.1016/j.jpsychores.2008.11.002; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; IPUMS Health Surveys, 2019, FREQUENTLY ASKED QUE; IPUMS Health Surveys, 2017, US NOT SAMPL WEIGHTS; Jakobsson S, 2021, SCAND J CARING SCI, V35, P833, DOI 10.1111/scs.12899; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2011, INT J METH PSYCH RES, V20, P62, DOI 10.1002/mpr.333; Kondo N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4471; Krebber AMH, 2014, PSYCHO-ONCOLOGY, V23, P121, DOI 10.1002/pon.3409; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lu D., 2019, CANCER RES; Massie Mary Jane, 2004, J Natl Cancer Inst Monogr, P57; McGregor BA, 2009, BRAIN BEHAV IMMUN, V23, P159, DOI 10.1016/j.bbi.2008.08.002; Meyers David J, 2021, JAMA Health Forum, V2, pe210235, DOI 10.1001/jamahealthforum.2021.0235; Miller GE, 2001, HEALTH PSYCHOL, V20, P47, DOI 10.1037/0278-6133.20.1.47; Mohanty SS, 2021, GENES DIS, V8, P117, DOI 10.1016/j.gendis.2019.09.006; Moreno X, 2014, GAC SANIT, V28, P246, DOI 10.1016/j.gaceta.2013.07.006; National Cancer Institute, 2019, UND CANC PROGN; National Center for Health Statistics, 2018, NHANES RESP RAT POP; National Center for Health Statistics, 2019, NATL HLTH INTERVIEW; National Center for Health Statistics (USA), 2018, NAT HLTH INT SURV; National Centers for Health Statistics, 2020, NCHS DAT LINK NDI MO; Office of Research Protections and Integrity, 2020, GUID EX ACT DO DO NO; Patrician PA, 2002, RES NURS HEALTH, V25, P76, DOI 10.1002/nur.10015; Pierre-Victor D, 2020, CANCER EPIDEMIOL, V65, DOI 10.1016/j.canep.2020.101694; SAS Institute Inc, 2013, SAS ACCESS 9 4 INT A; Schnittker J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084933; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Sephton S, 2003, BRAIN BEHAV IMMUN, V17, P321, DOI 10.1016/S0889-1591(03)00078-3; Singh Simple D, 2016, MMWR Morb Mortal Wkly Rep, V63, P17, DOI 10.15585/mmwr.mm6355a4; Smith MJ, 2014, APPL NURS RES, V27, P67, DOI 10.1016/j.apnr.2013.11.004; StataCorp, 2021, STATA STAT SOFTWARE; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stress Measurement Network, 2020, PSYCH MEAS; Thaker PH, 2008, SEMIN CANCER BIOL, V18, P164, DOI 10.1016/j.semcancer.2007.12.005; U.S. Cancer Statistics Working Group, 2021, US CANC STAT DAT VIS; van de Mortel TF, 2008, AUST J ADV NURS, V25, P40; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Yao YQ, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0462-4	66	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260481	10.1371/journal.pone.0260481	http://dx.doi.org/10.1371/journal.pone.0260481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852013	gold, Green Published			2022-12-26	WOS:000755762900038
J	D'Amora, P; Silva, IDCG; Budib, MA; Ayache, R; Silva, RMS; Silva, FC; Appel, RM; Sarat, S; Pontes, HBD; Alvarenga, AC; Arima, EC; Martins, WG; Silva, NLF; Diaz, RS; Salzgeber, MB; Palma, AM; Evans, SS; Nagourney, RA				D'Amora, Paulo; Silva, Ismael Dale C. G.; Budib, Maria Auxiliadora; Ayache, Ricardo; Siufi Silva, Rafaela Moraes; Silva, Fabricio Colacino; Appel, Robson Mateus; Sarat Junior, Saturnino; Dorsa Pontes, Henrique Budib; Alvarenga, Ana Carolina; Arima, Emilli Carvalho; Martins, Wellington Galhano; Silva, Nakal Laurenco F.; Diaz, Ricardo Sobhie; Salzgeber, Marcia B.; Palma, Anton M.; Evans, Steven S.; Nagourney, Robert A.			Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection	PLOS ONE			English	Article								This study investigated the association between COVID-19 infection and host metabolic signatures as prognostic markers for disease severity and mortality. We enrolled 82 patients with RT-PCR confirmed COVID-19 infection who were classified as mild, moderate, or severe/critical based upon their WHO clinical severity score and compared their results with 31 healthy volunteers. Data on demographics, comorbidities and clinical/laboratory characteristics were obtained from medical records. Peripheral blood samples were collected at the time of clinical evaluation or admission and tested by quantitative mass spectrometry to characterize metabolic profiles using selected metabolites. The findings in COVID-19 (+) patients reveal changes in the concentrations of glutamate, valeryl-carnitine, and the ratios of Kynurenine/Tryptophan (Kyn/Trp) to Citrulline/Ornithine (Cit/Orn). The observed changes may serve as predictors of disease severity with a (Kyn/Trp)/(Cit/Orn) Receiver Operator Curve (ROC) AUC = 0.95. Additional metabolite measures further characterized those likely to develop severe complications of their disease, suggesting that underlying immune signatures (Kyn/Trp), glutaminolysis (Glutamate), urea cycle abnormalities (Cit/Orn) and alterations in organic acid metabolism (C5) can be applied to identify individuals at the highest risk of morbidity and mortality from COVID-19 infection. We conclude that host metabolic factors, measured by plasma based biochemical signatures, could prove to be important determinants of Covid-19 severity with implications for prognosis, risk stratification and clinical management.	[D'Amora, Paulo; Silva, Ismael Dale C. G.; Salzgeber, Marcia B.] Fed Univ Sao Paulo EPM UNIFESP, Dept Gynecol, Mol Gynecol & Metabol Lab, Coll Med, Sao Paulo, SP, Brazil; [D'Amora, Paulo; Evans, Steven S.; Nagourney, Robert A.] Nagourney Inst, Long Beach, CA 90806 USA; [D'Amora, Paulo; Evans, Steven S.; Nagourney, Robert A.] Metabolomycs Inc, Long Beach, CA 90806 USA; [Silva, Ismael Dale C. G.; Evans, Steven S.; Nagourney, Robert A.] Nagourney Canc Inst, Long Beach, CA USA; [Budib, Maria Auxiliadora; Ayache, Ricardo; Siufi Silva, Rafaela Moraes; Silva, Fabricio Colacino; Appel, Robson Mateus; Sarat Junior, Saturnino; Dorsa Pontes, Henrique Budib; Alvarenga, Ana Carolina; Arima, Emilli Carvalho; Martins, Wellington Galhano; Silva, Nakal Laurenco F.] CASSEMS Hosp, Dept Emergency & Intens Care Unit, Campo Grande, MS, Brazil; [Diaz, Ricardo Sobhie] Fed Univ Sao Paulo EPM UNIFESP, Dept Med, Infect Dis Div, Retrovirol Lab,Coll Med, Sao Paulo, SP, Brazil; [Palma, Anton M.] Univ Calif Irvine, Inst Clin & Translat Sci, Irvine, CA USA; [Nagourney, Robert A.] Mem Med Ctr Long Beach, Todd Canc Inst, Long Beach, CA USA; [Nagourney, Robert A.] Univ Calif Irvine, Dept Obstet & Gynecol, Orange, CA 92668 USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); University of California System; University of California Irvine; University of California System; University of California Irvine	D'Amora, P (corresponding author), Fed Univ Sao Paulo EPM UNIFESP, Dept Gynecol, Mol Gynecol & Metabol Lab, Coll Med, Sao Paulo, SP, Brazil.; D'Amora, P (corresponding author), Nagourney Inst, Long Beach, CA 90806 USA.; D'Amora, P (corresponding author), Metabolomycs Inc, Long Beach, CA 90806 USA.	d.amora@unifesp.br	D'Amora, Paulo/O-8477-2019; D'Amora, Paulo/V-3371-2018	D'Amora, Paulo/0000-0003-2341-5340; D'Amora, Paulo/0000-0003-2341-5340	Nagourney Institute, Long Beach, California, USA [95-4731388, 001-2021]; National Center for Research Resources, National Institutes of Health [UL1 TR001414]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR001414]	Nagourney Institute, Long Beach, California, USA; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by a Research Grant from the Nagourney Institute, Long Beach, California, USA (ID#95-4731388, Grant 001-2021). AMP was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR001414. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funder provided support in the form of consulting fees for authors PD and IDCGS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], WHO COVID 19 CLIN MA; Ayres JS, 2020, NAT METAB, V2, P572, DOI 10.1038/s42255-020-0237-2; Bornstein SR, 2020, NAT REV ENDOCRINOL, V16, P297, DOI 10.1038/s41574-020-0353-9; Bos LDJ, 2021, JAMA INTERN MED, V181, P9, DOI 10.1001/jamainternmed.2020.6047; Carayol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135437; Caterino M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82426-7; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Davanzo, 2020, SARS COV 2 USES CD4, DOI [10.1101/2020.09.25.20200329, DOI 10.1101/2020.09.25.20200329]; Ejaz H, 2020, J INFECT PUBLIC HEAL, V13, P1833, DOI 10.1016/j.jiph.2020.07.014; Floegel A, 2018, EUR J EPIDEMIOL, V33, P55, DOI 10.1007/s10654-017-0333-0; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Haberle J, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-32; Hasan MR, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.721556; Oostdam ASHV, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256784; Kiluk M, 2021, J CLIN MED, V10, DOI 10.3390/jcm10112484; Kuhn T, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0552-3; Law SH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051149; Meirelles Gustavo de Souza Portes, 2020, Radiol Bras, V53, P320, DOI 10.1590/0100-3984.2020.0074; Navarrete-Munoz MA, 2020, VIRULENCE, V11, P889, DOI 10.1080/21505594.2020.1788887; Paglia G, 2018, CLIN CHIM ACTA, V486, P320, DOI 10.1016/j.cca.2018.08.014; Pang ZQ, 2021, NUCLEIC ACIDS RES, V49, pW388, DOI 10.1093/nar/gkab382; Perez M.M., MEDRXIV2021010720248, DOI [10.1101/2021.01.07.20248970, DOI 10.1101/2021.01.07.20248970]; Scarpellini B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173164; Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012; Singh S, 2020, GASTROENTEROLOGY, V159, P768, DOI 10.1053/j.gastro.2020.04.064; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Thomas T, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140327; Van Egeren D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250780; Wan SX, 2020, J MED VIROL, V92, P797, DOI 10.1002/jmv.25783; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3	32	3	3	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0259909	10.1371/journal.pone.0259909	http://dx.doi.org/10.1371/journal.pone.0259909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851990	gold, Green Published			2022-12-26	WOS:000755762900018
J	Del Pino, R; Murueta-Goyena, A; Ayala, U; Acera, M; Fernandez, M; Tijero, B; Carmona, M; Fernandez, T; Gabilondo, I; Gomez-Esteban, JC				Del Pino, Rocio; Murueta-Goyena, Ane; Ayala, Unai; Acera, Marian; Fernandez, Monica; Tijero, Beatriz; Carmona, Mar; Fernandez, Tamara; Gabilondo, Inigo; Carlos Gomez-Esteban, Juan			Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson's disease	PLOS ONE			English	Article							QUALITY-OF-LIFE; NONMOTOR SYMPTOMS; RISK-FACTORS; DISORDERS; PREDICTORS; DIAGNOSIS; SCALE; PD	Objective To prospectively evaluate nocturnal sleep problems and excessive daytime sleepiness (EDS) in Parkinson's disease (PD) patients, and analyze the influence of motor symptoms, treatment, and sex differences on sleep problems in PD. Methods Sleep disturbances of 103 PD patients were assessed with Parkinson's Disease Sleep Scale (PDSS) and the Epworth Sleepiness Scale (ESS). Student's t-test for related samples, one-way ANOVA with Tukey's HSD post hoc test were used to assess group differences. Bivariate correlations and mixed-effects linear regression models were used to analyze the association between clinical aspects and sleep disturbances over time. Results At baseline, 48.5% of PD patients presented nocturnal problems and 40% of patients presented EDS. The PDSS and ESS total score slightly improve over time. Nocturnal problems were associated with age and motor impartment, explaining the 51% of the variance of the PDSS model. Males presented less nocturnal disturbances and more EDS than females. Higher motor impairment and combined treatment (L-dopa and agonist) were related to more EDS, while disease duration and L-dopa in monotherapy were related to lower scores, explaining the 59% of the model. Conclusions Sleep disturbances changed over time and age, diseases duration, motor impairment, treatment and sex were associated with nocturnal sleep problems and EDS. Agonist treatment alone or in combination with L-dopa might predict worse daytime sleepiness, while L-dopa in monotherapy is related to lower EDS, which significantly affects the quality of life of PD patients.	[Del Pino, Rocio; Murueta-Goyena, Ane; Acera, Marian; Tijero, Beatriz; Carmona, Mar; Fernandez, Tamara; Gabilondo, Inigo; Carlos Gomez-Esteban, Juan] Biocruces Bizkaia Hlth Res Inst, Neurodegenerat Dis Grp, Baracaldo, Bizkaia, Spain; [Murueta-Goyena, Ane; Carlos Gomez-Esteban, Juan] Univ Basque Country UPV EHU, Dept Neurosci, Leioa, Bizkaia, Spain; [Ayala, Unai] Mondragon Unibertsitatea, Biomed Engn Dept, Fac Engn, Arrasate Mondragon, Gipuzkoa, Spain; [Fernandez, Monica] Univ Basque Country UPV EHU, Fac Med Neurol, Leioa, Spain; [Tijero, Beatriz; Fernandez, Tamara; Gabilondo, Inigo; Carlos Gomez-Esteban, Juan] Cruces Univ Hosp, Baracaldo, Bizkaia, Spain; [Gabilondo, Inigo] Ikerbasque Basque Fdn Sci, Bilbao, Spain	University of Basque Country; Mondragon Unibertsitatea; University of Basque Country; Hospital Universitario Cruces; Basque Foundation for Science	Del Pino, R (corresponding author), Biocruces Bizkaia Hlth Res Inst, Neurodegenerat Dis Grp, Baracaldo, Bizkaia, Spain.	delpinorocio@gmail.com	Gabilondo, Iñigo/I-8274-2012; Murueta-Goyena, Ane/P-7610-2017	Gabilondo, Iñigo/0000-0001-6045-2840; Murueta-Goyena, Ane/0000-0002-9808-6943; Del Pino, Rocio/0000-0002-6612-4757				Abbott RD, 2005, NEUROLOGY, V65, P1442, DOI 10.1212/01.wnl.0000183056.89590.0d; Amara AW, 2017, J NEUROL NEUROSUR PS, V88, P653, DOI 10.1136/jnnp-2016-315023; Anang JBM, 2014, NEUROLOGY, V83, P1253, DOI 10.1212/WNL.0000000000000842; Arnulf I, 2000, NEUROLOGY, V55, P1732, DOI 10.1212/WNL.55.11.1732; Arnulf I, 2002, NEUROLOGY, V58, P1019, DOI 10.1212/WNL.58.7.1019; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Breen DP, 2013, J NEUROL NEUROSUR PS, V84, P233, DOI 10.1136/jnnp-2012-304097; Chahine LM, 2017, SLEEP MED REV, V35, P33, DOI 10.1016/j.smrv.2016.08.001; Chaudhuri KR, 2002, J NEUROL NEUROSUR PS, V73, P629, DOI 10.1136/jnnp.73.6.629; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Comella CL, 2007, MOVEMENT DISORD, V22, pS367, DOI 10.1002/mds.21682; Fahn S., 1987, RECENT DEV PARKINSON, P153; Gjerstad MD, 2006, NEUROLOGY, V67, P853, DOI 10.1212/01.wnl.0000233980.25978.9d; Goetz CG, 2005, NEUROLOGY, V64, P81, DOI 10.1212/01.WNL.0000148479.10865.FE; Gomez-Esteban JC, 2006, MOVEMENT DISORD, V21, P983, DOI 10.1002/mds.20874; Gros P, 2020, CLIN GERIATR MED, V36, P119, DOI 10.1016/j.cger.2019.09.005; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; Hoglund A, 2019, PARKINSONS DIS-US, V2019, DOI 10.1155/2019/5708515; Hu Y., 2021, NEUROPSYCH DIS TREAT, P17; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Iranzo A, 2011, J NEUROL SCI, V310, P283, DOI 10.1016/j.jns.2011.07.049; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Junho BT, 2018, J CLIN NEUROL, V14, P530, DOI 10.3988/jcn.2018.14.4.530; Karlsen KH, 1999, J NEUROL NEUROSUR PS, V66, P431, DOI 10.1136/jnnp.66.4.431; Kumar S, 2002, MOVEMENT DISORD, V17, P775, DOI 10.1002/mds.10167; Kurtis MM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00369; Leng Y, 2019, LANCET NEUROL, V18, P307, DOI 10.1016/S1474-4422(18)30461-7; Marano M., 2020, J NEUROL SCI, P410; Martinez-Martin P, 2004, MOVEMENT DISORD, V19, P1226, DOI 10.1002/mds.20144; Mondragon-Rezola E, 2010, REV NEUROLOGIA, V50, pS21; Neikrug AB, 2014, SLEEP, V37, P177, DOI 10.5665/sleep.3332; Neikrug AB, 2013, J CLIN SLEEP MED, V9, P1119, DOI 10.5664/jcsm.3148; Ruiz Morales A, 2013, REV COLOMB NEUMOL, V25; Scaravilli T, 2003, NEUROL SCI, V24, P209, DOI 10.1007/s10072-003-0134-y; Stavitsky K, 2010, PARKINSONISM RELAT D, V16, P280, DOI 10.1016/j.parkreldis.2010.02.001; Tandberg E, 1998, MOVEMENT DISORD, V13, P895, DOI 10.1002/mds.870130606; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Xiang YQ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00121; Zhang JQ, 2015, PARKINSONISM RELAT D, V21, P23, DOI 10.1016/j.parkreldis.2014.10.017; Zhu KD, 2016, PARKINSONISM RELAT D, V24, P34, DOI 10.1016/j.parkreldis.2016.01.020	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0259935	10.1371/journal.pone.0259935	http://dx.doi.org/10.1371/journal.pone.0259935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851977	gold, Green Published			2022-12-26	WOS:000755762900020
J	Rodriguez, OL; Sharp, AJ; Watson, CT				Rodriguez, Oscar L.; Sharp, Andrew J.; Watson, Corey T.			Limitations of lymphoblastoid cell lines for establishing genetic reference datasets in the immunoglobulin loci	PLOS ONE			English	Article							INTEGRATED MAP; HAPLOTYPE MAP; SEQUENCE	Lymphoblastoid cell lines (LCLs) have been critical to establishing genetic resources for biomedical science. They have been used extensively to study human genetic diversity, genome function, and inform the development of tools and methodologies for augmenting disease genetics research. While the validity of variant callsets from LCLs has been demonstrated for most of the genome, previous work has shown that DNA extracted from LCLs is modified by V(D)J recombination within the immunoglobulin (IG) loci, regions that harbor antibody genes critical to immune system function. However, the impacts of V(D)J on short read sequencing data generated from LCLs has not been extensively investigated. In this study, we used LCL-derived short read sequencing data from the 1000 Genomes Project (n = 2,504) to identify signatures of V(D)J recombination. Our analyses revealed sample-level impacts of V(D)J recombination that varied depending on the degree of inferred monoclonality. We showed that V(D)J associated somatic deletions impacted genotyping accuracy, leading to adulterated population-level estimates of allele frequency and linkage disequilibrium. These findings illuminate limitations of using LCLs and short read data for building genetic resources in the IG loci, with implications for interpreting previous disease association studies in these regions.	[Rodriguez, Oscar L.; Watson, Corey T.] Univ Louisville, Sch Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA; [Sharp, Andrew J.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	University of Louisville; Icahn School of Medicine at Mount Sinai	Watson, CT (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA.	corey.watson@louisville.edu		Sharp, Andrew/0000-0003-1415-5129; Watson, Corey/0000-0001-7248-8787; Rodriguez, Oscar L/0000-0002-4587-6124	U.S. National Institutes of Health [NIH R24AI138963, NIH 1F31NS108797]; Scientific Computing at the Icahn School of Medicine at Mount Sinai	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scientific Computing at the Icahn School of Medicine at Mount Sinai	This work was supported in part by grants from the U.S. National Institutes of Health NIH R24AI138963 (to CTW) and NIH 1F31NS108797 (to OLR). This work was supported in part through the computational resources and staff expertise provided by the Scientific Computing at the Icahn School of Medicine at Mount Sinai.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Byrska-Bishop M., 2021, BIORXIV2021020643006; Chaisson MJP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08148-z; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frisan T., EPSTEIN BARR VIRUS P, P125; Herbeck JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006915; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Londin ER, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-464; Murphy KM., 2016, JANEWAYS IMMUNOBIOLO, V9, DOI DOI 10.1201/9781315533247; Nickles D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-477; Rodriguez OL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02136; Schafer CM, 2013, GENOMICS, V102, P270, DOI 10.1016/j.ygeno.2013.05.005; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Vettermann C, 2010, IMMUNOL REV, V237, P22, DOI 10.1111/j.1600-065X.2010.00935.x; Watson CT, 2012, GENES IMMUN, V13, P363, DOI 10.1038/gene.2012.12; Watson CT, 2017, J IMMUNOL, V198, P3371, DOI 10.4049/jimmunol.1700306; Watson CT, 2013, AM J HUM GENET, V92, P530, DOI 10.1016/j.ajhg.2013.03.004; Zook JM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.25; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0261374	10.1371/journal.pone.0261374	http://dx.doi.org/10.1371/journal.pone.0261374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898642	Green Submitted, gold, Green Published			2022-12-26	WOS:000755176200039
J	Bijwaard, GE; Alessie, R; Angelini, V; Lumey, LH				Bijwaard, Govert E.; Alessie, Rob; Angelini, Viola; Lumey, L. H.			Physical and psychological health at adolescence and home care use later in life	PLOS ONE			English	Article							CHILDHOOD SOCIOECONOMIC-STATUS; PRENATAL FAMINE EXPOSURE; ADULT MORTALITY; EDUCATION; ORIGINS; DISEASE; MODELS	Objectives To examine the relation between physical and psychological health indicators at adolescence (age 18) and household, personal, and nursing home care use later in life at ages 57-69 years. Methods Using medical examinations on men born in 1944-1947 who were evaluated for military service at age 18 in the Netherlands, we link physical and psychological health assessments to national administrative microdata on the use of home care services at ages 57-69 years. We postulate a panel probit model for home care use over these years. In the analyses, we account for selective survival through correlated panel probit models. Results Poor mental health and being overweight at age 18 are important predictors of later life home care use. Home care use at ages 57-69 years is also highly related to and interacts with father's socioeconomic status and recruits' education at age 18. Discussion Specific health characteristics identified at age 18 are highly related to the later utilization of home-care at age 57-69 years. Some characteristics may be amenable to early life health interventions to decrease the future costs of long-term home care.	[Bijwaard, Govert E.] Univ Groningen, Netherlands Interdisciplinary Demog Inst, NIDI KNAW, Groningen, Netherlands; [Alessie, Rob; Angelini, Viola] Univ Groningen, Dept Econ Econometr & Finance, Groningen, Netherlands; [Lumey, L. H.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Royal Netherlands Academy of Arts & Sciences; Netherlands Interdisciplinary Demographic Institute (NIDI-KNAW); University of Groningen; University of Groningen; Columbia University	Bijwaard, GE (corresponding author), Univ Groningen, Netherlands Interdisciplinary Demog Inst, NIDI KNAW, Groningen, Netherlands.	Bijwaard@nidi.nl		Bijwaard, Govert/0000-0002-6458-1647; Alessie, Rob/0000-0002-5128-6753				Alessie RJM, 2019, SOC SCI MED, V224, P77, DOI 10.1016/j.socscimed.2019.02.006; Almond D, 2018, J ECON LIT, V56, P1360, DOI 10.1257/jel.20171164; Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2004, BMJ-BRIT MED J, V329, P585, DOI 10.1136/bmj.329.7466.585; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Bijwaard GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141200; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Case A, 2010, DEMOGRAPHY, V47, pS65, DOI 10.1353/dem.2010.0007; Clark D, 2013, AM ECON REV, V103, P2087, DOI 10.1257/aer.103.6.2087; Cohen S, 2010, ANN NY ACAD SCI, V1186, P37, DOI 10.1111/j.1749-6632.2009.05334.x; Conti G, 2010, PERSPECT PSYCHOL SCI, V5, P585, DOI 10.1177/1745691610383502; Currie J, 2009, J ECON LIT, V47, P87, DOI 10.1257/jel.47.1.87; Deary I, 2008, NATURE, V456, P175, DOI 10.1038/456175a; Doblhammer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074915; Ekamper P, 2014, SOC SCI MED, V119, P232, DOI 10.1016/j.socscimed.2013.10.027; Ekamper P, 2015, AM J EPIDEMIOL, V181, P271, DOI 10.1093/aje/kwu288; Galama TJ, 2019, ECON J, V129, P338, DOI 10.1111/ecoj.12577; Portrait F, 2000, HEALTH ECON, V9, P513, DOI 10.1002/1099-1050(200009)9:6<513::AID-HEC534>3.0.CO;2-R; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Roodman D, 2011, STATA J, V11, P159, DOI 10.1177/1536867X1101100202; Stein Z., 1975, Famine and human development. The Dutch hunger winter of 1944-1945.; Swinkels JC, 2016, AGEING SOC, V36, P1870, DOI 10.1017/S0144686X1500077X; van den Berg G, 2011, DEMOGRAPHY, V48, P507, DOI 10.1007/s13524-011-0021-8; Van Den Berg GJ, 2006, AM ECON REV, V96, P290, DOI 10.1257/000282806776157740; Vasunilashorn S, 2013, J AGING HEALTH, V25, P758, DOI 10.1177/0898264313491426; Zimmer Z, 2016, DEMOGR RES, V34, P285, DOI 10.4054/DemRes.2016.34.10	27	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0261078	10.1371/journal.pone.0261078	http://dx.doi.org/10.1371/journal.pone.0261078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY2LS	34879115	Green Published, gold			2022-12-26	WOS:000754625200049
J	Kane, NS; Anastasides, N; Litke, DR; Helmer, DA; Hunt, SC; Quigley, KS; Pigeon, WR; McAndrew, LM				Kane, Naomi S.; Anastasides, Nicole; Litke, David R.; Helmer, Drew A.; Hunt, Stephen C.; Quigley, Karen S.; Pigeon, Wilfred R.; McAndrew, Lisa M.			Under-recognition of medically unexplained symptom conditions among US Veterans with Gulf War Illness	PLOS ONE			English	Article							PHYSICAL SYMPTOMS; DIAGNOSIS; SOMATIZATION; PERCEPTIONS; CHALLENGES; DEPLOYMENT; DISORDERS; EXPOSURES	Objective Conditions defined by persistent "medically unexplained" physical symptoms and syndromes (MUS) are common and disabling. Veterans from the Gulf War (deployed 1990-1991) have notably high prevalence and disability from MUS conditions. Individuals with MUS report that providers do not recognize their MUS conditions. Our goal was to determine if Veterans with MUS receive an ICD-10 diagnosis for a MUS condition or receive disability benefits available to them for these conditions. Methods A chart review was conducted with US Veterans who met case criteria for Gulf War Illness, a complex MUS condition (N = 204, M = 53 years-old, SD = 7). Three coders independently reviewed Veteran's medical records for MUS condition diagnosis or service-connection along with comorbid mental and physical health conditions. Service-connection refers to US Veterans Affairs disability benefits eligibility for conditions or injuries experienced during or exacerbated by military service. Results Twenty-nine percent had a diagnosis of a MUS condition in their medical record, the most common were irritable colon/irritable bowel syndrome (16%) and fibromyalgia (11%). Slightly more Veterans were service-connected for a MUS condition (38%) as compared to diagnosed. There were high rates of diagnoses and service-connection for mental health (diagnoses 76% and service-connection 74%), musculoskeletal (diagnoses 86%, service-connection 79%), and illness-related conditions (diagnoses 98%, service-connection 49%). Conclusion Given that all participants were Gulf War Veterans who met criteria for a MUS condition, our results suggest that MUS conditions in Gulf War Veterans are under-recognized with regard to clinical diagnosis and service-connected disability. Veterans were more likely to be diagnosed and service-connected for musculoskeletal-related and mental health conditions than MUS conditions. Providers may need education and training to facilitate diagnosis of and service-connection for MUS conditions. We believe that greater acknowledgement and validation of MUS conditions would increase patient engagement with healthcare as well as provider and patient satisfaction with care.	[Kane, Naomi S.; Anastasides, Nicole; Litke, David R.; Helmer, Drew A.; McAndrew, Lisa M.] VA New Jersey Hlth Care Syst, War Related Illness & Injury Study Ctr, E Orange, NJ 07018 USA; [Litke, David R.] NYU, Grossman Sch Med, Dept Rehabil Med, New York, NY USA; [Helmer, Drew A.] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety IQuESt, Houston, TX USA; [Hunt, Stephen C.] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Hunt, Stephen C.] Univ Washington, Dept Med, Seattle, WA USA; [Quigley, Karen S.] VA Bedford Healthcare Syst, Ctr Hlth Org & Implementat Res, Bedford, MA USA; [Quigley, Karen S.] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Pigeon, Wilfred R.] Finger Lakes Healthcare Syst, VISN 2 Ctr Excellence Suicide Prevent, Canandaigua, NY USA; [Pigeon, Wilfred R.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA; [McAndrew, Lisa M.] SUNY Albany, Dept Educ & Counseling Psychol, Albany, NY 12222 USA	New York University; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Northeastern University; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Albany	McAndrew, LM (corresponding author), VA New Jersey Hlth Care Syst, War Related Illness & Injury Study Ctr, E Orange, NJ 07018 USA.; McAndrew, LM (corresponding author), SUNY Albany, Dept Educ & Counseling Psychol, Albany, NY 12222 USA.	lisa.mcandrew@va.gov	McAndrew, Lisa/H-7035-2017	McAndrew, Lisa/0000-0002-1350-8773	Veterans Affairs Clinical Services Research and Development [I01CX001053]; Veterans Affairs Health Services Research and Development [1IK2HX001369]	Veterans Affairs Clinical Services Research and Development; Veterans Affairs Health Services Research and Development(US Department of Veterans Affairs)	This work was supported by the Veterans Affairs Clinical Services Research and Development, Grant Number: I01CX001053 to LMM, the Veterans Affairs Health Services Research and Development, Grant Number: 1IK2HX001369 to LMM. The funders had no role in study design, data collection an analysis, decision to publish or preparation of the manuscript.	Aiarzaguena JM, 2008, SCAND J PRIM HEALTH, V26, P99, DOI 10.1080/02813430802048662; Anastasides N, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-018-0881-8; Barsky AJ, 2005, ARCH GEN PSYCHIAT, V62, P903, DOI 10.1001/archpsyc.62.8.903; Bell NS, 2010, MIL MED, V175, P227, DOI 10.7205/MILMED-D-10-00046; Bloeser K, 2021, SOC SCI MED, V284, DOI 10.1016/j.socscimed.2021.114211; Bodurow CC., 2008, IMPROVING PRESUMPTIV; Burton C, 2003, BRIT J GEN PRACT, V53, P231; Burton C, 2020, BMC MED, V18, DOI 10.1186/s12916-020-1505-4; Department of Veterans Affairs, 2011, Fed Regist, V76, P41696; Donnachie E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66685-4; Fitzcharles MA, 2003, RHEUMATOLOGY, V42, P263, DOI 10.1093/rheumatology/keg075; Franke TM, 2012, AM J EVAL, V33, P448, DOI 10.1177/1098214011426594; Fried DA, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010662; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Gittins R, 2018, PAIN MED, V19, P491, DOI 10.1093/pm/pnx155; Greenberg LM, 2018, CLIN SOC WORK J, V46, P100, DOI 10.1007/s10615-017-0616-7; Haller H, 2015, DTSCH ARZTEBL INT, V112, P279, DOI 10.3238/arztebl.2015.0279; Henningsen P, 2003, PSYCHOSOM MED, V65, P528, DOI 10.1097/01.PSY.0000075977.90337.E7; Huibers MJH, 2006, PSYCHOL MED, V36, P895, DOI 10.1017/S0033291705006926; Johansen ML, 2017, PATIENT EDUC COUNS, V100, P647, DOI 10.1016/j.pec.2016.11.015; Komaroff AL, 2019, JAMA-J AM MED ASSOC, V322, P499, DOI 10.1001/jama.2019.8312; Kroenke K, 2006, J PSYCHOSOM RES, V60, P335, DOI 10.1016/j.jpsychores.2006.01.022; Management of Chronic Multisymptom Illness Guideline Working G, 2014, VA DOD CLIN PRACT GU, P1; Marks EM, 2015, BRIT J PAIN, V9, P109, DOI 10.1177/2049463714535372; McAndrew LM, 2021, LIFE SCI, V284, DOI 10.1016/j.lfs.2021.119757; McAndrew Lisa M, 2016, Mil Behav Health, V4, P299, DOI 10.1080/21635781.2016.1175980; McAndrew LM, 2018, J PSYCHOSOM RES, V111, P140, DOI 10.1016/j.jpsychores.2018.05.015; McAndrew LM, 2016, J REHABIL RES DEV, V53, P59, DOI 10.1682/JRRD.2014.10.0255; Metzger-Smith V, 2017, SAGE OPEN MED, V5, DOI 10.1177/2050312117746567; Mohanty AF, 2018, J GEN INTERN MED, V33, P1419, DOI 10.1007/s11606-018-4479-6; Nimnuan C, 2000, QJM-INT J MED, V93, P21, DOI 10.1093/qjmed/93.1.21; Peters S, 1998, SOC SCI MED, V46, P559, DOI 10.1016/S0277-9536(97)00200-1; Petersen MW, 2020, SCAND J PUBLIC HEALT, V48, P567, DOI 10.1177/1403494819868592; Phillips LA, 2019, COUNS PSYCHOL, V47, P770, DOI 10.1177/0011000019890317; Phillips LA, 2017, PATIENT EDUC COUNS, V100, P1580, DOI 10.1016/j.pec.2017.03.011; Proctor SP, 1998, INT J EPIDEMIOL, V27, P1000, DOI 10.1093/ije/27.6.1000; Rayhan RU, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00181; Richardson RD, 2001, ARCH INTERN MED, V161, P1289, DOI 10.1001/archinte.161.10.1289; Salmon P, 1999, BRIT MED J, V318, P372, DOI 10.1136/bmj.318.7180.372; Salmon P, 2007, J GEN INTERN MED, V22, P565, DOI 10.1007/s11606-006-0094-z; Smith RC, 2007, J GEN INTERN MED, V22, P685, DOI 10.1007/s11606-006-0067-2; Solomon L, 2004, ARCH INTERN MED, V164, P2241, DOI 10.1001/archinte.164.20.2241; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Sullivan N, 2019, INT J BEHAV MED, V26, P665, DOI 10.1007/s12529-019-09817-z; Ustun T. B., 2010, Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0); Walitt B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157235; Warrens M. J., 2015, J PSYCHOL PSYCHOTHER, V5, P197, DOI [10.4172/2161- 0487.1000197, DOI 10.4172/2161-0487.1000197, 10.4172/2161-0487.1000197]; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Winograd DM, 2021, LIFE SCI, V279, DOI 10.1016/j.lfs.2021.119219; Wolfe F, 2019, ARTHRIT CARE RES, V71, P343, DOI 10.1002/acr.23731; Wolfe F, 2016, SEMIN ARTHRITIS RHEU, V46, P319, DOI 10.1016/j.semarthrit.2016.08.012; Yon K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009593; Zevestoski S, 2004, SOC SCI MED, V58, P161, DOI 10.1016/S0277-9536(03)00157-6	53	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0259341	10.1371/journal.pone.0259341	http://dx.doi.org/10.1371/journal.pone.0259341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YW7TO	34874939	Green Published, gold			2022-12-26	WOS:000753617500004
J	Omolo, MO; Ndiege, IO; Hassanali, A				Omolo, Maurice O.; Ndiege, Isaiah O.; Hassanali, Ahmed			Semiochemical signatures associated with differential attraction of Anopheles gambiae to human feet	PLOS ONE			English	Article							SENSU-STRICTO DIPTERA; HOST-SEEKING BEHAVIOR; HUMAN SKIN EMANATIONS; L-LACTIC ACID; MALARIA MOSQUITO; CARBON-DIOXIDE; HUMAN SWEAT; TSETSE ATTRACTANTS; PREFERRED BUFFALO; LIMBURGER CHEESE	Background Several human-produced volatiles have been reported to mediate the host-seeking process under laboratory conditions, yet no effective lure or repellent has been developed for field application. Previously, we found a gradation of the attractiveness of foot odors of different malaria free individuals to Anopheles gambiae sensu stricto Giles. In this study, foot odor of the individual with the most attractive 'smelly' feet to the An. gambiae was collected, analyzed and attractive blend components identified. Methods The foot odor of the individual with the most attractive 'smelly' feet to the An. gambiae was trapped on Porapak Q and analyzed by gas chromatography-linked mass spectrometry (GC-MS). Specific constituents perceived by the insect olfactory system were then identified by GC-linked to electro-antennography detector (GC-EAD) and characterized by GC-MS. The contribution of each constituent to the behavioral response of An. gambiae was assessed through subtractive assays under semi-field conditions in a screen-house using Counter Flow Geometry (CFG traps) baited with (i) the blend of all the EAD-active and (ii) other blends containing all components with exclusion of one component at a time. The number of mosquitoes trapped in the baited CFG traps were compared with those in the control traps. Results Eleven major and minor constituents: 2 carboxylic acids, six aldehydes, two ketones and one phenolic compound, were confirmed to be EAD-active. The contribution of each constituent to the behavioral response of An. gambiae was assessed through subtractive assays under semi- field conditions. Exclusion/ subtraction of one of the following compounds: i-butyric acid, i-valeric acid, n-octanal, n-nonanal, n-decanal, n-dodecanal, undecanal or n-tridecanal, from each blend led to reduction in the attractiveness of all the resulting blends, suggesting that all of them are critical/important for the attractiveness of the foot odor to An. gambiae mosquitoes. However, exclusion/subtraction of 4-ethoxyacetophenone, 4-ethylacetophenone and/or 2-methylphenol, led to significant enhancements in the attractiveness of the resulting blends, suggesting that each of these compounds had repellent effect on An. gambiae ss. Undecanal exhibited kairomonal activity at low natural concentrations under semi-field conditions but repellent activity at high unnatural conditions in the laboratory. Furthermore, the comparison of the mean mosquito catches in traps baited with the nine-component blend without 4-ethoxyacetophenone, 4-ethylacetophenone and the complete foot odor collection revealed that the former is significantly more attractive and confirmed the repellent effect of the two carbonyl compounds at low natural concentration levels. Conclusion These results suggest that differential attractiveness of An. gambiae to human feet is due to qualitative and/or qualitative differences in the chemical compositions of the foot odors from individual human beings and relative proportions of the two chemical signatures (attractants versus repellents) as observed from the ratios of the bioactive components in the foot odors of the most attractive and least attractive individuals. Chemical signature means the ensemble of the compounds released by the organism in a specific physiological state. The chemical signature is emitter-dependent, but does not depend on receiver response. Thus, there is only one chemical signature for one individual or species that may eventually include inactive, attractive and repellent components for another organism. The nine-component attractive blend has a potential as an effective field bait for trapping of malaria vectors in human dwellings.	[Omolo, Maurice O.; Ndiege, Isaiah O.; Hassanali, Ahmed] Kenyatta Univ, Sch Pure & Appl Sci, Dept Chem, Nairobi, Kenya; [Omolo, Maurice O.; Hassanali, Ahmed] ICIPE, BCED, Nairobi, Kenya; [Omolo, Maurice O.] MMUST, Fac Sci, Dept Pure & Appl Chem, Kakamega, Kenya; [Omolo, Maurice O.] MMUST, CAMNFF, Kakamega, Kenya	Kenyatta University; International Centre of Insect Physiology & Ecology (ICIPE)	Omolo, MO (corresponding author), Kenyatta Univ, Sch Pure & Appl Sci, Dept Chem, Nairobi, Kenya.; Omolo, MO (corresponding author), ICIPE, BCED, Nairobi, Kenya.; Omolo, MO (corresponding author), MMUST, Fac Sci, Dept Pure & Appl Chem, Kakamega, Kenya.; Omolo, MO (corresponding author), MMUST, CAMNFF, Kakamega, Kenya.	momolo@mmust.ac.ke	Omolo, Maurice/GNP-7064-2022	Omolo, Maurice Vincent O./0000-0002-0787-7492	UNDP/World Bank/WHO/TDR/MIN [A10442, A10638]; German Academic Exchange Service (DAAD)	UNDP/World Bank/WHO/TDR/MIN; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by funds from UNDP/World Bank/WHO/TDR/MIN (Grant No. A10442 of 2002; and A10638 of 2005); and the German Academic Exchange Service (DAAD) scholarship to Maurice Omolo.	ACREE F, 1968, SCIENCE, V161, P1346, DOI 10.1126/science.161.3848.1346; Andreasen MH, 2004, B ENTOMOL RES, V94, P291, DOI 10.1079/BER2004295; Bernier UR, 2002, J AM MOSQUITO CONTR, V18, P186; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; BOWEN MF, 1991, ANNU REV ENTOMOL, V36, P139, DOI 10.1146/annurev.en.36.010191.001035; Braks MAH, 1999, J CHEM ECOL, V25, P663, DOI 10.1023/A:1020970307748; Busula AO, 2017, MED VET ENTOMOL, V31, P320, DOI 10.1111/mve.12242; CLARK L, 1991, J WILDLIFE MANAGE, V55, P538, DOI 10.2307/3808987; Clark L, 1997, P USDA RES CTR C DEN, P343; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Costantini C, 1996, MED VET ENTOMOL, V10, P220, DOI 10.1111/j.1365-2915.1996.tb00734.x; Costantini C, 2001, MED VET ENTOMOL, V15, P259, DOI 10.1046/j.0269-283x.2001.00297.x; DEJONG R, 1995, EXPERIENTIA, V51, P80, DOI 10.1007/BF01964925; deJong R, 1996, CIBA F SYMP, V200, P89; Dekker T, 1998, MED VET ENTOMOL, V12, P136, DOI 10.1046/j.1365-2915.1998.00073.x; Dekker T, 1998, ENTOMOL EXP APPL, V87, P295, DOI 10.1023/A:1003278228021; Ephrussi B, 1936, AM NAT, V70, P218, DOI 10.1086/280658; G. WHO, 1996, REP WHO INF CONS EV; Gikonyo NK, 2003, J CHEM ECOL, V29, P2331, DOI 10.1023/A:1026230615877; Gikonyo NK, 2002, J CHEM ECOL, V28, P969, DOI 10.1023/A:1015205716921; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; GILLIES MT, 1967, ANN TROP MED PARASIT, V61, P68, DOI 10.1080/00034983.1967.11686460; HASSANALI A, 1986, INSECT SCI APPL, V7, P5, DOI 10.1017/S1742758400003027; Hassanali A, 2014, Patent No. [8,734,773, 8734773]; James A G, 2004, Int J Cosmet Sci, V26, P149, DOI 10.1111/j.1467-2494.2004.00214.x; James AG, 2004, WORLD J MICROB BIOT, V20, P787, DOI 10.1007/s11274-004-5843-8; KLINE DL, 1990, MED VET ENTOMOL, V4, P383, DOI 10.1111/j.1365-2915.1990.tb00455.x; Knols BGJ, 1997, B ENTOMOL RES, V87, P151, DOI 10.1017/S0007485300027292; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; Knols BGJ, 1996, PARASITOL TODAY, V12, P159, DOI 10.1016/0169-4758(96)10002-8; LINDSAY SW, 1993, J MED ENTOMOL, V30, P368, DOI 10.1093/jmedent/30.2.368; Mathenge EM, 2002, MED VET ENTOMOL, V16, P67, DOI 10.1046/j.0269-283x.2002.00350.x; Mboera LEG, 1997, B ENTOMOL RES, V87, P173, DOI 10.1017/S0007485300027322; MCIVER SB, 1968, J MED ENTOMOL, V5, P422, DOI 10.1093/jmedent/5.4.422; MEHR ZA, 1985, J AM MOSQUITO CONTR, V1, P143; Meijerink J, 1999, J INSECT PHYSIOL, V45, P365, DOI 10.1016/S0022-1910(98)00135-8; Meijerink J, 2001, J INSECT PHYSIOL, V47, P455, DOI 10.1016/S0022-1910(00)00136-0; Meijerink J, 2000, J CHEM ECOL, V26, P1367, DOI 10.1023/A:1005475422978; Mishra S, 2009, J APIC SCI, V53, P21; Mukabana Wolfgang R., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-17; Mukabana WR, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-1; MUKWAYA LG, 1976, PHYSIOL ENTOMOL, V1, P271, DOI 10.1111/j.1365-3032.1976.tb00976.x; Mwangi MT, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.4301; NICOLAIDES N, 1968, J INVEST DERMATOL, V51, P83, DOI 10.1038/jid.1968.96; Odalo JO, 2005, ACTA TROP, V95, P210, DOI 10.1016/j.actatropica.2005.06.007; OKECH M, 1990, INSECT SCI APPL, V11, P363, DOI 10.1017/S1742758400012789; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Omolo MO, 2013, ACTA TROP, V128, P144, DOI 10.1016/j.actatropica.2013.07.012; Omolo MO, 2004, PHYTOCHEMISTRY, V65, P2797, DOI 10.1016/j.phytochem.2004.08.035; Omolo MO, 2010, Patent No. [2010/143753, 2010143753]; Omolo MO, 2010, Patent No. [2010/143752, 2010143752]; Owino EA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0866-6; Owino EA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-451; Pates HV, 2001, B ENTOMOL RES, V91, P289, DOI 10.1079/BER200198; Pickett JA, 1996, CIBA F SYMP, V200, P109; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Robinson A, 2018, P NATL ACAD SCI USA, V115, pE4209, DOI 10.1073/pnas.1721610115; Roton L, 1996, Patent No. 05695807; Saini RK, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005977; SCHRECK CE, 1989, J AM MOSQUITO CONTR, V5, P247; Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010; Smallegange RC, 2011, TRENDS PARASITOL, V27, P143, DOI 10.1016/j.pt.2010.12.009; Smallegange RC, 2010, ECOL CONT VECTOR-BOR, V2, P143; Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7; SNOW WF, 1970, B ENTOMOL RES, V60, P43, DOI 10.1017/S0007485300034131; Suer R, 2011, THESIS WAGENINGEN U; TAKKEN W, 1989, J AM MOSQUITO CONTR, V5, P311; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; Takken W, 1997, J INSECT BEHAV, V10, P395, DOI 10.1007/BF02765606; Takken W, 2001, J INSECT PHYSIOL, V47, P303, DOI 10.1016/S0022-1910(00)00107-4; Takken W, 2017, CURR OPIN INSECT SCI, V20, P68, DOI 10.1016/j.cois.2017.03.011; TORR SJ, 1995, B ENTOMOL RES, V85, P157, DOI 10.1017/S000748530005210X; Tristantini D., 2014, INT J ENGIN TECH, V3, P14; Van de Meent, 1994, IDENTIFICATION CHEM, P1; van den Broek IVF, 1999, J INSECT PHYSIOL, V45, P1001, DOI 10.1016/S0022-1910(99)00081-5; Verhulst NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015829; Wanzala W, 2004, CHEMOECOLOGY, V14, P229, DOI 10.1007/s00049-004-0280-6; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2	80	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0260149	10.1371/journal.pone.0260149	http://dx.doi.org/10.1371/journal.pone.0260149			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY3JJ	34860850	Green Published, gold			2022-12-26	WOS:000754686900003
J	Bennett, S; Tiollier, E; Brocherie, F; Owens, DJ; Morton, JP; Louis, J				Bennett, Samuel; Tiollier, Eve; Brocherie, Franck; Owens, Daniel J.; Morton, James P.; Louis, Julien			Three weeks of a home-based "sleep low-train low" intervention improves functional threshold power in trained cyclists: A feasibility study	PLOS ONE			English	Article							REDUCED CARBOHYDRATE AVAILABILITY; SKELETAL-MUSCLE ADAPTATION; FAT ADAPTATION; TRANSCRIPTIONAL REGULATION; MITOCHONDRIAL BIOGENESIS; GLYCOGEN AVAILABILITY; ATHLETIC PERFORMANCE; SIGNALING RESPONSES; EXERCISE INTENSITY; ADAPTIVE RESPONSE	Background "Sleep Low-Train Low" is a training-nutrition strategy intended to purposefully reduce muscle glycogen availability around specific exercise sessions, potentially amplifying the training stimulus via augmented cell signalling. The aim of this study was to assess the feasibility of a 3-week home-based "sleep low-train low" programme and its effects on cycling performance in trained athletes. Methods Fifty-five trained athletes (Functional Threshold Power [FTP]: 258 52W) completed a home-based cycling training program consisting of evening high-intensity training (6 x 5 min at 105% FTP), followed by low-intensity training (1 hr at 75% FTP) the next morning, three times weekly for three consecutive weeks. Participant's daily carbohydrate (CHO) intake (6 g.kg(-1).d(-1)) was matched but timed differently to manipulate CHO availability around exercise: no CHO consumption post- HIT until post-LIT sessions [Sleep Low (SL), n = 28] or CHO consumption evenly distributed throughout the day [Control (CON), n = 27]. Sessions were monitored remotely via power data uploaded to an online training platform, with performance tests conducted pre-, post-intervention. Results LIT exercise intensity reduced by 3% across week 1, 3 and 2% in week 2 (P < 0.01) with elevated RPE in SL vs. CON (P < 0.01). SL enhanced FTP by +5.5% vs. +1.2% in CON (P < 0.01). Comparable increases in 5-min peak power output (PPO) were observed between groups (P < 0.01) with +2.3% and +2.7% in SL and CON, respectively (P = 0.77). SL 1-min PPO was unchanged (+0.8%) whilst CON improved by +3.9% (P = 0.0144). Conclusion Despite reduced relative training intensity, our data demonstrate short-term "sleep low-train low" intervention improves FTP compared with typically "normal" CHO availability during exercise. Importantly, training was completed unsupervised at home (during the COVID-19 pandemic), thus demonstrating the feasibility of completing a "sleep low-train low" protocol under non-laboratory conditions.	[Bennett, Samuel; Owens, Daniel J.; Morton, James P.; Louis, Julien] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci RISES, Liverpool, Merseyside, England; [Bennett, Samuel; Tiollier, Eve; Brocherie, Franck] French Inst Sport, Lab Sport Expertise & Performance EA 7370, Paris, France	Liverpool John Moores University	Louis, J (corresponding author), Liverpool John Moores Univ, Res Inst Sport & Exercise Sci RISES, Liverpool, Merseyside, England.	J.B.Louis@ljmu.ed.uk		Bennett, Samuel/0000-0002-3588-1819; Owens, Daniel/0000-0002-1908-8677; Brocherie, Franck/0000-0002-0808-7986				Allen H., 2019, TRAINING RACING POWE; Andrade-Souza VA, 2020, FASEB J, V34, P1602, DOI 10.1096/fj.201901207RR; Areta JL, 2018, SPORTS MED, V48, P2091, DOI 10.1007/s40279-018-0941-1; Bartlett JD, 2013, AM J PHYSIOL-REG I, V304, pR450, DOI 10.1152/ajpregu.00498.2012; Borg G, 2001, INT J SPORT PSYCHOL, V32, P110; Borszcz FK, 2020, INT J SPORTS MED, V41, P175, DOI 10.1055/a-1018-1965; Borszcz FK, 2018, INT J SPORTS MED, V39, P737, DOI 10.1055/s-0044-101546; Bouillod A, 2017, INT J SPORT PHYSIOL, V12, P1023, DOI 10.1123/ijspp.2016-0436; Burke LM, 2006, J APPL PHYSIOL, V100, P7, DOI 10.1152/japplphysiol.01238.2005; Burke LM, 2001, SPORTS MED, V31, P267, DOI 10.2165/00007256-200131040-00003; Burke LM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234027; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cochran AJR, 2015, INT J SPORT NUTR EXE, V25, P463, DOI 10.1123/ijsnem.2014-0263; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa VP, 2019, ISOKINET EXERC SCI, V27, P55, DOI 10.3233/IES-181198; Czajkowski M., 2016, SRM DEVICE J SCI CYC, P5; De Pauw K, 2013, INT J SPORT PHYSIOL, V8, P111, DOI 10.1123/ijspp.8.2.111; Decroix L, 2016, INT J SPORT PHYSIOL, V11, P204, DOI 10.1123/ijspp.2015-0153; Denham J, 2020, J STRENGTH COND RES, V34, P3489, DOI 10.1519/JSC.0000000000002253; Duhamel TA, 2006, AM J PHYSIOL-REG I, V291, pR1100, DOI 10.1152/ajpregu.00858.2005; Fell JM, 2021, J PHYSIOL-LONDON, V599, P2823, DOI 10.1113/JP281127; Gejl KD, 2017, MED SCI SPORT EXER, V49, P2486, DOI 10.1249/MSS.0000000000001377; Gejl KD, 2014, MED SCI SPORT EXER, V46, P496, DOI 10.1249/MSS.0000000000000132; Ghiarone T, 2019, J APPL PHYSIOL, V127, P713, DOI 10.1152/japplphysiol.00060.2019; Halson SL, 2013, INT J SPORT PHYSIOL, V8, P597, DOI 10.1123/ijspp.8.6.597; Hansen AK, 2005, J APPL PHYSIOL, V98, P93, DOI 10.1152/japplphysiol.00163.2004; Hargreaves M, 1997, Exerc Sport Sci Rev, V25, P21; Havemann L, 2006, J APPL PHYSIOL, V100, P194, DOI 10.1152/japplphysiol.00813.2005; HAWLEY JA, 1992, EUR J APPL PHYSIOL, V65, P79, DOI 10.1007/BF01466278; Hawley JA, 2013, NESTLE NUTR WORKS SE, V75, P1, DOI 10.1159/000345813; Hearris MA, 2019, J APPL PHYSIOL, V126, P1587, DOI 10.1152/japplphysiol.00913.2018; Hearris MA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030298; HOLLOSZY JO, 1970, BIOCHEM BIOPH RES CO, V40, P1368, DOI 10.1016/0006-291X(70)90017-3; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hoon M., 2016, J SCI CYCLING, V5, P11; Hopkins WG., 2015, SPORTSCIENCE, V19, P36; Howlett RA, 1998, AM J PHYSIOL-REG I, V275, pR418, DOI 10.1152/ajpregu.1998.275.2.R418; Hulston CJ, 2010, MED SCI SPORT EXER, V42, P2046, DOI 10.1249/MSS.0b013e3181dd5070; Hurst HT., 2015, J SCI CYCLING, V4, P21; Impey SG, 2018, SPORTS MED, V48, P1031, DOI 10.1007/s40279-018-0867-7; Impey SG, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12803; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jeukendrup A E, 2000, J Sci Med Sport, V3, P414, DOI 10.1016/S1440-2440(00)80008-0; Kim J, 2014, CLIN ORTHOP SURG, V6, P103, DOI 10.4055/cios.2014.6.1.103; Lane SC, 2015, J APPL PHYSIOL, V119, P643, DOI 10.1152/japplphysiol.00857.2014; Lillo-Bevia JR, 2022, J STRENGTH COND RES, V36, P167, DOI 10.1519/JSC.0000000000003403; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lindsay FH, 1996, MED SCI SPORT EXER, V28, P1427, DOI 10.1097/00005768-199611000-00013; MacInnis MJ, 2019, INT J SPORT PHYSIOL, V14, P38, DOI 10.1123/ijspp.2018-0100; Maier T, 2017, INT J SPORTS MED, V38, P456, DOI 10.1055/s-0043-102945; Marquet LA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120755; Marquet LA, 2016, MED SCI SPORT EXER, V48, P663, DOI 10.1249/MSS.0000000000000823; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; McGRATH Eanna, 2019, Int J Exerc Sci, V12, P1334; Montalvo-Perez A, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21072277; Morton JP, 2009, J APPL PHYSIOL, V106, P1513, DOI 10.1152/japplphysiol.00003.2009; Novak AR, 2016, MEAS PHYS EDUC EXERC, V20, P167, DOI 10.1080/1091367X.2016.1191496; Ortenblad N, 2011, J PHYSIOL-LONDON, V589, P711, DOI 10.1113/jphysiol.2010.195982; Pallares JG, 2018, J SPORT SCI MED, V17, P305; Philp A, 2012, AM J PHYSIOL-ENDOC M, V302, pE1343, DOI 10.1152/ajpendo.00004.2012; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Pilegaard H, 2005, METABOLISM, V54, P1048, DOI 10.1016/j.metabol.2005.03.008; Pilegaard H, 2004, P NUTR SOC, V63, P221, DOI 10.1079/PNS2004345; Pilegaard H, 2002, J PHYSIOL-LONDON, V541, P261, DOI 10.1113/jphysiol.2002.016832; Podlogar T, 2021, EUR J SPORT SCI, V21, P213, DOI 10.1080/17461391.2020.1730447; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Psilander N, 2013, EUR J APPL PHYSIOL, V113, P951, DOI 10.1007/s00421-012-2504-8; Riis S, 2019, SCAND J MED SCI SPOR, V29, P1866, DOI 10.1111/sms.13541; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Schneeweiss P., 2018, THE J, V7, P3, DOI DOI 10.28985/180130.JSC.02; Sorensen A, 2019, SPORTS, V7, DOI 10.3390/sports7100217; Stannard S.R., 2015, SPORTS TECHNOLOGY, V8, P44, DOI [10.1080/19346182.2015.1108979, DOI 10.1080/19346182.2015.1108979]; Starritt EC, 1999, J APPL PHYSIOL, V86, P450, DOI 10.1152/jappl.1999.86.2.450; Steinberg GR, 2006, APPL PHYSIOL NUTR ME, V31, P302, DOI 10.1139/H06-003; Stellingwerff T, 2006, AM J PHYSIOL-ENDOC M, V290, pE380, DOI 10.1152/ajpendo.00268.2005; Stellingwerff T, 2007, PFLUG ARCH EUR J PHY, V454, P635, DOI 10.1007/s00424-007-0236-0; Stellingwerff T, 2019, INT J SPORT NUTR EXE, V29, P141, DOI 10.1123/ijsnem.2018-0305; Stellingwerff T, 2012, INT J SPORT NUTR EXE, V22, P392, DOI 10.1123/ijsnem.22.5.392; Stepto NK, 2001, MED SCI SPORT EXER, V33, P303; Stocks B, 2019, AM J PHYSIOL-ENDOC M, V316, pE230, DOI 10.1152/ajpendo.00311.2018; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Teixeira V, 2018, NUTR DIET, V75, P219, DOI 10.1111/1747-0080.12401; van Loon LJC, 2001, J PHYSIOL-LONDON, V536, P295, DOI 10.1111/j.1469-7793.2001.00295.x; Wainwright B, 2017, J SPORT SCI, V35, P1451, DOI 10.1080/02640414.2016.1215495; Waterworth SP, 2020, INT J SPORT NUTR EXE, V30, P105, DOI 10.1123/ijsnem.2019-0275; Wojtaszewski JFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE813, DOI 10.1152/ajpendo.00436.2002; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yeo WK, 2008, J APPL PHYSIOL, V105, P1519, DOI 10.1152/japplphysiol.90540.2008; Yeo WK, 2008, J APPL PHYSIOL, V105, P1462, DOI 10.1152/japplphysiol.90882.2008; Yeo WK, 2010, EXP PHYSIOL, V95, P351, DOI 10.1113/expphysiol.2009.049353; Zamuner AR, 2011, J SPORT SCI MED, V10, P130	93	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260959	10.1371/journal.pone.0260959	http://dx.doi.org/10.1371/journal.pone.0260959			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855913	gold, Green Accepted, Green Published			2022-12-26	WOS:000735299000157
J	Ehara, H; Tatsumi, K; Takafuji, Y; Kawao, N; Ishida, M; Okada, K; Mackman, N; Kaji, H				Ehara, Hiroki; Tatsumi, Kohei; Takafuji, Yoshimasa; Kawao, Naoyuki; Ishida, Masayoshi; Okada, Kiyotaka; Mackman, Nigel; Kaji, Hiroshi			Role of tissue factor in delayed bone repair induced by diabetic state in mice	PLOS ONE			English	Article							HEMOSTASIS; BLOOD; PATHWAY; GROWTH; SITE	Background Tissue factor (TF) is the primary activator of the extrinsic coagulation protease cascade. Although TF plays roles in various pathological states, such as thrombosis, inflammatory diseases, cancer, and atherosclerosis, its involvement in bone metabolism remains unknown. Materials and methods The present study examined the roles of TF in delayed bone repair induced by a diabetic state in mice using wild-type (WT) and low TF-expressing (LTF) male mice. A diabetic state was induced by intraperitoneal injections of streptozotocin (STZ). Results A prolonged diabetic state significantly reduced total and trabecular bone mineral densities (BMD) as well as cortical bone thickness in WT and LTF mice; these BMD parameters were similar between WT and LTF mice treated with or without STZ. The diabetic state induced in WT mice delayed the repair of the femur following injury. The diabetic state induced in LTF mice was associated with further delays in bone repair. In in vitro experiments, TF significantly decreased receptor activator of nuclear factor-kappa B ligand-induced osteoclast formation and osteoclastogenic gene expression in RAW264.7 cells. However, it did not affect the gene expression levels of runt-related transcription factor 2 and osterix as well as alkaline phosphatase activity in mouse primary osteoblasts. Conclusion Low TF state was associated with enhanced bone repair delay induced by diabetic state in mice. The TF-induced suppression of bone remodeling may be a contributing factor to the protective effects of TF against delayed bone repair in a diabetic state.	[Ehara, Hiroki; Tatsumi, Kohei; Takafuji, Yoshimasa; Kawao, Naoyuki; Ishida, Masayoshi; Okada, Kiyotaka; Kaji, Hiroshi] Kindai Univ, Fac Med, Dept Physiol & Regenerat Med, Osakasayama, Osaka, Japan; [Tatsumi, Kohei] Nara Med Univ, Adv Med Sci Thrombosis & Hemostasis, Kashihara, Nara, Japan; [Mackman, Nigel] Univ N Carolina, UNC Blood Res Inst, Dept Med, Div Hematol, Chapel Hill, NC 27515 USA	Nara Medical University; University of North Carolina; University of North Carolina Chapel Hill	Kaji, H (corresponding author), Kindai Univ, Fac Med, Dept Physiol & Regenerat Med, Osakasayama, Osaka, Japan.	hkaji@med.kindai.ac.jp	Takafuji, Yoshimasa/HDO-7262-2022	Ishida, Masayoshi/0000-0003-2807-651X	Mitsui Life Social Welfare Foundation; Japan Osteoporosis Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [15H05935]; JSPS KAKENHI [18K09123, 20K09514]	Mitsui Life Social Welfare Foundation; Japan Osteoporosis Foundation(Japan Osteoporosis Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was partly supported by Mitsui Life Social Welfare Foundation, Japan Osteoporosis Foundation, JSPS KAKENHI Grant-in-Aid for Scientific Research (Grant Number 18K09123 and 20K09514), and Grant-in-Aid for Scientific Research on Innovative Areas (grant number 15H05935, "Living in Space") from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Antoniak S, 2016, J THROMB HAEMOST, V14, P1238, DOI 10.1111/jth.13307; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; Rodriguez-Merchan EC, 2019, BLOOD REV, V33, P6, DOI 10.1016/j.blre.2018.05.002; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dauble V, 2007, FEBS LETT, V581, P2611, DOI 10.1016/j.febslet.2007.04.078; Grover SP, 2018, ARTERIOSCL THROM VAS, V38, P709, DOI 10.1161/ATVBAHA.117.309846; Hoffman Maureane, 2012, Front Biosci (Schol Ed), V4, P713; Ichikawa J, 2012, CANCER-AM CANCER SOC, V118, P2494, DOI 10.1002/cncr.26518; Jasser-Nitsche H, 2020, PEDIATR DIABETES, V21, P1210, DOI 10.1111/pedi.13086; Kaji H, 2016, COMPR PHYSIOL, V6, P1873, DOI 10.1002/cphy.c160004; Kawao N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123982; Kawao N, 2014, AM J PHYSIOL-ENDOC M, V307, pE278, DOI 10.1152/ajpendo.00129.2014; Kawao N, 2013, J BONE MINER RES, V28, P1561, DOI 10.1002/jbmr.1921; Key NS, 2010, SEMIN THROMB HEMOST, V36, P865, DOI 10.1055/s-0030-1267040; Ko KI, 2015, DIABETOLOGIA, V58, P633, DOI 10.1007/s00125-014-3470-y; Mao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092686; O'Neill KR, 2012, J ORTHOP RES, V30, P1271, DOI 10.1002/jor.22071; Okada K, 2020, BONE, V134, DOI 10.1016/j.bone.2020.115310; Parry GCN, 1998, J CLIN INVEST, V101, P560, DOI 10.1172/JCI814; Paschou SA, 2017, J CLIN ENDOCR METAB, V102, P3621, DOI 10.1210/jc.2017-00042; Pedersen B, 2005, BLOOD, V105, P2777, DOI 10.1182/blood-2004-09-3724; Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P673, DOI 10.1111/j.1600-0501.2010.01923.x; Rothmeier AS, 2018, BLOOD, V131, P674, DOI 10.1182/blood-2017-02-768218; Saito M, 2018, J BONE MINER RES, V33, P2048, DOI 10.1002/jbmr.3537; Sato N, 2016, BONE, V83, P23, DOI 10.1016/j.bone.2015.10.005; Schaffner F, 2009, ARTERIOSCL THROM VAS, V29, P1999, DOI 10.1161/ATVBAHA.108.177428; Schulman S, 2020, J CLIN INVEST, V130, P5302, DOI 10.1172/JCI133780; Shimoide T, 2018, ENDOCRINOLOGY, V159, P1875, DOI 10.1210/en.2018-00085; Smith R, 2004, J BONE MINER RES, V19, P507, DOI 10.1359/JBMR.0301248; Takafuji Y, 2020, BONE, V134, DOI 10.1016/j.bone.2020.115298; Tieken C, 2016, THROMB HAEMOSTASIS, V115, P1025, DOI 10.1160/TH15-07-0541; Toomey JR, 1996, BLOOD, V88, P1583; Yuasa M, 2015, J CLIN INVEST, V125, P3723, DOI 10.1172/JCI84059; Zhang CH, 2019, DIABETES METAB SYNDR, V12, P2819, DOI 10.2147/DMSO.S225761	36	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260754	10.1371/journal.pone.0260754	http://dx.doi.org/10.1371/journal.pone.0260754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855855	gold, Green Published			2022-12-26	WOS:000735299000112
J	Yang, CZ; Hu, LH; Huang, ZY; Deng, L; Guo, W; Liu, S; Xiao, X; Yang, HX; Lin, JT; Sun, LL; Lin, LZ				Yang, Cai-Zhi; Hu, Lei-Hao; Huang, Zhong-Yu; Deng, Li; Guo, Wei; Liu, Shan; Xiao, Xi; Yang, Hong-Xing; Lin, Jie-Tao; Sun, Ling-Ling; Lin, Li-Zhu			Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; COMPLEX DISEASES; LNCRNA; EXPRESSION; IDENTIFICATION; CHEMOKINES; MEDICINE; PATTERNS; LINE; RISK	Globally, non-small cell lung cancer (NSCLC) is the most common malignancy and its prognosis remains poor because of the lack of reliable early diagnostic biomarkers. The competitive endogenous RNA (ceRNA) network plays an important role in the tumorigenesis and prognosis of NSCLC. Tumor immune microenvironment (TIME) is valuable for predicting the response to immunotherapy and determining the prognosis of NSCLC patients. To understand the TIME-related ceRNA network, the RNA profiling datasets from the Genotype-Tissue Expression and The Cancer Genome Atlas databases were analyzed to identify the mRNAs, microRNAs, and lncRNAs associated with the differentially expressed genes. Weighted gene co-expression network analysis revealed that the brown module of mRNAs and the turquoise module of lncRNAs were the most important. Interactions among microRNAs, lncRNAs, and mRNAs were prognosticated using miRcode, miRDB, TargetScan, miRTarBase, and starBase databases. A prognostic model consisting of 13 mRNAs was established using univariate and multivariate Cox regression analyses and validated by the receiver operating characteristic (ROC) curve. The 22 immune infiltrating cell types were analyzed using the CIBERSORT algorithm, and results showed that the high-risk score of this model was related to poor prognosis and an immunosuppressive TIME. A lncRNA-miRNA-mRNA ceRNA network that included 69 differentially expressed lncRNAs (DElncRNAs) was constructed based on the five mRNAs obtained from the prognostic model. ROC survival analysis further showed that the seven DElncRNAs had a substantial prognostic value for the overall survival (OS) in NSCLC patients; the area under the curve was 0.65. In addition, the high-risk group showed drug resistance to several chemotherapeutic and targeted drugs including cisplatin, paclitaxel, docetaxel, gemcitabine, and gefitinib. The differential expression of five mRNAs and seven lncRNAs in the ceRNA network was supported by the results of the HPA database and RT-qPCR analyses. This comprehensive analysis of a ceRNA network identified a set of biomarkers for prognosis and TIME prediction in NSCLC.	[Yang, Cai-Zhi; Hu, Lei-Hao; Liu, Shan] Guangzhou Univ Chinese Med, Sch Med 1, Guangzhou, Peoples R China; [Huang, Zhong-Yu] Jinan Univ, Integrated Chinese & Western Med Postdoctoral Res, Guangzhou, Peoples R China; [Deng, Li] Guangdong Second Prov Gen Hosp, Dept Radiotherapy, Guangzhou, Peoples R China; [Guo, Wei; Lin, Jie-Tao; Sun, Ling-Ling; Lin, Li-Zhu] Guangzhou Univ Chinese Med, Dept Oncol, Affiliated Hosp 1, Guangzhou, Peoples R China; [Xiao, Xi; Yang, Hong-Xing] Guangzhou Univ Chinese Med, Postdoctoral Res Stn, Guangzhou, Peoples R China	Guangzhou University of Chinese Medicine; Jinan University; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Sun, LL; Lin, LZ (corresponding author), Guangzhou Univ Chinese Med, Dept Oncol, Affiliated Hosp 1, Guangzhou, Peoples R China.	sunlingling5094@gzucm.edu.cn; lizhulin05@gmail.com	Lin, Jietao/GXF-2015-2022	Hu, Leihao/0000-0003-4956-7019; Huang, Zhongyu/0000-0001-5990-2103	Natural Science Foundation of Guangdong - Science and Technology Department of Guangdong Province [2018B030311023, 2020A1515011176]; National Natural Science Foundation of China - Ministry of Science and Technology of the People's Republic of China [81973775, 82004256]; National Administration of Traditional Chinese Medicine: 2019 Project of building evidence based practice capacity for TCM - National Administration of Traditional Chinese Medicine [2019XZZX-ZL001]; Pilot Project of Integrated Traditional Chinese and Western Medicine Clinical Collaboration for Major and Difficult Diseases (Lung Cancer)	Natural Science Foundation of Guangdong - Science and Technology Department of Guangdong Province; National Natural Science Foundation of China - Ministry of Science and Technology of the People's Republic of China; National Administration of Traditional Chinese Medicine: 2019 Project of building evidence based practice capacity for TCM - National Administration of Traditional Chinese Medicine; Pilot Project of Integrated Traditional Chinese and Western Medicine Clinical Collaboration for Major and Difficult Diseases (Lung Cancer)	L.L received the Natural Science Foundation of Guangdong (Grant No.2018B030311023, 2020A1515011176) funded by Science and Technology Department of Guangdong Province (http://gdstc.gd.gov.cn/).L.S and Z.H received the National Natural Science Foundation of China (Grant No. 81973775 and No.82004256 respectively) funded by Ministry of Science and Technology of the People's Republic of China (http://www.nsfc.gov.cn/).L.L received the Pilot Project of Integrated Traditional Chinese and Western Medicine Clinical Collaboration for Major and Difficult Diseases (Lung Cancer) and National Administration of Traditional Chinese Medicine: 2019 Project of building evidence based practice capacity for TCM (No. 2019XZZX-ZL001) funded by National Administration of Traditional Chinese Medicine (http://www.satcm.gov.cn/) both. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; AMSTAD P, 1988, MOL CARCINOGEN, V1, P151, DOI 10.1002/mc.2940010303; Aran D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01027-z; Brody R, 2017, LUNG CANCER, V112, P200, DOI 10.1016/j.lungcan.2017.08.005; Carlucci A, 2010, J BIOL CHEM, V285, P39260, DOI 10.1074/jbc.M110.174706; Catacchio I, 2018, TRANSL ONCOL, V11, P825, DOI 10.1016/j.tranon.2018.04.006; Celiktas M, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw231; Chen LJ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0943-0; Chen X, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007209; Chen X, 2019, BRIEF BIOINFORM, V20, P515, DOI 10.1093/bib/bbx130; Chen X, 2017, BRIEF BIOINFORM, V18, P558, DOI 10.1093/bib/bbw060; Chen X, 2018, BIOINFORMATICS, V34, P4256, DOI 10.1093/bioinformatics/bty503; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Cui ZG, 2018, CANCER MANAG RES, V10, P3141, DOI 10.2147/CMAR.S170783; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Downing JR, 2012, NAT GENET, V44, P619, DOI 10.1038/ng.2287; Frazee AC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-449; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; Gray JE, 2020, J THORAC ONCOL, V15, P288, DOI 10.1016/j.jtho.2019.10.002; Grenda A, 2019, ONCOL LETT, V17, P5193, DOI 10.3892/ol.2019.10207; Guo WB, 2019, ONCOL REP, V42, P1075, DOI 10.3892/or.2019.7221; Harada Y, 2010, CANCER RES, V70, P5829, DOI 10.1158/0008-5472.CAN-10-0255; He R, 2017, BIOMED PHARMACOTHER, V95, P331, DOI 10.1016/j.biopha.2017.08.057; Howlader NR, 2020, BREAST CANCER RES TR, V182, P739, DOI 10.1007/s10549-020-05738-8; Hu L, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060545; Ivanov SV, 2013, BRIT J CANCER, V109, P444, DOI 10.1038/bjc.2013.326; Jiang JZ, 2020, J CELL MOL MED, V24, P5375, DOI 10.1111/jcmm.15193; Kanehira M, 2007, ONCOGENE, V26, P6448, DOI 10.1038/sj.onc.1210466; Kim J, 2017, NATURE, V546, P168, DOI 10.1038/nature22359; Knudsen ES, 2019, ONCOGENE, V38, P3355, DOI 10.1038/s41388-018-0650-0; Lamberti G, 2020, CRIT REV ONCOL HEMAT, V156, DOI 10.1016/j.critrevonc.2020.103119; Lang YG, 2014, BIOCHEM BIOPH RES CO, V450, P154, DOI 10.1016/j.bbrc.2014.05.084; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LEE YC, 1985, JPN J CLIN ONCOL, V15, P637; Li Ai, 2009, BMC Res Notes, V2, P142, DOI 10.1186/1756-0500-2-142; Li C, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0202-x; Li K, 2018, CANCER LETT, V420, P80, DOI 10.1016/j.canlet.2018.01.060; Li N, 2019, EPMA J, V10, P273, DOI 10.1007/s13167-019-00175-0; Li SX, 2020, J CANCER RES CLIN, V146, P883, DOI 10.1007/s00432-020-03161-6; Li Y, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00526; Li Y, 2017, CANCER LETT, V393, P40, DOI 10.1016/j.canlet.2017.02.016; Liang WH, 2019, THERANOSTICS, V9, P2056, DOI 10.7150/thno.28119; Liu C, 2018, FUTURE ONCOL, V14, P2875, DOI 10.2217/fon-2018-0155; Liu HS, 2020, KNOWL-BASED SYST, V191, DOI 10.1016/j.knosys.2019.105261; Liu N, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00935; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mambo E, 2005, ONCOGENE, V24, P4496, DOI 10.1038/sj.onc.1208669; Miller KD, 2019, CA-CANCER J CLIN, V69, P363, DOI 10.3322/caac.21565; Mounir M, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006701; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nurieva R, 2013, IMMUNOTHERAPY-UK, V5, P513, DOI [10.2217/imt.13.33, 10.2217/IMT.13.33]; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Paassilta P, 1999, AM J HUM GENET, V64, P1036, DOI 10.1086/302328; Pathak R, 2020, CANCERS, V12, DOI 10.3390/cancers12123851; Paz-Ares L, 2018, NEW ENGL J MED, V379, P2040, DOI 10.1056/NEJMoa1810865; Rivas-Fuentes S, 2015, J CANCER, V6, P938, DOI 10.7150/jca.12286; Rotow J, 2017, NAT REV CANCER, V17, P637, DOI 10.1038/nrc.2017.84; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sequist LV, 2020, LANCET ONCOL, V21, P373, DOI 10.1016/S1470-2045(19)30785-5; Seung SJ, 2020, CURR ONCOL, V27, pE361, DOI 10.3747/co.27.6049; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Tokunaga R, 2018, CANCER TREAT REV, V63, P40, DOI 10.1016/j.ctrv.2017.11.007; Unfried JP, 2019, CANCER RES, V79, P5167, DOI 10.1158/0008-5472.CAN-19-0400; Vargas AJ, 2016, NAT REV CANCER, V16, P525, DOI 10.1038/nrc.2016.56; Wang HF, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/4686132; Wang H, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0680-1; Wang JF, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2230-9; Wang XW, 2019, ONCOL REP, V42, P2402, DOI 10.3892/or.2019.7378; Wang XY, 2019, J THORAC DIS, V11, P1772, DOI 10.21037/jtd.2019.05.69; Xie M, 2019, CANCER LETT, V443, P67, DOI 10.1016/j.canlet.2018.11.032; Yang JZ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1107-y; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zeng JH, 2017, ONCOTARGET, V8, P16811, DOI 10.18632/oncotarget.15161; Zhang HD, 2019, ONCOL LETT, V18, P6261, DOI 10.3892/ol.2019.10959; Zhang L, 2021, INTERDISCIP SCI, V13, P535, DOI 10.1007/s12539-021-00458-z; Zhang L, 2021, GENOMICS, V113, P874, DOI 10.1016/j.ygeno.2021.02.002; Zhang YA, 2000, GENE THER, V7, P2041, DOI 10.1038/sj.gt.3301331	78	0	0	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260720	10.1371/journal.pone.0260720	http://dx.doi.org/10.1371/journal.pone.0260720			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855841	gold, Green Published			2022-12-26	WOS:000735299000104
J	Anjorin, AA; Odetokun, IA; Abioye, AI; Elnadi, H; Umoren, MV; Damaris, BF; Eyedo, J; Umar, HI; Nyandwi, JB; Abdalla, MM; Tijani, SO; Awiagah, KS; Idowu, GA; Fabrice, SNA; Maisara, AMO; Razouqi, Y; Mhgoob, ZE; Parker, S; Asowata, OE; Adesanya, IO; Obara, MA; Jaumdally, S; Kitema, GF; Okuneye, TA; Mbanzulu, KM; Daitoni, H; Hallie, EF; Mosbah, R; Fasina, FO				Anjorin, AbdulAzeez A.; Odetokun, Ismail A.; Abioye, Ajibola, I; Elnadi, Hager; Umoren, Mfon Valencia; Damaris, Bamu F.; Eyedo, Joseph; Umar, Haruna, I; Nyandwi, Jean B.; Abdalla, Mena M.; Tijani, Sodiq O.; Awiagah, Kwame S.; Idowu, Gbolahan A.; Fabrice, Sifeuh N. Achille; Maisara, Aala M. O.; Razouqi, Youssef; Mhgoob, Zuhal E.; Parker, Salim; Asowata, Osaretin E.; Adesanya, Ismail O.; Obara, Maureen A.; Jaumdally, Shameem; Kitema, Gatera F.; Okuneye, Taofik A.; Mbanzulu, Kennedy M.; Daitoni, Hajj; Hallie, Ezekiel F.; Mosbah, Rasha; Fasina, Folorunso O.			Will Africans take COVID-19 vaccination?	PLOS ONE			English	Article							VACCINES; HEALTH	The economic and humanistic impact of COVID-19 pandemic is enormous globally. No definitive treatment exists, hence accelerated development and approval of COVID-19 vaccines, offers a unique opportunity for COVID-19 prevention and control. Vaccine hesitancy may limit the success of vaccine distribution in Africa, therefore we assessed the potentials for coronavirus vaccine hesitancy and its determinants among Africans. An online cross-sectional African-wide survey was administered in Arabic, English, and French languages. Questions on demographics, self-reported health status, vaccine literacy, knowledge and perception on vaccines, past experience, behavior, infection risk, willingness to receive and affordability of the SARS-COV-2 vaccine were asked. Data were subjected to descriptive and inferential statistics. A total of 5,416 individuals completed the survey. Approximately, 94% were residents of 34 African countries while the other Africans live in the Diaspora. Only 63% of all participants surveyed were willing to receive the COVID-19 vaccination as soon as possible and 79% were worried about its side effects. Thirty-nine percent expressed concerns of vaccine-associated infection. The odds of vaccine hesitancy was 0.28 (95% CI: 0.22, 0.30) among those who believed their risk of infection was very high, compared to those who believed otherwise. The odds of vaccine hesitancy was one-fifth (OR = 0.21, 95% CI: 0.16, 0.28) among those who believed their risk of falling sick was very high, compared to those who believed their risk of falling very sick was very low. The OR of vaccine hesitancy was 2.72 (95% CI: 2.24, 3.31) among those who have previously refused a vaccine for themselves or their child compared to counterparts with no self-reported history of vaccine hesitancy. Participants want the vaccines to be mandatory (40%), provided free of charge (78%) and distributed in homes and offices (44%). COVID-19 vaccine hesitancy is substantial among Africans based on perceived risk of coronavirus infection and past experiences.	[Anjorin, AbdulAzeez A.; Eyedo, Joseph] Lagos State Univ, Dept Microbiol Virol Res, Lagos, Nigeria; [Odetokun, Ismail A.] Univ Ilorin, Dept Vet Publ Hlth & Prevent Med, Ilorin, Nigeria; [Abioye, Ajibola, I] Harvard Univ, Boston, MA 02115 USA; [Elnadi, Hager] Tours Univ, Tours, France; [Umoren, Mfon Valencia] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Damaris, Bamu F.; Obara, Maureen A.] Hannover Med Sch, Hannover, Germany; [Umar, Haruna, I] Fed Univ Technol Akure, Dept Biochem, Akure, Ondo State, Nigeria; [Nyandwi, Jean B.] Univ Rwanda, Dept Pharm, Gyeongsang, South Korea; [Nyandwi, Jean B.] Gyeongsang Natl Univ, Coll Med, Dept Pharmacol, Gyeongsang, South Korea; [Abdalla, Mena M.] Minya Hlth Insurance Hosp, Dept Obstet & Gynaecol, Al Minya, Egypt; [Tijani, Sodiq O.] Univ Lagos, Coll Med, Dept Med Microbiol & Parasitol, Lagos, Nigeria; [Awiagah, Kwame S.] Korle Bu Teaching Hosp, Accid & Emergency Ctr, Accra, Ghana; [Idowu, Gbolahan A.] Lagos State Univ, Dept Math, Lagos, Nigeria; [Fabrice, Sifeuh N. Achille] Hlth Res Fdn, Buea, Cameroon; [Maisara, Aala M. O.] Int Univ Africa, Dept Nephrol, Bahre Teaching Hosp, Khartoum, Sudan; [Maisara, Aala M. O.] Int Univ Africa, Bahre Teaching Hosp, Hemodialysis Ctr, Khartoum, Sudan; [Maisara, Aala M. O.] Int Univ Africa, Fac Med, Khartoum, Sudan; [Razouqi, Youssef] Sultan Moulay Slimane Univ Beni Mellal, Biol Engn Lab, Beni Mellal, Morocco; [Mhgoob, Zuhal E.] Aljawda Hosp, Dept Publ Hlth & Infect Control, Khartoum, Sudan; [Mhgoob, Zuhal E.] El Nileen Univ, Community Dev Coll, Khartoum, Sudan; [Parker, Salim] Univ Cape Town, Div Infect Dis & HIV Med, Cape Town, South Africa; [Asowata, Osaretin E.] Univ KwaZulu Natal, Africa Hlth Res Inst, Durban, South Africa; [Adesanya, Ismail O.] BayouCity Phys, Us Army Reserve & Hospitalist, Spring, TX USA; [Jaumdally, Shameem] Univ Cape Town, Lung Inst, Cape Town, South Africa; [Kitema, Gatera F.] Univ Rwanda, Dept Ophthalmol, Kigali, Rwanda; [Kitema, Gatera F.] St Andrews Univ, St Andrews, Fife, Scotland; [Okuneye, Taofik A.] Gen Hosp Odan, Dept Family Med, Lagos, Nigeria; [Mbanzulu, Kennedy M.] Univ Kinshasa, Dept Trop Med Parasit & Infect Dis, Kinshasa, DEM REP CONGO; [Daitoni, Hajj] Malawi & Islamic Hlth Assoc Malawi, HIV & Malaria Res Unit, Limbe, Malawi; [Hallie, Ezekiel F.] Univ Liberia, Sch Pharm, Dept Pharmacol & Toxicol, Monrovia, Liberia; [Mosbah, Rasha] Zagazig Univ, Infect Control Unit, Zagazig, Egypt; [Mosbah, Rasha] Ahram Canadian Univ, Fac Oral & Dent Med, 6th Of October City, Egypt; [Fasina, Folorunso O.] Univ Pretoria, Food & Agr Org United Nations FAO, Emergency Ctr Transboundary Anim Dis ECTAD, Dept Vet Trop Dis, Pretoria, South Africa	Lagos State University; University of Ilorin; Harvard University; Cincinnati Children's Hospital Medical Center; Hannover Medical School; Gyeongsang National University; University of Lagos; Lagos State University; Sultan Moulay Slimane University of Beni Mellal; University of Cape Town; Africa Health Research Institute; University of Kwazulu Natal; University of Cape Town; University of Rwanda; University of St Andrews; Universite de Kinshasa; Egyptian Knowledge Bank (EKB); Zagazig University; University of Pretoria	Fasina, FO (corresponding author), Univ Pretoria, Food & Agr Org United Nations FAO, Emergency Ctr Transboundary Anim Dis ECTAD, Dept Vet Trop Dis, Pretoria, South Africa.	daydupe2003@yahoo.co.uk	Anjorin, AbdulAzeez A./J-2967-2017; Odetokun, Ismail Ayoade/A-5431-2018; Abdalla, Mena/AAG-7311-2021	Anjorin, AbdulAzeez A./0000-0002-4152-8659; Odetokun, Ismail Ayoade/0000-0002-5171-1895; Abdalla, Mena/0000-0002-6395-0391; Sifeuh Noussi, Achille Fabrice/0000-0002-3506-4894; Umar, Haruna/0000-0001-9427-9804; KITEMA, GATERA Fiston/0000-0002-1623-9302; Razouqi, Youssef/0000-0002-9111-5879; Abioye, Ajibola/0000-0002-6632-613X; Eyedo, Joseph/0000-0001-8221-1319				Africa-CDC, 2020, OUTBR BRIEF 15 COVID; Aiyewumi O, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020375; Anjorin AA, 2021, TROP MED INT HEALTH, V26, P2, DOI 10.1111/tmi.13504; Anjorin AA, 2020, ASIAN PAC J TROP MED, V13, P199, DOI 10.4103/1995-7645.281612; [Anonymous], 2021, COVID 19 CAS AFR TOP; [Anonymous], 2021, AMSP OP COVID 19 VAC; British Broadcasting Corporation (BBC), 2020, COR WHAT MIS HAS SPR; Chevallier C, 2021, TRENDS COGN SCI, V25, P331, DOI 10.1016/j.tics.2021.02.002; Chirisa I, 2022, GEOJOURNAL, V87, P815, DOI 10.1007/s10708-020-10281-6; Chung JY, 2021, ADV DRUG DELIVER REV, V170, P1, DOI 10.1016/j.addr.2020.12.011; Dinga JN, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020175; Diop BZ, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002699; Elnadi H, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247351; Gur-Arie R, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004877; International Federation of Red Cross and Red Crescent (IFRC), 2020, 7 IFRC; Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812; Iwasaki A, 2020, CELL, V183, P290, DOI 10.1016/j.cell.2020.09.040; Karlsson LC, 2021, PERS INDIV DIFFER, V172, DOI 10.1016/j.paid.2020.110590; Lasco G, 2020, GLOB PUBLIC HEALTH, V15, P1417, DOI 10.1080/17441692.2020.1807581; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Lee K, 2009, GLOB INST, P1; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Makoni M, 2021, LANCET, V397, P566, DOI 10.1016/S0140-6736(21)00362-7; Nzaji MK, 2020, PRAGMAT OBS RES, V11, P103, DOI 10.2147/POR.S271096; Odetokun IA, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8040243; Osibogun A., 2020, MORBIDITY MORTALITY; Ovenseri-Ogbomo G.O., 2020, J GLOB HEALTH REP, DOI DOI 10.29392/001C.17606; Saied SM, 2021, J MED VIROL, V93, P4280, DOI 10.1002/jmv.26910; Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160; Schaffer DeRoo S, 2020, JAMA-J AM MED ASSOC, V323, P2458, DOI 10.1001/jama.2020.8711; Schmidt T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244420; Shaham A, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8327-3; Singh JA, 2020, J INFECT DIS, V222, P351, DOI 10.1093/infdis/jiaa303; Thomas Elise., 2020, ID2020 BILL GATES MA; Tregoning JS, 2020, CLIN EXP IMMUNOL, V202, P162, DOI 10.1111/cei.13517; University of Oxford, 2021, OUR WORLD DAT 2021; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n699; Wiysonge CS, 2022, HUM VACC IMMUNOTHER, V18, P1, DOI 10.1080/21645515.2021.1893062; Woods ET, 2020, NATIONS NATL, V26, P807, DOI 10.1111/nana.12644; World Health Organization, 2019, 10 THREATS GLOB HLTH; World Health Organization (WHO), 2021, COVAX WORKING GLOB E; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	43	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260575	10.1371/journal.pone.0260575	http://dx.doi.org/10.1371/journal.pone.0260575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851998	Green Published, gold			2022-12-26	WOS:000755762900047
J	Jang, JH; Kim, TY; Lim, HS; Yoon, D				Jang, Jong-Hwan; Kim, Tae Young; Lim, Hong-Seok; Yoon, Dukyong			Unsupervised feature learning for electrocardiogram data using the convolutional variational autoencoder	PLOS ONE			English	Article							REDUCTION	Most existing electrocardiogram (ECG) feature extraction methods rely on rule-based approaches. It is difficult to manually define all ECG features. We propose an unsupervised feature learning method using a convolutional variational autoencoder (CVAE) that can extract ECG features with unlabeled data. We used 596,000 ECG samples from 1,278 patients archived in biosignal databases from intensive care units to train the CVAE. Three external datasets were used for feature validation using two approaches. First, we explored the features without an additional training process. Clustering, latent space exploration, and anomaly detection were conducted. We confirmed that CVAE features reflected the various types of ECG rhythms. Second, we applied CVAE features to new tasks as input data and CVAE weights to weight initialization for different models for transfer learning for the classification of 12 types of arrhythmias. The f1-score for arrhythmia classification with extreme gradient boosting was 0.86 using CVAE features only. The f1-score of the model in which weights were initialized with the CVAE encoder was 5% better than that obtained with random initialization. Unsupervised feature learning with CVAE can extract the characteristics of various types of ECGs and can be an alternative to the feature extraction method for ECGs.	[Jang, Jong-Hwan; Yoon, Dukyong] Yonsei Univ, Dept Biomed Syst Informat, Coll Med, Yongin, Gyeonggi Do, South Korea; [Kim, Tae Young] BUD On Inc, Jeonju, South Korea; [Lim, Hong-Seok] Ajou Univ, Dept Cardiol, Sch Med, Suwon, Gyeonggi Do, South Korea; [Yoon, Dukyong] Yonsei Univ Hlth Syst, Yongin Severance Hosp, Ctr Digital Hlth, Yongin, South Korea	Yonsei University; Yonsei University Health System; Ajou University; Yonsei University; Yonsei University Health System	Yoon, D (corresponding author), Yonsei Univ, Dept Biomed Syst Informat, Coll Med, Yongin, Gyeonggi Do, South Korea.; Yoon, D (corresponding author), Yonsei Univ Hlth Syst, Yongin Severance Hosp, Ctr Digital Hlth, Yongin, South Korea.	dukyong.yoon@yonsei.ac.kr		Lim, Hong-Seok/0000-0002-3127-2071; Yoon, Dukyong/0000-0003-1635-8376	Korea Medical Device Development Fund - Korea government (the Ministry of Science and ICT) [1711138152, KMDF_PR_20200901_0095]; Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy) [1711138152, KMDF_PR_20200901_0095]; Korea Medical Device Development Fund - Korea government (Ministry of Health Welfare) [1711138152, KMDF_PR_20200901_0095]; Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety) [1711138152, KMDF_PR_20200901_0095]; Government-wide R&D Fund project for infectious disease research (GFID), Republic of Korea [HG18C0067]	Korea Medical Device Development Fund - Korea government (the Ministry of Science and ICT)(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy); Korea Medical Device Development Fund - Korea government (Ministry of Health Welfare); Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety); Government-wide R&D Fund project for infectious disease research (GFID), Republic of Korea	`This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety) (Project Number: 1711138152, KMDF_PR_20200901_0095).(https://www.kmdf.org/](https://www.kmdf.org/) This work was also supported by Government-wide R&D Fund project for infectious disease research (GFID), Republic of Korea (grant numbers: HG18C0067). (https://www.gfid.or.kr/kr/index.php](https://www.gfid.or.kr/kr/index.php) BUD.on Inc provided support in the form of salaries for author TYK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. BUD.on Inc had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia ZI, 2019, LANCET, V394, P861, DOI 10.1016/S0140-6736(19)31721-0; Attia ZI, 2019, NAT MED, V25, P70, DOI 10.1038/s41591-018-0240-2; Bank D., 2020, ARXIV; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chiang HT, 2019, IEEE ACCESS, V7, P60806, DOI 10.1109/ACCESS.2019.2912036; Choi B, 2019, HEALTHC INFORM RES, V25, P274, DOI 10.4258/hir.2019.25.4.274; Huang Henry D, 2011, J Electrocardiol, V44, DOI 10.1016/j.jelectrocard.2011.06.002; Kashou AH, 2020, CURR CARDIOL REP, V22, DOI 10.1007/s11886-020-01317-x; Kim D, 2017, STUD HEALTH TECHNOL, V245, P1271, DOI 10.3233/978-1-61499-830-3-1271; Kingma Diederik P, 2014, 2 INT C LEARNING REP; Lee S., 2016, CONSTRUCTING BIOSIGN, P372, DOI [10.1145/2994551.2996712, DOI 10.1145/2994551.2996712]; Lian J, 2011, AM J CARDIOL, V107, P1494, DOI 10.1016/j.amjcard.2011.01.028; Linderman GC, 2019, SIAM J MATH DATA SCI, V1, P313, DOI [10.1137/18M1216134, 10.1137/18m1216134]; Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724; Pereira J, 2019, INT J DATA MIN BIOIN, V22, P389, DOI 10.1504/IJDMB.2019.101395; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Sharma J., 2012, INT J COMPUTER APPL, V50, P6, DOI [10.5120/7845-0912, DOI 10.5120/7845-0912]; Verenich E., 2020, UTILITY FEATURE REUS; Williams B, 2008, PREHOSP DISASTER MED, V23, P526, DOI 10.1017/S1049023X00006361; Zheng JW, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0386-x; Zhu HL, 2020, LANCET DIGIT HEALTH, V2, pE348, DOI 10.1016/S2589-7500(20)30107-2; Ziegel ER., 1994, TECHNOMETRICS, V36, P435, DOI [10.2307/1269981, DOI 10.2307/1269981]	24	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260612	10.1371/journal.pone.0260612	http://dx.doi.org/10.1371/journal.pone.0260612			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852002	Green Published, gold			2022-12-26	WOS:000755762900049
J	Zhu, YH; Minami, K; Iwahara, Y; Oda, K; Hidaka, K; Hoson, O; Morishita, K; Hirota, M; Tsuru, S; Shirakawa, H; Miyashita, K				Zhu, Yanhui; Minami, Kenji; Iwahara, Yuka; Oda, Kentaro; Hidaka, Koichi; Hoson, Osamu; Morishita, Koji; Hirota, Masahito; Tsuru, Sentaro; Shirakawa, Hokuto; Miyashita, Kazushi			Seasonal variation in fish school spatial distribution and abundance under the Kuroshio regular pattern and the large meander in Suzu coastal waters	PLOS ONE			English	Article							PELAGIC FISH; AREA; DYNAMICS; SEA; BAY	The Kuroshio Current can take two paths; usually it follows the regular pattern but occasionally it follows a pattern known as the large meander. In this study, we investigated the abundance of fish that migrate to coastal waters and the spatial distribution of fish schools under both Kuroshio patterns in Suzu district, Kochi prefecture, where the set net is the main fishery industry. We clarified the seasonal variation in the density and distribution of fish schools using a quantitative echo sounder. The effects of the Kuroshio large meander (LM) depended on the season. There was no effect of current pattern in summer or autumn, but in winter and spring the LM altered the marine environment and fish distributions. Cold water masses were formed in the survey area during winter and spring during the LM, and the water temperature dropped significantly compared with during the Kuroshio non-large meander (NLM). This altered the fish species and the distribution of fish schools in the survey area. The catches of Japanese horse mackerels (Trachurus japonicus) and Yellowtails (Seriola quinqueradiata) were much higher during the LM compared with those during the NLM. Unlike these two species, the small-sized pelagic fishes in spring has decreased significantly during the LM.	[Zhu, Yanhui] Hokkaido Univ, Grad Sch Environm Sci, Hakodate, Hokkaido, Japan; [Minami, Kenji] Shimane Univ, Estuary Res Ctr, Matsue, Shimane, Japan; [Iwahara, Yuka; Oda, Kentaro; Hidaka, Koichi; Hoson, Osamu; Morishita, Koji; Hirota, Masahito] Japan Fisheries Res & Educ Agcy, Natl Res & Dev Agcy, Marine Fisheries Res & Dev Ctr JAMARC, Yokohama, Kanagawa, Japan; [Tsuru, Sentaro] Japan Fisheries Res & Educ Agcy, Planning & Coordinat Dept, Fisheries Technol Inst, Natl Res & Dev Agcy,Yamaguchi Reg Alliance Off, Shimonoseki, Yamaguchi, Japan; [Shirakawa, Hokuto] Japan Fisheries Res & Educ Agcy, Fisheries Resources Inst, Fisheries Stock Assessment Ctr, Natl Res & Dev Agcy, Niigata, Japan; [Miyashita, Kazushi] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Hakodate, Hokkaido, Japan	Hokkaido University; Shimane University; Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Hokkaido University	Zhu, YH (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Hakodate, Hokkaido, Japan.	zhuyanhui0817@ejs.hokudai.ac.jp		Zhu, Yanhui/0000-0003-3570-0253	Marine Fisheries Research and Development Center; Japan Fisheries Research and Education Agency (Empirical Research Project for Marine Fisheries Resource Development)	Marine Fisheries Research and Development Center; Japan Fisheries Research and Education Agency (Empirical Research Project for Marine Fisheries Resource Development)	Marine Fisheries Research and Development Center, Japan Fisheries Research and Education Agency (Empirical Research Project for Marine Fisheries Resource Development: Set-net in Suzu, Kochi prefecture, Fiscal Year 2016-2018) http://jamarc.fra.affrc.go.jp/index-e.html Funders: Decision to publish The funders had role in study design, data collection and decision to publish.	AOKI I, 1988, NIPPON SUISAN GAKK, V54, P1747; Aono S., 2007, ELUCIDATION MIGRATIO, V104, P31; Axenrot T, 2004, ESTUAR COAST SHELF S, V60, P541, DOI 10.1016/j.ecss.2004.02.004; Baba Y, 2018, J JAPAN SOC CIVIL EN, V74, P553, DOI [10.2208/jscejhe.74.5_I_553, DOI 10.2208/JSCEJHE.74.5_I_553]; Fujimoto M., 1980, B TOKAI REGIONAL FIS, V103, P17; Fujino T, 2005, NIPPON SUISAN GAKK, V71, P947, DOI 10.2331/suisan.71.947; Hamano A., 2019, FISHEREIS ENG, V55, P175, DOI [10.18903/fisheng.55.3_175, DOI 10.18903/FISHENG.55.3_175]; Hasegawa M., 2019, FISHERIES BIOL OCEAN, V20, P83; Hirata Tomonori, 2011, Japanese Journal of Ichthyology, V58, P49; Ichikawa T, 2004, OCEANOGRAPHY JAPAN, V13, P259, DOI [10.5928/kaiyou.13.259, DOI 10.5928/KAIYOU.13.259]; Inai T., 2002, FISHERIES BIOL OCEAN, V3, P47; Inohara R., 2019, FISHERIES BIOL OCEAN, V20, P9; Ishida Y., 1987, FISHEREIS ENG, V23, P33, DOI [10.18903/fishengold.23.2_33, DOI 10.18903/FISHENGOLD.23.2_33]; Ito S., 2012, UMI NO KENKYU, V21, P33, DOI 10.5928/kaiyou.21.2_33; Kakimoto H., 1998, FISHEREIS ENG, V34, P305, DOI [10.18903/fisheng.34.3_305, DOI 10.18903/FISHENG.34.3_305]; Kamada S., 2011, FISHERIES BIOL OCEAN, V12, P153; Kang M., 2006, ACOUSTICS 2006, P493; Kawabe M., 2003, OCEANOGRAPHY JAPAN, V12, P247; Kawano M., 2008, B YAMAGUCHI PREFECTU, V6, P61; Kawauchi Y, 2019, NIPPON SUISAN GAKK, V85, P2, DOI 10.2331/suisan.18-00008; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Miida F., 1999, TOKYO U MARINE SCI T, V86, P55; Miyama T., 2019, FISHERIES BIOL OCEAN, V20, P3; Miyata K., 1980, BULL JPN SOC FISH OC, V36, P38; Murase H, 2009, ICES J MAR SCI, V66, P1417, DOI 10.1093/icesjms/fsp105; Nakata N., 1981, B KANAGAWA PREFECTUR, V3, P19; Nakatani Y., 2012, J JAPAN SOC CIVIL EN, V68, P976, DOI [10.2208/kaigan.68.I_976, DOI 10.2208/KAIGAN.68.I_976]; Niiya Y, 2001, NIPPON SUISAN GAKK, V67, P429; NISHIYAMA K, 1980, PAP METEOROL GEOPHYS, V31, P43, DOI 10.2467/mripapers.31.43; Ogawa Yoshihiko, 1992, Bulletin of the National Research Institute of Fisheries Science, V4, P71; Pinilla J, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9040299; Sakaji H., 2012, FISHERIES BIOL OCEAN, V13, P37; Sakamoto H., 1971, B NANSEI REGIONAL FI, V4, P37; Sekine Y., 1992, BULL JPN SOC FISH OC, V56, P13; Shida O, 2008, NIPPON SUISAN GAKK, V74, P152, DOI 10.2331/suisan.74.152; Shimmonds J., 2006, FISHERIES ACOUSTICS, VSecond, P63; Sugimoto T., 2005, B COASTAL OCEANOGRAP, V43, P19, DOI [10.32142/engankaiyo.43.1_19, DOI 10.32142/ENGANKAIYO.43.1_19]; Suzue Y., 2017, J JAPAN SOC CIVIL EN, V73, P457, DOI [10.2208/kaigan.73.I_457, DOI 10.2208/KAIGAN.73.I_457]; Suzuki S., 1982, B KYOTO I OCEANIC FI, V6, P13; Takamura S., 2017, B KANAGAWA PREFECTUR, V8, P33; Takamura S., 2014, B KANAGAWA PREFECTUR, V7, P65; Takamura S., 2019, FISHERIES BIOL OCEAN, V20, P31; Tameishi Hideo, 1994, Bulletin of the Japanese Society of Fisheries Oceanography, V58, P77; Toida S., 2019, FISHERIES BIOL OCEAN, V20, P115; Toyoshima S., 1999, COASTAL CURRENT TOSA, V17, P20; Usui N, 2013, J OCEANOGR, V69, P647, DOI 10.1007/s10872-013-0197-1; Yamada H., 2007, B FISHERIES RES DIVI, V15, P7; Yamada T., 1969, BULL FAC FISH NAGAS, V28, P111; Zhu YH, 2021, J MAR SCI TECH-TAIW, V29, P146	49	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2021	16	11							e0260629	10.1371/journal.pone.0260629	http://dx.doi.org/10.1371/journal.pone.0260629			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9KP	34847206	Green Published, gold			2022-12-26	WOS:000735928900051
J	Bodden, C; Pang, TY; Feng, YS; Mridha, F; Kong, G; Li, SS; Watt, MJ; Reichelt, AC; Hannan, AJ				Bodden, Carina; Pang, Terence Y.; Feng, Yingshi; Mridha, Faria; Kong, Geraldine; Li, Shanshan; Watt, Matthew J.; Reichelt, Amy C.; Hannan, Anthony J.			Intergenerational effects of a paternal Western diet during adolescence on offspring gut microbiota, stress reactivity, and social behavior	FASEB JOURNAL			English	Article						behavioral phenotyping; epigenetic inheritance; gut microbiome; high-fat; high-sugar diet; intergenerational inheritance; paternal effects	HIGH-FAT DIET; MATERNAL DIET; SEX-RATIO; MICE; OBESITY; INHERITANCE; METABOLISM; CONTRIBUTE; EPIGENOME; IMPACT	The global consumption of highly processed, calorie-dense foods has contributed to an epidemic of overweight and obesity, along with negative consequences for metabolic dysfunction and disease susceptibility. As it becomes apparent that overweight and obesity have ripple effects through generations, understanding of the processes involved is required, in both maternal and paternal epigenetic inheritance. We focused on the patrilineal effects of a Western-style high-fat (21%) and high-sugar (34%) diet (WD) compared to control diet (CD) during adolescence and investigated F0 and F1 mice for physiological and behavioral changes. F0 males (fathers) showed increased body weight, impaired glycemic control, and decreased attractiveness to females. Paternal WD caused significant phenotypic changes in F1 offspring, including higher body weights of pups, increased Actinobacteria abundance in the gut microbiota (ascertained using 16S microbiome profiling), a food preference for WD pellets, increased male dominance and attractiveness to females, as well as decreased behavioral despair. These results collectively demonstrate the long-term intergenerational effects of a Western-style diet during paternal adolescence. The behavioral and physiological alterations in F1 offspring provide evidence of adaptive paternal programming via epigenetic inheritance. These findings have important implications for understanding paternally mediated intergenerational inheritance, and its relevance to offspring health and disease susceptibility.	[Bodden, Carina; Pang, Terence Y.; Feng, Yingshi; Mridha, Faria; Kong, Geraldine; Li, Shanshan; Reichelt, Amy C.; Hannan, Anthony J.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Watt, Matthew J.; Hannan, Anthony J.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Anat & Physiol, Melbourne, Vic, Australia; [Reichelt, Amy C.] Univ Adelaide, Adelaide Med Sch, Dept Med Sci, Adelaide, SA, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Adelaide	Bodden, C; Hannan, AJ (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia.	carina.bodden@florey.edu.au; anthony.hannan@florey.edu.au	Pang, Terence Y/D-2826-2012; Pang, Terence Y/L-6444-2019	Pang, Terence Y/0000-0002-7000-5304; Feng, Yingshi/0000-0001-9065-4945; Hannan, Anthony/0000-0001-7532-8922; Reichelt, Amy/0000-0002-0637-0411; Bodden, Carina/0000-0002-8749-8846	Australian Research Council (ARC) [DP180101974]; NEIMRC; DHB Foundation	Australian Research Council (ARC)(Australian Research Council); NEIMRC; DHB Foundation	This work was supported by an Australian Research Council (ARC) Discovery Project grant (DP180101974 to ACR and AJH). AJH is a National Health and Medical Research Council (NI IMRC) Principal Research Fellow and is also supported by NEIMRC Project Grants and the DHB Foundation, Equity 'frustees.	Allen AP, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.191; An T, 2017, ONCOTARGET, V8, P47876, DOI 10.18632/oncotarget.18138; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Barandouzi ZA, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00541; Barbosa TD, 2016, MOL METAB, V5, P184, DOI 10.1016/j.molmet.2015.12.002; Barnes TD, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00243; Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4; Bellisari A, 2008, OBES REV, V9, P165, DOI 10.1111/j.1467-789X.2007.00392.x; Bergmann S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01156; Beynon RJ, 2002, J CHEM ECOL, V28, P1429, DOI 10.1023/A:1016252703836; Blumberg MS, 2001, PSYCHOL REV, V108, P83, DOI 10.1037//0033-295X.108.1.83; Bodden C, 2020, TRENDS ENDOCRIN MET, V31, P131, DOI 10.1016/j.tem.2019.10.005; Boesveldt S, 2017, PERCEPTION, V46, P307, DOI 10.1177/0301006616685576; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bromfield JJ, 2014, P NATL ACAD SCI USA, V111, P2200, DOI 10.1073/pnas.1305609111; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Consitt LA, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13583; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; D'Amato FR, 2005, BEHAV GENET, V35, P103, DOI 10.1007/s10519-004-0860-9; Edwards AM, 2014, TRENDS ECOL EVOL, V29, P158, DOI 10.1016/j.tree.2013.12.003; Fan Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120775; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fennell KA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72560-z; Ferramosca A, 2016, ANDROLOGY-US, V4, P520, DOI 10.1111/andr.12182; Fontelles CC, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0729-x; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Garratt M, 2011, J EVOLUTION BIOL, V24, P2398, DOI 10.1111/j.1420-9101.2011.02367.x; Giller K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0101; Gonzalez A, 2018, NAT METHODS, V15, P796, DOI 10.1038/s41592-018-0141-9; Hasegawa Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71592-9; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hassan AM, 2019, NUTR NEUROSCI, V22, P877, DOI 10.1080/1028415X.2018.1465713; Huypens P, 2016, NAT GENET, V48, P497, DOI 10.1038/ng.3527; Ibanez CA, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00807; Kim SJ, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1557-9; Kleinert M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28540-5; Korgan AC, 2018, PSYCHONEUROENDOCRINO, V91, P20, DOI 10.1016/j.psyneuen.2018.02.010; Kumar V, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.117903; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lee W, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1570; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Lohse T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148563; Lowe CJ, 2020, LANCET CHILD ADOLESC, V4, P388, DOI 10.1016/S2352-4642(19)30404-3; Macpherson AJ, 2017, NAT REV IMMUNOL, V17, P508, DOI 10.1038/nri.2017.58; Malo AF, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1159; McPherson NO, 2014, FERTIL STERIL, V101, P865, DOI 10.1016/j.fertnstert.2013.12.007; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Mitra R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036092; Natt D, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000559; NCHS, 1999, NATL HLTH NUTR EXAMI; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ost A, 2014, CELL, V159, P1352, DOI 10.1016/j.cell.2014.11.005; Pecina S, 2003, J NEUROSCI, V23, P9395; Rabasa C, 2016, HORM BEHAV, V85, P56, DOI 10.1016/j.yhbeh.2016.07.008; Ribeiro CT, 2018, ASIAN J ANDROL, V20, P385, DOI 10.4103/aja.aja_68_17; Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014; Rodriguez-Correa E, 2020, NUTR DIABETES, V10, DOI 10.1038/s41387-020-0127-4; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; Schacht R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45316-7; Screven LA, 2018, BEHAV PROCESS, V157, P171, DOI 10.1016/j.beproc.2018.09.011; Sharma S, 2013, INT J OBESITY, V37, P382, DOI 10.1038/ijo.2012.48; Short AK, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.109; Sjodin KS, 2019, ALLERGY, V74, P176, DOI 10.1111/all.13485; Speakman JR, 2019, INT J OBESITY, V43, P1491, DOI 10.1038/s41366-019-0363-7; Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621; Walker AK, 2009, PSYCHONEUROENDOCRINO, V34, P1515, DOI 10.1016/j.psyneuen.2009.05.010; Wang W, 2014, J CLIN MICROBIOL, V52, P398, DOI 10.1128/JCM.01500-13; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Watkins AJ, 2018, P NATL ACAD SCI USA, V115, P10064, DOI 10.1073/pnas.1806333115; WHO, 2003, WHO TECH REP SER, V916, P1; Wiklund P, 2016, J SPORT HEALTH SCI, V5, P151, DOI 10.1016/j.jshs.2016.04.001; Winther G, 2018, NEUROSCIENCE, V388, P87, DOI 10.1016/j.neuroscience.2018.07.014; World Health Organization, 2020, OB OV FACTSH; Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44	78	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e21981	10.1096/fj.202100920RR	http://dx.doi.org/10.1096/fj.202100920RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34907601	Green Published, Green Submitted			2022-12-26	WOS:000734992000036
J	Campden, RI; Warren, AL; Greene, CJ; Chiriboga, JA; Arnold, CR; Aggarwal, D; McKenna, N; Sandall, CF; MacDonald, JA; Yates, RM				Campden, Rhiannon, I; Warren, Amy L.; Greene, Catherine J.; Chiriboga, Jose A.; Arnold, Corey R.; Aggarwal, Devin; McKenna, Neil; Sandall, Christina F.; MacDonald, Justin A.; Yates, Robin M.			Extracellular cathepsin Z signals through the alpha(5) integrin and augments NLRP3 inflammasome activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE CATHEPSINS; CRYSTALLINE SILICA; NALP3 INFLAMMASOME; CELLS; PROTEASE; PROREGION; IL-1-BETA; MECHANISM; PATHWAYS; PLATFORM	Respiratory silicosis is a preventable occupational disease that develops secondary to the aspiration of crystalline silicon dioxide (silica) into the lungs, activation of the NLRP3 inflammasome, and IL-1 beta production. Cathepsin Z has been associated with the development of inflammation and IL-1 beta production; however, the mechanism of how cathepsin Z leads to IL-1 beta production is unknown. Here, the requirement for cathepsin Z in silicosis was determined using WT mice and mice deficient in cathepsin Z. The activation of the NLRP3 inflammasome in macrophages was studied using WT and cathepsin Z-deficient bone marrow-derived murine dendritic cells and the human monocytic cell line THP-1. The cells were activated with silica, and IL-1 beta release was determined using enzyme-linked immunosorbent assay or IL-1 beta bioassays. The relative contribution of the active domain or integrin-binding domain of cathepsin Z was studied using recombinant cathepsin Z constructs and the a 5 integrin neutralizing antibody. We report that the lysosomal cysteine protease cathepsin Z potentiates the development of inflammation associated with respiratory silicosis by augmenting NLRP3 inflammasome-derived IL-1 beta expression in response to silica. The secreted cathepsin Z functions nonproteolytically via the internal integrin-binding domain to impact caspase-1 activation and the production of active IL-1 beta through integrin alpha(5) without affecting the transcription levels of NLRP3 inflammasome components. This work reveals a regulatory pathway for the NLRP3 inflammasome that occurs in an outside-in fashion and provides a link between extracellular cathepsin Z and inflammation. Furthermore, it reveals a level of NLRP3 inflammasome regulation that has previously only been found downstream of extracellular pathogens.	[Campden, Rhiannon, I; Greene, Catherine J.; Aggarwal, Devin; McKenna, Neil; Sandall, Christina F.; MacDonald, Justin A.; Yates, Robin M.] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Campden, Rhiannon, I; Greene, Catherine J.; Arnold, Corey R.; McKenna, Neil; Yates, Robin M.] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada; [Warren, Amy L.; Chiriboga, Jose A.] Univ Calgary, Fac Vet Med, Dept Vet Clin & Diagnost Sci, Calgary, AB, Canada; [McKenna, Neil; Yates, Robin M.] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Yates, RM (corresponding author), Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB, Canada.; Yates, RM (corresponding author), Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada.	rmyates@ucalgary.ca			Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We are grateful to Dr Thomas Reinheckel for the use of cathepsin Z deficient mice and to Dr Daniel Muruve for the use of the Asc deficient mice and for help with producing the NLRP3<SUP>-/-</SUP> THP-1 cells. Thank you to Drs Yan Shi and Morley Hollenberg for their critical feedback on experimental design and to Dr Antoine Dufour for his critical reading of the article. This work was supported by the Multiple Sclerosis Society of Canada, the Canadian Institutes of Health Research, and the Natural Sciences and Engineering Research Council of Canada.	Aiba Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30146-w; Akkari L, 2014, GENE DEV, V28, P2134, DOI 10.1101/gad.249599.114; Allan ERO, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0874-x; Bang KM, 2015, MMWR-MORBID MORTAL W, V64, P117; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bernhardt A, 2010, J BIOL CHEM, V285, P33691, DOI 10.1074/jbc.M110.146183; Bouwens E, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.009555; Brand-Schieber E, 2005, J NEUROSCI RES, V80, P798, DOI 10.1002/jnr.20474; Campden RI, 2019, ARCH BIOCHEM BIOPHYS, V670, P32, DOI 10.1016/j.abb.2019.02.015; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chevallet M, 2007, PROTEOMICS, V7, P1757, DOI 10.1002/pmic.200601024; Cole MB, 2016, ARTHRITIS RHEUMATOL, V68, P2936, DOI 10.1002/art.39792; Dera AA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46068-0; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Glanzer JG, 2007, J NEUROCHEM, V102, P627, DOI 10.1111/j.1471-4159.2007.04568.x; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hamilton RF, 2008, FREE RADICAL BIO MED, V44, P1246, DOI 10.1016/j.freeradbiomed.2007.12.027; Hari A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07281; Hayashi J, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9091-8; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Hegde B, 2018, J IMMUNOL, V200, P3556, DOI 10.4049/jimmunol.1701504; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hou YZ, 2010, J BIOL CHEM, V285, P35497, DOI 10.1074/jbc.M109.066035; Huynh JL, 2014, NAT NEUROSCI, V17, P121, DOI 10.1038/nn.3588; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jun HK, 2012, IMMUNITY, V36, P755, DOI 10.1016/j.immuni.2012.05.002; Lakatos HF, 2006, EXP LUNG RES, V32, P181, DOI 10.1080/01902140600817465; Lau A, 2018, J CLIN INVEST, V128, P2894, DOI 10.1172/JCI96640; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Li W, 2018, CELL SIGNAL, V50, P131, DOI 10.1016/j.cellsig.2018.07.001; Lin CC, 2017, J IMMUNOL, V198, P4553, DOI 10.4049/jimmunol.1700263; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mortimer L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004887; Nagler DK, 1998, FEBS LETT, V434, P135, DOI 10.1016/S0014-5793(98)00964-8; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P12648, DOI 10.1021/bi991371z; Orlowski GM, 2015, J IMMUNOL, V195, P1685, DOI 10.4049/jimmunol.1500509; Peeters PM, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0058-0; Perdereau C, 2006, BBA-MOL BASIS DIS, V1762, P351, DOI 10.1016/j.bbadis.2005.10.005; Pineda-Torra I, 2015, METHODS MOL BIOL, V1339, P101, DOI 10.1007/978-1-4939-2929-0_6; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sivaraman J, 2000, J MOL BIOL, V295, P939, DOI 10.1006/jmbi.1999.3410; Song LY, 2014, J CELL MOL MED, V18, P1773, DOI 10.1111/jcmm.12341; Stattin K, 2019, EUR J PREV CARDIOL, V26, P1865, DOI 10.1177/2047487319868033; Staudt ND, 2010, HAEMATOL-HEMATOL J, V95, P1452, DOI 10.3324/haematol.2009.018671; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Teller A, 2015, PATHOL RES PRACT, V211, P62, DOI 10.1016/j.prp.2014.09.005; Therrien C, 2001, BIOCHEMISTRY-US, V40, P2702, DOI 10.1021/bi002460a; Thygesen C, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00397; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Wendt W, 2009, J NEUROCHEM, V110, P1931, DOI 10.1111/j.1471-4159.2009.06283.x; Zou LL, 2019, MOL MED REP, V19, P3972, DOI 10.3892/mmr.2019.10088	55	2	2	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101459	10.1016/j.jbc.2021.101459	http://dx.doi.org/10.1016/j.jbc.2021.101459			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP0ZE	34864055	Green Published, gold			2022-12-26	WOS:000748357700015
J	Cheng, KC; Hwang, YL; Chiang, HC				Kuan-Chung Cheng; Yu-Luen Hwang; Hsueh-Cheng Chiang			The double-edged sword effect of HDAC6 in A beta toxicities	FASEB JOURNAL			English	Article						A beta; HDAC6; learning and memory; tau	INDUCED MICROTUBULE DEFECTS; AMYLOID-BETA; COGNITIVE DEFICITS; ALZHEIMERS-DISEASE; MOUSE MODEL; TAU; ACETYLATION; DROSOPHILA; PROTEIN; NEURODEGENERATION	Alzheimer's disease (AD) is marked by cognitive impairment, massive cell death, and reduced life expectancy. Pathologically, accumulated beta-amyloid (A beta) aggregates and hyperphosphorylated tau protein is the hallmark of the disease. Although changes in cellular function and protein accumulates have been demonstrated in many different AD animal models, the molecular mechanism involved in different cellular functions and the correlation and causative relation between different protein accumulations remain elusive. Our in vivo genetic studies revealed that the molecular mechanisms involved in memory loss and lifespan shortening are different and that tau plays an essential role in mediating A beta-induced early death. We found that when the first deacetylase (DAC) domain of histone deacetylase 6 (HDAC6) activity was increased, it regulated cortactin deacetylation to reverse A beta-induced learning and memory deficit, but with no effect on the lifespan of the A beta flies. On the other hand, an increased amount of the second DAC domain of HDAC6 promoted tau phosphorylation to facilitate A beta-induced lifespan shortening without affecting learning performance in the A beta flies. Our data also confirmed decreased acetylation in two major HDAC6 downstream proteins, suggesting increased HDAC6 activity in A beta flies. Our data established the double-edged sword effect of HDAC6 activity in A beta-induced pathologies. Not only did we segregate memory loss and lifespan shortening in A beta flies, but we also provided evidence to link the A beta with tau signaling.	[Kuan-Chung Cheng; Yu-Luen Hwang; Hsueh-Cheng Chiang] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Kuan-Chung Cheng; Hsueh-Cheng Chiang] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University	Chiang, HC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan.	chianghc@mail.ncku.edu.tw			Ministry of Science and Technology, Taiwan (MOST) [107-2320-B-006-049-MY3, 108-2321B-006-025-MY2]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: 107-2320-B-006-049-MY3 and 108-2321B-006-025-MY2	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Buhl E, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104507; Busche MA, 2020, NAT NEUROSCI, V23, P1183, DOI 10.1038/s41593-020-0687-6; Carlonnagno Y, 2017, J BIOL CHEM, V292, P15277, DOI 10.1074/jbc.M117.794602; Cheng KC, 2018, MOL NEUROBIOL, V55, P7523, DOI 10.1007/s12035-018-0942-y; Chiang HC, 2010, P NATL ACAD SCI USA, V107, P7060, DOI 10.1073/pnas.0909314107; Cuadrado-Tejedor M, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00149; d'Errico P, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00265; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Esteves AR, 2019, BBA-MOL BASIS DIS, V1865, P2008, DOI 10.1016/j.bbadis.2018.11.014; Fan SJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0688-5; Francis YI, 2009, J ALZHEIMERS DIS, V18, P131, DOI 10.3233/JAD-2009-1134; Frost B, 2014, NAT NEUROSCI, V17, P357, DOI 10.1038/nn.3639; Govindarajan N, 2013, EMBO MOL MED, V5, P52, DOI 10.1002/emmm.201201923; He F, 2020, BIOORG CHEM, V103, DOI 10.1016/j.bioorg.2020.104109; Huang JK, 2013, NEUROBIOL DIS, V51, P161, DOI 10.1016/j.nbd.2012.11.006; Huang YP, 2015, J ALZHEIMERS DIS, V45, P235, DOI 10.3233/JAD-141608; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Kommaddi RP, 2018, J NEUROSCI, V38, P1085, DOI 10.1523/JNEUROSCI.2127-17.2017; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Mao CX, 2017, DIS MODEL MECH, V10, P1245, DOI 10.1242/dmm.028316; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Odagiri S, 2013, BIOCHEM BIOPH RES CO, V430, P394, DOI 10.1016/j.bbrc.2012.11.034; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; Perry S, 2017, CELL REP, V18, P1337, DOI 10.1016/j.celrep.2017.01.028; Pickett EK, 2019, CELL REP, V29, P3592, DOI 10.1016/j.celrep.2019.11.044; Puzzo D, 2020, J CLIN INVEST, V130, P4831, DOI 10.1172/JCI137040; Rabal O, 2019, ACS CHEM NEUROSCI, V10, P4076, DOI 10.1021/acschemneuro.9b00303; Richter-Landsberg C, 2013, ACTA NEUROPATHOL, V126, P793, DOI 10.1007/s00401-013-1158-x; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rush T, 2018, J NEUROSCI, V38, P10349, DOI 10.1523/JNEUROSCI.1409-18.2018; Salvadores N, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.581767; Schnoor M, 2018, TRENDS CELL BIOL, V28, P79, DOI 10.1016/j.tcb.2017.10.009; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011; Su M, 2011, J NEUROCHEM, V117, P112, DOI 10.1111/j.1471-4159.2011.07180.x; Trzeciakiewicz H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19317-4; Tsushima H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8781; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Xiong Y, 2013, P NATL ACAD SCI USA, V110, P4604, DOI 10.1073/pnas.1207586110; Yan C, 2018, CELL REP, V25, P1051, DOI 10.1016/j.celrep.2018.09.075; Yoshikawa M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00124	51	1	1	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22072	10.1096/fj.202101061R	http://dx.doi.org/10.1096/fj.202101061R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34907598				2022-12-26	WOS:000734992000041
J	Farfel, JM; Leurgans, SE; Capuano, AW; Sampaio, MCD; Wilson, RS; Schneider, JA; Bennett, DA				Farfel, Jose M.; Leurgans, Sue E.; Capuano, Ana W.; de Moraes Sampaio, Maria Carolina; Wilson, Robert S.; Schneider, Julie A.; Bennett, David A.			Dementia and autopsy-verified causes of death in racially-diverse older Brazilians	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ORAL-HEALTH; POPULATION; ASSOCIATION; PREVALENCE; PNEUMONIA; MORTALITY; CANCER; DIAGNOSIS; RISK	Background While dementia has been associated with specific causes of death, previous studies were relatively small autopsy series or population-based studies lacking autopsy confirmation and were restricted to Non-Latinx Whites. Here, we examine the association of dementia with autopsy-verified causes of death in racially-diverse older Brazilians. Methods As part of the Pathology, Alzheimers and Related Dementias Study (PARDoS), a community-based study in Brazil, we included 1941 racially-diverse deceased, 65 years or older at death. We conducted a structured interview with legal informants including the Clinical Dementia Rating (CDR) Scale for dementia proximate to death. Causes of death were assessed after full-body autopsy and macroscopic examination of the brain, thoracic and abdominal/pelvic organs. Up to four causes of death were reported for each decedent. Causes of death were classified as circulatory, infectious, cancer and other. Logistic regression was used to determine associations of dementia with cause of death, controlling for age, sex, race, and education. Results Dementia was associated with a higher odds of an infectious cause of death (OR = 1.81, 95%CI:1.45-2.25), and with a lower odds of a circulatory disease as cause of death (OR = 0.69, 95%CI:0.54-0.86) and cancer as cause of death (OR = 0.41, 95%CI:0.24-0.71). Dementia was associated with a higher odds of pneumonia (OR = 1.92, 95%CI:1.53-2.40) and pulmonary embolism (OR = 2.31, 95%CI:1.75-3.05) as causes of death and with a lower odds of acute myocardial infarction (OR = 0.42, 95%CI:0.31-0.56) and arterial disease (OR = 0.76, 95%CI:0.61-0.94) as causes of death. Conclusion Racially-diverse older Brazilians with dementia had a higher odds of an infectious cause of death and a lower odds of cancer and circulatory disease as causes of death than those without dementia.	[Farfel, Jose M.; Leurgans, Sue E.; Capuano, Ana W.; Wilson, Robert S.; Schneider, Julie A.; Bennett, David A.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA; [Farfel, Jose M.; Schneider, Julie A.] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Farfel, Jose M.; Capuano, Ana W.; de Moraes Sampaio, Maria Carolina; Bennett, David A.] Inst Assistencia Med Servidor Publ Estado IAMSPE, Hlth Sci Program, Sao Paulo, Brazil; [Leurgans, Sue E.; Capuano, Ana W.; Wilson, Robert S.; Schneider, Julie A.; Bennett, David A.] Rush Med Coll, Dept Neurol Sci, Chicago, IL 60612 USA; [Wilson, Robert S.] Rush Med Coll, Dept Psychiat & Behav Sci, Chicago, IL 60612 USA	Rush University; Rush University; Rush University; Rush University	Farfel, JM (corresponding author), Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA.; Farfel, JM (corresponding author), Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA.; Farfel, JM (corresponding author), Inst Assistencia Med Servidor Publ Estado IAMSPE, Hlth Sci Program, Sao Paulo, Brazil.	Jose_Farfel@rush.edu			NIA [R01AG54058]	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was funded by NIA grant R01AG54058 awarded to DAB as Principal Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attems J, 2005, J ALZHEIMERS DIS, V8, P57; Beach Thomas G, 2021, medRxiv, DOI 10.1101/2021.01.07.21249410; Beard CM, 1996, ANN EPIDEMIOL, V6, P195, DOI 10.1016/1047-2797(95)00068-2; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Brookmeyer R, 2002, ARCH NEUROL-CHICAGO, V59, P1764, DOI 10.1001/archneur.59.11.1764; Brunnstrom HR, 2009, EUR J NEUROL, V16, P488, DOI 10.1111/j.1468-1331.2008.02503.x; Capuano AW, 2021, INT J GERIATR PSYCH, V36, P901, DOI 10.1002/gps.5491; Chamandy N, 2005, NEUROEPIDEMIOLOGY, V25, P75, DOI 10.1159/000086287; Chen TY, 2018, CHEST, V153, P161, DOI 10.1016/j.chest.2017.07.030; Crimmins EM, 2018, J GERONTOL B-PSYCHOL, V73, pS20, DOI 10.1093/geronb/gbx135; DAVIS PB, 1991, ARCH NEUROL-CHICAGO, V48, P613, DOI 10.1001/archneur.1991.00530180069019; Degerskar ANW, 2020, EUR J NEUROL, V27, P2415, DOI 10.1111/ene.14450; Driver JA, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1442; Ferretti Renata Eloah de Lucena, 2010, Dement. neuropsychol., V4, P138, DOI 10.1590/S1980-57642010DN40200011; FRATIGLIONI L, 1991, NEUROLOGY, V41, P1886, DOI 10.1212/WNL.41.12.1886; Fu C, 2004, ARCH PATHOL LAB MED, V128, P32; Ganguli M, 2005, ARCH NEUROL-CHICAGO, V62, P779, DOI 10.1001/archneur.62.5.779; Garcia-Ptacek S, 2016, J AM GERIATR SOC, V64, pE137, DOI 10.1111/jgs.14421; Heron Melonie, 2019, Natl Vital Stat Rep, V68, P1; Jackson LA, 2003, NEW ENGL J MED, V348, P1747, DOI 10.1056/NEJMoa022678; James BD, 2014, NEUROLOGY, V82, P1045, DOI 10.1212/WNL.0000000000000240; Kammoun S, 2000, ACTA NEUROL SCAND, V102, P96, DOI 10.1034/j.1600-0404.2000.00314.x; Kawas C, 2000, NEUROLOGY, V54, P2072, DOI 10.1212/WNL.54.11.2072; Keene J, 2001, INT J GERIATR PSYCH, V16, P969, DOI 10.1002/gps.474; Kubota Y, 2017, JAMA INTERN MED, V177, P1165, DOI 10.1001/jamainternmed.2017.1877; Lobo A, 2000, NEUROLOGY, V54, pS4; Manabe T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213825; Manabe T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140060; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; Matthews KA, 2019, ALZHEIMERS DEMENT, V15, P17, DOI 10.1016/j.jalz.2018.06.3063; Mazure CM, 2016, LANCET NEUROL, V15, P451, DOI 10.1016/S1474-4422(16)00067-3; Mojon P, 1999, AGE AGEING, V28, P463, DOI 10.1093/ageing/28.5.463; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Musicco M, 2013, NEUROLOGY, V81, P322, DOI 10.1212/WNL.0b013e31829c5ec1; NEWENS AJ, 1993, J EPIDEMIOL COMMUN H, V47, P293, DOI 10.1136/jech.47.4.293; Parra MA, 2018, NEUROLOGY, V90, P222, DOI 10.1212/WNL.0000000000004897; Pottier P, 2009, THROMB RES, V124, P468, DOI 10.1016/j.thromres.2009.05.006; Prince M, 2013, POLICY BRIEF HEADS G; Roe CM, 2010, NEUROLOGY, V74, P106, DOI 10.1212/WNL.0b013e3181c91873; Savoca MR, 2010, J AM GERIATR SOC, V58, P1225, DOI 10.1111/j.1532-5415.2010.02909.x; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Tolppanen AM, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01744-z; Trifiro G, 2010, ANN INTERN MED, V152, P418, DOI 10.7326/0003-4819-152-7-201004060-00006; Tschanz JT, 2004, NEUROLOGY, V62, P1156, DOI 10.1212/01.WNL.0000118210.12660.C2; van de Vorst IE, 2016, J ALZHEIMERS DIS, V53, P117, DOI 10.3233/JAD-150925; Waite L, 1999, ALZ DIS ASSOC DIS, V13, P34, DOI 10.1097/00002093-199903000-00005; Yarchoan M, 2017, J ALZHEIMERS DIS, V56, P699, DOI 10.3233/JAD-160977	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0261036	10.1371/journal.pone.0261036	http://dx.doi.org/10.1371/journal.pone.0261036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY5KW	34910735	gold, Green Published			2022-12-26	WOS:000754828900032
J	DeClercq, V; Nearing, JT; Langille, MGI				DeClercq, Vanessa; Nearing, Jacob T.; Langille, Morgan G., I			Investigation of the impact of commonly used medications on the oral microbiome of individuals living without major chronic conditions	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; GUT MICROBIOTA; DISEASE; ASSOCIATION; PARTNERSHIP; DYSBIOSIS; PROJECT; COHORT	Background Commonly used medications produce changes in the gut microbiota, however, the impact of these medications on the composition of the oral microbiota is understudied. Methods Saliva samples were obtained from 846 females and 368 males aged 35-69 years from a Canadian population cohort, the Atlantic Partnership for Tomorrow's Health (PATH). Samples were analyzed by 16S rRNA gene sequencing and differences in microbial community compositions between nonusers, single-, and multi-drug users as well as the 3 most commonly used medications (thyroid hormones, statins, and proton pump inhibitors (PPI)) were examined. Results Twenty-six percent of participants were taking 1 medication and 21% were reported taking 2 or more medications. Alpha diversity indices of Shannon diversity, Evenness, Richness, and Faith's phylogenetic diversity were similar among groups, likewise beta diversity as measured by Bray-Curtis dissimilarity (R-2 = 0.0029, P = 0.053) and weighted UniFrac distances (R-2 = 0.0028, P = 0.161) were non-significant although close to our alpha value threshold (P = 0.05). After controlling for covariates (sex, age, BMI), six genera (Saprospiraceae uncultured, Bacillus, Johnsonella, Actinobacillus, Stenotrophomonas, and Mycoplasma) were significantly different from non-medication users. Thyroid hormones, HMG-CoA reductase inhibitors (statins) and PPI were the most reported medications. Shannon diversity differed significantly among those taking no medication and those taking only thyroid hormones, however, there were no significant difference in other measures of alpha- or beta diversity with single thyroid hormone, statin, or PPI use. Compared to participants taking no medications, the relative abundance of eight genera differed significantly in participants taking thyroid hormones, six genera differed in participants taking statins, and no significant differences were observed with participants taking PPI. Conclusion The results from this study show negligible effect of commonly used medications on microbial diversity and small differences in the relative abundance of specific taxa, suggesting a minimal influence of commonly used medication on the salivary microbiome of individuals living without major chronic conditions.	[DeClercq, Vanessa; Langille, Morgan G., I] Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada; [DeClercq, Vanessa] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Nearing, Jacob T.; Langille, Morgan G., I] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	DeClercq, V (corresponding author), Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada.; DeClercq, V (corresponding author), Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada.	vanessa.de.clercq@dal.ca			Canadian Partnership Against Cancer and Health Canada; Nova Scotia Graduate Scholarship; ResearchNS Scotia Scholars award	Canadian Partnership Against Cancer and Health Canada; Nova Scotia Graduate Scholarship; ResearchNS Scotia Scholars award	Thank you to all participants of the Atlantic PATH project for donating their time, personal health information and biological samples to this project, and to Atlantic PATH team members for data collection and management. The data used in this research were made available by the Atlantic Partnership for Tomorrow's Health (Atlantic PATH) study, which is the Atlantic Canada regional component of the Canadian Partnership for Tomorrow Project funded by the Canadian Partnership Against Cancer and Health Canada. The views expressed herein represent the views of the authors and do not necessarily represent the views of Health Canada. JTN is funded by both a Nova Scotia Graduate Scholarship and a ResearchNS Scotia Scholars award.	Al-Zyoud W, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010256; Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00191-16; Amir I, 2014, ENVIRON MICROBIOL, V16, P2905, DOI 10.1111/1462-2920.12285; Belstrom D, 2020, J ORAL MICROBIOL, V12, DOI 10.1080/20002297.2020.1723975; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Buckley JP, 2013, INFLAMM BOWEL DIS, V19, P2725, DOI 10.1097/01.MIB.0000435442.07237.a4; Chhibber-Goel J, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/s41522-016-0009-7; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Doestzada M, 2018, PROTEIN CELL, V9, P432, DOI 10.1007/s13238-018-0547-2; Dummer TJB, 2018, CAN MED ASSOC J, V190, pE710, DOI 10.1503/cmaj.170292; Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Gnjidic D, 2017, PUBLIC HEALTH RES PR, V27, DOI 10.17061/phrp27341702; Hsiao WWL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-345; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Imhann F, 2017, GUT MICROBES, V8, P351, DOI 10.1080/19490976.2017.1284732; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Jackson MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05184-7; Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861; Jia YJ, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.658203; Kaul A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02114; Kawar N, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80170-y; Keats MR, 2021, SUPPORT CARE CANCER, V29, P713, DOI 10.1007/s00520-020-05529-3; Khan TJ, 2018, OMICS, V22, P154, DOI 10.1089/omi.2017.0130; Long J, 2017, J PERIODONTAL RES, V52, P636, DOI 10.1111/jre.12432; Mallick H, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009442; Martin BD, 2020, ANN APPL STAT, V14, P94, DOI [10.1214/19-AOAS1283, 10.1214/19-aoas1283]; Mishiro T, 2018, J GASTROEN HEPATOL, V33, P1059, DOI 10.1111/jgh.14040; Moura CS, 2022, CHRONIC ILLN, V18, P729, DOI 10.1177/1742395320985913; Nearing JT, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00451-20; Nearing JT, 2021, BIOINFORMATICS, V2021, DOI [10.1101/2021.05.10.443486, DOI 10.1101/2021.05.10.443486]; Pedersen E, 2021, J CLIN EPIDEMIOL, V135, P115, DOI 10.1016/j.jclinepi.2021.02.015; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rademacher WMH, 2020, ORAL DIS, V26, P213, DOI 10.1111/odi.13199; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Said HS, 2014, DNA RES, V21, P15, DOI 10.1093/dnares/dst037; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Seidel CL, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218218; Shi YC, 2019, GENOM PROTEOM BIOINF, V17, P52, DOI 10.1016/j.gpb.2018.12.004; Sweeney E, 2017, INT J EPIDEMIOL, V46, P1762, DOI 10.1093/ije/dyx124; Vieira-Silva S, 2020, NATURE, V581, P310, DOI 10.1038/s41586-020-2269-x; Vila AV, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14177-z; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wang JZ, 2019, INTEST RES, V17, P496, DOI 10.5217/ir.2019.00050; WHO, 2018, GUIDELINES ATC CLASS; Yamashita Y, 2017, J ORAL SCI, V59, P201, DOI 10.2334/josnusd.16-0856; Yang Y, 2020, AGING-US, V12, P13090, DOI 10.18632/aging.103399; Yao ZY, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00495; Yuan A, 2015, OR SURG OR MED OR PA, V119, P35, DOI 10.1016/j.oooo.2014.09.009; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zimmermann M, 2019, NATURE, V570, P462, DOI 10.1038/s41586-019-1291-3	53	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0261032	10.1371/journal.pone.0261032	http://dx.doi.org/10.1371/journal.pone.0261032			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882708	Green Published, gold			2022-12-26	WOS:000755037200054
J	Ogawa, T; Hoekstra, SP; Kamijo, YI; Goosey-Tolfrey, VL; Walsh, JJ; Tajima, FF; Leicht, CA				Ogawa, Takahiro; Hoekstra, Sven P.; Kamijo, Yoshi-Ichiro; Goosey-Tolfrey, Victoria L.; Walsh, Jeremy J.; Tajima, Fumihiro F.; Leicht, Christof A.			Serum and plasma brain-derived neurotrophic factor concentration are elevated by systemic but not local passive heating	PLOS ONE			English	Article							BDNF LEVELS; HUMAN PLATELETS; BLOOD-FLOW; EXERCISE; RESPONSES; AGE; TEMPERATURE; HEALTHY; STRESS; INDEX	Brain-derived neurotrophic factor (BDNF) plays a key role in neuronal adaptations. While previous studies suggest that whole-body heating can elevate circulating BDNF concentration, this is not known for local heating protocols. This study investigated the acute effects of whole-body versus local passive heating on serum and plasma BDNF concentration. Using a water-perfused suit, ten recreationally active males underwent three 90 min experimental protocols: heating of the legs with upper-body cooling (LBH), whole-body heating (WBH) and a control condition (CON). Blood samples were collected before, immediately after and 1 h post-heating for the determination of serum and plasma BDNF concentration, platelet count as well as the BDNF release per platelet. Rectal temperature, cardiac output and femoral artery shear rate were assessed at regular intervals. Serum and plasma BDNF concentration were elevated after WBH (serum: 19.1 +/- 5.0 to 25.9 +/- 11.3 ng/ml, plasma: 2.74 +/- 0.9 to 4.58 +/- 2.0; p<0.044), but not LBH (serum: 19.1 +/- 4.7 to 22.3 +/- 4.8 ng/ml, plasma: 3.25 +/- 1.13 to 3.39 +/- 0.90 ng/ml; p>0.126), when compared with CON (serum: 18.6 +/- 6.4 to 16.8 +/- 3.4 ng/ml, plasma: 2.49 +/- 0.69 to 2.82 +/- 0.89 ng/ml); accompanied by an increase in platelet count (p<0.001). However, there was no change in BDNF content per platelet after either condition (p = 0.392). All physiological measures were elevated to a larger extent after WBH compared with LBH (p<0.001), while shear rate and rectal temperature were higher during LBH than CON (p<0.038). In conclusion, WBH but not LBH acutely elevates circulating BDNF concentration. While these findings further support the use of passive heating to elevate BDNF concentration, a larger increase in shear rate, sympathetic activity and/or rectal temperature than found after LBH appears needed to induce an acute BDNF response by passive heating.	[Ogawa, Takahiro; Kamijo, Yoshi-Ichiro; Tajima, Fumihiro F.] Wakayama Med Univ, Dept Rehabil Med, Wakayama, Japan; [Hoekstra, Sven P.; Goosey-Tolfrey, Victoria L.; Tajima, Fumihiro F.; Leicht, Christof A.] Loughborough Univ, Peter Harrison Ctr Disabil Sport, Loughborough, Leics, England; [Walsh, Jeremy J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	Wakayama Medical University; Loughborough University; McMaster University	Leicht, CA (corresponding author), Loughborough Univ, Peter Harrison Ctr Disabil Sport, Loughborough, Leics, England.	c.a.leicht@lboro.ac.uk			Kyoten Research Center of Sports for Persons with Impairments	Kyoten Research Center of Sports for Persons with Impairments	This project was supported by the Kyoten Research Center of Sports for Persons with Impairments. The funders were not involved in any stage of the research process.	Bain AR, 2017, EXP PHYSIOL, V102, P663, DOI 10.1113/EP086336; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Binzoni T, 1999, ADV EXP MED BIOL, V471, P623; Chiesa ST, 2015, AM J PHYSIOL-HEART C, V309, pH369, DOI 10.1152/ajpheart.00078.2015; Cui Jian, 2014, Curr Heart Fail Rep, V11, P139, DOI 10.1007/s11897-014-0191-y; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Dinenno FA, 1999, CIRCULATION, V100, P164, DOI 10.1161/01.CIR.100.2.164; Dinoff A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163037; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Frank SM, 1999, J APPL PHYSIOL, V86, P1588, DOI 10.1152/jappl.1999.86.5.1588; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Glazachev OS, 2020, J THERM BIOL, V89, DOI 10.1016/j.jtherbio.2019.102482; GOBEL FL, 1978, CIRCULATION, V57, P549, DOI 10.1161/01.CIR.57.3.549; Goekint M, 2011, NEUROSCI LETT, V494, P150, DOI 10.1016/j.neulet.2011.03.001; Hoekstra SP, 2021, APPL PHYSIOL NUTR ME, V46, P808, DOI 10.1139/apnm-2020-0704; Hoekstra Sven P, 2020, Exerc Immunol Rev, V26, P42; Hunt AP, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01556; Jeon YK, 2017, ENVIRON HEALTH PREV, V22, DOI 10.1186/s12199-017-0643-6; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Kojima D, 2018, INT J HYPERTHER, V34, P834, DOI 10.1080/02656736.2017.1394502; Leicht CA, 2016, MED SCI SPORT EXER, V48, P1161, DOI 10.1249/MSS.0000000000000874; LEWIS JF, 1984, CIRCULATION, V70, P425, DOI 10.1161/01.CIR.70.3.425; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Maffioletti E, 2014, BIOTECHNIQUES, V57, P111, DOI 10.2144/000114204; McGinn R, 2017, APPL PHYSIOL NUTR ME, V42, P1232, DOI 10.1139/apnm-2017-0322; Moran DS, 1998, AM J PHYSIOL-REG I, V275, pR129, DOI 10.1152/ajpregu.1998.275.1.R129; Mu JS, 1999, BRAIN RES, V835, P259, DOI 10.1016/S0006-8993(99)01592-9; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Notley SR, 2021, ACTA DIABETOL, V58, P809, DOI 10.1007/s00592-021-01684-z; Piepoli MF, 2011, EUR J HEART FAIL, V13, P347, DOI 10.1093/eurjhf/hfr017; Prigent-Tessier A, 2013, CARDIOVASC RES, V100, P374, DOI 10.1093/cvr/cvt219; Shepley BR, 2021, J APPL PHYSIOL, V130, P792, DOI 10.1152/japplphysiol.00645.2020; Suzuki M, 2019, INTERNAL MED, V58, P53, DOI 10.2169/internalmedicine.0825-18; Thijssen DHJ, 2009, MED SCI SPORT EXER, V41, P1072, DOI 10.1249/MSS.0b013e3181923957; Thomas KN, 2017, AM J PHYSIOL-REG I, V312, pR281, DOI 10.1152/ajpregu.00404.2016; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Walsh JJ, 2018, APPL PHYSIOL NUTR ME, V43, P1095, DOI 10.1139/apnm-2018-0192; Walsh JJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00746; Wang R, 2018, AGEING RES REV, V48, P109, DOI 10.1016/j.arr.2018.10.002; Watson P, 2005, AM J PHYSIOL-REG I, V288, pR1689, DOI 10.1152/ajpregu.00676.2004; Zouhal H, 2013, SPORTS MED, V43, P591, DOI 10.1007/s40279-013-0039-8	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260775	10.1371/journal.pone.0260775	http://dx.doi.org/10.1371/journal.pone.0260775			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882699	Green Published, gold			2022-12-26	WOS:000755037200040
J	van Hooft, P; Getz, WM; Greyling, BJ; Zwaan, B; Bastos, ADS				van Hooft, Pim; Getz, Wayne M.; Greyling, Barend J.; Zwaan, Bas; Bastos, Armanda D. S.			A continent-wide high genetic load in African buffalo revealed by clines in the frequency of deleterious alleles, genetic hitchhiking and linkage disequilibrium	PLOS ONE			English	Article							INBREEDING DEPRESSION; MICROSATELLITE ANALYSIS; BOVINE TUBERCULOSIS; SYNCERUS-CAFFER; MUTATION LOAD; POPULATION; DIVERSITY; SELECTION; WILD; HETEROZYGOSITY	A high genetic load can negatively affect population viability and increase susceptibility to diseases and other environmental stressors. Prior microsatellite studies of two African buffalo (Syncerus caffer) populations in South Africa indicated substantial genome-wide genetic load due to high-frequency occurrence of deleterious alleles. The occurrence of these alleles, which negatively affect male body condition and bovine tuberculosis resistance, throughout most of the buffalo's range were evaluated in this study. Using available microsatellite data (2-17 microsatellite loci) for 1676 animals from 34 localities (from 25 degrees S to 5 degrees N), we uncovered continent-wide frequency clines of microsatellite alleles associated with the aforementioned male traits. Frequencies decreased over a south-to-north latitude range (average per-locus Pearson r = -0.22). The frequency clines coincided with a multilocus-heterozygosity cline (adjusted R-2 = 0.84), showing up to a 16% decrease in southern Africa compared to East Africa. Furthermore, continent-wide linkage disequilibrium (LD) at five linked locus pairs was detected, characterized by a high fraction of positive interlocus associations (0.66, 95% CI: 0.53, 0.77) between male-deleterious-trait-associated alleles. Our findings suggest continent-wide and genome-wide selection of male-deleterious alleles driven by an earlier observed sex-chromosomal meiotic drive system, resulting in frequency clines, reduced heterozygosity due to hitchhiking effects and extensive LD due to male-deleterious alleles co-occurring in haplotypes. The selection pressures involved must be high to prevent destruction of allele-frequency clines and haplotypes by LD decay. Since most buffalo populations are stable, these results indicate that natural mammal populations, depending on their genetic background, can withstand a high genetic load.	[van Hooft, Pim] Wageningen Univ, Wildlife Ecol & Conservat Grp, Wageningen, Netherlands; [Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa; [Greyling, Barend J.] Agr Res Council, Irene, South Africa; [Zwaan, Bas] Wageningen Univ, Lab Genet, Wageningen, Netherlands; [Bastos, Armanda D. S.] Univ Pretoria, Dept Zool & Entomol, Hatfield, South Africa	Wageningen University & Research; University of California System; University of California Berkeley; University of Kwazulu Natal; Agricultural Research Council of South Africa; Wageningen University & Research; University of Pretoria	van Hooft, P (corresponding author), Wageningen Univ, Wildlife Ecol & Conservat Grp, Wageningen, Netherlands.	pim.vanhooft@wur.nl	Bastos, Armanda/B-6357-2009; Zwaan, Bas/D-8721-2015	Bastos, Armanda/0000-0002-9223-4204; Zwaan, Bas/0000-0002-8221-4998				Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Acevedo-Whitehouse K, 2006, MOL ECOL, V15, P1973, DOI 10.1111/j.1365-294X.2006.02903.x; Agrawal AF, 2012, ANNU REV ECOL EVOL S, V43, P115, DOI 10.1146/annurev-ecolsys-110411-160257; ALEXANDER RA, 1990, B PSYCHONOMIC SOC, V28, P335; Baird SJE, 1995, EVOLUTION, V49, P1038, DOI [10.2307/2410429, 10.1111/j.1558-5646.1995.tb04431.x]; Bengis RG, 2002, REV SCI TECH OIE, V21, P53; Benton CH, 2018, J ANIM ECOL, V87, P1500, DOI 10.1111/1365-2656.12878; Bouzat JL, 2010, CONSERV GENET, V11, P463, DOI 10.1007/s10592-010-0049-0; Campbell RB, 2007, B MATH BIOL, V69, P2249, DOI 10.1007/s11538-007-9218-9; Caron A, 2003, ECOL APPL, V13, P1338, DOI 10.1890/02-5266; Charlesworth B., 2010, ELEMENTS EVOLUTIONAR, DOI [10.1038/ng0910-734, DOI 10.1038/NG0910-734]; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Chen L, 2019, SCIENCE, V364, P1152, DOI 10.1126/science.aav6202; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Connallon T, 2013, EVOLUTION, V67, P908, DOI 10.1111/j.1558-5646.2012.01800.x; Coop G, 2012, GENETICS, V192, P205, DOI 10.1534/genetics.112.141861; de Jager D, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83823-8; de Jager D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236717; de Jong MA, 2013, MOL ECOL, V22, P341, DOI 10.1111/mec.12114; de Manuel M, 2016, SCIENCE, V354, P477, DOI 10.1126/science.aag2602; Ellis JS, 2011, GENETICA, V139, P353, DOI 10.1007/s10709-011-9554-4; Epps CW, 2013, J HERED, V104, P172, DOI 10.1093/jhered/ess142; Ernest EM, 2012, CONSERV GENET, V13, P381, DOI 10.1007/s10592-011-0291-0; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; GALLAGHER DS, 1992, J HERED, V83, P287, DOI 10.1093/oxfordjournals.jhered.a111215; Goedbloed DJ, 2014, EUR J WILDLIFE RES, V60, P803, DOI 10.1007/s10344-014-0850-z; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 2018, FSTAT VERSION 293 PR; Gravel S, 2016, GENETICS, V203, P451, DOI 10.1534/genetics.115.184630; Gray MM, 2009, GENETICS, V181, P1493, DOI 10.1534/genetics.108.098830; Greyling BJ, 2008, AFR J BIOTECHNOL, V7, P655; Greyling BJ, 2007, THESIS U PRETORIA PR; Guerrero RF, 2014, EVOLUTION, V68, P2747, DOI 10.1111/evo.12481; HASTINGS A, 1984, GENETICS, V106, P153; Heller R, 2008, MOL ECOL, V17, P4845, DOI 10.1111/j.1365-294X.2008.03961.x; Heller R, 2012, MOL ECOL, V21, P3947, DOI 10.1111/j.1365-294X.2012.05671.x; Henn BM, 2015, NAT REV GENET, V16, P333, DOI 10.1038/nrg3931; Herrero-Medrano JM, 2013, BMC GENET, P14, DOI [10.1186/1471-2156-14-14, DOI 10.1186/1471-2156-14-14]; Ihara N, 2004, GENOME RES, V14, P1987, DOI 10.1101/gr.2741704; Johri P, 2021, MOL BIOL EVOL, V38, P2986, DOI 10.1093/molbev/msab050; Khatkar MS., 2008, BMC GENOMICS, P9, DOI [10.1186/1471-2164-9-9, DOI 10.1186/1471-2164-9-9]; LaHood ES, 2002, MOL ECOL NOTES, V2, P187, DOI 10.1046/j.1471-8286.2002.00174.x; Lane-deGraaf KE, 2015, CONSERV GENET, V16, P289, DOI 10.1007/s10592-014-0658-0; Laurie CC, 2007, PLOS GENET, V3, P1487, DOI 10.1371/journal.pgen.0030144; Lindholm AK, 2016, TRENDS ECOL EVOL, V31, P315, DOI 10.1016/j.tree.2016.02.001; MAY RM, 1975, AM NAT, V109, P659, DOI 10.1086/283036; Miller JM, 2011, MOL ECOL RESOUR, V11, P314, DOI 10.1111/j.1755-0998.2010.02918.x; Miller JM, 2015, ECOL EVOL, V5, P3401, DOI 10.1002/ece3.1612; NEI M, 1978, GENETICS, V89, P583; NUR N, 1987, OIKOS, V48, P338, DOI 10.2307/3565523; O'Grady JJ, 2006, BIOL CONSERV, V133, P42, DOI 10.1016/j.biocon.2006.05.016; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Ryan C, 1998, ANIM CONSERV, V1, P85, DOI 10.1111/j.1469-1795.1998.tb00015.x; Ortego J, 2007, MOL ECOL, V16, P3712, DOI 10.1111/j.1365-294X.2007.03406.x; Paiva SR, 2011, J HERED, V102, P697, DOI 10.1093/jhered/esr101; Palamara PF, 2018, NAT GENET, V50, P1311, DOI 10.1038/s41588-018-0177-x; Park SDE, 2001, THESIS; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pilot M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2189; Presson AP, 2006, J COMPUT BIOL, V13, P1131, DOI 10.1089/cmb.2006.13.1131; Presson AP., 2008, BMC BIOINFORMATICS, P9, DOI [10.1186/1471-2105-9-9, DOI 10.1186/1471-2105-9-9]; Prins HHT., 2016, ANTELOPE CONSERVATIO; Queiros J, 2016, INFECT GENET EVOL, V43, P203, DOI 10.1016/j.meegid.2016.05.031; Reid JM, 2003, P ROY SOC B-BIOL SCI, V270, P2151, DOI 10.1098/rspb.2003.2480; Schaid DJ, 2004, GENETICS, V166, P505, DOI 10.1534/genetics.166.1.505; SLATKIN M, 1973, GENETICS, V75, P733; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Smitz N, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0203-2; Smitz N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056235; Smolyanitsky AG, 2004, INT CONGR SER, V1261, P242, DOI 10.1016/S0531-5131(03)01610-8; Teixeira JC, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015096118; Townsend AK, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2407; Townsend AK, 2009, P ROY SOC B-BIOL SCI, V276, P2057, DOI 10.1098/rspb.2008.1852; Traill LW, 2004, S AFR J WILDL RES, V34, P13; Trinkel M, 2011, J WILDLIFE DIS, V47, P494, DOI 10.7589/0090-3558-47.3.494; Ubeda F, 2011, P ROY SOC B-BIOL SCI, V278, P855, DOI 10.1098/rspb.2010.1201; van Hooft P., 2021, Microsatellite data from various African buffalo ( Syncerus caffer ) populations throughout Africa, DOI 10.5061/dryad.s7h44j14c; van Hooft P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221168; van Hooft P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191481; van Hooft P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111778; van Hooft P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-106; van Hooft P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001086; van Hooft WF, 2000, MOL ECOL, V9, P2017, DOI 10.1046/j.1365-294X.2000.01101.x; Weigand H, 2018, ZOOL J LINN SOC-LOND, V184, P528, DOI 10.1093/zoolinnean/zly007; Weir BS, 1990, GENETIC DATA ANAL; Weng ZQ, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-34; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Xu L, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9030083; Zhang Y, 2011, ANIM GENET, V42, P366, DOI 10.1111/j.1365-2052.2010.02166.x; Zhao H, 2005, GENET RES, V86, P77, DOI 10.1017/S001667230500769X	92	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0259685	10.1371/journal.pone.0259685	http://dx.doi.org/10.1371/journal.pone.0259685			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882683	Green Published, gold			2022-12-26	WOS:000755037200010
J	Shah, NR; Kim, KM; Wong, V; Cohen, E; Rosenbaum, S; Cahan, EM; Milstein, A; Sorensen, HT; Horvath-Puho, E				Shah, Nirav R.; Kim, Kyung Mi; Wong, Venus; Cohen, Eyal; Rosenbaum, Sarah; Cahan, Eli M.; Milstein, Arnold; Sorensen, Henrik Toft; Horvath-Puho, Erzsebet			Mothers of children with major congenital anomalies have increased health care utilization over a 20-year post-birth time horizon	PLOS ONE			English	Article							DEMENTIA CAREGIVERS; MORTALITY; QUALITY; SMOKING; BURDEN; BLACK; RISK	Objective This population-based, matched cohort study aimed to evaluate utilization of health care services by mothers of children with major congenital anomalies (MCAs), compared to mothers of children without MCAs over a 20-year post-birth time horizon in Denmark. Methods Our analytic sample included mothers who gave birth to an infant with a MCA (n = 23,927) and a cohort of mothers matched to them by maternal age, parity and infant's year of birth (n = 239,076). Primary outcomes were period prevalence and mothers' quantity of health care utilization (primary, inpatient, outpatient, surgical, and psychiatric services) stratified by their child's age (i.e., ages 0-6 = before school, ages 7-13 = pre-school + primary education, and ages 14-18 = secondary education or higher). The secondary outcome measure was length of hospital stays. Outcome measures were adjusted for maternal age at delivery, parity, marital status, income quartile, level of education in the year prior to the index birth, previous spontaneous abortions, maternal pregnancy complications, maternal diabetes, hypertension, alcohol-related diseases, and maternal smoking. Results In both cohorts the majority of mothers were between 26 and 35 years of age, married, and employed, and 47% were primiparous. Mothers of infants with anomalies had greater utilization of outpatient, inpatient, surgical, and psychiatric services, compared with mothers in the matched cohort. Inpatient service utilization was greater in the exposed cohort up to 13 years after a child's birth, with the highest risk in the first six years after birth [adjusted risk ratio, 1.13; 95% confidence interval (CI), 1.12-1.14], with a decrease over time. Regarding the quantity of health care utilization, the greatest difference between the two groups was in inpatient service utilization, with a 39% increased rate in the exposed cohort during the first six years after birth (adjusted rate ratio, 1.39; 95% CI, 1.37-1.42). During the first 6 years after birth, mothers of children with anomalies stayed a median of 6 days (interquartile range [IQR], 3-13) in hospital overall, while the comparison cohort stayed a median of 4 days (IQR, 2-7) in hospital overall. Rates of utilization of outpatient clinics (adjusted rate ratio, 1.36; 95% CI, 1.29-1.42), as well as inpatient (adjusted rate ratio, 1.77; 95% CI, 1.68-1.87), and surgical services (adjusted rate ratio, 1.33; 95% CI, 1.26-1.41) was higher in mothers of children with multiple-organ MCAs during 0 to 6 years after birth. Among mothers at the lowest income levels, utilization of psychiatric clinic services increased to 59% and when their child was 7 to 13 years of age (adjusted rate ratio, 1.59; 95% CI, 1.24-2.03). Conclusion Mothers of infants with a major congenital anomaly had greater health care utilization across services. Health care utilization decreased over time or remained stable for outpatient, inpatient, and surgical care services, whereas psychiatric utilization increased for up to 13 years after an affected child's birth. Healthcare utilization was significantly elevated among mothers of children with multiple MCAs and among those at the lowest income levels.	[Shah, Nirav R.; Kim, Kyung Mi; Wong, Venus; Rosenbaum, Sarah; Cahan, Eli M.; Milstein, Arnold] Stanford Univ, Clin Excellence Res Ctr, Sch Med, Stanford, CA 94305 USA; [Cohen, Eyal] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [Cohen, Eyal] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Cahan, Eli M.] NYU, Sch Med, New York, NY USA; [Sorensen, Henrik Toft; Horvath-Puho, Erzsebet] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Sorensen, Henrik Toft] Stanford Univ, Dept Hlth Res & Policy, Div Epidemiol, Stanford, CA 94305 USA	Stanford University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; New York University; Aarhus University; Stanford University	Shah, NR (corresponding author), Stanford Univ, Clin Excellence Res Ctr, Sch Med, Stanford, CA 94305 USA.	nirav.shah@stanford.edu		Toft Sorensen, Henrik/0000-0003-4299-7040; Kim, Kyung Mi/0000-0001-5064-470X; Shah, Nirav/0000-0003-2044-7865; Horvath-Puho, Erzsebet/0000-0002-3594-2212				Cohen E, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2320; Cohen E, 2016, JAMA-J AM MED ASSOC, V316, P2515, DOI 10.1001/jama.2016.18425; Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20; Eurocat,, PREV CHARTS TABL; Fonseca A, 2012, DISABIL HEALTH J, V5, P67, DOI 10.1016/j.dhjo.2011.11.001; Glinianaia SV, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003356; Grewal J, 2008, BIRTH DEFECTS RES A, V82, P519, DOI 10.1002/bdra.20461; Guiller CA, 2009, REV LAT-AM ENFERM, V17, P495, DOI 10.1590/S0104-11692009000400010; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Haley WE, 2004, AGING MENT HEALTH, V8, P316, DOI 10.1080/13607860410001728998; Haley WE, 1995, PSYCHOL AGING, V10, P540, DOI 10.1037/0882-7974.10.4.540; Hunfeld JAM, 1999, J PEDIATR PSYCHOL, V24, P515, DOI 10.1093/jpepsy/24.6.515; Janbek J, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034318; Macintosh MCM, 2006, BRIT MED J, V333, P177, DOI 10.1136/bmj.38856.692986.AE; National Academies of Sciences Engineering and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on Health Care Utilization and Adults with Disabilities, 2018, HLTH CARE UTILIZATIO, DOI 10.17226/24969.https://www.ncbi.nlm.nih.gov/books/NBK500097/; PEARLIN LI, 1981, J HEALTH SOC BEHAV, V22, P337, DOI 10.2307/2136676; Rahman A, 2019, PHARMACY-BASEL, V7, DOI 10.3390/pharmacy7040138; Rotberg B, 2020, ACTA PSYCHIAT SCAND, V142, P264, DOI 10.1111/acps.13181; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Schmidt M, 2019, CLIN EPIDEMIOL, V11, P563, DOI 10.2147/CLEP.S179083; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schneider EC, 2017, MIRROR MIRROR 2017 I; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Stueve A, 1997, AM J ORTHOPSYCHIAT, V67, P199, DOI 10.1037/h0080223; Woolf-King SE, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004862; Zhu CW, 2015, ALZHEIMERS DEMENT, V11, P444, DOI 10.1016/j.jalz.2013.12.018	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260962	10.1371/journal.pone.0260962	http://dx.doi.org/10.1371/journal.pone.0260962			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY2LS	34879106	gold, Green Published			2022-12-26	WOS:000754625200040
J	Yu, X; He, CH; Wang, YP; Kang, LN; Miao, L; Chen, J; Zhao, QH; Huang, XN; Zhu, J; Liang, J; Li, Q; Wang, MX; Liu, HM				Yu, Xue; He, Chunhua; Wang, Yanping; Kang, Leni; Miao, Lei; Chen, Jian; Zhao, Qihui; Huang, Xiaona; Zhu, Jun; Liang, Juan; Li, Qi; Wang, Meixian; Liu, Hanmin			Preterm neonatal mortality in China during 2009-2018: A retrospective study	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; BIRTH; COSTS; PREGNANCY; MORBIDITY; INFANTS; TRENDS	In this retrospective analysis, we aimed to analyze the epidemic characteristics of neonatal mortality due to preterm birth at 28-36 weeks gestation in different regions from 2009 to 2018. Data were obtained from China's Under-5 Child Mortality Surveillance System (U5CMSS). The chi(2) trend test, Poisson regression and the Cochran-Mantel-Haenszel method were used in this study. We found that 51.3%, 42.0% and 44.5% of neonate deaths were preterm infants, and immaturity was mainly attributed to 60.1%, 64.1% and 69.5% of these deaths, in the eastern, central and western regions, respectively. The preterm neonatal mortality rate due to immaturity dropped from 149.2, 216.5 and 339.5 in 2009 to 47.4, 83.8 and 170.1 per 100 000 live births in 2018, giving an average annual decline rate of 12.1%, 11.6% and 6.3% in the eastern, central and western regions, respectively, during the studying period. The relative risk of preterm neonatal mortality due to immaturity were 1.3 and 2.3 for the central regions and western regions in 2009-2010, ascending to 2.2 and 3.9 in 2017-2018. The proportion of preterm neonatal deaths with a gestational age <32 weeks was highest among the eastern region. There were significantly more preterm neonatal infants who were not delivered at medical institutions in the western region than in the eastern and central regions. The preterm infant, especially with gestational age <32 weeks, should receive the most attention through enhanced policies and programs to improve child survival. Priority interventions should be region-specific, depending on the availability of economic and healthcare resources.	[Yu, Xue; He, Chunhua; Wang, Yanping; Kang, Leni; Miao, Lei; Zhu, Jun; Liang, Juan] Sichuan Univ, West China Univ Hosp 2, Natl Off Maternal & Child Hlth Surveillance China, Chengdu, Sichuan, Peoples R China; [Chen, Jian] Sichuan Univ, West China Univ Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, Minist Educ, Chengdu, Peoples R China; [Zhao, Qihui] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu, Peoples R China; [Huang, Xiaona] Meishan Maternal & Child Care Hosp, Dept Pediat, Chengdu, Peoples R China; [Zhu, Jun; Wang, Meixian; Liu, Hanmin] Pidu Maternal & Child Care Hosp, Dept Pediat, Chengdu, Peoples R China; [Liu, Hanmin] UNICEF China, Hlth Nutr & Water, Sanitat & Hyg, Beijing, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Wang, MX; Liu, HM (corresponding author), Pidu Maternal & Child Care Hosp, Dept Pediat, Chengdu, Peoples R China.; Liu, HM (corresponding author), UNICEF China, Hlth Nutr & Water, Sanitat & Hyg, Beijing, Peoples R China.	wangmeix1101@163.com; hanmin@vip.163.com						Agustin Conde-Agudelo, 2014, COCHRANE DB SYST REV; [Anonymous], 2016, REPUBLIC TNHC OPINIO; Austeng D, 2010, ACTA PAEDIATR, V99, P978, DOI 10.1111/j.1651-2227.2010.01846.x; Bank TW, 2019, MORT RAT NEON PER 10; Bank W, 2019, LEVELS TRENDS CHILD; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Berard A, 2012, ARCH DIS CHILD-FETAL, V97, pF329, DOI 10.1136/fetalneonatal-2011-300969; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Burguet A, 2004, BJOG-INT J OBSTET GY, V111, P258, DOI 10.1046/j.1471-0528.2003.00037.x; Callaghan WM, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.09.097; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Colaizy TT, 2012, PUBLIC HEALTH NUTR, V15, P702, DOI 10.1017/S1368980011002229; Darmstadt GL, 2014, LANCET, V384, P174, DOI 10.1016/S0140-6736(14)60458-X; Gee RE, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.034; Gonzalez R, 2006, PEDIATRICS, V117, pE949, DOI 10.1542/peds.2005-2354; He CH, 2017, LANCET GLOB HEALTH, V5, pE186, DOI [10.1016/S2214-109X(16)30334-5, 10.1016/s2214-109x(16)30334-5]; Ho JJ., 2000, COCHRANE DB SYST REV, V7, pD2271; Howson CP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S1; Hug L, 2019, LANCET GLOB HEALTH, V7, pE710, DOI 10.1016/S2214-109X(19)30163-9; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Institute of party history and literature of the CPC central committee, 2019, MEM PEOPL REP CHIN O; Jing SW, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039303; Korvenranta E, 2010, PEDIATRICS, V125, pE1109, DOI 10.1542/peds.2009-2882; Leadford AE, 2013, PEDIATRICS, V132, pE128, DOI 10.1542/peds.2012-2030; Li Q., 2005, CHINESE J CONT PEDIA, V7, P25; Liang J, 2011, PAEDIATR PERINAT EP, V25, P593, DOI 10.1111/j.1365-3016.2011.01232.x; Library WE., 2015, NATL BUREAU STAT CHI; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Lu RF, 2016, PEDIATR RES, V79, P689, DOI 10.1038/pr.2016.6; Macdorman M, 2014, INT RANKINGS INFANT; National Bureau of Statistics of China, 2020, CHIN HLTH STAT YB 20; National Bureau of Statistics of China, 2019, PERS INC CONS SPEND; Petrou S, 2009, VALUE HEALTH, V12, P1124, DOI 10.1111/j.1524-4733.2009.00580.x; Qiao J, 2014, TRANSL PEDIATR, V3, P91, DOI 10.3978/j.issn.2224-4336.2014.01.06; Rogers LK, 2011, LIFE SCI, V89, P417, DOI 10.1016/j.lfs.2011.07.017; Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799; Singh K, 2014, MATERN CHILD HLTH J, V18, P242, DOI 10.1007/s10995-013-1260-7; The State Council Information office of the People's Republic of China, NAT PROGR ACT CHILD; UN, 2015, SUSTAINABLE DEV GOAL; Vos T, 2013, LANCET, V381, P628; Wang YP, 2012, ARCH DIS CHILD-FETAL, V97, pF285, DOI 10.1136/archdischild-2011-300412; Wen Shi Wu, 2004, Semin Fetal Neonatal Med, V9, P429, DOI 10.1016/j.siny.2004.04.002; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8; Zhang T, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0543-9; Zhang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144809; Zhao N., 2013, CHINESE J HLTH POLIC	46	1	2	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260611	10.1371/journal.pone.0260611	http://dx.doi.org/10.1371/journal.pone.0260611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879099	gold, Green Published			2022-12-26	WOS:000754625200022
J	Giral, JB; Bloch, F; Sot, M; Zevering, Y; El Nar, A; Vermion, JC; Goetz, C; Lhuillier, L; Perone, JM				Giral, Jean Baptiste; Bloch, Florian; Sot, Maxime; Zevering, Yinka; El Nar, Arpine; Vermion, Jean Charles; Goetz, Christophe; Lhuillier, Louis; Perone, Jean-Marc			Efficacy and safety of single-step transepithelial photorefractive keratectomy with the all-surface laser ablation SCHWIND platform without mitomycin-C for high myopia: A retrospective study of 69 eyes	PLOS ONE			English	Article							KERATOMILEUSIS; COMPLICATIONS; OUTCOMES; LASIK; HAZE; ASLA	Background Studies suggest that transepithelial photorefractive keratectomy (TransPRK) with the all-surface laser ablation (ASLA)-SCHWIND platform is effective and safe for both low-moderate myopia and high myopia. In most studies, mitomycin-C is administered immediately after surgery to prevent corneal opacification (haze), which is a significant complication of photorefractive keratectomy in general. However, there is evidence that adjuvant mitomycin-C induces endothelial cytotoxicity. Moreover, a recent study showed that omitting adjuvant mitomycin-C did not increase haze in low-moderate myopia. The present case-series study examined the efficacy, safety, and haze rates of eyes with high myopia that underwent ASLA-SCHWIND TransPRK without adjuvant mitomycin-C. Methods All consecutive eyes with high myopia (<=-6 D) that were treated in 2018-2020 with the SCHWIND Amaris 500E (R) TransPRK excimer laser without adjuvant mitomycin-C in a tertiary-care hospital (France) and were followed up for 6 months were identified. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), and spherical equivalent (SE) were recorded before and after surgery. Postoperative haze was graded using the 4-grade Fantes scale. Efficacy rate (frequency of eyes with 6-month UCVA <= 0.1 logMAR), safety rate (frequency of eyes that lost <2 BSCVA lines), predictability (frequency of eyes with 6-month SE equal to target SE0.5 D), efficacy index (mean UCVA at 6 months/preoperative BSCVA), and safety index (BSCVA at 6 months/preoperative BSCVA) were computed. Results Sixty-nine eyes (38 patients) were included. Mean preoperative and 6-month SE were -7.44 and -0.05 D, respectively. Mean 6-month UCVA and BSCVA were 0.00 and -0.02 logMAR, respectively. Efficacy rate and index were 95.7% and 1.08, respectively. Safety rate and index were 95.7% and 1.13, respectively. Predictability was 85.5%. Grade 3-4 haze never arose. At 6 months, the haze rate was zero. Conclusions ASLA-SCHWIND TransPRK without mitomycin-C appears to be safe as well as effective and accurate for high myopia.	[Giral, Jean Baptiste; Bloch, Florian; Sot, Maxime; Zevering, Yinka; Vermion, Jean Charles; Lhuillier, Louis; Perone, Jean-Marc] Univ Lorraine, Metz Thionville Reg Hosp Ctr, Mercy Hosp, Dept Ophthalmol, Metz, France; [El Nar, Arpine; Goetz, Christophe] Univ Lorraine, Metz Thionville Reg Hosp Ctr, Mercy Hosp, Clin Res Support Unit, Metz, France	CHR Metz-Thionville; Universite de Lorraine; CHR Metz-Thionville; Universite de Lorraine	Perone, JM (corresponding author), Univ Lorraine, Metz Thionville Reg Hosp Ctr, Mercy Hosp, Dept Ophthalmol, Metz, France.	jm.perone@chr-metz-thionville.fr		perone, jean marc/0000-0002-1427-7567; Zevering, Yinka/0000-0002-2966-0251				Adib-Moghaddam S, 2018, J CATARACT REFR SURG, V44, P1267, DOI 10.1016/j.jcrs.2018.07.021; Adib-Moghaddam S, 2018, J REFRACT SURG, V34, P400, DOI 10.3928/1081597X-20180402-02; Adib-Moghaddam S, 2017, INT J OPHTHALMOL-CHI, V10, P445, DOI 10.18240/ijo.2017.03.19; Alio JL, 1998, J CATARACT REFR SURG, V24, P619, DOI 10.1016/S0886-3350(98)80256-3; Ambrosio Renato Jr, 2003, Semin Ophthalmol, V18, P2, DOI 10.1080/08820530390897738; Antonios R, 2017, BRIT J OPHTHALMOL, V101, P1106, DOI 10.1136/bjophthalmol-2016-309409; Arevalo JF, 2001, J CATARACT REFR SURG, V27, P674, DOI 10.1016/S0886-3350(01)00821-5; Aslanides IM, 2017, CONTACT LENS ANTERIO, V40, P42, DOI 10.1016/j.clae.2016.11.004; Aslanides IM, 2015, CLIN OPHTHALMOL, V9, P33, DOI 10.2147/OPTH.S73424; Aslanides IM, 2012, CLIN OPHTHALMOL, V6, P973, DOI 10.2147/OPTH.S32374; Azar Dimitri T, 2012, Cornea, V31 Suppl 1, pS9, DOI 10.1097/ICO.0b013e31826ab0a7; Carones F, 2002, J CATARACT REFR SURG, V28, P2088, DOI 10.1016/S0886-3350(02)01701-7; Clinch TE, 1999, OPHTHALMOLOGY, V106, P483, DOI 10.1016/S0161-6420(99)90135-5; Fadlallah A, 2011, J CATARACT REFR SURG, V37, P1852, DOI 10.1016/j.jcrs.2011.04.029; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665, DOI 10.1001/archopht.1990.01070070051034; Gadde AK, 2020, INDIAN J OPHTHALMOL, V68, P755, DOI 10.4103/ijo.IJO_1126_19; Gershoni A, 2019, INT OPHTHALMOL, V39, P753, DOI 10.1007/s10792-018-0868-4; Hashemi Hassan, 2004, BMC Ophthalmol, V4, P12, DOI 10.1186/1471-2415-4-12; Jiang JJ, 2020, INT OPHTHALMOL, V40, P1419, DOI 10.1007/s10792-020-01308-5; Loewenstein A, 1997, J CATARACT REFR SURG, V23, P1174, DOI 10.1016/S0886-3350(97)80311-2; Luger MHA, 2012, J CATARACT REFR SURG, V38, P1414, DOI 10.1016/j.jcrs.2012.03.028; Majmuder PA, 2000, OPHTHALMOLOGY, V107, P89, DOI 10.1016/S0161-6420(99)00019-6; Margo Jordan A, 2016, Int Ophthalmol Clin, V56, P111, DOI 10.1097/IIO.0000000000000112; Melki SA, LASIK COMPLICATIONS, P22; Mounir A, 2020, INT J OPHTHALMOL-CHI, V13, P129, DOI 10.18240/ijo.2020.01.19; MUNNERLYN CR, 1988, J CATARACT REFR SURG, V14, P46, DOI 10.1016/S0886-3350(88)80063-4; Murueta-Goyena A, 2018, J OPTOM, V11, P121, DOI 10.1016/j.optom.2017.09.002; Na KS, 2012, INVEST OPHTH VIS SCI, V53, P7116, DOI 10.1167/iovs.12-9826; Naderi Mostafa, 2016, J Ophthalmic Vis Res, V11, P358; Nassiri N, 2008, J CATARACT REFR SURG, V34, P902, DOI 10.1016/j.jcrs.2008.03.007; Netto MV, 2006, J REFRACT SURG, V22, P562; Randleman JB, 2003, OPHTHALMOLOGY, V110, P267, DOI 10.1016/S0161-6420(02)01727-X; Shortt AJ, 2006, OPHTHALMOLOGY, V113, P1897, DOI 10.1016/j.ophtha.2006.08.013; Spadea L, 2019, CLIN OPHTHALMOL, V13, P2305, DOI 10.2147/OPTH.S233125; Stein HA, 1999, J REFRACT SURG, V15, pS232; Wang DM, 2012, INT J OPHTHALMOL-CHI, V5, P334, DOI 10.3980/j.issn.2222-3959.2012.03.16; Wen DZ, 2018, J REFRACT SURG, V34, P726, DOI 10.3928/1081597X-20180905-01; Wolle MA., 2016, COMPLICATIONS REFRAC, V13; Xi L, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0888-x; Zhang JF, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01515-9	40	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0259993	10.1371/journal.pone.0259993	http://dx.doi.org/10.1371/journal.pone.0259993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874947	gold, Green Published			2022-12-26	WOS:000753617500013
J	Alhayyani, S; McLeod, L; West, AC; Balic, JJ; Hodges, C; Yu, L; Smith, JA; Prodanovic, Z; Bozinovski, S; Kumar, B; Ruwanpura, SM; Saad, MI; Jenkins, BJ				Alhayyani, Sultan; McLeod, Louise; West, Alison C.; Balic, Jesse J.; Hodges, Christopher; Yu, Liang; Smith, Julian A.; Prodanovic, Zdenka; Bozinovski, Steven; Kumar, Beena; Ruwanpura, Saleela M.; Saad, Mohamed I.; Jenkins, Brendan J.			Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer	ONCOGENE			English	Article							K-RAS MUTATIONS; MITOCHONDRIAL STAT3; SIGNAL TRANSDUCER; EPITHELIAL-CELLS; ACTIVATION; EXPRESSION; MYC; TRANSCRIPTION; RECEPTOR; TYROSINE	The oncogenic potential of the latent transcription factor signal transducer and activator of transcription (STAT)3 in many human cancers, including lung cancer, has been largely attributed to its nuclear activity as a tyrosine-phosphorylated (pY(705) site) transcription factor. By contrast, an alternate mitochondrial pool of serine phosphorylated (pS(727) site) STAT3 has been shown to promote tumourigenesis by regulating metabolic processes, although this has been reported in only a restricted number of mutant RAS-addicted neoplasms. Therefore, the involvement of STAT3 serine phosphorylation in the pathogenesis of most cancer types, including mutant KRAS lung adenocarcinoma (LAC), is unknown. Here, we demonstrate that LAC is suppressed in oncogenic Kras(G12D)-driven mouse models engineered for pS(727)-STAT3 deficiency. The proliferative potential of the transformed Kras(G12D) lung epithelium, and mutant KRAS human LAC cells, was significantly reduced upon pS(727)-STAT3 deficiency. Notably, we uncover the multifaceted capacity of constitutive pS(727)-STAT3 to metabolically reprogramme LAC cells towards a hyper-proliferative state by regulating nuclear and mitochondrial (mt) gene transcription, the latter via the mtDNA transcription factor, TFAM. Collectively, our findings reveal an obligate requirement for the transcriptional activity of pS(727)-STAT3 in mutant KRAS-driven LAC with potential to guide future therapeutic targeting approaches.	[Alhayyani, Sultan; McLeod, Louise; West, Alison C.; Balic, Jesse J.; Hodges, Christopher; Yu, Liang; Ruwanpura, Saleela M.; Saad, Mohamed I.; Jenkins, Brendan J.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia; [Alhayyani, Sultan; McLeod, Louise; West, Alison C.; Balic, Jesse J.; Hodges, Christopher; Yu, Liang; Ruwanpura, Saleela M.; Saad, Mohamed I.; Jenkins, Brendan J.] Monash Univ, Sch Clin Sci, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia; [Alhayyani, Sultan] King Abdulaziz Univ, Coll Arts & Sci, Dept Chem, Rabigh, Saudi Arabia; [Smith, Julian A.] Monash Univ, Sch Clin Sci, Dept Surg, Monash Hlth, Clayton, Vic 3168, Australia; [Smith, Julian A.] Monash Hlth, Dept Cardiothorac Surg, Clayton, Vic 3168, Australia; [Prodanovic, Zdenka] Monash Hlth, Monash Biobank, Clayton, Vic 3168, Australia; [Bozinovski, Steven] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic 3082, Australia; [Kumar, Beena] Monash Hlth, Dept Anat Pathol, Clayton, Vic 3168, Australia	Hudson Institute of Medical Research; Monash University; King Abdulaziz University; Monash University; Royal Melbourne Institute of Technology (RMIT)	Jenkins, BJ (corresponding author), Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia.; Jenkins, BJ (corresponding author), Monash Univ, Sch Clin Sci, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia.	brendan.jenkins@hudson.org.au	Alhayyani/AAR-7025-2020	Saad, Mohamed I./0000-0002-4855-2360; Bozinovski, Steven/0000-0001-6533-8641; McLeod, Louise/0000-0002-7595-6432	National Health and Medical Research Council (NHMRC) of Australia; Cancer Council Victoria Postdoctoral Fellowship by the Victorian Government of Australia; Department of Chemistry, College of Sciences and Arts, King Abdulaziz University, Rabigh, Saudi Arabia; NHMRC Senior Medical Research Fellowship; Cancer Council Victoria Postdoctoral Fellowship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria Postdoctoral Fellowship by the Victorian Government of Australia; Department of Chemistry, College of Sciences and Arts, King Abdulaziz University, Rabigh, Saudi Arabia; NHMRC Senior Medical Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	We are deeply grateful to D. Gough and S. Fernando (Hudson Institute of Medical Research, Melbourne, Australia) for expert technical assistance and proofreading of the manuscript, as well as A. Vais (Monash Histology Platform, Melbourne, Australia) for immunofluorescence expertise. This work was supported by a research grant awarded by the National Health and Medical Research Council (NHMRC) of Australia to BJJ, as well as the Operational Infrastructure Support Programme by the Victorian Government of Australia. MIS is supported by a Cancer Council Victoria Postdoctoral Fellowship. SA was sponsored by the Department of Chemistry, College of Sciences and Arts, King Abdulaziz University, Rabigh, Saudi Arabia. BJJ is supported by a NHMRC Senior Medical Research Fellowship.	Ahrendt SA, 2001, CANCER, V92, P1525, DOI 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H; Balic JJ, 2019, CANCER RES, V79, P5272, DOI 10.1158/0008-5472.CAN-19-0974; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Brooks GD, 2016, CANCER RES, V76, P866, DOI 10.1158/0008-5472.CAN-15-2388; Caetano MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07042-y; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; D'Amico S, 2018, GENE DEV, V32, P1175, DOI 10.1101/gad.311852.118; Dragoj M, 2015, TUMOR BIOL, V36, P8773, DOI 10.1007/s13277-015-3620-y; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Dutta P, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6649-2; Garama DJ, 2016, CYTOKINE, V87, P20, DOI 10.1016/j.cyto.2016.05.019; Garassino MC, 2011, ANN ONCOL, V22, P235, DOI 10.1093/annonc/mdq680; Gough DJ, 2014, BLOOD, V124, P2252, DOI 10.1182/blood-2013-02-484196; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Grabner B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7285; Han YH, 2008, ONCOL REP, V20, P689, DOI 10.3892/or_00000061; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirahara K, 2015, IMMUNITY, V42, P877, DOI 10.1016/j.immuni.2015.04.014; Hirsch FR, 2017, LANCET, V389, P299, DOI 10.1016/S0140-6736(16)30958-8; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Janes MR, 2018, CELL, V172, P578, DOI 10.1016/j.cell.2018.01.006; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jones SA, 2018, NAT REV IMMUNOL, V18, P773, DOI 10.1038/s41577-018-0066-7; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim HS, 2010, CANCER-AM CANCER SOC, V116, P676, DOI 10.1002/cncr.24748; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li Y, 2007, CANCER RES, V67, P8494, DOI 10.1158/0008-5472.CAN-07-0647; Liou GY, 2016, CELL REP, V14, P2325, DOI 10.1016/j.celrep.2016.02.029; Liu YD, 2019, INT J CANCER, V144, P3056, DOI 10.1002/ijc.32060; Macias E, 2014, J INVEST DERMATOL, V134, P1971, DOI 10.1038/jid.2014.68; Mao YQ, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00058; Marson VJ, 2004, HISTOPATHOLOGY, V45, P125, DOI 10.1111/j.1365-2559.2004.01893.x; McClelland MR, 2007, AM J RESP CELL MOL, V36, P343, DOI 10.1165/rcmb.2006-0311OC; Meissl K, 2017, CYTOKINE, V89, P12, DOI 10.1016/j.cyto.2015.11.011; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nagao A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020238; Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177; Noonan KL, 2015, J THORAC ONCOL, V10, P1523, DOI 10.1097/JTO.0000000000000667; Oft M, 2014, CANCER IMMUNOL RES, V2, P194, DOI 10.1158/2326-6066.CIR-13-0214; Poli V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00121; Roman M, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0789-x; Ruwanpura SM, 2011, AM J RESP CELL MOL, V45, P720, DOI 10.1165/rcmb.2010-0462OC; Saad MI, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809976; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Shen YH, 2004, MOL CELL BIOL, V24, P407, DOI 10.1128/MCB.24.1.407-419.2004; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tong MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182282; Tran PT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002125; Walser Tonya, 2008, Proc Am Thorac Soc, V5, P811, DOI 10.1513/pats.200809-100TH; Wang XC, 2016, ONCOTARGETS THER, V9, P5461, DOI 10.2147/OTT.S94745; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Weng MT, 2013, PROTEIN CELL, V4, P807, DOI 10.1007/s13238-013-3056-3; WESTRA WH, 1993, CANCER-AM CANCER SOC, V72, P432, DOI 10.1002/1097-0142(19930715)72:2<432::AID-CNCR2820720219>3.0.CO;2-#; Wong MCS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14513-7; Yang Q, 2012, EXP MOL PATHOL, V93, P227, DOI 10.1016/j.yexmp.2012.04.009; Yu CH, 2015, AM J PHYSIOL-GASTR L, V309, pG146, DOI 10.1152/ajpgi.00462.2014; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yu L, 2018, CLIN CANCER RES, V24, P1459, DOI 10.1158/1078-0432.CCR-17-2485; Zhou J, 2015, ONCOGENE, V34, P3804, DOI 10.1038/onc.2014.318; Zhu SG, 2014, BLOOD, V124, P403, DOI 10.1182/blood-2013-05-499707; Zhu ZH, 2014, CANCER DISCOV, V4, P452, DOI 10.1158/2159-8290.CD-13-0646; Zouein FA, 2013, HYPERTENS RES, V36, P496, DOI 10.1038/hr.2012.223	71	2	2	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2022	41	6					809	823		10.1038/s41388-021-02134-4	http://dx.doi.org/10.1038/s41388-021-02134-4		DEC 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YT5VS	34857889				2022-12-26	WOS:000725388800002
J	Tran, VQ; Mai, HVT; Nguyen, TA; Ly, HB				Tran, Van Quan; Mai, Hai-Van Thi; Nguyen, Thuy-Anh; Ly, Hai-Bang			Investigation of ANN architecture for predicting the compressive strength of concrete containing GGBFS	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; BLAST-FURNACE SLAG; SHEAR-STRENGTH; SILICA FUME; BEHAVIOR	An extensive simulation program is used in this study to discover the best ANN model for predicting the compressive strength of concrete containing Ground Granulated Blast Furnace Slag (GGBFS). To accomplish this purpose, an experimental database of 595 samples is compiled from the literature and utilized to find the best ANN architecture. The cement content, water content, coarse aggregate content, fine aggregate content, GGBFS content, carboxylic type hyper plasticizing content, superplasticizer content, and testing age are the eight inputs in this database. As a result, the optimal selection of the ANN design is carried out and evaluated using conventional statistical metrics. The results demonstrate that utilizing the best architecture [8-14-4-1] among the 240 investigated architectures, and the best ANN model, is a very efficient predictor of the compressive strength of concrete using GGBFS, with a maximum R-2 value of 0.968 on the training part and 0.965 on the testing part. Furthermore, a sensitivity analysis is performed over 500 Monte Carlo simulations using the best ANN model to determine the reliability of ANN model in predicting the compressive strength of concrete. The findings of this research may make it easier and more efficient to apply the ANN model to many civil engineering challenges.	[Tran, Van Quan; Mai, Hai-Van Thi; Nguyen, Thuy-Anh; Ly, Hai-Bang] Univ Transport Technol, Hanoi, Vietnam		Tran, VQ (corresponding author), Univ Transport Technol, Hanoi, Vietnam.	quantv@utt.edu.vn		Tran, Van Quan/0000-0002-4157-7717				Abdalla JA, 2011, MOD SIM APPL OPT ICM, P1, DOI [10.1109/ICMSAO.2011.5775518, DOI 10.1109/ICMSAO.2011.5775518]; Abdalla JA, 2015, ENVIRON EARTH SCI, V73, P5463, DOI 10.1007/s12665-014-3800-x; Abdul-Razzak AA, 2011, APPL MATH MODEL, V35, P2901, DOI 10.1016/j.apm.2010.11.073; Abuodeh O, 2019, 2019 8 INT C MOD SIM, DOI DOI 10.1109/ICMSAO.2019.8880284; Adeli H, 2001, COMPUT-AIDED CIV INF, V16, P126, DOI 10.1111/0885-9507.00219; Ahmadi M, 2014, ARCH CIV MECH ENG, V14, P510, DOI 10.1016/j.acme.2014.01.006; Asteris PG, 2020, NEURAL COMPUT APPL, V32, P11807, DOI 10.1007/s00521-019-04663-2; Asteris PG, 2019, COMPUT CONCRETE, V24, P469, DOI 10.12989/cac.2019.24.5.469; Avila C, 2004, NEUREL 2004: SEVENTH SEMINAR ON NEURAL NETWORK APPLICATIONS IN ELECTRICAL ENGINEERING, PROCEEDINGS, P39; Bilim C, 2009, ADV ENG SOFTW, V40, P334, DOI 10.1016/j.advengsoft.2008.05.005; BISCHOFF PH, 1991, MATER STRUCT, V24, P425, DOI 10.1007/BF02472016; Boga AR, 2013, COMPOS PART B-ENG, V45, P688, DOI 10.1016/j.compositesb.2012.05.054; Boukhatem B, 2011, ACI MATER J, V108, P55; Cachim PB, 2011, CONSTR BUILD MATER, V25, P4175, DOI 10.1016/j.conbuildmat.2011.04.054; Chidiac SE, 2008, CEMENT CONCRETE COMP, V30, P63, DOI 10.1016/j.cemconcomp.2007.09.003; Chopra P, 2018, ADV CIV ENG, V2018, DOI 10.1155/2018/5481705; Chopra P, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/7648467; de Larrard F, 2002, CEMENT CONCRETE RES, V32, P1699, DOI 10.1016/S0008-8846(02)00861-X; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Garcez MR, 2018, J CLEAN PROD, V172, P27, DOI 10.1016/j.jclepro.2017.10.153; Goldstein A, 2015, J COMPUT GRAPH STAT, V24, P44, DOI 10.1080/10618600.2014.907095; HAGAN MT, 1994, IEEE T NEURAL NETWOR, V5, P989, DOI 10.1109/72.329697; Ly HB, 2021, CONSTR BUILD MATER, V301, DOI 10.1016/j.conbuildmat.2021.124081; Ly HB, 2021, NEURAL COMPUT APPL, V33, P3437, DOI 10.1007/s00521-020-05214-w; Ly HB, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12072709; Ly HB, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9183841; Han IJ, 2019, MATERIALS, V12, DOI 10.3390/ma12223708; HOLYOAK KJ, 1987, SCIENCE, V236, P992, DOI 10.1126/science.236.4804.992; HSU KL, 1995, WATER RESOUR RES, V31, P2517, DOI 10.1029/95WR01955; Jiang GM, 2016, WATER RES, V92, P52, DOI 10.1016/j.watres.2016.01.029; Jurman G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041882; Kandiri A, 2020, CONSTR BUILD MATER, V248, DOI 10.1016/j.conbuildmat.2020.118676; Khademi Faezehossadat, 2016, International Journal of Sustainable Built Environment, V5, P355, DOI 10.1016/j.ijsbe.2016.09.003; Li J, 2016, J STRUCT ENG, V142, DOI 10.1061/(ASCE)ST.1943-541X.0001442; Ly HB, 2021, ADV CIV ENG, V2021, DOI 10.1155/2021/8873993; Ly HB, 2021, NEURAL COMPUT APPL, V33, P17331, DOI 10.1007/s00521-021-06321-y; Mansour MY, 2004, ENG STRUCT, V26, P781, DOI 10.1016/j.engstruct.2004.01.011; Mazloom M, 2018, ADV MATER RES-KR, V7, P407, DOI 10.12989/amr.2018.7.1.407; Menard S, 2000, AM STAT, V54, P17, DOI 10.2307/2685605; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; Naderpour H, 2018, MEASUREMENT, V126, P299, DOI 10.1016/j.measurement.2018.05.051; Nagendra S., 1998, PRACTICAL ASPECTS US; Neville A.M., 2013, PROPERTIES CONCRETE; Nguyen T.-A, 2021, COMPLEXITY, V2021; Nguyen TA, 2020, ADV MATER SCI ENG, V2020, DOI 10.1155/2020/9682740; Ozcan F, 2009, ADV ENG SOFTW, V40, P856, DOI 10.1016/j.advengsoft.2009.01.005; Oner A, 2007, CEMENT CONCRETE COMP, V29, P505, DOI 10.1016/j.cemconcomp.2007.01.001; Paola J.D, 1994, NEURAL NETWORK CLASS; Perera R, 2010, COMPOS PART B-ENG, V41, P287, DOI 10.1016/j.compositesb.2010.03.003; Pitroda J, 2015, INT J ADV RES ENG SC, P1; POPOVICS S, 1990, ACI MATER J, V87, P517; Prasad BKR, 2009, CONSTR BUILD MATER, V23, P117, DOI 10.1016/j.conbuildmat.2008.01.014; Rabczuk T, 2005, INT J SOLIDS STRUCT, V42, P1327, DOI 10.1016/j.ijsolstr.2004.07.019; Ripley B. D., 1993, NETWORKS CHAOS STAT, P40, DOI DOI 10.1007/978-1-4899-3099-6_2; Saridemir M, 2009, CONSTR BUILD MATER, V23, P1279, DOI 10.1016/j.conbuildmat.2008.07.021; Shariq M, 2010, CONSTR BUILD MATER, V24, P1469, DOI 10.1016/j.conbuildmat.2010.01.007; Sheela KG, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/425740; Shen JR, 2019, CONSTR BUILD MATER, V195, P19, DOI 10.1016/j.conbuildmat.2018.11.046; Nguyen TA, 2020, MATH PROBL ENG, V2020, DOI 10.1155/2020/8845768; Topcu IB, 2008, COMP MATER SCI, V41, P305, DOI 10.1016/j.commatsci.2007.04.009; Tsiskreli G., 1970, HYDROTECH CONSTRUCT, V4, P448; Tumidajski PJ, 2006, CAN J CIVIL ENG, V33, P206, DOI [10.1139/l05-090, 10.1139/L05-090]; Wang C., 1994, THEORY GEN LEARNING; Yeh IC, 1998, CEMENT CONCRETE RES, V28, P1797, DOI 10.1016/S0008-8846(98)00165-3; Zhou JK, 2011, SADHANA-ACAD P ENG S, V36, P357, DOI 10.1007/s12046-011-0024-6	65	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0260847	10.1371/journal.pone.0260847	http://dx.doi.org/10.1371/journal.pone.0260847			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY3JJ	34860842	Green Published, gold			2022-12-26	WOS:000754686900008
J	Al Suman, A; Russo, C; Carrigan, A; Nalepka, P; Liquet-Weiland, B; Newport, RA; Kumari, P; Di Ieva, A				Al Suman, Abdulla; Russo, Carlo; Carrigan, Ann; Nalepka, Patrick; Liquet-Weiland, Benoit; Newport, Robert Ahadizad; Kumari, Poonam; Di Ieva, Antonio			Spatial and time domain analysis of eye-tracking data during screening of brain magnetic resonance images	PLOS ONE			English	Article							PERCEPTION; EXPERTISE; RADIOLOGY; FRACTALS; PATTERN; ERRORS	Introduction Eye-tracking research has been widely used in radiology applications. Prior studies exclusively analysed either temporal or spatial eye-tracking features, both of which alone do not completely characterise the spatiotemporal dynamics of radiologists' gaze features. Purpose Our research aims to quantify human visual search dynamics in both domains during brain stimuli screening to explore the relationship between reader characteristics and stimuli complexity. The methodology can be used to discover strategies to aid trainee radiologists in identifying pathology, and to select regions of interest for machine vision applications. Method The study was performed using eye-tracking data 5 seconds in duration from 57 readers (15 Brain-experts, 11 Other-experts, 5 Registrars and 26 Naives) for 40 neuroradiological images as stimuli (i.e., 20 normal and 20 pathological brain MRIs). The visual scanning patterns were analysed by calculating the fractal dimension (FD) and Hurst exponent (HE) using re-scaled range (R/S) and detrended fluctuation analysis (DFA) methods. The FD was used to measure the spatial geometrical complexity of the gaze patterns, and the HE analysis was used to measure participants' focusing skill. The focusing skill is referred to persistence/anti-persistence of the participants' gaze on the stimulus over time. Pathological and normal stimuli were analysed separately both at the "First Second" and full "Five Seconds" viewing duration. Results All experts were more focused and a had higher visual search complexity compared to Registrars and Naives. This was seen in both the pathological and normal stimuli in the first and five second analyses. The Brain-experts subgroup was shown to achieve better focusing skill than Other-experts due to their domain specific expertise. Indeed, the FDs found when viewing pathological stimuli were higher than those in normal ones. Viewing normal stimuli resulted in an increase of FD found in five second data, unlike pathological stimuli, which did not change. In contrast to the FDs, the scanpath HEs of pathological and normal stimuli were similar. However, participants' gaze was more focused for "Five Seconds" than "First Second" data. Conclusions The HE analysis of the scanpaths belonging to all experts showed that they have greater focus than Registrars and Naives. This may be related to their higher visual search complexity than non-experts due to their training and expertise.	[Al Suman, Abdulla; Russo, Carlo; Newport, Robert Ahadizad; Kumari, Poonam; Di Ieva, Antonio] Macquarie Univ, Computat NeuroSurg CNS Lab, Fac Med Hlth & Human Sci, Sydney, NSW, Australia; [Carrigan, Ann; Nalepka, Patrick] Macquarie Univ, Fac Med Hlth & Human Sci, Sch Psychol Sci, Sydney, NSW, Australia; [Carrigan, Ann; Nalepka, Patrick; Di Ieva, Antonio] Macquarie Univ, Ctr Elite Performance Expertise & Training, Sydney, NSW, Australia; [Liquet-Weiland, Benoit] Macquarie Univ, Fac Sci & Engn, Dept Math & Stat, Sydney, NSW, Australia	Macquarie University; Macquarie University; Macquarie University; Macquarie University	Di Ieva, A (corresponding author), Macquarie Univ, Computat NeuroSurg CNS Lab, Fac Med Hlth & Human Sci, Sydney, NSW, Australia.; Di Ieva, A (corresponding author), Macquarie Univ, Ctr Elite Performance Expertise & Training, Sydney, NSW, Australia.	antonio.diieva@mq.edu.au		liquet, benoit/0000-0002-8136-2294; Suman, Abdulla Al/0000-0002-6876-482X; Newport, Robert Ahadizad/0000-0002-1395-4415; Carrigan, Ann/0000-0002-2525-9241; Di Ieva, Antonio/0000-0002-5341-5416; Russo, Carlo/0000-0001-8296-4345; Kumari, Poonam/0000-0001-8582-3636; Nalepka, Patrick/0000-0003-1719-8044	Centre for Elite Performance, Expertise & Training (Macquarie University, Sydney) [080619]; Australian Research Council (ARC) [FT190100623]	Centre for Elite Performance, Expertise & Training (Macquarie University, Sydney); Australian Research Council (ARC)(Australian Research Council)	This work was funded by the Centre for Elite Performance, Expertise & Training (Macquarie University, Sydney) Seeding Grant awarded to Dr Patrick Nalepka, Dr Ann Carrigan, & Prof. Antonio Di Ieva in 2019 (080619) and by an Australian Research Council (ARC) Future Fellowship granted to Prof. Antonio Di Ieva in 2019 (FT190100623). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamudun F, 2017, MED PHYS, V44, P832, DOI 10.1002/mp.12100; Amor TA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20815; Berlin L, 2005, AM J ROENTGENOL, V185, P1416, DOI 10.2214/AJR.05.0838; Brennan PC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26100-5; Carrigan AJ, 2021, HUM FACTORS, V63, P635, DOI 10.1177/0018720820902576; Carrigan AJ, 2018, COGN RES, V3, DOI 10.1186/s41235-018-0096-5; Cavaro-Menard C, 2010, PROC SPIE, V7627, DOI 10.1117/12.844505; Cross SS, 1997, J PATHOL, V182, P1; Crowe EM, 2018, COGN RES, V3, DOI 10.1186/s41235-018-0097-4; Di Ieva A, 2008, NEUROQUANTOLOGY, V6, P182; Di Ieva A, 2016, SPR SER COMPUT NEURO, P3, DOI 10.1007/978-1-4939-3995-4_1; Di Ieva A, 2015, NEUROSCIENTIST, V21, P30, DOI 10.1177/1073858413513928; Di Ieva A, 2014, NEUROSCIENTIST, V20, P403, DOI 10.1177/1073858413513927; Feder J, 1988, FRACTALS; Gandomkar Z, 2018, MED PHYS, V45, P4844, DOI 10.1002/mp.13161; Ganesan Karthikeyan, 2013, IEEE Rev Biomed Eng, V6, P77, DOI 10.1109/RBME.2012.2232289; Graber ML, 2012, BMJ QUAL SAF, V21, P535, DOI 10.1136/bmjqs-2011-000149; Hardstone R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00450; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Kapoula Z, 2010, LEONARDO, V43, P153, DOI 10.1162/leon.2010.43.2.153; Kelly BS, 2016, RADIOLOGY, V280, P252, DOI 10.1148/radiol.2016150409; Kok EM, 2016, ADV HEALTH SCI EDUC, V21, P189, DOI 10.1007/s10459-015-9624-y; Krupinski EA, 1996, P SOC PHOTO-OPT INS, V2712, P95, DOI 10.1117/12.236845; Kundel HL, 2008, ACAD RADIOL, V15, P881, DOI 10.1016/j.acra.2008.01.023; Kundel HL, 2007, RADIOLOGY, V242, P396, DOI 10.1148/radiol.2422051997; Kundel HL, 2007, PROC SPIE, V6515, DOI 10.1117/12.718061; KUNDEL HL, 1978, INVEST RADIOL, V13, P175, DOI 10.1097/00004424-197805000-00001; MANDELBROT BB, 1984, NATURE, V308, P721, DOI 10.1038/308721a0; Manning DJ, 2004, BRIT J RADIOL, V77, P231, DOI 10.1259/bjr/28883951; Matsumoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028928; Milosevic NT, 2013, I C CONTR SYS COMP S, P299, DOI 10.1109/CSCS.2013.52; Reingold EM, 2011, OXFORD HDB EYE MOVEM, P528, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0029; Stan C, 2014, J NEUROSCI METH, V232, P102, DOI 10.1016/j.jneumeth.2014.05.010; Voisin S, 2013, MED PHYS, V40, DOI 10.1118/1.4820536; Williams L, 2021, PSYCHON B REV, V28, P503, DOI 10.3758/s13423-020-01826-4; Wood G, 2013, SKELETAL RADIOL, V42, P165, DOI 10.1007/s00256-012-1503-5; Zhang J, 2014, MED PHYS, V41, DOI 10.1118/1.4892173	37	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260717	10.1371/journal.pone.0260717	http://dx.doi.org/10.1371/journal.pone.0260717			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855867	gold, Green Published			2022-12-26	WOS:000735299000101
J	Liu, HT; Yang, CH; Lee, HL; Chang, PC; Wo, HT; Wen, MS; Wang, CC; Yeh, SJ; Chou, CC				Liu, Hao-Tien; Yang, Chia-Hung; Lee, Hui-Ling; Chang, Po-Cheng; Wo, Hung-Ta; Wen, Ming-Shien; Wang, Chun-Chieh; Yeh, San-Jou; Chou, Chung-Chuan			Clinical Outcomes of low-voltage area-guided left atrial linear ablation for non-paroxysmal atrial fibrillation patients	PLOS ONE			English	Article							CATHETER ABLATION	Background The therapeutic effect of low-voltage area (LVA)-guided left atrial (LA) linear ablation for non-paroxysmal atrial fibrillation (non-PAF) is uncertain. We aimed to investigate the efficacy of LA linear ablation based on the preexisting LVA and its effects on LA reverse remodeling in non-PAF patients. Methods We retrospectively evaluated 145 consecutive patients who underwent radiofrequency catheter ablation for drug-refractory non-PAF. CARTO-guided bipolar voltage mapping was performed in atrial fibrillation (AF). LVA was defined as sites with voltage <= 0.5 mV. If circumferential pulmonary vein isolation couldn't convert AF into sinus rhythm, additional LA linear ablation was performed preferentially at sites within LVA. Results After a mean follow-up duration of 48 33 months, 29 of 145 patients had drugs-refractory AF/LA tachycardia recurrence. Low LA emptying fraction, large LA size and high extent of LVA were associated with AF recurrence. There were 136 patients undergoing LA linear ablation. The rate of linear block at the mitral isthmus was significantly higher via LVA-guided than non-LVA-guided linear ablation. Patients undergoing LVA-guided linear ablation had larger LA size and higher extent of LVA, but the long-term AF/LA tachycardia-free survival rate was higher than the non-LVA-guided group. The LA reverse remodeling effects by resuming sinus rhythm were noted even in patients with a diseased left atrium undergoing extensive LA linear ablation. Conclusions LVA-guided linear ablation through targeting the arrhythmogenic LVA and reducing LA mass provides a better clinical outcome than non-LVA guided linear ablation, and outweighs the harmful effects of iatrogenic scaring in non-PAF patients.	[Liu, Hao-Tien; Yang, Chia-Hung; Chang, Po-Cheng; Wo, Hung-Ta; Wen, Ming-Shien; Chou, Chung-Chuan] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Linkou Branch, Taoyuan, Taiwan; [Lee, Hui-Ling; Wang, Chun-Chieh; Yeh, San-Jou] Chang Gung Mem Hosp, Dept Anesthesia, Taipei Branch, Taipei, Taiwan; [Wen, Ming-Shien; Chou, Chung-Chuan] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chou, CC (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Linkou Branch, Taoyuan, Taiwan.; Chou, CC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	2867@cgmh.org.tw		Liu, Hao-Tien/0000-0003-0546-4181; Chou, Chung-Chuan/0000-0003-4465-0016				Blandino A, 2017, PACE, V40, P199, DOI 10.1111/pace.13015; Brooks AG, 2010, HEART RHYTHM, V7, P835, DOI 10.1016/j.hrthm.2010.01.017; Calkins H, 2018, EUROPACE, V20, P157, DOI [10.1093/europace/eux275, 10.1016/j.hrthm.2017.05.012, 10.1093/europace/eux274]; Chou CC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191196; Cutler MJ, 2016, J CARDIOVASC ELECTR, V27, P13, DOI 10.1111/jce.12830; den Uijl DW, 2018, J CARDIOVASC ELECTR, V29, P740, DOI 10.1111/jce.13482; Efremidis M, 2019, J CARDIOVASC ELECTR, V30, P47, DOI 10.1111/jce.13763; Fassini G, 2005, J CARDIOVASC ELECTR, V16, P1150, DOI 10.1111/j.1540-8167.2005.50192.x; Habibi M, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002769; Hwang YT, 2021, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.605642; Jadidi A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65564-2; Jadidi AS, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.002962; Jais P, 2004, CIRCULATION, V110, P2996, DOI 10.1161/01.CIR.0000146917.75041.58; Jeevanantham V, 2010, AM J CARDIOL, V105, P1317, DOI 10.1016/j.amjcard.2009.12.046; Kircher S, 2018, EUROPACE, V20, P1766, DOI 10.1093/europace/eux310; Knecht S, 2008, EUR HEART J, V29, P2359, DOI 10.1093/eurheartj/ehn302; Kottkamp H, 2016, J CARDIOVASC ELECTR, V27, P22, DOI 10.1111/jce.12870; Machino-Ohtsuka T, 2013, CIRC J, V77, P1695, DOI 10.1253/circj.CJ-12-1518; Mandapati R, 2000, CIRCULATION, V101, P194, DOI 10.1161/01.CIR.101.2.194; Masuda M, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.015927; Packer M, 2019, EUR HEART J, V40, P1873, DOI 10.1093/eurheartj/ehz284; Pak HN, 2011, HEART RHYTHM, V8, P199, DOI 10.1016/j.hrthm.2010.10.015; Qureshi NA, 2019, HEART RHYTHM, V16, P1357, DOI 10.1016/j.hrthm.2019.05.032; Rodriguez-Manero M, 2018, JACC-CLIN ELECTROPHY, V4, P1541, DOI 10.1016/j.jacep.2018.08.015; Rolf S, 2014, CIRC-ARRHYTHMIA ELEC, V7, P825, DOI 10.1161/CIRCEP.113.001251; Takahashi Y, 2007, J AM COLL CARDIOL, V49, P1306, DOI 10.1016/j.jacc.2006.11.033; Verma A, 2005, J AM COLL CARDIOL, V45, P285, DOI 10.1016/j.jacc.2004.10.035; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Vlachos K, 2017, J CARDIOVASC ELECTR, V28, P1393, DOI 10.1111/jce.13321; Willems S, 2006, EUR HEART J, V27, P2871, DOI 10.1093/eurheartj/ehl093; Wittkampf FHM, 2005, EUR HEART J, V26, P689, DOI 10.1093/eurheartj/ehi095; Yamaguchi T, 2016, J CARDIOVASC ELECTR, V27, P1055, DOI 10.1111/jce.13019	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260834	10.1371/journal.pone.0260834	http://dx.doi.org/10.1371/journal.pone.0260834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855901	Green Published, gold			2022-12-26	WOS:000735299000133
J	Nishida, A; Nakagawa, M; Yamamura, M				Nishida, Akifumi; Nakagawa, Mayuko; Yamamura, Masayuki			Determinism of microbial community assembly by drastic environmental change	PLOS ONE			English	Article							GROWTH; CONTINGENCY; DIVERSITY; IMPACT; URBAN	Microbial community assembly is shaped by deterministic and stochastic processes, but the relationship between these processes and the environment is not understood. Here we describe a rule for the determinism and stochasticity of microbial community assembly affected by the environment using in silico, in situ, and ex situ experiments. The in silico experiment with a simple mathematical model showed that the existence of essential symbiotic microorganisms caused stochastic microbial community assembly, unless the community was exposed to a non-adapted nutritional concentration. Then, a deterministic assembly occurred due to the low number of microorganisms adapted to the environment. In the in situ experiment in the middle of a river, the microbial community composition was relatively deterministic after the drastic environmental change caused by the treated wastewater contamination, as analyzed by 16S rRNA gene sequencing. Furthermore, by culturing microbial communities collected from the upstream natural area and downstream urban area of the river in test tubes with varying carbon source concentrations, the upstream community assembly became deterministic with high carbon concentrations while the downstream community assembly became deterministic with low carbon concentrations. These results suggest that large environmental changes, which are different from the original environment, result in a deterministic microbial community assembly.	[Nishida, Akifumi] Waseda Univ, Dept Elect Engn & Biosci, Tokyo, Japan; [Nishida, Akifumi; Yamamura, Masayuki] Tokyo Inst Technol, Sch Comp, Ookayama, Kanagawa, Japan; [Nakagawa, Mayuko] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo, Japan	Waseda University; Tokyo Institute of Technology; Tokyo Institute of Technology	Nishida, A (corresponding author), Waseda Univ, Dept Elect Engn & Biosci, Tokyo, Japan.; Nishida, A (corresponding author), Tokyo Inst Technol, Sch Comp, Ookayama, Kanagawa, Japan.	nishida.a.aa@aoni.waseda.jp		Nishida, Akifumi/0000-0003-0296-6637	Nippon Life Insurance Foundation [2018-17]; Waseda University [2020C-300]; JSPS KAKENHI [JP17K14412, JP17H0615]; Tokyu Foundation [2018-16]	Nippon Life Insurance Foundation(Nippon Life Insurance Foundation); Waseda University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokyu Foundation	AN was supported by Nippon Life Insurance Foundation (2018-17, http://www.nihonseimei-zaidan.or.jp/kankyo/02.html) and Waseda University (2020C-300, https://www.waseda.jp/top/en/).MN was supported by JSPS KAKENHI grants (JP17K14412 and JP17H0615, https://www.jsps.go.jp/english/e-grants/).MY was supported by Tokyu Foundation (2018-16, https://foundation.tokyu.co.jp/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; BAGLEY ST, 1985, INFECT CONT HOSP EP, V6, P52, DOI 10.1017/S0195941700062603; Bisanz JE, 2019, CELL HOST MICROBE, V26, P265, DOI 10.1016/j.chom.2019.06.013; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Clifford RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048558; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Drury B, 2013, APPL ENVIRON MICROB, V79, P1897, DOI 10.1128/AEM.03527-12; Estrela S., 2020, METABOLIC RULES MICR, DOI [10.1101/2020.03.09.984278, DOI 10.1101/2020.03.09.984278]; Estrela S, 2021, ELIFE, V10, DOI 10.7554/eLife.65948; Farmer JJ, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P564, DOI 10.1007/0-387-30746-x_19; Friedman J, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0109; Goldford JE, 2018, SCIENCE, V361, P469, DOI 10.1126/science.aat1168; Hekstra DR, 2012, CELL, V149, P1164, DOI 10.1016/j.cell.2012.03.040; Higashi K, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006143; Hubbell Stephen P., 2001, V32, pi; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Jari Oksanen FGB., 2017, VEGAN COMMUNITY ECOL; Kochling T, 2017, INT MICROBIOL, V20, P11, DOI 10.2436/20.1501.01.281; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lau SKP, 2018, COMPUT STRUCT BIOTEC, V16, P54, DOI 10.1016/j.csbj.2018.02.004; Moore ERB, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P646, DOI 10.1007/0-387-30746-x_21; Morris JJ, 2008, APPL ENVIRON MICROB, V74, P4530, DOI 10.1128/AEM.02479-07; Nishida A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191650; Oliphant K, 2019, ISME J, V13, P3080, DOI 10.1038/s41396-019-0498-5; Pande S, 2017, TRENDS MICROBIOL, V25, P349, DOI 10.1016/j.tim.2017.02.015; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, R LANG ENV STAT COMP; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; Species IIO., 1968, J BACTERIOL, V95, P1520, DOI [10.1128/jb.95.5.1520-1541.1968, DOI 10.1128/JB.95.5.1520-1541.1968]; Stegen JC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11237; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; SUZUKI S, 1988, J GEN MICROBIOL, V134, P2353; de Oliveira LFV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120608; VandeWalle JL, 2012, ENVIRON MICROBIOL, V14, P2538, DOI 10.1111/j.1462-2920.2012.02757.x; Vannette RL, 2014, ECOL LETT, V17, P115, DOI 10.1111/ele.12204; Vega NM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000633; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Zelezniak A, 2015, P NATL ACAD SCI USA, V112, P6449, DOI 10.1073/pnas.1421834112; Zhou JZ, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00002-17	40	0	0	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260591	10.1371/journal.pone.0260591	http://dx.doi.org/10.1371/journal.pone.0260591			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855810	gold, Green Published			2022-12-26	WOS:000735299000073
J	Nobi, A; Tuhin, KH; Lee, JW				Nobi, Ashadun; Tuhin, Kamrul Hasan; Lee, Jae Woo			Application of principal component analysis on temporal evolution of COVID-19	PLOS ONE			English	Article								The COVID-19 is one of the worst pandemics in modern history. We applied principal component analysis (PCA) to the daily time series of the COVID-19 death cases and confirmed cases for the top 25 countries from April of 2020 to February of 2021. We calculated the eigenvalues and eigenvectors of the cross-correlation matrix of the changes in daily accumulated data over monthly time windows. The largest eigenvalue describes the overall evolution dynamics of the COVID-19 and indicates that evolution was faster in April of 2020 than in any other period. By using the first two PC coefficients, we can identify the group dynamics of the COVID-19 evolution. We observed groups under critical states in the loading plot and found that American and European countries are represented by strong clusters in the loading plot. The first PC plays an important role and the correlations (C-1) between the normalized logarithmic changes in deaths or confirmed cases and the first PCs may be used as indicators of different phases of the COVID-19. By varying C-1 over time, we identified different phases of the COVID-19 in the analyzed countries over the target time period.	[Nobi, Ashadun; Tuhin, Kamrul Hasan] Noakhali Sci & Technol Univ, Dept Comp Sci & Telecommun Engn, Sonapur, Noakhali, Bangladesh; [Lee, Jae Woo] Inha Univ, Dept Phys, Incheon, South Korea	Noakhali Science & Technology University (NSTU); Inha University	Lee, JW (corresponding author), Inha Univ, Dept Phys, Incheon, South Korea.	jaewlee@inha.ac.kr		Lee, Jae Woo/0000-0003-0622-4649	Ministry of Education of the Republic of Korea; National Research Foundation of Korea [NRF2019S1A5C2A03081234]	Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF2019S1A5C2A03081234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention, COR DIS 2019 SOC DIS; Chae SY, 2020, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.00311; Chen BQ, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-041397; Duarte P, 2021, ANN MED SURG, V66, DOI 10.1016/j.amsu.2021.102437; Fujisawa K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95698-w; James N, 2020, CHAOS, V30, DOI 10.1063/5.0013156; Kwuimy CAK, 2020, NONLINEAR DYNAM, V101, P1545, DOI 10.1007/s11071-020-05815-z; Li LX, 2020, INFECT DIS MODEL, V5, P282, DOI 10.1016/j.idm.2020.03.002; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Mahmoudi MR, 2021, RESULTS PHYS, V25, DOI 10.1016/j.rinp.2021.104071; Mahmoudi MR, 2021, ALEX ENG J, V60, P457, DOI 10.1016/j.aej.2020.09.013; Mahmoudi MR, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110230; Maleki M, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101742; Maleki M, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110151; Manchein C, 2020, CHAOS, V30, DOI 10.1063/5.0009454; Nobi A, 2017, PHYSICA A, V482, P337, DOI 10.1016/j.physa.2017.04.105; Nobi A, 2016, PHYSICA A, V450, P85, DOI 10.1016/j.physa.2015.12.144; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Rajagopal K, 2020, NONLINEAR DYNAM, V101, P711, DOI 10.1007/s11071-020-05757-6; Sharma A, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106054; World Health Organization, REP WHO CHIN JOINT M; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]; Wu YC, 2020, J CHIN MED ASSOC, V83, P217, DOI 10.1097/JCMA.0000000000000270; Ye WJ, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.570614; Zhu J, 2020, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.564061	25	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260899	10.1371/journal.pone.0260899	http://dx.doi.org/10.1371/journal.pone.0260899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855909	Green Published, gold			2022-12-26	WOS:000735299000152
J	van Zanden, JE; Leuvenink, HGD; Verschuuren, EAM; Erasmus, ME; Hottenrott, MC				van Zanden, Judith E.; Leuvenink, Henri G. D.; Verschuuren, Erik A. M.; Erasmus, Michiel E.; Hottenrott, Maximilia C.			A translational rat model for ex vivo lung perfusion of pre-injured lungs after brain death	PLOS ONE			English	Article							DONOR LUNG; GRAFT PRESERVATION; ACTIVATION; ORGANS; DAMAGE	The process of brain death (BD) detrimentally affects donor lung quality. Ex vivo lung perfusion (EVLP) is a technique originally designed to evaluate marginal donor lungs. Nowadays, its potential as a treatment platform to repair damaged donor lungs is increasingly studied in experimental models. Rat models for EVLP have been described in literature before, yet the pathophysiology of BD was not included in these protocols and prolonged perfusion over 3 hours without anti-inflammatory additives was not achieved. We aimed to establish a model for prolonged EVLP of rat lungs from brain-dead donors, to provide a reliable platform for future experimental studies. Rat lungs were randomly assigned to one of four experimental groups (n = 7/group): 1) healthy, directly procured lungs, 2) lungs procured from rats subjected to 3 hours of BD and 1 hour cold storage (CS), 3) healthy, directly procured lungs subjected to 6 hours EVLP and 4), lungs procured from rats subjected to 3 hours of BD, 1 hour CS and 6 hours EVLP. Lungs from brain-dead rats showed deteriorated ventilation parameters and augmented lung damage when compared to healthy controls, in accordance with the pathophysiology of BD. Subsequent ex vivo perfusion for 6 hours was achieved, both for lungs of healthy donor rats as for pre-injured donor lungs from brain-dead rats. The worsened quality of lungs from brain-dead donors was evident during EVLP as well, as corroborated by deteriorated ventilation performance, increased lactate production and augmented inflammatory status during EVLP. In conclusion, we established a stable model for prolonged EVLP of pre-injured lungs from brain-dead donor rats. In this report we describe tips and pitfalls in the establishment of the rat EVLP model, to enhance reproducibility by other researchers.	[van Zanden, Judith E.; Leuvenink, Henri G. D.; Hottenrott, Maximilia C.] Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands; [Verschuuren, Erik A. M.] Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands; [Erasmus, Michiel E.] Univ Med Ctr Groningen, Dept Cardiothorac Surg, Groningen, Netherlands; [Hottenrott, Maximilia C.] Univ Hosp Regensburg, Dept Surg, Regensburg, Germany	University of Groningen; University of Groningen; University of Groningen; University of Regensburg	van Zanden, JE (corresponding author), Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands.	j.e.van.zanden@umcg.nl		Verschuuren, Erik/0000-0002-6807-6744; Leuvenink, Henri/0000-0001-5036-2999	Tekke Huizinga Fonds [THF 2014-01-04]	Tekke Huizinga Fonds	This work was supported by Tekke Huizinga Fonds (awarded to M.E.E., grant number THF 2014-01-04, http://tekkehuizingafonds.nl/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar ASMT, 2019, ACUTE CRIT CARE, V34, P14, DOI 10.4266/acc.2019.00430; Avlonitis VS, 2005, AM J TRANSPLANT, V5, P684, DOI 10.1111/j.1600-6143.2005.00755.x; Avlonitis VS, 2003, TRANSPLANTATION, V75, P1928, DOI 10.1097/01.TP.0000066351.87480.9E; Bassani GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167898; Cheng Q, 2018, AM J TRANSPLANT, V18, P2417, DOI 10.1111/ajt.14717; Cruz FF, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1645-x; Cypel M, 2009, AM J TRANSPLANT, V9, P2262, DOI 10.1111/j.1600-6143.2009.02775.x; Cypel M, 2020, J THORAC CARDIOV SUR, V159, P346, DOI 10.1016/j.jtcvs.2019.06.123; Cypel M, 2019, INTENS CARE MED, V45, P354, DOI 10.1007/s00134-019-05568-3; Cypel M, 2008, J HEART LUNG TRANSPL, V27, P1319, DOI 10.1016/j.healun.2008.09.003; Dacho C, 2013, IN VIVO, V27, P49; Davis RP, 2020, TRANSPLANT DIRECT, V6, DOI 10.1097/TXD.0000000000000968; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Francioli C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173916; Hijiya K, 2019, GEN THORAC CARDIOVAS, V67, P457, DOI 10.1007/s11748-018-1038-3; Hirata T, 2001, RESPIRATION, V68, P292, DOI 10.1159/000050513; Hodyc D, 2008, J HEART LUNG TRANSPL, V27, P890, DOI 10.1016/j.healun.2008.05.019; Hsin M, 2018, J THORAC DIS, V10, pS1871, DOI 10.21037/jtd.2018.04.119; Inokawa H, 2006, ANN THORAC SURG, V82, P1219, DOI 10.1016/j.athoracsur.2006.05.004; Kolkert JLP, 2007, LAB ANIM-UK, V41, P363, DOI 10.1258/002367707781282848; Krebs J, 2010, CRIT CARE, V14, DOI 10.1186/cc9291; Liu MY, 2000, AM J PHYSIOL-LUNG C, V278, pL1071, DOI 10.1152/ajplung.2000.278.5.L1071; Loix S, 2011, ACTA ANAESTH BELG, V62, P47; Markou T, 2014, J THORAC CARDIOV SUR, V148, P2335, DOI 10.1016/j.jtcvs.2014.04.037; Mehra MR, 2004, J AM COLL CARDIOL, V43, P806, DOI 10.1016/j.jacc.2003.08.059; Motoyama H, 2013, J HEART LUNG TRANSPL, V32, P505, DOI 10.1016/j.healun.2013.02.007; Munneke AJ, 2013, TRANSPL INT, V26, P751, DOI 10.1111/tri.12113; Nelson K, 2015, JOVE-J VIS EXP, DOI 10.3791/52309; Nelson Kevin, 2014, World J Exp Med, V4, P7, DOI 10.5493/wjem.v4.i2.7; Noda K, 2014, EUR J CARDIO-THORAC, V45, pE54, DOI 10.1093/ejcts/ezt598; NOVITZKY D, 1988, TRANSPLANTATION, V45, P32; Ohsumi A, 2020, AM J PHYSIOL-LUNG C, V319, pL61, DOI 10.1152/ajplung.00256.2019; Pego-Fernandes PM, 2010, TRANSPL P, V42, P444, DOI 10.1016/j.transproceed.2010.01.016; Reeb J, 2016, CLIN TRANSPLANT, V30, P183, DOI 10.1111/ctr.12680; Roffia V, 2018, MOLECULES, V23, DOI 10.3390/molecules23123061; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Somers J, 2015, TRANSPL INT, V28, P170, DOI 10.1111/tri.12470; Takada M, 1998, TRANSPLANTATION, V65, P1533, DOI 10.1097/00007890-199806270-00001; Valenza F, 2014, TRANSPL INT, V27, P553, DOI 10.1111/tri.12295; van der Hoeven JAB, 2000, ANN SURG, V232, P804, DOI 10.1097/00000658-200012000-00009; Van Raemdonck Dirk, 2009, Proc Am Thorac Soc, V6, P28, DOI 10.1513/pats.200808-098GO; van Zanden JE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242827; Watts RP, 2013, J TRANSPLANT, V2013, DOI 10.1155/2013/521369; Yeung JC, 2012, J HEART LUNG TRANSPL, V31, P1120, DOI 10.1016/j.healun.2012.08.016	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260705	10.1371/journal.pone.0260705	http://dx.doi.org/10.1371/journal.pone.0260705			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855870	gold, Green Published			2022-12-26	WOS:000735299000098
J	Silesh, M; Lemma, T				Silesh, Mulualem; Lemma, Tesfanesh			Maternal satisfaction with intrapartum care and associated factors among postpartum women at public hospitals of North Shoa Zone Ethiopia	PLOS ONE			English	Article								Background Maternal satisfaction is an essential indicator of the quality and the efficiency of the health care systems. At a time when efforts are being made globally to reduce maternal and neonatal mortality and morbidity, assessing maternal satisfaction is essential. There is a dearth of studies on maternal satisfaction with intrapartum care, particularly in the study area. This study aimed to assess maternal satisfaction with intrapartum care and associated factors among postpartum women at public hospitals of North Shoa Zone Ethiopia. Methods A facility-based cross-sectional study with a systematic random sampling technique was conducted from May1-30/ 2020. Data were entered into EpiData version 4.6 and analyzed using a statistical package for the social sciences version 25. Bivariate and multivariable logistic regression were employed. In multivariable logistic regression analysis, level of statistical significance was declared at variables with p < 0.05 and the strength of the association was measured by an adjusted odds ratio and 95% confidence interval. Result Of the total 394 participants, 111 (28.2%) [95% CI: 23.9, 32.5] of postpartum women were satisfied with the intrapartum care. Place of residence [AOR: 1.934; 95% CI (1.183, 3.162)], planned status of the pregnancy [AOR: 2.245; 95% CI, (1.212, 4.158)], number of antenatal care visit [AOR: 2.389; 95% (1.437, 3.974)] and duration of labour [AOR: 2.463; 95% (1.378, 4.402)] were factors significantly associated with maternal satisfaction with intrapartum care. Conclusion The proportion of maternal satisfaction with intrapartum care was low. Therefore, designing strategies to enhance maternal satisfaction by strengthening adherence to antenatal care visits, provision of family planning to prevent unplanned pregnancy, and strict utilization of partograph to prevent prolonged labour and childbirth-related complications are crucial.	[Silesh, Mulualem; Lemma, Tesfanesh] Debre Berhan Univ, Coll Hlth Sci, Dept Midwifery, Debre Berhan, Ethiopia		Silesh, M (corresponding author), Debre Berhan Univ, Coll Hlth Sci, Dept Midwifery, Debre Berhan, Ethiopia.	sileshmulualem22@gmail.com		Silesh, Mulualem/0000-0002-1943-041X				Abame Desta Erkalo, 2019, J Reprod Infertil, V20, P42; Agumasie M., 2018, GYNECOL OBSTET, V08, DOI [10.4172/2161-0932.1000473, DOI 10.4172/2161-0932.1000473]; Al-Abri Rashid, 2014, Oman Med J, V29, P3, DOI 10.5001/omj.2014.02; Al-asadi J.N., 2018, ADV RES J MULTIDISCI, V23, P1; Alkema L, 2019, TRENDS MATERNAL MORT; [Anonymous], 2017, CLIN MED RES, DOI [10.11648/j.cmr.20170601.13, DOI 10.11648/J.CMR.20170601.13]; Asamrew N, 2020, J ENVIRON PUBLIC HEA, V2020, DOI 10.1155/2020/2473469; Asres G.D., 2018, PRIM HLTH CARE OPEN, Vvol. 08, DOI [10.4172/2167-1079.1000293, DOI 10.4172/2167-1079.1000293]; Atiya K.M., 2016, INT J NURS MIDWIFERY, V8, P18; Babure Z.K., 2019, J WOMENS HLTH CARE R, V9, P1; Bazant ES, 2009, INT J QUAL HEALTH C, V21, P79, DOI 10.1093/intqhc/mzn058; Bitew K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/460767; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Bulto GA, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-02998-6; Christiaens Wendy, 2007, BMC Pregnancy Childbirth, V7, P26; CLEARY PD, 1991, HEALTH AFFAIR, V10, P254, DOI 10.1377/hlthaff.10.4.254; Demas T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1428-z; Demis A, 2020, J PREGNANCY, V2020, DOI 10.1155/2020/8279372; Dewana Z, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0125-0; Dzomeku MV., 2011, INT J NURS MIDWIFERY, V3, P30, DOI DOI 10.5897/IJNM.9000029; Ethiopian Public Health Institute (EPHI) [Ethiopia] and ICF, 2019, ETH MIN DEM HLTH SUR; FMOH, 2015, ETH HLTH SECT TRANSF, V20; Gashaye KT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210693; Gitobu CM, 2018, J ENVIRON PUBLIC HEA, V2018, DOI 10.1155/2018/4902864; Hailemariam Shewangizaw, 2020, Int J Reprod Med, V2020, P6746459, DOI 10.1155/2020/6746459; Kifle MM, 2017, OBSTET GYNECOL INT, V2017, DOI 10.1155/2017/3717408; Kone Pefoyo Anna J, 2013, BMC Res Notes, V6, P509, DOI 10.1186/1756-0500-6-509; Mehata S, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1532-0; Melese T, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.76.3189; Mocumbi S, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2449-6; Mohammad K., 2014, INT J NURS MIDWIFERY, V6, P32, DOI [10.5897/ijnm2014.0127, DOI 10.5897/IJNM2014.0127]; Morris S. M., 2013, PATIENT SATISFACTION; Panth A, 2018, OBSTET GYNECOL INT, V2018, DOI 10.1155/2018/4530161; Redshaw M., 2010, NATL PERINAT EPIDEMI, P63; Rosen HE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0728-4; Taddese AA, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05079-8; Tadele M, 2020, REPROD HEALTH, V17, DOI 10.1186/s12978-020-00911-0; Tayelgn A, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-78; Tehsin F., 2018, J SOC OBSTET GYNAECO, V8, P169; Translating Research into Action TRAction, 2015, HARVARD U SCH PUBLIC; United Nations Department of Economic and Social Affairs Population Division, 2019, WORLD MORT 2019 HIGH; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; WHO (World Health Organization), 2015, STRAT END PREV MAT M; Wolka S, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6403123; World Health Organization, 2007, REP WHO TECHN CONS B; World Health Organization, 2016, WORLD HEAL ORGAN, V6, pe1140; World Health Organization, MAT MORT; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R, DOI [10.1016/j.optm.2005.08.001, DOI 10.1016/J.OPTM.2005.08.001]; Yohannes B., 2013, NTERNATIONAL J SCI T, V2, P74	49	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260710	10.1371/journal.pone.0260710	http://dx.doi.org/10.1371/journal.pone.0260710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852019	gold, Green Published			2022-12-26	WOS:000755762900059
J	Sitprija, S; Chanhome, L; Reamtong, O; Thiangtrongjit, T; Vasaruchapong, T; Khow, O; Noiphrom, J; Laoungbua, P; Tubtimyoy, A; Chaiyabutr, N; Kumkate, S				Sitprija, Siravit; Chanhome, Lawan; Reamtong, Onrapak; Thiangtrongjit, Tipparat; Vasaruchapong, Taksa; Khow, Orawan; Noiphrom, Jureeporn; Laoungbua, Panithi; Tubtimyoy, Arissara; Chaiyabutr, Narongsak; Kumkate, Supeecha			Proteomics and immunocharacterization of Asian mountain pit viper (Ovophis monticola) venom	PLOS ONE			English	Article							OPHIOPHAGUS-HANNAH VENOM; SNAKE-VENOM; PHOSPHOLIPASE A(2); ENZYMATIC TOXINS; HABU; NEUTRALIZATION; DIVERGENCE; COMPONENTS; PROTEINS; ACID	The venomic profile of Asian mountain pit viper Ovophis monticola is clarified in the present study. Using mass spectrometry-based proteomics, 247 different proteins were identified in crude venom of O. monticola found in Thailand. The most abundant proteins were snake venom metalloproteases (SVMP) (36.8%), snake venom serine proteases (SVSP) (31.1%), and phospholipases A(2) (PLA(2)) (12.1%). Less abundant proteins included L-amino acid oxidase (LAAO) (5.7%), venom nerve growth factor (3.6%), nucleic acid degrading enzymes (3.2%), C-type lectins (CTL) (1.6%), cysteine-rich secretory proteins (CRISP) (1.2%) and disintegrin (1.2%). The immunoreactivity of this viper's venom to a monovalent antivenom against green pit viper Trimeresurus albolabris, or to a polyvalent antivenom against hemotoxic venom was investigated by indirect ELISA and two-dimensional (2D) immunoblotting. Polyvalent antivenom showed substantially greater reactivity levels than monovalent antivenom. A titer for the monovalent antivenom was over 1:1.28x10(7) dilution while that of polyvalent antivenom was 1:5.12x10(7). Of a total of 89 spots comprising 173 proteins, 40 spots of predominantly SVMP, SVSP and PLA(2) were specific antigens for antivenoms. The 49 unrecognized spots containing 72 proteins were characterized as non-reactive proteins, and included certain types of CTLs and CRISPs. These neglected venom constituents could limit the effectiveness of antivenom-based therapy currently available for victims of pit viper envenomation.	[Sitprija, Siravit; Tubtimyoy, Arissara; Kumkate, Supeecha] Mahidol Univ, Fac Sci, Dept Biol, Bangkok, Thailand; [Chanhome, Lawan; Vasaruchapong, Taksa; Laoungbua, Panithi; Chaiyabutr, Narongsak] Thai Red Cross Soc, Queen Saovabha Mem Inst, Snake Farm, Bangkok, Thailand; [Reamtong, Onrapak; Thiangtrongjit, Tipparat] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Khow, Orawan; Noiphrom, Jureeporn; Chaiyabutr, Narongsak] Thai Red Cross Soc, Dept Res & Dev, Queen Saovabha Mem Inst, Bangkok, Thailand	Mahidol University; Thai Red Cross Society; Mahidol University; Thai Red Cross Society	Kumkate, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biol, Bangkok, Thailand.; Chanhome, L (corresponding author), Thai Red Cross Soc, Queen Saovabha Mem Inst, Snake Farm, Bangkok, Thailand.	lchanhome@yahoo.com; supeecha.kum@mahidol.edu			Center of Excellence on Biodiversity [BDCPG4-161009]	Center of Excellence on Biodiversity	This research was funded by the Center of Excellence on Biodiversity, grant number BDCPG4-161009.	Abe Y, 1998, BIOL PHARM BULL, V21, P924; Aird SD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-790; Alencar LRV, 2016, MOL PHYLOGENET EVOL, V105, P50, DOI 10.1016/j.ympev.2016.07.029; Andrews Robert K., 2003, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V1, P143, DOI 10.2174/1568016033477559; Asia WHORofS-E, 2021, GUIDELINES MANAGEMEN, Vsecond; Aung HT, 2010, TOXINS, V2, P2478, DOI 10.3390/toxins2102478; Boda F, 2018, TOXINS, V10, DOI 10.3390/toxins10070259; Burin SM, 2018, INT J BIOL MACROMOL, V109, P664, DOI 10.1016/j.ijbiomac.2017.12.101; Castro HC, 2004, CELL MOL LIFE SCI, V61, P843, DOI 10.1007/s00018-003-3325-z; Chaisakul J, 2021, TOXINS, V13, DOI 10.3390/toxins13080521; Chanhome L, 2002, J NAT TOXINS, V11, P251; Chanhome L, 1998, MIL MED, V163, P310, DOI 10.1093/milmed/163.5.310; Correa-Netto C, 2010, TOXICON, V55, P1222, DOI 10.1016/j.toxicon.2009.12.018; Cox MJ., 2018, FIELD GUIDE VENOMOUS; Damm M, 2021, TOXINS, V13, DOI 10.3390/toxins13060427; Danpaiboon W, 2014, TOXINS, V6, P1526, DOI 10.3390/toxins6051526; Davies EL, 2019, TOXINS, V11, DOI 10.3390/toxins11120711; Dormann D, 2001, BLOOD, V97, P929, DOI 10.1182/blood.V97.4.929; Gibbs HL, 2011, J PROTEOMICS, V74, P2169, DOI 10.1016/j.jprot.2011.06.013; Gowtham YJ, 2014, INT IMMUNOPHARMACOL, V21, P148, DOI 10.1016/j.intimp.2014.04.012; Gutierrez JM, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.79, 10.1038/nrdp.2017.63]; Habib AG, 2018, TOXICON, V150, P115, DOI 10.1016/j.toxicon.2018.05.009; Hiu JJ, 2020, BIOCHEM SOC T, V48, P719, DOI 10.1042/BST20200110; HUTTON RA, 1993, BLOOD REV, V7, P176, DOI 10.1016/0268-960X(93)90004-N; Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x; Kini RM, 2001, HAEMOSTASIS, V31, P218; Kumkate S, 2020, TOXINS, V12, DOI 10.3390/toxins12010054; Lomonte B, 2010, CURR PHARM DESIGN, V16, P3224, DOI 10.2174/138161210793292456; Long CB, 2020, TOXINS, V12, DOI 10.3390/toxins12120749; Mackessy SP, 2006, TOXICON, V47, P537, DOI 10.1016/j.toxicon.2006.01.007; Madrigal M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005793; Malhotra A, 2011, MOL PHYLOGENET EVOL, V59, P444, DOI 10.1016/j.ympev.2011.02.010; Markland FS, 2013, TOXICON, V62, P3, DOI 10.1016/j.toxicon.2012.09.004; Matsunaga Y, 2009, J BIOCHEM, V145, P365, DOI 10.1093/jb/mvn174; Menezes MC, 2006, TOXICON, V47, P304, DOI 10.1016/j.toxicon.2005.11.007; NAKASHIMA KI, 1995, P NATL ACAD SCI USA, V92, P5605, DOI 10.1073/pnas.92.12.5605; Organization WH., 2021, FACT SHEET; Pandey Deb Prasad, 2021, J Venom Res, V11, P1; Pontes AS, 2014, TOXICON, V80, P27, DOI 10.1016/j.toxicon.2013.12.013; Shibata H, 2016, MOL PHYLOGENET EVOL, V101, P91, DOI 10.1016/j.ympev.2016.04.027; Shin J, 2003, BIOCHEMISTRY-US, V42, P14408, DOI 10.1021/bi0300276; Swenson S, 2005, TOXICON, V45, P1021, DOI 10.1016/j.toxicon.2005.02.027; Tan CH, 2021, TOXINS, V13, DOI 10.3390/toxins13080514; Tan NH, 2015, J PROTEOMICS, V128, P403, DOI 10.1016/j.jprot.2015.08.017; Tang ELH, 2016, J PROTEOMICS, V148, P44, DOI 10.1016/j.jprot.2016.07.006; Vejayan J, 2010, J VENOM ANIM TOXINS, V16, P623, DOI 10.1590/S1678-91992010000400013; Yamazaki Y, 2002, EUR J BIOCHEM, V269, P2708, DOI 10.1046/j.1432-1033.2002.02940.x; Yokoi H, 2020, TOXICON, V188, P142, DOI 10.1016/j.toxicon.2020.10.027	48	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260496	10.1371/journal.pone.0260496	http://dx.doi.org/10.1371/journal.pone.0260496			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851989	Green Published, gold			2022-12-26	WOS:000755762900040
J	Yan, HJ; Hu, XF; Wu, DW; Zhang, JN				Yan, Haijuan; Hu, Xiaofei; Wu, Dawei; Zhang, Jianing			Exploring the green development path of the Yangtze River Economic Belt using the entropy weight method and fuzzy-set qualitative comparative analysis	PLOS ONE			English	Article							ENVIRONMENTAL-REGULATION; EFFICIENCY; GROWTH; INNOVATION	Green development is an effective way to achieve economic growth and social development in a harmonious, sustainable, and efficient manner. Although the Yangtze River Economic Belt (YREB) plays an important strategic role in China, our understanding of its spatiotemporal characteristics, as well as the multiple factors affecting its green development level (GDL), remains limited. This study used the entropy weight method (EWM) to analyze the temporal evolution and spatial differentiation characteristics of the GDL in the YREB from 2011 to 2019. Further, fuzzy-set qualitative comparative analysis (fsQCA) was used to analyze the influence path of GDL. The results showed that the GDL of the YREB increased from 2015 to 2019, but the overall level was still not high, with high GDL mainly concentrated in the lower reaches. The GDL model changed from being environmentally driven and government supported in 2011 to being environmentally and economically driven since 2014. The core conditions for high GDL changed from economic development level (EDL) to scientific technological innovation level (STIL) and environmental regulation (ER). The path for improving GDL is as follows: In regions with high EDL, effective ER, moderate openness level (OL), and high STIL are the basis, supplemented by a reasonable urbanization scale (US). In areas with low EDL, reasonable industrial structure (IS) and STIL are the core conditions for development; further, EDL should be improved and effective ER and OL implemented. Alternatively, without considering changes to EDL, improvement can be achieved through reasonable OL and US or effective ER. This study provides a new method for exploring the path of GDL and a reference for governments to effectively adjust green development policies.	[Yan, Haijuan; Hu, Xiaofei; Zhang, Jianing] Nanchang Univ, Sch Management, Nanchang, Jiangxi, Peoples R China; [Wu, Dawei] Nanjing Univ Sci & Technol, Sch Econ & Management, Nanjing, Peoples R China	Nanchang University; Nanjing University of Science & Technology	Hu, XF (corresponding author), Nanchang Univ, Sch Management, Nanchang, Jiangxi, Peoples R China.	huxiaofei@ncu.edu.cn		zhang, jia ning/0000-0001-7615-5226	National Natural Science Foundation of China [31770749]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (grant no. 31770749); Xiaofei Hu received the award, her website URL is: http://glxy.ncu.edu.cn/szdw/yjsds/xxglx/43940.html; The funders had no role in data collection and analysis, preparation of the manuscript.	Ali Z., 2021, REP MECH ENG, V2, P105, DOI [10.31181/rme2001020105t, DOI 10.31181/RME2001020105T]; Asian Development Bank, EN NAT POS GROWTH PE; Bouraima M. B., 2021, OPER RES ENG SCI, V4, P13, DOI [DOI 10.31181/ORESTA20402013B, http%3A//doi.org/10.31181/oresta20402013b]; Chen CF, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8020153; Chen LL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245961; [陈明华 Chen Minghua], 2020, [中国人口·资源与环境, China Population Resources and Environment], V30, P121; [陈明华 Chen Minghua], 2020, [资源科学, Resources Science], V42, P1087; Chen YH, 2017, SCI BULL, V62, P648, DOI 10.1016/j.scib.2017.04.009; [程钰 Cheng Yu], 2019, [地理研究, Geographical Research], V38, P2745; Delgado A, 2016, ENVIRON MODELL SOFTW, V77, P108, DOI 10.1016/j.envsoft.2015.12.011; Department of Energy National Bureau of Statistics., 2019, CHIN ENV STAT YB; Department of Urban Social and Economic Survey National Bureau of Statistics., 2020, CHIN CIT STAT YB; Du Y.Z., 2017, MANAGE WORLD WASTE, V6, P155, DOI DOI 10.19744/J.CNKI.11-1235/F.2017.06.012; Fan XH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221264; Feng C, 2017, J CLEAN PROD, V144, P323, DOI 10.1016/j.jclepro.2017.01.005; Fiss PC, 2007, ACAD MANAGE REV, V32, P1180, DOI 10.5465/AMR.2007.26586092; [郭付友 Guo Fuyou], 2020, [地理科学, Scientia Geographica Sinica], V40, P200; Guo LL, 2017, J CLEAN PROD, V162, P894, DOI 10.1016/j.jclepro.2017.05.210; Guo YH, 2020, J CLEAN PROD, V258, DOI 10.1016/j.jclepro.2020.120584; [郝国彩 Hao Guocai], 2018, [中国人口·资源与环境, China Population Resources and Environment], V28, P75; Hojnik J, 2021, RENEW ENERG, V174, P733, DOI 10.1016/j.renene.2021.04.037; Hou CM, 2021, J CLEAN PROD, V279, DOI 10.1016/j.jclepro.2020.123638; Hu SL, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18116111; [黄寰 Huang Huan], 2020, [华中师范大学学报. 自然科学版, Journal of Central China Normal University. Natural Sciences Edition], V54, P567; [黄磊 Huang Lei], 2020, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V29, P1075; [黄磊 Huang Lei], 2019, [中国人口·资源与环境, China Population Resources and Environment], V29, P40; Jia ZJ, 2021, ENERGY, V233, DOI 10.1016/j.energy.2021.121179; Jin PZ, 2019, CHINA ECON REV, V55, P1, DOI 10.1016/j.chieco.2019.02.008; Kim SE, 2014, FUTURES, V63, P37, DOI 10.1016/j.futures.2014.08.002; Liu K, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18083960; Liu YQ, 2020, TECHNOL FORECAST SOC, V155, DOI 10.1016/j.techfore.2020.119993; Meyer C, 2018, ECOSYST SERV, V34, P169, DOI 10.1016/j.ecoser.2018.07.008; Meyer C, 2015, J ENVIRON MANAGE, V157, P146, DOI 10.1016/j.jenvman.2015.03.053; [穆学英 Mu Xueying], 2017, [地理科学进展, Progress in Geography], V36, P1006; National Bureau of Statistics, 2020, CHIN STAT YB; PORTER ME, 1995, J ECON PERSPECT, V9, P97, DOI 10.1257/jep.9.4.97; Prokop V, 2021, TECHNOL FORECAST SOC, V168, DOI 10.1016/j.techfore.2021.120787; Rihoux B., 2017, CONFIGURATIONAL COMP, DOI [10.1136/bmjopen-2017-016400, DOI 10.1136/BMJOPEN-2017-016400]; Rustemoglu H, 2019, ENVIRON SCI POLLUT R, V26, P6636, DOI 10.1007/s11356-019-04132-2; Shao SA, 2016, ECOL INDIC, V69, P758, DOI 10.1016/j.ecolind.2016.04.050; SMITH HL, 1990, POPUL DEV REV, V16, P784, DOI 10.2307/1972971; Sun CZ, 2018, SUSTAIN CITIES SOC, V41, P52, DOI 10.1016/j.scs.2018.05.006; [滕堂伟 Teng Tangwei], 2019, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V28, P2574; Tian Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243459; *UNDP, 2002, CHIN HUM DEV REP 200; Vilela M., 2020, DECIS APPL MANAG ENG, V3, P97, DOI [10.31181/dmame2003097v, DOI 10.31181/DMAME2003097V]; Vis B, 2012, SOCIOL METHOD RES, V41, P168, DOI 10.1177/0049124112442142; Wang KL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230963; Wang XL, 2019, SCI TOTAL ENVIRON, V660, P1346, DOI 10.1016/j.scitotenv.2019.01.094; [王勇 Wang Yong], 2018, [中国人口·资源与环境, China Population Resources and Environment], V28, P96; Weng QQ, 2020, J CLEAN PROD, V277, DOI 10.1016/j.jclepro.2020.124076; World Commission on Environment and Development, 1987, REPORT WORLD COMMISS; Wu C.-Q., 2018, J CHINA U GEOSCIE, V18, P46; Wu HT, 2020, SCI TOTAL ENVIRON, V708, DOI 10.1016/j.scitotenv.2019.135085; Yang Q, 2015, SUSTAINABILITY-BASEL, V7, P4492, DOI 10.3390/su7044492; Yang YY, 2019, RESOUR POLICY, V61, P261, DOI 10.1016/j.resourpol.2019.02.003; Yuan BL, 2018, J CLEAN PROD, V176, P895, DOI 10.1016/j.jclepro.2017.12.034; Zeng G, 2020, POL J ENVIRON STUD, V29, P3901, DOI 10.15244/pjoes/116443; [曾贤刚 Zeng Xiangang], 2020, [中国环境科学, China Environmental Science], V40, P906; Zhang JX, 2018, J CLEAN PROD, V182, P395, DOI 10.1016/j.jclepro.2018.02.067; Zhu BZ, 2020, ENERG ECON, V85, DOI 10.1016/j.eneco.2019.104601; Zhu BZ, 2019, ENERG POLICY, V134, DOI 10.1016/j.enpol.2019.110946; [诸大建 Zhu Dajian], 2016, [中国人口·资源与环境, China Population Resources and Environment], V26, P1; Zhu NP, 2020, J CLEAN PROD, V245, DOI 10.1016/j.jclepro.2019.118908; Zhu WW, 2019, J CLEAN PROD, V239, DOI 10.1016/j.jclepro.2019.118065	65	3	3	27	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	12							e0260985	10.1371/journal.pone.0260985	http://dx.doi.org/10.1371/journal.pone.0260985			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1MC	34871330	Green Published, gold			2022-12-26	WOS:000728598900006
J	Kanovicova, P; Cermakova, P; Kubalova, D; Babelova, L; Vesela, P; Valachovic, M; Zahumensky, J; Horvath, A; Malinsky, J; Balazova, M				Kanovicova, Paulina; Cermakova, Petra; Kubalova, Dominika; Babelova, Lenka; Vesela, Petra; Valachovic, Martin; Zahumensky, Jakub; Horvath, Anton; Malinsky, Jan; Balazova, Maria			Blocking phosphatidylglycerol degradation in yeast defective in cardiolipin remodeling results in a new model of the Barth syndrome cellular phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL PHOSPHATIDYLETHANOLAMINE; LYMPHOBLAST MITOCHONDRIA; PHOSPHOLIPASE-C; VALPROIC ACID; SYNTHASE; INOSITOL; GENE; LITHIUM; MUTANT	Barth syndrome (BTHS) is an inherited mitochondrial disorder characterized by a decrease in total cardiolipin and the accumulation of its precursor monolysocardiolipin due to the loss of the transacylase enzyme tafazzin. However, the molecular basis of BTHS pathology is still not well understood. Here we characterize the double mutant pgc1Ataz1 Delta of Saccharomyces cerevisiae deficient in phosphatidylglycerol-specific phospholipase C and tafazzin as a new yeast model of BTHS. Unlike the taz1 Delta mutant used to date, this model accumulates phosphatidylglycerol, thus better approximating the human BTHS cells. We demonstrate that increased phosphatidylglycerol in this strain leads to more pronounced mitochondrial respiratory defects and an increased incidence of aberrant mitochondria compared to the single taz1 Delta mutant. We also show that the mitochondria of the pgc1 Delta taz1 Delta mutant exhibit a reduced rate of respiration due to decreased cytochrome c oxidase and ATP synthase activities. Finally, we determined that the mood-stabilizing anticonvulsant valproic acid has a positive effect on both lipid composition and mitochondrial function in these yeast BTHS models. Overall, our results show that the pgc1 Delta taz1 Delta mutant better mimics the cellular phenotype of BTHS patients than taz1 Delta cells, both in terms of lipid composition and the degree of disruption of mitochondrial structure and function. This favors the new model for use in future studies.	[Kanovicova, Paulina; Kubalova, Dominika; Babelova, Lenka; Valachovic, Martin; Balazova, Maria] Slovak Acad Sci, Ctr Biosci, Inst Anim Biochem & Genet, Dept Membrane Biochem, Bratislava, Slovakia; [Cermakova, Petra; Horvath, Anton] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava, Slovakia; [Vesela, Petra; Zahumensky, Jakub; Malinsky, Jan] Acad Sci Czech Republ, Inst Expt Med, Dept Funct Org Biomembranes, Prague, Czech Republic	Slovak Academy of Sciences; Comenius University Bratislava; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Balazova, M (corresponding author), Slovak Acad Sci, Ctr Biosci, Inst Anim Biochem & Genet, Dept Membrane Biochem, Bratislava, Slovakia.; Malinsky, J (corresponding author), Acad Sci Czech Republ, Inst Expt Med, Dept Funct Org Biomembranes, Prague, Czech Republic.	jan.malinsky@iem.cas.cz; maria.balazova@savba.sk	Valachovic, Martin/O-5962-2017; Zahumensky, Jakub/AAG-3061-2020; Malinsky, Jan/H-2484-2014	Valachovic, Martin/0000-0001-7096-9325; Zahumensky, Jakub/0000-0002-8332-9789; Malinsky, Jan/0000-0002-1433-0989; Horvath, Anton/0000-0003-0785-4204; Balazova, Maria/0000-0001-8113-6855	Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Slovak Academy of Sciences [2/0165/18, SAS-MOST JRP 2016/4]; Slovak Research and Development Agency [APVV-20-0129]; AS CR & SAV Joint Project [SAV-18-25]; Czech Science Foundation [19-04052S]; European Regional Development Fund [CZ.2.16/3.1.00/21527]	Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Slovak Academy of Sciences(Slovak Academy of Sciences); Slovak Research and Development Agency(Slovak Research and Development Agency); AS CR & SAV Joint Project; Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund(European Commission)	The work was supported by the Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences [grant numbers 2/0165/18] to M. B., the Slovak Research and Development Agency contracts [grant number APVV-20-0129] to M. B., AS CR & SAV Joint Project [grant number SAV-18-25] to M. B. and J. M., Slovak Academy of Sciences [grant number SAS-MOST JRP 2016/4] to M. B. and the Czech Science Foundation project [grant number 19-04052S] to J. M. It is a result of the "Advanced Bioimaging of Living Tissues" project, [grant number CZ.2.16/3.1.00/21527] to J. M., which was financed from the budget of the European Regional Development Fund and public budgets of the Czech Republic through the Operational Programme Prague -Competitiveness.	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; Ball WB, 2018, FEBS LETT, V592, P1273, DOI 10.1002/1873-3468.12887; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; CARMAN GM, 1983, CAN J MICROBIOL, V29, P1452, DOI 10.1139/m83-222; Chaillot J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01956; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; de Avalos SV, 2005, J BIOL CHEM, V280, P7170, DOI 10.1074/jbc.M411058200; de Tilques MD, 2017, DIS MODEL MECH, V10, P439, DOI 10.1242/dmm.027540; Dugail I, 2017, BIOCHIMIE, V141, P47, DOI 10.1016/j.biochi.2017.05.005; Feng LJ, 2010, CHINESE MED J-PEKING, V123, P544, DOI 10.3760/cma.j.issn.0366-6999.2010.05.007; Furse Samuel, 2017, Journal of Chemical Biology, V10, P1, DOI 10.1007/s12154-016-0159-3; Garaiova M, 2014, FEMS YEAST RES, V14, P310, DOI 10.1111/1567-1364.12107; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Griac P, 1996, J BIOL CHEM, V271, P25692, DOI 10.1074/jbc.271.41.25692; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Gunes A, 2007, BASIC CLIN PHARMACOL, V100, P383, DOI 10.1111/j.1742-7843.2007.00061.x; Gunther A, 2001, RESPIR RES, V2, P353, DOI 10.1186/rr86; Hauff KD, 2010, BIOCHEM CELL BIOL, V88, P595, DOI 10.1139/O09-186; He Q, 2004, MOL MICROBIOL, V53, P1243, DOI 10.1111/j.1365-2958.2004.04202.x; Holic R, 2014, BBA-MOL CELL BIOL L, V1841, P1483, DOI 10.1016/j.bbalip.2014.07.014; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Ju SL, 2003, MOL MICROBIOL, V49, P1595, DOI 10.1046/j.1365-2958.2003.03641.x; KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6; Kubalova D, 2019, FEMS YEAST RES, V19, DOI 10.1093/femsyr/foz045; LOPER JC, 1992, J STEROID BIOCHEM, V43, P1107, DOI 10.1016/0960-0760(92)90339-K; Lu YW, 2016, HUM MOL GENET, V25, P1754, DOI 10.1093/hmg/ddw046; Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Matsumura A, 2018, FEBS LETT, V592, P209, DOI 10.1002/1873-3468.12948; Niwa T, 2014, CURR DRUG METAB, V15, P651; O'Donnell T, 2000, BRAIN RES, V880, P84, DOI 10.1016/S0006-8993(00)02797-9; Ouellet D, 2007, BRIT J CLIN PHARMACO, V63, P59, DOI 10.1111/j.1365-2125.2006.02709.x; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Pokorna L, 2016, BBA-BIOENERGETICS, V1857, P34, DOI 10.1016/j.bbabio.2015.10.004; Sato N, 2004, J PLANT RES, V117, P495, DOI 10.1007/s10265-004-0183-1; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Simockova M, 2008, J BIOL CHEM, V283, P17107, DOI 10.1074/jbc.M800868200; Simova Z, 2013, YEAST, V30, P229, DOI 10.1002/yea.2956; Spencer CT, 2006, PEDIATRICS, V118, pE337, DOI 10.1542/peds.2005-2667; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; Takeda A, 2011, EUR J PEDIATR, V170, P1481, DOI 10.1007/s00431-011-1576-5; Bui TT, 2019, J PHYS CHEM B, V123, P6161, DOI 10.1021/acs.jpcb.9b03413; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Valachovic M, 2017, METHODS MOL BIOL, V1494, P95, DOI 10.1007/978-1-4939-6445-1_7; Voelker DR, 2019, J BIOL CHEM, V294, P4282, DOI 10.1074/jbc.AW118.003229; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wen X, 2001, BRIT J CLIN PHARMACO, V52, P547, DOI 10.1046/j.0306-5251.2001.01474.x; Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274; Yu WX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182534; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200; Zhong Q, 2003, J BIOL CHEM, V278, P33978, DOI 10.1074/jbc.M305242200	61	1	1	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101462	10.1016/j.jbc.2021.101462	http://dx.doi.org/10.1016/j.jbc.2021.101462			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP0ZE	34864056	gold, Green Published			2022-12-26	WOS:000748357700012
J	Mahmud, F; Roy, R; Mohamed, MF; Aboonabi, A; Moric, M; Ghoreishi, K; Bayat, M; Kuzel, TM; Reiser, J; Shafikhani, SH				Mahmud, Foyez; Roy, Ruchi; Mohamed, Mohamed F.; Aboonabi, Anahita; Moric, Mario; Ghoreishi, Kamran; Bayat, Mohammad; Kuzel, Timothy M.; Reiser, Jochen; Shafikhani, Sasha H.			Therapeutic evaluation of immunomodulators in reducing surgical wound infection	FASEB JOURNAL			English	Article						CCL3 (MIP-1 alpha); fMLP (fMLF); immunomodulators; innate immune system; leukocytes; lipopolysaccharides (LPS); neutrophils; Pseudomonas aeruginosa; surgical site infection (SSI); wound healing; wound infection	CARE-ASSOCIATED INFECTIONS; PSEUDOMONAS-AERUGINOSA; SITE INFECTION; PATTERN-RECOGNITION; FUNCTIONAL-CHARACTERIZATION; ANTIMICROBIAL PROPHYLAXIS; ANTIBIOTIC-PROPHYLAXIS; RISK-FACTORS; GM-CSF; TOBRAMYCIN	Despite many advances in infection control practices, including prophylactic antibiotics, surgical site infections (SSIs) remain a significant cause of morbidity, prolonged hospitalization, and death worldwide. Our innate immune system possesses a multitude of powerful antimicrobial strategies which make it highly effective in combating bacterial, fungal, and viral infections. However, pathogens use various stealth mechanisms to avoid the innate immune system, which in turn buy them time to colonize wounds and damage tissues at surgical sites. We hypothesized that immunomodulators that can jumpstart and activate innate immune responses at surgical sites, would likely reduce infection at surgical sites. We used three immunomodulators; fMLP (formyl-Methionine-Lysine-Proline), CCL3 (MIP-1 alpha), and LPS (Lipopolysaccharide), based on their documented ability to elicit strong inflammatory responses; in a surgical wound infection model with Pseudomonas aeruginosa to evaluate our hypothesis. Our data indicate that one-time topical treatment with these immunomodulators at low doses significantly increased proinflammatory responses in infected and uninfected surgical wounds and were as effective, (or even better), than a potent prophylactic antibiotic (Tobramycin) in reducing P. aeruginosa infection in wounds. Our data further show that immunomodulators did not have adverse effects on tissue repair and wound healing processes. Rather, they enhanced healing in both infected and uninfected wounds. Collectively, our data demonstrate that harnessing the power of the innate immune system by immunomodulators can significantly boost infection control and potentially stimulate healing. We propose that topical treatment with these immunomodulators at the time of surgery may have therapeutic potential in combating SSI, alone or in combination with prophylactic antibiotics.	[Mahmud, Foyez; Roy, Ruchi; Mohamed, Mohamed F.; Aboonabi, Anahita; Kuzel, Timothy M.; Reiser, Jochen; Shafikhani, Sasha H.] Rush Univ, Dept Med, Med Ctr, Chicago, IL 60612 USA; [Mahmud, Foyez; Roy, Ruchi; Mohamed, Mohamed F.; Aboonabi, Anahita; Kuzel, Timothy M.; Shafikhani, Sasha H.] Rush Univ, Div Hematol Oncol Cell Therapy, Med Ctr, Chicago, IL 60612 USA; [Moric, Mario] Rush Univ, Dept Anesthesiol, Med Ctr, Chicago, IL 60612 USA; [Ghoreishi, Kamran] Qom Univ, Dept Stat, Qom, Iran; [Bayat, Mohammad] Shahid Beheshti Univ Med Sci, Sch Med, Dept Biol & Anat Sci, Tehran, Iran; [Bayat, Mohammad] Univ Louisville, Price Inst Surg Res, Louisville, KY USA; [Bayat, Mohammad] Noveratech LLC Louisville, Louisville, KY USA; [Shafikhani, Sasha H.] Rush Univ, Canc Ctr, Med Ctr, Chicago, IL 60612 USA	Rush University; Rush University; Rush University; Shahid Beheshti University Medical Sciences; University of Louisville; Rush University	Shafikhani, SH (corresponding author), Rush Univ, Dept Med, Med Ctr, Chicago, IL 60612 USA.	Sasha_Shafikhani@rush.edu	ROY, RUCHI/AEV-9556-2022	ROY, RUCHI/0000-0001-8298-1321; Mahmud, K A Foyez/0000-0001-7485-4699; Shafikhani, Sasha/0000-0003-1755-9997	National Institutes of Health (NIH) [R01AI150668, RO1DK107713]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank the rest of Shafikhani lab members for their valued opinions on these studies. This work was supported by the National Institutes of Health (NIH) grants R01AI150668 and RO1DK107713, both to (S.H.S.).	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; Allegranzi Benedetta, 2016, Lancet Infect Dis, V16, pe288, DOI 10.1016/S1473-3099(16)30402-9; Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/676022, 10.1017/S0899823X00193869]; Anderson DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008305; Anesi JA, 2018, TRANSPLANTATION, V102, P21, DOI 10.1097/TP.0000000000001848; Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091, DOI 10.1177/039139880502801106; Avent ML, 2011, INTERN MED J, V41, P441, DOI 10.1111/j.1445-5994.2011.02452.x; Balazovich KJ, 1996, BLOOD, V88, P690, DOI 10.1182/blood.V88.2.690.bloodjournal882690; Ban KA, 2017, J AM COLL SURGEONS, V224, P59, DOI 10.1016/j.jamcollsurg.2016.10.029; Becattini S, 2016, TRENDS MOL MED, V22, P458, DOI 10.1016/j.molmed.2016.04.003; Berrios SI, 2017, JAMA SURG, V152, P784, DOI 10.1001/jamasurg.2017.0904; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bhavsar I, 2015, GEN METHODS BIOMARKE, P223, DOI DOI 10.1007/978-94-007-7696-8_27; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Bothra M, 2012, EXPERT OPIN PHARMACO, V13, P565, DOI 10.1517/14656566.2012.656090; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Bratzler DW, 2013, SURG INFECT, V14, P73, DOI 10.1089/sur.2013.9999; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BROUQUI P, 1995, ANTIMICROB AGENTS CH, V39, P2423, DOI 10.1128/AAC.39.11.2423; Brubaker AL, 2013, J IMMUNOL, V190, P1746, DOI 10.4049/jimmunol.1201213; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; BUSSOLINO F, 1989, NATURE, V337, P471, DOI 10.1038/337471a0; Campbell J, 2014, AM J SPORT MED, V42, P973, DOI 10.1177/0363546513519950; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; CHRISTOU NV, 1987, ARCH SURG-CHICAGO, V122, P239; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; de Oliveira S, 2016, NAT REV IMMUNOL, V16, P378, DOI 10.1038/nri.2016.49; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; DERIAN CK, 1995, J IMMUNOL, V154, P308; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Dovi JV, 2004, THROMB HAEMOSTASIS, V92, P275, DOI 10.1160/TH03-11-0720; Drummond RA, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00039; Edmiston CE, 2013, AM J INFECT CONTROL, V41, pS49, DOI 10.1016/j.ajic.2012.10.030; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Faure E, 2014, AM J RESP CRIT CARE, V189, P799, DOI 10.1164/rccm.201307-1358OC; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; Gaynes RP, 2001, CLIN INFECT DIS, V33, pS69, DOI 10.1086/321860; Gillespie BM, 2017, BRIT J SURG, V104, pE55, DOI 10.1002/bjs.10428; Glotzbecker MP, 2013, J PEDIATR ORTHOPED, V33, P479, DOI 10.1097/BPO.0b013e318285c507; Goldufsky J, 2015, WOUND REPAIR REGEN, V23, P557, DOI 10.1111/wrr.12310; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gupta KH, 2017, DEV CELL, V41, P674, DOI 10.1016/j.devcel.2017.05.014; Hamilton JL, 2021, EUR CELLS MATER, V42, P122, DOI 10.22203/eCM.v042a09; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; Hodson ME, 2002, EUR RESPIR J, V20, P658, DOI 10.1183/09031936.02.00248102; HOFF G E, 1974, Scandinavian Journal of Infectious Diseases, V6, P333, DOI 10.3109/inf.1974.6.issue-4.07; Hsu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134852; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jones Stuart G, 2004, Int J Low Extrem Wounds, V3, P201, DOI 10.1177/1534734604271810; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kienle K, 2016, IMMUNOL REV, V273, P76, DOI 10.1111/imr.12458; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Kim YK, 2016, YONSEI MED J, V57, P5, DOI 10.3349/ymj.2016.57.1.5; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; Kroin JS, 2018, REGION ANESTH PAIN M, V43, P795, DOI 10.1097/AAP.0000000000000820; Kroin JS, 2016, J MED MICROBIOL, V65, P738, DOI 10.1099/jmm.0.000295; Kroin JS, 2015, ANESTH ANALG, V120, P1289, DOI 10.1213/ANE.0000000000000650; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Lu ZY, 2018, FASEB J, V32, P3614, DOI 10.1096/fj.201701164R; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Madianos PN, 2005, J CLIN PERIODONTOL, V32, P57, DOI 10.1111/j.1600-051X.2005.00821.x; Magill SS, 2012, INFECT CONT HOSP EP, V33, P283, DOI 10.1086/664048; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132715; Mehta HM, 2015, J IMMUNOL, V195, P1341, DOI 10.4049/jimmunol.1500861; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Metruccio MME, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14243-w; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Namba RS, 2013, J BONE JOINT SURG AM, V95A, P775, DOI 10.2106/JBJS.L.00211; Panahi P, 2012, CLIN ORTHOP RELAT R, V470, P2690, DOI 10.1007/s11999-012-2252-4; Panaro MA, 1999, IMMUNOPHARM IMMUNOT, V21, P397, DOI 10.3109/08923979909007117; Redel H, 2013, J INFECT DIS, V207, P1105, DOI 10.1093/infdis/jit005; Rivas-Santiago B, 2009, INFECT IMMUN, V77, P4690, DOI 10.1128/IAI.01515-08; Roy R, 2022, J INVEST DERMATOL, V142, P692, DOI 10.1016/j.jid.2021.08.428; Sabroe I, 2003, J IMMUNOL, V170, P5268, DOI 10.4049/jimmunol.170.10.5268; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Saunders KT, 2018, OBSTET GYNECOL, V131, p83S, DOI 10.1097/01.AOG.0000533379.96988.6a; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Sharma P, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty001; Shawar RM, 1999, ANTIMICROB AGENTS CH, V43, P2877, DOI 10.1128/AAC.43.12.2877; Sidhwa F, 2015, SURG INFECT, V16, P14, DOI 10.1089/sur.2015.010; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smyth STM, 2000, J HOSP INFECT, V45, P173, DOI 10.1053/jhin.2000.0736; Stannard JP, 2012, J ORTHOP TRAUMA, V26, P37, DOI 10.1097/BOT.0b013e318216b1e5; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005; Teneback CC, 2013, ANTIMICROB AGENTS CH, V57, P5559, DOI 10.1128/AAC.00500-13; Tosh PK, 2011, INFECT CONT HOSP EP, V32, P1179, DOI 10.1086/662712; Trda L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00219; van de Vosse E, 2009, LANCET INFECT DIS, V9, P688, DOI 10.1016/S1473-3099(09)70255-5; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Wagner C, 2006, CLIN EXP IMMUNOL, V143, P70, DOI 10.1111/j.1365-2249.2005.02963.x; WAKEFIELD PE, 1990, J AM ACAD DERMATOL, V23, P903, DOI 10.1016/0190-9622(90)70313-7; Wang NZ, 2010, FASEB J, V24, P2178, DOI 10.1096/fj.09-136895; WOOD CA, 1988, J INFECT DIS, V158, P13, DOI 10.1093/infdis/158.1.13; Wood S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004934; Wood S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091574; Wood SJ, 2015, J BIOL CHEM, V290, P29063, DOI 10.1074/jbc.M115.689950; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917; Zibert A, 2004, HUM GENE THER, V15, P21, DOI 10.1089/10430340460732436; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	120	1	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22090	10.1096/fj.202101019R	http://dx.doi.org/10.1096/fj.202101019R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34907595				2022-12-26	WOS:000734992000001
J	Marchiano, S; Biagioli, M; Roselli, R; Zampella, A; Di Giorgio, C; Bordoni, M; Bellini, R; Morretta, E; Monti, MC; Distrutti, E; Fiorucci, S				Marchiano, Silvia; Biagioli, Michele; Roselli, Rosalinda; Zampella, Angela; Di Giorgio, Cristina; Bordoni, Martina; Bellini, Rachele; Morretta, Elva; Monti, Maria Chiara; Distrutti, Eleonora; Fiorucci, Stefano			Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling	FASEB JOURNAL			English	Article						bile acids; cardiovascular diseases; FXR; GPBAR1; intestinal microbiota; liver metabolism; statins	FARNESOID-X-RECEPTOR; BILE-ACID METABOLISM; OBETICHOLIC ACID; INSULIN-RESISTANCE; GUT MICROBES; CHOLESTEROL; TGR5; MICE; DISEASE; ACTIVATION	Farnesoid-x-receptor (FXR) agonists, currently trialed in patients with non-alcoholic steatosis (NAFLD), worsen the pro-atherogenic lipid profile and might require a comedication with statin. Here we report that mice feed a high fat/high cholesterol diet (HFD) are protected from developing a pro-atherogenic lipid profile because their ability to dispose cholesterol through bile acids. This protective mechanism is mediated by suppression of FXR signaling in the liver by muricholic acids (MCAs) generated in mice from chenodeoxycholic acid (CDCA). In contrast to CDCA, MCAs are FXR antagonists and promote a CYP7A1-dependent increase of bile acids synthesis. In mice feed a HFD, the treatment with obeticholic acid, a clinical stage FXR agonist, failed to improve the liver histopathology while reduced Cyp7a1 and Cyp8b1 genes expression and bile acids synthesis and excretion. In contrast, treating mice with atorvastatin mitigated liver and vascular injury caused by the HFD while increased the bile acids synthesis and excretion. Atorvastatin increased the percentage of 7 alpha-dehydroxylase expressing bacteria in the intestine promoting the formation of deoxycholic acid and litocholic acid, two GPBAR1 agonists, along with the expression of GPBAR1-regulated genes in the white adipose tissue and colon. In conclusion, present results highlight the central role of bile acids in regulating lipid and cholesterol metabolism in response to atorvastatin and provide explanations for limited efficacy of FXR agonists in the treatment of NAFLD.	[Marchiano, Silvia; Biagioli, Michele; Di Giorgio, Cristina; Bordoni, Martina; Bellini, Rachele; Fiorucci, Stefano] Univ Perugia, Dept Med & Surg, Perugia, Italy; [Roselli, Rosalinda; Zampella, Angela] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Morretta, Elva; Monti, Maria Chiara] Univ Salerno, Dept Pharm, Salerno, Italy; [Distrutti, Eleonora] Azienda Osped Perugia, Perugia, Italy	University of Perugia; University of Naples Federico II; University of Salerno; University of Perugia; Azienda Ospedaliera di Perugia	Fiorucci, S (corresponding author), Univ Perugia, Dept Med & Surg, Perugia, Italy.	stefano.fiorucci@unipg.it						Alexander M, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5367; Bervoets L, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-10; Biagioli M, 2019, CELL MOL GASTROENTER, V8, P447, DOI 10.1016/j.jcmgh.2019.06.003; Biagioli M, 2017, J IMMUNOL, V199, P718, DOI 10.4049/jimmunol.1700183; Carino A, 2021, FASEB J, V35, DOI 10.1096/fj.202001386R; Carino A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051132; Carino A, 2019, FASEB J, V33, P2809, DOI 10.1096/fj.201801373RR; Carino A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13102-y; Carino A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42801; Chen JY, 2002, J BIOL CHEM, V277, P42588, DOI 10.1074/jbc.M205117200; Chiang John Y L, 2017, Liver Res, V1, P3, DOI 10.1016/j.livres.2017.05.001; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Chiang John Yl, 2017, F1000Res, V6, P2029, DOI 10.12688/f1000research.12449.1; Cipriani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025637; Cipriani S, 2010, J LIPID RES, V51, P771, DOI 10.1194/jlr.M001602; de Boer JF, 2020, J LIPID RES, V61, P291, DOI 10.1194/jlr.RA119000243; de Boer JF, 2017, GASTROENTEROLOGY, V152, P1126, DOI 10.1053/j.gastro.2016.12.037; Donepudi AC, 2017, HEPATOLOGY, V65, P813, DOI 10.1002/hep.28707; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; Eng JM, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071805; Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Fang N, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001920; Festa C, 2014, J MED CHEM, V57, P8477, DOI 10.1021/jm501273r; Fiorucci S, 2005, J PHARMACOL EXP THER, V313, P604, DOI 10.1124/jpet.104.079665; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Fiorucci S, 2021, EXPERT OPIN DRUG DIS, V16, P1193, DOI 10.1080/17460441.2021.1916465; Fiorucci S, 2021, PROG LIPID RES, V82, DOI 10.1016/j.plipres.2021.101094; Fiorucci S, 2020, EXPERT OPIN INV DRUG, V29, P623, DOI 10.1080/13543784.2020.1763302; Fiorucci S, 2019, HANDB EXP PHARMACOL, V256, P3, DOI 10.1007/164_2019_238; Fiorucci S, 2019, HANDB EXP PHARMACOL, V256, P283, DOI 10.1007/164_2019_227; Fiorucci S, 2018, PHARMACOL RES, V134, P289, DOI 10.1016/j.phrs.2018.07.014; Fiorucci S, 2017, AM J PHYSIOL-HEART C, V312, pH21, DOI 10.1152/ajpheart.00577.2016; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Gaillard D, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22137163; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guo GCL, 2020, J LIPID RES, V61, P269, DOI 10.1194/jlr.C120000621; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; Huang YB, 2013, J ATHEROSCLER THROMB, V20, P108, DOI 10.5551/jat.14001; Ichikawa R, 2012, IMMUNOLOGY, V136, P153, DOI 10.1111/j.1365-2567.2012.03554.x; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, WORLD J GASTROENTERO, V14, P5620, DOI 10.3748/wjg.14.5620; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Keitel V, 2015, CLIN REV ALLERG IMMU, V48, P218, DOI 10.1007/s12016-014-8443-x; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; Kida T, 2014, J PHARMACOL EXP THER, V348, P125, DOI 10.1124/jpet.113.209288; Kida T, 2013, ARTERIOSCL THROM VAS, V33, P1663, DOI 10.1161/ATVBAHA.113.301565; Levy C, 2019, J HEPATOL, V70, pE400, DOI 10.1016/S0618-8278(19)30787-X; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Li TG, 2013, HEPATOLOGY, V58, P1111, DOI 10.1002/hep.26427; Lonardo A, 2018, J HEPATOL, V68, P335, DOI 10.1016/j.jhep.2017.09.021; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; Mencarelli A, 2013, DIABETES, V62, P3384, DOI 10.2337/db13-0299; Mencarelli A, 2009, AM J PHYSIOL-HEART C, V296, pH272, DOI 10.1152/ajpheart.01075.2008; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Nevens F, 2016, NEW ENGL J MED, V375, P631, DOI 10.1056/NEJMoa1509840; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Pockros PJ, 2019, LIVER INT, V39, P2082, DOI 10.1111/liv.14209; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; Renga B, 2015, AM J PHYSIOL-HEART C, V309, pH114, DOI 10.1152/ajpheart.00087.2015; Renga B, 2011, BBA-GENE REGUL MECH, V1809, P157, DOI 10.1016/j.bbagrm.2011.01.008; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Sepe V, 2016, STEROIDS, V105, P59, DOI 10.1016/j.steroids.2015.11.003; Sepe V, 2016, SCI REP-UK, V6, DOI 10.1038/srep19008; Sepe V, 2014, J MED CHEM, V57, P7687, DOI 10.1021/jm500889f; Shapiro H, 2018, J EXP MED, V215, P383, DOI 10.1084/jem.20171965; Sinn DH, 2020, J GASTROEN HEPATOL, V35, P833, DOI 10.1111/jgh.14856; Smith GI, 2020, J CLIN INVEST, V130, P1453, DOI 10.1172/JCI134165; Soehnlein O, 2021, NAT REV DRUG DISCOV, V20, P589, DOI 10.1038/s41573-021-00198-1; Song C, 2007, INT J CANCER, V121, P1055, DOI 10.1002/ijc.22808; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Song ZW, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0628-3; Straniero S, 2020, J LIPID RES, V61, P480, DOI 10.1194/jlr.RA119000307; Takahashi S, 2016, J LIPID RES, V57, P2130, DOI 10.1194/jlr.M071183; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vassileva G, 2010, J ENDOCRINOL, V205, P225, DOI 10.1677/JOE-10-0009; Veseli BE, 2017, EUR J PHARMACOL, V816, P3, DOI 10.1016/j.ejphar.2017.05.010; Vital M, 2019, COMPUT STRUCT BIOTEC, V17, P1016, DOI 10.1016/j.csbj.2019.07.012; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Xu GR, 2004, AM J PHYSIOL-GASTR L, V286, pG730, DOI 10.1152/ajpgi.00397.2003; Xu PR, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-283; Younossi ZM, 2019, LANCET, V394, P2184, DOI 10.1016/S0140-6736(19)33041-7; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	97	5	5	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22060	10.1096/fj.202101397R	http://dx.doi.org/10.1096/fj.202101397R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34862975				2022-12-26	WOS:000734992000060
J	Raveendra-Panickar, D; Finlay, D; Layng, FI; Lambert, LJ; Celeridad, M; Zhao, M; Barbosa, K; De Backer, LJS; Kwong, E; Gosalia, P; Rodiles, S; Holleran, J; Ardecky, R; Grotegut, S; Olson, S; Hutchinson, JH; Pasquale, EB; Vuori, K; Deshpande, AJ; Cosford, NDP; Tautz, L				Raveendra-Panickar, Dhanya; Finlay, Darren; Layng, Fabiana Izidro; Lambert, Lester J.; Celeridad, Maria; Zhao, Ming; Barbosa, Karina; De Backer, Laurent J. S.; Kwong, Elizabeth; Gosalia, Palak; Rodiles, Socorro; Holleran, John; Ardecky, Robert; Grotegut, Stefan; Olson, Steven; Hutchinson, John H.; Pasquale, Elena B.; Vuori, Kristiina; Deshpande, Aniruddha J.; Cosford, Nicholas D. P.; Tautz, Lutz			Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTPN11; CANCER; BREAST; RESISTANCE; STRATEGIES; MUTATIONS; GAB2	Disturbance of the dynamic balance between tyrosine phosphorylation and dephosphorylation of signaling molecules, controlled by protein tyrosine kinases and protein tyrosine phosphatases (PTPs), is known to lead to the development of cancer. While most approved targeted cancer therapies are tyrosine kinase inhibitors, PTPs have long been stigmatized as undruggable and have only recently gained renewed attention in drug discovery. One PTP target is the Src-homology 2 domain-containing phosphatase 2 (SHP2). SHP2 is implicated in tumor initiation, progression, metastasis, and treatment resistance, primarily because of its role as a signaling nexus of the extracellular signal-regulated kinase pathway, acting upstream of the small GTPase Ras. Efforts to develop small molecules that target SHP2 are ongoing, and several SHP2 allosteric inhibitors are currently in clinical trials for the treatment of solid tumors. However, while the reported allosteric inhibitors are highly effective against cells expressing WT SHP2, none have significant activity against the most frequent oncogenic SHP2 variants that drive leukemogenesis in several juvenile and acute leukemias. Here, we report the discovery of novel furanylbenzamide molecules as inhibitors of both WT and oncogenic SHP2. Importantly, these inhibitors readily cross cell membranes, bind and inhibit SHP2 under physiological conditions, and effectively decrease the growth of cancer cells, including triple-negative breast cancer cells, acute myeloid leukemia cells expressing either WT or oncogenic SHP2, and patient-derived acute myeloid leukemia cells. These novel compounds are effective chemical probes of active SHP2 and may serve as starting points for therapeutics targeting WT or mutant SHP2 in cancer.	[Raveendra-Panickar, Dhanya; Finlay, Darren; Layng, Fabiana Izidro; Lambert, Lester J.; Celeridad, Maria; Zhao, Ming; Barbosa, Karina; De Backer, Laurent J. S.; Kwong, Elizabeth; Hutchinson, John H.; Pasquale, Elena B.; Vuori, Kristiina; Deshpande, Aniruddha J.; Cosford, Nicholas D. P.; Tautz, Lutz] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, La Jolla, CA 92037 USA; [Gosalia, Palak; Rodiles, Socorro; Holleran, John; Ardecky, Robert; Grotegut, Stefan; Olson, Steven] Sanford Burnham Prebys Med Discovery Inst, Conrad Prebys Ctr Chem Genom, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Tautz, L (corresponding author), Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, La Jolla, CA 92037 USA.	tautz@sbpdiscovery.org		Barbosa Guerra, Karina/0000-0002-6233-3332; Finlay, Darren/0000-0002-8718-9453; Lambert, Lester/0000-0002-6274-1811	National Cancer Institute (NCI) of the National Institutes of Health [1R21CA195422, 1R21NS067502]; NCI Cancer Center support grant [P30CA030199]; Epstein Family Foundation; NCI, National Institutes of Health, under Chemical Biology Consortium [HHSN261200800001E]	National Cancer Institute (NCI) of the National Institutes of Health; NCI Cancer Center support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Epstein Family Foundation; NCI, National Institutes of Health, under Chemical Biology Consortium	Research reported in this publication was supported by the National Cancer Institute (NCI) of the National Institutes of Health under award number 1R21CA195422 (to L. T.) and 1R21NS067502 (to E. B. P. and N. D. P. C.), NCI Cancer Center support grant P30CA030199, and an Epstein Family Foundation award (to N. D. P. C.). In addition, this project has been funded in whole or in part with Federal funds from the NCI, National Institutes of Health, under Chemical Biology Consortium contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Aggarwal S, 2010, NAT REV DRUG DISCOV, V9, P427, DOI 10.1038/nrd3186; Ahmed TA, 2019, CELL REP, V26, P65, DOI 10.1016/j.celrep.2018.12.013; Alfayez M, 2021, LEUKEMIA, V35, P691, DOI 10.1038/s41375-020-0920-z; Barr AJ, 2010, FUTURE MED CHEM, V2, P1563, DOI [10.4155/fmc.10.241, 10.4155/FMC.10.241]; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Beucher A., 2019, NAT PROTOC EXCHANGE, DOI [10.21203/rs.2.1831/v1, DOI 10.21203/RS.2.1831/V1]; Bialy L, 2005, ANGEW CHEM INT EDIT, V44, P3814, DOI 10.1002/anie.200461517; Bocanegra M, 2010, ONCOGENE, V29, P774, DOI 10.1038/onc.2009.364; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Cabiddu MG, 2002, SYNTHESIS-STUTTGART, P875; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Elson A, 2018, INT J BIOCHEM CELL B, V96, P135, DOI 10.1016/j.biocel.2017.09.013; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fedele C, 2021, J EXP MED, V218, DOI 10.1084/jem.20201414; Ferguson FM, 2018, NAT REV DRUG DISCOV, V17, P353, DOI 10.1038/nrd.2018.21; Frankson R, 2017, CANCER RES, V77, P5701, DOI 10.1158/0008-5472.CAN-17-1510; He RJ, 2013, FEBS J, V280, P731, DOI 10.1111/j.1742-4658.2012.08718.x; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Kerr DL, 2021, CURR OPIN CHEM BIOL, V62, P1, DOI 10.1016/j.cbpa.2020.11.007; Lambert LJ, 2020, JOVE-J VIS EXP, DOI 10.3791/61457; LaRochelle JR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06823-9; Lu Hengyu, 2020, Oncotarget, V11, P265, DOI 10.18632/oncotarget.27435; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Nichols RJ, 2018, NAT CELL BIOL, V20, P1064, DOI 10.1038/s41556-018-0169-1; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Niogret C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02468; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Padua RAP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06814-w; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Prahallad A, 2015, CELL REP, V12, P1978, DOI 10.1016/j.celrep.2015.08.037; Ran H, 2016, CANCER CELL, V30, P194, DOI 10.1016/j.ccell.2016.07.010; Romero C, 2020, J BIOL CHEM, V295, P2601, DOI 10.1074/jbc.RA119.010838; Sergienko E, 2012, ACS CHEM BIOL, V7, P366, DOI 10.1021/cb2004274; Stanford SM, 2017, TRENDS PHARMACOL SCI, V38, P524, DOI 10.1016/j.tips.2017.03.004; Stieglitz E, 2015, NAT GENET, V47, P1326, DOI 10.1038/ng.3400; Sun X, 2018, LEUKEMIA, V32, P1246, DOI 10.1038/s41375-018-0020-5; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tautz L, 2005, J BIOL CHEM, V280, P9400, DOI 10.1074/jbc.M413122200; Tautz L, 2013, METHODS MOL BIOL, V1053, P179, DOI 10.1007/978-1-62703-562-0_13; Tsutsumi R, 2018, FEBS OPEN BIO, V8, P1405, DOI 10.1002/2211-5463.12493; Vainonen JP, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abe2967; Vazquez J, 2007, J MED CHEM, V50, P2137, DOI 10.1021/jm061481l; Zeng LF, 2014, J MED CHEM, V57, P6594, DOI 10.1021/jm5006176; Zhang HJ, 2020, NAT CANCER, V1, P826, DOI 10.1038/s43018-020-0103-x; Zhou X, 2008, HISTOPATHOLOGY, V53, P389, DOI 10.1111/j.1365-2559.2008.03103.x	50	1	1	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101477	10.1016/j.jbc.2021.101477	http://dx.doi.org/10.1016/j.jbc.2021.101477			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1GJ	34896393	Green Published, gold			2022-12-26	WOS:000748376400002
J	Arauz, PG; Garcia, MG; Velez, M; Leon, C; Velez, F; Martin, B				Arauz, Paul Gonzalo; Garcia, Maria-Gabriela; Velez, Mauricio; Leon, Cesar; Velez, Francisco; Martin, Bernard			Does treadmill workstation use affect user's kinematic gait symmetry?	PLOS ONE			English	Article							JOINT COORDINATE SYSTEM; TOTAL HIP-ARTHROPLASTY; SIMULATED OFFICE WORK; PERFORMANCE OUTCOMES; WALKING; ASYMMETRY; HEAD; INTERVENTION; PRODUCTIVITY; OVERWEIGHT	The effects of treadmill workstation use on kinematic gait symmetry and computer work performance remain unclear. The purpose of this pilot study was to analyze the effects of treadmill workstation use on lower body motion symmetry while performing a typing task when compared to overground and treadmill walking. The lower body motion of ten healthy adults (6 males and 4 females) was recorded by a motion capture system. Hip, knee, and ankle joint rotations were computed and compared for each condition. Despite comparable lower body kinematic gait asymmetries across conditions, asymmetric knee flexion motions at early gait cycle were only found in treadmill workstation users (left knee significantly more flexed than the right one). This demonstrates that the interaction between walking and another task is dependent on the task cognitive content. Our findings suggest that lower body kinematic gait symmetry may be influenced by the use of treadmill workstations.	[Arauz, Paul Gonzalo] Univ San Francisco Quito, Dept Mech Engn, Quito, Ecuador; [Garcia, Maria-Gabriela; Velez, Mauricio; Leon, Cesar; Velez, Francisco] Univ San Francisco Quito, Dept Ind Engn, Quito, Ecuador; [Martin, Bernard] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Arauz, PG (corresponding author), Univ San Francisco Quito, Dept Mech Engn, Quito, Ecuador.	parauz@usfq.edu.ec		Garcia, Maria Gabriela/0000-0002-5666-2156; Arauz, Paul/0000-0002-8724-7035	Universidad San Francisco de Quito, Quito, Pichincha, Ecuador [16873]	Universidad San Francisco de Quito, Quito, Pichincha, Ecuador	This document is the results of the research project funded by a Collaboration Grant from Universidad San Francisco de Quito, Quito, Pichincha, Ecuador (Grant number: 16873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Juaid R, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12122101; Alderman BL, 2014, J PHYS ACT HEALTH, V11, P752, DOI 10.1123/jpah.2012-0097; Arauz P, 2018, J BIOMECH, V77, P131, DOI 10.1016/j.jbiomech.2018.07.013; Arauz P, 2018, INT ORTHOP, V42, P2817, DOI 10.1007/s00264-018-3986-8; Arauz P, 2016, J BIOMECH, V49, P4009, DOI 10.1016/j.jbiomech.2016.10.047; Arauz PG, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4032967; Arauz PG., 2016, MECH MODELING ANAL H; Baker R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081678; Barkley Jacob E, 2016, BMC Res Notes, V9, P195, DOI 10.1186/s13104-016-2001-y; Bates BT., 1977, J PHYS ED RECREATION, V48, P68; Bautmans I, 2011, GAIT POSTURE, V33, P366, DOI 10.1016/j.gaitpost.2010.12.003; Beach Tyson A C, 2005, Spine J, V5, P145, DOI 10.1016/j.spinee.2004.07.036; Ben-Ner A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088620; Bergman F, 2018, LANCET PUBLIC HEALTH, V3, pE523, DOI 10.1016/S2468-2667(18)30163-4; Botter J, 2016, ERGONOMICS, V59, P449, DOI 10.1080/00140139.2015.1080861; Cao CM, 2016, J PHYS ACT HEALTH, V13, P562, DOI 10.1123/jpah.2014-0565; Carr LJ, 2016, AM J PREV MED, V50, P9, DOI 10.1016/j.amepre.2015.06.022; Cifuentes M, 2015, AM J HEALTH PROMOT, V30, P93, DOI 10.4278/ajhp.140123-QUAL-43; Coenen P, 2018, ERGONOMICS, V61, P1187, DOI 10.1080/00140139.2018.1462891; Cox RH, 2011, J PHYS ACT HEALTH, V8, P332, DOI 10.1123/jpah.8.3.332; Dufek J., 2016, J NOV PHYSIOTHER, V6, DOI [10.4172/2165-7025.1000e144, DOI 10.4172/2165-7025.1000E144]; Dunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020; Eggleston JD, 2019, GAIT POSTURE, V74, P200, DOI 10.1016/j.gaitpost.2019.09.011; Eggleston JD, 2017, GAIT POSTURE, V55, P162, DOI 10.1016/j.gaitpost.2017.04.026; Ferrante S, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-47; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Garcia MG, 2020, ERGONOMICS, V63, P163, DOI 10.1080/00140139.2019.1677949; Garcia MG, 2016, HUM FACTORS, V58, P1117, DOI 10.1177/0018720816669444; Gorecka MM, 2020, J CLIN EXP NEUROPSYC, V42, P794, DOI 10.1080/13803395.2020.1811207; Grindle DM, 2018, J APPL BIOMECH, V34, P349, DOI 10.1123/jab.2017-0124; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; GUITTON D, 1987, J NEUROPHYSIOL, V58, P427, DOI 10.1152/jn.1987.58.3.427; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Harry J.R., 2018, TRANSL J AM COLL SPO, V3, P74, DOI 10.1249/TJX.0000000000000062; Hendrickson J, 2014, GAIT POSTURE, V39, P177, DOI 10.1016/j.gaitpost.2013.06.022; Herold F, 2019, BRAIN TOPOGR, V32, P472, DOI 10.1007/s10548-019-00699-8; Imai T, 2001, EXP BRAIN RES, V136, P1, DOI 10.1007/s002210000533; John D, 2011, J PHYS ACT HEALTH, V8, P1034, DOI 10.1123/jpah.8.8.1034; John D, 2009, J PHYS ACT HEALTH, V6, P617, DOI 10.1123/jpah.6.5.617; Karol S, 2015, WORK, V52, P255, DOI 10.3233/WOR-152168; Kim KH, 2007, COMPUT BIOL MED, V37, P1009, DOI 10.1016/j.compbiomed.2006.08.019; Koepp GA, 2013, OBESITY, V21, P705, DOI 10.1002/oby.20121; Larson MJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00723; Lee SJ, 2008, J APPL PHYSIOL, V104, P747, DOI 10.1152/japplphysiol.01380.2006; Levine JA, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.032755; Lis AM, 2007, EUR SPINE J, V16, P283, DOI 10.1007/s00586-006-0143-7; MacEwen BT, 2015, PREV MED, V70, P50, DOI 10.1016/j.ypmed.2014.11.011; MARRAS WS, 1995, ERGONOMICS, V38, P377, DOI 10.1080/00140139508925111; Matthis JS, 2018, CURR BIOL, V28, P1224, DOI 10.1016/j.cub.2018.03.008; Mummery WK, 2005, AM J PREV MED, V29, P91, DOI 10.1016/j.amepre.2005.04.003; Neuhaus M, 2014, OBES REV, V15, P822, DOI 10.1111/obr.12201; Pataky TC, 2012, COMPUT METHOD BIOMEC, V15, P295, DOI 10.1080/10255842.2010.527837; Pataky TC, 2010, J BIOMECH, V43, P1976, DOI 10.1016/j.jbiomech.2010.03.008; Patterson KK, 2008, ARCH PHYS MED REHAB, V89, P304, DOI 10.1016/j.apmr.2007.08.142; Rempel D, 2018, J OCCUP ENVIRON MED, V60, pE319, DOI 10.1097/JOM.0000000000001351; Ricci F, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00199; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Roffey DM, 2010, SPINE J, V10, P252, DOI 10.1016/j.spinee.2009.12.005; Ryde GC, 2013, AM J PREV MED, V45, P448, DOI 10.1016/j.amepre.2013.05.018; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Shorter KA, 2008, CLIN BIOMECH, V23, P459, DOI 10.1016/j.clinbiomech.2007.11.009; Sliter M, 2015, J OCCUP HEALTH PSYCH, V20, P259, DOI 10.1037/a0038175; Srygley JM, 2009, BRAIN RES, V1253, P92, DOI 10.1016/j.brainres.2008.11.067; Straker LM, 2009, HUM FACTORS, V51, P831, DOI 10.1177/0018720810362079; Sui WY, 2019, APPL ERGON, V75, P27, DOI 10.1016/j.apergo.2018.09.002; Thompson WG, 2011, WORK, V40, P473, DOI 10.3233/WOR-2011-1258; Tsai TY, 2015, J BIOMECH, V48, P555, DOI 10.1016/j.jbiomech.2015.01.021; Tsai TY, 2014, J BIOMECH, V47, P1572, DOI 10.1016/j.jbiomech.2014.03.012; Wennman H, 2020, J SCI MED SPORT, V23, P596, DOI 10.1016/j.jsams.2019.12.015; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Yamaguchi M, 2017, J EXP PSYCHOL LEARN, V43, P1432, DOI 10.1037/xlm0000385; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	74	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261140	10.1371/journal.pone.0261140	http://dx.doi.org/10.1371/journal.pone.0261140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905578	gold, Green Published			2022-12-26	WOS:000754615500023
J	Diaz-Alvarez, J; Roiz, P; Gorospe, L; Ayala, A; Perez-Pinto, S; Martinez-Sanz, J; Sanchez-Conde, M; Casado, JL; Perez-Elias, MJ; Moreno, A; Ron, R; Vivancos, MJ; Vizcarra, P; Moreno, S; Serrano-Villar, S				Diaz-Alvarez, Jorge; Roiz, Patricia; Gorospe, Luis; Ayala, Ana; Perez-Pinto, Sergio; Martinez-Sanz, Javier; Sanchez-Conde, Matilde; Casado, Jose L.; Perez-Elias, Maria J.; Moreno, Ana; Ron, Raquel; Vivancos, Maria J.; Vizcarra, Pilar; Moreno, Santiago; Serrano-Villar, Sergio			Implementation of a lung cancer screening initiative in HIV-infected subjects	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; PEOPLE	In this pilot program of low-dose computed tomography (LDCT) for the screening of lung cancer (LC) in a targeted population of people with HIV (PWH), its prevalence was 3.6%; the number needed to screen in order to detect one case of lung cancer was 28, clearly outweighing the risks associated with lung cancer screening. While data from additional cohorts with longitudinal measurements are needed, PWH are a target population for lung cancer screening with LDCT.	[Diaz-Alvarez, Jorge; Martinez-Sanz, Javier; Sanchez-Conde, Matilde; Casado, Jose L.; Perez-Elias, Maria J.; Moreno, Ana; Ron, Raquel; Vivancos, Maria J.; Vizcarra, Pilar; Moreno, Santiago; Serrano-Villar, Sergio] Univ Alcala, Dept Infect Dis, Hosp Univ Ramon Y Cajal, Fac Med,IRYCIS, Madrid, Spain; [Roiz, Patricia] Hosp Univ Ramon Y Cajal, Dept Internal Med, Madrid, Spain; [Roiz, Patricia] Hosp Univ Ramon Y Cajal, Dept Radiol, Madrid, Spain; [Gorospe, Luis; Ayala, Ana] Hosp Avila, Dept Internal Med, Avila, Spain; [Perez-Pinto, Sergio] Hosp Univ Ramon Y Cajal, Dept Infect Dis, Madrid, Spain	Hospital Universitario Ramon y Cajal; Universidad de Alcala; Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal	Serrano-Villar, S (corresponding author), Univ Alcala, Dept Infect Dis, Hosp Univ Ramon Y Cajal, Fac Med,IRYCIS, Madrid, Spain.	sergio.serrano@salud.madrid.org	Serrano-Villar, Sergio/AEU-8833-2022	Serrano-Villar, Sergio/0000-0002-5447-3554; Vizcarra, Pilar/0000-0001-8553-6995; Casado, Jose Luis/0000-0002-7639-8591; Martinez-Sanz, Javier/0000-0003-2020-3908	Instituto de Salud Carlos III [AC17/00019, PI18/00154, COV20/00349, ICI20/0058]; European Regional Development Fund "A way to make Europe"; Fundacion SEIMC-GESIDA (Ayuda SEIMC)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund "A way to make Europe"; Fundacion SEIMC-GESIDA (Ayuda SEIMC)	This work was supported by the Instituto de Salud Carlos III (projects AC17/00019, PI18/00154, COV20/00349, and ICI20/0058), co-funded by European Regional Development Fund "A way to make Europe"; and by a mobility grant and by the Fundacion SEIMC-GESIDA (Ayuda SEIMC). The funders had no role in the study design, data analysis, or interpretation of the results.	Aboulafia DM, 2017, WOMENS HEALTH, V13, P68, DOI 10.1177/1745505717731970; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Barta JA, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2419; Black WC, 2014, NEW ENGL J MED, V371, P1793, DOI 10.1056/NEJMoa1312547; Bommart S, 2017, HIV MED, V18, P787, DOI 10.1111/hiv.12517; Chiu CG, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3229-1; de Koning HJ, 2020, NEW ENGL J MED, V382, P503, DOI 10.1056/NEJMoa1911793; Horeweg N, 2013, EUR RESPIR J, V42, P1659, DOI 10.1183/09031936.00197712; Hulbert A, 2014, J THORAC ONCOL, V9, P752, DOI 10.1097/JTO.0000000000000161; Fukunaga MI, 2021, JAMA ONCOL, V7, P684, DOI 10.1001/jamaoncol.2020.8376; Kiderlen TR, 2017, ONCOL RES TREAT, V40, P88, DOI 10.1159/000458442; Kong CY, 2018, AIDS, V32, P1333, DOI [10.1097/qad.0000000000001818, 10.1097/QAD.0000000000001818]; Makinson A, 2016, AIDS, V30, P573, DOI 10.1097/QAD.0000000000000943; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Oudkerk M, 2017, LANCET ONCOL, V18, pE754, DOI [10.1016/S1470-2045(17)30861-6, 10.1016/s1470-2045(17)30861-6]; Robbins HA, 2014, AIDS, V28, P881, DOI 10.1097/QAD.0000000000000163; Ronit A, 2017, AIDS, V31, P1973, DOI 10.1097/QAD.0000000000001600; Shepherd L, 2019, CLIN INFECT DIS, V68, P650, DOI 10.1093/cid/ciy508; Shiels MS, 2018, ANN INTERN MED, V168, P866, DOI [10.7326/m17-2499, 10.7326/M17-2499]; Sigel K, 2017, CURR OPIN HIV AIDS, V12, P31, DOI 10.1097/COH.0000000000000326; Tanner NT, 2016, AM J RESP CRIT CARE, V193, P534, DOI 10.1164/rccm.201507-1420OC; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085	22	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0260069	10.1371/journal.pone.0260069	http://dx.doi.org/10.1371/journal.pone.0260069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890391	gold, Green Published			2022-12-26	WOS:000747293600007
J	Osorio, D; Munyangaju, I; Nacarapa, E; Muhiwa, A; Nhangave, AV; Ramos, JM				Osorio, Dulce; Munyangaju, Isabelle; Nacarapa, Edy; Muhiwa, Argentina; Nhangave, Amancio Vicente; Ramos, Jose Manuel			Mother-to-child transmission of HIV infection and its associated factors in the district of Bilene, Gaza Province-Mozambique	PLOS ONE			English	Article							VERTICAL TRANSMISSION; RISK-FACTORS; SERVICES; HEALTH; COINFECTIONS; PREVENTION; PREGNANCY; QUALITY	Background Mother-to-child transmission of HIV infection is a significant problem in Mozambique. This study aims to determine the risk factors associated with mother-to-child transmission of HIV in rural Mozambique. Methods Retrospective case-control study in a rural area of Bilene District, on the coast of southern Mozambique, performed from January 2017 to June 2018. The analysis considered the clinical data of HIV exposed children with definitive HIV positive results and their respective infected mothers (cases), and the data of HIV exposed children with definitive HIV negative results and their respective infected mothers (controls) registered in At Risk Child Clinics from 1st January 2017 to 30th June 2018 at the Macia and Praia de Bilene health facilities in Bilene district, Gaza province-Mozambique. Results Ninety pregnant women with HIV were involved in the study, including 30 who had transmitted the infection to their children and 60 who had not. Statistical analysis, adjusted for maternal age and gestational age at first antenatal care visit, showed that independent risk factors for transmission were gestational age at first visit (adjusted odds ratio [aOR] 1.19, 95% confidence interval [CI] 1.05-1.36), non-adherence to combination antiretroviral therapy (56.7% vs. 5%; aOR 14.12, 95% CI 3.15-63.41); a viral load of 1000 copies/mL or more (90% vs. 5%; aOR: 156, 95% CI 22.91-1,062) and female sex of the neonate (80% vs. 51.7%; aOR: 4.43, 95% CI 1.33-15.87). Conclusion A high viral load and non-adherence to antiretroviral therapy are important predictors of mother-to-child HIV transmission.	[Osorio, Dulce] Macia Hlth Ctr, Gen Med Dept, Macia, Gaza, Mozambique; [Munyangaju, Isabelle; Nacarapa, Edy; Muhiwa, Argentina] Tinpswalo Assoc Vincentian Assoc Fight AIDS & TB, Maputo, Gaza, Mozambique; [Nacarapa, Edy] Carmelo Hosp, Dept Internal Med, Chokwe, Gaza, Mozambique; [Nhangave, Amancio Vicente] Prov Hlth Directorate, Gaza Prov Res Nucleus, Xai Xai, Mozambique; [Ramos, Jose Manuel] Gen Univ Hosp Alicante, Dept Internal Med, Alicante, Spain; [Ramos, Jose Manuel] Univ Miguel Hernandez de Elche, Alicante, Spain	General University Hospital of Alicante; Universidad Miguel Hernandez de Elche	Munyangaju, I (corresponding author), Tinpswalo Assoc Vincentian Assoc Fight AIDS & TB, Maputo, Gaza, Mozambique.	imunyangaju@gmail.com	Munyangaju, Isabelle/GLR-2285-2022; Ramos, Jose M./B-6420-2018; Nacarapa, Edy/AAV-6228-2021	Munyangaju, Isabelle/0000-0002-7190-6016; Ramos, Jose M./0000-0002-6501-9867; Nacarapa, Edy/0000-0002-0617-9609; Osorio, Dulce/0000-0002-9091-3844				Ahoua L, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8406-5; [Anonymous], 2020, MOZAMBIQUE; [Anonymous], GLOBAL HIV AIDS STAT; Barral MFM, 2014, REV INST MED TROP SP, V56, P133, DOI 10.1590/S0036-46652014000200008; Bucagu M, 2013, ARCH PUBLIC HEALTH, V71, DOI 10.1186/0778-7367-71-4; E. de P. E. EPE, 2017, ANUARIO ESTATISTICO; Ellington SR, 2011, FUTURE VIROL, V6, P1451, DOI [10.2217/fvl.11.119, 10.2217/FVL.11.119]; Gayle KD, 2001, CLIN MICROBIOL REV, V14, P327, DOI 10.1128/CMR.14.2.327-335.2001; Gimbel S, 2016, JAIDS-J ACQ IMM DEF, V72, pS108, DOI 10.1097/QAI.0000000000001055; Gumbo FZ, 2010, J PERINATOL, V30, P717, DOI 10.1038/jp.2010.31; Johnson LF, 2012, JAIDS-J ACQ IMM DEF, V59, P417, DOI 10.1097/QAI.0b013e3182432f27; Kassa GM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3126-5; King CC, 2013, CURR HIV RES, V11, P10; Marotta C, 2020, AFR HEALTH SCI, V20, P1053, DOI 10.4314/ahs.v20i3.8; Marotta C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071350; Marotta C, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5646-8; Ministerio da Saude (MISAU) Instituto Nacional de Estatistica (INE) Com a Assistencia Tecnica de ICF., 2018, INQ IND IM MAL HIV S; Pozniak A, 2020, LANCET HIV, V7, pE159, DOI 10.1016/S2352-3018(20)30045-X; Rustagi AS, 2017, INT J STD AIDS, V28, P788, DOI 10.1177/0956462416668766; Rustagi AS, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0009-3; Schuster RC, 2018, INT J HEALTH POLICY, V7, P630, DOI 10.15171/ijhpm.2017.137; Volmink Jimmy, 2008, BMJ Clin Evid, V2008; World Health Organisation, 2007, WHO CAS DEF HIV SURV; Yaya S, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2540-z	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0260941	10.1371/journal.pone.0260941	http://dx.doi.org/10.1371/journal.pone.0260941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890430	Green Published, gold			2022-12-26	WOS:000747293600023
J	D'Haene, E; Vandevelde, S; Minten, B				D'Haene, Eline; Vandevelde, Senne; Minten, Bart			Fasting, food and farming: Value chains and food taboos in Ethiopia	PLOS ONE			English	Article							HEALTH-RISKS; MEAT	The impact of food taboos-often because of religion-is understudied. In Ethiopia, religious fasting by Orthodox Christians is assumed to be an important impediment for the sustainable development of a competitive dairy sector and desired higher milk consumption, especially by children. However, evidence is limited. Relying on unique data, we shed light on three major issues. First, we observe that the average annual number of fasting days that Orthodox adults are effectively adhering to is 140, less than commonly cited averages. Using this as an estimate for extrapolation, fasting is estimated to reduce annual dairy consumption by approximately 12 percent nationally. Second, farms adapt to declining milk demand during fasting by increased processing of milk into storable products-fasting contributes to larger price swings for these products. We further note continued sales of milk by non-remote farmers and reduced production-by adjusting lactation times for dairy animals-for remote farmers. Third, fasting is mostly associated with increased milk consumption by the children of dairy farmers, seemingly because of excess milk availability during fasting periods. Our results suggest that fasting habits are not a major explanation for the observed poor performance of Ethiopia's dairy sector nor low milk consumption by children. To reduce the impact of fasting on the dairy sector in Ethiopia further, investment is called for in improved milk processing, storage, and infrastructure facilities.	[D'Haene, Eline] Univ Ghent, Dept Plants & Crops, Ghent, Belgium; [Vandevelde, Senne] European Commiss, Directorate Gen Int Partnerships, Brussels, Belgium; [Minten, Bart] Int Food Policy Res Inst, Yangon, Myanmar	Ghent University	D'Haene, E (corresponding author), Univ Ghent, Dept Plants & Crops, Ghent, Belgium.	Eline.DHaene@UGent.be			American people through USAID under the Feed the Future Innovation Lab for Livestock Systems (LSIL); United States Agency for International Development (USAID) through a five-year Leader with Associates Cooperative Agreement Award [AID-OAA-L-15-00003]	American people through USAID under the Feed the Future Innovation Lab for Livestock Systems (LSIL); United States Agency for International Development (USAID) through a five-year Leader with Associates Cooperative Agreement Award(United States Agency for International Development (USAID))	The research presented here was conducted as part of the CGIAR Research Program on Policies, Institutions, and Markets (PIM), which is led by IFPRI. This study was made possible by the generous support of the American people through USAID under the Feed the Future Innovation Lab for Livestock Systems (LSIL), which is implemented by the Institute of Food and Agricultural Sciences of the University of Florida in partnership with the International Livestock Research Institute (ILRI). LSIL is funded by the United States Agency for International Development (USAID) through a five-year Leader with Associates Cooperative Agreement Award No. AID-OAA-L-15-00003. The funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abegaz GA., 2018, INT FOOD POLICY RES; Bachewe F, 2019, 134 ESSP IFPRI; Bachewe F., 2018, 122 ESSP IFPRI; Bachewe F, 2017, 108 ESSP IFPRI; Boylston T, 2013, BLACKW COMPANION ANT, P257; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; CSA, 2010, POPULATION HOUSING C; Desalegn BB, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010138; Desalegn BB, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081767; Farouk MM, 2015, FOOD RES INT, V76, P882, DOI 10.1016/j.foodres.2015.05.028; Francesconi GN, 2010, FOOD POLICY, V35, P60, DOI 10.1016/j.foodpol.2009.06.003; Gizaw S., 2016, 23 LIVES ILRI; Heiman A, 2019, FOOD POLICY, V83, P363, DOI 10.1016/j.foodpol.2017.07.007; Hirvonen K, 2016, PUBLIC HEALTH NUTR, V19, P1723, DOI 10.1017/S1368980015003237; Hoddinott J, 2015, J DEV STUD, V51, P958, DOI 10.1080/00220388.2015.1018903; Iyer S, 2016, J ECON LIT, V54, P395, DOI 10.1257/jel.54.2.395; Kim SS, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12695; Kitaw G., 2012, LIQUID MILK FEED VAL, DOI [10.1093/heapol/czs035, DOI 10.1093/HEAPOL/CZS035]; KNUTSSON KE, 1970, AM J CLIN NUTR, V23, P956; Kumera G, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0248-0; Land O'Lakes, 2010, NEXT STAG DAIR DEV E; Meyer-Rochow VB, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-18; Minten B, 2021, FOOD POLICY, V98, DOI 10.1016/j.foodpol.2020.101860; MoA ILRI, 2013, DAIR VAL CHAIN VIS S; Pew Research Centre, 2017, CHANG GLOB REL LANDS; Potts KS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020354; Qian F, 2020, DIABETES CARE, V43, P265, DOI 10.2337/dci19-0063; Ranabhat CL, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020459; Richi EB, 2015, INT J VITAM NUTR RES, V85, P70, DOI 10.1024/0300-9831/a000224; Sheehy T, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0471-1; Tegegne A., 2013, 31 IPMS ILRI; The Ethiopian Orthodox Tewahedo Church, 2003, REL HOL CAL 2003 PLA; USAID/Ethiopia, 2013, VAL CHAIN AN ETH MEA; van der Lee J, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10114324; van der Valk O, 2010, 2010033 LEI; Vandercasteelen J, 2018, WORLD DEV, V106, P393, DOI 10.1016/j.worlddev.2018.03.006; Ware Timothy, 1997, ORTHODOX CHURCH; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Zijlstra J., 2015, INVESTMENT OPPORTUNI	39	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0259982	10.1371/journal.pone.0259982	http://dx.doi.org/10.1371/journal.pone.0259982			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882689	gold, Green Published			2022-12-26	WOS:000755037200017
J	Sakamoto, D; Hamaguchi, T; Nakayama, Y; Hada, T; Abo, M				Sakamoto, Daigo; Hamaguchi, Toyohiro; Nakayama, Yasuhide; Hada, Takuya; Abo, Masahiro			Changes in motor paralysis involving upper extremities of outpatient chronic stroke patients from temporary rehabilitation interruption due to spread of COVID-19 infection: An observational study on pre- and post-survey data without a control group	PLOS ONE			English	Article							TOXIN TYPE-A; THERAPY; SPASTICITY; HOME	Background Outpatient rehabilitation was temporarily suspended because of coronavirus disease (COVID-19), and there was a risk that patients' activities of daily living (ADLs) would decrease and physical functions unmaintained. Therefore, we investigated the ADLs and motor functions of chronic stroke patients whose outpatient rehabilitation was temporarily interrupted. Methods In this observational study, the Fugl-Meyer Assessment of the Upper Extremity (FMA-UE), Action Research Arm Test (ARAT), and Barthel Index (BI) scores of 49 stroke hemiplegic patients at 6 and 3 months before rehabilitation interruptions were retrospectively determined and were prospectively investigated on resumption of outpatient rehabilitation. Presence or absence of symptoms and difficulties caused by the interruption period (IP) was investigated using a binomial method. Deltas were analyzed using a generalized linear model (GLM) according to the survey period. Age, sex, severity of FMA-UE immediately post-resumption and post-onset period were used as covariates. For survey items showing significant model fit, the 95% confidence interval of minimum detectable change (MDC95) was calculated, and the amount of change was compared. Questionnaire responses were tested via proportion ratio. Statistical significance was set at 5%. Results The FMA-UE part A and total scores were significantly model fit depending on periods. The estimated FMA-UE total score decreased by 1.64 (z = -2.38, p = 0.02) during the 3-month IP. No fits were observed by GLM in other parts of the FMA-UE, ARAT, or BI. The calculated MDC95 was 3.58 for FMA-UE part A and 4.50 for FMA-UE overall. Answers to questions regarding sleep disturbance and physical pain were significantly biased toward "no" in the psychosomatic function items (p<0.05). There was no bias in the distribution of answers to questions regarding joint stiffness, muscle weakness, muscle stiffness, and difficulty in moving arms and hands. All 16 questions regarding activities and participation items were significantly biased toward answers "no" (p<0.05). Conclusions The FMA-UE part A and total scores were affected. Patients complained of subjective symptoms related to upper limb paralysis after the IP. Since ADLs of patients were maintained, the therapist can recommend that patients not receiving outpatient treatments be evaluated in relation to the shoulder, elbow, and forearm and instructed on self-training to maintain motor function.	[Sakamoto, Daigo; Nakayama, Yasuhide] Jikei Univ, Dept Rehabil Med, Sch Med Hosp, Tokyo, Japan; [Sakamoto, Daigo; Hamaguchi, Toyohiro] Saitama Prefectural Univ, Grad Sch Hlth Sci, Dept Rehabil, Saitama, Japan; [Nakayama, Yasuhide; Hada, Takuya; Abo, Masahiro] Jikei Univ, Dept Rehabil Med, Sch Med, Tokyo, Japan	Jikei University; Jikei University	Hamaguchi, T (corresponding author), Saitama Prefectural Univ, Grad Sch Hlth Sci, Dept Rehabil, Saitama, Japan.; Abo, M (corresponding author), Jikei Univ, Dept Rehabil Med, Sch Med, Tokyo, Japan.	hamaguchi-toyohiro@spu.ac.jp; abo@jikei.ac.jp		Sakamoto, Daigo/0000-0002-9019-1853	JSPS KAKENHI [18K10691]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 18K10691.	Ammar A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061583; [Anonymous], 2020, DECLARATION STATE EM; Aubertin-Leheudre M, 2020, J AM MED DIR ASSOC, V21, P973, DOI 10.1016/j.jamda.2020.04.022; Boldrini P, 2020, EUR J PHYS REHAB MED, V56, P316, DOI 10.23736/S1973-9087.20.06256-5; CARROLL D, 1965, J CHRON DIS, V18, P479, DOI 10.1016/0021-9681(65)90030-5; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Childers MK, 2004, ARCH PHYS MED REHAB, V85, P1063, DOI 10.1016/j.apmr.2003.10.015; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Foley N, 2013, ARCH PHYS MED REHAB, V94, P977, DOI 10.1016/j.apmr.2012.12.006; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Hamaguchi T, 2019, TOXINS, V11, DOI 10.3390/toxins11080453; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; Legg L, 2004, LANCET, V363, P352; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; MAHONEY F I, 1965, Md State Med J, V14, P61; Martinez-Ferran M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061549; McMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412; Moradi V, 2021, WORK, V68, P77, DOI 10.3233/WOR-203356; Rosales RL, 2008, J NEURAL TRANSM, V115, P617, DOI 10.1007/s00702-007-0869-3; Santisteban L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154792; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; Stanton R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114065; Thorsen AM, 2005, STROKE, V36, P297, DOI 10.1161/01.STR.0000152288.42701.a6; van der Lee JH, 2004, STROKE, V35, P1410, DOI 10.1161/01.STR.0000126900.24964.7e; W.H. Organization, 2020, GEN OP REM MED BRIEF; Walker MF, 2004, STROKE, V35, P2226, DOI 10.1161/01.STR.0000137766.17092.fb; WHO, 2020, CRIT REL COVID 19 PA; Woodbury ML, 2013, ARCH PHYS MED REHAB, V94, P1527, DOI 10.1016/j.apmr.2013.03.007; World Health Organization, 2001, ICF INT CLASFUNCT; Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260743	10.1371/journal.pone.0260743	http://dx.doi.org/10.1371/journal.pone.0260743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882736	gold, Green Published			2022-12-26	WOS:000755037200038
J	Harada, K; Ishinuki, T; Ohashi, Y; Tanaka, T; Chiba, A; Numasawa, K; Imai, T; Hayasaka, S; Tsugiki, T; Miyanishi, K; Nagayama, M; Takemasa, I; Kato, J; Mizuguchi, T				Harada, Kohei; Ishinuki, Tomohiro; Ohashi, Yoshiya; Tanaka, Takeo; Chiba, Ayaka; Numasawa, Kanako; Imai, Tatsuya; Hayasaka, Shun; Tsugiki, Takahito; Miyanishi, Koji; Nagayama, Minoru; Takemasa, Ichiro; Kato, Junji; Mizuguchi, Toru			Nature of the liver volume depending on the gender and age assessing volumetry from a reconstruction of the computed tomography	PLOS ONE			English	Article							HEPATIC RESECTION; SURFACE-AREA; RISK-FACTORS; BODY-WEIGHT; FAILURE; TRANSPLANTATION; HEPATECTOMY; MORTALITY; FORMULA	Although the liver is a regenerating organ, excessive loss of liver volume (LV) can cause fatal liver failure. It is unclear whether LV is correlated with age; however, it is known that liver function decreases with age. In addition, the gender-related role of LV remains unclear. This study aimed to investigate the changes in LV by age and gender. Between January and December 2018, 374 consecutive patients who underwent abdominal multidetector computed tomography (MDCT) for any abdominal examinations were enrolled. LV was evaluated using MDCT. The relationship between the LV and body mass index (BMI), body surface area (BSA), age, and gender was investigated. The modified LV (mLV) was calculated by a formula measured LV x 1.5/BSA. LV correlated to BSA more than to BMI in both the males (R: 0.559 vs. 0.416) and females (R: 0.479 vs. 0.300) in our study. Age was negatively correlated to LV and BSA, and correlated to LV more than to BSA in males (R: 0.546 vs. 0.393) and females (R: 0.506 vs. 0.385). In addition, the absolute slope between age and LV in the males was higher than that in the females (14.1 vs. 10.2, respectively). Furthermore, the absolute slope of age and mLV in the males was slightly higher than in the females (9.1 vs. 7.3, respectively). In conclusion, LV in the normal liver is correlated to age rather than the one in the diseased liver. Liver volume in the males decreased more with age than LV in the females.	[Harada, Kohei; Ohashi, Yoshiya; Tanaka, Takeo; Chiba, Ayaka; Numasawa, Kanako; Imai, Tatsuya; Hayasaka, Shun; Tsugiki, Takahito] Sapporo Med Univ Hosp, Div Radiol, Sapporo, Hokkaido, Japan; [Ishinuki, Tomohiro; Mizuguchi, Toru] Sapporo Med Univ, Postgrad Sch Hlth Sci & Med, Sapporo, Hokkaido, Japan; [Miyanishi, Koji; Kato, Junji] Sapporo Med Univ, Dept Med Oncol, Sapporo, Hokkaido, Japan; [Nagayama, Minoru; Takemasa, Ichiro; Mizuguchi, Toru] Sapporo Med Univ, Dept Surg, Sapporo, Hokkaido, Japan; [Nagayama, Minoru; Takemasa, Ichiro; Mizuguchi, Toru] Sapporo Med Univ, Dept Surg Sci & Oncol, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Harada, K (corresponding author), Sapporo Med Univ Hosp, Div Radiol, Sapporo, Hokkaido, Japan.	kouhey@sapmed.ac.jp		Harada, Kohei/0000-0002-3245-6980				Bachellier P, 2011, ANN SURG, V253, P173, DOI 10.1097/SLA.0b013e3181f193ba; Benzoni Enrico, 2006, Hepatobiliary Pancreat Dis Int, V5, P526; Buchard B, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010186; Chan SC, 2006, WORLD J GASTROENTERO, V12, P2217, DOI 10.3748/wjg.v12.i4.2217; Chin KM, 2020, WORLD J SURG, V44, P4197, DOI 10.1007/s00268-020-05713-w; Chouker A, 2004, LIVER TRANSPLANT, V10, P678, DOI 10.1002/lt.20113; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fleming TP, 2018, LANCET, V391, P1842, DOI [10.1016/S0140-6736(18)30312-X, 10.1016/s0140-6736(18)30312-x]; Fu-Gui L, 2009, TRANSPL P, V41, P4052, DOI 10.1016/j.transproceed.2009.08.079; Gavriilidis P, 2018, TRANSPL INT, V31, P1071, DOI 10.1111/tri.13317; Harada K., 2019, WORLD J META-ANAL, V7, P234, DOI [10.13105/wjma.v7.i5.234, DOI 10.13105/WJMA.V7.I5.234]; Hashimoto T, 2006, J GASTROEN HEPATOL, V21, P1710, DOI 10.1111/j.1440-1746.2006.04433.x; Imamura H, 2003, ARCH SURG-CHICAGO, V138, P1198, DOI 10.1001/archsurg.138.11.1198; Inoue Y, 2019, J GASTROINTEST SURG, V23, P914, DOI 10.1007/s11605-018-3985-5; Kauffmann Rondi, 2014, Hepatobiliary Surg Nutr, V3, P238, DOI 10.3978/j.issn.2304-3881.2014.09.01; Llovet Josep M, 2004, Liver Transpl, V10, pS115, DOI 10.1002/lt.20034; MARUYAMA Y, 1991, GASTROENTEROL JPN, V26, P435; Morine Y, 2017, ANTICANCER RES, V37, P5693, DOI 10.21873/anticanres.12006; Biondo-Simoes MDP, 2009, ACTA CIR BRAS, V24, P3, DOI 10.1590/S0102-86502009000100002; Poon RT, 2005, J HEPATO-BILIARY-PAN, V12, P31, DOI 10.1007/s00534-004-0945-0; Ribeiro HSC, 2013, EJSO-EUR J SURG ONC, V39, P380, DOI 10.1016/j.ejso.2012.12.020; Saadat LV, 2021, HPB, V23, P551, DOI 10.1016/j.hpb.2020.08.013; Shoup M, 2003, J GASTROINTEST SURG, V7, P325, DOI 10.1016/S1091-255X(02)00370-0; Son JH, 2020, EUR RADIOL, V30, P3486, DOI 10.1007/s00330-020-06665-4; Soreide JA, 2021, EJSO-EUR J SURG ONC, V47, P216, DOI 10.1016/j.ejso.2020.09.001; Sugawara Y, 2002, LIVER TRANSPLANT, V8, P58, DOI 10.1053/jlts.2002.29761; Surasi DSS, 2021, ULTRASOUND Q, V37, P198, DOI 10.1097/RUQ.0000000000000472; Surman OS, 2003, LANCET, V362, P674, DOI 10.1016/S0140-6736(03)14239-0; Tan CY, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt465; URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5; van den Broek MAJ, 2008, LIVER INT, V28, P767, DOI 10.1111/j.1478-3231.2008.01777.x; Vauthey JN, 2010, HPB, V12, P289, DOI 10.1111/j.1477-2574.2010.00181.x; Vauthey JN, 2002, LIVER TRANSPLANT, V8, P233, DOI 10.1053/jlts.2002.31654; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Yasuda S, 2020, J INVEST SURG, V33, P332, DOI 10.1080/08941939.2018.1517839; Yoshizumi T, 2003, TRANSPLANT P, V35, P1415, DOI 10.1016/S0041-1345(03)00482-2; Yu HC, 2004, LIVER TRANSPLANT, V10, P779, DOI 10.1002/lt.20188; Yuan D, 2008, TRANSPL P, V40, P3536, DOI 10.1016/j.transproceed.2008.07.135	39	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0261094	10.1371/journal.pone.0261094	http://dx.doi.org/10.1371/journal.pone.0261094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879120	gold, Green Published			2022-12-26	WOS:000754625200050
J	Duran, N; Atkinson, AP				Duran, Nazire; Atkinson, Anthony P.			Foveal processing of emotion-informative facial features	PLOS ONE			English	Article							SOCIAL ATTENTION; EFFECT SIZE; FACE; RECOGNITION; AMYGDALA; FEAR; EXPRESSIONS; GAZE; EYES; PATTERNS	Certain facial features provide useful information for recognition of facial expressions. In two experiments, we investigated whether foveating informative features of briefly presented expressions improves recognition accuracy and whether these features are targeted reflexively when not foveated. Angry, fearful, surprised, and sad or disgusted expressions were presented briefly at locations which would ensure foveation of specific features. Foveating the mouth of fearful, surprised and disgusted expressions improved emotion recognition compared to foveating an eye or cheek or the central brow. Foveating the brow led to equivocal results in anger recognition across the two experiments, which might be due to the different combination of emotions used. There was no consistent evidence suggesting that reflexive first saccades targeted emotion-relevant features; instead, they targeted the closest feature to initial fixation. In a third experiment, angry, fearful, surprised and disgusted expressions were presented for 5 seconds. Duration of task-related fixations in the eyes, brow, nose and mouth regions was modulated by the presented expression. Moreover, longer fixation at the mouth positively correlated with anger and disgust accuracy both when these expressions were freely viewed (Experiment 2b) and when briefly presented at the mouth (Experiment 2a). Finally, an overall preference to fixate the mouth across all expressions correlated positively with anger and disgust accuracy. These findings suggest that foveal processing of informative features is functional/contributory to emotion recognition, but they are not automatically sought out when not foveated, and that facial emotion recognition performance is related to idiosyncratic gaze behaviour.	[Duran, Nazire; Atkinson, Anthony P.] Univ Durham, Dept Psychol, Durham, England	Durham University	Atkinson, AP (corresponding author), Univ Durham, Dept Psychol, Durham, England.	a.p.atkinson@durham.ac.uk		Duran, Nazire/0000-0002-2569-6433				Abbruzzese L, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02371; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Allen Micah, 2019, Wellcome Open Res, V4, P63, DOI 10.12688/wellcomeopenres.15191.1; Arizpe J, 2017, VISION RES, V141, P191, DOI 10.1016/j.visres.2016.10.013; Arizpe J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031106; Atkinson AP, 2020, J EXP PSYCHOL HUMAN, V46, P292, DOI 10.1037/xhp0000712; Atkinson AP, 2013, EMOT REV, V5, P30, DOI 10.1177/1754073912457226; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Beaudry O, 2014, COGNITION EMOTION, V28, P416, DOI 10.1080/02699931.2013.833500; Bindemann M, 2010, J EXP PSYCHOL HUMAN, V36, P1477, DOI 10.1037/a0019057; Bindemann M, 2009, J VISION, V9, DOI 10.1167/9.2.7; Birmingham E, 2008, Q J EXP PSYCHOL, V61, P986, DOI 10.1080/17470210701410375; Blais C, 2012, NEUROPSYCHOLOGIA, V50, P2830, DOI 10.1016/j.neuropsychologia.2012.08.010; Bodenschatz CM, 2019, PSYCHOL REP, V122, P1432, DOI 10.1177/0033294118789041; Boll S, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00255; Burt DM, 1997, NEUROPSYCHOLOGIA, V35, P685, DOI 10.1016/S0028-3932(96)00111-X; Butler S, 2005, NEUROPSYCHOLOGIA, V43, P52, DOI 10.1016/j.neuropsychologia.2004.06.005; Caldara R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009708; Calder AJ, 2000, COGNITION, V76, P105, DOI 10.1016/S0010-0277(00)00074-3; Chamberland J, 2017, SOC NEUROSCI-UK, V12, P751, DOI 10.1080/17470919.2016.1251964; Corden B, 2008, NEUROPSYCHOLOGIA, V46, P137, DOI 10.1016/j.neuropsychologia.2007.08.005; Du SC, 2014, P NATL ACAD SCI USA, V111, pE1454, DOI 10.1073/pnas.1322355111; Du SC, 2011, J VISION, V11, DOI 10.1167/11.13.24; Eisenbarth H, 2011, EMOTION, V11, P860, DOI 10.1037/a0022758; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; FINDLAY JM, 1982, VISION RES, V22, P1033, DOI 10.1016/0042-6989(82)90040-2; Fletcher-Watson S, 2008, PERCEPTION, V37, P571, DOI 10.1068/p5705; Gagnon M, 2010, J NONVERBAL BEHAV, V34, P27, DOI 10.1007/s10919-009-0076-z; Gamer M, 2013, CURR BIOL, V23, pR917, DOI 10.1016/j.cub.2013.09.008; Gamer M, 2010, P NATL ACAD SCI USA, V107, P9400, DOI 10.1073/pnas.1000985107; Gamer M, 2009, J NEUROSCI, V29, P9123, DOI 10.1523/JNEUROSCI.1883-09.2009; Guo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042585; Hall E.T., 1966, HIDDEN DIMENSION, V609; Hall JK, 2010, COGNITION EMOTION, V24, P629, DOI 10.1080/02699930902906882; Hampson E, 2006, EVOL HUM BEHAV, V27, P401, DOI 10.1016/j.evolhumbehav.2006.05.002; Hayward WG, 2016, J EXP PSYCHOL HUMAN, V42, P1482, DOI 10.1037/xhp0000246; HE PY, 1989, VISION RES, V29, P1165, DOI 10.1016/0042-6989(89)90063-1; Hessels RS, 2016, BEHAV RES METHODS, V48, P1694, DOI 10.3758/s13428-015-0676-y; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Jack RE, 2014, CURR BIOL, V24, P187, DOI 10.1016/j.cub.2013.11.064; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Kanan C, 2015, VISION RES, V108, P67, DOI 10.1016/j.visres.2015.01.013; Kelley K, 2007, BEHAV RES METHODS, V39, P979, DOI 10.3758/BF03192993; Kelley K, 2007, J STAT SOFTW, V20, P1; Kliemann D, 2012, J NEUROSCI, V32, P9469, DOI 10.1523/JNEUROSCI.5294-11.2012; Kliemann D, 2010, J NEUROSCI, V30, P12281, DOI 10.1523/JNEUROSCI.0688-10.2010; Laidlaw KEW, 2012, J EXP PSYCHOL HUMAN, V38, P1132, DOI 10.1037/a0027075; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; McKone E, 2009, VISION RES, V49, P268, DOI 10.1016/j.visres.2008.10.020; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Or CCF, 2015, J VISION, V15, DOI 10.1167/15.13.12; Oruc I, 2010, J VISION, V10, DOI 10.1167/10.12.20; Peterson MF, 2013, PSYCHOL SCI, V24, P1216, DOI 10.1177/0956797612471684; Peterson MF, 2012, P NATL ACAD SCI USA, V109, pE3314, DOI 10.1073/pnas.1214269109; Poncet F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245777; ROBSON JG, 1981, VISION RES, V21, P409, DOI 10.1016/0042-6989(81)90169-3; Rosenholtz R, 2016, ANNU REV VIS SCI, V2, P437, DOI 10.1146/annurev-vision-082114-035733; Ross DA, 2015, VIS COGN, V23, P533, DOI 10.1080/13506285.2015.1049678; ROTTER NG, 1988, J NONVERBAL BEHAV, V12, P139, DOI 10.1007/BF00986931; Roy-Charland A, 2014, COGNITION EMOTION, V28, P1214, DOI 10.1080/02699931.2013.878687; Scheller E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041792; Schurgin MW, 2014, J VISION, V14, DOI 10.1167/14.13.14; Smith FW, 2009, PSYCHOL SCI, V20, P1202, DOI 10.1111/j.1467-9280.2009.02427.x; Smith ML, 2018, J VISION, V18, DOI 10.1167/18.9.10; Smith ML, 2014, EMOTION, V14, P478, DOI 10.1037/a0035588; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Strasburger H, 2011, J VISION, V11, DOI 10.1167/11.5.13; Sullivan S, 2007, J GERONTOL B-PSYCHOL, V62, pP53, DOI 10.1093/geronb/62.1.P53; Sullivan S, 2017, J GERONTOL B-PSYCHOL, V72, P441, DOI 10.1093/geronb/gbv033; Tanaka J.W., 2011, OXFORD HDB FACE PERC, P177, DOI [DOI 10.1093/OXFORDHB/9780199559053.013.0010, 10.1093/oxfordhb/9780199559053.013.0010]; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Vaidya AR, 2014, COGNITION, V133, P443, DOI 10.1016/j.cognition.2014.07.004; WAGNER HL, 1993, J NONVERBAL BEHAV, V17, P3, DOI 10.1007/BF00987006; Wandell BA., 1995, FDN VISION, DOI [10.1016/0042-6989(94)00122-3, DOI 10.1016/0042-6989(94)00122-3]; Wegrzyn M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177239; Wells LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168307; Widen SC, 2010, EMOTION, V10, P455, DOI 10.1037/a0019151; Wong B, 2005, NEUROPSYCHOLOGY, V19, P739, DOI 10.1037/0894-4105.19.6.739; Yang N, 2014, J VISION, V14, DOI 10.1167/14.8.17; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6	83	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260814	10.1371/journal.pone.0260814	http://dx.doi.org/10.1371/journal.pone.0260814			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855898	Green Accepted, Green Published, gold			2022-12-26	WOS:000735299000130
J	Lee, SY; Teng, Y; Son, M; Ku, B; Moon, HS; Tergaonkar, V; Chow, PKH; Lee, DW; Nam, DH				Lee, Sang-Yun; Teng, Yvonne; Son, Miseol; Ku, Bosung; Moon, Ho Sang; Tergaonkar, Vinay; Chow, Pierce Kah-Hoe; Lee, Dong Woo; Nam, Do-Hyun			High-dose drug heat map analysis for drug safety and efficacy in multi-spheroid brain normal cells and GBM patient-derived cells	PLOS ONE			English	Article							CULTURE; MODELS; TEMOZOLOMIDE	To test the safety and efficacy of drugs via a high does drug heat map, a multi-spheroids array chip was developed by adopting a micropillar and microwell structure. In the chip, patient-derived cells were encapsulated in alginate and grown to maturity for more than 7 days to form cancer multi-spheroids. Multi-spheroids grown in conventional well plates require many cells and are easily damaged as a result of multiple pipetting during maintenance culture or experimental procedures. To address these issues, we applied a micropillar and microwell structure to the multi-spheroids array. Patient-derived cells from patients with Glioblastoma (GBM), the most common and lethal form of central nervous system cancer, were used to validate the array chip performance. After forming multi-spheroids with a diameter greater than 100 mu m in a 12x36 pillar array chip (25mm x 75mm), we tested 70 drug compounds (6 replicates) using a high-dose to determine safety and efficacy for drug candidates. Comparing the drug response of multi-spheroids derived from normal cells and cancer cells, we found that four compounds (Dacomitinib, Cediranib, LY2835219, BGJ398) did not show toxicity to astrocyte cell and were efficacious to patient-derived GBM cells.	[Lee, Sang-Yun; Nam, Do-Hyun] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea; [Lee, Sang-Yun; Ku, Bosung; Moon, Ho Sang] Med & Bio Device MBD Co Ltd, Cent R&D Ctr, Suwon, South Korea; [Teng, Yvonne; Son, Miseol] AVATAMED Pte Ltd, Res & Dev Dept, Singapore, Singapore; [Tergaonkar, Vinay] ASTAR, Lab NFkB Signaling, Inst Mol & Cell Biol IMCB, Singapore, Singapore; [Tergaonkar, Vinay] Natl Univ Singapore NUS, Yong Loo Lin Sch Med, Dept Pathol, Singapore, Singapore; [Chow, Pierce Kah-Hoe] Natl Canc Ctr Singapore NCCS, Div Surg & Surg Oncol, Singapore, Singapore; [Chow, Pierce Kah-Hoe] Singapore Gen Hosp SGH, Dept Hepatopancreatobiliary & Transplant Surg, Singapore, Singapore; [Chow, Pierce Kah-Hoe] Duke NUS Med Sch, Surg Acad Clin Programme, Singapore, Singapore; [Chow, Pierce Kah-Hoe] Genome Inst Singapore GIS, Singapore, Singapore; [Chow, Pierce Kah-Hoe] Inst Mol Cell Biol IMCB, Singapore, Singapore; [Lee, Dong Woo] Konyang Univ, Dept Biomed Engn, Daejon, South Korea; [Nam, Do-Hyun] Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurosurg, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Singapore General Hospital; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Konyang University; Sungkyunkwan University (SKKU); Samsung Medical Center	Nam, DH (corresponding author), Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea.; Lee, DW (corresponding author), Konyang Univ, Dept Biomed Engn, Daejon, South Korea.; Nam, DH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurosurg, Sch Med, Seoul, South Korea.	dw2010.lee@gmail.com; nsnam@skku.edu		Chow, Pierce/0000-0003-0584-2584; Lee, Dong Woo/0000-0003-4436-8272	Korea Medical Device Development Fund - Korean government (Ministry of Science and ICT) [KMDF_PR_20200901_0153-2021]; Korea Medical Device Development Fund - Korean government (Ministry of Trade, Industry and Energy) [KMDF_PR_20200901_0153-2021]; Korea Medical Device Development Fund - Korean government (Ministry of Health and Welfare) [KMDF_PR_20200901_0153-2021]; Korea Medical Device Development Fund - Korean government (Ministry of Food and Drug Safety) [KMDF_PR_20200901_0153-2021]; Korea Medical Device Development Fund - Korea government (Ministry of Science and ICT); Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy); Korea Medical Device Development Fund - Korea government (Ministry of Health Welfare); Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety) [KMDF_PR_20200901_0135-2021]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea [HI17C2412]; National Research Foundation of Korea(NRF) - Korea government (Ministry of Science and ICT) [NRF-2020M2D9A3094087]	Korea Medical Device Development Fund - Korean government (Ministry of Science and ICT); Korea Medical Device Development Fund - Korean government (Ministry of Trade, Industry and Energy); Korea Medical Device Development Fund - Korean government (Ministry of Health and Welfare); Korea Medical Device Development Fund - Korean government (Ministry of Food and Drug Safety); Korea Medical Device Development Fund - Korea government (Ministry of Science and ICT); Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy); Korea Medical Device Development Fund - Korea government (Ministry of Health Welfare); Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety); Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea(NRF) - Korea government (Ministry of Science and ICT)	This work was supported by the Korea Medical Device Development Fund grant funded by the Korean government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health and Welfare, the Ministry of Food and Drug Safety) (Project Number: KMDF_PR_20200901_0153-2021). This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety) (Project Number: KMDF_PR_20200901_0135-2021). This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI17C2412). This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government (the Ministry of Science and ICT) (No. NRF-2020M2D9A3094087).	Andersen Therese, 2015, Microarrays (Basel), V4, P133, DOI 10.3390/microarrays4020133; Astashkina A, 2014, ADV DRUG DELIVER REV, V69, P1, DOI 10.1016/j.addr.2014.02.008; Beier D, 2012, J NEURO-ONCOL, V109, P45, DOI 10.1007/s11060-012-0878-4; Bokhari M, 2007, J ANAT, V211, P567, DOI 10.1111/j.1469-7580.2007.00778.x; Dekkers JF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8278; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Elkayam T, 2006, TISSUE ENG, V12, P1357, DOI 10.1089/ten.2006.12.1357; Es HA, 2018, TRENDS BIOTECHNOL, V36, P358, DOI 10.1016/j.tibtech.2017.12.005; Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715; Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054; Jabs J, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177697; Joo KM, 2013, CELL REP, V3, P260, DOI 10.1016/j.celrep.2012.12.013; Kang J, 2016, LAB CHIP, V16, P2265, DOI 10.1039/c6lc00526h; Lee DW, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7218707; Lee DW, 2014, ANAL CHEM, V86, P535, DOI 10.1021/ac402546b; Lee JK, 2018, NAT GENET, V50, P1399, DOI 10.1038/s41588-018-0209-6; Lee SY, 2018, ANAL CHEM, V90, P8354, DOI 10.1021/acs.analchem.7b05328; Li GN, 2007, TISSUE ENG, V13, P1035, DOI 10.1089/ten.2006.0251; Lv DL, 2017, ONCOL LETT, V14, P6999, DOI 10.3892/ol.2017.7134; Raub TJ, 2015, DRUG METAB DISPOS, V43, P1360, DOI 10.1124/dmd.114.062745; Schyschka L, 2013, ARCH TOXICOL, V87, P1581, DOI 10.1007/s00204-013-1080-y; Sirenko O, 2015, ASSAY DRUG DEV TECHN, V13, P402, DOI 10.1089/adt.2015.655; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Verissimo CS, 2016, ELIFE, V5, DOI 10.7554/eLife.18489; Weeber F, 2017, CELL CHEM BIOL, V24, P1092, DOI 10.1016/j.chembiol.2017.06.012; Xinaris C, 2015, NEPHRON, V130, P191, DOI 10.1159/000433566; Zahonero C, 2015, MOL CANCER THER, V14, P1548, DOI 10.1158/1535-7163.MCT-14-0736	27	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0251998	10.1371/journal.pone.0251998	http://dx.doi.org/10.1371/journal.pone.0251998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855773	gold, Green Published			2022-12-26	WOS:000735299000001
J	Yadav, S; Longkumer, I; Garg, PR; Joshi, S; Rajkumari, S; Devi, NK; Saraswathy, KN				Yadav, Suniti; Longkumer, Imnameren; Garg, Priyanka Rani; Joshi, Shipra; Rajkumari, Sunanda; Devi, Naorem Kiranmala; Saraswathy, Kallur Nava			Association of air pollution and homocysteine with global DNA methylation: A population-based study from North India	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; CARDIOVASCULAR-DISEASE; PARTICULATE MATTER; HEALTHY-CHILDREN; B VITAMINS; EXPOSURE; HYPERHOMOCYSTEINEMIA; HYPOMETHYLATION; EPIGENETICS; FOLATE	Background Anthropogenic air pollution has been implicated in aberrant changes of DNA methylation and homocysteine increase (>15 mu M/L). Folate (<3 ng/mL) and vitamin B-12 (<220 pg/mL) deficiencies also reduce global DNA methylation via homocysteine increase. Although B-vitamin supplements can attenuate epigenetic effects of air pollution but such understanding in population-specific studies are lacking. Hence, the present study aims to understand the role of air pollution, homocysteine, and nutritional deficiencies on methylation. Methods We examined cross-sectionally, homocysteine, folate, vitamin B-12 (chemiluminescence) and global DNA methylation (colorimetric ELISA Assay) among 274 and 270 individuals from low- and high- polluted areas, respectively, from a single Mendelian population. Global DNA methylation results were obtained on 254 and 258 samples from low- and high- polluted areas, respectively. Results Significant decline in median global DNA methylation was seen as a result of air pollution [high-0.84 (0.37-1.97) vs. low-0.96 (0.45-2.75), p = 0.01]. High homocysteine in combination with air pollution significantly reduced global DNA methylation [high-0.71 (0.34-1.90) vs. low-0.93 (0.45-3.00), p = 0.003]. Folate deficient individuals in high polluted areas [high-0.70 (0.37-1.29) vs. low-1.21 (0.45-3.65)] showed significantly reduced global methylation levels (p = 0.007). In low polluted areas, despite folate deficiency, if normal vitamin B-12 levels were maintained, global DNA methylation levels improved significantly [2.03 (0.60-5.24), p = 0.007]. Conversely, in high polluted areas despite vitamin B-12 deficiency, if normal folate status was maintained, global DNA methylation status improved significantly [0.91 (0.36-1.63)] compared to vitamin B-12 normal individuals [0.54 (0.26-1.13), p = 0.04]. Conclusions High homocysteine may aggravate the effects of air pollution on DNA methylation. Vitamin B-12 in low-polluted and folate in high-polluted areas may be strong determinants for changes in DNA methylation levels. The effect of air pollution on methylation levels may be reduced through inclusion of dietary or supplemented B-vitamins. This may serve as public level approach in natural settings to prevent metabolic adversities at community level.	[Yadav, Suniti; Longkumer, Imnameren; Rajkumari, Sunanda; Devi, Naorem Kiranmala; Saraswathy, Kallur Nava] Univ Delhi, Dept Anthropol, Lab Biochem & Mol Anthropol, Delhi, India; [Garg, Priyanka Rani] MAMTA Hlth Inst Mother & Child, New Delhi, India; [Joshi, Shipra] Manbhum Ananda Ashram Nityananda Trust MANT, Kolkata, W Bengal, India	University of Delhi	Saraswathy, KN (corresponding author), Univ Delhi, Dept Anthropol, Lab Biochem & Mol Anthropol, Delhi, India.	knsaraswathy@yahoo.com		Saraswathy, Kallur Nava/0000-0002-0826-9675	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR14378/MED/30/535/2010]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The present study was part of a major project received by the corresponding author KNS. Fund number BT/PR14378/MED/30/535/2010 Name of the funder is Department of Biotechnology, Ministry of Science and Technology, Government of India. URL of funder: https://dbtindia.gov.in/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1994, PROBL GEN SURG, V11, P147; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Baccarelli A., EFFECTS SHORT TERM E; Baccarelli A, 2007, ENVIRON HEALTH PERSP, V115, P176, DOI 10.1289/ehp.9517; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Barchitta M, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00514; Bellavia A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000212; Biswas SK, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5698931; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Bromberg A, 2008, SCHIZOPHR RES, V101, P50, DOI 10.1016/j.schres.2008.01.009; Byun HM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003218; Calderon-Garciduenas L, 2008, INHAL TOXICOL, V20, P499, DOI 10.1080/08958370701864797 ; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Chi GC, 2016, THESIS; Chi GC, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0202-4; Chia N, 2011, EPIGENETICS-US, V6, P853, DOI 10.4161/epi.6.7.16461; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; De Nys S, 2018, ENVIRON INT, V111, P301, DOI 10.1016/j.envint.2017.11.002; De Prins S, 2013, ENVIRON INT, V59, P418, DOI 10.1016/j.envint.2013.07.007; Duan HW, 2013, ARCH TOXICOL, V87, P2013, DOI 10.1007/s00204-013-1046-0; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Fustinoni S, 2012, MED LAV, V103, P84; Gonzalez-Jaramillo V, 2019, J HUM HYPERTENS, V33, P703, DOI 10.1038/s41371-019-0218-7; Gori AM, 2005, AM J CLIN NUTR, V82, P335, DOI 10.1093/ajcn/82.2.335; He LX, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00585; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Kelly FJ, 2011, CLIN EXP ALLERGY, V41, P1059, DOI 10.1111/j.1365-2222.2011.03776.x; Kile ML, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-47; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Kumar A, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0233-z; Lan Yahui, 2019, J Life Sci (Westlake Village), V1, P1; Lee MH, 2017, ENVIRON RES, V158, P333, DOI 10.1016/j.envres.2017.06.017; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Li JX, 2017, SCI BULL, V62, P743, DOI 10.1016/j.scib.2017.05.009; Lucock M, 2017, P NATL ACAD SCI USA, V114, pE3878, DOI 10.1073/pnas.1704662114; Madrigano J, 2011, ENVIRON HEALTH PERSP, V119, P977, DOI 10.1289/ehp.1002773; Manisalidis I, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00014; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Misra A, 2002, EUR J NUTR, V41, P68, DOI 10.1007/s003940200010; Muka T, 2016, INT J CARDIOL, V212, P174, DOI 10.1016/j.ijcard.2016.03.062; Mukherjee A, 2020, TRANSPORT RES D-TR E, V86, DOI 10.1016/j.trd.2020.102442; Nagendra SMS, 2016, TRANSPORT RES D-TR E, V48, P1, DOI 10.1016/j.trd.2016.07.006; Park SK, 2008, AM J RESP CRIT CARE, V178, P283, DOI 10.1164/rccm.200708-1286OC; Peluso M, 2012, INT J EPIDEMIOL, V41, P1753, DOI 10.1093/ije/dys129; Pena MSB, 2017, CARDIOL CLIN, V35, P71, DOI 10.1016/j.ccl.2016.09.001; Pfeiffer L, 2015, CIRC-CARDIOVASC GENE, V8, P334, DOI 10.1161/CIRCGENETICS.114.000804; Plusquin M, 2017, ENVIRON INT, V108, P127, DOI 10.1016/j.envint.2017.08.006; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Refsum H, 2001, AM J CLIN NUTR, V74, P233; Ren CZ, 2010, EPIDEMIOLOGY, V21, P198, DOI 10.1097/EDE.0b013e3181cc8bfc; Rider CF, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0713-2; Rodrigo R, 2003, J CLIN PHARMACOL, V43, P1299, DOI 10.1177/0091270003258190; Rogers EJ, 2007, NEW ENGL J MED, V357, P421, DOI 10.1056/NEJMc066569; Rossnerova A, 2013, MUTAT RES-FUND MOL M, V741, P18, DOI 10.1016/j.mrfmmm.2013.02.003; Rusiecki JA, 2008, ENVIRON HEALTH PERSP, V116, P1547, DOI 10.1289/ehp.11338; Sanchez-Guerra M, 2015, EPIGENETICS-US, V10, P633, DOI 10.1080/15592294.2015.1050174; Silva RA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034005; Singh AL, 2005, HABITAT INT, V29, P591, DOI 10.1016/j.habitatint.2004.04.010; Sofowote UM, 2019, ATMOS ENVIRON-X, V1, DOI 10.1016/j.aeaoa.2019.100005; Tang WY, 2007, REV ENDOCR METAB DIS, V8, P173, DOI 10.1007/s11154-007-9042-4; Tang WY, 2012, ENVIRON HEALTH PERSP, V120, P1195, DOI 10.1289/ehp.1103744; Tao MH, 2014, ENVIRON RES, V134, P325, DOI 10.1016/j.envres.2014.08.017; Tarantini L, 2009, ENVIRON HEALTH PERSP, V117, P217, DOI 10.1289/ehp.11898; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; Wang CC, 2020, EPIGENETICS-US, V15, P524, DOI 10.1080/15592294.2019.1699894; Wang YH, 2020, ENVIRON INT, V134, DOI 10.1016/j.envint.2019.105296; WHO, 2016, AMBIENT AIR POLLUTIO; WHO fact sheets, WHO FACT SHEETS AMBI; Willmer T, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00744; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Zhang DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123423; Zhong J, 2017, P NATL ACAD SCI USA, V114, P3503, DOI 10.1073/pnas.1618545114	72	0	0	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260860	10.1371/journal.pone.0260860	http://dx.doi.org/10.1371/journal.pone.0260860			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855899	Green Published, gold			2022-12-26	WOS:000735299000142
J	Al-Ezzi, EM; Veitch, ZW; Salah, SH; Van der Kwast, TH; Stockley, TL; Selvarajah, S; Zhang, T; Sridhar, SS; Sacher, AG; Fallah-Rad, N; Kulkarni, GS; Zlotta, AR; Finelli, A; Hansen, AR				Al-Ezzi, Esmail M.; Veitch, Zachary W.; Salah, Samer H.; Van der Kwast, Theodorus H.; Stockley, Tracy L.; Selvarajah, Shamini; Zhang, Tong; Sridhar, Srikala S.; Sacher, Adrian G.; Fallah-Rad, Nazanin; Kulkarni, Girish S.; Zlotta, Alexandre R.; Finelli, Antonio; Hansen, Aaron R.			Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; GROWTH-FACTOR RECEPTOR; UROTHELIAL CARCINOMA; RADICAL CYSTECTOMY; PROGNOSTIC VALUE; CANCER; P53; EXPRESSION; PATTERNS; BIOMARKERS	Background Non-schistosomiasis related-squamous cell carcinoma of urinary bladder (NSR-SCCUB) is a rare tumor subtype distinct from urothelial carcinoma (UC). Studies assessing molecular biomarkers in bladder cancer have generally focused on UC, and genomic data of NSR-SCCUB is limited. We aim to provide additional insight into the molecular underpinnings of this rare entity. Methods NSR-SCCUB patients were identified retrospectively at Princess Margaret Cancer Centre between 2002 and 2017. Demographics, disease characteristics, therapeutic approaches, and outcomes were collected. Tissue samples were interrogated using the Oncomine Comprehensive Assay v3 (ThermoFisher). Kaplan-Meier method was used to estimate the disease-free survival and overall survival (OS). Results Overall, 11 patients with NSR-SCCUB were identified between 2002 and 2017 with adequate tissue samples. Median age was 71 years (45-86), predominantly male (63.6%). At time of diagnosis, 9 patients (81.8%) had muscle-invasive disease, 1 (9.1%) had non-muscle invasive, and 1 (9.1%) had advanced disease. Nine (81.8%) patients had radical cystectomy and pelvic lymph nodes dissection. Eight (72.7%) patients had pT3 or pT4 with N0, and 5 (45.5%) were grade 3. Median OS was 12.5 months (95% CI 7.7-17.2 months). Single nucleotide variants or insertion/deletions were identified in TP53, TERT, PIK3CA, PTEN, CREBBP, FBXW7, and FGFR3. Amplifications were found in CCND1, and EGFR. Conclusions NSR-SCCUB has potentially actionable genomic alterations with anticancer agents and many of these aberrations are also seen in UC. The recruitment of NSR-SCCUB patients harboring such mutations should be considered in biomarker driven urinary bladder cancer studies.	[Al-Ezzi, Esmail M.; Veitch, Zachary W.; Sridhar, Srikala S.; Sacher, Adrian G.; Fallah-Rad, Nazanin; Hansen, Aaron R.] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada; [Salah, Samer H.] King Hussain Canc Ctr, Div Med Oncol & Hematol, Amman, Jordan; [Van der Kwast, Theodorus H.] Toronto Gen Hosp, Dept Pathol, Toronto, ON, Canada; [Stockley, Tracy L.; Selvarajah, Shamini; Zhang, Tong] Univ Hlth Network, Div Clin Lab Genet, Lab Med Program, Toronto, ON, Canada; [Kulkarni, Girish S.; Zlotta, Alexandre R.; Finelli, Antonio] Princess Margaret Canc Ctr, Div Urol Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Hansen, AR (corresponding author), Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada.	aaron.hansen@uhn.ca			Genitourinary Medical Oncologists of Canada (GUMOC)	Genitourinary Medical Oncologists of Canada (GUMOC)	This project received support from the Genitourinary Medical Oncologists of Canada (GUMOC) research grant 2017. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Princess Margaret Cancer Centre Genitourinary Group would like to acknowledge the Genitourinary Medical Oncologists of Canada (GUMOC) research award.	Anari F, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.7_suppl.399; Badawy Afkar A, 2017, Curr Urol, V9, P192, DOI 10.1159/000447140; Badr KM, 2004, HUM PATHOL, V35, P184, DOI 10.1016/j.humpath.2003.10.006; Brenner DR, 2020, CAN MED ASSOC J, V192, pE199, DOI 10.1503/cmaj.191292; Chalasani Venu, 2009, Can Urol Assoc J, V3, pS193; Colquhoun AJ, 2002, POSTGRAD MED J, V78, P584, DOI 10.1136/pmj.78.924.584; Cowan M, 2016, MODERN PATHOL, V29, P511, DOI 10.1038/modpathol.2016.53; Eissa S, 2005, CLIN BIOCHEM, V38, P142, DOI 10.1016/j.clinbiochem.2004.09.004; EL-Kenawy AE, 2003, INT J BIOL MARKER, V18, P284, DOI 10.1177/172460080301800406; Felix AS, 2008, CANCER CAUSE CONTROL, V19, P421, DOI 10.1007/s10552-007-9104-7; Geynisman DM, 2016, J CLIN ONCOL, V34, DOI 10.1200/jco.2016.34.2_suppl.423; Ghoneim MA, 1997, J UROLOGY, V158, P393, DOI 10.1016/S0022-5347(01)64487-2; Goodman RH, 2000, GENE DEV, V14, P1553; Guo CC, 2009, HUM PATHOL, V40, P1448, DOI 10.1016/j.humpath.2009.03.005; Haitel A, 2001, J UROLOGY, V165, P1481, DOI 10.1016/S0022-5347(05)66332-X; Hammam Olfat, 2014, J Egypt Soc Parasitol, V44, P733; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kassouf W, 2007, CANCER, V110, P764, DOI 10.1002/cncr.22853; Kastritis E, 2006, ANTICANCER RES, V26, P3865; Kim PH, 2015, EUR UROL, V67, P198, DOI 10.1016/j.eururo.2014.06.050; Ligresti G, 2009, CELL CYCLE, V8, P1352, DOI 10.4161/cc.8.9.8255; Loriot Y, 2019, NEW ENGL J MED, V381, P338, DOI 10.1056/NEJMoa1817323; Lu ML, 2002, CLIN CANCER RES, V8, P171; Manley KV, 2017, ANN ROY COLL SURG, V99, P155, DOI 10.1308/rcsann.2016.0343; Manunta A, 2005, BJU INT, V95, P497, DOI 10.1111/j.1464-410X.2005.05327.x; Martin JW, 2016, ARAB J UROL, V14, P183, DOI 10.1016/j.aju.2016.07.001; Millis SZ, 2015, CLIN GENITOURIN CANC, V13, pE37, DOI 10.1016/j.clgc.2014.07.010; Raheem AMA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-16; Rose M, 2020, ONCOGENE, V39, P6856, DOI 10.1038/s41388-020-01465-y; Seiler R, 2014, MODERN PATHOL, V27, P87, DOI 10.1038/modpathol.2013.125; Shokeir AA, 2004, BJU INT, V93, P216, DOI 10.1111/j.1464-410X.2004.04588.x; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Spradling K, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.03.023; STERNBERG CN, 1989, CANCER, V64, P2448, DOI 10.1002/1097-0142(19891215)64:12<2448::AID-CNCR2820641209>3.0.CO;2-7; Wan S, 2021, BIOENGINEERED, V12, P1495, DOI 10.1080/21655979.2021.1915725; Wang SB, 2020, J PATHOL CLIN RES, V6, P207, DOI 10.1002/cjp2.163; Ye F, 2014, AM J CLIN EXP UROL, V2, P1; Yeh CH, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0857-2; Youssef R, 2011, BJU INT, V108, P31, DOI 10.1111/j.1464-410X.2010.09854.x; Youssef RF, 2015, J UROLOGY, V193, P451, DOI 10.1016/j.juro.2014.08.109; Zaharieva BM, 2003, J PATHOL, V201, P603, DOI 10.1002/path.1481; Zheng LF, 2018, ONCOL LETT, V15, P568, DOI 10.3892/ol.2017.7344	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0259272	10.1371/journal.pone.0259272	http://dx.doi.org/10.1371/journal.pone.0259272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851968	Green Published, gold			2022-12-26	WOS:000755762900010
J	Gruszka, J; Matuszewski, S				Gruszka, Joanna; Matuszewski, Szymon			Insect rearing protocols in forensic entomology: Benefits from collective rearing of larvae in a carrion beetle Necrodes littoralis L. (Silphidae)	PLOS ONE			English	Article							THANATOPHILUS-MICANS FABRICIUS; BLOW FLY; COLEOPTERA SILPHIDAE; DEVELOPMENT MODELS; DIPTERA; TEMPERATURE; CALLIPHORIDAE; DENSITY; SURVIVAL; FLIES	Forensic entomologists frequently use a developmental method to estimate a post-mortem interval (PMI). Such estimates are based usually on the blow fly larvae or puparia. Data on their development is obtained by rearing them in colonies. In the case of beetles, which can be also useful for PMI estimation, development data is frequently collected by rearing them individually. However, some carrion beetles are gregarious, for instance, Necrodes littoralis (Linnaeus, 1758) (Silphidae). We compared mortality, rate of development and body size of emerged adult beetles reared individually and in aggregations. Mortality was much higher for beetles reared individually, particularly at low temperatures. The rearing protocol affected the time of immature development and the size of adult insects. Individually reared specimens developed much longer at 16 degrees C, whereas at 20 degrees C and 26 degrees C development times of individually reared beetles were slightly shorter. Significant differences in the body size were observed only at 16 degrees C; beetles that developed in aggregations were larger at this temperature. These findings demonstrate that aggregating is particularly beneficial for larvae of N. littoralis at low temperatures, where it largely reduces mortality and facilitates growth. Moreover, these results indicate that in forensic entomology the protocol of individual rearing is unsuitable for gregarious beetles, as it produces reference developmental data of low quality.	[Gruszka, Joanna; Matuszewski, Szymon] Adam Mickiewicz Univ, Lab Criminalist, Poznan, Poland; [Gruszka, Joanna; Matuszewski, Szymon] Adam Mickiewicz Univ, Wielkopolska Ctr Adv Technol, Poznan, Poland; [Gruszka, Joanna] Adam Mickiewicz Univ, Dept Anim Taxon & Ecol, Poznan, Poland	Adam Mickiewicz University; Adam Mickiewicz University; Adam Mickiewicz University	Gruszka, J (corresponding author), Adam Mickiewicz Univ, Lab Criminalist, Poznan, Poland.; Gruszka, J (corresponding author), Adam Mickiewicz Univ, Wielkopolska Ctr Adv Technol, Poznan, Poland.; Gruszka, J (corresponding author), Adam Mickiewicz Univ, Dept Anim Taxon & Ecol, Poznan, Poland.	joanna.gruszka@amu.edu.pl		Gruszka, Joanna/0000-0003-3338-3338	National Science Center of Poland [2016/21/B/NZ8/00788]; Faculty of Biology Adam Mickiewicz University in Poznan [GDWB-11/2019]	National Science Center of Poland(National Science Centre, Poland); Faculty of Biology Adam Mickiewicz University in Poznan	The study was funded by the National Science Center of Poland (https://www.ncn.gov.pl), grant no. 2016/21/B/NZ8/00788. J.G. received financial support from the Dean of the Faculty of Biology Adam Mickiewicz University in Poznan (http://biologia.amu.edu.pl), grant no. GDWB-11/2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendt J, 2011, FORENSIC SCI MED PAT, V7, P379, DOI 10.1007/s12024-010-9209-2; Amendt J, 2007, INT J LEGAL MED, V121, P90, DOI 10.1007/s00414-006-0086-x; Byrd JH, 1997, J MED ENTOMOL, V34, P353, DOI 10.1093/jmedent/34.3.353; Byrd JH, 2001, FORENSIC SCI INT, V120, P79, DOI 10.1016/S0379-0738(01)00431-5; CATTS EP, 1992, J AGR ENTOMOL, V9, P245; Charabidze D, 2016, INT J LEGAL MED, V130, P273, DOI 10.1007/s00414-015-1253-8; Fratczak K, 2014, FORENSIC SCI INT, V241, P20, DOI 10.1016/j.forsciint.2014.04.026; Fratczak-Lagiewska K, 2020, INT J LEGAL MED, V134, P1531, DOI 10.1007/s00414-020-02275-3; GOODBROD JR, 1990, J MED ENTOMOL, V27, P338, DOI 10.1093/jmedent/27.3.338; Grassberger M, 2001, FORENSIC SCI INT, V120, P32, DOI 10.1016/S0379-0738(01)00413-3; Green PWC, 2003, EUR J ENTOMOL, V100, P39, DOI 10.14411/eje.2003.008; GREENBERG B, 1991, J MED ENTOMOL, V28, P565, DOI 10.1093/jmedent/28.5.565; Gruszka J, 2020, FORENSIC SCI INT, V314, DOI 10.1016/j.forsciint.2020.110407; Gruszka J, 2020, ANIM BEHAV, V162, P1, DOI 10.1016/j.anbehav.2020.01.011; Hu GL, 2020, FORENSIC SCI INT, V311, DOI 10.1016/j.forsciint.2020.110275; Lambiase S, 2018, J FORENSIC SCI, V63, P469, DOI 10.1111/1556-4029.13580; Martin-Vega D, 2017, J MED ENTOMOL, V54, P1140, DOI 10.1093/jme/tjx110; Matuszewski S, 2021, FRONT ZOOL, V18, DOI 10.1186/s12983-020-00385-7; Matuszewski S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20796-1; Matuszewski S, 2011, FORENSIC SCI INT, V212, P180, DOI 10.1016/j.forsciint.2011.06.010; Matuszewski S, 2010, FORENSIC SCI INT, V195, P42, DOI 10.1016/j.forsciint.2009.11.007; Matuszewski S, 2010, FORENSIC SCI INT, V194, P85, DOI 10.1016/j.forsciint.2009.10.016; Michalski M, 2018, FORENSIC SCI INT, V287, P153, DOI 10.1016/j.forsciint.2018.03.042; Midgley J, 2009, INT J LEGAL MED, V123, P103, DOI 10.1007/s00414-008-0260-4; Montoya-Molina S, 2021, J MED ENTOMOL, V58, P1041, DOI 10.1093/jme/tjaa255; RATCLIFFE B C, 1972, Transactions of the American Entomological Society (Philadelphia), V98, P359; Richards CS, 2009, MED VET ENTOMOL, V23, P269, DOI 10.1111/j.1365-2915.2009.00819.x; Ridgeway JA, 2014, INT J LEGAL MED, V128, P207, DOI 10.1007/s00414-013-0865-0; Rivers DB, 2011, B ENTOMOL RES, V101, P599, DOI 10.1017/S0007485311000241; Saunders DS, 1995, EUR J ENTOMOL, V92, P615; Scanvion Q, 2018, ANIM BEHAV, V141, P221, DOI 10.1016/j.anbehav.2018.05.012; SULLIVAN RL, 1963, ECOLOGY, V44, P120, DOI 10.2307/1933186; Sustek Z., 1981, ZPRAVY CESKOSLOVENSK, V2, P1; Velasquez Y, 2009, FORENSIC SCI INT, V185, P107, DOI 10.1016/j.forsciint.2008.12.020; Villet MH, 2007, ENTOMOL EXP APPL, V122, P279, DOI 10.1111/j.1570-7458.2006.00520.x; Voss SC, 2014, FORENSIC SCI MED PAT, V10, P314, DOI 10.1007/s12024-014-9565-4; Wang Y, 2020, J FORENSIC LEG MED, V72, DOI 10.1016/j.jflm.2020.101946; Zanetti NI, 2016, J FORENSIC SCI, V61, P375, DOI 10.1111/1556-4029.12965	38	2	2	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260680	10.1371/journal.pone.0260680	http://dx.doi.org/10.1371/journal.pone.0260680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852020	Green Published, gold			2022-12-26	WOS:000755762900055
J	Iqbal, AJ; Krautter, F; Blacksell, IA; Wright, RD; Austin-Williams, SN; Voisin, MB; Hussain, MT; Law, HL; Niki, T; Hirashima, M; Bombardieri, M; Pitzalis, C; Tiwari, A; Nash, GB; Norling, LV; Cooper, D				Iqbal, Asif J.; Krautter, Franziska; Blacksell, Isobel A.; Wright, Rachael D.; Austin-Williams, Shani N.; Voisin, Mathieu-Benoit; Hussain, Mohammed T.; Law, Hannah L.; Niki, Toshiro; Hirashima, Mitsuomi; Bombardieri, Michele; Pitzalis, Costantino; Tiwari, Alok; Nash, Gerard B.; Norling, Lucy, V; Cooper, Dianne			Galectin-9 mediates neutrophil capture and adhesion in a CD44 and beta 2 integrin-dependent manner	FASEB JOURNAL			English	Article						adhesion; innate immunity; leukocyte trafficking	ENDOTHELIAL-CELLS; TRANSENDOTHELIAL MIGRATION; RHEUMATOID-ARTHRITIS; LINKER PEPTIDE; IN-VITRO; EXPRESSION; HYALURONAN; SELECTIN; LIGAND; CHEMOATTRACTANT	Neutrophil trafficking is a key component of the inflammatory response. Here, we have investigated the role of the immunomodulatory lectin Galectin-9 (Gal-9) on neutrophil recruitment. Our data indicate that Gal-9 is upregulated in the inflamed vasculature of RA synovial biopsies and report the release of Gal-9 into the extracellular environment following endothelial cell activation. siRNA knockdown of endothelial Gal-9 resulted in reduced neutrophil adhesion and neutrophil recruitment was significantly reduced in Gal-9 knockout mice in a model of zymosan-induced peritonitis. We also provide evidence for Gal-9 binding sites on human neutrophils; Gal-9 binding induced neutrophil activation (increased expression of beta 2 integrins and reduced expression of CD62L). Intra-vital microscopy confirmed a pro-recruitment role for Gal-9, with increased numbers of transmigrated neutrophils following Gal-9 administration. We studied the role of both soluble and immobilized Gal-9 on human neutrophil recruitment. Soluble Gal-9 significantly strengthened the interaction between neutrophils and the endothelium and inhibited neutrophil crawling on ICAM-1. When immobilized, Gal-9 functioned as an adhesion molecule and captured neutrophils from the flow. Neutrophils adherent to Gal-9 exhibited a spread/activated phenotype that was inhibited by CD18 and CD44 neutralizing antibodies, suggesting a role for these molecules in the pro-adhesive effects of Gal-9. Our data indicate that Gal-9 is expressed and released by the activated endothelium and functions both in soluble form and when immobilized as a neutrophil adhesion molecule. This study paves the way for further investigation of the role of Gal-9 in leukocyte recruitment in different inflammatory settings.	[Iqbal, Asif J.; Krautter, Franziska; Hussain, Mohammed T.; Nash, Gerard B.] Univ Birmingham, Coll Med & Dent Sci, Inst Cardiovasc Sci ICVS, Birmingham B15 2TT, W Midlands, England; [Blacksell, Isobel A.; Wright, Rachael D.; Austin-Williams, Shani N.; Voisin, Mathieu-Benoit; Law, Hannah L.; Bombardieri, Michele; Pitzalis, Costantino; Norling, Lucy, V; Cooper, Dianne] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England; [Niki, Toshiro] GalPharma Co Ltd, Res Div, Takamatsu, Kagawa, Japan; [Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunol & Immunopathol, Takamatsu, Kagawa, Japan; [Tiwari, Alok] Univ Hosp Birmingham, Dept Vasc Surg, Birmingham, W Midlands, England	University of Birmingham; University of London; Queen Mary University London; Kagawa University; University of Birmingham	Iqbal, AJ (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Cardiovasc Sci ICVS, Birmingham B15 2TT, W Midlands, England.; Cooper, D (corresponding author), Queen Mary Univ London, Ctr Biochem Pharmacol, Barts & London Sch Med, William Harvey Res Inst, London EC1M 6BQ, England.	a.j.iqbal@bham.ac.uk; d.cooper@qmul.ac.uk	Law, Hannah/GPS-7197-2022; Nash, Gerard B/E-4182-2010	Nash, Gerard B/0000-0002-5935-2831; Iqbal, Asif/0000-0002-3224-3651; Pitzalis, Costantino/0000-0003-1326-5051	Versus Arthritis [20387]; ARTS Springboard [W003 1156]	Versus Arthritis(Versus Arthritis); ARTS Springboard	Versus Arthritis, Grant/Award Number: 20387; ARTS Springboard, Grant/Award Number: W003 1156	ABBASSI O, 1993, J CLIN INVEST, V92, P2719, DOI 10.1172/JCI116889; Alam S, 2011, J BIOL CHEM, V286, P44211, DOI 10.1074/jbc.M111.242289; Alstergren P, 2004, CELL IMMUNOL, V231, P146, DOI 10.1016/j.cellimm.2005.01.007; Begandt D, 2017, J LEUKOCYTE BIOL, V102, P699, DOI 10.1189/jlb.3MR0117-026RR; Bi SG, 2011, P NATL ACAD SCI USA, V108, P10650, DOI 10.1073/pnas.1017954108; Butler LM, 2009, EXP CELL RES, V315, P3433, DOI 10.1016/j.yexcr.2009.08.012; Chakraborty A, 2021, J AUTOIMMUN, V117, DOI 10.1016/j.jaut.2020.102575; Chavakis T, 2004, J BIOL CHEM, V279, P55602, DOI 10.1074/jbc.M404676200; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Cooper D, 2008, J LEUKOCYTE BIOL, V83, P1459, DOI 10.1189/jlb.1207831; Cooper D, 2012, ANN NY ACAD SCI, V1253, P181, DOI 10.1111/j.1749-6632.2011.06291.x; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; David BA, 2019, IMMUNOL REV, V289, P9, DOI 10.1111/imr.12757; Eckardt V, 2020, EMBO REP, V21, DOI 10.15252/embr.201947852; Fujisaki T, 1999, CANCER RES, V59, P4427; Fujita K, 2018, J GASTROEN HEPATOL, V33, P492, DOI 10.1111/jgh.13851; Fujita Y, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-02158-3; Gillespie J, 2012, ARTHRITIS RHEUM-US, V64, P418, DOI 10.1002/art.33382; Giovannone N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05770-9; Gittens BR, 2017, J IMMUNOL, V198, P4458, DOI 10.4049/jimmunol.1600709; Goswami D, 2017, BLOOD, V129, P1811, DOI 10.1182/blood-2016-08-733394; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; He J, 2006, LAB INVEST, V86, P578, DOI 10.1038/labinvest.3700420; Horio Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180742; HUMBRIA A, 1994, ARTHRITIS RHEUM, V37, P342, DOI 10.1002/art.1780370307; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Ishikawa A, 2004, IMMUNOL CELL BIOL, V82, P410, DOI 10.1111/j.0818-9641.2004.01248.x; Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; KUIJPERS TW, 1992, J CELL BIOL, V117, P565, DOI 10.1083/jcb.117.3.565; Kurose Y, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-23; Ley K, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat4579; Li N, 2018, MOL BIOL CELL, V29, P408, DOI 10.1091/mbc.E16-12-0827; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; Lokuta MA, 2005, J LEUKOCYTE BIOL, V78, P210, DOI 10.1189/jlb.0205067; Malik RKJ, 2009, GLYCOBIOLOGY, V19, P1402, DOI 10.1093/glycob/cwp077; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Matsuoka N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227069; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Nishi N, 2006, GLYCOBIOLOGY, V16, p15C, DOI 10.1093/glycob/cwl028; Nishi N, 2008, GLYCOBIOLOGY, V18, P1065, DOI 10.1093/glycob/cwn089; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Rainger GE, 1998, BLOOD, V92, P4819, DOI 10.1182/blood.V92.12.4819.424k16_4819_4827; Reinhardt PH, 1997, BLOOD, V89, P3837, DOI 10.1182/blood.V89.10.3837.3837_3837_3846; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sato M, 2002, GLYCOBIOLOGY, V12, P191, DOI 10.1093/glycob/12.3.191; Schaefer K, 2017, GLYCOBIOLOGY, V27, P878, DOI 10.1093/glycob/cwx065; Seveau S, 2001, MOL BIOL CELL, V12, P3550, DOI 10.1091/mbc.12.11.3550; Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416; van den Hoogen LL, 2018, ANN RHEUM DIS, V77, P1810, DOI 10.1136/annrheumdis-2018-213497; Vega-Carrascal I, 2014, J IMMUNOL, V192, P2418, DOI 10.4049/jimmunol.1300711; Vilar KD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223191; Wiersma VR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20164046; Wilson ZS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58882-y; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; YURUKER B, 1992, J CELL SCI, V101, P403; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	63	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22065	10.1096/fj.202100832R	http://dx.doi.org/10.1096/fj.202100832R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34847625				2022-12-26	WOS:000734992000061
J	Snyder, SN; Mak, PJ				Snyder, Samuel N.; Mak, Piotr J.			Structure-function characterization of the mono- and diheme forms of MhuD, a noncanonical heme oxygenase from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN; HORSERADISH-PEROXIDASE; RECOMBINANT PROTEINS; COUPLED OXIDATION; CATALYTIC SITE; AXIAL LIGAND; DEGRADATION; MYOGLOBIN; ISDG; VINYL	MhuD is a noncanonical heme oxygenase (HO) from Mycobacterium tuberculosis (Mtb) that catalyzes unique heme degradation chemistry distinct from canonical HOs, generating mycobilin products without releasing carbon monoxide. Its crucial role in the Mtb heme uptake pathway has identified MhuD as an auspicious drug target. MhuD is capable of binding either one or two hemes within a single active site, but only the monoheme form was previously reported to be enzymatically active. Here we employed resonance Raman (rR) spectroscopy to examine several factors proposed to impact the reactivity of mono- and diheme MhuD, including heme ruffling, heme pocket hydrophobicity, and amino acid-heme interactions. We determined that the distal heme in the diheme MhuD active site has negligible effects on both the planarity of the His-coordinated heme macrocycle and the strength of the Fe-N-His linkage relative to the monoheme form. Our rR studies using isotopically labeled hemes unveiled unexpected biomolecular dynamics for the process of heme binding that converts MhuD from mono- to diheme form, where the second incoming heme replaces the first as the His75-coordinated heme. Ferrous CO-ligated diheme MhuD was found to exhibit multiple Fe-C-O conformers, one of which contains catalytically predisposed H-bonding interactions with the distal Asn7 residue identical to those in the monoheme form, implying that it is also enzymatically active. This was substantiated by activity assays and MS product analysis that confirmed the diheme form also degrades heme to mycobilins, redefining MhuD's functional paradigm and further expanding our understanding of its role in Mtb physiology.	[Snyder, Samuel N.; Mak, Piotr J.] St Louis Univ, Dept Chem, St Louis, MO 63103 USA	Saint Louis University; Washington University (WUSTL)	Mak, PJ (corresponding author), St Louis Univ, Dept Chem, St Louis, MO 63103 USA.	piotr.mak@slu.edu		Snyder, Samuel/0000-0002-2571-4048	Saint Louis University President's Research Fund	Saint Louis University President's Research Fund	We would like to thank Professors Dana Baum (SLU) for advice on biochemical methods and James Edwards and his laboratory members (SLU) for high-resolution mass spectrometry measurements. This work was funded by Saint Louis University President's Research Fund.	Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.241102; Acharya G, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1033-6; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BROWN SB, 1970, BIOCHEM J, V117, P733, DOI 10.1042/bj1170733; Carter EL, 2017, J BIOL CHEM, V292, P11280, DOI 10.1074/jbc.M117.783118; Chao A, 2019, BIOCHEMISTRY-US, V58, P4610, DOI 10.1021/acs.biochem.9b00726; Chen H, 2008, J AM CHEM SOC, V130, P1953, DOI 10.1021/ja076679p; Chen ZC, 2004, BIOCHEMISTRY-US, V43, P1798, DOI 10.1021/bi034920g; Chim N, 2011, TUBERCULOSIS, V91, P155, DOI 10.1016/j.tube.2010.11.009; Chim N, 2010, J MOL BIOL, V395, P595, DOI 10.1016/j.jmb.2009.11.025; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; CZERNUSZEWICZ RS, 1989, J AM CHEM SOC, V111, P7024, DOI 10.1021/ja00200a019; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; Dziedzic-Kocurek K, 2009, ACTA PHYS POL A, V115, P552, DOI 10.12693/APhysPolA.115.552; Evans TC, 1998, PROTEIN SCI, V7, P2256, DOI 10.1002/pro.5560071103; FEIS A, 1994, BIOCHEMISTRY-US, V33, P4577, DOI 10.1021/bi00181a019; GALLAGHER WA, 1973, ANN NY ACAD SCI, V206, P463, DOI 10.1111/j.1749-6632.1973.tb43230.x; GALLAGHER WA, 1967, BIOCHEM J, V105, P461, DOI 10.1042/bj1050461; Graves AB, 2016, J PHYS CHEM B, V120, P3844, DOI 10.1021/acs.jpcb.6b01497; Graves AB, 2014, INORG CHEM, V53, P5931, DOI 10.1021/ic500033b; Hannauer M, 2015, MOL MICROBIOL, V96, P1192, DOI 10.1111/mmi.13000; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Huang Q, 2005, J RAMAN SPECTROSC, V36, P363, DOI 10.1002/jrs.1326; Jentzen W, 1997, J PHYS CHEM B, V101, P1684, DOI 10.1021/jp963142h; KALSBECK WA, 1995, J AM CHEM SOC, V117, P10959, DOI 10.1021/ja00149a019; KAWAMURAKONISHI Y, 1988, EUR J BIOCHEM, V170, P589, DOI 10.1111/j.1432-1033.1988.tb13738.x; Kincaid J. R., 2000, PORPHYRIN HDB, P225; LEE KB, 1991, J AM CHEM SOC, V113, P3576, DOI 10.1021/ja00009a054; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; LI XY, 1989, J AM CHEM SOC, V111, P7012, DOI 10.1021/ja00200a018; Liu Y, 2000, J BIOL CHEM, V275, P34501, DOI 10.1074/jbc.M004245200; Loutet SA, 2013, J BIOL CHEM, V288, P25749, DOI 10.1074/jbc.M113.470518; Mak PJ, 2011, J AM CHEM SOC, V133, P1357, DOI 10.1021/ja105869p; Matsui T, 2016, P NATL ACAD SCI USA, V113, P3779, DOI 10.1073/pnas.1523333113; Matsui T, 2013, BIOCHEMISTRY-US, V52, P3025, DOI 10.1021/bi400382p; Matthews S, 2019, ACS INFECT DIS, V5, P1855, DOI 10.1021/acsinfecdis.9b00181; McLean KJ, 2017, DRUG DISCOV TODAY, V22, P566, DOI 10.1016/j.drudis.2016.11.004; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; OCARRA P, 1969, BIOCHEM J, V115, pP13; OCARRA PO, 1970, BIOCHEM J, V119, pP42, DOI 10.1042/bj1190042P; Owens CP, 2013, FUTURE MED CHEM, V5, P1391, DOI 10.4155/fmc.13.109; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; ROUSSEAU DG, 1992, J STRUCT BIOL, V109, P13; Rousseau DL, 2005, J INORG BIOCHEM, V99, P306, DOI 10.1016/j.jinorgbio.2004.11.007; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; SHACK J, 1947, J BIOL CHEM, V171, P143; Spiro T. G., 1988, BIOLOGICAL APPL RAMA, V3; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; SUN J, 1993, BIOCHEMISTRY-US, V32, P14151, DOI 10.1021/bi00214a012; SUN J, 1994, BIOCHEMISTRY-US, V33, P13734, DOI 10.1021/bi00250a026; Syvitski RT, 2002, J AM CHEM SOC, V124, P14296, DOI 10.1021/ja028108x; TAKAHASHI S, 1994, J BIOL CHEM, V269, P1010; TAKAHASHI S, 1994, BIOCHEMISTRY-US, V33, P5531, DOI 10.1021/bi00184a023; Takahashi S, 2020, BIOCHEMISTRY-US, V59, P3918, DOI 10.1021/acs.biochem.0c00731; Takayama SJ, 2015, BIOCHEMISTRY-US, V54, P2613, DOI 10.1021/acs.biochem.5b00239; TENHUNEN R, 1972, BIOCHEMISTRY-US, V11, P1716, DOI 10.1021/bi00759a029; Thakuri B, 2021, BIOCHEMISTRY-US, V60, P918, DOI 10.1021/acs.biochem.0c00892; Thakuri B, 2018, METALLOMICS, V10, P1560, DOI 10.1039/c8mt00238j; Traore ES, 2021, MOLECULES, V26, DOI 10.3390/molecules26030549; TSUBAKI M, 1982, BIOCHEMISTRY-US, V21, P1132, DOI 10.1021/bi00535a004; Videira MAM, 2018, MOL MICROBIOL, V109, P385, DOI 10.1111/mmi.14060; Vogel KM, 2000, INORG CHIM ACTA, V297, P11, DOI 10.1016/S0020-1693(99)00253-4; WATANABE T, 1994, J BACTERIOL, V176, P4465, DOI 10.1128/JB.176.15.4465-4472.1994; Wilks A, 2014, ACCOUNTS CHEM RES, V47, P2291, DOI 10.1021/ar500028n; YOSHIDA T, 1978, J BIOL CHEM, V253, P4230	68	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101475	10.1016/j.jbc.2021.101475	http://dx.doi.org/10.1016/j.jbc.2021.101475			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1GJ	34883099	Green Published, gold			2022-12-26	WOS:000748376400004
J	Wang, GY; Zhao, CE; Shen, YZ; Yin, N				Wang, Gangyi; Zhao, Chang'e; Shen, Yuzhuo; Yin, Ni			Estimation of cost efficiency of fattening pigs, sows, and piglets using SFA approach analysis: Evidence from China	PLOS ONE			English	Article							FINISH SWINE PRODUCTION; TECHNICAL EFFICIENCY; ENERGY EFFICIENCY; FRONTIER APPROACH; DETERMINANTS; FARMS; MANAGERIAL; INDUSTRY; HAWAII; IMPACT	The hog industry is the core industry in the field of agriculture and animal husbandry in China, which development is related to the improvement of people's quality of life. The production of the hog industry has been restricted by environmental regulations, which needs to reduce costs and improve efficiency. Based on the data of 29 provinces from 2008 to 2019, this paper aims to use the stochastic frontier analysis method to calculate the cost efficiency of fattening pigs, sows, and piglets in three stages of pig production and focuses on the impact of environmental regulation policies on cost efficiency. The study found that the cost efficiency of fattening pigs, sows, and piglets in China were 0.77, 0.79, and 0.53, respectively, and the efficiency losses were 23%, 21%, and 47%, respectively. The impact of environmental regulation policies on the cost efficiency of fattening pigs showed an ' N ' trend, and the impact on the cost efficiency of sows and piglets showed an inverted ' N ' trend. For fattening pigs, increasing the intensity of environmental regulation, and exceeding the second inflection point of the ' N ' curve can achieve the dual goals of environmental governance and cost reduction and efficiency increase. For sows, reducing the intensity of environmental regulation appropriately can avoid cost-efficiency loss. For piglets, environmental regulation policies have not effectively incentives the cost efficiency of piglets. In addition, raising the level of technology investment in fattening pigs and sows can achieve cost efficiency gains, and can farmers use emerging financial product tools such as ' insurance + futures ' to avoid market risks and efficiency losses.	[Wang, Gangyi; Zhao, Chang'e; Shen, Yuzhuo] Northeast Agr Univ, Coll Econ & Management, Harbin, Heilongjiang, Peoples R China; [Wang, Gangyi] Chongqing Univ Arts & Sci, Chongqing, Peoples R China; [Yin, Ni] HARBIN GuangSha Coll, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Chongqing University of Arts & Sciences	Zhao, CE (corresponding author), Northeast Agr Univ, Coll Econ & Management, Harbin, Heilongjiang, Peoples R China.	azce@neau.edu.cn			National Natural Science Foundation of China [71673273]; Natural Science Foundation of Heilongjiang Province China [LH2019G002]; Humanities and Social Science Foundation of Ministry of education of China [21YJA790053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province China(Natural Science Foundation of Heilongjiang Province); Humanities and Social Science Foundation of Ministry of education of China(Ministry of Education, China)	This research is supported by the National Natural Science Foundation of China (grant numbers 71673273); the Natural Science Foundation of Heilongjiang Province China (grant number LH2019G002); and the Humanities and Social Science Foundation of Ministry of education of China (grant number 21YJA790053). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adetunji M. O., 2012, American Journal of Experimental Agriculture, V2, P382; Ahmad M, 1996, J PROD ANAL, V7, P399, DOI 10.1007/BF00162049; Aigner D., 1977, J ECONOMETRICS, V6, P21, DOI DOI 10.1016/0304-4076(77)90052-5; Alem H, 2018, INT J PRODUCT PERFOR, V67, P1418, DOI 10.1108/IJPPM-01-2018-0026; Alemdar T, 2011, J ANIM VET ADV, V10, P6; Battese G.E., 1995, EMPIR ECON, V20, P325, DOI [10.1007/BF01205442, DOI 10.1007/BF01205442]; Cao HZ., 2003, THESIS CHINA AGR U; Chen CF, 2007, TOURISM MANAGE, V28, P696, DOI 10.1016/j.tourman.2006.04.023; Chen PC, 2012, J PROD ANAL, V38, P319, DOI 10.1007/s11123-012-0267-1; Coelli TJ., 1997, INTRO EFFICIENCY PRO; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; Filippini M, 2012, ENERG ECON, V34, P1484, DOI 10.1016/j.eneco.2012.06.013; Galanopoulos K, 2006, AGR SYST, V88, P125, DOI 10.1016/j.agsy.2005.03.002; Hu K, 2007, THESIS NANCHANG U; Huynh TTT, 2006, ASIAN J AGRIC DEV, V3, P69; KUMBHAKAR SC, 1991, J BUS ECON STAT, V9, P279, DOI 10.2307/1391292; Lansink AO, 2004, AGR SYST, V79, P353, DOI 10.1016/S0308-521X(03)00091-X; Latruffe L, 2013, MANAG DECIS ECON, V34, P409, DOI 10.1002/mde.2600; Lin BQ, 2014, ENERG POLICY, V72, P87, DOI 10.1016/j.enpol.2014.04.043; Manevska-Tasevska G, 2017, MANAG DECIS ECON, V38, P890, DOI 10.1002/mde.2823; Mugambi DK., 2017, STOCHASTIC FRONTIER; Nguyen Thi Ly, 2016, Japanese Journal of Rural Economics, V18, P56; Petrovska M, 2011, EFFICIENCY PIG FARM; Piot-Lepetit I, 2007, ENVIRON RESOUR ECON, V38, P433, DOI 10.1007/s10640-007-9086-7; Rodriguez SV, 2014, ANN OPER RES, V219, P5, DOI 10.1007/s10479-013-1465-6; Rowland W. W., 1998, Journal of Agricultural and Applied Economics, V30, P189; Sharma KR, 1997, J PROD ANAL, V8, P447, DOI 10.1023/A:1007744327504; Sharma KR, 1999, AGR ECON, V20, P23, DOI 10.1016/S0169-5150(98)00072-3; [沈鑫琪 Shen Xinqi], 2019, [中国农业大学学报, Journal of China Agricultural University], V24, P228; Shephard R. W, 1953, COST PRODUCTION FUNC; Shepherd RW., 1970, THEORY COST PRODUCTI; Smith A., 1976, INQUIRY NATURE CAUSE; Tan S, 2010, NJAS-WAGEN J LIFE SC, V57, P117, DOI 10.1016/j.njas.2010.02.001; TAN Y, 2021, J AGROTECHNICAL EC, P93; Theodoridis M., 2008, DATA ENVELOPMENT ANA, V2, P53; Tian X, 2015, J INTEGR AGR, V14, P1057, DOI 10.1016/S2095-3119(14)60989-8; Tonsor GT, 2009, REV AGR ECON, V31, P493, DOI 10.1111/j.1467-9353.2009.01450.x; Wang JJ., 2014, WORLD AGR, P119; Wang S., 2018, 2018 IEEE S EL COMP; Wang SG., 2021, CHINESE J AGR RESOUR, V42, P49; Wu Y., 2009, RES CORPORATE ENV IN; Xu XiaoHua, 2011, Journal of China Agricultural University, V16, P148; Yang CC, 2008, AGR ECON-BLACKWELL, V39, P51, DOI 10.1111/j.1574-0862.2008.00314.x; Zhou P, 2012, APPL ENERG, V90, P196, DOI 10.1016/j.apenergy.2011.02.025	44	1	1	14	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0261240	10.1371/journal.pone.0261240	http://dx.doi.org/10.1371/journal.pone.0261240			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ0LY	34898638	gold, Green Published			2022-12-26	WOS:000755176200029
J	Yoo, J; Lee, BJ				Yoo, Junghun; Lee, Bum Ju			Anthropometric, biochemical, and nutritional risk factors for osteoporosis in Korean adults based on a large cross-sectional study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; VITAMIN-D DEFICIENCY; POSTMENOPAUSAL WOMEN; NATIONAL-HEALTH; BLOOD-PRESSURE; ELDERLY-MEN; FRACTURE; GUIDELINES; DIAGNOSIS; CALCIUM	Background Osteoporosis a common bone disorder characterized by decreases in bone mass, tension, and strength. Although many previous studies worldwide have sought to identify the risk factors for osteoporosis, studies that simultaneously examine a variety of factors, such as biochemical, anthropometric and nutritional components, are very rare. Therefore, the objective of this study was to simultaneously examine the association of osteoporosis with biochemical profiles, anthropometric factors, and nutritional components in a large-scale cross-sectional study. Method This cross-sectional study was based on data from the Korea National Health and Nutrition Examination Survey (KNHANES VI-VII) from 2015 to 2018. Based on data from 16,454 participants, logistic regression was used to examine the association between various parameters in a crude analysis and in models adjusted for confounders. Results In men, osteoporosis was significantly associated with the anthropometric variables height and weight; the biochemical components hemoglobin, hematocrit, urea nitrogen and urine pH and creatinine; and the nutritional components total food intake, energy, water, protein, phosphorus, and kalium. However, these associations disappeared in adjusted model 2. In women, osteoporosis was significantly related to the anthropometric measures height, weight, and systolic blood pressure; the biochemical components hemoglobin, hematocrit and urine pH; and the nutritional components total food intake, water, calcium, phosphorus, and kalium. Most of these associations were maintained in the adjusted models. Conclusion Osteoporosis was linked to various anthropometric, biochemical and urine and nutritional components in Korean women, but the association between osteoporosis and risk factors differed according to sex.	[Yoo, Junghun] Korea Inst Oriental Med, KM Data Div, Daejeon, South Korea; [Lee, Bum Ju] Korea Inst Oriental Med, Digital Hlth Res Div, Daejeon, South Korea	Korea Institute of Oriental Medicine (KIOM); Korea Institute of Oriental Medicine (KIOM)	Lee, BJ (corresponding author), Korea Inst Oriental Med, Digital Hlth Res Div, Daejeon, South Korea.	bjlee@kiom.re.kr		Yoo, Junghun/0000-0002-0980-6364; Lee, Bum Ju/0000-0003-2682-5716	Korea Institute of Oriental Medicine (KIOM) - Korean Government [KSN2013110]	Korea Institute of Oriental Medicine (KIOM) - Korean Government	This work was supported by a Grant from the Korea Institute of Oriental Medicine (KIOM), funded by the Korean Government (KSN2013110). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOIA JF, 1985, AM J MED, V78, P95, DOI 10.1016/0002-9343(85)90468-1; Asaoka D, 2015, THER CLIN RISK MANAG, V11, P381, DOI 10.2147/TCRM.S80647; Assantachai P, 2006, OSTEOPOROSIS INT, V17, P1096, DOI 10.1007/s00198-006-0099-9; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Collier J. D., 2002, Gut, V50, pi1, DOI 10.1136/gut.50.suppl_1.i1; Cui ZY, 2020, ARCH OSTEOPOROS, V15, DOI 10.1007/s11657-019-0670-6; Curry SJ, 2018, JAMA-J AM MED ASSOC, V319, P2521, DOI 10.1001/jama.2018.7498; de Sire A, 2021, WORLD J ORTHOP, V12, P456, DOI 10.5312/wjo.v12.i7.456; de Sire A, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9070892; Gimigliano F, 2018, AGING CLIN EXP RES, V30, P625, DOI 10.1007/s40520-018-0921-1; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; Heidari B, 2015, ARCH OSTEOPOROS, V10, DOI 10.1007/s11657-015-0217-4; Holm JP, 2016, ENDOCRINE, V54, P241, DOI 10.1007/s12020-016-0987-5; Ilesanmi-Oyelere BL, 2020, LIFE-BASEL, V10, DOI 10.3390/life10100220; Ilesanmi-Oyelere BL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061262; Iolascon G, 2021, EUR J PHYS REHAB MED, V57, P273, DOI 10.23736/S1973-9087.21.06581-3; JOON YOON, 2016, [Korean Journal of Clinical Laboratory Science, 대한임상검사과학회지], V48, P296; Kanis JA, 1998, MATURITAS, V30, P229, DOI 10.1016/S0378-5122(98)00090-5; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Keramat A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-28; Kim DE, 2016, J INT MED RES, V44, P1103, DOI 10.1177/0300060516662402; Kim MH, 2015, J AM COLL NUTR, V34, P400, DOI 10.1080/07315724.2014.945197; Korea Centers for Disease Control and Prevention, 2016, QUAL CONTR CLIN LAB; Korea Centers for Disease Control and Prevention, 2016, GUID 7 KOR NAT HLTH; Krall EA, 1999, J BONE MINER RES, V14, P215, DOI 10.1359/jbmr.1999.14.2.215; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lane NE, 2006, AM J OBSTET GYNECOL, V194, pS3, DOI 10.1016/j.ajog.2005.08.047; Lee BJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207373; Lian XL, 2017, EUR REV MED PHARMACO, V21, P4386; Lin PC, 2007, ORTHOP NURS, V26, P155, DOI 10.1097/01.NOR.0000276964.23270.92; Lips P, 2005, OSTEOPOROSIS INT, V16, P447, DOI 10.1007/s00198-004-1762-7; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Lorentzon M, 2022, CLIMACTERIC, V25, P4, DOI 10.1080/13697137.2021.1951206; Mangiafico RA, 2008, OSTEOPOROSIS INT, V19, P49, DOI 10.1007/s00198-007-0438-5; Miller PD, 2016, JAMA-J AM MED ASSOC, V316, P722, DOI 10.1001/jama.2016.11136; Nguyen TV, 2000, J BONE MINER RES, V15, P322, DOI 10.1359/jbmr.2000.15.2.322; Oldmeadow LB, 2006, ANZ J SURG, V76, P607, DOI 10.1111/j.1445-2197.2006.03786.x; Overgaard J, 2013, WORLD J ORTHOP, V4, P248, DOI 10.5312/wjo.v4.i4.248; PEEL NFA, 1995, ANN RHEUM DIS, V54, P801, DOI 10.1136/ard.54.10.801; Pouresmaeili F, 2018, THER CLIN RISK MANAG, V14, P2029, DOI 10.2147/TCRM.S138000; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Ringe JD, 2020, ARCH OSTEOPOROS, V15, DOI 10.1007/s11657-020-00842-0; Sanchez-Rodriguez MA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-124; SEEMAN E, 1983, AM J MED, V75, P977, DOI 10.1016/0002-9343(83)90878-1; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; Woo J, 2009, J HUM HYPERTENS, V23, P451, DOI 10.1038/jhh.2008.156; Yim MH, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84892-5; Zhou R, 2014, CURR ALZHEIMER RES, V11, P706, DOI 10.2174/1567205011666140812115818	48	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0261361	10.1371/journal.pone.0261361	http://dx.doi.org/10.1371/journal.pone.0261361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898647	gold, Green Published			2022-12-26	WOS:000755176200037
J	Emami, P; Ueno, M				Emami, Parvaneh; Ueno, Masaru			3,3'-Diindolylmethane induces apoptosis and autophagy in fission yeast	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; BREAST-CANCER CELLS; SCHIZOSACCHAROMYCES-POMBE; OXIDATIVE STRESS; IN-VIVO; 3,3'-DIINDOLYLMETHANE; DEATH; INDUCTION; GROWTH; LEM2	3,3'-Diindolylmethane (DIM) is a compound derived from the digestion of indole-3-carbinol, found in the broccoli family. It induces apoptosis and autophagy in some types of human cancer. DIM extends lifespan in the fission yeast Schizosaccharomyces pombe. The mechanisms by which DIM induces apoptosis and autophagy in humans and expands lifespan in fission yeasts are not fully understood. Here, we show that DIM induces apoptosis and autophagy in log-phase cells, which is dose-dependent in fission yeast. A high concentration of DIM disrupted the nuclear envelope (NE) structure and induced chromosome condensation at an early time point. In contrast, a low concentration of DIM induced autophagy but did not disrupt NE structure. The mutant defective in autophagy was more sensitive to a low concentration of DIM, demonstrating that the autophagic pathway contributes to the survival of cells against DIM. Moreover, our results showed that the lem2 mutant is more sensitive to DIM. NE in the lem2 mutant was disrupted even at the low concentration of DIM. Our results demonstrate that the autophagic pathway and NE integrity are important to maintain viability in the presence of a low concentration of DIM. The mechanism of apoptosis and autophagy induction by DIM might be conserved in fission yeast and humans. Further studies will contribute to the understanding of the mechanism of apoptosis and autophagy by DIM in fission yeast and humans.	[Emami, Parvaneh; Ueno, Masaru] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Hiroshima, Japan	Hiroshima University	Ueno, M (corresponding author), Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Hiroshima, Japan.	scmueno@hiroshima-u.ac.jp						Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Agus HH, 2018, TOXICOL RES-UK, V7, P848, DOI [10.1039/c8tx00100f, 10.1039/C8TX00100F]; Agus HH, 2020, FEMS YEAST RES, V20, DOI 10.1093/femsyr/foaa022; Cerantola V, 2007, BIOCHEM J, V401, P205, DOI 10.1042/BJ20061128; Cheng JS, 2011, ARCH TOXICOL, V85, P1257, DOI 10.1007/s00204-011-0670-9; Erler A, 2006, YEAST, V23, P813, DOI 10.1002/yea.1396; Frohlich KU, 2007, SEMIN CANCER BIOL, V17, P112, DOI 10.1016/j.semcancer.2006.11.006; Fukuda T, 2020, ELIFE, V9, DOI 10.7554/eLife.61245; Gao X, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134642; Goldberg Alexander A, 2015, Genes Cancer, V6, P265; Gong YX, 2006, CANCER RES, V66, P4880, DOI 10.1158/0008-5472.CAN-05-4162; Gonzalez Y, 2012, NUCLEUS-PHILA, V3, P60, DOI 10.4161/nucl.18824; Gu MY, 2017, P NATL ACAD SCI USA, V114, pE2166, DOI 10.1073/pnas.1613916114; Guerin R, 2008, MOL BIOL CELL, V19, P4404, DOI 10.1091/mbc.E08-02-0188; Guerin R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006244; Hernandez-Elvira M, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7080106; Higby KJ, 2017, APOPTOSIS, V22, P393, DOI 10.1007/s10495-016-1338-y; Hirano Y, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081908; Hirano Y, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0999-9; Ito H, 2019, BIOCHEM BIOPH RES CO, V511, P820, DOI 10.1016/j.bbrc.2019.02.128; Kandala PK, 2012, ONCOTARGET, V3, P435; Kim EJ, 2007, J NUTR, V137, P31, DOI 10.1093/jn/137.1.31; Kim SM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071155; Kimmig P, 2012, ELIFE, V1, DOI 10.7554/eLife.00048; Kinugasa Y, 2019, J CELL SCI, V132, DOI 10.1242/jcs.229021; Kohda TA, 2007, GENES CELLS, V12, P155, DOI 10.1111/j.1365-2443.2007.01041.x; Kume K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09623-x; Lanza-Jacoby S, 2018, PHARM BIOL, V56, P407, DOI 10.1080/13880209.2018.1495747; Liang K, 2017, MOL MED REP, V16, P9553, DOI 10.3892/mmr.2017.7788; Lin SJ, 2014, FEMS YEAST RES, V14, P119, DOI 10.1111/1567-1364.12113; Low CP, 2008, J CELL SCI, V121, P2671, DOI 10.1242/jcs.028977; Matsuda A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8753; Matsuhara H, 2016, GENES CELLS, V21, P65, DOI 10.1111/gtc.12320; McCullough J, 2018, ANNU REV CELL DEV BI, V34, P85, DOI 10.1146/annurev-cellbio-100616-060600; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mukaiyama H, 2010, FEBS LETT, V584, P1327, DOI 10.1016/j.febslet.2009.12.037; Mukaiyama H, 2009, MICROBIOL-SGM, V155, P3816, DOI 10.1099/mic.0.034389-0; Munakarmi S, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051178; Mutoh N, 2011, BIOSCI BIOTECH BIOCH, V75, P1113, DOI 10.1271/bbb.110019; Nachshon-Kedmi M, 2003, FOOD CHEM TOXICOL, V41, P745, DOI 10.1016/S0278-6915(03)00004-8; Nakamura S, 2018, MOL CELLS, V41, P65, DOI 10.14348/molcells.2018.2333; Pan Z, 2018, RSC ADV, V8, P38910, DOI 10.1039/c8ra06566g; Pfeffer CM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020448; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Rodriguez-Menocal L, 2004, FEMS YEAST RES, V5, P111, DOI 10.1016/j.femsyr.2004.07.007; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Shimasaki T, 2020, GENES CELLS, V25, P825, DOI 10.1111/gtc.12815; Staub RE, 2006, CHEM RES TOXICOL, V19, P436, DOI 10.1021/tx050325z; Stephan J, 2013, AGING CELL, V12, P574, DOI 10.1111/acel.12077; Sun J, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/5459209; Sun LL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003715; Tange Y, 2016, GENES CELLS, V21, P812, DOI 10.1111/gtc.12385; Taricani L, 2002, J BIOL CHEM, V277, P10562, DOI 10.1074/jbc.M110686200; Tian XL, 2019, CANCER LETT, V448, P20, DOI 10.1016/j.canlet.2019.01.031; Tsai JY, 2012, J RECEPT SIG TRANSD, V32, P271, DOI 10.3109/10799893.2012.707212; Verhoeven DTH, 1997, CHEM-BIOL INTERACT, V103, P79, DOI 10.1016/S0009-2797(96)03745-3; Vessoni AT, 2013, CELL DEATH DIFFER, V20, P1444, DOI 10.1038/cdd.2013.103; Wang ZW, 2008, MOL CANCER THER, V7, P341, DOI 10.1158/1535-7163.MCT-07-0476; Yang HJ, 2017, J BIOCHEM, V161, P471, DOI 10.1093/jb/mvx020; Ye Y, 2021, ANTI-CANCER DRUG, V32, P189, DOI 10.1097/CAD.0000000000000997; Ye Y, 2016, BIOCHEM PHARMACOL, V115, P77, DOI 10.1016/j.bcp.2016.06.018; Ye Y, 2015, ONCOL LETT, V9, P2393, DOI 10.3892/ol.2015.3008; Yu ZQ, 2020, AUTOPHAGY, V16, P2036, DOI 10.1080/15548627.2020.1713644; Yun CW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113466; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200; Zhao D, 2020, MOL CELL, V79, P963, DOI 10.1016/j.molcel.2020.07.019	67	2	2	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0255758	10.1371/journal.pone.0255758	http://dx.doi.org/10.1371/journal.pone.0255758			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890395	Green Submitted, gold, Green Published			2022-12-26	WOS:000747293600002
J	Bergin, M; Tucker, K; Vicenzino, B; Hodges, PW				Bergin, Michael; Tucker, Kylie; Vicenzino, Bill; Hodges, Paul W.			"Taking action" to reduce pain-Has interpretation of the motor adaptation to pain been too simplistic?	PLOS ONE			English	Article							CHRONIC MUSCULOSKELETAL PAIN; MUSCLE PAIN; BACK-PAIN; VARIABILITY; TASK; MECHANISMS; MOVEMENT; INCREASE; FORCES	Movement adapts during acute pain. This is assumed to reduce nociceptive input, but the interpretation may not be straightforward. We investigated whether movement adaptation during pain reflects a purposeful search for a less painful solution. Three groups of participants performed two blocks (Baseline, Experimental) of wrist movements in the radial-ulnar direction. For the Control group (n = 10) both blocks were painfree. In two groups, painful electrical stimulation was applied at the elbow in Experimental conditions when the wrist crossed radial-ulnar neutral. Different stimulus intensities were given for specific wrist angles in a secondary direction (flexion-extension) as the wrist passed radial-ulnar neutral (Pain 5-1 group:painful stimulation at similar to 5 or similar to 1/10-n = 21; Pain 5-0 group:similar to 5 or 0(no stimulation)/10-n = 6)). Participants were not informed about the less painful alternative and could use any strategy. We recorded the percentage of movements using the wrist flexion/extension alignment that evoked the lower intensity noxious stimulus, movement variability, and change in wrist/forearm alignment during pain. Participants adapted their strategy of wrist movement during pain provocation and reported less pain over time. Three adaptations of wrist movement were observed; (i) greater use of the wrist alignment with no/less noxious input (Pain 5-1, n = 8/21; Pain 5-0, n = 2/6); (ii) small (n = 9/21; n = 3/6) or (iii) large (n = 4/21; n = 1/6) change of wrist/forearm alignment to a region that was not allocated to provide an actual reduction in noxious stimulus. Pain reduction was achieved with "taking action" to relieve pain and did not depend on reduced noxious stimulus.	[Bergin, Michael; Tucker, Kylie; Vicenzino, Bill; Hodges, Paul W.] Univ Queensland, Sch Hlth & Rehabil Sci, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, St Lucia, Qld, Australia; [Bergin, Michael] Spaulding Rehabil Hosp, Neurorehabil Lab, Charlestown, MA USA; [Vicenzino, Bill] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia	University of Queensland; Harvard University; Spaulding Rehabilitation Hospital; University of Queensland	Hodges, PW (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, St Lucia, Qld, Australia.	p.hodges@uq.edu.au	Hodges, Paul/B-6578-2008	Hodges, Paul/0000-0002-1206-9107				Anderson FC, 2001, J BIOMECH ENG-T ASME, V123, P381, DOI 10.1115/1.1392310; Bergin MJG, 2014, EUR J APPL PHYSIOL, V114, P385, DOI 10.1007/s00421-013-2777-6; Boudreau S, 2007, PAIN, V132, P169, DOI 10.1016/j.pain.2007.07.019; Clarke RW, 2004, BRAIN RES REV, V46, P163, DOI 10.1016/j.brainresrev.2004.07.005; Conley KE, 2002, J EXP BIOL, V205, P2175; Crombez G, 1997, PAIN, V70, P149, DOI 10.1016/S0304-3959(96)03304-0; Gasser HS, 1929, AM J PHYSIOL, V88, P581, DOI 10.1152/ajplegacy.1929.88.4.581; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Hu XG, 2011, NEUROSCI LETT, V490, P121, DOI 10.1016/j.neulet.2010.12.040; Hug F., 2014, J NEUROPHYSIOL; Hug F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154524; Hug F, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1908; Hug F, 2014, J NEUROPHYSIOL, V111, P2298, DOI 10.1152/jn.00911.2013; Hug F, 2013, J ELECTROMYOGR KINES, V23, P1413, DOI 10.1016/j.jelekin.2013.08.014; Ingham D, 2011, EUR J PAIN, V15, P1028, DOI 10.1016/j.ejpain.2011.04.006; Jonas R, 2018, ANN NEUROL, V83, P945, DOI 10.1002/ana.25231; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kurniawan IT, 2010, PSYCHOL SCI, V21, P840, DOI 10.1177/0956797610370160; LUND JP, 1991, CAN J PHYSIOL PHARM, V69, P683, DOI 10.1139/y91-102; Madeleine P, 2008, EXP BRAIN RES, V185, P689, DOI 10.1007/s00221-007-1199-2; Moseley GL, 2006, BEHAV NEUROSCI, V120, P474, DOI 10.1037/0735-7044.120.2.474; Murray GM, 2007, J OROFAC PAIN, V21, P263; PANDY MG, 1995, J BIOMECH ENG-T ASME, V117, P15, DOI 10.1115/1.2792265; ROLAND MO, 1986, CLIN BIOMECH, V1, P102, DOI 10.1016/0268-0033(86)90085-9; Salomoni SE, 2013, EUR J APPL PHYSIOL, V113, P567, DOI 10.1007/s00421-012-2461-2; Salomoni SE, 2012, EUR J APPL PHYSIOL, V112, P3607, DOI 10.1007/s00421-012-2343-7; SCHAIBLE HG, 1993, PAIN, V55, P5, DOI 10.1016/0304-3959(93)90183-P; Svensson P, 1996, PAIN, V64, P241, DOI 10.1016/0304-3959(95)00133-6; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Tucker KJ, 2010, EUR J PAIN, V14, P932, DOI 10.1016/j.ejpain.2010.03.006; Van Dillen LR, 2009, MANUAL THER, V14, P52, DOI 10.1016/j.math.2007.09.012; Van Ryckeghem DML, 2012, PAIN, V153, P2345, DOI 10.1016/j.pain.2012.07.032; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Wall Patrick David, 2000, PAIN SCI SUFFERING; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260715	10.1371/journal.pone.0260715	http://dx.doi.org/10.1371/journal.pone.0260715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879091	gold, Green Published			2022-12-26	WOS:000754625200026
J	Khairoun, M; Uffen, JW; Ocak, G; Koopsen, R; Haitjema, S; Oosterheert, JJ; Kaasjager, K				Khairoun, Meriem; Uffen, Jan Willem; Ocak, Gurbey; Koopsen, Romy; Haitjema, Saskia; Oosterheert, Jan Jelrik; Kaasjager, Karin			The incidence, mortality and renal outcomes of acute kidney injury in patients with suspected infection at the emergency department	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; SEPSIS; PATHOPHYSIOLOGY; RECOVERY	Background Acute kidney injury (AKI) is a major health problem associated with considerable mortality and morbidity. Studies on clinical outcomes and mortality of AKI in the emergency department are scarce. The aim of this study is to assess incidence, mortality and renal outcomes after AKI in patients with suspected infection at the emergency department. Methods We used data from the SPACE-cohort (SePsis in the ACutely ill patients in the Emergency department), which included consecutive patients that presented to the emergency department of the internal medicine with suspected infection. Hazard ratios (HR) were assessed using Cox regression to investigate the association between AKI, 30-days mortality and renal function decline up to 1 year after AKI. Survival in patients with and without AKI was assessed using Kaplan-Meier analyses. Results Of the 3105 patients in the SPACE-cohort, we included 1716 patients who fulfilled the inclusion criteria. Of these patients, 10.8% had an AKI episode. Mortality was 12.4% for the AKI group and 4.2% for the non-AKI patients. The adjusted HR for all-cause mortality at 30-days in AKI patients was 2.8 (95% CI 1.7-4.8). Moreover, the cumulative incidence of renal function decline was 69.8% for AKI patients and 39.3% for non-AKI patients. Patients with an episode of AKI had higher risk of developing renal function decline (adjusted HR 3.3, 95% CI 2.4-4.5) at one year after initial AKI-episode at the emergency department. Conclusion Acute kidney injury is common in patients with suspected infection in the emergency department and is significantly associated with 30-days mortality and renal function decline one year after AKI.	[Khairoun, Meriem; Kaasjager, Karin] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Uffen, Jan Willem; Koopsen, Romy; Oosterheert, Jan Jelrik; Kaasjager, Karin] Univ Med Ctr Utrecht, Dept Acute Internal Med, Utrecht, Netherlands; [Ocak, Gurbey] St Antonius Hosp, Dept Internal Med & Nephrol, Nieuwegein, Netherlands; [Haitjema, Saskia] Univ Med Ctr Utrecht, Dept Lab Clin Chem Haematol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center	Khairoun, M (corresponding author), Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands.	m.khairoun@umcutrecht.nl		Uffen, Jan Willem/0000-0001-7196-1229; Oosterheert, Jan Jelrik/0000-0001-6146-3808				Akram AR, 2010, CHEST, V138, P825, DOI 10.1378/chest.09-3071; Al-Jaghbeer M, 2018, J AM SOC NEPHROL, V29, P654, DOI 10.1681/ASN.2017070765; Argyropoulos A, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1237-x; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Bernardo EO, 2018, ACAD EMERG MED, V25, P758, DOI 10.1111/acem.13421; Bernier-Jean A, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0552-3; Bhandari S, 1996, QJM-MON J ASSOC PHYS, V89, P415; Bhatraju PK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.2682; Challiner R, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-84; Chawla LS, 2017, NAT REV NEPHROL, V13, P241, DOI 10.1038/nrneph.2017.2; Connell A, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0100-6; Doyle JF, 2016, BIOL-TARGETS THER, V10, P149, DOI 10.2147/BTT.S87385; Doyle JF, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1353-y; Foxwell DA, 2020, NEPHROLOGY, V25, P457, DOI 10.1111/nep.13672; Gist KM, 2020, NEPHRON, V144, P673, DOI 10.1159/000508101; Harel Z, 2013, KIDNEY INT, V83, P901, DOI 10.1038/ki.2012.451; Holmes J, 2017, QJM-INT J MED, V110, P741, DOI 10.1093/qjmed/hcx151; Jones J, 2012, AM J KIDNEY DIS, V60, P402, DOI 10.1053/j.ajkd.2012.03.014; Joslin J, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/760623; Kaddourah A, 2017, NEW ENGL J MED, V376, P11, DOI 10.1056/NEJMoa1611391; Kellum JA, 2019, NAT REV NEPHROL, V15, P663, DOI 10.1038/s41581-019-0203-y; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kumar S, 2018, KIDNEY INT, V93, P27, DOI 10.1016/j.kint.2017.07.030; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Liu KD, 2020, CLIN J AM SOC NEPHRO, V15, P1838, DOI 10.2215/CJN.15611219; Lumlertgul N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65764-w; Macedo E, 2010, CRIT CARE, V14, DOI 10.1186/cc9004; Makris Konstantinos, 2016, Clin Biochem Rev, V37, P85; Martinez DA, 2020, ANN EMERG MED, V76, P501, DOI 10.1016/j.annemergmed.2020.05.026; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Peerapornratana S, 2019, KIDNEY INT, V96, P1083, DOI 10.1016/j.kint.2019.05.026; Reynvoet E, 2009, CRIT CARE MED, V37, P2203, DOI 10.1097/CCM.0b013e3181a03961; Rosenovist M, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0283-9; Sawhney S, 2017, KIDNEY INT, V92, DOI 10.1016/j.kint.2017.02.019; Scheuermeyer Frank Xavier, 2017, Can J Kidney Health Dis, V4, p2054358117703985, DOI 10.1177/2054358117703985; Schunk SJ, 2019, LANCET, V394, P488, DOI 10.1016/S0140-6736(19)30769-X; See EJ, 2019, KIDNEY INT, V95, P160, DOI 10.1016/j.kint.2018.08.036; Selby NM, 2019, J AM SOC NEPHROL, V30, P505, DOI 10.1681/ASN.2018090886; Shum HP, 2016, RENAL FAILURE, V38, P706, DOI 10.3109/0886022X.2016.1157749; Silver SA, 2017, J HOSP MED, V12, P70, DOI 10.12788/jhm.2683; Teo SH, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1466-z; Togel Florian, 2014, F1000Prime Rep, V6, P83, DOI 10.12703/P6-83; Tollitt J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216412; Uffen JW, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0293-7; Vandijck DM, 2007, ACTA CLIN BELG, V62, P332, DOI 10.1179/acb.2007.075; Wilson FP, 2015, LANCET, V385, P1966, DOI 10.1016/S0140-6736(15)60266-5; Xu JR, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1613-6; Zarbock A, 2014, CURR OPIN CRIT CARE, V20, P588, DOI 10.1097/MCC.0000000000000153	51	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260942	10.1371/journal.pone.0260942	http://dx.doi.org/10.1371/journal.pone.0260942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879093	gold, Green Published			2022-12-26	WOS:000754625200038
J	Chagas, ETC; Barros, PH; Cardoso-Pereira, I; Ponte, IV; Ximenes, P; Figueiredo, F; Murai, F; da Silva, APC; Almeida, JM; Loureiro, AAF; Ramos, HS				Chagas, Eduarda T. C.; Barros, Pedro H.; Cardoso-Pereira, Isadora; Ponte, Igor V.; Ximenes, Pablo; Figueiredo, Flavio; Murai, Fabricio; Couto da Silva, Ana Paula; Almeida, Jussara M.; Loureiro, Antonio A. F.; Ramos, Heitor S.			Effects of population mobility on the COVID-19 spread in Brazil	PLOS ONE			English	Article								This article proposes a study of the SARS-CoV-2 virus spread and the efficacy of public policies in Brazil. Using both aggregated (from large Internet companies) and fine-grained (from Departments of Motor Vehicles) mobility data sources, our work sheds light on the effect of mobility on the pandemic situation in the Brazilian territory. Our main contribution is to show how mobility data, particularly fine-grained ones, can offer valuable insights into virus propagation. For this, we propose a modification in the SENUR model to add mobility information, evaluating different data availability scenarios (different information granularities), and finally, we carry out simulations to evaluate possible public policies. In particular, we conduct a case study that shows, through simulations of hypothetical scenarios, that the contagion curve in several Brazilian cities could have been milder if the government had imposed mobility restrictions soon after reporting the first case. Our results also show that if the government had not taken any action and the only safety measure taken was the population's voluntary isolation (out of fear), the time until the contagion peak for the first wave would have been postponed, but its value would more than double.	[Chagas, Eduarda T. C.; Barros, Pedro H.; Cardoso-Pereira, Isadora; Figueiredo, Flavio; Murai, Fabricio; Couto da Silva, Ana Paula; Almeida, Jussara M.; Loureiro, Antonio A. F.; Ramos, Heitor S.] Univ Fed Minas Gerais, Dept Comp Sci, Belo Horizonte, MG, Brazil; [Ponte, Igor V.; Ximenes, Pablo] Govt State Ceara, Dept Motor Vehicles, Fortaleza, Ceara, Brazil; [Ximenes, Pablo] Georgia Inst Technol, Sch Cybersecur & Privacy, Coll Comp, Atlanta, GA 30332 USA	Universidade Federal de Minas Gerais; University System of Georgia; Georgia Institute of Technology	Ramos, HS (corresponding author), Univ Fed Minas Gerais, Dept Comp Sci, Belo Horizonte, MG, Brazil.	ramosh@dcc.ufmg.br	Ramos, Heitor/C-7790-2009; da Silva, Ana/GXH-4851-2022; Barros, Pedro Henrique Silva Souza/AAC-6017-2019	Ramos, Heitor/0000-0003-4523-6466; Barros, Pedro Henrique Silva Souza/0000-0001-6606-0135; Ximenes, Pablo/0000-0003-1845-1160	Pro-Reitoria de Pesquisa (PRPq) of the Universidade Federal de Minas Gerais (UFMG); Sao Paulo Research Foundation (FAPESP) [2020/05121-4, 2018/230648]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq [311750/2018-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, FAPEMIG [APQ02337-21]	Pro-Reitoria de Pesquisa (PRPq) of the Universidade Federal de Minas Gerais (UFMG); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	HSR acknowledges funding support from the Pro-Reitoria de Pesquisa (PRPq) of the Universidade Federal de Minas Gerais (UFMG) for the publication costs. HSR is funded by grant #2020/05121-4, Sao Paulo Research Foundation (FAPESP). AFFL is funded by grant #2018/230648, Sao Paulo Research Foundation (FAPESP). HSR is funded by grant 311750/2018-4, Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico, CNPq. ETCC and ICP hold scholarships from the Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior, CAPES. PHB holds a scholarship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq. FM is funded by grant APQ02337-21, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott S., 2020, TEMPORAL VARIATION T; [Anonymous], 2020, OPENDATASUS DATASET; [Anonymous], 2020, PAINEL CASOS DOEN CA; [Anonymous], 2020, COMO BRASIL FOI AFET; [Anonymous], 2020, MANTENDO WAZE ATUALI; [Anonymous], 2020, GOOGLE MOBILITY DATA; [Anonymous], 2020, GOVERNADOR CAMILO SA; [Anonymous], 2014, DESENVOLVIMENTO HUMA; [Anonymous], 2020, CORONAVIRUS COVID 19; [Anonymous], 2020, BEBE TRES MESES IDAD; [Anonymous], 2020, RETRATO PACIENTE COM; Buckee CO, 2020, SCIENCE, V368, P145, DOI 10.1126/science.abb8021; Candido DS, 2020, SCIENCE, V369, P1255, DOI 10.1126/science.abd2161; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Castro MC, 2021, SCIENCE, V372, P821, DOI 10.1126/science.abh1558; Chatzilena A, 2019, EPIDEMICS-NETH, V29, DOI 10.1016/j.epidem.2019.100367; Chen TM, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00640-3; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Coelho FC, 2020, ASSESSING POTENTIAL, DOI 10.1101/2020.03.19.20039131v2; Costa GS, 2020, PHYS REV RES, V2, DOI 10.1103/PhysRevResearch.2.043306; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Du ZW, 2020, EMERG INFECT DIS, V26, P1049, DOI 10.3201/eid2605.200146; Gamerman D, 2006, MARKOV CHAIN MONTE C; Goel R, 2019, PHYSICA A, V518, P50, DOI 10.1016/j.physa.2018.11.035; Grad S., 2020, SOCIAL DISTANCING ST, V2020, DOI [10.11392/jsao.49.40, DOI 10.1101/2020.03.22.20041079]; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Li MT, 2020, MATH BIOSCI ENG, V17, P3710, DOI 10.3934/mbe.2020208; Peixoto PS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235732; Riddell A, 2021, PYSTAN 3 0 0; Serafino M, 2021, ARXIV PREPRINT ARXIV; Sweeney L, 2002, INT J UNCERTAIN FUZZ, V10, P571, DOI 10.1142/S021848850200165X; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260610	10.1371/journal.pone.0260610	http://dx.doi.org/10.1371/journal.pone.0260610			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874978	gold, Green Published			2022-12-26	WOS:000753617500032
J	Matei, SA; Kulzick, R; Sinclair-Chapman, V; Potts, L				Matei, Sorin Adam; Kulzick, Robert; Sinclair-Chapman, Valeria; Potts, Lauren			Setting the agenda in environmental crisis: Relationships between tweets, Google search trends, and newspaper coverage during the California drought	PLOS ONE			English	Article							SOCIAL MEDIA; CONSERVATION; TWITTER; NEWS	Nuanced public responses to droughts and other chronic environmental crises reflect today's increasingly complex communication ecosystem. At once global and infinitely customizable, this vast array of media and information channels requires existing theory to address the implications of interactions among social media, "traditional" mass media outlets, and information-seeking tools such as search engines. How do these channels intervene in public conversation? What might the agenda-setting perspective have to say? Data collected during peak years of the California drought, 2013-2015, indicate that California residents responded to worsening drought conditions Twitter first, which was the only media behavior directly stimulated by environmental stressors. Google searches stimulated newspaper coverage and Twitter activity, revealing the centrality of search behaviors in this environmental crisis. The findings suggest significant changes to the communication landscape as individual and collective users become increasingly dependent on non-mainstream media channels for information in chronic crisis situations.	[Matei, Sorin Adam] Purdue Univ, Brian Lamb Sch Commun, W Lafayette, IN 47907 USA; [Kulzick, Robert] PSB Market Res, Washington, DC USA; [Sinclair-Chapman, Valeria] Purdue Univ, Dept Polit Sci, W Lafayette, IN 47907 USA; [Potts, Lauren] Michigan State Univ, E Lansing, MI 48824 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Michigan State University	Matei, SA (corresponding author), Purdue Univ, Brian Lamb Sch Commun, W Lafayette, IN 47907 USA.	smatei@purdue.edu			Purdue University Discovery Park Grand Challenge Competition - Mellon foundations	Purdue University Discovery Park Grand Challenge Competition - Mellon foundations	The work was funded by the Purdue University Discovery Park Grand Challenge Competition, which was suppored by the Mellon foundations. Dr Matei and Chapman were a part of one of the winning teams. The funders played no part in the study design, data colection, manuscript preparation or decision to publish. https://www.purdue.edu/breaking-through/prior-teams/equitable-water-policy.php.	[Anonymous], 2021, GOOGL SUPP; [Anonymous], 2016, COMSC REL JAN 2016 U; Case DO., 2012, LOOKING INFORM SURVE, V3rd; Coombs WT, 2015, BUS HORIZONS, V58, P141, DOI 10.1016/j.bushor.2014.10.003; de Oliver M, 1999, ENVIRON BEHAV, V31, P372, DOI 10.1177/00139169921972155; Ewoldsen D.R., 2019, MEDIA EFFECTS ADV TH, V(4th), P83; Eyre R, 2019, COLUMBIA POLITICAL R; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Grabowski M, 2011, ACM T COMPUT-HUM INT, V18, DOI 10.1145/2063231.2063233; Granka L. A, 2010, MEASURING AGENDA SET; Harder RA, 2017, INT J PRESS/POLIT, V22, P275, DOI 10.1177/1940161217704969; Howarth D, 2004, WA SCI TECHNOL, V4, P33, DOI 10.2166/ws.2004.0041; Howitt R., 2015, UC DAVIS CTR WATERSH; Jin Y., 2010, HDB CRISIS COMMUNICA, P677, DOI [DOI 10.1002/9781444314885.CH33, 10.1002/9781444314885.ch33]; Jin Y, 2009, PUBLIC RELAT REV, V35, P310, DOI 10.1016/j.pubrev.2009.02.003; Kong N, 2016, PAPERS APPL GEOGRAPH, V2, P189, DOI [10.1080/23754931.2015.1116106, DOI 10.1080/23754931.2015.1116106]; Langer AI, 2021, INT J PRESS/POLIT, V26, P313, DOI 10.1177/1940161220925023; LAZARUS RS, 1991, AM PSYCHOL, V46, P352, DOI 10.1037/0003-066X.46.4.352; Leong CML, 2015, J ASSOC INF SYST, V16, P174, DOI 10.17705/1jais.00390; Mann ME, 2015, P NATL ACAD SCI USA, V112, P3858, DOI 10.1073/pnas.1503667112; Matthes J, 2006, INT J PUBLIC OPIN R, V18, P422, DOI 10.1093/ijpor/edh118; McCombs M., 2014, OXFORD HDB ONLINE; McCombs M.E., 2014, AGENDA SETTING THEOR, V2nd; MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990; MCKEE TB, 1993, P 8 C APPL CLIM AN C; Mellon J, 2014, J ELECT PUBLIC OPIN, V24, P45, DOI 10.1080/17457289.2013.846346; Messner M, 2008, JOURNALISM STUD, V9, P447, DOI 10.1080/14616700801999287; Miller C., 2014, KQED SCI; Mitchell KE, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003823; Murray J., 2012, MANAGING CRISES DISA; Neuman WR, 2014, J COMMUN, V64, P193, DOI 10.1111/jcom.12088; Palazzo J, 2017, WATER RESOUR RES, V53, P4459, DOI 10.1002/2016WR020136; Palen L., 2007, P 3 INT C E SOCIAL S, P7; Program to calculate standardized precipitation index (SPI Generator), 2018, NAT DROUGHT MIT CTR; Purohit H, 2014, COMPUT SUPP COOP W J, V23, P513, DOI 10.1007/s10606-014-9209-y; Qualman E., 2012, SOCIALNOMICS SOCIAL, DOI [10.14670/HH-27.13, DOI 10.14670/HH-27.13]; Ragas MW, 2014, JOURNALISM STUD, V15, P48, DOI 10.1080/1461670X.2013.793509; Raschka S, 2014, ARXIV14105329CS; Rogstad I, 2016, J INF TECHNOL POLITI, V13, P142, DOI 10.1080/19331681.2016.1160263; Rojecki A, 2016, NEW MEDIA SOC, V18, P25, DOI 10.1177/1461444814535724; Scharkow M, 2011, INT J PUBLIC OPIN R, V23, P104, DOI 10.1093/ijpor/edq048; Shapiro M. A., 2014, 2585126 SSRN, DOI [10.2139/ssrn.2585126, DOI 10.2139/SSRN.2585126]; Shklovski I, 2008, CSCW: 2008 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, CONFERENCE PROCEEDINGS, P127; Shoemaker P.J., 2013, MEDIATING MESSAGE 21, DOI [10.4324/9780203930434, DOI 10.4324/9780203930434]; Sturges D.L., 1994, MANAGE COMMUN Q, V7, P297, DOI [10.1177/0893318994007003004, DOI 10.1177/0893318994007003004]; Su Y, 2019, J INF TECHNOL POLITI, V16, P236, DOI 10.1080/19331681.2019.1641451; Swain D, 2016, CALIFORNIA WEATHER B, DOI [10.1111/nph.15048, DOI 10.1111/NPH.15048]; Valenzuela S, 2017, J BROADCAST ELECTRON, V61, P615, DOI 10.1080/08838151.2017.1344673; Weaver DH, 2007, J COMMUN, V57, P142, DOI 10.1111/j.1460-2466.2006.00333.x; Wei J, 2006, 2006 IEEE INTERNATIONAL CONFERENCE ON MANAGEMENT OF INNOVATION AND TECHNOLOGY, VOLS 1 AND 2, PROCEEDINGS, P330; Zwitter A., 2016, CRISIS ANALYTICS BIG	51	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0259494	10.1371/journal.pone.0259494	http://dx.doi.org/10.1371/journal.pone.0259494			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874943	gold, Green Published			2022-12-26	WOS:000753617500006
J	Conroy, JM; Pabla, S; Glenn, ST; Seager, RJ; Van Roey, E; Gao, S; Burgher, B; Andreas, J; Giamo, V; Mallon, M; Lee, YH; DePietro, P; Nesline, M; Wang, YR; Lenzo, FL; Klein, R; Zhang, SL				Conroy, Jeffrey M.; Pabla, Sarabjot; Glenn, Sean T.; Seager, R. J.; Van Roey, Erik; Gao, Shuang; Burgher, Blake; Andreas, Jonathan; Giamo, Vincent; Mallon, Melissa; Lee, Yong Hee; DePietro, Paul; Nesline, Mary; Wang, Yirong; Lenzo, Felicia L.; Klein, Roger; Zhang, Shengle			A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors	PLOS ONE			English	Article							FOR-MOLECULAR-PATHOLOGY; ANALYTICAL VALIDATION; CANCER; ONCOLOGY; GUIDELINES; THERAPY; STANDARDS; VARIANTS; BLOCKADE; MEDICINE	Timely and accurate identification of molecular alterations in solid tumors is essential for proper management of patients with advanced cancers. This has created a need for rapid, scalable comprehensive genomic profiling (CGP) systems that detect an increasing number of therapeutically-relevant variant types and molecular signatures. In this study, we assessed the analytical performance of the TruSight Oncology 500 High-Throughput assay for detection of somatic alterations from formalin-fixed paraffin-embedded tissue specimens. In parallel, we developed supporting software and automated sample preparation systems designed to process up to 70 clinical samples in a single NovaSeq 6000(TM) sequencing run with a turnaround time of <7 days from specimen receipt to report. The results demonstrate that the scalable assay accurately and reproducibly detects small variants, copy number alterations, microsatellite instability (MSI) and tumor mutational burden (TMB) from 40ng DNA, and multiple gene fusions, including known and unknown partners and splice variants from 20ng RNA. 717 tumor samples and reference materials with previously known alterations in 96 cancer-related genes were sequenced to evaluate assay performance. All variant classes were reliably detected at consistent and reportable variant allele percentages with >99% overall accuracy and precision. Our results demonstrate that the high-throughput CGP assay is a reliable method for accurate detection of molecular alterations in support of precision therapeutics in oncology. The supporting systems and scalable workflow allow for efficient interpretation and prompt reporting of hundreds of patient cancer genomes per week with excellent analytical performance.	[Conroy, Jeffrey M.; Glenn, Sean T.; Burgher, Blake; Andreas, Jonathan; Giamo, Vincent; Mallon, Melissa; Lenzo, Felicia L.] OmniSeq Inc, Res & Dev, Buffalo, NY USA; [Conroy, Jeffrey M.] Roswell Pk Comprehens Canc Ctr, Res Support Serv, Buffalo, NY USA; [Pabla, Sarabjot; Seager, R. J.; Van Roey, Erik; Gao, Shuang] OmniSeq Inc, Bioinformat, Buffalo, NY USA; [Glenn, Sean T.; Zhang, Shengle] OmniSeq Inc, Lab Operat, Buffalo, NY 14203 USA; [Glenn, Sean T.] Roswell Pk Comprehens Canc Ctr, HemePath Mol, Buffalo, NY USA; [Lee, Yong Hee; DePietro, Paul; Nesline, Mary] OmniSeq Inc, Clin Evidence Dev, Buffalo, NY USA; [Wang, Yirong] OmniSeq Inc, Informat Technol, Buffalo, NY USA; [Klein, Roger] OmniSeq Inc, Med Affairs, Buffalo, NY USA		Zhang, SL (corresponding author), OmniSeq Inc, Lab Operat, Buffalo, NY 14203 USA.	Shengle.Zhang@omniseq.com	Klein, Roger/AAO-9749-2021	Klein, MD JD, Roger/0000-0002-7155-6642	OmniSeq, Inc. (Buffalo, NY)	OmniSeq, Inc. (Buffalo, NY)	This research was funded by OmniSeq, Inc. (Buffalo, NY). The funder provided support in the form of salaries for authors JC, SP, SG, RJS, EVR, SG, BB, JA, VG, MM, YHL, PD, MN, YW, FL, RK and SZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Beaubier Nike, 2019, Oncotarget, V10, P2384, DOI 10.18632/oncotarget.26797; Bianchi V, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00075; Bonneville R, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00073; Buchhalter I, 2019, INT J CANCER, V144, P848, DOI 10.1002/ijc.31878; Canchola J.A., 2016, SAS GLOBAL FORUM 201, DOI [10.13140/RG.2.1.4799.4969, DOI 10.13140/RG.2.1.4799.4969]; Carr TH, 2016, NAT REV CANCER, V16, P319, DOI 10.1038/nrc.2016.35; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; CLSI, 2008, ORDER; Committee for Medicinal Products for Human Use (CHMP), 2017, GUIDELINE EVALUATION, V44; Conroy JM, 2018, J MOL DIAGN, V20, P95, DOI 10.1016/j.jmoldx.2017.10.001; Drilon A, 2018, NEW ENGL J MED, V378, P731, DOI 10.1056/NEJMoa1714448; Drilon A, 2015, CLIN CANCER RES, V21, P3631, DOI 10.1158/1078-0432.CCR-14-2683; Dudley JC, 2016, CLIN CANCER RES, V22, P813, DOI 10.1158/1078-0432.CCR-15-1678; Endris V, 2019, INT J CANCER, V144, P2303, DOI 10.1002/ijc.32002; Fabrizio DA, 2018, J GASTROINTEST ONCOL, V9, P610, DOI 10.21037/jgo.2018.05.06; Fancello L, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0647-4; Jardim DLF, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv253; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Gutierrez ME, 2017, CLIN LUNG CANCER, V18, P651, DOI 10.1016/j.cllc.2017.04.004; Haraldsdottir S, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00189; Haslem DS, 2017, J ONCOL PRACT, V13, pE108, DOI 10.1200/JOP.2016.011486; Hellmann MD, 2018, NEW ENGL J MED, V378, P2093, DOI 10.1056/NEJMoa1801946; Hovelson DH, 2015, NEOPLASIA, V17, P385, DOI 10.1016/j.neo.2015.03.004; Huang FW, 2019, CELL, V177, P8, DOI 10.1016/j.cell.2019.02.049; Illumina, 2020, TRUSIGHT ONC 500 HIG; Jennings LJ, 2017, J MOL DIAGN, V19, P341, DOI 10.1016/j.jmoldx.2017.01.011; Li MM, 2017, J MOL DIAGN, V19, P4, DOI 10.1016/j.jmoldx.2016.10.002; Lih CJ, 2017, J MOL DIAGN, V19, P313, DOI 10.1016/j.jmoldx.2016.10.007; Longshore JW, 2020, CLIN CHEM, V66, P138, DOI 10.1373/clinchem.2019.304626; MacConaill LE, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4428-5; Marabelle A, 2020, LANCET ONCOL, V21, P1353, DOI 10.1016/S1470-2045(20)30445-9; Massard C, 2017, CANCER DISCOV, V7, P586, DOI 10.1158/2159-8290.CD-16-1396; Meric-Bernstam F, 2015, J CLIN ONCOL, V33, P2753, DOI 10.1200/JCO.2014.60.4165; MERINO D. M., 2020, ALIGNMENT TMB MEASUR, DOI [10.1158/1538-7445.am2020-5671, DOI 10.1158/1538-7445.AM2020-5671]; Merino DM, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000147; National Comprehensive Cancer Network`, 2021, NCCN CLIN PRACTICE G, DOI 10.6004/jnccn.2009.0057; New York State Department of Health, 2020, NEXT GENERATION SEQU, DOI [10.1093/jncics/pkaa018, DOI 10.1093/JNCICS/PKAA018]; O'Kane GM, 2017, TRENDS MOL MED, V23, P1121, DOI 10.1016/j.molmed.2017.10.007; Olsen D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00105; Pabla Sarabjot, 2019, Oncotarget, V10, P5181, DOI 10.18632/oncotarget.27142; Parkinson DR, 2012, CLIN CANCER RES, V18, P619, DOI 10.1158/1078-0432.CCR-11-2017; Pennell NA, 2019, JCO PRECIS ONCOL, V3, DOI 10.1200/PO.18.00356; Pestinger V, 2020, MOL DIAGN THER, V24, P339, DOI 10.1007/s40291-020-00462-x; Poh A, 2017, CANCER DISCOV, V7, P656, DOI 10.1158/2159-8290.CD-NB2017-078; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Roy S, 2018, J MOL DIAGN, V20, P4, DOI 10.1016/j.jmoldx.2017.11.003; Roy S, 2016, ARCH PATHOL LAB MED, V140, P958, DOI 10.5858/arpa.2015-0507-RA; Samstein RM, 2019, NAT GENET, V51, P202, DOI 10.1038/s41588-018-0312-8; Schwaederle M, 2016, JAMA ONCOL, V2, P1452, DOI 10.1001/jamaoncol.2016.2129; Sicklick JK, 2019, NAT MED, V25, P744, DOI 10.1038/s41591-019-0407-5; Singer J., 2017, BRIEF BIOINFORM, DOI [10.1002/ijc.30828 28597939, DOI 10.1002/IJC.3082828597939]; Sleijfer S, 2013, J CLIN ONCOL, V31, P1834, DOI 10.1200/JCO.2012.45.3639; U. FDA, 2007, GUIDANCE IND FDA STA; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Wheler JJ, 2016, CANCER RES, V76, P3690, DOI 10.1158/0008-5472.CAN-15-3043; Yan L, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0274-3	58	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260089	10.1371/journal.pone.0260089	http://dx.doi.org/10.1371/journal.pone.0260089			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855780	gold, Green Published			2022-12-26	WOS:000735299000030
J	Dreyer, AM; Rieger, JW				Dreyer, Alexander M.; Rieger, Jochem W.			High-gamma mirror activity patterns in the human brain during reach-to-grasp movement observation, retention, and execution-An MEG study	PLOS ONE			English	Article							HAND ACTIONS; MOTOR; IMITATION; PREMOTOR; CORTEX; RHYTHMS; AREAS; SYNCHRONIZATION; LOCALIZATION; OSCILLATIONS	While the existence of a human mirror neuron system is evident, the involved brain areas and their exact functional roles remain under scientific debate. A number of functionally different mirror neuron types, neurons that selectively respond to specific grasp phases and types for example, have been reported with single cell recordings in monkeys. In humans, spatially limited, intracranially recorded electrophysiological signals in the high-gamma (HG) range have been used to investigate the human mirror system, as they are associated with spiking activity in single neurons. Our goal here is to complement previous intracranial HG studies by using magnetoencephalography to record HG activity simultaneously from the whole head. Participants performed a natural reach-to-grasp movement observation and delayed imitation task with different everyday objects and grasp types. This allowed us to characterize the spatial organization of cortical areas that show HG-activation modulation during movement observation (mirroring), retention (mnemonic mirroring), and execution (motor control). Our results show mirroring related HG modulation patterns over bilateral occipito-parietal as well as sensorimotor areas. In addition, we found mnemonic mirroring related HG modulation over contra-lateral fronto-temporal areas. These results provide a foundation for further human mirror system research as well as possible target areas for brain-computer interface and neurorehabilitation approaches.	[Dreyer, Alexander M.; Rieger, Jochem W.] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg	Dreyer, AM (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Psychol, Oldenburg, Germany.	alexander.dreyer@uol.de		Dreyer, Alexander/0000-0001-5291-1621; Rieger, Jochem/0000-0003-0955-2306	"Forschungspool" of the School of Medicine and Health Sciences, University of Oldenburg [2017-006]	"Forschungspool" of the School of Medicine and Health Sciences, University of Oldenburg	This work was supported by the "Forschungspool" of the School of Medicine and Health Sciences, University of Oldenburg (https://uol.de/medizin/forschungspool; Grant 2017-006 awarded to AD and JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2019, P NATL ACAD SCI USA, V116, P26274, DOI 10.1073/pnas.1902276116; Babiloni C, 2016, CLIN NEUROPHYSIOL, V127, P641, DOI 10.1016/j.clinph.2015.04.068; Bauer M, 2006, J NEUROSCI, V26, P490, DOI 10.1523/JNEUROSCI.5228-04.2006; Begliomini C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00676; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Breveglieri R, 2019, CURR BIOL, V29, P1218, DOI 10.1016/j.cub.2019.02.027; Breveglieri R, 2018, CEREB CORTEX, V28, P2028, DOI 10.1093/cercor/bhx109; Breveglieri R, 2016, SCI REP-UK, V6, DOI 10.1038/srep28893; Brookes MJ, 2011, NEUROIMAGE, V55, P1804, DOI 10.1016/j.neuroimage.2010.10.074; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Buccino G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0185; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Castiello U, 2008, NEUROSCIENTIST, V14, P157, DOI 10.1177/1073858407312080; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; CHEYNE D, 1989, EXP BRAIN RES, V78, P604; Cheyne D, 2008, NEUROIMAGE, V42, P332, DOI 10.1016/j.neuroimage.2008.04.178; Cheyne DO, 2013, EXP NEUROL, V245, P27, DOI 10.1016/j.expneurol.2012.08.030; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Cross KA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0176; Dalal SS, 2008, NEUROIMAGE, V40, P1686, DOI 10.1016/j.neuroimage.2008.01.023; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Darvas F, 2013, J CLIN NEUROPHYSIOL, V30, P299, DOI 10.1097/WNP.0b013e3182872f40; Davare M, 2011, CURR OPIN NEUROBIOL, V21, P565, DOI 10.1016/j.conb.2011.05.021; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; Eaves DL, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3382/fnins.2015.00514; Fattori P, 2017, CEREB CORTEX, V27, P1149, DOI 10.1093/cercor/bhv302; Ferrari PF, 2009, PHILOS T R SOC B, V364, P2311, DOI 10.1098/rstb.2009.0062; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Grezes J, 1998, COGN NEUROPSYCHOL, V15, P553, DOI 10.1080/026432998381023; Hinkley LBN, 2011, CEREB CORTEX, V21, P519, DOI 10.1093/cercor/bhq102; Huo XL, 2011, BRAIN TOPOGR, V23, P375, DOI 10.1007/s10548-010-0151-0; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jeannerod M, 1999, HUM MOVEMENT SCI, V18, P201, DOI 10.1016/S0167-9457(99)00008-1; Jeannerod M., 1981, INTERSEGMENTAL COORD, P153; Karl JM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00208; Kilner JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004925; Kraskov A, 2009, NEURON, V64, P922, DOI 10.1016/j.neuron.2009.12.010; Lachaux JP, 2012, PROG NEUROBIOL, V98, P279, DOI 10.1016/j.pneurobio.2012.06.008; Leszczynski M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb0977; Malmivuo J., 1995, BIOELECTROMAGNETISM, DOI [10.3109/03091909509030281, DOI 10.3109/03091909509030281]; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Marshall B, 2020, RES DEV DISABIL, V98, DOI 10.1016/j.ridd.2019.103570; Miller KJ, 2014, NEUROIMAGE, V85, P711, DOI 10.1016/j.neuroimage.2013.08.070; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Muthukumaraswamy SD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00138; Muthukumaraswamy SD, 2010, J NEUROPHYSIOL, V104, P2873, DOI 10.1152/jn.00607.2010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perry A, 2018, CEREB CORTEX, V28, P1039, DOI 10.1093/cercor/bhx013; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Shirinbayan SI, 2017, J NEUROSCI METH, V280, P16, DOI 10.1016/j.jneumeth.2017.01.015; Shirinbayan SI, 2019, HUM BRAIN MAPP, V40, P151, DOI 10.1002/hbm.24361; Takahashi K, 2017, J NEUROSCI, V37, P1733, DOI 10.1523/JNEUROSCI.1537-16.2016; Vesia M, 2012, EXP BRAIN RES, V221, P1, DOI 10.1007/s00221-012-3158-9; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	65	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260304	10.1371/journal.pone.0260304	http://dx.doi.org/10.1371/journal.pone.0260304			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855777	Green Published, gold			2022-12-26	WOS:000735299000041
J	Rehman, MZ; Zamli, KZ; Almutairi, M; Chiroma, H; Aamir, M; Kader, MA; Nawi, NM				Rehman, Muhammad Zubair; Zamli, Kamal Z.; Almutairi, Mubarak; Chiroma, Haruna; Aamir, Muhammad; Kader, Md Abdul; Nawi, Nazri Mohd			A novel state space reduction algorithm for team formation in social networks	PLOS ONE			English	Article							OPTIMIZATION	Team formation (TF) in social networks exploits graphs (i.e., vertices = experts and edges = skills) to represent a possible collaboration between the experts. These networks lead us towards building cost-effective research teams irrespective of the geolocation of the experts and the size of the dataset. Previously, large datasets were not closely inspected for the large-scale distributions & relationships among the researchers, resulting in the algorithms failing to scale well on the data. Therefore, this paper presents a novel TF algorithm for expert team formation called SSR-TF based on two metrics; communication cost and graph reduction, that will become a basis for future TF's. In SSR-TF, communication cost finds the possibility of collaboration between researchers. The graph reduction scales the large data to only appropriate skills and the experts, resulting in real-time extraction of experts for collaboration. This approach is tested on five organic and benchmark datasets, i.e., UMP, DBLP, ACM, IMDB, and Bibsonomy. The SSR-TF algorithm is able to build cost-effective teams with the most appropriate experts-resulting in the formation of more communicative teams with high expertise levels.	[Rehman, Muhammad Zubair] Sohar Univ, Fac Comp & Informat Technol, Sohar, Oman; [Zamli, Kamal Z.; Kader, Md Abdul] Univ Malaysia Pahang UMP, Fac Comp, Gambang, Pahang, Malaysia; [Almutairi, Mubarak; Chiroma, Haruna] Univ Hafr Al Batin, Coll Comp Sci & Engn, Hafar Al Batin, Saudi Arabia; [Chiroma, Haruna] Abubakar Tafawa Balewa Univ, Bauchi, Nigeria; [Aamir, Muhammad] Univ Derby, Derby, England; [Nawi, Nazri Mohd] Univ Tun Hussein Onn Malaysia UTHM, Fac Comp Sci & Informat Technol, Soft Comp & Data Min Ctr SMC, Batu Pahat, Malaysia	Sohar University; Universiti Malaysia Pahang; Hafr Albatin University; University of Derby; University of Tun Hussein Onn Malaysia	Chiroma, H (corresponding author), Univ Hafr Al Batin, Coll Comp Sci & Engn, Hafar Al Batin, Saudi Arabia.; Chiroma, H (corresponding author), Abubakar Tafawa Balewa Univ, Bauchi, Nigeria.	freedonchi@yahoo.com	Kader, Abdul/HHC-1471-2022; Chiroma, Haruna/O-2934-2013	Kader, Md. Abdul/0000-0003-0949-5030; Chiroma, Haruna/0000-0003-3446-4316; Mohd Nawi, Nazri/0000-0003-0685-7892				Abdelsalam HME, 2009, STUD COMPUT INTELL, V203, P461; Alqahtani M., 2020, DIVERSE GROUP FORMAT, DOI [10.5220/0010106301690178, DOI 10.5220/0010106301690178]; Anagnostopoulos A., 2012, P 21 INT C WORLD WID, P839, DOI DOI 10.1145/2187836.2187950; Ashenagar B, 2015, 2015 7TH CONFERENCE ON INFORMATION AND KNOWLEDGE TECHNOLOGY (IKT); Ashenagar B, 2015, 2015 12TH INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY (FSKD), P946, DOI 10.1109/FSKD.2015.7382071; Bagherina A., 2018, INT J ADV ROBOT EXPT, V1, P13; Basiri J, 2017, WORLD WIDE WEB, V20, P1385, DOI 10.1007/s11280-017-0440-6; Baykasoglu A, 2007, CYBERNET SYST, V38, P155, DOI 10.1080/01969720601139041; Brownlee J., 2020, MACH LEARN MASTER; Campelo M, 2021, COMPUT OPER RES, V133, DOI 10.1016/j.cor.2021.105354; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; El-Ashmawi Walaa H., 2019, Journal of Industrial Engineering International, V15, P53, DOI 10.1007/s40092-018-0282-6; El-Ashmawi Walaa H., 2018, International Journal of Information Technology and Computer Science, V10, P16, DOI 10.5815/ijitcs.2018.05.02; El-Ashmawi WH, 2020, SOFT COMPUT, V24, P16627, DOI 10.1007/s00500-020-04965-x; Fathian M, 2017, IEEE T ENG MANAGE, V64, P586, DOI 10.1109/TEM.2017.2715825; Furini Fabio, 2014, Combinatorial Optimization. Third International Symposium, ISCO 2014. Revised Selected Papers. LNCS: 8596, P267, DOI 10.1007/978-3-319-09174-7_23; Kader Md Abdul, 2020, ICSCA 2020: Proceedings of the 2020 9th International Conference on Software and Computer Applications, P62, DOI 10.1145/3384544.3384593; Kargar Mehdi, 2012, Machine Learning and Knowledge Discovery in Databases. Proceedings of the European Conference (ECML PKDD 2012), P483, DOI 10.1007/978-3-642-33486-3_31; Kargar M., 2011, 2011 IEEE International Conference on Data Mining Workshops, P1231, DOI 10.1109/ICDMW.2011.162; Kouvatis I., 2020, Adv Database Technol-EDBT, P363, DOI [10.5441/002/edbt.2020.33, 10.5441/002/EDBT.2020.33]; Lappas T, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P467; Li LY, 2016, CIKM'16: PROCEEDINGS OF THE 2016 ACM CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P2485, DOI 10.1145/2983323.2983340; Najaflou Y, 2021, IEEE T EMERG TOP COM, V9, P204, DOI 10.1109/TETC.2018.2869377; Najaflou Y, 2017, P IEEE INT C E-SCI, P158, DOI 10.1109/eScience.2017.28; Niveditha M, 2017, INT CONF ADV COMPU, P123, DOI 10.1109/ICoAC.2017.7951757; Rahman H, 2015, IEEE DATA MINING, P949, DOI 10.1109/ICDM.2015.119; Salami Hamza O., 2016, International Journal of Intelligent Systems and Applications, V8, P51, DOI 10.5815/ijisa.2016.10.06; SIKLOSSY L, 1991, INFORM PROCESS LETT, V38, P187, DOI 10.1016/0020-0190(91)90098-3; Singhbaghel V., 2018, 2018 11 INT C CONT C, V2, P2, DOI [10.1109/IC3.2018.8530662, DOI 10.1109/IC3.2018.8530662]; Teng YC, 2014, LECT NOTES ARTIF INT, V8643, P125, DOI 10.1007/978-3-319-13186-3_12; van Staden WJC, 2016, INFO SECUR S AFR, P91, DOI 10.1109/ISSA.2016.7802934; Wang XY, 2015, LECT NOTES COMPUT SC, V9049, P389, DOI 10.1007/978-3-319-18120-2_23; Wu J, 2016, 2016 INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND APPLICATIONS (ICCIA), P67, DOI 10.1109/ICCIA.2016.20; Xinyu Wang, 2016, IEEE Transactions on Big Data, V2, P70, DOI 10.1109/TBDATA.2016.2546303; Zamli KZ., 2020, UMP DATASET; Zamli KZ., 2020, IMDB DATASET; Zamli KZ., 2020, DBLP DATASET; Zamli KZ., 2020, ACM DATASET; Zhang LY, 2013, COMPUT IND ENG, V64, P804, DOI 10.1016/j.cie.2012.12.015	39	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0259786	10.1371/journal.pone.0259786	http://dx.doi.org/10.1371/journal.pone.0259786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855771	Green Published			2022-12-26	WOS:000735299000021
J	Yde, CC; Jensen, HM; Christensen, N; Servant, F; Lelouvier, B; Lahtinen, S; Stenman, LK; Airaksinen, K; Kailanto, HM				Yde, Christian Clement; Jensen, Henrik Max; Christensen, Niels; Servant, Florence; Lelouvier, Benjamin; Lahtinen, Sampo; Stenman, Lotta K.; Airaksinen, Kaisa; Kailanto, Henna-Maria			Polydextrose with and without Bifidobacterium animalis ssp. lactis 420 drives the prevalence of Akkermansia and improves liver health in a multi-compartmental obesogenic mice study	PLOS ONE			English	Article							INTERNATIONAL SCIENTIFIC ASSOCIATION; GUT MICROBIOME; CONSENSUS STATEMENT; SERUM METABOLOME; DOUBLE-BLIND; WEIGHT; IMPACT; OVERWEIGHT; OBESITY; BETAINE	The past two decades of research have raised gut microbiota composition as a contributing factor to the development of obesity, and higher abundance of certain bacterial species has been linked to the lean phenotype, such as Akkermansia muciniphila. The ability of pre- and probiotics to affect metabolic health could be via microbial community alterations and subsequently changes in metabolite profiles, modulating for example host energy balance via complex signaling pathways. The aim of this mice study was to determine how administration of a prebiotic fiber, polydextrose (PDX) and a probiotic Bifidobacterium animalis ssp. lactis 420 (B420), during high fat diet (HFD; 60 kcal% fat) affects microbiota composition in the gastrointestinal tract and adipose tissue, and metabolite levels in gut and liver. In this study C57Bl/6J mice (N = 200) were split in five treatments and daily gavaged: 1) Normal control (NC); 2) HFD; 3) HFD + PDX; 4) HFD + B420 or 5) HFD + PDX + B420 (HFD+S). At six weeks of treatment intraperitoneal glucose-tolerance test (IPGTT) was performed, and feces were collected at weeks 0, 3, 6 and 9. At end of the intervention, ileum and colon mucosa, adipose tissue and liver samples were collected. The microbiota composition in fecal, ileum, colon and adipose tissue was analyzed using 16S rDNA sequencing, fecal and liver metabolomics were performed by nuclear magnetic resonance (NMR) spectroscopy. It was found that HFD+PDX intervention reduced body weight gain and hepatic fat compared to HFD. Sequencing the mice adipose tissue (MAT) identified Akkermansia and its prevalence was increased in HFD+S group. Furthermore, by the inclusion of PDX, fecal, lleum and colon levels of Akkermansia were increased and liver health was improved as the detoxification capacity and levels of methyl-donors were increased. These new results demonstrate how PDX and B420 can affect the interactions between gut, liver and adipose tissue.	[Yde, Christian Clement; Jensen, Henrik Max; Christensen, Niels] IFF Enabling Technol, Aarhus, Denmark; [Yde, Christian Clement] Aarhus Univ, Dept Food Sci, Aarhus N, Denmark; [Servant, Florence; Lelouvier, Benjamin] Vaiomer, Labege, France; [Lahtinen, Sampo; Stenman, Lotta K.; Airaksinen, Kaisa; Kailanto, Henna-Maria] IFF Hlth & Biosci, Kantvik, Finland	Aarhus University	Yde, CC (corresponding author), IFF Enabling Technol, Aarhus, Denmark.; Yde, CC (corresponding author), Aarhus Univ, Dept Food Sci, Aarhus N, Denmark.	Christian-Clement.Yde@iff.com		Yde, Christian Clement/0000-0003-4959-9192; Servant, Florence/0000-0003-1063-6531	IFF Health Biosciences; Innovation Fund Denmark [422800010B]	IFF Health Biosciences; Innovation Fund Denmark	This study was funded by IFF Health & Biosciences. CCY was financially supported by the Innovation Fund Denmark (Project No. 422800010B). IFF Health & Biosciences manufactures the prebiotic (Litesse (R) polydextrose) and probiotic (HOWARU (R) Shape (10B CFU B. lactis B420 (TM)) used in this study. Investigating the effects of these commercial products was the reason to initiate the study incl. study design, data collection and analysis and decision to publish. The specific roles of these authors are articulated in the `author contributions' section.	Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Beckonert O, 2010, NAT PROTOC, V5, P1019, DOI 10.1038/nprot.2010.45; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Corbin KD, 2012, CURR OPIN GASTROEN, V28, P159, DOI 10.1097/MOG.0b013e32834e7b4b; Costabile A, 2012, BRIT J NUTR, V108, P471, DOI 10.1017/S0007114511005782; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Day CR, 2016, BBA-GEN SUBJECTS, V1860, P1098, DOI 10.1016/j.bbagen.2016.02.001; Depommier C, 2019, NAT MED, V25, P1096, DOI 10.1038/s41591-019-0495-2; Indiani CMDP, 2018, CHILD OBES, V14, P501, DOI 10.1089/chi.2018.0040; Escudie F, 2018, BIOINFORMATICS, V34, P1287, DOI 10.1093/bioinformatics/btx791; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Feng J, 2013, METABOLITES, V3, P1011, DOI 10.3390/metabo3041011; Ghetti FD, 2018, EUR J NUTR, V57, P861, DOI 10.1007/s00394-017-1524-x; Gibson GR, 2017, NAT REV GASTRO HEPAT, V14, P491, DOI 10.1038/nrgastro.2017.75; Gogiashvili M, 2017, ANAL BIOANAL CHEM, V409, P1591, DOI 10.1007/s00216-016-0100-1; Hao J, 2014, NAT PROTOC, V9, P1416, DOI 10.1038/nprot.2014.090; Hasanzadeh-Moghadam M, 2018, VET RES FORUM, V9, P129, DOI 10.30466/vrf.2018.30834; Hibberd AA, 2019, BENEF MICROBES, V10, P121, DOI 10.3920/BM2018.0028; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Holscher HD, 2015, AM J CLIN NUTR, V101, P55, DOI 10.3945/ajcn.114.092064; Honda Y, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0652-3; Hull S, 2012, APPETITE, V59, P706, DOI 10.1016/j.appet.2012.08.004; Ibarra A, 2017, APPETITE, V110, P15, DOI 10.1016/j.appet.2016.12.002; KAPLOWITZ N, 1981, YALE J BIOL MED, V54, P497; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kobyliak N, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0067-0; Lahtinen SJ, 2010, BIOSCI BIOTECH BIOCH, V74, P2016, DOI 10.1271/bbb.100251; Lamichhane S, 2018, J PROTEOME RES, V17, P1041, DOI 10.1021/acs.jproteome.7b00683; Lamichhane S, 2014, J AGR FOOD CHEM, V62, P9944, DOI 10.1021/jf5031218; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358; Lluch J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142334; Lu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep37589; Lukovac S, 2014, MBIO, V5, DOI 10.1128/mBio.01438-14; Meroni M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112642; Olli K, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-2; Ondee T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85449-2; Organisation for Economic Co-operation and Development, 2019, The heavy burden of obesity. The economics of prevention, DOI 10.1787/67450d67-en; Ottman N, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01014-17; Ouwerkerk JP, 2016, INT J SYST EVOL MICR, V66, P4614, DOI 10.1099/ijsem.0.001399; Paul HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20683; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Perakakis N, 2021, LIVER INT, V41, P1853, DOI 10.1111/liv.14888; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Raza GS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05259-3; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shang Y, 2017, LIPIDS, V52, P499, DOI 10.1007/s11745-017-4253-2; Sousa SAA, 2013, CHEMOMETR INTELL LAB, V122, P93, DOI 10.1016/j.chemolab.2013.01.006; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Stenman LK, 2014, BENEF MICROBES, V5, P437, DOI 10.3920/BM2014.0014; Stenman LK, 2016, EBIOMEDICINE, V13, P190, DOI 10.1016/j.ebiom.2016.10.036; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Tripathi A, 2018, NAT REV GASTRO HEPAT, V15, P397, DOI 10.1038/s41575-018-0011-z; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vernocchi P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01144; Wang KC, 2013, ANAL CHEM, V85, P1231, DOI 10.1021/ac303233c; Wiedeman AM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101513; Yoneshiro T, 2019, NATURE, V572, P614, DOI 10.1038/s41586-019-1503-x; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774	63	2	2	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260765	10.1371/journal.pone.0260765	http://dx.doi.org/10.1371/journal.pone.0260765			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855861	gold, Green Published			2022-12-26	WOS:000735299000115
J	Park, JS; Kim, DW; Lee, D; Lee, T; Koo, KC; Han, WK; Ha Chung, B; Lee, KS				Park, Jee Soo; Kim, Dong Wook; Lee, Dongu; Lee, Taeju; Koo, Kyo Chul; Han, Woong Kyu; Ha Chung, Byung; Lee, Kwang Suk			Development of prediction models of spontaneous ureteral stone passage through machine learning: Comparison with conventional statistical analysis	PLOS ONE			English	Article							GUIDELINES; MANAGEMENT; EXPULSION	Objectives To develop a prediction model of spontaneous ureteral stone passage (SSP) using machine learning and logistic regression and compare the performance of the two models. Indications for management of ureteral stones are unclear, and the clinician determines whether to wait for SSP or perform active treatment, especially in well-controlled patients, to avoid unwanted complications. Therefore, suggesting the possibility of SSP would help make a clinical decision regarding ureteral stones. Methods Patients diagnosed with unilateral ureteral stones at our emergency department between August 2014 and September 2018 were included and underwent non-contrast-enhanced computed tomography 4 weeks from the first stone episode. Predictors of SSP were applied to build and validate the prediction model using multilayer perceptron (MLP) with the Keras framework. Results Of 833 patients, SSP was observed in 606 (72.7%). SSP rates were 68.2% and 75.6% for stone sizes 5-10 mm and <5 mm, respectively. Stone opacity, location, and whether it was the first ureteral stone episode were significant predictors of SSP. Areas under the curve (AUCs) for receiver operating characteristic (ROC) curves for MLP, and logistic regression were 0.859 and 0.847, respectively, for stones <5 mm, and 0.881 and 0.817, respectively, for 5-10 mm stones. Conclusion SSP prediction models were developed in patients with well-controlled unilateral ureteral stones; the performance of the models was good, especially in identifying SSP for 5-10-mm ureteral stones without definite treatment guidelines. To further improve the performance of these models, future studies should focus on using machine learning techniques in image analysis.	[Park, Jee Soo; Lee, Dongu; Lee, Taeju; Koo, Kyo Chul; Han, Woong Kyu; Ha Chung, Byung; Lee, Kwang Suk] Yonsei Univ, Dept Urol, Coll Med, Seoul, South Korea; [Park, Jee Soo] Sorokdo Natl Hosp, Dept Urol, Goheung, South Korea; [Kim, Dong Wook] Yonsei Univ, Dept Oral & Maxillofacial Surg, Coll Dent, Seoul, South Korea; [Lee, Kwang Suk] Yonsei Univ, Dept Mech Engn, Coll Engn, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Lee, KS (corresponding author), Yonsei Univ, Dept Urol, Coll Med, Seoul, South Korea.; Lee, KS (corresponding author), Yonsei Univ, Dept Mech Engn, Coll Engn, Seoul, South Korea.	winner0428@gmail.com		Koo, Kyo Chul/0000-0001-7303-6256; Chung, Byung Ha/0000-0001-9817-3660; Han, Woong Kyu/0000-0002-2527-4046; Kim, Dongwook/0000-0001-6167-6475; Lee, Kwang Suk/0000-0002-7961-8393				Ahmed AF, 2015, ARAB J UROL, V13, P84, DOI 10.1016/j.aju.2014.11.004; Aldaqadossi HA, 2013, UROLITHIASIS, V41, P235, DOI 10.1007/s00240-013-0551-1; Allaire J., R INTERFACE TO KERAS; Bai YJ, 2017, J ENDOUROL, V31, P557, DOI 10.1089/end.2016.0837; Burt JR, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170545; Campschroer T., 2014, SYST REV-LONDON, P4, DOI [10.1186/2046-4053-3-4, DOI 10.1186/2046-4053-3-4]; Chartrand G, 2017, RADIOGRAPHICS, V37, P2113, DOI 10.1148/rg.2017170077; Chen J, 2019, BJU INT, V124, P567, DOI 10.1111/bju.14852; Cosma G, 2017, EXPERT SYST APPL, V70, P1, DOI 10.1016/j.eswa.2016.11.006; Dellabella M, 2003, J UROLOGY, V170, P2202, DOI 10.1097/01.ju.0000096050.22281.a7; Fazal MI, 2018, EUR J RADIOL, V105, P246, DOI 10.1016/j.ejrad.2018.06.020; Fazlioglu A., 2014, BMC UROL, P14, DOI [10.1186/1471-2490-14-14, DOI 10.1186/1471-2490-14-14]; IBRAHIM AIA, 1991, BRIT J UROL, V67, P358, DOI 10.1111/j.1464-410X.1991.tb15161.x; Kim W, 2012, J BREAST CANCER, V15, P230, DOI 10.4048/jbc.2012.15.2.230; Lee KS, 2017, YONSEI MED J, V58, P988, DOI 10.3349/ymj.2017.58.5.988; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Ozcan C, 2015, J UROLOGY, V194, P1009, DOI 10.1016/j.juro.2015.04.104; Park CH, 2013, KOREAN J UROL, V54, P615, DOI 10.4111/kju.2013.54.9.615; Quhal F, 2021, CURR OPIN UROL, V31, P125, DOI 10.1097/MOU.0000000000000855; Seitz C, 2009, EUR UROL, V56, P455, DOI 10.1016/j.eururo.2009.06.012; Shabaniyan T, 2019, AUSTRALAS PHYS ENG S, V42, P771, DOI 10.1007/s13246-019-00780-3; Siegel C., 2002, J UROLOGY, P168, DOI [10.1016/s0022-5347(05)64854-9, DOI 10.1016/S0022-5347(05)64854-9]; Takahashi N, 1998, RADIOLOGY, V208, P97, DOI 10.1148/radiology.208.1.9646798; TEACH RL, 1981, COMPUT BIOMED RES, V14, P542, DOI 10.1016/0010-4809(81)90012-4; Turk C, 2016, EUR UROL, V69, P468, DOI 10.1016/j.eururo.2015.07.040; UENO A, 1977, Urology, V10, P544, DOI 10.1016/0090-4295(77)90097-8	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260517	10.1371/journal.pone.0260517	http://dx.doi.org/10.1371/journal.pone.0260517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851999	Green Published, gold			2022-12-26	WOS:000755762900042
J	Virata, MD; Shenoi, SV; Ladines-Lim, J; Villanueva, MS; Barakat, LA				Virata, Michael D.; Shenoi, Sheela, V; Ladines-Lim, Joseph; Villanueva, Merceditas S.; Barakat, Lydia A.			Cumulative burden of non-communicable diseases predicts COVID hospitalization among people with HIV: A one-year retrospective cohort study	PLOS ONE			English	Article							CORONAVIRUS; DEATH	There continue to be conflicting data regarding the outcomes of people with HIV (PWH) who have COVID-19 infection with most studies describing the early epidemic. We present a single site experience spanning a later timeframe from the first report on January 21, 2020 to January 20, 2021 and describe clinical outcomes and predictors of hospitalization among a cohort of PWH in an urban center in Connecticut, USA. Among 103 PWH with controlled HIV disease, hospitalization occurred in 33% and overall mortality was 1%. HIV associated factors (CD4 count, HIV viral suppression) were not associated with hospitalization. Chronic lung disease (OR: 3.35, 95% CI:1.28-8.72), and cardiovascular disease (OR: 3.4, 95% CI:1.27-9.12) were independently associated with hospitalization. An increasing number of non-communicable comorbidities increased the likelihood of hospitalization (OR: 1.61, 95% CI:1.22-2.13).	[Virata, Michael D.; Shenoi, Sheela, V; Villanueva, Merceditas S.; Barakat, Lydia A.] Yale Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06510 USA; [Ladines-Lim, Joseph] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ladines-Lim, Joseph] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA	Yale University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Virata, MD (corresponding author), Yale Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06510 USA.	michael.virata@yale.edu	Shenoi, Sheela/GRY-6103-2022; Shenoi, Sheela/Z-2641-2019	Shenoi, Sheela/0000-0001-7654-4344; Virata, Michael/0000-0003-3636-9283; Ladines-Lim, Joseph/0000-0002-2461-2752; Villanueva, Merceditas/0000-0003-1022-7746	Doris Duke Charitable Foundation [201516]	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	Sheela Shenoi received support from the Doris Duke Charitable Foundation (#201516). The funder did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. All other authors received no specific funding for this work.	Bhaskaran K, 2021, LANCET HIV, V8, pe24, DOI 10.1016/S2352-3018(20)30305-2; Blanco JL, 2020, LANCET HIV, V7, pE314, DOI 10.1016/S2352-3018(20)30111-9; Boulle A, 2021, CLIN INFECT DIS, V73, pE2005, DOI 10.1093/cid/ciaa1198; Cooper TJ, 2020, HIV MED, V21, P567, DOI 10.1111/hiv.12911; del Amo J, 2021, ANN INTERN MED, V174, P581, DOI 10.7326/L20-1399; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Durstenfeld Matthew S, 2021, medRxiv, DOI 10.1101/2021.04.05.21254938; Gallant J, 2017, J INFECT DIS, V216, P1525, DOI 10.1093/infdis/jix518; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Geretti AM, 2021, CLIN INFECT DIS, V73, pE2095, DOI 10.1093/cid/ciaa1605; Gervasoni C, 2020, CLIN INFECT DIS, V71, P2276, DOI 10.1093/cid/ciaa579; Harter G, 2020, INFECTION, V48, P681, DOI 10.1007/s15010-020-01438-z; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Karmen-Tuohy S, 2020, JAIDS-J ACQ IMM DEF, V85, P6, DOI 10.1097/QAI.0000000000002423; Mehraeen E, 2020, EUR J INTEGR MED, V40, DOI 10.1016/j.eujim.2020.101226; Mirzaei H, 2021, AIDS BEHAV, V25, P85, DOI 10.1007/s10461-020-02983-2; Moran C.A., 2021, C RETR OPP INF VIRT; SeyedAlinaghi S, 2021, EUR J MED RES, V26, DOI 10.1186/s40001-021-00524-8; Sigel K, 2020, CLIN INFECT DIS, V71, P2933, DOI 10.1093/cid/ciaa880; Sun J., 2021, C RETR OPP INF VIRT; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yendewa G.A., 2021, C RETR OPP INF VIRT; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2233, DOI 10.1093/cid/ciaa408; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260251	10.1371/journal.pone.0260251	http://dx.doi.org/10.1371/journal.pone.0260251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851963	Green Published, gold			2022-12-26	WOS:000755762900028
J	Kleene, R; Loers, G; Castillo, G; Schachner, M				Kleene, Ralf; Loers, Gabriele; Castillo, Gaston; Schachner, Melitta			Cell adhesion molecule L1 interacts with the chromo shadow domain of heterochromatin protein 1 isoforms alpha, beta, and gamma via its intracellular domain	FASEB JOURNAL			English	Article						cell adhesion molecule L1; chromo shadow domain; heterochromatin protein 1; neuritogenesis; neuronal migration; PxVxL motif	RECOGNITION MOLECULES; PRESENILIN/GAMMA-SECRETASE; IMMUNOGLOBULIN SUPERFAMILY; NUCLEAR TRANSLOCATION; CLINICAL SPECTRUM; HP1 SUGGESTS; MIGRATION; L1CAM; ASSOCIATION; CLEAVAGE	Cell adhesion molecule L1 regulates multiple cell functions and L1 deficiency is linked to several neural diseases. Proteolytic processing generates functionally decisive L1 fragments, which are imported into the nucleus. By computational analysis, we found at L1's C-terminal end the chromo shadow domain-binding motif PxVxL, which directs the binding of nuclear proteins to the heterochromatin protein 1 (HP1) isoforms alpha, beta, and gamma. By enzyme-linked immunosorbent assay, we show that the intracellular L1 domain binds to all HP1 isoforms. These interactions involve the HP1 chromo shadow domain and are mediated via the sequence 1158KDET1161 in the intracellular domain of murine L1, but not by L1's C-terminal PxVxL motif. Immunoprecipitation using nuclear extracts from the brain and from cultured cerebellar and cortical neurons indicates that HP1 isoforms interact with a yet unknown nuclear L1 fragment of approximately 55 kDa (L1-55), which carries ubiquitin residues. Proximity ligation indicates a close association between L1-55 and the HP1 isoforms in neuronal nuclei. This association is reduced after the treatment of neurons with inhibitors of metalloproteases, beta-site of amyloid precursor protein cleaving enzyme (BACE1), or gamma-secretase, suggesting that cleavage of full-length L1 by these proteases generates L1-55. Reduction of HP1 alpha, -beta, or -gamma expression by siRNA decreases L1-dependent neurite outgrowth from cultured cortical neurons and decreases the L1-dependent migration of L1-transfected HEK293 cells in a scratch assay. These findings indicate that the interaction of the novel fragment L1-55 with HP1 isoforms in nuclei affects L1-dependent functions, such as neurite outgrowth and neuronal migration.	[Kleene, Ralf; Loers, Gabriele; Castillo, Gaston] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Res Grp Biosynth Neural Struct, Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick	Schachner, M (corresponding author), Rutgers State Univ, Keck Ctr Collaborat Neurosci, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.	schachner@dls.rutgers.edu						Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Bosch-Presegue L, 2017, CELL REP, V21, P2048, DOI 10.1016/j.celrep.2017.10.092; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Brown JP, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-9; Canudas S, 2011, GENE DEV, V25, P1807, DOI 10.1101/gad.17325211; Canzio D, 2014, TRENDS CELL BIOL, V24, P377, DOI 10.1016/j.tcb.2014.01.002; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Charo NL, 2018, BBA-MOL CELL RES, V1865, P432, DOI 10.1016/j.bbamcr.2017.11.015; Chen Y, 2021, J ENDOCRINOL INVEST, V44, P1739, DOI 10.1007/s40618-020-01485-1; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Fankhauser CD, 2016, J CLIN PATHOL, V69, P460, DOI 10.1136/jclinpath-2016-203603; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fransen E, 1996, AM J MED GENET, V64, P73, DOI 10.1002/(SICI)1096-8628(19960712)64:1<73::AID-AJMG11>3.0.CO;2-P; Guseva D, 2009, BRAIN, V132, P2180, DOI 10.1093/brain/awp160; Gutwein P, 2005, CLIN CANCER RES, V11, P2492, DOI 10.1158/1078-0432.CCR-04-1688; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Hayakawa T, 2003, J CELL SCI, V116, P3327, DOI 10.1242/jcs.00635; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Hortsch Michael, 2014, Adv Neurobiol, V8, P195; Kakad PP, 2018, J BIOL CHEM, V293, P17442, DOI 10.1074/jbc.RA118.004240; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kleene R, 2021, J NEUROCHEM, V157, P1102, DOI 10.1111/jnc.15201; Kraus K, 2018, MOL NEUROBIOL, V55, P7164, DOI 10.1007/s12035-018-0901-7; Kurumaji A, 2001, AM J MED GENET, V105, P99; Kwon SH, 2008, MOL CELLS, V26, P217; Kwon SH, 2011, BIOESSAYS, V33, P280, DOI 10.1002/bies.201000138; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Linneberg C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39884-x; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; Lutz D, 2016, MOL NEUROBIOL, V53, P3360, DOI 10.1007/s12035-015-9277-0; Lutz D, 2014, J BIOL CHEM, V289, P13503, DOI 10.1074/jbc.M113.530238; Lutz D, 2014, J NEUROCHEM, V128, P713, DOI 10.1111/jnc.12473; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Maeng YS, 2015, STEM CELLS, V33, P1512, DOI 10.1002/stem.1954; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Mrazkova B, 2018, AGING-US, V10, P434, DOI 10.18632/aging.101404; Nayeem N, 1999, J CELL SCI, V112, P4739; Nock ML, 2006, EXP NEUROL, V202, P262, DOI 10.1016/j.expneurol.2006.05.029; Oshiro H, 2015, GENES CELLS, V20, P108, DOI 10.1111/gtc.12205; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; POLTORAK M, 1995, EXP NEUROL, V131, P266, DOI 10.1016/0014-4886(95)90048-9; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; Saftig P, 2015, PROG NEUROBIOL, V135, P1, DOI 10.1016/j.pneurobio.2015.10.003; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Sewduth RN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093036; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Smallwood A, 2012, GENOME RES, V22, P1426, DOI 10.1101/gr.124818.111; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Soria G, 2013, CELL CYCLE, V12, P422, DOI 10.4161/cc.23215; Stephens GE, 2005, BIOCHEMISTRY-US, V44, P13394, DOI 10.1021/bi051006+; Strekalova H, 2006, NEUROBIOL AGING, V27, P1, DOI 10.1016/j.neurobiolaging.2004.11.013; Sytnyk V, 2017, TRENDS NEUROSCI, V40, P295, DOI 10.1016/j.tins.2017.03.003; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Wakabayashi Y, 2008, PROG NEURO-PSYCHOPH, V32, P1199, DOI 10.1016/j.pnpbp.2008.03.005; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009; Zhang C, 2018, CARDIOVASC RES, V114, P443, DOI 10.1093/cvr/cvx236; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465	73	4	4	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22074	10.1096/fj.202100816R	http://dx.doi.org/10.1096/fj.202100816R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34859928				2022-12-26	WOS:000734992000047
J	Rogers, JA; Jones, G; Cook, J; Squibb, K; Wills, K; Lahham, A; Winzenberg, T				Rogers, Jason Andrew; Jones, Graeme; Cook, Jill; Squibb, Kathryn; Wills, Karen; Lahham, Aroub; Winzenberg, Tania			Chronic plantar heel pain modifies associations of ankle plantarflexor strength and body mass index with calcaneal bone density and microarchitecture	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; HEALTH; VALIDATION; FASCIITIS; QUALITY; IMPACT	Chronic plantar heel pain (CPHP) is associated with calcaneal bone spurs, but its associations with other calcaneal bone features are unknown. This study therefore aimed to determine associations between having CPHP and bone density and microarchitecture of the calcaneus. We assessed 220 participants with CPHP and 100 age- and sex-matched population-based controls. Trabecular bone density, thickness, separation and number, BV/TV, and cortical density, thickness and area were measured using a Scanco Xtreme1 HR-pQCT scanner at a plantar and mid-calcaneal site. Clinical, physical activity and disease history data were also collected. Associations with bone outcomes were assessed using multivariable linear regression adjusting for age, sex, physical activity, BMI and ankle plantarflexor strength. We assessed for potential effect modification of CPHP on these covariates using interaction terms. There were univariable associations at the plantar calcaneus where higher trabecular bone density, BV/TV and thickness and lower trabecular separation were associated with CPHP. In multivariable models, having CPHP was not independently associated with any bone outcome, but modified associations of BMI and ankle plantarflexor strength with mid-calcaneal and plantar bone outcomes respectively. Beneficial associations of BMI with mid-calcaneal trabecular density (BMI-case interaction standardised X/unstandardised Y beta-10.8(mgHA/cm(3)) (se 4.6), thickness -0.002(mm) (se 0.001) and BV/ TV-0.009(%) (se 0.004) were reduced in people with CPHP. Beneficial associations of ankle plantarflexor strength with plantar trabecular density (ankle plantarflexor strength-case interaction -11.9(mgHA/cm(3)) (se 4.4)), thickness -0.003(mm) (se 0.001), separation -0.003(mm) (se 0.001) and BV/TV -0.010(%) (se 0.004) were also reduced. CPHP may have consequences for calcaneal bone density and microarchitecture by modifying associations of BMI and ankle plantarflexor strength with calcaneal bone outcomes. The reasons for these case-control differences are uncertain but could include a bone response to entheseal stress, altered loading habits and/or pain mechanisms. Confirmation with longitudinal study is required.	[Rogers, Jason Andrew; Jones, Graeme; Squibb, Kathryn; Wills, Karen; Lahham, Aroub; Winzenberg, Tania] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Cook, Jill] La Trobe Univ, La Trobe Sport & Exercise Med Ctr, Melbourne, Vic, Australia; [Squibb, Kathryn] Tasmanian Hlth Serv, Dept Hlth, Scottsdale, Tas, Australia; [Lahham, Aroub] Monash Univ, Dept Allergy Clin Immunol & Resp Med, Melbourne, Vic, Australia; [Winzenberg, Tania] Univ Tasmania, Fac Hlth, Hobart, Tas, Australia	University of Tasmania; Menzies Institute for Medical Research; La Trobe University; Monash University; University of Tasmania	Winzenberg, T (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.; Winzenberg, T (corresponding author), Univ Tasmania, Fac Hlth, Hobart, Tas, Australia.	Tania.winzenberg@utas.edu.au		Winzenberg, Tania/0000-0002-4112-3491; Rogers, Jason/0000-0002-1361-105X	Physiotherapy Research Foundation [S14-025]; Halifax Foundation; Arthritis Australia; Royal Hobart Hospital Research Foundation [17203]; Rebecca L Cooper Medical Research Foundation	Physiotherapy Research Foundation; Halifax Foundation; Arthritis Australia; Royal Hobart Hospital Research Foundation; Rebecca L Cooper Medical Research Foundation	This research was funded by grants from the Physiotherapy Research Foundation (JR, seeding grant S14-025, https://australian.physio/ PRF), grants from the Halifax Foundation (JR, philanthropic/ UTAS), grants-in aid from Arthritis Australia (JR, 2015, https://arthritisaustralia.com. au/programs-research/national-research-program/ our-grants/), establishment grants from the Royal Hobart Hospital Research Foundation (GJ/ JR, 17203, https://www.rhhresearchfoundation.org/), grants from the Rebecca L Cooper Medical Research Foundation (JR, 2015 https://www. cooperfoundation.org.au/), and a donation from Allcare Physiotherapy Tasmania (JR, 2015/ 2016, https://allcarephysio.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett PJ, 1998, J AM PODIAT MED ASSN, V88, P419, DOI 10.7547/87507315-88-9-419; Best A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188200; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Cao JJ, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-30; Copeland JL, 2009, J AGING PHYS ACTIV, V17, P17, DOI 10.1123/japa.17.1.17; Erdemir A, 2004, J BONE JOINT SURG AM, V86A, P546, DOI 10.2106/00004623-200403000-00013; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Grassel S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0485-1; Irving DB, 2008, J AM PODIAT MED ASSN, V98, P283, DOI 10.7547/0980283; Jones Kevin B, 2004, Iowa Orthop J, V24, P123; Kumai T, 2002, J RHEUMATOL, V29, P1957; Laib A, 1998, Technol Health Care, V6, P329; Laib A, 1999, COMPUT MED IMAG GRAP, V23, P69, DOI 10.1016/S0895-6111(98)00071-8; McPoil TG, 2008, J ORTHOP SPORT PHYS, V38, pA1, DOI 10.2519/jospt.2008.0302; Metcalf LM, 2018, BONE, V106, P69, DOI 10.1016/j.bone.2017.09.013; Moraux A, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-104; Pialat JB, 2012, BONE, V50, P111, DOI 10.1016/j.bone.2011.10.003; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Richardson J, 2004, AUST ECON REV, V37, P62, DOI DOI 10.1111/j.1467-8462.2004.00308.x; Rogers J, 2021, J ORTHOP SPORT PHYS, V51, P449, DOI 10.2519/jospt.2021.10018; Shapses SA, 2017, NUTR RES, V39, P1, DOI 10.1016/j.nutres.2016.12.010; Shea JE, 2001, J ANAT, V198, P153, DOI 10.1046/j.1469-7580.2001.19820153.x; Smith S., 2007, FOOT, V17, P25, DOI DOI 10.1016/J.FOOT.2006.10.002; Sullivan J, 2015, GAIT POSTURE, V41, P688, DOI 10.1016/j.gaitpost.2015.01.025; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; van Leeuwen KDB, 2016, BRIT J SPORT MED, V50, P972, DOI 10.1136/bjsports-2015-094695; VOGEL JM, 1988, BONE MINER, V5, P35, DOI 10.1016/0169-6009(88)90005-0; Whittier DE, 2020, OSTEOPOROSIS INT, V31, P1607, DOI 10.1007/s00198-020-05438-5	32	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260925	10.1371/journal.pone.0260925	http://dx.doi.org/10.1371/journal.pone.0260925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882710	Green Accepted, gold, Green Published			2022-12-26	WOS:000755037200048
J	Cherubini, A; Rusconi, F; Lazzari, L				Cherubini, Alessandro; Rusconi, Francesco; Lazzari, Lorenza			Identification of the best housekeeping gene for RT-qPCR analysis of human pancreatic organoids	PLOS ONE			English	Article							EXPRESSION; SELECTION; PCR; NORMALIZATION; TECHNOLOGY; CULTURE; MODELS; CELLS	In the last few years, there has been a considerable increase in the use of organoids, which is a new three-dimensional culture technology applied in scientific research. The main reasons for their extensive use are their plasticity and multiple applications, including in regenerative medicine and the screening of new drugs. The aim of this study was to better understand these structures by focusing on the choice of the best housekeeping gene (HKG) to perform accurate molecular analysis on such a heterogeneous system. This feature should not be underestimated because the inappropriate use of a HKG can lead to misleading data and incorrect results, especially when the subject of the study is innovative and not totally explored like organoids. We focused our attention on the newly described human pancreatic organoids (hPOs) and compared 12 well-known HKGs (ACTB, B2M, EF1 alpha, GAPDH, GUSB, HPRT, PPIA, RNA18S, RPL13A TBP, UBC and YWHAZ). Four different statistical algorithms (NormFinder, geNorm, BestKeeper and Delta Ct) were applied to estimate the expression stability of each HKG, and RefFinder was used to identify the most suitable genes for RT-qPCR data normalization. Our results showed that the intragroup and intergroup comparisons could influence the best choice of the HKG, making clear that the identification of a stable reference gene for accurate and reproducible RT-qPCR data normalization remains a critical issue. In summary, this is the first report on HKGs in human organoids, and this work provides a strong basis to pave the way for further gene analysis in hPOs.	[Cherubini, Alessandro; Rusconi, Francesco; Lazzari, Lorenza] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Lab Regenerat Med Cell Factory, Dept Transfus Med & Haematol, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico	Lazzari, L (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Lab Regenerat Med Cell Factory, Dept Transfus Med & Haematol, Milan, Italy.	lorenza.lazzari@policlinico.mi.it	Lazzari, Lorenza/J-4279-2015; Rusconi, Francesco/B-5294-2018	Lazzari, Lorenza/0000-0002-9434-4538; Rusconi, Francesco/0000-0002-2691-6610				Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bacher R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0927-y; Benito-Kwiecinski S, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a035709; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Broutier L, 2017, NAT MED, V23, P1424, DOI 10.1038/nm.4438; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Curtis KM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-61; Dossena M, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-1585-2; Dutta D, 2017, TRENDS MOL MED, V23, P393, DOI 10.1016/j.molmed.2017.02.007; Georgakopoulos N, 2020, BMC DEV BIOL, V20, DOI 10.1186/s12861-020-0209-5; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Jesnowski R, 2002, PANCREATOLOGY, V2, P421, DOI 10.1159/000065091; Kloubert V, 2019, J TRACE ELEM MED BIO, V56, P192, DOI 10.1016/j.jtemb.2019.08.007; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Liu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30904; Low JH, 2019, CELL STEM CELL, V25, P373, DOI 10.1016/j.stem.2019.06.009; Lun ATL, 2017, GENOME RES, V27, P1795, DOI 10.1101/gr.222877.117; McLoughlin KJ, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00033; Mellin R, 2020, TRENDS PARASITOL, V36, P158, DOI 10.1016/j.pt.2019.12.003; Nakamura T, 2018, CELL MOL GASTROENTER, V5, P51, DOI 10.1016/j.jcmgh.2017.10.006; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pradhan S, 2020, CELL MOL GASTROENTER, V10, P171, DOI 10.1016/j.jcmgh.2020.02.006; Ragni E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101188; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Turabelidze A, 2010, WOUND REPAIR REGEN, V18, P460, DOI 10.1111/j.1524-475X.2010.00611.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xiao XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep21127; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yan ZP, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8367063	38	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260902	10.1371/journal.pone.0260902	http://dx.doi.org/10.1371/journal.pone.0260902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879096	gold, Green Published			2022-12-26	WOS:000754625200034
J	Rady, B; Nishio, T; Dhar, D; Liu, X; Erion, M; Kisseleva, T; Brenner, DA; Pocai, A				Rady, Brian; Nishio, Takahiro; Dhar, Debanjan; Liu, Xiao; Erion, Mark; Kisseleva, Tatiana; Brenner, David A.; Pocai, Alessandro			PNPLA3 downregulation exacerbates the fibrotic response in human hepatic stellate cells	PLOS ONE			English	Article							FATTY LIVER-DISEASE; VARIANT; ASSOCIATION; SEVERITY; FIBROSIS; RISK; MICE	Non-alcoholic steatohepatitis (NASH) results, in part, from the interaction of metabolic derangements with predisposing genetic variants, leading to liver-related complications and mortality. The strongest genetic determinant is a highly prevalent missense variant in patatin-like phospholipase domain-containing protein 3 (PNPLA3 p.I148M). In human liver hepatocytes PNPLA3 localizes to the surface of lipid droplets where the mutant form is believed to enhance lipid accumulation and release of pro-inflammatory cytokines. Less is known about the role of PNPLA3 in hepatic stellate cells (HSCs). Here we characterized HSC obtained from patients carrying the wild type (n = 8 C/C) and the heterozygous (n = 6, C/G) or homozygous (n = 6, G/G) PNPLA3 I148M and investigated the effect of genotype and PNPLA3 downregulation on baseline and TGF-beta-stimulated fibrotic gene expression. HSCs from all genotypes showed comparable baseline levels of PNPLA3 and expression of the fibrotic genes alpha-SMA, COL1A1, TIMP1 and SMAD7. Treatment with TGF-beta increased PNPLA3 expression in all 3 genotypes (similar to 2-fold) and resulted in similar stimulation of the expression of several fibrogenic genes. In primary human HSCs carrying wild-type (WT) PNPLA3, siRNA treatment reduced PNPLA3 mRNA by 79% resulting in increased expression of alpha-SMA, Col1a1, TIMP1, and SMAD7 in cells stimulated with TGF-beta. Similarly, knock-down of PNPLA3 in HSCs carrying either C/G or G/G genotypes resulted in potentiation of TGF-beta induced expression of fibrotic genes. Knockdown of PNPLA3 did not impact fibrotic gene expression in the absence of TGF-beta treatment. Together, these data indicate that the presence of the I148M PNPLA3 mutation in HSC has no effect on baseline activation and that downregulation of PNPLA3 exacerbates the fibrotic response irrespective of the genotype.	[Rady, Brian; Erion, Mark; Pocai, Alessandro] Janssen Pharmaceut, Cardiovasc Metab, Spring House, PA 19477 USA; [Nishio, Takahiro; Dhar, Debanjan; Liu, Xiao; Kisseleva, Tatiana; Brenner, David A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA; University of California System; University of California San Diego	Rady, B (corresponding author), Janssen Pharmaceut, Cardiovasc Metab, Spring House, PA 19477 USA.	Brianrady@gmail.com		Pocai, Alessandro/0000-0003-1450-9521				Bruschi FV, 2020, LIVER INT, V40, P1098, DOI 10.1111/liv.14402; Bruschi FV, 2019, HEPATOL COMMUN, V3, P1191, DOI 10.1002/hep4.1395; Bruschi FV, 2017, HEPATOLOGY, V65, P1875, DOI 10.1002/hep.29041; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; Fuchs CD, 2012, HEPATOLOGY, V56, P270, DOI 10.1002/hep.25601; Kim CW, 2017, CELL METAB, V26, P394, DOI 10.1016/j.cmet.2017.07.009; Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Linden D, 2019, MOL METAB, V22, P49, DOI 10.1016/j.molmet.2019.01.013; Perttila J, 2012, AM J PHYSIOL-ENDOC M, V302, pE1063, DOI 10.1152/ajpendo.00125.2011; Pingitore P, 2019, BBA-MOL CELL BIOL L, V1864, P900, DOI 10.1016/j.bbalip.2018.06.018; Pingitore P, 2016, HUM MOL GENET, V25, P5212, DOI 10.1093/hmg/ddw341; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Ross TT, 2020, CELL MOL GASTROENTER, V10, P829, DOI 10.1016/j.jcmgh.2020.06.001; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Salameh H, 2016, J CLIN TRANSL HEPATO, V4, P175, DOI 10.14218/JCTH.2016.00009; Sandhu B, 2019, JHEP REP, V1, P199, DOI 10.1016/j.jhepr.2019.05.007; Santoro N, 2010, HEPATOLOGY, V52, P1281, DOI 10.1002/hep.23832; Schwartz BE, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102247; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shang LS, 2018, J GASTROENTEROL, V53, P6, DOI 10.1007/s00535-017-1404-4; Smagris E, 2015, HEPATOLOGY, V61, P108, DOI 10.1002/hep.27242; Stender S, 2020, HEPATOLOGY, V71, P777, DOI 10.1002/hep.31113; Su SY, 2020, J CELL MOL MED, V24, P10063, DOI 10.1111/jcmm.15614; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; Weiskirchen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075692; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09284; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	28	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260721	10.1371/journal.pone.0260721	http://dx.doi.org/10.1371/journal.pone.0260721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879108	Green Published, gold			2022-12-26	WOS:000754625200027
J	Frizzell, EY; Windsor, LC				Frizzell, Emily Y.; Windsor, Leah Cathryn			Effects of teaching experience and culture on choral directors' descriptions of choral tone	PLOS ONE			English	Article							MUSIC; PERCEPTIONS	In this study we examine the effects of experience and culture on choral teachers' description of choral tone across a range of genres. What does a "good" choral music performance sound like? Is there an objective standard of performance excellence, or is beauty in the eye of the beholder? In teacher preparation programs, choral directors in the United States have been taught to identify and teach particular, culturally-bounded standards of choral tone in their students. Choral directors evaluate their students' voices along two dimensions: health and appropriateness. They discern and describe whether the student's musical instrument-their voice-is producing sound in a healthy and non-damaging way. They also judge whether the style of their sound is appropriate for the music they are singing. However, teacher preparation programs do not provide common standards or lexicon for describing tone. This may increase implicit bias of individual directors, and inadvertently exacerbate ethnocentrism and harm students' self-perception. Using a computational text analysis approach, we evaluate the content of open-ended survey responses from teachers, finding that the language used to describe and rate choral performance varies by experience, and by the choral selection (e.g., whether it is a traditional Western or non-Western song). We suggest that regularizing the terminology and providing common training through professional organizations can minimize potential bias and generate more systematic, precise use of qualitative descriptors of health and appropriateness, which will benefit students and teachers.	[Frizzell, Emily Y.] Univ Memphis, Rudi E Scheidt Sch Mus, Memphis, TN 38152 USA; [Windsor, Leah Cathryn] Univ Memphis, Dept English, Memphis, TN 38152 USA; [Windsor, Leah Cathryn] Univ Memphis, Inst Intelligent Syst, Memphis, TN 38152 USA	University of Memphis; University of Memphis; University of Memphis	Frizzell, EY (corresponding author), Univ Memphis, Rudi E Scheidt Sch Mus, Memphis, TN 38152 USA.	emily.frizzell@memphis.edu						[Anonymous], 2020, NATL ASS SCH MUSIC H; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Brinson B.A., 2014, CHORAL MUSIC METHODS; Campbell PS, 1993, AM MUSIC TEACH, V42, P67; CARGILE AC, 1994, LANG COMMUN, V14, P211, DOI 10.1016/0271-5309(94)90001-9; Cash S, 2019, INT J RES CHORAL SIN, V7, P36; Cheek JA., 2007, THESIS; Chin LC, 1996, UPDATE APPL RES MUSI, V15, P28; Cho R., 2015, CHORAL J, V55, P59; COOKSEY JM, 1977, J RES MUSIC EDUC, V25, P100, DOI 10.2307/3345190; Coupland N., 1988, LANG COMMUN; Dahl RE, 2018, NATURE, V554, P441, DOI 10.1038/nature25770; Doerksen PF, 1999, J RES MUSIC EDUC, V47, P78, DOI 10.2307/3345830; Droe KL, 2008, J RES MUSIC EDUC, V56, P267, DOI 10.1177/0022429408326800; Elliott M., 2007, SINGING STYLE GUIDE; Figgers M, 2003, THESIS FLORIDA STATE; Ford J.K., 2003, INT J RES CHORAL SIN, V1, P29; Garrett P., 2010, ATTITUDES LANGUAGE; Gluszek A, 2010, J LANG SOC PSYCHOL, V29, P224, DOI 10.1177/0261927X09359590; GOODWIN AW, 1980, J RES MUSIC EDUC, V28, P119, DOI 10.2307/3344820; Hansen CM., 2017, THESIS U N CAROLINA; Howard K, 2014, J MUSIC TEACH EDUC, V24, P26, DOI 10.1177/1057083713494011; Howell W. S., 1982, EMPATHIC COMMUNICATO, V1st; Kirsh ER, 2013, J VOICE, V27, DOI 10.1016/j.jvoice.2013.06.004; Knapp D.H., 2012, THESIS FLORIDA STATE; Legette R.M, 2003, J MUSIC TEACH EDUC, V13, P51, DOI [10.1177/10570837030130010107, DOI 10.1177/10570837030130010107]; Lind V. R., 2016, CULTURALLY RESPONSIV; Mann LM, 2014, INT J RES CHORAL SIN, V5; MCCRARY J, 1993, J RES MUSIC EDUC, V41, P200, DOI 10.2307/3345325; McKinney J.C., 2005, DIAGNOSIS CORRECTION; Miller R., 1986, STRUCTURE SINGING SY; Miller Richard, 1996, ART SINGING; Miralis YC., 2002, UPDATE APPL RES MUSI, V22, P44; Moore J. A., 1993, THESIS KENT STATE U; Murdock JA., 2015, PREFERENCE MEETS PRA; Music Standards (Ensemble), 2014, MUS STAND ENS; Nelson LK., 2017, SOCIOL METHODS RES; Nettl B., 2015, STUDY ETHNOMUSICOLOG; Niederhoffer KG, 2002, J LANG SOC PSYCHOL, V21, P337, DOI 10.1177/026192702237953; Norman K, 1999, B COUN RES MUSIC ED, P37; Olwage G., 2004, ETHNOMUSICOL FORUM, V13, P203, DOI [DOI 10.1080/1741191042000286167, 10.1080/1741191042000286167]; Paluck EL, 2009, ANNU REV PSYCHOL, V60, P339, DOI 10.1146/annurev.psych.60.110707.163607; Pennebaker, 2011, SECRET LIFE PRONOUNS, DOI 10.1387/gogoa.17916; Pennebaker J. W., 2015, DEV PSYCHOMETRIC PRO, DOI DOI 10.15781/T29G6Z; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Phillips K.H., 2004, DIRECTING CHORAL MUS; Quist AR., 2008, CHORAL RESONANCE RE; Radocy R. E., 1989, MUSIC EDUC J, V76, P30, DOI [DOI 10.2307/3401012, 10.2307/3401012]; Ralph P, 2009, MUZIKOLOGIJA, V9, P195; Shaw J., 2012, MUSIC EDUC J, V98, P75, DOI [10.1177/0027432112443561, DOI 10.1177/0027432112443561]; SHEHAN PK, 1985, J RES MUSIC EDUC, V33, P149, DOI 10.2307/3344802; STANDLEY JM, 1991, J RES MUSIC EDUC, V39, P5, DOI 10.2307/3344604; Tamte-Horan MW., 1989, THESIS; Taylor SV, 2011, INNOV LEAD ENGL LANG, V4, P1; Wang JC, 2009, INT J MUSIC EDUC, V27, P19, DOI 10.1177/0255761408099062; Winnie B., 2014, THESIS U WASHINGTON; Wollenzien TJ., 2000, ANAL UNDERGRADUATE M; Wu SA, 2012, BRIT J MUSIC EDUC, V29, P303, DOI 10.1017/S026505171200037X; Yoo H., 2017, MUSIC EDUC J, V104, P34	59	0	0	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0256587	10.1371/journal.pone.0256587	http://dx.doi.org/10.1371/journal.pone.0256587			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874933	Green Published, gold			2022-12-26	WOS:000753617500002
J	Frey, P; Devisme, A; Rose, K; Schrempp, M; Freihen, V; Andrieux, G; Boerries, M; Hecht, A				Frey, Patrick; Devisme, Antoine; Rose, Katja; Schrempp, Monika; Freihen, Vivien; Andrieux, Geoffroy; Boerries, Melanie; Hecht, Andreas			SMAD4 mutations do not preclude epithelial-mesenchymal transition in colorectal cancer	ONCOGENE			English	Article							CONSENSUS MOLECULAR SUBTYPES; EPHB3 TUMOR-SUPPRESSOR; SNAIL TRANSCRIPTION; EXPRESSION; GENE; PROGRESSION	Transforming growth factor beta (TGF beta) superfamily signaling is a prime inducer of epithelial-mesenchymal transitions (EMT) that foster cancer cell invasion and metastasis, a major cause of cancer-related deaths. Yet, TGF beta signaling is frequently inactivated in human tumor entities including colorectal cancer (CRC) and pancreatic adenocarcinoma (PAAD) with a high proportion of mutations incapacitating SMAD4, which codes for a transcription factor (TF) central to canonical TGF beta and bone morphogenetic protein (BMP) signaling. Beyond its role in initiating EMT, SMAD4 was reported to crucially contribute to subsequent gene regulatory events during EMT execution. It is therefore widely assumed that SMAD4-mutant (SMAD4(mut)) cancer cells are unable to undergo EMT. Here, we scrutinized this notion and probed for potential SMAD4-independent EMT execution using SMAD4(mut) CRC cell lines. We show that SMAD4(mut) cells exhibit morphological changes, become invasive, and regulate EMT marker genes upon induction of the EMT-TF SNAIL1. Furthermore, SNAIL1-induced EMT in SMAD4(mut) cells was found to be entirely independent of TGF beta/BMP receptor activity. Global assessment of the SNAIL1-dependent transcriptome confirmed the manifestation of an EMT gene regulatory program in SMAD4(mut) cells highly related to established EMT signatures. Finally, analyses of human tumor transcriptomes showed that SMAD4 mutations are not underrepresented in mesenchymal tumor samples and that expression patterns of EMT-associated genes are similar in SMAD4(mut) and SMAD4 wild-type (SMAD4(wt)) cases. Altogether, our findings suggest that alternative TFs take over the gene regulatory functions of SMAD4 downstream of EMT-TFs, arguing for considerable plasticity of gene regulatory networks operating in EMT execution. Further, they establish that EMT is not categorically precluded in SMAD4(mut) tumors, which is relevant for their diagnostic and therapeutic evaluation.	[Frey, Patrick; Rose, Katja; Schrempp, Monika; Freihen, Vivien; Hecht, Andreas] Univ Freiburg, Fac Med, Inst Mol Med & Cell Res, Freiburg, Germany; [Frey, Patrick; Hecht, Andreas] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany; [Frey, Patrick; Devisme, Antoine; Hecht, Andreas] Univ Freiburg, Fac Biol, Freiburg, Germany; [Andrieux, Geoffroy; Boerries, Melanie] Univ Freiburg, Fac Med, Med Ctr, Inst Med Bioinformat & Syst Med, Freiburg, Germany; [Andrieux, Geoffroy; Boerries, Melanie] German Canc Consortium DKTK, Freiburg, Germany; [Andrieux, Geoffroy; Boerries, Melanie] German Canc Res Ctr, Heidelberg, Germany; [Hecht, Andreas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg	Hecht, A (corresponding author), Univ Freiburg, Fac Med, Inst Mol Med & Cell Res, Freiburg, Germany.; Hecht, A (corresponding author), Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany.; Hecht, A (corresponding author), Univ Freiburg, Fac Biol, Freiburg, Germany.; Hecht, A (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.	andreas.hecht@mol-med.uni-freiburg.de			Excellence Initiative of the German Research Foundation [GSC-4]; Ministry for Science, Research and Arts of the State of Baden-Wuerttemberg; Deutsche Forschungsgemeinschaft (DFG) [CRC-850]; German Federal Ministry of Education and Research by MIRACUM within the Medical Informatics Funding Scheme [FKZ 01ZZ1801B]; DFG [CRC-1479, 441891347-S1, CRC-1160, CRC-1453, 431984000-S1, TRR167]	Excellence Initiative of the German Research Foundation(German Research Foundation (DFG)); Ministry for Science, Research and Arts of the State of Baden-Wuerttemberg; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research by MIRACUM within the Medical Informatics Funding Scheme; DFG(German Research Foundation (DFG))	The authors wish to thank the team at the Lighthouse Core Facility Freiburg, Germany for cell sorting assistance, M. Bewerunge-Hudler and her team from the Genomics and Proteomics Core Facility at the German Cancer Research Center (DKFZ), Heidelberg, Germany for their microarray services, and all members of the Hecht laboratory for critical reading of the manuscript. The results shown here are in part based upon data generated by the TCGA Research Network: https://www.cancer.gov/tcga.This study was supported in part by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School) and in part by the Ministry for Science, Research and Arts of the State of Baden-Wuerttemberg. Additional financial support was obtained from the Deutsche Forschungsgemeinschaft (DFG) (CRC-850 subprojects B5 to AH; C9 and Z1 to MB). MB received further funding from the German Federal Ministry of Education and Research by MIRACUM within the Medical Informatics Funding Scheme (FKZ 01ZZ1801B), and from the DFG within the following consortia: CRC-1479 (Project ID: 441891347-S1), CRC-1160 (Project Z02), CRC-1453 (Project ID 431984000-S1), and TRR167 (Project Z01).	Aguirre AJ, 2017, CANCER CELL, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Batlle E, 2019, IMMUNITY, V50, P924, DOI 10.1016/j.immuni.2019.03.024; Beyes S, 2019, ONCOGENE, V38, P6647, DOI 10.1038/s41388-019-0905-4; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Cook DP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16066-2; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eide PW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16747-x; Feldker N, 2020, EMBO J, V39, DOI 10.15252/embj.2019103209; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Freihen V, 2020, INT J CANCER, V146, P2229, DOI 10.1002/ijc.32644; Frey P, 2020, CANCERS, V12, DOI 10.3390/cancers12041019; Groger CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051136; Guerrero-Martinez JA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19877-5; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Haeussler M, 2019, NUCLEIC ACIDS RES, V47, pD853, DOI 10.1093/nar/gky1095; Hayashi Y, 2011, CANCER SCI, V102, P1228, DOI 10.1111/j.1349-7006.2011.01910.x; Herwig R, 2016, NAT PROTOC, V11, P1889, DOI 10.1038/nprot.2016.117; Inamoto S, 2016, CLIN CANCER RES, V22, P492, DOI 10.1158/1078-0432.CCR-15-0726; Jagle S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007109; Jagle S, 2014, P NATL ACAD SCI USA, V111, P4886, DOI 10.1073/pnas.1314523111; Ji Q, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1119-y; Khan FM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00268-2; Kolmykov S, 2021, NUCLEIC ACIDS RES, V49, pD104, DOI 10.1093/nar/gkaa1057; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Linnekamp JF, 2018, CELL DEATH DIFFER, V25, P616, DOI 10.1038/s41418-017-0011-5; Ma CQ, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-0212-5; Ma ZQ, 2018, SEMIN CANCER BIOL, V50, P21, DOI 10.1016/j.semcancer.2018.02.004; Mak MP, 2016, CLIN CANCER RES, V22, P609, DOI 10.1158/1078-0432.CCR-15-0876; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McFaline-Figueroa JL, 2019, NAT GENET, V51, P1389, DOI 10.1038/s41588-019-0489-5; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Mei Z, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4298-5; Meyer-Schaller N, 2019, DEV CELL, V48, P539, DOI 10.1016/j.devcel.2018.12.023; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pires BRB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169622; Ramirez D, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00054; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ronsch K, 2015, MOL ONCOL, V9, P335, DOI 10.1016/j.molonc.2014.08.016; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Smith AP, 2009, ONCOGENE, V28, P422, DOI 10.1038/onc.2008.395; Stanisavljevic J, 2011, J CELL SCI, V124, P4159, DOI 10.1242/jcs.078824; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tascilar M, 2001, CLIN CANCER RES, V7, P4115; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Voorneveld PW, 2014, GASTROENTEROLOGY, V147, P196, DOI 10.1053/j.gastro.2014.03.052; Wang GH, 2018, PATHOL RES PRACT, V214, P1362, DOI 10.1016/j.prp.2018.06.018; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056664; Wang Y, 2021, LAB INVEST, V101, P463, DOI 10.1038/s41374-020-00517-x; Wendt Michael K, 2014, JAKSTAT, V3, pe28975, DOI 10.4161/jkst.28975; Woodford-Richens KL, 2001, P NATL ACAD SCI USA, V98, P9719, DOI 10.1073/pnas.171321498; Wu WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18101-7; Yan P, 2016, CLIN CANCER RES, V22, P3037, DOI 10.1158/1078-0432.CCR-15-0939; Zhang B, 2014, BRIT J CANCER, V110, P946, DOI 10.1038/bjc.2013.789; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304; Zhang YE, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022129; Zhang Y, 2019, BIOMED PHARMACOTHER, V110, P400, DOI 10.1016/j.biopha.2018.11.112	64	1	1	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2022	41	6					824	837		10.1038/s41388-021-02128-2	http://dx.doi.org/10.1038/s41388-021-02128-2		DEC 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YT5VS	34857888	hybrid, Green Published			2022-12-26	WOS:000725388800001
J	Chowdhury, MAB; Islam, M; Rahman, J; Uddin, MT; Haque, MR; Uddin, MJ				Chowdhury, Muhammad Abdul Baker; Islam, Mirajul; Rahman, Jakia; Uddin, Mohammed Taj; Haque, Md Rabiul; Uddin, Md Jamal			Changes in prevalence and risk factors of hypertension among adults in Bangladesh: An analysis of two waves of nationally representative surveys	PLOS ONE			English	Article							DISEASE; MANAGEMENT; COUNTRIES	Introduction Bangladesh is one of the countries where the prevalence of non-communicable diseases (NCDs) such as hypertension is rising due to rising living standards, sedentary lifestyles, and epidemiological transition. Among the NCDs, hypertension is a major risk factor for CVD, accounting for half of all coronary heart disease worldwide. However, detailed research in this area has been limited in Bangladesh. The objective of the study was to estimate changes in the prevalence and risk factors of hypertension among Bangladeshi adult population. The study also sought to identify socioeconomic status-related inequality of hypertension prevalence in Bangladesh. Methods Cross-sectional analysis was conducted using nationally representative two waves of the Bangladesh Demographic and Health Survey (BDHS) in 2011 and 2017-18. Survey participants were adults 18 years or older- which included detailed biomarker and anthropometric measurements of 23539 participants. The change in prevalence of hypertension was estimated, and adjusted odds ratios were obtained using multivariable survey logistic regression models. Further, Wagstaff decomposition method was also used to analyze the relative contributions of factors to hypertension. Results From 2011 to 2018, the hypertension prevalence among adults aged >= 35 years increased from 25.84% to 39.40% (p<0.001), with the largest relative increase (97%) among obese individuals. The prevalence among women remained higher than men whereas the relative increase among men and women were 75% and 39%, respectively. Regression analysis identified age and BMI as the independent risk factors of hypertension. Other risk factors of hypertension were sex, marital status, education, geographic region, wealth index, and diabetes status in both survey years. Female adults had significantly higher hypertension risk in both survey years in the overall analysis in, however, in the subgroup analysis, the gender difference in hypertension risk was not significant in rural 2011 and urban 2018 samples. Decomposition analysis revealed that the contributions of socio-economic status related inequality of hypertension in 2011 were46.58% and 20.85% for wealth index and BMI, respectively. However, the contributions of wealth index and BMI have shifted to 12.60% and 55.29%, respectively in 2018. Conclusion The prevalence of hypertension among Bangladeshi adults has increased significantly, and there is no subgroup where it is decreasing. Population-level approaches directed at high-risk groups (overweight, obese) should be implemented thoroughly. We underscore prevention strategies by following strong collaboration with stakeholders in the health system of the country to adopt healthy lifestyle choices.	[Chowdhury, Muhammad Abdul Baker] Univ Florida, Coll Med, Dept Neurosurg, Gainesville, FL USA; [Islam, Mirajul] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Islam, Mirajul] Univ Dhaka, Dept Stat, Dhaka, Bangladesh; [Rahman, Jakia] BRAC Univ, Dept Math & Nat Sci, Dhaka, Bangladesh; [Uddin, Mohammed Taj; Uddin, Md Jamal] Shahjalal Univ Sci & Technol, Dept Stat, Sylhet, Bangladesh; [Haque, Md Rabiul] Univ Dhaka, Dept Populat Sci, Dhaka, Bangladesh	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Dhaka; Bangladesh Rural Advancement Committee BRAC; BRAC University; Shahjalal University of Science & Technology (SUST); University of Dhaka	Uddin, MJ (corresponding author), Shahjalal Univ Sci & Technol, Dept Stat, Sylhet, Bangladesh.	jamal-sta@sust.edu	Uddin, Md Jamal/AAD-6412-2021	Uddin, Md Jamal/0000-0002-8360-3274; Chowdhury, Muhammad Abdul Baker/0000-0002-2145-0938				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Afroz A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002420; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; Ali N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029364; [Anonymous], 2020, Circulation, V141, pe33, DOI 10.1161/CIR.0000000000000746; Arima H, 2012, HYPERTENSION, V59, P1118, DOI 10.1161/HYPERTENSIONAHA.111.187252; Bangladesh H, 2016, BANGL HOUS INC EXP S; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Chowdhury MZI, 2020, CLIN HYPERTENS, V26, DOI 10.1186/s40885-020-00143-1; Chowdhury MAB, 2021, J HUM HYPERTENS, V35, P912, DOI 10.1038/s41371-020-00435-x; Chowdhury MAB, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018468; Chowdhury MAB, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0197-3; Chowdhury MAB, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2413-y; Hossain MB., 2015, IMPACT DEMOGRAPHIC T, P49; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Islam A K M Monwarul, 2012, Indian Heart J, V64, P319, DOI 10.1016/S0019-4832(12)60096-0; Islam M, 2011, J EPIDEMIOL COMMUN H, V65, pA116, DOI 10.1136/jech.2011.142976d.74; Islam Shiekh Mohammed Shariful, 2015, Glob Cardiol Sci Pract, V2015, P43, DOI 10.5339/gcsp.2015.43; Kario K, 2018, HYPERTENSION, V71, P979, DOI 10.1161/HYPERTENSIONAHA.118.11203; Kaur P, 2012, INT J PUBLIC HEALTH, V57, P87, DOI 10.1007/s00038-011-0303-3; Khanam MA, 2015, J HYPERTENS, V33, P2399, DOI 10.1097/HJH.0000000000000712; Khanam MA, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25028; Khuda EB., 2015, IMPACT DEMOGRAPHIC T, P49; Kyu HH, 2018, LANCET, V392, P1859, DOI 10.1016/s0140-6736(18)32335-3; MALIK A, 1976, Bangladesh Medical Research Council Bulletin, V2, P115; Mkuu RS, 2021, PUBLIC HEALTH, V198, P180, DOI 10.1016/j.puhe.2021.07.031; Mkuu R, 2021, PREV MED REP, V22, DOI 10.1016/j.pmedr.2021.101340; Mkuu RS, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170401; Mohammad M., 2019, J PUBLIC HLTH; Mohammad Mahmuda, 2018, Int J Adolesc Med Health, V33, DOI 10.1515/ijamh-2018-0105; NIPORT) NIoPRaT Associates Ma, 2020, INT 1 BANGL DEM HLTH; NIPORT) NIoPRaT Associates Ma, 2011, INT 1 BANGL DEM HLTH; O'Donnell O., 2008, Analyzing health equity using household survey data: a guide to techniques and their implementation; Rahman MM, 2015, J HYPERTENS, V33, P465, DOI 10.1097/HJH.0000000000000421; Rahman MM, 2013, B WORLD HEALTH ORGAN, V91, P449, DOI 10.2471/BLT.12.115428; Rahman M, 2018, J HUM HYPERTENS, V32, P334, DOI 10.1038/s41371-017-0018-x; Rahman M, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0101-5; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Soenarta AA, 2020, J CLIN HYPERTENS, V22, P423, DOI 10.1111/jch.13753; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Wei YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170218; WHO, 2004, LANCET, V363, P902; World Health O, 2006, DEF DIAGN DIAB MELL	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0259507	10.1371/journal.pone.0259507	http://dx.doi.org/10.1371/journal.pone.0259507			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855768	Green Submitted, gold, Green Published			2022-12-26	WOS:000735299000017
J	Loganathan, T; Chan, ZEX; Hassan, F; Kunpeuk, W; Suphanchaimat, R; Yi, HS; Majid, HA				Loganathan, Tharani; Chan, Zhie X.; Hassan, Fikri; Kunpeuk, Watinee; Suphanchaimat, Rapeepong; Yi, Huso; Majid, Hazreen Abdul			Education for non-citizen children in Malaysia during the COVID-19 pandemic: A qualitative study	PLOS ONE			English	Article							SCHOOL ATTENDANCE; INCOME	The COVID-19 pandemic disrupted schooling for children worldwide. Most vulnerable are non-citizen children without access to public education. This study aims to explore challenges faced in achieving education access for children of refugee and asylum-seekers, migrant workers, stateless and undocumented persons in Malaysia during the pandemic. In-depth interviews of 33 stakeholders were conducted from June 2020 to March 2021. Data were thematically analysed. Our findings suggest that lockdowns disproportionately impacted non-citizen households as employment, food and housing insecurity were compounded by xenophobia, exacerbating pre-existing inequities. School closures disrupted school meals and deprived children of social interaction needed for mental wellbeing. Many non-citizen children were unable to participate in online learning due to the scarcity of digital devices, and poor internet connectivity, parental support, and home learning environments. Teachers were forced to adapt to online learning and adopt alternative arrangements to ensure continuity of learning and prevent school dropouts. The lack of government oversight over learning centres meant that measures taken were not uniform. The COVID-19 pandemic presents an opportunity for the design of more inclusive national educational policies, by recognising and supporting informal learning centres, to ensure that no child is left behind.	[Loganathan, Tharani; Chan, Zhie X.; Hassan, Fikri] Univ Malaya, Ctr Epidemiol & Evidence Based Practice, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Kunpeuk, Watinee; Suphanchaimat, Rapeepong] Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand; [Suphanchaimat, Rapeepong] Minist Publ Hlth, Div Epidemiol, Dept Dis Control, Nonthaburi, Thailand; [Yi, Huso] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Yi, Huso] Natl Univ Hlth Syst, Singapore, Singapore; [Majid, Hazreen Abdul] Univ Malaya, Ctr Populat Hlth, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Majid, Hazreen Abdul] Univ Airlangga, Fac Publ Hlth, Dept Nutr, Surabaya, Indonesia	Universiti Malaya; Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; National University of Singapore; National University of Singapore; Universiti Malaya; Airlangga University	Loganathan, T (corresponding author), Univ Malaya, Ctr Epidemiol & Evidence Based Practice, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	drtharani@ummc.edu.my	Loganathan, Tharani/L-8836-2018; Abdul Majid, Hazreen/B-8619-2010	Loganathan, Tharani/0000-0001-6690-000X; Yi, Huso/0000-0003-4724-5235; Abdul Majid, Hazreen/0000-0002-2718-8424	Asia Pacific Observatory (APO) on Health Systems and Policies [IF034-2020]	Asia Pacific Observatory (APO) on Health Systems and Policies	This research was funded by The Asia Pacific Observatory (APO) on Health Systems and Policies grant number IF034-2020 awarded to Tharani Loganathan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Allerton C, 2014, TILBURG LAW REV, V19, P26, DOI 10.1163/22112596-01902004; [Anonymous], 1954, SANSHO DAYU; Azizan H., 2018, THE STAR 0401; Azman F., 2020, ASTROAWANI 0415; Beaunoyer E, 2020, COMPUT HUM BEHAV, V111, DOI 10.1016/j.chb.2020.106424; Bol T., 2020, INEQUALITY HOMESCHOO, DOI [10.31235/osf.io/hf32q, DOI 10.31235/OSF.IO/HF32Q, https://doi.org/10.31235/osf.io/hf32q]; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Burgess S., 2020, VOXEU ORG; Carrillo C, 2020, EUR J TEACH EDUC, V43, P466, DOI 10.1080/02619768.2020.1821184; Cullinane, 2020, COVID 19 SOCIAL MOBI; Department of Statistics Malaysia, LIV BIRTHS STAT SEX; Dhawan S, 2020, J ED TECHNOL SYST, V49, P5, DOI [10.1177/0047239520934018, DOI 10.1177/0047239520934018]; Dietrich H, 2021, EUR SOC, V23, pS348, DOI 10.1080/14616696.2020.1826556; Dijk JAGMv, 2020, EXP GROUP M SOC JUST; Equal Rights Trust and Institute of Human Rights and Peace Studies Mahidol University, 2014, EQUAL ONL NAM HUM RI; Esses VM, 2021, GROUP PROCESS INTERG, V24, P253, DOI 10.1177/1368430220983470; Fernandez K., 2020, EXPLAINING RISE HATE; Fishbein Emily., 2020, NEW HUMANITARIA 0525; Gennetian LA, 2018, ECON EDUC REV, V63, P20, DOI 10.1016/j.econedurev.2018.01.003; Gong R, 2020, DIGITAL INCLUSION AS; Hammerly C, 2022, LINGUIST INQ, V53, P823, DOI 10.1162/ling_a_00422; International Labour Organization, 2020, COVID 19 IMP MIGR WO; International Rescue Committee, 2012, SEARCH SURV SANCT CI; Jacobs J., 2020, EDGE MALAYSIA 1019; Kassim A., 2018, ANAL SITUATION UNDOC; Klein M, 2020, CHILD YOUTH SERV REV, V118, DOI 10.1016/j.childyouth.2020.105432; Kneale Dylan, 2020, F1000Res, V9, P352, DOI 10.12688/f1000research.23631.1; Lai J, 2021, APPL ECON PERSPECT P, V43, P458, DOI 10.1002/aepp.13104; Larsen L, 2022, EUR CHILD ADOLES PSY, V31, P1231, DOI 10.1007/s00787-021-01758-x; Lorente LML, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12219091; Letchamanana H, 2013, J INT COMP EDUC, V2, P86, DOI 10.14425/00.50.24; Lumayag LA, 2016, ASIAN STUD REV, V40, P192, DOI 10.1080/10357823.2016.1158238; Nasri NM, 2020, J EDUC TEACHING, V46, P546, DOI 10.1080/02607476.2020.1802582; Morrissey TW, 2014, DEV PSYCHOL, V50, P741, DOI 10.1037/a0033848; Munoz Villalobos V., 2009, REPORT SPECIAL RAPPO; Nah AM., 2010, FORCED MIGRATION REV; OECD (Organisation for Economic Co-operation and Development), 1997, 471 OECD, DOI [10.1787/9789264071247-en, DOI 10.1787/9789264071247-EN]; Onyema E.M., 2020, J ED PRACTICE, V11, P108; Palik J., 2020, ED ROHINGYA REFUGEE, P2; Ratification Status for Malaysia, UN TREAT BOD DAT, V2021; Razak R., 2020, MALAY MAIL 0711; Rosenthal DM, 2020, LANCET PUBLIC HEALTH, V5, pE241, DOI 10.1016/S2468-2667(20)30080-3; Shaw SA, 2021, FAM RELAT, V70, P514, DOI 10.1111/fare.12518; Singh S, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113429; Special Rapporteur on the right to education, 2020, RIGHT ED IMP COR DIS; SUHAKAM, REP ACC ED MAL 2013; Teoh M., 2020, THESTAR 1120; Tuangratananon T, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030430; UNHCR, REFUGEE DATA FINDER; UNICEF, 2019, STATE WORLDS CHILDRE; UNICEF, MAPP ALT LEARN APPR; United Nations, 2020, POL BRIEF ED COVID 1; van Waas L, 2020, INT J REFUG LAW, V32, P498, DOI 10.1093/ijrl/eeaa029; Wang GH, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30547-X; Yunus A., 2020, NEW STRAITS TIMES; Zainul Harris., 2020, DISINFORMATION XENOP	58	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0259546	10.1371/journal.pone.0259546	http://dx.doi.org/10.1371/journal.pone.0259546			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855770	Green Published, gold			2022-12-26	WOS:000735299000018
J	Nkambule, R; Philip, NM; Reid, G; Mnisi, Z; Nuwagaba-Biribonwoha, H; Ao, TT; Ginindza, C; Duong, YT; Patel, H; Saito, S; Solmo, C; Brown, K; Moore, CS; Voetsch, AC; Bicego, G; Bock, N; Mhlanga, F; Dlamini, T; Mabuza, K; Zwane, A; Sahabo, R; Dobbs, T; Parekh, BS; El-Sadr, W; Ryan, C; Justman, J				Nkambule, Rejoice; Philip, Neena M.; Reid, Giles; Mnisi, Zandile; Nuwagaba-Biribonwoha, Harriet; Ao, Tony T.; Ginindza, Choice; Duong, Yen T.; Patel, Hetal; Saito, Suzue; Solmo, Chelsea; Brown, Kristin; Moore, Chiara S.; Voetsch, Andrew C.; Bicego, George; Bock, Naomi; Mhlanga, Fortune; Dlamini, Tengetile; Mabuza, Khanya; Zwane, Amos; Sahabo, Ruben; Dobbs, Trudy; Parekh, Bharat S.; El-Sadr, Wafaa; Ryan, Caroline; Justman, Jessica			HIV incidence, viremia, and the national response in Eswatini: Two sequential population-based surveys	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MALE CIRCUMCISION; SOUTH-AFRICA; PREVENTION; INFECTION; COMMUNITY; ACQUISITION; TREAT; RISK; MEN	With the highest HIV incidence and prevalence globally, the government of Eswatini started a substantial scale-up of HIV treatment and prevention services in 2011. Two sequential large population-based surveys were conducted before and after service expansion to assess the impact of the national response. Cross-sectional, household-based, nationally representative samples of adults, ages 18 to 49 years, were sampled in 2011 and 2016. We measured HIV prevalence, incidence (recent infection based on limiting antigen <= 1.5 optical density units and HIV RNA >= 1000 copies/mL), viral load suppression (HIV RNA <1000 copies/mL among all seropositive adults) and unsuppressed viremia (HIV RNA <greater than or equal to>1000 copies/mL among all, regardless of HIV status) and assessed for temporal changes by conducting a trend analysis of the log ratio of proportions, using a Z statistic distribution. HIV prevalence remained stable from 2011 to 2016 [32% versus 30%, p = 0.10]. HIV incidence significantly declined 48% [2.48% versus 1.30%, p = 0.01]. Incidence remained higher among women than men [2011: 3.16% versus 1.83%; 2016: 1.76% versus 0.86%], with a smaller but significant relative reduction among women [44%; p = 0.04] than men [53%; p = 0.09]. The proportion of seropositive adults with viral load suppression significantly increased from 35% to 71% [p < .001]. The proportion of the total adult population with unsuppressed viremia decreased from 21% to 9% [p < .001]. National HIV incidence in Eswatini decreased by nearly half and viral load suppression doubled over a five-year period. Unsuppressed viremia in the total population decreased 58%. These population-based findings demonstrate the national impact of expanded HIV services in a hyperendemic country.	[Nkambule, Rejoice; Mnisi, Zandile] Minist Hlth, Mbabane, Eswatini; [Philip, Neena M.; Reid, Giles; Duong, Yen T.; Saito, Suzue; Solmo, Chelsea; El-Sadr, Wafaa; Justman, Jessica] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY 10027 USA; [Nuwagaba-Biribonwoha, Harriet; El-Sadr, Wafaa; Justman, Jessica] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Nuwagaba-Biribonwoha, Harriet; Sahabo, Ruben] Columbia Univ, Mailman Sch Publ Hlth, ICAP, Mbabane, Eswatini; [Ao, Tony T.; Ryan, Caroline] US Ctr Dis Control & Prevent Eswatini, Mbabane, Eswatini; [Ginindza, Choice; Mhlanga, Fortune; Zwane, Amos] Cent Stat Off, Mbabane, Eswatini; [Patel, Hetal; Brown, Kristin; Voetsch, Andrew C.; Bicego, George; Bock, Naomi; Dobbs, Trudy; Parekh, Bharat S.] US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Atlanta, GA USA; [Moore, Chiara S.] PHI CDC Global Hlth Fellowship Program, Oakland, CA USA; [Dlamini, Tengetile; Mabuza, Khanya] Natl Emergency Response Council HIV AIDS NERCHA, Mbabane, Eswatini	Columbia University; Columbia University; Centers for Disease Control & Prevention - USA	Philip, NM (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY 10027 USA.	nmp6@cumc.columbia.edu	Voetsch, Andrew/CAF-1978-2022	Brown, Kristin/0000-0001-9256-533X; Voetsch, Andrew/0000-0002-0783-1312	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [U2GPS002005, NU2GGH001271]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of cooperative agreements U2GPS002005 (NMP, JJ) and NU2GGH001271 (NMP, GR, HNB, YTG, SS, CS, RS, WES, JJ). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, AUST J EMERG MANAG, V30, P9; ASHRAE (American Society of Heating Refrigerating and Air-Conditioning Engineers), 2017, STANDARD 55 2017 THE; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bicego GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077101; Borgdorff MW, 2018, LANCET HIV, V5, pE241, DOI 10.1016/S2352-3018(18)30025-0; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; de Oliveira T, 2017, LANCET HIV, V4, pE41, DOI 10.1016/S2352-3018(16)30186-2; Dixon J R Jr, 1998, Qual Assur, V6, P65; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Duong YT, 2019, AIDS RES HUM RETROV, V35, P896, DOI [10.1089/aid.2018.0284, 10.1089/AID.2018.0284]; Duong YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114947; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Grabowski MK, 2017, NEW ENGL J MED, V377, P2154, DOI [10.1056/NEJMoa1702150, 10.1056/nejmoa1702150]; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Havlir DV, 2019, NEW ENGL J MED, V381, P219, DOI 10.1056/NEJMoa1809866; Hayes RJ, 2019, NEW ENGL J MED, V381, P207, DOI 10.1056/NEJMoa1814556; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; International Diabetes Federation, 2019, IDF DIABETES ATLAS, VNinth; Iwuji CC, 2018, LANCET HIV, V5, pE116, DOI 10.1016/S2352-3018(17)30205-9; Justman J, 2017, LANCET HIV, V4, pE83, DOI 10.1016/S2352-3018(16)30190-4; Karim SSA, 2019, NEW ENGL J MED, V381, P286, DOI 10.1056/NEJMe1907279; Kong XR, 2016, JAMA-J AM MED ASSOC, V316, P182, DOI 10.1001/jama.2016.7292; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Makhema J, 2019, NEW ENGL J MED, V381, P230, DOI 10.1056/NEJMoa1812281; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Okano JT, 2016, LANCET INFECT DIS, V16, P789, DOI 10.1016/S1473-3099(16)30022-6; Oldenburg CE, 2016, CLIN INFECT DIS, V63, P548, DOI 10.1093/cid/ciw335; South African National HIV Prevalence, 2017, INC BEH COMM SURV; Tanser F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam8012; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; The Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK END AIDS; UNAIDS, 2021, GLOB HIV AIDS STAT F; UNAIDS, UNAIDS2000; Vandormael A, 2018, CLIN INFECT DIS, V66, P1254, DOI 10.1093/cid/cix976; Voetsch AC, 2021, JAIDS-J ACQ IMM DEF, V87, pS73, DOI 10.1097/QAI.0000000000002707; World Health Organization, 2013, CONSOLIDATED GUIDELI	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260892	10.1371/journal.pone.0260892	http://dx.doi.org/10.1371/journal.pone.0260892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855890	gold, Green Published			2022-12-26	WOS:000735299000149
J	Wekunda, PW; Aduda, DSO; Guyah, B				Wekunda, Paul Waliaula; Aduda, Dickens S. Omondi; Guyah, Bernard			Determinants of tuberculosis treatment interruption among patients in Vihiga County, Kenya	PLOS ONE			English	Article							NONADHERENCE; ADHERENCE; URBAN	Background Despite robust Tuberculosis (TB) program with effective chemotherapy and high coverage, treatment interruption remains a serious problem. Interrupting TB treatment means that patients remain infectious for longer time and are at risk of developing drug resistance and death. This study was conducted to identify and describe predictors of TB treatment interruption. Methods A cohort of 291 notified TB patients from 20 selected health facilities in Vihiga County were enrolled in to the study and followed up until the end of treatment. Patient characteristics that potentially predict treatment interruption were recorded during treatment initiation using structured questionnaires. Patients who interrupted treatment were traced and reasons for stoppage of treatment recorded. Kaplan Meier method was used to estimate probabilities of treatment interruption by patient characteristics and determine time intervals. The Log rank test for the equality of survival distributions analyzed significance of survival differences among categorical variables. For multivariable analysis, Cox proportional hazard model, was fitted to identify predictors of TB treatment interruption through calculation of hazard ratios with 95% Confidence Intervals (CIs). For variable analysis, statistical significance was set at P <= 0.05. Reasons for treatment interruption were categorized according to most recurrent behavioral or experiential characteristics. Results Participants' median age was 40 years (IQR = 32-53) and 72% were male. Of the 291 patients, 11% (n = 32) interrupted treatment. Incidences of treatment interruption significantly occurred during intensive phase of treatment. Independent predictors of treatment interruption included alcohol consumption (HR = 9.2, 95% CI; 2.6-32.5, p < 0.001), being female (HR = 5.01, 95% CI; 1.68-15.0, p = 0.004), having primary or lower education level (HR = 3.09, 95% CI; 1.13-8.49, p < 0.029) and having a treatment supporter (HR = 0.33, 95% CI; 0.14-0.76, p = 0.009). Reasons for interrupting treatment were categorized as: alcoholism, feeling better after treatment initiation, associated TB stigma, long distance to health facility, lack of food, perception of not having TB and pill burden. Conclusion TB treatment interruption was high and largely associated with patients' socio-demographic and behavioral characteristics. These multidimensional factors suggest the need for interventions that not only target individual patients but also environment in which they live and receive healthcare services.	[Wekunda, Paul Waliaula] Dept Hlth TB Leprosy & Lung Dis Control, Vihiga County, Kenya; [Aduda, Dickens S. Omondi] Jaramogi Oginga Odinga Univ Sci & Technol, Sch Hlth Sci, Directorate Res Innovat & Partnerships, Bondo, Kenya; [Guyah, Bernard] Maseno Univ, Dept Biomed Sci, Kisumu, Kenya	Jaramogi Oginga Odinga University of Science & Technology; Maseno University	Wekunda, PW (corresponding author), Dept Hlth TB Leprosy & Lung Dis Control, Vihiga County, Kenya.	wekundapaul@gmail.com		Wekunda, Paul/0000-0002-6190-0331				Aduda DSO, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-27; Ali Ahmed Osman Ahmed, 2016, Pan Afr Med J, V25, P80, DOI 10.11604/pamj.2016.25.80.9447; Amuha MG, 2009, AFR HEALTH SCI, V9, pS8; Bauleth M.F., 2017, CLIN NURSING STUDIES, V5, P12, DOI [10.5430/cns.v5n4p12, DOI 10.5430/CNS.V5N4P12]; Billoro BB., 2019, J SCI INNOV RES, V8, P98; Bryan FJ., 1992, DESIGN ANAL RES STUD; Chimeh RA, 2020, INT J TUBERC LUNG D, V24, P811, DOI 10.5588/ijtld.19.0754; Floyd K, 2018, INT J TUBERC LUNG D, V22, P723, DOI 10.5588/ijtld.17.0835; Gitatui M, 2019, AFR HEALTH SCI, V19, P2906, DOI 10.4314/ahs.v19i4.12; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Imtiaz S, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00216-2017; Kenya National Bureau of Statistics, 2019, KEN POP HOUS CENS, V1; Kigozi G, 2017, INT J INFECT DIS, V54, P95, DOI 10.1016/j.ijid.2016.11.407; Kimani E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248820; Krasniqi S, 2017, TUBERC RES TREAT, V2017, DOI 10.1155/2017/4850324; Kunutsor S, 2011, AIDS BEHAV, V15, P1795, DOI 10.1007/s10461-011-9927-9; MacIntyre CR, 2003, INT J TUBERC LUNG D, V7, P848; Masini EO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164172; Mekonnen Habtamu Sewunet, 2018, BMC Res Notes, V11, P691, DOI 10.1186/s13104-018-3789-4; Ministry of Health, 2019, NAT STRAT PLAN TB LE; Ministry of Health, 2021, INT GUID TUB LEPR LU; Ministry of Health, 2019, ANN REP 2019; Ministry of Health, 2016, KEN TUB PREV SURV 20; Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P10; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Naing Nyi Nyi, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P369; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; Nxumalo N, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000842; Ong'ang'o JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088937; Pradipta IS, 2020, NPJ PRIM CARE RESP M, V30, DOI 10.1038/s41533-020-0179-x; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Sang RK., 2017, SCI J PUBLIC HEAL, V5, P329; Sarkar S., 2016, MYCOBACT DIS, V6, P1, DOI DOI 10.4172/2161-1068.1000209; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Tola HH, 2015, IRAN J PUBLIC HEALTH, V44, P1; Vernon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002884; WHO, 2015, INT PHARM, P1; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; World Health Organization, 2021, 10 THREATS GLOB HLTH; Zegeye A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210422	41	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260669	10.1371/journal.pone.0260669	http://dx.doi.org/10.1371/journal.pone.0260669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855844	gold, Green Published			2022-12-26	WOS:000735299000088
J	Ng, OH; Akyoney, S; Sahin, I; Soykam, HO; Akcapinar, GB; Ozdemir, O; Kancagi, DD; Karakus, GS; Yurtsever, B; Kocagoz, AS; Ovali, E; Ozbek, U				Hatirnaz Ng, Ozden; Akyoney, Sezer; Sahin, Ilayda; Soykam, Huseyin Okan; Bayram Akcapinar, Gunseli; Ozdemir, Ozkan; Kancagi, Derya Dilek; Sir Karakus, Gozde; Yurtsever, Bulut; Kocagoz, Ayse Sesin; Ovali, Ercument; Ozbek, Ugur			Mutational landscape of SARS-CoV-2 genome in Turkey and impact of mutations on spike protein structure	PLOS ONE			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS	The Coronavirus Disease 2019 (COVID-19) was declared a pandemic in March 2020 by the World Health Organization (WHO). As of May 25th, 2021 there were 2.059.941 SARS-COV2 genome sequences that have been submitted to the GISAID database, with numerous variations. Here, we aim to analyze the SARS-CoV-2 genome data submitted to the GISAID database from Turkey and to determine the variant and clade distributions by the end of May 2021, in accordance with their appearance timeline. We compared these findings to USA, Europe, and Asia data as well. We have also evaluated the effects of spike protein variations, detected in a group of genome sequences of 13 patients who applied to our clinic, by using 3D modeling algorithms. For this purpose, we analyzed 4607 SARS-CoV-2 genome sequences submitted by different lab centers from Turkey to the GISAID database between March 2020 and May 2021. Described mutations were also introduced in silico to the spike protein structure to analyze their isolated impacts on the protein structure. The most abundant clade was GR followed by G, GH, and GRY and we did not detect any V clade. The most common variant was B.1, followed by B.1.1, and the UK variant, B.1.1.7. Our results clearly show a concordance between the variant distributions, the number of cases, and the timelines of different variant accumulations in Turkey. The 3D simulations indicate an increase in the surface hydrophilicity of the reference spike protein and the detected mutations. There was less surface hydrophilicity increase in the Asp614Gly mutation, which exhibits a more compact conformation around the ACE-2 receptor binding domain region, rendering the structure in a "down" conformation. Our genomic findings can help to model vaccination programs and protein modeling may lead to different approaches for COVID-19 treatment strategies.	[Hatirnaz Ng, Ozden; Akyoney, Sezer] Acibadem Mehmet Ali Aydinlar Univ, Dept Med Biol, Sch Med, Istanbul, Turkey; [Hatirnaz Ng, Ozden; Ozdemir, Ozkan; Ozbek, Ugur] Acibadem Mehmet Ali Aydinlar Univ Rare Dis & Orph, Istanbul, Turkey; [Akyoney, Sezer; Soykam, Huseyin Okan] Acibadem Mehmet Ali Aydinlar Univ, Dept Biostat & Bioinformat, Inst Hlth Sci, Istanbul, Turkey; [Sahin, Ilayda; Bayram Akcapinar, Gunseli] Acibadem Mehmet Ali Aydinlar Univ, Dept Med Biotechnol, Inst Hlth Sci, Istanbul, Turkey; [Sahin, Ilayda; Ozbek, Ugur] Acibadem Mehmet Ali Aydinlar Univ, Dept Med Genet, Sch Med, Istanbul, Turkey; [Ozdemir, Ozkan] Acibadem Mehmet Ali Aydinlar Univ, Dept Genome Studies, Inst Hlth Sci, Istanbul, Turkey; [Kancagi, Derya Dilek; Sir Karakus, Gozde; Yurtsever, Bulut; Ovali, Ercument] Acibadem Labcell Cellular Therapy Lab, Istanbul, Turkey; [Kocagoz, Ayse Sesin] Acibadem Mehmet Ali Aydinlar Univ, Dept Infect Dis & Clin Microbiol, Sch Med, Istanbul, Turkey	Acibadem University; Acibadem University; Acibadem University; Acibadem University; Acibadem University; Acibadem University	Ozbek, U (corresponding author), Acibadem Mehmet Ali Aydinlar Univ Rare Dis & Orph, Istanbul, Turkey.; Ozbek, U (corresponding author), Acibadem Mehmet Ali Aydinlar Univ, Dept Med Genet, Sch Med, Istanbul, Turkey.	ugur.ozbek@acibadem.edu.tr		Akyoney, Sezer/0000-0003-2514-4142	Acibadem Mehmet Ali Aydinlar University Research Fund (ABAPKO) [2020/02/09]; Acibadem Healthcare Group; TUBITAK 2247-C Trainee Researcher Scholarship Program (STAR); TUBITAK-BIDEB 2244 Industrial Ph.D. Program [118C082]	Acibadem Mehmet Ali Aydinlar University Research Fund (ABAPKO); Acibadem Healthcare Group; TUBITAK 2247-C Trainee Researcher Scholarship Program (STAR)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); TUBITAK-BIDEB 2244 Industrial Ph.D. Program	This project was supported partially by Acibadem Mehmet Ali Aydinlar University Research Fund (ABAPKO, grant number 2020/02/09) and partially by Acibadem Healthcare Group. Sezer Akyoney is funded by TUBITAK 2247-C Trainee Researcher Scholarship Program (STAR). Ilayda Sahin is funded by TUBITAK-BIDEB 2244 Industrial Ph.D. Program [grant number 118C082].	Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; Adebali O, 2020, TURK J BIOL, V44, P146, DOI 10.3906/biy-2005-35; Aktas E, 2021, BIOINFORM BIOL INSIG, V15, DOI 10.1177/11779322211018200; Alm E, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.32.2001410; [Anonymous], 2021, REPUBLIC TURKEY MINI; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Associated Press, 2021, ASS PRESS; Ayub M, 2021, PLANT BIOSYST, V155, P535, DOI 10.1080/11263504.2020.1762785; Bhattarai N, 2021, J PHYS CHEM B, V125, P7101, DOI 10.1021/acs.jpcb.1c01626; Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681; Chen YX, 2021, LANCET INFECT DIS, V21, P1071, DOI 10.1016/S1473-3099(21)00287-5; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Demir AB, 2020, TURK J BIOL, V44, P178, DOI 10.3906/biy-2005-69; Diaz NC, 2021, PROTEINS, V89, P531, DOI 10.1002/prot.26037; Eskier D, 2021, TURK J BIOL, V45, P104, DOI 10.3906/biy-2008-56; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fuglebakk E, 2012, BIOINFORMATICS, V28, P2431, DOI 10.1093/bioinformatics/bts445; GISAID, 2021, CLAD LIN NOM; Gobeil SMC, 2021, SCIENCE, V373, P641, DOI [10.1126/science.abi6226, 10.1101/2021.03.11.435037]; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Gregoret LM, 1998, FOLD DES, V3, P119, DOI 10.1016/S1359-0278(98)00017-0; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Grubaugh ND, 2020, CELL, V182, P794, DOI 10.1016/j.cell.2020.06.040; Hamed SM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87713-x; Henderson R., 2020, NAT STRUCT MOL BIOL, V27, DOI [DOI 10.1038/s41594-020-0479-4, 10.1038/s41594-020-0479-4]; Hou YXJ, 2020, SCIENCE, V370, P1464, DOI 10.1126/science.abe8499; Huang HY, 2021, CELL DEATH DIFFER, V28, P2840, DOI 10.1038/s41418-021-00846-4; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iftikhar H, 2020, COMPUT BIOL MED, V122, DOI 10.1016/j.compbiomed.2020.103848; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karacan I, 2020, NORTH CLIN ISTANB, V7, P203, DOI 10.14744/nci.2020.90532; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khailany RA, 2020, GENE REP, V19, DOI 10.1016/j.genrep.2020.100682; Knapp B, 2010, J COMPUT CHEM, V31, P2868, DOI 10.1002/jcc.21581; Koyama T, 2020, B WORLD HEALTH ORGAN, V98, P495, DOI 10.2471/BLT.20.253591; Letunic I, 2021, NUCLEIC ACIDS RES, V49, pW293, DOI 10.1093/nar/gkab301; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Mercatelli D, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01800; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Motozono C, 2021, CELL HOST MICROBE, V29, P1124, DOI 10.1016/j.chom.2021.06.006; Ou JX, 2021, J VIROL, V95, DOI 10.1128/JVI.00617-21; PANGO lineages, LIN DESCR LIST; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Public Health England-GOV.UK, COR COVID 19 RUL GUI; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanyaolu A, 2021, THER ADV INFECT DIS, V8, DOI 10.1177/20499361211024372; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shen LS, 2021, EMERG MICROBES INFEC, V10, P1293, DOI 10.1080/22221751.2021.1943540; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Tan YJ, 2005, ANTIVIR RES, V65, P69, DOI 10.1016/j.antiviral.2004.10.001; Tastan C, 2020, TURK J BIOL, V44, P192, DOI 10.3906/biy-2004-113; Verkhivker GM, 2021, ACS OMEGA, V6, P16216, DOI 10.1021/acsomega.1c02336; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2; WHO, 2021, NATURE, DOI DOI 10.1101/2020.06.17.156455; Woo H, 2020, J PHYS CHEM B, V124, P7128, DOI 10.1021/acs.jpcb.0c04553; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xie XP, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01270-4, 10.1101/2021.01.27.427998]; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037	63	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	12							e0260438	10.1371/journal.pone.0260438	http://dx.doi.org/10.1371/journal.pone.0260438			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1MC	34871297	Green Published, gold			2022-12-26	WOS:000728598900001
J	Linnehan, BK; Gomez, FM; Huston, SM; Hsu, A; Takeshita, R; Colegrove, KM; Harms, CA; Barratclough, A; Deming, AC; Rowles, TK; Musser, WB; Zolman, ES; Wells, RS; Jensen, ED; Schwacke, LH; Smith, CR				Linnehan, Barbara K.; Gomez, Forrest M.; Huston, Sharon M.; Hsu, Adonia; Takeshita, Ryan; Colegrove, Kathleen M.; Harms, Craig A.; Barratclough, Ashley; Deming, Alissa C.; Rowles, Teri K.; Musser, Whitney B.; Zolman, Eric S.; Wells, Randall S.; Jensen, Eric D.; Schwacke, Lori H.; Smith, Cynthia R.			Cardiac assessments of bottlenose dolphins (Tursiops truncatus) in the Northern Gulf of Mexico following exposure to Deepwater Horizon oil	PLOS ONE			English	Article							CRUDE-OIL; DIVE BEHAVIOR; HEART-DISEASE; DOPPLER; ECHOCARDIOGRAPHY; DOGS; AGE; ELECTROCARDIOGRAM; HYPERTENSION; POPULATIONS	The Deepwater Horizon (DWH) oil spill profoundly impacted the health of bottlenose dolphins (Tursiops truncatus) in Barataria Bay, LA (BB). To comprehensively assess the cardiac health of dolphins living within the DWH oil spill footprint, techniques for in-water cardiac evaluation were refined with dolphins cared for by the U.S. Navy Marine Mammal Program in 2018 and applied to free-ranging bottlenose dolphins in BB (n = 34) and Sarasota Bay, Florida (SB) (n = 19), a non-oiled reference population. Cardiac auscultation detected systolic murmurs in the majority of dolphins from both sites (88% BB, 89% SB) and echocardiography showed most of the murmurs were innocent flow murmurs attributed to elevated blood flow velocity [1]. Telemetric six-lead electrocardiography detected arrhythmias in BB dolphins (43%) and SB dolphins (31%), all of which were considered low to moderate risk for adverse cardiac events. Echocardiography showed BB dolphins had thinner left ventricular walls, with significant differences in intraventricular septum thickness at the end of diastole (p = 0.002), and left ventricular posterior wall thickness at the end of diastole (p = 0.033). BB dolphins also had smaller left atrial size (p = 0.004), higher prevalence of tricuspid valve prolapse (p = 0.003), higher prevalence of tricuspid valve thickening (p = 0.033), and higher prevalence of aortic valve thickening (p = 0.008). Two dolphins in BB were diagnosed with pulmonary arterial hypertension based on Doppler echocardiography-derived estimates and supporting echocardiographic findings. Histopathology of dolphins who stranded within the DWH oil spill footprint showed a significantly higher prevalence of myocardial fibrosis (p = 0.003), regardless of age, compared to dolphins outside the oil spill footprint. In conclusion, there were substantial cardiac abnormalities identified in BB dolphins which may be related to DWH oil exposure, however, future work is needed to rule out other hypotheses and further elucidate the connection between oil exposure, pulmonary disease, and the observed cardiac abnormalities.	[Linnehan, Barbara K.; Gomez, Forrest M.; Takeshita, Ryan; Barratclough, Ashley; Musser, Whitney B.; Zolman, Eric S.; Schwacke, Lori H.; Smith, Cynthia R.] Natl Marine Mammal Fdn, San Diego, CA USA; [Huston, Sharon M.; Hsu, Adonia] San Diego Vet Cardiol, San Diego, CA USA; [Colegrove, Kathleen M.] Univ Illinois, Zool Pathol Program, Brookfield, IL USA; [Harms, Craig A.] N Carolina State Univ, Ctr Marine Sci & Technol, Morehead City, NC USA; [Deming, Alissa C.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Rowles, Teri K.] Natl Ocean & Atmospher Adm, Off Protected Resources, Silver Spring, MD USA; [Wells, Randall S.] Chicago Zool Societys Sarasota Dolphin Res Progra, Mote Marine Lab, Sarasota, FL USA; [Jensen, Eric D.] US Navy Marine Mammal Program, Naval Informat Warfare Ctr Pacific, San Diego, CA USA	University of Illinois System; University of North Carolina; North Carolina State University; Dauphin Island Sea Lab; National Oceanic Atmospheric Admin (NOAA) - USA; Mote Marine Laboratory & Aquarium; Naval Information Warfare Center Pacific; United States Department of Defense; United States Navy	Linnehan, BK (corresponding author), Natl Marine Mammal Fdn, San Diego, CA USA.	Barb.Linnehan@nmmf.org	Linnehan, Barbara/AAB-5415-2022	Linnehan, Barbara/0000-0003-1560-3878; Harms, Craig/0000-0002-1262-9274	Gulf of Mexico Research Initiative [SA 18-12]; Alabama Marine Mammal Stranding Network; National Fish and Wildlife Foundation Gulf Environmental Benefit Fund [45720]	Gulf of Mexico Research Initiative; Alabama Marine Mammal Stranding Network; National Fish and Wildlife Foundation Gulf Environmental Benefit Fund	This research was made possible by a grant from The Gulf of Mexico Research Initiative (Award # SA 18-12). https://gulfresearchinitiative. org/ The Alabama Marine Mammal Stranding Network was funded in part through the John H. Prescott Marine Mammal Rescue Assistance Grant Program, National Fish and Wildlife Foundation Gulf Environmental Benefit Fund (#45720), Dauphin Island Sea Lab, Alabama Department of Conservation and Natural Resources, and the Alabama Emergency Management Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KJ, 2016, EQUINE VET EDUC, V28, P89, DOI 10.1111/eve.12410; Barratclough A, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00444; Batista JS., 2013, REV MED VET, P5; Bickett N, 2016, FASEB J, V30; Brette F, 2017, SCI REP-UK, V7, DOI 10.1038/srep41476; Brette F, 2014, SCIENCE, V343, P772, DOI 10.1126/science.1242747; Chetboul V, 2012, J VET CARDIOL, V14, P511, DOI 10.1016/j.jvc.2012.07.002; Colegrove KM, 2016, DIS AQUAT ORGAN, V119, P1, DOI 10.3354/dao02969; Currie KD, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01700; D'Andrea MA, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00117; De Guise S., 2017, ENDANGER SPECIES RES, P33; Elmegaard SL, 2016, CURR BIOL, V26, pR1175, DOI 10.1016/j.cub.2016.10.020; Fahlman A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00838; Forfia PR, 2013, PULM CIRC, V3, P5, DOI 10.4103/2045-8932.109910; Fulghum Kyle, 2018, Front Cardiovasc Med, V5, P127, DOI 10.3389/fcvm.2018.00127; Galie N, 2015, EUR RESPIR J, V46, P903, DOI 10.1183/13993003.01032-2015; Goldbogen JA, 2019, P NATL ACAD SCI USA, V116, P25329, DOI 10.1073/pnas.1914273116; HAMLIN RL, 1970, AM J VET RES, V31, P501; Harms CA, 2013, J ZOO WILDLIFE MED, V44, P972, DOI 10.1638/2013-0093.1; Harr KE, 2017, ECOTOX ENVIRON SAFE, V146, P76, DOI 10.1016/j.ecoenv.2017.04.010; Herrman JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242273; Hoelzel AR, 1998, P ROY SOC B-BIOL SCI, V265, P1177, DOI 10.1098/rspb.1998.0416; HOHN AA, 1989, MAR MAMMAL SCI, V5, P315, DOI 10.1111/j.1748-7692.1989.tb00346.x; Incardona JP, 2017, ARCH ENVIRON CON TOX, V73, P19, DOI 10.1007/s00244-017-0381-1; Incardona JP, 2014, P NATL ACAD SCI USA, V111, pE1510, DOI 10.1073/pnas.1320950111; KITABATAKE A, 1983, CIRCULATION, V68, P302, DOI 10.1161/01.CIR.68.2.302; Klatsky LJ, 2007, J MAMMAL, V88, P59, DOI 10.1644/05-MAMM-A-365R1.1; Lane SM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1944; Levine SA, 1933, J AMER MED ASSOC, V101, P436, DOI 10.1001/jama.1933.02740310020005; Linnehan BK, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.570055; MATE BR, 1995, MAR MAMMAL SCI, V11, P452, DOI 10.1111/j.1748-7692.1995.tb00669.x; Mattoon J. S., 2014, SMALL ANIMAL DIAGNOS; McClain AM., 2021, P IAAAM VIRT C MAY 2; McFee WE, 2012, AQUAT MAMM, V38, P17, DOI 10.1578/AM.38.1.2012.17; Mead JG., 1995, RECOGNIZING 2 POPULA; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Miedler S., 2008, HDB TRANSTHORACIC CA; Miedler S, 2015, J EXP BIOL, V218, P3604, DOI 10.1242/jeb.131532; Mostrom MS., 1998, 1994 LIVESTOCK FIELD; Nelson D, 2016, AQUAT TOXICOL, V180, P274, DOI 10.1016/j.aquatox.2016.10.012; Otto C.M., 2013, TXB CLIN ECHOCARDIOG, Vfifth; Patteson M, 1995, EQUINE CARDIOLOGY; Perrichon P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203949; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; RAEKALLIO M, 1992, ACTA VET SCAND, V33, P71; Reef V B, 1995, Equine Vet J Suppl, P71; Rouhani S, 2017, MAR ECOL PROG SER, V576, P111, DOI 10.3354/meps11811; SCHEFFER CWJ, 1995, VET REC, V137, P371, DOI 10.1136/vr.137.15.371; Schwacke LH, 2017, ENDANGER SPECIES RES, V33, P265, DOI 10.3354/esr00777; Schwacke LH, 2014, ENVIRON SCI TECHNOL, V48, P93, DOI 10.1021/es403610f; Serres F, 2007, J VET INTERN MED, V21, P1280, DOI 10.1892/07-064.1; Serres FJ, 2006, JAVMA-J AM VET MED A, V229, P1772, DOI 10.2460/javma.229.11.1772; Sklansky M, 2006, J ZOO WILDLIFE MED, V37, P454, DOI 10.1638/05-116.1; Smith CR, 2017, ENDANGER SPECIES RES, V33, P127, DOI 10.3354/esr00778; SOMMER LS, 1968, AM J PHYSIOL, V215, P1498, DOI 10.1152/ajplegacy.1968.215.6.1498; Stephen B, 1999, CHEST, V116, P73, DOI 10.1378/chest.116.1.73; Strelitz J, 2016, OCCUP ENV MED, V73, pA54, DOI [10.1136/oemed-2016-103951.146, DOI 10.1136/OEMED-2016-103951.146]; Strelitz J, 2019, AM J EPIDEMIOL, V188, P917, DOI 10.1093/aje/kwz017; Strelitz J, 2019, ENVIRON RES, V168, P70, DOI 10.1016/j.envres.2018.09.026; Strelitz J, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0408-8; Takeshita R., 2017, ENDANGER SPECIES RES, P33; Tilley LP., 2008, MANUAL CANINE FELINE; Turner RE, 2019, ENVIRON POLLUT, V252, P1367, DOI 10.1016/j.envpol.2019.05.134; UEHARA Y, 1993, J VET MED SCI, V55, P307, DOI 10.1292/jvms.55.307; van Loon G., 2010, CARDIOLOGY HORSE, P59; Vasan Ramachandran S., 1995, CIRCULATION, V91, P734, DOI [10.1161/01.cir.91.3.734, DOI 10.1161/01.CIR.91.3.734]; Venn-Watson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126538; Venn-Watson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117248; Wasfy MM, 2015, J AM SOC ECHOCARDIOG, V28, P1434, DOI 10.1016/j.echo.2015.08.002; Wells R., 2017, ENDANGER SPECIES RES, P33; Wells R.S., 2014, PRIMATES CETACEANS F, P149, DOI DOI 10.1007/978-4-431-54523-1_8; Wells Randall S, 2013, Front Endocrinol (Lausanne), V4, P139, DOI 10.3389/fendo.2013.00139; Williams TM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7055; Yaw TJ, 2018, J ZOO WILDLIFE MED, V49, P689, DOI 10.1638/2017-0140.1; Zheng W, 2017, TOXICOLOGIST SUPPLEM, P479; Zipes DP, 2018, BRAUNWALDS HEART DIS	76	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261112	10.1371/journal.pone.0261112	http://dx.doi.org/10.1371/journal.pone.0261112			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905585	Green Published, gold			2022-12-26	WOS:000754615500021
J	Lu, SF; Lu, YF; Sun, Y				Lu, Shaofeng; Lu, Yuefeng; Sun, Ying			Collaborative calculation and application of interreal and real interval relations to protect privacy	PLOS ONE			English	Article							COMPUTATION	The determination of the relation between a number and a numerical interval is one of the core problems in the scientific calculation of privacy protection. The calculation of the relationship between two numbers and a numerical interval to protect privacy is also the basic problem of collaborative computing. It is widely used in data queries, location search and other fields. At present, most of the solutions are still fundamentally limited to the integer level, and there are few solutions at the real number level. To solve these problems, this paper first uses Bernoulli inequality generalization and a monotonic function property to extend the solution to the real number level and designs two new protocols based on the homomorphic encryption scheme, which can not only protect the data privacy of both parties involved in the calculation, but also extend the number domain to real numbers. In addition, this paper designs a solution to the confidential cooperative determination problem between real numbers by using the sign function and homomorphism multiplication. Theoretical analysis shows that the proposed solution is safe and efficient. Finally, some extension applications based on this protocol are given.	[Lu, Shaofeng] Northeastern Univ, Sch Comp Sci & Engn, Shenyang, Peoples R China; [Lu, Yuefeng; Sun, Ying] Shandong Univ Technol, Sch Civil & Architectural Engn, Zibo, Peoples R China; [Lu, Yuefeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China	Northeastern University - China; Shandong University of Technology; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Lu, YF (corresponding author), Shandong Univ Technol, Sch Civil & Architectural Engn, Zibo, Peoples R China.; Lu, YF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	yflu@sdut.edu.cn		lu, yue feng/0000-0003-4251-1573	State Key Laboratory of Resources and Environmental Information System of China; Strategic Priority Research Program of Chinese Academy of Sciences [XDA 20030302]	State Key Laboratory of Resources and Environmental Information System of China; Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	Yuefeng Lu was funded by the grant from State Key Laboratory of Resources and Environmental Information System of China and the Strategic Priority Research Program of Chinese Academy of Sciences (Grant No. XDA 20030302). The funder play a role in the decision to publish and preparation of the manuscript.	Agrawal R, 2000, SIGMOD REC, V29, P439, DOI 10.1145/335191.335438; [Anonymous], 2006, OSS DIGEST, P11; Atallah MJ, 2001, LECT NOTES COMPUT SC, V2125, P165; Beigel R., 2003, TR03087 ECCC; Ben-Or M, 2006, ANN IEEE SYMP FOUND, P249; [陈振华 Chen Zhenhua], 2017, [计算机研究与发展, Journal of Computer Research and Development], V54, P1549; Costa B, 2021, ENTROPY-SWITZ, V23, DOI 10.3390/e23081001; [窦家维 Dou Jiawei], 2018, [电子学报, Acta Electronica Sinica], V46, P2057; Du WL, 2004, SIAM PROC S, P222; Du WL, 2001, P IEEE CSFW, P273, DOI 10.1109/CSFW.2001.930152; ELGAMAL T, 1985, IEEE T INFORM THEORY, V31, P469, DOI 10.1109/TIT.1985.1057074; Fagin R, 1996, COMMUN ACM, V39, P77, DOI 10.1145/229459.229469; Goldreich O, 2004, FDN CRYPTOGRAPHY BAS, P599; Goldreich O., 1987, 19 ANN ACM S THEOR C, P218; Goldreich O., 1998, SECURE MULTIPARTY CO, P78; [郭奕旻 Guo Yimin], 2017, [计算机学报, Chinese Journal of Computers], V40, P1664; Li SD, 2014, INFORM SCIENCES, V282, P401, DOI 10.1016/j.ins.2014.04.004; Li Shundong, 2008, Journal of Xi'an Jiaotong University, V42, P231; Lindell Y, 2002, J CRYPTOL, V15, P177, DOI 10.1007/s00145-001-0019-2; Liu Wen, 2007, Journal of China Institute of Communications, V28, P1; Lu Shao-feng, 2008, Computer Engineering and Applications, V44, P130, DOI 10.3778/j.issn.1002-8331.2008.36.036; Luo Yong-Long, 2007, Chinese Journal of Computers, V30, P248; Paillier P, 1999, LECT NOTES COMPUT SC, V1592, P223; Shen E, 2015, COMPUTER, V48, P78, DOI 10.1109/MC.2015.101; Tang CM, 2011, SCI CHINA INFORM SCI, V54, P1654, DOI 10.1007/s11432-011-4272-1; Yao A. C., 1982, 23rd Annual Symposium on Foundations of Computer Science, P160, DOI 10.1109/SFCS.1982.38	26	0	0	8	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261213	10.1371/journal.pone.0261213	http://dx.doi.org/10.1371/journal.pone.0261213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905572	gold, Green Published			2022-12-26	WOS:000754615500027
J	Hegelund, ER; Teasdale, TW; Okholm, GT; Osler, M; Sorensen, TIA; Christensen, K; Mortensen, EL				Hegelund, Emilie R.; Teasdale, Thomas W.; Okholm, Gunhild T.; Osler, Merete; Sorensen, Thorkild I. A.; Christensen, Kaare; Mortensen, Erik L.			The secular trend of intelligence test scores: The Danish experience for young men born between 1940 and 2000	PLOS ONE			English	Article							OF-DIMINISHING-RETURNS; IQ GAINS; INCREASES; NUTRITION; HEIGHT; METAANALYSIS; RELIABILITY; EDUCATION; REVERSAL; DECLINE	The present study investigated the Danish secular trend of intelligence test scores among young men born between 1940 and 2000, as well as the possible associations of birth cohort changes in family size, nutrition, education, and intelligence test score variability with the increasing secular trend. The study population included all men born from 1940 to 2000 who appeared before a draft board before 2020 (N = 1,556,770). At the mandatory draft board examination, the approximately 19-year-old men underwent a medical examination and an intelligence test. In the statistical analyses, the IQ mean and standard deviation (SD) were estimated separately for each of the included annual birth cohorts based on information from birth cohorts with available total intelligence test scores for all tested individuals (i.e. 1940-1958 and 1987-2000; the mean and SD were interpolated for the intermediate birth cohorts). Moreover, the possible associations with birth cohort changes in family size, height as a proxy for nutritional status, education, and IQ variability were investigated among those birth cohorts for whom a secular increase in intelligence test scores was found. The results showed that the estimated mean IQ score increased from a baseline set to 100 (SD: 15) among individuals born in 1940 to 108.9 (SD: 12.2) among individuals born in 1980, since when it has decreased. Focusing on the birth cohorts of 1940-1980, for whom a secular increase in intelligence test scores was found, birth cohort changes in family size, height, and education explained large proportions of the birth cohort variance in mean intelligence test scores, suggesting that these factors may be important contributors to the observed Flynn effect in Denmark.	[Hegelund, Emilie R.; Okholm, Gunhild T.; Osler, Merete; Sorensen, Thorkild I. A.; Mortensen, Erik L.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Teasdale, Thomas W.] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Okholm, Gunhild T.; Osler, Merete] Bispebjerg Hosp, Ctr Clin Res & Prevent, Frederiksberg, Denmark; [Okholm, Gunhild T.; Osler, Merete] Frederiksberg Univ Hosp, Ctr Clin Res & Prevent, Frederiksberg, Denmark; [Christensen, Kaare] Univ Southern Denmark, Dept Publ Hlth, Odense, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark	Hegelund, ER (corresponding author), Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.	emhe@sund.ku.dk	Christensen, Kaare/C-2360-2009	Christensen, Kaare/0000-0002-5429-5292; Okholm, Gunhild Tidemann/0000-0001-9729-708X; Mortensen, Erik Lykke/0000-0002-6985-451X; Hegelund, Emilie Rune/0000-0001-8677-7133				Bentham J, 2016, ELIFE, V5, DOI 10.7554/eLife.13410.001; CECI SJ, 1991, DEV PSYCHOL, V27, P703, DOI 10.1037/0012-1649.27.5.703; Colom R, 2005, INTELLIGENCE, V33, P83, DOI 10.1016/j.intell.2004.07.010; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Dutton E, 2016, INTELLIGENCE, V59, P163, DOI 10.1016/j.intell.2016.10.002; Fagt S., 2016, KODS ROLLE KOSTEN; Flynn JR, 2018, INTELLIGENCE, V66, P112, DOI 10.1016/j.intell.2017.11.010; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; FLYNN JR, 1984, PSYCHOL BULL, V95, P29, DOI 10.1037/0033-2909.95.1.29; Hartmann P, 2005, PERS INDIV DIFFER, V39, P1193, DOI 10.1016/j.paid.2005.03.017; Hartmann P, 2004, INTELLIGENCE, V32, P499, DOI 10.1016/j.intell.2004.06.009; Hegelund ER, 2021, INTELLIGENCE, V85, DOI 10.1016/j.intell.2021.101525; Hegelund ER, 2020, INTELLIGENCE, V78, DOI 10.1016/j.intell.2019.101419; Herrnstein R J, 1994, BELL CURVE; LYNN R, 1990, PERS INDIV DIFFER, V11, P273, DOI 10.1016/0191-8869(90)90241-I; LYNN R, 1989, BRIT J EDUC PSYCHOL, V59, P372, DOI 10.1111/j.2044-8279.1989.tb03112.x; Lynn R, 2009, INTELLIGENCE, V37, P16, DOI 10.1016/j.intell.2008.07.008; MORTENSEN EL, 1989, SCAND J PSYCHOL, V30, P315, DOI 10.1111/j.1467-9450.1989.tb01094.x; Nielsen T, 2020, SCAND J PSYCHOL, V61, P161, DOI 10.1111/sjop.12586; Nisbett RE, 2012, AM PSYCHOL, V67, P130, DOI 10.1037/a0026699; Perkins JM, 2016, NUTR REV, V74, P149, DOI 10.1093/nutrit/nuv105; Pietschnig J, 2015, INTELLIGENCE, V53, P145, DOI 10.1016/j.intell.2015.10.004; Pietschnig J, 2015, PERSPECT PSYCHOL SCI, V10, P282, DOI 10.1177/1745691615577701; Rindermann H, 2013, INTELLIGENCE, V41, P821, DOI 10.1016/j.intell.2013.06.016; Ritchie SJ, 2018, PSYCHOL SCI, V29, P1358, DOI 10.1177/0956797618774253; Teasdale TW, 2008, INTELLIGENCE, V36, P121, DOI 10.1016/j.intell.2007.01.007; Teasdale TW, 2011, SCAND J PSYCHOL, V52, P126, DOI 10.1111/j.1467-9450.2010.00862.x; TEASDALE TW, 1989, INTELLIGENCE, V13, P255, DOI 10.1016/0160-2896(89)90021-4; TEASDALE TW, 1987, NATURE, V325, P119, DOI 10.1038/325119a0; Teasdale TW, 2000, INTELLIGENCE, V28, P115, DOI 10.1016/S0160-2896(99)00034-3; Teasdale TW, 2005, PERS INDIV DIFFER, V39, P837, DOI 10.1016/j.paid.2005.01.029; TEASDALE TW, 1989, BRIT MED J, V298, P1292, DOI 10.1136/bmj.298.6683.1292; Trahan LH, 2014, PSYCHOL BULL, V140, P1332, DOI 10.1037/a0037173; Woodley MA, 2012, PERS INDIV DIFFER, V53, P152, DOI 10.1016/j.paid.2011.03.028; Woodley of Menie M. A., 2017, EVOLUTIONARY BEHAV S, DOI 10.1037/ebs0000106; Zajonc RB, 1997, AM PSYCHOL, V52, P685	36	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0261117	10.1371/journal.pone.0261117	http://dx.doi.org/10.1371/journal.pone.0261117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882746	Green Published, gold			2022-12-26	WOS:000755037200061
J	Larsen, K; Heide-Jorgensen, MP				Larsen, Knud; Heide-Jorgensen, Mads Peter			Conservation of A-to-I RNA editing in bowhead whale and pig	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE ANTIZYME; AMPA RECEPTOR CHANNELS; INOSINE RNA; NUCLEAR RETENTION; GENE-EXPRESSION; ADENOSINE; CANCER; PROTEIN; TRANSCRIPT; APOPTOSIS	RNA editing is a post-transcriptional process in which nucleotide changes are introduced into an RNA sequence, many of which can contribute to proteomic sequence variation. The most common type of RNA editing, contributing to nearly 99% of all editing events in RNA, is A-to-I (adenosine-to-inosine) editing mediated by double-stranded RNA-specific adenosine deaminase (ADAR) enzymes. A-to-I editing at 'recoding' sites results in non-synonymous substitutions in protein-coding sequences. Here, we present studies of the conservation of A-to-I editing in selected mRNAs between pigs, bowhead whales, humans and two shark species. All examined mRNAs-NEIL1, COG3, GRIA2, FLNA, FLNB, IGFBP7, AZIN1, BLCAP, GLI1, SON, HTR2C and ADAR2 -showed conservation of A-to-I editing of recoding sites. In addition, novel editing sites were identified in NEIL1 and GLI1 in bowhead whales. The A-to-I editing site of human NEIL1 in position 242 was conserved in the bowhead and porcine homologues. A novel editing site was discovered in Tyr244. Differential editing was detected at the two adenosines in the NEIL1 242 codon in both pig and bowhead NEIL1 mRNAs in various tissues and organs. No conservation of editing of KCNB1 and EEF1A mRNAs was seen in bowhead whales. In silico analyses revealed conservation of five adenosines in ADAR2, some of which are subject to A-to-I editing in bowheads and pigs, and conservation of a regulatory sequence in GRIA2 mRNA that is responsible for recognition of the ADAR editing enzyme.	[Larsen, Knud] Aarhus Univ, Dept Mol Biol & Genet, Aarhus C, Denmark; [Heide-Jorgensen, Mads Peter] Greenland Inst Nat Resources, Copenhagen K, Denmark	Aarhus University; Greenland Institute of Natural Resources	Larsen, K (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus C, Denmark.	Knud.Larsen@mbg.au.dk						Bakhtiarizadeh MR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193316; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Ben-Aroya S, 2018, CANCER CELL, V33, P789, DOI 10.1016/j.ccell.2018.04.006; Berg KA, 2001, BRIT J PHARMACOL, V134, P386, DOI 10.1038/sj.bjp.0704255; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Boddy AM, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101373; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Chan THM, 2016, GASTROENTEROLOGY, V151, P637, DOI 10.1053/j.gastro.2016.06.043; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chen W, 2017, ONCOTARGET, V8, P39417, DOI 10.18632/oncotarget.17034; Clutterbuck DR, 2005, BIOINFORMATICS, V21, P2590, DOI 10.1093/bioinformatics/bti411; Czermak P, 2018, RNA BIOL, V15, P877, DOI 10.1080/15476286.2018.1480252; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; Daniel C, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1324-x; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Decher N, 2010, EMBO J, V29, P2101, DOI 10.1038/emboj.2010.88; DeGregori J, 2017, CANCER RES, V77, P6065, DOI 10.1158/0008-5472.CAN-17-1207; Dirksen WP, 2003, J BIOL CHEM, V278, P9722, DOI 10.1074/jbc.M207969200; Dominissini D, 2011, CARCINOGENESIS, V32, P1569, DOI 10.1093/carcin/bgr124; Eisenberg E, 2018, NAT REV GENET, V19, P473, DOI 10.1038/s41576-018-0006-1; Fan DG, 2011, EXP BIOL MED, V236, P1030, DOI 10.1258/ebm.2011.010315; Farajzadeh L, 2013, BIOCHEM BIOPH RES CO, V438, P346, DOI 10.1016/j.bbrc.2013.07.074; Fresard L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126776; Fritzell K, 2018, SEMIN CELL DEV BIOL, V79, P123, DOI 10.1016/j.semcdb.2017.11.018; Fu Y, 2016, ONCOL LETT, V12, P788, DOI 10.3892/ol.2016.4734; Funkhouser SA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3766-7; Galeano F, 2010, INT J CANCER, V127, P127, DOI 10.1002/ijc.25022; Gatsiou A, 2018, ANTIOXID REDOX SIGN, V29, P846, DOI 10.1089/ars.2017.7295; Green MR, 2012, LAB MANUAL; Gromova I, 2002, INT J CANCER, V98, P539, DOI 10.1002/ijc.10244; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; Heide-Jorgensen M. P., 2012, Journal of Cetacean Research and Management, V12, P329; Henriksen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079127; Henriksen C, 2009, GENE, V430, P105, DOI 10.1016/j.gene.2008.10.023; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Holmes AP, 2013, BIOGERONTOLOGY, V14, P395, DOI 10.1007/s10522-013-9433-8; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Hu XD, 2015, CANCER LETT, V357, P510, DOI 10.1016/j.canlet.2014.12.006; Jain M, 2018, EMBO J, V37, DOI 10.15252/embj.201694813; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Keane M, 2015, CELL REP, V10, P112, DOI 10.1016/j.celrep.2014.12.008; Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542; Kung SS, 2001, FEBS LETT, V509, P277, DOI 10.1016/S0014-5793(01)03183-0; Larsen K, 2016, BIOCHEM BIOPH RES CO, V479, P596, DOI 10.1016/j.bbrc.2016.09.125; Larsen K, 2016, BIOCHIMIE, V121, P189, DOI 10.1016/j.biochi.2015.12.011; Lee SH, 2017, CANCER RES TREAT, V49, P1077, DOI 10.4143/crt.2016.301; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Levillain O, 2012, AMINO ACIDS, V43, P2153, DOI 10.1007/s00726-012-1300-4; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Madsen LB, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-72; Martin CBP, 2013, MOL PSYCHIATR, V18, P656, DOI 10.1038/mp.2012.171; Martinez-Montes AM, 2017, ANIM GENET, V48, P151, DOI 10.1111/age.12507; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Nunney L, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0161; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Peng XX, 2018, CANCER CELL, V33, P817, DOI 10.1016/j.ccell.2018.03.026; Porath HT, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1315-y; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Price RD, 2000, MOL PHARMACOL, V58, P859, DOI 10.1124/mol.58.4.859; Price RD, 2001, J BIOL CHEM, V276, P44663, DOI 10.1074/jbc.M106745200; Qin YR, 2014, CANCER RES, V74, P840, DOI 10.1158/0008-5472.CAN-13-2545; Rae FK, 2000, INT J CANCER, V88, P726, DOI 10.1002/1097-0215(20001201)88:5<726::AID-IJC7>3.0.CO;2-H; Ramos-Molina B, 2014, FEBS OPEN BIO, V4, P510, DOI 10.1016/j.fob.2014.05.004; Romo L, 2017, CELL REP, V20, P3057, DOI 10.1016/j.celrep.2017.09.009; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Roux PF, 2016, G3-GENES GENOM GENET, V6, P321, DOI 10.1534/g3.115.022251; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Sakurai M, 2014, GENOME RES, V24, P522, DOI 10.1101/gr.162537.113; Savva YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-252; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shallev L, 2018, RNA, V24, P828, DOI 10.1261/rna.064659.117; Sharma A, 2010, MOL BIOL CELL, V21, P650, DOI 10.1091/mbc.E09-02-0126; Shigeyasu K, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99976; Shimokawa T, 2013, RNA BIOL, V10, P321, DOI 10.4161/rna.23343; Snyder EM, 2017, BIOL REPROD, V96, P244, DOI 10.1095/biolreprod.116.145151; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Streit AK, 2014, J BIOL CHEM, V289, P26762, DOI 10.1074/jbc.M113.545731; Stulic M, 2013, RNA BIOL, V10, P1611, DOI 10.4161/rna.26216; Su AAH, 2011, BIOCHEMISTRY-MOSCOW+, V76, P932, DOI 10.1134/S0006297911080098; Tan MH, 2017, NATURE, V550, P249, DOI 10.1038/nature24041; Tejada-Martinez D, 2021, P ROY SOC B-BIOL SCI, V288, DOI 10.1098/rspb.2020.2592; Teoh PJ, 2018, BLOOD, V132, P1304, DOI 10.1182/blood-2018-02-832576; Tollis M, 2019, MOL BIOL EVOL, V36, P1746, DOI 10.1093/molbev/msz099; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; Veno MT, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0801-3; Veno MT, 2012, RNA BIOL, V9, P1054, DOI 10.4161/rna.21082; Walkley CR, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1347-3; Wang H, 2012, TUMOR BIOL, V33, P1943, DOI 10.1007/s13277-012-0455-7; Wang ZS, 2019, GENES-BASEL, V10, DOI 10.3390/genes10050327; Werry TD, 2008, PHARMACOL THERAPEUT, V119, P7, DOI 10.1016/j.pharmthera.2008.03.012; YANG JH, 1995, NATURE, V374, P77, DOI 10.1038/374077a0; Yang WD, 2004, MOL BRAIN RES, V124, P70, DOI 10.1016/j.molbrainres.2004.02.010; Yao J, 2007, MOL CELL BIOCHEM, V297, P81, DOI 10.1007/s11010-006-9332-2; Yeo JC, 2010, P NATL ACAD SCI USA, V107, P20715, DOI 10.1073/pnas.1009231107; Yim HS, 2014, NAT GENET, V46, P88, DOI 10.1038/ng.2835; Zaidan H, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4409-8; Zhang HF, 2014, CANCERS, V6, P1408, DOI 10.3390/cancers6031408; Zhang YY, 2019, J ANIM SCI BIOTECHNO, V10, DOI 10.1186/s40104-019-0331-z; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zhao M, 2016, ONCOL REP, V35, P3050, DOI 10.3892/or.2016.4686; Zilberman DE, 2011, UROL ONCOL-SEMIN ORI, V29, P21, DOI 10.1016/j.urolonc.2008.11.006; Zuo ZH, 2006, TUMOR BIOL, V27, P221, DOI 10.1159/000093057	116	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260081	10.1371/journal.pone.0260081	http://dx.doi.org/10.1371/journal.pone.0260081			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882682	gold, Green Published			2022-12-26	WOS:000755037200019
J	Miller, HA; Schake, MA; Bony, BA; Curtis, ET; Gee, CC; McCue, IS; Ripperda, TJ; Chatzizisis, YS; Kievit, FM; Pedrigi, RM				Miller, Hunter A.; Schake, Morgan A.; Bony, Badrul Alam; Curtis, Evan T.; Gee, Connor C.; McCue, Ian S.; Ripperda, Thomas J.; Chatzizisis, Yiannis S.; Kievit, Forrest M.; Pedrigi, Ryan M.			Smooth muscle cells affect differential nanoparticle accumulation in disturbed blood flow-induced murine atherosclerosis	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; RESONANCE-IMAGING CONTRAST; ENDOTHELIAL SHEAR-STRESS; CORONARY ATHEROSCLEROSIS; PLAQUE BURDEN; FOLIC-ACID; AGENTS; MICE; NEOVASCULARIZATION; CLASSIFICATION	Atherosclerosis is a lipid-driven chronic inflammatory disease that leads to the formation of plaques in the inner lining of arteries. Plaques form over a range of phenotypes, the most severe of which is vulnerable to rupture and causes most of the clinically significant events. In this study, we evaluated the efficacy of nanoparticles (NPs) to differentiate between two plaque phenotypes based on accumulation kinetics in a mouse model of atherosclerosis. This model uses a perivascular cuff to induce two regions of disturbed wall shear stress (WSS) on the inner lining of the instrumented artery, low (upstream) and multidirectional (downstream), which, in turn, cause the development of an unstable and stable plaque phenotype, respectively. To evaluate the influence of each WSS condition, in addition to the final plaque phenotype, in determining NP uptake, mice were injected with NPs at intermediate and fully developed stages of plaque growth. The kinetics of artery wall uptake were assessed in vivo using dynamic contrast-enhanced magnetic resonance imaging. At the intermediate stage, there was no difference in NP uptake between the two WSS conditions, although both were different from the control arteries. At the fully-developed stage, however, NP uptake was reduced in plaques induced by low WSS, but not multidirectional WSS. Histological evaluation of plaques induced by low WSS revealed a significant inverse correlation between the presence of smooth muscle cells and NP accumulation, particularly at the plaque-lumen interface, which did not exist with other constituents (lipid and collagen) and was not present in plaques induced by multidirectional WSS. These findings demonstrate that NP accumulation can be used to differentiate between unstable and stable murine atherosclerosis, but accumulation kinetics are not directly influenced by the WSS condition. This tool could be used as a diagnostic to evaluate the efficacy of experimental therapeutics for atherosclerosis.	[Miller, Hunter A.; Bony, Badrul Alam; Curtis, Evan T.; Gee, Connor C.; Kievit, Forrest M.] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68588 USA; [Schake, Morgan A.; McCue, Ian S.; Ripperda, Thomas J.; Pedrigi, Ryan M.] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA; [Chatzizisis, Yiannis S.] Univ Nebraska Med Ctr, Cardiovasc Div, Omaha, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center	Kievit, FM (corresponding author), Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68588 USA.; Pedrigi, RM (corresponding author), Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA.	fkievit2@unl.edu; rpedrigi@unl.edu	BONY, BADRUL ALAM/J-4009-2019	BONY, BADRUL ALAM/0000-0001-5139-6541	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [P30GM127200]; Nebraska Center for Integrated Biomolecular Communication [P20GM113126]; American Heart Association (AHA) [19CDA34660218]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the NIH [R21EB028960]; National Heart, Lung, and Blood Institute (NHLBI) of the NIH [R01HL144690]; National Science Foundation Graduate Research Fellowship [DGE-1610400]; National Science Foundation [ECCS: 2025298]	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH); Nebraska Center for Integrated Biomolecular Communication; American Heart Association (AHA)(American Heart Association); National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the NIH; National Heart, Lung, and Blood Institute (NHLBI) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	We acknowledge support from an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) to RMP and FK (P30GM127200) and the Nebraska Center for Integrated Biomolecular Communication to RMP (NIH NIGMS grant number P20GM113126), grant funding from the American Heart Association (AHA) to RMP (19CDA34660218), the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the NIH to RMP (R21EB028960), and from the National Heart, Lung, and Blood Institute (NHLBI) of the NIH to YC (R01HL144690). This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1610400 to HM. The research was performed in part in the Nebraska Nanoscale Facility: National Nanotechnology Coordinated Infrastructure and the Nebraska Center for Materials and Nanoscience, which are supported by the National Science Foundation under Award ECCS: 2025298, and the Nebraska Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hijji MA, 2019, CIRC-CARDIOVASC INTE, V12, DOI 10.1161/CIRCINTERVENTIONS.119.007791; Beldman TJ, 2019, ACS NANO, V13, P13759, DOI 10.1021/acsnano.8b08875; Bonvin D, 2017, DALTON T, V46, P12692, DOI 10.1039/c7dt02139a; Bony BA, 2020, ACS OMEGA, V5, P16220, DOI 10.1021/acsomega.0c01890; Bony BA, 2014, BIOMATER SCI-UK, V2, P1287, DOI 10.1039/c4bm00107a; Chamie D, 2011, CURR CARDIOVASC IMAG, V4, P276, DOI 10.1007/s12410-011-9090-8; Chatzizisis YS, 2008, CIRCULATION, V117, P993, DOI 10.1161/CIRCULATIONAHA.107.695254; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Chatzizisis YS, 2011, CIRCULATION, V123, P621, DOI 10.1161/CIRCULATIONAHA.110.970038; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; Chertok B, 2008, BIOMATERIALS, V29, P487, DOI 10.1016/j.biomaterials.2007.08.050; Dai FY, 2014, J MATER CHEM B, V2, P2240, DOI 10.1039/c3tb21732a; Davies PF, 2013, CARDIOVASC RES, V99, P315, DOI 10.1093/cvr/cvt101; Dunmore BJ, 2007, J VASC SURG, V45, P155, DOI 10.1016/j.jvs.2006.08.072; FALK E, 1992, CIRCULATION, V86, P30; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Fang J, 2014, BIOMATERIALS, V35, P1636, DOI 10.1016/j.biomaterials.2013.11.032; Fraga-Silva RA, 2015, VASC PHARMACOL, V74, P103, DOI 10.1016/j.vph.2015.08.014; Frueh J, 2013, CARDIOVASC RES, V99, P334, DOI 10.1093/cvr/cvt108; Grumezescu AM., 2017, MULTIFUNCTIONAL SYST, Vxvi, P356; KUMAMOTO M, 1995, HUM PATHOL, V26, P450, DOI 10.1016/0046-8177(95)90148-5; Lobatto ME, 2015, ACS NANO, V9, P1837, DOI 10.1021/nn506750r; Lobatto ME, 2011, NAT REV DRUG DISCOV, V10, P835, DOI 10.1038/nrd3578; Longmire M, 2008, NANOMEDICINE-UK, V3, P703, DOI 10.2217/17435889.3.5.703; Luo YT, 2017, CELL RES, V27, P352, DOI 10.1038/cr.2017.8; Marangoni VS, 2017, P NATL ACAD SCI USA, V114, P6960, DOI 10.1073/pnas.1701944114; Miller HA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52622-7; Moreno PR, 2004, CIRCULATION, V110, P2032, DOI 10.1161/01.CIR.0000143233.87854.23; Niccoli G, 2013, JACC-CARDIOVASC IMAG, V6, P1108, DOI 10.1016/j.jcmg.2013.05.004; Otsuka F, 2015, ATHEROSCLEROSIS, V241, P772, DOI 10.1016/j.atherosclerosis.2015.05.011; Pedrigi RM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160588; Pedrigi RM, 2015, CIRCULATION, V132, P1003, DOI 10.1161/CIRCULATIONAHA.115.016270; Pfenniger A, 2015, ATHEROSCLEROSIS, V243, P1, DOI 10.1016/j.atherosclerosis.2015.08.029; Phinikaridou A, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004910; Poulsen CB, 2018, EUROINTERVENTION, V14, P1129, DOI 10.4244/EIJ-D-17-01028; Puri R, 2014, J AM COLL CARDIOL, V63, P1134, DOI 10.1016/j.jacc.2013.05.088; Rademakers T, 2013, ARTERIOSCL THROM VAS, V33, P249, DOI 10.1161/ATVBAHA.112.300087; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; Sasayama Y, 2019, J CONTROL RELEASE, V311, P245, DOI 10.1016/j.jconrel.2019.09.004; Segers D, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/936109; Seneviratne AN, 2015, J MOL CELL CARDIOL, V89, P168, DOI 10.1016/j.yjmcc.2015.10.034; Stone PH, 2012, CIRCULATION, V126, P172, DOI 10.1161/CIRCULATIONAHA.112.096438; Tang J, 2016, P NATL ACAD SCI USA, V113, pE6731, DOI 10.1073/pnas.1609629113; van Bochove GS, 2011, CONTRAST MEDIA MOL I, V6, P35, DOI 10.1002/cmmi.402; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Xia W, 2009, BLOOD, V113, P438, DOI 10.1182/blood-2008-04-150789; Zhang WZ, 2018, THERANOSTICS, V8, P2521, DOI 10.7150/thno.23789; Zhou ZJ, 2019, ADV MATER, V31, DOI 10.1002/adma.201804567	48	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260606	10.1371/journal.pone.0260606	http://dx.doi.org/10.1371/journal.pone.0260606			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882722	Green Published, gold			2022-12-26	WOS:000755037200032
J	Khodeir, MM; Shabana, HA; Rasheed, Z; Alkhamiss, AS; Khodeir, M; Alkhowailed, MS; Alharbi, S; Alsoghair, M; Alsagaby, SA; Al Abdulmonem, W				Khodeir, Mostafa M.; Shabana, Hassan A.; Rasheed, Zafar; Alkhamiss, Abdullah S.; Khodeir, Mohamed; Alkhowailed, Mohammad S.; Alharbi, Sami; Alsoghair, Mansour; Alsagaby, Suliman A.; Al Abdulmonem, Waleed			COVID-19: Post-recovery long-term symptoms among patients in Saudi Arabia	PLOS ONE			English	Article							QUALITY-OF-LIFE; SURVIVORS; COMPLICATIONS; CORONAVIRUS; SARS	Background After recovery from acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many patients experience long-term symptoms in different body systems. The aim of the present study was to identify these symptoms, their severity, and their duration as a first step in building a system to classify post-recovery long-term symptoms of coronavirus disease 2019 (COVID-19). Methods An online-based cross-sectional survey was administered between September and October 2020. Data regarding the severity of post-recovery symptoms and their duration were collected using an Arabic questionnaire divided into six categories encompassing the 20 most prevalent symptoms. Results A total of 979 patients recovered from COVID-19 in Saudi Arabia in the study period, of whom 53% were male and 47% were female. The most common symptoms included general fatigue and weakness (73% each), with moderate severity of neurological symptoms including mood changes (41%) and insomnia (39%). Among the special senses, loss of smell and taste of marked severity were reported by 64% and 55% among respiratory symptoms, cough of mild severity (47%), and dyspnea of moderate severity (43%). Loss of appetite of moderate severity was reported in 42%, and diarrhea, abdominal pain, and nausea of mild severity were reported by 53%, 50%, and 44% of respondents, respectively. Conclusions Long-term symptoms after recovery from COVID-19 warrant patient follow-up. The authors propose a classification system as a starting point to guide the identification and follow-up of long-term symptoms post-recovery, and recommend larger-scale studies to broaden the definition of recovery from COVID-19, which appears to have two phases, acute and chronic.	[Khodeir, Mostafa M.] Cairo Univ, Dept Pathol, Fac Med, Cairo, Egypt; [Khodeir, Mostafa M.; Alkhamiss, Abdullah S.; Al Abdulmonem, Waleed] Qassim Univ, Dept Pathol, Coll Med, Buraydah, Qassim, Saudi Arabia; [Shabana, Hassan A.] Cairo Univ, Chest Dis Dept, Fac Med, Cairo, Egypt; [Rasheed, Zafar] Qassim Univ, Dept Med Biochem, Coll Med, Buraydah, Qassim, Saudi Arabia; [Khodeir, Mohamed] Brook Hosp, Dept Psychiat, Louisville, KY USA; [Alkhowailed, Mohammad S.] Qassim Univ, Dept Dermatol, Coll Med, Buraydah, Qassim, Saudi Arabia; [Alharbi, Sami] King Fahad Specialist Hosp, Dept Pulm, Minist Hlth, Buraydah, Saudi Arabia; [Alsoghair, Mansour] Qassim Univ, Dept Family & Community Med, Coll Med, Buraydah, Qassim, Saudi Arabia; [Alsagaby, Suliman A.] Majmaah Univ, Dept Med Labs, Cent Biosci Res Labs, Coll Sci Al Zulfi, Al Majmaah, Saudi Arabia	Egyptian Knowledge Bank (EKB); Cairo University; Qassim University; Egyptian Knowledge Bank (EKB); Cairo University; Qassim University; Qassim University; Qassim University; Majmaah University	Khodeir, MM (corresponding author), Cairo Univ, Dept Pathol, Fac Med, Cairo, Egypt.; Khodeir, MM (corresponding author), Qassim Univ, Dept Pathol, Coll Med, Buraydah, Qassim, Saudi Arabia.; Rasheed, Z (corresponding author), Qassim Univ, Dept Med Biochem, Coll Med, Buraydah, Qassim, Saudi Arabia.	dr.mustafa31@gmail.com; zafarrasheed@qumed.edu.sa	Rasheed, Zafar/J-6135-2018; Alsagaby, Suliman/AHD-8154-2022	Rasheed, Zafar/0000-0002-8651-4218; Alsagaby, Suliman/0000-0002-2242-5638; Aref Shabana, Hassan/0000-0002-6589-360X; alsoghair, mansour/0000-0003-4606-3317				Ahmed H, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2694; Ahmed MU, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00518; [Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; Bagheri A., 2020, COINC COVID 19 EP OF, V34, P62, DOI [DOI 10.1101/2020.03.23.20041889, 10.34171/mjiri.34.62]; Bolay H, 2020, HEADACHE, V60, P1415, DOI 10.1111/head.13856; Carod-Artal FJ, 2020, REV NEUROLOGIA, V70, P311, DOI 10.33588/rn.7009.2020179; Chan KS, 2003, RESPIROLOGY, V8, pS36, DOI 10.1046/j.1440-1843.2003.00522.x; Chan Y H, 2003, Singapore Med J, V44, P614; Chary E, 2020, AM J RHINOL ALLERGY, V34, P686, DOI 10.1177/1945892420930954; Comfrey A.L., 1992, 1 COURSE FACTOR ANAL, V2nd ed, DOI [10.4324/9781315827506, DOI 10.4324/9781315827506]; Prous MJGDY, 2009, REUMATOL CLIN, V5, P171, DOI 10.1016/j.reuma.2008.09.007; Denke C, 2018, J INT MED RES, V46, P2265, DOI 10.1177/0300060518762040; Moussaoui R, 2006, CHEST, V130, P1165, DOI 10.1378/chest.130.4.1165; Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0; Fan E, 2014, CRIT CARE MED, V42, P849, DOI 10.1097/CCM.0000000000000040; Forster P, 2020, P NATL ACAD SCI USA, V117, P9241, DOI 10.1073/pnas.2004999117; Gabarre P, 2020, INTENS CARE MED, V46, P1339, DOI 10.1007/s00134-020-06153-9; Gane SB, 2020, RHINOLOGY, V58, P299, DOI 10.4193/Rhin20.114; Garrigues E, 2020, J INFECTION, V81, pE4, DOI 10.1016/j.jinf.2020.08.029; Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330; Glick HA, 2021, CLIN INFECT DIS, V73, P283, DOI 10.1093/cid/ciaa595; Halpin SJ, 2021, J MED VIROL, V93, P1013, DOI 10.1002/jmv.26368; Heidari F, 2020, RHINOLOGY, V58, P302, DOI 10.4193/Rhin20.140; Hopkins C, 2020, J OTOLARYNGOL-HEAD N, V49, DOI 10.1186/s40463-020-00423-8; Horemans HL, 2004, ARCH PHYS MED REHAB, V85, P392, DOI 10.1016/j.apmr.2003.06.007; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hummel T, 2017, RHINOLOGY, V54, P7, DOI 10.4193/Rhino16.248; Hwang Chi-Shin, 2006, Acta Neurol Taiwan, V15, P26; Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096; Kapfhammer HP, 2004, AM J PSYCHIAT, V161, P45, DOI 10.1176/appi.ajp.161.1.45; Klok FA, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01494-2020; Klopfenstein T, 2020, MED MALADIES INFECT, V50, P436, DOI 10.1016/j.medmal.2020.04.006; Kochi AN, 2020, J CARDIOVASC ELECTR, V31, P1003, DOI 10.1111/jce.14479; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lake MA, 2020, CLIN MED, V20, P124, DOI 10.7861/clinmed.2019-coron; Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1; Lee DJ, 2020, CAN J EMERG MED, V22, P595, DOI 10.1017/cem.2020.420; Li S, 2006, AM J CHINESE MED, V34, P937, DOI 10.1142/S0192415X06004417; Mak IWC, 2009, GEN HOSP PSYCHIAT, V31, P318, DOI 10.1016/j.genhosppsych.2009.03.001; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Memish ZA, 2020, LANCET, V395, P1063, DOI 10.1016/S0140-6736(19)33221-0; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Mitrani RD, 2020, HEART RHYTHM, V17, P1984, DOI 10.1016/j.hrthm.2020.06.026; Moein ST, 2020, INT FORUM ALLERGY RH, V10, P944, DOI 10.1002/alr.22587; Ong KC, 2004, EUR RESPIR J, V24, P436, DOI 10.1183/09031936.04.00007104; Oudkerk M, 2020, BRIT J RADIOL, V93, DOI [10.1259/bjr.20200718, 10.1759/bir.70700718]; Park WB, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e169; Patel Kishan P, 2020, J Clin Virol, V128, P104386, DOI 10.1016/j.jcv.2020.104386; Petrosillo N, 2020, CLIN MICROBIOL INFEC, V26, P729, DOI 10.1016/j.cmi.2020.03.026; Pons S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03062-7; Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE212, DOI 10.1111/jdv.16387; Ronco C, 2020, NAT REV NEPHROL, V16, P308, DOI 10.1038/s41581-020-0284-7; Schett G, 2020, NAT REV RHEUMATOL, V16, P465, DOI 10.1038/s41584-020-0451-z; Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2; Townsend L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240784; Tsang S, 2017, SAUDI J ANAESTH, V11, pS80, DOI 10.4103/sja.SJA_203_17; Turkmen D, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13923; Wu D, 2020, INT J INFECT DIS, V94, P44, DOI 10.1016/j.ijid.2020.03.004; Wyrwich KW, 2015, PATIENT-RELAT OUTCOM, V6, P215, DOI 10.2147/PROM.S85779; Yan CH., 2020, INT FORUM ALLERGY RH, V10, P806, DOI [10.1002/alr.22579, DOI 10.1002/alr.22579]; Zhao Q, 2020, J EUR ACAD DERMATOL, V34, P2505, DOI 10.1111/jdv.16778; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	62	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260259	10.1371/journal.pone.0260259	http://dx.doi.org/10.1371/journal.pone.0260259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879074	gold, Green Published			2022-12-26	WOS:000754625200010
J	Kitagawa, Y; Kawamura, I; Suzuki, K; Okada, H; Ishihara, T; Tomita, H; Suzuki, K; Takada, C; Sampei, S; Kano, S; Kondo, K; Asano, H; Wakayama, Y; Kamidani, R; Kawasaki, Y; Fukuda, H; Nishio, A; Miyake, T; Fukuta, T; Yasuda, R; Oiwa, H; Kakino, Y; Miyazaki, N; Watanabe, T; Yoshida, T; Doi, T; Suzuki, A; Yoshida, S; Matsuo, H; Ogura, S				Kitagawa, Yuichiro; Kawamura, Itta; Suzuki, Keiko; Okada, Hideshi; Ishihara, Takuma; Tomita, Hiroyuki; Suzuki, Kodai; Takada, Chihiro; Sampei, So; Kano, Soichiro; Kondo, Kohei; Asano, Hirotaka; Wakayama, Yugo; Kamidani, Ryo; Kawasaki, Yuki; Fukuda, Hirotsugu; Nishio, Ayane; Miyake, Takahito; Fukuta, Tetsuya; Yasuda, Ryu; Oiwa, Hideaki; Kakino, Yoshinori; Miyazaki, Nagisa; Watanabe, Takatomo; Yoshida, Takahiro; Doi, Tomoaki; Suzuki, Akio; Yoshida, Shozo; Matsuo, Hitoshi; Ogura, Shinji			Serum syndecan-1 concentration in hospitalized patients with heart failure may predict readmission-free survival	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; LEFT-VENTRICULAR MASS; ENDOTHELIAL GLYCOCALYX; BIOMARKERS; DISEASE; SEPSIS; MODEL; RISK; EXTRAVASATION; HYPERTROPHY	Syndecan-1 is found in the endothelial glycocalyx and is released into the bloodstream during stressed conditions, including severe diseases such as acute kidney injury, chronic kidney disease, and cardiovascular disease. This study investigated the prognostic value of serum syndecan-1 concentration in patients with heart failure upon admission. Serum syndecan-1 concentration was analyzed in 152 patients who were hospitalized for worsening heart failure from September 2017 to June 2018. The primary outcome of the study was readmission-free survival, defined as the time from the first admission to readmission for worsened heart failure or death from any cause, which was assessed at 30 months after discharge from the hospital. The secondary outcome of the study was survival time. Blood samples and echocardiogram data were analyzed. Univariate and multivariable time-dependent Cox regression analyses adjusted for age, creatinine levels, and use of antibiotics were conducted. The serum syndecan-1 concentration was significantly associated with readmission-free survival. Subsequently, the syndecan-1 concentration may have gradually decreased with treatment. The administration of human atrial natriuretic peptide and antibiotics may have modified the relationship between readmission-free survival and serum syndecan-1 concentration (p = 0.01 and 0.008, respectively). Serum syndecan-1 concentrations, which may indicate injury to the endothelial glycocalyx, predict readmission-free survival in patients with heart failure.	[Kitagawa, Yuichiro; Okada, Hideshi; Suzuki, Kodai; Takada, Chihiro; Sampei, So; Kano, Soichiro; Kondo, Kohei; Asano, Hirotaka; Wakayama, Yugo; Kamidani, Ryo; Kawasaki, Yuki; Fukuda, Hirotsugu; Nishio, Ayane; Miyake, Takahito; Fukuta, Tetsuya; Oiwa, Hideaki; Kakino, Yoshinori; Watanabe, Takatomo; Yoshida, Takahiro; Ogura, Shinji] Gifu Univ, Dept Emergency & Disaster Med, Grad Sch Med, Gifu, Japan; [Kawamura, Itta; Matsuo, Hitoshi] Gifu Heart Ctr, Gifu, Japan; [Suzuki, Keiko; Suzuki, Akio] Gifu Univ Hosp, Dept Pharm, Gifu, Japan; [Ishihara, Takuma] Gifu Univ Hosp, Innovat & Clin Res Promot Ctr, Gifu, Japan; [Tomita, Hiroyuki] Gifu Univ, Dept Tumor Pathol, Grad Sch Med, Gifu, Japan; [Yasuda, Ryu] Gifu Univ, Dept Abuse Prevent Emergency Med, Grad Sch Med, Gifu, Japan; [Miyazaki, Nagisa] Asahi Univ, Sch Dent, Dept Internal Med, Mizuho, Japan; [Watanabe, Takatomo] Gifu Univ Hosp, Dept Clin Lab, Gifu, Japan	Gifu University; Gifu University; Gifu University; Gifu University; Gifu University; Asahi University; Gifu University	Okada, H (corresponding author), Gifu Univ, Dept Emergency & Disaster Med, Grad Sch Med, Gifu, Japan.	hideshi@gifu-u.ac.jp	Kamidani, Ryo/GXZ-6859-2022	Kamidani, Ryo/0000-0002-8478-9197; Okada, Hideshi/0000-0002-7775-4308				Ando Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35976-2; Anker SD, 2014, J CACHEXIA SARCOPENI, V5, P1, DOI 10.1007/s13539-014-0135-0; Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z; Berg S, 2002, ACTA ANAESTH SCAND, V46, P166, DOI 10.1034/j.1399-6576.2002.460207.x; Bettencourt P, 2004, CIRCULATION, V110, P2168, DOI 10.1161/01.CIR.0000144310.04433.BE; Burke-Gaffney A, 2012, CRIT CARE, V16, DOI 10.1186/cc11239; CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190; Chelazzi C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0741-z; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Frati-Munari Alberto C., 2013, Arch. Cardiol. Méx., V83, P303, DOI 10.1016/j.acmx.2013.04.015; Haider AW, 1998, J AM COLL CARDIOL, V32, P1454, DOI 10.1016/S0735-1097(98)00407-0; Henrich M, 2010, THESCIENTIFICWORLDJO, V10, P917, DOI 10.1100/tsw.2010.88; Huo YL, 2009, J APPL PHYSIOL, V107, P500, DOI 10.1152/japplphysiol.91013.2008; Inagawa R, 2018, CHEST, V154, P317, DOI 10.1016/j.chest.2018.03.003; Joseph SM, 2009, TEX HEART I J, V36, P510; Kalogeropoulos AP, 2012, PROG CARDIOVASC DIS, V55, P3, DOI 10.1016/j.pcad.2012.05.004; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Li LY, 2012, MOL BIOSYST, V8, P1613, DOI 10.1039/c2mb25021g; Liborio AB, 2015, AM J TROP MED HYG, V92, P611, DOI 10.4269/ajtmh.14-0232; LUFT JH, 1966, FED PROC, V25, P1773; Machin DR, 2018, AM J PHYSIOL-HEART C, V315, pH531, DOI 10.1152/ajpheart.00104.2018; Maeda K, 2000, J AM COLL CARDIOL, V36, P1587, DOI 10.1016/S0735-1097(00)00912-8; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Mangini S, 2013, EINSTEIN-SAO PAULO, V11, P383, DOI 10.1590/S1679-45082013000300022; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Mitic VT, 2020, TOHOKU J EXP MED, V250, P233, DOI 10.1620/tjem.250.233; Motiwala SR, 2013, CARDIOL REV, V21, P127, DOI 10.1097/CRD.0b013e3182769073; Nakada Y, 2019, CIRC J, V83, P395, DOI 10.1253/circj.CJ-18-0523; Nakada Y, 2016, AM J PHYSIOL-HEART C, V310, pH813, DOI 10.1152/ajpheart.00602.2015; Oda K, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091320; Okada H, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1841-8; Ostrowski SR, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0918-5; Padberg JS, 2014, ATHEROSCLEROSIS, V234, P335, DOI 10.1016/j.atherosclerosis.2014.03.016; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Puskarich MA, 2016, J CRIT CARE, V36, P125, DOI 10.1016/j.jcrc.2016.06.027; Rehm M, 2004, ANESTHESIOLOGY, V100, P1211, DOI 10.1097/00000542-200405000-00025; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; RICKHAM PP, 1964, BRIT MED J, V2, P173; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Salmon AHJ, 2012, J PATHOL, V226, P562, DOI 10.1002/path.3964; Schellings MWM, 2010, HYPERTENSION, V55, P249, DOI 10.1161/HYPERTENSIONAHA.109.137885; Suzuki K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88303-7; Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001; Tromp J, 2014, CIRC-HEART FAIL, V7, P457, DOI 10.1161/CIRCHEARTFAILURE.113.000846; Verdecchia P, 2001, J AM COLL CARDIOL, V38, P1829, DOI 10.1016/S0735-1097(01)01663-1; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515; Zhang XB, 2006, AM J PHYSIOL-HEART C, V291, pH2950, DOI 10.1152/ajpheart.01160.2005	52	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260350	10.1371/journal.pone.0260350	http://dx.doi.org/10.1371/journal.pone.0260350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879094	Green Published, gold			2022-12-26	WOS:000754625200014
J	Bataineh, MTAL; Soares, NC; Semreen, MH; Cacciatore, S; Dash, NR; Hamad, M; Mousa, MK; Salam, JSA; Al Gharaibeh, MF; Zerbini, LF; Hamad, M				A. L. Bataineh, Mohammad Tahseen; Soares, Nelson Cruz; Semreen, Mohammad Harb; Cacciatore, Stefano; Dash, Nihar Ranjan; Hamad, Mohamad; Mousa, Muath Khairi; Salam, Jasmin Shafarin Abdul; Al Gharaibeh, Mutaz F.; Zerbini, Luiz F.; Hamad, Mawieh			Candida albicans PPG1, a serine/threonine phosphatase, plays a vital role in central carbon metabolisms under filament-inducing conditions: A multi-omics approach	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; CANDIDA-ALBICANS; PROTEIN PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; VIRULENCE; GENE; PHOSPHORYLATION; MECHANISMS; TRANSPORT; MORPHOGENESIS	Candida albicans is the leading cause of life-threatening bloodstream candidiasis, especially among immunocompromised patients. The reversible morphological transition from yeast to hyphal filaments in response to host environmental cues facilitates C. albicans tissue invasion, immune evasion, and dissemination. Hence, it is widely considered that filamentation represents one of the major virulence properties in C. albicans. We have previously characterized Ppg1, a PP2A-type protein phosphatase that controls filament extension and virulence in C. albicans. This study conducted RNA sequencing analysis of samples obtained from C. albicans wild type and ppg1 Delta/Delta strains grown under filament-inducing conditions. Overall, ppg1 Delta/Delta strain showed 1448 upregulated and 710 downregulated genes, representing approximately one-third of the entire annotated C. albicans genome. Transcriptomic analysis identified significant downregulation of well-characterized genes linked to filamentation and virulence, such as ALS3, HWP1, ECE1, and RBT1. Expression analysis showed that essential genes involved in C. albicans central carbon metabolisms, including GDH3, GPD1, GPD2, RHR2, INO1, AAH1, and MET14 were among the top upregulated genes. Subsequent metabolomics analysis of C. albicans ppg1 Delta/Delta strain revealed a negative enrichment of metabolites with carboxylic acid substituents and a positive enrichment of metabolites with pyranose substituents. Altogether, Ppg1 in vitro analysis revealed a link between metabolites substituents and filament formation controlled by a phosphatase to regulate morphogenesis and virulence.	[A. L. Bataineh, Mohammad Tahseen; Dash, Nihar Ranjan; Al Gharaibeh, Mutaz F.] Univ Sharjah, Coll Med, Sharjah, U Arab Emirates; [A. L. Bataineh, Mohammad Tahseen; Soares, Nelson Cruz; Semreen, Mohammad Harb; Hamad, Mohamad; Hamad, Mawieh] Univ Sharjah, Res Inst Med & Hlth Sci, Sharjah, U Arab Emirates; [A. L. Bataineh, Mohammad Tahseen] Khalifa Univ Sci & Technol, Ctr Biotechnol, Abu Dhabi, U Arab Emirates; [A. L. Bataineh, Mohammad Tahseen] Khalifa Univ Sci & Technol, Dept Genet & Mol Biol, Coll Med & Hlth Sci, Abu Dhabi, U Arab Emirates; [Soares, Nelson Cruz; Semreen, Mohammad Harb; Mousa, Muath Khairi; Salam, Jasmin Shafarin Abdul] Univ Sharjah, Dept Med Chem, Coll Pharm, Sharjah, U Arab Emirates; [Cacciatore, Stefano; Zerbini, Luiz F.] Int Ctr Genet Engn & Biotechnol, Canc Genom Grp, Cape Town, South Africa; [Cacciatore, Stefano] Imperial Coll, Inst Reprod & Dev Biol, London, England; [Hamad, Mohamad; Hamad, Mawieh] Univ Sharjah, Dept Med Lab Sci, Coll Hlth Sci, Sharjah, U Arab Emirates	University of Sharjah; University of Sharjah; Khalifa University of Science & Technology; Khalifa University of Science & Technology; University of Sharjah; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; Imperial College London; University of Sharjah	Bataineh, MTAL (corresponding author), Univ Sharjah, Coll Med, Sharjah, U Arab Emirates.; Bataineh, MTAL; Hamad, M (corresponding author), Univ Sharjah, Res Inst Med & Hlth Sci, Sharjah, U Arab Emirates.; Bataineh, MTAL (corresponding author), Khalifa Univ Sci & Technol, Ctr Biotechnol, Abu Dhabi, U Arab Emirates.; Bataineh, MTAL (corresponding author), Khalifa Univ Sci & Technol, Dept Genet & Mol Biol, Coll Med & Hlth Sci, Abu Dhabi, U Arab Emirates.; Hamad, M (corresponding author), Univ Sharjah, Dept Med Lab Sci, Coll Hlth Sci, Sharjah, U Arab Emirates.	mohammad.bataineh@ku.ac.ae	Zerbini, Luiz/B-7720-2015	Zerbini, Luiz/0000-0003-0736-9508; Dash, Nihar/0000-0002-6550-140X; da Cruz Soares, Nelson/0000-0003-2331-8532	University of Sharjah, Sharjah, UAE [MTA/1701090226-P, MH/1901050144]; Research Institute for Medical and Health Sciences, University of Sharjah UAE	University of Sharjah, Sharjah, UAE; Research Institute for Medical and Health Sciences, University of Sharjah UAE	MTA/1701090226-P, MH/1901050144, University of Sharjah, Sharjah, UAE. the Research Institute for Medical and Health Sciences, University of Sharjah UAE. This work was supported by research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albataineh MT, 2016, MED MYCOL, V54, P333, DOI 10.1093/mmy/myv098; Albataineh MT, 2014, EUKARYOT CELL, V13, P1538, DOI 10.1128/EC.00199-14; Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Aoki W, 2011, J BIOCHEM, V150, P431, DOI 10.1093/jb/mvr073; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Banerjee M, 2008, MOL BIOL CELL, V19, P1354, DOI 10.1091/mbc.E07-11-1110; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Buurman ET, 1998, P NATL ACAD SCI USA, V95, P7670, DOI 10.1073/pnas.95.13.7670; Cacciatore S, 2017, BIOINFORMATICS, V33, P621, DOI 10.1093/bioinformatics/btw705; Chen YL, 2008, INFECT IMMUN, V76, P2793, DOI 10.1128/IAI.01514-07; Day AM, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00261; Desai JV, 2015, PATHOGENS, V4, P573, DOI 10.3390/pathogens4030573; Desai JV, 2013, MBIO, V4, DOI 10.1128/mBio.00637-12; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Donalies UEB, 2002, YEAST, V19, P475, DOI 10.1002/yea.849; Duhring S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00625; Eck R, 1999, MICROBIOL-UK, V145, P2415, DOI 10.1099/00221287-145-9-2415; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Evans DRH, 1997, GENETICS, V145, P227; Fitzmaurice C, 2019, JAMA ONCOL, V5, P1749, DOI 10.1001/jamaoncol.2019.2996; Furukawa K, 2018, CELL REP, V23, P3579, DOI 10.1016/j.celrep.2018.05.064; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Garcia-Carnero LC, 2020, CURR PROTEIN PEPT SC, V21, P245, DOI 10.2174/1389203721666191231105546; Han TL, 2019, NPJ BIOFILMS MICROBI, V5, DOI 10.1038/s41522-019-0086-5; Han TL, 2012, METABOLOMICS, V8, P1204, DOI 10.1007/s11306-012-0416-6; Han TL, 2012, FEMS YEAST RES, V12, P879, DOI 10.1111/j.1567-1364.2012.00837.x; Han TL, 2011, FUNGAL GENET BIOL, V48, P747, DOI 10.1016/j.fgb.2011.04.002; Hartland CL., 2010, PROBE REPORTS NIH MO; Hebecker B, 2014, EXPERT REV ANTI-INFE, V12, P867, DOI 10.1586/14787210.2014.916210; Hoyer LL, 1998, J BACTERIOL, V180, P5334, DOI 10.1128/JB.180.20.5334-5343.1998; Hubmann G, 2011, APPL ENVIRON MICROB, V77, P5857, DOI 10.1128/AEM.05338-11; Jin JHQ, 2003, MICROBIOL-SGM, V149, P3371, DOI 10.1099/mic.0.26644-0; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee CM, 2004, MOL MICROBIOL, V51, P691, DOI 10.1111/j.1365-2958.2003.03879.x; Lee YJ, 2012, MOL CELL BIOL, V32, P4705, DOI 10.1128/MCB.00897-12; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192328; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Luo SS, 2013, J INFECT DIS, V207, P594, DOI 10.1093/infdis/jis718; Martin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058613; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Mitchell AP, 1998, CURR OPIN MICROBIOL, V1, P687, DOI 10.1016/S1369-5274(98)80116-1; Mu CH, 2019, FUNGAL GENET BIOL, V124, P47, DOI 10.1016/j.fgb.2018.12.010; NELSON RD, 1991, CLIN MICROBIOL REV, V4, P1; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; ODDS FC, 1994, J AM ACAD DERMATOL, V31, pS2, DOI 10.1016/S0190-9622(08)81257-1; Offley SR, 2019, CURR GENET, V65, P41, DOI 10.1007/s00294-018-0884-y; Grainha TRR, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy022; Scorzoni L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00036; Semreen MH, 2019, MOLECULES, V24, DOI 10.3390/molecules24030399; Sexton JA, 2007, YEAST, V24, P847, DOI 10.1002/yea.1514; Shareck J, 2011, EUKARYOT CELL, V10, P565, DOI 10.1128/EC.00305-10; SHERWOOD J, 1992, J MED VET MYCOL, V30, P461; Sturtevant Joy, 1997, Revista Iberoamericana de Micologia, V14, P90; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Vieira N, 2010, MOL MICROBIOL, V75, P1337, DOI 10.1111/j.1365-2958.2009.07003.x; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; West L, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.478743; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	63	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0259588	10.1371/journal.pone.0259588	http://dx.doi.org/10.1371/journal.pone.0259588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874940	gold, Green Published			2022-12-26	WOS:000753617500007
J	Janhunen, M; Piironen, J; Vainikka, A; Hyvarinen, P				Janhunen, Matti; Piironen, Jorma; Vainikka, Anssi; Hyvarinen, Pekka			The effects of environmental enrichment on hatchery-performance, smolt migration and capture rates in landlocked Atlantic salmon	PLOS ONE			English	Article							REARING ENVIRONMENT; DISEASE RESISTANCE; RAINBOW-TROUT; BODY-SIZE; SALAR; SURVIVAL; WILD; CONSERVATION; BEHAVIOR; VARIABILITY	Enrichment of rearing environment with natural elements has been suggested to improve the welfare and post-release survival of cultured fish. We studied the combined effects of shelter structures, periodical water flow and water level changes on pre- and post-release performance of critically endangered landlocked Atlantic salmon (Salmo salar m. sebago). Relative to standard (plain) rearing tanks, provision of enrichment improved fish condition factor and survival during the first year of rearing when most mortality was attributable to parasitic and bacterial infections. The consequent higher density in enriched tanks probably induced greater growth variation and more dorsal fin damages than found in fish of standard tanks. Possibly this was partly due to the applied changes in water level. Experimentally determined smolt migration tendency at age 3 did not differ, on average, between the rearing groups, but enriched-reared fish showed clearly less variation in total movement activity than standard-reared fish. Experimental angling in earthen ponds did not suggest divergent vulnerability between the differentially reared fish at age 3, but decreased condition during the preceding growth season increased vulnerability to fishing. Based on long-term post-stocking tag returns in large-lake fisheries, fish length at release but not rearing method affected the capture rates of fish released at age 2. When released at age 3 the fish grown in enriched environment had a higher risk to be captured with stationary gears and earlier by hook and line gears compared to standard-reared conspecifics. Earlier time of maximal smolt migration activity was associated with an increased risk of being captured. We suggest that environmental enrichment may modulate growth- and behavior-related qualities that indirectly increased the vulnerability to fishing in natural conditions but not in experimental setting. The favorable effects of enrichment on early survival encourages adopting enriched rearing practices in supportive breeding of landlocked salmon.	[Janhunen, Matti; Piironen, Jorma] Nat Resources Inst Finland Luke, Joensuu, Finland; [Vainikka, Anssi] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland; [Hyvarinen, Pekka] Nat Resources Inst Finland Luke, Paltamo, Finland	Natural Resources Institute Finland (Luke); University of Eastern Finland; Natural Resources Institute Finland (Luke)	Janhunen, M (corresponding author), Nat Resources Inst Finland Luke, Joensuu, Finland.	matti.janhunen@luke.fi		Janhunen, Matti/0000-0002-5651-5287	Lake Hoytiainen Fishery District; Ministry of Agriculture and Forestry of Finland; Natural Resources Institute Finland (Luke); Emil Aaltonen Foundation; Rapala foundation	Lake Hoytiainen Fishery District; Ministry of Agriculture and Forestry of Finland; Natural Resources Institute Finland (Luke); Emil Aaltonen Foundation; Rapala foundation	Author: Funder JP: Lake Hoytiainen Fishery District JP: Ministry of Agriculture and Forestry of Finland MJ, JP, PH: Natural Resources Institute Finland (Luke) AV: Emil Aaltonen Foundation AV: Rapala foundation The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup K, 2014, MAR ECOL PROG SER, V496, P197, DOI 10.3354/meps10614; Alos J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38093; Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Araki H, 2010, AQUACULTURE, V308, pS2, DOI 10.1016/j.aquaculture.2010.05.036; Arechavala-Lopez P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68306-6; Arndt RE, 2001, N AM J AQUACULT, V63, P312, DOI 10.1577/1548-8454(2001)063&lt;0312:IORSAD&gt;2.0.CO;2; Becker LA, 2014, AQUACULTURE, V422, P160, DOI 10.1016/j.aquaculture.2013.12.010; Berejikian BA, 2005, N AM J AQUACULT, V67, P289, DOI 10.1577/A05-002.1; BOSAKOWSKI T, 1995, AQUACULTURE, V130, P159, DOI 10.1016/0044-8486(94)00223-B; Braithwaite VA, 2005, P ROY SOC B-BIOL SCI, V272, P1107, DOI 10.1098/rspb.2005.3062; Brockmark S, 2007, T AM FISH SOC, V136, P1453, DOI 10.1577/T06-245.1; Brown C, 2001, J FISH BIOL, V59, P471, DOI [10.1006/jfbi.2001.1689, 10.1111/j.1095-8649.2001.tb02354.x]; Brown C, 2002, FISH FISH, V3, P79, DOI 10.1046/j.1467-2979.2002.00077.x; Christie MR, 2012, P NATL ACAD SCI USA, V109, P238, DOI 10.1073/pnas.1111073109; Dehler CE, 2017, AQUACULTURE, V467, P149, DOI 10.1016/j.aquaculture.2016.07.017; FANGSTAM H, 1993, J FISH BIOL, V43, P517, DOI 10.1111/j.1095-8649.1993.tb00436.x; Fast DE, 2008, T AM FISH SOC, V137, P1507, DOI 10.1577/T07-143.1; Ferguson A, 2019, J FISH BIOL, V95, P692, DOI 10.1111/jfb.14005; Finnish Environment Institute, 2021, DAT DOWNL SERV LAPIO; Fuss H, 2002, N AM J AQUACULT, V64, P267, DOI 10.1577/1548-8454(2002)064&lt;0267:DISAPB&gt;2.0.CO;2; Gilmour KM, 2005, INTEGR COMP BIOL, V45, P263, DOI 10.1093/icb/45.2.263; Harkonen L, 2014, CAN J FISH AQUAT SCI, V71, P1900, DOI 10.1139/cjfas-2014-0221; Hatanpaa A, 2021, CAN J FISH AQUAT SCI, V78, P184, DOI 10.1139/cjfas-2019-0334; Hojesjo J, 2004, BEHAV ECOL SOCIOBIOL, V56, P286, DOI 10.1007/s00265-004-0784-7; Huntingford FA, 2004, J FISH BIOL, V65, P122, DOI 10.1111/j.0022-1112.2004.00562.x; Hutchings JA, 2019, CAN J FISH AQUAT SCI, V76, P1697, DOI 10.1139/cjfas-2018-0413; Huuskonen H, 2019, ECOL FRESHW FISH, V28, P533, DOI 10.1111/eff.12495; Hyvarinen P, 2004, ECOL FRESHW FISH, V13, P77, DOI 10.1111/j.1600-0633.2004.00050.x; Hyvarinen P, 2003, N AM J FISH MANAGE, V23, P1126, DOI 10.1577/M02-174; Hyvarinen P, 2000, FISHERIES MANAG ECOL, V7, P503, DOI 10.1046/j.1365-2400.2000.00217.x; Hyvarinen P, 2013, CAN J FISH AQUAT SCI, V70, P1386, DOI 10.1139/cjfas-2013-0147; Janhunen M, 2012, AQUACULTURE, V370, P123, DOI 10.1016/j.aquaculture.2012.10.013; JOBLING M, 1985, AQUACULTURE, V44, P83, DOI 10.1016/0044-8486(85)90011-0; Johnsson JI, 2014, J FISH BIOL, V85, P1946, DOI 10.1111/jfb.12547; Jones RE, 1999, AQUACULT ENG, V20, P261, DOI 10.1016/S0144-8609(99)00020-5; Kallio-Nyberg I, 2011, FISH RES, V109, P285, DOI 10.1016/j.fishres.2011.02.015; Karvonen A, 2016, J APPL ECOL, V53, P213, DOI 10.1111/1365-2664.12568; Kemp PS, 2005, RIVER RES APPL, V21, P1053, DOI 10.1002/rra.864; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kiiskinen P, 2002, J FISH BIOL, V60, P1015, DOI 10.1111/j.1095-8649.2002.tb02425.x; Krebs J., 2017, J FISHERIES LIVEST P, V5, P247, DOI [10.4172/2332-2608.1000247, DOI 10.4172/2332-2608.1000247]; Leinonen T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232723; Lemopoulos A, 2019, G3-GENES GENOM GENET, V9, P2887, DOI 10.1534/g3.119.400369; Lennox RJ, 2017, FISH FISH, V18, P986, DOI 10.1111/faf.12219; MacLean A, 2000, AQUACULTURE, V184, P291, DOI 10.1016/S0044-8486(99)00333-6; MCCARTHY ID, 1992, J FISH BIOL, V41, P257, DOI 10.1111/j.1095-8649.1992.tb02655.x; McCormick SD, 1998, CAN J FISH AQUAT SCI, V55, P77, DOI 10.1139/d98-011; Mes D, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.212258; Morrell CH, 1998, BIOMETRICS, V54, P1560, DOI 10.2307/2533680; Naish KA, 2008, ADV MAR BIOL, V53, P61, DOI 10.1016/S0065-2881(07)53002-6; Naslund J, 2019, ENVIRON BIOL FISH, V102, P705, DOI 10.1007/s10641-019-00864-9; Naslund J, 2016, FISH FISH, V17, P1, DOI 10.1111/faf.12088; Naslund J, 2013, CAN J FISH AQUAT SCI, V70, P585, DOI 10.1139/cjfas-2012-0302; Naslund J, 2012, CAN J FISH AQUAT SCI, V69, P1481, DOI [10.1139/F2012-074, 10.1139/f2012-074]; National Land Survey of Finland, 2021, DAT FIL SERV OP DAT; Olla BL, 1998, B MAR SCI, V62, P531; Persson L, 2014, J FISH BIOL, V85, P645, DOI 10.1111/jfb.12443; Piironen J, 2013, ANN ZOOL FENN, V50, P1; Pursiainen M., 1998, STOCKING INTRO FISH, P46; Raiha V, 2019, J APPL ECOL, V56, P1741, DOI 10.1111/1365-2664.13393; Roberts LJ, 2011, BIOL CONSERV, V144, P1972, DOI 10.1016/j.biocon.2011.04.017; Rodewald P, 2011, ECOL FRESHW FISH, V20, P569, DOI 10.1111/j.1600-0633.2011.00505.x; Rosengren M, 2017, CAN J FISH AQUAT SCI, V74, P396, DOI 10.1139/cjfas-2015-0515; Saloniemi I, 2004, ICES J MAR SCI, V61, P782, DOI 10.1016/j.icesjms.2004.03.032; Salvanes AGV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1331; Solas MR, 2019, J FISH BIOL, V95, P575, DOI 10.1111/jfb.14004; THORPE JE, 1994, AQUACULTURE, V121, P105, DOI 10.1016/0044-8486(94)90012-4; THORPE JE, 1980, J FISH BIOL, V17, P13, DOI 10.1111/j.1095-8649.1980.tb02738.x; Turnbull JF, 1998, AQUACULTURE, V159, P345, DOI 10.1016/S0044-8486(97)00233-0; Vainikka A, 2021, CAN J FISH AQUAT SCI, V78, P1586, DOI 10.1139/cjfas-2020-0313; Vainikka A, 2012, CAN J FISH AQUAT SCI, V69, P1981, DOI 10.1139/f2012-119; Vidergar D, 2003, CHINOOK SALMON SEMIN; Watz J, 2019, J FISH BIOL, V95, P638, DOI 10.1111/jfb.14049; Webster TMU, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00691-18; Woodworth LM, 2002, CONSERV GENET, V3, P277, DOI 10.1023/A:1019954801089	76	1	1	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260944	10.1371/journal.pone.0260944	http://dx.doi.org/10.1371/journal.pone.0260944			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855922	Green Published, gold			2022-12-26	WOS:000735299000154
J	Kuang, LH; Zhou, W; Jiang, YM				Kuang, Linghan; Zhou, Wei; Jiang, Yongmei			Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis	PLOS ONE			English	Article							PRACTICE GUIDELINE; GUT; STEATOHEPATITIS; PATHOGENESIS; PERMEABILITY; PROBIOTICS; DIAGNOSIS; INSULIN; NASH; INFLAMMATION	It has been suggested that small intestinal bacterial overgrowth (SIBO) could cause nonalcoholic fatty liver disease (NAFLD), but this association was not examined in children by meta-analysis. This meta-analysis aimed to determine the association between SIBO and NAFLD in children. The electronic databases PubMed, Embase, and Cochrane Library were searched for studies published before April 22, 2021. The outcome was the association between SIBO and NAFLD. Three studies and 205 children were included. All three studies reported the association between SIBO and NAFLD. Children with SIBO were more likely to have NAFLD (odds ratio = 5.27, 95% confidence interval (CI): 1.66-16.68, P<0.001; I-2 = 63.5%, P-heterogeneity = 0.065). When directly pooling the reported relative risks (RR) from two studies, children with NAFLD had an over 2-fold increased relative risk of developing SIBO (RR = 2.17, 05%CI: 1.66-2.82, P<0.001; I-2 = 0.0%, P-heterogeneity = 0.837). This meta-analysis reports a possible association between SIBO and NAFLD in children.	[Kuang, Linghan; Zhou, Wei; Jiang, Yongmei] Sichuan Univ, West China Univ Hosp 2, Dept Lab Med, Chengdu, Peoples R China; [Kuang, Linghan; Zhou, Wei; Jiang, Yongmei] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Minist Educ, Chengdu, Peoples R China	Sichuan University; Sichuan University	Jiang, YM (corresponding author), Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Minist Educ, Chengdu, Peoples R China.	jym85501201@163.com			 [2019YJ0083]		This work was supported by drug resistance and drug resistance mechanism of Group B streptococcus colonized in the birth canal of pregnant women. This research was supported by the Study on drug resistance and drug resistance mechanism of Group B streptococcus colonized in the birth canal of pregnant women [No.2019YJ0083].	Abu Shanab A, 2011, DIGEST DIS SCI, V56, P1524, DOI 10.1007/s10620-010-1447-3; Anderson EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140908; Andrade RJ, 2011, J ANTIMICROB CHEMOTH, V66, P1431, DOI 10.1093/jac/dkr159; Augustyn M, 2019, CLIN EXP HEPATOL, V5, P1, DOI 10.5114/ceh.2019.83151; Belei O, 2017, J PEDIATR ENDOCR MET, V30, P1161, DOI 10.1515/jpem-2017-0252; Bouhnik Y, 1999, AM J GASTROENTEROL, V94, P1327, DOI 10.1111/j.1572-0241.1999.01016.x; Brandt A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091013; BUCHMAN AL, 1995, HEPATOLOGY, V22, P1399, DOI 10.1002/hep.1840220510; Bures J, 2010, WORLD J GASTROENTERO, V16, P2978, DOI 10.3748/wjg.v16.i24.2978; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chen WC, 2014, INDIAN J MED RES, V140, P582; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Ferolla SM, 2014, NUTRIENTS, V6, P5583, DOI 10.3390/nu6125583; Ferrajolo C, 2017, DRUG SAFETY, V40, P305, DOI 10.1007/s40264-016-0493-y; Fialho A, 2016, J GASTROINTEST LIVER, V25, P159, DOI 10.15403/jgld.2014.1121.252.iwg; Gatta L, 2017, ALIMENT PHARM THER, V45, P604, DOI 10.1111/apt.13928; Ghetti FD, 2018, EUR J NUTR, V57, P861, DOI 10.1007/s00394-017-1524-x; Ghoshal Uday C, 2006, Indian J Gastroenterol, V25, P6; Ghoshal UC, 2017, INDIAN J GASTROENTER, V36, P390, DOI 10.1007/s12664-017-0797-6; Ghoshal UC, 2011, J NEUROGASTROENTEROL, V17, P312, DOI 10.5056/jnm.2011.17.3.312; Grabherr F, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00611; Hartmann Phillipp, 2018, Clin Liver Dis (Hoboken), V11, P11, DOI 10.1002/cld.685; Jin X, 2007, WORLD J GASTROENTERO, V13, P1732, DOI 10.3748/wjg.v13.i11.1732; Kapil S, 2016, J GASTROEN HEPATOL, V31, P213, DOI 10.1111/jgh.13058; Lei Q., 2016, J DIGEST DIS, V17, P13; Lim R, 2014, CASE REP PEDIAT, V2014, DOI 10.1155/2014/156389; Lo CKL, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-45; Lonardo A, 2017, WORLD J GASTROENTERO, V23, P6571, DOI 10.3748/wjg.v23.i36.6571; Ludwig DS, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-4078; Majewska Monika, 2006, Postepy Hig Med Dosw (Online), V60, P52; Marra F, 2018, J HEPATOL, V68, P280, DOI 10.1016/j.jhep.2017.11.014; Marra F, 2013, CURR PHARM DESIGN, V19, P5250, DOI 10.2174/13816128113199990344; Masarone M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9547613; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Mohamad B, 2015, AM J GASTROENTEROL, V110, pS988, DOI 10.14309/00000434-201510001-02380; Nongthombam SNB., 2015, J CLIN EXP HEPATOL, V5, pS23; Opioids, 2012, LIVERTOX CLIN RES IN; Ota T, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00204; Ponziani FR, 2016, EXPERT REV GASTROENT, V10, P215, DOI 10.1586/17474124.2016.1110017; Rana SV, 2008, SCAND J GASTROENTERO, V43, P1030, DOI 10.1080/00365520801947074; Rezaie Ali, 2016, Curr Gastroenterol Rep, V18, P8, DOI 10.1007/s11894-015-0482-9; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979; Rorato R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071431; Sachdev AH, 2013, THER ADV CHRONIC DIS, V4, P223, DOI 10.1177/2040622313496126; Sajjad A, 2005, ALIMENT PHARM THER, V22, P291, DOI 10.1111/j.1365-2036.2005.02562.x; Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020; Selcuk AA, 2019, TURK ARCH OTORHINOL, V57, P57, DOI 10.5152/tao.2019.4058; Shi J, 2020, GASTROENT RES PRACT, V2020, DOI 10.1155/2020/4181748; Simren M, 2006, GUT, V55, P297, DOI 10.1136/gut.2005.075127; Stepanov YM., 2019, GASTROENTEROLOGIA, V53, P266; Temple JL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060947; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Troisi J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050485; Volynets V, 2012, DIGEST DIS SCI, V57, P1932, DOI 10.1007/s10620-012-2112-9; Vos MB, 2017, J PEDIATR GASTR NUTR, V64, P319, DOI 10.1097/MPG.0000000000001482; Wigg AJ, 2001, GUT, V48, P206, DOI 10.1136/gut.48.2.206; Wijarnpreecha K, 2020, EUR J GASTROEN HEPAT, V32, P601, DOI 10.1097/MEG.0000000000001541; Wu HZ, 2017, J CLIN INVEST, V127, P43, DOI [10.1172/JCI88880, 10.1172/jci88880]; Zhong CQ, 2017, J CLIN GASTROENTEROL, V51, P300, DOI 10.1097/MCG.0000000000000814; Zhou YL, 2018, CELL PHYSIOL BIOCHEM, V51, P2123, DOI 10.1159/000495830; Zhu LX, 2015, PEDIATR RES, V77, P245, DOI 10.1038/pr.2014.157; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	67	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260479	10.1371/journal.pone.0260479	http://dx.doi.org/10.1371/journal.pone.0260479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855819	Green Published, gold			2022-12-26	WOS:000735299000061
J	Ioannou, GN; Green, P; Locke, ER; Berry, K				Ioannou, George N.; Green, Pamela; Locke, Emily R.; Berry, Kristin			Factors associated with early receipt of COVID-19 vaccination and adherence to second dose in the Veterans Affairs healthcare system	PLOS ONE			English	Article							UNITED-STATES; ICD-9-CM	Background We aimed to determine factors independently associated with early COVID-19 vaccination and adherence to two-dose regimens. Methods Among persons receiving care in the Veterans Affairs (VA) healthcare system (n = 5,766,638), we identified those who received at least one dose of COVID-19 vaccination through the VA, during the first similar to 3 months following emergency use authorization, from December 11, 2020 to March 9, 2021 (n = 1,569,099, or 27.2%, including 880,200 (56.1%) Moderna, 676,279 (43.1%) Pfizer-BioNTech and 12,620 (0.8%) Janssen vaccines). Results Follow-up for receipt of vaccination began on December 11, 2020. After adjustment for baseline characteristics ascertained as of December 11, 2020, factors significantly associated with vaccination included older age, higher comorbidity burden, higher body mass index category, Black (vs. White) race (adjusted hazard ratio [AHR] 1.19, 95% CI 1.19-1.20), Hispanic (vs. non-Hispanic) ethnicity (AHR 1.12, 95% CI 1.11-1.13), urban (vs. rural) residence (AHR 1.31, 95% CI 1.31-1.31), and geographical region, while AI/AN race (vs. White), was associated with lower vaccination rate (AHR 0.85, 95% CI 0.84-0.87). Among persons who received both doses of Moderna or Pfizer-BioNTech vaccines, 95.3% received the second dose within 4 days of the recommended date. Among persons who received the first vaccine dose, only 3.2% did not receive the second dose within 42 days for Pfizer versus 4.0% for Moderna (p<0.001). Factors independently associated with higher likelihood of missing the second dose included younger age (10.83% in 18-50 yo vs. 2.72% in 70-75 yo), AI/AN race, female sex, rural location, geographical region and prior positive test for SARS-CoV-2. Conclusions We identified sociodemographic and clinical factors that may be used to target vaccination efforts and to further improve adherence to second vaccine dosing.	[Ioannou, George N.] Vet Affairs Puget Sound Healthcare Syst, Div Gastroenterol, Seattle, WA 98108 USA; [Ioannou, George N.] Univ Washington, Seattle, WA 98195 USA; [Ioannou, George N.; Green, Pamela; Locke, Emily R.; Berry, Kristin] Vet Affairs Puget Sound Hlth Care Syst, Res & Dev, Seattle, WA 98108 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Ioannou, GN (corresponding author), Vet Affairs Puget Sound Healthcare Syst, Div Gastroenterol, Seattle, WA 98108 USA.; Ioannou, GN (corresponding author), Univ Washington, Seattle, WA 98195 USA.; Ioannou, GN (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Res & Dev, Seattle, WA 98108 USA.	georgei@medicine.washington.edu			Department of Veterans Affairs, CSRD grant [COVID19-8900-11]; Department of Veterans Affairs, HSRD grant [C19 21-278]	Department of Veterans Affairs, CSRD grant(US Department of Veterans Affairs); Department of Veterans Affairs, HSRD grant(US Department of Veterans Affairs)	The study was supported in part by the Department of Veterans Affairs, CSR&D grant COVID19-8900-11 and HSR&D grant C19 21-278 both to GNI. The funding agency had no role in study design, data collection, analysis or publication.	Bassett MT, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003402; Centers for Disease Control and Prevention, COVID DAT TRACK DEM; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dai CZL, 2021, CLIN INFECT DIS, V73, P2193, DOI [10.1093/cid/ciab154, 10.1101/2020.10.14.20212803]; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dooling K, 2021, MMWR-MORBID MORTAL W, V69, P1657, DOI 10.15585/mmwr.mm695152e2; Eastment MC, 2021, OBESITY, V29, P900, DOI 10.1002/oby.23111; Escobar GJ, 2021, ANN INTERN MED, V174, P786, DOI 10.7326/M20-6979; Fan Vincent S, 2021, Clin Infect Dis, V73, pe3085, DOI 10.1093/cid/ciaa1624; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P1517, DOI 10.15585/mmwr.mm6942e1; Ioannou GN, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.4347; Ioannou GN, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22310; King JT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241825; Kriss JL, 2021, MMWR-MORBID MORTAL W, V70, P389, DOI 10.15585/mmwr.mm7011e2; Mackey K, 2021, ANN INTERN MED, V174, P362, DOI 10.7326/M20-6306; Painter EM, 2021, MMWR-MORBID MORTAL W, V70, P174, DOI 10.15585/mmwr.mm7005e1; Peterson K, 2018, AM J PUBLIC HEALTH, V108, pE1, DOI [10.2105/AJPH.2017.304246, 10.2105/ajph.2017.304246]; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rentsch CT, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003379; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4	21	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0259696	10.1371/journal.pone.0259696	http://dx.doi.org/10.1371/journal.pone.0259696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851970	Green Published, gold			2022-12-26	WOS:000755762900014
J	Kamonseki, DH; Haik, MN; Ribeiro, LP; de Almeida, RF; de Almeida, LA; Fonseca, CL; Camargo, PR				Kamonseki, Danilo Harudy; Haik, Melina Nevoeiro; Ribeiro, Larissa Pechincha; de Almeida, Rafaela Firmino; de Almeida, Lucas Araujo; Fonseca, Carlos Luques; Camargo, Paula Rezende			Measurement properties of the Brazilian versions of Fear-Avoidance Beliefs Questionnaire and Tampa Scale of Kinesiophobia in individuals with shoulder pain	PLOS ONE			English	Article							CROSS-CULTURAL ADAPTATION; TEST-RETEST RELIABILITY; LOW-BACK-PAIN; PSYCHOMETRIC PROPERTIES; MUSCULOSKELETAL PAIN; CONSTRUCT-VALIDITY; FUNCTIONAL SCALE; RESPONSIVENESS; PORTUGUESE; DISABILITY	Purpose To verify the measurement properties of the Brazilian versions of Fear-avoidance Beliefs Questionnaire (FABQ) and Tampa Scale of Kinesiophobia (TSK) in individuals with shoulder pain. Methods Individuals with shoulder pain (>18 years) were included in this study. Structural validity was verified by exploratory factor analysis, which was used to identify dimensionality of the FABQ and TSK. Test-retest reliability was assessed with intraclass correlation coefficient((3,1)) and internal consistency with Cronbach's alpha. Floor or ceiling effects were also investigated. Responsiveness was verified by effect sizes and area under the receiver operating characteristic curve (AUC). Results Exploratory factor analysis identified two and one factor in the FABQ and TSK, respectively. FABQ and TSK presented moderate to good reliability and adequate internal consistency (Cronbach's alpha > 0.70). The floor effect was present in one factor of the FABQ. The FABQ and TSK showed small to moderate effect sizes and did not show adequate AUC. Conclusion FABQ and TSK are multidimensional and unidimensional instruments, respectively. Those instruments presented moderate to good reliability and the responsiveness was considered to be suboptimal in individuals with shoulder pain.	[Kamonseki, Danilo Harudy; Haik, Melina Nevoeiro; Ribeiro, Larissa Pechincha; de Almeida, Rafaela Firmino; de Almeida, Lucas Araujo; Camargo, Paula Rezende] Univ Fed Sao Carlos UFSCar, Lab Anal & Intervent Shoulder Complex, Sao Carlos, SP, Brazil; [Fonseca, Carlos Luques] Fac Anhanguera, Sorocaba, SP, Brazil	Universidade Federal de Sao Carlos	Camargo, PR (corresponding author), Univ Fed Sao Carlos UFSCar, Lab Anal & Intervent Shoulder Complex, Sao Carlos, SP, Brazil.	prcamargo@ufscar.br	Kamonseki, Danilo/B-4909-2013; Haik, Melina N/J-8617-2014	Kamonseki, Danilo/0000-0001-7552-8959; Haik, Melina/0000-0002-8703-8356	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP [2018/04911-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq [142373/2018-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP (DHK: 2018/04911-1), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (DHK, MNH, LPR, RFA, LAA: CAPES), and Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnolo ' gico -CNPq (DHK: 142373/2018-4, https://www.gov.br/cnpq/pt-br).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar AS, 2017, J ORAL REHABIL, V44, P500, DOI 10.1111/joor.12515; AL-Shudifat A, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020292; Askary-Ashtiani A, 2014, SPINE, V39, pE1095, DOI 10.1097/BRS.0000000000000438; Bagattini Angela Maria, 2018, Value Health Reg Issues, V17, P88, DOI 10.1016/j.vhri.2017.11.002; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Burwinkle T, 2005, J PAIN, V6, P384, DOI 10.1016/j.jpain.2005.01.355; Calixtre LB, 2021, BRAZ J PHYS THER, V25, P70, DOI 10.1016/j.bjpt.2020.02.003; Chang CH, 2005, EVAL HEALTH PROF, V28, P264, DOI 10.1177/0163278705278275; Cleland JA, 2006, SPINE, V31, P598, DOI 10.1097/01.brs.0000201241.90914.22; Cleland JA, 2008, AM J PHYS MED REHAB, V87, P109, DOI 10.1097/PHM.0b013e31815b61f1; de Abreu AM, 2008, CAD SAUDE PUBLICA, V24, P615, DOI 10.1590/S0102-311X2008000300015; Puga VOD, 2013, J ORTHOP SPORT PHYS, V43, P404, DOI 10.2519/jospt.2013.4441; de Souza FS, 2008, SPINE, V33, P1028, DOI 10.1097/BRS.0b013e31816c8329; Santo Salvador EME, 2021, BRAZ J PHYS THER, V25, P168, DOI 10.1016/j.bjpt.2020.05.004; Gatchel RJ, 2016, J ORTHOP SPORT PHYS, V46, P38, DOI 10.2519/jospt.2016.0601; Goubert L, 2004, CLIN J PAIN, V20, P103, DOI 10.1097/00002508-200403000-00007; Grotle M, 2006, J REHABIL MED, V38, P346, DOI 10.1080/16501970600722403; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Haik MN, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10110928; Hallman DM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022006; Hefford C, 2012, J ORTHOP SPORT PHYS, V42, P56, DOI 10.2519/jospt.2012.3953; Holtz KA, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967117748599; Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1; Igwesi-Chidobe CN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216482; Kamonseki DH, 2021, MUSCULOSKEL SCI PRAC, V55, DOI 10.1016/j.msksp.2021.102416; Kamonseki DH, 2021, BRAZ J PHYS THER, V25, P221, DOI 10.1016/j.bjpt.2020.08.001; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Kikuchi N, 2015, J ORTHOP SCI, V20, P985, DOI 10.1007/s00776-015-0751-3; Koho P, 2014, PHYSIOTHERAPY, V100, P356, DOI 10.1016/j.physio.2013.11.007; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kuijpers T, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-83; La Touche R, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092831; Larsson C, 2014, PHYSIOTHER THEOR PR, V30, P421, DOI 10.3109/09593985.2013.877546; Lee KC, 2006, CLIN REHABIL, V20, P909, DOI 10.1177/026921550506072186; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; Lexell JE, 2005, AM J PHYS MED REHAB, V84, P719, DOI 10.1097/01.phm.0000176452.17771.20; Lim S, 2019, PSYCHOL METHODS, V24, P452, DOI 10.1037/met0000230; Lundberg M, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/494196; MacDermid JC, 2004, J SHOULDER ELB SURG, V13, P593, DOI 10.1016/j.jse.2004.03.009; Marks D, 2019, AUST HEALTH REV, V43, P540, DOI 10.1071/AH17242; Martinez-Calderon J, 2020, ARCH PHYS MED REHAB, V101, P329, DOI 10.1016/j.apmr.2019.08.470; Martinez-Calderon J, 2018, MUSCULOSKEL SCI PRAC, V37, P29, DOI 10.1016/j.msksp.2018.06.010; Miller RP, 1991, CLIN J PAIN, V7, DOI DOI 10.1097/00002508-199103000-00053; Mintken PE, 2010, ARCH PHYS MED REHAB, V91, P1128, DOI 10.1016/j.apmr.2010.04.009; Monticone M, 2010, SPINE, V35, P1241, DOI 10.1097/BRS.0b013e3181bfcbf6; Orfale AG, 2005, BRAZ J MED BIOL RES, V38, P293, DOI 10.1590/S0100-879X2005000200018; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Pfingsten M, 2000, EUR J PAIN-LONDON, V4, P259, DOI 10.1053/eujp.2000.0178; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Pituch K.A., 2015, APPL MULTIVARIATE ST, DOI DOI 10.4324/9781315814919; Portney LG, 2009, FDN CLIN RES APPL PR; Riley SP, 2019, PHYSIOTHER THEOR PR, V35, P464, DOI 10.1080/09593985.2018.1453004; Roelofs J, 2007, PAIN, V131, P181, DOI 10.1016/j.pain.2007.01.008; Rostami M, 2014, J BACK MUSCULOSKELET, V27, P213, DOI 10.3233/BMR-130439; Santos M, 2016, MED DECIS MAKING, V36, P253, DOI 10.1177/0272989X15613521; Swinkels-Meewisse EJCM, 2003, MANUAL THER, V8, P29, DOI 10.1054/math.2002.0484; Tabachnick B. G.., 2012, USING MULTIVARIATE S; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tkachuk GA, 2012, J PAIN, V13, P970, DOI 10.1016/j.jpain.2012.07.001; Trolle N, 2019, PATIENT-RELAT OUTCOM, V10, P83, DOI 10.2147/PROM.S191782; Vlaeyen JWS, 1999, MANUAL THER, V4, P187, DOI 10.1054/math.1999.0199; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Woby SR, 2005, PAIN, V117, P137, DOI 10.1016/j.pain.2005.05.029	64	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260452	10.1371/journal.pone.0260452	http://dx.doi.org/10.1371/journal.pone.0260452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852000	Green Published, gold			2022-12-26	WOS:000755762900034
J	Liu, L; Cao, MW; Sun, YG				Liu, Lei; Cao, Mingwei; Sun, Yeguo			A fusion data security protection scheme for sensitive E-documents in the open network environment	PLOS ONE			English	Article							CP-ABE; PERFORMANCE EVALUATION; ENCRYPTION	E-documents are carriers of sensitive data, and their security in the open network environment has always been a common problem with the field of data security. Based on the use of encryption schemes to construct secure access control, this paper proposes a fusion data security protection scheme. This scheme realizes the safe storage of data and keys by designing a hybrid symmetric encryption algorithm, a data security deletion algorithm, and a key separation storage method. The scheme also uses file filter driver technology to design a user operation state monitoring method to realize real-time monitoring of user access behavior. In addition, this paper designs and implements a prototype system. Through the verification and analysis of its usability and security, it is proved that the solution can meet the data security protection requirements of sensitive E-documents in the open network environment.	[Liu, Lei] Huainan Normal Univ, Sch Comp Sci, Huainan, Peoples R China; [Cao, Mingwei] Hefei Univ Technol, Sch Comp Sci & Informat Engn, Hefei, Peoples R China; [Cao, Mingwei] Anhui Prov Key Lab Ind Safety & Emergency Technol, Hefei, Peoples R China; [Sun, Yeguo] Huainan Normal Univ, Sch Finance & Math, Huainan, Peoples R China	Huainan Normal University; Hefei University of Technology; Huainan Normal University	Liu, L (corresponding author), Huainan Normal Univ, Sch Comp Sci, Huainan, Peoples R China.	liulei@hnnu.edu.cn		, Liu Lei/0000-0002-1807-6906	University Social Science Foundation of Anhui Province [SK2020A0421]; University Natural Science Foundation of Anhui Province [KJ2019ZD48]	University Social Science Foundation of Anhui Province; University Natural Science Foundation of Anhui Province	This study received support from the following sources: the University Social Science Foundation of Anhui Province (Grant No. SK2020A0421) and the University Natural Science Foundation of Anhui Province (Grant No. KJ2019ZD48, awarded to SY).	Afrianto I., 2020, IOP Conference Series: Materials Science and Engineering, V879, DOI 10.1088/1757-899X/879/1/012042; Ameri MH, 2020, IEEE T CLOUD COMPUT, V8, P660, DOI 10.1109/TCC.2018.2825983; Batra G, 2019, J COMPUT SECUR, V27, P483, DOI 10.3233/JCS-191315; Bethencourt J, 2007, P IEEE S SECUR PRIV, P321, DOI 10.1109/sp.2007.11; Bhanot R, 2015, INT J SECUR APPL, V9, P289, DOI 10.14257/ijsia.2015.9.4.27; [蔡婷 Cai Ting], 2016, [计算机应用研究, Application Research of Computers], V33, P882; Deng H, 2020, IEEE T INF FOREN SEC, V15, P3168, DOI 10.1109/TIFS.2020.2985532; Dorman G, 2014, U.S. patent.., Patent No. [9,953,036, 9953036]; Elminaaml DSA, 2008, INT J COMPUT SCI NET, V8, P280; Gai KK, 2021, IEEE T BIG DATA, V7, P678, DOI 10.1109/TBDATA.2017.2705807; Ge CP, 2021, IEEE T DEPEND SECURE, V18, P1214, DOI 10.1109/TDSC.2019.2899300; Ghafoorian M, 2019, IEEE T PARALL DISTR, V30, P778, DOI 10.1109/TPDS.2018.2870652; Goyal V, 2006, P 13 ACM C COMP SEC; Joshi M, 2018, PROCEEDINGS 2018 IEEE 11TH INTERNATIONAL CONFERENCE ON CLOUD COMPUTING (CLOUD), P932, DOI 10.1109/CLOUD.2018.00139; Khan F, 2017, IEEE 2 INT C DAT SCI; Li JG, 2018, IEEE SYST J, V12, P1767, DOI 10.1109/JSYST.2017.2667679; Li JG, 2021, IEEE T EMERG TOP COM, V9, P983, DOI 10.1109/TETC.2019.2904637; Li RH, 2017, 2017 IEEE SECOND INTERNATIONAL CONFERENCE ON DATA SCIENCE IN CYBERSPACE (DSC), P172, DOI 10.1109/DSC.2017.97; Li YN, 2019, IEEE T DEPEND SECURE, V16, P72, DOI 10.1109/TDSC.2017.2662216; Liu G, 2021, J IND INF INTEGR, V22, DOI 10.1016/j.jii.2021.100200; Lozupone V, 2018, INT J INFORM MANAGE, V38, P42, DOI 10.1016/j.ijinfomgt.2017.08.004; Malviya DK., 2018, INT J FUTURE REVOLUT, V4, P126; Mousa A., 2006, IJCSA, V3, P44; Namasudra S, 2019, CONCURR COMP-PRACT E, V31, DOI 10.1002/cpe.4364; Priya A., 2018, INTER J ONLINE HUMAN, V5, DOI [10.24113/ojssports.v5i3.70, DOI 10.24113/OJSSPORTS.V5I3.70]; Rao KR, 2021, COMPUT COMMUN, V166, P140, DOI 10.1016/j.comcom.2020.12.006; Sahai A, 2005, LECT NOTES COMPUT SC, V3494, P457, DOI 10.1007/11426639_27; Shynu PG, 2017, J INF SCI ENG, V33, P837, DOI 10.6688/JISE.2017.33.3.15; Subramanya R, 2016, U.S. patent, Patent No. [9,292,529, 9292529]; Sun PJ, 2019, IEEE ACCESS, V7, P147420, DOI 10.1109/ACCESS.2019.2946185; Taha MB, 2019, PROCEDIA COMPUT SCI, V155, P425, DOI 10.1016/j.procs.2019.08.059; Wang SP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205675; Yu Bo, 2020, Computer Engineering and Applications, V56, P84, DOI 10.3778/j.issn.1002-8331.1901-0361; Zhang J., 2019, INT J HIGH PERFORMAN, V13, P321, DOI 10.1504/IJHPCN.2019.098573	34	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0258464	10.1371/journal.pone.0258464	http://dx.doi.org/10.1371/journal.pone.0258464			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910722	gold, Green Published			2022-12-26	WOS:000754828900005
J	Mio, C; Dal Secco, C; Marzinotto, S; Bruno, C; Pimpo, S; Betto, E; Bertoni, M; Pipan, C; Sozio, E; Tascini, C; Damante, G; Curcio, F				Mio, Catia; Dal Secco, Chiara; Marzinotto, Stefania; Bruno, Claudio; Pimpo, Santa; Betto, Elena; Bertoni, Martina; Pipan, Corrado; Sozio, Emanuela; Tascini, Carlo; Damante, Giuseppe; Curcio, Francesco			Local occurrence and fast spread of B.1.1.7 lineage: A glimpse into Friuli Venezia Giulia	PLOS ONE			English	Article								In-depth study of the entire SARS-CoV-2 genome has uncovered many mutations, which have replaced the lineage that characterized the first wave of infections all around the world. In December 2020, the outbreak of variant of concern (VOC) 202012/01 (lineage B.1.1.7) in the United Kingdom defined a turning point during the pandemic, immediately posing a worldwide threat on the Covid-19 vaccination campaign. Here, we reported the evolution of B.1.1.7 lineage-related infections, analyzing samples collected from January 1st 2021, until April 15th 2021, in Friuli Venezia Giulia, a northeastern region of Italy. A cohort of 1508 nasopharyngeal swabs was analyzed by High Resolution Melting (HRM) and 479 randomly selected samples underwent Next Generation Sequencing analysis (NGS), uncovering a steady and continuous accumulation of B.1.1.7 lineage-related specimens, joined by sporadic cases of other known lineages (i.e. harboring the Spike glycoprotein p.E484K mutation). All the SARS-CoV-2 genome has been analyzed in order to highlight all the rare mutations that may eventually result in a new variant of interest. This work suggests that a thorough monitoring of the SARS-CoV-2 genome by NGS is essential to contain any new variant that could jeopardize all the efforts that have been made so far to resolve the emergence of the pandemic.	[Mio, Catia; Dal Secco, Chiara; Bruno, Claudio; Pimpo, Santa; Pipan, Corrado; Tascini, Carlo; Damante, Giuseppe; Curcio, Francesco] Univ Udine, Dept Med DAME, Udine, Italy; [Marzinotto, Stefania; Betto, Elena; Bertoni, Martina; Pipan, Corrado; Damante, Giuseppe; Curcio, Francesco] Univ Hosp Udine, Dept Lab Med, Udine, Italy; [Sozio, Emanuela; Tascini, Carlo] Univ Hosp Udine, Infect Dis Clin, Udine, Italy	University of Udine; University of Udine; University Hospital of Udine; University of Udine; University Hospital of Udine	Curcio, F (corresponding author), Univ Udine, Dept Med DAME, Udine, Italy.; Curcio, F (corresponding author), Univ Hosp Udine, Dept Lab Med, Udine, Italy.	francesco.curcio@uniud.it	Sozio, Emanuela/B-1450-2017	Sozio, Emanuela/0000-0001-6247-5958; mio, catia/0000-0002-6245-8266; Damante, Giuseppe/0000-0003-2312-4009				Alm E, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.32.2001410; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Cella E, 2021, CHEMOTHERAPY, V66, P3, DOI 10.1159/000515340; Collier DA, 2021, NATURE, V593, P136, DOI 10.1038/s41586-021-03412-7; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Di Giallonardo F, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13050794; Ibba G, 2021, J INFECT DEV COUNTR, V15, P242, DOI 10.3855/jidc.14972; Lai A, 2021, VIROL J, V18, DOI 10.1186/s12985-021-01638-5; Leung K, 2021, EUROSURVEILLANCE, V26, P15, DOI 10.2807/1560-7917.ES.2020.26.1.2002106; Lo Menzo S, 2021, INFECTION, V49, P1341, DOI 10.1007/s15010-021-01609-6; Loconsole D, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18094766; Mio C, 2021, DIS MARKERS, V2021, DOI 10.1155/2021/8890221; Mio C, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/8869424; Moustafa Ahmed M, 2021, bioRxiv, DOI 10.1101/2021.04.21.440801; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Pietro RD., 2021, GENETIC DRIFT VERSUS, DOI [10.1101/2020.05.08.20095448, DOI 10.1101/2020.05.08.20095448]; Plante JA, 2021, CELL HOST MICROBE, V29, P508, DOI 10.1016/j.chom.2021.02.020; Rambaut A., 2020, PHYLODYNAMIC ANAL; Shen Xiaoying, 2021, Cell Host Microbe, V29, P529, DOI [10.1101/2021.01.27.428516, 10.1016/j.chom.2021.03.002]; Tao KM, 2021, NAT REV GENET, V22, P757, DOI 10.1038/s41576-021-00408-x; Volz E, 2021, NATURE, V593, P266, DOI 10.1038/s41586-021-03470-x; Washington NL, 2021, CELL, V184, P2587, DOI 10.1016/j.cell.2021.03.052; Washington Nicole L, 2021, medRxiv, DOI 10.1101/2021.02.06.21251159	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261229	10.1371/journal.pone.0261229	http://dx.doi.org/10.1371/journal.pone.0261229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905574	Green Published, gold			2022-12-26	WOS:000754615500029
J	Toepp, SL; Turco, CV; Rehsi, RS; Nelson, AJ				Toepp, Stephen L.; Turco, Claudia V.; Rehsi, Ravjot S.; Nelson, Aimee J.			The distribution and reliability of TMS-evoked short- and long-latency afferent interactions	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MILD COGNITIVE IMPAIRMENT; MOTOR CORTEX EXCITABILITY; ALZHEIMERS-DISEASE; INHIBITION; MODULATION; CIRCUITS	Short-latency afferent inhibition (SAI) and long-latency afferent inhibition (LAI) occur when the motor evoked potential (MEP) elicited by transcranial magnetic stimulation (TMS) is reduced by the delivery of a preceding peripheral nerve stimulus. The intra-individual variability in SAI and LAI is considerable, and the influence of sample demographics (e.g., age and biological sex) and testing context (e.g., time of day) is not clear. There are also no established normative values for these measures, and their reliability varies from study-to-study. To address these issues and facilitate the interpretation of SAI and LAI research, we pooled data from studies published by our lab between 2014 and 2020 and performed several retrospective analyses. Patterns in the depth of inhibition with respect to age, biological sex and time of testing were investigated, and the relative reliability of measurements from studies with repeated baseline SAI and LAI assessments was examined. Normative SAI and LAI values with respect to the mean and standard deviation were also calculated. Our data show no relationship between the depth of inhibition for SAI and LAI with either time of day or age. Further, there was no significant difference in SAI or LAI between males and females. Intra-class correlation coefficients (ICC) for repeated measurements of SAI and LAI ranged from moderate (ICC = 0.526) to strong (ICC = 0.881). The mean value of SAI was 0.71 +/- 0.27 and the mean value of LAI was 0.61 +/- 0.34. This retrospective study provides normative values, reliability estimates, and an exploration of demographic and testing influences on these measures as assessed in our lab. To further facilitate the interpretation of SAI and LAI data, similar studies should be performed by other labs that use these measures.	[Toepp, Stephen L.; Turco, Claudia V.; Rehsi, Ravjot S.; Nelson, Aimee J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	McMaster University	Nelson, AJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	nelsonaj@mcmaster.ca		Toepp, Stephen/0000-0002-3928-9871	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2020-06757]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Natural Sciences and Engineering Research Council of Canada (NSERC), RGPIN-2020-06757 to AJN URL: https://www.nserccrsng.gc.ca/NSERC-CRSNG/FundingDecisions- DecisionsFinancement/ResearchGrantsSubventionsDeRecherche/ResultsInsDetail- ResultatsEtabDetails_eng.asp?Year= 2020&Institution=34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AZ, 2016, J NEUROPHYSIOL, V116, P637, DOI 10.1152/jn.00276.2016; Beaulieu LD, 2017, BRAIN STIMUL, V10, P196, DOI 10.1016/j.brs.2016.12.008; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Benussi A, 2017, NEUROLOGY, V89, P665, DOI 10.1212/WNL.0000000000004232; Bhandari A, 2016, CLIN NEUROPHYSIOL, V127, P2834, DOI 10.1016/j.clinph.2016.05.363; Biabani M, 2018, NEUROSCI LETT, V674, P94, DOI 10.1016/j.neulet.2018.03.026; Bocquillon P, 2017, SLEEP MED, V30, P31, DOI 10.1016/j.sleep.2016.03.007; Brown KE, 2017, BRAIN STIMUL, V10, P1102, DOI 10.1016/j.brs.2017.07.011; Cantone M, 2014, CLIN NEUROPHYSIOL, V125, P1509, DOI 10.1016/j.clinph.2014.04.010; Cengiz B, 2019, MUSCLE NERVE, V59, P699, DOI 10.1002/mus.26464; Chen R, 1999, EXP BRAIN RES, V129, P77, DOI 10.1007/s002210050938; Di Lazzaro V, 2005, J NEUROL NEUROSUR PS, V76, P1064, DOI 10.1136/jnnp.2004.051334; Di Lazzaro V, 2002, NEUROLOGY, V59, P392, DOI 10.1212/WNL.59.3.392; Dubbioso R., 2019, FRONT HUM NEUROSCI, P13, DOI [10.3389/fnhum.2019.00013, DOI 10.3389/FNHUM.2019.00013]; Goldsworthy MR, 2016, NEUROSCIENCE, V320, P205, DOI 10.1016/j.neuroscience.2016.02.012; Harasym D, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00129; Helmich RCG, 2005, EXP BRAIN RES, V167, P211, DOI 10.1007/s00221-005-0014-1; Hwang Yun Tae, 2018, Alzheimers Dement (N Y), V4, P103, DOI 10.1016/j.trci.2018.02.001; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Mimura Y, 2021, NEUROSCI BIOBEHAV R, V121, P47, DOI 10.1016/j.neubiorev.2020.12.003; Motta C, 2018, J NEUROL NEUROSUR PS, V89, P1237, DOI 10.1136/jnnp-2017-317879; Nardone R, 2006, J NEURAL TRANSM, V113, P1679, DOI 10.1007/s00702-006-0551-1; Nardone R, 2014, ACTA NEUROL SCAND, V129, P351, DOI 10.1111/ane.12223; Nardone R, 2008, J NEURAL TRANSM, V115, P1557, DOI 10.1007/s00702-008-0129-1; Nardone R, 2012, SLEEP MED, V13, P919, DOI 10.1016/j.sleep.2012.03.009; Portney LG, 2009, FDN CLIN RES APPL PR; Sailer A, 2003, BRAIN, V126, P1883, DOI 10.1093/brain/awg183; Schambra HM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00335; Toepp SL, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9120339; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; Tsang P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120731; Tsang P, 2014, CLIN NEUROPHYSIOL, V125, P2253, DOI 10.1016/j.clinph.2014.02.026; Turco CV, 2021, CLIN NEUROPHYSIOL, V132, P1462, DOI 10.1016/j.clinph.2021.02.402; Turco CV, 2019, BRAIN RES, V1723, DOI 10.1016/j.brainres.2019.146394; Turco CV, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8040064; Turco CV, 2018, BRAIN STIMUL, V11, P59, DOI 10.1016/j.brs.2017.09.009; Turco CV, 2017, J NEUROPHYSIOL, V118, P610, DOI 10.1152/jn.00118.2017; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Zdunczyk A, 2013, ACTA NEUROCHIR, V155, P1309, DOI 10.1007/s00701-013-1665-5	40	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0260663	10.1371/journal.pone.0260663	http://dx.doi.org/10.1371/journal.pone.0260663			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905543	gold, Green Published			2022-12-26	WOS:000754615500009
J	Bernanke, A; Burnette, E; Murphy, J; Hernandez, N; Zimmerman, S; Walker, QD; Wander, R; Sette, S; Reavis, Z; Francis, R; Armstrong, C; Risher, ML; Kuhn, C				Bernanke, Alyssa; Burnette, Elizabeth; Murphy, Justine; Hernandez, Nathaniel; Zimmerman, Sara; Walker, Q. David; Wander, Rylee; Sette, Samantha; Reavis, Zackery; Francis, Reynold; Armstrong, Christopher; Risher, Mary-Louise; Kuhn, Cynthia			Behavior and Fos activation reveal that male and female rats differentially assess affective valence during CTA learning and expression	PLOS ONE			English	Article							CONDITIONED TASTE-AVERSION; GUSTATORY INSULAR CORTEX; NUCLEUS-ACCUMBENS SHELL; INDUCED C-FOS; MEDIAL PREFRONTAL CORTEX; VENTRAL TEGMENTAL AREA; ARGININE METHYL-ESTER; IMMEDIATE-EARLY GENES; KHZ USV PRODUCTION; SEX-DIFFERENCES	Females are more affected by psychiatric illnesses including eating disorders, depression, and post-traumatic stress disorder than males. However, the neural mechanisms mediating these sex differences are poorly understood. Animal models can be useful in exploring such neural mechanisms. Conditioned taste aversion (CTA) is a behavioral task that assesses how animals process the competition between associated reinforcing and aversive stimuli in subsequent task performance, a process critical to healthy behavior in many domains. The purpose of the present study was to identify sex differences in this behavior and associated neural responses. We hypothesized that females would value the rewarding stimulus (Boost (R)) relative to the aversive stimulus (LiCl) more than males in performing CTA. We evaluated behavior (Boost (R) intake, LiCl-induced behaviors, ultrasonic vocalizations (USVs), CTA performance) and Fos activation in relevant brain regions after the acute stimuli [acute Boost (R) (AB), acute LiCl (AL)] and the context-only task control (COT), Boost (R) only task (BOT) and Boost (R)-LiCl task (BLT). Acutely, females drank more Boost (R) than males but showed similar aversive behaviors after LiCl. Females and males performed CTA similarly. Both sexes produced 55 kHz USVs anticipating BOT and inhibited these calls in the BLT. However, more females emitted both 22 kHz and 55 kHz USVs in the BLT than males: the latter correlated with less CTA. Estrous cycle stage also influenced 55 kHz USVs. Fos responses were similar in males and females after AB or AL. Females engaged the gustatory cortex and ventral tegmental area (VTA) more than males during the BOT and males engaged the amygdala more than females in both the BOT and BLT. Network analysis of correlated Fos responses across brain regions identified two unique networks characterizing the BOT and BLT, in both of which the VTA played a central role. In situ hybridization with RNAscope identified a population of D1-receptor expressing cells in the CeA that responded to Boost (R) and D2 receptor-expressing cells that responded to LiCl. The present study suggests that males and females differentially process the affective valence of a stimulus to produce the same goal-directed behavior.	[Bernanke, Alyssa; Burnette, Elizabeth; Murphy, Justine; Hernandez, Nathaniel; Zimmerman, Sara; Walker, Q. David; Wander, Rylee; Sette, Samantha; Reavis, Zackery; Francis, Reynold; Armstrong, Christopher; Kuhn, Cynthia] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Risher, Mary-Louise] Marshall Univ, Joan C Edwards Sch Med, Dept Biomed Sci, Huntington, WV USA	Duke University; Marshall University	Kuhn, C (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	ckuhn@duke.edu		Hernandez, Nathaniel/0000-0002-3729-4095	National Institute on Alcohol Abuse and Alcoholism [AA017621]; Department of Pharmacology and Cancer Biology from the Duke Medical Scientist Training Program [GM007171]	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Department of Pharmacology and Cancer Biology from the Duke Medical Scientist Training Program	AA017621 from the National Institute on Alcohol Abuse and Alcoholism (https://www.niaaa. nih.gov) and funds from the Department of Pharmacology and Cancer Biology (https:// pharmacology.duke.edu) for CK Grant No. GM007171 from the Duke Medical Scientist Training Program (https://medschool.duke.edu/education/degree-programs-and-admissions/ medical-scientist-training-program/about-mstp-program) AB.	Abe K, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00646-w; Borja GPA, 2020, NEUROBIOL LEARN MEM, V174, DOI 10.1016/j.nlm.2020.107277; ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; Alonso-Alonso M, 2013, AM J PSYCHIAT, V170, P1082, DOI 10.1176/appi.ajp.2013.13070932; Anderson RI, 2013, NEUROSCIENCE, V249, P214, DOI 10.1016/j.neuroscience.2012.12.028; Angulo R, 2021, J COMP PSYCHOL, V135, P315, DOI 10.1037/com0000275; Angulo R, 2020, BEHAV BRAIN RES, V394, DOI 10.1016/j.bbr.2020.112813; Arieli E, 2020, J PHYSIOL-LONDON, V598, P5505, DOI 10.1113/JP280213; Asarian L, 2013, AM J PHYSIOL-REG I, V305, pR1215, DOI 10.1152/ajpregu.00446.2012; Bangasser DA, 2014, FRONT NEUROENDOCRIN, V35, P303, DOI 10.1016/j.yfrne.2014.03.008; Barragan R, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101539; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Berman DE, 2000, J NEUROSCI, V20, P7017, DOI 10.1523/JNEUROSCI.20-18-07017.2000; Beyeler A, 2018, CELL REP, V22, P905, DOI 10.1016/j.celrep.2017.12.097; BLANCHARD RJ, 1991, PHYSIOL BEHAV, V50, P967, DOI 10.1016/0031-9384(91)90423-L; Bodnar RJ, 2018, APPETITE, V122, P17, DOI 10.1016/j.appet.2016.12.015; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; CAGIANO R, 1989, PHARMACOL BIOCHEM BE, V34, P53, DOI 10.1016/0091-3057(89)90352-3; CECHETTO DF, 1987, J COMP NEUROL, V262, P27, DOI 10.1002/cne.902620104; Chambers Kathleen C, 2018, World J Otorhinolaryngol Head Neck Surg, V4, P92, DOI 10.1016/j.wjorl.2018.02.003; Chao AM, 2020, BIOL RES NURS, V22, P82, DOI 10.1177/1099800419872824; Chen Ke, 2011, Front Med, V5, P294, DOI 10.1007/s11684-011-0144-8; Costa G, 2020, PROG NEURO-PSYCHOPH, V97, DOI 10.1016/j.pnpbp.2019.109797; Cubero I, 1999, BRAIN RES, V839, P323, DOI 10.1016/S0006-8993(99)01745-X; Dalla C, 2008, PHYSIOL BEHAV, V93, P595, DOI 10.1016/j.physbeh.2007.10.020; Dalla C, 2010, BASIC CLIN PHARMACOL, V106, P226, DOI 10.1111/j.1742-7843.2009.00516.x; Dalla C, 2009, PHYSIOL BEHAV, V97, P229, DOI 10.1016/j.physbeh.2009.02.035; Dela Cruz JAD, 2015, BRAIN RES BULL, V111, P9, DOI 10.1016/j.brainresbull.2014.11.002; Dela Cruz JAD, 2016, JOVE-J VIS EXP, DOI 10.3791/53897; DELPRATO DJ, 1965, PSYCHOL REP, V17, P209, DOI 10.2466/pr0.1965.17.1.209; Demaestri C, 2019, BEHAV BRAIN RES, V360, P134, DOI 10.1016/j.bbr.2018.12.005; DENNIS M, 1972, EXP NEUROL, V37, P256, DOI 10.1016/0014-4886(72)90072-6; DREWNOWSKI A, 1989, ANN NY ACAD SCI, V575, P399; DREWNOWSKI A, 1987, AM J CLIN NUTR, V46, P442, DOI 10.1093/ajcn/46.3.442; Dwyer JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146966; Fenu S, 2001, J NEUROSCI, V21, P6897, DOI 10.1523/JNEUROSCI.21-17-06897.2001; Ferrari AJ, 2013, PSYCHOL MED, V43, P471, DOI 10.1017/S0033291712001511; Ferreira G, 2005, EUR J NEUROSCI, V22, P2596, DOI 10.1111/j.1460-9568.2005.04440.x; Foy MR, 2003, INTEGR PHYS BEH SCI, V38, P203, DOI 10.1007/BF02688854; Franceschini A, 2021, EUR J PHARMACOL, V896, DOI 10.1016/j.ejphar.2021.173895; Frank GKW, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.199; Frank GKW, 2018, JAMA PSYCHIAT, V75, P1071, DOI 10.1001/jamapsychiatry.2018.2151; Frank S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00499; Friederich HC, 2013, INT J EAT DISORDER, V46, P425, DOI 10.1002/eat.22099; Fu O, 2019, CELL REP, V27, P1650, DOI 10.1016/j.celrep.2019.04.040; Gal-Ben-Ari S, 2012, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00087; GALLO M, 1992, BEHAV BRAIN RES, V52, P91, DOI 10.1016/S0166-4328(05)80328-6; GARCIA J, 1970, PSYCHON SCI, V20, P313, DOI 10.3758/BF03329085; Geddes RI, 2008, BEHAV NEUROSCI, V122, P1038, DOI 10.1037/a0012748; Gonzalez MC, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00408; Gore F, 2015, CELL, V162, P134, DOI 10.1016/j.cell.2015.06.027; Hamdani S, 2011, BEHAV BRAIN RES, V217, P88, DOI 10.1016/j.bbr.2010.09.026; Head MA, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00297; Hefner K, 2008, J NEUROSCI, V28, P8074, DOI 10.1523/JNEUROSCI.4904-07.2008; Herisson FM, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12381; Hernadi I, 2000, BRAIN RES BULL, V53, P751, DOI 10.1016/S0361-9230(00)00361-0; Hernandez VS, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00092; HINDERLITER CF, 1993, PERCEPT MOTOR SKILL, V77, P1403, DOI 10.2466/pms.1993.77.3f.1403; Hodes GE, 2015, J NEUROSCI, V35, P16362, DOI 10.1523/JNEUROSCI.1392-15.2015; Houpt TA, 2003, J NEUROSCI, V23, P1498, DOI 10.1523/JNEUROSCI.23-04-01498.2003; Houpt TA, 1996, PHYSIOL BEHAV, V60, P1535, DOI 10.1016/S0031-9384(96)00326-5; Huang ACW, 2020, NEUROBIOL LEARN MEM, V172, DOI 10.1016/j.nlm.2020.107248; Hurley SW, 2020, J NEUROSCI, V40, P6888, DOI 10.1523/JNEUROSCI.0137-20.2020; Inui T, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0004-19.2019; Jahng JW, 2004, NEUROSCI RES, V50, P485, DOI 10.1016/j.neures.2004.08.016; Jahng JW, 2003, YONSEI MED J, V44, P869, DOI 10.3349/ymj.2003.44.5.869; Jones JD, 2006, PHARMACOL BIOCHEM BE, V83, P554, DOI 10.1016/j.pbb.2006.03.017; Kim EU, 2016, BEHAV BRAIN RES, V296, P260, DOI 10.1016/j.bbr.2015.09.022; Kim J, 2017, NEURON, V93, P1464, DOI 10.1016/j.neuron.2017.02.034; Kim J, 2016, NAT NEUROSCI, V19, P1636, DOI 10.1038/nn.4414; Kim Y, 2016, BIOL PSYCHIAT, V79, P878, DOI 10.1016/j.biopsych.2015.04.026; King MS, 2018, BRAIN RES, V1683, P67, DOI 10.1016/j.brainres.2018.01.018; Kinzeler NR, 2008, AM J PHYSIOL-REG I, V295, pR436, DOI 10.1152/ajpregu.00189.2008; Klockars OA, 2018, NEUROREPORT, V29, P504, DOI 10.1097/WNR.0000000000001005; Koehnle TJ, 2007, AM J PHYSIOL-REG I, V292, pR1212, DOI 10.1152/ajpregu.00666.2006; Kokras N, 2014, BRIT J PHARMACOL, V171, P4595, DOI 10.1111/bph.12710; KOSAR E, 1986, BRAIN RES, V379, P342, DOI 10.1016/0006-8993(86)90788-2; KOSAR E, 1986, BRAIN RES, V379, P329, DOI 10.1016/0006-8993(86)90787-0; Kwon B, 2010, BRAIN RES, V1333, P36, DOI 10.1016/j.brainres.2010.03.068; Lammel S, 2014, NEUROPHARMACOLOGY, V76, P351, DOI 10.1016/j.neuropharm.2013.03.019; Lamprecht R, 1995, NEUROREPORT, V7, P289, DOI 10.1097/00001756-199512290-00069; Lavi K, 2018, CELL REP, V24, P278, DOI 10.1016/j.celrep.2018.06.053; Li Y, 2016, NEUROSCIENCE, V315, P45, DOI 10.1016/j.neuroscience.2015.11.063; Limebeer CL, 2012, BRIT J PHARMACOL, V167, P1126, DOI 10.1111/j.1476-5381.2012.02066.x; Lin JY, 2015, NEUROBIOL LEARN MEM, V119, P77, DOI 10.1016/j.nlm.2015.01.005; Lin JY, 2012, BRAIN RES, V1448, P82, DOI 10.1016/j.brainres.2012.02.013; Litvin Y, 2007, BEHAV BRAIN RES, V182, P166, DOI 10.1016/j.bbr.2006.11.038; Livneh Y, 2017, NATURE, V546, P611, DOI 10.1038/nature22375; Lockwood DR, 2003, PHYSIOL BEHAV, V78, P635, DOI 10.1016/S0031-9384(03)00040-4; Lowen SB, 2015, NEUROIMAGE-CLIN, V8, P652, DOI 10.1016/j.nicl.2015.06.012; Marotta R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00153; McCutcheon JE, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00137; McLaughlin RJ, 2007, NEUROSCIENCE, V146, P1484, DOI 10.1016/j.neuroscience.2007.03.025; MEACHUM CL, 1992, PHYSIOL BEHAV, V52, P895, DOI 10.1016/0031-9384(92)90368-C; Mediavilla C, 2005, NEUROSCI BIOBEHAV R, V29, P1107, DOI 10.1016/j.neubiorev.2005.06.002; Mickley GA, 2007, BRAIN RES, V1152, P139, DOI 10.1016/j.brainres.2007.03.050; Mickley GA, 2005, BRAIN RES, V1051, P176, DOI 10.1016/j.brainres.2005.05.033; MITCHELL D, 1976, PHYSIOL BEHAV, V17, P691, DOI 10.1016/0031-9384(76)90171-2; Montag-Sallaz M, 1999, J NEUROBIOL, V38, P234, DOI 10.1002/(SICI)1097-4695(19990205)38:2<234::AID-NEU6>3.0.CO;2-G; Moscarello JM, 2009, BEHAV BRAIN RES, V197, P9, DOI 10.1016/j.bbr.2008.07.025; Moscarello JM, 2007, BRAIN RES, V1169, P69, DOI 10.1016/j.brainres.2007.06.064; Mulvihill KG, 2019, PHARMACOL BIOCHEM BE, V176, P23, DOI 10.1016/j.pbb.2018.11.006; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Nasser HM, 2013, LEARN MEMORY, V20, P220, DOI 10.1101/lm.029744.112; Nerad L, 1996, NEUROBIOL LEARN MEM, V66, P44, DOI 10.1006/nlme.1996.0042; O'Neill PK, 2018, CURR OPIN NEUROBIOL, V49, P175, DOI 10.1016/j.conb.2018.02.012; OLSON BR, 1993, MOL CELL NEUROSCI, V4, P93, DOI 10.1006/mcne.1993.1011; OLSON BR, 1991, ENDOCRINOLOGY, V129, P785, DOI 10.1210/endo-129-2-785; Olszewski PK, 2000, AM J PHYSIOL-REG I, V279, pR1504, DOI 10.1152/ajpregu.2000.279.4.R1504; Park TH, 1998, BRAIN RES, V805, P169, DOI 10.1016/S0006-8993(98)00719-7; Parker LA, 2014, EUR J PHARMACOL, V722, P122, DOI 10.1016/j.ejphar.2013.09.070; PELCHAT ML, 1983, J COMP PSYCHOL, V97, P140, DOI 10.1037/0735-7036.97.2.140; Petrovich GD, 2011, PHYSIOL BEHAV, V104, P582, DOI 10.1016/j.physbeh.2011.04.059; Piekut DT, 1996, SYNAPSE, V23, P312, DOI 10.1002/(SICI)1098-2396(199608)23:4<312::AID-SYN9>3.0.CO;2-A; Pirnik Z, 2004, NEUROCHEM INT, V45, P597, DOI 10.1016/j.neuint.2004.04.003; Pirnik Zdeno, 2002, Endocr Regul, V36, P23; PRADOALCALA R, 1984, BRAIN RES, V297, P265, DOI 10.1016/0006-8993(84)90567-5; Ramirez-Lugo L, 2007, CHEM SENSES, V32, P93, DOI 10.1093/chemse/bjl023; Ramirez-Lugo L, 2016, J NEUROSCI, V36, P10574, DOI 10.1523/JNEUROSCI.0796-16.2016; Randall-Thompson JF, 2003, PHARMACOL BIOCHEM BE, V76, P373, DOI 10.1016/j.pbb.2003.08.010; Reilly S, 2005, NEUROSCI BIOBEHAV R, V29, P1067, DOI 10.1016/j.neubiorev.2005.03.025; Reno JM, 2017, ALCOHOL CLIN EXP RES, V41, P786, DOI 10.1111/acer.13344; Rinaman L, 2007, AM J PHYSIOL-REG I, V293, pR1495, DOI 10.1152/ajpregu.00393.2007; Rinker JA, 2008, PHARMACOL BIOCHEM BE, V88, P427, DOI 10.1016/j.pbb.2007.09.016; Rogers-Carter MM, 2018, NAT NEUROSCI, V21, P404, DOI 10.1038/s41593-018-0071-y; Roitman MF, 2010, LEARN MEMORY, V17, P539, DOI 10.1101/lm.1869710; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Roussin AT, 2012, J NEUROSCI, V32, P10494, DOI 10.1523/JNEUROSCI.1856-12.2012; Sakai N, 1997, NEUROREPORT, V8, P2215, DOI 10.1097/00001756-199707070-00025; Sakai N, 1999, NEUROSCI RES, V35, P53, DOI 10.1016/S0168-0102(99)00067-X; Sanchez-Catalan MJ, 2017, NEUROPSYCHOPHARMACOL, V42, P638, DOI 10.1038/npp.2016.139; Sangarapillai N, 2021, BEHAV BRAIN RES, V398, DOI 10.1016/j.bbr.2020.112926; Schramm-Sapyta NL, 2014, PSYCHOPHARMACOLOGY, V231, P1831, DOI 10.1007/s00213-013-3319-y; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Singh T, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00126; Snyder DJ, 2000, NEUROREPORT, V11, P2681, DOI 10.1097/00001756-200008210-00015; Soto A, 2017, NEUROSCI LETT, V647, P32, DOI 10.1016/j.neulet.2017.03.025; Spencer CM, 2001, MOL BRAIN RES, V93, P113, DOI 10.1016/S0169-328X(01)00173-5; Spencer CM, 2012, PHYSIOL BEHAV, V105, P151, DOI 10.1016/j.physbeh.2011.08.022; Spray KJ, 2000, BRAIN RES, V852, P225, DOI 10.1016/S0006-8993(99)02203-9; St Andre J, 2007, BRAIN RES, V1135, P122, DOI 10.1016/j.brainres.2006.12.010; Sticht MA, 2016, NEUROPHARMACOLOGY, V102, P92, DOI 10.1016/j.neuropharm.2015.10.039; SUNDAY SR, 1990, PHYSIOL BEHAV, V48, P587, DOI 10.1016/0031-9384(90)90196-B; SWANK MW, 1995, BRAIN RES, V673, P251, DOI 10.1016/0006-8993(94)01421-D; SWANK MW, 1994, BRAIN RES, V636, P202, DOI 10.1016/0006-8993(94)91018-9; Tang W, 2020, J NEUROSCI, V40, P3969, DOI 10.1523/JNEUROSCI.1796-19.2020; Taylor JO, 2017, BEHAV NEUROSCI, V131, P115, DOI 10.1037/bne0000184; Thakore N, 2016, BEHAV BRAIN RES, V302, P228, DOI 10.1016/j.bbr.2016.01.042; Thiele TE, 1996, ALCOHOL CLIN EXP RES, V20, P1023, DOI 10.1111/j.1530-0277.1996.tb01941.x; Torrealba F, 2017, ADV EXP MED BIOL, V1015, P59, DOI 10.1007/978-3-319-62817-2_4; TRAVERS SP, 1991, J NEUROPHYSIOL, V65, P1372, DOI 10.1152/jn.1991.65.6.1372; Uematsu A, 2015, CEREB CORTEX, V25, P2719, DOI 10.1093/cercor/bhu069; Wald HS, 2020, AM J PHYSIOL-REG I, V319, pR673, DOI 10.1152/ajpregu.00201.2020; Walker QD, 2002, PHARMACOL BIOCHEM BE, V73, P743, DOI 10.1016/S0091-3057(02)00883-3; WATSON PJ, 1988, PHYSIOL BEHAV, V43, P697, DOI 10.1016/0031-9384(88)90366-6; Weiss MS, 2014, J NEUROPHYSIOL, V111, P1655, DOI 10.1152/jn.00643.2013; Welzl H, 2001, BEHAV BRAIN RES, V125, P205, DOI 10.1016/S0166-4328(01)00302-3; Wheeler AL, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002853; Willey AR, 2012, BEHAV BRAIN RES, V226, P613, DOI 10.1016/j.bbr.2011.10.001; YAMAMOTO T, 1993, NEUROSCI RES, V16, P181, DOI 10.1016/0168-0102(93)90122-7; Yamamoto T, 2008, ACTA PHYSIOL HUNG, V95, P165, DOI 10.1556/APhysiol.95.2008.2.2; YAMAMOTO T, 1994, BEHAV BRAIN RES, V65, P123, DOI 10.1016/0166-4328(94)90097-3; YAMAMOTO T, 1992, NEUROREPORT, V3, P1049, DOI 10.1097/00001756-199212000-00004; Yamamoto T, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00076; Yasoshima Y, 2006, NEUROSCIENCE, V141, P35, DOI 10.1016/j.neuroscience.2006.03.019; Yiannakas A, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00335; YIM CY, 1982, BRAIN RES, V239, P401; Yuan L, 2019, J NEUROSCI, V39, P6472, DOI 10.1523/JNEUROSCI.0271-19.2019; Zhang X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07679-9; Zhang XY, 2020, NEURON, V105, P1077, DOI 10.1016/j.neuron.2019.12.025	170	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0260577	10.1371/journal.pone.0260577	http://dx.doi.org/10.1371/journal.pone.0260577			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898621	gold, Green Published			2022-12-26	WOS:000755176200013
J	Bhagat, S; Biswas, I; Alam, MI; Khan, M; Khan, GA				Bhagat, Saumya; Biswas, Indranil; Alam, Md Iqbal; Khan, Madiha; Khan, Gausal A.			Key role of Extracellular RNA in hypoxic stress induced myocardial injury	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; INFLAMMATORY RESPONSE; ISCHEMIA; ACTIVATION; INFARCTION; LUNG; MECHANISMS; APOPTOSIS; STIFFNESS; ELASTASE	Myocardial infarction (MI), atherosclerosis and other inflammatory and ischemic cardiovascular diseases (CVDs) have a very high mortality rate and limited therapeutic options. Although the diagnosis is based on markers such as cardiac Troponin-T (cTrop-T), the mechanism of cTrop-T upregulation and release is relatively obscure. In the present study, we have investigated the mechanism of cTrop-T release during acute hypoxia (AH) in a mice model by ELISA & immunohistochemistry. Our study showed that AH exposure significantly induces the expression and release of sterile inflammatory as well as MI markers in a time-dependent manner. We further demonstrated that activation of TLR3 (mediated by eRNA) by AH exposure in mice induced cTrop-T release and Poly I:C (TLR3 agonist) also induced cTrop-T release, but the pre-treatment of TLR3 immuno-neutralizing antibody or silencing of Tlr3 gene or RNaseA treatment two hrs before AH exposure, significantly abrogated AH-induced Caspase 3 activity as well as cTrop-T release. Our immunohistochemistry and Masson Trichrome (MT) staining studies further established the progression of myocardial injury by collagen accumulation, endothelial cell and leukocyte activation and adhesion in myocardial tissue which was abrogated significantly by pre-treatment of RNaseA 2 hrs before AH exposure. These data indicate that AH induced cTrop-T release is mediated via the eRNA-TLR3-Caspase 3 pathway.	[Bhagat, Saumya; Biswas, Indranil] Def Inst Physiol & Allied Sci, Dept Physiol, New Delhi, India; [Alam, Md Iqbal] Jamia Hamdard, HIMSAR, Dept Physiol, New Delhi, India; [Khan, Madiha] Heritage Sch, Kolkata, India; [Khan, Gausal A.] Fiji Natl Univ, Coll Med Nursing & Hlth Sci, Dept Physiol & Physiotherapy, Suva, Fiji Islands, Fiji	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); Jamia Hamdard University; Fiji National University (FNU)	Khan, GA (corresponding author), Fiji Natl Univ, Coll Med Nursing & Hlth Sci, Dept Physiol & Physiotherapy, Suva, Fiji Islands, Fiji.	gausalk@gmail.com	Khan, Gausal A/B-9525-2009	Khan, Gausal A/0000-0002-0306-6641	Ministry of Defense , Govt. of India [DIP253]; Grand Challenge Canada [R-ST-POC-180713914]	Ministry of Defense , Govt. of India; Grand Challenge Canada	This work was supported by grants from the Ministry of Defense (DIP253), Govt. of India and Grand Challenge Canada (R-ST-POC-180713914) to GAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadou I, 2019, CARDIOVASC RES, V115, P1117, DOI 10.1093/cvr/cvz050; Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Bhagat S, 2020, BLOOD CELL MOL DIS, V84, DOI 10.1016/j.bcmd.2020.102459; Biswas I, 2015, EUR J IMMUNOL, V45, P3158, DOI 10.1002/eji.201545597; Biswas I, 2012, BLOOD CELL MOL DIS, V49, P92, DOI 10.1016/j.bcmd.2012.05.001; Cabrera-Fuentes HA, 2014, THROMB HAEMOSTASIS, V112, P1110, DOI 10.1160/TH14-08-0703; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chen C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000683; De Meyer SF, 2012, ARTERIOSCL THROM VAS, V32, P1884, DOI 10.1161/ATVBAHA.112.250993; Deftereos S, 2014, MED CHEM, V10, P653, DOI 10.2174/1573406410666140806103651; DOERING CW, 1988, CARDIOVASC RES, V22, P686, DOI 10.1093/cvr/22.10.686; Dollery CM, 2003, CIRCULATION, V107, P2829, DOI 10.1161/01.CIR.0000072792.65250.4A; Eefting F, 2004, CARDIOVASC RES, V61, P414, DOI 10.1016/j.cardiores.2003.12.023; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; ENGVALL E, 1972, J IMMUNOL, V109, P129; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Frohlich S, 2013, AM J RESP CELL MOL, V48, P271, DOI 10.1165/rcmb.2012-0137TR; Gumina RJ, 1996, CIRCULATION, V94, P3327, DOI 10.1161/01.CIR.94.12.3327; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; HILL A, 1989, CLIN PERINATOL, V16, P435, DOI 10.1016/S0095-5108(18)30640-7; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kosar F, 1998, ANGIOLOGY, V49, P193, DOI 10.1177/000331979804900305; Liaudet Lucas, 2013, Front Biosci (Schol Ed), V5, P86; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LIP GYH, 1995, AM J CARDIOL, V76, P453, DOI 10.1016/S0002-9149(99)80129-5; Lu C, 2014, BBA-MOL BASIS DIS, V1842, P22, DOI 10.1016/j.bbadis.2013.10.006; MEHTA P, 1986, THROMB RES, V41, P731, DOI 10.1016/0049-3848(86)90370-1; Mishra PK, 2019, AM J PHYSIOL-HEART C, V317, pH891, DOI 10.1152/ajpheart.00259.2019; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Pasotti M, 2006, HEART, V92, P1552, DOI 10.1136/hrt.2005.086934; Piper HM, 2003, ANN THORAC SURG, V75, pS644, DOI 10.1016/S0003-4975(02)04686-6; Scarabelli TM, 2004, CELL DEATH DIFFER, V11, pS144, DOI 10.1038/sj.cdd.4401544; Singh B, 2016, EUR J IMMUNOL, V46, P2388, DOI 10.1002/eji.201646386; Stroka KM, 2012, J BIOMECH, V45, P1828, DOI 10.1016/j.jbiomech.2012.04.011; Sun Z, 2001, SCAND J GASTROENTERO, V36, P55, DOI 10.1080/00365520150218066; Tamassia N, 2008, J IMMUNOL, V181, P6563, DOI 10.4049/jimmunol.181.9.6563; Toldo S, 2018, NAT REV CARDIOL, V15, P203, DOI 10.1038/nrcardio.2017.161; van Herck H, 2000, LAB ANIM, V34, P10, DOI 10.1258/002367700780577993; Walberer M, 2009, CURR NEUROVASC RES, V6, P12, DOI 10.2174/156720209787466037; White HD, 2011, J AM COLL CARDIOL, V57, P2406, DOI 10.1016/j.jacc.2011.01.029; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yoon S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.450; Zernecke A, 2016, CIRC RES, V118, P469, DOI 10.1161/CIRCRESAHA.115.307961	45	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260835	10.1371/journal.pone.0260835	http://dx.doi.org/10.1371/journal.pone.0260835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882718	gold, Green Published			2022-12-26	WOS:000755037200045
J	Burgund, ED				Burgund, E. Darcy			Task-domain and hemisphere-asymmetry effects in cisgender and transmale individuals	PLOS ONE			English	Article							SENSITIVE COGNITIVE PERFORMANCE; TO-FEMALE TRANSSEXUALS; SEX-DIFFERENCES; MENTAL ROTATION; CEREBRAL LATERALIZATION; SPATIAL ABILITIES; GENDER IDENTITY; HORMONAL CONTRACEPTIVES; OLDER-ADULTS; HANDEDNESS	The present research examined the extent to which transmale individuals' functional brain organization resembles that of their assigned sex or gender identity. Cisgender-female, cisgender-male, and transmale participants, who were assigned female sex but did not have a female gender identity, were compared in terms of effects that have been observed in cisgender individuals: task-domain effects, in which males perform better than females on spatial tasks and females perform better than males on verbal tasks; and hemisphere-asymmetry effects, in which males show larger differences between the left and right hemispheres than females. In addition, the present research measured participants' intelligence in order to control for potential moderating effects. Participants performed spatial (mental rotation) and verbal (lexical decision) tasks presented to each hemisphere using a divided-visual field paradigm, and then completed an intelligence assessment. In the mental-rotation task, cismale and transmale participants performed better than cisfemale participants, however this group difference was explained by intelligence scores, with higher scores predicting better performance. In the lexical-decision task, cismale and transmale participants exhibited a greater left-hemisphere advantage than cisfemales, and this difference was not affected by intelligence scores. Taken together, results do not support task-domain effects when intelligence is accounted for; however, they do demonstrate a hemisphere-asymmetry effect in the verbal domain that is moderated by gender identity and not assigned sex.	[Burgund, E. Darcy] Macalester Coll, Dept Psychol, St Paul, MN 55105 USA	Macalester College	Burgund, ED (corresponding author), Macalester Coll, Dept Psychol, St Paul, MN 55105 USA.	dburgund@macalester.edu		Burgund, Darcy/0000-0002-2611-1337				Anomal RF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232660; Beltz AM, 2015, HORM BEHAV, V74, P209, DOI 10.1016/j.yhbeh.2015.06.012; Borella E, 2014, DEV PSYCHOL, V50, P384, DOI 10.1037/a0033818; Bradley M., 1999, TECHNICAL REPORT, DOI DOI 10.1109/MIC.2008.114; Bronnick MK, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.556577; Burke SM, 2016, J PSYCHIATR NEUROSCI, V41, P395, DOI 10.1503/jpn.150147; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Carrillo B, 2010, PSYCHONEUROENDOCRINO, V35, P1213, DOI 10.1016/j.psyneuen.2010.02.010; CHIARELLO C, 1989, BRAIN COGNITION, V11, P18, DOI 10.1016/0278-2626(89)90002-X; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen-Kettenis PT, 1998, PSYCHONEUROENDOCRINO, V23, P631; Collins K, 2013, LATERALITY, V18, P491, DOI 10.1080/1357650X.2012.724072; de Castell S, 2019, ACTA PSYCHOL, V199, DOI 10.1016/j.actpsy.2019.102895; Doyle RA, 2012, J APPL DEV PSYCHOL, V33, P112, DOI 10.1016/j.appdev.2012.01.002; Etchell A, 2018, NEUROPSYCHOLOGIA, V114, P19, DOI 10.1016/j.neuropsychologia.2018.04.011; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Govier E, 2010, INT J TRANSGENDERISM, V12, P144, DOI 10.1080/15532739.2010.514219; Griksiene R, 2018, HORM BEHAV, V100, P29, DOI 10.1016/j.yhbeh.2018.03.004; Griksiene R, 2011, PSYCHONEUROENDOCRINO, V36, P1239, DOI 10.1016/j.psyneuen.2011.03.001; Guizzo F, 2019, ACTA PSYCHOL, V194, P63, DOI 10.1016/j.actpsy.2019.01.013; Haraldsen IR, 2005, PSYCHIAT RES, V137, P161, DOI 10.1016/j.psychres.2005.05.014; Haraldsen IR, 2003, PSYCHONEUROENDOCRINO, V28, P906, DOI 10.1016/S0306-4530(02)00107-5; Herlitz A, 2013, DEV NEUROPSYCHOL, V38, P167, DOI 10.1080/87565641.2012.759580; HILLGER LA, 1991, J COGNITIVE NEUROSCI, V3, P42, DOI 10.1162/jocn.1991.3.1.42; Hines M, 2020, J NEUROSCI, V40, P37, DOI 10.1523/JNEUROSCI.0750-19.2019; Hirnstein M, 2019, LATERALITY, V24, P204, DOI 10.1080/1357650X.2018.1497044; Hunter CR, 2016, NEUROPSYCHOLOGIA, V91, P451, DOI 10.1016/j.neuropsychologia.2016.09.007; Hunter ZR, 2008, NEUROPSYCHOLOGIA, V46, P316, DOI 10.1016/j.neuropsychologia.2007.07.007; Hyde JS, 2014, ANNU REV PSYCHOL, V65, P373, DOI 10.1146/annurev-psych-010213-115057; HYDE JS, 1988, PSYCHOL BULL, V104, P53, DOI 10.1037/0033-2909.104.1.53; JUST MA, 1985, PSYCHOL REV, V92, P137, DOI 10.1037/0033-295X.92.2.137; Karalexi MA, 2020, PSYCHONEUROENDOCRINO, V119, DOI 10.1016/j.psyneuen.2020.104721; Kreukels BPC, 2016, INT REV PSYCHIATR, V28, P120, DOI 10.3109/09540261.2015.1113163; Laird S, 2019, CURR PSYCHIAT RES RE, V15, P116, DOI 10.2174/1573400515666190521113841; Naveh-Benjamin M, 2018, PSYCHOL AGING, V33, P1, DOI 10.1037/pag0000235; Nguyen HB, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0973-0; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papadatou-Pastou M, 2017, LATERALITY, V22, P123, DOI 10.1080/1357650X.2016.1149485; Ramon M, 2012, BRAIN COGNITION, V78, P7, DOI 10.1016/j.bandc.2011.10.009; Reilly D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039904; Rider GN, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1683; Rilea SL, 2004, BRAIN COGNITION, V56, P332, DOI 10.1016/j.bandc.2004.09.002; Rilea SL, 2008, BRAIN COGNITION, V67, P168, DOI 10.1016/j.bandc.2008.01.001; Rossell SL, 2002, BRAIN LANG, V80, P97, DOI 10.1006/brln.2000.2449; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Santarnecchi E, 2015, HUM BRAIN MAPP, V36, P3586, DOI 10.1002/hbm.22864; Sato M, 2020, NEUROPSYCHOLOGIA, V140, DOI 10.1016/j.neuropsychologia.2020.107404; Scheim AI, 2015, J SEX RES, V52, P1, DOI 10.1080/00224499.2014.893553; Schoning S, 2010, J SEX MED, V7, P1858, DOI 10.1111/j.1743-6109.2009.01484.x; Siegel-Hinson RI, 2002, LATERALITY, V7, P59, DOI 10.1080/13576500143000078; Soleman RS, 2013, J SEX MED, V10, P1969, DOI 10.1111/jsm.12083; Sommer IE, 2008, BRAIN RES, V1206, P76, DOI 10.1016/j.brainres.2008.01.003; Swaab DF, 2009, FUNCT NEUROL, V24, P17; Van der Haegen L, 2011, NEUROPSYCHOLOGIA, V49, P2879, DOI 10.1016/j.neuropsychologia.2011.06.014; Van Dyke SA, 2009, DEV NEUROPSYCHOL, V34, P381, DOI 10.1080/87565640902964516; Varriale V, 2018, INTELLIGENCE, V69, P146, DOI 10.1016/j.intell.2018.05.007; Vogel JJ, 2003, BRAIN COGNITION, V52, P197, DOI 10.1016/S0278-2626(03)00056-3; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Voyer D, 2011, BRAIN COGNITION, V76, P245, DOI 10.1016/j.bandc.2011.02.001; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Willemin J, 2016, LATERALITY, V21, P502, DOI 10.1080/1357650X.2015.1130716; Winter S, 2016, LANCET, V388, P390, DOI 10.1016/S0140-6736(16)00683-8; Wisniewski AB, 2005, ARCH SEX BEHAV, V34, P167, DOI 10.1007/s10508-005-1794-x; Zell E, 2015, AM PSYCHOL, V70, P10, DOI 10.1037/a0038208; Zhao BL, 2019, PSYCHOL AGING, V34, P502, DOI 10.1037/pag0000359; Zhao BL, 2018, Q J EXP PSYCHOL, V71, P1574, DOI 10.1080/17470218.2017.1342670	66	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260542	10.1371/journal.pone.0260542	http://dx.doi.org/10.1371/journal.pone.0260542			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874973	gold, Green Published			2022-12-26	WOS:000753617500030
J	Wasave, S; Wasave, S; Chaudhari, K; Shingare, P; Yadav, B; Patil, S; Naik, B				Wasave, Suhas; Wasave, Sangita; Chaudhari, Ketankumar; Shingare, Prakash; Yadav, Bharat; Patil, Sandesh; Naik, Bhalchandra			Knowledge, Awareness, and Practices (KAP) towards COVID-19 among the marine fishers of Maharashtra State of India: An online cross-sectional Analysis	PLOS ONE			English	Article							WUHAN; PNEUMONIA; CHINA	The knowledge, awareness, and practices (KAP) about COVID-19 among the marine fishers who are engaged in the high-risk occupations and depend on the vulnerable sources of income in the Maharashtra state of India, were investigated to understand the behavioral changes and vulnerability among the respondents because of COVID-19. Data were collected through an online survey from 1st July to 30th July 2020 during the first peak of COVID-19 in the study area by using the questionnaire. Authors based on the latest recommendations by the World Health Organization (WHO) developed the questionnaire and covered the KAP aspects under study. The questionnaire was administered through Google form link and the link was disseminated through social media such as Facebook and What's App. The completed responses (n = 533) received from the eligible sample, excluding those outsides of the fisher community and duplicate entries were considered for analysis. Appropriate statistical tools were used to analyze the data. Among the respondents, 447 men (83.86%) and 86 women (16.14%), with a mean age of 45.4 years (M = 45.4, SD = 1.18). The results revealed that 70.92% of respondents perceived a low risk of infection because of COVID-19 with M = 1.77 and SD = 0.583, but authors found the perceived severity score high (M = 3.95, SD = 1.21) among the 60.97% of respondents. Around 95% of respondents were aware of the COVID-19, while almost all respondents knew the medium of infection and symptoms of COVID-19. The behavior of respondents towards COVID-19 infection was positive and was following sufficient precautionary measures suggested by WHO to protect themselves from COVID-19 infection. The results of multiple regression analysis revealed that the demographic features of respondents like age, education were significantly contributing to the KAP of the fisher community. The results confirmed the importance of KAP which is reflected in the behavioral responses of the fishers while tackling the COVID-19 pandemic situation. The results regarding the risk perception, severity, KAP about COVID-19 provide a collective understanding of the emerging infectious disease among the marine fishers of Maharashtra state of India.	[Wasave, Suhas; Chaudhari, Ketankumar; Yadav, Bharat; Patil, Sandesh; Naik, Bhalchandra] Ratnagiri Dr BS Konkan Krishi Vidyapeeth, Coll Fisheries, Dept Fisheries Resources Econ Stat & Extens Educ, Ratnagiri, Maharashtra, India; [Wasave, Sangita] Ratnagiri Dr BS Konkan Krishi Vidyapeeth, Coll Fisheries, Dept Aquaculture, Ratnagiri, Maharashtra, India; [Shingare, Prakash] Ratnagiri Dr BS Konkan Krishi Vidyapeeth, Coll Fisheries, Ratnagiri, Maharashtra, India	College of Fisheries, Mangalore; College of Fisheries, Mangalore; College of Fisheries, Mangalore	Wasave, S (corresponding author), Ratnagiri Dr BS Konkan Krishi Vidyapeeth, Coll Fisheries, Dept Fisheries Resources Econ Stat & Extens Educ, Ratnagiri, Maharashtra, India.	suhaswasave@gmail.com		WASAVE, SUHAS/0000-0001-6496-5571				Ali SH, 2020, JMIR PUBLIC HLTH SUR, V6, P154, DOI 10.2196/21071; Alimohamadi Yousef, 2020, J Prev Med Public Health, V53, P151, DOI 10.3961/jpmph.20.076; Allcott H, 2017, J ECON PERSPECT, V31, P211, DOI 10.1257/jep.31.2.211; [Anonymous], 2002, Bull World Health Organ, V80, P983; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Bashirian S, 2020, J HOSP INFECT, V105, P430, DOI 10.1016/j.jhin.2020.04.035; CDC, 2020, COVID 19 GUID OLD AD; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen Y, 2020, J MED INTERNET RES, V22, DOI 10.2196/23729; Clements John M, 2020, JMIR Public Health Surveill, V6, pe19161, DOI 10.2196/19161; de Lima BF, 2021, ACTA DIABETOL, V58, P19, DOI 10.1007/s00592-020-01580-y; De Wandel D, 2010, AM J CRIT CARE, V19, P230, DOI 10.4037/ajcc2010892; Desalegn Z, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244780; Dhand R, 2020, AM J RESP CRIT CARE, V202, P651, DOI 10.1164/rccm.202004-1263PP; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Downing J, 2020, NEW MEDIA SOC, V22, P449, DOI 10.1177/1461444819864572; Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254; Fridman I, 2020, JMIR PUBLIC HLTH SUR, V6, P398, DOI 10.2196/22060; Fung ICH, 2006, TROP MED INT HEALTH, V11, P1749, DOI 10.1111/j.1365-3156.2006.01734.x; Gandhi RT, 2020, NEW ENGL J MED, V383, P1757, DOI 10.1056/NEJMcp2009249; Geana Mugur V, 2020, Kans J Med, V13, P160; Geldsetzer P, 2020, ANN INTERN MED, V173, P157, DOI 10.7326/M20-0912; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gupta Naveen, 2020, Med J Armed Forces India, V76, P132, DOI 10.1016/j.mjafi.2020.04.001; Hager E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236918; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huckins JF, 2020, J MED INTERNET RES, V22, DOI 10.2196/20185; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lee M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092977; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Mohamed AAO, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10319-5; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Molla KA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250465; Myers C, 2014, MEDIA HIST, V20, P431, DOI 10.1080/13688804.2014.950639; Niu ZM, 2020, J MED INTERNET RES, V22, DOI 10.2196/19995; Qutob N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244925; Rugarabamu S., 2020, BMJ YALE, V216, P2020, DOI [10.1136/bmjgh-2019-001955, DOI 10.1101/2020.04.26.20080820]; Sharma SV, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200322; Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4; Singh JP, 2020, J HEALTH MANAG, V22, P281, DOI 10.1177/0972063420935669; Suhas Wasave, 2017, Indian Journal of Ecology, V44, P124; Tao N, 2003, J ANHUI I ED, V21, P78; Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wolfsfeld G, 2013, INT J PRESS/POLIT, V18, P115, DOI 10.1177/1940161212471716; Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]; Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204; Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X; Zhang M, 2020, ASIA-PAC J PUBLIC HE, V32, P533, DOI 10.1177/1010539520951408; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221; Zhong BL, 2017, J GERONTOL B-PSYCHOL, V72, P120, DOI 10.1093/geronb/gbw037; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	54	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0261055	10.1371/journal.pone.0261055	http://dx.doi.org/10.1371/journal.pone.0261055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY3JJ	34860859	gold, Green Published			2022-12-26	WOS:000754686900025
J	Bergamini, G; Perico, ME; Di Palma, S; Sabatini, D; Andreetta, F; Defazio, R; Felici, A; Ferrari, L				Bergamini, Gabriella; Perico, Maria Elisa; Di Palma, Stefano; Sabatini, Daniela; Andreetta, Filippo; Defazio, Rossella; Felici, Antonio; Ferrari, Livia			Mouse pneumonia model by Acinetobacter baumannii multidrug resistant strains: Comparison between intranasal inoculation, intratracheal instillation and oropharyngeal aspiration techniques	PLOS ONE			English	Article							MURINE MODEL; TIGECYCLINE; INFECTION; NEUTROPHILS; ANTIBIOTICS; PENETRATION; FLUID; LUNG	Infectious pneumonia induced by multidrug resistant (MDR) Acinetobacter baumannii strains is among the most common and deadly forms of healthcare acquired infections. Over the years, different strategies have been put in place to increase host susceptibility to MDR A. baumannii, since only a self-limiting pneumonia with no or limited local bacterial replication was frequently obtained in mouse models. Direct instillation into the trachea or intranasal inoculation of the bacterial suspension are the techniques used to induce the infection in most of the preclinical models of pneumonia developed to date. More recently, the oropharyngeal aspiration procedure has been widely described in the literature for a variety of purposes including pathogens administration. Aim of this study was to compare the oropharyngeal aspiration technique to the intranasal inoculation and intratracheal instillation in the ability of inducing a consistent lung infection with two MDR A. baumannii clinical isolates in immunocompromised mice. Moreover, pneumonia obtained by bacteria administration with two out of three techniques, intratracheal and oropharyngeal, was characterised in terms of histopathology of pulmonary lesions, biomarkers of inflammation level and leukocytes cells infiltration extent after mice treatment with either vehicle or the antibiotic tigecycline. The data generated clearly showed that both strains were not able to colonize the lungs when inoculated by intranasal route. By contrast, the bacterial load in lungs of mice intratracheally or oropharyngeally infected significantly increased during 26 hours of monitoring, thus highlighting the ability of these strains to generate the infection when directly instilled into the lower respiratory airways. Furthermore, the intragroup variability of mice was significantly reduced with respect to those intranasally administered. Tigecycline was efficacious in lung bacterial load and cytokines release reduction. Findings were supported by semi-quantitative histopathological evaluation of the pulmonary lesions and by inflammatory biomarkers analysis. To conclude, both intratracheal instillation and oropharyngeal aspiration techniques showed to be suitable methods for inducing a robust and consistent pneumonia infection in mice when difficult MDR A. baumannii clinical isolates were used. Noteworthy, oropharyngeal aspiration not requiring specific technical skills and dedicated equipment, was proven to be a safer, easier and faster technique in comparison to the intratracheal instillation.	[Bergamini, Gabriella; Ferrari, Livia] Aptuit Verona Srl, Antibacterial Discovery, Translat Microbiol, Verona, Italy; [Perico, Maria Elisa; Andreetta, Filippo] Aptuit Verona Srl, In Vitro Pharmacol, Verona, Italy; [Di Palma, Stefano; Defazio, Rossella] Aptuit Verona Srl, Preclin Dev, Pathol, Verona, Italy; [Sabatini, Daniela; Felici, Antonio] Aptuit Verona Srl, In Vitro Pharmacol, Microbiol Discovery, Verona, Italy		Bergamini, G (corresponding author), Aptuit Verona Srl, Antibacterial Discovery, Translat Microbiol, Verona, Italy.	gabriella.bergamini@evotec.com	Di Palma, Stefano/AAX-5649-2020	Di Palma, Stefano/0000-0002-9466-3918; Felici, Antonio/0000-0003-2918-5427				Bale S, 2016, INDIAN J PHARMACOL, V48, P643, DOI 10.4103/0253-7613.194859; Beinart D, 2017, EXP LUNG RES, V43, P434, DOI 10.1080/01902148.2017.1397822; Bergamini G, 2017, JOVE-J VIS EXP, DOI 10.3791/55499; Breslow JM, 2011, INFECT IMMUN, V79, P3317, DOI 10.1128/IAI.00069-11; Crandon JL, 2009, J ANTIMICROB CHEMOTH, V64, P837, DOI 10.1093/jac/dkp301; de Breij A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030673; De Vooght V, 2009, TOXICOLOGY, V259, P84, DOI 10.1016/j.tox.2009.02.007; Dexter C, 2015, EXPERT REV ANTI-INFE, V13, P567, DOI 10.1586/14787210.2015.1025055; Dijkshoorn L, 2004, ANTIMICROB AGENTS CH, V48, P4919, DOI 10.1128/AAC.48.12.4919-4921.2004; Dikshit N, 2018, MUCOSAL IMMUNOL, V11, P257, DOI 10.1038/mi.2017.50; Egger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063432; Eveillard M, 2010, J INFECTION, V60, P154, DOI 10.1016/j.jinf.2009.09.004; Gil-Perotin S, 2012, CRIT CARE, V16, DOI 10.1186/cc11357; Harris G, 2013, ANTIMICROB AGENTS CH, V57, P3601, DOI 10.1128/AAC.00944-13; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Keane-Myers AM, 1998, J IMMUNOL, V160, P1036; Kimura G, 2017, MYCOSES, V60, P728, DOI 10.1111/myc.12653; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Lin MF, 2014, WORLD J CLIN CASES, V2, P787, DOI 10.12998/wjcc.v2.i12.787; Livermore DM, 2005, J ANTIMICROB CHEMOTH, V56, P611, DOI 10.1093/jac/dki291; Martin-Aspas A, 2018, INFECT DRUG RESIST, V11, P861, DOI 10.2147/IDR.S163944; Meagher AK, 2005, DIAGN MICR INFEC DIS, V52, P165, DOI 10.1016/j.diagmicrobio.2005.05.006; Medina E, 2010, METHODS MOL BIOL, V602, P405, DOI 10.1007/978-1-60761-058-8_22; Ong CT, 2005, J ANTIMICROB CHEMOTH, V56, P498, DOI 10.1093/jac/dki260; Pratt TS, 2007, EXP LUNG RES, V33, P459, DOI 10.1080/01902140701731805; Qiu HY, 2009, MICROBES INFECT, V11, P946, DOI 10.1016/j.micinf.2009.06.003; Raad II, 2011, BIOMATERIALS, V32, P2689, DOI 10.1016/j.biomaterials.2010.12.015; Rao GVS, 2003, J TOXICOL ENV HEAL A, V66, P1441, DOI 10.1080/15287390306417; Rayamajhi M, 2011, JOVE-J VIS EXP, DOI 10.3791/2702; Renckens R, 2006, J INFECT DIS, V193, P187, DOI 10.1086/498876; Rice LB, 2006, CLIN INFECT DIS, V43, pS100, DOI 10.1086/504487; Sandri A, 2018, VIRULENCE, V9, P1008, DOI 10.1080/21505594.2018.1489198; Shevchenko MA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-78; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]; Ubagai T, 2021, MOL IMMUNOL, V129, P39, DOI 10.1016/j.molimm.2020.11.012; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; Wong D, 2017, CLIN MICROBIOL REV, V30, P409, DOI 10.1128/CMR.00058-16; Yu H, 2008, LAB ANIM-UK, V42, P294, DOI 10.1258/la.2007.007055; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55	40	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260627	10.1371/journal.pone.0260627	http://dx.doi.org/10.1371/journal.pone.0260627			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855837	Green Published, gold			2022-12-26	WOS:000735299000081
J	Leleux, JA; Albershardt, TC; Reeves, R; James, R; Krull, J; Parsons, AJ; ter Meulen, J; Berglund, P				Leleux, Jardin A.; Albershardt, Tina C.; Reeves, Rebecca; James, Reice; Krull, Jordan; Parsons, Andrea J.; ter Meulen, Jan; Berglund, Peter			Intratumoral expression of IL-12 from lentiviral or RNA vectors acts synergistically with TLR4 agonist (GLA) to generate anti-tumor immunological memory	PLOS ONE			English	Article							T-CELL MEMORY; PHASE-I TRIAL; INTERLEUKIN-12; PLASMID; ANTIGEN; VACCINE; TUMORS; IMMUNOTHERAPY; COMBINATION; ACTIVATION	Systemic interleukin-12 (IL12) anti-tumor therapy is highly potent but has had limited utility in the clinic due to severe toxicity. Here, we present two IL12-expressing vector platforms, both of which can overcome the deficiencies of previous systemic IL12 therapies: 1) an integrating lentiviral vector, and 2) a self-replicating messenger RNA formulated with polyethyleneimine. Intratumoral administration of either IL12 vector platform resulted in recruitment of immune cells, including effector T cells and dendritic cells, and the complete remission of established tumors in multiple murine models. Furthermore, concurrent intratumoral administration of the synthetic TLR4 agonist glucopyranosyl lipid A formulated in a stable emulsion (GLA-SE) induced systemic memory T cell responses that mediated complete protection against tumor rechallenge in all survivor mice (8/8 rechallenged mice), whereas only 2/6 total rechallenged mice treated with intratrumoral IL12 monotherapy rejected the rechallenge. Taken together, expression of vectorized IL12 in combination with a TLR4 agonist represents a varied approach to broaden the applicability of intratumoral immune therapies of solid tumors.	[Leleux, Jardin A.; Albershardt, Tina C.; Reeves, Rebecca; James, Reice; Krull, Jordan; Parsons, Andrea J.; ter Meulen, Jan; Berglund, Peter] Immune Design Corp, Seattle, WA 98102 USA; [Leleux, Jardin A.; Albershardt, Tina C.; Reeves, Rebecca; James, Reice; Krull, Jordan; Parsons, Andrea J.; ter Meulen, Jan; Berglund, Peter] Merck & Co Inc, Kenilworth, NJ USA	Merck & Company	Leleux, JA (corresponding author), Immune Design Corp, Seattle, WA 98102 USA.	jardin.leleux@gmail.com						Albershardt TC, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.10; Anwer K, 2013, GYNECOL ONCOL, V131, P169, DOI 10.1016/j.ygyno.2013.07.081; Athie-Morales V, 2004, J IMMUNOL, V172, P61, DOI 10.4049/jimmunol.172.1.61; Barrett JA, 2018, CANCER GENE THER, V25, P106, DOI 10.1038/s41417-018-0019-0; Bennett JJ, 2001, ANN SURG, V233, P819, DOI 10.1097/00000658-200106000-00012; Berg JV, 2013, J EXP MED, V210, P2803, DOI 10.1084/jem.20130678; Berraondo P, 2018, CLIN CANCER RES, V24, P2716, DOI 10.1158/1078-0432.CCR-18-0381; Bhatia S, 2020, CLIN CANCER RES, V26, P598, DOI 10.1158/1078-0432.CCR-19-0972; Burkart C, 2018, GENE THER, V25, P93, DOI 10.1038/s41434-018-0006-y; Chiocca EA, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw5680; Chowdhury FZ, 2011, BLOOD, V118, P3890, DOI 10.1182/blood-2011-05-357111; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Cui WG, 2014, J IMMUNOL, V192, P4221, DOI 10.4049/jimmunol.1302569; Daud AI, 2008, J CLIN ONCOL, V26, P5896, DOI 10.1200/JCO.2007.15.6794; Desbien AL, 2015, EUR J IMMUNOL, V45, P407, DOI 10.1002/eji.201444543; Eckert F, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1323161; Hess SD, 2001, CANCER GENE THER, V8, P371, DOI 10.1038/sj.cgt.7700314; Hewitt SL, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat9143; Hubby B, 2007, VACCINE, V25, P8180, DOI 10.1016/j.vaccine.2007.09.038; Iwai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002404; Kaspar B.K., 2009, ENCY NEUROSCIENCE, P633, DOI [10.1016/B978-008045046-9.00012-7, DOI 10.1016/B978-008045046-9.00012]; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; Kilinc MO, 2006, J IMMUNOL, V177, P6962, DOI 10.4049/jimmunol.177.10.6962; KINNEY RM, 1993, J VIROL, V67, P1269, DOI 10.1128/JVI.67.3.1269-1277.1993; Krasnova Y, 2017, CLIN IMMUNOL, V177, P50, DOI 10.1016/j.clim.2015.10.001; Lasek W., 2016, INTERLEUKIN 12 ANTIT, P43, DOI [10.1007/978-3-319-46906-5_3, DOI 10.1007/978-3-319-46906-5_3]; Lasek W, 2014, CANCER IMMUNOL IMMUN, V63, P419, DOI 10.1007/s00262-014-1523-1; Li L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14000-z; Lohr F, 2000, MOL THER, V2, P195, DOI 10.1006/mthe.2000.0114; Mahvi DM, 2007, CANCER GENE THER, V14, P717, DOI 10.1038/sj.cgt.7701064; Momin N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw2614; Mukhopadhyay A, 2019, GENE THER, V26, P1, DOI 10.1038/s41434-018-0044-5; Odegard JM, 2015, J IMMUNOTHER, V38, P41, DOI 10.1097/CJI.0000000000000067; Ohs I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13708; Oldham RAA, 2015, IMMUNOTHERAPY-UK, V7, P271, DOI [10.2217/IMT.14.108, 10.2217/imt.14.108]; Pantel A, 2012, EUR J IMMUNOL, V42, P101, DOI 10.1002/eji.201141855; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Pearl TM, 2019, MOL THER-ONCOLYTICS, V13, P14, DOI 10.1016/j.omto.2019.03.001; Pegram HJ, 2012, BLOOD, V119, P4133, DOI 10.1182/blood-2011-12-400044; Pollack SM, 2017, J IMMUNOTHER, V40, P302, DOI 10.1097/CJI.0000000000000183; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Quetglas JI, 2015, CANCER IMMUNOL RES, V3, P449, DOI 10.1158/2326-6066.CIR-14-0216; Radoja S, 2001, J IMMUNOL, V166, P6074, DOI 10.4049/jimmunol.166.10.6074; Reed SG, 2018, SEMIN IMMUNOL, V39, P22, DOI 10.1016/j.smim.2018.10.004; Riise RE, 2015, J IMMUNOL, V195, P1121, DOI 10.4049/jimmunol.1500709; Robson NC, 2003, IMMUNOLOGY, V110, P95, DOI 10.1046/j.1365-2567.2003.01705.x; Rodriguez-Madoz JR, 2005, MOL THER, V12, P153, DOI 10.1016/j.ymthe.2005.02.011; Ryffel B, 1997, CLIN IMMUNOL IMMUNOP, V83, P18, DOI 10.1006/clin.1996.4306; Schultz J, 2000, CANCER GENE THER, V7, P1557, DOI 10.1038/sj.cgt.7700273; Seydoux E, 2018, J IMMUNOL, V201, P98, DOI 10.4049/jimmunol.1701604; Shen C, 2017, INT J NANOMED, V12, P5443, DOI 10.2147/IJN.S137980; Steding CE, 2011, IMMUNOLOGY, V133, P221, DOI 10.1111/j.1365-2567.2011.03429.x; Strauss J, 2019, CLIN CANCER RES, V25, P99, DOI 10.1158/1078-0432.CCR-18-1512; Suzuki R, 2010, J CONTROL RELEASE, V142, P245, DOI 10.1016/j.jconrel.2009.10.027; Tareen SU, 2014, MOL THER, V22, P575, DOI 10.1038/mt.2013.278; Thomas ED, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0282-3; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tugues S, 2015, CELL DEATH DIFFER, V22, P237, DOI 10.1038/cdd.2014.134; Vacaflores A, 2017, MOL IMMUNOL, V81, P1, DOI 10.1016/j.molimm.2016.11.008; Vacaflores A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157175; Vijayakumar G, 2020, J VIROL, V94, DOI 10.1128/JVI.01677-19; Watkins SK, 2007, J IMMUNOL, V178, P1357, DOI 10.4049/jimmunol.178.3.1357; Wee EG, 2017, MOL THER, V25, P494, DOI 10.1016/j.ymthe.2016.12.004; Wojno EDT, 2019, IMMUNITY, V50, P851, DOI 10.1016/j.immuni.2019.03.011; Xiao ZG, 2009, J IMMUNOL, V182, P2786, DOI 10.4049/jimmunol.0803484; Ye ZM, 2008, CELL MOL IMMUNOL, V5, P147, DOI 10.1038/cmi.2008.18; Zaharoff DA, 2010, J IMMUNOTHER, V33, P697, DOI 10.1097/CJI.0b013e3181eb826d; Zhang LB, 2015, J IMMUNOTHER, V38, P137, DOI 10.1097/CJI.0000000000000074; Zhao JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046241; Zhao QN, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0631-z; Zhao X, 2011, MOL THER, V19, P805, DOI 10.1038/mt.2010.295; Zheng H, 2016, ADV EXP MED BIOL, V941, P117, DOI 10.1007/978-94-024-0921-56	72	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0259301	10.1371/journal.pone.0259301	http://dx.doi.org/10.1371/journal.pone.0259301			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855754	gold, Green Published			2022-12-26	WOS:000735299000013
J	Salazar, FDG; Ibarguengoitia, MER; Lopez, JRA; Cantu, AG				Garza Salazar, Fernando De la; Romero Ibarguengoitia, Maria Elena; Azpiri Lopez, Jose Ramon; Gonzalez Cantu, Arnulfo			Optimizing ECG to detect echocardiographic left ventricular hypertrophy with computer-based ECG data and machine learning	PLOS ONE			English	Article							ELECTROCARDIOGRAPHIC CRITERIA; DIAGNOSIS; ASSOCIATION; RECOMMENDATIONS; RISK; QRS	Background Left ventricular hypertrophy detected by echocardiography (Echo-LVH) is an independent predictor of mortality. Integration of the Philips DXL-16 algorithm into the electrocardiogram (ECG) extensively analyses the electricity of the heart. Machine learning techniques such as the C5.0 could lead to a new decision tree criterion to detect Echo-LVH. Objectives To search for a new combination of ECG parameters predictive of Echo-LVH. The final model is called the Cardiac Hypertrophy Computer-based model (CHCM). Methods We extracted the 458 ECG parameters provided by the Philips DXL-16 algorithm in patients with Echo-LVH and controls. We used the C5.0 ML algorithm to train, test, and validate the CHCM. We compared its diagnostic performance to validate state-of-the-art criteria in our patient cohort. Results We included 439 patients and considered an alpha value of 0.05 and a power of 99%. The CHCM includes T voltage in I (<= 0.055 mV), peak-to-peak QRS distance in aVL (>1.235 mV), and peak-to-peak QRS distance in aVF (>0.178 mV). The CHCM had an accuracy of 70.5% (CI95%, 65.2-75.5), a sensitivity of 74.3%, and a specificity of 68.7%. In the external validation cohort (n = 156), the CHCM had an accuracy of 63.5% (CI95%, 55.4-71), a sensitivity of 42%, and a specificity of 82.9%. The accuracies of the most relevant state-of-the-art criteria were: Romhilt-Estes (57.4%, CI95% 49-65.5), VDP Cornell (55.7%, CI95%47.6-63.7), Cornell (59%, CI95%50.8-66.8), Dalfo (62.9%, CI95%54.7-70.6), Sokolow Lyon (53.9%, CI95%45.7-61.9), and Philips DXL-16 algorithm (54.5%, CI95%46.3-62.5). Conclusion ECG computer-based data and the C5.0 determined a new set of ECG parameters to predict Echo-LVH. The CHCM classifies patients as Echo-LVH with repolarization abnormalities or LVH with increased voltage. The CHCM has a similar accuracy, and is slightly more sensitive than the state-of-the-art criteria.	[Garza Salazar, Fernando De la; Romero Ibarguengoitia, Maria Elena; Gonzalez Cantu, Arnulfo] Univ Monterrey, Sch Med, Med Specialties, Monterrey, Nuevo Leon, Mexico; [Garza Salazar, Fernando De la] Hosp Christus Muguerza Alta Especialidad, Dept Internal Med, Monterrey, Nuevo Leon, Mexico; [Romero Ibarguengoitia, Maria Elena; Gonzalez Cantu, Arnulfo] Christus Muguerza Hlth Syst, Dept Med Educ & Res Hlth, Monterrey, Nuevo Leon, Mexico; [Azpiri Lopez, Jose Ramon] Hosp Christus Muguerza, Dept Cardiol, Alta Especialidad, Monterrey, Nuevo Leon, Mexico	Universidad de Monterrey	Cantu, AG (corresponding author), Univ Monterrey, Sch Med, Med Specialties, Monterrey, Nuevo Leon, Mexico.; Cantu, AG (corresponding author), Christus Muguerza Hlth Syst, Dept Med Educ & Res Hlth, Monterrey, Nuevo Leon, Mexico.	drgzzcantu@gmail.com	Gonzalez, Arnulfo/AAD-9873-2019	De la Garza Salazar, Fernando/0000-0003-0080-487X; Romero-Ibarguengoitia, Maria Elena/0000-0002-2572-4043; Gonzalez-Cantu, Arnulfo/0000-0003-0103-0079				Auer R, 2012, JAMA-J AM MED ASSOC, V307, P1497, DOI 10.1001/jama.2012.434; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Bressman M, 2020, AM J MED, V133, pE495, DOI 10.1016/j.amjmed.2020.01.042; Brijain M, SURVEY DECISION TREE; CASALE PN, 1985, J AM COLL CARDIOL, V6, P572, DOI 10.1016/S0735-1097(85)80115-7; Dahlof B, 1998, HYPERTENSION, V32, P989, DOI 10.1161/01.HYP.32.6.989; Dalfo, 1997, AM J HYPERTENS, V10; Salazar FD, 2021, ACTA CARDIOL, V76, P272, DOI [10.1080/00015385.2020.1721718, 10.24875/acm.20000246, 10.24875/ACM.20000246]; De la Garza-Salazar F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232657; Dilaveris P, 2000, CLIN CARDIOL, V23, P600, DOI 10.1002/clc.4960230811; Estes EH, 2015, AM HEART J, V170, P1220, DOI 10.1016/j.ahj.2015.09.016; Grant R., 1957, SPATIAL VECTOR APPRO; Gubner R, 1943, ARCH INTERN MED, V72, P196, DOI 10.1001/archinte.1943.00210080052005; Hancock EW, 2009, CIRCULATION, V119, pE251, DOI 10.1161/CIRCULATIONAHA.108.191097; HOLT DH, 1962, AM HEART J, V63, P65, DOI 10.1016/0002-8703(62)90221-1; KANNEL W B, 1970, Annals of Internal Medicine, V72, P813; Kwon JM, 2020, EUROPACE, V22, P412, DOI 10.1093/europace/euz324; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Lewis T, 1914, HEART-J STUD CIRC, V5, P367; Lu N, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0637-8; Luo W, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5870; McPHIE JOHN, 1958, AUSTRALASIAN ANN MED, V7, P317; MOLLOY TJ, 1992, J AM COLL CARDIOL, V20, P1180, DOI 10.1016/0735-1097(92)90376-X; NORMAN JE, 1993, J AM COLL CARDIOL, V21, P1680, DOI 10.1016/0735-1097(93)90387-G; Ogah OS., ELECTROCARDIOGRAPHIC, DOI [10.10520/EJC23083, DOI 10.10520/EJC23083]; Okin PM, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007564; Okin PM, 2002, J AM COLL CARDIOL, V40, P1395, DOI 10.1016/S0735-1097(02)02171-X; Okin PM, 1996, HYPERTENSION, V27, P251, DOI 10.1161/01.HYP.27.2.251; Pewsner D, 2007, BMJ-BRIT MED J, V335, P711, DOI 10.1136/bmj.39276.636354.AE; Prineas RJ, 2001, J ELECTROCARDIOL, V34, P91, DOI 10.1054/jelc.2001.23360; ROMHILT DW, 1968, AM HEART J, V75, P752, DOI 10.1016/0002-8703(68)90035-5; ROMHILT DW, 1969, CIRCULATION, V40, P185, DOI 10.1161/01.CIR.40.2.185; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; Sokolow M, 1956, AM J MED SCI, V232; Sparapani R, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.009959; Sundstrom J, 2001, CIRCULATION, V103, P2346	36	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2021	16	11							e0260661	10.1371/journal.pone.0260661	http://dx.doi.org/10.1371/journal.pone.0260661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9KP	34847202	gold, Green Published			2022-12-26	WOS:000735928900054
J	Deba, F; Munoz, K; Peredia, E; Akk, G; Hamouda, AK				Deba, Farah; Munoz, Kemburli; Peredia, Eloisa; Akk, Gustav; Hamouda, Ayman K.			Assessing potentiation of the (alpha 4)3(beta 2)2 nicotinic acetylcholine receptor by the allosteric agonist CMPI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITE; FLUSTRA-FOLIACEA; ALPHA-4-BETA-2; STOICHIOMETRY; MODULATOR; NS9283; DESFORMYLFLUSTRABROMINE; PHARMACOLOGY; TRANSITIONS; ACTIVATION	The extracellular domain of the nicotinic acetylcholine receptor isoforms formed by three alpha 4 and two beta 2 subunits ((alpha 4) 3(beta 2)2 nAChR) harbors two high-affinity "canonical" acetylcholine (ACh)-binding sites located in the two alpha 4:beta 2 intersubunit interfaces and a low-affinity "noncanonical" ACh-binding site located in the alpha 4:alpha 4 intersubunit interface. In this study, we used ACh, cytisine, and nicotine (which bind at both the alpha 4:alpha 4 and alpha 4:beta 2 interfaces), TC-2559 (which binds at the alpha 4:(32 but not at the alpha 4:alpha 4 interface), and 3-(2-chlorophenyl)-5(5-methyl-1-(piperidin-4-yl)-1H-pyrrazol-4-yl)isoxazole (CMPI, which binds at the alpha 4:alpha 4 but not at the alpha 4:(32 interface), to investigate the binding and gating properties of CMPI at the alpha 4:alpha 4 interface. We recorded whole-cell currents from Xenopus laevis oocytes expressing (alpha 4)3(beta 2)2 nAChR in response to applications of these ligands, alone or in combination. The electrophysiological data were analyzed in the framework of a modified Monod-Wyman-Changeux allosteric activation model. We show that CMPI is a high-affinity, high-efficacy agonist at the alpha 4:alpha 4 binding site and that its weak direct activating effect is accounted for by its inability to productively interact with the alpha 4:beta 2 sites. The data presented here enhance our understanding of the functional contributions of ligand binding at the alpha 4:alpha 4 subunit interface to (alpha 4)3(beta 2)2 nAChR-channel gating. These findings support the potential use of alpha 4:alpha 4 specific ligands to increase the efficacy of the neurotransmitter ACh in conditions associated with decline in nAChRs activity in the brain.	[Deba, Farah; Peredia, Eloisa; Hamouda, Ayman K.] Univ Texas Tyler, Dept Pharmaceut Sci, Tyler, TX 75799 USA; [Munoz, Kemburli] Texas A&M HSC, Dept Pharmaceut Sci, Kingsville, TX USA; [Akk, Gustav] Washington Univ, Dept Anesthesiol, St Louis, MO USA; [Akk, Gustav] Washington Univ, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63110 USA	University of Texas System; University of Texas at Tyler; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Washington University (WUSTL); Washington University (WUSTL)	Hamouda, AK (corresponding author), Univ Texas Tyler, Dept Pharmaceut Sci, Tyler, TX 75799 USA.	Ahamouda@uttyler.edu	Akk, Gustav/CAG-1703-2022	Hamouda, Ayman/0000-0001-7819-3074	National Institutes of Health, National Institute of Neurological Disorders and Stroke [R15NS-093590]; National Institute of General Medical Sciences [R01GM108580, R35GM140947]; University of Texas System Faculty Science and Technology Acquisition and Retention (STARs) Program; Taylor Family Institute for Innovative Psychiatric Research	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Texas System Faculty Science and Technology Acquisition and Retention (STARs) Program; Taylor Family Institute for Innovative Psychiatric Research	This work was supported in part by funds from the National Institutes of Health, National Institute of Neurological Disorders and Stroke [Grant R15NS-093590 to (A. K. H.)], the National Institute of General Medical Sciences [Grants R01GM108580, R35GM140947 to (G. A.)], The University of Texas System Faculty Science and Technology Acquisition and Retention (STARs) Program (A. K. H.), and from the Taylor Family Institute for Innovative Psychiatric Research (G. A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrecht BK, 2008, BIOORG MED CHEM LETT, V18, P5209, DOI 10.1016/j.bmcl.2008.08.080; Benallegue N, 2013, BRIT J PHARMACOL, V170, P304, DOI 10.1111/bph.12268; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Changeux JP, 2010, ANNU REV PHARMACOL, V50, P1, DOI 10.1146/annurev.pharmtox.010909.105741; CONNOLLY J, 1992, BRIT J PHARMACOL, V105, P657, DOI 10.1111/j.1476-5381.1992.tb09035.x; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Deba F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19790-4; DeDominicis KE, 2017, MOL PHARMACOL, V92, P327, DOI 10.1124/mol.116.106880; Eaton MM, 2016, CURR NEUROPHARMACOL, V14, P772, DOI 10.2174/1570159X14666160202121319; Forman SA, 2012, CURR OPIN ANESTHESIO, V25, P411, DOI 10.1097/ACO.0b013e328354feea; Giniatullin RA, 2000, MOL PHARMACOL, V58, P778, DOI 10.1124/mol.58.4.778; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Grupe M, 2013, BRIT J PHARMACOL, V168, P2000, DOI 10.1111/bph.12095; Hamouda AK, 2021, NEUROPHARMACOLOGY, V190, DOI 10.1016/j.neuropharm.2021.108568; Hamouda AK, 2016, MOL PHARMACOL, V89, P575, DOI 10.1124/mol.116.103341; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Indurthi DC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161154; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Kim JS, 2007, BIOORG MED CHEM LETT, V17, P4855, DOI 10.1016/j.bmcl.2007.06.047; Lester HA, 2009, AAPS J, V11, P167, DOI 10.1208/s12248-009-9090-7; Li P, 2010, BRIT J PHARMACOL, V160, P1906, DOI 10.1111/j.1476-5381.2010.00761.x; Marks MJ, 1999, J PHARMACOL EXP THER, V289, P1090; Mazzaferro S, 2019, CELL MOL LIFE SCI, V76, P1151, DOI 10.1007/s00018-018-2993-7; Mazzaferro S, 2014, J BIOL CHEM, V289, P21795, DOI 10.1074/jbc.M114.555136; Mohamed TS, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00071; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moroni M, 2006, J MOL NEUROSCI, V30, P95, DOI 10.1385/JMN:30:1:95; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Olsen JA, 2014, J BIOL CHEM, V289, P24911, DOI 10.1074/jbc.M114.568097; Peters L, 2004, PLANTA MED, V70, P883, DOI 10.1055/s-2004-832610; Richter L, 2012, NAT CHEM BIOL, V8, P455, DOI [10.1038/nchembio.917, 10.1038/NCHEMBIO.917]; Sala F, 2005, NEUROSCI LETT, V373, P144, DOI 10.1016/j.neulet.2004.10.002; SINE SM, 1984, BIOPHYS J, V46, P277, DOI 10.1016/S0006-3495(84)84022-9; Springer SK, 2008, BIOORG MED CHEM LETT, V18, P5643, DOI 10.1016/j.bmcl.2008.08.092; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Steinbach JH, 2019, MOL PHARMACOL, V95, P106, DOI 10.1124/mol.118.113787; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Walsh RM, 2018, NATURE, V557, P261, DOI 10.1038/s41586-018-0081-7; Wang JY, 2018, BRIT J PHARMACOL, V175, P1805, DOI 10.1111/bph.13745; Wang JY, 2015, J BIOL CHEM, V290, P13907, DOI 10.1074/jbc.M115.646786; Wang ZJ, 2017, J BIOL CHEM, V292, P9988, DOI 10.1074/jbc.M116.771246; Weltzin MM, 2015, J PHARMACOL EXP THER, V354, P184, DOI 10.1124/jpet.115.223933	46	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101455	10.1016/j.jbc.2021.101455	http://dx.doi.org/10.1016/j.jbc.2021.101455			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP0ZE	34861241	Green Published, gold			2022-12-26	WOS:000748357700010
J	Pelc, LA; Koester, SK; Kukla, CR; Chen, ZW; Di Cera, E				Pelc, Leslie A.; Koester, Sarah K.; Kukla, Cassandra R.; Chen, Zhiwei; Di Cera, Enrico			The active site region plays a critical role in Na+ binding to thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-THROMBIN; CRYSTAL-STRUCTURE; PROTEIN-C; CONFORMATIONAL SELECTION; THERMODYNAMIC LINKAGE; CONVERTING TRYPSIN; STRUCTURAL BASIS; RAPID KINETICS; INDUCED FIT; RESIDUE 225	The catalytic activity of thrombin and other enzymes of the blood coagulation and complement cascades is enhanced significantly by binding of Na+ to a site >15 angstrom away from the catalytic residue S195, buried within the 180 and 220 loops that also contribute to the primary specificity of the enzyme. Rapid kinetics support a binding mechanism of conformational selection where the Natbinding site is in equilibrium between open (N) and closed (N*) forms and the cation binds selectively to the N form. Allosteric transduction of this binding step produces enhanced catalytic activity. Molecular details on how Na(+ )gains access to this site and communicates allosterically with the active site remain poorly defined. In this study, we show that the rate of the N* -> N transition is strongly correlated with the analogous E* -> E transition that governs the interaction of synthetic and physiologic substrates with the active site. This correlation supports the active site as the likely point of entry for Na+ to its binding site. Mutagenesis and structural data rule out an alternative path through the pore defined by the 180 and 220 loops. We suggest that the active site communicates allosterically with the Na+ site through a network of H-bonded water molecules that embeds the primary specificity pocket. Perturbation of the mobility of 5195 and its H-bonding capabilities alters interaction with this network and influences the kinetics of Na+ binding and allosteric transduction. These findings have general mechanistic relevance for Na+ activated proteases and allosteric enzymes.	[Pelc, Leslie A.; Koester, Sarah K.; Kukla, Cassandra R.; Chen, Zhiwei; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Koester, Sarah K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Saint Louis University; Washington University (WUSTL)	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu		Koester, Sarah/0000-0003-4626-504X	National Institutes of Health [HL049413, HL139554, HL147821]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the National Institutes of Health Research Grants HL049413, HL139554 and HL147821 (E. D. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ayala YM, 2000, PROTEIN SCI, V9, P1589, DOI 10.1110/ps.9.8.1589; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baird TT, 2006, PROTEIN SCI, V15, P1229, DOI 10.1110/ps.062179006; BODE W, 1992, PROTEIN SCI, V1, P426; Chakraborty P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21728-9; Chakraborty P, 2017, BIOCHEMISTRY-US, V56, P2853, DOI 10.1021/acs.biochem.7b00340; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; Di Cera E, 2006, J BIOL CHEM, V281, P1305, DOI 10.1074/jbc.R500023200; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera Enrico, 2020, Biophys Rev, V1, P011303, DOI 10.1063/5.0020997; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EDGINGTON TS, 1991, THROMB HAEMOSTASIS, V66, P67; EIGEN M, 1957, DISCUSS FARADAY SOC, P25; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fersht A.R., 1999, ENZYME STRUCTURE MEC; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Gianni S, 2007, BIOPHYS CHEM, V131, P111, DOI 10.1016/j.bpc.2007.09.009; Gohara DW, 2016, J BIOL CHEM, V291, P20840, DOI 10.1074/jbc.R116.737833; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Guinto ER, 1999, P NATL ACAD SCI USA, V96, P1852, DOI 10.1073/pnas.96.5.1852; HEDSTROM L, 1994, BIOCHEMISTRY-US, V33, P8764, DOI 10.1021/bi00195a018; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Krem MM, 1998, PROTEINS, V30, P34, DOI 10.1002/(SICI)1097-0134(19980101)30:1<34::AID-PROT3>3.0.CO;2-K; Krem MM, 2003, BIOPHYS CHEM, V100, P315, DOI 10.1016/S0301-4622(02)00289-2; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; Krem MM, 2001, EMBO J, V20, P3036, DOI 10.1093/emboj/20.12.3036; Malikayil JA, 1997, BIOCHEMISTRY-US, V36, P1034, DOI 10.1021/bi9622231; Mather T, 1996, EMBO J, V15, P6822, DOI 10.1002/j.1460-2075.1996.tb01073.x; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Niu WL, 2011, BIOCHEMISTRY-US, V50, P6301, DOI 10.1021/bi200878c; Niu WL, 2009, J BIOL CHEM, V284, P36175, DOI 10.1074/jbc.M109.069500; ORTHNER CL, 1978, ARCH BIOCHEM BIOPHYS, V185, P400, DOI 10.1016/0003-9861(78)90182-0; ORTHNER CL, 1980, ARCH BIOCHEM BIOPHYS, V202, P63, DOI 10.1016/0003-9861(80)90406-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Pelc LA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48839-1; Pelc LA, 2015, BIOCHEMISTRY-US, V54, P1457, DOI 10.1021/acs.biochem.5b00014; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Pineda AO, 2006, J BIOL CHEM, V281, P32922, DOI 10.1074/jbc.M605530200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Pozzi N, 2012, BLOOD, V120, P664, DOI 10.1182/blood-2012-03-415323; Prasad S, 2003, P NATL ACAD SCI USA, V100, P13785, DOI 10.1073/pnas.2333109100; Rana S, 2011, P NATL ACAD SCI USA, V108, P5221, DOI 10.1073/pnas.1018860108; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Schmidt AE, 2005, J MOL BIOL, V350, P78, DOI 10.1016/j.jmb.2005.04.052; Schmidt AE, 2002, J BIOL CHEM, V277, P28987, DOI 10.1074/jbc.M201892200; Shamanaev A, 2021, J THROMB HAEMOST, V19, P330, DOI 10.1111/jth.15149; Sichler K, 2002, J MOL BIOL, V322, P591, DOI 10.1016/S0022-2836(02)00747-7; STEINER SA, 1980, BIOCHEM BIOPH RES CO, V94, P340, DOI 10.1016/S0006-291X(80)80226-9; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Stojanovski BM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68078-z; Stojanovski BM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54564-6; Underwood MC, 2000, J BIOL CHEM, V275, P36876, DOI 10.1074/jbc.M001386200; Van Opdenbosch N, 2019, IMMUNITY, V50, P1352, DOI 10.1016/j.immuni.2019.05.020; Vogt AD, 2015, J BIOL CHEM, V290, P22435, DOI 10.1074/jbc.M115.675538; Vogt AD, 2014, BIOPHYS CHEM, V186, P13, DOI 10.1016/j.bpc.2013.09.003; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Vogt AD, 2010, J PHYS CHEM B, V114, P16125, DOI 10.1021/jp105502c; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Yamamoto E, 2011, BIOSCI BIOTECH BIOCH, V75, P2070, DOI 10.1271/bbb.110515; Zhang EL, 1997, BIOPHYS CHEM, V63, P185, DOI 10.1016/S0301-4622(96)02227-2; Zhou Y, 2004, BIOCHEMISTRY-US, V43, P4978, DOI 10.1021/bi049876z	72	2	2	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101458	10.1016/j.jbc.2021.101458	http://dx.doi.org/10.1016/j.jbc.2021.101458			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP0ZE	34861239	gold, Green Published			2022-12-26	WOS:000748357700006
J	Rosa, LP; Eimanifar, A; Kimes, AG; Brooks, SA; Ellis, JD				Rosa, Laura Patterson; Eimanifar, Amin; Kimes, Abigail G.; Brooks, Samantha A.; Ellis, James D.			Attack of the dark clones the genetics of reproductive and color traits of South African honey bees (Apis mellifera spp.)	PLOS ONE			English	Article							THELYTOCOUS PARTHENOGENESIS; SOCIAL PARASITISM; WORKER; CAPENSIS; DROSOPHILA; PIGMENTATION; ASSOCIATION; DYNAMICS; MUTANTS; INSIGHT	The traits of two subspecies of western honey bees, Apis mellifera scutellata and A.m. capensis, endemic to the Republic of South Africa (RSA), are of biological and commercial relevance. Nevertheless, the genetic basis of important phenotypes found in these subspecies remains poorly understood. We performed a genome wide association study on three traits of biological relevance in 234 A.m. capensis, 73 A.m. scutellata and 158 hybrid individuals. Thirteen markers were significantly associated to at least one trait (P <= 4.28 x 10(-6)): one for ovariole number, four for scutellar plate and eight for tergite color. We discovered two possible causative variants associated to the respective phenotypes: a deletion in GB46429 or Ebony (NC_007070.3:g.14101325G>del) (R69Efs*85) and a nonsense on GB54634 (NC_007076.3:g.4492792A>G;p.Tyr128*) causing a premature stop, substantially shortening the predicted protein. The mutant genotypes are significantly associated to phenotypes in A.m. capensis. Loss-of-function of Ebony can cause accumulation of circulating dopamine, and increased dopamine levels correlate to ovary development in queenless workers and pheromone production. Allelic association (P = 1.824 x 10(-5)) of NC_007076.3:g.4492792A> G;p.Tyr128* to ovariole number warrants further investigation into function and expression of the GB54634 gene. Our results highlight genetic components of relevant production/conservation behavioral phenotypes in honey bees.	[Rosa, Laura Patterson; Ellis, James D.] Univ Florida, Dept Entomol & Nematol, Honey Bee Res & Extens Lab, Gainesville, FL 32611 USA; [Kimes, Abigail G.; Brooks, Samantha A.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Brooks, Samantha A.] Univ Florida, UF Genet Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Rosa, LP (corresponding author), Univ Florida, Dept Entomol & Nematol, Honey Bee Res & Extens Lab, Gainesville, FL 32611 USA.	lpattersonr@ufl.edu	Patterson Rosa, Laura/GLU-7082-2022	Patterson Rosa, Laura/0000-0001-5960-3883; Ellis, James/0000-0003-0318-8646; Brooks, Samantha/0000-0002-4500-2689	United States Department of Agriculture, Animal and Plant Health Inspection Service; Florida Department of Agriculture and Consumer Services	United States Department of Agriculture, Animal and Plant Health Inspection Service(United States Department of Agriculture (USDA)); Florida Department of Agriculture and Consumer Services	This work was supported through various cooperative agreements provided by the United States Department of Agriculture, Animal and Plant Health Inspection Service and by the Florida Department of Agriculture and Consumer Services through the guidance of the Honey Bee Technical Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alburaki M, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-117; Allsopp M, 1992, S AFR BEE J, V64, P52; Aumer D, 2019, MOL BIOL EVOL, V36, P516, DOI 10.1093/molbev/msy232; Beggs KT, 2007, P NATL ACAD SCI USA, V104, P2460, DOI 10.1073/pnas.0608224104; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Bustamante T, 2020, APIDOLOGIE, V51, P123, DOI 10.1007/s13592-019-00651-6; Caron D., 2001, AFRICANIZED HONEY BE; Chapman NC, 2015, HEREDITY, V114, P584, DOI 10.1038/hdy.2014.127; Christmas MJ, 2019, MOL BIOL EVOL, V36, P1764, DOI 10.1093/molbev/msz100; Cole-Clark MP, 2017, APIDOLOGIE, V48, P623, DOI 10.1007/s13592-017-0505-7; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Delhey K, 2019, BIOL REV, V94, P1294, DOI 10.1111/brv.12503; Dietemann V, 2007, J EVOLUTION BIOL, V20, P997, DOI 10.1111/j.1420-9101.2007.01303.x; Dombroski TCD, 2003, APIDOLOGIE, V34, P281, DOI 10.1051/apido:2003024; Eimanifar A, 2020, PEERJ, V8, DOI 10.7717/peerj.8280; Eimanifar A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4998-x; Eimanifar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19759-3; Goudie F, 2015, INSECT SOC, V62, P325, DOI 10.1007/s00040-015-0401-y; Gruber K, 2013, ECOL EVOL, V3, P3204, DOI 10.1002/ece3.711; Hartel S, 2006, APIDOLOGIE, V37, P462, DOI 10.1051/apido:2006012; HEISENBERG M, 1971, J EXP BIOL, V55, P85; Hepburn H.R., 1998, HONEYBEES AFRICA; Holman L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09567-2; HOTTA Y, 1969, NATURE, V222, P354, DOI 10.1038/222354a0; Hovemann BT, 1998, GENE, V221, P1, DOI 10.1016/S0378-1119(98)00440-5; Howe J, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00055; Jaffe R, 2009, MOL ECOL, V18, P1511, DOI 10.1111/j.1365-294X.2009.04143.x; Kahsai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011480; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kono Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137407; Kriventseva EV, 2019, NUCLEIC ACIDS RES, V47, pD807, DOI 10.1093/nar/gky1053; Lattorff HMG, 2005, HEREDITY, V94, P533, DOI 10.1038/sj.hdy.6800654; Linksvayer TA, 2009, GENETICS, V183, P693, DOI 10.1534/genetics.109.105452; Massey JH, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00518; Meiselman MR, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0484-9; MORITZ RFA, 1994, HEREDITY, V73, P98, DOI 10.1038/hdy.1994.104; Mumoki FN, 2021, ANN ENTOMOL SOC AM, V114, P219, DOI 10.1093/aesa/saaa056; Nassel DR, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041531; Neumann P, 2001, BEHAV ECOL, V12, P419, DOI 10.1093/beheco/12.4.419; NEWBY LM, 1991, J NEUROGENET, V7, P85, DOI 10.3109/01677069109066213; Onions GW, 1912, AGR J UN S AFR, V1, P720; Phiancharoen M, 2010, APIDOLOGIE, V41, P129, DOI 10.1051/apido/2009054; Pratavieira M, 2018, J PROTEOME RES, V17, P2358, DOI 10.1021/acs.jproteome.8b00098; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RINDERER TE, 1993, SCI AM, V269, P84, DOI 10.1038/scientificamerican1293-84; Rosa LP, 2020, MOL CELL PROBE, V53, DOI 10.1016/j.mcp.2020.101620; Ruttner F., CAPE BEE BIOL CURIOS; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Seeley T. D., 2014, HONEYBEE ECOLOGY STU; Sheppard W., 2015, HIVE HONEY BEE, P53; Shultz M, 2007, J MED LIBR ASSOC, V95, P442, DOI 10.3163/1536-5050.95.4.442; Takahashi A, 2007, GENETICS, V177, P1233, DOI 10.1534/genetics.107.075283; Takahashi A, 2013, GENES GENET SYST, V88, P165, DOI 10.1266/ggs.88.165; Takeuchi H, 2003, INSECT MOL BIOL, V12, P291, DOI 10.1046/j.1365-2583.2003.00414.x; van Noort S., 2021, WASPWEB HYMENOPTERA; Wallberg A, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5642-0; Wallberg A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006792; Wallberg A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006097; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077; Weich K, 2020, GENES-BASEL, V11, DOI 10.3390/genes11010075; Yagound B, 2020, CURR BIOL, V30, P2248, DOI 10.1016/j.cub.2020.04.033; Yamamoto S, 2014, EXP ANIM TOKYO, V63, P107, DOI 10.1538/expanim.63.107; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966	64	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0260833	10.1371/journal.pone.0260833	http://dx.doi.org/10.1371/journal.pone.0260833			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905583	Green Published, gold			2022-12-26	WOS:000754615500014
J	Artelt, N; Ritter, AM; Leitermann, L; Kliewe, F; Schluter, R; Simm, S; van den Brandt, J; Endlich, K; Endlich, N				Artelt, Nadine; Ritter, Alina M.; Leitermann, Linda; Kliewe, Felix; Schlueter, Rabea; Simm, Stefan; van den Brandt, Jens; Endlich, Karlhans; Endlich, Nicole			The podocyte-specific knockout of palladin in mice with a 129 genetic background affects podocyte morphology and the expression of palladin interacting proteins	PLOS ONE			English	Article							LINKING PROTEIN; ACTIN-BINDING; CELL; GLOMERULOSCLEROSIS; STRESS; LASP-1; ALPHA-ACTININ-4; PROGRESSION; MEMBRANE; DYNAMICS	Proper and size selective blood filtration in the kidney depends on an intact morphology of podocyte foot processes. Effacement of interdigitating podocyte foot processes in the glomeruli causes a leaky filtration barrier resulting in proteinuria followed by the development of chronic kidney diseases. Since the function of the filtration barrier is depending on a proper actin cytoskeleton, we studied the role of the important actin-binding protein palladin for podocyte morphology. Podocyte-specific palladin knockout mice on a C57BL/6 genetic background (PodoPalldBL/6-/-) were back crossed to a 129 genetic background (PodoPalld129-/-) which is known to be more sensitive to kidney damage. Then we analyzed the morphological changes of glomeruli and podocytes as well as the expression of the palladin-binding partners Pdlim2, Lasp-1, Amotl1, ezrin and VASP in 6 and 12 months old mice. PodoPalld129-/- mice in 6 and 12 months showed a marked dilatation of the glomerular tuft and a reduced expression of the mesangial marker protein integrin alpha 8 compared to controls of the same age. Furthermore, ultrastructural analysis showed significantly more podocytes with morphological deviations like an enlarged sub-podocyte space and regions with close contact to parietal epithelial cells. Moreover, PodoPalld129-/- of both age showed a severe effacement of podocyte foot processes, a significantly reduced expression of pLasp-1 and Pdlim2, and significantly reduced mRNA expression of Pdlim2 and VASP, three palladin-interacting proteins. Taken together, the results show that palladin is essential for proper podocyte morphology in mice with a 129 background.	[Artelt, Nadine; Ritter, Alina M.; Leitermann, Linda; Kliewe, Felix; Endlich, Karlhans; Endlich, Nicole] Univ Med Greifswald, Inst Anat & Cell Biol, Greifswald, Germany; [Schlueter, Rabea] Univ Greifswald, Dept Biol, Imaging Ctr, Greifswald, Germany; [Simm, Stefan] Univ Med Greifswald, Inst Bioinformat, Greifswald, Germany; [van den Brandt, Jens] Univ Med Greifswald, Cent Core, Greifswald, Germany; [van den Brandt, Jens] Univ Med Greifswald, Res Facil Lab Anim ZSFV, Greifswald, Germany	Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Endlich, N (corresponding author), Univ Med Greifswald, Inst Anat & Cell Biol, Greifswald, Germany.	nicole.endlich@uni-greifswald.de		Endlich, Karlhans/0000-0001-6052-6061				Artelt N, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00292; Artelt N, 2018, J AM SOC NEPHROL, V29, P1662, DOI 10.1681/ASN.2017091039; Beck MR, 2013, J MOL BIOL, V425, P3325, DOI 10.1016/j.jmb.2013.06.016; Boukhelifa M, 2004, CELL MOTIL CYTOSKEL, V58, P17, DOI 10.1002/cm.10173; Butt E, 2003, J BIOL CHEM, V278, P15601, DOI 10.1074/jbc.M209009200; Chew CS, 2002, J CELL SCI, V115, P4787, DOI 10.1242/jcs.00174; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; Gagne V, 2009, CELL MOTIL CYTOSKEL, V66, P754, DOI 10.1002/cm.20405; Garg P, 2018, AM J NEPHROL, V47, P3, DOI 10.1159/000481633; Grunewald TGP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-31; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hartner A, 1999, KIDNEY INT, V56, P1468, DOI 10.1046/j.1523-1755.1999.00662.x; Hartner A, 2008, AM J NEPHROL, V28, P168, DOI 10.1159/000110022; Hartner A, 2010, AM J PHYSIOL-RENAL, V299, pF1151, DOI 10.1152/ajprenal.00058.2010; Hoffmann S, 2004, J AM SOC NEPHROL, V15, P1475, DOI 10.1097/01.ASN.0000127988.42710.A7; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Hugo C, 1998, KIDNEY INT, V54, P1934, DOI 10.1046/j.1523-1755.1998.00195.x; Ishola DA, 2006, NEPHROL DIAL TRANSPL, V21, P591, DOI 10.1093/ndt/gfi303; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kawaguchi K, 2017, BIOL PHARM BULL, V40, P381, DOI 10.1248/bpb.b16-01011; Kindt F, 2017, BRIT J PHARMACOL, V174, P163, DOI 10.1111/bph.13667; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Kriz W, 2018, J AM SOC NEPHROL, V29, P1075, DOI 10.1681/ASN.2018020200; Kriz W, 2015, J AM SOC NEPHROL, V26, P258, DOI 10.1681/ASN.2014030278; Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012; Le Hir M, 2001, J AM SOC NEPHROL, V12, P2060, DOI 10.1681/ASN.V12102060; Lepa C, 2020, FASEB J, V34, P5453, DOI 10.1096/fj.201901443R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Maeda M, 2009, FEBS J, V276, P2775, DOI 10.1111/j.1742-4658.2009.07001.x; Michaud JL, 2003, J AM SOC NEPHROL, V14, P1200, DOI 10.1097/01.ASN.0000059864.88610.5E; Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060; NAGATA M, 1992, KIDNEY INT, V42, P148, DOI 10.1038/ki.1992.272; Ougaard MKE, 2018, INT J NEPHROL, V2018, DOI 10.1155/2018/8424502; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Perico L, 2016, NAT REV NEPHROL, V12, P692, DOI 10.1038/nrneph.2016.127; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Ronty M, 2004, FEBS LETT, V566, P30, DOI 10.1061/j.febslet.2004.04.006; Safiri S, 2019, ANN RHEUM DIS, V78, P1463, DOI 10.1136/annrheumdis-2019-215920; Sato S, 2009, PATHOBIOLOGY, V76, P221, DOI 10.1159/000228897; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Sistani L, 2011, KIDNEY INT, V80, P1045, DOI 10.1038/ki.2011.231; Smeets B, 2012, SEMIN NEPHROL, V32, P357, DOI 10.1016/j.semnephrol.2012.06.007; Steppan J, 2020, HYPERTENS RES, V43, P1175, DOI 10.1038/s41440-020-0467-4; Tan J, 2017, NEURAL DEV, V12, DOI 10.1186/s13064-017-0081-6; Wang HV, 2008, DEV DYNAM, V237, P3342, DOI 10.1002/dvdy.21755; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wong GT, 2002, NEUROPEPTIDES, V36, P230, DOI 10.1054/npep.2002.0905	52	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260878	10.1371/journal.pone.0260878	http://dx.doi.org/10.1371/journal.pone.0260878			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879092	gold, Green Published			2022-12-26	WOS:000754625200033
J	Zhang, YM; Chen, QC; Huang, YH; Zhao, RQ; Sun, J; Yuan, XD; Xu, HM; Liu, HY; Wu, YS				Zhang, Yangmei; Chen, Qicong; Huang, Yuanheng; Zhao, Ruiqiang; Sun, Jian; Yuan, Xidong; Xu, Huiming; Liu, Huiyu; Wu, Yaosheng			Gene excavation and expression analysis of CYP and UGT related to the post modifying stage of gypenoside biosynthesis in Gynostemma pentaphyllum (Thunb.) Makino by comprehensive analysis of RNA and proteome sequencing	PLOS ONE			English	Article							TRITERPENOID SAPONINS; P450S	Previous studies have revealed that gypenosides produced from Gynostemma pentaphyllum (Thunb.) Makino are mainly dammarane-type triterpenoid saponins with diverse structures and important biological activities, but the mechanism of diversity for gypenoside biosynthesis is still unclear. In this study, a combination of isobaric tags for relative and absolute quantification (iTRAQ) proteome analysis and RNA sequencing transcriptome analysis was performed to identify the proteins and genes related to gypenoside biosynthesis. A total of 3925 proteins were identified by proteomic sequencing, of which 2537 were quantified. Seventeen cytochrome P450 (CYP) and 11 uridine 5'-diphospho-glucuronosyltransferase (UDP-glucuronosyltransferase, UGT) candidate genes involved in the side chain synthesis and modification of gypenosides were found. Seven putative CYPs (CYP71B19, CYP77A3, CYP86A7, CYP86A8, CYP89A2, CYP90A1, CYP94A1) and five putative UGTs (UGT73B4, UGT76B1, UGT74F2, UGT91C1 and UGT91A1) were selected as candidate structural modifiers of triterpenoid saponins, which were cloned for gene expression analysis. Comprehensive analysis of RNA sequencing and proteome sequencing showed that some CYPs and UGTs were found at both the transcription and translation levels. In this study, an expression analysis of 7 CYPs and 5 UGTs that contributed to gypenoside biosynthesis and distribution in G. pentaphyllum was performed, providing consistent results that will inspire more future research on vital genes/proteins involved in gypenoside biosynthesis.	[Zhang, Yangmei; Chen, Qicong; Huang, Yuanheng; Zhao, Ruiqiang; Sun, Jian; Yuan, Xidong; Xu, Huiming; Liu, Huiyu; Wu, Yaosheng] Guangxi Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Biol Mol Med Res Guangxi Higher Educ, Nanning, Peoples R China; [Zhang, Yangmei] Sichuan Nursing Vocat Coll, Dept Nursing, Nanchong, Sichuan, Peoples R China; [Chen, Qicong] South China Univ Technol, Sch Biomed Sci & Engn, Guangzhou, Guangdong, Peoples R China	Guangxi Medical University; South China University of Technology	Wu, YS (corresponding author), Guangxi Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Biol Mol Med Res Guangxi Higher Educ, Nanning, Peoples R China.	wuyaosheng03@sina.com		Chen, Qicong/0000-0002-3903-5361	Natural Science Foundation of Guangxi [2018GXNSFAA281209]; 2019 Innovation Research Fund for scientific research and cultivation of Basic Medical College [GXMUBMSTCF-G33]	Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province); 2019 Innovation Research Fund for scientific research and cultivation of Basic Medical College	This research was funded by General projects of Natural Science Foundation of Guangxi, (grant number 2018GXNSFAA281209) and 2019 Innovation Research Fund for scientific research and cultivation of Basic Medical College (grant number GXMUBMSTCF-G33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L, 2016, ONCOTARGET, V7, P31226, DOI 10.18632/oncotarget.8886; Chen Q., 2018, INVESTIGATION GENE I; Chen QC, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/7840914; Chen WP, 2014, GENOME BIOL EVOL, V6, P1620, DOI 10.1093/gbe/evu132; Cordova P, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3942-9; Ghosh S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01886; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062714; Hamid K, 2015, CURR TOP MED CHEM, V15, P2406, DOI 10.2174/1568026615666150619141940; Haralampidis K, 2002, ADV BIOCHEM ENG BIOT, V75, P31; Hernandez-Martinez F, 2016, FUNGAL BIOL-UK, V120, P1077, DOI 10.1016/j.funbio.2016.06.005; Hu YM, 2010, PHYTOCHEMISTRY, V71, P1149, DOI 10.1016/j.phytochem.2010.04.003; Huang LL, 2012, PLANTA, V236, P1571, DOI 10.1007/s00425-012-1712-0; Huang SQ, 2013, MOL BIOSYST, V9, P2565, DOI 10.1039/c3mb70188c; Jia D, 2015, CARBOHYD POLYM, V122, P93, DOI 10.1016/j.carbpol.2014.12.032; Liang TT, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6000-y; Liu MH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1477-5; Luo X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30088-3; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; Mestres J, 2005, PROTEINS, V58, P596, DOI 10.1002/prot.20354; Mo GY, 2019, CHIN J NAT MEDICINES, V17, P131, DOI 10.1016/S1875-5364(19)30015-9; Moses T, 2015, MOL PLANT, V8, P122, DOI 10.1016/j.molp.2014.11.004; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Poulos TL., 1995, STRUCTURES CYTOCHROM; Qian JY, 2019, INT J GENOMICS, V2019, DOI 10.1155/2019/5913491; Qian JY, 2017, BMC MOL BIOL, V18, DOI 10.1186/s12867-017-0081-4; Rahimi S, 2019, BIOTECHNOL ADV, V37, DOI 10.1016/j.biotechadv.2019.04.016; Sawai S, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00025; Seki H, 2015, PLANT CELL PHYSIOL, V56, P1463, DOI 10.1093/pcp/pcv062; Shen CY, 2018, J AGR FOOD CHEM, V66, P11337, DOI 10.1021/acs.jafc.8b03903; Shi L, 2011, J ASIAN NAT PROD RES, V13, P168, DOI 10.1080/10286020.2010.547029; Syed K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095616; Tai WCS, 2016, PROTEOMICS, V16, P1557, DOI 10.1002/pmic.201500293; Wang J, 2017, J AGR FOOD CHEM, V65, P5926, DOI 10.1021/acs.jafc.7b01477; Wilson AE, 2019, PLANT J, V100, P1273, DOI 10.1111/tpj.14514; Xiao H, 2019, TRENDS BIOTECHNOL, V37, P618, DOI 10.1016/j.tibtech.2018.11.008; Xu J, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix093; Yu HS, 2011, PHYTOCHEMISTRY, V72, P862, DOI 10.1016/j.phytochem.2011.03.020; Zeng JG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053409, 10.1371/journal.pone.0082091]; Zhang XS, 2017, PHYTOCHEMISTRY, V144, P226, DOI 10.1016/j.phytochem.2017.09.021; Zhang Z, 2010, PHYTOCHEMISTRY, V71, P693, DOI 10.1016/j.phytochem.2009.12.017; Zheng BB, 2014, J PROTEOME RES, V13, P2998, DOI 10.1021/pr500126g; [朱灵英 Zhu Lingying], 2019, [中草药, Chinese Traditional and Herbal Drugs], V50, P5597	42	3	3	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260027	10.1371/journal.pone.0260027	http://dx.doi.org/10.1371/journal.pone.0260027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874937	gold, Green Published			2022-12-26	WOS:000753617500014
J	Moriarty, RV; Golfinos, AE; Gellerup, DD; Schweigert, H; Mathiaparanam, J; Balgeman, AJ; Weiler, AM; Friedrich, TC; Keele, BF; Davenport, MP; Venturi, V; O'Connor, SL				Moriarty, Ryan, V; Golfinos, Athena E.; Gellerup, Dane D.; Schweigert, Hannah; Mathiaparanam, Jaffna; Balgeman, Alexis J.; Weiler, Andrea M.; Friedrich, Thomas C.; Keele, Brandon F.; Davenport, Miles P.; Venturi, Vanessa; O'Connor, Shelby L.			The mucosal barrier and anti-viral immune responses can eliminate portions of the viral population during transmission and early viral growth	PLOS ONE			English	Article							CLASS-I ALLELES; DISEASE PROGRESSION; VIRUS; ESCAPE; INFECTION; MAMU-A-ASTERISK-01; MACAQUES	Little is known about how specific individual viral lineages replicating systemically during acute Human Immunodeficiency Virus or Simian Immunodeficiency Virus (HIV/SIV) infection persist into chronic infection. In this study, we use molecularly barcoded SIV (SIVmac239M) to track distinct viral lineages for 12 weeks after intravenous (IV) or intrarectal (IR) challenge in macaques. Two Mafa-A1*063+ cynomolgus macaques (Macaca fascicularis, CM) were challenged IV, and two Mamu-A1*001+ rhesus macaques (Macaca mulatta, RM) were challenged IR with 200,000 Infectious Units (IU) of SIVmac239M. We sequenced the molecular barcode of SIVmac239M from all animals over the 12 weeks of the study to characterize the diversity and persistence of virus lineages. During the first three weeks post-infection, we found ~70-560 times more unique viral lineages circulating in the animals challenged IV compared to those challenged IR, which is consistent with the hypothesis that the challenge route is the primary driver restricting the transmission of individual viral lineages. We also characterized the sequences of T cell epitopes targeted during acute SIV infection, and found that the emergence of escape variants in acutely targeted epitopes can occur on multiple virus templates simultaneously, but that elimination of some of these templates is likely a consequence of additional host factors. These data imply that virus lineages present during acute infection can still be eliminated from the systemic virus population even after initial selection.	[Moriarty, Ryan, V; Golfinos, Athena E.; Schweigert, Hannah; Mathiaparanam, Jaffna; Balgeman, Alexis J.; O'Connor, Shelby L.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Moriarty, Ryan, V] Univ Wisconsin, Microbiol Doctoral Training Program, Madison, WI USA; [Gellerup, Dane D.; Weiler, Andrea M.; Friedrich, Thomas C.; O'Connor, Shelby L.] Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Weiler, Andrea M.; Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Keele, Brandon F.] Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD USA; [Davenport, Miles P.; Venturi, Vanessa] UNSW Sydney, Kirby Inst Infect & Immun, Infect Analyt Program, Sydney, NSW, Australia	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of New South Wales Sydney; Kirby Institute	O'Connor, SL (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.; O'Connor, SL (corresponding author), Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.	slfeinberg@wisc.edu		Moriarty, Ryan/0000-0001-7100-1906	Office of The Director, National Institutes of Health [P51OD011106]; WNPRC Pilot Grant program; NIH [R01 AI08415]; National Cancer Institute, National Institutes of Health [75N91019D00024]; Australian National Health and Medical Research Council (NHMRC) [1080001, 1052979, 1067590]	Office of The Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WNPRC Pilot Grant program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by the Office of The Director, National Institutes of Health under Award Number P51OD011106 to the Wisconsin National Primate Research Center, University of Wisconsin-Madison, including support through the WNPRC Pilot Grant program. (https://www.nih.gov/institutes-nih/nih-office-director) (RVM, AEG, DDG, HS, JM, AJB, AMW, TCF, and SLO) This project was also supported as follows: a. A supplemental task order to NIH R01 AI08415 (SLO, DDG, HS, and JM) b.The National Cancer Institute, National Institutes of Health, under Contract No. 75N91019D00024 (BFK) (https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci) c. The Australian National Health and Medical Research Council (NHMRC) grants 1080001 and 1052979 (to MPD) (https://www.nhmrc.gov.au) d. An NHMRC Career Development Fellowship 1067590 (to VV). (https://www.nhmrc.gov.au/funding/find-funding/development-grants) The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Adnan S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004633; Aliota MT, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006964; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Budde ML, 2012, J VIROL, V86, P7596, DOI 10.1128/JVI.00716-12; Butler DM, 2009, J VIROL METHODS, V162, P280, DOI 10.1016/j.jviromet.2009.08.002; Cline AN, 2005, J MED PRIMATOL, V34, P303; Del Prete GQ, 2014, J VIROL, V88, P8077, DOI 10.1128/JVI.01026-14; Deleage C, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav7116; Fennessey CM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006359; Gellerup DD, 2016, J VIROL, V90, P545, DOI 10.1128/JVI.02587-15; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Immonen TT, 2020, P NATL ACAD SCI USA, V117, P494, DOI 10.1073/pnas.1914967117; Kaizu M, 2007, IMMUNOGENETICS, V59, P693, DOI 10.1007/s00251-007-0233-7; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Khanal S, 2020, J VIROL, V94, DOI 10.1128/JVI.01420-19; Kijak GH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006510; Loh L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040012; Martin CJ, 2017, MBIO, V8, DOI 10.1128/mBio.00312-17; Moriarty RV., SIV TRANSMISSION STU; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; O'Connor DH, 2003, J VIROL, V77, P9029, DOI 10.1128/JVI.77.16.9029-9040.2003; O'Connor SL, 2012, J VIROL, V86, P605, DOI 10.1128/JVI.05511-11; O'Connor SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000524; Pinkevych M, 2019, ELIFE, V8, DOI 10.7554/eLife.49022; Pinkevych M, 2018, J VIROL, V92, DOI 10.1128/JVI.01667-17; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Shaw GM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006965; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sutton MS, 2018, J VIROL, V92, DOI 10.1128/JVI.00830-18; Vanderford TH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002048; Weger-Lucarelli J, 2018, VIROLOGY, V521, P138, DOI 10.1016/j.virol.2018.06.004; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Zhang ZQ, 2002, J VIROL, V76, P12845, DOI 10.1128/JVI.76.24.12845-12854.2002	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260010	10.1371/journal.pone.0260010	http://dx.doi.org/10.1371/journal.pone.0260010			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855793	gold, Green Published			2022-12-26	WOS:000735299000026
J	Shi, PH; Chen, ZX; Meng, J; Su, MM; Yang, XG; Fan, WG; Shi, HX; Gao, Y; Lu, XL				Shi, Penghui; Chen, Zhixia; Meng, Juan; Su, Miaomiao; Yang, Xuegang; Fan, Weiguang; Shi, Haoxi; Gao, Ying; Lu, Xinli			Molecular transmission networks and pre-treatment drug resistance among individuals with acute HIV-1 infection in Baoding, China	PLOS ONE			English	Article								Background Human immunodeficiency virus type 1 (HIV-1) genetic diversity and pre-treatment drug resistance (PDR) are major barriers to successful antiretroviral therapy (ART). In China, sexual intercourse is the most frequent route of HIV-1 transmission. However, few studies have analyzed PDR and transmission networks in detail among individuals in China with acute HIV-1 infection and their sexual contacts. Methods A cross-sectional study was conducted in Baoding City, Hebei Province, China from 2019-2020. CD4 T cell counts and viral loads were assessed and a HIV-1 genotypic PDR assay was developed in-house. Transmission networks were visualized using Cytoscape with a threshold genetic distance of 0.015 among HIV-1 subtypes. Results From 139 newly diagnosed and drug-naive individuals with HIV-1, 132 pol gene sequences were obtained and revealed eight HIV-1 subtypes. Circulating recombinant form (CRF)01_AE was the most frequent subtype (53.0%, 70/132) followed by CRF07_BC (26.5%, 35/132), B (13.6%, 18/132), unique recombinant forms (2.3%, 3/132), CRF55_01B (1.5%, 2/132), CRF103_01B (1.5%, 2/132), CRF65_cpx (0.8%, 1/132), and C (0.8%, 1/132). A total of 47 pol gene sequences were used to generate 10 molecular transmission networks. The overall prevalence of PDR was 7.6% and that of PDR to non-nucleotide reverse transcriptase inhibitors was 6.1%. Of three transmission networks for PDR, two were closely associated with Beijing and Tianjin, while another was restricted to sequences determined in this study. Conclusions These results demonstrate that during acute HIV-1 infection, PDR is transmitted in dynamic networks. This suggests that early detection, diagnosis, surveillance, and treatment are critical to effectively control HIV-1 spread.	[Shi, Penghui; Fan, Weiguang; Shi, Haoxi; Gao, Ying] Peoples Hosp Baoding, Clin Lab, Baoding, Hebei, Peoples R China; [Chen, Zhixia; Meng, Juan; Su, Miaomiao; Yang, Xuegang] Peoples Hosp Baoding, Infect Div, Baoding, Hebei, Peoples R China; [Lu, Xinli] Hebei Prov Ctr Dis Control & Prevent, Dept AIDS Res, Shjiazhuang, Hebei, Peoples R China		Lu, XL (corresponding author), Hebei Prov Ctr Dis Control & Prevent, Dept AIDS Res, Shjiazhuang, Hebei, Peoples R China.	lxlii2009@163.com		lu, xinli/0000-0003-4613-2028	Science and Technology Planning Project of Baoding Prefecture [1951ZF007]; People's Hospital of Baoding; The findings and conclusions in this article are those of the authors and do not necessarily represent the official position	Science and Technology Planning Project of Baoding Prefecture; People's Hospital of Baoding; The findings and conclusions in this article are those of the authors and do not necessarily represent the official position	This study was supported by the Science and Technology Planning Project of Baoding Prefecture (1951ZF007) through the People's Hospital of Baoding. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the funding agencies.	AIDS and Hepatitis C Professional Group Society of Infectious Diseases Chinese Medical Association, 2018, Zhonghua Nei Ke Za Zhi, V57, P867, DOI 10.3760/cma.j.issn.0578-1426.2018.12.002; [Anonymous], YAN ZHAO EVENING NEW; Chen Suliang, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P460; Chinese Center for Disease Control and Prevention, 2016, MAN NAT FREE ANT TRE, V4th; Cihlar T, 2016, CURR OPIN VIROL, V18, P50, DOI 10.1016/j.coviro.2016.03.004; Gupta RK, 2018, LANCET INFECT DIS, V18, P346, DOI [10.1016/s1473-3099(17)30702-8, 10.1016/S1473-3099(17)30702-8]; Kang RH, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00668-5; Lu Da-Yong, 2018, Infectious Disorders - Drug Targets, V18, P15, DOI 10.2174/1871526517666170505122800; Lu XL, 2018, AIDS RES HUM RETROV, V34, P1083, DOI [10.1089/aid.2018.0142, 10.1089/AID.2018.0142]; Lu XL, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0133-3; Macdonald V, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25656; Mackie N., 2006, ANTIRETROVIRAL RESIS; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Simonetti FR, 2015, CURR OPIN HIV AIDS, V10, P49, DOI 10.1097/COH.0000000000000120; UNAIDS, 2021 PROGR REP GLOB; UNAIDS, 2014, UND FAST TRACK ACC A; Usach I, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18567; Wang TX., SUMMARY HIV AIDS EPI; Wang ZY, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3927-1; World Health Organization, UPD REC 1 2 LIN ANT; World Health Organization, 2019, HIV DRUG RES REP 201; Ye JR, 2020, AIDS, V34, P609, DOI 10.1097/QAD.0000000000002468; Zeng R, 2020, AIDS RES HUM RETROV, V36, P852, DOI [10.1089/AID.2020.0056, 10.1089/aid.2020.0056]	23	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260670	10.1371/journal.pone.0260670	http://dx.doi.org/10.1371/journal.pone.0260670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855860	gold, Green Published			2022-12-26	WOS:000735299000089
J	Bradshaw, E; Whale, K; Burston, A; Wylde, V; Gooberman-Hill, R				Bradshaw, E.; Whale, K.; Burston, A.; Wylde, V; Gooberman-Hill, R.			Value, transparency, and inclusion: A values-based study of patient involvement in musculoskeletal research	PLOS ONE			English	Article							PUBLIC INVOLVEMENT; SOCIOECONOMIC-STATUS; CITIZENS JURIES; HEALTH RESEARCH; QUALITY; PEOPLE; SAFETY; POLICY; CARE	Background Patient and public involvement work (PPI) is essential to good research practice. Existing research indicates that PPI offers benefits to research design, conduct, communication, and implementation of findings. Understanding how PPI works and its value helps to provide information about best practice and highlight areas for further development. This study used a values-based approach to reporting PPI at a Research Unit focused on musculoskeletal conditions within a UK medical school. Methods The study was conducted between October 2019 and January 2020 using Gradinger's value system framework as a theoretical basis. The framework comprises three value systems each containing five clusters. All PPI members and researchers who had attended PPI groups were invited to participate. Participants completed a structured questionnaire based on the value system framework; PPI members also provided further information through telephone interviews. Data were deductively analysed using a framework approach with data mapped onto value systems. Results Twelve PPI members and 17 researchers took part. Views about PPI activity mapped onto all three value systems. PPI members felt empowered to provide their views, and that their opinions were valued by researchers. It was important to PPI members that they were able to 'give back' and to do something positive with their experiences. Researchers would have liked the groups to be more representative of the wider population, patients highlighted that groups could include more younger members. Researchers recognised the value of PPI, and the study highlighted areas where researchers members might benefit from further awareness. Conclusions Three areas for development were identified: (i) facilitating researcher engagement in training about the value and importance of PPI in research; (ii) support for researchers to reflect on the role that PPI plays in transparency of healthcare research; (iii) work to further explore and address aspects of diversity and inclusion in PPI.	[Bradshaw, E.; Whale, K.; Wylde, V; Gooberman-Hill, R.] Univ Bristol, Bristol, Avon, England; [Bradshaw, E.] Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol, Avon, England; [Whale, K.; Burston, A.; Wylde, V; Gooberman-Hill, R.] Univ Bristol, Bristol Med Sch, Musculoskeletal Res Unit, Translat Hlth Sci, Bristol, Avon, England; [Whale, K.; Wylde, V; Gooberman-Hill, R.] Univ Hosp Bristol & Weston NHS Fdn Trust, Natl Inst Hlth Res Bristol, Biomed Res Ctr, Bristol, Avon, England	University of Bristol; University of Bristol	Whale, K (corresponding author), Univ Bristol, Bristol, Avon, England.; Whale, K (corresponding author), Univ Bristol, Bristol Med Sch, Musculoskeletal Res Unit, Translat Hlth Sci, Bristol, Avon, England.; Whale, K (corresponding author), Univ Hosp Bristol & Weston NHS Fdn Trust, Natl Inst Hlth Res Bristol, Biomed Res Ctr, Bristol, Avon, England.	katie.whale@bristol.ac.uk		Bradshaw, Elizabeth/0000-0002-6176-9759; Gooberman-Hill, Rachael/0000-0003-3353-2882; Wylde, Vikki/0000-0002-8460-1529	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme [RP-PG-061320001]; NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust; University of Bristol; National Institute for Health Research and Versus Arthritis	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust; University of Bristol; National Institute for Health Research and Versus Arthritis	RGH, AB, LB: National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme [RP-PG-061320001] https://www.nihr.ac.uk/KW, RGH, VW: This study was also supported by the NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. https://www.nihr.ac.uk/https://www.bristolbrc.nihr.ac.uk/The work of PEP-R has been variously funded in grants from the National Institute for Health Research and Versus Arthritis. https://www.nihr.ac.uk/https://www.versusarthritis.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Alvarez-Galvez J, 2016, SOC SCI RES, V56, P133, DOI 10.1016/j.ssresearch.2015.12.011; Austin JM, 2016, JAMA-J AM MED ASSOC, V316, P1661, DOI 10.1001/jama.2016.14039; Bagley Heather J, 2016, Res Involv Engagem, V2, P15, DOI 10.1186/s40900-016-0029-8; Barber S., 2019, HEALTH EXPECT, P1, DOI [10.1111/hex.12863, DOI 10.1111/HEX.12863]; Birchley G, 2020, HEALTH CARE ANAL, V28, P73, DOI 10.1007/s10728-019-00380-y; Boote J, 2010, HEALTH POLICY, V95, P10, DOI 10.1016/j.healthpol.2009.11.007; Boylan AM, 2019, HEALTH EXPECT, V22, P721, DOI 10.1111/hex.12883; Brett J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016948; Chew-Graham CA, 2019, HEALTH EXPECT, V22, P273, DOI 10.1111/hex.12922; Crocker JC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4738; Davies C., 2006, CITIZENS CTR DELIBER; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Dudley L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128817; Excellence NTNIfHaC, 2013, PATIENT PUBLIC INVOL; Fudge N, 2008, BMJ-BRIT MED J, V336, P313, DOI 10.1136/bmj.39456.552257.BE; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gooberman-Hill R, 2008, HEALTH EXPECT, V11, P272, DOI 10.1111/j.1369-7625.2008.00502.x; Gooberman-Hill R, 2013, MUSCULOSKELET CARE, V11, P187, DOI 10.1002/msc.1060; Gooberman-Hill R, 2013, HEALTH EXPECT, V16, pE100, DOI 10.1111/hex.12043; Gradinger F, 2015, HEALTH EXPECT, V18, P661, DOI 10.1111/hex.12158; Grand A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121874; Greenhalgh T, 2019, HEALTH EXPECT, V22, P785, DOI 10.1111/hex.12888; Hewlett S, 2006, ARTHRIT RHEUM-ARTHR, V55, P676, DOI 10.1002/art.22091; INVOLVE, 2012, BRIEF NOT RES INV PU; Ives J, 2013, J MED ETHICS, V39, P181, DOI 10.1136/medethics-2011-100150; Keenan J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215953; Kernick D, 2010, J INTERPROF CARE, V24, P31, DOI 10.3109/13561820903012073; Komporozos-Athanasiou A, 2018, HUM RELAT, V71, P1264, DOI 10.1177/0018726717740410; Lungu E, 2016, Open Orthop J, V10, P213, DOI 10.2174/1874325001610010213; Madden M, 2017, FRONT SOCIOL, V2, DOI 10. 3389/fsoc. 2017. 00007; Mangir N, 2019, CURR OPIN UROL, V29, P414, DOI 10.1097/MOU.0000000000000622; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; MHRA, 2017, MED HEALTHC PROD REG; Morse JM, 2015, QUAL HEALTH RES, V25, P1212, DOI 10.1177/1049732315588501; Mota REM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-225; Ocloo JE, 2012, HEALTH EXPECT, V15, P424, DOI 10.1111/j.1369-7625.2011.00695.x; Oversveen E, 2017, SCAND J PUBLIC HEALT, V45, P103, DOI 10.1177/1403494816686711; Parkinson J, 2004, PUBLIC ADMIN, V82, P377, DOI 10.1111/j.0033-3298.2004.00399.x; Pimbert, 2001, PLA NOTES, P23; Registry NJ, 2020, NATION JOINT REGISTR; Research NIfH, NIHR EV 2020; Research NIfH, 2020, STRENGTH OUR COMM EQ; Salsberg J, 2019, PLOS ONE, V14; Schilling Imke, 2019, Res Involv Engagem, V5, P15, DOI 10.1186/s40900-019-0145-3; Shimmin C, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2463-1; Staley K, 2014, HEALTH EXPECT, V17, P755, DOI 10.1111/hex.12017; Street J, 2014, SOC SCI MED, V109, P1, DOI 10.1016/j.socscimed.2014.03.005; Tracy SJ, 2010, QUAL INQ, V16, P837, DOI 10.1177/1077800410383121; Ward PR, 2010, J SOCIOL, V46, P63, DOI 10.1177/1440783309351771	49	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260617	10.1371/journal.pone.0260617	http://dx.doi.org/10.1371/journal.pone.0260617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852018	Green Published, gold			2022-12-26	WOS:000755762900051
J	Shutters, ST				Shutters, Shade T.			Modelling long-term COVID-19 impacts on the US workforce of 2029	PLOS ONE			English	Article								While ensuring employment opportunities is critical for global progress and stability, workers are now subject to several disruptive trends, including automation, rapid changes in technology and skill requirements, and transitions to low-carbon energy production. Yet, these trends seem almost insignificant compared to labor impact of the COVID-19 pandemic. While much has been written about the pandemic's short-term impacts, this study analyzes anticipated long-term impacts on the labor force of 2029 by comparing original 2029 labor projections to special COVID-adjusted projections recently published by the US Bureau of Labor Statistics. Results show that future demand for nearly every type of labor skill and knowledge will increase, while the nature of work shifts from physical to more cognitive activities. Of the nearly three million jobs projected to disappear by 2029 due to COVID, over 91% are among workers without a bachelor's degree. Among workers with a degree demand shifts primarily from business-related degrees to computer and STEM degrees. Results further show that the socialness of labor, which is important for both innovation and productivity, increases in many more industries than it decreases. Finally, COVID will likely accelerate the adoption of teleworking and slightly decrease the rate of workforce automation. These impacts, combined with a shift to more cognitive worker activities, will likely impact the nature of workforce health and safety with less focus on physical injuries and more on illnesses related to sedentary lifestyles. Overall, results suggest that future workers will need to engage more often in training and skill acquisition, requiring life-long learning and skill maintenance strategies.	[Shutters, Shade T.] Arizona State Univ, Sch Complex Adapt Syst, Tempe, AZ 85281 USA; [Shutters, Shade T.] Global Climate Forum, Berlin, Germany	Arizona State University; Arizona State University-Tempe	Shutters, ST (corresponding author), Arizona State Univ, Sch Complex Adapt Syst, Tempe, AZ 85281 USA.; Shutters, ST (corresponding author), Global Climate Forum, Berlin, Germany.	shade.shutters@asu.edu		Shutters, Shade T./0000-0002-8072-4134	US National Science Foundation [2029146]	US National Science Foundation(National Science Foundation (NSF))	STS was supported by Grant 2029146 from the US National Science Foundation www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author and do not necessarily reflect the views of the National Science Foundation.	Abedi V, 2021, J RACIAL ETHN HEALTH, V8, P732, DOI [10.1007/s40615-020-00833-4, 10.1101/2020.04.26.20079756]; Abraham J, 2017, NEW POLIT SCI, V39, P218, DOI 10.1080/07393148.2017.1301313; Bayham J, 2020, LANCET PUBLIC HEALTH, V5, pE271, DOI 10.1016/S2468-2667(20)30082-7; Blundell R, 2020, FISC STUD, V41, P291, DOI 10.1111/1475-5890.12232; Buchan D., 2012, ENERGIEWENDE GERMANY; Cortes G.M., 2020, HETEROGENEOUS LABOR, DOI 10.17848/wp20-327; Dedele A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234595; Deming DJ., 2019, NATL BUREAU EC RES W; Dingel JI, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104235; Frey CB, 2017, TECHNOL FORECAST SOC, V114, P254, DOI 10.1016/j.techfore.2016.08.019; Gawel E, 2014, ENERGY SUSTAIN SOC, V4, DOI 10.1186/s13705-014-0015-7; Gownder J. P., 2017, FUTURE JOBS 2027 WOR; Groshen Erica L, 2020, Bus Econ, V55, P213, DOI 10.1057/s11369-020-00193-1; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Harpaz I., 2002, WORK STUDY, V51, P74, DOI [10.1108/00438020210418791, DOI 10.1108/00438020210418791, https://doi.org/10.1108/00438020210418791]; Healy M L, 2000, AAOHN J, V48, P305; Ice L, 2021, MON LABOR REV; International Organization for Migration, 2015, WORLD MIGRATION REPO; Joice Wendell., 2007, PUBLIC MANAGER, V36, P64, DOI 10.1016/j.ijcard.2013.03.078; Karako K, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-5334; Khamis M., 2021, 58 WORLD BANK GROUP; Kord H., 2017, DUTCH J FINANCE MANA, V1, P44, DOI [10.29333/djfm/5820, DOI 10.29333/DJFM/5820]; Larue B, 2020, CAN J AGR ECON, V68, P231, DOI 10.1111/cjag.12233; Lee MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241468; Manyika J., 2017, WORKFORCE TRANSITION; Morton T, 2016, ENERG POLICY, V99, P277, DOI 10.1016/j.enpol.2016.05.024; National Center for O*NET Development, O NET DAT VERS 25 2; National Science Foundation U.S, 10 BIG ID FUT NSF IN; O'Brien W, 2020, ENERG BUILDINGS, V225, DOI 10.1016/j.enbuild.2020.110298; Oranye NO, 2016, WORKPLACE HEALTH SAF, V64, P141, DOI 10.1177/2165079916630552; Painter DT, 2021, URBAN SCI, V5, DOI 10.3390/urbansci5010021; PCAST, 2016, TECHN FUT CIT REP PR; PriceWaterhouseCoopers LLC, 2017, SIZING PRIZE WHATS R; Reichelt M, 2021, EUR SOC, V23, pS228, DOI 10.1080/14616696.2020.1823010; Robertson MM., 2003, PROF SAF, V48, P30; Schwab K., 2015, FOREIGN AFF, P1; U.S. Department of Defense, 2014 QUADR DEF REV R; US Bureau of Labor Statistics, 2021, EMPL PROJ PAND ALT S; US Bureau of Labor Statistics, 2020, NAT EMPL MATR 2019 2; USCB [US Census Bureau], 2020, AM COMMUNITY SURVEY; World Economic Forum, 2020, FUT JOBS REP	41	4	4	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260797	10.1371/journal.pone.0260797	http://dx.doi.org/10.1371/journal.pone.0260797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852022	gold, Green Published			2022-12-26	WOS:000755762900065
J	Rajani, MS; Bedair, MF; Li, H; Duff, SMG				Rajani, M. S.; Bedair, Mohamed F.; Li, Hong; Duff, Stephen M. G.			Phenotypic effects from the expression of a deregulated AtGAD1 transgene and GABA pathway suppression mutants in maize	PLOS ONE			English	Article							AMINOBUTYRIC-ACID GABA; SUCCINIC-SEMIALDEHYDE DEHYDROGENASE; GLUTAMATE-DECARBOXYLASE; GAMMA-AMINOBUTYRATE; AUTOINHIBITORY DOMAIN; GENE-EXPRESSION; UP-REGULATION; ACCUMULATION; SHUNT; OVEREXPRESSION	Glutamate decarboxylase (GAD; EC 4.1.1.15) catalyzes the irreversible decarboxylation of glutamate to produce gamma-aminobutyric acid (GABA); a ubiquitous non-protein amino acid involved in the regulation of several aspects of plant metabolism and physiology. To study the function of GAD and GABA in maize, we have; 1) introduced native and deregulated forms of AtGAD1 into maize with the intent of increasing the synthesis of GABA and 2) introduced constructs into maize designed to suppress the activity of several GABA shunt, GABA transport and GABA pathway genes. Maize plants expressing the deregulated AtGAD1 exhibit a severe chlorosis and retarded growth phenotype and have high levels of GABA, and Ca++/CaM-independent GAD activity. Plants expressing the suppression constructs for GABA biosynthetic and transport pathway genes had no observable phenotype whereas a knockout of GABA catabolic pathway genes led to growth and developmental defects under standard growth conditions. The implications of this study to our understanding of the action and function of GABA and GAD in crops are discussed.	[Rajani, M. S.; Bedair, Mohamed F.; Li, Hong; Duff, Stephen M. G.] Bayer US, Chesterfield, MO 63017 USA		Duff, SMG (corresponding author), Bayer US, Chesterfield, MO 63017 USA.	stephen.duff@bayer.com		Duff, Stephen/0000-0002-5411-1991; Bedair, Mohamed/0000-0002-2667-5845				Akama K, 2007, J EXP BOT, V58, P2699, DOI 10.1093/jxb/erm120; Akama K, 2020, RICE, V13, DOI 10.1186/s12284-020-00380-w; Ansari MI, 2021, PLANT GROWTH REGUL, V94, P131, DOI 10.1007/s10725-021-00710-y; Baum G, 1996, EMBO J, V15, P2988, DOI 10.1002/j.1460-2075.1996.tb00662.x; Beuve N, 2004, PLANT CELL ENVIRON, V27, P1035, DOI 10.1111/j.1365-3040.2004.01208.x; Bouche N, 2004, PLANT MOL BIOL, V55, P315, DOI 10.1007/s11103-004-0650-z; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Bown AW, 2016, TRENDS PLANT SCI, V21, P811, DOI 10.1016/j.tplants.2016.08.001; Duff SMG, 2011, PLANT PHYSIOL BIOCH, V49, P251, DOI 10.1016/j.plaphy.2010.12.006; Eamens AL, 2014, METHODS MOL BIOL, V1062, P211, DOI 10.1007/978-1-62703-580-4_11; Fait A, 2011, PLANT PHYSIOL, V157, P1026, DOI 10.1104/pp.111.179986; Fromm H, 2020, J EXP BOT, V71, P6238, DOI 10.1093/jxb/eraa358; Li L, 2021, PLANT SIGNAL BEHAV, V16, DOI 10.1080/15592324.2020.1862565; Michaeli S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00419; Michaeli S, 2011, PLANT J, V67, P485, DOI 10.1111/j.1365-313X.2011.04612.x; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Nonaka S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06400-y; Park DH, 2010, PLANT J, V64, P318, DOI 10.1111/j.1365-313X.2010.04327.x; Podlesakova K, 2019, NEW BIOTECHNOL, V48, P53, DOI 10.1016/j.nbt.2018.07.003; Ramos-Ruiz R, 2019, COGENT FOOD AGR, V5, DOI 10.1080/23311932.2019.1670553; Rice EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094238; Saiz-Fernandez I, 2017, PLANT PHYSIOL BIOCH, V120, P213, DOI 10.1016/j.plaphy.2017.10.006; Shelp BJ, 2017, BOTANY, V95, P1015, DOI 10.1139/cjb-2017-0135; Shelp BJ, 2017, PLANT SIGNAL BEHAV, V12, DOI 10.1080/15592324.2017.1322244; Shelp BJ, 2012, BOTANY, V90, P651, DOI [10.1139/B2012-030, 10.1139/b2012-030]; Shimajiri Y, 2013, PLANT BIOTECHNOL J, V11, P594, DOI 10.1111/pbi.12050; Sidorov V, 2009, METHODS MOL BIOL, V526, P47, DOI 10.1007/978-1-59745-494-0_4; Simpson JP, 2010, BOTANY, V88, P522, DOI 10.1139/B10-020; Sita Kumari, 2020, Plant Physiology Reports, V25, DOI 10.1007/s40502-020-00553-1; Studart-Guimaraes C, 2007, PLANT PHYSIOL, V145, P626, DOI 10.1104/pp.107.103101; Takayama M, 2017, PLANT CELL REP, V36, P103, DOI 10.1007/s00299-016-2061-4; Toyokura K, 2011, PLANT CELL PHYSIOL, V52, P1340, DOI 10.1093/pcp/pcr079; Wang PK, 2021, HORTIC RES-ENGLAND, V8, DOI 10.1038/s41438-021-00517-y; Wang YC, 2017, SCI REP-UK, V7, DOI 10.1038/srep43609; Wang YH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69253-y; Yin YH, 1997, PLANT J, V12, P1179, DOI 10.1046/j.1365-313X.1997.12051179.x; Yin YQ, 2018, RSC ADV, V8, P20456, DOI 10.1039/c8ra03940b	38	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	12							e0259365	10.1371/journal.pone.0259365	http://dx.doi.org/10.1371/journal.pone.0259365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1MC	34871322	Green Published, gold			2022-12-26	WOS:000728598900010
J	Wilcock, WSD; Hilmo, RS				Wilcock, William S. D.; Hilmo, Rose S.			A method for tracking blue whales (Balaenoptera musculus) with a widely spaced network of ocean bottom seismometers	PLOS ONE			English	Article							MARINE MAMMALS; FIN WHALES; LOCATION; PACIFIC; CALLS; LOCALIZATION; VOCALIZATIONS	Passive acoustic monitoring is an important tool for studying marine mammals. Ocean bottom seismometer networks provide data sets of opportunity for studying blue whales (Balaenoptera musculus) which vocalize extensively at seismic frequencies. We describe methods to localize calls and obtain tracks using the B call of northeast Pacific blue whale recorded by a large network of widely spaced ocean bottom seismometers off the coast of the Pacific Northwest. The first harmonic of the B call at similar to 15 Hz is detected using spectrogram cross-correlation. The seasonality of calls, inferred from a dataset of calls identified by an analyst, is used to estimate the probability that detections are true positives as a function of the strength of the detection. Because the spacing of seismometers reaches 70 km, faint detections with a significant probability of being false positives must be considered in multi-station localizations. Calls are located by maximizing a likelihood function which considers each strong detection in turn as the earliest arrival time and seeks to fit the times of detections that follow within a feasible time and distance window. An alternative procedure seeks solutions based on the detections that maximize their sum after weighting by detection strength and proximity. Both approaches lead to many spurious solutions that can mix detections from different B calls and include false detections including misidentified A calls. Tracks that are reliable can be obtained iteratively by assigning detections to localizations that are grouped in space and time, and requiring groups of at least 20 locations. Smooth paths are fit to tracks by including constraints that minimize changes in speed and direction while fitting the locations to their uncertainties or applying the double difference relocation method. The reliability of localizations for future experiments might be improved by increasing sampling rates and detecting harmonics of the B call.	[Wilcock, William S. D.; Hilmo, Rose S.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wilcock, WSD (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	wilcock@uw.edu		Wilcock, William/0000-0001-7224-7246	Office of Naval Research [N00014-14-1-0423]	Office of Naval Research(Office of Naval Research)	WSDW, N00014-14-1-0423, Office of Naval Research awardhttps://www.onr.navy.mil/en/ Science-Technology/Departments/Code-32/allprograms/marine-mammals-biology The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner MF, 2008, J ACOUST SOC AM, V124, P1339, DOI 10.1121/1.2945155; Boyer TP, 2013, NOAA ATLAS NESDIS 72, DOI [DOI 10.7289/V5NZ85MT, 10.7289/V5NZ85MT]; Dahlheim ME., 1987, BIOACOUSTICS GRAY WH; Dreo R, 2019, DEEP-SEA RES PT II, V161, P132, DOI 10.1016/j.dsr2.2018.04.005; Dunn RA, 2009, J ACOUST SOC AM, V126, P1084, DOI 10.1121/1.3158929; Dziak RP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09423-7; Frank SD, 2011, J ACOUST SOC AM, V130, P731, DOI 10.1121/1.3605550; Gedamke J, 2001, J ACOUST SOC AM, V109, P3038, DOI 10.1121/1.1371763; Harris D, 2013, J ACOUST SOC AM, V134, P3522, DOI 10.1121/1.4821207; Hilmo R, 2020, GEOCHEM GEOPHY GEOSY, V21, DOI 10.1029/2020GC009085; Jarvis SM, 2014, MAR TECHNOL SOC J, V48, P5, DOI 10.4031/MTSJ.48.1.1; Lewis LA, 2018, MAR MAMMAL SCI, V34, P311, DOI 10.1111/mms.12458; Matias L, 2015, J ACOUST SOC AM, V138, P504, DOI 10.1121/1.4922706; MCDONALD MA, 1995, J ACOUST SOC AM, V98, P712, DOI 10.1121/1.413565; McDonald MA, 1999, J ACOUST SOC AM, V105, P2643, DOI 10.1121/1.426880; McDonald Mark A., 2006, Journal of Cetacean Research and Management, V8, P55; Mellinger DK, 2000, J ACOUST SOC AM, V107, P3518, DOI 10.1121/1.429434; Mellinger DK, 1997, MAR FRESHW BEHAV PHY, V29, P163, DOI 10.1080/10236249709379005; Menke W, 2012, GEOPHYSICAL DATA ANALYSIS: DISCRETE INVERSE THEORY, 3RD EDITION, P1; Nosal EM, 2013, J ACOUST SOC AM, V134, P2383, DOI 10.1121/1.4816549; Oleson EM, 2003, MAR MAMMAL SCI, V19, P407; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; PORTER MB, 1987, J ACOUST SOC AM, V82, P1349, DOI 10.1121/1.395269; Rebull OG, 2006, J ACOUST SOC AM, V120, P2077, DOI 10.1121/1.2336751; Ryan WBF, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002332; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Soule DC, 2013, J ACOUST SOC AM, V133, P1751, DOI 10.1121/1.4774275; Spiesberger JL, 2001, J ACOUST SOC AM, V109, P3076, DOI 10.1121/1.1373442; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stakes D, 1998, GEOPHYS RES LETT, V25, P2745, DOI 10.1029/98GL01937; Tiemann CO, 2002, OCEANS 2002 MTS/IEEE CONFERENCE & EXHIBITION, VOLS 1-4, CONFERENCE PROCEEDINGS, P1360, DOI 10.1109/OCEANS.2002.1191836; Toomey DR, 2014, OCEANOGRAPHY, V27, P138, DOI 10.5670/oceanog.2014.49; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; WATKINS WA, 1972, DEEP-SEA RES, V19, P691, DOI 10.1016/0011-7471(72)90061-7; WATKINS WA, 1987, J ACOUST SOC AM, V82, P1901, DOI 10.1121/1.395685; Wessel P, 2019, GEOCHEM GEOPHY GEOSY, V20, P5556, DOI 10.1029/2019GC008515; Wilcock WSD, 2012, J ACOUST SOC AM, V132, P2408, DOI 10.1121/1.4747017; Zimmer WM., 2011, PASSIVE ACOUSTIC MON, DOI 10.1017/CBO9780511977107	38	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0260273	10.1371/journal.pone.0260273	http://dx.doi.org/10.1371/journal.pone.0260273			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910750	gold, Green Published			2022-12-26	WOS:000754828900015
J	Rosen, J; Noreland, M; Stattin, K; Lipcsey, M; Frithiof, R; Malinovschi, A; Hultstrom, M				Rosen, Jacob; Noreland, Maria; Stattin, Karl; Lipcsey, Miklos; Frithiof, Robert; Malinovschi, Andrei; Hultstrom, Michael		Uppsala Intensive Care COVID-19 Re	ECG pathology and its association with death in critically ill COVID-19 patients, a cohort study	PLOS ONE			English	Article							OF-CARDIOLOGY-FOUNDATION; ARRHYTHMIAS COMMITTEE; SCIENTIFIC STATEMENT; CLINICAL CARDIOLOGY; AHA/ACCF/HRS RECOMMENDATIONS; PULMONARY-EMBOLISM; ELECTROCARDIOGRAM; STANDARDIZATION; COUNCIL; OUTCOMES	Background We investigated the prevalence of ECG abnormalities and their association with mortality, organ dysfunction and cardiac biomarkers in a cohort of COVID-19 patients admitted to the intensive care unit (ICU). Methods This cohort study included patients with COVID-19 admitted to the ICU of a tertiary hospital in Sweden. ECG, clinical data and laboratory findings during ICU stay were extracted from medical records and ECGs obtained near ICU admission were reviewed by two independent physicians. Results Eighty patients had an acceptable ECG near ICU-admission. In the entire cohort 30-day mortality was 28%. Compared to patients with normal ECG, among whom 30-day mortality was 16%, patients with ECG fulfilling criteria for prior myocardial infarction had higher mortality, 63%, odds ratio (OR) 9.61 (95% confidence interval (CI) 2.02-55.6) adjusted for Simplified Acute Physiology Score 3 and patients with ST-T abnormalities had 50% mortality and OR 6.05 (95% CI 1.82-21.3) in univariable analysis. Both prior myocardial infarction pattern and ST-T pathology were associated with need for vasoactive treatment and higher peak plasma levels of troponin-I, NT-pro-BNP (N-terminal pro-Brain Natriuretic Peptide), and lactate during ICU stay compared to patients with normal ECG. Conclusion ECG with prior myocardial infarction pattern or acute ST-T pathology at ICU admission is associated with death, need for vasoactive treatment and higher levels of biomarkers of cardiac damage and strain in severely ill COVID-19 patients, and should alert clinicians to a poor prognosis.	[Rosen, Jacob; Stattin, Karl; Lipcsey, Miklos; Frithiof, Robert; Hultstrom, Michael] Uppsala Univ, Dept Surg Sci Anaesthesiol & Intens Care Med, Uppsala, Sweden; [Noreland, Maria; Malinovschi, Andrei] Uppsala Univ, Dept Med Sci, Clin Physiol, Uppsala, Sweden; [Lipcsey, Miklos] Uppsala Univ, CIRRUS, Dept Surg Sci Anaesthesiol & Intens Care Med, Hedenstierna Lab, Uppsala, Sweden; [Hultstrom, Michael] Uppsala Univ, Dept Med Cell Biol, Integrat Physiol, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University	Rosen, J (corresponding author), Uppsala Univ, Dept Surg Sci Anaesthesiol & Intens Care Med, Uppsala, Sweden.	jacob.rosen@surgsci.uu.se	Hultström, Michael/H-3642-2019	Hultström, Michael/0000-0003-4675-1099; Rosen, Jacob/0000-0001-9518-5834	SciLifeLab/KAW national COVID-19 research program project [KAW 2020.0182, KAW 2020.0241]; Swedish Heart-Lung Foundation [20210089, 20190639, 20190637]; Swedish Research Council [2014-02569, 2014-07606]; Swedish Kidney Foundation [F2020-0054]	SciLifeLab/KAW national COVID-19 research program project; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Kidney Foundation	The study was funded by grants from SciLifeLab/KAW national COVID-19 research program project to M.H. (KAW 2020.0182 and KAW 2020.0241), the Swedish Heart-Lung Foundation (20210089, 20190639, 20190637) to M.H., the Swedish Research Council to R.F. (2014-02569 and 2014-07606) and Swedish Kidney Foundation (F2020-0054) to R.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MP, 2020, J CARDIOVASC ELECTR, V31, P3086, DOI 10.1111/jce.14772; Akhtar Z, 2021, PACE, V44, P875, DOI 10.1111/pace.14232; Anttila IJT., 2013, EUR HEART J, V34, DOI [10.1093/eurheartj/eht308.P1540, DOI 10.1093/EURHEARTJ/EHT308.P1540]; Bangalore S, 2020, NEW ENGL J MED, V382, P2478, DOI 10.1056/NEJMc2009020; Barman HA, 2021, AM J EMERG MED, V46, P317, DOI 10.1016/j.ajem.2020.10.005; Bavishi C, 2020, PROG CARDIOVASC DIS, V63, P682, DOI 10.1016/j.pcad.2020.05.013; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Bergamaschi L, 2021, ANN NONINVAS ELECTRO, V26, DOI 10.1111/anec.12815; Bertini M, 2020, EUROPACE, V22, P1848, DOI 10.1093/europace/euaa258; Butta C, 2020, ANN NONINVAS ELECTRO, V25, P125, DOI 10.1111/anec.12726; Changal K, 2021, BMC CARDIOVASC DISOR, V21, DOI 10.1186/s12872-021-01963-1; DeFilippis AP, 2019, CIRCULATION, V140, P1661, DOI 10.1161/CIRCULATIONAHA.119.040631; Doyen D, 2020, LANCET, V395, P1516, DOI 10.1016/S0140-6736(20)30912-0; Einthoven W, 1900, ARCH GESAMTE PHYSIOL, V80, P139, DOI 10.1007/BF01663110; Elias P, 2020, MAYO CLIN PROC, V95, P2099, DOI 10.1016/j.mayocp.2020.07.028; Garcia-Rodriguez D, 2021, REV ESP CARDIOL, V74, P111, DOI [10.1016/j.recesp.2020.09.021, 10.1016/j.rec.2020.09.027]; Giustino G, 2020, J AM COLL CARDIOL, V76, P2043, DOI 10.1016/j.jacc.2020.08.069; Goldstein B., 1997, CARD ELECTROPHYSIOL, V1, P308, DOI [10.1023/A:1009944301690, DOI 10.1023/A:1009944301690]; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Hancock EW, 2009, J AM COLL CARDIOL, V53, P992, DOI 10.1016/j.jacc.2008.12.015; He J, 2020, CAN J CARDIOL, V36, DOI 10.1016/j.cjca.2020.03.028; Ho JSY, 2020, HEART LUNG, V49, P681, DOI 10.1016/j.hrtlng.2020.08.013; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hultstrom M, 2020, J HYPERTENS, V38, P1613, DOI 10.1097/HJH.0000000000002531; Jimenez-Jaimez J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78360-9; Kho J, 2020, AM J EMERG MED, V38, P2142, DOI 10.1016/j.ajem.2020.07.054; Lala A, 2020, J AM COLL CARDIOL, V76, P533, DOI [10.1016/j.jacc.2020.06.007, 10.1101/2020.04.20.20072702]; Li DZ, 2020, CIRC RES, V127, P397, DOI 10.1161/CIRCRESAHA.120.317070; Lippi G, 2020, PROG CARDIOVASC DIS, V63, P390, DOI 10.1016/j.pcad.2020.03.001; Longchamp G, 2021, THROMB J, V19, DOI 10.1186/s12959-021-00266-x; Luther T, 2021, ACTA ANAESTH SCAND, V65, P364, DOI 10.1111/aas.13746; Maeda T, 2021, HEART LUNG CIRC, V30, P848, DOI 10.1016/j.hlc.2020.10.025; Malas MB, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100639; Mason JW, 2007, J AM COLL CARDIOL, V49, P1128, DOI 10.1016/j.jacc.2007.01.025; Mccullough SA, 2020, J CARD FAIL, V26, P626, DOI 10.1016/j.cardfail.2020.06.005; Meyer P, 2020, EUR HEART J, V41, P1860, DOI 10.1093/eurheartj/ehaa306; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Nadim MK, 2020, NAT REV NEPHROL, V16, P747, DOI 10.1038/s41581-020-00356-5; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pellegrini D, 2021, CIRCULATION, V143, P1031, DOI 10.1161/CIRCULATIONAHA.120.051828; Poterucha TJ, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.018476; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]; Puntmann VO, 2020, JAMA CARDIOL, V5, P1265, DOI 10.1001/jamacardio.2020.3557; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rubin GA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.6842; Ferrando ES, 2022, CYTOKINE, V149, DOI 10.1016/j.cyto.2021.155727; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Surawicz B, 2009, J AM COLL CARDIOL, V53, P976, DOI 10.1016/j.jacc.2008.12.013; Tavazzi G, 2020, EUR J HEART FAIL, V22, P911, DOI 10.1002/ejhf.1828; Thygesen K, 2019, EUR HEART J, V40, P237, DOI [10.1093/eurheartj/ehy462, 10.1016/j.jacc.2018.08.1038, 10.1016/j.rec.2018.11.011]; van Dam LF, 2020, THROMB RES, V193, P86, DOI 10.1016/j.thromres.2020.06.010; Wagner GS, 2009, J AM COLL CARDIOL, V53, P1003, DOI 10.1016/j.jacc.2008.12.016; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; ZEMA MJ, 1981, CHEST, V79, P195, DOI 10.1378/chest.79.2.195; Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	58	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261315	10.1371/journal.pone.0261315	http://dx.doi.org/10.1371/journal.pone.0261315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905575	Green Published, gold			2022-12-26	WOS:000754615500034
J	Shichiri-Negoro, Y; Tsutsumi-Arai, C; Arai, Y; Satomura, K; Arakawa, S; Wakabayashi, N				Shichiri-Negoro, Yuka; Tsutsumi-Arai, Chiaki; Arai, Yuki; Satomura, Kazuhito; Arakawa, Shinichi; Wakabayashi, Noriyuki			Ozone ultrafine bubble water inhibits the early formation of Candida albicans biofilms	PLOS ONE			English	Article							FREE-RADICAL GENERATION; OZONATED-WATER; DENTURE STOMATITIS; ORAL CANDIDOSIS; GENE; BACTERIA; ADHESION; EFFICACY	This study aimed to investigate the effect of ozone ultrafine bubble water (OUFBW) on the formation and growth of Candida albicans (C. albicans) biofilms and surface properties of denture base resins. OUFBWs were prepared under concentrations of 6 (OUFBW6), 9 (OUFBW9), and 11 ppm (OUFBW11). Phosphate buffered saline and ozone-free electrolyte aqueous solutions (OFEAS) were used as controls. Acrylic resin discs were made according to manufacturer instructions, and C. albicans was initially cultured on the discs for 1.5 h. A colony forming unit (CFU) assay was performed by soaking the discs in OUFBW for 5 min after forming a 24-h C. albicans biofilm. The discs after initial attachment for 1.5 h were immersed in OUFBW and then cultured for 0, 3, and 5 h. CFUs were subsequently evaluated at each time point. Moreover, a viability assay, scanning electron microscopy (SEM), Alamar Blue assay, and quantitative real-time polymerase chain reaction (qRT-PCR) test were performed. To investigate the long-term effects of OUFBW on acrylic resin surface properties, Vickers hardness (VH) and surface roughness (Ra) were measured. We found that OUFBW9 and OUFBW11 significantly degraded the formed 24-h biofilm. The time point CFU assay showed that C. albicans biofilm formation was significantly inhibited due to OUFBW11 exposure. Interestingly, fluorescence microscopy revealed that almost living cells were observed in all groups. In SEM images, the OUFBW group had lesser number of fungi and the amount of non-three-dimensional biofilm than the control group. In the Alamar Blue assay, OUFBW11 was found to suppress Candida metabolic function. The qRT-PCR test showed that OUFBW down-regulated ALS1 and ALS3 expression regarding cell-cell, cell-material adhesion, and biofilm formation. Additionally, VH and Ra were not significantly different between the two groups. Overall, our data suggest that OUFBW suppressed C. albicans growth and biofilm formation on polymethyl methacrylate without impairing surface properties.	[Shichiri-Negoro, Yuka; Arai, Yuki; Wakabayashi, Noriyuki] Tokyo Med & Dent Univ TMDU, Grad Sch, Dept Removable Partial Prosthodont, Tokyo, Japan; [Tsutsumi-Arai, Chiaki; Satomura, Kazuhito] Tsurumi Univ, Sch Dent Med, Dept Oral Med & Stomatol, Yokohama, Kanagawa, Japan; [Arakawa, Shinichi] Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Lifetime Oral Hlth Care Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tsurumi University; Tokyo Medical & Dental University (TMDU)	Arai, Y (corresponding author), Tokyo Med & Dent Univ TMDU, Grad Sch, Dept Removable Partial Prosthodont, Tokyo, Japan.	y.arai.rpro@tmd.ac.jp		Wakabayashi, Noriyuki/0000-0002-0517-6756				Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Argimon S, 2007, EUKARYOT CELL, V6, P682, DOI 10.1128/EC.00340-06; Arita M, 2005, ORAL MICROBIOL IMMUN, V20, P206, DOI 10.1111/j.1399-302X.2005.00213.x; Azuma K, 2014, BIOMED REP, V2, P671, DOI 10.3892/br.2014.290; Budtz-Jorgensen E, 2000, COMMUNITY DENT ORAL, V28, P141, DOI 10.1034/j.1600-0528.2000.028002141.x; d'Enfert C, 2009, CURR OPIN MICROBIOL, V12, P358, DOI 10.1016/j.mib.2009.05.008; Desai JV, 2018, J FUNGI, V4, DOI 10.3390/jof4010010; Elvis A M, 2011, J Nat Sci Biol Med, V2, P66, DOI 10.4103/0976-9668.82319; Filippi A., 2001, CLIN ORAL SURG; Fu Y, 1998, INFECT IMMUN, V66, P1783, DOI 10.1128/IAI.66.4.1783-1786.1998; Gad MM, 2020, DENT MED PROBL, V57, P95, DOI 10.17219/dmp/112861; Gao QQ, 2014, MICROB CELL, V1, P94, DOI 10.15698/mic2014.01.131; Gleiznys Alvydas, 2015, Stomatologija, V17, P54; Gulati M, 2016, MICROBES INFECT, V18, P310, DOI 10.1016/j.micinf.2016.01.002; Hayakumo S, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/5/055003; Hayashi K, 2019, BIOCHEM BIOPHYS REP, V20, DOI 10.1016/j.bbrep.2019.100697; Hirai K, 2019, BIOCONTROL SCI, V24, P155, DOI 10.4265/bio.24.155; Hirasawa M, 2018, ARCH ORAL BIOL, V87, P143, DOI 10.1016/j.archoralbio.2017.12.024; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Karamah EF., 2019, APPL OZONATED WATER, V509, P12004, DOI [10.1556/650.2019.3139331055963, DOI 10.1556/650.2019.3139331055963]; Khadre MA, 2001, J FOOD SCI, V66, P1242, DOI 10.1111/j.1365-2621.2001.tb15196.x; Kim JG, 2000, J FOOD SCI, V65, P521, DOI 10.1111/j.1365-2621.2000.tb16040.x; Klotz SA, 2007, MED MYCOL, V45, P363, DOI 10.1080/13693780701299333; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Kwolek-Mirek M, 2014, FEMS YEAST RES, V14, P1068, DOI 10.1111/1567-1364.12202; Lee R, 2016, PHYS CHEM CHEM PHYS, V18, P24663, DOI 10.1039/c6cp05064f; Leewananthawet A, 2019, SCI TECHNOL ADV MAT, V20, P589, DOI 10.1080/14686996.2019.1614980; Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10; Mishra Nagendra Nath, 2007, Acta Microbiologica et Immunologica Hungarica, V54, P201, DOI 10.1556/AMicr.54.2007.3.1; Morschhauser J, 2010, FUNGAL GENET BIOL, V47, P94, DOI 10.1016/j.fgb.2009.08.002; Mourer T, 2021, RES MICROBIOL, V172, DOI 10.1016/j.resmic.2021.103813; Murakami H, 1996, Dent Mater J, V15, P220; Nagayoshi M, 2004, ORAL MICROBIOL IMMUN, V19, P240, DOI 10.1111/j.1399-302X.2004.00146.x; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Pereira-Cenci T, 2008, J APPL ORAL SCI, V16, P86, DOI 10.1590/S1678-77572008000200002; Razak FA, 2019, JCPSP-J COLL PHYSICI, V29, P387, DOI 10.29271/jcpsp.2019.04.387; Seki M, 2017, IN VIVO, V31, P579, DOI 10.21873/invivo.11097; Singh Arun, 2014, J Oral Maxillofac Pathol, V18, pS81, DOI 10.4103/0973-029X.141325; Takahashi M, 2007, J PHYS CHEM B, V111, P1343, DOI 10.1021/jp0669254; Takahashi M, 2021, LANGMUIR, V37, P5005, DOI 10.1021/acs.langmuir.1c00469; Tati S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005522; Terada C, 2018, INT J PHOTOENERGY, V2018, DOI 10.1155/2018/2635964; Theberge S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-246; Tiwari S., 2017, SAUDI J DENT RES, V8, P105, DOI [DOI 10.1016/J.SJDR.2016.06.005, 10.1016/j.sjdr.2016.06.005]; Tsutsumi C, 2016, J DENT, V44, P37, DOI 10.1016/j.jdent.2015.11.010; Tsutsumi-Arai C, 2022, LASER MED SCI, V37, P857, DOI 10.1007/s10103-021-03323-z; Tsutsumi-Arai C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217496; Tsutsumi-Arai C, 2019, LASER MED SCI, V34, P1457, DOI 10.1007/s10103-019-02751-2; Webb BC, 1998, AUST DENT J, V43, P45, DOI 10.1111/j.1834-7819.1998.tb00152.x; Williams DW, 2011, PERIODONTOL 2000, V55, P250, DOI 10.1111/j.1600-0757.2009.00338.x; Xiaomin Zhao., 2019, PHYSIOL BEHAV, V176, P139, DOI [10.1099/mic.0.28959-0.Candida, DOI 10.1099/MIC.0.28959-0.CANDIDA]; Yadav R, 2013, J CRANIO MAX DIS, V2, P22, DOI [10.4103/2278-9588.113582, DOI 10.4103/2278-9588.113582]; Zargaran M, 2017, Curr Med Mycol, V3, P26, DOI [10.29252/cmm.3.2.26, 10.18869/acadpub.cmm.3.2.26]	54	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0261180	10.1371/journal.pone.0261180	http://dx.doi.org/10.1371/journal.pone.0261180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890423	gold, Green Published			2022-12-26	WOS:000747293600032
J	Wu, YFO; Bryant, AT; Nelson, NT; Madey, AG; Fernandes, GF; Goodson, HV				Wu, Yueh-Fu O.; Bryant, Annamarie T.; Nelson, Nora T.; Madey, Alexander G.; Fernandes, Gail F.; Goodson, Holly V.			Overexpression of the microtubule-binding protein CLIP-170 induces a plus TIP network superstructure consistent with a biomolecular condensate	PLOS ONE			English	Article							INTRINSICALLY DISORDERED REGIONS; PHASE-SEPARATION; ACTIN; DYNAMICS; ENDS; XMAP215; EB1; CENTROSOME; PREDICTION; MECHANISM	Proper regulation of microtubule (MT) dynamics is critical for cellular processes including cell division and intracellular transport. Plus-end tracking proteins (+TIPs) dynamically track growing MTs and play a key role in MT regulation. +TIPs participate in a complex web of intra- and inter- molecular interactions known as the +TIP network. Hypotheses addressing the purpose of +TIP:+TIP interactions include relieving +TIP autoinhibition and localizing MT regulators to growing MT ends. In addition, we have proposed that the web of +TIP:+TIP interactions has a physical purpose: creating a dynamic scaffold that constrains the structural fluctuations of the fragile MT tip and thus acts as a polymerization chaperone. Here we examine the possibility that this proposed scaffold is a biomolecular condensate (i.e., liquid droplet). Many animal +TIP network proteins are multivalent and have intrinsically disordered regions, features commonly found in biomolecular condensates. Moreover, previous studies have shown that overexpression of the +TIP CLIP-170 induces large "patch" structures containing CLIP-170 and other +TIPs; we hypothesized that these structures might be biomolecular condensates. To test this hypothesis, we used video microscopy, immunofluorescence staining, and Fluorescence Recovery After Photobleaching (FRAP). Our data show that the CLIP-170-induced patches have hallmarks indicative of a biomolecular condensate, one that contains +TIP proteins and excludes other known condensate markers. Moreover, bioinformatic studies demonstrate that the presence of intrinsically disordered regions is conserved in key +TIPs, implying that these regions are functionally significant. Together, these results indicate that the CLIP-170 induced patches in cells are phase-separated liquid condensates and raise the possibility that the endogenous +TIP network might form a liquid droplet at MT ends or other +TIP locations.	[Wu, Yueh-Fu O.; Bryant, Annamarie T.; Nelson, Nora T.; Madey, Alexander G.; Fernandes, Gail F.; Goodson, Holly V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Wu, Yueh-Fu O.; Bryant, Annamarie T.; Goodson, Holly V.] Univ Notre Dame, Integrated Biomed Sci Grad Program, Notre Dame, IN USA; [Goodson, Holly V.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Goodson, HV (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.; Goodson, HV (corresponding author), Univ Notre Dame, Integrated Biomed Sci Grad Program, Notre Dame, IN USA.; Goodson, HV (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	hgoodson@nd.edu	Goodson, Holly/AAE-6079-2022	Bryant, Annamarie/0000-0002-4383-0894; Goodson, Holly/0000-0001-7942-8349	American Heart Association [17PRE33670896]; National Science Foundation [1817966]	American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF))	This research was funded by a fellowship from the American Heart Association https://www.heart.org/en (#17PRE33670896) to YOW and a grant from the National Science Foundation https://www.nsf.gov/(MCB #1817966) to HVG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2015, NAT REV MOL CELL BIO, V16, P711, DOI 10.1038/nrm4084; Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Al-Bassam J, 2011, TRENDS CELL BIOL, V21, P604, DOI 10.1016/j.tcb.2011.06.007; Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Alberti S, 2017, CURR BIOL, V27, pR1097, DOI 10.1016/j.cub.2017.08.069; Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Bracha D, 2019, NAT BIOTECHNOL, V37, P1435, DOI 10.1038/s41587-019-0341-6; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Brouhard GJ, 2018, NAT REV MOL CELL BIO, V19, P451, DOI 10.1038/s41580-018-0009-y; Bulinski JC, 2001, J CELL SCI, V114, P3885; Case LB, 2019, ANNU REV BIOPHYS, V48, P465, DOI 10.1146/annurev-biophys-052118-115534; Case LB, 2019, SCIENCE, V363, P1093, DOI 10.1126/science.aau6313; Chen YD, 2019, J BIOL CHEM, V294, P918, DOI 10.1074/jbc.RA118.006125; Choi JM, 2020, ANNU REV BIOPHYS, V49, P107, DOI 10.1146/annurev-biophys-121219-081629; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; Ditlev JA, 2018, J MOL BIOL, V430, P4666, DOI 10.1016/j.jmb.2018.08.003; Dragestein KA, 2008, J CELL BIOL, V180, P729, DOI 10.1083/jcb.200707203; Erdos Gabor, 2020, Curr Protoc Bioinformatics, V70, pe99, DOI 10.1002/cpbi.99; Folker ES, 2005, MOL BIOL CELL, V16, P5373, DOI 10.1091/mbc.E04-12-1106; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Gammons M, 2018, CURR OPIN CELL BIOL, V51, P42, DOI 10.1016/j.ceb.2017.10.008; Gardner MK, 2011, CELL, V146, P582, DOI 10.1016/j.cell.2011.06.053; Goodson HV, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022608; Goodson HV, 2003, CELL MOTIL CYTOSKEL, V55, P156, DOI 10.1002/cm.10114; Gupta KK, 2014, BIOESSAYS, V36, P818, DOI 10.1002/bies.201400029; Gupta KK, 2009, J BIOL CHEM, V284, P6735, DOI 10.1074/jbc.M807675200; Henty-Ridilla JL, 2016, SCIENCE, V352, P1004, DOI 10.1126/science.aaf1709; Holehouse AS, 2018, BIOCHEMISTRY-US, V57, P2415, DOI 10.1021/acs.biochem.7b01136; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; Hyman AA, 1996, CELL, V84, P401, DOI 10.1016/S0092-8674(00)81285-4; KAWANO JI, 1994, J HISTOCHEM CYTOCHEM, V42, P363, DOI 10.1177/42.3.8308253; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Lallemand-Breitenbach V., 2010, CSH PERSPECT BIOL, V2, DOI [10.1101/cshperspect.a000661, DOI 10.1101/cshperspect.a000661]; Lewkowicz E, 2008, J CELL BIOL, V183, P1287, DOI 10.1083/jcb.200807023; Li WJ, 2012, J CELL BIOL, V199, P849, DOI 10.1083/jcb.201206101; Lomakin AJ, 2011, MOL BIOL CELL, V22, P4029, DOI 10.1091/mbc.E11-03-0260; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Margolin G, 2012, MOL BIOL CELL, V23, P642, DOI 10.1091/mbc.E11-08-0688; Matamoros AJ, 2016, BRAIN RES BULL, V126, P217, DOI 10.1016/j.brainresbull.2016.06.016; McIntosh JR, 2018, J CELL BIOL, V217, P2691, DOI 10.1083/jcb.201802138; McSwiggen DT, 2019, GENE DEV, V33, P1619, DOI 10.1101/gad.331520.119; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mirarab S, 2015, J COMPUT BIOL, V22, P377, DOI 10.1089/cmb.2014.0156; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Mittasch M, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201912036; Moesa HA, 2012, MOL BIOSYST, V8, P3262, DOI 10.1039/c2mb25202c; Namkoong S, 2018, MOL CELL, V70, P175, DOI 10.1016/j.molcel.2018.02.025; Necci M, 2017, BIOINFORMATICS, V33, P1402, DOI 10.1093/bioinformatics/btx015; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; PIERRE P, 1994, J CELL SCI, V107, P1909; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Potenza E, 2015, NUCLEIC ACIDS RES, V43, pD315, DOI 10.1093/nar/gku982; Potter SC, 2018, NUCLEIC ACIDS RES, V46, pW200, DOI 10.1093/nar/gky448; Rale MJ, 2018, BIOCHEMISTRY-US, V57, P30, DOI 10.1021/acs.biochem.7b01064; RICKARD JE, 1991, J BIOL CHEM, V266, P17597; Scheel J, 1999, J BIOL CHEM, V274, P25883, DOI 10.1074/jbc.274.36.25883; SCHEER U, 1984, CELL, V39, P111, DOI 10.1016/0092-8674(84)90196-X; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sear RP, 2007, SOFT MATTER, V3, P680, DOI 10.1039/b618126k; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simon C, 2019, NAT PHYS, V15, P602, DOI 10.1038/s41567-019-0464-1; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Snead WT, 2019, MOL CELL, V76, P295, DOI 10.1016/j.molcel.2019.09.016; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Tan R, 2019, NAT CELL BIOL, V21, P1078, DOI 10.1038/s41556-019-0375-5; Trivedi P, 2019, NAT CELL BIOL, V21, P1127, DOI 10.1038/s41556-019-0376-4; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Wachsmuth M, 2014, PROTOPLASMA, V251, P373, DOI 10.1007/s00709-013-0604-x; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Webster AW., 2014, M EASY PROTOCOL FRAP; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Wiegand T, 2020, EMERG TOP LIFE SCI, V4, P247, DOI 10.1042/ETLS20190174; Woodruff JB, 2017, CELL, V169, P1066, DOI 10.1016/j.cell.2017.05.028; Zanic M, 2013, NAT CELL BIOL, V15, P688, DOI 10.1038/ncb2744	84	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0260401	10.1371/journal.pone.0260401	http://dx.doi.org/10.1371/journal.pone.0260401			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890409	Green Submitted, Green Published, gold			2022-12-26	WOS:000747293600011
J	Douglas, MR; Mussmann, SM; Chafin, TK; Anthonysamy, WJB; Davis, MA; Mulligan, MP; Schooley, RL; Louis, W; Douglas, ME				Douglas, Marlis R.; Mussmann, Steven M.; Chafin, Tyler K.; Anthonysamy, Whitney J. B.; Davis, Mark A.; Mulligan, Matthew P.; Schooley, Robert L.; Louis, Wade; Douglas, Michael E.			Population connectivity in voles (Microtus sp.) as a gauge for tall grass prairie restoration in midwestern North America	PLOS ONE			English	Article							SMALL-MAMMAL COMMUNITIES; LAND-USE CHANGE; HABITAT FRAGMENTATION; GENETIC-STRUCTURE; ECOLOGICAL RESTORATION; LINKAGE DISEQUILIBRIUM; SOCIAL-ORGANIZATION; ECOSYSTEM SERVICES; IXODES-SCAPULARIS; RE-IMPLEMENTATION	Ecological restoration can promote biodiversity conservation in anthropogenically fragmented habitats, but effectiveness of these management efforts need to be statistically validated to determine 'success.' One such approach is to gauge the extent of recolonization as a measure of landscape permeability and, in turn, population connectivity. In this context, we estimated dispersal and population connectivity in prairie vole (Microtus ochrogaster; N = 231) and meadow vole (M. pennsylvanicus; N = 83) within five tall-grass prairie restoration sites embedded within the agricultural matrix of midwestern North America. We predicted that vole dispersal would be constrained by the extent of agricultural land surrounding restored habitat patches, spatially isolating vole populations and resulting in significant genetic structure. We first employed genetic assignment tests based on 15 microsatellite DNA loci to validate field-derived species-designations, then tested reclassified samples with multivariate and Bayesian clustering to assay for spatial and temporal genetic structure. Population connectivity was further evaluated by calculating pairwise F-ST, then potential demographic effects explored by computing migration rates, effective population size (N-e), and average relatedness (r). Genetic species assignments reclassified 25% of initial field identifications (N = 11 M. ochrogaster; N = 67 M. pennsylvanicus). In M. ochrogaster population connectivity was high across the study area, reflected in little to no spatial or temporal genetic structure. In M. pennsylvanicus genetic structure was detected, but relatedness estimates identified it as kin-clustering instead, underscoring social behavior among populations rather than spatial isolation as the cause. Estimates of N-e and r were stable across years, reflecting high dispersal and demographic resilience. Combined, these metrics suggest the agricultural matrix is highly permeable for voles and does not impede dispersal. High connectivity observed confirms that the restored landscape is productive and permeable for specific management targets such as voles and also demonstrates population genetic assays as a tool to statistically evaluate effectiveness of conservation initiatives.	[Douglas, Marlis R.; Douglas, Michael E.] Univ Arkansas, Biol Sci, Fayetteville, AR 72701 USA; [Mussmann, Steven M.] US Fish & Wildlife Serv, Southwestern Nat Aquat Resources & Recovery Ctr, Dexter, NM USA; [Chafin, Tyler K.] Univ Colorado, Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Anthonysamy, Whitney J. B.] St Louis Coll Pharm, Basic Sci, St Louis, MO USA; [Davis, Mark A.] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Mulligan, Matthew P.] Lincoln Pk Zoo, Chicago, IL USA; [Schooley, Robert L.] Univ Illinois, Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Louis, Wade] Illinois Dept Nat Resources, Gibson City, IL USA	University of Arkansas System; University of Arkansas Fayetteville; United States Department of the Interior; US Fish & Wildlife Service; University of Colorado System; University of Colorado Boulder; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Douglas, MR (corresponding author), Univ Arkansas, Biol Sci, Fayetteville, AR 72701 USA.	mrd1@uark.edu		Douglas, Michael/0000-0001-9670-7825	U.S. Fish and Wildlife Service (USFWS) Federal Aid in Wildlife Restoration Program by the Illinois Department of Natural Resources (IDNR); University of Arkansas/Fayetteville; MED (21st Century Chair in Global Change Biology)	U.S. Fish and Wildlife Service (USFWS) Federal Aid in Wildlife Restoration Program by the Illinois Department of Natural Resources (IDNR); University of Arkansas/Fayetteville; MED (21st Century Chair in Global Change Biology)	The U.S. Fish and Wildlife Service (USFWS) Federal Aid in Wildlife Restoration Program, as administered by the Illinois Department of Natural Resources (IDNR), provided funding for this project (awarded to MRD and MED). Additional funding was provided by endowments through University of Arkansas/Fayetteville to MRD (Bruker Professor of Life Sciences) and MED (21st Century Chair in Global Change Biology).	Aerts R, 2018, BRIT MED BULL, V127, P5, DOI 10.1093/bmb/ldy021; Amaral KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148842; Anderson SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117500; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Batzli GO, 2016, INTEGR ZOOL, V11, P469, DOI 10.1111/1749-4877.12209; Berry B, 2017, AM MIDL NAT, V177, P165, DOI 10.1674/0003-0031-177.2.165; BOONSTRA R, 1993, BEHAV ECOL, V4, P83, DOI 10.1093/beheco/4.1.83; Capdevila P, 2020, TRENDS ECOL EVOL, V35, P776, DOI 10.1016/j.tree.2020.05.001; Chafin TK, 2020, PRION, V14, P238, DOI 10.1080/19336896.2020.1832947; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chiappero MB, 2016, J MAMMAL, V97, P424, DOI 10.1093/jmammal/gyv186; Coffman CJ, 2001, OIKOS, V93, P3, DOI 10.1034/j.1600-0706.2001.930101.x; Coffman CJ, 1997, THESIS N CAROLINA ST; Corlett RT, 2015, TRENDS ECOL EVOL, V30, P36, DOI 10.1016/j.tree.2014.10.007; Ayram CAC, 2016, PROG PHYS GEOG, V40, P7, DOI 10.1177/0309133315598713; Cosentino BJ, 2012, P ROY SOC B-BIOL SCI, V279, P1575, DOI 10.1098/rspb.2011.1880; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crooks K. R., 2006, CONNECTIVITY CONSERV; DIFFENDORFER JE, 1995, ECOLOGY, V76, P827, DOI 10.2307/1939348; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Douglas MR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230735; EDWARDS AWF, 1971, BIOMETRICS, V27, P873, DOI 10.2307/2528824; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fargione JE, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat1869; Fischer J, 2014, CONSERV LETT, V7, P149, DOI 10.1111/conl.12084; Frare CF, 2017, J WILDLIFE MANAGE, V81, P248, DOI 10.1002/jwmg.21193; Gauffre B, 2008, MOL ECOL, V17, P4619, DOI 10.1111/j.1365-294X.2008.03950.x; Gauffre B, 2014, MOL ECOL, V23, P3214, DOI 10.1111/mec.12818; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; GETZ LL, 1972, J MAMMAL, V53, P310, DOI 10.2307/1379167; GETZ LL, 1978, J MAMMAL, V59, P208, DOI 10.2307/1379900; Getz LL, 2001, J MAMMAL, V82, P22, DOI 10.1644/1545-1542(2001)082<0022:TFYOPF>2.0.CO;2; GETZ LL, 1993, J MAMMAL, V74, P44, DOI 10.2307/1381904; Gilbert L, 2013, J APPL ECOL, V50, P1226, DOI 10.1111/1365-2664.12141; Gottdenker NL, 2014, ECOHEALTH, V11, P619, DOI 10.1007/s10393-014-0941-z; Hammock EAD, 2005, GENES BRAIN BEHAV, V4, P289, DOI 10.1111/j.1601-183X.2005.00119.x; Henterly AC, 2011, AM MIDL NAT, V165, P412, DOI 10.1674/0003-0031-165.2.412; Henwood William D., 2010, Great Plains Research, V20, P121; Heroldova M, 2007, AGR ECOSYST ENVIRON, V120, P206, DOI 10.1016/j.agee.2006.09.007; Hoffmeister DF., 2002, MAMMALS ILLINOIS; Hunter-Ayad J, 2020, BIODIVERS CONSERV, V29, P1339, DOI 10.1007/s10531-020-01938-2; Janes JK, 2017, MOL ECOL, V26, P3594, DOI 10.1111/mec.14187; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Keane B, 2015, J MAMMAL, V96, P1194, DOI 10.1093/jmammal/gyv128; Kilpatrick AM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0117; Klatt BJ, 2015, AM MIDL NAT, V173, P241, DOI 10.1674/amid-173-02-241-252.1; KLINE VM, 1987, RESTORATION ECOLOGY, P75; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kuparinen A, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0036; Lee NS, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00052; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Levine BA, 2019, ECOL EVOL, V9, P11863, DOI 10.1002/ece3.5694; Lin YK, 2006, J MAMMAL, V87, P446, DOI 10.1644/05-MAMM-A-201R1.1; Lin YK, 2004, J MAMMAL, V85, P216, DOI 10.1644/1545-1542(2004)085<0216:MOVAHB>2.0.CO;2; Lin YTK, 2001, ECOL MONOGR, V71, P245, DOI 10.1890/0012-9615(2001)071[0245:TIOHQO]2.0.CO;2; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; MANTEL N, 1967, CANCER RES, V27, P209; Marchi C, 2013, HEREDITY, V111, P486, DOI 10.1038/hdy.2013.70; Martens JRT, 2015, CAN J PLANT SCI, V95, P1049, DOI 10.4141/CJPS-2014-173; Matthews JW, 2017, RESTOR ECOL, V25, P972, DOI 10.1111/rec.12525; Melis C, 2013, ECOL EVOL, V3, P770, DOI 10.1002/ece3.499; Mero TO, 2015, ANIM CONSERV, V18, P442, DOI 10.1111/acv.12191; Millins C, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0123; Moran S, 2008, MOL ECOL RESOUR, V8, P1267, DOI 10.1111/j.1755-0998.2008.02324.x; Morlando S, 2012, RESTOR ECOL, V20, P498, DOI 10.1111/j.1526-100X.2011.00796.x; Mulligan MP, 2013, RESTOR ECOL, V21, P678, DOI 10.1111/rec.12039; Mulligan MP, 2012, THESIS U ILLINOIS; Mussmann SM, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160736; Myers JH, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2841; Nabhan GP, 2020, ECOPSYCHOLOGY, V12, P195, DOI 10.1089/eco.2020.0003; Olden JD, 2005, CONSERV BIOL, V19, P2036, DOI 10.1111/j.1523-1739.2005.00288.x; Oliver TH, 2015, NAT CLIM CHANGE, V5, P941, DOI [10.1038/NCLIMATE2746, 10.1038/nclimate2746]; Ophir AG, 2008, HORM BEHAV, V54, P694, DOI 10.1016/j.yhbeh.2008.07.009; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Barral MP, 2015, AGR ECOSYST ENVIRON, V202, P223, DOI 10.1016/j.agee.2015.01.009; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Phalan BT, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10061760; Pilot M, 2010, MOL ECOL, V19, P2800, DOI 10.1111/j.1365-294X.2010.04692.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Prist PR, 2021, SCI TOTAL ENVIRON, V752, DOI 10.1016/j.scitotenv.2020.141967; Pritchard JK, 2000, GENETICS, V155, P945; Pryor S.C., 2014, CLIMATE CHANGE IMPAC, P418; R Core Team, 2020, R LANG ENV STAT COMP; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richmond T.C., 2014, CLIMATE CHANGE IMPAC, P257; Roberts RL, 1998, ANIM BEHAV, V55, P1131, DOI 10.1006/anbe.1997.0659; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rubio AV, 2014, ECOHEALTH, V11, P526, DOI 10.1007/s10393-014-0944-9; Runge JP, 2007, ECOLOGY, V88, P282, DOI 10.1890/0012-9658(2007)88[282:ESSAMW]2.0.CO;2; Rydzewski J, 2011, VECTOR-BORNE ZOONOT, V11, P1351, DOI 10.1089/vbz.2010.0160; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Smith JE, 2006, OIKOS, V112, P209; Solomon NG, 2009, MOL ECOL, V18, P4680, DOI 10.1111/j.1365-294X.2009.04361.x; Speldewinde PC, 2015, SCI TOTAL ENVIRON, V502, P276, DOI 10.1016/j.scitotenv.2014.09.028; Tracey JA, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00376.1; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Watts AG, 2018, LANDSCAPE ECOL, V33, P1925, DOI 10.1007/s10980-018-0715-z; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Young HS, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0124	108	0	0	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260344	10.1371/journal.pone.0260344	http://dx.doi.org/10.1371/journal.pone.0260344			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882713	gold, Green Published			2022-12-26	WOS:000755037200025
J	Wang, G; Gao, SH; Ding, H; Zhang, H; Cai, HM				Wang, Gang; Gao, Saihang; Ding, Han; Zhang, Hao; Cai, Hongmin			LIO-CSI: LiDAR inertial odometry with loop closure combined with semantic information	PLOS ONE			English	Article								Accurate and reliable state estimation and mapping are the foundation of most autonomous driving systems. In recent years, researchers have focused on pose estimation through geometric feature matching. However, most of the works in the literature assume a static scenario. Moreover, a registration based on a geometric feature is vulnerable to the interference of a dynamic object, resulting in a decline of accuracy. With the development of a deep semantic segmentation network, we can conveniently obtain the semantic information from the point cloud in addition to geometric information. Semantic features can be used as an accessory to geometric features that can improve the performance of odometry and loop closure detection. In a more realistic environment, semantic information can filter out dynamic objects in the data, such as pedestrians and vehicles, which lead to information redundancy in generated map and map-based localization failure. In this paper, we propose a method called LiDAR inertial odometry (LIO) with loop closure combined with semantic information (LIO-CSI), which integrates semantic information to facilitate the front-end process as well as loop closure detection. First, we made a local optimization on the semantic labels provided by the Sparse Point-Voxel Neural Architecture Search (SPVNAS) network. The optimized semantic information is combined into the front-end process of tightly-coupled light detection and ranging (LiDAR) inertial odometry via smoothing and mapping (LIO-SAM), which allows us to filter dynamic objects and improve the accuracy of the point cloud registration. Then, we proposed a semantic assisted scan-context method to improve the accuracy and robustness of loop closure detection. The experiments were conducted on an extensively used dataset KITTI and a self-collected dataset on the Jilin University (JLU) campus. The experimental results demonstrate that our method is better than the purely geometric method, especially in dynamic scenarios, and it has a good generalization ability.	[Wang, Gang; Ding, Han; Zhang, Hao] Jilin Univ, Coll Comp Sci & Technol, Changchun, Peoples R China; [Wang, Gang; Gao, Saihang] Jilin Univ, Sch Artificial Intelligence, Changchun, Peoples R China; [Wang, Gang; Gao, Saihang; Ding, Han; Zhang, Hao] Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Minist Educ, Changchun, Peoples R China; [Wang, Gang] Jilin Univ, State Key Lab Automot Simulat & Control, Changchun, Peoples R China; [Cai, Hongmin] South China Univ Technol, Sch Comp Sci & Engn, Guangzhou, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University; South China University of Technology	Wang, G (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun, Peoples R China.; Wang, G (corresponding author), Jilin Univ, Sch Artificial Intelligence, Changchun, Peoples R China.; Wang, G (corresponding author), Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Minist Educ, Changchun, Peoples R China.; Wang, G (corresponding author), Jilin Univ, State Key Lab Automot Simulat & Control, Changchun, Peoples R China.	wanggang.jlu@gmail.com	Zhang, Hao/AAR-8325-2020	Zhang, Hao/0000-0002-2058-7123				Behley J, 2019, IEEE I CONF COMP VIS, P9296, DOI 10.1109/ICCV.2019.00939; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Biber P, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P2743, DOI 10.1109/iros.2003.1249285; Chen SW, 2020, IEEE ROBOT AUTOM LET, V5, P612, DOI 10.1109/LRA.2019.2963823; Daoud HA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195878; Duymaz E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231412; Gauvain JL, 1994, IEEE T SPEECH AUDI P, V2, P291, DOI 10.1109/89.279278; Geiger A, 2012, PROC CVPR IEEE, P3354, DOI 10.1109/CVPR.2012.6248074; Han S., 2020, EUR C COMP VIS, P685, DOI DOI 10.1007/978-3-030-58604-1_41; Kim G, 2018, IEEE INT C INT ROBOT, P4802, DOI 10.1109/IROS.2018.8593953; Koide K., 2018, IEEE T HUM-MACH SYST; Lin Jiahao, 2019, ARXIV190808289; Lin JR, 2020, IEEE INT CONF ROBOT, P3126, DOI 10.1109/ICRA40945.2020.9197440; Mendes E, 2016, IEEE INT SYMP SAFE, P195, DOI 10.1109/SSRR.2016.7784298; Pfreundschuh P., 2021, ARXIV PREPRINT ARXIV; Rusu RB, 2010, IEEE INT C INT ROBOT, P2155, DOI 10.1109/IROS.2010.5651280; Shan TX, 2020, IEEE INT C INT ROBOT, P5135, DOI 10.1109/IROS45743.2020.9341176; Shan TX, 2018, IEEE INT C INT ROBOT, P4758, DOI 10.1109/IROS.2018.8594299; Steder B, 2011, IEEE INT C INT ROBOT, P1249, DOI 10.1109/IROS.2011.6048325; Wohlkinger W., 2011, 2011 IEEE International Conference on Robotics and Biomimetics (ROBIO), P2987, DOI 10.1109/ROBIO.2011.6181760; Xiong T, 2014, BIOMED CIRC SYST C, P9, DOI 10.1109/BioCAS.2014.6981632; Yokozuka M, 2020, IEEE INT C INT ROBOT, P5143, DOI 10.1109/IROS45743.2020.9341341	23	0	0	8	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0261053	10.1371/journal.pone.0261053	http://dx.doi.org/10.1371/journal.pone.0261053			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879118	Green Published, gold			2022-12-26	WOS:000754625200046
J	Yoshida, Y; Azuma, M; Kuwabara, H; Miyazawa, T; Nakano, Y; Furukawa, K; Hawthorne, KM; Izumizaki, M; Takaki, T; Sakaue, M; Mizuno, K				Yoshida, Yurika; Azuma, Minami; Kuwabara, Haruhiro; Miyazawa, Tokuo; Nakano, Yuya; Furukawa, Kazuna; Hawthorne, Keli M.; Izumizaki, Masahiko; Takaki, Takashi; Sakaue, Mari; Mizuno, Katsumi			Human milk-based fortifier is associated with less alteration of milk fat globule size than cow milk-based fortifier	PLOS ONE			English	Article							EXCLUSIVE HUMAN-MILK; NECROTIZING ENTEROCOLITIS; FEEDING TOLERANCE; PRETERM INFANTS; BREAST-MILK; FORTIFICATION; FORMULA; DIGESTION; OUTCOMES; DIET	We aimed to evaluate if human milk-based fortifier (HMBF) affects human milk fat globule (MFG) size less than cow milk-based fortifier (CMBF), which may impact overall infant feeding tolerance. Measurements of donated human milk were performed before fortification as well as at 1 hour, 24 hours, and 48 hours after fortification with CMBF or HMBF. MFG size in each sample of fortified milk was measured by laser light scattering. MFG size in the fortified milks increased gradually over time. At 24 and 48 hours after fortification, MFG size in the milk with CMBF was larger than that in the milk with HMBF (4.8 +/- 0.5 vs 4.3 +/- 0.3 mu m, p<0.01, 5.1 +/- 0.7 vs 4.5 +/- 0.4 mu m, p = 0.03, respectively). HMBF is associated with less alteration of MFG size than CMBF. This may have an impact on feeding tolerance of very preterm infants.	[Yoshida, Yurika; Azuma, Minami; Kuwabara, Haruhiro; Miyazawa, Tokuo; Nakano, Yuya; Furukawa, Kazuna; Mizuno, Katsumi] Showa Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Hawthorne, Keli M.] Univ Texas Austin, Dell Pediat Res Inst, Dell Med Sch, Dept Pediat, Austin, TX 78712 USA; [Izumizaki, Masahiko] Showa Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Takaki, Takashi] Showa Univ, Sch Med, Div Electron Microscopy, Tokyo, Japan; [Sakaue, Mari] Hitachi High Tech Corp, Anal Syst Solut Dev Dept, Tokyo, Japan; [Mizuno, Katsumi] Japanese Human Milk Bank Assoc, Tokyo, Japan	Showa University; University of Texas System; University of Texas Austin; Showa University; Showa University	Mizuno, K (corresponding author), Showa Univ, Sch Med, Dept Pediat, Tokyo, Japan.; Mizuno, K (corresponding author), Japanese Human Milk Bank Assoc, Tokyo, Japan.	katsuorobi@med.showa-u.ac.jp		Hawthorne, Keli/0000-0001-6325-9827				Abrams SA, 2014, BREASTFEED MED, V9, P281, DOI 10.1089/bfm.2014.0024; Armand M, 1996, PEDIATR RES, V40, P429, DOI 10.1203/00006450-199609000-00011; Asai HM.K., 2020, J NEO NURS, V26, P57; Assad M, 2016, J PERINATOL, V36, P216, DOI 10.1038/jp.2015.168; Berseth CL, 2014, PROSTAG LEUKOTR ESS, V91, P97, DOI 10.1016/j.plefa.2014.03.002; Cristofalo EA, 2013, J PEDIATR-US, V163, P1592, DOI 10.1016/j.jpeds.2013.07.011; De Curtis M, 1999, ARCH DIS CHILD-FETAL, V81, pF141, DOI 10.1136/fn.81.2.F141; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Ewer AK, 1996, ACTA PAEDIATR, V85, P1112, DOI 10.1111/j.1651-2227.1996.tb14227.x; Hair AB, 2016, BREASTFEED MED, V11, P70, DOI 10.1089/bfm.2015.0134; Jensen R.J., 1995, HDB MILK COMPOSITION, P718, DOI 10.1016/B978-012384430-9/50032-9; Jocson MAL, 1997, PEDIATRICS, V100, P240, DOI 10.1542/peds.100.2.240; Kamigaki T., 2019, MILK SCI, V68, P94; Le Huerou-Luron I, 2018, EUR J NUTR, V57, P463, DOI 10.1007/s00394-016-1329-3; Masafumi Aoki S.M., 2020, ANN CLIN CASE REPORT; Michalski MC, 2005, J DAIRY SCI, V88, P1927, DOI 10.3168/jds.S0022-0302(05)72868-X; Michalski MC, 2002, COLLOID SURFACE B, V23, P23, DOI 10.1016/S0927-7765(01)00203-X; Mizuno K, 2012, J HUM LACT, V28, P529, DOI 10.1177/0890334412455946; Mizuno K, 2009, INT BREASTFEED J, V4, DOI 10.1186/1746-4358-4-7; Moody GJ, 2000, J PEDIATR GASTR NUTR, V30, P408, DOI 10.1097/00005176-200004000-00011; Murase M, 2013, PEDIATR INT, V55, P114, DOI 10.1111/j.1442-200X.2012.03630.x; Rings EHHM, 2002, PEDIATR RES, V51, P57, DOI 10.1203/00006450-200201000-00011; Sandhu A, 2017, BREASTFEED MED, V12, P570, DOI 10.1089/bfm.2017.0017; Stanger J, 2014, J PEDIATR SURG, V49, P724, DOI 10.1016/j.jpedsurg.2014.02.054; Sullivan S, 2010, J PEDIATR-US, V156, P562, DOI 10.1016/j.jpeds.2009.10.040; Takahashi K, 2012, AM J PERINAT, V29, P283, DOI 10.1055/s-0031-1295659; Taylor SN, 2019, SEMIN PERINATOL, V43, DOI 10.1053/j.semperi.2019.06.006; Uchida HW.T, 2010, J JPN SOC PEINAT NEO, V46; Wei W, 2019, J AGR FOOD CHEM, V67, P13922, DOI 10.1021/acs.jafc.9b04247; Zou XQ, 2012, J AGR FOOD CHEM, V60, P7158, DOI 10.1021/jf3013597	30	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0257491	10.1371/journal.pone.0257491	http://dx.doi.org/10.1371/journal.pone.0257491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874946	gold, Green Published			2022-12-26	WOS:000753617500003
J	Aboelhadid, SM; Arafa, WM; Abdel-Baki, AAS; Sokmen, A; Al-Quraishy, S; Hassan, AO; Kamel, AA				Aboelhadid, Shawky M.; Arafa, Waleed M.; Abdel-Baki, Abdel-Azeem S.; Sokmen, Atalay; Al-Quraishy, Saleh; Hassan, Ahmed O.; Kamel, Asmaa A.			Acaricidal activity of Foeniculum vulgare against Rhipicephalus annulatus is mainly dependent on its constituent from trans-anethone	PLOS ONE			English	Article							PLANT ESSENTIAL OILS; FUMIGANT TOXICITY; INSECTICIDAL ACTIVITY; CHEMICAL-COMPOSITION; BOOPHILUS-ANNULATUS; SITOPHILUS-ORYZAE; TICKS; MICROPLUS; MOSQUITO; DIPTERA	Globally, the economic losses due to hard ticks infestation and the control of the associated diseases have been calculated at USD $13.9-18.7 billion per year. The economic impact is related to its direct damage to the skins, blood loss, anemia, severe immunological reactions and indirect losses that related to the effects of hemoparasites, cost of treatment for clinical cases and expenses incurred in the control of ticks. The current study evaluated the acaricidal activities of fennel Foeniculum vulgare essential oil and its main components; trans-anethole and fenchone; against R. annulatus. GC-MS analysis revealed that this oil contained 16 components representing 99.9% of the total identified compounds with E-anethole being the predominant component(64.29%), followed by fenchone (9.94%). The fennel oil and trans-anethole showed significant acaricidal activities. The LC50 of the fennel oil was attained at concentrations of 12.96% for adult ticks and 1.75% for tick larvae meanwhile the LC50 of trans-anethole was reached at concentrations of 2.36% for adult tick and 0.56% for tick larvae. On the contrary, fenchone showed no any significant adulticidal activities and its LC50 attained at a concentration of 9.11% for tick larvae. Regarding repellence activities, trans-anethole achieved 100% repellency at the concentration of 10% while fennel showed 86% repellency at the same concentration. Fenchone showed no repellency effect. Treatment of larvae with fennel, trans-anethole, and fenchone LC50 concentrations significantly inhibited the acetylcholinesterase activity. Meanwhile, glutathione s-transferase activity was significantly decreased in fennel treated larvae but no significant effect was found in the larvae of trans-anethole and fenchone groups. These results indicate that the acaricide effect of fennel oil may attributed to its high content of trans-anethole. This was supported by potent adulticidal, larvicidal, and repellency effects of trans-anethole against Rhipeciphalus annulatus tick and therefore it could be included in the list of acaricide of plant origin.	[Aboelhadid, Shawky M.; Arafa, Waleed M.; Kamel, Asmaa A.] Beni Suef Univ, Fac Vet Med, Parasitol Dept, Bani Suwayf, Egypt; [Abdel-Baki, Abdel-Azeem S.] Beni Suef Univ, Fac Sci, Zool Dept, Bani Suwayf, Egypt; [Sokmen, Atalay] Konya Food & Agr Univ, Fac Agr & Nat Sci, Dept Plant Prod & Technol, Konya, Turkey; [Al-Quraishy, Saleh] King Saud Univ, Coll Sci, Zool Dept, Riyadh, Saudi Arabia; [Hassan, Ahmed O.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Beni Suef University; Konya Food & Agriculture University; King Saud University; Washington University (WUSTL)	Aboelhadid, SM (corresponding author), Beni Suef Univ, Fac Vet Med, Parasitol Dept, Bani Suwayf, Egypt.	shawky.abohadid@vet.bsu.edu.eg	Abdel-Baki, Abdel-Azeem/R-6964-2016	Abdel-Baki, Abdel-Azeem/0000-0002-7877-5397	King Saud University [RSP2021/3]	King Saud University(King Saud University)	Researcher supporting Project (RSP2021/3), King Saud University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboelhadid SM, 2018, VET PARASITOL REG ST, V13, P198, DOI 10.1016/j.vprsr.2018.06.008; Aboelhadid SM, 2018, VET PARASITOL, V256, P35, DOI 10.1016/j.vetpar.2018.05.005; Adams R.P., 1995, IDENTIFICATION ESSEN; Adenubi OT, 2016, S AFR J BOT, V105, P178, DOI 10.1016/j.sajb.2016.03.010; Amizadeh M, 2013, INT J ACAROL, V39, P285, DOI 10.1080/01647954.2013.777782; Aprotosoaie AC, 2010, FARMACIA, V58, P46; Badgujar SB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/842674; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Benelli G, 2016, PARASITOL RES, V115, P2545, DOI 10.1007/s00436-016-5095-1; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Boulahbel B, 2015, AFR ENTOMOL, V23, P224, DOI 10.4001/003.023.0104; Cardoso AD, 2020, VET PARASITOL, V280, DOI 10.1016/j.vetpar.2020.109090; Chantawee A, 2018, ASIAN PAC J TROP BIO, V8, P217, DOI 10.4103/2221-1691.231284; Choi EM, 2004, FITOTERAPIA, V75, P557, DOI 10.1016/j.fitote.2004.05.005; Cosimi S, 2009, J STORED PROD RES, V45, P125, DOI 10.1016/j.jspr.2008.10.002; DRUMMOND RO, 1973, J ECON ENTOMOL, V66, P130, DOI 10.1093/jee/66.1.130; Ebadollahi A., 2014, Psyche: A Journal of Entomology, V2014, P424078, DOI 10.1155/2014/424078; El Zayyat EA, 2017, J ARTHROPOD-BORNE DI, V11, P147; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Eskezia B., 2016, J BIOL AGR HEALTHC, V6, P1; Estrada-Pena A, 2004, MED VET ENTOMOL, V18, P123, DOI 10.1111/j.0269-283X.2004.00486.x; FAO, 2004, RES MAN INT PAR CONT; Ferreira LL, 2017, VET PARASITOL, V239, P42, DOI 10.1016/j.vetpar.2017.04.021; Gemeda Negero, 2014, J Parasitol Res, V2014, P978537, DOI 10.1155/2014/978537; Gupta S., 2017, ARTHROPODS, V6, P93; He WP, 2011, J MED PLANTS RES, V5, P3595; Huang QC, 2017, PESTIC BIOCHEM PHYS, V137, P1, DOI 10.1016/j.pestbp.2016.09.006; Iori A, 2005, VET PARASITOL, V129, P173, DOI 10.1016/j.vetpar.2004.11.035; Jacob RF, 2005, J BIOL CHEM, V280, P39380, DOI 10.1074/jbc.M507587200; Khater H, 2016, PARASITOL RES, V115, P3747, DOI 10.1007/s00436-016-5136-9; Kim SW, 2013, J ASIA-PAC ENTOMOL, V16, P443, DOI 10.1016/j.aspen.2013.07.002; Kutukoglu F, 2012, TURK J VET ANIM SCI, V36, P554, DOI 10.3906/vet-1104-12; Lee HS, 2004, J AGR FOOD CHEM, V52, P2887, DOI 10.1021/jf049631t; Lee SE, 2001, PEST MANAG SCI, V57, P548, DOI 10.1002/ps.322; Li B, 2005, BIOCHEM PHARMACOL, V70, P1673, DOI 10.1016/j.bcp.2005.09.002; Lima R.K., 2008, BIOASSAY, V3, P16; LUCCA P. S. R., 2015, Rev. bras. plantas med., V17, P585, DOI 10.1590/1983-084X/14_036; Matos RS, 2019, TICKS TICK-BORNE DIS, V10, P314, DOI 10.1016/j.ttbdis.2018.11.003; Misra G, 1997, APPL MICROBIOL BIOT, V47, P572, DOI 10.1007/s002530050975; Pavela R, 2017, J PEST SCI, V90, P683, DOI 10.1007/s10340-016-0828-6; Pavela R, 2016, IND CROP PROD, V83, P275, DOI 10.1016/j.indcrop.2015.11.090; Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050; Piras A, 2014, NAT PROD RES, V28, P1819, DOI 10.1080/14786419.2014.948874; Preuss HG, 1998, J AM COLL NUTR, V17, P116, DOI 10.1080/07315724.1998.10718736; Rahimi V, 2018, J ECON ENTOMOL, V111, P662, DOI 10.1093/jee/toy006; Rodriguez-Vivas RI, 2018, PARASITOL RES, V117, P3, DOI 10.1007/s00436-017-5677-6; Seada M.A., 2016, J EXP BIOL ZOOL EGYP, V12, P1; Sedaghat MM, 2011, IRAN J ARTHROPOD-BOR, V5, P51; Semiz GD, 2012, J AGR SCI-TARIM BILI, V18, P177, DOI 10.1501/Tarimbil_0000001206; Seo SM, 2015, J AGR FOOD CHEM, V63, P9977, DOI 10.1021/acs.jafc.5b03586; Shahriari M, 2018, PESTIC BIOCHEM PHYS, V150, P40, DOI 10.1016/j.pestbp.2018.06.015; Souto R.N.P., 2011, BIOTA AMAZ NIA, V1, P42, DOI [10.18561/2179-5746/biotaamazonia.v1n1p42-48, DOI 10.18561/2179-5746/BIOTAAMAZONIA.V1N1P42-48]; Senra TDS, 2013, PARASITOL RES, V112, P1461, DOI 10.1007/s00436-013-3289-3; Tabari MA, 2017, VET PARASITOL, V245, P86, DOI 10.1016/j.vetpar.2017.08.012; Tak JH, 2016, PESTIC BIOCHEM PHYS, V133, P20, DOI 10.1016/j.pestbp.2016.03.009; Tawatsin Apiwat, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P915; Wanzala W, 2004, CHEMOECOLOGY, V14, P229, DOI 10.1007/s00049-004-0280-6; Yitayew Demessie, 2015, Advances in Biological Research, V9, P210; Zoubiri S, 2011, FOOD CHEM, V129, P179, DOI 10.1016/j.foodchem.2011.04.033; Zoubiri S, 2014, ARAB J CHEM, V7, P480, DOI 10.1016/j.arabjc.2010.11.006	60	2	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260172	10.1371/journal.pone.0260172	http://dx.doi.org/10.1371/journal.pone.0260172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855806	Green Published, gold			2022-12-26	WOS:000735299000034
J	Ahmadi, E; Zabihi, MR; Hosseinzadeh, R; Khosroshahi, LM; Noorbakhsh, F				Ahmadi, Ehsan; Zabihi, Mohammad Reza; Hosseinzadeh, Ramin; Khosroshahi, Leila Mohamed; Noorbakhsh, Farshid			SARS-CoV-2 spike protein displays sequence similarities with paramyxovirus surface proteins; a bioinformatics study	PLOS ONE			English	Article							ACTIVATION; HOMOPLASY	Recent emergence of SARS-CoV-2 and associated COVID-19 pandemic have posed a great challenge for the scientific community. In this study, we performed bioinformatic analyses on SARS-CoV-2 protein sequences, trying to unravel potential molecular similarities between this newly emerged pathogen with non-coronavirus ssRNA viruses. Comparing the proteins of SARS-CoV-2 with non-coronavirus positive and negative strand ssRNA viruses revealed multiple sequence similarities between SARS-CoV-2 and non-coronaviruses, including similarities between RNA-dependent RNA-polymerases and helicases (two highly-conserved proteins). We also observed similarities between SARS-CoV-2 surface (i.e. spike) protein with paramyxovirus fusion proteins. This similarity was restricted to a segment of spike protein S2 subunit which is involved in cell fusion. We next analyzed spike proteins from SARS-CoV-2 "variants of concern" (VOCs) and "variants of interests" (VOIs) and found that some of these variants show considerably higher spike-fusion similarity with paramyxoviruses. The 'spike-fusion' similarity was also observed for some pathogenic coronaviruses other than SARS-CoV-2. Epitope analysis using experimentally verified data deposited in Immune Epitope Database (IEDB) revealed that several B cell epitopes as well as T cell and MHC binding epitopes map within the spike-fusion similarity region. These data indicate that there might be a degree of convergent evolution between SARS-CoV-2 and paramyxovirus surface proteins which could be of pathogenic and immunological importance.	[Ahmadi, Ehsan; Zabihi, Mohammad Reza; Hosseinzadeh, Ramin; Khosroshahi, Leila Mohamed; Noorbakhsh, Farshid] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran; [Noorbakhsh, Farshid] Khatam Alanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran	Tehran University of Medical Sciences	Noorbakhsh, F (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran.; Noorbakhsh, F (corresponding author), Khatam Alanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran.	f-noorbakhsh@sina.tums.ac.ir		Hosseinzadeh, Ramin/0000-0002-8573-1157				Anbarasu A, 2020, HUM VACC IMMUNOTHER, V16, P2217, DOI 10.1080/21645515.2020.1773141; [Anonymous], 2021, TRACK SARS COV 2 VAR; Ashford JW, 2021, AM J MED, V134, P153, DOI 10.1016/j.amjmed.2020.10.003; Cox RM, 2017, CURR OPIN VIROL, V24, P105, DOI 10.1016/j.coviro.2017.05.004; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; da Costa VG, 2020, ARCH VIROL, V165, P1517, DOI 10.1007/s00705-020-04628-0; Fidel PL, 2020, MBIO, V11, DOI 10.1128/mBio.00907-20; Forni D, 2017, TRENDS MICROBIOL, V25, P35, DOI 10.1016/j.tim.2016.09.001; Franklin R, 2020, HOMOLOGOUS PROTEIN D, DOI [10.1101/2020.04.10.20053207, DOI 10.1101/2020.04.10.20053207]; Gold JE, 2020, MBIO, V11, DOI 10.1128/mBio.02628-20; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gujar N, 2021, HUM VACC IMMUNOTHER, V17, P3316, DOI 10.1080/21645515.2021.1930471; Haddad-Boubaker S, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-021-04045-3; Hall BK, 2007, J HUM EVOL, V52, P473, DOI 10.1016/j.jhevol.2006.11.010; HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; Hassani D, 2021, IRAN J IMMUNOL, V18, P47, DOI 10.22034/iji.2021.87990.1843; Jardetzky TS, 2014, CURR OPIN VIROL, V5, P24, DOI 10.1016/j.coviro.2014.01.005; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Marakasova E, 2021, MBIO, V12, DOI 10.1128/mBio.03447-20; MCINTOSH K, 1967, P NATL ACAD SCI USA, V57, P933, DOI 10.1073/pnas.57.4.933; Mysore V, 2021, MED-CAMBRIDGE, V2, P1050, DOI 10.1016/j.medj.2021.08.004; Netea MG, 2020, CELL, V181, P969, DOI 10.1016/j.cell.2020.04.042; O'Neill LAJ, 2020, NAT REV IMMUNOL, V20, P335, DOI 10.1038/s41577-020-0337-y; Okada S, 2003, INT IMMUNOL, V15, P1275, DOI 10.1093/intimm/dxg126; Parks GD, 2013, J MOL BIOL, V425, P4872, DOI 10.1016/j.jmb.2013.09.015; Russell CJ, 2006, TRENDS MICROBIOL, V14, P243, DOI 10.1016/j.tim.2006.04.004; Taheri Soodejani Moslem, 2021, Int J Mol Epidemiol Genet, V12, P35; Wake DB, 2011, SCIENCE, V331, P1032, DOI 10.1126/science.1188545; Wertheim JO, 2013, J VIROL, V87, P7039, DOI 10.1128/JVI.03273-12	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260360	10.1371/journal.pone.0260360	http://dx.doi.org/10.1371/journal.pone.0260360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855795	Green Published, gold			2022-12-26	WOS:000735299000047
J	Husaiyin, S; Jiao, Z; Yimamu, K; Maisaidi, R; Han, LL; Niyazi, M				Husaiyin, Sulaiya; Jiao, Zhen; Yimamu, Kailibinuer; Maisaidi, Reyilanmu; Han, Lili; Niyazi, Mayinuer			ThinPrep cytology combined with HPV detection in the diagnosis of cervical lesions in 1622 patients	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; CANCER; WOMEN; RISK; PREVENTION; PREVALENCE	The timely detection of precancerous lesions and early intervention can greatly reduce cervical cancer occurrence. The current study aimed to assess the diagnostic value and accuracy of different methods of cervical lesion screening. A total of 1622 females who visited the Outpatient Department of Xinjiang Uyghur Autonomous Region People's Hospital between January and December 2018 were consecutively enrolled. All participants underwent separate high-risk human papilloma virus (HR-HPV) DNA detection, ThinPrep cytology testing (TCT) and colposcopic biopsy. Their medical records were retrospectively analyzed. While considering biopsy outcomes as the gold standard, the diagnostic values of TCT, HR-HPV testing, and TCT+HR-HPV testing for cervical cancer screening were compared. The sensitivity, specificity and Youden index of each method were calculated. Among the different methods, TCT+HR-HPV testing had the highest sensitivity (89.8%), followed by TCT (79.9%) and HR-HPV testing (49.2%). The combined method also had the highest Youden value, and its screening outcomes exhibited the highest consistency with those of biopsy. In addition, the combined method had the largest area under the receiver operating characteristic (ROC) curve, which was 0.673 (0.647, 0.699), compared with any other screening method. Compared with TCT or HR-HPV testing alone, TCT+HR-HPV testing serves as a better screening method for cervical cancer and precancerous lesions.	[Husaiyin, Sulaiya; Jiao, Zhen; Yimamu, Kailibinuer; Maisaidi, Reyilanmu; Han, Lili; Niyazi, Mayinuer] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Gynecol, Urumqi, Peoples R China		Niyazi, M (corresponding author), Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Gynecol, Urumqi, Peoples R China.	mayinniya@163.com			Project on human leukocyte antigen gene and HPV infection (Natural Science Foundation of Xinjiang Uygur Autonomous Region) [2017D01C125]	Project on human leukocyte antigen gene and HPV infection (Natural Science Foundation of Xinjiang Uygur Autonomous Region)	This study was supported by the Project on human leukocyte antigen gene and HPV infection (Natural Science Foundation of Xinjiang Uygur Autonomous Region; 2017D01C125). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blatt AJ, 2015, CANCER CYTOPATHOL, V123, P282, DOI 10.1002/cncy.21544; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brisson M, 2020, LANCET, V395, P575, DOI 10.1016/S0140-6736(20)30068-4; Chen Y., 2008, CHINESE J CANC PREVE, V05, P329; Darragh TM, 2012, J LOW GENIT TRACT DI, V16, P205, DOI 10.1097/PGP.0b013e31826916c7; Di Jiangli, 2015, Asian Pac J Cancer Prev, V16, P7401; Fontham ETH, 2020, CA-CANCER J CLIN, V70, P321, DOI 10.3322/caac.21628; Han LL, 2018, CLIN LAB, V64, P1363, DOI 10.7754/Clin.Lab.2018.180138; Hu Z, 2018, CANCER MED-US, V7, P5217, DOI 10.1002/cam4.1501; Husaiyin S, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5083-1; Kahn JA, 2007, OBSTET GYNECOL, V110, P87, DOI 10.1097/01.AOG.0000266984.23445.9c; Kurban G., 2002, CHIN J CANCER, V05, P405; Long HQ., 2012, HAINAN MED J, V23, P100; Pan ZZ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39790-2; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schledermann D, 2006, DIAGN CYTOPATHOL, V34, P780, DOI 10.1002/dc.20515; Sun Xiao-Fei, 2013, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V27, P273; SYRJANEN K, 1990, SEX TRANSM DIS, V17, P15, DOI 10.1097/00007435-199017010-00004; Wang BH, 2015, ONCOLOGIST, V20, P627, DOI 10.1634/theoncologist.2014-0303; Wang J, 2019, HUM VACC IMMUNOTHER, V15, P1889, DOI [DOI 10.1080/21645515.2019.1578598, 10.1080/21645515.2019.1578598]; Wang J, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0785-3; Wang J, 2019, HUM VACC IMMUNOTHER, V15, P2637, DOI [10.1080/21645515.2019.1596713, 10.1080/21645515.2019.1578598]; Wardak Sebastian, 2016, Medycyna Doswiadczalna i Mikrobiologia, V68, P73; Wei LH., 2017, CHIN J CLIN OBSTET G, V2, P190; Xu Xiao-hong, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P298; Yao LL, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000013206, 10.1097/md.0000000000013206]; 姜淑清, 2006, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V22, P379	27	3	3	8	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260915	10.1371/journal.pone.0260915	http://dx.doi.org/10.1371/journal.pone.0260915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855928	Green Published, gold			2022-12-26	WOS:000735299000153
J	Kadelka, C; McCombs, A				Kadelka, Claus; McCombs, Audrey			Effect of homophily and correlation of beliefs on COVID-19 and general infectious disease outbreaks	PLOS ONE			English	Article							MULTIVARIATE BERNOULLI; RANDOM-VARIABLES; EXEMPTIONS; DISTRIBUTIONS; SIMULATION; IMPACT	Contact between people with similar opinions and characteristics occurs at a higher rate than among other people, a phenomenon known as homophily. The presence of clusters of unvaccinated people has been associated with increased incidence of infectious disease outbreaks despite high population-wide vaccination rates. The epidemiological consequences of homophily regarding other beliefs as well as correlations among beliefs or circumstances are poorly understood, however. Here, we use a simple compartmental disease model as well as a more complex COVID-19 model to study how homophily and correlation of beliefs and circumstances in a social interaction network affect the probability of disease outbreak and COVID-19-related mortality. We find that the current social context, characterized by the presence of homophily and correlations between who vaccinates, who engages in risk reduction, and individual risk status, corresponds to a situation with substantially worse disease burden than in the absence of heterogeneities. In the presence of an effective vaccine, the effects of homophily and correlation of beliefs and circumstances become stronger. Further, the optimal vaccination strategy depends on the degree of homophily regarding vaccination status as well as the relative level of risk mitigation high- and low-risk individuals practice. The developed methods are broadly applicable to any investigation in which node attributes in a graph might reasonably be expected to cluster or exhibit correlations.	[Kadelka, Claus] Iowa State Univ, Dept Math, Ames, IA 50011 USA; [McCombs, Audrey] Iowa State Univ, Dept Stat, Ames, IA USA	Iowa State University; Iowa State University	Kadelka, C (corresponding author), Iowa State Univ, Dept Math, Ames, IA 50011 USA.	ckadelka@iastate.edu	Kadelka, C/ABL-5824-2022	McCombs, Audrey/0000-0002-6786-7819; Kadelka, Claus/0000-0002-5712-8529				Barbiero A, 2017, COMMUN STAT-SIMUL C, V46, P5123, DOI 10.1080/03610918.2016.1146758; Barclay VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087042; Berg P, 2020, 52 US AIR TRAVELERS; Brenan, 2020, AM FACE MASK USAGE V; Bubar KM, 2021, SCIENCE, V371, P916, DOI 10.1126/science.abe6959; Campbell E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01905; Center PR, 2014, ANNU REV POLIT SCI; Centers for Disease Control and Prevention (CDC), 2020, PEOPL INCR RISK OTH; Chaganty NR, 2006, BIOMETRIKA, V93, P197, DOI 10.1093/biomet/93.1.197; Crabtree S, 2020, WHICH AM ARE MOST BE; EMRICH LJ, 1991, AM STAT, V45, P302, DOI 10.2307/2684460; Ernst KC, 2012, HUM VACC IMMUNOTHER, V8, P838, DOI 10.4161/hv.19743; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Fiorina MP, 2008, ANNU REV POLIT SCI, V11, P563, DOI 10.1146/annurev.polisci.11.053106.153836; Fontana R, 2018, J MULTIVARIATE ANAL, V168, P290, DOI 10.1016/j.jmva.2018.08.003; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Hamill L, 2009, JASSS-J ARTIF SOC S, V12; Hedlund J, 2000, Inj Prev, V6, P82, DOI 10.1136/ip.6.2.82; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Johnson NF, 2020, NATURE, V582, P230, DOI 10.1038/s41586-020-2281-1; Lall U, 2016, RISK ANAL, V36, P57, DOI 10.1111/risa.12432; May T, 2003, VACCINE, V21, P1048, DOI 10.1016/S0264-410X(02)00627-8; Mbah MLN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002469; McBryde ES, 2009, CLIN INFECT DIS, V48, P685, DOI 10.1086/597012; McCombs A, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008388; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Oman SD, 2009, COMPUT STAT DATA AN, V53, P999, DOI 10.1016/j.csda.2008.11.017; Omer SB, 2008, AM J EPIDEMIOL, V168, P1389, DOI 10.1093/aje/kwn263; Prem K, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005697; Reinhart R.J., 2020, GALLUP; Salathe M, 2008, J R SOC INTERFACE, V5, P1505, DOI 10.1098/rsif.2008.0271; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Singh M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3703-2; Smith KF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0950; TEUGELS JL, 1990, J MULTIVARIATE ANAL, V32, P256, DOI 10.1016/0047-259X(90)90084-U; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wang F, 2017, STRUCT SAF, V67, P105, DOI 10.1016/j.strusafe.2017.04.005; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	39	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260973	10.1371/journal.pone.0260973	http://dx.doi.org/10.1371/journal.pone.0260973			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855929	Green Published, gold			2022-12-26	WOS:000735299000162
J	Ngasa, SN; Tchouda, LAS; Abanda, C; Ngasa, NC; Sanji, EW; Dingana, TN; Babila, CS				Ngasa, Stewart Ndutard; Tchouda, Leticia Armelle Sani; Abanda, Christabel; Ngasa, Neh Chang; Sanji, Eric Wah; Dingana, Therence Nwana; Babila, Carlson-Sama			Prevalence and factors associated with anxiety and depression amongst hospitalised COVID-19 patients in Laquintinie Hospital Douala, Cameroon	PLOS ONE			English	Article							SURVIVORS	Studies assessing the mental health of patients with COVID-19 infection remain limited. Disasters and major emergencies, not just COVID-19, undoubtedly lead to greater incidence of mental health problems. Previous studies indicate that the novel Coronavirus disease can cause panic and stress in patients. Our literature search didn't reveal any previous published data from Cameroon and the Central African sub-region. In order to bridge this gap, we assessed the prevalence and factors associated with depression and anxiety in COVID-19 patients. We carried out a cross-sectional study in a secondary hospital in the Littoral Region of Cameroon. We recruited hospitalised COVID-19 patients during a 4-month period. We collected data on sociodemographic characteristics. The HADS score was used to assess levels of anxiety and depression. All analysis were done using Stata 14. A P value of <0.05 was used as the cut-off for statistical significance. A total number of 285 patients took part in this study with a mean age of 48.47 years. The prevalence of anxiety in COVID-19 patients was 60.35% while the prevalence of depression was 81.40%. At multivariate logistic regression male gender (OR: 1.89, P = 0.04), hypoxaemia (OR: 2.20, P = 0.01), presence of COVID-19 complications (OR: 1.61, P = 0.02) and current episode of depression (OR: 4.14, P<0.01) were independently associated with anxiety. Similarly, age > 35 years (OR:2.03, P = 0.02), presence of comorbidity (OR: 1.68, P = 0.01), BMI > = 30kg/m2 (OR: 1.78, P = 0.02), presence of COVID-19 complications (OR: 1.28, P = 0.01) and anxiety (OR: 4.60, P<0.001) were independently associated with depression. Hospitalised patients with COVID-19 experienced high levels of anxiety and depression. Treatment of hospitalised patients with COVID-19 should therefore include psychotherapy and psychiatric support.	[Ngasa, Stewart Ndutard; Tchouda, Leticia Armelle Sani; Abanda, Christabel; Ngasa, Neh Chang; Sanji, Eric Wah; Dingana, Therence Nwana; Babila, Carlson-Sama] Med Res & Careers Org, Bamenda, Northwest Regio, Cameroon; [Ngasa, Stewart Ndutard] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England; [Tchouda, Leticia Armelle Sani; Ngasa, Neh Chang] Univ Buea, Fac Hlth Sci, Buea, Southwest Regio, Cameroon; [Abanda, Christabel] Laquintinie Hosp Douala, Douala, Littoral Region, Cameroon; [Dingana, Therence Nwana] Tubah Dist Hosp, Reg Delegat Publ Hlth, Bambui, Northwest Regio, Cameroon; [Babila, Carlson-Sama] Nuffield Hlth Hosp, Royal Leamington Spa, Leamington, Warwick, England		Ngasa, SN (corresponding author), Med Res & Careers Org, Bamenda, Northwest Regio, Cameroon.; Ngasa, SN (corresponding author), Manchester Univ NHS Fdn Trust, Manchester, Lancs, England.	stewart.ndutard3@gmail.com		Ngasa, Stewart/0000-0001-5954-9717				Aly HM, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045281; Babatunde F, 2021, BRAIN BEHAV IMMUN HE, V16; Basheti IA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249716; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Cheng SKW, 2004, PSYCHOL MED, V34, P1187, DOI 10.1017/S0033291704002272; Dai LL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238416; Doumas M, 2020, J HUM HYPERTENS, V34, P764, DOI 10.1038/s41371-020-0380-y; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Health M of P, EPIDEMIE CORONAVIRUS; Kim HC, 2018, PSYCHIAT INVEST, V15, P355, DOI 10.30773/pi.2017.10.25.1; Kong X., 2020, PREVALENCE FACTORS A, DOI [10.1101/2020.03.24.20043075, DOI 10.1101/2020.03.24.20043075]; Santosh KYS, 2021, LANCET GASTROENTEROL, V6, P608, DOI 10.1016/S2468-1253(21)00190-4; Li Guo-qiang, 2003, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V15, P404; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m641; Mazza MG, 2020, BRAIN BEHAV IMMUN, V89, P594, DOI 10.1016/j.bbi.2020.07.037; Mude W, 2021, J GLOB HEALTH, V11, DOI 10.7189/jogh.11.05015; Nayak BS, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-044397; Ngasa NC, 2021, PRIPRINT, DOI 10.21203/rs.3.rs-712354/v1; Nochaiwong S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89700-8; Rajkumar RP, 2021, DISEASES-BASEL, V9, DOI 10.3390/diseases9020036; Saidi I, 2021, RESP MED, V186, DOI 10.1016/j.rmed.2021.106512; Sheng B, 2005, EUR PSYCHIAT, V20, P236, DOI 10.1016/j.eurpsy.2004.06.023; Tasnim R, 2021, BMC PSYCHIATRY, V21, DOI 10.1186/s12888-021-03243-w; Thakur V, 2020, BRAIN BEHAV IMMUN, V88, P952, DOI 10.1016/j.bbi.2020.04.062; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wu TC, 2021, J AFFECT DISORDERS, V281, P91, DOI 10.1016/j.jad.2020.11.117; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5	27	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260819	10.1371/journal.pone.0260819	http://dx.doi.org/10.1371/journal.pone.0260819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855877	gold, Green Submitted, Green Published			2022-12-26	WOS:000735299000131
J	Phillips, TK; Olsen, H; Teasdale, CA; Geller, A; Ts'oeu, M; Buono, N; Kayira, D; Ngeno, B; Modi, S; Abrams, EJ				Phillips, Tamsin K.; Olsen, Halli; Teasdale, Chloe A.; Geller, Amanda; Ts'oeu, Mamorapeli; Buono, Nicole; Kayira, Dumbani; Ngeno, Bernadette; Modi, Surbhi; Abrams, Elaine J.			Uninterrupted HIV treatment for women: Policies and practices for care transitions during pregnancy and breastfeeding in Cote d'Ivoire, Lesotho and Malawi	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; OPTION B PLUS; ANTIRETROVIRAL THERAPY; POSTPARTUM WOMEN; PREVENTION; RETENTION; CONTINUUM; PROGRAM	Transitions between services for continued antiretroviral treatment (ART) during and after pregnancy are a commonly overlooked aspect of the HIV care cascade, but ineffective transitions can lead to poor health outcomes for women and their children. In this qualitative study, we conducted interviews with 15 key stakeholders from Ministries of Health along with PEPFAR-supported and other in-country non-governmental organizations actively engaged in national programming for adult HIV care and prevention of mother-to-child-transmission of HIV (PMTCT) services in Cote d'Ivoire, Lesotho and Malawi. We aimed to understand perspectives regarding transitions into and out of PMTCT services for continued ART. Thematic analysis revealed that, although transitions of care are necessary and a potential point of loss from ART care in all three countries, there is a lack of clear guidance on transition approach and no formal way of monitoring transition between services. Several opportunities were identified to monitor and strengthen transitions of care for continued ART along the PMTCT cascade.	[Phillips, Tamsin K.] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa; [Olsen, Halli; Teasdale, Chloe A.; Abrams, Elaine J.] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Teasdale, Chloe A.; Abrams, Elaine J.] Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Teasdale, Chloe A.] CUNY Grad Sch Publ Hlth & Hlth Policy, Dept Epidemiol & Biostat, New York, NY USA; [Geller, Amanda; Ngeno, Bernadette; Modi, Surbhi] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Atlanta, GA USA; [Ts'oeu, Mamorapeli] CDC Lesotho, Div Global HIV & TB, Maseru, Lesotho; [Buono, Nicole; Kayira, Dumbani] CDC Malawi, Div Global HIV & TB, Lilongwe, Malawi; [Abrams, Elaine J.] Columbia Univ, Coll Phys & Surg, New York, NY USA	University of Cape Town; Columbia University; Centers for Disease Control & Prevention - USA; Columbia University	Phillips, TK (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa.	tammy.phillips@uct.ac.za		Olsen, Halli/0000-0001-7964-8405; Kayira, Dumbani/0000-0002-7772-8070; Phillips, Tamsin/0000-0003-4554-2922	US Centers for Disease Control and Prevention [U2GGH00994]; Columbia University; VECD Global Health Fellowship - Office of AIDS Research (OAR); Fogarty International Center (FIC) of the NIH [D43 TW009337]	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Columbia University; VECD Global Health Fellowship - Office of AIDS Research (OAR); Fogarty International Center (FIC) of the NIH	The authors listed from ICAP at Columbia University received funding from the US Centers for Disease Control and Prevention (U2GGH00994) to complete the work described in the paper. All funding was received by Columbia University (no individual funding). TKP was supported by a VECD Global Health Fellowship, funded by the Office of AIDS Research (OAR) and the Fogarty International Center (FIC) of the NIH (D43 TW009337). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EA, 2017, AIDS BEHAV, V21, P2670, DOI 10.1007/s10461-017-1714-9; Atanga PN, 2017, TROP MED INT HEALTH, V22, P161, DOI 10.1111/tmi.12816; Beck EJ, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1440782; Besada D, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020754; Cawley C, 2017, HEALTH POLICY PLANN, V32, P1316, DOI 10.1093/heapol/czx091; Cheshi Fatima Ladidi, 2019, Pan Afr Med J, V32, P15, DOI 10.11604/pamj.supp.2019.32.1.13315; Chi BH, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25571; Clouse K, 2017, JAIDS-J ACQ IMM DEF, V74, P383, DOI 10.1097/qai.0000000000001284; Dedoose, 2018, DED VERS 8 0 35 WEB; Dzangare J, 2016, TROP MED INT HEALTH, V21, P202, DOI 10.1111/tmi.12637; Geldsetzer P, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002768; Government of Lesotho, NAT GUID US ANT THER, VFifth; Guillaine Neza, 2017, Int J MCH AIDS, V6, P36, DOI 10.21106/ijma.186; Gupta RS, 2016, CURR OPIN HIV AIDS, V11, pS30, DOI 10.1097/COH.0000000000000261; Hackett S, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz183; International AIDS Society, 2016, DIFF CAR HIV DEC FRA; Jones H, 2019, B WORLD HEALTH ORGAN, V97, P200, DOI [10.2471/BLT.18.217471, 10.2471/blt.18.217471]; Killam WP, 2010, AIDS, V24, P85, DOI 10.1097/QAD.0b013e32833298be; Knettel BA, 2018, JAIDS-J ACQ IMM DEF, V77, P427, DOI 10.1097/QAI.0000000000001616; Kyaw KWY, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2627-6; [Malawi] MoH, 2016, MAL GUID CLIN MAN HI, V3rd ed; Ministere de la Sante et de l'Hygiene Publique, 2016, PLAN STRAT NAT 2016; Mugasha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115171; Myer L, 2015, JAIDS-J ACQ IMM DEF, V69, pE57, DOI 10.1097/QAI.0000000000000584; Otieno PA, 2010, AIDS CARE, V22, P729, DOI 10.1080/09540120903373565; Phillips T, 2015, JAIDS-J ACQ IMM DEF, V70, pE102, DOI 10.1097/QAI.0000000000000771; Phillips TK, 2021, J INT AIDS SOC, V24, DOI 10.1002/jia2.25633; Phillips TK, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25114; Rawizza HE, 2015, CURR HIV RES, V13, P201, DOI 10.2174/1570162X1303150506183256; Stover Kim Ethier, 2019, J Int Assoc Provid AIDS Care, V18, p2325958219855623, DOI 10.1177/2325958219855623; Suryavanshi N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203425; The World Bank, 2019, BIRTHS FERT DAT; Trafford Z, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5836-4; Tsague L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-753; UNAIDS, 2020, DAT 2020; UNAIDS, 2020, PREV PAND PUTT PEOPL; UNAIDS, 2019, START FREE STAY FREE, P1; UNICEF UNAIDS and WHO, 2020, GOING LAST MIL EMTCT; United Nations Joint Programme on HIV/AIDS (UNAIDS), 2021, START FREE STAY FREE; United Nations Joint Programme on HIV/AIDS (UNAIDS), GLOB PLAN EL NEW HIV; WHO, CONSOLIDATED GUIDELI	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260530	10.1371/journal.pone.0260530	http://dx.doi.org/10.1371/journal.pone.0260530			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855814	gold, Green Published			2022-12-26	WOS:000735299000067
J	Spencer, NR; Radnaa, E; Baljinnyam, T; Kechichian, T; Tantengco, OAG; Bonney, E; Kammala, AK; Sheller-Miller, S; Menon, R				Spencer, Nicholas R.; Radnaa, Enkhtuya; Baljinnyam, Tuvshintugs; Kechichian, Talar; Tantengco, Ourlad Alzeus G.; Bonney, Elizabeth; Kammala, Ananth Kumar; Sheller-Miller, Samantha; Menon, Ramkumar			Development of a mouse model of ascending infection and preterm birth	PLOS ONE			English	Article							PREMATURE RUPTURE; GESTATIONAL-AGE; INTRAAMNIOTIC INFLAMMATION; MICROBIAL INVASION; PRELABOR RUPTURE; LABOR; BIOMARKERS; WOMEN; SENESCENCE; APOPTOSIS	Background Microbial invasion of the intraamniotic cavity and intraamniotic inflammation are factors associated with spontaneous preterm birth. Understanding the route and kinetics of infection, sites of colonization, and mechanisms of host inflammatory response is critical to reducing preterm birth risk. Objectives This study developed an animal model of ascending infection and preterm birth with live bacteria (E. coli) in pregnant CD-1 mice with the goal of better understanding the process of microbial invasion of the intraamniotic cavity and intraamniotic inflammation. Study design Multiple experiments were conducted in this study. To determine the dose of E. coli required to induce preterm birth, CD-1 mice were injected vaginally with four different doses of E. coli (10(3), 10(6), 10(10), or 10(11) colony forming units [CFU]) in 40 mu L of nutrient broth or broth alone (control) on an embryonic day (E)15. Preterm birth (defined as delivery before E18.5) was monitored using live video. E. coli ascent kinetics were measured by staining the E. coli with lipophilic tracer DiD for visualization through intact tissue with an in vivo imaging system (IVIS) after inoculation. The E. coli were also directly visualized in reproductive tissues by staining the bacteria with carboxyfluorescein succinimidyl ester (CFSE) prior to administration and via immunohistochemistry (IHC) by staining tissues with anti-E. coli antibody. Each pup's amniotic fluid was cultured separately to determine the extent of microbial invasion of the intraamniotic cavity at different time points. Intraamniotic inflammation resulting from E. coli invasion was assessed with IHC for inflammatory markers (TLR-4, P-NF-kappa B) and neutrophil marker (Ly-6G) for chorioamnionitis at 6- and 24-h post-inoculation. Results Vaginally administered E. coli resulted in preterm birth in a dose-dependent manner with higher doses causing earlier births. In ex vivo imaging and IHC detected uterine horns proximal to the cervix had increased E. coli compared to the distal uterine horns. E. coli were detected in the uterus, fetal membranes (FM), and placenta in a time-dependent manner with 6 hr having increased intensity of E. coli positive signals in pups near the cervix and in all pups at 24 hr. Similarly, E. coli grew from the cultures of amniotic fluid collected nearest to the cervix, but not from the more distal samples at 6 hr post-inoculation. At 24 hr, all amniotic fluid cultures regardless of distance from the cervix, were positive for E. coli. TLR-4 and P-NF-kappa B signals were more intense in the tissues where E. coli was present (placenta, FM and uterus), displaying a similar trend toward increased signal in proximal gestational sacs compared to distal at 6 hr. Ly-6G+ cells, used to confirm chorioamnionitis, were increased at 24 hr compared to 6 hr post-inoculation and control. Conclusion We report the development of mouse model of ascending infection and the associated inflammation of preterm birth. Clinically, these models can help to understand mechanisms of infection associated preterm birth, determine targets for intervention, or identify potential biomarkers that can predict a high-risk pregnancy status early in pregnancy.	[Spencer, Nicholas R.; Radnaa, Enkhtuya; Kechichian, Talar; Tantengco, Ourlad Alzeus G.; Kammala, Ananth Kumar; Sheller-Miller, Samantha; Menon, Ramkumar] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA; [Baljinnyam, Tuvshintugs] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Tantengco, Ourlad Alzeus G.] Univ Philippines Manila, Coll Med, Dept Biochem & Mol Biol, Manila, Philippines; [Bonney, Elizabeth] Univ Vermont, Dept Obstet & Gynecol, Burlington, VT USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of the Philippines System; University of the Philippines Manila; University of Vermont	Menon, R (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA.	ra2menon@utmb.edu		Sheller-Miller, Samantha/0000-0002-3991-1747; Spencer, Nicholas/0000-0001-5141-6223; Tantengco, Ourlad Alzeus/0000-0002-4535-8837; Menon, Ramkumar/0000-0001-9213-6105; Radnaa, Enkhtuya/0000-0001-8142-8137	ILIAS Biologics; ILIAS Therapeutics, Inc., USA	ILIAS Biologics; ILIAS Therapeutics, Inc., USA	R.M. Grant Support from ILIAS Biologics & ILIAS Therapeutics, Inc., USA The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2016, J LEUKOCYTE BIOL, V100, P261, DOI 10.1189/jlb.3HI0515-200RR; Angelidou A, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-89; Baljinnyam T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250327; Baljinnyam T, 2020, BURNS, V46, P1914, DOI 10.1016/j.burns.2020.05.012; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bonney EA, 2016, PLACENTA, V43, P26, DOI 10.1016/j.placenta.2016.04.018; Buhimschi IA, 2003, AM J OBSTET GYNECOL, V188, P203, DOI 10.1067/mob.2003.112; Burd I, 2012, AM J REPROD IMMUNOL, V67, P287, DOI 10.1111/j.1600-0897.2012.01110.x; Burd I, 2010, J NEUROSCI RES, V88, P1872, DOI 10.1002/jnr.22368; Carbone IF, 2020, MOL DIAGN THER, V24, P409, DOI 10.1007/s40291-020-00468-5; Chalupska M, 2021, FETAL DIAGN THER, V48, P58, DOI 10.1159/000512102; Cobo T, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.02.049; Cobo T, 2018, FETAL DIAGN THER, V43, P241, DOI 10.1159/000480232; Dixon CL, 2018, ENDOCRINOLOGY, V159, P2229, DOI 10.1210/en.2018-00073; DRAPER D, 1995, AM J OBSTET GYNECOL, V173, P1506, DOI 10.1016/0002-9378(95)90640-1; Dutta EH, 2016, MOL HUM REPROD, V22, P143, DOI 10.1093/molehr/gav074; Enkhbaatar P, 2006, SHOCK, V25, P522, DOI 10.1097/01.shk.0000209525.50990.28; Enkhtuya R, 2014, GENES CELLS, V19, P350, DOI 10.1111/gtc.12135; Faro J, 2019, BIOL REPROD, V100, P1290, DOI 10.1093/biolre/ioy261; Fichorova RN, 2015, AM J REPROD IMMUNOL, V73, P162, DOI 10.1111/aji.12313; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomez-Lopez N, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.08.008; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Holst RM, 2005, ACTA OBSTET GYN SCAN, V84, P551, DOI 10.1111/j.0001-6349.2005.00708.x; Horton AL, 2012, OBSTET GYN CLIN N AM, V39, P17, DOI 10.1016/j.ogc.2011.12.008; Jacobs SO, 2021, AM J REPROD IMMUNOL, V85, DOI 10.1111/aji.13368; Jacobsson B, 2004, BEST PRACT RES CL OB, V18, P425, DOI 10.1016/j.bpobgyn.2004.02.011; Kacerovsky M, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.01.043; Kacerovsky M, 2014, J MATERN-FETAL NEO M, V27, P1627, DOI 10.3109/14767058.2014.887068; Kacerovsky M, 2014, REPROD SCI, V21, P283, DOI 10.1177/1933719113503415; Kacerovsky M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.028; Kayem G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206290; Kenyon S, 2008, LANCET, V372, P1310, DOI 10.1016/S0140-6736(08)61202-7; Klebanoff M, 2006, BJOG-INT J OBSTET GY, V113, P43, DOI 10.1111/j.1471-0528.2006.01121.x; Knowles SJ, 2015, BJOG-INT J OBSTET GY, V122, P663, DOI 10.1111/1471-0528.12892; Lamont RF, 2020, PLACENTA, V98, P13, DOI 10.1016/j.placenta.2020.05.007; LeBrun M, 1999, ANTIMICROB AGENTS CH, V43, P1020, DOI 10.1128/AAC.43.5.1020; Lien YC, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.592689; Malaeb S, 2009, J CHILD NEUROL, V24, P1119, DOI 10.1177/0883073809338066; Manning R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47756-7; Manuel CR, 2017, CURR PHARM DESIGN, V23, P6142, DOI 10.2174/1381612823666171012101114; McCabe ERB, 2014, PEDIATRICS, V134, P1193, DOI 10.1542/peds.2014-2541; McCarthy R, 2018, BIOL REPROD, V99, P922, DOI 10.1093/biolre/ioy109; McElrath TF, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2019.01.220; MCGREGOR JA, 1986, AM J OBSTET GYNECOL, V154, P109, DOI 10.1016/0002-9378(86)90404-7; Menon R, 2004, J SOC GYNECOL INVEST, V11, P427, DOI 10.1016/j.jsgi.2004.04.001; Menon R, 2008, ACTA OBSTET GYN SCAN, V87, P590, DOI 10.1080/00016340802005126; Menon R, 2007, BEST PRACT RES CL OB, V21, P467, DOI 10.1016/j.bpobgyn.2007.01.008; Menon R, 2006, AM J OBSTET GYNECOL, V194, P1609, DOI 10.1016/j.ajog.2006.02.052; Menon R, 2020, SEMIN IMMUNOPATHOL, V42, P431, DOI 10.1007/s00281-020-00808-x; Menon R, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa009; Menon R, 2019, OBSTET GYNECOL, V134, P765, DOI 10.1097/AOG.0000000000003470; Menon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031136; Menon R, 2011, REPROD SCI, V18, P1046, DOI 10.1177/1933719111415548; Miller J, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060707; Ngo TTM, 2018, SCIENCE, V360, P1133, DOI 10.1126/science.aar3819; Nielsen BW, 2016, REPROD SCI, V23, P482, DOI 10.1177/1933719115604729; Oh KJ, 2019, J PERINAT MED, V47, P288, DOI 10.1515/jpm-2018-0351; Park H, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1780-7; Polettini J., 2016, J PERINAT MED; Polettini J, 2018, PLACENTA, V63, P26, DOI 10.1016/j.placenta.2018.01.009; Polettini J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137188; Richardson LS, 2020, LAB CHIP, V20, P4486, DOI 10.1039/d0lc00875c; Rodriguez-Trujillo A, 2016, ACTA OBSTET GYN SCAN, V95, P926, DOI 10.1111/aogs.12905; ROMERO R, 1990, AM J OBSTET GYNECOL, V163, P757, DOI 10.1016/0002-9378(90)91063-I; Romero R, 2007, NUTR REV, V65, pS194, DOI 10.1301/nr.2007.dec.S194-S202; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Romero R, 2019, J PERINAT MED, V47, P915, DOI 10.1515/jpm-2019-0297; Romero R, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12440; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Saade GR, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.02.001; Sheller-Miller S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd3865; SILVERMAN NS, 1994, OBSTET GYNECOL, V84, P1021; Silwedel C, 2017, EXPERT REV CLIN IMMU, V13, P1073, DOI 10.1080/1744666X.2017.1381559; Suff N, 2018, AM J PATHOL, V188, P2164, DOI 10.1016/j.ajpath.2018.06.016; Tedesco RP, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1508; Thinkhamrop J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002250.pub2; Urushiyama D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11699-8; Vadillo-Ortega F, 2005, BJOG-INT J OBSTET GY, V112, P19, DOI 10.1111/j.1471-0528.2005.00579.x; Yost NP, 2000, CLIN OBSTET GYNECOL, V43, P759, DOI 10.1097/00003081-200012000-00006; Zhang L, 2012, REPROD SCI, V19, P1181, DOI 10.1177/1933719112446079	83	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260370	10.1371/journal.pone.0260370	http://dx.doi.org/10.1371/journal.pone.0260370			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855804	Green Published, gold			2022-12-26	WOS:000735299000049
J	Kamalanathan, M; Hillhouse, J; Claflin, N; Rodkey, T; Mondragon, A; Prouse, A; Nguyen, M; Quigg, A				Kamalanathan, Manoj; Hillhouse, Jessica; Claflin, Noah; Rodkey, Talia; Mondragon, Andrew; Prouse, Alexandra; Nguyen, Michelle; Quigg, Antonietta			Influence of nutrient status on the response of the diatom Phaeodactylum tricornutum to oil and dispersant	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; DELTA-AMINOLEVULINIC-ACID; GULF-OF-MEXICO; NITROGEN LIMITATION; THALASSIOSIRA-PSEUDONANA; ELEMENTAL STOICHIOMETRY; MARINE-PHYTOPLANKTON; EVOLUTIONARY INHERITANCE; PHYSIOLOGICAL CONDITION; PHOTOSYSTEM-II	Phytoplankton play a central role in our ecosystems, they are responsible for nearly 50 percent of the global primary productivity and major drivers of macro-elemental cycles in the ocean. Phytoplankton are constantly subjected to stressors, some natural such as nutrient limitation and some manmade such as oil spills. With increasing oil exploration activities in coastal zones in the Gulf of Mexico and elsewhere, an oil spill during nutrient-limited conditions for phytoplankton growth is highly likely. We performed a multifactorial study exposing the diatom Phaeodactylum tricornutum (UTEX 646) to oil and/or dispersants under nitrogen and silica limitation as well as co-limitation of both nutrients. Our study found that treatments with nitrogen limitation (-N and-N-Si) showed overall lower growth and chlorophyll a, lower photosynthetic antennae size, lower maximum photosynthetic efficiency, lower protein in exopolymeric substance (EPS), but higher connectivity between photosystems compared to non-nitrogen limited treatments (-Si and +N+Si) in almost all the conditions with oil and/or dispersants. However, certain combinations of nutrient limitation and oil and/or dispersant differed from this trend indicating strong interactive effects. When analyzed for significant interactive effects, the-N treatment impact on cellular growth in oil and oil plus dispersant conditions; and oil and oil plus dispersant conditions on cellular growth in-N-Si and-N treatments were found to be significant. Overall, we demonstrate that nitrogen limitation can affect the oil resistant trait of P. tricornutum, and oil with and without dispersants can have interactive effects with nutrient limitation on this diatom.	[Kamalanathan, Manoj; Hillhouse, Jessica; Claflin, Noah; Rodkey, Talia; Mondragon, Andrew; Prouse, Alexandra; Nguyen, Michelle; Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Quigg, Antonietta] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Rodkey, Talia] Lehigh Univ, Bethlehem, PA 18015 USA; [Nguyen, Michelle] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Texas A&M University System; Texas A&M University System; Texas A&M University College Station; Lehigh University; Oregon State University	Kamalanathan, M (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	manojka@tamug.edu		Kamalanathan, Manoj/0000-0001-9617-1362; Quigg, Antonietta/0000-0001-5640-1426	Gulf of Mexico Research Initiative [ADDOMEX2]; NSF REU Program [1560242]	Gulf of Mexico Research Initiative; NSF REU Program(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was funded by the Gulf of Mexico Research Initiative (grant number ADDOMEX2) awarded to AQ. This study was also funded by the NSF REU Program (grant number 1560242) awarded to TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTE RS, 1981, BIOCHIM BIOPHYS ACTA, V635, P304, DOI 10.1016/0005-2728(81)90029-3; Almeda R, 2018, ENVIRON SCI TECHNOL, V52, P5718, DOI 10.1021/acs.est.8b00335; BEALE SI, 1973, BIOCHEM BIOPH RES CO, V52, P143, DOI 10.1016/0006-291X(73)90966-2; BEARDALL J, 1991, CAN J BOT, V69, P1146, DOI 10.1139/b91-147; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Berges JA, 1998, LIMNOL OCEANOGR, V43, P129, DOI 10.4319/lo.1998.43.1.0129; Berges JA, 2001, J PHYCOL, V37, P1138, DOI 10.1046/j.1529-8817.2001.01052.x; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Bopp SK, 2007, GENE, V396, P293, DOI 10.1016/j.gene.2007.03.013; BOROWITZKA MA, 1978, J PHYCOL, V14, P10; BOROWITZKA MA, 1977, J PHYCOL, V13, P162, DOI 10.1111/j.0022-3646.1977.00162.x; Bretherton L, 2020, MAR POLLUT BULL, V153, DOI 10.1016/j.marpolbul.2020.110906; Bretherton L, 2019, AQUAT TOXICOL, V206, P43, DOI 10.1016/j.aquatox.2018.11.004; Bretherton L, 2018, J PHYCOL, V54, P317, DOI 10.1111/jpy.12625; Carvalho RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026985; Carvalho RN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-159; Carvalho RN, 2011, AQUAT TOXICOL, V101, P244, DOI 10.1016/j.aquatox.2010.10.004; Daly KL, 2016, ANTHROPOCENE, V13, P18, DOI 10.1016/j.ancene.2016.01.006; De Martino A, 2007, J PHYCOL, V43, P992, DOI 10.1111/j.1529-8817.2007.00384.x; De Martino A, 2011, PROTIST, V162, P462, DOI 10.1016/j.protis.2011.02.002; DORTCH Q, 1992, CONT SHELF RES, V12, P1293, DOI 10.1016/0278-4343(92)90065-R; Doyle SM, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00668-20; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Finkel ZV, 2006, LIMNOL OCEANOGR, V51, P2690, DOI 10.4319/lo.2006.51.6.2690; Finkel ZV, 2020, MAR POLLUT BULL, V151, DOI 10.1016/j.marpolbul.2019.110798; Frada MJ, 2013, J PHYCOL, V49, P381, DOI 10.1111/jpy.12046; FUFSLER TP, 1984, PLANT PHYSIOL, V74, P928, DOI 10.1104/pp.74.4.928; GEIDER RJ, 1993, J PHYCOL, V29, P755, DOI 10.1111/j.0022-3646.1993.00755.x; Gonzalez J, 2013, ESTUAR COAST SHELF S, V124, P13, DOI 10.1016/j.ecss.2013.03.015; Graziano LM, 1996, AQUAT MICROB ECOL, V11, P53, DOI 10.3354/ame011053; Grieco M, 2015, BBA-BIOENERGETICS, V1847, P607, DOI 10.1016/j.bbabio.2015.03.004; Hook SE, 2012, AQUAT TOXICOL, V124, P139, DOI 10.1016/j.aquatox.2012.08.005; Jiang YL, 2012, PLANT PHYSIOL BIOCH, V54, P70, DOI 10.1016/j.plaphy.2012.02.012; Johnson MW, 2006, AQUAT BOT, V85, P103, DOI 10.1016/j.aquabot.2006.02.003; Kamalanathan M, 2019, PLANT PHYSIOL, V180, P1898, DOI 10.1104/pp.19.00301; Kamalanathan M, 2018, MAR POLLUT BULL, V130, P170, DOI 10.1016/j.marpolbul.2018.03.027; Kamalanathan M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00798; Kamalanathan M, 2016, J APPL PHYCOL, V28, P1509, DOI 10.1007/s10811-015-0726-y; Lazar D, 1999, BBA-BIOENERGETICS, V1412, P1, DOI 10.1016/S0005-2728(99)00047-X; Lazar D, 2001, PHOTOSYNTH RES, V68, P247, DOI 10.1023/A:1012973402023; LEVASSEUR M, 1993, J PHYCOL, V29, P587, DOI 10.1111/j.0022-3646.1993.00587.x; LEWIN JC, 1958, J GEN MICROBIOL, V18, P427, DOI 10.1099/00221287-18-2-427; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Napoleon C, 2014, MAR ECOL PROG SER, V505, P49, DOI 10.3354/meps10772; OHHAMA T, 1982, BIOCHEM BIOPH RES CO, V105, P647, DOI 10.1016/0006-291X(82)91483-8; Okay OS, 2002, B ENVIRON CONTAM TOX, V68, P600, DOI 10.1007/s001280296; Ozhan K, 2014, ENVIRON MONIT ASSESS, V186, P3941, DOI 10.1007/s10661-014-3670-4; Ozhan K, 2014, ECOTOXICOLOGY, V23, P370, DOI 10.1007/s10646-014-1195-9; Pantorno A, 2013, PHYCOLOGIA, V52, P288, DOI 10.2216/12-064.1; Passow U, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035301; Peperzak L, 2003, J PLANKTON RES, V25, P365, DOI 10.1093/plankt/25.4.365; QIAN KX, 1993, APPL BIOCHEM BIOTECH, V38, P93; Quigg A, 2003, PLANT CELL ENVIRON, V26, P693, DOI 10.1046/j.1365-3040.2003.01004.x; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Quigg A., 2020, DEEP OIL SPILLS, P196, DOI 10.1007/978-3-030-11605-7_12; Quigg A., 2021, MAR POLL B; Quigg A, 2016, LIMNOL OCEANOGR LETT, V1, P3, DOI 10.1002/lol2.10030; Quigg A, 2011, AQUAT GEOCHEM, V17, P519, DOI 10.1007/s10498-011-9134-3; Quigg A, 2011, P ROY SOC B-BIOL SCI, V278, P526, DOI 10.1098/rspb.2010.1356; Rodriguez RM, 2015, IEEE INT FUZZY SYST; ROY S, 1988, J EXP MAR BIOL ECOL, V118, P137, DOI 10.1016/0022-0981(88)90236-5; Saeck EA, 2016, MAR ECOL PROG SER, V552, P81, DOI 10.3354/meps11729; Santschi PH, 2020, MAR CHEM, V218, DOI 10.1016/j.marchem.2019.103734; Singer M.M., 2001, INT OIL SPILL C, V2001, P1269, DOI 10.7901/2169-3358-2001-2-1269; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOSIK HM, 1991, LIMNOL OCEANOGR, V36, P910, DOI 10.4319/lo.1991.36.5.0910; Spilling K, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00327; Steichen JL, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00186; Stirbet A, 2013, PHOTOSYNTH RES, V116, P189, DOI 10.1007/s11120-013-9863-9; Turner RE, 2013, AQUAT MICROB ECOL, V68, P159, DOI 10.3354/ame01607; Urakawa H, 2019, ENVIRON MICROBIOL, V21, P18, DOI 10.1111/1462-2920.14391; Wade TL, 2011, GEOPHYS MONOGR SER, V195, P77, DOI 10.1029/2011GM001103; Williams AK, 2017, MAR POLLUT BULL, V121, P32, DOI 10.1016/j.marpolbul.2017.05.033; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508	75	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0259506	10.1371/journal.pone.0259506	http://dx.doi.org/10.1371/journal.pone.0259506			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851969	gold, Green Published			2022-12-26	WOS:000755762900012
J	Wu, QS; Yin, XF; Zhao, WB; Xu, WL; Chen, LZ				Wu, Quansheng; Yin, Xiaofeng; Zhao, Wenbo; Xu, Wenli; Chen, Laizhao			Downregulation of SFRP2 facilitates cancer stemness and radioresistance of glioma cells via activating Wnt/beta-catenin signaling	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-2; WNT PATHWAY; TUMORS; GLIOBLASTOMA; RADIOTHERAPY; METHYLATION; BRAIN	Secreted frizzled-related protein 2 (SFRP2) is a glycoprotein with frizzled-like cysteine-rich domain that binds with Wnt ligands or frizzled receptors to regulate Wnt signaling. SFRP2 is frequently hypermethylated in glioma patients, and analysis of TCGA data indicates that SFRP2 is one of the most downregulated genes in radiotherapy treated glioma patients. In the present study, we aimed to explore the potential function of SFRP2 in tumorigenesis and radioresistance of glioma. The RNA sequencing data of TCGA glioma samples were downloaded and analyzed. SFRP2 expression in 166 glioma patients was evaluated by qRT-PCR. The potential functions of SFRP2 in glioma were evaluated by loss-of-function assays and gain-of-function assays in glioma cell lines. We found that SFRP2 was downregulated in radiotherapy-treated glioma patients, and low SFRP2 expression was correlated with advanced tumor stage and poor prognosis. CRISP/Cas9-meidated SFRP2 knockdown promoted soft agar colony formation, cancer stemness and radioresistance of glioma cells, while enforced SFRP2 expression exhibited opposite effects. Moreover, Wnt/beta-catenin signaling was activated in radiotherapy treated glioma patients. SFRP2 knockdown activated Wnt/beta-catenin signaling in glioma cell lines, while overexpression of SFRP2 inhibited Wnt/beta-catenin activation. Besides, pharmacological inhibition of Wnt/beta-catenin signaling by XAV-939 abrogated the effects of SFRP2 knockdown on cancer stemness and radioresistance of glioma cells. Our data for the first time demonstrated a role of SFRP2 in radioresistance of glioma cells, and suggested that inhibition of Wnt/beta-catenin signaling might be a potential strategy for increasing radiosensitivity of glioma patients.	[Wu, Quansheng; Yin, Xiaofeng; Zhao, Wenbo; Xu, Wenli; Chen, Laizhao] Shanxi Med Univ, Hosp 2, Dept Neurosurg, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University	Chen, LZ (corresponding author), Shanxi Med Univ, Hosp 2, Dept Neurosurg, Taiyuan, Shanxi, Peoples R China.	chenlaizhaosx@163.com						Alfaro MP, 2010, J BIOL CHEM, V285, P35645, DOI 10.1074/jbc.M110.135335; Ali MY, 2020, CANCERS, V12, DOI 10.3390/cancers12092511; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Cheng YY, 2007, BRIT J CANCER, V97, P895, DOI 10.1038/sj.bjc.6603968; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Gotze S, 2010, INT J CANCER, V126, P2584, DOI 10.1002/ijc.24981; Guo M., 2021, ONCOGENE; Han MZ, 2020, BRAIN, V143, P512, DOI 10.1093/brain/awz406; Han XT, 2017, ONCOTARGET, V8, P100931, DOI 10.18632/oncotarget.21753; He L, 2019, J CELL PHYSIOL, V234, P2217, DOI 10.1002/jcp.27186; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Kim Y, 2012, LAB INVEST, V92, P466, DOI 10.1038/labinvest.2011.161; Kress E, 2009, J BIOL CHEM, V284, P1234, DOI 10.1074/jbc.M806548200; Larjavaara S, 2007, NEURO-ONCOLOGY, V9, P319, DOI 10.1215/15228517-2007-016; Lee Y, 2016, LAB INVEST, V96, P137, DOI 10.1038/labinvest.2015.140; Liu S, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0655-3; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Majchrzak-Celinska A, 2016, J APPL GENET, V57, P189, DOI 10.1007/s13353-015-0312-7; Mannino M, 2011, MOL ONCOL, V5, P374, DOI 10.1016/j.molonc.2011.05.001; Mohammed SI, 2020, CANCERS, V12, DOI 10.3390/cancers12020418; Ong DST, 2017, P NATL ACAD SCI USA, V114, pE9086, DOI 10.1073/pnas.1708122114; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Roth W, 2000, ONCOGENE, V19, P4210, DOI 10.1038/sj.onc.1203783; Singh SK, 2003, CANCER RES, V63, P5821; Skah S, 2015, EXP CELL RES, V330, P56, DOI 10.1016/j.yexcr.2014.10.014; Stanzani E, 2017, ONCOTARGET, V8, P73640, DOI 10.18632/oncotarget.18363; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Techavichit P, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2909-6; van Loon K, 2021, CANCER METAST REV, V40, P191, DOI 10.1007/s10555-020-09941-3; Vincent KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep42719; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; WALKER MD, 1978, J NEUROSURG, V49, P333, DOI 10.3171/jns.1978.49.3.0333; Wang GZ, 2017, CLIN CANCER RES, V23, P6640, DOI 10.1158/1078-0432.CCR-17-0774; Wang WJ, 2016, CANCER LETT, V371, P274, DOI 10.1016/j.canlet.2015.12.012; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Xiao C, 2014, MOL MED REP, V10, P2293, DOI 10.3892/mmr.2014.2542; Yamamura S, 2010, MOL CANCER THER, V9, P1680, DOI 10.1158/1535-7163.MCT-10-0012	39	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260864	10.1371/journal.pone.0260864	http://dx.doi.org/10.1371/journal.pone.0260864			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852024	gold, Green Published			2022-12-26	WOS:000755762900066
J	Rimmer, CN; Hetelekides, SM; Eliseeva, S; Georas, S; Veazey, J				Rimmer, Clara N.; Hetelekides, Savas M.; Eliseeva, Sophia; Georas, Steve; Veazey, Janelle			Budesonide promotes airway epithelial barrier integrity following double-stranded RNA challenge	PLOS ONE			English	Article							ASTHMA; DYSFUNCTION; DISRUPTS; INNATE; CELLS; LONG	Airway epithelial barrier dysfunction is increasingly recognized as a key feature of asthma and other lung diseases. Respiratory viruses are responsible for a large fraction of asthma exacerbations, and are particularly potent at disrupting epithelial barrier function through pattern recognition receptor engagement leading to tight junction dysfunction. Although different mechanisms of barrier dysfunction have been described, relatively little is known about whether barrier integrity can be promoted to limit disease. Here, we tested three classes of drugs commonly prescribed to treat asthma for their ability to promote barrier function using a cell culture model of virus-induced airway epithelial barrier disruption. Specifically, we studied the corticosteroid budesonide, the long acting beta-agonist formoterol, and the leukotriene receptor antagonist montelukast for their ability to promote barrier integrity of a monolayer of human bronchial epithelial cells (16HBE) before exposure to the viral mimetic double-stranded RNA. Of the three, only budesonide treatment limited transepithelial electrical resistance and small molecule permeability (4 kDa FITC-dextran flux). Next, we used a mouse model of acute dsRNA challenge that induces transient epithelial barrier disruption in vivo, and studied the effects budesonide when administered prophylactically or therapeutically. We found that budesonide similarly protected against dsRNA-induced airway barrier disruption in the lung, independently of its effects on airway inflammation. Taken together, these data suggest that an under-appreciated effect of inhaled budesonide is to maintain or promote airway epithelial barrier integrity during respiratory viral infections.	[Rimmer, Clara N.; Hetelekides, Savas M.; Eliseeva, Sophia; Georas, Steve] Univ Rochester, Dept Med Pulm & Crit Care Univ, 601 Elmwood Ave, Rochester, NY 14642 USA; [Georas, Steve; Veazey, Janelle] Univ Rochester, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA; [Veazey, Janelle] Cornell Univ, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	University of Rochester; University of Rochester; Cornell University	Rimmer, CN; Georas, S (corresponding author), Univ Rochester, Dept Med Pulm & Crit Care Univ, 601 Elmwood Ave, Rochester, NY 14642 USA.; Georas, S; Veazey, J (corresponding author), Univ Rochester, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.; Veazey, J (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	clararimmer@gmail.com; Steve_Georas@urmc.rochester.edu; jv448@cornell.edu		Veazey, Janelle/0000-0002-3061-0251	National Institute of Health/National Heart, Lung, and Blood Institute [R01 HL12424, F31 HL14079501]; National Institute of Health/National Institute of Allergy and Infectious Disease [R01 AI144241, T32AI007285]	National Institute of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Health/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work reported here was supported by the following grants: R01 HL12424 (SG) from National Institute of Health/National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov/) R01 AI144241 (SG) from National Institute of Health/National Institute of Allergy and Infectious Disease (https://www.niaid.nih.gov/) F31 HL14079501 (JV) from National Institute of Health/National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov/) T32AI007285 (JV) from National Institute of Health/National Institute of Allergy and Infectious Disease (https://www.niaid.nih.gov/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Comstock AT, 2011, J VIROL, V85, P6795, DOI 10.1128/JVI.02074-10; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; Ganesan S, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24997; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Heffler E, 2018, J ALLER CL IMM-PRACT, V6, P776, DOI 10.1016/j.jaip.2018.01.025; Heijink IH, 2016, RESP RES, V17, DOI 10.1186/s12931-015-0318-z; Kim SR, 2018, ANTIVIR RES, V151, P87, DOI 10.1016/j.antiviral.2018.01.012; LILES WC, 1995, BLOOD, V86, P3181; Lotvall J, 2002, PULM PHARMACOL THER, V15, P497, DOI 10.1006/pupt.2002.0400; Pelaia G, 2016, PULM PHARMACOL THER, V40, P15, DOI 10.1016/j.pupt.2016.07.001; Peng WS, 2014, PEDIAT ALLERG IMM-UK, V25, P143, DOI 10.1111/pai.12124; Pulendran B, 2015, CURR TOP MICROBIOL, V386, P23, DOI 10.1007/82_2014_405; Rezaee F, 2014, AM J RESP CELL MOL, V50, P857, DOI 10.1165/rcmb.2013-0541RT; Rezaee F, 2013, J VIROL, V87, P11088, DOI 10.1128/JVI.01573-13; Rezaee F, 2011, J ALLERGY CLIN IMMUN, V128, P1216, DOI 10.1016/j.jaci.2011.08.035; Rusu AD, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.190278; Saatian B, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24333; Sajjan U, 2008, AM J RESP CRIT CARE, V178, P1271, DOI 10.1164/rccm.200801-136OC; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Sindi A, 2009, CHEST, V136, P145, DOI 10.1378/chest.08-2149; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Smallcombe CC, 2019, AM J PHYSIOL-LUNG C, V316, pL358, DOI 10.1152/ajplung.00345.2018; Veazey J., 2017, SIDHAYE KOVAL LUNG E; Veazey JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216056; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038	28	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	12							e0260706	10.1371/journal.pone.0260706	http://dx.doi.org/10.1371/journal.pone.0260706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1MC	34871316	Green Published, gold			2022-12-26	WOS:000728598900007
J	Craven, SJ; Condon, SGF; Vazquez, GD; Cui, Q; Senes, A				Craven, Samuel J.; Condon, Samson G. F.; Vazquez, Gladys Diaz; Cui, Qiang; Senes, Alessandro			The coiled-coil domain of Escherichia coli FtsLB is a structurally detuned element critical for modulating its activation in bacterial cell division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; DIVISOME; LOCALIZATION; SUBCOMPLEX; COMPLEX; SPECIFICITY; DATABASE; DYNAMICS; RECRUIT; PACKAGE	The FtsLB complex is a key regulator of bacterial cell division, existing in either an off state or an on state, which supports the activation of septal peptidoglycan synthesis. In Escherichia coli, residues known to be critical for this activation are located in a region near the C-terminal end of the pertplasmic coiled-coil domain of FtsLB, raising questions about the precise role of this conserved domain in the activation mechanism. Here, we investigate an unusual cluster of polar amino acids found within the core of the FtsLB coiled coil. We hypothesized that these amino acids likely reduce the structural stability of the domain and thus may be important for governing conformational changes. We found that mutating these positions to hydrophobic residues increased the thermal stability of FtsLB but caused cell division defects, suggesting that the coiled-coil domain is a "detuned" structural element. In addition, we identified suppressor mutations within the polar cluster, indicating that the precise identity of the polar amino acids is important for fine-tuning the structural balance between the off and on states. We propose a revised structural model of the tetrameric FtsLB (named the "Y-model") in which the periplasmic domain splits into a pair of coiled-coil branches. In this configuration, the hydrophilic terminal moieties of the polar amino acids remain more favorably exposed to water than in the original four-helix bundle model ("I-model"). We propose that a shift in this architecture, dependent on its marginal stability, is involved in activating the FtsLB complex and triggering septal cell wall reconstruction.	[Craven, Samuel J.; Condon, Samson G. F.; Vazquez, Gladys Diaz; Senes, Alessandro] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA; [Craven, Samuel J.; Condon, Samson G. F.] Univ Wisconsin, Integrated Program Biochem, Madison, WI USA; [Vazquez, Gladys Diaz] Univ Wisconsin, Biophys Grad Program, Madison, WI USA; [Cui, Qiang] Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Boston University	Senes, A (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	senes@wisc.edu		Condon, Samson/0000-0001-5072-9316; Craven, Samuel/0000-0002-8418-0437	National Institutes of Health [R01-GM099752, R35-GM130339]; National Science Foundation [CHE-1829555]; Dr James Chieh-Hsia Mao Wisconsin Distinguished Fellowship; Arthur B. Michael Departmental Fellowship; William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; SciMed GRS Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Dr James Chieh-Hsia Mao Wisconsin Distinguished Fellowship; Arthur B. Michael Departmental Fellowship; William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; SciMed GRS Fellowship	This work was supported in part by the National Institutes of Health grant R01-GM099752 and R35-GM130339 (to A. S.) and National Science Foundation grant CHE-1829555 (to Q. C.). S. J. C. was supported in part by a Dr James Chieh-Hsia Mao Wisconsin Distinguished Fellowship. S. G. F. C. was supported in part by theY Arthur B. Michael Departmental Fellowship and the William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship. G. D. V. was supported in part by a SciMed GRS Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; AUGUST DA, 1985, CANCER-AM CANCER SOC, V55, P1490, DOI 10.1002/1097-0142(19850401)55:7<1490::AID-CNCR2820550712>3.0.CO;2-N; Bhate MP, 2018, J AM CHEM SOC, V140, P7471, DOI 10.1021/jacs.7b09670; Booth S, 2019, PROTEIN SCI, V28, P2042, DOI 10.1002/pro.3722; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; BOTTA GA, 1981, J BACTERIOL, V145, P333, DOI 10.1128/JB.145.1.333-340.1981; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Buddelmeijer N, 2002, P NATL ACAD SCI USA, V99, P6316, DOI 10.1073/pnas.092128499; Chamberlain Scott A, 2013, F1000Res, V2, P191, DOI 10.12688/f1000research.2-191.v1; Cho H, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.172, 10.1038/nmicrobiol.2016.172]; Choi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36001-2; Condon SGF, 2018, J BIOL CHEM, V293, P1623, DOI 10.1074/jbc.RA117.000426; den Blaauwen T, 2017, CURR OPIN MICROBIOL, V36, P85, DOI 10.1016/j.mib.2017.01.007; Du SS, 2017, MOL MICROBIOL, V105, P177, DOI 10.1111/mmi.13696; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Egan AJF, 2020, NAT REV MICROBIOL, V18, P446, DOI 10.1038/s41579-020-0366-3; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Fernandez P, 2019, MBIO, V10, DOI 10.1128/mBio.02564-19; Fraipont C, 2011, MICROBIOL-SGM, V157, P251, DOI 10.1099/mic.0.040071-0; Gerding MA, 2009, J BACTERIOL, V191, P7383, DOI 10.1128/JB.00811-09; Ghigo JM, 2000, J BACTERIOL, V182, P116, DOI 10.1128/JB.182.1.116-129.2000; Ghigo JM, 1999, MOL MICROBIOL, V31, P725, DOI 10.1046/j.1365-2958.1999.01213.x; Glas M, 2015, J BIOL CHEM, V290, P21498, DOI 10.1074/jbc.M115.654756; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011; Gonzalez MD, 2010, J BACTERIOL, V192, P2757, DOI 10.1128/JB.01609-09; Gonzalez MD, 2009, J BACTERIOL, V191, P2815, DOI 10.1128/JB.01597-08; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khadria AS, 2013, BIOCHEMISTRY-US, V52, P7542, DOI 10.1021/bi4009837; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kuhn M., 2020, TIDYMODELS COLLECTIO; Kureisaite-Ciziene D, 2018, MBIO, V9, DOI 10.1128/mBio.01346-18; LaPointe LM, 2013, BIOCHEMISTRY-US, V52, P2574, DOI 10.1021/bi400222r; Leclercq S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43306; Lesne E, 2016, MBIO, V7, DOI 10.1128/mBio.02089-15; Li Y, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009366; Liu B, 2015, MOL MICROBIOL, V95, P945, DOI 10.1111/mmi.12906; Marmont LS, 2020, P NATL ACAD SCI USA, V117, P23879, DOI 10.1073/pnas.2004598117; Masson S, 2009, J BIOL CHEM, V284, P27687, DOI 10.1074/jbc.M109.019471; McCausland JW, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20873-y; Meeske AJ, 2016, NATURE, V537, P634, DOI 10.1038/nature19331; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Mirdita M, 2021, BIOINFORMATICS, V37, P3029, DOI 10.1093/bioinformatics/btab184; Mohammadi T, 2014, J BIOL CHEM, V289, P14707, DOI 10.1074/jbc.M114.557371; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; NAKAGAWA J, 1979, AGR BIOL CHEM TOKYO, V43, P1379, DOI 10.1080/00021369.1979.10863634; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Page` s H., 2019, BIOSTRINGS EFFICIENT; Paintdakhi A, 2016, MOL MICROBIOL, V99, P767, DOI 10.1111/mmi.13264; Park KT, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2107210118; Park KT, 2020, MBIO, V11, DOI 10.1128/mBio.03012-20; Pedersen TL., 2020, Tidygraph: A Tidy API for Graph Manipulation; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pichoff S, 2015, MOL MICROBIOL, V95, P971, DOI 10.1111/mmi.12907; RCore Team, 2020, R LANG ENV STAT COMP; Schmidt NW, 2017, PROTEIN SCI, V26, P414, DOI 10.1002/pro.3095; Steinegger M, 2017, NAT BIOTECHNOL, V35, P1026, DOI 10.1038/nbt.3988; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taguchi A, 2019, NAT MICROBIOL, V4, P587, DOI 10.1038/s41564-018-0345-x; Testa OD, 2009, NUCLEIC ACIDS RES, V37, pD315, DOI 10.1093/nar/gkn675; Tsang MJ, 2015, MOL MICROBIOL, V95, P925, DOI 10.1111/mmi.12905; Ursinus A, 2004, J BACTERIOL, V186, P6728, DOI 10.1128/JB.186.20.6728-6737.2004; Villanelo F, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-28; Wagschal K, 1999, PROTEIN SCI, V8, P2312; Winter DJ, 2017, R J, V9, P520, DOI 10.32614/RJ-2017-058; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Yang JC, 2004, MOL MICROBIOL, V52, P651, DOI 10.1111/j.1365-2958.2004.03991.x; Yang XX, 2021, NAT MICROBIOL, V6, P584, DOI 10.1038/s41564-020-00853-0; Zeileis A, 2005, J STAT SOFTW, V14	77	2	2	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101460	10.1016/j.jbc.2021.101460	http://dx.doi.org/10.1016/j.jbc.2021.101460			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP0ZE	34871549	gold, Green Published			2022-12-26	WOS:000748357700008
J	Kurane, T; Matsunaga, T; Ida, T; Sawada, K; Nishimura, A; Fukui, M; Umemura, M; Nakayama, M; Ohara, N; Matsumoto, S; Akaike, T; Matsuzaki, G; Takaesu, G				Kurane, Tomomi; Matsunaga, Tetsuro; Ida, Tomoaki; Sawada, Kazuko; Nishimura, Akira; Fukui, Masayuki; Umemura, Masayuki; Nakayama, Masaaki; Ohara, Naoya; Matsumoto, Sohkichi; Akaike, Takaaki; Matsuzaki, Goro; Takaesu, Giichi			GRIM-19 is a target of mycobacterial Zn2+ metalloprotease 1 and indispensable for NLRP3 inflammasome activation	FASEB JOURNAL			English	Article						inflammasome; interleukin-1 beta; macrophages; mitochondria; Mycobacterium tuberculosis	MITOCHONDRIAL COMPLEX-I; REGULATORY GENE-PRODUCT; CELL-DEATH; RESPIRATORY-CHAIN; INTERFERON-BETA; TUBERCULOSIS; PROTEIN; MACROPHAGES; VECTOR; ESX-1	Tuberculosis is a communicable disease caused by Mycobacterium tuberculosis which primarily infects macrophages and establishes intracellular parasitism. A mycobacterial virulence factor Zn2+ metalloprotease 1 (Zmp1) is known to suppress interleukin (IL)-1 beta production by inhibiting caspase-1 resulting in phagosome maturation arrest. However, the molecular mechanism of caspase-1 inhibition by Zmp1 is still elusive. Here, we identified GRIM-19 (also known as NDUFA13), an essential subunit of mitochondrial respiratory chain complex I, as a novel Zmp1-binding protein. Using the CRISPR/Cas9 system, we generated GRIM-19 knockout murine macrophage cell line J774.1 and found that GRIM-19 is essential for IL-1 beta production during mycobacterial infection as well as in response to NLRP3 inflammasome-activating stimuli such as extracellular ATP or nigericin. We also found that GRIM-19 is required for the generation of mitochondrial reactive oxygen species and NLRP3-dependent activation of caspase-1. Loss of GRIM-19 or forced expression of Zmp1 resulted in a decrease in mitochondrial membrane potential. Our study revealed a previously unrecognized role of GRIM-19 as an essential regulator of NLRP3 inflammasome and a molecular mechanism underlying Zmp1-mediated suppression of IL-1 beta production during mycobacterial infection.	[Kurane, Tomomi; Umemura, Masayuki; Matsuzaki, Goro; Takaesu, Giichi] Univ Ryukyus, Grad Sch Med, Dept Host Def, Nishihara, Okinawa, Japan; [Matsunaga, Tetsuro; Ida, Tomoaki; Nishimura, Akira; Akaike, Takaaki] Tohoku Univ, Dept Environm Med & Mol Toxicol, Grad Sch Med, Sendai, Miyagi, Japan; [Sawada, Kazuko; Fukui, Masayuki; Umemura, Masayuki; Matsuzaki, Goro; Takaesu, Giichi] Univ Ryukyus, Trop Biosphere Res Ctr, Mol Microbiol Grp, 1 Senbaru, Nishihara, Okinawa 9030213, Japan; [Umemura, Masayuki; Matsuzaki, Goro; Takaesu, Giichi] Univ Ryukyus, Fac Med, Adv Med Res Ctr, Nishihara, Okinawa, Japan; [Nakayama, Masaaki; Ohara, Naoya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Microbiol, Okayama, Japan; [Matsumoto, Sohkichi] Niigata Univ, Dept Bacteriol, Sch Med, Niigata, Japan; [Nishimura, Akira] Nara Inst Sci & Technol, Grad Sch Sci & Technol, Nara, Japan; [Fukui, Masayuki] Aomori Univ, Dept Pharmacol, Aomori, Japan	University of the Ryukyus; Tohoku University; University of the Ryukyus; University of the Ryukyus; Okayama University; Niigata University; Nara Institute of Science & Technology	Matsuzaki, G; Takaesu, G (corresponding author), Univ Ryukyus, Trop Biosphere Res Ctr, Mol Microbiol Grp, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	matsuzak@comb.u-ryukyu.ac.jp; takaesug@comb.u-ryukyu.ac.jp	Takaesu, Giichi/AFT-9970-2022; OHARA, Naoya/B-2481-2011	Takaesu, Giichi/0000-0002-1581-1055; Matsunaga, Tetsuro/0000-0003-2944-3326	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP18K07179, JP20H03487]; Takeda Science	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science	Japan Society for the Promotion of Science (JSPS) KAK.ENHI, Grant/Award Number: JP18K07179 and JP20H03487; Takeda Science	Akaike T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01311-y; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Chung IC, 2020, MOL CELL PROTEOMICS, V19, P142, DOI 10.1074/mcp.RA119.001808; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; GOREN MB, 1976, P NATL ACAD SCI USA, V73, P2510, DOI 10.1073/pnas.73.7.2510; GOTO Y, 1991, FEMS MICROBIOL LETT, V83, P277; Groschel MI, 2017, CELL REP, V18, P2752, DOI 10.1016/j.celrep.2017.02.057; Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002; Hu HX, 2017, P NATL ACAD SCI USA, V114, P11908, DOI 10.1073/pnas.1704723114; Huang G, 2007, CELL DEATH DIFFER, V14, P327, DOI 10.1038/sj.cdd.4402004; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Kurenuma T, 2009, INFECT IMMUN, V77, P3992, DOI 10.1128/IAI.00015-09; Lu H, 2008, MOL BIOL CELL, V19, P1893, DOI 10.1091/mbc.E07-07-0683; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Mantovani A, 2019, IMMUNITY, V50, P778, DOI 10.1016/j.immuni.2019.03.012; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Nallar SC, 2017, CYTOKINE GROWTH F R, V33, P1, DOI 10.1016/j.cytogfr.2016.09.001; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Saiga H, 2012, INT IMMUNOL, V24, P637, DOI 10.1093/intimm/dxs062; Scialo F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00428; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wada T, 2015, SCI REP-UK, V5, DOI 10.1038/srep17827; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	40	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22096	10.1096/fj.202101074RR	http://dx.doi.org/10.1096/fj.202101074RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34907600	hybrid			2022-12-26	WOS:000734992000013
J	Xue, L; Khan, MH; Yue, J; Zhu, ZL; Niu, LW				Xue, Lu; Khan, Muhammad Hidayatullah; Yue, Jian; Zhu, Zhongliang; Niu, Liwen			The two paralogous copies of the YoeB-YefM toxin-antitoxin module in Staphylococcus aureus differ in DNA binding and recognition patterns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; INTERACTION SPECIFICITY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SYSTEMS; TRANSCRIPTION; TRANSLATION; DISORDER; RIBOSOME; STRESS	Toxin-antitoxin (TA) systems are ubiquitous regulatory modules for bacterial growth and cell survival following stress. YefM-YoeB, the most prevalent type II TA system, is present in a variety of bacterial species. In Staphylococcus aureus, the YefM-YoeB system exists as two independent paralogous copies. Our previous research resolved crystal structures of the two oligomeric states (heterotetramer and heterohexamer-DNA ternary complex) of the first paralog as well as the molecular mechanism of transcriptional autoregulation of this module. However, structural details reflecting molecular diversity in both paralogs have been relatively unexplored. To understand the molecular mechanism of how Sa(2)YoeB and Sa(2)YefM regulate their own transcription and how each paralog functions independently, we solved a series of crystal structures of the Sa(2)YoeB-Sa(2)YefM. Our structural and biochemical data demonstrated that both paralogous copies adopt similar mechanisms of transcriptional autoregulation. In addition, structural analysis suggested that molecular diversity between the two paralogs might be reflected in the interaction profile of YefM and YoeB and the recognition pattern of promoter DNA by YefM. Interaction analysis revealed unique conformational and activating force effected by the interface between Sa(2)YoeB and Sa(2)YefM. In addition, the recognition pattern analysis demonstrated that residues Thr(7) and Tyr(14) of Sa(2)YefM specifically recognizes the flanking sequences (G and C) of the promoter DNA. Together, these results provide the structural insights into the molecular diversity and independent function of the paralogous copies of the YoeB-YefM TA system.	[Xue, Lu; Khan, Muhammad Hidayatullah; Yue, Jian; Zhu, Zhongliang; Niu, Liwen] Univ Sci & Technol China, Div Mol & Cellular Biophys, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; [Xue, Lu; Khan, Muhammad Hidayatullah; Yue, Jian; Zhu, Zhongliang; Niu, Liwen] Univ Sci & Technol China, Sch Life Sci, Div Life Sci & Med, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhu, ZL; Niu, LW (corresponding author), Univ Sci & Technol China, Div Mol & Cellular Biophys, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China.; Zhu, ZL; Niu, LW (corresponding author), Univ Sci & Technol China, Sch Life Sci, Div Life Sci & Med, Hefei, Anhui, Peoples R China.	zlzhu63@ustc.edu.cn; lwniu@ustc.edu.cn		Xue, Lu/0000-0003-1900-0839	National Natural Science Foundation of China [U1632124, 31270770, 31621002]; Ministry of Science and Technology of China [2017YFA0503600, 2017YFA0504903]; Hefei National Science Center Pilot Project Funds	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Hefei National Science Center Pilot Project Funds	This work was supported by the National Natural Science Foundation of China (U1632124 to L. N., 31270770 to Z. Z., and 31621002 to L. N.) and the Ministry of Science and Technology of China (2017YFA0503600 to L. N. and 2017YFA0504903 to L. N.). This work was also supported in part by the Hefei National Science Center Pilot Project Funds.	Aakre CD, 2015, CELL, V163, P594, DOI 10.1016/j.cell.2015.09.055; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bertram R, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00006; Boggild A, 2012, STRUCTURE, V20, P1641, DOI 10.1016/j.str.2012.08.017; Chan WT, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00009; Chan WT, 2012, MICROBIOL MOL BIOL R, V76, P773, DOI 10.1128/MMBR.00030-12; Chan WT, 2011, J BACTERIOL, V193, P4612, DOI 10.1128/JB.05187-11; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Donegan NP, 2009, J BACTERIOL, V191, P2795, DOI 10.1128/JB.01713-08; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng S, 2013, NUCLEIC ACIDS RES, V41, P9549, DOI 10.1093/nar/gkt742; Fiebig A, 2010, MOL MICROBIOL, V77, P236, DOI 10.1111/j.1365-2958.2010.07207.x; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Grabe GJ, 2021, NAT CHEM BIOL, V17, P1296, DOI 10.1038/s41589-021-00862-y; Hallez R, 2010, MOL MICROBIOL, V76, P719, DOI 10.1111/j.1365-2958.2010.07129.x; Harms A, 2018, MOL CELL, V70, P768, DOI 10.1016/j.molcel.2018.01.003; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kang SM, 2018, TOXINS, V10, DOI 10.3390/toxins10120515; Kumar P, 2008, J MOL BIOL, V383, P482, DOI 10.1016/j.jmb.2008.08.067; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; LeRoux M, 2020, MOL CELL, V79, P280, DOI 10.1016/j.molcel.2020.05.028; Liang YJ, 2014, J BIOL CHEM, V289, P21191, DOI 10.1074/jbc.M114.559773; Lobato-Marquez D, 2016, FEMS MICROBIOL REV, V40, P592, DOI 10.1093/femsre/fuw022; Loris R, 2014, CHEM REV, V114, P6933, DOI 10.1021/cr400656f; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Nolle N, 2013, MICROBIOL-SGM, V159, P1575, DOI 10.1099/mic.0.068049-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Paul P, 2019, MOL ORAL MICROBIOL, V34, P97, DOI 10.1111/omi.12258; Pavelich IJ, 2019, NUCLEIC ACIDS RES, V47, P10400, DOI 10.1093/nar/gkz760; Qi Xinyu, 2021, J Bone Jt Infect, V6, P241, DOI 10.5194/jbji-6-241-2021; Rownicki M, 2020, TOXINS, V12, DOI 10.3390/toxins12090568; Schuster CF, 2016, TOXINS, V8, DOI 10.3390/toxins8050140; Sierra R, 2019, BBA-GENE REGUL MECH, V1862, P742, DOI 10.1016/j.bbagrm.2018.07.009; Wen W, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00032-18; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Xu JL, 2018, TOXINS, V10, DOI 10.3390/toxins10110467; Xue L, 2020, NUCLEIC ACIDS RES, V48, P10527, DOI 10.1093/nar/gkaa706; Yoshizumi S, 2009, J BACTERIOL, V191, P5868, DOI 10.1128/JB.00623-09; Zander I, 2020, ENVIRON MICROBIOL, V22, P5048, DOI 10.1111/1462-2920.15102; Zhang SP, 2021, COMPUT STRUCT BIOTEC, V19, P86, DOI 10.1016/j.csbj.2020.12.002; Zheng CK, 2015, SCI REP-UK, V5, DOI 10.1038/srep13125	47	2	2	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101457	10.1016/j.jbc.2021.101457	http://dx.doi.org/10.1016/j.jbc.2021.101457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP0ZE	34861238	Green Published, gold			2022-12-26	WOS:000748357700003
J	Yang, QY; Liu, J; Wang, Y; Zhao, W; Wang, WJ; Cui, J; Yang, JJ; Yue, Y; Zhang, S; Chu, MQ; Lyu, QJ; Ma, LZ; Tang, YW; Hu, YP; Miao, K; Zhao, HC; Tian, JH; An, L				Yang, Qianying; Liu, Juan; Wang, Yue; Zhao, Wei; Wang, Wenjing; Cui, Jian; Yang, Jiajun; Yue, Yuan; Zhang, Shuai; Chu, Meiqiang; Lyu, Qingji; Ma, Lizhu; Tang, Yawen; Hu, Yupei; Miao, Kai; Zhao, Haichao; Tian, Jianhui; An, Lei			A proteomic atlas of ligand-receptor interactions at the ovine maternal-fetal interface reveals the role of histone lactylation in uterine remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOMETRIAL STROMAL CELLS; EPITHELIAL-CELLS; INTERFERON-TAU; PREGNANCY RECOGNITION; PYRUVATE-CARBOXYLASE; ADHESION MOLECULES; GENE-EXPRESSION; MOUSE EMBRYOS; CYSTATIN-C; IFN-TAU	Well-orchestrated maternal-fetal cross talk occurs via secreted ligands, interacting receptors, and coupled intracellular pathways between the conceptus and endometrium and is essential for successful embryo implantation. However, previous studies mostly focus on either the conceptus or the endometrium in isolation. The lack of integrated analysis impedes our understanding of early maternal-fetal cross talk. Herein, focusing on ligand-receptor complexes and coupled pathways at the maternal-fetal interface in sheep, we provide the first comprehensive proteomic map of ligand-receptor pathway cascades essential for embryo implantation. We demonstrate that these cascades are associated with cell adhesion and invasion, redox homeostasis, and the immune response. Candidate interactions and their physiological roles were further validated by functional experiments. We reveal the physical interaction of albumin and claudin 4 and their roles in facilitating embryo attachment to endometrium. We also demonstrate a novel function of enhanced conceptus glycolysis in remodeling uterine receptivity by inducing endometrial histone lactylation, a newly identified histone modification. Results from in vitro and in vivo models supported the essential role of lactate in inducing endometrial H3K18 lactylation and in regulating redox homeostasis and apoptotic balance to ensure successful implantation. By reconstructing a map of potential ligand-receptor pathway cascades at the maternal-fetal interface, our study presents new concepts for understanding molecular and cellular mechanisms that fine-tune conceptus- endometrium cross talk during implantation. This provides more direct and accurate insights for developing potential clinical intervention strategies to improve pregnancy outcomes following both natural and assisted conception.	[Yang, Qianying; Liu, Juan; Wang, Yue; Zhao, Wei; Wang, Wenjing; Cui, Jian; Yang, Jiajun; Yue, Yuan; Zhang, Shuai; Chu, Meiqiang; Lyu, Qingji; Ma, Lizhu; Tang, Yawen; Hu, Yupei; Miao, Kai; Zhao, Haichao; Tian, Jianhui; An, Lei] China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod, Natl Engn Lab Anim Breeding,Minist Agr, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	An, L (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod, Natl Engn Lab Anim Breeding,Minist Agr, Beijing, Peoples R China.	anleim@cau.edu.cn	An, Lei/GQB-0039-2022	Yang, Qianying/0000-0003-0077-7437; Zhao, Wei/0000-0003-0716-297X; Yang, Jiajun/0000-0002-0922-3783; Zhao, Haichao/0000-0002-0076-3425	National Key RD Program [2017YFD0501905, 2017YFD0501901]; National Natural Science Foundation of China [3167246, 31972573]; National Support Program for Youth Top-notch Talents; Earmarked Fund for the Innovative Teams of Beijing Swine Industrialization Research Program, National transgenic major program [2009ZX08006-008B, 2008ZX08006-002, 2011ZX08006-002, 2013ZX08006-002]	National Key RD Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Support Program for Youth Top-notch Talents; Earmarked Fund for the Innovative Teams of Beijing Swine Industrialization Research Program, National transgenic major program	We thank the members of our laboratory for their helpful comments on the manuscript. This work was supported by the grants from National Key R&D Program (2017YFD0501905 and 2017YFD0501901), National Natural Science Foundation of China (No. 3167246 and 31972573), National Support Program for Youth Top-notch Talents and the Earmarked Fund for the Innovative Teams of Beijing Swine Industrialization Research Program, National transgenic major program (2009ZX08006-008B and 2008ZX08006-002, 2011ZX08006-002, 2013ZX08006-002).	Al-Gubory KH, 2017, THERIOGENOLOGY, V99, P111, DOI 10.1016/j.theriogenology.2017.05.017; Al-Gubory KH, 2012, INT J BIOCHEM CELL B, V44, P1511, DOI 10.1016/j.biocel.2012.06.017; Armant DR, 2011, CELL CYCLE, V10, P574, DOI 10.4161/cc.10.4.14846; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Bazer Fuller W, 2011, Front Biosci (Schol Ed), V3, P745, DOI 10.2741/s184; Bazer FW, 1997, AM J REPROD IMMUNOL, V37, P412; BAZER FW, 1975, J ANIM SCI, V41, P1376, DOI 10.2527/jas1975.4151376x; BAZER FW, 1992, P SOC EXP BIOL MED, V199, P373, DOI 10.3181/00379727-199-43371A; Behringer R, 2014, MANIPULATING MOUSE E, V4; BELT JA, 1979, BIOCHEMISTRY-US, V18, P3506, DOI 10.1021/bi00583a011; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Berneau SC, 2019, MOL HUM REPROD, V25, P265, DOI 10.1093/molehr/gaz011; Biase FH, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000046; Brooks K, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.141945; CANESTRARI F, 1995, CLIN CHIM ACTA, V234, P127, DOI 10.1016/0009-8981(94)05990-A; Carson DD, 2002, MOL HUM REPROD, V8, P871, DOI 10.1093/molehr/8.9.871; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chae JI, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-41; Chen YZ, 2007, REPRODUCTION, V134, P123, DOI 10.1530/REP-07-0387; Chen ZY, 2015, P NATL ACAD SCI USA, V112, P4618, DOI 10.1073/pnas.1422088112; Chin C., 2009, GENOME INFORM, V5, P2; Choi YS, 2001, BIOL REPROD, V65, P1038, DOI 10.1095/biolreprod65.4.1038; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Desta IT, 2020, STRUCTURE, V28, P1071, DOI 10.1016/j.str.2020.06.006; Dobrinsky JR, 1996, BIOL REPROD, V55, P1069, DOI 10.1095/biolreprod55.5.1069; Dorniak P, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097063; Edwards RG, 2006, REPROD BIOMED ONLINE, V13, P887, DOI 10.1016/S1472-6483(10)61454-X; Estepa IM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082870; Feng J, 2007, BIOINFORMATICS, V23, P2210, DOI 10.1093/bioinformatics/btm267; Gardner DK, 2015, BIOESSAYS, V37, P364, DOI 10.1002/bies.201400155; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Goossens K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-1; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Groulx JF, 2011, MATRIX BIOL, V30, P195, DOI 10.1016/j.matbio.2011.03.002; Gu XW, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aba3396; Gu XW, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12737; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Harris SE, 2005, THERIOGENOLOGY, V64, P992, DOI 10.1016/j.theriogenology.2005.01.004; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hu SG, 2014, J CLIN ENDOCR METAB, V99, pE2744, DOI 10.1210/jc.2014-2155; Hu W, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2071-6; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin ES, 2016, NMR BIOMED, V29, P466, DOI 10.1002/nbm.3479; Kaneko Y, 2014, HISTOCHEM CELL BIOL, V141, P423, DOI 10.1007/s00418-013-1165-y; Kang YJ, 2014, HUM REPROD, V29, P739, DOI 10.1093/humrep/det433; Kelly A, 1996, DEV DYNAM, V207, P300; Kim YJ, 2007, BIOL PHARM BULL, V30, P1052, DOI 10.1248/bpb.30.1052; Koch JM, 2010, J PROTEOME RES, V9, P3878, DOI 10.1021/pr100096b; Kong CC, 2016, J CLIN ENDOCR METAB, V101, P1478, DOI 10.1210/jc.2015-1588; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Kramer AC, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa098; Kumar MP, 2018, CELL REP, V25, P1458, DOI 10.1016/j.celrep.2018.10.047; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; LEESE HJ, 1988, J REPROD FERTIL, V82, P843, DOI 10.1530/jrf.0.0820843; Lefebvre T, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00549; Leitao B, 2010, FASEB J, V24, P1541, DOI 10.1096/fj.09-149153; Lessey BA, 2002, J REPROD IMMUNOL, V55, P101, DOI 10.1016/S0165-0378(01)00139-5; Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Li MQ, 2013, HUM REPROD, V28, P2822, DOI 10.1093/humrep/det248; Madaan A, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.09.072; Mamo S, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099945; Mansouri-Attia N, 2009, P NATL ACAD SCI USA, V106, P5687, DOI 10.1073/pnas.0812722106; Marlier JF, 2013, BIOCHEMISTRY-US, V52, P2888, DOI 10.1021/bi400075t; Martal JL, 1998, BIOCHIMIE, V80, P755, DOI 10.1016/S0300-9084(99)80029-7; MERKLE S, 1992, COMP BIOCHEM PHYS B, V101, P309, DOI 10.1016/0305-0491(92)90004-B; Merritt ME, 2011, P NATL ACAD SCI USA, V108, P19084, DOI 10.1073/pnas.1111247108; Minadakis G, 2019, BIOINFORMATICS, V35, P889, DOI 10.1093/bioinformatics/bty693; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moraes JGN, 2020, BIOL REPROD, V102, P456, DOI 10.1093/biolre/ioz191; Moraes JGN, 2020, BIOL REPROD, V102, P571, DOI 10.1093/biolre/ioz197; Morel O, 2012, THERIOGENOLOGY, V78, P1763, DOI 10.1016/j.theriogenology.2012.06.012; Muramatsu H, 2019, ONCOL REP, V42, P224, DOI 10.3892/or.2019.7171; Nie JZ, 2013, J PROTEOME RES, V12, P3843, DOI 10.1021/pr301044b; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Oliveira JF, 2008, ENDOCRINOLOGY, V149, P1252, DOI 10.1210/en.2007-0863; Payen VL, 2020, MOL METAB, V33, P48, DOI 10.1016/j.molmet.2019.07.006; Quinn CE, 2006, BIOCHEM BIOPH RES CO, V349, P236, DOI 10.1016/j.bbrc.2006.08.054; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Romero JJ, 2017, BIOL REPROD, V97, P273, DOI 10.1093/biolre/iox078; Rosenfeld CS, 2002, BIOL REPROD, V67, P847, DOI 10.1095/biolreprod.102.004267; Ruane PT, 2017, MOL HUM REPROD, V23, P617, DOI 10.1093/molehr/gax043; Seguinot-Tarafa I, 2020, REPROD SCI, V27, P1812, DOI 10.1007/s43032-020-00257-9; Simintiras CA, 2021, BIOL REPROD, V104, P1022, DOI 10.1093/biolre/ioab021; Simon C, 1997, J CLIN ENDOCR METAB, V82, P2607, DOI 10.1210/jc.82.8.2607; Singh H, 2009, J ANAT, V215, P3, DOI 10.1111/j.1469-7580.2008.01034.x; Smith DG, 2013, BIOCHEM SOC T, V41, P664, DOI 10.1042/BST20120352; Song G, 2008, BIOL REPROD, V79, P376, DOI 10.1095/biolreprod.108.068403; Song G, 2010, BIOL REPROD, V82, P854, DOI 10.1095/biolreprod.109.080929; Spencer TE, 2004, REPRODUCTION, V128, P657, DOI 10.1530/rep.1.00398; Spencer TE, 2004, ANIM REPROD SCI, V82-3, P537, DOI 10.1016/j.anireprosci.2004.04.014; Spencer TE, 1999, BIOL REPROD, V60, P241, DOI 10.1095/biolreprod60.2.241; Spencer TE, 2007, REPROD FERT DEVELOP, V19, P65, DOI 10.1071/RD06102; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui LL, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.124248; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; TABIBZADEH S, 1991, ENDOCR REV, V12, P272, DOI 10.1210/edrv-12-3-272; Tan K, 2016, P NATL ACAD SCI USA, V113, P3197, DOI 10.1073/pnas.1523538113; Vajda S, 2017, PROTEINS, V85, P435, DOI 10.1002/prot.25219; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; Wadehra M, 2005, DEV BIOL, V287, P336, DOI 10.1016/j.ydbio.2005.09.003; Wan PC, 2011, REPROD DOMEST ANIM, V46, P840, DOI 10.1111/j.1439-0531.2011.01752.x; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang Y, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-39; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WIMSATT WA, 1950, AM J ANAT, V87, P391, DOI 10.1002/aja.1000870304; Wu JJ, 2011, J PHYSIOL-LONDON, V589, P863, DOI 10.1113/jphysiol.2010.200808; Xie KM, 2010, REPRODUCTION, V139, P799, DOI 10.1530/REP-09-0490; Yang QY, 2020, J ANIM SCI BIOTECHNO, V11, DOI 10.1186/s40104-019-0405-y; Yu J, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-021-02308-z; Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhang Y, 2018, NAT GENET, V50, P96, DOI 10.1038/s41588-017-0003-x; Zhao HC, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0017-0; Zinaman MJ, 1996, FERTIL STERIL, V65, P503, DOI 10.1016/S0015-0282(16)58144-8	118	5	5	8	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101456	10.1016/j.jbc.2021.101456	http://dx.doi.org/10.1016/j.jbc.2021.101456			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP0ZE	34861240	Green Submitted, Green Published, gold			2022-12-26	WOS:000748357700013
J	Jansky, M; Schade, F; Rieder, N; Lohrmann, D; Gebel, C; Kloppenburg, L; Wedding, U; Simon, ST; Bausewein, C; Nauck, F				Jansky, Maximiliane; Schade, Franziska; Rieder, Nicola; Lohrmann, Danica; Gebel, Cordula; Kloppenburg, Lars; Wedding, Ulrich; Simon, Steffen T.; Bausewein, Claudia; Nauck, Friedemann		PallPan Study Grp	'It felt like a black hole, great uncertainty, but we have to take care for our patients'-Qualitative findings on the effects of the COVID-19 pandemic on specialist palliative home care	PLOS ONE			English	Article							LIFE; END	Background The COVID-19 pandemic has affected health care systems worldwide. Multidisciplinary teams provide specialist palliative home care (SPHC) for patients with incurable, severe, progressive diseases. These patients are at the same time at high risk, if infected, highly constricted by containment measures, and dependent on support. Aim To explore i) how German SPHC teams were affected by the pandemic during the first wave, ii) which challenges they faced, and iii) which strategies helped to handle the consequences of the COVID-19 pandemic for providing good SPHC. Method Four focus groups (with representatives of 18 SPHC teams) and five guided interviews with stakeholders were conducted and analysed using qualitative content analysis. Results Seven key categories emerged from the data. A category in the background describes dependence on organizational characteristics (e.g. sponsorship), which varied by regional factors. Information management was a challenge to SPHC teams, as they had to collect, interpret and adapt, and disseminate information. They reported a shift in patient care because of the COVID-19 pandemic, due to restricted home visits, visitation ban in nursing homes, and difficulties for hospital, hospice and nursing home admissions. Measures to reduce risk of infection impeded teamwork. Teams relied upon their local networks in crisis management, but felt often overlooked by local health authorities. Their respective SPHC state associations supported them in information management and exchange. Discussion The pandemic has severely impacted home care for especially vulnerable seriously ill and dying people. A good network with local health providers and authorities could help to harmonize local regulations and ensure quality care for all patient groups. SPHC teams could play an important role in caring for palliative patients with COVID-19 who are not admitted to a hospital due to preferences or resources.	[Jansky, Maximiliane; Schade, Franziska; Rieder, Nicola; Lohrmann, Danica; Nauck, Friedemann] Georg August Univ Gottingen, Univ Med Ctr, Dept Palliat Med, Gottingen, Germany; [Gebel, Cordula; Kloppenburg, Lars; Wedding, Ulrich] Jena Univ Hosp, Dept Palliat Care, Jena, Germany; [Simon, Steffen T.] Univ Cologne, Fac Med, Dept Palliat Med, Cologne, Germany; [Simon, Steffen T.] Univ Cologne, Univ Hosp, Cologne, Germany; [Bausewein, Claudia] Munich Univ Hosp, Dept Palliat Med, Munich, Germany	University of Gottingen; Friedrich Schiller University of Jena; University of Cologne; University of Cologne; University of Munich	Jansky, M (corresponding author), Georg August Univ Gottingen, Univ Med Ctr, Dept Palliat Med, Gottingen, Germany.	Maximiliane.jansky@med.uni-goettingen.de		Gebel, Cordula/0000-0002-8305-9176; Jansky, Maximiliane/0000-0002-5292-2934	Network University Medicine by the German Ministry of Education and Research [Forderkennzeichen 01KX2021]	Network University Medicine by the German Ministry of Education and Research	PallPan is funded within the Network University Medicine by the German Ministry of Education and Research (Forderkennzeichen 01KX2021). https://www.netzwerkuniversitaetsmedizin.de/projekte The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bausewein Claudia., 2021, ZENODO, DOI [10.5281/ZENODO.5012504, DOI 10.5281/ZENODO.5012504]; Ditscheid B, 2020, BUNDESGESUNDHEITSBLA, V63, P1502, DOI 10.1007/s00103-020-03240-6; Dunleavy L, 2021, PALLIATIVE MED, V35, P814, DOI 10.1177/02692163211000660; Freytag A, 2019, BMC PALLIAT CARE, V18, DOI 10.1186/s12904-019-0398-5; Greenhalgh T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1182; Konradsen H, 2021, PROG PALLIAT CARE, V29, P186, DOI 10.1080/09699260.2021.1872139; Leitlinienprogramm Onkologie der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e. V. (AWMF), 2015, S3 LEITL PALL PAT NI; Marques ICD, 2021, AM J SURG, V221, P918, DOI 10.1016/j.amjsurg.2020.10.009; Mayring P., 2015, QUALITATIVE INHALTSA, V12; Munch U, 2020, SCHMERZ, V34, P303, DOI 10.1007/s00482-020-00483-9; Pelz C., 2004, KNOWLEDGE MAPPING TO; Radbruch L, 2010, EUR J PALLIAT CARE, V17, P22; Radbruch L, 2020, LANCET, V395, P1467, DOI 10.1016/S0140-6736(20)30964-8; Robert Koch-Institut, 2021, STUF STIKO PRIOR COV; Rogers JEB, 2021, AM J HOSP PALLIAT ME, V38, P521, DOI 10.1177/1049909121989987; Schloesser K, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06987-z; Schoenmaekers JJAO, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01405; Stewart DW, 2017, J ADVERTISING, V46, P48, DOI 10.1080/00913367.2016.1252288; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tran DL, 2020, J PAIN SYMPTOM MANAG, V60, pE45, DOI 10.1016/j.jpainsymman.2020.03.040; World Health Organization, 2020, FACT SHEET PALL CAR	21	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0260767	10.1371/journal.pone.0260767	http://dx.doi.org/10.1371/journal.pone.0260767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY5KW	34910741	gold, Green Published			2022-12-26	WOS:000754828900027
J	Fahey, PP; Page, A; Astell-Burt, T; Stone, G				Fahey, Paul P.; Page, Andrew; Astell-Burt, Thomas; Stone, Glenn			Imputing pre-diagnosis health behaviour in cancer registry data and investigating its relationship with oesophageal cancer survival time	PLOS ONE			English	Article							SIMULATION; MODEL	Background As oesophageal cancer has short survival, it is likely pre-diagnosis health behaviours will have carry-over effects on post-diagnosis survival times. Cancer registry data sets do not usually contain pre-diagnosis health behaviours and so need to be augmented with data from external health surveys. A new algorithm is introduced and tested to augment cancer registries with external data when one-to-one data linkage is not available. Methods The algorithm is to use external health survey data to impute pre-diagnosis health behaviour for cancer patients, estimate misclassification errors in these imputed values and then fit misclassification corrected Cox regression to quantify the association between pre-diagnosis health behaviour and post-diagnosis survival. Data from US cancer registries and a US national health survey are used in testing the algorithm. Results It is demonstrated that the algorithm works effectively on simulated smoking data when there is no age confounding. But age confounding does exist (risk of death increases with age and most health behaviours change with age) and interferes with the performance of the algorithm. The estimate of the hazard ratio (HR) of pre-diagnosis smoking was HR = 1.32 (95% CI 0.82,2.68) with HR = 1.93 (95% CI 1.08,7.07) in the squamous cell sub-group and pre-diagnosis physical activity was protective of survival with HR = 0.25 (95% CI 0.03, 0.81). But the method failed for less common behaviours (such as heavy drinking). Conclusions Further improvements in the I2C2 algorithm will permit enrichment of cancer registry data through imputation of new variables with negligible risk to patient confidentiality, opening new research opportunities in cancer epidemiology.	[Fahey, Paul P.; Page, Andrew] Western Sydney Univ, Translat Hlth Res Inst, Campbelltown, NSW, Australia; [Astell-Burt, Thomas] Univ Wollongong, Sch Hlth & Soc, Populat Wellbeing & Environm Res Lab PowerLab, Fac Social Sci, Wollongong, NSW, Australia; [Stone, Glenn] Western Sydney Univ, Sch Comp Data & Math Sci, Parramatta, NSW, Australia	University of Sydney; Western Sydney University; University of Wollongong; Western Sydney University	Fahey, PP (corresponding author), Western Sydney Univ, Translat Hlth Res Inst, Campbelltown, NSW, Australia.	p.fahey@westernsydney.edu.au	Fahey, Paul P/B-7985-2013	Fahey, Paul P/0000-0002-6351-9876				Agaku IT, 2020, TOB CONTROL, V29, P269, DOI 10.1136/tobaccocontrol-2019-054948; Azagba S, 2020, SUBST USE MISUSE, V55, P990, DOI 10.1080/10826084.2020.1717538; Bang H, 2013, J STAT THEORY PRACT, V7, P381, DOI 10.1080/15598608.2013.772830; Bender R, 2005, STAT MED, V24, P1713, DOI 10.1002/sim.2059; Blanchette Christopher M, 2013, Drugs Context, V2013, P212258, DOI 10.7573/dic.212258; Centers for Disease Control and Prevention, 2013, BRFSS DAT US GUID; Centers for Disease Control and Prevention, 2021, BURD CIG US US; Doll KM, 2018, JAMA SURG, V153, P588, DOI 10.1001/jamasurg.2018.0501; Fahey PP, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-00957-5; Fahey PP, 2015, CANCER CAUSE CONTROL, V26, P1365, DOI 10.1007/s10552-015-0635-z; Friedenreich CM, 2020, JNCI CANCER SPECT, V4, DOI 10.1093/jncics/pkz080; Grucza RA, 2018, ALCOHOL CLIN EXP RES, V42, P1939, DOI 10.1111/acer.13859; Gupta V, 2018, J THORAC CARDIOV SUR, V156, P847, DOI 10.1016/j.jtcvs.2018.03.146; Jurek AM, 2005, INT J EPIDEMIOL, V34, P680, DOI 10.1093/ije/dyi060; Kuang JJ, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/7682387; Leventhal AM, 2019, JAMA INTERN MED, V179, P777, DOI 10.1001/jamainternmed.2019.0192; McMenamin UC, 2017, BEST PRACT RES CL GA, V31, P569, DOI 10.1016/j.bpg.2017.09.015; Morseth B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231581; National Cancer Institute, 2021, CANC STAT FACTS ES C; National Center for Health Statistics, 2021, NATL HLTH INTERVIEW; Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059; Nordholt ES, 1998, INT STAT REV, V66, P157, DOI 10.2307/1403488; Schneeweiss S, 2009, EPIDEMIOLOGY, V20, P512, DOI 10.1097/EDE.0b013e3181a663cc; Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943; Ward ZJ, 2019, NEW ENGL J MED, V381, P2440, DOI 10.1056/NEJMsa1909301; Zucker DM, 2008, STAT MED, V27, P1911, DOI 10.1002/sim.3159	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261416	10.1371/journal.pone.0261416	http://dx.doi.org/10.1371/journal.pone.0261416			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905568	Green Published, gold			2022-12-26	WOS:000754615500041
J	Govindasamy, K; John, AS; Lal, V; Arif, M; Solomon, RM; Ghosal, J; Dutta, A				Govindasamy, Karthikeyan; John, Annamma S.; Lal, Vivek; Arif, Mohammad; Solomon, Raju Moturu; Ghosal, Jyoti; Dutta, Ambarish			A comparison of three types of targeted, community-based methods aimed at promoting early detection of new leprosy cases in rural parts of three endemic states in India	PLOS ONE			English	Article							RISK-FACTORS; BANGLADESH; CONTACTS; ELIMINATION; CAMPAIGN; PROGRAM; DELAY; COST	Background India achieved elimination of leprosy nationally in 2005, but since then the number of patients with grade 2 disability at diagnosis increased steadily indicating delay in diagnosis. Therefore, there was a need for public health interventions which can increase case finding in their earlier stage. The objective of this study is to compare the effectiveness of three such community-based interventions; 1) Enhancement of community awareness on leprosy; 2) Education and motivation of "Index" leprosy cases; and 3) Involvement of Non-Formal Health Practitioners (NFHPs) to promote early detection of new cases of leprosy. Methodology/principal findings Three community-based interventions were implemented between April 2016 and March 2018, embedded within the National Leprosy Eradication Program (NLEP) of India. Interventions were 1) increasing awareness through involvement of Gram Panchayat (local government) in the community regarding early signs of leprosy (Awareness), 2) providing health education and motivating newly diagnosed leprosy patients to bring suspects from their contacts (Index) and 3) training local non-formal health practitioners (NFHP). Each intervention was implemented in a group of ten blocks (sub-division of district) with an additional ten blocks as control (with no intervention). The main outcomes were number of new cases detected and number of grade 2 disability among them. They were obtained from the routine NLEP information system and compared between these interventions. On an average, there was an addition of 1.98 new cases in Awareness blocks, 1.13 in NFHP blocks and 1.16 cases in Index intervention blocks per month per block after adjusting for changes in control blocks during the same period. In terms of ratio, there was a 61%, 40% and 41% increase in case notification in awareness, Index and NFHP intervention, respectively. Overall, the percentage of grade 2 disability across intervention blocks declined. Conclusion The Awareness intervention appears to be more effective in detection of new cases, compared to Index case motivation and sensitization of NFHPs. However, it is important to stress that while selecting strategies to increase early diagnosis it is important to determine, which is the most appropriate for each context or area and must be decided depending on the local context.	[Govindasamy, Karthikeyan; John, Annamma S.; Solomon, Raju Moturu] Leprosy Miss Trust India, Res Domain, New Delhi, India; [Lal, Vivek] German Leprosy & TB Relief Assoc GLRA India, Kolkata, W Bengal, India; [Arif, Mohammad] Netherlands Leprosy Relief India, New Delhi, India; [Ghosal, Jyoti] Indian Council Med Res, Reg Med Res Ctr, Bhubaneswar, Orissa, India; [Dutta, Ambarish] Indian Inst Publ Hlth, Publ Hlth Fdn India, Bhubaneswar, Orissa, India; [Lal, Vivek] Sasakawa India Leprosy Fdn, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre (RMRC), Bhubaneswar; Public Health Foundation of India	Govindasamy, K (corresponding author), Leprosy Miss Trust India, Res Domain, New Delhi, India.	karthikot@hotmail.com	Ghosal, Jyoti/GWD-0668-2022	Dutta, Ambarish/0000-0002-4019-7472; SOLOMON RAJU, MOTURU/0000-0002-4233-6843; Govindasamy, Karthikeyan/0000-0001-5500-1308	Leprosy Research Initiative [703.15.15]	Leprosy Research Initiative	ASJ, VL and MA received award to conduct this study. Grant reference is 703.15.15. Name of the funder is Leprosy Research Initiative. The URL of funder is https://leprosyresearch.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, Weekly Epidemiological Record, V94, P389; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P461; Brandsma JW, 2003, LEPROSY REV, V74, P366; Commission IT, 2001, ILEP TECHN GUID INT; Ezenduka C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001818; Feenstra SG, 2011, LEPROSY REV, V82, P178; Fischer EAJ, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-125; Halder A, 2001, Indian J Public Health, V45, P88; Independent, 2020, INDEPENDENT; Kumar A., 2019, INDIAN J LEPR, V91, P105; Kumar A, 2020, LEPROSY REV, V91, P145; Manta FSN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52640-5; Moet FJ, 2006, J INFECT DIS, V193, P346, DOI 10.1086/499278; Moet FJ, 2004, LEPROSY REV, V75, P310; Nicholls PG, 2006, LEPROSY REV, V77, P298; Nicholls PG, 2005, LEPROSY REV, V76, P35; NLEP, 2019, ANN REP 2018 19; Norman G, 2006, Indian J Lepr, V78, P167; Padhi T, 2015, LEPROSY REV, V86, P170; Pathak VK, 2019, DIAGN MICR INFEC DIS, V95, DOI 10.1016/j.diagmicrobio.2019.06.007; Peters RMH., 2014, DISABIL CBR INCL DEV, DOI [10.5463/DCID.v25i4.389, DOI 10.5463/DCID.V25I4.389]; Porter JDH, 2001, LEPROSY REV, V72, P246; R Core Team, 2021, R LANGUAGE ENV STAT; Rao P Narasimha, 2018, Indian Dermatol Online J, V9, P83, DOI 10.4103/idoj.IDOJ_282_17; Richardus JH, 2005, INT J LEPROSY, V73, P249; Samraj A, 2012, Indian J Lepr, V84, P123; Sengupta U, 2018, INDIAN J DERMATOL VE, V84, P131, DOI 10.4103/ijdvl.IJDVL_1070_16; Shukla LK, 2015, INDIAN J DERMATOL VE, V81, P257, DOI 10.4103/0378-6323.154793; Singh A, 2015, TROP MED INT HEALTH, V20, P1223, DOI 10.1111/tmi.12540; Smith WCS, 2014, LEPROSY REV, V85, P2; Sudhinaraset M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054978; Thangaraju P, 2018, TROP DOCT, V48, P72, DOI 10.1177/0049475517702059; Thilakavathi S, 2015, Indian J Lepr, V87, P155; Van Veen NHJ, 2006, LEPROSY REV, V77, P356; World Health Organization, 2020, Weekly Epidemiological Record, V95, P417	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261219	10.1371/journal.pone.0261219	http://dx.doi.org/10.1371/journal.pone.0261219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905570	gold, Green Published			2022-12-26	WOS:000754615500028
J	Saito, M; Iida, T; Saito, K; Kano, M; Itagaki, K; Maruko, I; Sekiryu, T				Saito, Masaaki; Iida, Tomohiro; Saito, Kuniharu; Kano, Mariko; Itagaki, Kanako; Maruko, Ichiro; Sekiryu, Tetsuju			Long-term characteristics of exudative age-related macular degeneration in Japanese patients	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; PHOTODYNAMIC THERAPY; RANIBIZUMAB; VERTEPORFIN; NEOVASCULARIZATION; OUTCOMES; BEVACIZUMAB; MECHANISM; TRIALS	Purpose The present study aimed to evaluate the clinical characteristics of exudative age-related macular degeneration (AMD) in Japanese patients over a 10-year period and to compare the past our report. Methods We retrospectively reviewed 1,600 treatment-naive patients (1,777 eyes) with exudative AMD. The 10 years were divided into 2-year phases I to V. Results Of the 1,600 patients, 720 (45.0%), 733 (45.8%), 98 (6.1%), and 49 (3.1%) were diagnosed with typical AMD, polypoidal choroidal vasculopathy (PCV), retinal angiomatous proliferation, and combined subtypes, respectively. The prevalence of PCV decreased from 54.7% in phase I to 46.0% at phase V. Of the 1,777 eyes, the mean baseline logarithm of the minimum angle of resolution best-corrected visual acuities (BCVAs) in phases I, II, III, IV, and V were 0.70, 0.66, 0.55, 0.50, and 0.48, respectively. Phases III, IV, and V had significantly (P = 0.0012, P<0.0001, P<0.0001, respectively) better baseline VAs compared with phase I. The mean lesion sizes in phases I, II, III, IV, and V were 8.6, 6.7, 5.3, 5.7, and 5.7 Macular Photocoagulation Study disc areas, respectively. The sizes were significantly (P<0.0001 for all comparisons) smaller in phases III, IV, and V compared with phase I. Conclusions Although the prevalence of PCV decreased from 54.7% in phase I to 46.0% at phase V, PCV has nevertheless been highly prevalent in Japanese patients with AMD compared with Caucasian patients. The annual better baseline VAs and smaller lesion sizes over time might be related to development of treatment and better concerns about AMD.	[Saito, Masaaki; Iida, Tomohiro; Saito, Kuniharu; Kano, Mariko; Itagaki, Kanako; Maruko, Ichiro; Sekiryu, Tetsuju] Fukushima Med Univ, Dept Ophthalmol, Sch Med, Fukushima, Japan; [Saito, Masaaki] Hirosaki Univ, Dept Ophthalmol, Grad Sch Med, Hirosaki, Aomori, Japan; [Iida, Tomohiro; Kano, Mariko; Maruko, Ichiro] Tokyo Womens Med Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan	Fukushima Medical University; Hirosaki University; Tokyo Women's Medical University	Saito, M (corresponding author), Fukushima Med Univ, Dept Ophthalmol, Sch Med, Fukushima, Japan.; Saito, M (corresponding author), Hirosaki Univ, Dept Ophthalmol, Grad Sch Med, Hirosaki, Aomori, Japan.	masaaki@hirosaki-u.ac.jp		Sekiryu, Tetsuju/0000-0001-8042-2729; Saito, Masaaki/0000-0003-1494-6350				[Anonymous], 1991, Arch Ophthalmol, V109, P1220; Arnold J, 2001, OPHTHALMOLOGY, V108, P841; Arnold J, 2001, AM J OPHTHALMOL, V131, P541; Baumal CR, 2020, OPHTHALMOLOGY, V127, P1345, DOI 10.1016/j.ophtha.2020.04.017; Blumenkranz MS, 2001, ARCH OPHTHALMOL-CHIC, V119, P198; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Byeon SH, 2008, JPN J OPHTHALMOL, V52, P57, DOI 10.1007/s10384-007-0498-2; Clemens CR, 2016, OPHTHALMOLOGICA, V235, P1, DOI 10.1159/000439445; Dansingani KK, 2015, AM J OPHTHALMOL, V160, P1243, DOI 10.1016/j.ajo.2015.08.028; Davis SJ, 2014, RETINA-J RET VIT DIS, V34, P2185, DOI 10.1097/IAE.0000000000000206; Dugel PU, 2021, OPHTHALMOLOGY, V128, P89, DOI [10.1016/j.opatha.2020.06.028, 10.1016/j.ophtha.2020.06.028]; Dugel PU, 2020, OPHTHALMOLOGY, V127, P72, DOI 10.1016/j.ophtha.2019.04.017; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; GASS JDM, 1994, AM J OPHTHALMOL, V118, P285, DOI 10.1016/S0002-9394(14)72951-4; Haug Sara J, 2020, Am J Ophthalmol Case Rep, V18, P100680, DOI 10.1016/j.ajoc.2020.100680; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Imamura Y, 2010, SURV OPHTHALMOL, V55, P501, DOI 10.1016/j.survophthal.2010.03.004; Koh AHC, 2013, RETINA-J RET VIT DIS, V33, P686, DOI 10.1097/IAE.0b013e3182852446; Ladas ID, 2004, EYE, V18, P455, DOI 10.1038/sj.eye.6700706; Lafaut BA, 2000, GRAEF ARCH CLIN EXP, V238, P752, DOI 10.1007/s004170000180; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Maruko I, 2021, GRAEF ARCH CLIN EXP, V259, P2857, DOI 10.1007/s00417-021-05136-w; Maruko I, 2010, GRAEF ARCH CLIN EXP, V248, P361, DOI 10.1007/s00417-009-1276-2; Matsumoto H, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86014-7; Nagiel A, 2013, AM J OPHTHALMOL, V156, P981, DOI 10.1016/j.ajo.2013.06.024; Pang CE, 2015, RETINA-J RET VIT DIS, V35, P1, DOI 10.1097/IAE.0000000000000331; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Saito M, 2008, BRIT J OPHTHALMOL, V92, P1642, DOI 10.1136/bjo.2007.137075; Saito M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243458; Saito M, 2012, RETINA-J RET VIT DIS, V32, P1250, DOI 10.1097/IAE.0b013e318236e503; Saito M, 2010, AM J OPHTHALMOL, V149, P472, DOI 10.1016/j.ajo.2009.09.016; Saito Masaaki, 2009, Nippon Ganka Gakkai Zasshi, V113, P792; Saito M, 2008, AM J OPHTHALMOL, V146, P935, DOI 10.1016/j.ajo.2008.06.033; Scassellati-Sforzolini B, 2001, RETINA-J RET VIT DIS, V21, P121, DOI 10.1097/00006982-200104000-00004; Tamura H, 2007, BRIT J OPHTHALMOL, V91, P1152, DOI 10.1136/bjo.2006.112318; Wen F, 2004, GRAEF ARCH CLIN EXP, V242, P625, DOI 10.1007/s00417-003-0667-z; Yannuzzi LA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1503; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Ying GS, 2015, OPHTHALMOLOGY, V122, P2523, DOI 10.1016/j.ophtha.2015.08.015; Ying GS, 2013, OPHTHALMOLOGY, V120, P122, DOI 10.1016/j.ophtha.2012.07.042	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261320	10.1371/journal.pone.0261320	http://dx.doi.org/10.1371/journal.pone.0261320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905560	Green Published, gold			2022-12-26	WOS:000754615500035
J	Kouzuki, M; Furukawa, S; Mitani, K; Urakami, K				Kouzuki, Minoru; Furukawa, Shota; Mitani, Keisuke; Urakami, Katsuya			Examination of the cognitive function of Japanese community-dwelling older adults in a class for preventing cognitive decline during the COVID-19 pandemic	PLOS ONE			English	Article							LEISURE ACTIVITIES; RATING-SCALE; DEMENTIA; KNOWLEDGE; RISK; DISEASE	We examined the changes in cognitive function due to restrictions in daily life during the coronavirus disease 2019 (COVID-19) pandemic in community-dwelling older adults with mild cognitive decline. This was a retrospective, case-control study. The participants include 88 older adults with mild cognitive decline (mean age = 81.0 [standard deviation = 6.5] years) who participated in a class designed to help prevent cognitive decline. This class was suspended from early-March to end of May 2020 to prevent the spread of COVID-19, and resumed in June 2020. We collected demographic and cognitive function test data (Touch Panel-type Dementia Assessment Scale [TDAS]) before and after class suspension and questionnaire data on their lifestyle and thoughts during the suspension. Change in TDAS scores from before and after the suspension was used to divide the participants into decline (2 or more points worsening) and non-decline (all other participants) groups, with 16 (18.2%) and 72 (81.8%) participants in each group, respectively. A logistic regression model showed that the odds ratio (OR) for cognitive decline was lower in participants whose responses were "engaged in hobbies" (OR = 0.07, p = 0.015), "worked on a worksheet about cognitive training provided by the town hall" (OR = 0.19, p = 0.026), and "had conversations over the phone" (OR = 0.28, p = 0.0495). There was a significant improvement in TDAS scores after class was resumed (p < 0.01). A proactive approach to intellectual activities and social ties may be important for the prevention of cognitive decline during periods of restrictions due to COVID-19. We found that cognitive function test scores before class suspension significantly improved after resuming classes. We speculate that continued participation in this class led to positive behavioral changes in daily life during periods of restriction due to COVID-19.	[Kouzuki, Minoru; Furukawa, Shota; Mitani, Keisuke; Urakami, Katsuya] Tottori Univ, Fac Med, Sch Hlth Sci, Dept Biol Regulat, Tottori, Japan	Tottori University	Kouzuki, M (corresponding author), Tottori Univ, Fac Med, Sch Hlth Sci, Dept Biol Regulat, Tottori, Japan.	kouzuki@tottori-u.ac.jp		Kouzuki, Minoru/0000-0001-8122-3254				Akbaraly TN, 2009, NEUROLOGY, V73, P854, DOI 10.1212/WNL.0b013e3181b7849b; Arai Y, 2008, INT J GERIATR PSYCH, V23, P433, DOI 10.1002/gps.1977; Baschi R, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.590134; Bassuk SS, 1999, ANN INTERN MED, V131, P165, DOI 10.7326/0003-4819-131-3-199908030-00002; Chinnadurai R, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01803-5; Del Brutto OH, 2021, EUR J NEUROL, V28, P3245, DOI 10.1111/ene.14775; Devasia RA, 2009, AM J RESP CRIT CARE, V180, P365, DOI 10.1164/rccm.200901-0146OC; Evans IEM, 2019, J ALZHEIMERS DIS, V70, pS119, DOI 10.3233/JAD-180501; Evans IEM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201008; Gavelin HM, 2021, AGEING RES REV, V66, DOI 10.1016/j.arr.2020.101232; Glynn RW, 2017, AGE AGEING, V46, P865, DOI 10.1093/ageing/afx082; Inoue M, 2011, PSYCHOGERIATRICS, V11, P28, DOI 10.1111/j.1479-8301.2010.00345.x; Izcovich A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241955; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kouzuki M, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01691-7; Kouzuki M, 2020, ANN CLIN TRANSL NEUR, V7, P318, DOI 10.1002/acn3.50993; Kouzuki M, 2018, NEUROL SCI, V39, P321, DOI 10.1007/s10072-017-3187-z; Kuiper JS, 2015, AGEING RES REV, V22, P39, DOI 10.1016/j.arr.2015.04.006; Lian JS, 2020, CLIN INFECT DIS, V71, P740, DOI 10.1093/cid/ciaa242; Liew TM, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00673-8; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; McMaster M, 2020, J AM GERIATR SOC, V68, P2629, DOI 10.1111/jgs.16762; Miners S, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00744-w; Ministry of Internal Affairs and Communications JAPAN, 2020, RES FY2019 COMM US T; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Rosenberg A, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-1493-4; Rossi PG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238281; Saito T, 2018, J EPIDEMIOL COMMUN H, V72, P7, DOI 10.1136/jech-2017-209811; Shen C, 2018, PREV MED, V113, P140, DOI 10.1016/j.ypmed.2018.05.018; Shimada H, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0480-5; Sun F, 2014, J CROSS-CULT GERONTO, V29, P173, DOI 10.1007/s10823-014-9229-6; Turunen M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219541; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Wei CC, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01811-5; Yamada M, 2020, J NUTR HEALTH AGING, DOI [10.1007/s12603-020-1424-2, 10.1007/s12603-020-1501-6]; Yamada Y, 2020, J AM MED DIR ASSOC, V21, P1387, DOI 10.1016/j.jamda.2020.07.039; Zhao SZ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186692	39	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0248446	10.1371/journal.pone.0248446	http://dx.doi.org/10.1371/journal.pone.0248446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ0LY	34898633	Green Submitted, Green Published, gold			2022-12-26	WOS:000755176200001
J	Suzuki, Y; Nakajima, Y; Nakatani, T; Okuwa, M; Sugama, J				Suzuki, Yuiko; Nakajima, Yukari; Nakatani, Toshio; Okuwa, Mayumi; Sugama, Junko			Comparison of normal hindlimb lymphatic systems in rats with detours present after lymphatic flow blockage	PLOS ONE			English	Article							CANCER-RELATED LYMPHEDEMA; DRAINAGE; LYMPHADENECTOMY; PREVENTION; THERAPY; WOMEN; NODE	In the present study, we aimed to identify the normal hindlimb lymphatic systems in rats and compare them with the detours after lymphatic flow blockage. The lymphatic systems of the hindlimbs of normal rats were investigated via lymphography using a near-infrared fluorescence imaging system. The lymphatic vessels were stained using Evans Blue. The lymphatic flow was blocked through lymphatic vessel ligation combined with inguinal and popliteal lymph node dissection. Detours that appeared after 30 days were visualized using lymphography and immunostaining with anti-podoplanin antibodies. Three main results were obtained in the present study. First, the deep medial system, the superficial medial system, a connection between the superficial and deep medial lymphatic systems, and the superficial lateral system, were elucidated. Second, three types of detours, namely the detour of the lateral abdomen, the detour to the lymphatic vessel near the midline of the abdomen, and the detour to the contralateral inguinal lymph node, were identified after lymphatic flow blockage. Lastly, detours were located in the fatty layer above the panniculus carnosus muscle and their lumina were wide. The histology suggested that the detour was a pre-collecting lymphatic vessel. Lymphatic routes in the rat hindlimbs after lymphatic flow blockage were different from those of the normal rat lymphatic system. It was suggested that the detour is a pre-collecting lymphatic vessel and that encouraging its development may be a new method of simple lymphatic drainage.	[Suzuki, Yuiko] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Kanazawa, Ishikawa, Japan; [Suzuki, Yuiko] Komatsu Univ, Fac Hlth Sci, Komatsu, Ishikawa, Japan; [Nakajima, Yukari; Nakatani, Toshio; Okuwa, Mayumi] Kanazawa Univ, Fac Hlth Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Sugama, Junko] Fujita Hlth Univ, Res Ctr Implementat Nursing Sci Initiat, Sch Hlth Sci, Toyoake, Aichi, Japan	Kanazawa University; Kanazawa University; Fujita Health University	Nakajima, Y (corresponding author), Kanazawa Univ, Fac Hlth Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan.; Sugama, J (corresponding author), Fujita Hlth Univ, Res Ctr Implementat Nursing Sci Initiat, Sch Hlth Sci, Toyoake, Aichi, Japan.	ynakajima@staff.kanazawa-u.ac.jp; junko.sugama@fujita-hu.ac.jp			Japan Society for the Promotion of Science KAKENHI [20K23231, 20H03959]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Japan Society for the Promotion of Science KAKENHI Grant Number 20K23231 to YS and 20H03959 to YN. https://www.jsps.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorso J, 2016, PSYCHO-ONCOLOGY, V25, P865, DOI 10.1002/pon.4021; Asano K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227814; Bahtiyarca ZT, 2019, TURK J PH MED REHAB, V65, P309, DOI 10.5606/tftrd.2019.3126; Breslin JW, 2019, COMPR PHYSIOL, V9, P207, DOI 10.1002/cphy.c180015; Breslin JW, 2014, MICROVASC RES, V96, P46, DOI 10.1016/j.mvr.2014.07.013; Donmez AA, 2017, EUR J ONCOL NURS, V31, P12, DOI 10.1016/j.ejon.2017.09.004; Frueh FS, 2016, SCI REP-UK, V6, DOI 10.1038/srep34673; Frueh FS, 2016, J SURG RES, V200, P208, DOI 10.1016/j.jss.2015.07.005; Gillespie TC, 2018, GLAND SURG, V7, P379, DOI 10.21037/gs.2017.11.04; Kayiran O, 2017, TURK J SURG, V33, P51, DOI 10.5152/turkjsurg.2017.3870; Kwon S, 2016, BIOMED OPT EXPRESS, V7, P1100, DOI 10.1364/BOE.7.001100; Kwon S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106034; Liu NF, 2009, J VASC SURG, V49, P980, DOI 10.1016/j.jvs.2008.11.029; Nakajima Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25383-y; Sakorafas GH, 2006, SURG ONCOL, V15, P153, DOI 10.1016/j.suronc.2006.11.003; Shaitelman SF, 2015, CA-CANCER J CLIN, V65, P55, DOI 10.3322/caac.21253; Suami H, 2011, ANAT REC, V294, P1566, DOI 10.1002/ar.21446; Taghian NR, 2014, CRIT REV ONCOL HEMAT, V92, P227, DOI 10.1016/j.critrevonc.2014.06.004; Takeno Y, 2017, LYMPHOLOGY, V50, P131; Takeno Y, 2013, LYMPHOLOGY, V46, P12; TILNEY NL, 1971, J ANAT, V109, P369; Unno N, 2008, EUR J VASC ENDOVASC, V36, P230, DOI 10.1016/j.ejvs.2008.04.013; Williams AF, 2002, EUR J CANCER CARE, V11, P254, DOI 10.1046/j.1365-2354.2002.00312.x; Yamaji Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23693-9	24	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0260404	10.1371/journal.pone.0260404	http://dx.doi.org/10.1371/journal.pone.0260404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898636	gold, Green Published			2022-12-26	WOS:000755176200011
J	Wohl, DA; Barzin, AH; Napravnik, S; Davy-Mendez, T; Smedberg, JR; Thompson, CM; Ruegsegger, L; Gilleskie, M; Weber, DJ; Whinna, HC; Miller, MB				Wohl, David A.; Barzin, Amir H.; Napravnik, Sonia; Davy-Mendez, Thibaut; Smedberg, Jason R.; Thompson, Cecilia M.; Ruegsegger, Laura; Gilleskie, Matt; Weber, David J.; Whinna, Herbert C.; Miller, Melissa B.			COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2	PLOS ONE			English	Article							NEW-YORK-CITY; OUTCOMES	Introduction Symptoms associated with SARS-CoV-2 infection remain incompletely understood, especially among ambulatory, non-hospitalized individuals. With host factors, symptoms predictive of SARS-CoV-2 could be used to guide testing and intervention strategies. Methods Between March 16 and September 3, 2020, we examined the characteristics and symptoms reported by individuals presenting to a large outpatient testing program in the Southeastern US for nasopharyngeal SARS-CoV-2 RNA RT-PCR testing. Using self-reported symptoms, demographic characteristics, and exposure and travel histories, we identified the variables associated with testing positive using modified Poisson regression. Results Among 20,177 tested individuals, the proportion positive was 9.4% (95% CI, 9.0-9.8) and was higher for men, younger individuals, and racial/ethnic minorities (all P<0.05); the positivity proportion was higher for Hispanics (26.9%; 95% CI. 24.9-29.0) compared to Blacks (8.6%; 95% CI, 7.6-9.7) or Whites (5.8%; 95% CI, 5.4-6.3). Individuals reporting contact with a COVID-19 case had the highest positivity proportion (22.8%; 95% CI, 21.5-24.1). Among the subset of 8,522 symptomatic adults who presented for testing after May 1, when complete symptom assessments were performed, SARS-CoV-2 RNA PCR was detected in 1,116 (13.1%). Of the reported symptoms, loss of taste or smell was most strongly associated with SARS-CoV-2 RNA detection with an adjusted risk ratio of 3.88 (95% CI, 3.46-4.35). The presence of chills, fever, cough, aches, headache, fatigue and nasal congestion also significantly increased the risk of detecting SARS-CoV-2 RNA, while diarrhea or nausea/vomiting, although not uncommon, were significantly more common in those with a negative test result. Symptom combinations were frequent with 67.9% experiencing <greater than or equal to>4 symptoms, including 19.8% with >= 8 symptoms; report of greater than three symptoms increased the risk of SARS-CoV-2 RNA detection. Conclusions In a large outpatient population in the Southeastern US, several symptoms, most notably loss of taste or smell, and greater symptom burden were associated with detection of SARS-CoV-2 RNA. Persons of color and those with who were a contact of a COVID-19 case were also more likely to test positive. These findings suggest that, given limited SARS-CoV-2 testing capacity, symptom presentation and host characteristics can be used to guide testing and intervention prioritization.	[Wohl, David A.; Napravnik, Sonia; Davy-Mendez, Thibaut; Ruegsegger, Laura; Gilleskie, Matt; Weber, David J.] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27515 USA; [Barzin, Amir H.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27515 USA; [Davy-Mendez, Thibaut] Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA 94143 USA; [Smedberg, Jason R.; Thompson, Cecilia M.; Miller, Melissa B.] Univ N Carolina, Med Ctr, McLendon Clin Labs, Clin Microbiol Lab, Chapel Hill, NC 27515 USA; [Whinna, Herbert C.; Miller, Melissa B.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA; [Thompson, Cecilia M.] TriCore Reference Labs, Albuquerque, NM USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wohl, DA (corresponding author), Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27515 USA.	wohl@med.unc.edu	Thompson, Cecilia/AGY-0270-2022; Davy-Mendez, Thibaut/V-7750-2019	Thompson, Cecilia/0000-0002-1013-7313; Davy-Mendez, Thibaut/0000-0002-8505-9268	National Institute of Allergy and Infectious Diseases [UM1 AI-068636]; UNC Chapel Hill AIDS Clinical Trials Unit [UM1 AI069423]; UNC Center for AIDS Research [P30 AI50410]; NA-ACCORD COVID-19 Supplement [U01 AI069918]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [UL1 TR002489]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UNC Chapel Hill AIDS Clinical Trials Unit; UNC Center for AIDS Research; NA-ACCORD COVID-19 Supplement; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Research support was provided by the National Institute of Allergy and Infectious Diseases-sponsored AIDS Clinical Trials Group (ACTG) (UM1 AI-068636), the UNC Chapel Hill AIDS Clinical Trials Unit (UM1 AI069423), the UNC Center for AIDS Research (P30 AI50410), and the NA-ACCORD COVID-19 Supplement (U01 AI069918); and the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (UL1 TR002489). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyeman AA, 2020, MAYO CLIN PROC, V95, P1621, DOI 10.1016/j.mayocp.2020.05.030; [Anonymous], 2020, NAT COVID 19 TEST TR; [Anonymous], CORONAVIRUS DIS 2019; [Anonymous], CDC COVID DATA TRACK; [Anonymous], 2020, COR DIS 2019 COVID 1; [Anonymous], COVID 19 RESP; Argenziano MG, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1996; Benezit F, 2020, LANCET INFECT DIS, V20, P1014, DOI 10.1016/S1473-3099(20)30297-8; Burke RM, 2020, MMWR-MORBID MORTAL W, V69, P904, DOI 10.15585/mmwr.mm6928a2; Centers for Disease Control and Prevention, PEOPL RISK FLU COMPL; Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2; de Lusignan S, 2020, LANCET INFECT DIS, V20, P1034, DOI 10.1016/S1473-3099(20)30371-6; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Khazanchi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19933; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Lan FY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235460; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270; Munoz-Price LS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.21892; Myers LC, 2020, JAMA-J AM MED ASSOC, V323, P2195, DOI 10.1001/jama.2020.7202; Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.7681]; Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259; Spinato G, 2020, JAMA-J AM MED ASSOC, V323, P2089, DOI 10.1001/jama.2020.6771; Suleyman G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12270; Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P993, DOI [10.15585/mmwr.mm6930e1, 10.15585/mmwr.mm6930e1externalicon]; Tostmann A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.16.2000508; Wang D, 2020, J AEROSPACE ENG, V33, DOI 10.1061/(ASCE)AS.1943-5525.0001149; WHO, WHO COR DIS COVID 19; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Xie YW, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05371-2; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017	37	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0260879	10.1371/journal.pone.0260879	http://dx.doi.org/10.1371/journal.pone.0260879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890441	gold, Green Published			2022-12-26	WOS:000747293600020
J	Casas-Deza, D; Bernal-Monterde, V; Aranda-Alonso, AN; Montil-Miguel, E; Julian-Gomara, AB; Letona-Gimenez, L; Arbones-Mainar, JM				Casas-Deza, Diego; Bernal-Monterde, Vanesa; Nicolas Aranda-Alonso, Angel; Montil-Miguel, Enrique; Belen Julian-Gomara, Ana; Letona-Gimenez, Laura; Arbones-Mainar, Jose M.			Age-related mortality in 61,993 confirmed COVID-19 cases over three epidemic waves in Aragon, Spain. Implications for vaccination programmes	PLOS ONE			English	Article								Background Risk for severe COVID-19 increases with age. Different vaccination strategies are currently being considered, including those aimed at slowing down transmission and those aimed at providing direct protection to those most at risk. Methods The objectives of the current study were i) to assess age-related incidence and survival between PCR-diagnosed COVID-19 cases (n = 61,993) in the Autonomous Community of Aragon from March to November 2020, and ii) to characterize age differences regarding the course of the disease in hospitalized patients in a tertiary university hospital. Results We found a similar incidence of COVID-19 in individuals between 10 and 79 years. Incidence increased in those over 80 years possibly because of the elevated transmission within the nursing homes. We observed a profound disparity among age groups; case fatality rates (CFRs) were near 0 in cases younger than 39 years throughout different waves. In contrast, there was an age-dependent and progressive increase in the CFRs, especially during the first pandemic wave. SARS-CoV-2 infection caused a more severe and rapid progression in older patients. The elderly required faster hospitalization, presented more serious symptoms on admission, and had a worse clinical course. Hospitalized older individuals, even without comorbidities, had an increased mortality risk directly associated with their age. Lastly, the existence of comorbidities dramatically increased the CFRs in the elderly, especially in males. Conclusion The elevated incidence of COVID-19 and the vulnerability of the elderly call for their prioritization in vaccination and targeted prevention measures specifically focused on this aged population.	[Casas-Deza, Diego; Bernal-Monterde, Vanesa; Montil-Miguel, Enrique; Belen Julian-Gomara, Ana] Miguel Servet Univ Hosp, Gastroenterol Dept, Zaragoza, Spain; [Casas-Deza, Diego; Bernal-Monterde, Vanesa; Arbones-Mainar, Jose M.] Inst Invest Sanitaria IIS Aragon, Zaragoza, Spain; [Nicolas Aranda-Alonso, Angel; Letona-Gimenez, Laura] Miguel Servet Univ Hosp, Internal Med Dept, Zaragoza, Spain; [Arbones-Mainar, Jose M.] Miguel Servet Univ Hosp, Inst Aragones Ciencias Salud, Translat Res Unit, Zaragoza, Spain; [Arbones-Mainar, Jose M.] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain	Miguel Servet University Hospital; Miguel Servet University Hospital; Miguel Servet University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Arbones-Mainar, JM (corresponding author), Inst Invest Sanitaria IIS Aragon, Zaragoza, Spain.; Arbones-Mainar, JM (corresponding author), Miguel Servet Univ Hosp, Inst Aragones Ciencias Salud, Translat Res Unit, Zaragoza, Spain.; Arbones-Mainar, JM (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain.	jmarbones.iacs@aragon.es	Casas-Deza, Diego/AAB-3462-2020; Arbones-Mainar, Jose M/AGL-8624-2022	Casas-Deza, Diego/0000-0001-6883-8940; Arbones-Mainar, Jose M/0000-0002-8982-3737; Bernal-Monterde, Vanesa/0000-0002-4016-2165	Instituto de Salud Carlos III [PI17/02268]; Fondo Europeo de Desarrollo Regional (FEDER); DGA Group Biology of adipose tissue and metabolic complications [B03_20R]; FEDER Aragon 2014-2020: "Construyendo Europa desde Aragon''	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); DGA Group Biology of adipose tissue and metabolic complications; FEDER Aragon 2014-2020: "Construyendo Europa desde Aragon''	JMA-M is partially supported by the project PI17/02268 (Instituto de Salud Carlos III and co-financed by Fondo Europeo de Desarrollo Regional (FEDER): "Una manera de hacer Europa") and by the DGA Group Biology of adipose tissue and metabolic complications (B03_20R), cofinanced with the FEDER Arago ' n 2014-2020: "Construyendo Europa desde Arago ' n". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqahtani JS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233147; Amit M, 2020, NAT MED, V26, P1167, DOI 10.1038/s41591-020-0927-z; Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bernal-Monterde V, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8090328; Blagosklonny MV, 2020, AGING-US, V12, P10004, DOI 10.18632/aging.103493; Bonaga B, 2018, J AM MED DIR ASSOC, V19, P46, DOI 10.1016/j.jamda.2017.07.008; Catala-Fortaleza J, 2020, TUTORIAL RX TORAX AC; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen TL, 2020, J GERONTOL A-BIOL, V75, P1788, DOI 10.1093/gerona/glaa089; Covino M, 2020, GERIATR GERONTOL INT, V20, P704, DOI 10.1111/ggi.13960; Deusdad B, 2020, RASP-RES AGEING SOC, V8, P142, DOI 10.4471/rasp.2020.5598; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Du YZ, 2020, AM J RESP CRIT CARE, V201, P1372, DOI 10.1164/rccm.202003-0543OC; Faes C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207560; Haneef R, 2020, ARCH PUBLIC HEALTH, V78, DOI 10.1186/s13690-020-00436-9; Hessami A, 2021, AM J EMERG MED, V46, P382, DOI 10.1016/j.ajem.2020.10.022; Horby PW, 2020, LANCET, V396, P1345, DOI 10.1016/S0140-6736(20)32013-4; Instituto de Salud Carlos III, DAIL MORT SURV SYST; Jarow JP, 2017, JAMA-J AM MED ASSOC, V318, P703, DOI 10.1001/jama.2017.9991; Khinda J, 2021, J MED VIROL, V93, P1078, DOI 10.1002/jmv.26411; Lee JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e223; Levin AT, 2020, EUR J EPIDEMIOL, V35, P1123, DOI 10.1007/s10654-020-00698-1; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nieto Garrido EM, 2021, FREE SECUR JUSTICE E, P197; Niu Shengmei, 2020, Arch Gerontol Geriatr, V89, P104058, DOI 10.1016/j.archger.2020.104058; Oyelade T, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5020080; Palmieri L, 2020, J GERONTOL A-BIOL, V75, P1796, DOI 10.1093/gerona/glaa146; Paneni F, 2017, J AM COLL CARDIOL, V69, P1952, DOI 10.1016/j.jacc.2017.01.064; Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001; Pearce N, 2020, AM J PUBLIC HEALTH, V110, P949, DOI 10.2105/AJPH.2020.305708; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Rajgor DD, 2020, LANCET INFECT DIS, V20, P776, DOI 10.1016/S1473-3099(20)30244-9; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Redondo-Bravo L, 2020, EUROSURVEILLANCE, V25, P15, DOI 10.2807/1560-7917.ES.2020.25.50.2001431; Rees EM, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01726-3; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sinnathamby MA, 2020, EUROSURVEILLANCE, V25, P13, DOI 10.2807/1560-7917.ES.2020.25.28.2001239; Subirana I, 2014, J STAT SOFTW, V57; Sudharsanan N, 2020, ANN INTERN MED, V173, P714, DOI 10.7326/M20-2973; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Trias-Llimos S, 2020, LANCET PUBLIC HEALTH, V5, pE576, DOI 10.1016/S2468-2667(20)30234-6; Wang L, 2020, J INFECTION, V80, P639, DOI 10.1016/j.jinf.2020.03.019; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Woolf SH, 2021, JAMA-J AM MED ASSOC, V325, P123, DOI 10.1001/jama.2020.24865; Wu JT, 2020, NAT MED, V26, P506, DOI 10.1038/s41591-020-0822-7; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	52	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0261061	10.1371/journal.pone.0261061	http://dx.doi.org/10.1371/journal.pone.0261061			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY8LQ	34882740	gold, Green Published			2022-12-26	WOS:000755037200057
J	Chacon, GP; Fathima, P; Jones, M; Barnes, R; Richmond, PC; Gidding, HF; Moore, HC; Snelling, TL				Chacon, Gladymar Perez; Fathima, Parveen; Jones, Mark; Barnes, Rosanne; Richmond, Peter C.; Gidding, Heather F.; Moore, Hannah C.; Snelling, Thomas L.			Pertussis immunisation in infancy and atopic outcomes: A protocol for a population-based cohort study using linked administrative data	PLOS ONE			English	Article							VACCINATION; BIRTH; RISK; ANAPHYLAXIS; DISEASE; ALLERGY; ASTHMA; TIME	Introduction The burden of IgE-mediated food allergy in Australian born children is reported to be among the highest globally. This illness shares risk factors and frequently coexists with asthma, one of the most common noncommunicable diseases of childhood. Findings from a case-control study suggest that compared to immunisation with acellular pertussis vaccine, early priming of infants with whole-cell pertussis vaccine may be associated with a lower risk of subsequent IgE-mediated food allergy. If whole-cell vaccination is protective of food allergy and other atopic diseases, especially if protective against childhood asthma, the population-level effects could justify its preferential recommendation. However, the potential beneficial effects of whole-cell pertussis vaccination for the prevention of atopic diseases at a population-scale are yet to be investigated. Methods and analysis Analyses of population-based record linkage data will be undertaken to compare the rates of admissions to hospital for asthma in children aged between 5 and 15 years old, who were born in Western Australia (WA) or New South Wales (NSW) between 1997 and 1999 (329,831) when pertussis immunisation in Australia transitioned from whole-cell to acellular only schedules. In the primary analysis we will estimate hazard ratios and 95% confidence intervals for the time-to-first-event (hospital admissions as above) using Cox proportional hazard models in recipients of a first dose of whole-cell versus acellular pertussis-containing vaccine before 112 days old (similar to 4 months of age). Similarly, we will also fit time-to-recurrent events analyses using Andersen-Gill models, and robust variance estimates to account for potential within-child dependence. Hospitalisations for all-cause anaphylaxis, food anaphylaxis, venom, all-cause urticaria and atopic dermatitis will also be examined in children who received at least one dose of pertussis-containing vaccine by the time of the cohort entry, using analogous statistical methods. Presentations to the emergency departments will be assessed separately using the same statistical approach.	[Chacon, Gladymar Perez; Fathima, Parveen; Barnes, Rosanne; Richmond, Peter C.; Moore, Hannah C.; Snelling, Thomas L.] Univ Western Australia, Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Perth, WA, Australia; [Chacon, Gladymar Perez; Moore, Hannah C.; Snelling, Thomas L.] Curtin Univ, Curtin Sch Populat Hlth, Fac Hlth Sci, Bentley, WA, Australia; [Jones, Mark; Snelling, Thomas L.] Univ Sydney, Sydney Sch Publ Hlth, Fac Med & Hlth, Hlth & Clin Analyt Lab, Sydney, NSW, Australia; [Richmond, Peter C.] Univ Western Australia, Div Paediat, Perth, WA, Australia; [Gidding, Heather F.] Univ Sydney, Northern Clin Sch, Sydney, NSW, Australia; [Gidding, Heather F.] Northern Sydney Local Hlth Dist, Kolling Inst, Women & Babies Hlth Res, Sydney, NSW, Australia; [Gidding, Heather F.] Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Sydney, NSW, Australia	Telethon Kids Institute; University of Western Australia; Wesfarmers Limited; Curtin University; University of Sydney; University of Western Australia; University of Sydney; University of Sydney; Kolling Institute of Medical Research; University of Sydney	Snelling, TL (corresponding author), Univ Western Australia, Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Perth, WA, Australia.; Snelling, TL (corresponding author), Curtin Univ, Curtin Sch Populat Hlth, Fac Hlth Sci, Bentley, WA, Australia.; Snelling, TL (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Fac Med & Hlth, Hlth & Clin Analyt Lab, Sydney, NSW, Australia.	tom.snelling@sydney.edu.au	Moore, Hannah/AHH-1092-2022	Moore, Hannah/0000-0001-6434-8290; Snelling, Thomas/0000-0003-4670-0638; Richmond, Peter/0000-0001-7562-7228	Population Health Research Network Proof of Concept Project, a capability of the Commonwealth Government Collaborative Research Infrastructure Strategy and Education Investment Fund Super Science Initiative; Australian National Health and Medical Research Council (NHMRC) [GNT1082342]; Wesfarmers Centre of Vaccines and Infectious Diseases seed funding grant; Australian National Health and Medical Research Council fellowships; Medical Research Future Fund Investigator Grant [MRF1195153]; Australian Department of Education and Training Endeavour Scholarship; Wesfarmers Centre of Vaccine and Infectious Diseases at the Telethon Kids Institute; Forrest Research Foundation supplementary scholarship	Population Health Research Network Proof of Concept Project, a capability of the Commonwealth Government Collaborative Research Infrastructure Strategy and Education Investment Fund Super Science Initiative; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Wesfarmers Centre of Vaccines and Infectious Diseases seed funding grant; Australian National Health and Medical Research Council fellowships(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Future Fund Investigator Grant(Medical Research Future Fund (MRFF)); Australian Department of Education and Training Endeavour Scholarship; Wesfarmers Centre of Vaccine and Infectious Diseases at the Telethon Kids Institute; Forrest Research Foundation supplementary scholarship	This study was funded by the Population Health Research Network Proof of Concept Project (www.phrn.org.au/), a capability of the Commonwealth Government Collaborative Research Infrastructure Strategy and Education Investment Fund Super Science Initiative, the Australian National Health and Medical Research Council (NHMRC project grant GNT1082342, chief investigator HFG; www.nhmrc.gov.au/) and the Wesfarmers Centre of Vaccines and Infectious Diseases seed funding grant (round 1 - 2018, GPC, HCM, HFG, TLS; infectiousdiseases.telethonkids. org.au/). HFG and HCM are funded by the Australian National Health and Medical Research Council fellowships (www.nhmrc.gov.au/).TS is supported by a Medical Research Future Fund Investigator Grant (MRF1195153; www.health.gov.au/initiatives-and-programs/medical-researchfuture-fund).GPC is funded by the Australian Department of Education and Training Endeavour Scholarship (www.dese.gov.au/endeavourleadership-program), Wesfarmers Centre of Vaccine and Infectious Diseases at the Telethon Kids Institute, top-up scholarship (infectiousdiseases.telethonkids.org.au/), and Forrest Research Foundation supplementary scholarship (https://www.forrestresearch.org.au/).The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirthalingam G, 2013, EUROSURVEILLANCE, V18, P19, DOI 10.2807/1560-7917.ES2013.18.38.20587; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Australian Bureau of Statistics, 2020, 2016 CENS QUICKSTATS; Australian Institute of Health and Welfare, 2020, ASTHM WEB PAG DAT TA; Australian Institute of Health and Welfare, 2013, ASTHM HOSP AUSTR 201; Barnes R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025360; BayesFusion, 2021, GENIE MOD COMP PROGR; CHERRY J D, 1988, Pediatrics, V81, P939; Christensen D, 2014, AUST J SOC ISSUES, V49, P423, DOI 10.1002/j.1839-4655.2014.tb00322.x; Commonwealth Department of Health and Aged Care, 2001, OCCASIONAL PAPERS NE, V14; Conrado AB, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n251; COX DR, 1972, J R STAT SOC B, V34, P187; Estcourt MJ, 2020, J ALLER CL IMM-PRACT, V8, P2004, DOI 10.1016/j.jaip.2019.12.020; Estcourt MJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020232; Gehrt L, 2021, J ALLER CL IMM-PRACT, V9, P1520, DOI 10.1016/j.jaip.2020.09.024; Gidding H F, 2017, Int J Popul Data Sci, V2, P406, DOI 10.23889/ijpds.v2i1.406; Hernan M., 2020, CAUSAL INFERENCE WHA; Herve C, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0132-6; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Hull BP, 2003, AUST NZ J PUBL HEAL, V27, P533, DOI 10.1111/j.1467-842X.2003.tb00829.x; Ierodiakonou D, 2016, JAMA-J AM MED ASSOC, V316, P1181, DOI 10.1001/jama.2016.12623; Karmaus W, 2002, J EPIDEMIOL COMMUN H, V56, P209, DOI 10.1136/jech.56.3.209; Karmaus W, 2001, AM J EPIDEMIOL, V154, P909, DOI 10.1093/aje/154.10.909; Khoo SK, 2019, J IMMUNOL, V202, P1845, DOI 10.4049/jimmunol.1800178; Kiraly N, 2016, ALLERGY, V71, P541, DOI 10.1111/all.12830; Kiraly N, 2013, ALLERGY, V68, P1168, DOI 10.1111/all.12216; McDonald KL, 2008, J ALLERGY CLIN IMMUN, V121, P626, DOI 10.1016/j.jaci.2007.11.034; McIntyre P, 1998, Commun Dis Intell, V22, P125; McKeever TM, 2004, AM J PUBLIC HEALTH, V94, P985, DOI 10.2105/AJPH.94.6.985; Moore HC, 2016, AUST NZ J PUBL HEAL, V40, P159, DOI 10.1111/1753-6405.12481; Mullins RJ, 2015, J ALLERGY CLIN IMMUN, V136, P367, DOI 10.1016/j.jaci.2015.05.009; Nilsson L, 1998, ARCH PEDIAT ADOL MED, V152, P734; Pavord ID, 2018, LANCET, V391, P350, DOI 10.1016/S0140-6736(17)30879-6; Chacon GP, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-042838; Pink B., 2008, INTRO SOCIO EC INDEX; R Core Team, 2020, R LANG ENV STAT COMP; Reddel HK., 2013, ASTHMA CONTROL AUSTR; Roberts RF, 1998, MED J AUSTRALIA, V169, pS32, DOI 10.5694/j.1326-5377.1998.tb123473.x; Rueter K, 2017, J ALLER CL IMM-PRACT, V5, P858, DOI 10.1016/j.jaip.2016.10.017; SATO Y, 1984, LANCET, V1, P122; Schuler MS, 2017, AM J EPIDEMIOL, V185, P65, DOI 10.1093/aje/kww165; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Toelle BG, 2020, PEDIAT ALLERG IMM-UK, V31, P857, DOI 10.1111/pai.13300; Tuttle KL, 2020, ANN ALLERG ASTHMA IM, V124, P150, DOI 10.1016/j.anai.2019.11.026; Utazi CE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09611-1; VanderWeele TJ, 2019, EUR J EPIDEMIOL, V34, pCP3, DOI 10.1007/s10654-019-00494-6; Venter C, 2016, J ALLER CL IMM-PRACT, V4, P1248, DOI 10.1016/j.jaip.2016.06.005; Voort AMMSVD, 2014, J ALLERGY CLIN IMMUN, V133, P1317, DOI 10.1016/j.jaci.2013.12.1082; Wolsk HM, 2016, ALLERGY, V71, P820, DOI 10.1111/all.12847; Yeung KHT, 2017, LANCET INFECT DIS, V17, P974, DOI 10.1016/S1473-3099(17)30390-0; Zubrick S., 2004, W AUSTR ABORIGINAL C	52	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260388	10.1371/journal.pone.0260388	http://dx.doi.org/10.1371/journal.pone.0260388			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874968	Green Published, gold			2022-12-26	WOS:000753617500022
J	Koester, A; Ford, AK; Ferse, SCA; Migani, V; Bunbury, N; Sanchez, C; Wild, C				Koester, Anna; Ford, Amanda K.; Ferse, Sebastian C. A.; Migani, Valentina; Bunbury, Nancy; Sanchez, Cheryl; Wild, Christian			First insights into coral recruit and juvenile abundances at remote Aldabra Atoll, Seychelles	PLOS ONE			English	Article							LIFE-HISTORY STRATEGIES; GREAT-BARRIER-REEF; SCLERACTINIAN CORAL; FRENCH-POLYNESIA; PATTERNS; RECOVERY; DISPERSAL; MORTALITY; CONNECTIVITY; ARCHIPELAGO	Coral recruitment and successive growth are essential for post-disturbance reef recovery. As coral recruit and juvenile abundances vary across locations and under different environmental regimes, their assessment at remote, undisturbed reefs improves our understanding of early life stage dynamics of corals. Here, we first explored changes in coral juvenile abundance across three locations (lagoon, seaward west and east) at remote Aldabra Atoll (Seychelles) between 2015 and 2019, which spanned the 2015/16 global coral bleaching event. Secondly, we measured variation in coral recruit abundance on settlement tiles from two sites (lagoon, seaward reef) during August 2018-August 2019. Juvenile abundance decreased from 14.1 +/- 1.2 to 7.4 +/- 0.5 colonies m(-2) (mean +/- SE) during 2015-2016 and increased to 22.4 +/- 1.2 colonies m(-2) during 2016-2019. Whilst juvenile abundance increased two- to three-fold at the lagoonal and seaward western sites during 2016-2018 (from 7.7-8.3 to 17.3-24.7 colonies m(-2)), increases at the seaward eastern sites occurred later (2018-2019; from 5.8-6.9 to 16.6-24.1 colonies m(-2)). The composition of coral recruits on settlement tiles was dominated by Pocilloporidae (64-92% of all recruits), and recruit abundance was 7- to 47-fold higher inside than outside the lagoon. Recruit abundance was highest in October-December 2018 (2164 +/- 453 recruits m(-2)) and lowest in June-August 2019 (240 +/- 98 recruits m(-2)). As Acroporid recruit abundance corresponded to this trend, the results suggest that broadcast spawning occurred during October-December, when water temperature increased from 26 to 29 degrees C. This study provides the first published record on coral recruit abundance in the Seychelles Outer Islands, indicates a rapid (2-3 years) increase of juvenile corals following a bleaching event, and provides crucial baseline data for future research on reef resilience and connectivity within the region.	[Koester, Anna; Ferse, Sebastian C. A.; Wild, Christian] Univ Bremen, Fac Biol Chem, Marine Ecol Dept, Bremen, Germany; [Koester, Anna; Bunbury, Nancy; Sanchez, Cheryl] Seychelles Isl Fdn, Victoria, Mahe, Seychelles; [Ford, Amanda K.] Univ South Pacific, Sch Agr Geog Environm Ocean & Nat Sci, Suva, Fiji; [Ferse, Sebastian C. A.] Leibniz Ctr Trop Marine Res, Bremen, Germany; [Migani, Valentina] Univ Bremen, Inst Ecol, Fac Biol & Chem, Bremen, Germany; [Bunbury, Nancy] Univ Exeter, Ctr Ecol & Conservat, Cornwall Campus, Penryn, Cornwall, England; [Sanchez, Cheryl] Univ Pisa, Dept Biol, Pisa, Italy	University of Bremen; University of the South Pacific; Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen; University of Exeter; University of Pisa	Koester, A (corresponding author), Univ Bremen, Fac Biol Chem, Marine Ecol Dept, Bremen, Germany.; Koester, A (corresponding author), Seychelles Isl Fdn, Victoria, Mahe, Seychelles.	a.koester@mail.de		Koester, Anna/0000-0003-0183-4907; Ferse, Sebastian/0000-0003-0930-5356	Global Environment Facility	Global Environment Facility	We thank all former and current staff of the Seychelles Islands Foundation (SIF) for their work and support. Specifically, we thank Jude Brice, April J Burt, Karen Chong-Seng, Marvin Roseline, Joel Bonne, Shane Brice, Ella Nancy, Leeroy Estrale, Ronny Marie, Jake Letori, Lorraine Cook, Jilani Suleman, Germano Soru, Diane Ernesta and Luke A'Bear for data collection and support in the field. A special thanks also goes to Jessica Constance for the analysis of settlement tiles. We further thank the Global Environment Facility for supporting the development of the Aldabra Reef Monitoring programme. Thanks also go to Philip Haupt, Anthony Bernard and Nick Riddin from the South African Institute for Aquatic Biodiversity and SIF staff for establishing the permanent transects.	Adjeroud M, 2007, J EXP MAR BIOL ECOL, V341, P204, DOI 10.1016/j.jembe.2006.10.048; Adjeroud M, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11020021; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Ayre DJ, 2004, MAR ECOL PROG SER, V277, P95, DOI 10.3354/meps277095; Babcock RC, 2003, ZOOL STUD, V42, P211; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Cerutti JMB, 2020, CORAL REEFS, V39, P15, DOI 10.1007/s00338-019-01853-1; Chong-Seng KM, 2014, CORAL REEFS, V33, P449, DOI 10.1007/s00338-014-1137-2; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; Combosch DJ, 2013, ECOL EVOL, V3, P3379, DOI 10.1002/ece3.721; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Crochelet E, 2016, REG STUD MAR SCI, V7, P159, DOI 10.1016/j.rsma.2016.06.007; Dajka JC, 2019, CORAL REEFS, V38, P637, DOI 10.1007/s00338-019-01785-w; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; Dietzel A, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.1432; Doropoulos C, 2016, ECOL MONOGR, V86, P20, DOI 10.1890/15-0668.1; Doropoulos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128535; Doropoulos C, 2012, ECOLOGY, V93, P2131, DOI 10.1890/12-0495.1; Drew E. A., 1977, Atoll Res Bull, VNo. 193, P1; Dunstan PK, 1998, CORAL REEFS, V17, P71, DOI 10.1007/s003380050098; Edmunds PJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185167; Edmunds PJ, 2000, MAR ECOL PROG SER, V202, P113, DOI 10.3354/meps202113; Elmhirst T, 2009, CORAL REEFS, V28, P949, DOI 10.1007/s00338-009-0530-8; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Fadlallah Y.H., 1983, Coral Reefs, V2, P129, DOI 10.1007/BF00336720; FARROW GE, 1971, PHILOS T ROY SOC B, V260, P93, DOI 10.1098/rstb.1971.0008; Ferse SCA, 2013, RESTOR ECOL, V21, P745, DOI 10.1111/rec.12004; FISK DA, 1990, MAR BIOL, V107, P485, DOI 10.1007/BF01313433; Ford AK, 2018, ECOL INDIC, V85, P308, DOI 10.1016/j.ecolind.2017.10.002; Foster T., 2018, MATTERS, P1, DOI [10.19185/matters.201807000008, DOI 10.19185/MATTERS.201807000008]; Foster T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03175-2; Gamoyo M, 2019, J GEOPHYS RES-BIOGEO, V124, P2446, DOI 10.1029/2019JG005128; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Glassom D, 2006, MAR ECOL PROG SER, V318, P111, DOI 10.3354/meps318111; Glassom D, 2004, MAR BIOL, V144, P641, DOI 10.1007/s00227-003-1243-0; Gouezo M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59111-2; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Hamylton Sarah, 2018, Atoll Research Bulletin, P45; Harrison P.L., 1990, P133; Hartig F., 2022, DHARMA RESIDUAL DIAG; Hata T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02402-y; Heron SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep38402; Heywood KJ, 1996, DEEP-SEA RES PT I, V43, P555, DOI 10.1016/0967-0637(96)00097-0; Hughes TP, 2019, NATURE, V568, P387, DOI 10.1038/s41586-019-1081-y; Hughes TP, 2018, NATURE, V556, P492, DOI 10.1038/s41586-018-0041-2; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Johns KA, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2349; Johnston EC, 2020, FUNCT ECOL, V34, P2315, DOI 10.1111/1365-2435.13653; Jouval F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214163; Keith SA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0011; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Koester A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74077-x; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Levitan DR., 2014, MAR ECOL PROG SER, DOI [10.3354/meps10820 27239082, DOI 10.3354/MEPS1082027239082]; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Mangubhai S, 2008, MAR ECOL PROG SER, V360, P85, DOI 10.3354/meps07385; Mangubhai S, 2007, MAR ECOL PROG SER, V348, P149, DOI 10.3354/meps07090; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2014, CORAL REEFS, V33, P939, DOI 10.1007/s00338-014-1178-6; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McWilliam M, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2019.2628; Mumby P., 2013, CORAL REEFS, DOI [10.1007/s00338-012-0947-3 24443641, DOI 10.1007/S00338-012-0947-324443641]; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nugues MM, 2006, CORAL REEFS, V25, P585, DOI 10.1007/s00338-006-0147-0; Onset Computer Corporation, 2012, HOBO WAT TEMP PRO V2; Penin L, 2007, B MAR SCI, V80, P379; Penin L, 2013, MAR ECOL PROG SER, V473, P149, DOI 10.3354/meps10101; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Perez K, 2014, PEERJ, V2, DOI 10.7717/peerj.387; Perry CT, 2017, CORAL REEFS, V36, P1189, DOI 10.1007/s00338-017-1610-9; Pratchett MS, 2020, CORAL REEFS, V39, P783, DOI 10.1007/s00338-020-01936-4; PUGH DT, 1981, ESTUAR COAST SHELF S, V13, P389, DOI 10.1016/S0302-3524(81)80036-9; R Core Team, R LANGUAGE ENV STAT; Richmond Robert H., 1997, P175; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Sawall Y, 2013, MAR POLLUT BULL, V74, P374, DOI 10.1016/j.marpolbul.2013.06.022; Sola E, 2015, AFR J MAR SCI, V37, P557, DOI 10.2989/1814232X.2015.1113201; Stobart Ben, 2002, P232; Swearer SE, 2002, B MAR SCI, V70, P251; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; TAYLOR JD, 1971, PHILOS T ROY SOC B, V260, P173, DOI 10.1098/rstb.1971.0010; Tioho H, 2001, MAR ECOL PROG SER, V213, P79, DOI 10.3354/meps213079; Trapon ML, 2013, MAR ECOL PROG SER, V488, P157, DOI 10.3354/meps10389; Ward S., 2002, P1123; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson SK, 2019, CORAL REEFS, V38, P625, DOI 10.1007/s00338-019-01818-4; WoRMS Editorial Board, WORLD REGISTER MARIN; Yadav S, 2018, CORAL REEFS, V37, P1245, DOI 10.1007/s00338-018-1735-5	97	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260516	10.1371/journal.pone.0260516	http://dx.doi.org/10.1371/journal.pone.0260516			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874982	Green Published, gold			2022-12-26	WOS:000753617500028
J	Panatto, D; Orsi, A; Pennati, BM; Lai, PL; Mosca, S; Bruzzone, B; Caligiuri, P; Napoli, C; Bertamino, E; Orsi, GB; Manini, I; Loconsole, D; Centrone, F; Pandolfi, E; Ciofi Degli Atti, ML; Concato, C; Linardos, G; Onetti Muda, A; Raponi, M; Piccioni, L; Rizzo, C; Chironna, M; Icardi, G				Panatto, Donatella; Orsi, Andrea; Pennati, Beatrice Marina; Lai, Piero Luigi; Mosca, Stefano; Bruzzone, Bianca; Caligiuri, Patrizia; Napoli, Christian; Bertamino, Enrico; Orsi, Giovanni Battista; Manini, Ilaria; Loconsole, Daniela; Centrone, Francesca; Pandolfi, Elisabetta; Ciofi Degli Atti, Marta Luisa; Concato, Carlo; Linardos, Giulia; Onetti Muda, Andrea; Raponi, Massimiliano; Piccioni, Livia; Rizzo, Caterina; Chironna, Maria; Icardi, Giancarlo			No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020	PLOS ONE			English	Article								Background On 9th January 2020, China CDC reported a novel coronavirus (later named SARS-CoV-2) as the causative agent of the coronavirus disease 2019 (COVID-19). Identifying the first appearance of virus is of epidemiological importance to tracking and mapping the spread of SARS-CoV-2 in a country. We therefore conducted a retrospective observational study to detect SARS-CoV-2 in oropharyngeal samples collected from hospitalized patients with a Severe Acute Respiratory Infection (SARI) enrolled in the DRIVE (Development of Robust and Innovative Vaccine Effectiveness) study in five Italian hospitals (CIRI-IT BIVE hospitals network) (1st November 2019 - 29th February 2020). Objectives To acquire new information on the real trend in SARS-CoV-2 infection during pandemic phase I and to determine the possible early appearance of the virus in Italy. Materials and methods Samples were tested for influenza [RT-PCR assay (A/H1N1, A/H3N2, B/Yam, B/Vic)] in accordance with the DRIVE study protocol. Subsequently, swabs underwent molecular testing for SARS-COV-2. [one-step real-time multiplex retro-transcription (RT) PCR]. Results In the 1683 samples collected, no evidence of SARS-CoV-2 was found. Moreover, 28.3% (477/1683) of swabs were positive for influenza viruses, the majority being type A (358 vs 119 type B). A/H3N2 was predominant among influenza A viruses (55%); among influenza B viruses, B/Victoria was prevalent. The highest influenza incidence rate was reported in patients aged 0-17 years (40.3%) followed by those aged 18-64 years (24.4%) and >= 65 years (14.8%). Conclusions In Italy, some studies have shown the early circulation of SARS-CoV-2 in northern regions, those most severely affected during phase I of the pandemic. In central and southern regions, by contrast no early circulation of the virus was registered. These results are in line with ours. These findings highlight the need to continue to carry out retrospective studies, in order to understand the epidemiology of the novel coronavirus, to better identify the clinical characteristics of COVID-19 in comparison with other acute respiratory illnesses (ARI), and to evaluate the real burden of COVID-19 on the healthcare system.	[Panatto, Donatella; Orsi, Andrea; Pennati, Beatrice Marina; Lai, Piero Luigi; Mosca, Stefano; Manini, Ilaria; Icardi, Giancarlo] Interuniv Res Ctr Influenza & Other Transmissible, Genoa, Italy; [Panatto, Donatella; Orsi, Andrea; Lai, Piero Luigi; Icardi, Giancarlo] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Orsi, Andrea; Bruzzone, Bianca; Caligiuri, Patrizia; Icardi, Giancarlo] Policlin San Martino Hosp, Genoa, Italy; [Napoli, Christian] Univ Sapienza, Dept Med Surg Sci & Translat Med, Rome, Italy; [Bertamino, Enrico] Univ Sapienza, SantAndrea Hosp, Rome, Italy; [Orsi, Giovanni Battista] Univ Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy; [Manini, Ilaria] Univ Siena, Dept Mol & Dev Med, Siena, Italy; [Loconsole, Daniela; Centrone, Francesca; Chironna, Maria] Univ Bari, Hyg Sect, Dept Biomed Sci & Human Oncol, Bari, Italy; [Pandolfi, Elisabetta; Ciofi Degli Atti, Marta Luisa; Concato, Carlo; Linardos, Giulia; Onetti Muda, Andrea; Raponi, Massimiliano; Piccioni, Livia; Rizzo, Caterina] Bambino Gesu Pediat Hosp, Rome, Italy	University of Genoa; Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; University of Siena; Universita degli Studi di Bari Aldo Moro; IRCCS Bambino Gesu	Panatto, D (corresponding author), Interuniv Res Ctr Influenza & Other Transmissible, Genoa, Italy.; Panatto, D (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.	panatto@unige.it	degli Atti, Marta Ciofi/K-4650-2018; Onetti Muda, Andrea/G-5384-2012; napoli, christian/B-9924-2018; napoli, christian/H-1862-2012	degli Atti, Marta Ciofi/0000-0001-6492-4497; Onetti Muda, Andrea/0000-0002-0274-6178; napoli, christian/0000-0002-5775-2276; napoli, christian/0000-0002-5775-2276; Panatto, Donatella/0000-0002-2677-0551; Loconsole, Daniela/0000-0003-2057-9745; Orsi, Andrea/0000-0002-2433-9610; chironna, maria/0000-0002-1043-1256				Amendola A, 2021, EMERG INFECT DIS, V27, P648, DOI 10.3201/eid2702.204632; Apolone G, 2021, TUMORI J, V107, P446, DOI 10.1177/0300891620974755; Bar-Or I., REGRESSING SARS COV; Calderaro A, 2021, INT J INFECT DIS, V102, P79, DOI 10.1016/j.ijid.2020.09.1473; Capalbo C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228461; Centers for Disease Control and Prevention, 2020, CORONAVIRUS DIS 2019; Deslandes A, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.106006; Epicentro Istituto Superiore di Sanita Italy, COVID 19 INT SURV DA; Epicentro Istituto Superiore di Sanita Italy. FluNews-Italia, RAPP SORV INT INFL; Faury H, 2021, J INFECTION, V82, pE36, DOI 10.1016/j.jinf.2020.08.017; Giovanetti M, 2020, J MED VIROL, V92, P518, DOI 10.1002/jmv.25699; La Rosa G, 2021, SCI TOTAL ENVIRON, V750, DOI 10.1016/j.scitotenv.2020.141711; Lescure FX., 2020, LANCET INFECT DIS, V20, P697; Tomb RM, 2020, J INFECTION, V81, P476, DOI 10.1016/j.jinf.2020.06.022; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang X, 2020, INT J INFECT DIS, V94, P107, DOI 10.1016/j.ijid.2020.04.023; WHO, WHO ANN COVID 19 OUT; WHO Global Influenza Surveillance Network, MAN LAB DIAGN VIR SU; Wuhan City Health Committee (WCHC), WUH MUN HLTH HLTH CO	19	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260947	10.1371/journal.pone.0260947	http://dx.doi.org/10.1371/journal.pone.0260947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874956	Green Published, gold			2022-12-26	WOS:000753617500041
J	Arreyndip, NA				Arreyndip, Nkongho Ayuketang			Identifying agricultural disaster risk zones for future climate actions	PLOS ONE			English	Article							HEAT-STRESS; WEATHER; WAVES	Identifying agricultural disaster risk regions before the occurrence of climate-related disasters is critical for early mitigation planning. This paper aims to identify these regions based on data from the Food and Agriculture Organization of the United Nations (FAO), the bilateral and multilateral trade network data of the World Integrated Trade Solution(WITS) and the agent-based economic model Acclimate. By applying a uniform forcing across agricultural sectors of some breadbasket regions (US, EU and China), when single and simultaneous extreme weather events occur, such as the 2018 European heatwave, production and consumption value losses and gains are calculated at regional and global levels. Comparing the FAO data sets, WITS, and Acclimate's production value losses, the results show a strong dependence of agricultural production losses on a region's output and connectivity level in the global supply and trade network. While India, Brazil, Russia, Canada, Australia, and Iran are highly vulnerable, the imposition of export restrictions to compensate for demand shortfalls makes Sub-Saharan Africa the most vulnerable region, as it is heavily dependent on agricultural imports. In addition, simultaneous extreme weather events can exacerbate the loss of value of agricultural production relative to single extreme weather events. Agricultural practices to increase production such as smart farming, increased investment in plantation agriculture, and diversification of trading partners can help mitigate future food security risks in Sub-Saharan Africa and other agricultural import-dependent regions.	[Arreyndip, Nkongho Ayuketang] Univ Buea, Dept Elect & Elect Engn, Buea, Cameroon		Arreyndip, NA (corresponding author), Univ Buea, Dept Elect & Elect Engn, Buea, Cameroon.	ayuketang@aims-cameroon.org	Arreyndip, Nkongho Ayuketang/AAV-2025-2020; Arreyndip, Nkongho Ayuketang/B-2526-2015	Arreyndip, Nkongho Ayuketang/0000-0002-5316-4063	Alexander von Humbold Foundation	Alexander von Humbold Foundation(Alexander von Humboldt Foundation)	The author will like to thank the Alexander von Humbold Foundation for the financial support in the form of a stipend for the International Climate Protection Fellowship 2020. The author will also want to thank the members of the Department of Complexity Sciences of the Potsdam Institute for Climate Impact research (PIK) in Potsdam, Germany for their immense material support during the time spent there.	Burkholz R, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab4864; Church JA, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1137; Colijn, 2016, N SEA REGION CLIMATE, DOI 10.1007/978-3-319-39745-013; Connors JPC, 2021, AGR LOSSES TELECOUPL, DOI [10.1002/9781119413738.ch5, DOI 10.1002/9781119413738.CH5]; Coumou D, 2014, P NATL ACAD SCI USA, V111, P12331, DOI 10.1073/pnas.1412797111; d'Amour CB, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/035007; Deng KQ, 2018, GEOPHYS RES LETT, V45, P11361, DOI 10.1029/2018GL079836; Field C.B., 2014, CLIM CHANG 2014 IMP, P1, DOI [DOI 10.1038/446727A, 10.1017/CBO9781107415379]; Gillett NP, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050226; Jochen H., 2013, IPCC SR OCEAN CRYOSP; Jones GS, 2013, J GEOPHYS RES-ATMOS, V118, P4001, DOI 10.1002/jgrd.50239; Jordan ER, 2003, J DAIRY SCI, V86, pE104, DOI 10.3168/jds.S0022-0302(03)74043-0; Kornhuber K, 2017, CLIM DYNAM, V49, P1961, DOI 10.1007/s00382-016-3399-6; Kornhuber K, 2020, NAT CLIM CHANGE, V10, P48, DOI 10.1038/s41558-019-0637-z; Kornhuber K, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab13bf; Kuhla K, 2020, EGU GEN ASSEMBLY, P2020, DOI [10.5194/egusphere-egu2020-11387, DOI 10.5194/EGUSPHERE-EGU2020-11387]; Kuhla K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251210; Lau WKM, 2012, J HYDROMETEOROL, V13, P392, DOI 10.1175/JHM-D-11-016.1; Lehmann J, 2015, CLIMATIC CHANGE, V132, P501, DOI 10.1007/s10584-015-1434-y; Liu Y, 2020, EARTHS FUTURE, V8, DOI 10.1029/2020EF001617; Moore FC, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6eb2; Otto C, 2017, J ECON DYN CONTROL, V83, P232, DOI 10.1016/j.jedc.2017.08.001; Parker L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213641; Petoukhov V, 2013, P NATL ACAD SCI USA, V110, P5336, DOI 10.1073/pnas.1222000110; Porfirio LL, 2018, PALGR COMMUN, V4, DOI 10.1057/s41599-018-0164-y; Puma MJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/024007; Saeed S, 2014, CLIM DYNAM, V43, P503, DOI 10.1007/s00382-013-1871-0; SAHAGIAN DL, 1994, NATURE, V367, P54, DOI 10.1038/367054a0; Sarhadi A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau3487; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Schaub S, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab68ab; Stevanovic M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501452; Vogel E, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab154b; Weis SWM, 2016, CLIMATIC CHANGE, V136, P615, DOI 10.1007/s10584-016-1642-0; Wenz L, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501026; West JW, 2003, J DAIRY SCI, V86, P2131, DOI 10.3168/jds.S0022-0302(03)73803-X; Wigley TML, 2013, CLIM DYNAM, V40, P1087, DOI 10.1007/s00382-012-1585-8; Willner SN, 2018, NAT CLIM CHANGE, V8, P594, DOI 10.1038/s41558-018-0173-2; Zscheischler J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700263	40	0	0	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260430	10.1371/journal.pone.0260430	http://dx.doi.org/10.1371/journal.pone.0260430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855827	Green Published, gold			2022-12-26	WOS:000735299000057
J	de Oliveira, EP; Rovida, AFD; Martins, JG; Pileggi, SAV; Schemczssen-Graeff, Z; Pileggi, M				de Oliveira, Elizangela Paz; da Silva Rovida, Amanda Flavia; Martins, Juliane Gabriele; Veiga Pileggi, Sonia Alvim; Schemczssen-Graeff, Zelinda; Pileggi, Marcos			Tolerance of Pseudomonas strain to the 2,4-D herbicide through a peroxidase system	PLOS ONE			English	Article							2,4-DICHLOROPHENOXYACETIC ACID; SUPEROXIDE-DISMUTASE; ANTIOXIDANT ENZYMES; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; DEFICIENT MUTANT; CATALASE; PESTICIDES; TOXICITY; GENES	Herbicides are widely used in agricultural practices for preventing the proliferation of weeds. Upon reaching soil and water, herbicides can harm nontarget organisms, such as bacteria, which need an efficient defense mechanism to tolerate stress induced by herbicides. 2,4-Dichlorophenoxyacetic acid (2,4-D) is a herbicide that exerts increased oxidative stress among bacterial communities. Bacterial isolates were obtained from the biofilm of tanks containing washing water from the packaging of different pesticides, including 2,4-D. The Pseudomonas sp. CMA-7.3 was selected because of its tolerance against 2,4-D toxicity, among several sensitive isolates from the biofilm collection. This study aimed to evaluate the antioxidative response system of the selected strain to 2,4-D. It was analyzed the activity of superoxide dismutase (SOD), catalase (CAT), ascorbate peroxidase (APX), and guaiacol peroxidase GPX enzymes, that are poorly known in the literature for bacterial systems. The Pseudomonas sp. CMA-7.3 presented an efficient response system in balancing the production of hydrogen peroxide, even at 25x the dose of 2,4-D used in agriculture. The antioxidative system was composed of Fe-SOD enzymes, less common than Mn-SOD in bacteria, and through the activities of KatA and KatB isoforms, working together with APX and GPX, having their activities coordinated possibly by quorum sensing molecules. The peroxide control is poorly documented for bacteria, and this work is unprecedented for Pseudomonas and 2,4-D. Not all bacteria harbor efficient response system to herbicides, therefore they could affect the diversity and functionality of microbiome in contaminated soils, thereby impacting agricultural production, environment sustainability and human health.	[de Oliveira, Elizangela Paz; da Silva Rovida, Amanda Flavia] Univ Estadual Maringa, Dept Biotecnol Genet & Biol Celular, Maringa, Parana, Brazil; [Martins, Juliane Gabriele; Veiga Pileggi, Sonia Alvim; Pileggi, Marcos] Univ Estadual Ponta Grossa, Dept Biol Estrutural & Mol & Genet, Lab Microbiol Ambiental, Setor Ciencias Biol & Saude, Ponta Grossa, Parana, Brazil; [Schemczssen-Graeff, Zelinda] Univ Fed Parana, Dept Biol Celular, Curitiba, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Ponta Grossa; Universidade Federal do Parana	Pileggi, M (corresponding author), Univ Estadual Ponta Grossa, Dept Biol Estrutural & Mol & Genet, Lab Microbiol Ambiental, Setor Ciencias Biol & Saude, Ponta Grossa, Parana, Brazil.	mpileggi@uepg.br	Pileggi, Marcos/B-8651-2012	Pileggi, Marcos/0000-0003-1633-8295; Schemczssen-Graeff, Zelinda/0000-0001-5859-1171				Aguiar LM, 2020, INT J PHYTOREMEDIAT, V22, P69, DOI 10.1080/15226514.2019.1644289; Al-Amri I, 2021, VET WORLD, V14, P709, DOI 10.14202/vetworld.2021.709-720; Azevedo RA, 1998, PHYSIOL PLANTARUM, V104, P280, DOI 10.1034/j.1399-3054.1998.1040217.x; Beffa R, 2019, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 3RD EDITION, P5; Bhat SV, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00044; Bianchi E, 2017, ARCH ENVIRON CON TOX, V72, P321, DOI 10.1007/s00244-016-0334-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN SM, 1995, J BACTERIOL, V177, P6536, DOI 10.1128/jb.177.22.6536-6544.1995; Bukowska B, 2006, POL J ENVIRON STUD, V15, P365; Rovida AFD, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.673211; Dobrzanski T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196166; Dourado MN, 2015, ENVIRON SCI POLLUT R, V22, P19922, DOI 10.1007/s11356-015-5204-1; Ermakova IT, 2010, APPL MICROBIOL BIOT, V88, P585, DOI 10.1007/s00253-010-2775-0; Freitas PNN, 2021, ENVIRON POLLUT, V289, DOI 10.1016/j.envpol.2021.117896; Gaschler MM, 2017, BIOCHEM BIOPH RES CO, V482, P419, DOI 10.1016/j.bbrc.2016.10.086; Gravina F, 2017, ECOTOX ENVIRON SAFE, V139, P89, DOI 10.1016/j.ecoenv.2017.01.027; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Islam F, 2018, ENVIRON INT, V111, P332, DOI 10.1016/j.envint.2017.10.020; Jung IL, 2003, BIOCHEM BIOPH RES CO, V301, P915, DOI 10.1016/S0006-291X(03)00064-0; Li MM, 2020, J AGR FOOD CHEM, V68, P826, DOI 10.1021/acs.jafc.9b06897; Lima JY, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03996; Liu X, 2019, ENVIRON SCI POLLUT R, V26, P24695, DOI 10.1007/s11356-019-05769-9; Mahaseth T, 2017, MUTAT RES-REV MUTAT, V773, P274, DOI 10.1016/j.mrrev.2016.08.006; Martins PF, 2011, PROCESS BIOCHEM, V46, P1186, DOI 10.1016/j.procbio.2011.02.014; MATSUNO H, 1972, PLANT CELL PHYSIOL, V13, P1091; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Olchanheski LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099960; Pedersen HL, 2009, ACTA CRYSTALLOGR F, V65, P84, DOI 10.1107/S1744309109001110; Pezzoni M, 2016, MICROBIOL-SGM, V162, P855, DOI 10.1099/mic.0.000268; Pileggi M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05767; Prione LP, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0240-x; Qurratu A., 2016, INT J APPL ENG REEAR, V11, P9946; Richardson JR, 2019, ACTA NEUROPATHOL, V138, P343, DOI 10.1007/s00401-019-02033-9; Rydz E, 2021, ANN WORK EXPOS HEAL, V65, P377, DOI 10.1093/annweh/wxaa109; Shahid M, 2018, 3 BIOTECH, V8, P1, DOI 10.1007/s13205-018-1145-y; Silver MK, 2019, ENVIRON RES, V172, P486, DOI 10.1016/j.envres.2019.02.046; Smirnoff N, 2019, NEW PHYTOL, V221, P1197, DOI 10.1111/nph.15488; Song WJ, 2021, CHEMOSPHERE, V267, DOI 10.1016/j.chemosphere.2020.129225; Spirhanzlova P, 2019, ENVIRON POLLUT, V251, P460, DOI 10.1016/j.envpol.2019.05.006; Staerck C, 2021, J FUNGI, V7, DOI 10.3390/jof7070575; Tang J, 2020, AMB EXPRESS, V10, DOI 10.1186/s13568-020-01043-1; Tyagi S, 2020, GENOMICS, V112, P4208, DOI 10.1016/j.ygeno.2020.07.023; Van Bruggen AHC, 2018, SCI TOTAL ENVIRON, V616, P255, DOI 10.1016/j.scitotenv.2017.10.309; Yang ZM, 2017, BIORESOURCE TECHNOL, V232, P146, DOI 10.1016/j.biortech.2017.01.069	46	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0257263	10.1371/journal.pone.0257263	http://dx.doi.org/10.1371/journal.pone.0257263			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855750	Green Published, Green Submitted, gold			2022-12-26	WOS:000735299000007
J	Harvey, K; Lavretsky, P; Foth, J; Williams, CK				Harvey, Kayla; Lavretsky, Philip; Foth, Justyn; Williams, Christopher K.			Nest parasitism, promiscuity, and relatedness among wood ducks	PLOS ONE			English	Article							BROOD AMALGAMATION; FORCED COPULATION; SEX-RATIO; PATERNITY; ALIGNMENT; SEARCH; BIRDS; DNA	Nest parasitism is a common reproductive strategy used by many species of cavity nesting birds. Among these, the wood duck (Aix sponsa) is known to have evolved very specific strategies of when and whom to parasitize that is often based on population and/or environmental queues. Here, we investigated the genetic relationship of two female wood ducks competing over an artificial nesting box in Delaware, including the continued incubation of one female despite the death and body remains of the other female throughout the incubation process. We test whether such an extreme case of nest parasitism can be explained by relatedness, egg lineage composition, or a combination of other factors. To do so, we extracted genomic DNA from blood and tissue of the females, as well as chorioallantoic membranes of all viable and inviable eggs. Subsequently, we assessed relatedness among females and eggs based on hundreds of nuclear loci and the mitochondrial control region. We concluded that (1) the two incubating females were entirely unrelated, (2) the single clutch is in fact represented by a minimum of four unrelated females, and (3) a single female can lay eggs sired by different males. The latter finding is the first direct evidence for successful extra-pair copulation in wood ducks. With decreasing costs and increasing effectiveness, genomic methods have the potential to provide important insights into more complex ecological and evolutionary tactics of such populations.	[Harvey, Kayla] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Harvey, Kayla; Foth, Justyn; Williams, Christopher K.] Delaware Dept Nat Resources & Environm Control, Div Fish & Wildlife, Delaware, OH USA; [Lavretsky, Philip] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Foth, Justyn] US Fish & Wildlife Serv, Div Bird Habitat Conservat, Falls Church, VA USA; [Williams, Christopher K.] Univ Delaware, Dept Entomol & Wildlife Ecol, Newark, DE USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; University of Texas System; University of Texas El Paso; United States Department of the Interior; US Fish & Wildlife Service; University of Delaware	Harvey, K (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA.; Harvey, K (corresponding author), Delaware Dept Nat Resources & Environm Control, Div Fish & Wildlife, Delaware, OH USA.	kharvey3@esf.edu		Lavretsky, Philip/0000-0002-5904-8821	United States Fish and Wildlife Service's Wildlife & Sport Fish Restoration program [F19AF00963]; Delaware Division of Fish Wildlife; University of Texas at El Paso; Border Biomedical Research Center at The University of Texas at El Paso NIH Grant [5G12RR007592]	United States Fish and Wildlife Service's Wildlife & Sport Fish Restoration program; Delaware Division of Fish Wildlife; University of Texas at El Paso; Border Biomedical Research Center at The University of Texas at El Paso NIH Grant	This project was funded, in part, through a grant from the United States Fish and Wildlife Service's Wildlife & Sport Fish Restoration program under award number F19AF00963. We would also like to thank the Delaware Division of Fish & Wildlife for providing the necessary match to these Wildlife & Sport Fish Restoration program funds. We would also like to thank the University of Texas at El Paso, and the Border Biomedical Research Center at The University of Texas at El Paso NIH Grant #5G12RR007592. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson M., 1984, P195; Andersson M, 2019, BIOL REV, V94, P307, DOI 10.1111/brv.12455; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beauchamp G, 1997, AUK, V114, P11, DOI 10.2307/4089061; Bellrose F.C., 1994, ECOLOGY MANAGEMENT W; Brennan PLR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000418; Cakmak E, 2017, J VET DIAGN INVEST, V29, P59, DOI 10.1177/1040638716675197; CLUTTONBROCK TH, 1984, NATURE, V308, P358, DOI 10.1038/308358a0; DaCosta JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106713; Dunn PO, 1999, ANIM BEHAV, V57, P1071, DOI 10.1006/anbe.1998.1066; Eadie J, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P306; EADIE JM, 1988, CAN J ZOOL, V66, P1709, DOI 10.1139/z88-247; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EVARTS S, 1987, AUK, V104, P597, DOI 10.1093/auk/104.4.597; Gowaty PA, 1998, AM ZOOL, V38, P207; Graham CF, 2015, MOL ECOL RESOUR, V15, P1304, DOI 10.1111/1755-0998.12404; HEPP GR, 1989, ECOLOGY, V70, P897, DOI 10.2307/1941357; HEUSMANN HW, 1980, J WILDLIFE MANAGE, V44, P908, DOI 10.2307/3808323; Hou ZC., BIOPROJECT PRJNA5549; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Komdeur J, 1997, NATURE, V385, P522, DOI 10.1038/385522a0; Lavretsky P, 2015, MOL ECOL, V24, P5364, DOI 10.1111/mec.13402; Lavretsky P, 2014, MOL PHYLOGENET EVOL, V70, P402, DOI 10.1016/j.ympev.2013.08.008; Lawson DM., 2021, J WILDL MANAGE MANAG, DOI [10.1002/jwmg.21952, DOI 10.1002/JWMG.21952]; Lebigre C, 2010, MOL ECOL, V19, P1929, DOI 10.1111/j.1365-294X.2010.04614.x; Lee JCI, 2010, MOL CELL PROBE, V24, P27, DOI 10.1016/j.mcp.2009.08.003; McKinney Frank, 1998, Ornithological Monographs, V49, P163; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Nielsen CR, 2006, BEHAV ECOL, V17, P491, DOI 10.1093/beheco/arj057; Peters JL, 2005, MOL ECOL, V14, P3407, DOI 10.1111/j.1365-294X.2005.02618.x; Peters JL, 2003, AUK, V120, P883, DOI 10.1642/0004-8038(2003)120[0883:EPABSI]2.0.CO;2; ROHWER FC, 1989, CAN J ZOOL, V67, P239, DOI 10.1139/z89-035; Rohwer FC, 1988, CURRENT ORNITHOLOGY, V5, P187; Sayler Rodney D., 1992, P290; SEMEL B, 1986, AUK, V103, P813; Semel B, 2001, ANIM BEHAV, V61, P787, DOI 10.1006/anbe.2000.1657; Sorenson MD, 1996, P NATL ACAD SCI USA, V93, P15239, DOI 10.1073/pnas.93.26.15239; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Wong PBY, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-8; YOMTOV Y, 1980, BIOL REV, V55, P93, DOI 10.1111/j.1469-185X.1980.tb00689.x	43	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0257105	10.1371/journal.pone.0257105	http://dx.doi.org/10.1371/journal.pone.0257105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855769	gold, Green Published			2022-12-26	WOS:000735299000006
J	Luchen, CC; Mwaba, J; Ng'ombe, H; Alabi, PIO; Simuyandi, M; Chilyabanyama, ON; Hatyoka, LM; Mubanga, C; Bosomprah, S; Chilengi, R; Chisenga, CC				Luchen, Charlie Chaluma; Mwaba, John; Ng'ombe, Harriet; Alabi, Peter Ibukun Oluwa; Simuyandi, Michelo; Chilyabanyama, Obvious N.; Hatyoka, Luiza Miyanda; Mubanga, Cynthia; Bosomprah, Samuel; Chilengi, Roma; Chisenga, Cleopatra Caroline			Effect of HIV status and retinol on immunogenicity to oral cholera vaccine in adult population living in an endemic area of Lukanga Swamps, Zambia	PLOS ONE			English	Article							VIBRIOCIDAL ANTIBODY; VITAMIN-A; SUPPLEMENTATION; EMERGENCE; CHILDREN; DIARRHEA; INABA; ZINC	Background We set out to assess the impact of human immunodeficiency virus (HIV) and micronutrient deficiency as indicated by serum retinol levels on the immune responses to Oral Cholera Vaccine (Shanchol (TM)) in a cohort of participants in Lukanga Swamps, Zambia. Cholera remains endemic in Zambia with vaccines being the only effective preventive measures. However, the effect of these vaccines on populations living with HIV has not been widely documented. Methods HIV testing and confirmation was done using the Alere Determine (TM) HIV-1/2 and Uni-Gold (TM) kits while vibriocidal antibody assay was applied for vaccine immunogenicity. Serum retinol analysis was assessed by Shimadzu Prominence HCT-2010 High Performance Liquid Chromatography (HPLC). The primary outcome was log transformed geometric mean titre. Results From 47 participants screened for HIV, 51% (24) tested positive. There was a statistically significant reduction in Ogawa geometric mean ratio (GMR) by 67% (GMR = 0.33; 95% CI: -0.15, 0.76; p-value = 0.009) attributable to HIV positivity with a non-significant reduction in Inaba GMR by about 50% due to HIV positivity. When doubling of retinol levels modelled, GMR reduction against Ogawa were non-significant but that against Inaba resulted in a significant reduction in geometric mean titer (GMT) (GMT-0.33, C.I 0.16-0.66, p-value 0.002). At 1000copies/ml viral load cut off and 350 cells/mu l CD4 counts, Ogawa GMT was two times higher 11.16 (95%CI: 8.20-15.19) versus 6.06 (95%CI: 4.04-9.10) in low viremia participants, and three times higher in above threshold CD4 count participants; 24.81 (95%CI: 18.94-32.50) versus 7.07 (95%CI: 5.22-9.58). Conclusion Our results show that while Shanchol (TM) is immunogenic in both HIV+/- individuals, HIV + participants responded poorly. Viral load and CD4 count affected vaccine immunogenicity. More research is required for detailed understanding of this in order to appropriately inform policy and practice.	[Luchen, Charlie Chaluma; Mwaba, John; Ng'ombe, Harriet; Alabi, Peter Ibukun Oluwa; Simuyandi, Michelo; Chilyabanyama, Obvious N.; Hatyoka, Luiza Miyanda; Mubanga, Cynthia; Bosomprah, Samuel; Chilengi, Roma; Chisenga, Cleopatra Caroline] Ctr Infect Dis Res Zambia CIDRZ, Enter Dis & Vaccine Res Unit, Lusaka, Zambia; [Luchen, Charlie Chaluma] Univ Amsterdam, Inst Infect & Immun, Amsterdam UMC, Amsterdam, Netherlands; [Mwaba, John; Ng'ombe, Harriet] Univ Zambia, Sch Hlth Sci, Lusaka, Zambia; [Bosomprah, Samuel] Univ Ghana, Sch Publ Hlth, Dept Biostat, Accra, Ghana	University of Amsterdam; University of Zambia; University of Ghana	Luchen, CC (corresponding author), Ctr Infect Dis Res Zambia CIDRZ, Enter Dis & Vaccine Res Unit, Lusaka, Zambia.; Luchen, CC (corresponding author), Univ Amsterdam, Inst Infect & Immun, Amsterdam UMC, Amsterdam, Netherlands.	Chaluma.Luchen@cidrz.org	Mubanga, Cynthia/GVS-5931-2022	Mubanga, Cynthia/0000-0001-7557-6352; Chilengi, Roma/0000-0003-0221-9527	European Developing Countries Clinical Trials Partnership (EDTCP);  [TMA2016CDF-1550]	European Developing Countries Clinical Trials Partnership (EDTCP); 	Dr C C Chisenga received a career development fellowship award. Grant number: TMA2016CDF-1550. This study was funded by The European Developing Countries Clinical Trials Partnership (EDTCP). http://www.edctp.org/projects-2/edctp2-projects/career-developmentfellowships-2016/#The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MJ, 2003, J INFECT DIS, V187, P909, DOI 10.1086/368132; Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Bwire G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005407; Ciabattini A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00421; Finkelstein RA., 1996, MED MICROBIOLOGY, V4th; Fritzsche C, 2019, VACCINE, V37, P2278, DOI 10.1016/j.vaccine.2019.02.064; Garg P, 2000, J CLIN MICROBIOL, V38, P4249, DOI 10.1128/JCM.38.11.4249-4253.2000; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Ivers LC, 2015, J INFECT DIS, V212, P779, DOI 10.1093/infdis/jiv108; Kanungo S, 2009, VACCINE, V27, P6887, DOI 10.1016/j.vaccine.2009.09.008; Kapata N, 2018, J INFECT DIS, V218, pS181, DOI 10.1093/infdis/jiy490; Khan AI, 2010, SCAND J INFECT DIS, V42, P48, DOI 10.3109/00365540903289688; Kozakova H, 2003, MICROBES INFECT, V5, P405, DOI 10.1016/S1286-4579(03)00045-5; Legros D, 2018, J INFECT DIS, V218, pS137, DOI 10.1093/infdis/jiy486; Lopez AL, 2018, CLIN INFECT DIS, V66, P1960, DOI 10.1093/cid/cix1039; de Lima ABM, 2017, REV NUTR, V30, P605, DOI 10.1590/1678-98652017000500006; Murebwa-Chirambo R., OCCURRENCE CHOLERA L, V7; Mwanza-Lisulo M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0145; Penkert RR, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01576; Qadri F, 2004, VACCINE, V22, P416, DOI 10.1016/j.vaccine.2003.07.005; QADRI F, 1995, CLIN DIAGN LAB IMMUN, V2, P685, DOI 10.1128/CDLI.2.6.685-688.1995; Rudraraju R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086554; Seas C, 2000, AM J TROP MED HYG, V62, P513, DOI 10.4269/ajtmh.2000.62.513; Sinha R, 2017, VACCINE, V35, P3534, DOI 10.1016/j.vaccine.2017.05.036; Sinyange N, 2018, MMWR-MORBID MORTAL W, V67, P556, DOI 10.15585/mmwr.mm6719a5; Surman SL, 2016, CLIN VACCINE IMMUNOL, V23, P219, DOI 10.1128/CVI.00739-15; Taylor DN, 1999, AM J TROP MED HYG, V61, P869, DOI 10.4269/ajtmh.1999.61.869; THURNHAM DI, 1988, CLIN CHEM, V34, P377; von Seidlein L, 2008, TROP MED INT HEALTH, V13, P683, DOI 10.1111/j.1365-3156.2008.02051.x; West K. P. Jr., 2003, Food and Nutrition Bulletin, V24, pS78; Wierzba TF, 2019, HUM VACC IMMUNOTHER, V15, P1294, DOI 10.1080/21645515.2018.1504155; Zimmermann P, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00084-18	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260552	10.1371/journal.pone.0260552	http://dx.doi.org/10.1371/journal.pone.0260552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855835	Green Published, gold			2022-12-26	WOS:000735299000069
J	Tefera, BZ; Zeleke, H; Abate, A; Abebe, H; Mekonnen, Z; Sewale, Y				Tefera, Bitew Zewudie; Zeleke, Haymanot; Abate, Abebe; Abebe, Haimanot; Mekonnen, Zebene; Sewale, Yihenew			Magnitude and associated factors of low back pain among nurses working at intensive care unit of public hospitals in Amhara region, Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE	Background Low back pain is a common public health problem throughout the world with a global prevalence from 28% to 86%. Nurses working in intensive care units are handling people who are critically ill and helpless, which requires more assistance for transferring and handling activities. This possesses a risk for low back pain but little is known about it in Ethiopia. This study aimed to assess the magnitude of low back pain and associated factors among nurses who work at intensive care units in Amhara region public hospitals, North Ethiopia. Methods A multi-centered institution-based cross-sectional study was conducted at Amhara region public hospitals from March 1-30, 2020. A simple random sampling technique after proportional allocation was used to select the study participants. Data were collected using a standard modified Nordic musculoskeletal assessment tool. After data were checked for completeness and consistency, it was entered into Epidata version 3.1 and exported to Statistical Package for Social Science software version 26 for analysis. Descriptive statistics were computed. A binary logistic regression model was used to identify factors associated with low back pain. Finally, those variables with a p-value of <0.05 in multivariable analysis were considered statistically significant. Result Study was conducted among 412 intensive care unit nurses giving a response rate of 97.6%. The magnitude of low back pain was 313 (76%) [95% CI: (71.6%-79.9%)]. Being female [AOR = 2.674 (1.404, 5.076)], unavailability of assistive device for patient handling [AOR = 2.139 (1.035, 4.410)], lack of training on intensive care [AOR = 2.017 (1.092, 3.943)], lack of regular exercise [AOR = 2.164 (1.164, 4.108)] and job stress [AOR = 3.66 (1.955, 6.498)] were factors significantly associated with low back pain. Conclusions In this study the magnitude of low back pain was high. Being female, unavailability of an assistive device for patient handling, lack of training on intensive care, lack of regular exercise and job stress were factors associated with low back pain. Policymakers and concerned bodies should emphasize the accessibility of assistive devices for patient care, provision of training on intensive care, and adaptive working environment for intensive care unit nurses.	[Tefera, Bitew Zewudie; Abebe, Haimanot; Mekonnen, Zebene] Wolkite Univ, Dept Nursing, Wolkite, Ethiopia; [Zeleke, Haymanot; Abate, Abebe] Debre Markos Univ, Dept Nursing, Debre Markos, Ethiopia; [Sewale, Yihenew] Debre Birihan Univ, Dept Nursing, Debre Birihan, Ethiopia		Tefera, BZ (corresponding author), Wolkite Univ, Dept Nursing, Wolkite, Ethiopia.	bitewtefera1@gmail.com	Abebe, Haimanot Geletie/AGD-2238-2022	Tefera, Bitew/0000-0003-0558-5119				Adhikari S., 2015, J NEPAL HLTH RES COU; Bailey A, 2009, MENOPAUSE, V16, P3, DOI 10.1097/gme.0b013e31818e10a7; Belay M. M., 2016, East and Central African Journal of Surgery, V21, P113, DOI 10.4314/ecajs.v21i1.139040; Chauhan A., PHYS ACTIVITY STATUS; Deksisa Abebe A., 2015, EUROPEAN J PREVENTIV, V3, P188, DOI DOI 10.11648/J.EJPM.20150306.15; Duthey B., 2013, GLOBAL BURDEN DIS, P1; Ehrhardt MD, 2022, ETHNIC HEALTH, V27, P721, DOI 10.1080/13557858.2020.1760215; Firestein G.S., 2016, KELLEY FIRESTEINS TX, VVolume 1; Gaowgzeh RAM, 2019, J BACK MUSCULOSKELET, V32, P555, DOI 10.3233/BMR-181218; Hassan A.A., 2014, EGYPT RHEUMATOL REHA, V41, P109, DOI [DOI 10.4103/1110-161X.140525, 10.4103/1110-161X.140525]; Henschke N, 2016, BEST PRACT RES CL RH, V30, P1037, DOI 10.1016/j.berh.2017.08.004; Hinmikaiye CD., 2012, INT J NURSING SCI, V2, P23, DOI 10.5923/j.nursing.20120203.02; June KJ, 2011, J CLIN NURS, V20, P479, DOI 10.1111/j.1365-2702.2010.03210.x; Karahan A, 2013, WORKPLACE HEALTH SAF, V61, P75, DOI 10.3928/21650799-20130129-94; Lela M., 2012, S AFR J PHYSIOTHER R, V4, P63; Lin PH, 2012, INT J OCCUP MED ENV, V25, P41, DOI 10.2478/s13382-012-0008-8; Lopez-Aragon L, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9091514; Mekonnen TH, 2019, PAIN THER, V8, P239, DOI 10.1007/s40122-019-0129-x; Menzel NN, 2004, INT J NURS STUD, V41, P859, DOI 10.1016/j.ijnurstu.2004.03.012; Muhammed A.F, 2015, IOSR J NURSING HLTH, V4; Munabi IG, 2014, BMC NURS, V13, DOI 10.1186/1472-6955-13-7; Naude B., 2015, LOW BACK PAIN HOSP E; Ovayolu O, 2014, PAK J MED SCI, V30, P70, DOI 10.12669/pjms.301.3455; Pinar E, 2010, TURK J PUBLIC HLTH, V8, P94; Semachew A., 2018, LOW BACK PAIN NURSES, P507053; Sezgin D, 2015, INT NURS REV, V62, P92, DOI 10.1111/inr.12157; Sikiru L, 2010, AFR HEALTH SCI, V10, P26; Sikiru L., 2010, E AFRICAN J PUBLIC H, V6; Tierney LT, 2014, AUST CRIT CARE, V27, P77, DOI 10.1016/j.aucc.2013.11.003; Tosunoz IK., 2017, INT J CARING SCI, V10, P1728; Wang YXJ, 2016, QUANT IMAG MED SURG, V6, P199, DOI 10.21037/qims.2016.04.06; Woolf AD, 2012, BEST PRACT RES CL RH, V26, P183, DOI 10.1016/j.berh.2012.03.005; Yang S, 2019, WORKPLACE HEALTH SAF, V67, P275, DOI 10.1177/2165079918809107	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260361	10.1371/journal.pone.0260361	http://dx.doi.org/10.1371/journal.pone.0260361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855797	Green Published, Green Submitted, gold			2022-12-26	WOS:000735299000048
J	Wu, CN; Wu, SC; Chen, WC; Yang, YH; Chin, JC; Chien, CY; Fang, FM; Li, SH; Luo, SD; Chiu, TJ				Wu, Ching-Nung; Wu, Shao-Chun; Chen, Wei-Chih; Yang, Yao-Hsu; Chin, Jo-Chi; Chien, Chih-Yen; Fang, Fu-Min; Li, Shau-Hsuan; Luo, Sheng-Dean; Chiu, Tai-Jan			Angiotensin II receptor blockers and oral squamous cell carcinoma survival: A propensity-score-matched cohort study	PLOS ONE			English	Article							CANCER PATIENTS; SYSTEM; INHIBITION; RISK; PROGNOSIS; THERAPY	Objectives Angiotensin II receptor blockers (ARBs) improve the survival rates of patients with various cancers. However, it remains unclear whether ARBs confer a survival benefit on patients with oral squamous cell carcinoma (OSCC). Here, we assessed the associations between ARB use and survival in patients with OSCC of different stages. Materials and methods This was a 10-year retrospective cohort study of OSCC patients. We enrolled 7,558 patients diagnosed with oral cancer between January 2007 and December 2017 whose details had been entered into the Chang Gung Research Database. Seven hundred and fourteen patients were recruited from the Chang Gung Research Database after performing 1:1 propensity score-matching between ARB users and non-users. Cox's regression models with adjusted covariates were employed to detect factors influencing the survival rates of patients with OSCC. Results Kaplan-Meier analysis revealed that the overall survival (OS) rate of 180-day ARB users increased (p = 0.038). Cox's regression models indicated that ARB use, younger patients, early-stage OSCC, and patients without diabetes mellitus were independently prognostic of improved OS. Increased OS was more prominent in 180-day ARB users in stage III, Iva, and IVb categories. Conclusions ARB use for more than 180 days is associated with an increased survival rate and is a positive, independent prognostic factor in patients with OSCC. A further two-arm study should be conducted to confirm the clinical usefulness of ARBs in OSCC patients.	[Wu, Ching-Nung; Chen, Wei-Chih; Chien, Chih-Yen; Luo, Sheng-Dean] Kaohsiung Chang Gung Mem Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Wu, Ching-Nung; Wu, Shao-Chun; Chen, Wei-Chih; Chien, Chih-Yen; Fang, Fu-Min; Li, Shau-Hsuan; Luo, Sheng-Dean; Chiu, Tai-Jan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Wu, Ching-Nung] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan, Taiwan; [Wu, Shao-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Chin, Jo-Chi] Pk One Int Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Fang, Fu-Min] Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Li, Shau-Hsuan; Chiu, Tai-Jan] Kaohsiung Chang Gung Mem Hosp, Dept Hematol Oncol, Kaohsiung, Taiwan; [Luo, Sheng-Dean; Chiu, Tai-Jan] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Cheng Kung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Luo, SD (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Otolaryngol, Kaohsiung, Taiwan.; Luo, SD; Chiu, TJ (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Chiu, TJ (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Hematol Oncol, Kaohsiung, Taiwan.; Luo, SD; Chiu, TJ (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan.	rsd0323@cgmh.org.tw; kuerten@cgmh.org.tw	Wu, Ching-Nung/GVU-9045-2022; Chen, Wei Chih/GXZ-8894-2022	WU, Shaochun/0000-0002-0984-6921; CHIN, JO-CHI/0000-0001-7550-7322; Wu, Ching-Nung/0000-0001-9397-0986	Kaohsiung Chang Gung Memorial Hospital, Taiwan [CFRPG8H0401, CORPG8J0091]	Kaohsiung Chang Gung Memorial Hospital, Taiwan	This research was funded by Kaohsiung Chang Gung Memorial Hospital, Taiwan, CFRPG8H0401 and CORPG8J0091 to CNW and SCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgharzadeh F, 2020, LIFE SCI, V242, DOI 10.1016/j.lfs.2019.117181; Bagan J, 2010, ORAL ONCOL, V46, P414, DOI 10.1016/j.oraloncology.2010.03.009; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Busby J, 2018, ALIMENT PHARM THER, V47, P279, DOI 10.1111/apt.14388; Cardwell CR, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-28; Cerullo M, 2017, WORLD J SURG, V41, P2361, DOI 10.1007/s00268-017-4021-8; Facciorusso A, 2015, J GASTROEN HEPATOL, V30, P1643, DOI 10.1111/jgh.12988; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; Grimaldi-Bensouda L, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009147; Hinsley EE, 2017, EUR J ORAL SCI, V125, P247, DOI 10.1111/eos.12356; Holmes S, 2013, CANCER EPIDEMIOL, V37, P881, DOI 10.1016/j.canep.2013.09.001; Hsu WT, 2020, HYPERTENSION, V75, P483, DOI 10.1161/HYPERTENSIONAHA.119.13197; Huang CC, 2011, AM J CARDIOL, V107, P1028, DOI 10.1016/j.amjcard.2010.11.026; Kim ST, 2012, ONCOLOGY-BASEL, V83, P354, DOI 10.1159/000337979; Lambert DW, 2008, BIOCHEM PHARMACOL, V75, P781, DOI 10.1016/j.bcp.2007.08.012; Lever AF, 1998, LANCET, V352, P179, DOI 10.1016/S0140-6736(98)03228-0; Lin YT, 2021, CANCER-AM CANCER SOC, V127, P1606, DOI 10.1002/cncr.33391; Luo SD, 2020, CANCERS, V12, DOI 10.3390/cancers12061551; Mao YQ, 2016, ONCOTARGET, V7, P6765, DOI 10.18632/oncotarget.6837; Morris ZS, 2016, CANCER-AM CANCER SOC, V122, P2487, DOI 10.1002/cncr.30079; Nakai Y, 2010, BRIT J CANCER, V103, P1644, DOI 10.1038/sj.bjc.6605955; Nakamura T, 2011, EUR J ORAL SCI, V119, P345, DOI 10.1111/j.1600-0722.2011.00850.x; Pottegard A, 2017, J INTERN MED, V282, P322, DOI 10.1111/joim.12629; Rhodes DR, 2009, P NATL ACAD SCI USA, V106, P10284, DOI 10.1073/pnas.0900351106; Sekikawa S, 2020, J ORAL MAXIL SURG, V78, P469, DOI 10.1016/j.joms.2019.10.018; Shao SC, 2019, PHARMACOEPIDEM DR S, V28, P593, DOI 10.1002/pds.4713; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Tamim H, 2007, PHARMACOEPIDEM DR S, V16, P250, DOI 10.1002/pds.1360; Tanaka N, 2011, BRIT J CANCER, V105, P1331, DOI 10.1038/bjc.2011.399; Tsai MS, 2017, BIOMED J, V40, P263, DOI 10.1016/j.bj.2017.08.002; Weir MR, 2007, CLIN THER, V29, P1803, DOI 10.1016/j.clinthera.2007.09.019; World Health Organization; International Agency for Research on Cancer, 2019, CANC TODAY	32	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260772	10.1371/journal.pone.0260772	http://dx.doi.org/10.1371/journal.pone.0260772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855858	gold, Green Published			2022-12-26	WOS:000735299000116
J	Xu, Y; Wen, ZG; Deng, KL; Li, R; Yu, Q; Xiao, SM				Xu, Yang; Wen, Zhigang; Deng, Kaili; Li, Ran; Yu, Qing; Xiao, Su-Mei			Relationships of sex hormones with muscle mass and muscle strength in male adolescents at different stages of puberty	PLOS ONE			English	Article							BODY-COMPOSITION; LEAN MASS; TESTOSTERONE; ESTRADIOL; CHILDREN; MEN; DETERMINANTS; LEVEL; YOUNG; RISK	This study analysed the associations of sex steroids with fat-free mass (FFM) and handgrip strength in 641 Chinese boys. Serum total testosterone (TT) and oestradiol were measured by chemiluminescence immunoassay. Free testosterone (FT) and oestradiol were calculated. FFM and handgrip strength were measured by bioelectrical impedance analysis and a hand dynamometer, respectively. Generalised additive models and multiple linear regression were used to explore the relationships. A subgroup analysis was conducted in early-mid pubertal and late-post pubertal groups. Age, height, weight, physical activity, intake of dietary protein and/or stage of puberty were adjusted. TT and FT were positively related to FFM and handgrip strength, with a curvilinear relationship being detected for handgrip strength (p<0.050). This curvilinear relationship was only observed in the late-post pubertal group, suggesting a potential threshold effect (FT>11.99ng/dL, beta = 1.275, p = 0.039). In the early-mid pubertal group, TT and/or FT were linearly or near-linearly related to FFM or handgrip strength (beta = 0.003-0.271, p<0.050). The association between FT and FFM was stronger than that in the late-post pubertal group. This study found that serum T had different associations with muscle parameters in Chinese early-mid pubertal and late-post pubertal boys. In the late-post pubertal boys, serum T was curvilinearly related to muscle strength with a threshold effect and its link with muscle mass was weaker.	[Xu, Yang; Wen, Zhigang; Deng, Kaili; Li, Ran; Yu, Qing; Xiao, Su-Mei] Sun Yat Sen Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Peoples R China; [Wen, Zhigang] Sun Yat Sen Univ, Jiangmen Cent Hosp, Dept Endocrinol, Affiliated Jiangmen Hosp, Jiangmen, Guangdong, Peoples R China; [Xiao, Su-Mei] Sun Yat Sen Univ, Guangdong Prov Key Lab Food Nutr & Hlth, Sch Publ Hlth, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Xiao, SM (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Peoples R China.; Xiao, SM (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Food Nutr & Hlth, Sch Publ Hlth, Guangzhou, Peoples R China.	xiaosm3@mail.sysu.edu.cn			National Natural Science Foundation of China [81400857]; Natural Science Foundation of Guangdong Province [2017A030313697, 2021A1515011527]; Pearl River S&T Nova Program of Guangzhou [201610010093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Pearl River S&T Nova Program of Guangzhou	This work was supported by the National Natural Science Foundation of China (No. 81400857), Natural Science Foundation of Guangdong Province (No. 2017A030313697, 2021A1515011527), Pearl River S&T Nova Program of Guangzhou (No. 201610010093).	Andersson AM, 1997, J CLIN ENDOCR METAB, V82, P3976, DOI 10.1210/jc.82.12.3976; Auyeung TW, 2011, EUR J ENDOCRINOL, V164, P811, DOI 10.1530/EJE-10-0952; Bae YJ, 2019, J STEROID BIOCHEM, V193, DOI 10.1016/j.jsbmb.2019.105409; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/NEJM199607043350101; Bohannon RW, 2008, J STRENGTH COND RES, V22, P166, DOI 10.1519/JSC.0b013e31815f993d; Breitling LP, 2015, OSTEOPOROSIS INT, V26, P1271, DOI 10.1007/s00198-014-2996-7; Chan NPT, 2010, MATERN CHILD HLTH J, V14, P466, DOI 10.1007/s10995-009-0481-2; Cooke PS, 2017, PHYSIOL REV, V97, P995, DOI 10.1152/physrev.00018.2016; Curtis E, 2015, J CELL PHYSIOL, V230, P2618, DOI 10.1002/jcp.25001; de Almeida-Neto PF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165637; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Folland JP, 2012, EXP GERONTOL, V47, P437, DOI 10.1016/j.exger.2012.03.013; Gillen ZM, 2019, EUR J APPL PHYSIOL, V119, P1619, DOI 10.1007/s00421-019-04151-4; Guo B, 2016, J BONE MINER METAB, V34, P703, DOI 10.1007/s00774-015-0725-8; Handelsman DJ, 2018, ENDOCR REV, V39, P803, DOI 10.1210/er.2018-00020; Haring R, 2013, EUR J ENDOCRINOL, V169, P463, DOI 10.1530/EJE-13-0222; Herbst KL, 2004, CURR OPIN CLIN NUTR, V7, P271, DOI 10.1097/00075197-200405000-00006; Hou WW, 2015, DIABETIC MED, V32, P505, DOI 10.1111/dme.12602; Huang YJ, 2009, PEDIATR EXERC SCI, V21, P339, DOI 10.1123/pes.21.3.339; Hulthen L, 2001, J CLIN ENDOCR METAB, V86, P4765, DOI 10.1210/jc.86.10.4765; Kluka V, 2015, MED SCI SPORT EXER, V47, P718, DOI 10.1249/MSS.0000000000000463; Koopman-Verhoeff ME, 2020, J ADOLESCENT HEALTH, V66, P597, DOI 10.1016/j.jadohealth.2019.11.308; Li Dan, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P580; Lin SL, 2012, AM J HUM BIOL, V24, P183, DOI 10.1002/ajhb.22210; Mauras N, 1998, J CLIN ENDOCR METAB, V83, P1886, DOI 10.1210/jc.83.6.1886; Messina C, 2018, QUANT IMAG MED SURG, V8, P86, DOI [10.21037/qims.2018.01.01, 10.21037/qims.2018.04.07]; Norman K, 2011, CLIN NUTR, V30, P135, DOI 10.1016/j.clnu.2010.09.010; Orsso CE, 2019, CLIN NUTR, V38, P2002, DOI 10.1016/j.clnu.2019.04.012; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Parahiba SM, 2020, EXP GERONTOL, V142, DOI 10.1016/j.exger.2020.111106; Ramel SE, 2016, J PEDIATR-US, V173, P108, DOI 10.1016/j.jpeds.2016.03.003; Ramos E, 1998, INT J SPORTS MED, V19, P526, DOI 10.1055/s-2007-971955; Richmond EJ, 2007, NAT CLIN PRACT ENDOC, V3, P338, DOI 10.1038/ncpendmet0450; Schaap LA, 2005, CLIN ENDOCRINOL, V63, P152, DOI 10.1111/j.1365-2265.2005.02315.x; Siervogel RM, 2003, HORM RES, V60, P36, DOI 10.1159/000071224; Stancampiano MR, 2020, HORM RES PAEDIAT, V92, P215, DOI 10.1159/000504670; Steene-Johannessen J, 2009, MED SCI SPORT EXER, V41, P1361, DOI 10.1249/MSS.0b013e31819aaae5; Szulc P, 2004, AM J CLIN NUTR, V80, P496, DOI 10.1093/ajcn/80.2.496; Timpka S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-62; Vandenput L, 2010, EUR J ENDOCRINOL, V162, P737, DOI 10.1530/EJE-09-0696; Veldhuis JD, 2005, ENDOCR REV, V26, P114, DOI 10.1210/er.2003-0038; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Walker IV, 2020, J DEV ORIG HLTH DIS, V11, P168, DOI 10.1017/S2040174419000254; Willoughby DS, 2004, MED SCI SPORT EXER, V36, P1499, DOI 10.1249/01.MSS.0000139795.83030.D1; Xu L, 2011, J CLIN DENSITOM, V14, P458, DOI 10.1016/j.jocd.2011.04.001	45	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260521	10.1371/journal.pone.0260521	http://dx.doi.org/10.1371/journal.pone.0260521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855818	gold, Green Published			2022-12-26	WOS:000735299000064
J	Rodriguez-Luna, CR; Servin, J; Valenzuela-Galvan, D; List, R				Ricardo Rodriguez-Luna, Cesar; Servin, Jorge; Valenzuela-Galvan, David; List, Rurik			Trophic niche overlap between coyotes and gray foxes in a temperate forest in Durango, Mexico	PLOS ONE			English	Article							SYMPATRIC RED WOLVES; LATRANS FOOD-HABITS; CANIS-LATRANS; FEEDING-HABITS; UROCYON-CINEREOARGENTEUS; INTRAGUILD PREDATION; SEASONAL-VARIATION; DIETARY OVERLAP; CARNIVORES; COMPETITION	Resource partitioning, and especially dietary partitioning, is a mechanism that has been studied for several canid species as a means to understand competitive relationships and the ability of these species to coexist. Coyotes (Canis latrans) and gray foxes (Urocyon cinereoargenteus) are two canid species that are widely distributed, in Mexico, and they are sympatric throughout most of their distribution range. However, trophic dynamic and overlap between them have not been thoroughly studied. In order to better understand their ecological relationship and potential competitive interactions, we studied the trophic niche overlap between both canids in a temperate forest of Durango, Mexico. The results are based on the analysis of 540 coyote and 307 gray fox feces collected in 2018. Both species consumed a similar range of food items, but the coyote consumed large species while the gray fox did not. For both species, the most frequently consumed food categories throughout the year and seasonally were fruit and wild mammals (mainly rodents and lagomorphs). Coyotes had higher trophic diversity in their annual diet (H' = 2.33) than gray foxes (H' = 1.80). When analyzing diets by season, trophic diversity of both species was higher in winter and spring and tended to decrease in summer and autumn. When comparing between species, this parameter differed significantly during all seasons except for summer. Trophic overlap throughout the year was high (R-0 = 0.934), with seasonal variation between R-0 = 0.821 (autumn) and R-0 = 0.945 (spring). Both species based their diet on the most available food items throughout each season of the year, having high dietary overlap which likely can lead to intense exploitative competition processes. However, differences in trophic diversity caused by differential prey use can mitigate competitive interactions, allowing these different sized canid species to coexist in the study area.	[Ricardo Rodriguez-Luna, Cesar] Univ Autonoma Metropolitana, Ciencias Biol & Salud, Ciudad De Mexico, Mexico; [Servin, Jorge] Univ Autonoma Metropolita, Dept El Hombre & Ambiente, Div Ciencias Biol & Salud, Unidad Xochimilco, Mexico City, DF, Mexico; [Valenzuela-Galvan, David] Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac, Dept Ecol Evolut, Cuernavaca, Morelos, Mexico; [List, Rurik] Univ Autonoma Metropolitana, Dept Ciencias Ambientales, Div Ciencias Biol & Salud, Unidad Lerma, Mexico City, DF, Mexico	Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma del Estado de Morelos; Universidad Autonoma Metropolitana - Mexico	Valenzuela-Galvan, D (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac, Dept Ecol Evolut, Cuernavaca, Morelos, Mexico.	dvalen@uaem.mx	Galván, David Valenzuela/F-5218-2019	Galván, David Valenzuela/0000-0002-6324-4374	CONACYT [293353]; CONACYT	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	CRRL received funding from CONACYT through the doctoral grant #293353; CONACYT as funder, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Castaneda ST., 2015, GUIA IDENTIFICACION; ANDELT WF, 1985, WILDLIFE MONOGR, P1; ANDELT WF, 1987, J WILDLIFE MANAGE, V51, P273, DOI 10.2307/3801002; Aranda M., 2012, MANUAL RASTREO MAM F; Aranda Marcelo, 1995, Acta Zoologica Mexicana Nueva Serie, V65, P89; Arjo WM, 2002, J MAMMAL, V83, P754, DOI 10.1644/1545-1542(2002)083<0754:DOBWAC>2.0.CO;2; Azevedo FCC, 2006, J ZOOL, V269, P127, DOI 10.1111/j.1469-7998.2006.00075.x; BEKOFF M, 1977, Mammalian Species, V79, P1; BOWYER RT, 1983, AM MIDL NAT, V109, P266, DOI 10.2307/2425406; Breuer T, 2005, AFR J ECOL, V43, P181, DOI 10.1111/j.1365-2028.2005.00562.x; BRILLHART DE, 1995, SOUTHWEST NAT, V40, P160; CASE TJ, 1974, P NATL ACAD SCI USA, V71, P3073, DOI 10.1073/pnas.71.8.3073; Castellanos G., 2009, RESERVA ECOLOGICA PE, P371; Chao A, 2016, METHODS ECOL EVOL, V7, P919, DOI 10.1111/2041-210X.12551; Cherry MJ, 2016, WILDLIFE BIOL, V22, P64, DOI 10.2981/wlb.00144; Chomko SA., 1980, MAMMALIAN OSTEOLOGY, P72; Colwell RK, 2013, ESTIMATES STAT ESTIM; Crimmins SM, 2012, NORTHEAST NAT, V19, P411, DOI 10.1656/045.019.0304; Cruz-Espinoza A., 2010, NATURALEZA DESARROLL, V8, P33; Cuervo-Robayo AP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0209808; Cunningham SC, 2006, WEST N AM NATURALIST, V66, P169, DOI 10.3398/1527-0904(2006)66[169:GFACAA]2.0.CO;2; Cypher BL, 1998, J MAMMAL, V79, P204, DOI 10.2307/1382855; Cypher Brian L., 1993, Transactions of the Illinois State Academy of Science, V86, P139; DELIBES M, 1989, Z SAUGETIERKD, V54, P107; Dowd JLB, 2012, NORTHWEST SCI, V86, P289, DOI 10.3955/046.086.0405; du Preez B, 2017, J ZOOL, V302, P149, DOI 10.1111/jzo.12443; Elbroch M., 2006, ANIMAL SKULLS GUIDE; ERLINGE S, 1968, OIKOS, V19, P259, DOI 10.2307/3565013; Farias V, 2012, SOUTHWEST NAT, V57, P176, DOI 10.1894/0038-4909-57.2.176; Fedriani JM, 2000, OECOLOGIA, V125, P258, DOI 10.1007/s004420000448; Fedriani JM, 2001, ECOGRAPHY, V24, P325, DOI 10.1034/j.1600-0587.2001.240310.x; Fritzell E.K., 1987, P408; FRITZELL E K, 1982, Mammalian Species, P1, DOI 10.2307/3503957; Gadsden H., 1991, FOLIA ENTOMOL MEX, V81, P1; GIPSON PS, 1974, J WILDLIFE MANAGE, V38, P848, DOI 10.2307/3800055; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Gomez-Ortiz Y, 2015, ZOOL STUD, V54, DOI 10.1186/s40555-014-0102-7; Gompper ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146055; Gonzalez-Elizondo S., 1993, ACTA BOT MEX, V22, P1; Grajales-Tam Karina M., 2003, Acta Zoologica Mexicana Nueva Serie, V89, P17; GREEN J S, 1981, Great Basin Naturalist, V41, P251; Guerrero Sergio, 2002, Acta Zool. Mex, P119; Guerrero Sergio, 2004, Acta Zool. Mex, V20, P145; Halffter G., 1978, RESERVAS BIOSFERA ES, P17; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; HARRISON DJ, 1984, J WILDLIFE MANAGE, V48, P922, DOI 10.2307/3801439; Harrison RL, 1997, J WILDLIFE MANAGE, V61, P112, DOI 10.2307/3802420; HATFIELD DONALD M., 1939, JOUR MAMMAL, V20, P202, DOI 10.2307/1374378; HERNANDEZ L, 1994, J ARID ENVIRON, V26, P165, DOI 10.1006/jare.1994.1020; Hidalgo-Mihart MG, 2001, AM MIDL NAT, V146, P210, DOI 10.1674/0003-0031(2001)146[0210:CCLFHI]2.0.CO;2; Hillson S., 2016, MAMMAL BONES TEETH I; Hillson S., 2005, TEETH CAMBRIDGE MANU; Hinton JW, 2017, J MAMMAL, V98, P475, DOI 10.1093/jmammal/gyw233; HOCKMAN JG, 1983, AM MIDL NAT, V110, P276, DOI 10.2307/2425269; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; Horcada A, 2017, SPAN J AGRIC RES, V15, DOI 10.5424/sjar/2017154-11032; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; HUTCHESON K, 1970, J THEOR BIOL, V29, P151, DOI 10.1016/0022-5193(70)90124-4; Ibarra IIB., 2009, 60 ANOS COLECCION NA, P89; Kasper CB, 2016, MAMMALIA, V80, P143, DOI 10.1515/mammalia-2014-0126; Kays RW., 2009, MAMMALS N AM, V2nd ed.; Kitchen AM, 1999, CAN J ZOOL, V77, P1645, DOI 10.1139/cjz-77-10-1645; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Lanszki J, 1999, ACTA THERIOL, V44, P429, DOI 10.4098/AT.arch.99-41; Larson RN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228881; Larson RN, 2015, WEST N AM NATURALIST, V75, P339, DOI 10.3398/064.075.0311; LEOPOLD BD, 1986, J WILDLIFE MANAGE, V50, P290, DOI 10.2307/3801915; Lowenberg-Neto P, 2014, ZOOTAXA, V3802, P300, DOI 10.11646/zootaxa.3802.2.12; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MACCRACKEN JG, 1984, J WILDLIFE MANAGE, V48, P1420, DOI 10.2307/3801809; Magurran A.E, 1988, ECOLOGICAL DIVERSITY, DOI DOI 10.1007/978-94-015-7358-0_4; MAJOR JT, 1987, J WILDLIFE MANAGE, V51, P606, DOI 10.2307/3801278; Marquez-Linares MA., 2006, CIENCIA UANL, V9, P57; Martínez-Vázquez Jesús, 2010, Therya, V1, P145, DOI 10.12933/therya-10-4; MCCLURE MF, 1995, SOUTHWEST NAT, V40, P101; McDonald JH., 2014, HDB BIOL STAT; McVey JM, 2013, J MAMMAL, V94, P1141, DOI 10.1644/13-MAMM-A-109.1; MESSIER F, 1986, CAN J ZOOL, V64, P1134, DOI 10.1139/z86-170; Moehrenschlager A, 2007, J MAMMAL, V88, P1029, DOI 10.1644/06-MAMM-A-159R.1; Monroy-Vilchis O., 2003, GUIA IDENTIFICACION; Monroy-Vilchis O, 2005, CIENC ERGO-SUM, V12, P264; MURIE A, 1951, J MAMMAL, V32, P291, DOI 10.2307/1375660; Murie OJ., 2005, FIELD GUIDE ANIMAL T, V3; Neale JCC, 2001, CAN J ZOOL, V79, P1794, DOI 10.1139/cjz-79-10-1794; NELLIS CH, 1976, J WILDLIFE MANAGE, V40, P389, DOI 10.2307/3799940; NOVARO AJ, 1995, MAMMALIA, V59, P19, DOI 10.1515/mamm.1995.59.1.19; ORTEGA JC, 1987, SOUTHWEST NAT, V32, P152, DOI 10.2307/3672029; OZOGA JJ, 1966, J WILDLIFE MANAGE, V30, P809, DOI 10.2307/3798288; PARKER GR, 1986, CAN FIELD NAT, V100, P74; Patterson BR, 1998, CAN J ZOOL, V76, P1885, DOI 10.1139/cjz-76-10-1885; PIANKA ER, 1969, ECOLOGY, V50, P1012, DOI 10.2307/1936893; Poessel SA, 2017, CAN J ZOOL, V95, P287, DOI 10.1139/cjz-2016-0029; Quinn T, 1997, NORTHWEST SCI, V71, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Rodríguez-Luna César R., 2021, Therya, V12, P553, DOI 10.12933/therya-21-1128; ROSENZWEIG ML, 1966, J MAMMAL, V47, P602, DOI 10.2307/1377891; Santana EM, 2017, HUM-WILDL INTERACT, V11, P156; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; SCHOENER TW, 1986, ECOLOGY, V67, P260, DOI 10.2307/1938528; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Schrecengost JD, 2008, SOUTHEAST NAT, V7, P135, DOI 10.1656/1528-7092(2008)7[135:SFHOTC]2.0.CO;2; Servin J, 2003, J MAMMAL, V84, P547, DOI 10.1644/1545-1542(2003)084<0547:DTDBCC>2.0.CO;2; Servin J., 2014, MAMMALS MEXICO, P510; Servin J., 2014, MAMMALS MEXICO, P514; Servin Jorge, 1991, Acta Zoologica Mexicana Nueva Serie, V44, P1; SMITH G J, 1981, Wildlife Society Bulletin, V9, P88; Smith JA, 2018, OIKOS, V127, P890, DOI 10.1111/oik.04592; Taper ML, 1996, AM NAT, V147, P1072, DOI 10.1086/285893; THEBERGE JB, 1989, CAN J ZOOL, V67, P1285, DOI 10.1139/z89-183; TOWEILL DE, 1988, J WILDLIFE MANAGE, V52, P507, DOI 10.2307/3801600; Villalobos Escalante Alejandra, 2014, Therya, V5, P355, DOI 10.12933/therya-14-143; Viteri-Pasch M., 2019, REV MEXICANA MASTOZO, V9, P66; WHITE PJ, 1995, SOUTHWEST NAT, V40, P342; WOOD JE, 1954, J MAMMAL, V35, P406, DOI 10.2307/1375965	116	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260325	10.1371/journal.pone.0260325	http://dx.doi.org/10.1371/journal.pone.0260325			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851987	Green Published, gold			2022-12-26	WOS:000755762900031
J	Marr, C; Vaportzis, EJ; Niechcial, M; Dewar, M; Gow, A				Marr, Calum; Vaportzis, Eleftheria J.; Niechcial, Malwina; Dewar, Michaela; Gow, Alan			Measuring activity engagement in old age: An exploratory factor analysis	PLOS ONE			English	Article							MINI-MENTAL-STATE; LIFE-STYLE ENGAGEMENT; COGNITIVE PERFORMANCE; LEISURE ACTIVITIES; ASSOCIATIONS; DECLINE; HEALTH; PARTICIPATION; INDEXES; NUMBER	A growing body of literature suggests that higher engagement in a range of activities can be beneficial for cognitive health in old age. Such studies typically rely on self-report questionnaires to assess level of engagement. These questionnaires are highly heterogeneous across studies, limiting generalisability. In particular, the most appropriate domains of activity engagement remain unclear. The Victoria Longitudinal Study-Activity Lifestyle Questionnaire comprises one of the broadest and most diverse collections of activity items, but different studies report different domain structures. This study aimed to help establish a generalisable domain structure of the Victoria Longitudinal Study-Activity Lifestyle Questionnaire. The questionnaire was adapted for use in a sample of UK-based older adults (336 community-dwelling adults aged 65-92 with no diagnosed cognitive impairment). An exploratory factor analysis was conducted on 29 items. The final model retained 22 of these items in a six-factor structure. Activity domains were: Manual (e.g., household repairs), Intellectual (e.g., attending a public lecture), Games (e.g., card games), Religious (e.g., attending religious services), Exercise (e.g., aerobics) and Social (e.g., going out with friends). Given that beneficial activities have the potential to be adapted into interventions, it is essential that future studies consider the most appropriate measurement of activity engagement across domains. The factor structure reported here offers a parsimonious and potentially useful way for future studies to assess engagement in different kinds of activities.	[Gow, Alan] Heriot Watt Univ, Dept Psychol, Edinburgh, Midlothian, Scotland; Heriot Watt Univ, Ctr Appl Behav Sci, Edinburgh, Midlothian, Scotland; [Vaportzis, Eleftheria J.] Univ Bradford, Div Psychol, Bradford, W Yorkshire, England	Heriot Watt University; Heriot Watt University; University of Bradford	Gow, A (corresponding author), Heriot Watt Univ, Dept Psychol, Edinburgh, Midlothian, Scotland.	a.j.gow@hw.ac.uk	Vaportzis, Eleftheria/A-5531-2016; Gow, Alan/A-6070-2009	Vaportzis, Eleftheria/0000-0002-0522-5095; Gow, Alan/0000-0002-3320-4531; Niechcial, Malwina/0000-0002-6662-9333; Dewar, Michaela/0000-0002-7841-2975; Marr, Calum/0000-0003-3878-9505	Velux Stiftung, Switzerland [1034, 1034a]	Velux Stiftung, Switzerland	This work was supported by Velux Stiftung, Switzerland, https://veluxstiftung.ch, Project No. 1034 to A.J.G. and Project No. 1034a to A.J.G. and M.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KB, 2011, AGEING SOC, V31, P683, DOI 10.1017/S0144686X10001091; Bielak AAM, 2017, AGING NEUROPSYCHOL C, V24, P435, DOI 10.1080/13825585.2016.1221378; Bielak AAM, 2014, PSYCHOL AGING, V29, P863, DOI 10.1037/a0036960; Bielak AAM, 2010, GERONTOLOGY, V56, P507, DOI 10.1159/000264918; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; CAMPION WM, 1989, J MARKETING RES, V26, P485, DOI 10.2307/3172772; Carlson MC, 2012, J INT NEUROPSYCH SOC, V18, P286, DOI 10.1017/S135561771100169X; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; Enders C. K., 2010, APPL MISSING DATA AN; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ghisletta P, 2006, J GERONTOL B-PSYCHOL, V61, pP253, DOI 10.1093/geronb/61.5.P253; Goretzko D, 2020, EDUC PSYCHOL MEAS, V80, P756, DOI 10.1177/0013164419893413; Gow AJ, 2012, PSYCHOL AGING, V27, P250, DOI 10.1037/a0024144; HOFMANN RJ, 1978, MULTIVAR BEHAV RES, V13, P247, DOI 10.1207/s15327906mbr1302_9; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hultsch DF, 1999, PSYCHOL AGING, V14, P245, DOI 10.1037/0882-7974.14.2.245; HULTSCH DF, 1993, J GERONTOL, V48, pP1, DOI 10.1093/geronj/48.1.P1; Jopp DS, 2010, PSYCHOL ASSESSMENT, V22, P108, DOI 10.1037/a0017662; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kareholt I, 2011, INT J GERIATR PSYCH, V26, P65, DOI 10.1002/gps.2490; Kramer AF, 2004, J GERONTOL A-BIOL, V59, P940; Kuiper JS, 2016, INT J EPIDEMIOL, V45, P1169, DOI 10.1093/ije/dyw089; Lloret-Segura S, 2014, AN PSICOL-SPAIN, V30, P1151, DOI 10.6018/analesps.30.3.199361; Nassiri V, 2018, BEHAV RES METHODS, V50, P501, DOI [10.3758/s13428-017-1013-4, 10.3758/s13428-017-1000-9]; Opdebeeck C, 2016, AGING NEUROPSYCHOL C, V23, P40, DOI 10.1080/13825585.2015.1041450; Parslow RA, 2006, GERONTOLOGY, V52, P188, DOI 10.1159/000091829; R Core Team, 2020, R LANG ENV STAT COMP; Revelle William, 2020, CRAN; Schinka JA, 2005, J INT NEUROPSYCH SOC, V11, P108, DOI 10.1017/S1355617705050125; Scottish Government, 2016, GLOB CIT SCOTL INT D; Small BJ, 2012, NEUROPSYCHOLOGY, V26, P144, DOI 10.1037/a0026579; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; Verghese J, 2006, NEUROLOGY, V66, P821, DOI 10.1212/01.wnl.0000202520.68987.48; Wang HX, 2013, J GERONTOL A-BIOL, V68, P205, DOI 10.1093/gerona/gls153; Wilson RS, 2003, J CLIN EXP NEUROPSYC, V25, P634, DOI 10.1076/jcen.25.5.634.14572; Yong AG, 2013, TUTOR QUANT METHODS, V9, P79, DOI 10.20982/tqmp.09.2.p079	43	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	12							e0260996	10.1371/journal.pone.0260996	http://dx.doi.org/10.1371/journal.pone.0260996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM1MC	34871324	Green Published, gold			2022-12-26	WOS:000728598900003
J	Agborbesong, E; Zhou, JX; Li, LX; Calvet, JP; Li, XG				Agborbesong, Ewud; Zhou, Julie Xia; Li, Linda Xiaoyan; Calvet, James P.; Li, Xiaogang			Antioxidant enzyme peroxiredoxin 5 regulates cyst growth and ciliogenesis via modulating Plk1 stability	FASEB JOURNAL			English	Article						ADPKD; ciliogenesis; cyst growth; peroxiredoxin 5; Plk1	POLYCYSTIC KIDNEY-DISEASE; BETA-CATENIN; OXIDATIVE STRESS; CENTROSOME AMPLIFICATION; PRIMARY CILIUM; AURORA-A; EXPRESSION; GENE; HOMEOSTASIS; IDENTIFICATION	Oxidative stress is emerging as a contributing factor to the homeostasis in cystic diseases. However, the role antioxidant enzymes play in the pathogenesis of autosomal dominant polycystic kidney disease (ADPKD) remains elusive. Peroxiredoxin 5 (Prdx5) is an antioxidant enzyme that catalyzes the reduction of H2O2 and alkyl hydroperoxide and plays an important role in different biological processes. In this study, we show that Prdx5 is downregulated in a PKD mutant mouse model and ADPKD patient kidneys. Knockdown of Prdx5 resulted in the formation of cysts in a three-dimensional mouse inner medullar collecting duct (IMCD) cell Matrigel culture system. The mechanisms of Prdx5 deficiency mediated cyst growth include: (1) induction of oxidative stress as indicated by increased mRNA expression of heme oxygenase-1, an oxidant stress marker; (2) activation of Erk, S6 and mTORC1, which contribute to cystic renal epithelial cell proliferation and cyst growth; (3) abnormal centrosome amplification and multipolar spindle formation which result in genome instability; (4) upregulation of Polo-like kinase 1 (Plk1) and Aurora kinase A, important mitotic kinases involved in cell proliferation and ciliogenesis; (5) impaired formation of primary cilia in mouse IMCD3 and retinal pigment epithelial cells, which could be rescued by inhibiting Plk1 activity; and (6) restraining the effect of Wnt3a and Wnt5a ligands on primary cilia in mouse IMCD3 cells, while regulating the activity of the canonical and non-canonical Wnt signaling in a separate cilia independent mechanism, respectively. Importantly, we found that targeting Plk1 with its inhibitor, volasertib, delayed cyst growth in Pkd1 conditional knockout mouse kidneys. Together, these findings indicate that Prdx5 is an important antioxidant that regulates cyst growth via diverse mechanisms, in particular, the Prdx5-Plk1 axis, and that induction and activation of Prdx5, alone or together with inhibition of Plk1, represent a promising strategy for combatting ADPKD.	[Agborbesong, Ewud; Zhou, Julie Xia; Li, Linda Xiaoyan; Li, Xiaogang] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA; [Agborbesong, Ewud; Zhou, Julie Xia; Li, Linda Xiaoyan; Li, Xiaogang] Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA; [Agborbesong, Ewud; Calvet, James P.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA	Mayo Clinic; Mayo Clinic; University of Kansas; University of Kansas Medical Center	Li, XG (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.; Li, XG (corresponding author), Mayo Clin, Med, 200 1st St SW, Rochester, MN 55905 USA.	li.xiaogang@mayo.edu			NIH [RO1 DK126662, DK.129241, P30 DK106912]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: RO1 DK126662, DK.129241. and NIH P30 DK106912	Argyropoulou V, 2016, FREE RADICAL BIO MED, V100, pS92, DOI 10.1016/j.freeradbiomed.2016.10.229; Battini L, 2008, HUM MOL GENET, V17, P2819, DOI 10.1093/hmg/ddn180; Bernkopf DB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12203-8; Bur H, 2014, HISTOPATHOLOGY, V65, P319, DOI 10.1111/his.12389; Choi HI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149266; Drummen GPC, 2002, FREE RADICAL BIO MED, V33, P473, DOI 10.1016/S0891-5849(02)00848-1; Fernandez-Ranvier GG, 2008, WORLD J SURG, V32, P873, DOI 10.1007/s00268-008-9521-0; Fujita H, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1075643; Gerard AC, 2005, THYROID, V15, P205, DOI 10.1089/thy.2005.15.205; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gjertsen BT, 2015, LEUKEMIA, V29, P11, DOI 10.1038/leu.2014.222; Gleixner KV, 2010, CANCER RES, V70, P1513, DOI 10.1158/0008-5472.CAN-09-2181; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Goepfert TM, 2002, CANCER RES, V62, P4115; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Karihtala P, 2003, CLIN CANCER RES, V9, P3418; Kim JI, 2013, AM J PHYSIOL-RENAL, V304, pF1283, DOI 10.1152/ajprenal.00427.2012; Kim MH, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101315; Knoops B, 2011, ANTIOXID REDOX SIGN, V15, P817, DOI 10.1089/ars.2010.3584; Kropotov A, 2007, FEBS J, V274, P5804, DOI 10.1111/j.1742-4658.2007.06103.x; Kyun ML, 2020, CELL REP, V30, P1447, DOI 10.1016/j.celrep.2020.01.019; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lee EJ, 2020, P NATL ACAD SCI USA, V117, P29001, DOI 10.1073/pnas.2009334117; Lee KH, 2020, FEBS J, V287, P5027, DOI 10.1111/febs.15579; Lee KH, 2012, EMBO J, V31, P3104, DOI 10.1038/emboj.2012.144; Li A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.95874; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lin XR, 2020, AM J CANCER RES, V10, P2705; Ling NXY, 2020, NAT METAB, V2, P41, DOI 10.1038/s42255-019-0157-1; Liu ZX, 2017, TRANSL ONCOL, V10, P22, DOI 10.1016/j.tranon.2016.10.003; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; Lu Y, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aba3613; Ma M, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028209; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Ma YN, 2014, FREE RADICAL BIO MED, V76, P251, DOI 10.1016/j.freeradbiomed.2014.08.015; Maser RL, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134991; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Menezes LF, 2016, EBIOMEDICINE, V5, P183, DOI 10.1016/j.ebiom.2016.01.027; Miller MM, 2011, KIDNEY INT, V80, P147, DOI 10.1038/ki.2011.56; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Plaisant F, 2003, FREE RADICAL BIO MED, V34, P862, DOI 10.1016/S0891-5849(02)01440-5; Poprac P, 2017, TRENDS PHARMACOL SCI, V38, P592, DOI 10.1016/j.tips.2017.04.005; Rezatabar S, 2019, J CELL PHYSIOL, V234, P14951, DOI 10.1002/jcp.28334; Seeger-Nukpezah T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038838; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; Su LJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/5080843; Torres VE, 1997, J AM SOC NEPHROL, V8, P1283; Tyagi S, 2010, BIOCHEM PHARMACOL, V80, P1326, DOI 10.1016/j.bcp.2010.07.025; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wang G, 2013, J CELL SCI, V126, P1355, DOI 10.1242/jcs.114918; Wang MX, 2002, FEBS LETT, V531, P359, DOI 10.1016/S0014-5793(02)03511-1; Wuebken A, 2011, KIDNEY INT, V80, P135, DOI 10.1038/ki.2011.87; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zhang XQ, 2021, J AM SOC NEPHROL, V32, P2759, DOI 10.1681/ASN.2021040460; Zhou D, 2012, KIDNEY INT, V82, P537, DOI 10.1038/ki.2012.173; Zhou X, 2015, HUM MOL GENET, V24, P3982, DOI 10.1093/hmg/ddv136	65	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22089	10.1096/fj.202101270RR	http://dx.doi.org/10.1096/fj.202101270RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34888938				2022-12-26	WOS:000734992000019
J	Blake, C; Flaws, JA				Blake, Catherine; Flaws, Jodi A.			Using semantics to scale up evidence-based chemical risk-assessments	PLOS ONE			English	Article							HALLMARKS; CANCER; MODEL; TEXT	Background The manual processes used for risk assessments are not scaling to the amount of data available. Although automated approaches appear promising, they must be transparent in a public policy setting. Objective Our goal is to create an automated approach that moves beyond retrieval to the extraction step of the information synthesis process, where evidence is characterized as supporting, refuting, or neutral with respect to a given outcome. Methods We combine knowledge resources and natural language processing to resolve coordinated ellipses and thus avoid surface level differences between concepts in an ontology and outcomes in an abstract. As with a systematic review, the search criterion, and inclusion and exclusion criterion are explicit. Results The system scales to 482K abstracts on 27 chemicals. Results for three endpoints that are critical for cancer risk assessments show that refuting evidence (where the outcome decreased) was higher for cell proliferation (45.9%), and general cell changes (37.7%) than for cell death (25.0%). Moreover, cell death was the only end point where supporting claims were the majority (61.3%). If the number of abstracts that measure an outcome was used as a proxy for association there would be a stronger association with cell proliferation than cell death (20/27 chemicals). However, if the amount of supporting evidence was used (where the outcome increased) the conclusion would change for 21/27 chemicals (20 from proliferation to death and 1 from death to proliferation). Conclusions We provide decision makers with a visual representation of supporting, neutral, and refuting evidence whilst maintaining the reproducibility and transparency needed for public policy. Our findings show that results from the retrieval step where the number of abstracts that measure an outcome are reported can be misleading if not accompanied with results from the extraction step where the directionality of the outcome is established.	[Blake, Catherine] Univ Illinois, Sch Informat Sci, Urbana, IL 61801 USA; [Flaws, Jodi A.] Univ Illinois, Dept Comparat Biosci, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Blake, C (corresponding author), Univ Illinois, Sch Informat Sci, Urbana, IL 61801 USA.	clblake@illinois.edu		Blake, Catherine/0000-0001-9516-2683				Alamri A, 2016, J BIOMED SEMANT, V7, DOI 10.1186/s13326-016-0083-z; Ali I, 2016, TOXICOL LETT, V241, P32, DOI 10.1016/j.toxlet.2015.11.003; [Anonymous], 2019, ALIAS I LINGPIPE 412; [Anonymous], 2004, COCHRANE REV HDB 4 2; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Bada M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-161; Baker S, 2016, BIOINFORMATICS, V32, P432, DOI 10.1093/bioinformatics/btv585; Barupal DK, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP4713; Bilal M, 2021, J ENVIRON MANAGE, V291, DOI 10.1016/j.jenvman.2021.112685; Blake C, 2006, J AM SOC INF SCI TEC, V57, P1740, DOI 10.1002/asi.20487; Blake C, 2017, J BIOMED INFORM, V72, P120, DOI 10.1016/j.jbi.2017.07.001; Blake C, 2015, J BIOMED INFORM, V56, P42, DOI 10.1016/j.jbi.2015.05.004; Blake C, 2010, J BIOMED INFORM, V43, P173, DOI 10.1016/j.jbi.2009.11.001; Carbon S, 2021, NUCLEIC ACIDS RES, V49, pD325, DOI 10.1093/nar/gkaa1113; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Devlin J., 2018, ARXIV181004805; Fiszman M., 2007, P 2007 WORKSH BIOM N; Gebel S, 2013, BIOINFORM BIOL INSIG, V7, P97, DOI 10.4137/BBI.S11154; Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hersh W, 2009, INFORM RETRIEVAL, V12, P1, DOI 10.1007/s10791-008-9076-6; jsoup, 2019, JSOUP JAVA HTML PARS; Kim JD, 2003, BIOINFORMATICS, V19, pi180, DOI 10.1093/bioinformatics/btg1023; Kim JD, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S10-S3; Korhonen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033427; Korhonen A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-303; Koual M, 2020, ENVIRON HEALTH-GLOB, V19, DOI 10.1186/s12940-020-00670-2; Lee J, 2020, BIOINFORMATICS, V36, P1234, DOI 10.1093/bioinformatics/btz682; Lucic A., 2016, AM MED INF ASS S NOV; Mayer T., 2021, ARTIF INTELL MED, P118, DOI [10.1016/j.artmed.2021.102098 34412851, DOI 10.1016/J.ARTMED.2021.10209834412851]; Mueller KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116016; Mysid, MAJ EV MIT WIK COMM; Natl Res Council, 2011, REVIEW OF THE ENVIRONMENTAL PROTECTION AGENCY'S DRAFT IRIS ASSESSMENT OF FORMALDEHYDE, P1; Park DH., 2012, ASS COMPUTATIONAL LI, P1; Perera N, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00673; Pyysalo S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S10-S2; Sharma N, 2019, ENVIRON MOL MUTAGEN, V60, P668, DOI 10.1002/em.22319; Smith MT, 2020, CANCER EPIDEM BIOMAR, V29, P1887, DOI 10.1158/1055-9965.EPI-19-1346; Stanford, 2019, STANF DEP PARS VERS; Steinberg P, 1999, TOXICOL LETT, V111, P151, DOI 10.1016/S0378-4274(99)00176-9; Tawfik NS., 2018, MACHINE LEARNING DAT, V10934; Westra JW, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-105; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0260712	10.1371/journal.pone.0260712	http://dx.doi.org/10.1371/journal.pone.0260712			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910747	gold, Green Published			2022-12-26	WOS:000754828900026
J	Goncalves, CA; de Camargo, R; de Sousa, RTX; Soares, NS; de Oliveira, RC; Stanger, MC; Lana, RMQ; Lemes, EM				Goncalves, Carlos Andre; de Camargo, Reginaldo; Xavier de Sousa, Robson Thiago; Soares, Narcisa Silva; de Oliveira, Roberta Camargos; Stanger, Mayara Cristina; Quintao Lana, Regina Maria; Lemes, Ernane Miranda			Chemical and technological attributes of sugarcane as functions of organomineral fertilizer based on filter cake or sewage sludge as organic matter sources	PLOS ONE			English	Article							LAND-USE CHANGE; PHOSPHORUS; YIELD; SOIL; PRODUCTIVITY; EXPANSION	Sugarcane is one of the main alternative sources of biomass for the biofuel sector, and its large-scale production has considerable environmental impact. Organomineral fertilizers formulated with potential environmental contaminants, such as filter cake and sewage sludge, positively influence plant growth and development. The objective of the present study was to evaluate the chemical and physical characteristics of sugarcane fertilized with pelletized organomineral fertilizers based on filter cake or sewage sludge. Eight field treatments were applied, based on three organomineral fertilizer compositions (50%, 100%, and 150%) associated with two organic matter (OM) sources (filter cake or sewage sludge), in addition to a control with 100% mineral fertilizer application, and a no-fertilization control (0%). Sugarcane attributes were evaluated during two consecutive harvests. The weights of stalks per hectare (ton ha(-1)), sugarcane productivity (ton ha(-1)), quantity of sugar per hectare (TSH, ton ha(-1)), and physicochemical properties of sugarcane juice (pol [%], Brix [%], purity [%], and fiber [%]) were evaluated. There were no significant differences in the attributes between OM sources or organomineral fertilization treatments and the exclusive mineral fertilization. The organomineral fertilizer application rate recommended for maximum quantitative and qualitative sugarcane in the first sugarcane harvest was between 2 and 9% above the regular recommendation for mineral fertilizer, regardless of the OM source. In the second harvest, the sewage sludge source increased total sugar and sugarcane per hectare by 4.68 and 4.19%, respectively, compared to the sugarcane filter cake source. Sewage sludge and sugarcane filter cake are viable alternatives for organomineral composition and could improve economic returns and minimize negative environmental impacts in sugarcane cultivation systems.	[Goncalves, Carlos Andre; Soares, Narcisa Silva] Lutheran Univ Brazil ULBRA, Agron, Campus Itumbiara, Itumbiara, Go, Brazil; [de Camargo, Reginaldo; de Oliveira, Roberta Camargos; Stanger, Mayara Cristina; Quintao Lana, Regina Maria; Lemes, Ernane Miranda] Fed Univ Uberlandia UFU, Sci Agr Inst ICIAG, Campus Gloria, Uberlandia, MG, Brazil; [Xavier de Sousa, Robson Thiago] Vale Tijuco Sugarcane Mill Sugar & Alcohol Co Min, Uberaba, MG, Brazil	Universidade Federal de Uberlandia	Lemes, EM (corresponding author), Fed Univ Uberlandia UFU, Sci Agr Inst ICIAG, Campus Gloria, Uberlandia, MG, Brazil.	ernanefito@gmail.com		LEMES, ERNANE MIRANDA/0000-0001-6807-0644	Coordination of Superior Level Staff Improvement (CAPES); National Council for Scientific and Technological Development (CNPq); Special Fertilizers Study Group (GPFE-UFU)	Coordination of Superior Level Staff Improvement (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Special Fertilizers Study Group (GPFE-UFU)	We thank the Coordination of Superior Level Staff Improvement (CAPES) and National Council for Scientific and Technological Development (CNPq) for grant assistance, Lutheran University of Brazil (ULBRA), Federal University of Uberlandia (UFU) and Vale do Tijuco Sugarcane Mill for providing infrastructure and personal resources, and the Special Fertilizers Study Group (GPFE-UFU).	A lvarez Venegas V.H., 1999, RECOMENDACAO USO COR, P25, DOI DOI 10.1590/S0100-06832004000600008; ABISOLO, 2019, ASS BRAS IND TECN NU; Afáz Daniela Cristina de Souza, 2017, Rev. Ambient. Água, V12, P112, DOI 10.4136/ambi-agua.1965; de Oliveira ECA, 2011, REV CIENC AGRON, V42, P579; Almeida Junior JJ., 2020, BRAZ J DEV, V6, P7966, DOI [10.34117/bjdv6n10-281, DOI 10.34117/BJDV6N10-281]; Alves Filho A., 2016, INT J CURR RES, V8, P36802; Anjos ARM., 2000, SCI AGR, V57, P769, DOI [10.1590/S0103-90162000000400027, DOI 10.1590/S0103-90162000000400027]; [Anonymous], 2009, FONDLY WE HOPE FERVE; [Anonymous], 2010, SOILS PLANT GROWTH C; Araujo AP., 2006, NUTR MINERAL PLANTAS, P254; Beck HE, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.214; Bertoncini EI., 2015, APPL ENVIRON SOIL SC, V2015, P1, DOI [10.1155/2015/720167, DOI 10.1155/2015/720167]; BNDES, 2017, BANC NAC DES EC SOC; BRASIL, 2017, MANUAL METODOS ANALI; Buchkowski RW, 2016, SOIL BIOL BIOCHEM, V102, P29, DOI 10.1016/j.soilbio.2016.06.033; Caione Gustavo, 2011, Pesqui. Agropecu. Trop., V41, P66, DOI 10.5216/pat.v41i1.8497; Camargo R., 2020, REV CAMPO NEGOCIOS, V1, P26; Cardoso AF, 2015, REV CAATINGA, V28, P80, DOI 10.1590/1983-21252015v28n409rc; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Cherubin MR, 2016, GEODERMA, V265, P27, DOI 10.1016/j.geoderma.2015.11.017; Coleti J. T., 2006, STAB - Acucar, Alcool e Subprodutos, V24, P36; CONAB Nacional de Abastecimento Companhia, 2021, AC ENT SAFR BRAS, V7; CONSECANA, 2006, CONS PROD CAN DEAC A; da Mota RP, 2019, INT J RECYCLING ORG, V8, P131, DOI 10.1007/s40093-018-0237-3; Daros E, 45 ANOS VARIEDADES R, V1; de Almeida AB, 2011, REV BRAS ENG AGR AMB, V15, P1004, DOI 10.1590/S1415-43662011001000003; de Moraes ER, 2020, BIOSCI J, V36, P1564, DOI 10.14393/BJ-v36n5a2020-42189; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; EMBRAPA, 2011, MAN MET AN SOL, V2nd ed; EMBRAPA, 2013, EMPR BRAS PESQ AGR S, V3; de Fravet PRF, 2010, CIENC AGROTEC, V34, P618, DOI 10.1590/S1413-70542010000300013; Fernandes André L. T., 2007, Rev. bras. eng. agríc. ambient., V11, P159, DOI 10.1590/S1415-43662007000200005; Fernandes F., 2000, IMPACTO AMBIENTAL US, P45; Florentino AL, 2019, J CLEAN PROD, V220, P177, DOI 10.1016/j.jclepro.2019.02.065; Garcia JC., 2018, NUCLEUS, V15, P523, DOI [10.3738/1982.2278.2723, DOI 10.3738/1982.2278.2723]; Gonfa A., 2011, REV CERES, V7, P231, DOI [10.1590/S0034-737X2011000300014, DOI 10.1590/S0034-737X2011000300014]; Hailemariam WG, 2019, ENVIRON ENG SCI, V36, P798, DOI 10.1089/ees.2018.0549; Higashikawa F. S., 2017, Scientia Agraria, V18, P1, DOI 10.5380/rsa.v18i2.51219; IBGE. Instituto Brasileiro de Geografia e Estatistica, 2018, CLIMA; Kahiluoto H, 2015, ENVIRON SCI TECHNOL, V49, P2115, DOI 10.1021/es503387y; Kominko H, 2019, J ENVIRON MANAGE, V248, DOI 10.1016/j.jenvman.2019.109283; Korndorfer G. H., 1997, Sugar y Azucar, V92, P30; Lavanholi MGDP., 2010, CANA DEACUCAR, V32, P697; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Lucena Ehl, 2014, THESIS U FEDERAL RUR; Machado VJ., 2014, REV BRAS MILHO SORGO, V12, P203, DOI [10.18512/1980-6477/rbms.v12n3p203-213, DOI 10.18512/1980-6477/RBMS.V12N3P203-213]; Magela M. L. M., 2019, Australian Journal of Crop Science, V13, P863, DOI 10.21475/ajcs.19.13.06.p1538; Marques M. O., 2007, Bioscience Journal, V23, P111; Mendes LC, 2006, THESIS U FEDERAL VIC; Moraes ER., 2017, CANA DEACUCAR BIOEST, V13, P90, DOI [10.5747/ca.2017.v13.nesp2.000213, DOI 10.5747/CA.2017.V13.NESP2.000213]; Moraes ER, 2017, THESIS U FEDERAL UBE; Morais Katiule Pereira, 2017, Rev. Ceres, V64, P291, DOI 10.1590/0034-737x201764030010; Nautiyal C.Shekhar, FEMS MICROBIOL LETT, V170, P265, DOI [10.1111/j.1574-6968.1999.tb13411.x9987841, DOI 10.1111/J.1574-6968.1999.TB13411.X9987841, 10.1111/j.1574-6968.1999.tb13383.x, DOI 10.1111/J.1574-6968.1999.TB13383.X]; Negassa W, 2010, ENVIRON SCI TECHNOL, V44, P2092, DOI 10.1021/es902963c; Nunes Junior D., 2008, REV IDEA NEWS, V8, P22; Oliveira ARd., 2016, ENERG AGR, V31, P48, DOI [10.17224/EnergAgric.2016v31n1p48-58, DOI 10.17224/ENERGAGRIC.2016V31N1P48-58]; Oliveira DMS, 2019, RENEW SUST ENERG REV, V102, P346, DOI 10.1016/j.rser.2018.12.012; Ossom E. M., 2012, Tropical Agriculture, V89, P141; Otto R, 2016, BIOENERG RES, V9, P1272, DOI 10.1007/s12155-016-9763-x; Pavinato PS, 2009, SOIL TILL RES, V105, P149, DOI 10.1016/j.still.2009.07.001; Peres L. A. C., 2020, BRAZILIAN J DEV, V6, P10586, DOI [10.34117/bjdv6n3-075, DOI 10.34117/BJDV6N3-075]; Pina JC, 2015, REV BRAS ENG AGR AMB, V19, P650, DOI 10.1590/1807-1929/agriambi.v19n7p650-655; Prado R.M., 2013, APPL ENVIRON SOIL SC, V2013, P1, DOI [DOI 10.1155/2013/581984, 10.1155/2013/581984]; Ramos L. A., 2017, African Journal of Agricultural Research, V12, P20, DOI 10.5897/ajar2016.11024; Ripoli TCC., 2004, ELETRONICA EDITOR CO, P302; RODELLA AA, 1990, TURRIALBA, V40, P323; Rossetto R., 2007, ADUBACAO RESIDUOS AL; Santana Cleverton Tiago Carneiro de, 2012, Rev. Ciênc. Agron., V43, P22; Santos Diego Henriques, 2010, Pesqui. Agropecu. Trop., V40, P454; Santos DH, 2011, REV BRAS ENG AGR AMB, V15, P443, DOI 10.1590/S1415-43662011000500002; Sattolo TMS, 2017, AGR ECOSYST ENVIRON, V247, P63, DOI 10.1016/j.agee.2017.06.005; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Silva LG, 2017, SENSO COMUM GEOGRAFI; Soltangheisi A, 2019, REV BRAS CIENC SOLO, V43, DOI 10.1590/18069657rbcs20180227; Souza RTX., 2013, ENCICLOPEDIA BIOSFER, V9, P1196; Teixeira Edson Belisario, 2016, Cientifica (Jaboticabal), V44, P23, DOI 10.15361/1984-5529.2016v44n1p23-34; Teixeira WG, 2014, BIOSCI J, V30, P1729; Torres NH., 2012, REV CIENC AGROAMB, V10, P225; Trannin ICD, 2005, PESQUI AGROPECU BRAS, V40, P261, DOI 10.1590/S0100-204X2005000300010; Tukey JW., 1953, PROBLEM MULTIPLE COM; UNICA, 2021, IND CAN DE AC UN; Utami S. R., 2012, Journal of Agricultural Science (Toronto), V4, P153; Vasquez GH., 2015, BRAZ J BIOL ENG, V9, P53; Viator RP, 2002, AGRON J, V94, P1332, DOI 10.2134/agronj2002.1332; Water Environment Federation (WEF), 1996, DEV SOURC CONTR PROG, P382; Yadav SP, 2019, SUGAR TECH, V21, P170, DOI 10.1007/s12355-018-0641-z; Yao K., 2018, International Journal of Agricultural Policy and Research, V6, P1; Yehouenou E., 2009, B REC AGRON BENIN, V64, P27; Yuan ZG, 2012, CURR OPIN BIOTECH, V23, P878, DOI 10.1016/j.copbio.2012.08.001; Zar JH., 1999, BIOSTAT ANAL	90	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0236852	10.1371/journal.pone.0236852	http://dx.doi.org/10.1371/journal.pone.0236852			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910729	gold, Green Published			2022-12-26	WOS:000754828900001
J	Fransson, PA; Nilsson, MH; Rehncrona, S; Tjernstrom, F; Magnusson, M; Johansson, R; Patel, M				Fransson, Per-Anders; Nilsson, Maria H.; Rehncrona, Stig; Tjernstrom, Fredrik; Magnusson, Mans; Johansson, Rolf; Patel, Mitesh			Deep brain stimulation in the subthalamic nuclei alters postural alignment and adaptation in Parkinson's disease	PLOS ONE			English	Article							VIBRATORY PERTURBATIONS; CAMPTOCORMIA; BALANCE; TERM; STABILITY; TRUNK	Parkinson's disease (PD) can produce postural abnormalities of the standing body position such as kyphosis. We investigated the effects of PD, deep brain stimulation (DBS) in the subthalamic nucleus (STN), vision and adaptation on body position in a well-defined group of patients with PD in quiet standing and during balance perturbations. Ten patients with PD and 25 young and 17 old control participants were recruited. Body position was measured with 3D motion tracking of the ankle, knee, hip, shoulder and head. By taking the ankle as reference, we mapped the position of the joints during quiet standing and balance perturbations through repeated calf muscle vibration. We did this to explore the effect of PD, DBS in the STN, and vision on the motor learning process of adaptation in response to the repeated stimulus. We found that patients with PD adopt a different body position with DBS ON vs. DBS OFF, to young and old controls, and with eyes open vs. eyes closed. There was an altered body position in PD with greater flexion of the head, shoulder and knee (p <= 0.042) and a posterior position of the hip with DBS OFF (p <= 0.014). With DBS ON, body position was brought more in line with the position taken by control participants but there was still evidence of greater flexion at the head, shoulder and knee. The amplitude of movement during the vibration period decreased in controls at all measured sites with eyes open and closed (except at the head in old controls with eyes open) showing adaptation which contrasted the weaker adaptive responses in patients with PD. Our findings suggest that alterations of posture and greater forward leaning with repeated calf vibration, are independent from reduced movement amplitude changes. DBS in the STN can significantly improve body position in PD although the effects are not completely reversed. Patients with PD maintain adaptive capabilities by leaning further forward and reducing movement amplitude despite their kyphotic posture.	[Fransson, Per-Anders; Tjernstrom, Fredrik; Magnusson, Mans] Lund Univ, Dept Clin Sci, Lund, Sweden; [Nilsson, Maria H.] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Nilsson, Maria H.] Skane Univ Hosp, Memory Clin, Malmo, Sweden; [Nilsson, Maria H.] Lund Univ, Clin Memory Res Unit, Fac Med, Lund, Sweden; [Rehncrona, Stig] Lund Univ, Dept Neurosurg, Lund, Sweden; [Johansson, Rolf] Lund Univ, Dept Automat Control, Lund, Sweden; [Patel, Mitesh] Univ Wolverhampton, Sch Med & Clin Practice, Fac Sci, Wolverhampton, England	Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Lund University; University of Wolverhampton	Fransson, PA (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	per-anders.fransson@med.lu.se	Johansson, Rolf/C-1845-2013	Johansson, Rolf/0000-0002-0786-8561; Fransson, Per-Anders/0000-0002-9789-1748; Magnusson, Mans/0000-0002-4266-1996				Allert N, 2011, FORTSCHR NEUROL PSYC, V79, P97, DOI 10.1055/s-0029-1245994; Altman D.G., 1991, PRACTICAL STATISTIC; Artusi CA, 2018, ACTA NEUROL SCAND, V137, P481, DOI 10.1111/ane.12889; BARNES CD, 1983, BRAIN RES BULL, V11, P271, DOI 10.1016/0361-9230(83)90203-4; Bayot M, 2021, PARKINSONISM RELAT D, V84, P8, DOI 10.1016/j.parkreldis.2021.01.012; Bekkers EMJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00540; Benatru I, 2008, NEUROPHYSIOL CLIN, V38, P459, DOI 10.1016/j.neucli.2008.07.006; Bissolotti L, 2020, NEUROL SCI, V41, P3201, DOI 10.1007/s10072-020-04440-3; BRONSTEIN AM, 1990, BRAIN, V113, P767, DOI 10.1093/brain/113.3.767; Brown Elena V Donoso, 2020, J Phys Ther Sci, V32, P72, DOI 10.1589/jpts.32.72; Cabrera-Martos I, 2020, CLIN REHABIL, V34, P764, DOI 10.1177/0269215520918631; CALNE DB, 1993, NEW ENGL J MED, V329, P1021; Capelle HH, 2011, J NEUROL, V258, P96, DOI 10.1007/s00415-010-5695-0; Chan AK, 2019, J NEUROSURG, V131, P368, DOI 10.3171/2018.4.JNS173032; Chieng LO, 2015, J CLIN NEUROSCI, V22, P1555, DOI 10.1016/j.jocn.2015.05.018; Derost PP, 2007, NEUROLOGY, V68, P1345, DOI 10.1212/01.wnl.0000260059.77107.c2; Feller KJ, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00126; Fransson PA, 2004, EUR J APPL PHYSIOL, V91, P595, DOI 10.1007/s00421-003-1013-1; Fransson PA, 2003, IEEE T BIO-MED ENG, V50, P1310, DOI 10.1109/TBME.2003.819851; Fransson PA, 2003, IEEE ENG MED BIOL, V22, P53, DOI 10.1109/MEMB.2003.1195696; Fransson PA, 2002, BIOL CYBERN, V86, P355, DOI [10.1007/s00422-001-0305-y, 10.1007/s00422-001-305-y]; Fransson PA, 1998, GAIT POSTURE, V7, P64, DOI 10.1016/S0966-6362(97)00030-1; Fransson PA, 2000, GAIT POSTURE, V12, P14, DOI 10.1016/S0966-6362(00)00052-7; Fransson PA, 2007, J VESTIBUL RES-EQUIL, V17, P47; Fransson PA, 2020, J NEUROENG REHABIL, V17, DOI 10.1186/s12984-020-00677-3; Hafstrom A, 2014, HUM MOVEMENT SCI, V35, P30, DOI 10.1016/j.humov.2014.03.011; Honeine JL, 2017, J NEUROPHYSIOL, V117, P777, DOI 10.1152/jn.00725.2016; Hwang S, 2016, EXP BRAIN RES, V234, P2369, DOI 10.1007/s00221-016-4642-4; Ivanenko YP, 1999, EUR J NEUROSCI, V11, P647, DOI 10.1046/j.1460-9568.1999.00471.x; JOHANSSON R, 1988, IEEE T BIO-MED ENG, V35, P858, DOI 10.1109/10.7293; Kashihara K, 2012, PARKINSONISM RELAT D, V18, P290, DOI 10.1016/j.parkreldis.2011.11.012; Lai YJ, 2021, NPJ PARKINSONS DIS, V7, DOI 10.1038/s41531-020-00151-w; Lai YJ, 2021, J PARKINSON DIS, V11, P199, DOI 10.3233/JPD-202259; Liang SQ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.919682; Lyons M, 2012, TURK NEUROSURG, V22, P489, DOI 10.5137/1019-5149.JTN.3857-10.0; Margraf NG, 2016, J PARKINSON DIS, V6, P485, DOI 10.3233/JPD-160836; Melamed E, 2006, J NEUROL, V253, P14, DOI 10.1007/s00415-006-7004-5; Nakamura Y, 2019, SPINE SURG RELAT RES, V3, P348, DOI 10.22603/ssrr.2018-0046; Nilsson MH, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-13; Nilsson MH, 2005, ACTA NEUROL SCAND, V111, P301, DOI 10.1111/j.1600-0404.2005.00394.x; Ostergaard K, 2002, MOVEMENT DISORD, V17, P693, DOI 10.1002/mds.10188; Papalia R, 2019, Musculoskelet Surg, V103, P115, DOI 10.1007/s12306-018-0567-3; Patel M, 2008, EXP BRAIN RES, V185, P165, DOI 10.1007/s00221-007-1143-5; Patel M, 2010, GERONTOLOGY, V56, P284, DOI 10.1159/000265750; Patel M, 2021, GAIT POSTURE, V86, P217, DOI 10.1016/j.gaitpost.2021.03.023; Patel M, 2014, EXP BRAIN RES, V232, P2349, DOI 10.1007/s00221-014-3931-z; Roediger J, 2019, PARKINSONISM RELAT D, V62, P122, DOI 10.1016/j.parkreldis.2019.01.003; Sakai W, 2017, J PARKINSON DIS, V7, P247, DOI 10.3233/JPD-160948; Sakas DE, 2010, J NEUROSURG, V113, P1246, DOI 10.3171/2010.3.JNS09981; Schindlbeck KA, 2018, ACTA NEUROL SCAND, V137, P212, DOI 10.1111/ane.12859; Schlenstedt C, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01254; Schulz-Schaeffer WJ, 2015, MOVEMENT DISORD, V30, P368, DOI 10.1002/mds.26081; Srivanitchapoom P, 2016, J NEUROL NEUROSUR PS, V87, P75, DOI 10.1136/jnnp-2014-310049; Szlufik S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00906; Tjernstrom F, 2002, GAIT POSTURE, V15, P75, DOI 10.1016/S0966-6362(01)00175-8; Viseux FJF, 2020, NEUROPHYSIOL CLIN, V50, P479, DOI 10.1016/j.neucli.2020.10.013; Wang YJ, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.603814; Wright WG, 2007, EXP NEUROL, V208, P38, DOI 10.1016/j.expneurol.2007.07.002	58	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0259862	10.1371/journal.pone.0259862	http://dx.doi.org/10.1371/journal.pone.0259862			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905546	Green Published, gold			2022-12-26	WOS:000754615500002
J	Sinabulya, H; Silveira, A; Blomgren, L; Roy, J				Sinabulya, Helen; Silveira, Angela; Blomgren, Lena; Roy, Joy			Plasma levels of leucocyte elastase-generated cross linked fibrin degradation products (E-XDP) are elevated in chronic venous disease	PLOS ONE			English	Article							GRANULOCYTE-DERIVED ELASTASE; D-DIMER; MONOCLONAL-ANTIBODY; PREVALENCE	Patients with chronic venous disease (CVD) have elevated levels of leucocyte elastase (LE) released from the activation of leucocytes. In acute deep venous thrombosis (DVT), LE can degrade fibrin from the thrombus resulting in cross-linked fibrin degradation products (E-XDP) being released into the bloodstream. In patients with CVD the levels and significance of circulating E-XDP are unknown. We aimed to investigate the association between plasma E-XDP concentration and severity of CVD. Levels of E-XDP were quantified with a specific enzyme-linked immunosorbent assay (ELISA) in plasma from 142 consecutively recruited CVD patients (mean age 64 years, (range 23-89), 81 were females and 61 males). Patients were also divided into three groups based on CVD severity using the C-class of the Clinical-Etiological-Anatomical-Pathophysiological (CEAP) classification, with C 0-1 class as the reference group, C 2-3 as the second group and C 4-6 as the third group with the most severely affected patients. We found significantly elevated levels of E-XDP in patients with C 4-6 compared with patients with C 0-1 (p = 0.007) and increased with increasing disease severity across the groups (p = 0.02). Significant independent association was observed between levels of E-XDP and the classes C 4-6 after adjustment for age and sex (p < 0.05), but the association was no longer significant after further adjustment for use of statins, use of anticoagulants and history of DVT (p = 0.247). This exploratory study shows that E-XDP levels are elevated in patients with CVD, encouraging further studies on the role of E-XDP in CVD.	[Sinabulya, Helen; Roy, Joy] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Silveira, Angela] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Silveira, Angela] Karolinska Univ Hosp, Stockholm, Sweden; [Blomgren, Lena] Orebro Univ Hosp, Fac Med & Hlth, Dept Cardiovasc Surg, Karlskoga Vein Ctr, Orebro, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Orebro University	Sinabulya, H (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	helen.sinabulya@ki.se		Silveira, Angela/0000-0003-2063-4935; Sinabulya, Helen/0000-0002-9290-0393				Budzyn-Napierala M, 2016, PHLEBOLOGY, V31, P125, DOI 10.1177/0268355515569559; Criado PR, 2014, INT J LOW EXTR WOUND, V13, P130, DOI 10.1177/1534734614535407; Darvall KAL, 2009, J VASC SURG, V49, P1235, DOI 10.1016/j.jvs.2008.12.017; Davies AH, 2019, ADV THER, V36, P5, DOI 10.1007/s12325-019-0881-7; Eklof B, 2009, J VASC SURG, V49, P498, DOI 10.1016/j.jvs.2008.09.014; Favresse J, 2018, CRIT REV CL LAB SCI, V55, P548, DOI 10.1080/10408363.2018.1529734; Kamikura Y, 2005, THROMB RES, V115, P53, DOI 10.1016/j.thromres.2004.07.019; Karahan O., 2015, BLOOD COAGUL FIBRIN; Kohno I, 2000, BLOOD, V95, P1721, DOI 10.1182/blood.V95.5.1721.005k13_1721_1728; Liljeqvist ML, 2018, THROMB HAEMOSTASIS, V118, P329, DOI 10.1160/TH17-05-0348; Saanchez FSL, 2013, THROMB RES, V131, pE123, DOI 10.1016/j.thromres.2013.01.011; Lurie F, 2020, J VASC SURG-VENOUS L, V8, P342, DOI 10.1016/j.jvsv.2019.12.075; Madoiwa S, 2011, THROMB RES, V127, P349, DOI 10.1016/j.thromres.2010.12.008; Nowak M, 2021, POSTEP DERM ALERGOL, V38, P585, DOI 10.5114/ada.2021.108911; Olson JD, 2015, ADV CLIN CHEM, V69, P1, DOI 10.1016/bs.acc.2014.12.001; Raffetto JD, 2018, SURG CLIN N AM, V98, P337, DOI 10.1016/j.suc.2017.11.002; Sahebkar A, 2015, THROMB HAEMOSTASIS, V114, P546, DOI 10.1160/TH14-11-0937; Salim S., 2020, ANN SURG; SHIELDS DA, 1994, BRIT J SURG, V81, P1496, DOI 10.1002/bjs.1800811033; Suzuki A, 2007, THROMB RES, V121, P377, DOI 10.1016/j.thromres.2007.05.008; Vuylsteke ME, 2015, EUR J VASC ENDOVASC, V49, P432, DOI 10.1016/j.ejvs.2014.12.031; Yang CZ, 2020, BIOMARK MED, V14, P131, DOI 10.2217/bmm-2019-0225; Yang X, 2021, BMC NEUROL, V21, DOI 10.1186/s12883-021-02168-x; Zawadzki P, 2021, POL J SURG, V93, DOI 10.5604/01.3001.0014.9658	24	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261073	10.1371/journal.pone.0261073	http://dx.doi.org/10.1371/journal.pone.0261073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905581	Green Published, gold			2022-12-26	WOS:000754615500018
J	Pereira, J; Mouazen, AM; Foo, M; Ahmed, H				Pereira, Joao; Mouazen, Abdul Mounem; Foo, Mathias; Ahmed, Hafiz			A framework of artificial light management for optimal plant development for smart greenhouse application	PLOS ONE			English	Article							GROWTH; PHYTOCHROME; PHOTOSYNTHESIS; SURVIVAL; QUALITY; GENES; SHAPE	Smart greenhouse farming has emerged as one of the solutions to global food security, where farming productivity can be managed and improved in an automated manner. While it is known that plant development is highly dependent on the quantity and quality of light exposure, the specific impact of the different light properties is yet to be fully understood. In this study, using the model plant Arabidopsis, we systematically investigate how six different light properties (i.e., photoperiod, light offset, intensity, phase of dawn, duration of twilight and period) would affect plant development i.e., flowering time and hypocotyl (seedling stem) elongation using an established mathematical model of the plant circadian system relating light input to flowering time and hypocotyl elongation outputs for smart greenhouse application. We vary each of the light properties individually and then collectively to understand their effect on plant development. Our analyses show in comparison to the nominal value, the photoperiod of 18 hours, period of 24 hours, no light offset, phase of dawn of 0 hour, duration of twilight of 0.05 hour and a reduced light intensity of 1% are able to improve by at least 30% in days to flower (from 32.52 days to 20.61 days) and hypocotyl length (from 1.90 mm to 1.19mm) with the added benefit of reducing energy consumption by at least 15% (from 4.27 MWh/year to 3.62 MWh/year). These findings could provide beneficial solutions to the smart greenhouse farming industries in terms of achieving enhanced productivity while consuming less energy.	[Pereira, Joao] Coventry Univ, Sch Mech Aerosp & Automot Engn, Coventry, W Midlands, England; [Mouazen, Abdul Mounem] Univ Ghent, Dept Environm, Ghent, Belgium; [Foo, Mathias] Univ Warwick, Sch Engn, Coventry, W Midlands, England; [Ahmed, Hafiz] Bangor Univ, Nucl Futures Inst, Bangor, Gwynedd, Wales	Coventry University; Ghent University; University of Warwick; Bangor University	Ahmed, H (corresponding author), Bangor Univ, Nucl Futures Inst, Bangor, Gwynedd, Wales.	hafiz.ahmed@bangor.ac.uk	Ahmed, Hafiz/GWR-3787-2022; Mouazen, Abdul M./AAO-9709-2020; Foo, Mathias/GSO-3501-2022	Mouazen, Abdul M./0000-0002-0354-0067; Ahmed, Hafiz/0000-0001-8952-4190; Foo, Mathias/0000-0003-1400-2659	Royal Society [RGS/R2/180195]; Ser Cymru programme by Welsh European Funding Office (WEFO) under the European Regional Development Fund (ERDF)	Royal Society(Royal Society of London); Ser Cymru programme by Welsh European Funding Office (WEFO) under the European Regional Development Fund (ERDF)	MF acknowledges funding from the Royal Society via research grant RGS/R2/180195 (https://royalsociety.org/). HA is funded through the Ser Cymru programme by Welsh European Funding Office (WEFO) under the European Regional Development Fund (ERDF) (https://gov. wales/ser-cymru). The funders have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Gaadi KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162219; Baligar VC, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10101515; Bian ZH, 2015, J SCI FOOD AGR, V95, P869, DOI 10.1002/jsfa.6789; Borrill P, 2020, NEW PHYTOL, V228, P1721, DOI 10.1111/nph.16229; CASAL JJ, 1994, ANN BOT-LONDON, V73, P569, DOI 10.1006/anbo.1994.1071; CASAL JJ, 1989, PLANT CELL ENVIRON, V12, P855, DOI 10.1111/j.1365-3040.1989.tb01966.x; Chan AH., 2013, EXPEDITION, V3; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Corbesier L, 1996, PLANT J, V9, P947, DOI 10.1046/j.1365-313X.1996.9060947.x; De Caluwe J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00074; De Pinto A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231764; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dorais M., 2003, P CAN GREENH C TOR O; Dou HJ, 2017, HORTICULTURAE, V3, DOI 10.3390/horticulturae3020036; Fankhauser C, 1997, ANNU REV CELL DEV BI, V13, P203, DOI 10.1146/annurev.cellbio.13.1.203; Farre EM, 2012, PLANT BIOLOGY, V14, P401, DOI 10.1111/j.1438-8677.2011.00548.x; Fogelmark K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003705; Foo M, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007671; Foo M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004748; Food and Agriculture Organization of the United Nations, 2018, IMP DIS CRIS AGR FOO; Ghosh S, 2018, NAT PROTOC, V13, P2944, DOI 10.1038/s41596-018-0072-z; Gomez-Chabla R, 2019, ADV INTELL SYST COMP, V901, P68, DOI 10.1007/978-3-030-10728-4_8; Henriques R., 2018, ANN PLANT REV ONLINE, V1, P1, DOI DOI 10.1002/9781119312994.APR0655; Hiroki R, 2013, INT S NEW TECHN ENV; Hoff Mary, 2007, PLoS Biol, V5, pe227, DOI 10.1371/journal.pbio.0050227; Hotta CT, 2021, J EXP BOT, V72, P7668, DOI 10.1093/jxb/erab371; Hughes E., 2016, ELECT ELECT TECHNOLO; Inoue K, 2018, J PLANT RES, V131, P59, DOI 10.1007/s10265-017-0991-8; Jeong HW, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9050639; Jo HH, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0217-1; Jung C, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02011; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; 이혜인, 2013, Journal of Biosystems Engineering, V38, P279; Kunihiro A, 2011, PLANT CELL PHYSIOL, V52, P1315, DOI 10.1093/pcp/pcr076; Lai R, 2020, P 32 INT S POW SEM D; Lee JY, 2012, IEEE IJCNN; Lim R, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102726; Lork C, 2020, P 46 ANN C IEEE IND; Mahdavian M, 2017, MATH PROBL ENG, V2017, DOI 10.1155/2017/6862038; Mallik M., 2018, INT J PURE APPL BIOS, V6, P1033; Martin G, 2018, CURR BIOL, V28, P311, DOI 10.1016/j.cub.2017.12.021; Minh QT, 2017, P 8 INT S INF COMM T; Naznin MT, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8040093; Oakenfull RJ, 2017, PLANT CELL ENVIRON, V40, P2571, DOI 10.1111/pce.13033; Panayi E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181921; Paradiso R, 2022, J PLANT GROWTH REGUL, V41, P742, DOI 10.1007/s00344-021-10337-y; Pennisi G, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00305; Pokhilko A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.6; Pokhilko A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.69; Rayhana R, 2020, IEEE J RADIO FREQ ID, V4, P195, DOI 10.1109/JRFID.2020.2984391; Salazar JD, 2009, CELL, V139, P1170, DOI 10.1016/j.cell.2009.11.029; Schafer E., 2006, PHOTOMORPHOGENESIS P; Schmitt J, 1997, PLANT CELL ENVIRON, V20, P826, DOI 10.1046/j.1365-3040.1997.d01-96.x; Seaton DD, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145766; Tewolde FT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206592; Velasco MH, 2019, SCAND J FOREST RES, V34, P159, DOI 10.1080/02827581.2019.1578404; Watson A, 2018, NAT PLANTS, V4, P23, DOI 10.1038/s41477-017-0083-8; Watson RT., 2018, ENERGY INF, V1, P1, DOI DOI 10.1007/S42162-018-0005-7; Wenden B, 2011, PLANT J, V66, P480, DOI 10.1111/j.1365-313X.2011.04505.x; Zhang X, 2018, INT J AGR BIOL ENG, V11, P33, DOI [10.25165/j.ijabe.20181102.3420, 10.25165/j.ijabe.20181102.3240]	60	1	1	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0261281	10.1371/journal.pone.0261281	http://dx.doi.org/10.1371/journal.pone.0261281			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898651	Green Published, gold			2022-12-26	WOS:000755176200032
J	Borgogna, JLC; Anastario, M; Firemoon, P; Rink, E; Ricker, A; Ravel, J; Brotman, RM; Yeoman, CJ				Borgogna, Joanna-Lynn C.; Anastario, Michael; Firemoon, Paula; Rink, Elizabeth; Ricker, Adriann; Ravel, Jacques; Brotman, Rebecca M.; Yeoman, Carl J.			Vaginal microbiota of American Indian women and associations with measures of psychosocial stress	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; CORE REPORTING PRACTICES; BACTERIAL VAGINOSIS; HISTORICAL-TRAUMA; PSYCHOLOGICAL STRESS; HEALTH DISPARITIES; HIV ACQUISITION; SUBSTANCE USE; RACIAL MISCLASSIFICATION; NEISSERIA-GONORRHOEAE	Molecular-bacterial vaginosis (BV) is characterized by low levels of vaginal Lactobacillus species and is associated with higher risk of sexually transmitted infections (STI). Perceived psychosocial stress is associated with increased severity and persistence of infections, including STIs. American Indians have the highest rates of stress and high rates of STIs. The prevalence of molecular-BV among American Indian women is unknown. We sought to evaluate measures of psychosocial stress, such as historic loss (a multigenerational factor involving slavery, forced removal from one's land, legally ratified race-based segregation, and contemporary discrimination) and their association with the vaginal microbiota and specific metabolites associated with BV, in 70 Northwestern Plains American Indian women. Demographics, perceived psychosocial stressors, sexual practices, and known BV risk factors were assessed using a modified version of the American Indian Service Utilization, Psychiatric Epidemiology, Risk and Protective Factors Project survey. Self-collected mid-vaginal swabs were profiled for bacterial composition by 16S rRNA gene amplicon sequencing and metabolites quantified by targeted liquid-chromatography mass spectrometry. Sixty-six percent of the participants were classified as having molecular-BV, with the rest being either dominated by L. crispatus (10%) or L. iners (24%). High levels of lifetime trauma were associated with higher odds of having molecular-BV (adjusted Odds Ratio (aOR): 2.5, 95% Credible Interval (CrI): 1.1-5.3). Measures of psychosocial stress, including historic loss and historic loss associated symptoms, were significantly associated with lifestyle and behavioral practices. Higher scores of lifetime trauma were associated with increased concentrations of spermine (aFC: 3.3, 95% CrI: 1.2-9.2). Historic loss associated symptoms and biogenic amines were the major correlates of molecular-BV. Historical loss associated symptoms and lifetime trauma are potentially important underlying factors associated with BV.	[Borgogna, Joanna-Lynn C.; Yeoman, Carl J.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Borgogna, Joanna-Lynn C.; Yeoman, Carl J.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [Anastario, Michael] Florida Int Univ, Dept Hlth Promot & Dis Prevent, Miami, FL USA; [Firemoon, Paula] Ft Peck Commun Coll, Poplar, MT USA; [Rink, Elizabeth] Montana State Univ, Dept Hlth & Human Dev, Bozeman, MT USA; [Ricker, Adriann] Johns Hopkins Univ, Sch Nursing, Sch Publ Hlth, Baltimore, MD USA; [Ricker, Adriann] Johns Hopkins Univ, Sch Publ Hlth, Ctr Amer Indian Hlth, Baltimore, MD USA; [Ravel, Jacques; Brotman, Rebecca M.] Univ Maryland, Inst Genome Sci, Baltimore, MD USA; [Ravel, Jacques; Brotman, Rebecca M.] Univ Maryland, Sch Med, Baltimore, MD USA; [Ravel, Jacques] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD USA; [Ravel, Jacques] Univ Maryland, Sch Med, Baltimore, MD USA; [Brotman, Rebecca M.] Univ Maryland, Dept Epidemiol & Publ Hlth, Baltimore, MD USA; [Brotman, Rebecca M.] Univ Maryland, Sch Med, Baltimore, MD USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; State University System of Florida; Florida International University; Montana State University System; Montana State University Bozeman; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Yeoman, CJ (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.; Yeoman, CJ (corresponding author), Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA.	carl.yeoman@montana.edu	; Brotman, Rebecca/ABI-8373-2020	Borgogna, Joanna-Lynn/0000-0002-4488-4042; Brotman, Rebecca/0000-0001-8762-6214; Anastario, Michael/0000-0002-7761-572X	National Institutes of Health's National Institutes of General Medical Sciences (NIGMS); National Institute for Allergy & Infectious Disease (NIAID) [U54GM115371, P20GM103474, R21AI111145]; Montana Agricultural Experiment Station	National Institutes of Health's National Institutes of General Medical Sciences (NIGMS); National Institute for Allergy & Infectious Disease (NIAID); Montana Agricultural Experiment Station	This research was supported by the National Institutes of Health's National Institutes of General Medical Sciences (NIGMS; https://www.nigms.nih.gov/) and National Institute for Allergy & Infectious Disease (NIAID; https://www.niaid.nih.gov/) under award numbers U54GM115371 (CY), P20GM103474 (CY), and R21AI111145 (CY) and by the Montana Agricultural Experiment Station (https://agresearch.montana.edu/maes.html) (CY). The sponsors played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsen C, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170387; Adimora AA, 2011, AM J PUBLIC HEALTH, V101, P128, DOI 10.2105/AJPH.2009.174292; Ali MA, 2011, FOOD NUTR RES, V55, DOI [10.3402/fnr.v55i0.5572, 10.3402/fnr.v55i0.5455]; Amabebe E, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00568; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Anastario MP, 2013, J COMMUN HEALTH, V38, P894, DOI 10.1007/s10900-013-9695-8; Anastario M, 2020, J HEALTH COMMUN, V25, P412, DOI 10.1080/10810730.2020.1777599; Anastario M, 2020, SOC SCI MED, V258, DOI 10.1016/j.socscimed.2020.113120; Anastario M, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0146-1; Arbour M, 2009, JOGNN-J OBST GYN NEO, V38, P577, DOI 10.1111/j.1552-6909.2009.01053.x; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Beals J, 2005, AM J PSYCHIAT, V162, P1723, DOI 10.1176/appi.ajp.162.9.1723; Beals J, 2003, CULT MED PSYCHIAT, V27, P259, DOI 10.1023/A:1025347130953; Bertolli J, 2007, PUBLIC HEALTH REP, V122, P382, DOI 10.1177/003335490712200312; Biondi M, 1997, PSYCHOTHER PSYCHOSOM, V66, P3, DOI 10.1159/000289101; Black M.C., 2011, NATL INTIMATE PARTNE; Blankenstein T, 2015, ARCH GYNECOL OBSTET, V292, P355, DOI 10.1007/s00404-014-3613-x; Bohn Diane K, 2003, Issues Ment Health Nurs, V24, P333, DOI 10.1080/01612840305277; Borgogna JC, 2020, BJOG-INT J OBSTET GY, V127, P182, DOI 10.1111/1471-0528.15981; Borgogna JLC, 2021, APPL ENVIRON MICROB, V87, DOI 10.1128/AEM.03068-20; Borgogna JLC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60179-z; Brotman RM, 2008, AM J EPIDEMIOL, V168, P188, DOI 10.1093/aje/kwn103; Brotman RM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-471; Brotman RM, 2011, J CLIN INVEST, V121, P4610, DOI 10.1172/JCI57172; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Brotman RM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.043; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Carleton RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058067; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Carver CS, 1997, PERS SOC PSYCHOL B, V23, P865, DOI 10.1177/0146167297238007; Castor ML, 2006, AM J PUBLIC HEALTH, V96, P1478, DOI 10.2105/AJPH.2004.053942; Centers for Disease Control and Prevention, 2021, SEXUALLY TRANSMITTED, DOI [10.15620/cdc.79370, DOI 10.15620/CDC.79370]; Centers for Disease Control and Prevention (2022), WEB BAS INJ STAT QUE; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Cohen S, 2004, PSYCHOSOM MED, V66, P553, DOI 10.1097/01.psy.0000126200.05189.d3; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cohen S KR., 1998, MEASURING STRESS GUI; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Copen Casey E, 2017, Natl Health Stat Report, P1; Cox GR, 2021, SOCIOL HEALTH ILL, V43, P1774, DOI 10.1111/1467-9566.13355; Culhane J F, 2001, Matern Child Health J, V5, P127, DOI 10.1023/A:1011305300690; Culhane Jennifer F, 2006, Curr Infect Dis Rep, V8, P459, DOI 10.1007/s11908-006-0020-x; Culhane JF, 2002, AM J OBSTET GYNECOL, V187, P1272, DOI 10.1067/mob.2002.127311; de Ravello L, 2014, J SCHOOL HEALTH, V84, P25, DOI 10.1111/josh.12114; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; DUANE S, 1987, PHYS LETT B, V195, P216, DOI 10.1016/0370-2693(87)91197-X; Eitle D, 2015, SEX TRANSM DIS, V42, P64, DOI 10.1097/OLQ.0000000000000230; ELKIND AK, 1988, J ADV NURS, V13, P733, DOI 10.1111/j.1365-2648.1988.tb00564.x; Ellen JM, 1998, SEX TRANSM DIS, V25, P125, DOI 10.1097/00007435-199803000-00002; Espey DK, 2014, AM J PUBLIC HEALTH, V104, pS303, DOI 10.2105/AJPH.2013.301798; Evans-Campbell T, 2008, J INTERPERS VIOLENCE, V23, P316, DOI 10.1177/0886260507312290; Fernander A, 2010, ACTA OBSTET GYN SCAN, V89, P558, DOI 10.3109/00016340903508676; Fidler JA, 2009, NICOTINE TOB RES, V11, P1182, DOI 10.1093/ntr/ntp120; Fiori LM, 2008, J PSYCHIATR NEUROSCI, V33, P102; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gelman A HJ., 2007, DATA ANAL USING REGR; Gilad GM, 2002, BRAIN RES, V943, P23, DOI 10.1016/S0006-8993(02)02479-4; Gilad VH, 2001, BIOCHEM PHARMACOL, V61, P207, DOI 10.1016/S0006-2952(00)00517-7; Glaser R, 1999, JAMA-J AM MED ASSOC, V281, P2268, DOI 10.1001/jama.281.24.2268; Gong Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147637; Gong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107758; Gosmann C, 2017, IMMUNITY, V46, P29, DOI 10.1016/j.immuni.2016.12.013; Goytia M, 2013, FEMS MICROBIOL LETT, V343, P64, DOI 10.1111/1574-6968.12130; Goytia M, 2010, INFECT IMMUN, V78, P3187, DOI 10.1128/IAI.01301-09; Harling G, 2013, SEX TRANSM DIS, V40, P575, DOI 10.1097/OLQ.0b013e31829529cf; Hillier S, 1999, BACTERIAL VAGINOSIS; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; HILLIER SL, 1993, AM J OBSTET GYNECOL, V169, P455, DOI 10.1016/0002-9378(93)90340-O; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Hogben M, 2008, SEX TRANSM DIS, V35, pS13, DOI 10.1097/OLQ.0b013e31818d3cad; Holm JB, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00029-19; Imai K, 2008, J COMPUT GRAPH STAT, V17, P892, DOI 10.1198/106186008X384898; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; Kanjee U, 2013, ANNU REV MICROBIOL, V67, P65, DOI 10.1146/annurev-micro-092412-155708; Kaufman CE, 2007, SEX TRANSM DIS, V34, P767, DOI 10.1097/01.olq.0000260915.64098.cb; Kenyon C, 2018, EPIDEMIOL INFECT, V146, P2003, DOI 10.1017/S0950268818002157; Kunitz SJ, 1998, CHILD ABUSE NEGLECT, V22, P1079, DOI 10.1016/S0145-2134(98)00089-1; LIEB LE, 1992, J ACQ IMMUN DEF SYND, V5, P1137; Manson SM, 2005, AM J PUBLIC HEALTH, V95, P851, DOI 10.2105/AJPH.2004.054171; Martin DH, 2012, AM J MED SCI, V343, P2, DOI 10.1097/MAJ.0b013e31823ea228; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; McEwen A, 2008, NICOTINE TOB RES, V10, P843, DOI 10.1080/14622200802027248; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McKinnon LR, 2019, AIDS RES HUM RETROV, V35, P219, DOI [10.1089/aid.2018.0304, 10.1089/AID.2018.0304]; Miller HG, 1999, FAM PLANN PERSPECT, V31, P4, DOI 10.2307/2991550; Nansel TR, 2006, AM J OBSTET GYNECOL, V194, P381, DOI 10.1016/j.ajog.2005.07.047; Nardis C, 2013, Ann Ig, V25, P443, DOI 10.7416/ai.2013.1946; Neal R., HDB MARKOV CHAIN MON, P22011; Nelson TM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-14943-3; Nelson TM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00253; Newman LM, 2008, SEX TRANSM DIS, V35, pS4, DOI 10.1097/OLQ.0b013e31818eb90e; Office of the Surgeon General Center for Mental Health Services National Institute of Mental Health, 2001, MENT HLTH CULT RAC E; Peebles K, 2019, SEX TRANSM DIS, V46, P304, DOI 10.1097/OLQ.0000000000000972; Plummer EL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55929-7; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ravel J, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-29; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rink E, 2021, J ETHN CULT DIVERSIT, V30, P138, DOI 10.1080/15313204.2020.1770655; Rink E, 2017, J RURAL HEALTH, V33, P50, DOI 10.1111/jrh.12166; Rink E, 2015, J IMMIGR MINOR HEALT, V17, P1078, DOI 10.1007/s10903-014-0058-z; Rink E, 2015, INT J STD AIDS, V26, P98, DOI 10.1177/0956462414531240; Rosenberg M., 1979, CONCEIVING SELF; Rutman S, 2008, MATERN CHILD HLTH J, V12, pS76, DOI 10.1007/s10995-008-0351-3; Sandefur GD, 1997, POPUL RES POLICY REV, V16, P95, DOI 10.1023/A:1005788930351; Sandusky-Beltran LA, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0507-y; Sarche M, 2008, ANN NY ACAD SCI, V1136, P126, DOI 10.1196/annals.1425.017; Scales MB, 2009, HEALTH EDUC BEHAV, V36, P746, DOI 10.1177/1090198108317628; Schreiber JB, 2008, RES SOC ADM PHARM, V4, P83, DOI 10.1016/j.sapharm.2007.04.003; Schreiber JB, 2017, RES SOC ADMIN PHARM, V13, P634, DOI 10.1016/j.sapharm.2016.06.006; Seth P, 2011, PSYCHOL HEALTH MED, V16, P346, DOI 10.1080/13548506.2011.554562; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; Simoni JM, 2004, AIDS BEHAV, V8, P33, DOI 10.1023/B:AIBE.0000017524.40093.6b; Smilde AK, 2005, ANAL CHEM, V77, P6729, DOI 10.1021/ac051080y; Sobel JD, 2012, EUR J OBSTET GYN R B, V163, P81, DOI 10.1016/j.ejogrb.2012.03.022; SPIEGEL CA, 1980, NEW ENGL J MED, V303, P601, DOI 10.1056/NEJM198009113031102; Srinivasan S, 2015, MBIO, V6, DOI 10.1128/mBio.00204-15; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Stress in America&TRADE;, 2020, NAT MENT HLTH CRIS; Tamarelle J, 2019, CLIN MICROBIOL INFEC, V25, P35, DOI 10.1016/j.cmi.2018.04.019; TANFER K, 1995, FAM PLANN PERSPECT, V27, P196, DOI 10.2307/2136275; Thoroughman DA, 2002, AM J EPIDEMIOL, V155, P1137, DOI 10.1093/aje/155.12.1137; Tjaden PT N., 2000, FULL REPORT PREVALEN; TOOMEY KE, 1989, PUBLIC HEALTH REP, V104, P566; Turpin R., 2021, AM J EPIDEMIOL, V190, P2374, DOI [10.1093/aje/kwab147, DOI 10.1093/AJE/KWAB147]; Turpin R, 2019, ANN EPIDEMIOL, V32, P20, DOI 10.1016/j.annepidem.2019.01.010; van de Wijgert JHHM, 2009, SEX TRANSM DIS, V36, P357, DOI 10.1097/OLQ.0b013e3181a4f695; van der Veer C, 2017, CLIN INFECT DIS, V64, P24, DOI 10.1093/cid/ciw586; Vitali B, 2015, EUR J CLIN MICROBIOL, V34, P2367, DOI 10.1007/s10096-015-2490-y; Vodstrcil LA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171856; Walker FJ, 2015, J COMMUN HEALTH, V40, P484, DOI 10.1007/s10900-014-9961-4; Walters K.L., 1999, CULT DIVERS ETHN MIN, V5, P236, DOI [10.1037/1099-9809.5.3.236, DOI 10.1037/1099-9809.5.3.236]; Walters KL, 2011, DU BOIS REV, V8, P179, DOI 10.1017/S1742058X1100018X; Wei RM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19120-0; Whitbeck LB, 2004, AM J COMMUN PSYCHOL, V33, P119, DOI 10.1023/B:AJCP.0000027000.77357.31; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Williams-Washington, 2010, HDB AFRICAN AM HLTH, P31; Williams-Washington KN, 2018, J MULTICULT COUNS D, V46, P246, DOI 10.1002/jmcd.12113; Wirth M, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0484-1; Wolrath H, 2002, APMIS, V110, P819, DOI 10.1034/j.1600-0463.2002.1101108.x; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Yang J, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00004; Yang Q, 2016, CELL DEATH DIFFER, V23, P1850, DOI 10.1038/cdd.2016.71; Yeoman CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056111; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	153	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0260813	10.1371/journal.pone.0260813	http://dx.doi.org/10.1371/journal.pone.0260813			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890405	gold, Green Published			2022-12-26	WOS:000747293600018
J	Casu, C; Liu, A; De Rosa, G; Low, A; Suzuki, A; Sinha, S; Ginzburg, YZ; Abrams, C; Aghajan, M; Guo, S; Rivella, S				Casu, Carla; Liu, Alison; De Rosa, Gianluca; Low, Audrey; Suzuki, Aae; Sinha, Sayantani; Ginzburg, Yelena Z.; Abrams, Charles; Aghajan, Mariam; Guo, Shuling; Rivella, Stefano			Tmprss6-ASO as a tool for the treatment of Polycythemia Vera mice	PLOS ONE			English	Article							BETA-THALASSEMIA; IRON OVERLOAD; RUXOLITINIB; HEPCIDIN; MUTATION; ANEMIA; JAK2	Polycythemia Vera (PV) is a chronic myeloproliferative neoplasm resulting from an acquired driver mutation in the JAK2 gene of hematopoietic stem and progenitor cells resulting in the overproduction of mature erythrocytes and abnormally high hematocrit, in turn leading to thromboembolic complications. Therapeutic phlebotomy is the most common treatment to reduce the hematocrit levels and consequently decrease thromboembolic risk. Here we demonstrate that, by using the iron restrictive properties of the antisense oligonucleotides against Tmprss6 mRNA, we can increase hepcidin to achieve effects equivalent to therapeutic phlebotomy. We provide evidence that this less invasive approach could represent an additional therapeutic tool for the treatment of PV patients.	[Casu, Carla; Liu, Alison; De Rosa, Gianluca; Sinha, Sayantani; Rivella, Stefano] Childrens Hosp Philadelphia CHOP, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA; [Low, Audrey; Aghajan, Mariam; Guo, Shuling] Ionis Pharmaceut Inc, Carlsbad, CA 92008 USA; [Suzuki, Aae; Rivella, Stefano] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ginzburg, Yelena Z.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Rivella, Stefano] Univ Penn, Cell & Mol Biol Affin Grp CAMB, Philadelphia, PA 19104 USA; [Rivella, Stefano] Raymond G Perelman Ctr Cellular & Mol Therapeut C, Philadelphia, PA 19103 USA; [Rivella, Stefano] CHOP, Penn Ctr Musculoskeletal Disorders, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Ionis Pharmaceuticals, Inc.; University of Pennsylvania; Pennsylvania Medicine; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Casu, C (corresponding author), Childrens Hosp Philadelphia CHOP, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA.	casu.carla@gmail.com		casu, carla/0000-0001-8458-1786; Sinha, Sayantani/0000-0001-8197-0532	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01 DK090554, R01 DK095112]; MPN Foundation; National Heart, Lung, and Blood Institute of the National Institutes of Health [R01 HL146722, R01 HL146373]; Protagonist Therapeutics	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MPN Foundation; National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Protagonist Therapeutics	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (R01 DK090554, R01 DK095112) to S.R., MPN Foundation funding to Y.Z.G. and National Heart, Lung, and Blood Institute of the National Institutes of Health (R01 HL146722, R01 HL146373) to C.A. Ionis Pharmaceuticals did not provide financial support to this study. S.G. M.A. and A. L. are employees and shareholders of Ionis Pharmaceuticals. Y.Z.G. is a consultant for Ionis Pharmaceuticals and Protagonist Therapeutics and receives research funding from Protagonist Therapeutics. The remaining authors declare no competing financial interests. The specific roles of these authors are articulated in the `author contributions' section. Ionis Pharmaceuticals did not provide financial support to this study and only had roles in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casu C, 2020, BLOOD, V136, P1968, DOI 10.1182/blood.2019004719; Casu C, 2016, BLOOD, V128, P265, DOI 10.1182/blood-2015-10-676742; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Ginzburg Y KM., 2020, 62 ASH ANN M 1689 SE; Ginzburg YZ, 2018, LEUKEMIA, V32, P2105, DOI 10.1038/s41375-018-0207-9; Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Marchioli R, 2013, NEW ENGL J MED, V368, P22, DOI 10.1056/NEJMoa1208500; Mesa R, 2016, EUR J HAEMATOL, V97, P192, DOI 10.1111/ejh.12707; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Ramos E, 2012, BLOOD, V120, P3829, DOI 10.1182/blood-2012-07-440743; Ramos P, 2013, NAT MED, V19, P437, DOI 10.1038/nm.3126; Schmidt PJ, 2013, BLOOD, V121, P1200, DOI 10.1182/blood-2012-09-453977; Vannucchi AM, 2015, NEW ENGL J MED, V372, P426, DOI 10.1056/NEJMoa1409002	15	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0251995	10.1371/journal.pone.0251995	http://dx.doi.org/10.1371/journal.pone.0251995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890402	Green Published, gold			2022-12-26	WOS:000747293600001
J	Farooq, W; Tu, SS; Kazmi, SAA; Rehman, SU; Khan, AD; Khan, HA; Waqas, M; Rehman, OU; Ali, H; Noman, M				Farooq, Waqas; Tu, Shanshan; Kazmi, Syed Asfandyar Ali; Rehman, Sadaqat Ur; Khan, Adnan Daud; Khan, Haseeb Ahmad; Waqas, Muhammad; Rehman, Obaid Ur; Ali, Haider; Noman, Muhammad			Novel perovskite solar cell with Distributed Bragg Reflector	PLOS ONE			English	Article							EFFICIENCY; LAYER	This paper reports numerical modeling of perovskite solar cell which has been knotted with Distributed Bragg Reflector pairs to extract high energy efficiency. The geometry of the proposed cells is simulated with three different kinds of perovskite materials including CH3NH3PbI3, CH3NH3PbBr3, and CH3NH3SnI3. The toxic perovskite material based on Lead iodide and lead bromide appears to be more efficient as compared to non-toxic perovskite material. The executed simulated photovoltaic parameters with the highest efficient structure are open circuit voltage = 1.409 (V), short circuit current density = 24.09 mA/cm(2), fill factor = 86.18%, and efficiency = 24.38%. Moreover, a comparison of the current study with different kinds of structures has been made and surprisingly our novel geometry holds enhanced performance parameters that are featured with back reflector pairs (Si/SiO2). The applied numerical approach and presented designing effort of geometry are beneficial to obtain results that have the potential to address problems with less efficient thin-film solar cells.	[Farooq, Waqas; Kazmi, Syed Asfandyar Ali; Rehman, Obaid Ur] Sarhad Univ Sci & IT, Dept Elect Engn, Peshawar, Pakistan; [Tu, Shanshan; Waqas, Muhammad] Beijing Univ Technol, Fac Informat Technol, Engn Res Ctr Intelligent Percept & Autonomous Con, Beijing, Peoples R China; [Rehman, Sadaqat Ur] Namal Inst, Dept Comp Sci, Mianwali, Pakistan; [Khan, Adnan Daud; Noman, Muhammad] Univ Engn & Technol, US Pakistan Ctr Adv Studies Energy, Peshawar, Khyber Pukhtunk, Pakistan; [Khan, Haseeb Ahmad] Univ Engn & Technol, Dept Elect Engn, Mardan, Khyber Pukhtunk, Pakistan; [Ali, Haider] Univ Technol, Dept Elect & Elect Engn Technol, Nowshera, Pakistan	Beijing University of Technology; University of Engineering & Technology Peshawar	Tu, SS (corresponding author), Beijing Univ Technol, Fac Informat Technol, Engn Res Ctr Intelligent Percept & Autonomous Con, Beijing, Peoples R China.	sstu@bjut.edu.cn	Ur Rehman, Obaid/GRS-7096-2022	Noman, Muhammad/0000-0001-8718-6386; Waqas, Muhammad/0000-0003-0814-7544; Ali, Haider/0000-0002-2261-4105; Tu, Shanshan/0000-0002-6220-4119	Chongqing Industrial Control System Security Situational Awareness Platform; 2019 Industrial Internet Innovation and Development Project - Provincial Industrial Control System Security Situational Awareness Platform; Beijing Natural Science Foundation [4212015]; Natural Science Foundation of China [61801008]; China Ministry of Education - China Mobile Scientific Research Foundation [MCM20200102]; China Postdoctoral Science Foundation [2020M670074]; Beijing Municipal Commission of Education Foundation [KM201910005025]	Chongqing Industrial Control System Security Situational Awareness Platform; 2019 Industrial Internet Innovation and Development Project - Provincial Industrial Control System Security Situational Awareness Platform; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Ministry of Education - China Mobile Scientific Research Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Beijing Municipal Commission of Education Foundation(Beijing Municipal Commission of Education)	This work was sponsored through grants awarded to ST by Chongqing Industrial Control System Security Situational Awareness Platform, 2019 Industrial Internet Innovation and Development Project - Provincial Industrial Control System Security Situational Awareness Platform, Beijing Natural Science Foundation (No. 4212015), Natural Science Foundation of China (No. 61801008), China Ministry of Education - China Mobile Scientific Research Foundation (No. MCM20200102), China Postdoctoral Science Foundation (No. 2020M670074), and the Beijing Municipal Commission of Education Foundation (No. KM201910005025).	Ai HQ, 2020, J PHYS CHEM C, V124, P11221, DOI 10.1021/acs.jpcc.0c02498; Anctil A, 2020, APPL ENERG, V261, DOI 10.1016/j.apenergy.2019.114429; Baldha P, 2020, SMART INNOV SYST TEC, V161, P109, DOI 10.1007/978-981-32-9578-0_10; Birant G, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9040677; Duan JL, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201802346; Farooq W, 2020, IEEE ACCESS, V8, P210617, DOI 10.1109/ACCESS.2020.3038447; Farooq W, 2020, IEEE ACCESS, V8, P74093, DOI 10.1109/ACCESS.2020.2988325; Feng JS, 2018, ADV MATER, V30, DOI 10.1002/adma.201801418; Forghani K, 2019, IEEE PHOT SPEC CONF, P227, DOI 10.1109/PVSC40753.2019.8980776; Ghahremani AH, 2020, MATER DESIGN, V185, DOI 10.1016/j.matdes.2019.108237; Isabella O, 2012, J NON-CRYST SOLIDS, V358, P2295, DOI 10.1016/j.jnoncrysol.2011.11.025; Javed HMA, 2019, OPT COMMUN, V453, DOI 10.1016/j.optcom.2019.124408; Jung EH, 2019, NATURE, V567, P511, DOI 10.1038/s41586-019-1036-3; Kazmi SAA, 2020, APPL PHYS A-MATER, V126, DOI 10.1007/s00339-019-3221-5; Kodati R.B., ADV SCI LETT, V26; Lee H, 2020, ENERG ENVIRON SCI, V13, P404, DOI 10.1039/c9ee03348c; Lee JH, 2021, MATER LETT, V282, DOI 10.1016/j.matlet.2020.128828; Li M., 2020, ACS ENERGY LETT; Li SX, 2020, ACS ENERGY LETT, V5, P1554, DOI 10.1021/acsenergylett.0c00537; Li XP, 2020, SOL ENERGY, V195, P176, DOI 10.1016/j.solener.2019.11.045; Liu S, 2020, NAT PHOTONICS, V14, P300, DOI 10.1038/s41566-019-0573-5; Lo K.O., 2019, GOOGLE PATENTS; Mathur AS, 2020, OPTIK, V212, DOI 10.1016/j.ijleo.2020.164717; Mitra S, 2017, OPT COMMUN, V397, P1, DOI 10.1016/j.optcom.2017.03.070; Oliva D, 2019, J POWER SOURCES, V435, DOI 10.1016/j.jpowsour.2019.05.089; Peng YL, 2017, ENERGIES, V10, DOI 10.3390/en10050707; Ponnamma D, 2020, POLYM-PLAST TECH MAT, V59, P1, DOI 10.1080/25740881.2019.1614327; Prabeesh P, 2020, SOL ENERGY, V207, P419, DOI 10.1016/j.solener.2020.06.103; Ramanujam J, 2020, PROG MATER SCI, V110, DOI 10.1016/j.pmatsci.2019.100619; Rasheed M.S., 2019, INSIGHT ELECT, V1; Ren H, 2020, NAT PHOTONICS, V14, P154, DOI 10.1038/s41566-019-0572-6; Ren XD, 2020, INFOMAT, V2, P401, DOI 10.1002/inf2.12059; Sadegh F, 2020, NANO ENERGY, V75, DOI 10.1016/j.nanoen.2020.105038; Sato D, 2019, RENEW SUST ENERG REV, V104, P151, DOI 10.1016/j.rser.2018.12.051; Sebastian S, 2019, J MATER SCI-MATER EL, V30, P8024, DOI 10.1007/s10854-019-01124-3; Shahiduzzaman M, 2020, MATERIALS, V13, DOI 10.3390/ma13092207; Shariatinia Z, 2020, RENEW SUST ENERG REV, V119, DOI 10.1016/j.rser.2019.109608; Shi YQ, 2020, CHEMSUSCHEM, V13, P334, DOI 10.1002/cssc.201902966; Singh T, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201700677; Solanki A, 2020, ADV MATER, V32, DOI 10.1002/adma.201907864; Thambidurai M, 2020, MATER LETT, V274, DOI 10.1016/j.matlet.2020.128003; Tinedert IE, 2020, OPTIK, V208, DOI 10.1016/j.ijleo.2019.164112; Tune DD, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.201903261; Yamada S, 2020, SUPERLATTICE MICROST, V145, DOI 10.1016/j.spmi.2020.106640; Yoo JJ, 2019, ENERG ENVIRON SCI, V12, P2192, DOI 10.1039/c9ee00751b; Yu JC, 2019, ADV MATER, V31, DOI 10.1002/adma.201805554; Zhao YH, 2020, ACS APPL MATER INTER, V12, P12717, DOI 10.1021/acsami.9b21354	47	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0259778	10.1371/journal.pone.0259778	http://dx.doi.org/10.1371/journal.pone.0259778			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882697	gold, Green Published			2022-12-26	WOS:000755037200011
J	Hiadzi, RA; Boafo, IM; Tetteh, PM				Hiadzi, Rosemond Akpene; Boafo, Isaac Mensah; Tetteh, Peace Mamle			'God helps those who help themselves' ... religion and Assisted Reproductive Technology usage amongst urban Ghanaians	PLOS ONE			English	Article							IVF; DONATION	Assisted Reproductive Technology (ART) is increasingly becoming a viable option for infertile couples in Ghana. There exists significant literature that explores the gender, legal, religious and socio-cultural implications of ART usage. In this paper, we expand the discourse on the nexus between religion and ART usage by looking at how the former is used as a frame of reference in the decision-making process, as well as how it is employed to explain treatment successes and failures. Irrespective of religious orientation, there was a general acceptance of ART by participants in the study-with exceptions only when it came to some aspects of the procedure. Even here, participants' desperate desire to have children, tended to engender some accommodation of procedures they were uncomfortable with because of their religious beliefs. Thus, in contrast to some studies that suggest religion as interfering with ART use, we posit that religion is not an inhibiting factor to ART usage. On the contrary, it is an enabling factor, engendering the agentic attitude of participants to find a solution to their infertility in ART; as well as providing the strength to endure the physical and emotional discomfort associated with the biomedical process of conception and childbirth. In this context, religion thus provides participants with a frame of reference to navigate the spaces between decision-making, treatment processes and outcomes, and attributions of responsibility for the outcomes whatever they may be.	[Hiadzi, Rosemond Akpene; Boafo, Isaac Mensah; Tetteh, Peace Mamle] Univ Ghana, Coll Humanities, Dept Sociol, Accra, Ghana	University of Ghana	Boafo, IM (corresponding author), Univ Ghana, Coll Humanities, Dept Sociol, Accra, Ghana.	imboafo@gmail.com		Hiadzi, Rosemond Akpene/0000-0001-9376-877X				Adjah OA., 2011, AFRICAN RES DOCUMENT, V117, P3; Agbedor P., 2005, HDB EWELAND EWE TOGO, V3; Bawa S, 2019, AFR GEOGR REV, V38, P54, DOI 10.1080/19376812.2017.1286245; Benagiano G, 2004, REPROD BIOMED ONLINE, V9, P117, DOI 10.1016/S1472-6483(10)62118-9; Birenbaum-Carmeli D, 2004, SOCIOL HEALTH ILL, V26, P897, DOI 10.1111/j.0141-9889.2004.00422.x; Boafo IM, 2016, BMC NURS, V15, DOI 10.1186/s12912-016-0189-8; Braun V, 2019, QUAL RES SPORT EXERC, V11, P589, DOI 10.1080/2159676X.2019.1628806; CALDWELL JC, 1987, POPUL DEV REV, V13, P409, DOI 10.2307/1973133; Egblewogbe EY, 1987, UNIVERSITAS, V9, P189; Eshun EK, 2011, RELIG NATURE AKAN CU, DOI [10.1002/lt.22244, DOI 10.1002/LT.22244]; Gerrits Trudie, 2016, Reprod Biomed Soc Online, V2, P32, DOI 10.1016/j.rbms.2016.05.002; Hiadzi RA., 2019, GLOBAL REPROD HLTH, V4, pe32, DOI DOI 10.1097/GRH.0000000000000032; Horbst V, 2008, MUSLIM MED ETHICS TH, P118; Horbst V, 2016, ETHNIC HEALTH, V21, P357, DOI 10.1080/13557858.2015.1105184; Inhorn MC, 2006, CULT MED PSYCHIAT, V30, P427, DOI 10.1007/s11013-006-9027-x; Inhorn MC, 2010, REPROD BIOMED ONLINE, V21, P848, DOI 10.1016/j.rbmo.2010.09.008; Kahn SM, 2006, CULT MED PSYCHIAT, V30, P467, DOI 10.1007/s11013-006-9029-8; Kanaaneh RhodaAnn., 2002, BIRTHING NATION STRA; Kyei JM, 2020, INT J GYNECOL OBSTET, V149, P326, DOI 10.1002/ijgo.13132; Mbiti JohnS., 1990, AFRICAN RELIGIONS PH, V2nd Revised Enlarged ed.; Meyer B, 1992, J RELIG AFR, VXXXII; Nukunya G, 2013, TRADITION CHANGE GHA; Okonofua FE, 1997, HLTH TRANSIT REV, V7, P205, DOI 10.2307/40652279; Onah HE, 2008, J OBSTET GYNAECOL, V28, P96, DOI 10.1080/01443610701811928; Opoku KA, 1978, W AFRICAN TRADITIONA, DOI [10.1007/BF02235293, DOI 10.1007/BF02235293]; Parrinder G, 2014, W AFRICAN RELIG STUD; POBEE J, 1976, SOCIOL ANAL, V37, P1, DOI 10.2307/3710065; Roberts EFS, 2006, CULT MED PSYCHIAT, V30, P507, DOI 10.1007/s11013-006-9037-8; Sackey MB., 2002, I AFRICAN STUDIES RE, V18, P5; Shalev C, 2006, NASHIM, P151, DOI 10.1353/nsh.2006.0032	30	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260346	10.1371/journal.pone.0260346	http://dx.doi.org/10.1371/journal.pone.0260346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882706	gold, Green Published			2022-12-26	WOS:000755037200026
J	Hossain, MB; Alam, MZ; Islam, MS; Sultan, S; Faysal, MM; Rima, S; Hossain, MA; Al Mamun, A				Hossain, Mohammad Bellal; Alam, Md Zakiul; Islam, Md Syful; Sultan, Shafayat; Faysal, Md Mahir; Rima, Sharmin; Hossain, Md Anwer; Al Mamun, Abdullah			COVID-19 vaccine hesitancy among the adult population in Bangladesh: A nationwide cross-sectional survey	PLOS ONE			English	Article								Introduction Studies related to the COVID-19 vaccine hesitancy are scanty in Bangladesh, despite the growing necessity of understanding the population behavior related to vaccination. Thus, the present study was conducted to assess the prevalence of the COVID-19 vaccine hesitancy and its associated factors in Bangladesh to fill the knowledge gap. Methods and materials This study adopted a cross-sectional design to collect data from 1497 respondents using online (Google forms) and face-to-face interviews from eight administrative divisions of Bangladesh between 1-7 February 2021. We employed descriptive statistics and multiple logistic regression analysis. Results The prevalence of vaccine hesitancy was 46.2%. The Muslims (aOR = 1.80, p <= 0.01) and the respondents living in the city corporation areas (aOR = 2.14, p <= 0.001) had more hesitancy. There was significant variation in vaccine hesitancy by administrative divisions (geographic regions). Compared to the Sylhet division, the participants from Khulna (aOR = 1.31, p <= 0.001) had higher hesitancy. The vaccine hesitancy tended to decrease with increasing knowledge about the vaccine (aOR = 0.88, p <= 0.001) and the vaccination process (aOR = 0.91, p <= 0.01). On the other hand, hesitancy increased with the increased negative attitudes towards the vaccine (aOR = 1.17, p <= 0.001) and conspiracy beliefs towards the COVID-19 vaccine (aOR = 1.04, p <= 0.01). The perceived benefits of COVID-19 vaccination (aOR = 0.85, p <= 0.001) were negatively associated with hesitancy, while perceived barriers (aOR = 1.16, p <= 0.001) were positively associated. The participants were more hesitant to accept the vaccine from a specific country of origin (India, USA, Europe). Conclusions Our findings warrant that a vigorous behavior change communication campaign should be designed and implemented to demystify negative public attitudes and conspiracy beliefs regarding the COVID-19 Vaccine in Bangladesh. The policymakers should also think about revisiting the policy of the online registration process to receive the COVID-19 vaccine, as online registration is a key structural barrier for many due to the persistent digital divide in the country. Finally, the government should consider the population's preference regarding vaccines' country of manufacture to reduce the COVID-19 vaccine hesitancy.	[Hossain, Mohammad Bellal; Alam, Md Zakiul; Sultan, Shafayat; Faysal, Md Mahir; Hossain, Md Anwer; Al Mamun, Abdullah] Univ Dhaka, Dept Populat Sci, Dhaka, Bangladesh; [Islam, Md Syful] Jatiya Kabi Kazi Nazrul Islam Univ, Dept Populat Sci, Mymensingh, Bangladesh; [Rima, Sharmin] Ovibashi Karmi Unnayan Program OKUP, Dhaka, Bangladesh	University of Dhaka	Hossain, MB (corresponding author), Univ Dhaka, Dept Populat Sci, Dhaka, Bangladesh.	bellal@du.ac.bd	; Alam, Md. Zakiul/AAV-9704-2020	Islam, Md. Syful/0000-0001-9710-2377; Faysal, Md. Mahir/0000-0001-6074-5889; Hossain, Md. Anwer/0000-0002-8728-5250; Mamun, Abdullah Al/0000-0003-0126-4756; Alam, Md. Zakiul/0000-0003-0958-0147				A.Steptoe, 2020, medRxiv, DOI 10.1101/2020.10.21.20216218; Abedin M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250495; Ali I, 2020, MED ANTHROPOL, V39, P376, DOI 10.1080/01459740.2020.1745481; Ali M., 2021, BMJ OPEN, DOI [10.1136/bmjopen-2021-050303, DOI 10.1136/BMJOPEN-2021-050303]; Alwi SARS, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11071-6; Arshad MS, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9070720; Aziz A., 2020, MEDIA ASIA ROUTLEDGE, V47, P144, DOI [10.1080/01296612.2020.1843219, DOI 10.1080/01296612.2020.1843219]; Bangladesh Bureau of Statistics, 2019, REP BANGL SAMPL VIT; DeVellis R., 2003, SCALE DEV THEORY APP; Directorate General of Health Services (DGHS), 2021, COVID 19 VACC DASHB, DOI [10.1017/dmp.2021.151, DOI 10.1017/DMP.2021.151]; Eitze S, 2021, HEALTH PSYCHOL, V40, P77, DOI 10.1037/hea0001045; Elbarazi I, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016969; Elkalmi RM, 2021, J RELIG HEALTH, V60, P2411, DOI 10.1007/s10943-021-01212-x; Freeman D, 2022, PSYCHOL MED, V52, P3127, DOI [10.1017/S0033291720005188, 10.1017/S0033291721002609]; Guidry JPD, 2021, AM J INFECT CONTROL, V49, P137, DOI 10.1016/j.ajic.2020.11.018; Hasni NHM., 2021, J PUBLIC HEAL DEV; Hossain MB., 2021, MENDELEY DATA, pV1, DOI [10.17632/prgh4bb3yf.1, DOI 10.17632/PRGH4BB3YF.1]; Jain J, 2021, EPIDEMIOL INFECT, V149, DOI 10.1017/S0950268821001205; Kabir R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050416; Kanozia Rubal, 2021, MEDIA ASIA, V48, P313, DOI [10.1080/01296612.2021.1921963, DOI 10.1080/01296612.2021.1921963]; Kasozi KI., 2021, VACCINES-BASEL, P9, DOI [10.1038/s41541-020-00266-4, DOI 10.1038/S41541-020-00266-4]; Khan YH, 2020, AM J TROP MED HYG, V103, P603, DOI 10.4269/ajtmh.20-0654; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Latkin CA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246970; Lin C, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010016; Lin YL, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008961; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Mahmud S., 2021, ACCEPTANCE COVID 19, DOI [10.1371/journal.pone.0257096, DOI 10.1371/JOURNAL.PONE.0257096]; Mannan DKA, 2020, INT RES J BUS SOC SC, V6, P1, DOI 10.2139/ssrn.3763373; Mercadante AR, 2021, RES SOC ADMIN PHARM, V17, P1596, DOI 10.1016/j.sapharm.2020.12.012; Migrino J, 2020, WEST PAC SURVEILL RE, V11, DOI 10.5365/wpsar.2019.10.2.006; Momplaisir F, 2021, CLIN INFECT DIS, V73, P1784, DOI 10.1093/cid/ciab102; Munoz DC, 2015, INT J PUBLIC HEALTH, V60, P767, DOI 10.1007/s00038-015-0715-6; National Institute of Population Research and Training (NIPORT) ICF International, 2020, BANGL DEM HLTH SURV; Paul E, 2021, LANCET REG HEALTH-EU, V1, DOI 10.1016/j.lanepe.2020.100012; Peretti-Watel Patrick, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289; Qunaibi E, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050446; Rhodes A, 2021, LANCET INFECT DIS, V21, pE110, DOI 10.1016/S1473-3099(20)30724-6; Ruiz JB, 2021, VACCINE, V39, P1080, DOI 10.1016/j.vaccine.2021.01.010; Saad-Roy CM, 2020, SCIENCE, V370, P811, DOI 10.1126/science.abd7343; Saied SM, 2021, J MED VIROL, V93, P4280, DOI 10.1002/jmv.26910; Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010042; Sarathchandra D, 2018, PREV MED, V109, P1, DOI 10.1016/j.ypmed.2018.01.006; Shah GH, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18136772; Shapiro GK, 2016, PAPILLOMAVIRUS RES, V2, P167, DOI 10.1016/j.pvr.2016.09.001; Sheikh A, 2021, INFECT DIS REP, V13, P429, DOI 10.3390/idr13020041; Shmueli L., 2020, PREDICTING INTENTION, DOI [10.1101/2020.12.20.20248587, DOI 10.1101/2020.12.20.20248587]; Simas C, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00279-w; Taylor S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.575950; Ullah I, 2021, Vacunas, V22, P93, DOI 10.1016/j.vacun.2021.01.001; UN Prospects, 2019, A423 STESASER; United Nations Bangladesh, 2020, COVID 19 Q REP SUPP; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wiysonge CS, 2022, HUM VACC IMMUNOTHER, V18, P1, DOI 10.1080/21645515.2021.1893062; Wong LP, 2020, HUM VACC IMMUNOTHER, V16, P1511, DOI 10.1080/21645515.2019.1706935; Wong LP, 2020, HUM VACC IMMUNOTHER, V16, P2204, DOI 10.1080/21645515.2020.1790279; Wong MCS, 2021, VACCINE, V39, P1148, DOI 10.1016/j.vaccine.2020.12.083; World Bank, 2021, WORLD DEV IND 2021	58	14	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260821	10.1371/journal.pone.0260821	http://dx.doi.org/10.1371/journal.pone.0260821			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY8LQ	34882726	gold, Green Published, Green Submitted			2022-12-26	WOS:000755037200043
J	Huang, WT; Yu, JM; Yuan, ZJ; He, ZW; He, J; Deng, MH				Huang, Wentao; Yu, Jinman; Yuan, Zhijun; He, Zhongwei; He, Jun; Deng, Minghui			An adaptive under-frequency optimal control strategy for power system combined pumped storage and under-frequency load shedding	PLOS ONE			English	Article							UFLS SCHEMES; OPTIMIZATION; DESIGN	With the construction and development of ultra-high voltage (UHV) power grids, large-scale, long-distance power transmission has become common. A failure of the connecting line between the sending-end power grid and the receiving-end power grid will cause a large-scale power shortage and a frequency drop in the receiving-end power grid, which can result in the frequency collapse. Presently, under-frequency load shedding (UFLS) is adopted for solving the frequency control problem in emergency under-frequency conditions, which can easily cause large load losses. In this context, a frequency coordination optimal control strategy is proposed, which combines the mode transition of pumped storage units with UFLS to deal with emergency under-frequency problems. First, a mathematical model of the frequency dynamic response is established, which combines the mode transition of pumped storage units with UFLS based on a single-machine equivalent model. Then, an optimal model of the minimal area of the power system's operation frequency trajectory is introduced, yielding the optimal frequency trajectory, and is used for obtaining the action frequency of the joint control strategy. A simulated annealing algorithm based on the perturbation analysis is proposed for solving the optimal model, and the optimal action frequency is obtained that satisfies the transient frequency offset safety constraint of the power system. Thus, the joint optimal control of the mode transition of the pumped storage units and UFLS is realized. Finally, the EPRI-36 bus system and China's actual power grid are considered, for demonstrating the efficiency of the proposed strategy.	[Huang, Wentao; Yu, Jinman; Yuan, Zhijun; He, Jun; Deng, Minghui] Hubei Univ Technol, Sch Elect & Elect Engn, Wuhan, Hubei, Peoples R China; [He, Zhongwei] State Grid Hubei Elect Power Co Ltd, Enshi Power Supply Co, Enshi, Hubei, Peoples R China	Hubei University of Technology	Huang, WT; He, J (corresponding author), Hubei Univ Technol, Sch Elect & Elect Engn, Wuhan, Hubei, Peoples R China.	hwthwt1223@126.com; apm874@163.com		Yuan, Zhijun/0000-0002-3152-5171; He, Jun/0000-0002-2224-7333				Abedini M, 2014, IET GENER TRANSM DIS, V8, P2124, DOI 10.1049/iet-gtd.2013.0937; Acosta MN, 2020, ENERGIES, V13, DOI 10.3390/en13205390; [Anonymous], 2011, PRUEBA SOLEDAD PAISA; Arya Y, 2021, ENG SCI TECHNOL, V24, P384, DOI 10.1016/j.jestch.2020.08.015; Arya Y, 2020, IET GENER TRANSM DIS, V14, P2666, DOI 10.1049/iet-gtd.2019.1217; Arya Y, 2017, J RENEW SUSTAIN ENER, V9, DOI 10.1063/1.5018338; Banijamali SS, 2019, IEEE T POWER DELIVER, V34, P1098, DOI 10.1109/TPWRD.2018.2884089; Chen JH, 2017, ENGINEERING-PRC, V3, P512, DOI 10.1016/J.ENG.2017.04.019; Huang SJ, 2001, IEE P-GENER TRANSM D, V148, P165, DOI 10.1049/ip-gtd:20010020; Lai XJ, 2019, RENEW ENERG, V139, P302, DOI 10.1016/j.renene.2019.02.016; Li CG, 2020, IEEE T POWER SYST, V35, P950, DOI 10.1109/TPWRS.2019.2943150; [李琳 Li Lin], 2012, [电力系统自动化, Automation of Electric Power Systems], V36, P26; [梁亮 Liang Liang], 2015, [高电压技术, High Voltage Engineering], V41, P3288; Liu TC, 2019, IEEE ACCESS, V7, P68636, DOI 10.1109/ACCESS.2019.2914496; McGivern B, 2015, SIGARCH COMPUT ARCH, V39, P514, DOI [DOI 10.1145/1186736.1186737, 10.1145/1186736.1186737]; Perez-Diaz JI, 2020, WIRES ENERGY ENVIRON, V9, DOI 10.1002/wene.367; Rafinia A, 2020, INT J ELEC POWER, V121, DOI 10.1016/j.ijepes.2020.106137; Sarwar S, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12156234; Saxena Sahaj, 2021, Designs, V5, DOI 10.3390/designs5030052; Sigrist L, 2012, IEEE T POWER SYST, V27, P951, DOI 10.1109/TPWRS.2011.2174448; Sun ZL, 2017, INT T ELECTR ENERGY, V27, DOI 10.1002/etep.2365; Tang BJ, 2018, ENERG POLICY, V120, P365, DOI 10.1016/j.enpol.2018.04.067; Terzija VV, 2006, IEEE T POWER SYST, V21, P1260, DOI 10.1109/TPWRS.2006.879315; Xu X, 2017, IEEE T POWER SYST, V32, P2581, DOI 10.1109/TPWRS.2016.2619364; Xu YH, 2018, IEEE ACCESS, V6, P29067, DOI 10.1109/ACCESS.2018.2826015; Yang PH, 2019, IEEE ACCESS, V7, P144766, DOI 10.1109/ACCESS.2019.2946192; zhang s., P CSEE, P1, DOI [10.13334/j.0258-8013.pcsee.210531, DOI 10.13334/J.0258-8013.PCSEE.210531]; Zhang YC, 2017, IET GENER TRANSM DIS, V11, P3246, DOI 10.1049/iet-gtd.2016.1537; Zhao GP, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9163368	29	0	0	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0261093	10.1371/journal.pone.0261093	http://dx.doi.org/10.1371/journal.pone.0261093			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882730	gold, Green Published			2022-12-26	WOS:000755037200059
J	Muir, ER; Narayanan, D; Chandra, SB; Akimov, NP; Sohn, JH; Meyer, E; Renteria, RC; Duong, TQ				Muir, Eric R.; Narayanan, Divya; Chandra, Saurav B.; Akimov, Nikolay P.; Sohn, Jeong-Hyeon; Meyer, Evan; Renteria, Rene C.; Duong, Timothy Q.			Diabetic mice have retinal and choroidal blood flow deficits and electroretinogram deficits with impaired responses to hypercapnia	PLOS ONE			English	Article							MOUSE MODEL; CONTRAST SENSITIVITY; VASCULAR REACTIVITY; INS2(AKITA) MOUSE; CARBON-DIOXIDE; FOVEAL REGION; LIGHT PEAK; RETINOPATHY; OXYGEN; RATS	Purpose The purpose of this study was to investigate neuronal and vascular functional deficits in the retina and their association in a diabetic mouse model. We measured electroretinography (ERG) responses and choroidal and retinal blood flow (ChBF, RBF) with magnetic resonance imaging (MRI) in healthy and diabetic mice under basal conditions and under hypercapnic challenge. Methods Ins2(Akita) diabetic (Diab, n = 8) and age-matched, wild-type C57BL/6J mice (Ctrl, n = 8) were studied under room air and moderate hypercapnia (5% CO2). Dark-adapted ERG a-wave, b-wave, and oscillatory potentials (OPs) were measured for a series of flashes. Regional ChBF and RBF under air and hypercapnia were measured using MRI in the same mice. Results Under room air, Diab mice had compromised ERG b-wave and OPs (e.g., b-wave amplitude was 422.210.7 mu V in Diab vs. 600.1 +/- 13.9 mu V in Ctrl, p < 0.001). Under hypercapnia, OPs and b-wave amplitudes were significantly reduced in Diab (OPs by 30.3 +/- 3.0% in Diab vs. -3.0 +/- 3.6% in Ctrl, b-wave by 17.9 +/- 1.4% in Diab vs. 1.3 +/- 0.5% in Ctrl). Both ChBF and RBF had significant differences in regional blood flow, with Diab mice having substantially lower blood flow in the nasal region (ChBF was 5.4 +/- 1.0 ml/g/min in Diab vs. 8.6 +/- 1.0 ml/g/min in Ctrl, RBF was 0.91 +/- 0.10 ml/g/min in Diab vs. 1.52 +/- 0.24 ml/g/min in Ctrl). Under hypercapnia, ChBF increased in both Ctrl and Diab without significant group difference (31 +/- 7% in Diab vs. 17 +/- 7% in Ctrl, p > 0.05), but an increase in RBF was not detected for either group. Conclusions Inner retinal neuronal function and both retinal and choroidal blood flow were impaired in Diab mice. Hypercapnia further compromised inner retinal neuronal function in diabetes, while the blood flow response was not affected, suggesting that the diabetic retina has difficulty adapting to metabolic challenges due to factors other than impaired blood flow regulation.	[Muir, Eric R.] SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA; [Narayanan, Divya; Akimov, Nikolay P.; Sohn, Jeong-Hyeon; Renteria, Rene C.] Univ Texas Hlth San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Chandra, Saurav B.] Univ Texas Hlth San Antonio, Res Imaging Inst, San Antonio, TX USA; [Meyer, Evan] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Renteria, Rene C.] Univ Texas Hlth San Antonio, Ctr Biomed Neurosci, San Antonio, TX 78229 USA; [Renteria, Rene C.] Univ Incarnate Word, Sch Osteopath Med, Dept Clin & Appl Sci Educ, San Antonio, TX 78209 USA; [Duong, Timothy Q.] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Health San Antonio; Yeshiva University; Albert Einstein College of Medicine	Renteria, RC (corresponding author), Univ Texas Hlth San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA.; Renteria, RC (corresponding author), Univ Texas Hlth San Antonio, Ctr Biomed Neurosci, San Antonio, TX 78229 USA.; Renteria, RC (corresponding author), Univ Incarnate Word, Sch Osteopath Med, Dept Clin & Appl Sci Educ, San Antonio, TX 78209 USA.	rcrenter@uiwtx.edu		Duong, Tim/0000-0001-6403-2827	commercial company Biogen; commercial company Calyx; NIH [R01 EY023290, R01 EY027751]; Semp Russ Foundation; Lila G. and Dessey F. Taylor Fund of the San Antonio Area Foundation; IIMS/CTSA Translational Technology Award; IIMS/CTSA Center for Biomedical Neuroscience Pilot Project Award; National Center for Advancing Translational Sciences (NCATS) [8UL1TR001120]	commercial company Biogen; commercial company Calyx; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Semp Russ Foundation; Lila G. and Dessey F. Taylor Fund of the San Antonio Area Foundation; IIMS/CTSA Translational Technology Award; IIMS/CTSA Center for Biomedical Neuroscience Pilot Project Award; National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	DN received funding in the form of salary from the commercial company Biogen. SC received funding in the form of salary from the commercial company Calyx. This work was also supported by: NIH Grant R01 EY023290 (RCR; J-HS); NIH R01 EY027751 (TQD); the Semp Russ Foundation and Lila G. and Dessey F. Taylor Fund of the San Antonio Area Foundation (RCR, DN); IIMS/CTSA Translational Technology Award (RCR); IIMS/CTSA Center for Biomedical Neuroscience Pilot Project Award (RCR); the National Center for Advancing Translational Sciences (NCATS) Grant 8UL1TR001120. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abcouwer SF, 2014, ANN NY ACAD SCI, V1311, P174, DOI 10.1111/nyas.12412; ALM A, 1972, ACTA PHYSIOL SCAND, V84, P306, DOI 10.1111/j.1748-1716.1972.tb05182.x; ANDERSEN MVN, 1991, ACTA OPHTHALMOL, V69, P193; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Ashimatey BS, 2019, INVEST OPHTH VIS SCI, V60, P2468, DOI 10.1167/iovs.18-26417; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Basu R, 2009, AM J PHYSIOL-HEART C, V297, pH2096, DOI 10.1152/ajpheart.00452.2009; Berkowitz BA, 1999, INVEST OPHTH VIS SCI, V40, P2100; Blair NP, 2016, INVEST OPHTH VIS SCI, V57, P5903, DOI 10.1167/iovs.16-20082; Block F, 1998, GEN PHARMACOL-VASC S, V30, P281, DOI 10.1016/S0306-3623(97)00359-5; BRIAN JE, 1993, ANESTH ANALG, V77, P342, DOI 10.1213/00000539-199377020-00022; Campen MJ, 2005, J APPL PHYSIOL, V99, P807, DOI 10.1152/japplphysiol.00039.2005; Chandra S, 2016, INVEST OPHTH VIS SCI, V57, P826, DOI 10.1167/iovs.15-18291; Cioffi GA., 2003, ADLERS PHYSL EYE, V10th ed., P747; Clee SM, 2007, ENDOCR REV, V28, P48, DOI 10.1210/er.2006-0035; Constantinides Christakis, 2011, ILAR J, V52, pe21; Dmitriev AV, 2016, EXP EYE RES, V149, P16, DOI 10.1016/j.exer.2016.05.028; Drasdo N, 2002, LANCET, V359, P2251, DOI 10.1016/S0140-6736(02)09265-6; Eisma JH, 2015, WORLD J DIABETES, V6, P312, DOI 10.4239/wjd.v6.i2.312; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Geiser MH, 2000, CURR EYE RES, V21, P669, DOI 10.1076/0271-3683(200008)21:2;1-V;FT669; Granstam E, 1999, CURR EYE RES, V19, P330, DOI 10.1076/ceyr.19.4.330.5300; Gurley SB, 2010, AM J PHYSIOL-RENAL, V298, pF788, DOI 10.1152/ajprenal.90515.2008; Han ZC, 2013, INVEST OPHTH VIS SCI, V54, P574, DOI 10.1167/iovs.12-10959; Harris A, 1996, BRIT J OPHTHALMOL, V80, P209, DOI 10.1136/bjo.80.3.209; HIROI K, 1994, INVEST OPHTH VIS SCI, V35, P3957; Hombrebueno JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097970; Hosking SL, 2001, BRIT J OPHTHALMOL, V85, P1352, DOI 10.1136/bjo.85.11.1352; Kaldi I, 2003, EXP EYE RES, V76, P453, DOI 10.1016/S0014-4835(02)00334-2; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; Lei B, 2006, INVEST OPHTH VIS SCI, V47, P2732, DOI 10.1167/iovs.05-1461; Li G, 2012, EXP EYE RES, V101, P90, DOI 10.1016/j.exer.2012.06.006; Li Q, 2003, GRAEF ARCH CLIN EXP, V241, P747, DOI 10.1007/s00417-003-0740-7; LINSENMEIER RA, 1983, INVEST OPHTH VIS SCI, V24, P37; Maccotta L, 1997, NMR BIOMED, V10, P216, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<216::AID-NBM468>3.0.CO;2-U; Marro KI, 1997, NMR BIOMED, V10, P324, DOI 10.1002/(SICI)1099-1492(199710)10:7<324::AID-NBM491>3.0.CO;2-L; Mocko JA, 2011, INVEST OPHTH VIS SCI, V52, P4223, DOI 10.1167/iovs.10-6750; Muir ER, 2008, MAGN RESON MED, V60, P744, DOI 10.1002/mrm.21721; Muir ER, 2018, METHODS MOL BIOL, V1718, P59, DOI 10.1007/978-1-4939-7531-0_4; Muir ER, 2012, INVEST OPHTH VIS SCI, V53, P6488, DOI 10.1167/iovs.12-9758; Muir ER, 2011, MAGN RESON MED, V66, P1416, DOI 10.1002/mrm.22935; Munting LP, 2021, ELIFE, V10, DOI 10.7554/eLife.61279; Nair G, 2011, NEUROIMAGE, V54, P1063, DOI 10.1016/j.neuroimage.2010.09.020; Naito M, 2011, DIABETES, V60, P2265, DOI 10.2337/db10-1795; Nateras OS, 2014, CURR EYE RES, V39, P1059, DOI 10.3109/02713683.2014.892997; NIEMEYER G, 1984, VISION RES, V24, P275, DOI 10.1016/0042-6989(84)90131-7; Nowik M, 2010, CELL PHYSIOL BIOCHEM, V26, P1059, DOI 10.1159/000323984; PAKOLA SJ, 1993, INVEST OPHTH VIS SCI, V34, P2866; Peng Q, 2011, MAGN RESON MED, V65, P1768, DOI 10.1002/mrm.22763; Poulin MJ, 1996, J APPL PHYSIOL, V81, P1084, DOI 10.1152/jappl.1996.81.3.1084; Pournaras CJ, 2008, PROG RETIN EYE RES, V27, P284, DOI 10.1016/j.preteyeres.2008.02.002; Regan RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070751; RIVA CE, 1983, INVEST OPHTH VIS SCI, V24, P47; RIVA CE, 1994, INVEST OPHTH VIS SCI, V35, P4273; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Tummala SR, 2009, EXP EYE RES, V89, P801, DOI 10.1016/j.exer.2009.07.014; Lopez OV, 2010, DOC OPHTHALMOL, V121, P9, DOI 10.1007/s10633-010-9223-4; Venkataraman ST, 2008, EXP EYE RES, V87, P535, DOI 10.1016/j.exer.2008.08.020; Wang J, 2015, EXP EYE RES, V139, P48, DOI 10.1016/j.exer.2015.07.002; Wang L, 2008, EXP EYE RES, V86, P908, DOI 10.1016/j.exer.2008.03.005; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wolf NS, 2000, EXP EYE RES, V70, P683, DOI 10.1006/exer.2000.0835; Wong EC, 2014, J MAGN RESON IMAGING, V40, P1, DOI 10.1002/jmri.24565; Woodward WR, 2007, DOC OPHTHALMOL, V115, P187, DOI 10.1007/s10633-007-9079-4; Wright WS, 2012, EXP EYE RES, V98, P9, DOI 10.1016/j.exer.2012.03.003	67	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0259505	10.1371/journal.pone.0259505	http://dx.doi.org/10.1371/journal.pone.0259505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882677	gold, Green Published			2022-12-26	WOS:000755037200008
J	Tamin, S; Adham, M; Noer, A; Supriana, N; Bardosono, S				Tamin, Susyana; Adham, Marlinda; Noer, Arfan; Supriana, Nana; Bardosono, Saptawati			Upright epiglottis prevents aspiration in patients with nasopharyngeal carcinoma post-chemoradiation	PLOS ONE			English	Article							DYSPHAGIA; RADIOTHERAPY; THERAPY; MANAGEMENT; HEAD	NPC is the most widely found malignant tumor in the head and neck region in Indonesia. Chemoradiation therapy for NPC can induce swallowing disorders (dysphagia) that adversely affects a patients quality of life. This study aimed to assess the swallowing process by flexible endoscopic evaluation of swallowing in patients with nasopharyngeal carcinoma after chemoradiation. Thirty-nine patients with NPC who had chemoradiation therapy more than one month previously underwent flexible endoscopic evaluation of swallowing and were assessed for oral transport time, sensation, standing-secretion, pre-swallowing leakage, residue, penetration, aspiration, and silent aspiration. The most common structural abnormalities were an upright and swollen epiglottis (89.4%), poor oral hygiene, and velopharyngeal closure defects (56.4%). This examination also revealed a mild degree of standing secretion (38.5%) and aspiration (10.3%). No penetration was observed in 64.1% of the patients, and no silent aspiration was observed in any of the patients. A severe degree of residue (45.7%) was observed when administering oatmeal, while the residue was mild to moderate when administering gastric rice, crackers, and milk. The residue changed to a mild degree (32.3%-51.4%) in all food administrations after the watering maneuver. The highest penetration was noted after oatmeal administration (42.8%), and the highest aspiration was found after milk administration (8.6%). Standing secretion in almost all patients was caused by hyposensitivity of the hypopharynx. Persistent residue and hyposensitivity of the hypopharynx led to aspiration. The low percentage of aspiration and silent aspiration might have been caused by the upright and swollen epiglottis that prevented aspiration. Poor oral hygiene and a dry mouth led to prolonged oral transport. Therefore, most patients had hypopharyngeal abnormalities in the form of a swollen and upright epiglottis. Secretion and food residue were also detected. Drinking helps to expedite the swallowing process by facilitating oral phase transport and reducing residues.	[Tamin, Susyana; Adham, Marlinda; Noer, Arfan] Univ Indonesia, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Supriana, Nana] Univ Indonesia, Fac Med, Dept Radio Oncol, Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Bardosono, Saptawati] Univ Indonesia, Fac Med, Dept Nutr Sci, Cipto Mangunkusumo Hosp, Jakarta, Indonesia	University of Indonesia; University of Indonesia; University of Indonesia	Tamin, S (corresponding author), Univ Indonesia, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Cipto Mangunkusumo Hosp, Jakarta, Indonesia.	usyana@yahoo.com		Tamin, Susyana/0000-0002-6402-7021	Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Indonesia; Department of Radio Oncology, Faculty of Medicine, Universitas Indonesia; Department of Nutrition Science, Faculty of Public Health, Universitas Indonesia	Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Indonesia; Department of Radio Oncology, Faculty of Medicine, Universitas Indonesia; Department of Nutrition Science, Faculty of Public Health, Universitas Indonesia	We would like to thank the Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Indonesia; Department of Radio Oncology, Faculty of Medicine, Universitas Indonesia; and the Department of Nutrition Science, Faculty of Public Health, Universitas Indonesia, for supporting this study.	Abdullah B, 2009, MALAYS J MED SCI, V16, P50; Adham M, 2012, CHIN J CANCER, V31, P185, DOI 10.5732/cjc.011.10328; Akagunduz OO, 2019, ANN OTO RHINOL LARYN, V128, P73, DOI 10.1177/0003489418804260; Fattori B, 2016, ACTA OTORHINOLARYNGO, V36, P395, DOI 10.14639/0392-100X-829; Fong Raymond, 2020, World J Otorhinolaryngol Head Neck Surg, V6, P10, DOI 10.1016/j.wjorl.2020.02.005; Jayalie VF., 2016, EJOURNAL KEDOKTERAN, V4, P156; Jordan T, 2018, NUTR CANCER, V70, P23, DOI 10.1080/01635581.2017.1374417; Kanno M, 2019, CANCERS, V11, DOI 10.3390/cancers11081180; King SN, 2016, DYSPHAGIA, V31, P339, DOI 10.1007/s00455-016-9710-1; Ku PK, 2007, LARYNGOSCOPE, V117, P142, DOI 10.1097/01.mlg.0000248738.55387.44; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Lin YS, 2002, CANCER, V95, P404, DOI 10.1002/cncr.10668; Logrippo S, 2017, CLIN INTERV AGING, V12, P241, DOI 10.2147/CIA.S121905; Mahdavifar Neda, 2016, Osong Public Health Res Perspect, V7, P360, DOI 10.1016/j.phrp.2016.11.002; Matsuo K, 2008, PHYS MED REH CLIN N, V19, P691, DOI 10.1016/j.pmr.2008.06.001; Meccariello G, 2022, AURIS NASUS LARYNX, V49, P117, DOI 10.1016/j.anl.2021.05.007; Ng LKY, 2011, HEAD NECK-J SCI SPEC, V33, P1335, DOI 10.1002/hed.21627; Nurada IGK., 2020, INT J NASOPHARYNGEAL, V2, P112; Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4; Patterson JM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00401; Pauloski BR, 2015, HEAD NECK-J SCI SPEC, V37, P1575, DOI 10.1002/hed.23796; Pinna R, 2015, THER CLIN RISK MANAG, V11, P171, DOI 10.2147/TCRM.S70652; Reynolds J, 2016, ADV NEONAT CARE, V16, P37, DOI 10.1097/ANC.0000000000000245; Salehiniya H., 2018, NASOPHARYNGEAL CANC, V5, P1; Santoro GP, 2021, ORL J OTO-RHINO-LARY, V83, P304, DOI 10.1159/000513889; Seo HG, 2016, DYSPHAGIA, V31, P160, DOI 10.1007/s00455-015-9670-x; Serra A, 2016, EUR ARCH OTO-RHINO-L, V273, P4359, DOI 10.1007/s00405-016-4177-0; Servagi-Vernat S, 2015, EUR ANN OTORHINOLARY, V132, P25, DOI 10.1016/j.anorl.2013.09.006; Spieker MR, 2000, AM FAM PHYSICIAN, V61, P3639; Steele CM, 2010, DYSPHAGIA, V25, P323, DOI 10.1007/s00455-010-9301-5; Tamin S., 2018, J PHYS C S, V1073, DOI [10.1088/1742-6596/1073/2/022022, DOI 10.1088/1742-6596/1073/2/022022]; Wang Kevin H, 2017, Perm J, V21, P16, DOI 10.7812/TPP/16-180; Wu CH, 2000, ANN OTO RHINOL LARYN, V109, P320, DOI 10.1177/000348940010900315; Xie SH, 2013, EUR J CANCER, V49, P150, DOI 10.1016/j.ejca.2012.07.004	34	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0261110	10.1371/journal.pone.0261110	http://dx.doi.org/10.1371/journal.pone.0261110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882745	gold, Green Published			2022-12-26	WOS:000755037200060
J	Akiyoshi, K; Boersma, GJ; Johnson, MD; Velasquez, FC; Dunkerly-Eyring, B; O'Brien, S; Yamaguchi, A; Steenbergen, C; Tamashiro, KLK; Das, S				Akiyoshi, Kei; Boersma, Gretha J.; Johnson, Miranda D.; Velasquez, Fernanda Carrizo; Dunkerly-Eyring, Brittany; O'Brien, Shannon; Yamaguchi, Atsushi; Steenbergen, Charles; Tamashiro, Kellie L. K.; Das, Samarjit			Role of miR-181c in Diet-induced obesity through regulation of lipid synthesis in liver	PLOS ONE			English	Article							METABOLISM; GLUCOSE; DYSFUNCTION; LIPOGENESIS; ACTIVATION; EXPRESSION; MICRORNAS; PLAYS; IDH1	We recently identified a nuclear-encoded miRNA (miR-181c) in cardiomyocytes that can translocate into mitochondria to regulate mitochondrial gene mt-COX1 and influence obesity-induced cardiac dysfunction through the mitochondrial pathway. Because liver plays a pivotal role during obesity, we hypothesized that miR-181c might contribute to the pathophysiological complications associated with obesity. Therefore, we used miR-181c/d(-/-) mice to study the role of miR-181c in hepatocyte lipogenesis during diet-induced obesity. The mice were fed a high-fat (HF) diet for 26 weeks, during which indirect calorimetric measurements were made. Quantitative PCR (qPCR) was used to examine the expression of genes involved in lipid synthesis. We found that miR-181c/d(-/-) mice were not protected against all metabolic consequences of HF exposure. After 26 weeks, the miR-181c/d(-/-) mice had a significantly higher body fat percentage than did wild-type (WT) mice. Glucose tolerance tests showed hyperinsulinemia and hyperglycemia, indicative of insulin insensitivity in the miR-181c/d(-/-) mice. miR-181c/d(-/-) mice fed the HF diet had higher serum and liver triglyceride levels than did WT mice fed the same diet. qPCR data showed that several genes regulated by isocitrate dehydrogenase 1 (IDH1) were more upregulated in miR-181c/d(-/-) liver than in WT liver. Furthermore, miR-181c delivered in vivo via adeno-associated virus attenuated the lipogenesis by downregulating these same lipid synthesis genes in the liver. In hepatocytes, miR-181c regulates lipid biosynthesis by targeting IDH1. Taken together, the data indicate that overexpression of miR-181c can be beneficial for various lipid metabolism disorders.	[Akiyoshi, Kei; Velasquez, Fernanda Carrizo; Das, Samarjit] Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Boersma, Gretha J.; Johnson, Miranda D.; O'Brien, Shannon; Tamashiro, Kellie L. K.] Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Dunkerly-Eyring, Brittany; Steenbergen, Charles; Das, Samarjit] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Yamaguchi, Atsushi] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Saitama, Japan	Johns Hopkins University; Johns Hopkins Medicine; Jichi Medical University	Das, S (corresponding author), Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.; Tamashiro, KLK (corresponding author), Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.; Das, S (corresponding author), Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	ktamashiro@jhmi.edu; sdas11@jhmi.edu		Dunkerly-Eyring, Brittany/0000-0003-4684-5861; Das, Samarjit/0000-0002-4377-2823				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Bouchie A, 2013, NAT BIOTECHNOL, V31, P577, DOI 10.1038/nbt0713-577; Boutari C, 2020, METABOLISM, V103, DOI 10.1016/j.metabol.2019.154028; Brown MS, 2010, SCIENCE, V328, P1495, DOI 10.1126/science.1192409; Cho YE, 2013, AM J PHYSIOL-CELL PH, V305, pC1033, DOI 10.1152/ajpcell.00234.2013; Chu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08801; Das S, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004694; Das S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096820; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; Geng XF, 2016, GENE, V575, P224, DOI 10.1016/j.gene.2015.08.066; Ghadge AA, 2019, CYTOKINE, V121, DOI 10.1016/j.cyto.2019.154735; Harrison C, 2010, NAT REV DRUG DISCOV, V9, P515, DOI 10.1038/nrd3208; Hashimoto Y, 2010, CARCINOGENESIS, V31, P777, DOI 10.1093/carcin/bgq013; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kastaniotis AJ, 2017, BBA-MOL CELL BIOL L, V1862, P39, DOI 10.1016/j.bbalip.2016.08.011; Koh HJ, 2004, J BIOL CHEM, V279, P39968, DOI 10.1074/jbc.M402260200; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Li J, 2013, INT J CARDIOL, V168, P1441, DOI 10.1016/j.ijcard.2012.12.048; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lodhi IJ, 2014, CELL METAB, V19, P380, DOI 10.1016/j.cmet.2014.01.002; Mackenzie RM, 2013, CLIN SCI, V124, P403, DOI 10.1042/CS20120239; Martin SD, 2014, MOL METAB, V3, P408, DOI 10.1016/j.molmet.2014.02.001; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mukherjee A, 2014, J VIROL, V88, P7929, DOI 10.1128/JVI.00787-14; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Rio P, 2012, BLOOD, V119, P3042, DOI 10.1182/blood-2011-01-331017; Roman B, 2020, J MOL CELL CARDIOL, V144, P87, DOI 10.1016/j.yjmcc.2020.05.009; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Scott KA, 2010, BIOL REPROD, V83, P220, DOI 10.1095/biolreprod.109.082826; Shechter I, 2003, J LIPID RES, V44, P2169, DOI 10.1194/jlr.M300285-JLR200; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103	37	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0256973	10.1371/journal.pone.0256973	http://dx.doi.org/10.1371/journal.pone.0256973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879063	Green Submitted, gold, Green Published			2022-12-26	WOS:000754625200001
J	Lamichhane, A; Rana, S; Shrestha, K; Paudyal, R; Malla, P; Upadhyaya, S; Uprety, D; Gurung, J; Satow, E				Lamichhane, Ashish; Rana, Shubheksha; Shrestha, Krishna; Paudyal, Rakshya; Malla, Parash; Upadhyaya, Shanti; Uprety, Durga; Gurung, Julie; Satow, Elizabeth			Violence and sexual and reproductive health service disruption among girls and young women during COVID-19 pandemic in Nepal: A cross-sectional study using interactive voice response survey	PLOS ONE			English	Article							EVENTS	Introduction There is a paucity of data on the impact of COVID-19 pandemic on girls and young women. The study examines the prevalence and correlates of violence and sexual and reproductive health (SRH) service disruption among girls and young women during COVID-19 restrictions and lockdown. Methods An interactive voice response survey was conducted among girls and women aged 18-24 years between 10th March to 24th April 2021. The survey enrolled 1314 participants. Descriptive analysis was used to assess prevalence of violence and SRH service disruption. Two sampled test of proportion was used to asses difference in prevalence of violence before and after the pandemic. Logistic regression was used to examine relationship between the outcome variables and socio demographic predictors. Results The study did not find significant difference in prevalence of violence before and after the pandemic. Education was found to be protective against experience of both physical and sexual violence after the pandemic. Dalit participants were four times more likely to report physical violence after the pandemic than Brahmin/Chhetri participants (OR:3.80; CI:1.41-10.24). Participants from 22-24-year age group were twice as likely to experience sexual violence compared to girls and participants from 18-21year age group (OR:2.25; CI:1.04-4.84). Participants from urban municipalities were 29% less likely to report SRH services disruption than participants from rural municipalities (OR-0.71, 95% CI: 0.55-0.91). Participants with disability were twice as likely to report disruption than participants without disability (OR-2.35, 95% CI: 1.45-3.82). Conclusions To reduce violence against girls and women due to the pandemic, interventions should focus on Dalit women and on preventing education discontinuation among girls and women. SRH service during the pandemic needs to be improved for girls and women with focus on girls and women from rural municipalities and girls and women with disability.	[Lamichhane, Ashish; Rana, Shubheksha; Shrestha, Krishna; Paudyal, Rakshya; Malla, Parash; Upadhyaya, Shanti; Uprety, Durga; Gurung, Julie; Satow, Elizabeth] Plan Int Nepal, Kathmandu, Nepal		Lamichhane, A (corresponding author), Plan Int Nepal, Kathmandu, Nepal.	ashish.lamichhane@plan-international.org		Lamichhane, Ashish/0000-0001-8272-1538				Abuhammad S, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13824; Alkan O, 2021, BMC WOMENS HEALTH, V21, DOI 10.1186/s12905-021-01333-1; Behrman JA, 2017, J ADOLESCENT HEALTH, V60, P184, DOI 10.1016/j.jadohealth.2016.09.010; Bennet L., 2008, DHS FURTHER ANAL REP; Bhadra S., 2021, NEW YORK TIMES; Boserup B, 2020, AM J EMERG MED, V38, P2753, DOI 10.1016/j.ajem.2020.04.077; Bradbury-Jones C, 2020, J CLIN NURS, V29, P2047, DOI 10.1111/jocn.15296; CBS, 2012, NAT POP HOUS CENS 20; DoHS, 2018, ANN REP 2017 18; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Ghosh R, 2020, 2020 IEEE ELECTRICAL INSULATION CONFERENCE (EIC), P190, DOI [10.20529/IJME.2020.056, 10.1109/EIC47619.2020.9158742]; Grey M, 2005, FEM THEOL, V14, P127, DOI 10.1177/0966735005057806; Hagan E, 2021, SEX ABUSE-J RES TR, V33, P176, DOI 10.1177/1079063219889059; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Israel G.D., 1992, DETERMINING SAMPLE S; Lamichhane P, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-19; Landis D., 2018, COMPARE; Lavrakas P. J., 2008, ENCY SURVEY RES METH, DOI [DOI 10.4135/9781412963947, 10.4135/9781412963947]; Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1872; Ministry of Health and Population and New Era ICF Inc, 2017, NEP DEM HLTH SURV 20; Neil Jennifer, 2020, Aust J Gen Pract, V49, DOI 10.31128/AJGP-COVID-25; Office of the Prime Minister and Council of Ministers, 2012, STUD GEND BAS VIOL C; Pariyo GW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214450; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pokhrel D, 2021, REPROD HEALTH, V18, DOI 10.1186/s12978-020-01036-0; Samandari G, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-7; Sanchez OR, 2020, INT J GYNECOL OBSTET, V151, P180, DOI 10.1002/ijgo.13365; Sharma J., 2020, NEPAL HELPLINE SERVE; Sharma K, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.599280; Siddique JA, 2016, J INTERPERS VIOLENCE, V31, P2556, DOI 10.1177/0886260515579507; Singh DR, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06176-y; Sob D, 2012, VOICE DALIT, V5, P57; Szabo G., 2020, GLOBAL GIRLHOOD REPO; Tacoli Cecilia, 2012, URBANIZATION GENDER; Nguyen TA, 2021, LANCET REG HEALTH-W, V7, DOI 10.1016/j.lanwpc.2020.100077; UNDP, 2021, UNDP NEP; UNICEF, 2018, AN MENSTR HYG PRACT; Unicef, 2020, BUILD BACK EQ GIRLS; van Gelder N, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100348; Vieira Pâmela Rocha, 2020, Rev. bras. epidemiol., V23, pe200033, DOI 10.1590/1980-549720200033; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Vora M, 2020, ASIAN J PSYCHIATR, V53, DOI 10.1016/j.ajp.2020.102227; Wooldridge J. M., 2016, INTRO ECONOMETRICS M; Yahya Ahmed Saeed, 2020, Prim Care Companion CNS Disord, V22, DOI 10.4088/PCC.20com02634; Yu Z, 2022, OPER MANAGE RES, V15, P233, DOI 10.1007/s12063-021-00179-y	45	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260435	10.1371/journal.pone.0260435	http://dx.doi.org/10.1371/journal.pone.0260435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY2LS	34879111	gold, Green Published			2022-12-26	WOS:000754625200018
J	Wong, DH; Mardock, AL; Manrriquez, EN; Lai, TS; Sanaiha, Y; Sinno, AK; Benharash, P; Cohen, JG				Wong, Deanna H.; Mardock, Alexandra L.; Manrriquez, Erica N.; Lai, Tiffany S.; Sanaiha, Yas; Sinno, Abdulrahman K.; Benharash, Peyman; Cohen, Joshua G.			Trends in extent of surgical cytoreduction for patients with ovarian cancer	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; PRIMARY SURGERY; UNITED-STATES; SURVIVAL; DISPARITIES; CARE; VOLUME	Purpose To identify patient and hospital characteristics associated with extended surgical cytoreduction in the treatment of ovarian cancer. Methods A retrospective analysis using the National Inpatient Sample (NIS) database identified women hospitalized for surgery to remove an ovarian malignancy between 2013 and 2017. Extended cytoreduction (ECR) was defined as surgery involving the bowel, liver, diaphragm, bladder, stomach, or spleen. Chi-square and logistic regression were used to analyze patient and hospital demographics related to ECR, and trends were assessed using the Cochran-Armitage test. Results Of the estimated 79,400 patients undergoing ovarian cancer surgery, 22% received ECR. Decreased adjusted odds of ECR were found in patients with lower Elixhauser Comorbidity Index (ECI) scores (OR 0.61, p<0.001 for ECI 2, versus ECI >= 3) or residence outside the top income quartile (OR 0.71, p<0.001 for Q1, versus Q4), and increased odds were seen at hospitals with high ovarian cancer surgical volume (OR 1.25, p<0.001, versus low volume). From 2013 to 2017, there was a decrease in the proportion of cases with extended procedures (19% to 15%, p<0.001). There were significant decreases in the proportion of cases with small bowel, colon, and rectosigmoid resections (p<0.001). Patients who underwent ECR were more likely treated at a high surgical volume hospital (37% vs 31%, p<0.001) over the study period. For their hospital admission, patients who underwent ECR had increased mortality (1.6% vs. 0.5%, p<0.001), length of stay (9.6 days vs. 5.2 days, p<0.001), and mean cost ($32,132 vs. $17,363, p<0.001). Conclusions Likelihood of ECR was associated with increased medical comorbidity complexity, higher income, and undergoing the procedure at high surgical volume hospitals. The proportion of ovarian cancer cases with ECR has decreased from 2013-17, with more cases performed at high surgical volume hospitals.	[Wong, Deanna H.; Mardock, Alexandra L.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Manrriquez, Erica N.; Lai, Tiffany S.; Cohen, Joshua G.] Univ Calif Los Angeles, Dept Obstet & Gynecol, Div Gynecol Oncol, Los Angeles, CA 90024 USA; [Sanaiha, Yas; Benharash, Peyman] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiac Surg, Cardiovasc Outcomes Res Labs CORELAB, Los Angeles, CA 90095 USA; [Sinno, Abdulrahman K.] Univ Miami, Div Gynecol Oncol, Dept Obstet & Gynecol, Coral Gables, FL 33124 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Miami	Cohen, JG (corresponding author), Univ Calif Los Angeles, Dept Obstet & Gynecol, Div Gynecol Oncol, Los Angeles, CA 90024 USA.	JGCohen@mednet.ucla.edu		Wong, Deanna/0000-0003-4622-0511				Aletti GD, 2006, GYNECOL ONCOL, V100, P283, DOI 10.1016/j.ygyno.2005.08.027; Aletti GD, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.10.495; [Anonymous], 2019, SEER CANC STAT FACTS; Barrett M CR, 2017, METHODS APPLYING AHR; Bartels HC, 2019, GYNECOL ONCOL, V154, P622, DOI 10.1016/j.ygyno.2019.07.011; Boyd LR, 2011, CANCER-AM CANCER SOC, V117, P777, DOI 10.1002/cncr.25490; Bristow RE, 2015, OBSTET GYNECOL, V125, P833, DOI 10.1097/AOG.0000000000000643; Bristow RE, 2014, GYNECOL ONCOL, V132, P403, DOI 10.1016/j.ygyno.2013.12.017; Bristow RE, 2010, GYNECOL ONCOL, V118, P262, DOI 10.1016/j.ygyno.2010.05.025; Bristow RE, 2009, GYNECOL ONCOL, V115, P334, DOI 10.1016/j.ygyno.2009.08.025; Chan JK, 2008, J SURG ONCOL, V97, P103, DOI 10.1002/jso.20932; Chang SJ, 2012, GYNECOL ONCOL, V125, P483, DOI 10.1016/j.ygyno.2012.02.024; Eisenhauer EL, 2006, GYNECOL ONCOL, V103, P1083, DOI 10.1016/j.ygyno.2006.06.028; Eisenstein S, 2019, CLIN COLON RECT SURG, V32, P41, DOI 10.1055/s-0038-1673353; Elattar A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007565.pub2, 10.1002/14651858.CD007565]; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Eskander RN, 2018, GYNECOL ONCOL, V149, P525, DOI 10.1016/j.ygyno.2018.03.043; Gunakan Emre, 2020, Obstet Gynecol Sci, V63, P64, DOI 10.5468/ogs.2020.63.1.64; Howlader N., 2016, SEER CANC STAT REV; Jones NL, 2018, INT J GYNECOL CANCER, V28, P19, DOI 10.1097/IGC.0000000000001132; Kehoe S, 2015, LANCET, V386, P249, DOI 10.1016/S0140-6736(14)62223-6; Matsuo K, 2021, GYNECOL ONCOL, V160, P32, DOI 10.1016/j.ygyno.2020.10.027; Morrison J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005343.pub3; Moss JL, 2019, SUPPORT CARE CANCER, V27, P531, DOI 10.1007/s00520-018-4340-9; Nasioudis D, 2019, GYNECOL ONCOL, V154, P401, DOI 10.1016/j.ygyno.2019.05.016; Ross J, 2017, GYNECOL ONCOL, V145, P329, DOI 10.1016/j.ygyno.2017.02.025; Sinno AK, 2017, GYNECOL ONCOL, V145, P493, DOI 10.1016/j.ygyno.2017.03.020; Smith CG, 2019, HEALTHCARE-BASEL, V7, DOI 10.3390/healthcare7030085; Stewart SL, 2017, CANCER-AM CANCER SOC, V123, P5138, DOI 10.1002/cncr.31027; Torre LA, 2018, CA-CANCER J CLIN, V68, P284, DOI 10.3322/caac.21456; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Wallace S, 2017, GYNECOL ONCOL, V145, P21, DOI 10.1016/j.ygyno.2017.01.029; Walsh C, 2018, MINERVA GINECOL, V70, P150, DOI 10.23736/S0026-4784.17.04152-1; Wright JD, 2019, GYNECOL ONCOL, V154, P394, DOI 10.1016/j.ygyno.2019.05.025; Wright JD, 2017, OBSTET GYNECOL, V130, P545, DOI 10.1097/AOG.0000000000002164	35	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260255	10.1371/journal.pone.0260255	http://dx.doi.org/10.1371/journal.pone.0260255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879081	Green Published, gold			2022-12-26	WOS:000754625200009
J	Yang, J; Zhou, JY; Li, CL; Wang, SH				Yang, Jun; Zhou, Jiaying; Li, Cuili; Wang, Shaohua			Integrated analysis of the functions and prognostic values of RNA-binding proteins in neuroblastoma	PLOS ONE			English	Article							TRANSLATIONAL CONTROL; CLASSIFICATION; NETWORK; FAMILY	Background Neuroblastoma (NB) is the most common solid tumor in children. NB treatment has made significant progress; however, given the high degree of heterogeneity, basic research findings and their clinical application to NB still face challenges. Herein, we identify novel prognostic models for NB. Methods We obtained RNA expression data of NB and normal nervous tissue from TARGET and GTEx databases and determined the differential expression patterns of RNA binding protein (RBP) genes between normal and cancerous tissues. Lasso regression and Cox regression analyses identified the five most important differentially expressed genes and were used to construct a new prognostic model. The function and prognostic value of these RBPs were systematically studied and the predictive accuracy verified in an independent dataset. Results In total, 348 differentially expressed RBPs were identified. Of these, 166 were up-regulated and 182 down-regulated RBPs. Two hubs RBPs (CPEB3 and CTU1) were identified as prognostic-related genes and were chosen to build the prognostic risk score models. Multivariate Cox analysis was performed on genes from univariate Cox regression and Lasso regression analysis using proportional hazards regression model. A five gene prognostic model: Risk score = (-0.60901*expCPEB3)+(0.851637*expCTU1) was built. Based on this model, the overall survival of patients in the high-risk subgroup was lower (P = 2.152e-04). The area under the curve (AUC) of the receiver-operator characteristic curve of the prognostic model was 0.720 in the TARGET cohort. There were significant differences in the survival rate of patients in the high and low-risk subgroups in the validation data set GSE85047 (P = 0.1237e-08), with the AUC 0.730. The risk model was also regarded as an independent predictor of prognosis (HR = 1.535, 95% CI = 1.368-1.722, P = 2.69E-13). Conclusions This study identified a potential risk model for prognosis in NB using Cox regression analysis. RNA binding proteins (CPEB3 and CTU1) can be used as molecular markers of NB.	[Yang, Jun; Zhou, Jiaying; Li, Cuili] Univ Hong Kong, ShenZhen Hosp, Dept Pediat, Shenzhen, Peoples R China; [Wang, Shaohua] Univ South China, Dept Pediat, Women & Children Inst Futian, Shenzhen, Peoples R China	University of Hong Kong; University of South China	Wang, SH (corresponding author), Univ South China, Dept Pediat, Women & Children Inst Futian, Shenzhen, Peoples R China.	lwwsbs22@163.com						Ackermann S, 2018, SCIENCE, V362, P1165, DOI 10.1126/science.aat6768; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bennett CL, 2018, ACTA NEUROPATHOL, V136, P425, DOI 10.1007/s00401-018-1852-9; Chatterji P, 2018, TRENDS MOL MED, V24, P490, DOI 10.1016/j.molmed.2018.03.008; Chen YZ, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12615; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; D'Ambrogio A, 2013, NAT REV CANCER, V13, P283, DOI 10.1038/nrc3485; Degrauwe N, 2016, GENE DEV, V30, P2459, DOI 10.1101/gad.287540.116; Dominguez D, 2018, MOL CELL, V70, P854, DOI 10.1016/j.molcel.2018.05.001; Fernandez-Miranda G, 2012, AGEING RES REV, V11, P460, DOI 10.1016/j.arr.2012.03.004; Fioriti L, 2015, NEURON, V86, P1433, DOI 10.1016/j.neuron.2015.05.021; Fletcher JI, 2018, NAT REV CANCER, V18, P389, DOI 10.1038/s41568-018-0003-x; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Giangarra V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138794; Gupta SK, 2018, CIRC RES, V122, P246, DOI 10.1161/CIRCRESAHA.117.311335; Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130; Hu H, 2018, RNA BIOL, V15, P797, DOI 10.1080/15476286.2018.1457935; Jones DTW, 2019, NAT REV CANCER, V19, P420, DOI 10.1038/s41568-019-0169-x; Kamihara J, 2017, CLIN CANCER RES, V23, pE98, DOI 10.1158/1078-0432.CCR-17-0652; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kozlov E, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00577-6; Lee FCY, 2018, MOL CELL, V69, P354, DOI 10.1016/j.molcel.2018.01.005; Liu FY, 2019, J CELL BIOCHEM, V120, P12618, DOI 10.1002/jcb.28528; Liu HS, 2020, KNOWL-BASED SYST, V191, DOI 10.1016/j.knosys.2019.105261; Lujan DA, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1462; Matthay KK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.78; Oldridge DA, 2019, JNCI-J NATL CANCER I, V111, P1192, DOI 10.1093/jnci/djz027; Pereira B, 2017, TRENDS CANCER, V3, P506, DOI 10.1016/j.trecan.2017.05.003; Pinto NR, 2015, J CLIN ONCOL, V33, P3008, DOI 10.1200/JCO.2014.59.4648; Ramanathan M, 2018, NAT METHODS, V15, P207, DOI [10.1038/NMETH.4601, 10.1038/nmeth.4601]; Rapino F, 2018, NATURE, V558, P605, DOI 10.1038/s41586-018-0243-7; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Wang E, 2019, CANCER CELL, V35, P369, DOI 10.1016/j.ccell.2019.01.010; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang L, 2021, GENOMICS, V113, P874, DOI 10.1016/j.ygeno.2021.02.002; Zhang M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54286-9; Zhang Y, 2020, J GENE MED, V22, DOI 10.1002/jgm.3212; Zhao Q, 2018, MOL THER-NUCL ACIDS, V13, P464, DOI 10.1016/j.omtn.2018.09.020; Zhao Q, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00239; Zhong Q, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01637-4; Zou CD, 2016, ONCOTARGET, V7, P266, DOI 10.18632/oncotarget.5689; Zu T, 2017, NEURON, V95, P1292, DOI 10.1016/j.neuron.2017.08.039	43	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260876	10.1371/journal.pone.0260876	http://dx.doi.org/10.1371/journal.pone.0260876			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879089	Green Published, gold			2022-12-26	WOS:000754625200032
J	Andersson, ML; Hulthen, K; Blake, C; Bronmark, C; Nilsson, PA				Andersson, Matilda L.; Hulthen, Kaj; Blake, Charlie; Broenmark, Christer; Nilsson, P. Anders			Linking behavioural type with cannibalism in Eurasian perch	PLOS ONE			English	Article							SEXUAL CANNIBALISM; POPULATION; PERSONALITY; ECOLOGY; FLUVIATILIS; CONSEQUENCES; RECOGNITION; EVOLUTION; SELECTION; BOLDNESS	The propensity to kill and consume conspecifics (cannibalism) varies greatly between and within species, but the underlying mechanisms behind this variation remain poorly understood. A rich literature has documented that consistent behavioural variation is ubiquitous across the animal kingdom. Such inter-individual behavioural differences, sometimes referred to as personality traits, may have far-reaching ecological consequences. However, the link between predator personality traits and the propensity to engage in cannibalistic interactions remains understudied. Here, we first quantified personality in Eurasian perch (Perca fluviatilis), measured as activity (time spent moving) and sociability (time spent near conspecifics). We then gave perch of contrasting behavioural types the option to consume either conspecific or heterospecific (roach, Rutilus rutilus) prey. Individual perch characterized by a social-active behavioural phenotype (n = 5) selected roach before being cannibalistic, while asocial-inactive perch (n = 17) consumed conspecific and heterospecific prey evenly. Thus, asocial-inactive perch expressed significantly higher rates of cannibalism as compared to social-active individuals. Individual variation in cannibalism, linked to behavioural type, adds important mechanistic understanding to complex population and community dynamics, and also provides insight into the diversity and maintenance of animal personality.	[Andersson, Matilda L.; Hulthen, Kaj; Blake, Charlie; Broenmark, Christer; Nilsson, P. Anders] Lund Univ, Div Aquat Ecol, Dept Biol, Lund, Sweden; [Nilsson, P. Anders] Karlstad Univ, Dept Environm & Life Sci Biol, Karlstad, Sweden; [Andersson, Matilda L.] Uppsala Univ, Dept Ecol & Genet Limnol, Uppsala, Sweden; [Blake, Charlie] Webster Univ, Dept Biol, Webster, MO USA	Lund University; Karlstad University; Uppsala University; Webster University	Andersson, ML (corresponding author), Lund Univ, Div Aquat Ecol, Dept Biol, Lund, Sweden.; Andersson, ML (corresponding author), Uppsala Univ, Dept Ecol & Genet Limnol, Uppsala, Sweden.	matilda.andersson@ebc.uu.se	Nilsson, Anders/H-6836-2014	Nilsson, Anders/0000-0002-3541-9835; Blake, Charlie/0000-0003-4649-3472; Andersson, Matilda/0000-0001-5926-1246				Anthony CD, 2003, J INSECT BEHAV, V16, P23, DOI 10.1023/A:1022893127216; Arnqvist G, 1997, EVOL ECOL, V11, P255, DOI 10.1023/A:1018412302621; Behrmann-Godel J, 2006, BEHAV ECOL SOCIOBIOL, V59, P461, DOI 10.1007/s00265-005-0070-3; Bell AM, 2007, P ROY SOC B-BIOL SCI, V274, P755, DOI 10.1098/rspb.2006.0199; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Brabrand A., 1995, Ecology of Freshwater Fish, V4, P70, DOI 10.1111/j.1600-0633.1995.tb00119.x; Briffa M, 2010, CURR BIOL, V20, pR912, DOI 10.1016/j.cub.2010.09.019; Brodin T, 2013, SCIENCE, V339, P814, DOI 10.1126/science.1226850; Bystrom P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070404; Chang CC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40734; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; CHRISTENSEN B, 1993, BEHAV ECOL SOCIOBIOL, V32, P1; Claessen D, 2004, P ROY SOC B-BIOL SCI, V271, P333, DOI 10.1098/rspb.2003.2555; Colchen T, 2019, AQUAC RES, V50, P915, DOI 10.1111/are.13966; Craig J. F., 2008, PERCID FISHES SYSTEM; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; EKLOV P, 1992, ANIM BEHAV, V44, P313, DOI 10.1016/0003-3472(92)90037-A; EKLOV P, 1995, BEHAV ECOL SOCIOBIOL, V37, P169, DOI 10.1007/s002650050178; Fisher AM, 2020, BEHAV ECOL SOCIOBIOL, V74, DOI 10.1007/s00265-020-02839-8; Fisher AM, 2018, ECOL EVOL, V8, P6663, DOI 10.1002/ece3.4155; Green WW, 2008, NATURWISSENSCHAFTEN, V95, P269, DOI 10.1007/s00114-007-0319-y; Johnson JC, 2005, BEHAV ECOL SOCIOBIOL, V58, P390, DOI 10.1007/s00265-005-0943-5; Krause J., 2002, LIVING GROUP; Liu Xiaojun, 2017, Aquaculture and Fisheries, V2, P1, DOI 10.1016/j.aaf.2016.12.001; Magnhagen C, 2012, J ANIM ECOL, V81, P1311, DOI 10.1111/j.1365-2656.2012.02007.x; Magnhagen C, 2009, P ROY SOC B-BIOL SCI, V276, P3369, DOI 10.1098/rspb.2009.0851; McGhee KE, 2013, AM NAT, V182, P704, DOI 10.1086/673526; Michelangeli M, 2016, BEHAV ECOL, V27, P62, DOI 10.1093/beheco/arv123; Moiron M, 2020, ECOL LETT, V23, P399, DOI 10.1111/ele.13438; Nash RDM, 2006, FISHERIES, V31, P236; Naumowicz K, 2017, REV FISH BIOL FISHER, V27, P193, DOI 10.1007/s11160-017-9465-2; Pereira LS, 2017, REV FISH BIOL FISHER, V27, P499, DOI 10.1007/s11160-017-9469-y; Persson L, 2000, ECOLOGY, V81, P1058; Persson L, 2004, ECOL MONOGR, V74, P135, DOI 10.1890/02-4092; Persson L, 2003, P NATL ACAD SCI USA, V100, P4035, DOI 10.1073/pnas.0636404100; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Reid D, 2012, J ANIM ECOL, V81, P868, DOI 10.1111/j.1365-2656.2012.01969.x; RStudio_Team, 2015, RSTUDIO INT DEV ENV; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2008, ADV STUD BEHAV, V38, P227, DOI 10.1016/S0065-3454(08)00005-3; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Skov C, 2005, J FISH BIOL, V67, P1195, DOI 10.1111/j.1095-8649.2005.00814.x; Smith C., 1991, Reviews in Fish Biology and Fisheries, V1, P41, DOI 10.1007/BF00042661; Svenning MA, 2005, J FISH BIOL, V66, P957, DOI 10.1111/j.0022-1112.2005.00646.x; Sweeney K, 2013, BEHAV ECOL, V24, P1205, DOI 10.1093/beheco/art052; Toscano BJ, 2016, OECOLOGIA, V182, P55, DOI 10.1007/s00442-016-3648-8; Truemper HA, 2005, J FISH BIOL, V66, P135, DOI 10.1111/j.0022-1112.2005.00588.x; Vallon M, 2016, ECOL EVOL, V6, P7221, DOI 10.1002/ece3.2403; VANDENBOSCH F, 1988, J MATH BIOL, V26, P619, DOI 10.1007/BF00276144; Wagner JD, 1999, EVOL ECOL RES, V1, P375; Webster MM, 2009, BEHAV ECOL SOCIOBIOL, V63, P511, DOI 10.1007/s00265-008-0685-2; Wilson ADM, 2007, ANIM BEHAV, V74, P689, DOI 10.1016/j.anbehav.2007.01.009; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001	57	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0260938	10.1371/journal.pone.0260938	http://dx.doi.org/10.1371/journal.pone.0260938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY3JJ	34860864	Green Published, gold			2022-12-26	WOS:000754686900013
J	Nicosia, L; Boffo, FL; Ceccacci, E; Conforti, F; Pallavicini, I; Bedin, F; Ravasio, R; Massignani, E; Somervaille, TCP; Minucci, S; Bonaldi, T				Nicosia, Luciano; Boffo, Francesca Ludovica; Ceccacci, Elena; Conforti, Fabio; Pallavicini, Isabella; Bedin, Fabio; Ravasio, Roberto; Massignani, Enrico; Somervaille, Tim C. P.; Minucci, Saverio; Bonaldi, Tiziana			Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML	ONCOGENE			English	Article							DEMETHYLASE; GENE	The histone demethylase LSD1 is over-expressed in hematological tumors and has emerged as a promising target for anticancer treatment, so that several LSD1 inhibitors are under development and testing, in preclinical and clinical settings. However, the complete understanding of their complex mechanism of action is still unreached. Here, we unraveled a novel mode of action of the LSD1 inhibitors MC2580 and DDP-38003, showing that they can induce differentiation of AML cells through the downregulation of the chromatin protein GSE1. Analysis of the phenotypic effects of GSE1 depletion in NB4 cells showed a strong decrease of cell viability in vitro and of tumor growth in vivo. Mechanistically, we found that a set of genes associated with immune response and cytokine-signaling pathways are upregulated by LSD1 inhibitors through GSE1-protein reduction and that LSD1 and GSE1 colocalize at promoters of a subset of these genes at the basal state, enforcing their transcriptional silencing. Moreover, we show that LSD1 inhibitors lead to the reduced binding of GSE1 to these promoters, activating transcriptional programs that trigger myeloid differentiation. Our study offers new insights into GSE1 as a novel therapeutic target for AML.	[Nicosia, Luciano; Boffo, Francesca Ludovica; Ceccacci, Elena; Conforti, Fabio; Pallavicini, Isabella; Bedin, Fabio; Ravasio, Roberto; Massignani, Enrico; Minucci, Saverio; Bonaldi, Tiziana] European Inst Oncol IRCCS, Dept Expt Oncol, IEO, I-20139 Milan, Italy; [Nicosia, Luciano; Somervaille, Tim C. P.] Univ Manchester, ItalyLeukaemia Biol Lab, Canc Res UK Manchester Inst, Oglesby Canc Res Ctr Bldg, Manchester M20 4GJ, Lancs, England; [Minucci, Saverio] Univ Milan, Dept Biosci, I-20133 Milan, Italy; [Bonaldi, Tiziana] Univ Milan, Dept Oncol & Haematooncol, I-20133 Milan, Italy	IRCCS European Institute of Oncology (IEO); Cancer Research UK; University of Manchester; University of Milan; University of Milan	Bonaldi, T (corresponding author), European Inst Oncol IRCCS, Dept Expt Oncol, IEO, I-20139 Milan, Italy.; Bonaldi, T (corresponding author), Univ Milan, Dept Oncol & Haematooncol, I-20133 Milan, Italy.	tiziana.bonaldi@ieo.it	Ravasio, Roberto/AAP-8901-2020	Ravasio, Roberto/0000-0002-3144-0514; Ceccacci, Elena/0000-0002-2285-8994; Nicosia, Luciano/0000-0003-3016-931X; Somervaille, Tim/0000-0002-9188-4379	Italian Association for Cancer Research [15741]; EPIC-XS - Horizon 2020 programme of the European Union [823839]; European Institute of Oncology Foundation (FIEO); Italian Foundation for Cancer Research (FIRC); Italian Association for Cancer Research (AIRC) [24944]; Cancer Research UK [C5759/A20971]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); EPIC-XS - Horizon 2020 programme of the European Union; European Institute of Oncology Foundation (FIEO); Italian Foundation for Cancer Research (FIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Cancer Research UK(Cancer Research UK)	T.B. research activity is supported by grants from the Italian Association for Cancer Research (grant#15741) and by EPIC-XS, project number 823839, funded by the Horizon 2020 programme of the European Union; L.N. was supported by a Fellowship of the European Institute of Oncology Foundation (FIEO) and was a PhD student within the European School of Molecular Medicine (SEMM); E.M. is supported by a fellowship of the Italian Foundation for Cancer Research (FIRC) and is a PhD student within the European School of Molecular Medicine (SEMM); S.M. is supported by the Italian Association for Cancer Research (AIRC, grant#24944); T.S. is supported by Cancer Research UK grant number C5759/A20971.	Abdel-Aziz AK, 2020, HAEMATOLOGICA, V105, P2105, DOI 10.3324/haematol.2019.224501; Amente S, 2013, BBA-GENE REGUL MECH, V1829, P981, DOI 10.1016/j.bbagrm.2013.05.002; Bamodu OA, 2021, CANCERS, V13, DOI 10.3390/cancers13163959; Binda C, 2010, J AM CHEM SOC, V132, P6827, DOI 10.1021/ja101557k; Blagosklonny MV, 2003, SEMIN CANCER BIOL, V13, P97, DOI 10.1016/S1044-579X(02)00127-X; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Carnesecchi J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188871; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chai P, 2016, BIOCHEM BIOPH RES CO, V471, P123, DOI 10.1016/j.bbrc.2016.01.168; Chao A, 2017, ONCOTARGET, V8, P74434, DOI 10.18632/oncotarget.20158; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen YW, 2012, CRIT REV EUKAR GENE, V22, P53, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.40; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Ding KS, 2018, J BIOL CHEM, V293, P3949, DOI 10.1074/jbc.RA117.001103; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duan YC, 2017, EUR J MED CHEM, V140, P392, DOI 10.1016/j.ejmech.2017.09.038; Fang JW, 2017, ONCOTARGET, V8, P85085, DOI 10.18632/oncotarget.18564; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Huang M, 2019, CELL STEM CELL, V25, P433, DOI 10.1016/j.stem.2019.05.013; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Ishikawa Y, 2017, MOL CANCER THER, V16, P273, DOI 10.1158/1535-7163.MCT-16-0471; Kim SA, 2020, MOL CELL, V78, P903, DOI 10.1016/j.molcel.2020.04.019; Lan HY, 2019, P NATL ACAD SCI USA, V116, P12311, DOI 10.1073/pnas.1902012116; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lanneau D, 2007, PRION, V1, P53, DOI 10.4161/pri.1.1.4059; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Y, 2019, CANCER LETT, V454, P179, DOI 10.1016/j.canlet.2019.03.052; Liang XQ, 2013, BIOTECHNIQUES, V55, P267, DOI 10.2144/000114101; Lillico R, 2016, FUTURE MED CHEM, V8, P879, DOI 10.4155/fmc-2016-0021; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lokken AA, 2012, CANCER CELL, V21, P451, DOI 10.1016/j.ccr.2012.03.027; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maiques-Diaz A, 2018, CELL REP, V22, P3641, DOI 10.1016/j.celrep.2018.03.012; McClellan D, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00020-19; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Mihailovich M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9725; Nair SS, 2010, EMBO REP, V11, P438, DOI 10.1038/embor.2010.62; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Perillo B, 2020, EXP MOL MED, V52, P1936, DOI 10.1038/s12276-020-00542-2; Ravasio R, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax2746; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Sehrawat A, 2018, P NATL ACAD SCI USA, V115, pE4179, DOI 10.1073/pnas.1719168115; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Song P, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-020-00444-9; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tyner JW, 2018, NATURE, V562, P526, DOI 10.1038/s41586-018-0623-z; Vianello P, 2016, J MED CHEM, V59, P1501, DOI 10.1021/acs.jmedchem.5b01209; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Wang WB, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/8834923; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wiemann S, 2016, NAT METHODS, V13, P191, DOI 10.1038/nmeth.3776; Yamamoto Ryusuke, 2018, Oncotarget, V9, P21007, DOI 10.18632/oncotarget.24774; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang XF, 2018, NAT PROTOC, V13, P530, DOI 10.1038/nprot.2017.147; Zhang XL, 2019, DRUG DES DEV THER, V13, P3037, DOI 10.2147/DDDT.S209219; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao ZK, 2013, TUMOR BIOL, V34, P173, DOI 10.1007/s13277-012-0525-x; Zheng YC, 2016, EPIGENOMICS-UK, V8, P651, DOI 10.2217/epi-2015-0002; Zheng YC, 2015, MED RES REV, V35, P1032, DOI 10.1002/med.21350; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	72	5	5	4	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2022	41	6					878	894		10.1038/s41388-021-02123-7	http://dx.doi.org/10.1038/s41388-021-02123-7		DEC 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YT5VS	34862459	Green Published, hybrid			2022-12-26	WOS:000725939000002
J	Anderson, K; Bavishi, C; Kolte, D; Gohh, R; Arrighi, JA; Stockwell, P; Abbott, JD				Anderson, Kelsey; Bavishi, Chirag; Kolte, Dhaval; Gohh, Reginald; Arrighi, James A.; Stockwell, Philip; Abbott, J. Dawn			Relation of abnormal cardiac stress testing with outcomes in patients undergoing renal transplantation	PLOS ONE			English	Article							RISK-STRATIFICATION; DISEASE; KIDNEY	Cardiovascular risk stratification is often performed in patients considered for renal transplantation. In a single center, we sought to examine the association between abnormal stress testing with imaging and post-renal transplant major adverse cardiovascular events (MACE) using multivariable logistic regression. From January 2006 to May 2016 232 patients underwent renal transplantation and 59 (25%) had an abnormal stress test result. Compared to patients with a normal stress test, patients with an abnormal stress test had a higher prevalence of dyslipidemia, diabetes mellitus, obesity, coronary artery disease (CAD), and heart failure. Among those with an abnormal result, 45 (76%) had mild, 10 (17%) moderate, and 4 (7%) severe ischemia. In our cohort, 9 patients (3.9%) had MACE at 30-days post-transplant, 5 of whom had an abnormal stress test. The long-term MACE rate, at a median of 5 years, was 32%. After adjustment, diabetes (OR 2.37, 95% CI 1.12-5.00, p = 0.02), CAD (OR: 3.05, 95% CI 1.30-7.14, p = 0.01) and atrial fibrillation (OR: 5.86, 95% CI 1.86-18.44, p = 0.002) were independently associated with long-term MACE, but an abnormal stress test was not (OR: 0.83, 95% CI 0.37-1.92, p = 0.68). In conclusion, cardiac stress testing was not an independent predictor of long-term MACE among patients undergoing renal transplant.	[Anderson, Kelsey] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Bavishi, Chirag; Arrighi, James A.; Stockwell, Philip; Abbott, J. Dawn] Brown Univ, Cardiovasc Inst, Warren Alpert Med Sch, Providence, RI 02912 USA; [Kolte, Dhaval] Harvard Med Sch, Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02115 USA; [Gohh, Reginald] Brown Univ, Dept Internal Med, Renal Div, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University; Brown University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Brown University	Abbott, JD (corresponding author), Brown Univ, Cardiovasc Inst, Warren Alpert Med Sch, Providence, RI 02912 USA.	Jabbott@lifespan.org		Abbott, J. Dawn/0000-0002-2560-0155	Brown University	Brown University	Dr. Anderson received research funding from Brown University. The funding source played no role in the study design or intepretation.	[Anonymous], 2016, KIDN DIS STAT US; BERMAN DS, 1995, J AM COLL CARDIOL, V26, P639, DOI 10.1016/0735-1097(95)00218-S; Doukky R, 2018, J NUCL CARDIOL, V25, P2058, DOI 10.1007/s12350-017-0901-4; Dunn T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211161; Friedman SE, 2011, CLIN J AM SOC NEPHRO, V6, P1185, DOI 10.2215/CJN.09391010; De Lima JJG, 2010, CORONARY ARTERY DIS, V21, P164, DOI 10.1097/MCA.0b013e328332ee5e; Hachamovitch R, 1998, CIRCULATION, V97, P535; Hart A, 2019, Am J Transplant, V19 Suppl 2, P19, DOI 10.1111/ajt.15274; Herzog CA, 2021, J AM COLL CARDIOL, V78, P348, DOI 10.1016/j.jacc.2021.05.001; Jankowski J, 2021, CIRCULATION, V143, P1157, DOI 10.1161/CIRCULATIONAHA.120.050686; Lentine KL, 2012, J AM COLL CARDIOL, V60, P434, DOI 10.1016/j.jacc.2012.05.008; McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905; Park YH, 2013, TRANSPL P, V45, P1371, DOI 10.1016/j.transproceed.2013.01.063; Singh N, 2012, TRANSPLANTATION, V94, P1224, DOI 10.1097/TP.0b013e31827147d8; Tilkemeier P.L, 2006, J NUCL CARDIOL, V13, pe152, DOI [10.1016/j.nuclcard.2006.08.013, DOI 10.1016/J.NUCLCARD.2006.08.013]; Yao SS, 2003, J AM COLL CARDIOL, V42, P1084, DOI 10.1016/S0735-1097(03)00923-9	16	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260718	10.1371/journal.pone.0260718	http://dx.doi.org/10.1371/journal.pone.0260718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855868	gold, Green Published			2022-12-26	WOS:000735299000102
J	Fang, EE; Nyasa, RB; Ndi, EM; Zofou, D; Kwenti, TE; Lepezeu, EP; Titanji, VPK; Ndip, RN				Fang, Eugene Enah; Nyasa, Raymond Babila; Ndi, Emmanuel Menang; Zofou, Denis; Kwenti, Tebit Emmanuel; Lepezeu, Edith Pafoule; Titanji, Vincent P. K.; Ndip, Roland N.			Investigating the risk factors for seroprevalence and the correlation between CD4+T-cell count and humoral antibody responses to Toxoplasma gondii infection amongst HIV patients in the Bamenda Health District, Cameroon	PLOS ONE			English	Article								Background Toxoplasmosis is caused by an obligate intracellular tissue protozoan parasite, Toxoplasma gondii that infect humans and other warm-blooded animals. Transmission to humans is by eating raw or inadequately cooked infected meat or through ingestion of oocysts that cats have passed in faeces. Studies have shown life-threatening and substantial neurologic damage in immunocompromised patients; however, 80% of humans remain asymptomatic. The aim of this study was to determine the seroprevalence of Toxoplasma gondii infection in HIV positive patients and the risk factors associated with the infection, and to investigate the correlation between CD4+ T-cell count and toxoplasma specific antibodies as possible predictors of each other amongst HIV patients in the Bamenda Health District of the North West Region of Cameroon. Methods A cross-sectional study was conducted, in which 325 HIV patients were recruited for administration of questionnaire, serological diagnosis of T. gondii and measurement of CD4+ T-cell count. Bivariate and multivariate logistic regression was used to identify risk factors associated with T. gondii infection while the linear regression was used to investigate the relationship between CD4+ T-cell count and antibody levels against T. gondii. Results The findings showed that, majority (45.8%) of HIV patients suffered from chronic (IgG antibody) infection, and 6.5% from acute (IgM and IgM/IgG antibody) toxoplasma infection. The overall sero-prevalence of T. gondii infection amongst HIV patients was 50.5%. On the whole, 43 men (45.7%) and 127 women (55%) presented with anti- T. gondii antibodies; however, there was no significant difference amongst males and females who were positive to T. gondii infection (p = 0.131). Marital status (p = 0.0003), contact with garden soil (p = 0.0062), and garden ownership (p = 0.009), were factors that showed significant association with T. gondii infection. There was no significant difference (p = 0.909) between the mean CD4+ T-cell count of HIV patients negative for toxoplasma infection (502.7 cells/mL), chronically infected with T. gondii (517.7 cells/mL) and acutely infected with T. gondii (513.1 cells/mL). CD4+ T-cell count was neither a predictor of IgM antibody titer (r = 0.193, p = 0.401), nor IgG antibody titer (r = 0.149, p = 0.519) amongst HIV patients acutely infected with T. gondii. Conclusion The findings from this study underscore the need to implement preventive and control measures to fight against T. gondii infection amongst HIV patients in the Bamenda Health District.	[Fang, Eugene Enah; Nyasa, Raymond Babila; Ndip, Roland N.] Univ Buea, Dept Microbiol & Parasitol, Buea, Cameroon; [Nyasa, Raymond Babila; Ndi, Emmanuel Menang; Zofou, Denis; Titanji, Vincent P. K.] Univ Buea, Fac Sci, Biotechnol Unit, Buea, South West Regi, Cameroon; [Kwenti, Tebit Emmanuel] Univ Buea, Fac Hlth Sci, Dept Med Lab Sci, Buea, South West Regi, Cameroon; [Lepezeu, Edith Pafoule] Bamenda Reg Hosp, Bamenda, North West Regi, Cameroon; [Titanji, Vincent P. K.] Cameroon Christian Univ, Bali, North West Regi, Cameroon; [Ndip, Roland N.] Univ Buea, Lab Emerging Infect Dis, Buea, South West Regi, Cameroon		Nyasa, RB (corresponding author), Univ Buea, Dept Microbiol & Parasitol, Buea, Cameroon.; Nyasa, RB (corresponding author), Univ Buea, Fac Sci, Biotechnol Unit, Buea, South West Regi, Cameroon.	nyasab@yahoo.co.uk	; Tebit, Kwenti/P-8688-2018	Eugene Enah, Fang/0000-0001-5554-2913; Tebit, Kwenti/0000-0001-5526-9179; Nyasa, Raymond/0000-0001-5916-0058				Ardeleanu A., 2013, BMC INFECT DIS, V13, P8; Assob J. C. N., 2011, African Journal of Clinical and Experimental Microbiology, V12, P119, DOI 10.4314/ajcem.v12i3.6; Ayoade F., STATPEARLS; Ayoade F., HIV 1 ASS OPPORTUNIS; Basavaraju Anuradha, 2016, Trop Parasitol, V6, P129; CTK Biotech Inc., 2016, ONSITETM TOX IGG IGM; Dechassa T., 2019, ASIAN PAC J TROP MED, V9, P460; Emivi T.B., 2018, EUROPEAN SCI J, V14, P1857; Fan CK, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-141; Galvan-Ramirez MD, 2010, SCI MED, V20, P59; Hari KR, 2007, INT J STD AIDS, V18, P555, DOI 10.1258/095646207781439829; Jones JL, 2018, AM J TROP MED HYG, V98, P551, DOI 10.4269/ajtmh.17-0677; Jose Ernesto Vidal., 2019, J INT ASSOC PRO AIDS, P2325; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Okwuzu J. O., 2014, African Journal of Clinical and Experimental Microbiology, V15, P97, DOI 10.4314/ajcem.v15i2.7; Rahimi MT, 2015, IRAN J PARASITOL, V10, P584; Rezanezhad H, 2017, KOREAN J PARASITOL, V55, P99, DOI 10.3347/kjp.2017.55.1.99; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Rostami A, 2014, IRAN J PARASITOL, V9, P474; Suresh Kp, 2012, J Hum Reprod Sci, V5, P7, DOI 10.4103/0974-1208.97779; Techalew S., 2009, BIOMED CENTRAL RES N, V2, P692; Yesuf K.M., 2015, AM J HLTH RES, V3, P182; Zeleke Ayalew Jejaw, 2017, BMC Res Notes, V10, P70, DOI 10.1186/s13104-017-2390-6	23	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0256947	10.1371/journal.pone.0256947	http://dx.doi.org/10.1371/journal.pone.0256947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855762	Green Published, gold			2022-12-26	WOS:000735299000005
J	Volodina, M; Smetanin, N; Lebedev, M; Ossadtchi, A				Volodina, Maria; Smetanin, Nikolai; Lebedev, Mikhail; Ossadtchi, Alexei			Cortical and autonomic responses during staged Taoist meditation: Two distinct meditation strategies	PLOS ONE			English	Article							FRONTAL-MIDLINE-THETA; HEART-RATE; MINDFULNESS; ATTENTION; AWARENESS; STRESS; CONNECTIVITY; EXPERIENCE; REDUCTION; STATES	Meditation is a consciousness state associated with specific physiological and neural correlates. Numerous investigations of these correlates reported controversial results which prevented a consistent depiction of the underlying neurophysiological processes. Here we investigated the dynamics of multiple neurophysiological indicators during a staged meditation session. We measured the physiological changes at rest and during the guided Taoist meditation in experienced meditators and naive subjects. We recorded EEG, respiration, galvanic skin response, and photoplethysmography. All subjects followed the same instructions split into 16 stages. In the experienced meditators group we identified two subgroups with different physiological markers dynamics. One subgroup showed several signs of general relaxation evident from the changes in heart rate variability, respiratory rate, and EEG rhythmic activity. The other subgroup exhibited mind concentration patterns primarily noticeable in the EEG recordings while no autonomic responses occurred. The duration and type of previous meditation experience or any baseline indicators we measured did not explain the segregation of the meditators into these two groups. These results suggest that two distinct meditation strategies could be used by experienced meditators, which partly explains the inconsistent results reported in the earlier studies evaluating meditation effects. Our findings are also relevant to the development of the high-end biofeedback systems.	[Volodina, Maria; Smetanin, Nikolai; Lebedev, Mikhail; Ossadtchi, Alexei] HSE Univ, Ctr Bioelect Interfaces, Moscow, Russia; [Ossadtchi, Alexei] Artificial Intelligence Res Inst, Moscow, Russia	HSE University (National Research University Higher School of Economics)	Ossadtchi, A (corresponding author), HSE Univ, Ctr Bioelect Interfaces, Moscow, Russia.; Ossadtchi, A (corresponding author), Artificial Intelligence Res Inst, Moscow, Russia.	aossadtchi@hse.ru	Volodina, Maria A/H-4758-2014	Ossadtchi, Alex/0000-0001-8827-9429	Center for Bioelectric Interfaces NRU HSE, RF Government [075-15-2021-624]	Center for Bioelectric Interfaces NRU HSE, RF Government	This work is supported by the Center for Bioelectric Interfaces NRU HSE, RF Government grant, AG. No. 075-15-2021-624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftanas L, 2005, INT J NEUROSCI, V115, P893, DOI 10.1080/00207450590897969; Ahani A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-87; Amihai I, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731579; Amihai I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102990; Arnau S, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13581; Baevsky RM, 2017, CARDIOMETRY, P66, DOI 10.12710/cardiometry.2017.10.6676; Bazanova OM, 2014, NEUROSCI BIOBEHAV R, V44, P94, DOI 10.1016/j.neubiorev.2013.05.007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger AM, 2018, NEUROSCIENCE, V378, P189, DOI 10.1016/j.neuroscience.2017.06.007; Black DS, 2019, CURR OPIN PSYCHOL, V28, P302, DOI 10.1016/j.copsyc.2019.06.004; Boccia M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/419808; Bostic JQ, 2015, CHILD ADOL PSYCH CL, V24, P245, DOI 10.1016/j.chc.2014.11.010; Britton WB, 2014, ANN NY ACAD SCI, V1307, P64, DOI 10.1111/nyas.12279; Cahn BR, 2010, COGN PROCESS, V11, P39, DOI 10.1007/s10339-009-0352-1; Camm AJ, 1996, EUR HEART J, V17, P354; Clarke Tainya C, 2015, Natl Health Stat Report, P1; Compton RJ, 2019, COGN AFFECT BEHAV NE, V19, P1184, DOI 10.3758/s13415-019-00745-9; Crivelli D, 2019, MINDFULNESS, V10, P301, DOI 10.1007/s12671-018-0975-3; Das I., 2012, PSYCHOL THOUGHT INTE, V5; DeLosAngeles D, 2016, INT J PSYCHOPHYSIOL, V110, P27, DOI 10.1016/j.ijpsycho.2016.09.020; Ditto B, 2006, ANN BEHAV MED, V32, P227, DOI 10.1207/s15324796abm3203_9; Doppelmayr A, 2008, NEUROPSYCHOLOGIA, V46, P1463, DOI 10.1016/j.neuropsychologia.2007.12.026; Dor-Ziderman Y, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00582; ELSON BD, 1977, PSYCHOPHYSIOLOGY, V14, P52, DOI 10.1111/j.1469-8986.1977.tb01155.x; Faber PL, 2015, COGN PROCESS, V16, P87, DOI 10.1007/s10339-014-0637-x; Fan JQ, 1998, J AM STAT ASSOC, V93, P1007, DOI 10.2307/2669845; Garrison KA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00440; Gotink RA, 2016, BRAIN COGNITION, V108, P32, DOI 10.1016/j.bandc.2016.07.001; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Harmony T, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00083; Hilton L, 2017, ANN BEHAV MED, V51, P199, DOI 10.1007/s12160-016-9844-2; Hinterberger T, 2018, COMPLEMENT MED RES, V25, P313, DOI 10.1159/000489342; Hinterberger T, 2016, APPL PSYCHOPHYS BIOF, V41, P315, DOI 10.1007/s10484-016-9332-2; Hinterberger T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00099; Hood MM, 2017, GASTROENTEROL CLIN N, V46, P859, DOI 10.1016/j.gtc.2017.08.008; Jaseja H, 2006, MED HYPOTHESES, V66, P925, DOI 10.1016/j.mehy.2005.11.043; Kaur Chamandeep, 2015, Adv Prev Med, V2015, P614723, DOI 10.1155/2015/614723; Klimesch W, 2001, COGNITIVE BRAIN RES, V12, P33, DOI 10.1016/S0926-6410(01)00024-6; KOIZUMI K, 1985, J AUTONOM NERV SYST, V12, P251, DOI 10.1016/0165-1838(85)90065-7; Kubota Y, 2001, COGNITIVE BRAIN RES, V11, P281, DOI 10.1016/S0926-6410(00)00086-0; Kuijpers HJH, 2007, PSYCHOPATHOLOGY, V40, P461, DOI 10.1159/000108125; Last N, 2017, J ALZHEIMERS DIS, V56, P275, DOI 10.3233/JAD-160899; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lee DJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00178; Lee SH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015574; Lehmann D, 2012, NEUROIMAGE, V60, P1574, DOI 10.1016/j.neuroimage.2012.01.042; Lehrer P, 1999, PSYCHOSOM MED, V61, P812, DOI 10.1097/00006842-199911000-00014; Leonard A, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00062; Levine GN, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.002218; Lim S, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19071669; Lomas T, 2015, NEUROSCI BIOBEHAV R, V57, P401, DOI 10.1016/j.neubiorev.2015.09.018; Luders E, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00186; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Manna A, 2010, BRAIN RES BULL, V82, P46, DOI 10.1016/j.brainresbull.2010.03.001; Moak JP, 2007, HEART RHYTHM, V4, P1523, DOI 10.1016/j.hrthm.2007.07.019; Mole TB, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00613; Pascoe MC, 2017, J PSYCHIATR RES, V95, P156, DOI 10.1016/j.jpsychires.2017.08.004; Pasquini H, 2015, ELECTROPHYSIOLOGICAL; Peng CK, 1999, INT J CARDIOL, V70, P101, DOI 10.1016/S0167-5273(99)00066-2; Peng CK, 2004, INT J CARDIOL, V95, P19, DOI 10.1016/j.ijcard.2003.02.006; Ritter P, 2009, HUM BRAIN MAPP, V30, P1168, DOI 10.1002/hbm.20585; Rubia K, 2009, BIOL PSYCHOL, V82, P1, DOI 10.1016/j.biopsycho.2009.04.003; Rubik B, 2011, J ALTERN COMPLEM MED, V17, P109, DOI 10.1089/acm.2009.0191; Sauseng P, 2007, EUR J NEUROSCI, V25, P587, DOI 10.1111/j.1460-9568.2006.05286.x; Schlosser M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216643; Schoenberg PLA, 2018, CONSCIOUS COGN, V57, P41, DOI 10.1016/j.concog.2017.11.003; Schubert R, 2009, J COGNITIVE NEUROSCI, V21, P2407, DOI 10.1162/jocn.2008.21174; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Shapiro D H Jr, 1992, Int J Psychosom, V39, P62; Sieverdes John C, 2017, Mhealth, V3, P44, DOI 10.21037/mhealth.2017.09.04; SILVERMAN BW, 1981, J ROY STAT SOC B MET, V43, P97; Smetanin N, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00100; Steinhubl SR., 2015, CARDIOVASCULAR NERVO, V9, P1; Tang YY, 2009, P NATL ACAD SCI USA, V106, P8865, DOI 10.1073/pnas.0904031106; Thomas J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00197; Tomasino B, 2014, BRAIN COGNITION, V90, P32, DOI 10.1016/j.bandc.2014.03.013; Tyagi A, 2016, APPL PSYCHOPHYS BIOF, V41, P381, DOI 10.1007/s10484-016-9340-2; van Lutterveld R, 2017, NEUROIMAGE, V151, P117, DOI 10.1016/j.neuroimage.2016.02.047; Vickery CE, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02025; Whitmarsh S, 2014, NEUROIMAGE, V85, P803, DOI 10.1016/j.neuroimage.2013.07.031; Wu SD, 2008, BIOMED RES-TOKYO, V29, P245, DOI 10.2220/biomedres.29.245; ZEIER H, 1984, BIOFEEDBACK SELF-REG, V9, P497, DOI 10.1007/BF01000565	82	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260626	10.1371/journal.pone.0260626	http://dx.doi.org/10.1371/journal.pone.0260626			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855823	gold, Green Published, Green Submitted			2022-12-26	WOS:000735299000080
J	Mongwe, WT; Mbuvha, R; Marwala, T				Mongwe, Wilson Tsakane; Mbuvha, Rendani; Marwala, Tshilidzi			Bayesian inference of local government audit outcomes	PLOS ONE			English	Article							STATEMENT FRAUD DETECTION; MONTE-CARLO	The scandals in publicly listed companies have highlighted the large losses that can result from financial statement fraud and weak corporate governance. Machine learning techniques have been applied to automatically detect financial statement fraud with great success. This work presents the first application of a Bayesian inference approach to the problem of predicting the audit outcomes of financial statements of local government entities using financial ratios. Bayesian logistic regression (BLR) with automatic relevance determination (BLR-ARD) is applied to predict audit outcomes. The benefit of using BLR-ARD, instead of BLR without ARD, is that it allows one to automatically determine which input features are the most relevant for the task at hand, which is a critical aspect to consider when designing decision support systems. This work presents the first implementation of BLR-ARD trained with Separable Shadow Hamiltonian Hybrid Monte Carlo, No-U-Turn sampler, Metropolis Adjusted Langevin Algorithm and Metropolis-Hasting algorithms. Unlike the Gibbs sampling procedure that is typically employed in sampling from ARD models, in this work we jointly sample the parameters and the hyperparameters by putting a log normal prior on the hyperparameters. The analysis also shows that the repairs and maintenance as a percentage of total assets ratio, current ratio, debt to total operating revenue, net operating surplus margin and capital cost to total operating expenditure ratio are the important features when predicting local government audit outcomes using financial ratios. These results could be of use for auditors as focusing on these ratios could potentially speed up the detection of fraudulent behaviour in municipal entities, and improve the speed and quality of the overall audit.	[Mongwe, Wilson Tsakane; Marwala, Tshilidzi] Univ Johannesburg, Sch Elect Engn, Auckland Pk, Johannesburg, South Africa; [Mbuvha, Rendani] Univ Witwatersrand, Sch Stat & Actuarial Sci, Johannesburg, South Africa; [Mongwe, Wilson Tsakane; Mbuvha, Rendani; Marwala, Tshilidzi] Johannesburg Machine Intelligence Lab, Johannesburg, South Africa	University of Johannesburg; University of Witwatersrand	Mongwe, WT (corresponding author), Univ Johannesburg, Sch Elect Engn, Auckland Pk, Johannesburg, South Africa.; Mongwe, WT (corresponding author), Johannesburg Machine Intelligence Lab, Johannesburg, South Africa.	wilsonmongwe@gmail.com	Mongwe, Wilson/AFD-7741-2022	Mongwe, Wilson/0000-0003-2832-3584	Google PhD Fellowships; National Research Fund of South Africa	Google PhD Fellowships(Google Incorporated); National Research Fund of South Africa	Funding for this research was provided by Google PhD Fellowships and the National Research Fund of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar HM, 2021, PR MACH LEARN RES, V130; Amara I., 2013, INT J ACAD RES ACCOU, V3, P40, DOI DOI 10.6007/IJARAFMS/V3-I3/34; [Anonymous], 2006, NEW ALGORITHMS MACRO; Auditor-General South Africa, 2020, MFMA 2018 2019; Auditor-General South Africa,, 2011, BACKGR 3 ASP WE AUD; Barp A, 2018, ANNU REV STAT APPL, V5, P451, DOI 10.1146/annurev-statistics-031017-100141; Betancourt M, 2017, ARXIV170102434; Boumediene SL., 2014, ACCOUNTING TAXATION, V6, P1; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Bratton WW., 2002, FACULTY SCHOLARSHIP, DOI 10.2139/ssrn.301475; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Chen SD, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1707-6; Chen YJ, 2015, 4 INT C INF APPL ICI, P121; Cronje J., 2017, STEINHOFFS MARKET CA; Donnelly L., 2018, PIC STILL LIMPING ST; DUANE S, 1987, PHYS LETT B, V195, P216, DOI 10.1016/0370-2693(87)91197-X; Fanning K. M., 1998, International Journal of Intelligent Systems in Accounting, Finance and Management, V7, P21, DOI 10.1002/(SICI)1099-1174(199803)7:1<21::AID-ISAF138>3.0.CO;2-K; Fernandez-Gamez MA, 2016, NEURAL COMPUT APPL, V27, P1427, DOI 10.1007/s00521-015-1944-6; Gaganis C, 2009, INTELL SYST ACCOUNT, V16, P207, DOI 10.1002/isaf.303; Girolami M, 2011, J R STAT SOC B, V73, P123, DOI 10.1111/j.1467-9868.2010.00765.x; Glancy FH, 2011, DECIS SUPPORT SYST, V50, P595, DOI 10.1016/j.dss.2010.08.010; Gu MH, 2020, IEEE ACCESS, V8, P31595, DOI 10.1109/ACCESS.2020.2972611; Gupta R, 2012, INT J ADV COMPUT SC, V3, P189; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Healy PM, 2003, J ECON PERSPECT, V17, P3, DOI 10.1257/089533003765888403; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Humpherys SL, 2011, DECIS SUPPORT SYST, V50, P585, DOI 10.1016/j.dss.2010.08.009; Izaguirre JA, 2004, J COMPUT PHYS, V200, P581, DOI 10.1016/j.jcp.2004.04.016; Kiehl TR, 2005, EVOLVING MULTIVARIAT; Kirkos E, 2007, EXPERT SYST APPL, V32, P995, DOI 10.1016/j.eswa.2006.02.016; Kotsiantis S, 2006, LECT NOTES COMPUT SC, V4132, P672; Lin J.W., 2003, MANAG AUDIT J, V18, P657, DOI DOI 10.1108/02686900310495151; Mbuvha R, 2019, AUTOMATIC RELEVANCE; Mbuvha R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237126; Mbuvha R, 2019, LECT NOTES COMPUT SC, V11731, P420, DOI 10.1007/978-3-030-30493-5_42; Moepya SO, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON DATA MINING WORKSHOP (ICDMW), P183, DOI 10.1109/ICDMW.2014.141; Moepya SO, 2016, INT J INNOV COMPUT I, V12, P333; Mongwe WT, 2020, 2020 IEEE SYMPOSIUM SERIES ON COMPUTATIONAL INTELLIGENCE (SSCI), P1100; Mongwe Wilson T., 2020, SACJ, V32, P74, DOI 10.18489/sacj.v32i1.777; Mongwe WT, 2021, IEEE ACCESS, V9, P49857, DOI 10.1109/ACCESS.2021.3069196; National Treasury Republic Of South Africa, 2019, MUN FIN DAT; Neal RM, 2011, CH CRC HANDB MOD STA, P113; Neal Radford M, 2012, BAYESIAN LEARNING NE, V118; ODonnel J., 2020, WHOS BLAME WIRECARD; Omid P., 2012, AFR J BUS MANAGE, V6, P11077, DOI [10.5897/ajbm12.855, DOI 10.5897/AJBM12.855]; Perols J, 2011, AUDITING-J PRACT TH, V30, P19, DOI 10.2308/ajpt-50009; Perols JL, 2011, ADV ACCOUNT, V27, P39, DOI 10.1016/j.adiac.2010.10.004; Persons O.S., 2011, J APPL BUS RES JABR, V11, P38, DOI [10.19030/jabr.v11i3.5858, DOI 10.19030/JABR.V11I3.5858]; Radivojevic T, 2017, ARXIV PREPRINT ARXIV; Salimans T, 2015, PR MACH LEARN RES, V37, P1218; Schilit H. M., 2010, CFA I C P Q, V27, P67, DOI DOI 10.2469/CP.V27.N4.1; Song XP, 2014, J FORECASTING, V33, P611, DOI 10.1002/for.2294; Sweet CR, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3253687; Terzi S., 2012, MALIYE FINANS YAZILA, V26, P67; Vats D, 2019, BIOMETRIKA, V106, P321, DOI 10.1093/biomet/asz002	56	1	1	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261245	10.1371/journal.pone.0261245	http://dx.doi.org/10.1371/journal.pone.0261245			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY2HZ	34905553	Green Published, gold			2022-12-26	WOS:000754615500030
J	Altieri, JAC; Hertel, KJ				Altieri, Jessie A. C.; Hertel, Klemens J.			The influence of 4-thiouridine labeling on pre-mRNA splicing outcomes	PLOS ONE			English	Article							IN-VITRO	Metabolic labeling is a widely used tool to investigate different aspects of pre-mRNA splicing and RNA turnover. The labeling technology takes advantage of native cellular machineries where a nucleotide analog is readily taken up and incorporated into nascent RNA. One such analog is 4-thiouridine (4sU). Previous studies demonstrated that the uptake of 4sU at elevated concentrations (>50 mu M) and extended exposure led to inhibition of rRNA synthesis and processing, presumably induced by changes in RNA secondary structure. Thus, it is possible that 4sU incorporation may also interfere with splicing efficiency. To test this hypothesis, we carried out splicing analyses of pre-mRNA substrates with varying levels of 4sU incorporation (0-100%). We demonstrate that increased incorporation of 4sU into pre-mRNAs decreased splicing efficiency. The overall impact of 4sU labeling on pre-mRNA splicing efficiency negatively correlates with the strength of splice site signals such as the 3' and the 5' splice sites. Introns with weaker splice sites are more affected by the presence of 4sU. We also show that transcription by T7 polymerase and pre-mRNA degradation kinetics were impacted at the highest levels of 4sU incorporation. Increased incorporation of 4sU caused elevated levels of abortive transcripts, and fully labeled pre-mRNA is more stable than its uridine-only counterpart. Cell culture experiments show that a small number of alternative splicing events were modestly, but statistically significantly influenced by metabolic labeling with 4sU at concentrations considered to be tolerable (40 mu M). We conclude that at high 4sU incorporation rates small, but noticeable changes in pre-mRNA splicing can be detected when splice sites deviate from consensus. Given these potential 4sU artifacts, we suggest that appropriate controls for metabolic labeling experiments need to be included in future labeling experiments.	[Altieri, Jessie A. C.; Hertel, Klemens J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	University of California System; University of California Irvine	Hertel, KJ (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.	khertel@uci.edu		Hertel, Klemens/0000-0002-7560-9529; Altieri, Jessie/0000-0002-6817-6753	Foundation for the National Institutes of Health [R01 GM062287]	Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the Foundation for the National Institutes of Health, awarded to KJH (R01 GM062287). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burger K, 2013, RNA BIOL, V10, P1623, DOI 10.4161/rna.26214; Cavuzic M, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010027; DAGLE JM, 1991, ANTISENSE RES DEV, V1, P11, DOI 10.1089/ard.1991.1.11; Dimitrova DG, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020117; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Duffy EE, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1513; Erhard F, 2019, NATURE, V571, P419, DOI 10.1038/s41586-019-1369-y; Garibaldi A, 2017, METHODS MOL BIOL, V1648, P169, DOI 10.1007/978-1-4939-7204-3_13; GraphPad, PRISM; GREEN MR, 1983, CELL, V32, P681, DOI 10.1016/0092-8674(83)90054-5; Havranek KE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217497; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Herzog VA, 2017, NAT METHODS, V14, P1198, DOI [10.1038/NMETH.4435, 10.1038/nmeth.4435]; Hiller M, 2007, PLOS GENET, V3, P2147, DOI 10.1371/journal.pgen.0030204; IDT, 2016, MOD BLOCK NUCL DEGR; Lazar I., GELANALYZER 19 1; Meng M, 2018, MOLECULES, V23, DOI 10.3390/molecules23112941; Moore M., 1993, RNA WORLD, P303; Movassat M, 2014, METHODS MOL BIOL, V1126, P151, DOI 10.1007/978-1-62703-980-2_11; National Toxicology Program, 2004, NTP CERHR MON, P1; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	21	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0257503	10.1371/journal.pone.0257503	http://dx.doi.org/10.1371/journal.pone.0257503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898625	gold, Green Published, Green Submitted			2022-12-26	WOS:000755176200005
J	Iradukunda, A; Odjidja, EN; Ndayishima, SK; Ngendakumana, E; Ndayishimiye, GP; Sinarinzi, D; Izere, C; Ntakaburimvo, N; Akimana, A				Iradukunda, Arnaud; Odjidja, Emmanuel Nene; Ndayishima, Stephane Karl; Ngendakumana, Egide; Ndayishimiye, Gabin Pacifique; Sinarinzi, Darlene; Izere, Cheilla; Ntakaburimvo, Nestor; Akimana, Arlene			Prevalence and predictive risk factors of hypertension in patients hospitalized in Kamenge Military hospital and Kamenge University teaching hospital in 2019: A fixed effect modelling study in Burundi	PLOS ONE			English	Article							BURDEN; ADULTS	Introduction Hypertension is a major threat to public health globally. Especially in sub-Saharan African countries, this coexists with high burden of other infectious diseases, creating a complex public health situation which is difficult to address. Tackling this will require targeted public health intervention based on evidence that well defines the at risk population. In this study, using retrospective data from two referral hospitals in Burundi, we model the risk factors of hypertension in Burundi. Materials and methods Retrospective data of a sample of 353 randomly selected from a population of 4,380 patients admitted in 2019 in two referral hospitals in Burundi: Military and University teaching hospital of Kamenge. The predictive risk factors were carried out by fixed effect logistic regression. Model performance was assessed with Area under Curve (AUC) method. Model was internally validated using bootstrapping method with 2000 replications. Both data processing and data analysis were done using R software. Results Overall, 16.7% of the patients were found to be hypertensive. This study didn't showed any significant difference of hypertension's prevalences among women (16%) and men (17.7%). After adjustment of the model for cofounding covariates, associated risk factors found were advanced age (40-59 years) and above 60 years, high education level, chronic kidney failure, high body mass index, familial history of hypertension. In absence of these highlighted risk factors, the risk of hypertension occurrence was about 2 per 1000 persons. This probability is more than 90% in patients with more than three risk factors. Conclusion The relatively high prevalence and associated risk factors of hypertension in Burundi raises a call for concern especially in this context where there exist an equally high burden of infectious diseases, other chronic diseases including chronic malnutrition. Targeting interventions based on these identified risk factors will allow judicious channel of resources and effective public health planning.	[Iradukunda, Arnaud] Univ Burundi, Dept Med, Bujumbura, Burundi; [Iradukunda, Arnaud; Ndayishimiye, Gabin Pacifique; Sinarinzi, Darlene; Ntakaburimvo, Nestor] Lake Tanganyika Univ, Dept Stat, Mutanga, Burundi; [Iradukunda, Arnaud; Odjidja, Emmanuel Nene] Royal Soc Trop Med & Hyg, London, England; [Iradukunda, Arnaud; Izere, Cheilla; Ntakaburimvo, Nestor] ARNECH Res & Consulting Off, Dept Res & Innovat, Bujumbura, Burundi; [Odjidja, Emmanuel Nene] Monash Univ, Sch Clin Sci, Dept Med, Clayton, Vic, Australia; [Ndayishima, Stephane Karl] Univ Paris Est Creteil Val Marne, Departemend Med, Creteil, France; [Ngendakumana, Egide] Univ Lille, Dept Appl Econometr, Villeneuve Dascq, France; [Sinarinzi, Darlene] Inst Sci Campus Ctr, Dept Suivie Evaluat Projects, Ouagadougou, Burkina Faso; [Izere, Cheilla] Clermont Auvergne Univ, Dept Comp Math, Clermont Ferrand, France; [Akimana, Arlene] Inst Univ Sci Sante & Dev, Bujumbura, Burundi; [Akimana, Arlene] Aix Marseille Univ, Dept Publ Hlth, Marseille, France	Monash University; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite de Lille - ISITE; Universite de Lille; Universite Clermont Auvergne (UCA); UDICE-French Research Universities; Aix-Marseille Universite	Iradukunda, A (corresponding author), Univ Burundi, Dept Med, Bujumbura, Burundi.; Iradukunda, A (corresponding author), Lake Tanganyika Univ, Dept Stat, Mutanga, Burundi.; Iradukunda, A (corresponding author), Royal Soc Trop Med & Hyg, London, England.; Iradukunda, A (corresponding author), ARNECH Res & Consulting Off, Dept Res & Innovat, Bujumbura, Burundi.	arnaudiradukunda5@gmail.com	Iradukunda, arnaud/ABB-2321-2021	Iradukunda, arnaud/0000-0002-0995-800X				Ahmed S, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-0930-5; Bertram MY, 2021, INT J HEALTH POLICY, V10, P724, DOI 10.34172/ijhpm.2021.37; Cao CX, 2020, J MATERN-FETAL NEO M, V33, P1447, DOI 10.1080/14767058.2018.1519015; Chikowore T, 2021, EBIOMEDICINE, V65, DOI 10.1016/j.ebiom.2021.103260; Lavor LCD, 2020, REV ASSOC MED BRAS, V66, P630, DOI 10.1590/1806-9282.66.5.630; Desormais I, 2019, BMC CARDIOVASC DISOR, V19, DOI 10.1186/s12872-019-01273-7; Egbi OG, 2021, AFR J PRIM HEALTH CA, V13, DOI 10.4102/phcfm.v13i1.2833; Falk CF, 2021, PSYCHOL METHODS, DOI 10.1037/met0000422; HAMET P., 2020, SANTE MONDIALE; Hasan MM, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037592; Hu LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170238; Idris A., 2020, NIGERIAN J EC SOCIAL, V62; Jese NB, 2021, EUR HEART J SUPPL, V23, pB131, DOI 10.1093/eurheartj/suab030; Josephat P., 2018, INT J STAT APPL, V8, P9, DOI [10.5923/ j.statistics.20180801.02, DOI 10.5923/J.STATISTICS.20180801.02]; Kamble TS, 2019, COMMUN STAT-THEOR M, V48, P1981, DOI 10.1080/03610926.2018.1440598; Kidoguchi S, 2021, HYPERTENSION, V77, P16, DOI 10.1161/HYPERTENSIONAHA.120.16044; Lin XL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71908-9; Liu WJ, 2021, EUR RADIOL, V31, P2233, DOI 10.1007/s00330-020-07218-5; Agudelo EL, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1806527; Mills KT, 2020, NAT REV NEPHROL, V16, P223, DOI 10.1038/s41581-019-0244-2; Mogas SB, 2021, INTEGR BLOOD PRESS C, V14, P69, DOI 10.2147/IBPC.S293251; Mohamed SF, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-1270-7; Nahimana MR, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4536-9; Omar SM, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8386-5; Osei E, 2021, BMC MED INFORM DECIS, V21, DOI 10.1186/s12911-020-01381-x; Ostchega Yechiam, 2020, NCHS Data Brief, P1; Price AJ, 2018, LANCET DIABETES ENDO, V6, P208, DOI 10.1016/S2213-8587(17)30432-1; Rahman N., 2021, AM J HYPERTENSION EX, V8, P1; RCore Team, 2020, R LANG ENV STAT COMP; Rethy L, 2020, HYPERTENSION, V76, pE23, DOI 10.1161/HYPERTENSIONAHA.120.15153; Roba HS, 2019, INT J HYPERTENS, V2019, DOI 10.1155/2019/9878437; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Samanic CM, 2020, MMWR-MORBID MORTAL W, V69, P393, DOI 10.15585/mmwr.mm6914a1; Sapkota A, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06907-1; Sayed M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77035-9; Schouw DD, 2020, AFR J PRIM HEALTH CA, V12, DOI 10.4102/phcfm.v12i1.2217; Umashankar A, 2022, INDIAN J OTOLARYNGOL, V74, P3028, DOI 10.1007/s12070-021-02756-w; Vardell Emily, 2020, Medical Reference Services Quarterly, V39, P67, DOI 10.1080/02763869.2019.1693231; Villarreal-Zegarra D, 2021, J HUM HYPERTENS, V35, P462, DOI 10.1038/s41371-020-0361-1; Wang C, 2022, BIOACT MATER, V8, P494, DOI 10.1016/j.bioactmat.2021.06.005; Wang C, 2020, J AM COLL CARDIOL, V75, P2921, DOI 10.1016/j.jacc.2020.04.038; Williams B, 2018, J HYPERTENS, V36, P1953, DOI 10.1097/HJH.0000000000001940; Yaya S, 2021, J EPIDEMIOL GLOB HEA, P1, DOI [10.2991/jegh.k.201028.001, DOI 10.2991/JEGH.K.201028.001]; Zhang XM, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6645-6	44	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0260225	10.1371/journal.pone.0260225	http://dx.doi.org/10.1371/journal.pone.0260225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898616	gold, Green Published			2022-12-26	WOS:000755176200009
J	Dahanayaka, NJ; Agampodi, SB; Seneviratna, I; Warnasekara, J; Rajapakse, R; Ranathunga, K; Matthias, M; Vinetz, JM				Dahanayaka, Niroshana J.; Agampodi, Suneth B.; Seneviratna, Indika; Warnasekara, Janith; Rajapakse, Rukman; Ranathunga, Kosala; Matthias, Michael; Vinetz, Joseph M.			Clinical spectrum of endemic leptospirosis in relation to cytokine response	PLOS ONE			English	Article							ACUTE FEBRILE ILLNESS; SRI-LANKA; SEVERITY; OUTBREAK; DISEASE; KANDY	Objectives To describe the clinical spectrum and the cytokine response of leptospirosis patients in an endemic setting of Sri Lanka. Methods Patients presenting to the university teaching hospital, Anuradhapura, Sri Lanka with a leptospirosis-compatible illness were recruited over a period of 12 months starting from June 2012. Daily clinical and biochemical parameters of the patients were prospectively assessed with a follow-up of 14 days after discharge. A magnetic bead-based multiplex cytokine kit was used to detect 17 cytokines. Results Of the 142 clinically suspected leptospirosis patients recruited, 47 were confirmed and, 29 cases were labeled as "probable." Thrombocytopenia and leukocytosis were observed at least once during the hospital stay among 76(54%) and 39(28%) patients, respectively. Acute kidney injury was observed in 31 patients (22%) and it was significantly higher among confirmed and probable cases. Hu TNF-alpha and IL-1 beta were detected only in patients without complications. Hu MIP-1b levels were significantly higher among patients with complications. During the convalescence period, all tested serum cytokine levels were lower compared to the acute sample, except for IL-8. The cytokine response during the acute phase clustered in four different groups. High serum creatinine was associated GM-CSF, high IL-5 and IL-6 level were correlates with lung involvement and saturation drop. The patients with high billirubin (direct)>7 mmol/l had high IL-13 levels. Conclusions Results of this study confirms that the knowledge on cytokine response in leptospirosis could be more complex than other similar tropical disease, and biosignatures that provide diagnostic and prognostic information for human leptospirosis remain to be discovered.	[Dahanayaka, Niroshana J.; Rajapakse, Rukman; Ranathunga, Kosala] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Med, Saliyapura, Sri Lanka; [Dahanayaka, Niroshana J.] Univ Ruhuna, Dept Med, Fac Med, Matara, Sri Lanka; [Agampodi, Suneth B.; Matthias, Michael; Vinetz, Joseph M.] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Agampodi, Suneth B.; Warnasekara, Janith] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Saliyapura, Sri Lanka; [Seneviratna, Indika] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Biochem, Saliyapura, Sri Lanka	Rajarata University of Sri Lanka; University Ruhuna; Yale University; Rajarata University of Sri Lanka; Rajarata University of Sri Lanka	Agampodi, SB (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.; Agampodi, SB (corresponding author), Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Saliyapura, Sri Lanka.	suneth.agampodi@yale.edu	Agampodi, Suneth/G-3320-2012	Agampodi, Suneth/0000-0001-7810-1774; Vinetz, Joseph/0000-0001-8344-2004; Senavirathna, Indika/0000-0002-0343-1557				Agampodi SB, 2008, INDIAN J MED MICROBI, V26, P405, DOI 10.4103/0255-0857.43557; Agampodi S, 2009, LANCET INFECT DIS, V9, P524, DOI 10.1016/S1473-3099(09)70211-7; Agampodi SB, 2015, AM J TROP MED HYG, V92, P139, DOI 10.4269/ajtmh.14-0465; Agampodi SB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002626; Agampodi SB, 2011, AM J TROP MED HYG, V85, P471, DOI 10.4269/ajtmh.2011.11-0276; Agampodi SB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-332; Bandara K, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/9704532; Bandara KK, 2015, MEM I OSWALDO CRUZ, V110, P485, DOI 10.1590/0074-02760150070; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; CASSATELLA MA, 1994, J EXP MED, V179, P1695, DOI 10.1084/jem.179.5.1695; Chirathaworn C, 2016, CYTOKINE, V85, P80, DOI 10.1016/j.cyto.2016.06.007; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; De Silva Nipun Lakshitha, 2014, Int Arch Med, V7, P31, DOI 10.1186/1755-7682-7-31; Koizumi N, 2009, JPN J INFECT DIS, V62, P474; Kyriakidis I, 2011, CYTOKINE, V54, P117, DOI 10.1016/j.cyto.2011.01.014; Mikulski M, 2015, EUR J CLIN MICROBIOL, V34, P687, DOI 10.1007/s10096-014-2275-8; Naotunna C, 2016, ASIAN PAC J TROP MED, V9, P381, DOI 10.1016/j.apjtm.2016.03.009; Papa A, 2015, T ROY SOC TROP MED H, V109, P749, DOI 10.1093/trstmh/trv095; Rajapakse S, 2015, T ROY SOC TROP MED H, V109, P710, DOI 10.1093/trstmh/trv079; Reis EAG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002457; Reller ME, 2011, EMERG INFECT DIS, V17, P1678, DOI [10.3201/eid1709.100915, 10.3201/eid1709.100915.]; Senavirathna I, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-04986-9; Tajiki MH, 1996, CLIN INFECT DIS, V23, P1177, DOI 10.1093/clinids/23.5.1177; Taylor AJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003866; Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056; Torgerson PR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004122; Wagenaar JFP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000453	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0261025	10.1371/journal.pone.0261025	http://dx.doi.org/10.1371/journal.pone.0261025			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879100	gold, Green Published			2022-12-26	WOS:000754625200043
J	Cennamo, G; Solari, D; Montorio, D; Scala, MR; D'Andrea, L; Tranfa, F; Cavallo, LM				Cennamo, G.; Solari, D.; Montorio, D.; Scala, M. R.; D'Andrea, L.; Tranfa, F.; Cavallo, L. M.			The role of OCT- angiography in predicting anatomical and functional recovery after endoscopic endonasal pituitary surgery: A 1-year longitudinal study	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; VASCULAR ABNORMALITIES; DIABETIC-RETINOPATHY; QUANTIFICATION; ADENOMAS; DENSITY; IMAGES	Purpose The purpose of this study was to investigate the changes in structural spectral-domain optical coherence tomography (SD-OCT), OCT Angiography (OCTA) parameters, and visual acuity, 1 year after endoscopic endonasal approach for the removal of an intra-suprasellar pituitary adenoma compressing optic chiasm and compare outcomes with 48 hours postoperative data. Methods Sixteen eyes of eight patients (4 males, 4 females, mean age 52 11 years) were enrolled in this prospective study. The primary outcome was to evaluate the changes over time before and after surgery, analyzing the Best Corrected Visual Acuity (BCVA), Ganglion Cell Complex (GCC), Retinal Nerve Fiber Layer (RNFL) thicknesses, the retinal vessel density (VD) of Superficial Capillary Plexus (SCP), Deep Capillary Plexus (DCP), Radial Peripapillary Capillary (RPC) and the Foveal Avascular Zone (FAZ). The secondary outcome was to identify potential biomarkers that could predict visual acuity changes after 1-year follow-up. Results When comparing SD-OCT and OCTA measurements obtained after 1 year with those observed 48 hours after surgery, GCC and RNFL were significantly improved. After a significant reduction at 48 hours, GCC thickness showed a significant increase at 1 year after surgery (p = 0.007), while a significant restoration of RNFL thickness was found at 1 year (p = 0.005), as well as the VD of SCP, DCP, and RPC values. FAZ area did not change over time. BCVA significantly improved at each time after surgery (p = 0.037, p = 0.013). A statistically significant correlation was found between the preoperative BCVA, VD of SCP, DCP, RPC, and the postoperative BCVA at 1 year (p = 0.017, p = 0.029, p = 0.031, p = 0.023). Conclusion SD-OCT and OCTA provide helpful information to identify the retinal structural and vascular improvements 1 year after surgery. OCTA parameters could serve as potential predictive markers for visual acuity recovery at long-term follow-up.	[Cennamo, G.] Univ Napoli Federico II, Publ Hlth Dept, Naples, Italy; [Solari, D.; Scala, M. R.; Cavallo, L. M.] Univ Napoli Federico II, Dept Neurosci, Div Neurosurg Dept Neurosci Reprod Sci & Odontost, Naples, Italy; [Montorio, D.; D'Andrea, L.; Tranfa, F.] Univ Naples Federico II, Dept Neurosci Reprod Sci & Dent, Eye Clin, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Solari, D (corresponding author), Univ Napoli Federico II, Dept Neurosci, Div Neurosurg Dept Neurosci Reprod Sci & Odontost, Naples, Italy.	domenico.solari@unina.it		SOLARI, Domenico/0000-0003-1535-8737; D'Andrea, Luca/0000-0002-1964-4899				Blanch RJ, 2018, PITUITARY, V21, P515, DOI 10.1007/s11102-018-0906-2; Butenschoen VM, 2021, NEUROSURG REV, V44, P2245, DOI 10.1007/s10143-020-01408-x; Cennamo G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241295; Cennamo G, 2017, GRAEF ARCH CLIN EXP, V255, P1787, DOI 10.1007/s00417-017-3709-7; Cicinelli MV, 2018, BRIT J OPHTHALMOL, V102, P1192, DOI 10.1136/bjophthalmol-2017-311317; Dallorto L, 2020, ACTA OPHTHALMOL, V98, pE585, DOI 10.1111/aos.14322; de Carlo TE, 2015, OSLI RETINA, V46, P611, DOI 10.3928/23258160-20150610-03; Durbin MK, 2017, JAMA OPHTHALMOL, V135, P370, DOI 10.1001/jamaophthalmol.2017.0080; Grkovic D, 2013, SRP ARK CELOK LEK, V141, P296, DOI 10.2298/SARH1306296G; Hajiabadi M, 2016, J NEUROSURG, V125, P759, DOI 10.3171/2015.6.JNS1546; Huang D, 2016, DEV OPHTHALMOL, V56, P6, DOI 10.1159/000442770; Huang YP, 2014, OSLI RETINA, V45, P382, DOI 10.3928/23258160-20140909-08; Iqbal M, 2020, NEUROL INDIA, V68, P346, DOI 10.4103/0028-3886.280634; Ishibazawa A, 2015, AM J OPHTHALMOL, V160, P35, DOI 10.1016/j.ajo.2015.04.021; Jia YL, 2015, P NATL ACAD SCI USA, V112, pE2395, DOI 10.1073/pnas.1500185112; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Kniestedt Christoph, 2003, Ophthalmol Clin North Am, V16, P155, DOI 10.1016/S0896-1549(03)00013-0; Lake MG, 2013, AM FAM PHYSICIAN, V88, P319; Lee GI, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030697; Lee GI, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59158-1; Lo C, 2021, TAIWAN J OPHTHALMOL, V11, P3, DOI 10.4103/tjo.tjo_76_20; Miura M, 2015, AM J OPHTHALMOL, V159, P528, DOI 10.1016/j.ajo.2014.12.002; Moein HR, 2018, RETINA-J RET VIT DIS, V38, P2277, DOI 10.1097/IAE.0000000000001902; Ohkubo S, 2012, JPN J OPHTHALMOL, V56, P68, DOI 10.1007/s10384-011-0093-4; Park SH, 2021, INT OPHTHALMOL, V41, P2019, DOI 10.1007/s10792-021-01757-6; Parodi MB, 2017, BRIT J OPHTHALMOL, V101, P428, DOI 10.1136/bjophthalmol-2016-308925; Parodi MB, 2018, AM J OPHTHALMOL, V187, P61, DOI 10.1016/j.ajo.2017.12.013; Parodi MB, 2018, RETINA-J RET VIT DIS, V38, P237, DOI 10.1097/IAE.0000000000001539; Parodi MB, 2017, BRIT J OPHTHALMOL, V101, P780, DOI 10.1136/bjophthalmol-2016-308869; Rabiolo A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205773; Rao HL, 2016, AM J OPHTHALMOL, V171, P75, DOI 10.1016/j.ajo.2016.08.030; Samara WA, 2017, OPHTHALMOLOGY, V124, P235, DOI 10.1016/j.ophtha.2016.10.008; Samara WA, 2016, AM J OPHTHALMOL, V166, P76, DOI 10.1016/j.ajo.2016.03.033; Schwartz DM, 2014, OPHTHALMOLOGY, V121, P180, DOI 10.1016/j.ophtha.2013.09.002; Solari Domenico, 2022, J Neurosurg Sci, V66, P362, DOI 10.23736/S0390-5616.19.04687-3; Tan PEZ, 2015, INVEST OPHTH VIS SCI, V56, P3989, DOI 10.1167/iovs.14-15879; Thotakura Amit Kumar, 2017, Asian J Neurosurg, V12, P1, DOI 10.4103/1793-5482.149995; Trevisi G, 2019, WORLD NEUROSURG, V121, pE769, DOI 10.1016/j.wneu.2018.09.215; Yu SY, 2018, J CELL MOL MED, V22, P2023, DOI 10.1111/jcmm.13445	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260029	10.1371/journal.pone.0260029	http://dx.doi.org/10.1371/journal.pone.0260029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855775	gold, Green Published			2022-12-26	WOS:000735299000027
J	Cui, JW; Che, AL; Li, S; Cheng, YF				Cui, Jiawei; Che, Ailan; Li, Sheng; Cheng, Yongfeng			Evaluation method on seismic risk of substation in strong earthquake area	PLOS ONE			English	Article							FRAGILITY ANALYSIS; EQUIPMENT; VULNERABILITY; SPECTRA	Frequent earthquakes in strong earthquake areas pose a great threat to the safety operation of electric power facilities. There exists a pressing research need to develop an assessment method for the seismic risk of substations, i.e., the hubs of power system networks. In this study, based on Incremental Dynamic Analysis (IDA), Probabilistic Seismic Demand Model (PSDM) and reliability theory, a vulnerability model for a substation is obtained, based on considering the relationships between Peak Ground Acceleration (PGA) and four seismic damage states (complete, extensive, moderate, and slight.) via a probabilistic approach. After an earthquake, the scope of influence and PGA distribution are evaluated using information recorded by the seismic observation stations, based on using interpolation or an empirical formula for the PGA attenuation. Therefore, the seismic risk can be evaluated by combining ground motion evaluation and the pre-built vulnerability model. The Wuqia- Kashgar area of Xinjiang was selected as the study area; it is an Earthquake-prone area, and one of the starting points for new energy transmission projects in China. Under a hypothetical earthquake (M-S 7.9), the seismic risk of the substations was evaluated. The results show that: this method is able to give the probabilities of the four damage states of the substations, four substations close to the epicenter only have a probability of slight damage (45%-88%) and other substations are safer.	[Cui, Jiawei; Che, Ailan] Shanghai Jiao Tong Univ, Dept Civil Engn, Shanghai, Peoples R China; [Li, Sheng; Cheng, Yongfeng] China Elect Power Res Inst, Dept Elect Engn, Beijing, Peoples R China; [Cui, Jiawei; Che, Ailan] Shanghai Jiao Tong Univ, Ocean & Civil Engn, Shanghai, Peoples R China; [Li, Sheng; Cheng, Yongfeng] China Elect Power Res Inst, Beijing, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Che, AL (corresponding author), Shanghai Jiao Tong Univ, Dept Civil Engn, Shanghai, Peoples R China.; Che, AL (corresponding author), Shanghai Jiao Tong Univ, Ocean & Civil Engn, Shanghai, Peoples R China.	alche@sjtu.edu.cn		che, ailan/0000-0003-3523-2832	Ministry of Science and Technology of the People's Republic of China [2018YFC1504504, 2018YFC0809404]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was part of the Program on `Visualization of post-disaster information based on big data mining technology' and `Study on on-line seismic monitoring and rapid damage evaluation method for substation (converter station).' funded under the Ministry of Science and Technology of the People's Republic of China, (grant number 2018YFC1504504 and 2018YFC0809404) awarded to AC. The project provides funding for research into how to quickly and effectively assess damage and visualize disaster information after an earthquake.	Anshel J, 2004, 13 WORLD C EARTHQ EN, P2306; Aval SMM, 2015, ENERG BUILDINGS, V105, P236, DOI 10.1016/j.enbuild.2015.05.059; Baghmisheh AG, 2019, SOIL DYN EARTHQ ENG, V125, DOI 10.1016/j.soildyn.2019.105733; Baker JW., 2011, NEW GROUND MOTION SE; Bender J, 2018, ENG STRUCT, V162, P1, DOI 10.1016/j.engstruct.2018.01.052; Cheng Y., 2019, BUILD STRUCT, V49, P356; FEMA, 2003, HAZUS MH MULT LOSS E; Hailei H., 2011, POWER SYSTEM TECHNOL, V35, P25, DOI [10.13335/j.1000-3673.pst.2011.04.002, DOI 10.13335/J.1000-3673.PST.2011.04.002]; Haldar A., 2000, PROBABILITY RELIABIL, DOI [10.1002/ bate.200002930, DOI 10.1002/BATE.200002930]; He C, 2019, SOIL DYN EARTHQ ENG, V123, P498, DOI 10.1016/j.soildyn.2019.05.022; He JJ, 2020, ENVIRON POLLUT, V266, DOI 10.1016/j.envpol.2020.115133; Hwang HHM, 1998, PROBABILIST ENG MECH, V13, P107, DOI 10.1016/S0266-8920(97)00017-9; Jiang W, 2015, NUCL ENG DES, V293, P525, DOI 10.1016/j.nucengdes.2015.05.034; Johnson B, 2020, ELECTR POW SYST RES, V184, DOI 10.1016/j.epsr.2020.106332; Li S, 2018, COMPOS STRUCT, V194, P454, DOI 10.1016/j.compstruct.2018.02.036; [李圣 Li Sheng], 2016, [工程力学, Engineering Mechanics], V33, P91; Liang HB, 2020, STRUCTURES, V27, P650, DOI 10.1016/j.istruc.2020.06.017; Liu H, 2021, RELIAB ENG SYST SAFE, V206, DOI 10.1016/j.ress.2020.107299; Mabuti hiroshi yasushi. otake masakazu. sato haruo, 2004, WORLD EARTHQUAKE TRA, P1; Velasquez RMA, 2019, ENG FAIL ANAL, V97, P416, DOI 10.1016/j.engfailanal.2019.01.025; Mingpan X., 2016, RES VULNERABILITY HI; Paolacci F, 2014, SOIL DYN EARTHQ ENG, V67, P198, DOI 10.1016/j.soildyn.2014.09.014; Pires JA, 1996, NUCL ENG DES, V160, P427, DOI 10.1016/0029-5493(95)01119-6; Politopoulos I, 2007, EARTHQ ENG STRUCT D, V36, P975, DOI 10.1002/eqe.664; Porter K, 2013, ANAL DERIVATION SEIS; State Grid Corporation of China, 2021, GUID SEISM SAF RISK; State Grid Corporation of China, 2017, GEN DES POW TRANSM T; Sun QL, 2018, ENG STRUCT, V174, P861, DOI 10.1016/j.engstruct.2018.07.077; Vamvatsikos D, 2002, EARTHQUAKE ENG STRUC, V31, P491, DOI 10.1002/eqe.141; Zalohar J, 2018, DEV STRUCT GEOL GEOP, P173, DOI 10.1016/B978-0-12-814580-7.00014-9; Zareei SA, 2017, SOIL DYN EARTHQ ENG, V92, P79, DOI 10.1016/j.soildyn.2016.09.026; Zareei SA, 2016, ENG FAIL ANAL, V70, P273, DOI 10.1016/j.engfailanal.2016.09.007; Zhong J, 2019, THIN WALL STRUCT, V137, P436, DOI 10.1016/j.tws.2019.01.032	33	0	0	13	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0258792	10.1371/journal.pone.0258792	http://dx.doi.org/10.1371/journal.pone.0258792			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855758	gold, Green Published			2022-12-26	WOS:000735299000010
J	Brailovskaia, J; Schneider, S; Margraf, J				Brailovskaia, Julia; Schneider, Silvia; Margraf, Juergen			To vaccinate or not to vaccinate!? Predictors of willingness to receive Covid-19 vaccination in Europe, the US, and China	PLOS ONE			English	Article							MEASUREMENT INVARIANCE; MENTAL-HEALTH; SOCIAL NETWORKING; ACCEPTANCE SCALE; STRESS; DEPRESSION; NARCISSISM; BEHAVIOR; ANXIETY; GENDER	Researcher teams around the globe including the "Project Lightspeed" are intensively working on vaccines to fight the Covid-19 pandemic. However, the availability of effective vaccines does not guarantee the vaccination willingness among the population. In spring 2021, we investigated the vaccination willingness and its potential predictors in representative online samples in nine countries (China, France, Germany, Poland, Russia, Spain, Sweden, U.K., U.S.). Of the 9,264 participants, 79.9% revealed Covid-19 vaccination willingness. The highest willingness was in the U.K., followed by Spain and China, the lowest in Russia. In most countries, the perception of governmental Covid-19 measures as useful and the use of television reports as Covid-19 information source positively predicted the willingness. Further factors such as demographic variables, mental and physical health status, evaluation of governmental communication, social media use, and general adherence to Covid-19 measures showed a country-specific predictive pattern. Recommendations how to increase the vaccination willingness are provided.	[Brailovskaia, Julia; Margraf, Juergen] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Dept Clin Psychol & Psychotherapy, Bochum, Germany; [Schneider, Silvia] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Dept Clin Child & Adolescent Psychol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Brailovskaia, J (corresponding author), Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Dept Clin Psychol & Psychotherapy, Bochum, Germany.	julia.brailovskaia@rub.de	Brailovskaia, Julia/AAN-7333-2021; Margraf, Jürgen/A-6873-2008; Schneider, Silvia/C-5229-2015	Brailovskaia, Julia/0000-0001-7607-1305; Margraf, Jürgen/0000-0001-5207-7016; Schneider, Silvia/0000-0003-0698-8411	Open Access Publication Funds of the Ruhr-Universitat Bochum	Open Access Publication Funds of the Ruhr-Universitat Bochum	We acknowledge support by the Open Access Publication Funds of the Ruhr-Universitat Bochum to Julia Brailovskaia (JB) to pay the publication fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Alimoradi Z, 2021, ASIAN J SOC HEAL BEH, V4, P129, DOI 10.4103/shb.shb_100_21; Alley SJ, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020797; Allington D, 2021, PSYCHOL MED, V51, P1763, DOI [10.1017/S0033291721000593, 10.1017/S003329172000224X]; Apuke OD, 2021, TELEMAT INFORM, V56, DOI 10.1016/j.tele.2020.101475; Basta NE, VACCINES CANDIDATES; Benchekroun H, 2008, J ECON BEHAV ORGAN, V67, P239, DOI 10.1016/j.jebo.2006.08.010; Bendau A, 2021, INT IMMUNOPHARMACOL, V97, DOI 10.1016/j.intimp.2021.107724; Berry JW., 1989, HDB CROSS CULTURAL P, P1; Bieda A, 2017, PSYCHOL ASSESSMENT, V29, P408, DOI 10.1037/pas0000353; BioNTech, AIM ADDR GLOB COR PA; Brailovskaia J., 2021, J AFFECTIVE DISORDER, V3, P100067, DOI [10.1016/j.jadr.2020.100067, DOI 10.1016/J.JADR.2020.100067]; Brailovskaia J, 2020, INT J CLIN HLTH PSYC, V20, P183, DOI 10.1016/j.ijchp.2020.06.002; Brailovskaia J, 2020, CURR PSYCHOL, V39, P2192, DOI 10.1007/s12144-018-9911-x; Budhwani H, 2020, J MED INTERNET RES, V22, DOI 10.2196/19301; Cai D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01119; Chen IH, 2021, VACCINE, V39, P4510, DOI 10.1016/j.vaccine.2021.06.044; Chen MS, 2021, HUM VACC IMMUNOTHER, V17, P2279, DOI 10.1080/21645515.2020.1853449; Chew NWS, 2021, INT J INFECT DIS, V106, P52, DOI 10.1016/j.ijid.2021.03.069; Cohen J.E., 1988, STAT POWER ANAL BEHA; Daly M, 2021, AM J PREV MED, V60, P766, DOI 10.1016/j.amepre.2021.01.008; Depoux A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa031; Detoc M, 2020, VACCINE, V38, P7002, DOI 10.1016/j.vaccine.2020.09.041; Dodd RH, 2021, LANCET INFECT DIS, V21, P318, DOI 10.1016/S1473-3099(20)30559-4; Dzieciolowska S, 2021, AM J INFECT CONTROL, V49, P1152, DOI 10.1016/j.ajic.2021.04.079; Fan CW, 2021, HUM VACC IMMUNOTHER, V17, P3413, DOI 10.1080/21645515.2021.1933687; Feleszko W, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010044; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; Gandhi M, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2026913; Garland M, 2021, PFIZER TRANSFORMED I; Griner J, 2014, GLOBAL STUDIES J, V7, P2; Henze J, 2012, RES COMP INT EDUC, V7, P90, DOI 10.2304/rcie.2012.7.1.90; Huang PC, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9091046; IBM Corp, 2019, IBM SPSS STAT WINDOW; Jennings W, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060593; Kelly BJ, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06023-9; Keyes CLM, 2005, J CONSULT CLIN PSYCH, V73, P539, DOI 10.1037/0022-006X.73.3.539; Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255; Kukreti S, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030246; Kumari A, 2021, DIABETES METAB SYND, V15, P987, DOI 10.1016/j.dsx.2021.04.015; Lamb YN, 2021, DRUGS, V81, P495, DOI 10.1007/s40265-021-01480-7; Lazarus JV, 2020, J HEALTH COMMUN, V25, P799, DOI 10.1080/10810730.2020.1868630; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Li X, 2020, LANCET, V395, P1802, DOI 10.1016/S0140-6736(20)30122-7; Liu RG, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030292; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lukat Justina, 2016, BMC Psychol, V4, P8, DOI 10.1186/s40359-016-0111-x; Machida M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030210; Margraf J, 2022, J PSYCHOSOM OBST GYN, V43, P177, DOI 10.1080/0167482X.2020.1816959; Margraf J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249392; Margraf J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243523; Mayr S, 2007, TUTOR QUANT METHODS, V3, P51, DOI 10.20982/tqmp.03.2.p051; Mills MC, 2021, ECLINICALMEDICINE, V31, DOI 10.1016/j.eclinm.2020.100674; Milne S, 2000, J APPL SOC PSYCHOL, V30, P106, DOI 10.1111/j.1559-1816.2000.tb02308.x; Milton K, 2011, BRIT J SPORT MED, V45, P203, DOI 10.1136/bjsm.2009.068395; Muhlberger C., 2019, SOCIAL PSYCHOL ACTIO, P79, DOI DOI 10.1007/978-3-030-13788-5_6; Neumann-Bohme S, 2020, EUR J HEALTH ECON, V21, P977, DOI 10.1007/s10198-020-01208-6; Nohl A, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050424; Oberst U, 2017, J ADOLESCENCE, V55, P51, DOI 10.1016/j.adolescence.2016.12.008; Parrish BP, 2011, J SOC CLIN PSYCHOL, V30, P270, DOI 10.1521/jscp.2011.30.3.270; Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054; Pollak Y, 2020, PSYCHIAT CLIN NEUROS, V74, P602, DOI 10.1111/pcn.13122; Popovich L, 2011, RUSSIAN FEDERATION H; Randolph HE, 2020, IMMUNITY, V52, P737, DOI 10.1016/j.immuni.2020.04.012; Reiter PL, 2020, VACCINE, V38, P6500, DOI 10.1016/j.vaccine.2020.08.043; Rieger MO, 2021, ASIAN J SOC HEAL BEH, V4, P81, DOI 10.4103/shb.shb_7_21; Rodriguez-Blanco N, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18105272; Rogers R.W., 1983, SOCIAL PSYCHOPHYSIOL; Romero-Rodriguez JM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124336; Ryan KM, 2008, SEX ROLES, V58, P802, DOI 10.1007/s11199-008-9403-9; Schernhammer E, 2022, J PUBLIC HEALTH-UK, V44, pE106, DOI 10.1093/pubmed/fdab122; Scholten S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194642; Scholten S, 2017, SSM-POPUL HLTH, V3, P639, DOI 10.1016/j.ssmph.2017.07.010; Scholten S, 2017, PSYCHOL ASSESSMENT, V29, P1376, DOI 10.1037/pas0000440; SELIGMAN ME, 1972, ANNU REV MED, V23, P407, DOI 10.1146/annurev.me.23.020172.002203; Sherman SM, 2021, HUM VACC IMMUNOTHER, V17, P1612, DOI 10.1080/21645515.2020.1846397; Shishkin SV, 2014, ZH NOVAYA EKON ASSOT, P162; Suldo SM, 2008, SCHOOL PSYCHOL REV, V37, P52; Teasdale E, 2012, BRIT J HEALTH PSYCH, V17, P44, DOI 10.1111/j.2044-8287.2011.02017.x; Teismann T, 2018, BEHAV RES THER, V108, P40, DOI 10.1016/j.brat.2018.06.006; Tran VD, 2021, PHARM PRACT-GRANADA, V19, DOI [10.18549/PharmPract.2021.1.2276, 10.18549/pharmpract.2021.1.2276]; Truskauskaite-Kuneviciene I, 2022, CURR PSYCHOL, V41, P1951, DOI 10.1007/s12144-020-00714-3; Tso RV, 2020, CLIN INFECT DIS, V71, P2195, DOI 10.1093/cid/ciaa593; Velten J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258333; Verger P, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.3.2002047; Wang JH, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030482; Wang JL, 2012, COMPUT HUM BEHAV, V28, P2313, DOI 10.1016/j.chb.2012.07.001; Wang PW, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040380; Whiting A, 2013, QUAL MARK RES, V16, P362, DOI 10.1108/QMR-06-2013-0041; World Health Organization, STAT COVID 19 VACC 2; World Population Review, 2021, COUNTRIES WORLD POPU; Wortman C. B., 1975, ADV EXP SOC PSYCHOL, V8, P277, DOI [10.1016/S0065-2601(08)60253-1, DOI 10.1016/S0065-2601(08)60253-1]; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yahaghi R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9070684; Yeh YC, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030297; Yoda T, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010048; Rivas DRZ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245859; Zuckerman M., 2014, SENSATION SEEKING PS	98	13	13	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260230	10.1371/journal.pone.0260230	http://dx.doi.org/10.1371/journal.pone.0260230			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ9AQ	34851986	gold, Green Published			2022-12-26	WOS:000755762900027
J	Carlisle, RE; Farooqi, S; Zhang, MC; Liu, S; Lu, C; Phan, A; Brimble, E; Dickhout, JG				Carlisle, Rachel E.; Farooqi, Salwa; Zhang, Ming Chan; Liu, Sarah; Lu, Chao; Phan, Andy; Brimble, Elise; Dickhout, Jeffrey G.			Inhibition of histone deacetylation with vorinostat does not prevent tunicamycin-mediated acute kidney injury	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CELL-DEATH; CHEMICAL CHAPERONES; PROMOTES APOPTOSIS; CANCER CELLS; MOUSE MODEL; ER STRESS; TRICHOSTATIN; INDUCTION	Endoplasmic reticulum (ER) stress is associated with acute kidney injury (AKI) caused by various mechanisms, including antibiotics, non-steroidal anti-inflammatory drugs, cisplatin, and radiocontrast. Tunicamycin (TM) is a nucleoside antibiotic that induces ER stress and is a commonly used model of AKI. 4-phenylbutyrate (4-PBA) is a chemical chaperone and histone deacetylase (HDAC) inhibitor and has been shown to protect the kidney from ER stress, apoptosis, and structural damage in a tunicamycin model of AKI. The renal protection provided by 4-PBA is attributed to its ability to prevent misfolded protein aggregation and inhibit ER stress; however, the HDAC inhibitor effects of 4-PBA have not been examined in the TM-induced model of AKI. As such, the main objective of this study was to determine if histone hyperacetylation provides any protective effects against TM-mediated AKI. The FDA-approved HDAC inhibitor vorinostat was used, as it has no ER stress inhibitory effects and therefore the histone hyperacetylation properties alone could be investigated. In vitro work demonstrated that vorinostat inhibited histone deacetylation in cultured proximal tubular cells but did not prevent ER stress or protein aggregation induced by TM. Vorinostat induced a significant increase in cell death, and exacerbated TM-mediated total cell death and apoptotic cell death. Wild type male mice were treated with TM (0.5 mg/kg, intraperitoneal injection), with or without vorinostat (50 mg/kg/day) or 4-PBA (1 g/kg/day). Mice treated with 4-PBA or vorinostat exhibited similar levels of histone hyperacetylation. Expression of the pro-apoptotic protein CHOP was induced with TM, and not inhibited by vorinostat. Further, vorinostat did not prevent any renal damage or decline in renal function caused by tunicamycin. These data suggest that the protective mechanisms found by 4-PBA are primarily due to its molecular chaperone properties, and the HDAC inhibitors used did not provide any protection against renal injury caused by ER stress.	[Carlisle, Rachel E.; Farooqi, Salwa; Zhang, Ming Chan; Liu, Sarah; Lu, Chao; Phan, Andy; Brimble, Elise; Dickhout, Jeffrey G.] McMaster Univ, Hamilton, ON, Canada; [Carlisle, Rachel E.; Farooqi, Salwa; Zhang, Ming Chan; Liu, Sarah; Lu, Chao; Phan, Andy; Brimble, Elise; Dickhout, Jeffrey G.] St Josephs Healthcare Hamilton, Hamilton, ON, Canada; [Farooqi, Salwa] Univ Toronto, Dept Med, Toronto, ON, Canada	McMaster University; McMaster University; University of Toronto	Dickhout, JG (corresponding author), McMaster Univ, Hamilton, ON, Canada.; Dickhout, JG (corresponding author), St Josephs Healthcare Hamilton, Hamilton, ON, Canada.	jdickhou@stjosham.on.ca			Kidney Foundation of Canada [KFOC190012]; St. Joseph's Healthcare Hamilton; Research Institute Post-Doctoral Fellowship Award from St. Joseph's Healthcare Hamilton	Kidney Foundation of Canada; St. Joseph's Healthcare Hamilton; Research Institute Post-Doctoral Fellowship Award from St. Joseph's Healthcare Hamilton	This work was supported by a Biomedical Research Grant from the Kidney Foundation of Canada (KFOC190012). Financial support from St. Joseph's Healthcare Hamilton, salary support from St. Joseph's Healthcare Hamilton, and Division of Nephrology in the Department of Medicine at McMaster University are also acknowledged by Jeffrey G. Dickhout. Rachel E. Carlisle has been supported by a Research Institute Post-Doctoral Fellowship Award from St. Joseph's Healthcare Hamilton.	Bao LM, 2016, CELL BIOL TOXICOL, V32, P469, DOI 10.1007/s10565-016-9347-8; Carlisle RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084663; Chandrika BB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140025; Choi HS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30008-5; Cortez L, 2014, PRION, V8, P197, DOI 10.4161/pri.28938; Cosentino CC, 2013, J AM SOC NEPHROL, V24, P943, DOI 10.1681/ASN.2012111055; Das Gupta K, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2015.46; Dong G, 2008, J PHARMACOL EXP THER, V325, P978, DOI 10.1124/jpet.108.137398; Feng YY, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00274; Guha P, 2017, ONCOTARGET, V8, P68191, DOI 10.18632/oncotarget.19277; Gupta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048950; Hao Y, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20191538; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kikuchi S, 2015, LEUKEMIA, V29, P1918, DOI 10.1038/leu.2015.83; Kimbrough D, 2018, J MOL CELL CARDIOL, V119, P51, DOI 10.1016/j.yjmcc.2018.04.011; Kinugasa F, 2010, TRANSPL IMMUNOL, V23, P18, DOI 10.1016/j.trim.2010.02.003; Lim EJ, 2015, APOPTOSIS, V20, P1087, DOI 10.1007/s10495-015-1135-z; Liu DS, 2018, CELL PHYSIOL BIOCHEM, V46, P1821, DOI 10.1159/000489367; Liu J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0374-7; Liu XY, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2746521; Mami I, 2016, J AM SOC NEPHROL, V27, P2670, DOI 10.1681/ASN.2015060703; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Mimori S, 2013, BIOORG MED CHEM LETT, V23, P6015, DOI 10.1016/j.bmcl.2013.08.001; Mohammed-Ali Z, 2017, SCI REP-UK, V7, DOI 10.1038/srep41572; Mohammed-Ali Z, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/428508; Niki T, 1999, HEPATOLOGY, V29, P858, DOI 10.1002/hep.510290328; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Peyrou M, 2007, TOXICOL SCI, V99, P346, DOI 10.1093/toxsci/kfm152; Ponnusamy M, 2014, J PHARMACOL EXP THER, V350, P243, DOI 10.1124/jpet.113.212076; Poupon RE, 1999, HEPATOLOGY, V29, P1668, DOI 10.1002/hep.510290603; Prachasilchai W, 2008, EUR J PHARMACOL, V592, P138, DOI 10.1016/j.ejphar.2008.06.108; Prachasilchai W, 2009, J PHARMACOL SCI, V109, P311, DOI 10.1254/jphs.08272SC; Rishikof DC, 2004, J CELL BIOCHEM, V91, P740, DOI 10.1002/jcb.10742; Rombouts K, 2002, EXP CELL RES, V278, P184, DOI 10.1006/excr.2002.5577; Ruefli AA, 2001, P NATL ACAD SCI USA, V98, P10833, DOI 10.1073/pnas.191208598; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Silver Samuel A, 2015, Can J Kidney Health Dis, V2, P30, DOI 10.1186/s40697-015-0062-9; Upagupta C, 2017, BIOCHEM BIOPH RES CO, V486, P163, DOI 10.1016/j.bbrc.2017.03.019; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Wright G, 2011, LIVER INT, V31, P163, DOI 10.1111/j.1478-3231.2010.02302.x; Wu CT, 2010, TOXICOL SCI, V114, P295, DOI 10.1093/toxsci/kfq006; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Yu CR, 2003, CANCER BIOL THER, V2, P544, DOI 10.4161/cbt.2.5.454; Yum V, 2017, AM J PHYSIOL-RENAL, V312, pF230, DOI 10.1152/ajprenal.00119.2016	47	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2021	16	11							e0260519	10.1371/journal.pone.0260519	http://dx.doi.org/10.1371/journal.pone.0260519			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9KP	34847196	gold, Green Published			2022-12-26	WOS:000735928900038
J	Ruhs, S; Griesler, B; Huebschmann, R; Stroedecke, K; Straetz, N; Ihling, C; Sinz, A; Masch, A; Schutkowski, M; Gekle, M; Grossmann, C				Ruhs, Stefanie; Griesler, Bruno; Huebschmann, Ralf; Stroedecke, Katharina; Straetz, Nicole; Ihling, Christian; Sinz, Andrea; Masch, Antonia; Schutkowski, Mike; Gekle, Michael; Grossmann, Claudia			Modulation of transcriptional mineralocorticoid receptor activity by casein kinase 1	FASEB JOURNAL			English	Article						aldosterone; casein kinase 1; mineralocorticoid receptor; phosphorylation; cardiovascular diseases; aging; posttranslational modification	NUCLEAR-LOCALIZATION; BINDING-PROTEIN; REGULATES EXPRESSION; PHOSPHORYLATION; CK1; RNA; MOTIF	The mineralocorticoid receptor (MR) with its ligand aldosterone (aldo) physiologically regulates electrolyte homeostasis and blood pressure but it can also lead to pathophysiological effects in the cardiovascular system. Previous results show that posttranslational modifications (PTM) can influence MR signaling and function. Based on in silico and in vitro data, casein kinase 1 (CK1) was predicted as a candidate for MR phosphorylation. To gain a deeper mechanistic insight into MR activation, we investigated the influence of CK1 on MR function in HEK cells. Co-immunoprecipitation experiments indicated that the MR is located in a protein-protein complex with CK1 alpha and CK1 epsilon. Reporter gene assays with pharmacological inhibitors and MR constructs demonstrated that especially CK1 epsilon acts as a positive modulator of GRE activity via the C-terminal MR domains CDEF. CK1 enhanced the binding affinity of aldosterone to the MR, facilitated nuclear translocation and DNA interaction of the MR, and led to expression changes of pathophysiologically relevant genes like Per-1 and Phlda1. By peptide microarray and site-directed mutagenesis experiments, we identified the highly conserved T800 as a direct CK1 phosphorylation site of the MR, which modulates the nuclear import and genomic activity of the receptor. Direct phosphorylation of the MR was unable to fully account for all of the CK1 effects on MR signaling, suggesting additional phosphorylation of MR co-regulators. By LC/MS/MS, we identified the MR-associated proteins NOLC1 and TCOF1 as candidates for such CK1-regulated co-factors. Overall, we found that CK1 acts as a co-activator of MR GRE activity through direct and indirect phosphorylation, which accelerates cytosolic-nuclear trafficking, facilitates nuclear accumulation and DNA binding of the MR, and increases the expression of pathologically relevant MR-target genes.	[Ruhs, Stefanie; Griesler, Bruno; Huebschmann, Ralf; Stroedecke, Katharina; Straetz, Nicole; Gekle, Michael; Grossmann, Claudia] Martin Luther Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Magdeburger Str 6, D-06112 Halle, Saale, Germany; [Ruhs, Stefanie] Univ Hosp Halle Saale, Dept Anesthesiol & Surg Intens Care, Halle, Saale, Germany; [Ihling, Christian; Sinz, Andrea] Martin Luther Univ Halle Wittenberg, Ctr Struct Mass Spectrometry, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, Halle, Saale, Germany; [Masch, Antonia; Schutkowski, Mike] Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Dept Enzymol, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Grossmann, C (corresponding author), Martin Luther Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Magdeburger Str 6, D-06112 Halle, Saale, Germany.	claudia.grossmann@medizin.uni-halle.de			Deutsche Forschungsgemeinschaft (DEG) [GR 3415/1-5, RTG 2155 ProMoAge SP11]; European Section of the Aldosterone Council (ESAC); ttaPKoM (Graduate School of Medicine, Halle)	Deutsche Forschungsgemeinschaft (DEG)(German Research Foundation (DFG)); European Section of the Aldosterone Council (ESAC); ttaPKoM (Graduate School of Medicine, Halle)	This study was supported by the Deutsche Forschungsgemeinschaft (DEG): grant GR 3415/1-5 (CG) and RTG 2155 ProMoAge SP11 (CG) as well as the European Section of the Aldosterone Council (ESAC) (SR) and ttaPKoM (Graduate School of Medicine, Halle) (BG)	Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Cozza G, 2016, EXPERT OPIN THER TAR, V20, P319, DOI 10.1517/14728222.2016.1091883; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Faresse N, 2014, J STEROID BIOCHEM, V143, P334, DOI 10.1016/j.jsbmb.2014.04.015; Fuller PJ, 2017, J ENDOCRINOL, V234, pT23, DOI 10.1530/JOE-17-0060; Gadaleta RM, 2014, J MOL ENDOCRINOL, V52, pR137, DOI 10.1530/JME-13-0170; Gao XS, 2011, BMB REP, V44, P70, DOI 10.5483/BMBRep.2011.44.1.70; Giamas G, 2009, NUCLEIC ACIDS RES, V37, P3110, DOI 10.1093/nar/gkp136; Grossmann C, 2008, J BIOL CHEM, V283, P7109, DOI 10.1074/jbc.M708751200; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Guo YX, 2020, LIFE SCI, V245, DOI 10.1016/j.lfs.2020.117347; Han CJ, 2020, BRAIN BEHAV IMMUN, V88, P640, DOI 10.1016/j.bbi.2020.04.064; Horiuchi J, 2004, J BIOL CHEM, V279, P12117, DOI 10.1074/jbc.M212839200; Ihling A, 2015, J PROTEOME RES, V14, P3996, DOI 10.1021/acs.jproteome.5b00503; Kino T, 2010, MOL ENDOCRINOL, V24, P941, DOI 10.1210/me.2009-0395; Le Billan F, 2015, FASEB J, V29, P3977, DOI 10.1096/fj.15-274266; Lother A, 2015, ANNU REV PHARMACOL, V55, P289, DOI 10.1146/annurev-pharmtox-010814-124302; MEIER UT, 1992, CELL, V70, P127; MEIER UT, 1990, J CELL BIOL, V111, P2235, DOI 10.1083/jcb.111.6.2235; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P1158, DOI 10.1210/me.2004-0331; Pilipuk GP, 2007, BIOCHEMISTRY-US, V46, P1389, DOI 10.1021/bi0621819; Qiao YT, 2019, EUR J MED CHEM, V181, DOI 10.1016/j.ejmech.2019.111581; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Richards J, 2012, AM J PHYSIOL-RENAL, V303, pF918, DOI 10.1152/ajprenal.00678.2011; Ruhs S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15418-1; Sakai D, 2016, DEV GROWTH DIFFER, V58, P577, DOI 10.1111/dgd.12305; Schittek B, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-231; Shanware NP, 2007, J BIOL CHEM, V282, P6283, DOI 10.1074/jbc.M610674200; Shibata S, 2013, CELL METAB, V18, P660, DOI 10.1016/j.cmet.2013.10.005; Walther RF, 2005, J BIOL CHEM, V280, P17549, DOI 10.1074/jbc.M501548200; Wang CH, 2019, BBA-MOL CELL RES, V1866, P1282, DOI 10.1016/j.bbamcr.2019.03.014; Weigel NL, 1996, BIOCHEM J, V319, P657, DOI 10.1042/bj3190657; Werner A, 2015, NATURE, V525, P523, DOI 10.1038/nature14978; Yang J, 2014, MOL ENDOCRINOL, V28, P1571, DOI 10.1210/me.2014-1101; Yang J, 2009, J MOL ENDOCRINOL, V43, P53, DOI 10.1677/JME-09-0031; Yang PF, 2000, J BIOL CHEM, V275, P18905, DOI 10.1074/jbc.M002134200; Yasojima K, 2000, BRAIN RES, V865, P116, DOI 10.1016/S0006-8993(00)02200-9; Yong TJK, 2000, BBA-GENE STRUCT EXPR, V1492, P425, DOI 10.1016/S0167-4781(00)00146-9; Zhang PY, 2012, CANCER RES, V72, P1751, DOI 10.1158/0008-5472.CAN-11-3027	42	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22059	10.1096/fj.202100977RR	http://dx.doi.org/10.1096/fj.202100977RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34847273				2022-12-26	WOS:000734992000003
J	Tsai, YCC; Liew, L; Guo, ZJ; Liu, D; Mueller-Cajar, O				Tsai, Yi-Chin Candace; Liew, Lynette; Guo, Zhijun; Liu, Di; Mueller-Cajar, Oliver			The CbbQO-type rubisco activases encoded in carboxysome gene clusters can activate carboxysomal form IA rubiscos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; INCREASE PHOTOSYNTHESIS; FUNCTIONAL EXPRESSION; SUBSTRATE-SPECIFICITY; SUBUNIT INTERACTIONS; SIDE REACTIONS; STRAIN CA; IN-VITRO	The CO2-fixing enzyme rubisco is responsible for almost all carbon fixation. This process frequently requires rubisco activase (Rca) machinery, which couples ATP hydrolysis to the removal of inhibitory sugar phosphates, including the rubisco substrate ribulose 1,5-bisphosphate (RuBP). Rubisco is sometimes compartmentalized in carboxysomes, bacterial microcompartments that enable a carbon dioxide concentrating mechanism (CCM). Characterized carboxysomal rubiscos, however, are not prone to inhibition, and often no activase machinery is associated with these enzymes. Here, we characterize two carboxysomal rubiscos of the form IA(C) Glade that are associated with CbbQO-type Rcas. These enzymes release RuBP at a much lower rate than the canonical carboxysomal rubisco from Synechococcus PCC6301. We found that CbbQO-type Rcas encoded in carboxysome gene clusters can remove RuBP and the tight-binding transition state analog carboxyarabinitol 1,5-bisphosphate from cognate rubiscos. The Acid-ithiobacillus ferrooxidans genome encodes two form IA rubiscos associated with two sets of cbbQ and cbbO genes. We show that the two CbbQO activase systems display specificity for the rubisco enzyme encoded in the same gene cluster, and this property can be switched by substituting the C-terminal three residues of the large subunit. Our findings indicate that the kinetic and inhibitory properties of proteobacterial form IA rubiscos are diverse and predict that Rcas may be necessary for some alpha-carboxysomal CCMs. These findings will have implications for efforts aiming to introduce biophysical CCMs into plants and other hosts for improvement of carbon fixation of crops.	[Tsai, Yi-Chin Candace; Liew, Lynette; Guo, Zhijun; Liu, Di; Mueller-Cajar, Oliver] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mueller-Cajar, O (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	cajar@ntu.edu.sg		Tsai, Yi-chin/0000-0002-6276-4327	Ministry of Education (MOE) of Singapore [MOE2016-T2-2-088, MOE-T2EP30120-0005]; National Research Foundation (NRF) of Singapore [NRF2017-NRF-ISF002-2667]	Ministry of Education (MOE) of Singapore(Ministry of Education, Singapore); National Research Foundation (NRF) of Singapore(National Research Foundation, Singapore)	This work was funded by Ministry of Education (MOE) of Singapore tier 2 grants (MOE2016-T2-2-088 and MOE-T2EP30120-0005) and the National Research Foundation (NRF) of Singapore grant (NRF2017-NRF-ISF002-2667) (to O. M.-C.).	Andralojc PJ, 2012, BIOCHEM J, V442, P733, DOI 10.1042/BJ20111443; ANDREWS TJ, 1981, J BIOL CHEM, V256, P8445; Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; Bhat JY, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00020; Borden JS, 2021, CURR OPIN MICROBIOL, V61, P58, DOI 10.1016/j.mib.2021.03.002; Bouvier JW, 2021, MOL BIOL EVOL, V38, P2880, DOI 10.1093/molbev/msab079; Bracher A, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.2, 10.1038/nplants.2014.2]; Cai Fei, 2015, Life-Basel, V5, P1141, DOI 10.3390/life5021141; Chen IMA, 2021, NUCLEIC ACIDS RES, V49, pD751, DOI 10.1093/nar/gkaa939; Chen TY, 2022, ACS SYNTH BIOL, V11, P154, DOI 10.1021/acssynbio.1c00311; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Davidi D, 2020, EMBO J, V39, DOI 10.15252/embj.2019104081; Desmarais JJ, 2019, NAT MICROBIOL, V4, P2204, DOI 10.1038/s41564-019-0520-8; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Erb TJ, 2018, CURR OPIN BIOTECH, V49, P100, DOI 10.1016/j.copbio.2017.07.017; Esparza M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00603; Flamholz AI, 2020, ELIFE, V9, DOI 10.7554/eLife.59882; Flamholz AI, 2019, BIOCHEMISTRY-US, V58, P3365, DOI 10.1021/acs.biochem.9b00237; Flecken M, 2020, CELL, V183, P457, DOI 10.1016/j.cell.2020.09.010; Gilchrist CLM, 2021, BIOINFORMATICS, V37, P2473, DOI 10.1093/bioinformatics/btab007; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hayashi NR, 1998, J FERMENT BIOENG, V85, P150, DOI 10.1016/S0922-338X(97)86759-1; Heinhorst S., 2020, BACTERIAL ORGANELLES, P125, DOI [10.1007/978-3-030-60173-7_6, DOI 10.1007/978-3-030-60173-7_6]; Hernandez JM, 1996, J BACTERIOL, V178, P347, DOI 10.1128/jb.178.2.347-356.1996; HOLTHUIJZEN YA, 1987, ARCH MICROBIOL, V147, P285, DOI 10.1007/BF00463489; Horecker B. L., 1958, BIOCHEM PREP, V6, P83; Horken KM, 1999, J BACTERIOL, V181, P3935, DOI 10.1128/JB.181.13.3935-3941.1999; Iniguez C, 2020, PLANT J, V101, P897, DOI 10.1111/tpj.14643; JORDAN DB, 1985, ARCH BIOCHEM BIOPHYS, V236, P487, DOI 10.1016/0003-9861(85)90651-4; Kane HJ, 1998, PLANT PHYSIOL, V117, P1059, DOI 10.1104/pp.117.3.1059; KANE HJ, 1994, AUST J PLANT PHYSIOL, V21, P449, DOI 10.1071/PP9940449; Kerfeld CA, 2018, NAT REV MICROBIOL, V16, P277, DOI 10.1038/nrmicro.2018.10; Kerfeld CA, 2016, CURR OPIN PLANT BIOL, V31, P66, DOI 10.1016/j.pbi.2016.03.009; Kim K, 2004, FEBS LETT, V571, P124, DOI 10.1016/j.febslet.2004.06.064; Kubien DS, 2011, METHODS MOL BIOL, V684, P349, DOI 10.1007/978-1-60761-925-3_27; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LAN Y, 1991, PLANT PHYSIOL, V95, P604, DOI 10.1104/pp.95.2.604; Lechno-Yossef S, 2020, NEW PHYTOL, V225, P793, DOI 10.1111/nph.16195; LEE BG, 1991, ARCH BIOCHEM BIOPHYS, V291, P263, DOI 10.1016/0003-9861(91)90133-4; Letunic I, 2021, NUCLEIC ACIDS RES, V49, pW293, DOI 10.1093/nar/gkab301; LI LA, 1993, PLANT MOL BIOL, V21, P753, DOI 10.1007/BF00027109; Li LA, 1999, PLANT MOL BIOL, V40, P467, DOI 10.1023/A:1006251808625; Li LA, 1997, J BACTERIOL, V179, P3793, DOI 10.1128/jb.179.11.3793-3796.1997; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; Liu D, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx156; Loganathan N, 2016, P NATL ACAD SCI USA, V113, P14019, DOI 10.1073/pnas.1610758113; Long BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06044-0; LORIMER GH, 1976, BIOCHEMISTRY-US, V15, P529, DOI 10.1021/bi00648a012; Marin B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-85; McGrath JM, 2014, PLANT PHYSIOL, V164, P2247, DOI 10.1104/pp.113.232611; MORELL MK, 1994, J BIOL CHEM, V269, P8091; Mueller-Cajar O, 2008, BIOCHEM J, V414, P205, DOI 10.1042/BJ20080668; Mueller-Cajar O, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00031; Ng J, 2020, J BIOL CHEM, V295, P16427, DOI 10.1074/jbc.RA120.015759; Oltrogge LM, 2020, NAT STRUCT MOL BIOL, V27, P281, DOI 10.1038/s41594-020-0387-7; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; Pearce FG, 2006, BIOCHEM J, V399, P525, DOI 10.1042/BJ20060430; Pearce FG, 2003, J BIOL CHEM, V278, P32526, DOI 10.1074/jbc.M305493200; PIERCE J, 1980, BIOCHEMISTRY-US, V19, P934, DOI 10.1021/bi00546a018; Puchades C, 2020, NAT REV MOL CELL BIO, V21, P43, DOI 10.1038/s41580-019-0183-6; Rae BD, 2017, J EXP BOT, V68, P3717, DOI 10.1093/jxb/erx133; Rae BD, 2013, MICROBIOL MOL BIOL R, V77, P357, DOI 10.1128/MMBR.00061-12; READ BA, 1994, ARCH BIOCHEM BIOPHYS, V312, P210, DOI 10.1006/abbi.1994.1301; Rivas G, 2016, TRENDS BIOCHEM SCI, V41, P970, DOI 10.1016/j.tibs.2016.08.013; SALVUCCI ME, 1992, ARCH BIOCHEM BIOPHYS, V298, P688, DOI 10.1016/0003-9861(92)90467-B; Savir Y, 2010, P NATL ACAD SCI USA, V107, P3475, DOI 10.1073/pnas.0911663107; Scott KM, 2018, ENVIRON MICROBIOL, V20, P2686, DOI 10.1111/1462-2920.14090; Shih PM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10382; Shivhare D, 2017, PLANT PHYSIOL, V174, P1505, DOI 10.1104/pp.17.00554; Snider J, 2006, J STRUCT BIOL, V156, P200, DOI 10.1016/j.jsb.2006.02.009; Sommer M, 2019, PLANT PHYSIOL, V179, P156, DOI 10.1104/pp.18.01190; Stotz M, 2011, NAT STRUCT MOL BIOL, V18, P1366, DOI 10.1038/nsmb.2171; Sutter M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16243; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Tcherkez G, 2016, PLANT CELL ENVIRON, V39, P983, DOI 10.1111/pce.12629; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; Tourova TP, 2006, MICROBIOL-SGM, V152, P2159, DOI 10.1099/mic.0.28699-0; Toyoda K, 2018, J BIOSCI BIOENG, V126, P730, DOI 10.1016/j.jbiosc.2018.06.005; Tsai YCC, 2020, P NATL ACAD SCI USA, V117, P381, DOI 10.1073/pnas.1911123117; Tsai YCC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9883; VIALE AM, 1990, J BIOL CHEM, V265, P18386; Walker BJ, 2016, ANNU REV PLANT BIOL, V67, P107, DOI 10.1146/annurev-arplant-043015-111709; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814; Wilson RH, 2018, J BIOL CHEM, V293, P18, DOI 10.1074/jbc.M117.810861; Wong KS, 2012, J STRUCT BIOL, V179, P211, DOI 10.1016/j.jsb.2012.03.010; Wunder T, 2020, CURR OPIN PLANT BIOL, V58, P1, DOI 10.1016/j.pbi.2020.08.006; Wunder T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07624-w; Yoshizawa Y, 2004, J BACTERIOL, V186, P5685, DOI 10.1128/JB.186.17.5685-5691.2004; Young JN, 2016, J EXP BOT, V67, P3445, DOI 10.1093/jxb/erw163; Zarzycki J, 2013, J EXP BOT, V64, P787, DOI 10.1093/jxb/ers294; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	92	3	3	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101476	10.1016/j.jbc.2021.101476	http://dx.doi.org/10.1016/j.jbc.2021.101476			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1GJ	34890642	Green Published, gold			2022-12-26	WOS:000748376400007
J	Joo, YH; Lee, HJ; Park, JO; Seo, YJ; Kong, TH; Park, KH				Joo, Young-Hoon; Lee, Hyun-Jin; Park, Jun-Ook; Seo, Young Joon; Kong, Tae Hoon; Park, Kyoung Ho			The risk of laryngitis with herpes zoster infection: A nested case-control study using data from the Korean National Sample Cohort	PLOS ONE			English	Article							RAMSAY-HUNT-SYNDROME; LARYNX	Background Whether herpes zoster infection (HZI) affects laryngitis incidence remains unknown. Objective The purpose of this population-based retrospective study was to analyze the relationship between laryngitis and HZI using data from the Korean Health Insurance Review and Assessment Service-National Sample Cohort. Methods This study analyzed 1,197,093 medical claim codes from 2018. Patients with HZI (ICD-10: B02) were retrospectively identified. Laryngeal diseases were defined by ICD-10 codes for five subgroups: 1) malignant disease, 2) benign disease, 3) vocal cord palsy, 4) inflammatory disease, and 5) reflux disease. Results Among the Korean population older than 20 years, 12,809 experienced HZI. Subjects with HZI were more likely to be older (mean age: 51.54 years vs. 48.06 years, p <0.0001). The proportion of subjects with laryngeal disease was higher in those with HZI than in those without HZI (55.55% vs. 41.37%, p <0.0001). Laryngeal disease was significantly associated with HZI in multiple regression analysis (odds ratio (OR) = 1.77, 95% confidence interval: 1.71-1.84) after adjusting for age, sex, hypertension, diabetes, dyslipidemia, ischemic heart disease, cerebral stroke, and depression. Among laryngeal disease subgroups, inflammatory disease (OR = 1.05; 95% CI: 1.01-1.09) and reflux (OR = 1.20; 95% CI: 1.15-1.25) were associated with HZI. Conclusions HZI is independently associated with laryngitis. Results of this study have implications for etiological investigations and prevention strategies for laryngitis.	[Joo, Young-Hoon; Lee, Hyun-Jin; Park, Jun-Ook; Park, Kyoung Ho] Catholica Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Seo, Young Joon; Kong, Tae Hoon] Yonsei Univ, Dept Otorhinolaryngol, Wonju Coll Med, Wonju, South Korea	Catholic University of Korea; Yonsei University	Park, KH (corresponding author), Catholica Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.	khpent@catholic.ac.kr		Seo, Young Joon/0000-0002-2839-4676; Joo, Young-hoon/0000-0002-1158-0974	Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea	Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea	This study was supported by Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho JH, 2018, J NUTR HEALTH AGING, V22, P471, DOI 10.1007/s12603-017-0972-6; Choi JK, 2019, VACCINE, V37, P5153, DOI 10.1016/j.vaccine.2019.07.086; Coleman C, 2012, J VOICE, V26, pE27, DOI 10.1016/j.jvoice.2010.10.004; Dworkin JP, 2008, OTOLARYNG CLIN N AM, V41, P419, DOI 10.1016/j.otc.2007.11.011; Kim M, 2021, DERMATOLOGY, V237, P73, DOI 10.1159/000505911; Kinnari TJ, 2012, ARCH OTOLARYNGOL, V138, P467, DOI 10.1001/archoto.2012.637; Koudounarakis E, 2011, B-ENT, V7, P293; Lin YY, 2011, LARYNGOSCOPE, V121, P1627, DOI 10.1002/lary.21859; Lynch J S, 2000, Lippincotts Prim Care Pract, V4, P534; Morelli N, 2008, NEUROL SCI, V29, P497, DOI 10.1007/s10072-008-1022-2; Morinaka S, 2009, AURIS NASUS LARYNX, V36, P606, DOI 10.1016/j.anl.2009.01.011; Nisa L, 2013, J VOICE, V27, P636, DOI 10.1016/j.jvoice.2013.02.011; PAHOR AL, 1979, J LARYNGOL OTOL, V93, P93, DOI 10.1017/S0022215100086771; Park JM, 2020, EUR ARCH OTO-RHINO-L, V277, P2907, DOI 10.1007/s00405-020-06074-9; Pinto JA, 2002, J VOICE, V16, P560, DOI 10.1016/S0892-1997(02)00131-5; Stein DJ, 2013, ANN OTO RHINOL LARYN, V122, P771, DOI 10.1177/000348941312201207; Tulunay OE, 2008, OTOLARYNG CLIN N AM, V41, P437, DOI 10.1016/j.otc.2007.11.012; TYRING S, 1995, ANN INTERN MED, V123, P89, DOI 10.7326/0003-4819-123-2-199507150-00002; Van Den Bossche P, 2008, EUR ARCH OTO-RHINO-L, V265, P365, DOI 10.1007/s00405-007-0434-6; Watelet JB, 2007, EUR ARCH OTO-RHINO-L, V264, P505, DOI 10.1007/s00405-006-0207-7; Wood MJ, 1996, CLIN INFECT DIS, V22, P341, DOI 10.1093/clinids/22.2.341; Wu CL, 2004, ANN OTO RHINOL LARYN, V113, P113, DOI 10.1177/000348940411300205	22	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0261366	10.1371/journal.pone.0261366	http://dx.doi.org/10.1371/journal.pone.0261366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890416	Green Published, gold			2022-12-26	WOS:000747293600045
J	Ganoe, LS; Brown, JD; Lovallo, MJ; Yabsley, MJ; Garrett, KB; Thompson, AT; Poppenga, RH; Ruder, MG; Walter, WD				Ganoe, Laken S.; Brown, Justin D.; Lovallo, Matthew J.; Yabsley, Michael J.; Garrett, Kayla B.; Thompson, Alec T.; Poppenga, Robert H.; Ruder, Mark G.; Walter, W. David			Surveillance for diseases, pathogens, and toxicants of muskrat (Ondatra zibethicus) in Pennsylvania and surrounding regions	PLOS ONE			English	Article							HYDATIGERA-TAENIAEFORMIS BATSCH; TOXOPLASMA-GONDII; HEPATIC SARCOMA; INFECTION; IDENTIFICATION; POPULATIONS; MAMMALS; TAENIA; OTTERS; RIVER	Using diagnostic data and contemporary sampling efforts, we conducted surveillance for a diversity of pathogens, toxicants, and diseases of muskrats (Ondatra zibethicus). Between 1977 and 2019, 26 diagnostic cases were examined from Kansas and throughout the Southeast and Mid-Atlantic, USA. We identified multiple causes of mortality in muskrats, but trauma (8/26), Tyzzer's disease (5/6), and cysticercosis (5/26) were the most common. We also conducted necropsies, during November 2018-January 2019 Pennsylvania muskrat trapping season, on 380 trapper-harvested muskrat carcasses after the pelt was removed. Tissue samples and exudate were tested for presence of or exposure to a suite of pathogens and contaminants. Gastrointestinal tracts were examined for helminths. Intestinal helminths were present in 39.2% of necropsied muskrats, with Hymenolepis spp. (62%) and echinostome spp. (44%) being the most common Molecular testing identified a low prevalence of infection with Clostridium piliforme in the feces and Sarcocystis spp. in the heart. We detected a low seroprevalence to Toxoplasma gondii (1/380). No muskrats were positive for Francisella tularensis or Babesia spp. Cysticercosis was detected in 20% (5/26) of diagnostic cases and 15% (57/380) of our trapper-harvested muskrats. Toxic concentrations of arsenic, cadmium, lead, or mercury were not detected in tested liver samples. Copper, molybdenum, and zinc concentrations were detected at acceptable levels comparative to previous studies. Parasite intensity and abundance were typical of historic reports; however, younger muskrats had higher intensity of infection than older muskrats which is contradictory to what has been previously reported. A diversity of pathogens and contaminants have been reported from muskrats, but the associated disease impacts are poorly understood. Our data are consistent with historic reports and highlight the wide range of parasites, pathogens and contaminants harbored by muskrats in Pennsylvania. The data collected are a critical component in assessing overall muskrat health and serve as a basis for understanding the impacts of disease on recent muskrat population declines.	[Ganoe, Laken S.] Penn State Univ, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA; [Brown, Justin D.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA USA; [Lovallo, Matthew J.] Penn Game Commiss, Bur Wildlife Management, Harrisburg, PA USA; [Yabsley, Michael J.; Garrett, Kayla B.; Thompson, Alec T.; Ruder, Mark G.] Univ Georgia, Southeastern Cooperat Wildlife Dis Study, Athens, GA USA; [Yabsley, Michael J.; Garrett, Kayla B.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA USA; [Poppenga, Robert H.] Univ Calif Davis, Calif Anim Hlth & Food Safety Lab, Davis, CA USA; [Walter, W. David] Penn State Univ, Penn Cooperat Fish & Wildlife Res Unit, US Geol Survey, University Pk, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey	Ganoe, LS (corresponding author), Penn State Univ, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA.	lsganoe11@gmail.com		Walter, David/0000-0003-3068-1073; Ganoe, Laken/0000-0001-9038-3022; Yabsley, Michael/0000-0003-2452-5015	Pennsylvania Game Commission	Pennsylvania Game Commission	Pennsylvania Game Commission provided financial and logistical support for the project. The funder provided input on study design and preparation of the manuscript. The funder had no role in analysis or decision to publish.	Ahlers AA., 2018, J PARASITOL, V106, P346; Ahlers AA, 2017, J WILDLIFE MANAGE, V81, P1408, DOI 10.1002/jwmg.21328; Ahlers AA, 2015, J WILDLIFE DIS, V51, P488, DOI 10.7589/2014-03-071; Anderson D. R, 1966, Bull. Wildl. Dis. Ass., V2, P70; Artois M., 2009, WILDLIFE DIS SURVEIL; Birkenheuer AJ, 2008, PARASITOLOGY, V135, P33, DOI 10.1017/S0031182007003538; BLUS LJ, 1987, ENVIRON POLLUT, V44, P307, DOI 10.1016/0269-7491(87)90206-5; BOWLES J, 1994, AM J TROP MED HYG, V50, P33, DOI 10.4269/ajtmh.1994.50.1.TM0500010033; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Charles RA, 2012, PARASITOL RES, V110, P1855, DOI 10.1007/s00436-011-2710-z; Conrad PA, 2005, INT J PARASITOL, V35, P1155, DOI 10.1016/j.ijpara.2005.07.002; Dorney RS., 1953, WISCONSIN CONSERVATI, V8; Dubey J.P., 1988, P1; DVORAKOVA L, 1984, FOLIA PARASIT, V31, P127; Erb J.E., 2003, WILD MAMMALS N AM BI, P311; ERICKSON DW, 1983, J WILDLIFE MANAGE, V47, P550, DOI 10.2307/3808535; Errington P.L., 1961, MUSKRATS MARSH MANAG; Filigenzi MS, 2011, FOOD ADDIT CONTAM A, V28, P1324, DOI 10.1080/19440049.2011.604796; Friend M., 2006, TULAREMIA CIRCULAR 1; GALLATI WALTER W., 1956, OHIO JOUR SCI, V56, P71; Ganoe LS, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00233; Goldberg TL, 2014, EMERG INFECT DIS, V20, P109, DOI 10.3201/eid2001.131191; GRAY LF, 1964, J NUTR, V84, P31, DOI 10.1093/jn/84.1.31; HALBROOK RS, 1993, ARCH ENVIRON CON TOX, V25, P438; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; Irizarry-Rovira AR, 2007, J EXOT PET MED, V16, P45, DOI 10.1053/j.jepm.2006.11.008; Jackson VS., 2009, MANAGEMENT DIS WILD; Kellner K., 2019, JAGSUI WRAPPER RJAGS; Kennedy MJ., 2016, SYNOPSIS PARASITES V, DOI [10.5962/bhl.title.115662, DOI 10.5962/BHL.TITLE.115662]; Kimber KR, 2000, J ZOO WILDLIFE MED, V31, P452, DOI 10.1638/1042-7260(2000)031[0452:IAPDAC]2.0.CO;2; KNIGHT IOLA MUSFELDT, 1951, CANADIAN JOUR ZOOL, V29, P188, DOI 10.1139/z51-018; Kumar JM, 2006, VET PARASITOL, V141, P362, DOI 10.1016/j.vetpar.2006.05.029; Lavikainen A, 2016, INT J PARASITOL, V46, P361, DOI 10.1016/j.ijpara.2016.01.009; Lee LM, 2016, EMERG INFECT DIS, V22, P707, DOI 10.3201/eid2204.151446; Lehman B, 2019, EMERG INFECT DIS, V25, P1429, DOI 10.3201/eid2507.190223; Long PL, 1990, COCCIDIOSIS MAN DOME; Marcogliese DJ, 2011, TRENDS PARASITOL, V27, P123, DOI 10.1016/j.pt.2010.11.002; Marcogliese DJ, 2001, CAN J ZOOL, V79, P1331, DOI 10.1139/cjz-79-8-1331; McClure SJ, 1999, RES VET SCI, V67, P17, DOI 10.1053/rvsc.1998.0271; MEYER MC, 1950, AM MIDL NAT, V44, P467, DOI 10.2307/2421967; MOSES RA, 1986, WILDLIFE SOC B, V14, P403; Niedringhaus KD, 2022, J VET DIAGN INVEST, V34, P314, DOI 10.1177/10406387211064270; Parker GH, 2004, ENVIRON POLLUT, V129, P23, DOI 10.1016/j.envpol.2003.10.003; Pennsylvania Spatial Data Access, 2020, PENNS GAM COMM GAM R; Plummer M., 2003, P 3 INT WORKSH DISTR; R Core Team, 2020, R LANG ENV STAT COMP; Robbins C.T., 1983, WILDLIFE FEEDING NUT; RYAN MJ, 1982, J WILDLIFE DIS, V18, P29, DOI 10.7589/0090-3558-18.1.29; Stow CA, 2018, ECOL INFORM, V45, P26, DOI 10.1016/j.ecoinf.2018.03.002; Su C, 2010, PARASITOLOGY, V137, P1, DOI 10.1017/S0031182009991065	50	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260987	10.1371/journal.pone.0260987	http://dx.doi.org/10.1371/journal.pone.0260987			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882733	gold, Green Published			2022-12-26	WOS:000755037200050
J	Akombi-Inyang, B; Ghimire, PR; Archibong, E; Woolley, E; Razee, H				Akombi-Inyang, Blessing; Ghimire, Pramesh Raj; Archibong, Elizabeth; Woolley, Emma; Razee, Husna			Association between intimate partner violence and male alcohol use and the receipt of perinatal care: Evidence from Nepal demographic and health survey 2011-2016	PLOS ONE			English	Article							PRENATAL-CARE; PREGNANCY	The utilization of perinatal care services among women experiencing intimate partner violence (IPV) and male alcohol use is a major problem. Adequate and regular perinatal care is essential through the continuum of pregnancy to mitigate pregnancy and birth complications. The aim of this study is to determine the association between IPV and male alcohol use and the receipt of perinatal care in Nepal. This study used pooled data from 2011 and 2016 Nepal Demographic and Health Surveys (NDHS). A total of 3067 women who interviewed for domestic violence module and had most recent live birth 5 years prior surveys were included in the analysis. Multivariable logistic regression analysis was performed to determine the association between IPV and male alcohol use and the receipt of perinatal care. Of the total women interviewed, 22% reported physical violence, 14% emotional violence, and 11% sexual violence. Women who were exposed to physical violence were significantly more likely to report non-usage of institutional delivery [adjusted Odds Ratio (aOR) = 1.30 (95% Cl: 1.01, 1.68)] and skilled delivery assistants [aOR = 1.43 (95% Cl: 1.10, 1.88)]. Non-attendance of 4 or more skilled antenatal care visits was associated with a combination of alcohol use by male partner and exposure to emotional [aOR = 1.42 (95% Cl: 1.01, 2.00)] and physical violence [aOR = 1.39 (95% Cl: 1.03, 1.88)]. The negative association between IPV and perinatal care suggests it is essential to develop comprehensive community-based interventions which integrates IPV support services with other health services to increase the uptake of perinatal care through the continuum of pregnancy.	[Akombi-Inyang, Blessing; Razee, Husna] Univ New South Wales, Sch Populat Hlth, Sydney, NSW, Australia; [Akombi-Inyang, Blessing; Ghimire, Pramesh Raj; Archibong, Elizabeth] Western Sydney Univ, Sch Hlth Sci, Penrith, NSW, Australia; [Ghimire, Pramesh Raj] Ujyalo Nepal, Ratnanagar Municipal, Chitwan, Nepal; [Woolley, Emma] Macquarie Univ, Sch Educ, Sydney, NSW, Australia	University of New South Wales Sydney; Western Sydney University; Macquarie University	Akombi-Inyang, B (corresponding author), Univ New South Wales, Sch Populat Hlth, Sydney, NSW, Australia.; Akombi-Inyang, B (corresponding author), Western Sydney Univ, Sch Hlth Sci, Penrith, NSW, Australia.	b.akombi@unsw.edu.au	Akombi-Inyang, Blessing/AAT-6507-2020	Akombi-Inyang, Blessing/0000-0002-6410-4154; Woolley, Emma/0000-0003-4042-8047				Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Adhikari TB, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2264-7; Adjah ESO, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3041-x; Alkema L, 2019, TRENDS MATERNAL MORT; Ayele GS, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7818-6; Black E, 2019, CONFL HEALTH, V13, DOI 10.1186/s13031-019-0219-8; Campo Monica, 2015, DOMESTIC FAMILY VIOL; Clark CJ, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0715-4; da Rosa CQ, 2014, REV SAUDE PUBL, V48, P977, DOI [10.1590/S0034-8910.2014048005283, 10.1590/s0034-8910.2014048005283]; Deuba K, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0293-7; Diop-Sidibe N, 2006, SOC SCI MED, V62, P1260, DOI 10.1016/j.socscimed.2005.07.022; Neto ETD, 2013, CAD SAUDE PUBLICA, V29, P1664, DOI [10.1590/0102-311X00125612, 10.1590/S0102-311X2013001200018]; Ellsberg M, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25658; Furuta M, 2016, MIDWIFERY, V43, P7, DOI 10.1016/j.midw.2016.10.005; Gashaw BT, 2019, WOMEN BIRTH, V32, pE530, DOI 10.1016/j.wombi.2018.12.008; Ghimire A., 2017, UNDERSTANDING INTIMA; Goo L, 2012, MATERN CHILD HLTH J, V16, P1131, DOI 10.1007/s10995-011-0838-1; Islam MJ, 2017, MIDWIFERY, V47, P43, DOI 10.1016/j.midw.2017.02.002; Kwagala B, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0167-3; Leonard KE, 2005, ADDICTION, V100, P422, DOI 10.1111/j.1360-0443.2005.00994.x; Miczek K. A., 1994, UNDERSTANDING PREVEN, V3; Ministry of Health and Population and New Era ICF Inc, 2017, NEP DEM HLTH SURV 20; [Ministry of health and population New Era & ICF International Inc Government of Nepal], 2012, NEP DEM HLTH SURV 20; Mohammed BH, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2121-7; Moraes CL, 2010, REV SAUDE PUBL, V44, P667, DOI 10.1590/S0034-89102010000400010; Mulondo S.A., 2020, BRIT J MIDWIFERY, V28, P788, DOI [10.12968/bjom.2020.28.11.788, DOI 10.12968/BJOM.2020.28.11.788]; Musa A, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0735-0; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Refaat A, 2013, SAGE OPEN MED, V1, DOI 10.1177/2050312113508388; Rutstein SO, 2004, MEASURE DHS; Saimen A, 2016, S AFR FAM PRACT, V58, P172, DOI 10.1080/20786190.2016.1223796; Tayton S, 2014, REV EVALUATION DOMES; Tumwesigye NM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-399; Tura H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217407; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; United Nations Development Programme, 2014, NEP MASC GEND BAS VI; WHO, 2016, WHO TECH REP SER, V997, P1; World Health Organization, 2016, VIOL WOM INT PARTN S; World Health Organization, INTIMATE PARTNER VIO; World Health Organization, 2014, WHO REC POSTN CAR MO; World Health Organization London School of Hygiene & Tropical Medicine and South African Medical Research Council, 2013, GLOB REG EST VIOL WO	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0259980	10.1371/journal.pone.0259980	http://dx.doi.org/10.1371/journal.pone.0259980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874942	Green Published, gold			2022-12-26	WOS:000753617500012
J	Ahn, JH; Lee, EK; Kim, D; Kang, S; Choi, WJ; Byun, JH; Shim, JG; Lee, SH				Ahn, Jin Hee; Lee, Eun kyung; Kim, Doyeon; Kang, SeHee; Choi, Won-Jun; Byun, Jae-hun; Shim, Jae-Geum; Lee, Sung Hyun			Effect of changes in cerebral oximeter values during cardiac surgery on the incidence of postoperative neurocognitive deficits (POND): A retrospective study based on propensity score-matched analysis	PLOS ONE			English	Article							COGNITIVE DECLINE; OXYGEN-SATURATION; DELIRIUM; BYPASS; REPERFUSION; RELIABILITY; DYSFUNCTION; VALIDITY; ARREST; INJURY	Objectives The occurrence of postoperative neurocognitive deficits(POND)after major cardiac surgery is associated with an increase in perioperative mortality and morbidity. Oxidative stress caused by oxygen can affect neuronal damage, which can lead to POND. Whether the intraoperative rSO(2) value reflects oxidative stress and the associated incidence of POND is unknown. Methods Among 3482 patients undergoing cardiac surgery, 976 patients were allocated for this retrospective study. Of these, 230 patients (32.5%) were observed to have postoperative neurologic symptoms. After propensity score 1:2 ratio matching, a total of 690 patients were included in the analysis. Recorded data on the occurrence of POND from the postoperative period to predischarge were collected from the electronic records. Results The mean baseline rSO(2) value was higher in the POND (-) group than in the POND (+) group. The mean overall minimum rSO(2) value was lower in the POND (+) group (52.2 8.3 vs 48.3 +/- 10.5, P < 0.001). The mean overall maximum rSO(2) values were not significantly different between the two groups (72.7 +/- 8.3 vs 73.2 +/- 9.2, P = 0.526). However, there was a greater increase in the overall maximum rSO(2) values as compared with baseline in the POND (+) group (10.9 +/- 8.2 vs 17.9 +/- 10.2, P < 0.001). The degree of increase in the maximum rSO2 value was a risk factor affecting the occurrence of POND (adjusted odds ratio, 1.08; 95% confidence interval [CI], 1.04-1.11; P < 0.001). The areas under the receiver-operating characteristic curve for delta values of minimal and maximal compared with baseline values were 0.60 and 0.71, respectively. Conclusions Increased cerebral oximeter levels during cardiac surgery may also be a risk factor for POND. This is considered to reflect the possibility of oxidative neuronal damage, and further studies are needed in the future.	[Ahn, Jin Hee; Choi, Won-Jun; Byun, Jae-hun; Shim, Jae-Geum; Lee, Sung Hyun] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Anaesthesiol & Pain Med, Sch Med, Seoul, South Korea; [Lee, Eun kyung; Kim, Doyeon] Sungkyunkwan Univ, Dept Anaesthesiol & Pain Med, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Kang, SeHee] CHA Univ Korea, Dept Anaesthesiol & Pain Med, CHA Univ, Ilsan Med Ctr,Coll Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Pochon Cha University	Ahn, JH (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Anaesthesiol & Pain Med, Sch Med, Seoul, South Korea.	blatt.ahn@samsung.com	Ahn, Jin hee/C-6122-2019	Ahn, Jin hee/0000-0002-5861-1328				ABRAMSON NS, 1985, CRIT CARE MED, V13, P930, DOI 10.1097/00003246-198511000-00020; Arendash GW, 2009, NEUROREPORT, V20, P1087, DOI 10.1097/WNR.0b013e32832e6459; Brown CH, 2014, CURR OPIN ANESTHESIO, V27, P117, DOI 10.1097/ACO.0000000000000061; Daiello LA, 2019, ANESTHESIOLOGY, V131, P477, DOI 10.1097/ALN.0000000000002729; de Tournay-Jette E, 2011, J CARDIOTHOR VASC AN, V25, P95, DOI 10.1053/j.jvca.2010.03.019; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Fessel JP, 2002, P NATL ACAD SCI USA, V99, P16713, DOI 10.1073/pnas.252649099; Fong TG, 2009, NEUROLOGY, V72, P1570, DOI 10.1212/WNL.0b013e3181a4129a; HARKER LA, 1980, BLOOD, V56, P824; Hazelton JL, 2010, J NEUROTRAUM, V27, P753, DOI 10.1089/neu.2009.1186; Higami T, 1999, ANN THORAC SURG, V67, P1091, DOI 10.1016/S0003-4975(99)00135-6; Holmgaard F, 2019, BRIT J ANAESTH, V123, P196, DOI 10.1016/j.bja.2019.03.045; Hou X, 2004, FREE RADICAL BIO MED, V36, P163, DOI 10.1016/j.freeradbiomed.2003.10.024; Kilgannon JH, 2011, CIRCULATION, V123, P2717, DOI 10.1161/CIRCULATIONAHA.110.001016; Liu YB, 1998, STROKE, V29, P1679, DOI 10.1161/01.STR.29.8.1679; Lopez MG, 2020, ANESTHESIOLOGY, V132, P551, DOI 10.1097/ALN.0000000000003016; Lopez MG, 2017, FREE RADICAL BIO MED, V103, P192, DOI 10.1016/j.freeradbiomed.2016.12.039; Luger MF, 2014, GERIATR ORTHOP SURG, V5, P165, DOI 10.1177/2151458514548577; Murkin JM, 2007, ANESTH ANALG, V104, P51, DOI 10.1213/01.ane.0000246814.29362.f4; Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Salonia R, 2012, J NEUROTRAUM, V29, P1047, DOI 10.1089/neu.2011.1890; Scheeren TWL, 2019, ANESTH ANALG, V128, P265, DOI 10.1213/ANE.0000000000002812; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; TEASDALE G, 1974, LANCET, V2, P81; Watson NA, 2000, EUR J ANAESTH, V17, P152, DOI 10.1046/j.1365-2346.2000.00640.x; Whitlock R, 2005, CRIT CARE CLIN, V21, P589, DOI 10.1016/j.ccc.2005.04.003; Yao FSF, 2004, J CARDIOTHOR VASC AN, V18, P552, DOI 10.1053/j.jvca.2004.07.007; Yu Y, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010947.pub2; Zimpfer D, 2004, ANN THORAC SURG, V78, P513, DOI 10.1016/j.athoracsur.2004.03.006; Zorrilla-Vaca A, 2018, CAN J ANESTH, V65, P529, DOI 10.1007/s12630-018-1065-7	33	0	0	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0260945	10.1371/journal.pone.0260945	http://dx.doi.org/10.1371/journal.pone.0260945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY3JJ	34860854	gold, Green Published			2022-12-26	WOS:000754686900015
J	Guo, JX; Li, Y; Yang, ZX; Zhu, XP				Guo, Jiuxia; Li, Yang; Yang, Zongxin; Zhu, Xinping			Quantitative method for resilience assessment framework of airport network during COVID-19	PLOS ONE			English	Article							AIR; SYSTEMS; FUTURE	The resilience and vulnerability of airport networks are significant challenges during the COVID-19 global pandemic. Previous studies considered node failure of networks under natural disasters and extreme weather. Herein, we propose a complex network methodology combined with data-driven to assess the resilience of airport networks toward global-scale disturbance using the Chinese airport network (CAN) and the European airport network (EAN) as a case study. The assessment framework includes vulnerability and resilience analyses from the network- and node-level perspectives. Subsequently, we apply the framework to analyze the airport networks in China and Europe. Specifically, real air traffic data for 232 airports in China and 82 airports in Europe are selected to form the CAN and EAN, respectively. The complex network analysis reveals that the CAN and the EAN are scale-free small-world networks, that are resilient to random attacks. However, the connectivity and vulnerability of the CAN are inferior to those of the EAN. In addition, we select the passenger throughput from the top-50 airports in China and Europe to perform a comparative analysis. By comparing the resilience evaluation of individual airports, we discovered that the factors of resilience assessment of an airport network for global disturbance considers the network metrics and the effect of government policy in actual operations. Additionally, this study also proves that a country's emergency response-ability towards the COVID-19 has a significantly affectes the recovery of its airport network.	[Guo, Jiuxia; Yang, Zongxin; Zhu, Xinping] Civil Aviat Flight Univ China, Sch Air Traff Management, Guanghan, Sichuan, Peoples R China; [Li, Yang] Civil Aviat Adm China, Operat Supervisory Ctr, Beijing, Peoples R China	Civil Aviation Flight University of China	Guo, JX (corresponding author), Civil Aviat Flight Univ China, Sch Air Traff Management, Guanghan, Sichuan, Peoples R China.	didiyes@163.com			Civil Aviation Authority Security Capacity Building Funding Project [CAAC-2021-87, CAAC-2021-130]; Chinese college Production, innovation Funding [2021ALA02025]; special foundation for Local government Science and Technology Development of China [2020ZYD094]; Sichuan Science and Technology Project [2020YFS0541]	Civil Aviation Authority Security Capacity Building Funding Project; Chinese college Production, innovation Funding; special foundation for Local government Science and Technology Development of China; Sichuan Science and Technology Project	The Financial information list is: (1)The Civil Aviation Authority Security Capacity Building Funding Project (CAAC-2021-87) (2)The Civil Aviation Authority Security Capacity Building Funding Project (CAAC-2021-130) (3)The Chinese college Production, innovation Funding (2021ALA02025) (4)The special foundation for Local government Science and Technology Development of China (2020ZYD094) (5)Sichuan Science and Technology Project (2020YFS0541).	Air Transport Bureau, 2021, EFF NOV COR COVID 19; Bagler G, 2008, PHYSICA A, V387, P2972, DOI 10.1016/j.physa.2008.01.077; Chen XQ, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093678; Cong W, 2016, CHINESE J AERONAUT, V29, P512, DOI 10.1016/j.cja.2016.01.010; Cook A, 2016, J AIR TRANSP MANAG, V56, P38, DOI 10.1016/j.jairtraman.2016.02.007; Cook A, 2015, J AIR TRANSP MANAG, V42, P149, DOI 10.1016/j.jairtraman.2014.09.011; Czerny AI, 2021, J AIR TRANSP MANAG, V90, DOI 10.1016/j.jairtraman.2020.101971; Dall'Asta L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/P04006; Faturechi R, 2014, COMPUT OPER RES, V43, P335, DOI 10.1016/j.cor.2013.10.009; Filippone E, 2016, J AIR TRANSP MANAG, V56, P57, DOI 10.1016/j.jairtraman.2016.03.014; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Guo JX, 2021, MATH PROBL ENG, V2021, DOI 10.1155/2021/6622031; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hollnagel E, 2006, RESILIENCE ENG CONCE; Hossain MM, 2017, J AIR TRANSP MANAG, V60, P1, DOI 10.1016/j.jairtraman.2016.12.008; Hosseini S, 2016, RELIAB ENG SYST SAFE, V145, P47, DOI 10.1016/j.ress.2015.08.006; Janic M, 2015, TRANSPORT RES A-POL, V81, P77, DOI 10.1016/j.tra.2015.07.012; Li SM, 2015, CHINESE J AERONAUT, V28, P780, DOI 10.1016/j.cja.2015.04.002; Li W, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046106; Markolf SA, 2019, TRANSPORT POLICY, V74, P174, DOI 10.1016/j.tranpol.2018.11.003; Muriel-Villegas JE, 2016, RELIAB ENG SYST SAFE, V152, P151, DOI 10.1016/j.ress.2016.03.006; Murray-Tuite PM, 2006, Proceedings of the 2006 Winter Simulation Conference, Vols 1-5, P1398, DOI 10.1109/WSC.2006.323240; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pan SZ, 2021, PHYSICA A, V581, DOI 10.1016/j.physa.2021.126235; Pan X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203894; Ren FC, 2017, IEEE ACCESS, V5, P19352, DOI 10.1109/ACCESS.2017.2755043; Sun XQ, 2021, TRANSPORT POLICY, V110, P394, DOI 10.1016/j.tranpol.2021.06.018; Sun XQ, 2021, TRANSPORT POLICY, V105, P115, DOI 10.1016/j.tranpol.2021.03.005; Sun XQ, 2020, J AIR TRANSP MANAG, V89, DOI 10.1016/j.jairtraman.2020.101928; Wang YJ, 2019, CHINESE J AERONAUT, V32, P2694, DOI 10.1016/j.cja.2019.08.023; Woods DD, 2015, RELIAB ENG SYST SAFE, V141, P5, DOI 10.1016/j.ress.2015.03.018; [曾小舟 Zeng Xiaozhou], 2011, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V11, P175; Zhou L, 2020, TRANSPORT RES D-TR E, V83, DOI 10.1016/j.trd.2020.102362; Zhou YM, 2019, IEEE T INTELL TRANSP, V20, P4262, DOI 10.1109/TITS.2018.2883766	34	2	2	12	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0260940	10.1371/journal.pone.0260940	http://dx.doi.org/10.1371/journal.pone.0260940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY3JJ	34860845	gold, Green Published			2022-12-26	WOS:000754686900014
J	Luo, L; Zhang, LL; Tao, W; Xia, TL; Li, LY				Luo, Liang; Zhang, Lei-Lei; Tao, Wen; Xia, Tao-Lin; Li, Liao-Yuan			Prediction of potential prognostic biomarkers in metastatic prostate cancer based on a circular RNA-mediated competing endogenous RNA regulatory network	PLOS ONE			English	Article							PROGRESSION; PROMOTES; PROLIFERATION; MICRORNAS; MECHANISM	Recently, studies on competing endogenous RNA (ceRNA) networks have become prevalent, and circular RNAs (circRNAs) have crucial implications for the development and progression of carcinoma. However, studies relevant to metastatic prostate cancer (mPCa) are scant. This study aims to discover potential ceRNAs that may be related to the prognosis of mPCa. RNA-Seq data were obtained from the MiOncoCirc database and Gene Expression Omnibus (GEO). Differential expression patterns of RNAs were examined using R packages. Circular RNA Interactome, miRTarBase, miRDB and TargetScan were applied to predict the corresponding relation between circRNAs, miRNAs and mRNAs. The Gene Ontology (GO) annotations were performed to present related GO terms, and Gene Set Enrichment Analysis (GSEA) tools were applied for pathway annotations. Moreover, survival analysis was conducted for the hub genes. We found 820 circRNAs, 81 miRNAs and 179 mRNAs that were distinguishingly expressed between primary prostate cancer (PCa) and mPCa samples. A ceRNA network including 45 circRNAs, 24 miRNAs and 56 mRNAs was constructed. In addition, the protein-protein interaction (PPI) network was built, and 10 hub genes were selected by using the CytoHubba application. Among the 10 hub genes, survival analysis showed that ITGA1, LMOD1, MYH11, MYLK, SORBS1 and TGFBR3 were significantly connected with disease-free survival (DFS). The circRNA-mediated ceRNA network provides potential prognostic biomarkers for metastatic prostate cancer.	[Luo, Liang; Zhang, Lei-Lei] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Urol, Guangzhou, Peoples R China; [Luo, Liang; Zhang, Lei-Lei; Tao, Wen; Xia, Tao-Lin; Li, Liao-Yuan] Foshan First Municipal Peoples Hosp, Dept Urol, Foshan, Peoples R China	Sun Yat Sen University	Li, LY (corresponding author), Foshan First Municipal Peoples Hosp, Dept Urol, Foshan, Peoples R China.	heyadi2015@126.com			Guangdong Provincial Natural Science Foundation of China [2014A030313088, 2017A030313478]; Guangdong Provincial Science and Technology Foundation of China [2016A020215073]	Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Science and Technology Foundation of China	This work was supported by Guangdong Provincial Natural Science Foundation of China (2014A030313088, 2017A030313478), Guangdong Provincial Science and Technology Foundation of China (2016A020215073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakula A, 2016, EUR UROL, V69, P1120, DOI 10.1016/j.eururo.2015.09.019; Bai N, 2019, J CANCER, V10, P3893, DOI 10.7150/jca.31362; Berg KD, 2017, EUR J CANCER, V72, P20, DOI 10.1016/j.ejca.2016.11.025; Bhanvadia RR, 2018, CLIN CANCER RES, V24, P3668, DOI 10.1158/1078-0432.CCR-17-3673; Chakravarthi BVSK, 2018, MOL CANCER RES, V16, P1125, DOI 10.1158/1541-7786.MCR-17-0230; Cheng DL, 2015, TUMOR BIOL, V36, P479, DOI 10.1007/s13277-015-3093-z; Dai YQ, 2018, MED SCI MONITOR, V24, P3462, DOI 10.12659/MSM.908009; Ge JX, 2019, J CELL PHYSIOL, V234, P18872, DOI 10.1002/jcp.28525; Harrandah AM, 2018, CANCER LETT, V438, P126, DOI 10.1016/j.canlet.2018.09.019; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Kawahara R, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201900174; Kristensen LS, 2019, NAT REV GENET, V20, P675, DOI 10.1038/s41576-019-0158-7; Liu QC, 2020, J CELL BIOCHEM, V121, P1317, DOI 10.1002/jcb.29368; Liu W, 2020, MOL THER-ONCOLYTICS, V19, P163, DOI 10.1016/j.omto.2020.09.009; Lyu DB, 2017, RNA BIOL, V14, P1000, DOI 10.1080/15476286.2016.1227904; Manterola L, 2014, NEURO-ONCOLOGY, V16, P520, DOI 10.1093/neuonc/not218; Peng ZY, 2019, J CELL BIOCHEM, V120, P1457, DOI 10.1002/jcb.27291; Sanchez-Mejias A, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0129-1; SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852; Schroder FH, 2012, EUR UROL, V62, P745, DOI 10.1016/j.eururo.2012.05.068; Shen P, 2021, MOL CANCER, V20, DOI 10.1186/s12943-021-01333-7; Shi DM, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0957-2; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stahlhut C, 2013, GENOME MED, V5, DOI 10.1186/gm516; Vo JN, 2019, CELL, V176, P869, DOI 10.1016/j.cell.2018.12.021; Wang YF, 2016, TRENDS GENET, V32, P211, DOI 10.1016/j.tig.2016.02.001; Wang ZC, 2020, MOL MED REP, V22, P105, DOI 10.3892/mmr.2020.11124; Xiao WK, 2019, AGING-US, V11, P12043, DOI 10.18632/aging.102539; Yan J, 2016, CANCER RES, V76, P1603, DOI 10.1158/0008-5472.CAN-15-1898; Yang C, 2016, ONCOTARGET, V7, P13479, DOI 10.18632/oncotarget.7266; Yu LY, 2021, CANCER MANAG RES, V13, P5077, DOI 10.2147/CMAR.S276964; Yu-Lee LY, 2018, CANCER RES, V78, P2911, DOI 10.1158/0008-5472.CAN-17-1051; Zhang Y, 2014, BBA-MOL BASIS DIS, V1842, P1350, DOI 10.1016/j.bbadis.2014.04.018; Zhao XG, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1705-z; Zhong YX, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0827-8	35	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0260983	10.1371/journal.pone.0260983	http://dx.doi.org/10.1371/journal.pone.0260983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY3JJ	34860853	Green Published, gold			2022-12-26	WOS:000754686900020
J	Ponnaiah, M; Abdulkader, RS; Bhatnagar, T; Thangaraj, JWV; Kumar, MS; Sabarinathan, R; Velusamy, S; Sabde, Y; Singh, H; Murhekar, MV				Ponnaiah, Manickam; Abdulkader, Rizwan Suliankatchi; Bhatnagar, Tarun; Thangaraj, Jeromie Wesley Vivian; Kumar, Muthusamy Santhosh; Sabarinathan, Ramasamy; Velusamy, Saravanakumar; Sabde, Yogesh; Singh, Harpreet; Murhekar, Manoj Vasanth			COVID-19 testing, timeliness and positivity from ICMR's laboratory surveillance network in India: Profile of 176 million individuals tested and 188 million tests, March 2020 to January 2021	PLOS ONE			English	Article								Background The Indian Council of Medical Research set up a pan-national laboratory network to diagnose and monitor Coronavirus disease 2019 (COVID-19). Based on these data, we describe the epidemiology of the pandemic at national and sub-national levels and the performance of the laboratory network. Methods We included surveillance data for individuals tested and the number of tests from March 2020 to January 2021. We calculated the incidence of COVID-19 by age, gender and state and tests per 100,000 population, the proportion of symptomatic individuals among those tested, the proportion of repeat tests and test positivity. We computed median (Interquartile range-IQR) days needed for selected surveillance activities to describe timeliness. Results The analysis included 176 million individuals and 188 million tests. The overall incidence of COVID-19 was 0.8%, and 12,584 persons per 100,000 population were tested. 6.1% of individuals tested returned a positive result. Ten of the 37 Indian States and Union Territories accounted for about 75.6% of the total cases. Daily testing scaled up from 40,000 initially to nearly one million in March 2021. The median duration between symptom onset and sample collection was two (IQR = 0,3) days, median duration between both sample collection and testing and between testing and data entry were less than or equal to one day. Missing or invalid entries ranged from 0.01% for age to 0.7% for test outcome. Conclusion The laboratory network set-up by ICMR was scaled up massively over a short period, which enabled testing a large section of the population. Although all states and territories were affected, most cases were concentrated in a few large states. Timeliness between the various surveillance activities was acceptable, indicating good responsiveness of the surveillance system.	[Ponnaiah, Manickam; Abdulkader, Rizwan Suliankatchi; Bhatnagar, Tarun; Thangaraj, Jeromie Wesley Vivian; Kumar, Muthusamy Santhosh; Sabarinathan, Ramasamy; Velusamy, Saravanakumar; Murhekar, Manoj Vasanth] ICMR Natl Inst Epidemiol, Chennai, Tamil Nadu, India; [Sabde, Yogesh] ICMR Natl Inst Res Environm Hlth, Bhopal, Madhya Pradesh, India; [Singh, Harpreet] Indian Council Med Res ICMR, Div Biomed Informat, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Environmental Health (NIREH); Indian Council of Medical Research (ICMR)	Murhekar, MV (corresponding author), ICMR Natl Inst Epidemiol, Chennai, Tamil Nadu, India.	mmurhekar@gmail.com	A, Rizwan S/F-5289-2014	A, Rizwan S/0000-0002-3140-2614; Murhekar, Manoj/0000-0002-1720-7628; Ponnaiah, Manickam/0000-0002-0797-0822				Arisi I, 2020, RESEARCHSQUARE; Basu Parantap, 2021, Indian Econ Rev, V56, P215, DOI 10.1007/s41775-021-00113-w; Bellmunt JM, 2020, MED FAM-SEMERGEN, V46, P62, DOI 10.1016/j.semerg.2020.06.001; Bhadra A, 2021, MODEL EARTH SYST ENV, V7, P623, DOI 10.1007/s40808-020-00984-7; Bwire George M, 2020, SN Compr Clin Med, V2, P874, DOI 10.1007/s42399-020-00341-w; Carozzi F., 2020, 13440 IZA; Dandona L, 2017, LANCET, V390, P2437, DOI 10.1016/S0140-6736(17)32804-0; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Furuse Y, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18094655; Government of India, MYGOV; Gupta N, 2020, MONALDI ARCH CHEST D, V90, P675, DOI 10.4081/monaldi.2020.1507; Gupta N, 2020, MONALDI ARCH CHEST D, V90, DOI 10.4081/monaldi.2020.1294; Hasell J, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00688-8; ICMR, 2020, STRAT COV 19 TEST IN; ICMR Covid Study Grp, 2020, INDIAN J MED RES, V151, P424, DOI 10.4103/ijmr.IJMR_1896_20; Indian Council of Medical Research, 2021, COVID 19 TEST STAT U; Indian Council of Medical Research, 2020, REV STRAT COVID 19 T; Indian Council of Medical Research, INF TEST STRAT MOL B; Indian Council of Medical Research, ICMR INF COVID 19 TE; Kretzschmar ME, 2020, LANCET PUBLIC HEALTH, V5, pE452, DOI 10.1016/S2468-2667(20)30157-2; Kumar N, 2021, ECLINICALMEDICINE, V32, DOI 10.1016/j.eclinm.2020.100717; Lee K, 2009, GLOB INST, P1; Lima Francisca Elisângela Teixeira, 2021, Epidemiol. Serv. Saúde, V30, pe2020788, DOI [10.1590/S1679-4974202100010002, 10.1590/s1679-4974202100010002]; Maity S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-10051-6; Ministry of Health and Family Welfare, MOHFW COVID 19 IND D; Ministry of Home Affairs Government of India, 2021, GUID EFF CONTR COVID; Ministry of Home Affairs Government of India, 2021, CONT FRAM DON NO Z28; Mohan A, 2020, INDIAN J MED RES, V152, P61, DOI 10.4103/ijmr.IJMR_1788_20; Mueller AL, 2020, AGING-US, V12, P9959, DOI 10.18632/aging.103344; Murhekar MV, 2021, INT J INFECT DIS, V108, P145, DOI 10.1016/j.ijid.2021.05.040; Murhekar MV, 2021, LANCET GLOB HEALTH, V9, P257, DOI 10.1016/S2214-109X(20)30544-1; Murhekar MV, 2020, INDIAN J MED RES, V152, P48, DOI 10.4103/ijmr.IJMR_3290_20; O'Brien J, 2020, J OVARIAN RES, V13, DOI 10.1186/s13048-020-00734-4; Parasher A, 2021, POSTGRAD MED J, V97, P312, DOI 10.1136/postgradmedj-2020-138577; Pinchoff J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244053; Royal Society DELVE Initiative, 2020, TEST TRAC IS; Sex Gender and Covid-19 Project, COVID 19 SEX DIS DAT; World Health Organization, IND SCAL ITS LAB TES; World Health Organization, WHO DIR GEN OP REM M	39	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0260979	10.1371/journal.pone.0260979	http://dx.doi.org/10.1371/journal.pone.0260979			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY3JJ	34860841	gold, Green Published			2022-12-26	WOS:000754686900019
J	Zeng, QH; Ming, WH; Luo, J; Zhang, SA; Hu, W; Liu, Z; Zhou, CY				Zeng, Qinghe; Ming, WeiHua; Luo, Jin; Zhang, SongAn; Hu, Wei; Liu, Zhen; Zhou, CuiYing			A three-dimensional intelligent engineering management and control system for the construction of a long-span valve hall project based on a microservice architecture	PLOS ONE			English	Article								Three-dimensional intelligent engineering management and control systems (EMCS) based on the browser/server (B/S) model are an important part of intelligent engineering development. These systems are used for solving the difficulties encountered in engineering management with frequent cross-specialties and are vital tools for data exchange and service sharing among multiple departments. Currently, most engineering management and control systems are based on service-oriented architectures (SOAs). The integration mechanism and high coupling of SOAs leads to the reduction in system expansibility, service quality and service safety of the engineering system, making it difficult for these architectures to serve the construction of long-span valve hall engineering. To address these concerns, the management and application technology of the multidisciplinary data of valve hall engineering based on a microservice architecture (MSA) is proposed to improve the management efficiency of engineering data. A 3D integration modeling method for valve hall engineering structures and geological environments is proposed to establish the topological association between engineering structures and geological environments, without increasing the amount of model data required. A 3D intelligent engineering management and control technology for the entire process of the construction of long-span valve hall engineering is proposed, which realizes the entire process simulation and control of engineering construction based on WebGL technology. Accordingly, a three-dimensional intelligent engineering management and control system for the entire construction process of a long-span valve hall project in Southeast China is established, which can effectively manage and apply the data, display and analyze the three-dimensional model, and control and make decisions regarding the construction schedule. This study provides support for the construction of "smart engineering", promotes information communication and transmission between different project units, and speeds up the transformation from traditional construction management relying on drawings to three-dimensional intelligent construction management based on cloud services.	[Zeng, Qinghe] China Southern Power Grid Ehv Power Transmiss Co, Guangzhou, Peoples R China; [Ming, WeiHua; Luo, Jin; Zhang, SongAn; Hu, Wei; Liu, Zhen; Zhou, CuiYing] Sun Yat Sen Univ, Sch Civil Engn, Guangzhou, Peoples R China	China Southern Power Grid; Sun Yat Sen University	Liu, Z; Zhou, CY (corresponding author), Sun Yat Sen Univ, Sch Civil Engn, Guangzhou, Peoples R China.	liuzh8@mail.sysu.edu.cn; zhoucy@mail.sysu.edu.cn			National Natural Science Foundation of China (NSFC) [41530638, 41977230]; National Key Research and Development Program of China [2017YFC1501201, 2017YFC1501203]; Key Project of Applied Science & Technology Research and Development of Guangdong Province, China [2016B010124007]; Science and Technology Youth Top-Notch Talent Project of Guangdong Special Support Program [2015TQ01Z344]; Guangzhou Science and Technology Project [201803030005]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Key Project of Applied Science & Technology Research and Development of Guangdong Province, China; Science and Technology Youth Top-Notch Talent Project of Guangdong Special Support Program; Guangzhou Science and Technology Project	This research was funded by the National Natural Science Foundation of China (NSFC) (Grant No. 41530638, 41977230), National Key Research and Development Program of China, grant number (2017YFC1501201, 2017YFC1501203), Key Project of Applied Science & Technology Research and Development of Guangdong Province, China (Grant no. 2016B010124007), Science and Technology Youth Top-Notch Talent Project of Guangdong Special Support Program (Grant no. 2015TQ01Z344) and Guangzhou Science and Technology Project (Grant no. 201803030005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsiku O.E., 2012, J CONSTR ENG PROJ MA, V2, P25, DOI [10.6106/JCEPM.2012.2.4.025, DOI 10.6106/JCEPM.2012.2.4.025]; Cerny T, 2017, APPL COMPUT REV, V17, P29, DOI 10.1145/3129676.3129682; Dinggui Luo, 2011, 2011 Second International Conference on Mechanic Automation and Control Engineering, P2066; Esmaeili B, 2012, J CONSTR ENG M, V138, P955, DOI 10.1061/(ASCE)CO.1943-7862.0000499; Ismailov S. I., 2002, Urologiya (Moscow), P8; Liu HZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235980; Matthews J, 2015, AUTOMAT CONSTR, V58, P38, DOI 10.1016/j.autcon.2015.07.004; Messina A., 2016, 8 INT C ADV DAT KNOW, P35, DOI [10.13140/RG.2.1.3529.3681, DOI 10.13140/RG.2.1.3529.3681]; Messina A, 2016, LECT NOTES COMPUT SC, V9832, P223, DOI 10.1007/978-3-319-43949-5_18; Moon H. S., 2012, 2012 P 29 INT S AUT, P2, DOI 10.22260/isarc2012/0003; Pauwels P, 2014, BUILDINGS-BASEL, V4, P549, DOI 10.3390/buildings4030549; Rademacher F, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON SOFTWARE ARCHITECTURE WORKSHOPS (ICSAW), P38, DOI 10.1109/ICSAW.2017.32; To WM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201625; Wang XT, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10186311; Wu Y, 2011, APPL MECH MATER, V94-96, P1941, DOI 10.4028/www.scientific.net/AMM.94-96.1941; Yang Guofan, 2010, Proceedings of the 2010 Second World Congress on Software Engineering (WCSE 2010), P101, DOI 10.1109/WCSE.2010.123; Zhao NL, 2012, IET C PUBL, V2012, P17; Zhou CY, 2019, IEEE ACCESS, V7, P135582, DOI 10.1109/ACCESS.2019.2941348	18	1	1	13	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0261012	10.1371/journal.pone.0261012	http://dx.doi.org/10.1371/journal.pone.0261012			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY3JJ	34860837	Green Published, gold			2022-12-26	WOS:000754686900023
J	Lopera, TJ; Lujan, JA; Zurek, E; Zapata, W; Hernandez, JC; Toro, MA; Alzate, JF; Taborda, NA; Rugeles, MT; Aguilar-Jimenez, W				Lopera, Tulio J.; Lujan, Jorge A.; Zurek, Eduardo; Zapata, Wildeman; Hernandez, Juan C.; Toro, Miguel A.; Alzate, Juan F.; Taborda, Natalia A.; Rugeles, Maria T.; Aguilar-Jimenez, Wbeimar			A specific structure and high richness characterize intestinal microbiota of HIV-exposed seronegative individuals	PLOS ONE			English	Article							IMMUNE ACTIVATION; GUT MICROBIOME; T-CELLS; INFECTION; MUCOSAL; RESISTANCE; PHENOTYPE; BACTERIA; NOV.; RNA	Intestinal microbiota facilitates food breakdown for energy metabolism and influences the immune response, maintaining mucosal homeostasis. Overall, HIV infection is associated with intestinal dysbiosis and immune activation, which has been related to seroconversion in HIV-exposed individuals. However, it is unclear whether microbiota dysbiosis is the cause or the effect of immune alterations and disease progression or if it could modulate the risk of acquiring the HIV infection. We characterize the intestinal microbiota and determine its association with immune regulation in HIV-exposed seronegative individuals (HESN), HIV-infected progressors (HIV+), and healthy control (HC) subjects. For this, feces and blood were collected. The microbiota composition of HESN showed a significantly higher alpha (p = 0.040) and beta diversity (p = 0.006) compared to HC, but no differences were found compared to HIV+. A lower Treg percentage was observed in HESN (1.77%) than HC (2.98%) and HIV+ (4.02%), with enrichment of the genus Butyrivibrio (p = 0.029) being characteristic of this profile. Moreover, we found that Megasphaera (p = 0.017) and Victivallis (p = 0.0029) also are enriched in the microbiota composition in HESN compared to HC and HIV+ subjects. Interestingly, an increase in Succinivibrio and Prevotella, and a reduction in Bacteroides genus, which is typical of HIV-infected individuals, were observed in both HESN and HIV+, compared to HC. Thus, HESNs have a microbiota profile, similar to that observed in HIV+, most likely because HESN are cohabiting with their HIV+ partners.	[Lopera, Tulio J.; Lujan, Jorge A.; Zapata, Wildeman; Taborda, Natalia A.; Rugeles, Maria T.; Aguilar-Jimenez, Wbeimar] Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia; [Zurek, Eduardo] Univ Norte, Dept Syst Engn, Barranquilla, Colombia; [Zapata, Wildeman; Hernandez, Juan C.] Univ Cooperat Colombia, Fac Med, Grp Infettare, Medellin, Colombia; [Toro, Miguel A.; Alzate, Juan F.] Univ Antioquia UdeA, Sede Invest Univ SIU, Fac Med, Ctr Nacl Secuenciac Genom CNSG, Medellin, Colombia; [Toro, Miguel A.] Univ Antioquia, Fac Med, Grp Parasitol, Medellin, Colombia; [Taborda, Natalia A.] Corp Univ Remington, Fac Ciencias Salud, Programa Med, Grp Invest Biomed Uniremington, Medellin, Colombia	Universidad de Antioquia; Universidad del Norte; Universidad Cooperativa de Colombia; Universidad de Antioquia; Universidad de Antioquia	Aguilar-Jimenez, W (corresponding author), Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia.	wbeimar.aguilar@udea.edu.co	Alzate, Juan F./AFD-6646-2022; Hernandez, Juan C./C-1621-2018; Zapata, Wildeman/C-1622-2018	Alzate, Juan F./0000-0003-2578-4609; Hernandez, Juan C./0000-0002-9200-5698; Zapata, Wildeman/0000-0002-7351-8738; Toro Londono, Miguel Angel/0000-0002-7607-5151; Lopera Restrepo, Tulio Jose/0000-0002-8158-679X; Taborda Vanegas, Natalia Andrea/0000-0001-6085-855X; Aguilar Jimenez, Wbeimar/0000-0002-0790-055X	Universidad de Antioquia [CODI 2015-7857]; Universidad Cooperativa de Colombia [INV2732]; Corporacion Universitaria Remington	Universidad de Antioquia; Universidad Cooperativa de Colombia; Corporacion Universitaria Remington	This research was funded by Universidad de Antioquia (CODI 2015-7857; sostenibilidad), Universidad Cooperativa de Colombia (INV2732) and Corporacion Universitaria Remington.	Serna-Ortega PA, 2020, MICROBES INFECT, V22, P371, DOI 10.1016/j.micinf.2019.11.002; Annavajhala MK, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00798-19; Benning L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096844; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; Chen YA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243609; Chong J, 2020, NAT PROTOC, V15, P799, DOI 10.1038/s41596-019-0264-1; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295; Dill-McFarland KA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37298-9; Dillon SM, 2014, MUCOSAL IMMUNOL, V7, P983, DOI 10.1038/mi.2013.116; Dinh DM, 2015, J INFECT DIS, V211, P19, DOI 10.1093/infdis/jiu409; do Nascimento WM., 2020, 20245530 MEDRXIV, V2020, DOI [10.1101/2020.12.07.20245530, DOI 10.1101/2020.12.07.20245530]; Falivene J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11511; Gelpi M, 2020, CLIN INFECT DIS, V71, pE359, DOI 10.1093/cid/ciz1235; Gonzalez SM, 2016, IMMUNOL RES, V64, P765, DOI 10.1007/s12026-015-8775-5; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Imahashi M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80247-8; Kuebler PJ, 2016, J INFECT DIS, V213, P569, DOI 10.1093/infdis/jiv425; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li SX, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007611; Lozupone CA, 2013, CELL HOST MICROBE, V14, P329, DOI 10.1016/j.chom.2013.08.006; Lujan JA, 2019, CURR HIV RES, V17, P13, DOI 10.2174/1570162X17666190311114808; Ma L, 2014, J EUR ACAD DERMATOL, V28, P1079, DOI 10.1111/jdv.12288; McClelland RS, 2018, LANCET INFECT DIS, V18, P554, DOI 10.1016/S1473-3099(18)30058-6; Mitchell C, 2013, AIDS RES HUM RETROV, V29, P13, DOI [10.1089/aid.2012.0187, 10.1089/AID.2012.0187]; Montoya-Porras LM, 2018, ACTA TROP, V178, P327, DOI 10.1016/j.actatropica.2017.11.004; Moon CD, 2008, INT J SYST EVOL MICR, V58, P2041, DOI 10.1099/ijs.0.65845-0; Mutlu EA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003829; Noguera-Julian M, 2016, EBIOMEDICINE, V5, P135, DOI 10.1016/j.ebiom.2016.01.032; Nyirenda MH, 2011, J IMMUNOL, V187, P2278, DOI 10.4049/jimmunol.1003715; Ouyang J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00645; Rinaldi S, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009533; Ron R, 2021, J INFECT DIS, V224, P1247, DOI 10.1093/infdis/jiab068; Saulle I, 2016, AIDS RES HUM RETROV, V32, P129, DOI [10.1089/AID.2015.0019, 10.1089/aid.2015.0019]; Scepanovic P, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0747-x; Shen RZ, 2014, AM J REPROD IMMUNOL, V72, P219, DOI 10.1111/aji.12202; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Srinivasan S, 2021, INT J SYST EVOL MICR, V71, DOI 10.1099/ijsem.0.004702; Strober W, 2013, TRENDS IMMUNOL, V34, P423, DOI 10.1016/j.it.2013.07.001; Tomescu C, 2011, CLIN EXP IMMUNOL, V164, P158, DOI 10.1111/j.1365-2249.2011.04379.x; Toro-Londono MA, 2019, PEERJ, V7, DOI 10.7717/peerj.6200; Vazquez-Castellanos JF, 2015, MUCOSAL IMMUNOL, V8, P760, DOI 10.1038/mi.2014.107; Vesterbacka J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06675-1; Vujkovic-Cvijin I, 2019, CURR HIV-AIDS REP, V16, P204, DOI 10.1007/s11904-019-00441-w; Yao XD, 2014, MUCOSAL IMMUNOL, V7, P268, DOI 10.1038/mi.2013.44; Yu GQ, 2014, AIDS, V28, P753, DOI 10.1097/QAD.0000000000000154; Yuille S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201073; Zapata W, 2016, MICROBES INFECT, V18, P211, DOI 10.1016/j.micinf.2015.10.009; Zoetendal EG, 2003, INT J SYST EVOL MICR, V53, P211, DOI 10.1099/ijs.0.02362-0	49	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260729	10.1371/journal.pone.0260729	http://dx.doi.org/10.1371/journal.pone.0260729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855852	Green Published, gold			2022-12-26	WOS:000735299000107
J	Ahmed, SM; Alsamman, AM; Jighly, A; Mubarak, MH; Al-Shamaa, K; Istanbuli, T; Momtaz, OA; El Allali, A; Hamwieh, A				Ahmed, Shaimaa Mahmoud; Alsamman, Alsamman Mahmoud; Jighly, Abdulqader; Mubarak, Mohamed Hassan; Al-Shamaa, Khaled; Istanbuli, Tawffiq; Momtaz, Osama Ahmed; El Allali, Achraf; Hamwieh, Aladdin			Genome-wide association analysis of chickpea germplasms differing for salinity tolerance based on DArTseq markers	PLOS ONE			English	Article							CICER-ARIETINUM L.; GENOTYPES; STRESS	Soil salinity is significant abiotic stress that severely limits global crop production. Chickpea (Cicer arietinum L.) is an important grain legume that plays a substantial role in nutritional food security, especially in the developing world. This study used a chickpea population collected from the International Center for Agricultural Research in the Dry Area (ICARDA) genebank using the focused identification of germplasm strategy. The germplasm included 186 genotypes with broad Asian and African origins and genotyped with 1856 DArTseq markers. We conducted phenotyping for salinity in the field (Arish, Sinai, Egypt) and greenhouse hydroponic experiments at 100 mM NaCl concentration. Based on the performance in both hydroponic and field experiments, we identified seven genotypes from Azerbaijan and Pakistan (IGs: 70782, 70430, 70764, 117703, 6057, 8447, and 70249) as potential sources for high salinity tolerance. Multi-trait genome-wide association analysis (mtGWAS) detected one locus on chromosome Ca4 at 10618070 bp associated with salinity tolerance under hydroponic and field conditions. In addition, we located another locus specific to the hydroponic system on chromosome Ca2 at 30537619 bp. Gene annotation analysis revealed the location of rs5825813 within the Embryogenesis-associated protein (EMB8-like), while the location of rs5825939 is within the Ribosomal Protein Large P0 (RPLP0). Utilizing such markers in practical breeding programs can effectively improve the adaptability of current chickpea cultivars in saline soil. Moreover, researchers can use our markers to facilitate the incorporation of new genes into commercial cultivars.	[Ahmed, Shaimaa Mahmoud; Momtaz, Osama Ahmed] Agr Res Ctr, Agr Genet Engn Res Inst, Dept Plant Mol Biol, Gene Express & Regulat Technol Lab, Giza, Egypt; [Ahmed, Shaimaa Mahmoud; Istanbuli, Tawffiq; Hamwieh, Aladdin] Agr Res Ctr, Int Ctr Agr Res Dry Areas, Dept Biodivers & Crop Improvement, Giza, Egypt; [Alsamman, Alsamman Mahmoud] Agr Genet Engn Res Inst, Mol Genet & Genome Mapping, Giza, Egypt; [Alsamman, Alsamman Mahmoud; El Allali, Achraf] Mohammed VI Polytech Univ, African Genome Ctr, Ben Guerir, Morocco; [Jighly, Abdulqader] AgriBio, Ctr AgriBiosci, Agr Victoria, Bundoora, Vic, Australia; [Mubarak, Mohamed Hassan] Fac Environm Agr Sci, Plant Prod Dept, Al Arish, North Sinai, Egypt; [Al-Shamaa, Khaled] Int Ctr Agr Res Dry Areas, Geoinformat & Res Data Management, Giza, Egypt	Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Mohammed VI Polytechnic University; La Trobe University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Hamwieh, A (corresponding author), Agr Res Ctr, Int Ctr Agr Res Dry Areas, Dept Biodivers & Crop Improvement, Giza, Egypt.; Alsamman, AM (corresponding author), Agr Genet Engn Res Inst, Mol Genet & Genome Mapping, Giza, Egypt.; Alsamman, AM (corresponding author), Mohammed VI Polytech Univ, African Genome Ctr, Ben Guerir, Morocco.	smahmoud@ageri.sci.org; a.hamwieh@cgiar.org	Alsamman, Alsamman M/AAC-6126-2022; El Allali, Achraf/AAM-6468-2021	Alsamman, Alsamman M/0000-0002-7765-5035; Al-Shamaa, Khaled/0000-0002-7668-3798; El Allali, Achraf/0000-0002-4561-2161	Grain Legume and Dryland Cereals (GLDC); Grain Research and Development Cooperation (GRDC)	Grain Legume and Dryland Cereals (GLDC); Grain Research and Development Cooperation (GRDC)	This work was funded by the Grain Legume and Dryland Cereals (GLDC) and Grain Research and Development Cooperation (GRDC).	Abuo El-kasem S, 2017, J PLANT PRODUCTION, V8, P1177, DOI [10.21608/jpp.2017.41279, DOI 10.21608/JPP.2017.41279]; Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aslam M, 2018, PAK J BOT, V50, P1297; Baloch FS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167821; Basu U, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29926-1; BROWN AHD, 1980, GENETICS, V96, P523; Chander S, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11030604; Chen ZJ, 2021, BMC PLANT BIOL, V21, DOI 10.1186/s12870-021-02932-8; Dinauer R.C., 1982, METHODS SOIL ANAL; El-Esawi MA, 2019, ENVIRON EXP BOT, V159, P55, DOI 10.1016/j.envexpbot.2018.12.001; El-Saber MM, 2021, J SCI FOOD AGR, V101, P5550, DOI 10.1002/jsfa.11206; Emebiri LC, 2017, THEOR APPL GENET, V130, P309, DOI 10.1007/s00122-016-2812-1; FAO-Food of the United Nations AO, 2017, FAOSTAT STAT DAT; Farahani S, 2019, GENES-BASEL, V10, DOI 10.3390/genes10090676; Fatehi F, 2012, MOL BIOL REP, V39, P6387, DOI 10.1007/s11033-012-1460-z; Gilmour AR, 2009, ASREML USER GUIDE RE; Harris AM, 2017, G3-GENES GENOM GENET, V7, P671, DOI 10.1534/g3.116.037168; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kaashyap M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23116-9; Karami Omid, 2009, J Chem Biol, V2, P177, DOI 10.1007/s12154-009-0028-4; Khazaei H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063107; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mackay M.C., 2004, P 11 WHEAT BREED ASS, P138; Moustafa ESA, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11020281; NEI M, 1978, GENETICS, V89, P583; Oyiga BC, 2018, PLANT CELL ENVIRON, V41, P919, DOI 10.1111/pce.12898; Parihar P, 2015, ENVIRON SCI POLLUT R, V22, P4056, DOI 10.1007/s11356-014-3739-1; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pushpavalli R, 2020, J AGRON CROP SCI, V206, P405, DOI 10.1111/jac.12393; Pushpavalli R, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0491-8; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rice BR, 2020, PLANT CELL PHYSIOL, V61, P1427, DOI 10.1093/pcp/pcaa039; Rosegrant M. W., 2002, World water and food to 2025: dealing with scarcity; Saha B, 2016, ENVIRON EXP BOT, V128, P99, DOI 10.1016/j.envexpbot.2016.04.010; Shaheenuzzamn M., 2014, Bangladesh Journal of Agricultural Research, V39, P605; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smitha PK, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1988-3; Soren KR, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21145058; Tchorzewski M, 2002, INT J BIOCHEM CELL B, V34, P911, DOI 10.1016/S1357-2725(02)00012-2; Vadez V, 2012, MOL BREEDING, V30, P9, DOI 10.1007/s11032-011-9594-6; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Weir BS, 1996, SINAUER ASS SUNDERL; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/nmeth.2848, 10.1038/NMETH.2848]	48	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260709	10.1371/journal.pone.0260709	http://dx.doi.org/10.1371/journal.pone.0260709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852014	Green Published, gold			2022-12-26	WOS:000755762900058
J	Enawgaw, B; Aynalem, M; Melku, M; Asrie, F; Abebe, M; Yalew, A; Bekele, T; Mesfin, N; Ayalew, M; Shiferaw, E				Enawgaw, Bamlaku; Aynalem, Melak; Melku, Mulugeta; Asrie, Fikir; Abebe, Molla; Yalew, Aregawi; Bekele, Tiruzer; Mesfin, Nebiyu; Ayalew, Mulugeta; Shiferaw, Elias			Hematological malignancies in the Northwest Ethiopia	PLOS ONE			English	Article							CANCER; CHILDHOOD	Background The effect of malignant diseases is increasing globally, particularly in developing countries as shown by recent cancer statistics from the world health organization reports. It is anticipated that with an increase in life expectancy consequent upon the improved standard of living and increasing urbanization, the burden of hematological malignancies in sub-Saharan Africa particularly in Ethiopia is likely to increase recently. Therefore, this study was aimed to determine the incidence and trend of hematological malignancy in Northwest Ethiopia. Methods A facility-based retrospective study was conducted from 2015 to 2019 at the University of Gondar and Bahir-Dar Felegehiwot comprehensive specialized hospitals. Hematological malignancy data were collected by using a data collection sheet that was consisted of patients' socio-demography, clinical, and laboratory data. Then, data were entered into Epi-info 3.5.1 and exported to SPSS version 20 for analysis. Skewness and kurtosis were used to check data distribution. Descriptive statistics were summarized as percentages, means, and standard deviations of background variables, and the trend were analyzed. Results In this study, a total of 1,342 study participants were included. The mean age of study participants was 41.49 16.3 years with a range of 1 to 92 years. About 58.3%, 52.2%, and 80% of the cases were observed among males, 18-45 age group, and urban residences, respectively. Of the total cases, 92.9% and 7.1% were lymphoma and leukemia, respectively. On the other hand, from lymphoma cases, 72.3% and 27.7% were HL and NHL, respectively while from leukemic cases, 61.1%, 23.2, 6.3%, 4.2%, and 5.3% were CLL, ALL, CML, AML, and other HM types, respectively. In this study, there was no trend. Conclusion We concluded that lymphoma was the dominant type of hematological malignancy observed in northwest Ethiopia. The study indicated that the majority of cases were observed among male, urban residents, and adult populations aged 18-45 years. Therefore, special focus should be given to the highly affected population. Further, a prospective cohort study should be conducted for a better understanding of the prevalence and associated factors to it.	[Enawgaw, Bamlaku; Aynalem, Melak; Melku, Mulugeta; Asrie, Fikir; Abebe, Molla; Yalew, Aregawi; Shiferaw, Elias] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Hematol & Immunohematol, Gondar, Ethiopia; [Bekele, Tiruzer] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Pathol, Gondar, Ethiopia; [Mesfin, Nebiyu] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Internal Med, Gondar, Ethiopia; [Ayalew, Mulugeta] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Unit Pediat Hematol Oncol, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar; University of Gondar	Aynalem, M (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Hematol & Immunohematol, Gondar, Ethiopia.	melak.aynalem1234@gmail.com	Aynalem, Melak/AAE-3098-2022	Aynalem, Melak/0000-0003-1461-0160; Yimer, Mulugeta/0000-0003-3089-2567				[Anonymous], CANC TODAY CANC TODA; Perez GB, 2019, ONCOL LETT, V18, P5637, DOI 10.3892/ol.2019.10858; Catovsky D, 1996, CHRONIC LYMPHOCYTIC, P3419; Dierksen J, 2015, ANN CLIN LAB SCI, V45, P565; Errahhali ME, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2205-5; Ferlay J., 2016, GLOBOCAN, V1; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Fletcher CDM, 2002, WHO CLASSIFICATION T; Forkner CE, LEUKEMIA ALLIED DISO; Gopal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070361; Hamayun M., 2005, TURKISH J CANC, V35, P119; Hao T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48445-1; LaRussa A, 2015, FACTS STAT LEUKEMIA; Leak SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232848; Memirie ST, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00175; Olaniyi JA, 2011, PATHOL LAB MED INT, V3, P17, DOI 10.2147/PLMI.S20709; Othman RT, 2011, ASIAN PAC J CANCER P, V12, P1261; PARKIN DM, 1993, INT J CANCER, V54, P594, DOI 10.1002/ijc.2910540413; Parkin DM., 1991, CANC REGISTRATION PR, V95, P185; Quintanillad, 2015, FACTS STAT LEUK LYMP; Rodriguez-Abreu D, 2007, ANN ONCOL, V18, pI3, DOI 10.1093/annonc/mdl443; Schonfeld SJ, 2016, CANCER MED-US, V5, P728, DOI 10.1002/cam4.597; Sepp T, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2434; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tefferi A, 2009, CANCER-AM CANCER SOC, V115, P3842, DOI 10.1002/cncr.24440; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Yifru Sisay, 2015, BMC Res Notes, V8, P474, DOI 10.1186/s13104-015-1440-1	28	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260639	10.1371/journal.pone.0260639	http://dx.doi.org/10.1371/journal.pone.0260639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852010	gold, Green Published			2022-12-26	WOS:000755762900053
J	Sousa, MBE; de Andrade, LRB; de Souza, EH; Alves, AAC; de Oliveira, EJ				Bandeira e Sousa, Massaine; Braatz de Andrade, Luciano Rogerio; de Souza, Everton Hilo; Cunha Alves, Alfredo Augusto; de Oliveira, Eder Jorge			Reproductive barriers in cassava: Factors and implications for genetic improvement	PLOS ONE			English	Article							INBREEDING DEPRESSION; POLLEN TUBES; HYBRIDIZATION; ARABIDOPSIS; TEMPERATURE; DIVERSITY; GROWTH; RNASE	Cassava breeding is hampered by high flower abortion rates that prevent efficient recombination among promising clones. To better understand the factors causing flower abortion and propose strategies to overcome them, we 1) analyzed the reproductive barriers to intraspecific crossing, 2) evaluated pollen-pistil interactions to maximize hand pollination efficiency, and 3) identified the population structure of elite parental clones. From 2016 to 2018, the abortion and fertilization rates of 5,748 hand crossings involving 91 parents and 157 progenies were estimated. We used 16,300 single nucleotide polymorphism markers to study the parents' population structure via discriminant analysis of principal components, and three clusters were identified. To test for male and female effects, we used a mixed model in which the environment (month and year) was fixed, while female and male (nested to female) were random effects. Regardless of the population structure, significant parental effects were identified for abortion and fertilization rates, suggesting the existence of reproductive barriers among certain cassava clones. Matching ability between cassava parents was significant for pollen grains that adhered to the stigma surface, germinated pollen grains, and the number of fertilized ovules. Non-additive genetic effects were important to the inheritance of these traits. Pollen viability and pollen-pistil interactions in cross- and self-pollination were also investigated to characterize pollen-stigma compatibility. Various events related to pollen tube growth dynamics indicated fertilization abnormalities. These abnormalities included the reticulated deposition of callose in the pollen tube, pollen tube growth cessation in a specific region of the stylet, and low pollen grain germination rate. Generally, pollen viability and stigma receptivity varied depending on the clone and flowering stage and were lost during flowering. This study provides novel insights into cassava reproduction that can assist in practical crossing and maximize the recombination of contrasting clones.	[Bandeira e Sousa, Massaine; Braatz de Andrade, Luciano Rogerio; Cunha Alves, Alfredo Augusto; de Oliveira, Eder Jorge] Embrapa Mandioca & Fruticultura, Cruz Das Almas, BA, Brazil; [de Souza, Everton Hilo] Univ Fed Reconcavo Bahia, Ctr Agr Environm & Biol Sci, Cruz Das Almas, BA, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Reconcavo da Bahia	de Oliveira, EJ (corresponding author), Embrapa Mandioca & Fruticultura, Cruz Das Almas, BA, Brazil.	Eder.Oliveira@embrapa.br	de Souza, Everton Hilo/I-6842-2012; Oliveira, Eder/N-2216-2017	de Souza, Everton Hilo/0000-0002-8593-5010; Oliveira, Eder/0000-0001-8992-7459	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [409229/2018-0, 442050/2019-4, 303912/2018-9]; FAPESB (Fundacao de Amparo a Pesquisa do Estado da Bahia) [15/2014]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) [88882.315208/2019-01]; Bill & Melinda Gates Foundation [INV-007637]; UK's Foreign, Commonwealth & Development Office (FCDO)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESB (Fundacao de Amparo a Pesquisa do Estado da Bahia); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UK's Foreign, Commonwealth & Development Office (FCDO)	Eder Jorge de Oliveira: CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). Grant number: 409229/2018-0, 442050/2019-4 and 303912/2018-9 Eder Jorge de Oliveira: FAPESB (Fundacao de Amparo a Pesquisa do Estado da Bahia). Grant number: Pronem 15/2014 Everton Hilo de Souza: CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) Grant number: 88882.315208/2019-01 Eder Jorge de Oliveira, Alfredo Augusto Cunha Alves, Massaine Bandeira e Sousa and Luciano Rogerio Braatz de Andrade: UK's Foreign, Commonwealth & Development Office (FCDO) and the Bill & Melinda Gates Foundation. Grant number: INV-007637 The funder provided support in the form of fellowship and funds for the research, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo OS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181460; Adeyemo OS, 2019, PLANT REPROD, V32, P181, DOI 10.1007/s00497-018-00354-5; Alagna F, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00725; ALEXANDER MP, 1980, STAIN TECHNOL, V55, P13, DOI 10.3109/10520298009067890; Alves Alfredo Augusto Cunha, 2001, P67, DOI 10.1079/9780851995243.0067; Ayturk O, 2013, CURRENT PROGR BIOLOG, P319, DOI DOI 10.5772/53001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bredeson JV, 2016, NAT BIOTECHNOL, V34, P562, DOI 10.1038/nbt.3535; Ceballos H., 2017, Journal of Plant Breeding and Crop Science, V9, P19, DOI 10.5897/jpbcs2016.0617; COMSTOCK RE, 1948, BIOMETRICS, V4, P254, DOI 10.2307/3001412; Covarrubias-Pazaran G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156744; CRESTI M, 1976, PLANTA, V133, P35, DOI 10.1007/BF00386003; De Oliveira PHGA, 2018, AN ACAD BRAS CIENC, V90, P3853, DOI 10.1590/0001-3765201820180278; de Souza EH, 2017, SCI HORTIC-AMSTERDAM, V223, P53, DOI 10.1016/j.scienta.2017.04.027; Dzidzienyo DK, 2016, THEOR APPL GENET, V129, P1985, DOI 10.1007/s00122-016-2754-7; FAOSTAT, 2018, FOOD AGR ORG UN ONL; FARRIS JS, 1989, SYST ZOOL, V38, P406, DOI 10.2307/2992406; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Ha TM., 2014, ASIAN J AGR FOOD SCI, V2, P186; Hamblin MT, 2014, CROP SCI, V54, P2603, DOI 10.2135/cropsci2014.02.0160; Hegde V, 2019, INDIAN J HORTIC, V76, P104, DOI 10.5958/0974-0112.2019.00015.X; Hyde PT, 2020, PLANT GROWTH REGUL, V90, P441, DOI 10.1007/s10725-019-00542-x; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kawuki R. S., 2011, Journal of Plant Breeding and Crop Science, V3, P154; Kelly JK, 2002, AM J BOT, V89, P1021, DOI 10.3732/ajb.89.6.1021; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang M, 2020, NAT PLANTS, V6, P131, DOI 10.1038/s41477-020-0597-3; MARTIN FW, 1959, STAIN TECHNOL, V34, P125, DOI 10.3109/10520295909114663; Mayfield JA, 2000, NAT CELL BIOL, V2, P128, DOI 10.1038/35000084; Nie YB, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9020066; Nishikawa SI, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-22; Njoku D. N., 2015, Journal of Plant Breeding and Crop Science, V7, P61; OECD, 2017, SAF ASS TRANSG ORG E; Olasanmi B., 2014, J ROOT CROPS, V40, P15; Omolaja SS., 2009, AFRICAN CROP SCI J, V17, P41; Pacini E, 2005, FLORA, V200, P399, DOI 10.1016/j.flora.2005.02.006; Perera PIP, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/pls046; Pinheiro F, 2013, EVOLUTION, V67, P2024, DOI 10.1111/evo.12085; Qin P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-178; R Core Team, 2020, R LANG ENV STAT COMP; RAMIREZ N, 1990, AM J BOT, V77, P1260, DOI 10.2307/2444587; Ramos Abril L N, 2019, Commun Integr Biol, V12, P96, DOI 10.1080/19420889.2019.1631110; Ramu P, 2017, NAT GENET, V49, P959, DOI 10.1038/ng.3845; Rojas MC, 2009, CROP SCI, V49, P543, DOI 10.2135/cropsci2008.07.0419; Rukundo P, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01981; Schaffasz A, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9090508; Selak GV, 2014, ANN APPL BIOL, V164, P85, DOI 10.1111/aab.12082; da Silva DDS, 2018, PESQUI AGROPECU BRAS, V53, P182, DOI [10.1590/s0100-204x2018000200006, 10.1590/S0100-204X2018000200006]; Souza LD, 2006, ASPECTOS SOCIOECONOM, P70; Souza LS, 2020, SCI HORTIC-AMSTERDAM, V265, DOI 10.1016/j.scienta.2020.109253; Souza LS, 2018, SCI HORTIC-AMSTERDAM, V240, P544, DOI 10.1016/j.scienta.2018.06.070; Ukwu NU B., 2018, MODERN CONCEPTS DEV, V2, P183; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang C, 2011, BIOL PLANTARUM, V55, P469, DOI 10.1007/s10535-011-0112-9; WIENS D, 1987, OECOLOGIA, V71, P501, DOI 10.1007/BF00379288; de Freitas JPX, 2016, EUPHYTICA, V209, P137, DOI 10.1007/s10681-016-1649-7; Yang C, 2016, HORTSCIENCE, V51, P1020, DOI 10.21273/HORTSCI.51.8.1020; Yi WG, 2006, ANN BOT-LONDON, V97, P57, DOI 10.1093/aob/mcj013; Zhang D, 2008, PLANT PHYSIOL, V148, P1368, DOI 10.1104/pp.108.124420; Zinkl GM, 1999, DEVELOPMENT, V126, P5431	60	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2021	16	11							e0260576	10.1371/journal.pone.0260576	http://dx.doi.org/10.1371/journal.pone.0260576			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9KP	34847205	gold, Green Published			2022-12-26	WOS:000735928900045
J	Palmer, PK; Wehrmeyer, K; Florian, MP; Raison, C; Idler, E; Mascaro, JS				Palmer, Patricia K.; Wehrmeyer, Kathryn; Florian, Marianne P.; Raison, Charles; Idler, Ellen; Mascaro, Jennifer S.			The prevalence, grouping, and distribution of stressors and their association with anxiety among hospitalized patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; TRAIT ANXIETY; SOCIOECONOMIC-STATUS; HEALTH-CARE; DEPRESSION; SURGERY; ILLNESS; CANCER; STATE; PAIN	Anxiety is prevalent among hospital inpatients and it has harmful effects on patient well-being and clinical outcomes. We aimed to characterize the sources of hospital distress and their relationship to anxiety. We conducted a cross-sectional study of inpatients (n = 271) throughout two Southeastern U.S. metropolitan hospitals. Participants completed a survey to identify which of 38 stressors they were experiencing. They also completed the State Trait Anxiety Inventory six-item scale. We evaluated the prevalence of stressors, their distribution, and crude association with anxiety. We then used multivariate logistic regression to estimate the association between stressors and clinically relevant anxiety, with and without adjusting for demographic variables. We used factor analysis to describe the interrelationships among stressors and to examine whether groups of stressors tend to be endorsed together. The following stressors were highly endorsed across all unit types: pain, being unable to sleep, feelings of frustration, being overwhelmed, and fear of the unknown. Stressors relating to isolation/meaninglessness and fear/frustration tend to be endorsed together. Stressors were more frequently endorsed by younger, female, and uninsured or Medicaid-insured patients and being female and uninsured was associated with anxiety in bivariate analysis. After controlling for the sources of distress in multivariate linear analysis, gender and insurance status no longer predicted anxiety. Feelings of isolation, lack of meaning, frustration, fear, or a loss of control were predictive. Study results suggest that multiple stressors are prevalent among hospital inpatients and relatively consistent across hospital unit and disease type. Interventions for anxiety or emotional/spiritual burden may be best targeted to stressors that are frequently endorsed or associated with anxiety, especially among young and female patients.	[Palmer, Patricia K.; Raison, Charles; Mascaro, Jennifer S.] Emory Univ, Dept Spiritual Hlth, Woodruff Hlth Sci Ctr, Atlanta, GA 30322 USA; [Wehrmeyer, Kathryn; Mascaro, Jennifer S.] Emory Univ, Sch Med, Dept Family & Prevent Med, Atlanta, GA USA; [Florian, Marianne P.] Emory Univ, Grad Div Relig, Atlanta, GA 30322 USA; [Raison, Charles] Univ Wisconsin Madison, Sch Human Ecol, Madison, WI USA; [Idler, Ellen] Emory Univ, Dept Sociol, Atlanta, GA 30322 USA; [Idler, Ellen] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; University of Wisconsin System; University of Wisconsin Madison; Emory University; Emory University; Rollins School Public Health	Palmer, PK (corresponding author), Emory Univ, Dept Spiritual Hlth, Woodruff Hlth Sci Ctr, Atlanta, GA 30322 USA.	pkpalme@emory.edu						Addolorato G, 1999, J PSYCHOSOM RES, V46, P283, DOI 10.1016/S0022-3999(98)00109-3; Al Rahbi F, 2020, SAUDI J KIDNEY DIS T, V31, P1351, DOI 10.4103/1319-2442.308344; AlBekairy A, 2017, MED PRIN PRACT, V26, P547, DOI 10.1159/000484929; Arpey NC, 2017, J PRIM CARE COMMUNIT, V8, P169, DOI 10.1177/2150131917697439; Babinska D, 2017, LANGENBECK ARCH SURG, V402, P719, DOI 10.1007/s00423-016-1457-5; Beeler PE, 2020, EUR J INTERN MED, V73, P59, DOI 10.1016/j.ejim.2019.11.012; Benzer JK, 2012, PSYCHIAT SERV, V63, P672, DOI 10.1176/appi.ps.201100457; Bibbo J, 2019, ANTHROZOOS, V32, P541, DOI 10.1080/08927936.2019.1621541; Bradt J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006577.pub3; Bradt J, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006911.pub2, 10.1002/14651858.CD006911]; Brown L, 2019, PSYCHOSOM MED, V81, P595, DOI 10.1097/PSY.0000000000000722; BROWN SM, 1990, J ADV NURS, V15, P962, DOI 10.1111/j.1365-2648.1990.tb01952.x; Bu FF, 2020, THORAX, V75, P597, DOI 10.1136/thoraxjnl-2019-214445; Buxton OM, 2012, ANN INTERN MED, V157, P170, DOI [10.7326/0003-4819-156-12-201208070-00472, 10.7326/0003-4819-157-3-201208070-00472]; Caldeira S, 2017, INT J NURS KNOWL, V28, P44, DOI 10.1111/2047-3095.12105; Chlan Linda, 2003, J Nurs Meas, V11, P283, DOI 10.1891/jnum.11.3.283.61269; CHRISTENSEN KS, 1985, J AM DIET ASSOC, V85, P704; Dheensa S, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-4924-1; Eagly A. H., 2016, SOCIAL ROLE THEORY S, P1, DOI 10.1002/9781118663219.wbegss183; Eberhart L, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02552-w; Fattouh N, 2019, PERSPECT PSYCHIATR C, V55, P592, DOI 10.1111/ppc.12369; Feuchtinger J, 2014, J CLIN NURS, V23, P1900, DOI 10.1111/jocn.12467; Fillary Julie, 2015, Br J Nurs, V24, P536, DOI 10.12968/bjon.2015.24.10.536; Folkman S, 2000, PSYCHO-ONCOL, V9, P11, DOI 10.1002/(SICI)1099-1611(200001/02)9:1<11::AID-PON424>3.3.CO;2-Q; Garland EL, 2017, J GEN INTERN MED, V32, P1106, DOI 10.1007/s11606-017-4116-9; Giammanco MD, 2016, QUAL LIFE RES, V25, P2941, DOI 10.1007/s11136-016-1323-5; Gooding PA, 2012, INT J GERIATR PSYCH, V27, P262, DOI 10.1002/gps.2712; Greenwood KL, 2019, POPUL HEALTH MANAG, V22, P196, DOI 10.1089/pop.2018.0074; Gullich Inês, 2013, Rev. bras. epidemiol., V16, P644, DOI 10.1590/S1415-790X2013000300009; Handzo GF, 2008, J HEALTH CARE CHAPL, V14, P39, DOI 10.1080/08854720802053853; Hellstadius Y, 2016, Dis Esophagus, V29, P1128, DOI 10.1111/dote.12437; Hofmann S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179415; Idler EL, 2015, J SCI STUD RELIG, V54, P722, DOI 10.1111/jssr.12235; Johnson KS, 2011, J GEN INTERN MED, V26, P751, DOI 10.1007/s11606-011-1656-2; JOHNSTON M, 1980, PSYCHOL MED, V10, P145, DOI 10.1017/S0033291700039684; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; Karanci AN, 2003, J PSYCHOSOM RES, V55, P363, DOI 10.1016/S0022-3999(02)00631-1; Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005; Kepka S, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-134; Khan P, 2019, CUREUS, V11, DOI 10.7759/cureus.4254; Kvaal K, 2001, INT J GERIATR PSYCH, V16, P980, DOI 10.1002/gps.458; Lane DA, 2009, J PSYCHOSOM RES, V66, P203, DOI 10.1016/j.jpsychores.2008.10.007; Lee K, 2019, CLIN PSYCHOPHARM NEU, V17, P183, DOI 10.9758/cpn.2019.17.2.183; Mako C, 2006, J PALLIAT MED, V9, P1106, DOI 10.1089/jpm.2006.9.1106; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Mascaro JS, 2017, BEHAV NEUROSCI, V131, P262, DOI 10.1037/bne0000199; McKenzie DP, 2010, PSYCHOSOMATICS, V51, P302, DOI 10.1176/appi.psy.51.4.302; Morris AC, 2009, J ROY COLL PHYS EDIN, V39, P292, DOI 10.4997/JRCPE.2009.401; Nesami MB, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.25407; Nikayin S, 2016, GEN HOSP PSYCHIAT, V43, P23, DOI 10.1016/j.genhosppsych.2016.08.005; Park EM, 2018, PSYCHOSOMATICS, V59, P251, DOI 10.1016/j.psym.2018.01.007; Patel R, 2014, ACAD EMERG MED, V21, P1478, DOI 10.1111/acem.12543; Raubenheimer J., 2004, SA J IND PSYCHOL, V30, P59, DOI [10.10520/EJC89023, DOI 10.4102/SAJIP.V30I4.168, 10.4102/sajip.v30i4.168]; Refsgaard B, 2013, CANCER NURS, V36, P221, DOI 10.1097/NCC.0b013e318268f983; Rosiek A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1248396; Rosselli M, 2015, ASIAN J PSYCHIATR, V18, P91, DOI 10.1016/j.ajp.2015.08.003; Roy-Byrne PP, 2008, GEN HOSP PSYCHIAT, V30, P208, DOI 10.1016/j.genhosppsych.2007.12.006; Santos PR, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0619-1; Shah M, 2008, AM J HOSP PALLIAT ME, V25, P88, DOI 10.1177/1049909107310138; Strang P, 2004, J PAIN SYMPTOM MANAG, V27, P241, DOI 10.1016/j.jpainsymman.2003.07.003; Taub DE., 2003, SOCIOL FOCUS, V36, P159; Tesfaw G, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1037-9; Tluczek A, 2009, J NURS MEAS, V17, P19, DOI 10.1891/1061-3749.17.1.19; Umbrello M, 2019, MINERVA ANESTESIOL, V85, P886, DOI 10.23736/S0375-9393.19.13526-2; van den Brekel L, 2020, J PAIN SYMPTOM MANAG, V60, P522, DOI 10.1016/j.jpainsymman.2020.04.005; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; Walker J, 2018, PSYCHOL MED, V48, P2285, DOI 10.1017/S0033291718000624; Whelan CT, 2004, ARCH INTERN MED, V164, P175, DOI 10.1001/archinte.164.2.175; Wiesmann U, 2018, J HAPPINESS STUD, V19, P817, DOI 10.1007/s10902-017-9850-5; Yuan LL, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02796-6	70	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	12							e0260921	10.1371/journal.pone.0260921	http://dx.doi.org/10.1371/journal.pone.0260921			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM1MC	34871325	gold, Green Published			2022-12-26	WOS:000728598900002
J	Garcia-Padilla, C; Dominguez, JN; Lodde, V; Munk, R; Abdelmohsen, K; Gorospe, M; Jimenez-Sabado, V; Ginel, A; Hove-Madsen, L; Aranega, AE; Franco, D				Garcia-Padilla, Carlos; Dominguez, Jorge N.; Lodde, Valeria; Munk, Rachel; Abdelmohsen, Kotb; Gorospe, Myriam; Jimenez-Sabado, Veronica; Ginel, Antonino; Hove-Madsen, Leif; Aranega, Amelia E.; Franco, Diego			Identification of atrial-enriched lncRNA Walras linked to cardiomyocyte cytoarchitecture and atrial fibrillation	FASEB JOURNAL			English	Article						atrial fibrillation; lncRNA; post-transcriptional regulation	LONG NONCODING RNAS; MYOSIN HEAVY-CHAIN; EXPRESSION PROFILE; COMMON VARIANTS; ANGIOTENSIN-II; GENE; HEART; PITX2; ASSOCIATION; 4Q25	Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in humans. Genetic and genomic analyses have recently demonstrated that the homeobox transcription factor Pitx2 plays a fundamental role regulating expression of distinct growth factors, microRNAs and ion channels leading to morphological and molecular alterations that promote the onset of AF. Here we address the plausible contribution of long non-coding (lnc)RNAs within the Pitx2>Wnt>miRNA signaling pathway. In silico analyses of annotated lncRNAs in the vicinity of the Pitx2, Wnt8 and Wnt11 chromosomal loci identified five novel lncRNAs with differential expression during cardiac development. Importantly, three of them, Walaa, Walras, and Wallrd, are evolutionarily conserved in humans and displayed preferential atrial expression during embryogenesis. In addition, Walrad displayed moderate expression during embryogenesis but was more abundant in the right atrium. Walaa, Walras and Wallrd were distinctly regulated by Pitx2, Wnt8, and Wnt11, and Wallrd was severely elevated in conditional atrium-specific Pitx2-deficient mice. Furthermore, pro-arrhythmogenic and pro-hypertrophic substrate administration to primary cardiomyocyte cell cultures consistently modulate expression of these lncRNAs, supporting distinct modulatory roles of the AF cardiovascular risk factors in the regulation of these lncRNAs. Walras affinity pulldown assays revealed its association with distinct cytoplasmic and nuclear proteins previously involved in cardiac pathophysiology, while loss-of-function assays further support a pivotal role of this lncRNA in cytoskeletal organization. We propose that lncRNAs Walaa, Walras and Wallrd, distinctly regulated by Pitx2>Wnt>miRNA signaling and pro-arrhythmogenic and pro-hypertrophic factors, are implicated in atrial arrhythmogenesis, and Walras additionally in cardiomyocyte cytoarchitecture.	[Garcia-Padilla, Carlos; Dominguez, Jorge N.; Aranega, Amelia E.; Franco, Diego] Univ Jaen, Dept Expt Biol, Cardiovasc Dev Grp, Jaen, Spain; [Lodde, Valeria; Munk, Rachel; Abdelmohsen, Kotb; Gorospe, Myriam] NIA, Lab Genet & Genom, IRP, NIH, Baltimore, MD 21224 USA; [Lodde, Valeria] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Jimenez-Sabado, Veronica; Hove-Madsen, Leif] CIBERCV, Barcelona, Spain; [Ginel, Antonino] Hosp Santa Creu & Sant Pau, Dept Cardiac Surg, Barcelona, Spain; [Ginel, Antonino; Hove-Madsen, Leif] IIB St Pau, Biomed Res Inst, Barcelona, Spain; [Hove-Madsen, Leif] Biomed Res Inst Barcelona IIBB CSIC, Barcelona, Spain	Universidad de Jaen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Sassari; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Hospital of Santa Creu i Sant Pau; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB)	Franco, D (corresponding author), Univ Jaen, Dept Expt Biol, Cardiovasc Dev Res Grp, B3-362, Jaen 23071, Spain.	dfranco@ujaen.es	Aranega, Amelia/AAA-8908-2019	Aranega, Amelia/0000-0002-0046-9410; Garcia-Padilla, Carlos/0000-0003-2061-3157; Jimenez-Sabado, Veronica/0000-0001-7720-988X	Junta de Andalucia Regional Council [1CTS4461]; Ministry of Science, Innovation and Universities [RFU2015-67131P]; NIA IRE, NIH	Junta de Andalucia Regional Council(Junta de Andalucia); Ministry of Science, Innovation and Universities; NIA IRE, NIH	This work was supported by a grant-in-aid from the Junta de Andalucia Regional Council to DF and AA 1CTS4461 and by a grant from the Ministry of Science, Innovation and Universities for the Spanish Government to AA and DF (RFU2015-67131P). VF, RM, KA, and MG were supported by the NIA IRE, NIH	Aguirre LA, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0138-0; Anumonwo JMB, 2014, CARDIOL CLIN, V32, P485, DOI 10.1016/j.ccl.2014.07.007; Bai JY, 2020, IEEE ENG MED BIO, P2353, DOI 10.1109/EMBC44109.2020.9175466; Bai JY, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007678; Bai JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33958-y; Bar C, 2016, CIRCULATION, V134, P1484, DOI 10.1161/CIRCULATIONAHA.116.023686; Barreto-Chaves MLM, 2020, ENDOCR CONNECT, V9, pR59, DOI 10.1530/EC-19-0543; Boucher JM, 2011, J BIOL CHEM, V286, P28312, DOI 10.1074/jbc.M111.221945; Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Chen LL, 2016, TRENDS BIOCHEM SCI, V41, P761, DOI 10.1016/j.tibs.2016.07.003; Chinchilla A, 2011, CIRC-CARDIOVASC GENE, V4, P269, DOI 10.1161/CIRCGENETICS.110.958116; Coassin SR, 2014, METHODS MOL BIOL, V1211, P189, DOI 10.1007/978-1-4939-1459-3_15; Daimi H, 2015, HEART RHYTHM, V12, P1333, DOI 10.1016/j.hrthm.2015.02.018; Das S, 2018, CIRC RES, V123, P1298, DOI 10.1161/CIRCRESAHA.118.313207; de Lange FJ, 2003, GENESIS, V37, P1, DOI 10.1002/gene.10220; Dempsey J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5235-3; Dorr M, 2005, Minerva Endocrinol, V30, P199; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Engreitz JM, 2016, NAT REV MOL CELL BIO, V17, P756, DOI 10.1038/nrm.2016.126; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Garcia-Padilla C, 2019, BBA-GENE REGUL MECH, V1862, DOI 10.1016/j.bbagrm.2019.194435; Gloss BS, 2016, BBA-GENE REGUL MECH, V1859, P16, DOI 10.1016/j.bbagrm.2015.08.005; Gore-Panter SR, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003197; Goudis CA, 2015, J CARDIOL, V66, P361, DOI 10.1016/j.jjcc.2015.04.002; Granados-Riveron JT, 2010, HUM MOL GENET, V19, P4007, DOI 10.1093/hmg/ddq315; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Henningsen KMA, 2011, SCAND CARDIOVASC J, V45, P324, DOI 10.3109/14017431.2011.594081; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Higa Satoshi, 2021, Card Electrophysiol Clin, V13, P63, DOI 10.1016/j.ccep.2020.11.005; Hitachi K, 2019, EMBO REP, V20, DOI 10.15252/embr.201847468; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Hori Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5233-5; Jalife J, 2015, TRENDS CARDIOVAS MED, V25, P475, DOI 10.1016/j.tcm.2014.12.015; Jia YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160755; Jiang JM, 2013, SCIENCE, V342, P111, DOI 10.1126/science.1236921; Kaab S, 2009, EUR HEART J, V30, P813, DOI 10.1093/eurheartj/ehn578; Kiliszek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021790; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kumar Kartik R, 2015, Card Electrophysiol Clin, V7, P173, DOI 10.1016/j.ccep.2015.03.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano-Velasco Estefania, 2019, Cardiovascular & Hematological Disorders - Drug Targets, V19, P183, DOI 10.2174/1871529X19666190206150349; Lozano-Velasco E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188473; Lozano-Velasco E, 2016, CARDIOVASC RES, V109, P55, DOI 10.1093/cvr/cvv207; Lunde IG, 2011, J APPL PHYSIOL, V111, P1278, DOI 10.1152/japplphysiol.01383.2010; Mahlapuu M, 2001, DEVELOPMENT, V128, P155; Manso AM, 2017, P NATL ACAD SCI USA, V114, pE6250, DOI 10.1073/pnas.1701416114; Manso AM, 2013, J BIOL CHEM, V288, P4252, DOI 10.1074/jbc.M112.427484; Marian AJ, 2017, CIRC RES, V121, P749, DOI 10.1161/CIRCRESAHA.117.311059; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Mei B, 2018, EUR REV MED PHARMACO, V22, P6940, DOI 10.26355/eurrev_201810_16165; Mohanty S, 2013, J CARDIOVASC ELECTR, V24, P155, DOI 10.1111/jce.12017; Nielsen JB, 2018, NAT GENET, V50, P1234, DOI 10.1038/s41588-018-0171-3; Nooh MM, 2017, CELL SIGNAL, V29, P192, DOI 10.1016/j.cellsig.2016.10.014; Olesen MS, 2012, CAN J CARDIOL, V28, P191, DOI 10.1016/j.cjca.2011.11.016; Ounzain S, 2015, J MOL CELL CARDIOL, V89, P98, DOI 10.1016/j.yjmcc.2015.09.016; Panda Amaresh C, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.2062; Parvez B, 2013, HEART RHYTHM, V10, P849, DOI 10.1016/j.hrthm.2013.02.018; Pereyra AS, 2017, J BIOL CHEM, V292, P18443, DOI 10.1074/jbc.M117.800839; Perez-Hernandez M, 2016, CARDIOVASC RES, V109, P431, DOI 10.1093/cvr/cvv280; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Prisant L Michael, 2006, J Clin Hypertens (Greenwich), V8, P596, DOI 10.1111/j.1524-6175.2006.05180.x; Qian C, 2019, J CELL PHYSIOL, V234, P11620, DOI 10.1002/jcp.27819; Roselli C, 2018, NAT GENET, V50, P1225, DOI 10.1038/s41588-018-0133-9; Ruan ZB, 2015, INT J CLIN EXP PATHO, V8, P8402; Sasagawa S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00162; Satoh K, 2011, ARTERIOSCL THROM VAS, V31, P1116, DOI 10.1161/ATVBAHA.110.214601; Schnabel RB, 2011, CIRC-CARDIOVASC GENE, V4, P557, DOI 10.1161/CIRCGENETICS.110.959197; Shu Q, 2018, BIOCHEM BIOPH RES CO, V505, P317, DOI 10.1016/j.bbrc.2018.09.100; Su DM, 2014, BIOCHEM CELL BIOL, V92, P183, DOI 10.1139/bcb-2013-0124; Su Y, 2018, GENE, V642, P125, DOI 10.1016/j.gene.2017.11.025; Tang Y, 2014, CARDIOVASC PATHOL, V23, P101, DOI 10.1016/j.carpath.2013.11.002; Tao Y, 2014, CIRC-CARDIOVASC GENE, V7, P23, DOI 10.1161/CIRCGENETICS.113.000259; Terreri S, 2021, CANCERS, V13, DOI 10.3390/cancers13040681; Torrado M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090561; Tribulova N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082844; Veluchamy A, 2019, ARTERIOSCL THROM VAS, V39, P2542, DOI 10.1161/ATVBAHA.119.312552; Villegas VE, 2015, INT J MOL SCI, V16, P3251, DOI 10.3390/ijms16023251; Wang J, 2010, P NATL ACAD SCI USA, V107, P9753, DOI 10.1073/pnas.0912585107; Wang KCW, 2013, METABOLISM, V62, P1662, DOI 10.1016/j.metabol.2013.06.013; Wang YG, 2003, J PHYSIOL-LONDON, V546, P491, DOI 10.1113/jphysiol.2002.032847; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Welsh IC, 2015, CELL REP, V13, P337, DOI 10.1016/j.celrep.2015.08.075; Wolf CM, 2019, CARDIOVASC DIAGN THE, V9, pS388, DOI 10.21037/cdt.2019.02.01; Yadava M, 2014, CARDIOL CLIN, V32, P627, DOI 10.1016/j.ccl.2014.07.002; Zhang M, 2019, P NATL ACAD SCI USA, V116, P22692, DOI 10.1073/pnas.1907418116; Zhang QT, 2014, CARDIOVASC THER, V32, P233, DOI 10.1111/1755-5922.12089; Zhou B, 2009, CLIN CHIM ACTA, V400, P21, DOI 10.1016/j.cca.2008.09.028	91	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22051	10.1096/fj.202100844RR	http://dx.doi.org/10.1096/fj.202100844RR			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34861058	Green Published, hybrid			2022-12-26	WOS:000734992000007
J	Merritt, C; Chun, EM; Fattah, RJ; Silva, LM; Ma, QQ; Moayeri, M; Paliga, D; Neumann, S; Heumann, R; Leppla, SH; Bugge, TH				Merritt, Carly; Chun, Elizabeth M.; Fattah, Rasem J.; Silva, Lakmali M.; Ma, Quinn Q.; Moayeri, Mahtab; Paliga, Dennis; Neumann, Sebastian; Heumann, Rolf; Leppla, Stephen H.; Bugge, Thomas H.			Imaging of anthrax intoxication in mice reveals shared and individual functions of surface receptors CMG-2 and TEM-8 in cellular toxin entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; THERAPY PRODUCES REGRESSIONS; LETHAL TOXIN; MEDIATED DELIVERY; TUMOR-CELLS; IN-VITRO; CRE; CYTOSOL; EDEMA; TRANSLOCATION	Bacillus anthracis lethal toxin and edema toxin are binary toxins that consist of a common cell-binding moiety, protective antigen (PA), and the enzymatic moieties, lethal factor (LF) and edema factor (EF). PA binds to either of two receptors, capillary morphogenesis protein-2 (CMG-2) or tumor endothelial marker-8 (TEM-8), which triggers the binding and cytoplasmic translocation of LF and EF. However, the distribution of functional TEM-8 and CMG-2 receptors during anthrax toxin intoxication in animals has not been fully elucidated. Herein, we describe an assay to image anthrax toxin intoxication in animals, and we use it to visualize TEM-8- and CMG-2 dependent intoxication in mice. Specifically, we generated a chimeric protein consisting of the N-terminal domain of LF fused to a nuclear localization signal-tagged Cre recombinase (LFn-NLS-Cre). When PA and LFn-NLS-Cre were coadministered to transgenic mice expressing a red fluorescent protein in the absence of Cre and a green fluorescent protein in the presence of Cre, intoxication could be visualized at single-cell resolution by confocal microscopy or flow cytometry. Using this assay, we found that: (a) CMG-2 is critical for intoxication in the liver and heart, (b) TEM-8 is required for intoxication in the kidney and spleen, (c) CMG-2 and TEM-8 are redundant for intoxication of some organs, (d) combined loss of CMG-2 and TEM-8 completely abolishes intoxication, and (e) CMG-2 is the dominant receptor on leukocytes. The novel assay will be useful for basic and clinical/translational studies of Bacillus anthracis infection and for clinical development of reengineered toxin variants for cancer treatment.	[Merritt, Carly; Chun, Elizabeth M.; Silva, Lakmali M.; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, NIH, Bethesda, MD 20892 USA; [Fattah, Rasem J.; Ma, Quinn Q.; Moayeri, Mahtab; Leppla, Stephen H.] NIAID, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Paliga, Dennis; Neumann, Sebastian; Heumann, Rolf] Ruhr Univ Bochum, Fac Chem & Biochem, Dept Biochem Mol Neurobiochem 2, Bochum, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Ruhr University Bochum	Bugge, TH (corresponding author), Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, NIH, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov		Chun, Elizabeth/0000-0001-7916-9308; Merritt, Carly/0000-0001-9233-6940; Paliga, Dennis/0000-0002-0447-6212; Neumann, Sebastian/0000-0003-3706-9012; Moayeri, Mahtab/0000-0002-4448-8883; Leppla, Stephen/0000-0001-5233-0501	NIAID of the NIH; NIDCR Intramural Research Program of the NIH; NIDCR [1K99DE030124-01A1, ZIC DE000729-09, ZIC DE000750-01]; European Union [686841]	NIAID of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR Intramural Research Program of the NIH; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); European Union(European Commission)	Supported by the NIAID (S. H. L.) and NIDCR Intramural Research Program (T. H. B.) of the NIH, NIDCR 1K99DE030124-01A1 (L. M. S.), and the NIDCR Combined Technical Research Core (ZIC DE000729-09) and NIDCR Imaging Core: ZIC DE000750-01. R. H., S. N., and D. P. were funded by the European Union's Horizon 2020 research and innovation program grant agreement No. 686841 (MAGNEURON). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abi-Habib RJ, 2006, CLIN CANCER RES, V12, P7437, DOI 10.1158/1078-0432.CCR-06-2019; Abi-Habib RJ, 2006, MOL CANCER THER, V5, P2556, DOI 10.1158/1535-7163.MCT-06-0315; Alfano RW, 2010, MOL CANCER THER, V9, P190, DOI 10.1158/1535-7163.MCT-09-0694; Alfano RW, 2009, MOL CANCER RES, V7, P452, DOI 10.1158/1541-7786.MCR-08-0451; ARORA N, 1993, J BIOL CHEM, V268, P3334; ARORA N, 1994, INFECT IMMUN, V62, P4955, DOI 10.1128/IAI.62.11.4955-4961.1994; ARORA N, 1992, J BIOL CHEM, V267, P15542; Bachran C, 2013, MBIO, V4, DOI 10.1128/mBio.00201-13; Ballard JD, 1998, INFECT IMMUN, V66, P615, DOI 10.1128/IAI.66.2.615-619.1998; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Briones G, 2006, INFECT IMMUN, V74, P1084, DOI 10.1128/IAI.74.2.1084-1090.2006; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Doling AM, 1999, INFECT IMMUN, V67, P3290, DOI 10.1128/IAI.67.7.3290-3296.1999; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Goletz TJ, 1997, P NATL ACAD SCI USA, V94, P12059, DOI 10.1073/pnas.94.22.12059; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Guerrero F, 2015, PROTEIN EXPRES PURIF, V116, P42, DOI 10.1016/j.pep.2015.08.019; Hobson JP, 2006, NAT METHODS, V3, P259, DOI 10.1038/NMETH862; Kellendonk C, 1996, NUCLEIC ACIDS RES, V24, P1404, DOI 10.1093/nar/24.8.1404; Le YZ, 1999, NUCLEIC ACIDS RES, V27, P4703, DOI 10.1093/nar/27.24.4703; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Leppla SH, 2002, J CLIN INVEST, V110, P141, DOI [10.1172/JCI200216204, 10.1172/JCI0216204]; Leppla SH, 1999, J APPL MICROBIOL, V87, P284, DOI 10.1046/j.1365-2672.1999.00890.x; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liu SH, 2000, CANCER RES, V60, P6061; Liu SH, 2005, NAT BIOTECHNOL, V23, P725, DOI 10.1038/nbt1091; Liu SH, 2003, P NATL ACAD SCI USA, V100, P657, DOI 10.1073/pnas.0236849100; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Liu S, 2008, J BIOL CHEM, V283, P529, DOI 10.1074/jbc.M707419200; Liu SH, 2013, NATURE, V501, P63, DOI 10.1038/nature12510; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Liu XH, 2001, J BIOL CHEM, V276, P46326, DOI 10.1074/jbc.M108930200; Madsen DH, 2017, CELL REP, V21, P3662, DOI 10.1016/j.celrep.2017.12.011; Martin EW, 2015, ONCOTARGET, V6, P33534, DOI 10.18632/oncotarget.5214; McCluskey AJ, 2013, MOL CANCER THER, V12, P2273, DOI 10.1158/1535-7163.MCT-13-0358; McCluskey AJ, 2013, MOL ONCOL, V7, P440, DOI 10.1016/j.molonc.2012.12.003; Mehra V, 2001, BIOTECHNOL APPL BIOC, V33, P71, DOI 10.1042/BA20000072; Mendenhall MA, 2020, NAT MICROBIOL, V5, P1464, DOI 10.1038/s41564-020-0782-1; Moayeri M, 2015, ANNU REV MICROBIOL, V69, P185, DOI 10.1146/annurev-micro-091014-104523; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Moriya O, 2001, VACCINE, V20, P789, DOI 10.1016/S0264-410X(01)00407-8; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Paliga D, 2019, MOL NEUROBIOL, V56, P3393, DOI 10.1007/s12035-018-1311-6; Peitz M, 2007, GENESIS, V45, P508, DOI 10.1002/dvg.20321; Peters DE, 2014, TOXICOL APPL PHARM, V279, P220, DOI 10.1016/j.taap.2014.06.010; Phillips DD, 2013, J BIOL CHEM, V288, P9058, DOI 10.1074/jbc.M113.452110; Rono B, 2006, MOL CANCER THER, V5, P89, DOI 10.1158/1535-7163.MCT-05-0163; Schafer JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020532; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sharma M, 2000, BIOTECHNOL APPL BIOC, V32, P69, DOI 10.1042/BA20000037; Sicard C, 2014, ANAL BIOANAL CHEM, V406, P5395, DOI 10.1007/s00216-014-7935-0; Singh Y, 1999, INFECT IMMUN, V67, P1853; Su YP, 2007, CANCER RES, V67, P3329, DOI 10.1158/0008-5472.CAN-06-4642; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Xavier MAE, 2019, J NUCL MED, V60, P1474, DOI 10.2967/jnumed.119.226423; Zhang Y, 2001, MICROBIOL IMMUNOL, V45, P119, DOI 10.1111/j.1348-0421.2001.tb01279.x; Zornetta I, 2010, CELL MICROBIOL, V12, P1435, DOI 10.1111/j.1462-5822.2010.01480.x	58	0	0	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101467	10.1016/j.jbc.2021.101467	http://dx.doi.org/10.1016/j.jbc.2021.101467			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1JM	34871548	gold, Green Published			2022-12-26	WOS:000748384500003
J	Plaisance, L; Matterson, K; Fabricius, K; Drovetski, S; Meyer, C; Knowlton, N				Plaisance, Laetitia; Matterson, Kenan; Fabricius, Katharina; Drovetski, Sergei; Meyer, Chris; Knowlton, Nancy			Effects of low pH on the coral reef cryptic invertebrate communities near CO2 vents in Papua New Guinea	PLOS ONE			English	Article							OXIDASE SUBUNIT-I; OCEAN ACIDIFICATION; MONITORING STRUCTURES; SPECIES RICHNESS; RESPONSES; DIVERSITY; SAMPLES; ASSEMBLAGES; PRIMERS; SHALLOW	Small cryptic invertebrates (the cryptofauna) are extremely abundant, ecologically important, and species rich on coral reefs. Ongoing ocean acidification is likely to have both direct effects on the biology of these organisms, as well as indirect effects through cascading impacts on their habitats and trophic relationships. Naturally acidified habitats have been important model systems for studying these complex interactions because entire communities that are adapted to these environmental conditions can be analyzed. However, few studies have examined the cryptofauna because they are difficult to census quantitatively in topographically complex habitats and are challenging to identify. We addressed these challenges by using Autonomous Reef Monitoring Structures (ARMS) for sampling reef-dwelling invertebrates >2 mm in size and by using DNA barcoding for taxonomic identifications. The study took place in Papua New Guinea at two reef localities, each with three sites at varying distances from carbon dioxide seeps, thereby sampling across a natural gradient in acidification. We observed sharp overall declines in both the abundance (34-56%) and diversity (42-45%) of organisms in ARMS under the lowest pH conditions sampled (7.64-7.75). However, the overall abundance of gastropods increased slightly in lower pH conditions, and crustacean and gastropod families exhibited varying patterns. There was also variability in response between the two localities, despite their close proximity, as one control pH site displayed unusually low diversity and abundances for all invertebrate groups. The data illustrate the complexity of responses of the reef fauna to pH conditions, and the role of additional factors that influence the diversity and abundance of cryptic reef invertebrates.	[Plaisance, Laetitia; Meyer, Chris; Knowlton, Nancy] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Plaisance, Laetitia] UPS, Lab Evolut & Diversite Biol, CNRS, Toulouse, France; [Matterson, Kenan] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali BiGeA, Ravenna, Italy; [Fabricius, Katharina] Australian Inst Marine Sci, Townsville, Qld, Australia; [Drovetski, Sergei] US Geol Survey, Eastern Ecol Sci Ctr, Beltsville, MD USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Bologna; Australian Institute of Marine Science; United States Department of the Interior; United States Geological Survey	Plaisance, L (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA.; Plaisance, L (corresponding author), UPS, Lab Evolut & Diversite Biol, CNRS, Toulouse, France.	Laetitia.plaisance@univ-tlse3.fr		Plaisance, Laetitia/0000-0003-3375-4768; Meyer, Christopher/0000-0003-2501-7952	National Science Foundation [OCE 1558868]; Smithsonian Institution's Scholarly Studies awards; Great Barrier Reef Foundation's 'Resilient Coral Reefs Successfully Adapting to Climate Change' program; Smithsonian Sant Chair for Marine Science; Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-25-01]	National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution's Scholarly Studies awards; Great Barrier Reef Foundation's 'Resilient Coral Reefs Successfully Adapting to Climate Change' program; Smithsonian Sant Chair for Marine Science; Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR))	This study was financially supported by the National Science Foundation (grant OCE 1558868 to LP & NK), the Smithsonian Institution's Scholarly Studies awards (to LP & NK), the Great Barrier Reef Foundation's 'Resilient Coral Reefs Successfully Adapting to Climate Change' program (to KF), the Smithsonian Sant Chair for Marine Science (LP & NK), and a grant "Investissement d'Avenir" managed by the Agence Nationale de la Recherche (CEBA: ANR-10-LABX-25-01 to LP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rshaidat MMD, 2016, GENOME, V59, P724, DOI 10.1139/gen-2015-0208; Alberdi A, 2018, METHODS ECOL EVOL, V9, P134, DOI 10.1111/2041-210X.12849; Allen R, 2017, MAR POLLUT BULL, V124, P607, DOI 10.1016/j.marpolbul.2016.12.031; Anderson MJ., 2008, PERMANOVA PRIMER GUI, p214p; Brandl SJ, 2018, BIOL REV, V93, P1846, DOI 10.1111/brv.12423; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Chao A, 2009, ECOLOGY, V90, P1125, DOI 10.1890/07-2147.1; Chen C, 2018, MAR BIODIVERS, V48, P709, DOI 10.1007/s12526-017-0804-2; Cigliano M, 2010, MAR BIOL, V157, P2489, DOI 10.1007/s00227-010-1513-6; Clarke KR, 2015, PRIMER V7 USER MANUA; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Colwell RK, 2014, ECOGRAPHY, V37, P609, DOI 10.1111/ecog.00814; Connell SD, 2018, ECOLOGY, V99, P1005, DOI 10.1002/ecy.2209; Connell SD, 2017, CURR BIOL, V27, pR95, DOI 10.1016/j.cub.2016.12.004; Crook ED, 2012, CORAL REEFS, V31, P239, DOI 10.1007/s00338-011-0839-y; David R, 2019, MAR POLLUT BULL, V141, P420, DOI 10.1016/j.marpolbul.2019.02.066; Enochs IC, 2015, NAT CLIM CHANGE, V5, P1083, DOI 10.1038/NCLIMATE2758; Enochs IC, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1742; Fabricius KE, 2015, SCI REP-UK, V5, DOI 10.1038/srep09537; Fabricius KE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2479; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Garrard SL, 2014, J EXP MAR BIOL ECOL, V461, P31, DOI 10.1016/j.jembe.2014.07.011; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Glynn PW, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P273, DOI 10.1007/978-94-007-0114-4_18; Gonzalez-Delgado S, 2018, ADV MAR BIOL, V80, P57, DOI 10.1016/bs.amb.2018.08.001; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hurley KKC, 2016, CORAL REEFS, V35, P103, DOI 10.1007/s00338-015-1382-z; Inoue S, 2013, NAT CLIM CHANGE, V3, P683, DOI [10.1038/nclimate1855, 10.1038/NCLIMATE1855]; Kenkel CD, 2018, GLOBAL CHANGE BIOL, V24, P158, DOI [10.1111/gcb.13833, 10.1111/gcb.]; Kerrison P, 2011, ESTUAR COAST SHELF S, V94, P129, DOI 10.1016/j.ecss.2011.05.025; KLUMPP DW, 1988, MAR ECOL PROG SER, V45, P95, DOI 10.3354/meps045095; Knowlton Nancy, 2010, P65, DOI 10.1002/9781444325508.ch4; Kramer MJ, 2013, CORAL REEFS, V32, P575, DOI 10.1007/s00338-013-1009-1; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Marchini A, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00106; Nelson HR, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1399; Obst M, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.572680; Oksanen J., 2007, COMMUN ECOL PACK, P631; Pearman JK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26332-5; Pennesi C, 2017, MAR POLLUT BULL, V125, P56, DOI 10.1016/j.marpolbul.2017.08.001; Plaisance L, 2009, CORAL REEFS, V28, P977, DOI 10.1007/s00338-009-0543-3; Plaisance Laetitia, 2011, Diversity, V3, P581; Plaisance L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025026; Prayitno HB., 2020, ASEAN J SCI TECHNOL, V37, P123, DOI [10.29037/ajstd.638, DOI 10.29037/AJSTD.638]; Reaka-Kudla Marjorie L., 1997, P83; Reaka-Kudla ML, 2005, CARIBBEAN MARINE BIO, P259; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; ROTHANS TC, 1991, MAR BIOL, V110, P145, DOI 10.1007/BF01313101; Russell BD, 2013, MAR POLLUT BULL, V73, P463, DOI 10.1016/j.marpolbul.2013.01.031; Sanciangco JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056245; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith JN, 2016, NAT CLIM CHANGE, V6, P1124, DOI 10.1038/NCLIMATE3122; Stella JS, 2011, OCEANOGR MAR BIOL, V49, P43; Sunday JM, 2017, NAT CLIM CHANGE, V7, P81, DOI [10.1038/NCLIMATE3161, 10.1038/nclimate3161]; Uthicke S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01769; Uthicke S, 2016, GLOBAL CHANGE BIOL, V22, P2451, DOI 10.1111/gcb.13223; Vogel N, 2015, LIMNOL OCEANOGR, V60, P263, DOI 10.1002/lno.10021; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Wisshak M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045124; Wittmann AC, 2013, NAT CLIM CHANGE, V3, P995, DOI 10.1038/NCLIMATE1982	64	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0258725	10.1371/journal.pone.0258725	http://dx.doi.org/10.1371/journal.pone.0258725			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910721	Green Published, gold			2022-12-26	WOS:000754828900006
J	Delaroche, L; Bertine, M; Oger, P; Descamps, D; Damond, F; Genauzeau, E; Meicler, P; Le Hingrat, Q; Lamazou, F; Gschwind, R; Ruppe, E; Visseaux, B				Delaroche, Lucie; Bertine, Melanie; Oger, Pierre; Descamps, Diane; Damond, Florence; Genauzeau, Emmanuel; Meicler, Philippe; Le Hingrat, Quentin; Lamazou, Frederic; Gschwind, Remi; Ruppe, Etienne; Visseaux, Benoit			Evaluation of SARS-CoV-2 in semen, seminal plasma, and spermatozoa pellet of COVID-19 patients in the acute stage of infection	PLOS ONE			English	Article							CORONAVIRUS; PROTEIN; VIRUSES; CELLS	To date, there is limited information about the presence of SARS-CoV-2 in semen especially in the acute phase of the infection. While available data from cohort studies including a total of 342 patients in the acute or recovery phase of the infection are reassuring, one study mentioned detecting virus in the semen of 6/38 COVID-19 patients. Here we assessed SARS-CoV-2 presence in the semen of COVID-19 positive patients in the acute stage of infection, within 24 hours of the positive nasopharyngeal swabs. Semen, seminal plasma and spermatozoa pellet were screened for SARS-CoV-2 and manual or airborne contamination during semen sampling. Among the 32 COVID-19 volunteers, the median interval from the onset of symptoms to semen collection was 4 days [IQR: 0-8]. Only one presented positive SARS-CoV-2 PCR in semen and seminal plasma fractions, although the spermatozoa pellet was negative. Viral cultures were all negative. We observed slightly higher concentrations of bacterial DNA in the SARS-CoV-2 positive specimen than in all negative samples. The bacteria identified neither confirm nor rule out contamination by oropharyngeal secretions during collection. SARS-CoV-2 was rarely present in semen during the acute phase of the disease. This very rare situation could be connected to oral or manual contamination during semen collection. The possible presence of SARS-CoV-2 in semen calls for nasopharyngeal viral testing and strict hygiene protocols during semen collection before assisted reproductive attempts.	[Delaroche, Lucie; Oger, Pierre; Genauzeau, Emmanuel; Meicler, Philippe; Lamazou, Frederic] Hop Prive Parly 2, Inst Fertil Matern Parly 2, Ramsay Sante, Le Chesnay, France; [Delaroche, Lucie; Genauzeau, Emmanuel] Hop Prive Parly 2, Ctr Biol Med, Le Chesnay, France; [Bertine, Melanie; Descamps, Diane; Damond, Florence; Le Hingrat, Quentin; Gschwind, Remi; Ruppe, Etienne; Visseaux, Benoit] Univ Paris, INSERM, IAME, Paris, France; [Bertine, Melanie; Descamps, Diane; Damond, Florence; Le Hingrat, Quentin; Visseaux, Benoit] Hop Bichat Claude Bernard, AP HP, Lab Virol, Paris, France; [Ruppe, Etienne] Hop Bichat Claude Bernard, AP HP, Lab Bacteriol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Delaroche, L (corresponding author), Hop Prive Parly 2, Inst Fertil Matern Parly 2, Ramsay Sante, Le Chesnay, France.; Delaroche, L (corresponding author), Hop Prive Parly 2, Ctr Biol Med, Le Chesnay, France.	luciedelaroche@yahoo.fr	Le Hingrat, Quentin/AAC-7439-2021; RUPPE, ETIENNE/H-1073-2016	Le Hingrat, Quentin/0000-0001-9017-4941; RUPPE, ETIENNE/0000-0001-5282-2178	Ramsay Sante; French agency ANRS (National Agency for Research on AIDS and viral hepatitis)	Ramsay Sante; French agency ANRS (National Agency for Research on AIDS and viral hepatitis)	Funding was obtained from Ramsay Sante and the French agency ANRS (National Agency for Research on AIDS and viral hepatitis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud D, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00234; Best JC, 2021, WORLD J MENS HEALTH, V39, P489, DOI 10.5534/wjmh.200192; Borges E, 2021, ANDROLOGY-US, V9, P1066, DOI 10.1111/andr.13037; Burke CA, 2021, J ASSIST REPROD GEN, V38, P785, DOI 10.1007/s10815-021-02119-y; Chen L, 2021, J ULTRAS MED, V40, P1787, DOI 10.1002/jum.15558; Chen YW, 2010, AM J PATHOL, V176, P2986, DOI 10.2353/ajpath.2010.090665; Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001; Douglas GC, 2004, ENDOCRINOLOGY, V145, P4703, DOI 10.1210/en.2004-0443; Eisenberg ML, 2020, FERTIL STERIL, V113, P1154, DOI 10.1016/j.fertnstert.2020.04.039; Erbay G, 2021, ANDROLOGY-US, V9, P1060, DOI 10.1111/andr.13019; Fung B, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01535-20; Guo LQ, 2021, ANDROLOGY-US, V9, P42, DOI 10.1111/andr.12848; Guo TH, 2021, ASIAN J ANDROL, V23, P479, DOI 10.4103/aja.aja_31_21; Hallak J, 2021, ANDROLOGY-US, V9, P73, DOI 10.1111/andr.12896; Holtmann N, 2020, FERTIL STERIL, V114, P233, DOI 10.1016/j.fertnstert.2020.05.028; Zamora MJ, 2016, REPROD BIOMED ONLINE, V32, P584, DOI 10.1016/j.rbmo.2016.02.014; Kayaaslan B, 2020, UROL INT, V104, P678, DOI 10.1159/000510531; Li DG, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8292; Liu XX, 2020, SCI CHINA LIFE SCI, V63, P1006, DOI 10.1007/s11427-020-1705-0; Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889; Manabe YCC, 2020, ANTIGEN BASED TESTIN, DOI [10.1101/2020.10.02.20205708, DOI 10.1101/2020.10.02.20205708]; Massarotti C, 2021, ANDROLOGY-US, V9, P39, DOI 10.1111/andr.12839; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Moshrefi M, 2021, J ASSIST REPROD GEN, V38, P1691, DOI 10.1007/s10815-021-02097-1; Pan F, 2020, FERTIL STERIL, V113, P1135, DOI 10.1016/j.fertnstert.2020.04.024; Paoli D, 2020, J ENDOCRINOL INVEST, V43, P1819, DOI 10.1007/s40618-020-01261-1; Paoli D, 2021, ANDROLOGY-US, V9, P23, DOI 10.1111/andr.12825; Pavone C, 2020, INT J IMPOT RES, V32, P560, DOI 10.1038/s41443-020-00344-0; Rajak P, 2021, REPROD BIOL, V21, DOI 10.1016/j.repbio.2021.100559; Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049; Shen Q., 2020, J CELL MOL MED, DOI DOI 10.1111/jcmm.15541; Song C, 2020, BIOL REPROD, V103, P4, DOI 10.1093/biolre/ioaa050; Stanley KE, 2020, FERTIL STERIL, V114, P33, DOI 10.1016/j.fertnstert.2020.05.001; Tur-Kaspa Ilan, 2021, F S Rev, V2, P140, DOI 10.1016/j.xfnr.2021.01.002; Visseaux B, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104520; Wang SQ, 2020, NAT REV UROL, V17, P314, DOI 10.1038/s41585-020-0319-7; Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786; Wang ZP, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040920; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; World Health Organization, WHO LAB MAN EX PROC; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	41	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0260187	10.1371/journal.pone.0260187	http://dx.doi.org/10.1371/journal.pone.0260187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905541	gold, Green Published			2022-12-26	WOS:000754615500004
J	Ghosh, S; Straus, DL; Good, C; Phuntumart, V				Ghosh, Satyaki; Straus, David L.; Good, Christopher; Phuntumart, Vipaporn			Development and comparison of loop-mediated isothermal amplification with quantitative PCR for the specific detection of Saprolegnia spp.	PLOS ONE			English	Article							CHANNEL CATFISH; COPPER-SULFATE; WATER MOLDS; PARASITICA; DNA; IDENTIFICATION; PHYTOPHTHORA; PATHOGEN; ASSAY; PHYLOGENY	Saprolegniasis is an important disease in freshwater aquaculture, and is associated with oomycete pathogens in the genus Saprolegnia. Early detection of significant levels of Saprolegnia spp. pathogens would allow informed decisions for treatment which could significantly reduce losses. This study is the first to report the development of loop-mediated isothermal amplification (LAMP) for the detection of Saprolegnia spp. and compares it with quantitative PCR (qPCR). The developed protocols targeted the internal transcribed spacer (ITS) region of ribosomal DNA and the cytochrome C oxidase subunit 1 (CoxI) gene and was shown to be specific only to Saprolegnia genus. This LAMP method can detect as low as 10 fg of S. salmonis DNA while the qPCR method has a detection limit of 2 pg of S. salmonis DNA, indicating the superior sensitivity of LAMP compared to qPCR. When applied to detect the pathogen in water samples, both methods could detect the pathogen when only one zoospore of Saprolegnia was present. We propose LAMP as a quick (about 20-60 minutes) and sensitive molecular diagnostic tool for the detection of Saprolegnia spp. suitable for on-site applications.	[Ghosh, Satyaki; Phuntumart, Vipaporn] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [Straus, David L.] ARS, USDA, Harry K Dupree Stuttgart Natl Aquaculture Res Ctr, Stuttgart, AR USA; [Good, Christopher] Conservat Funds Freshwater Inst, Shepherdstown, WV USA; [Ghosh, Satyaki] AgriPlex Genom, Cleveland, OH USA	University System of Ohio; Bowling Green State University; United States Department of Agriculture (USDA)	Phuntumart, V (corresponding author), Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA.	vphuntu@bgsu.edu		Phuntumart, Vipa (Vipaporn)/0000-0003-4604-0043	Ohio Sea Grant [60063782]	Ohio Sea Grant	SG-Ohio Sea Grant (60063782), https:// ohioseagrant.osu.edu/ VP-Ohio Sea Grant (60063782), https://ohioseagrant.osu.edu/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Ali SE, 2013, VET MICROBIOL, V163, P133, DOI 10.1016/j.vetmic.2012.12.012; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bakkeren G, 2000, MYCOLOGIA, V92, P510, DOI 10.2307/3761510; Bala K, 2010, PERSOONIA, V25, P22, DOI 10.3767/003158510X524754; Banfield MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003590; Basenko EY, 2018, J FUNGI, V4, DOI 10.3390/jof4010039; Best N, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00067; Bharucha T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194412; BLY JE, 1993, J FISH DIS, V16, P541, DOI 10.1111/j.1365-2761.1993.tb00890.x; Cai SX, 2018, PEERJ, V6, DOI 10.7717/peerj.5993; Cao YY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13881-4; Dai TT, 2012, FEMS MICROBIOL LETT, V334, P27, DOI 10.1111/j.1574-6968.2012.02619.x; Das SK, 2012, J ENVIRON BIOL, V33, P545; Godoi PAD, 2017, PARASITOL INT, V66, P563, DOI 10.1016/j.parint.2017.06.001; Densmore CL, 2007, ILAR J, V48, P235, DOI 10.1093/ilar.48.3.235; DIEGUEZURIBEONDO J, 1994, MYCOL RES, V98, P810, DOI 10.1016/S0953-7562(09)81060-5; Dolka B, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1420-z; Feng WZ, 2019, PLANT DIS, V103, P298, DOI [10.1094/PDIS-05-18-0858-RE, 10.1094/pdis-05-18-0858-re]; Fernandez-Beneitez MJ, 2008, FEMS MICROBIOL LETT, V279, P23, DOI 10.1111/j.1574-6968.2007.01002.x; Fregeneda-Grandes JM, 2007, J FISH BIOL, V71, P510, DOI 10.1111/j.1095-8649.2007.01510.x; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; Hardinge P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43817-z; Iddya Karunasagar, 2003, Journal of Applied Aquaculture, V13, P231, DOI 10.1300/J028v13n03_03; Kong XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28935; Kralik P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00108; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leung MH, 2012, J CLIN MICROBIOL, V50, P2419, DOI 10.1128/JCM.06384-11; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Martin FN, 2012, PLANT DIS, V96, P1080, DOI 10.1094/PDIS-12-11-1036-FE; Naik P., 2019, BIORXIV594374, V594374, DOI [10.1101/594374, DOI 10.1101/594374]; Nakayama T, 2017, BIOCONTROL SCI, V22, P97, DOI 10.4265/bio.22.97; Nechwatal J, 2008, MYCOL RES, V112, P689, DOI 10.1016/j.mycres.2007.11.015; Niihara H, 2017, J DERMATOL, V44, pE174, DOI 10.1111/1346-8138.13861; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2011, J MOL DIAGN, V13, P100, DOI 10.1016/j.jmoldx.2010.11.003; Phillips AJ, 2008, TRENDS MICROBIOL, V16, P13, DOI 10.1016/j.tim.2007.10.013; Redekar NR, 2019, PHYTOBIOMES J, V3, P31, DOI 10.1094/PBIOMES-10-18-0043-R; Ricchi M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01174; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruthig GR, 2009, DIS AQUAT ORGAN, V84, P173, DOI 10.3354/dao02042; Sandoval-Sierra JV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132999; Seki M, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00057; Shin S, 2017, MYCOBIOLOGY, V45, P297, DOI 10.5941/MYCO.2017.45.4.297; SODERHALL K, 1991, AQUACULTURE, V92, P121, DOI 10.1016/0044-8486(91)90014-X; Straus DL, 2016, N AM J AQUACULT, V78, P243, DOI 10.1080/15222055.2016.1146183; Straus DL, 2009, J AQUAT ANIM HEALTH, V21, P91, DOI 10.1577/H07-057.1; Stueland S, 2005, J FISH DIS, V28, P445, DOI 10.1111/j.1365-2761.2005.00635.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thoen E, 2016, J FISH DIS, V39, P657, DOI 10.1111/jfd.12392; Torto-Alalibo T, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-46; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; van den Berg AH, 2013, FUNGAL BIOL REV, V27, P33, DOI 10.1016/j.fbr.2013.05.001; Van West Pieter, 2006, Mycologist, V20, P99, DOI 10.1016/j.mycol.2006.06.004; Sandoval-Sierra JV, 2014, FUNGAL BIOL-UK, V118, P559, DOI 10.1016/j.funbio.2013.10.005; Wolf K., 1969, P253; Zelaya-Molina LX, 2011, BIOTECHNOL LETT, V33, P715, DOI 10.1007/s10529-010-0478-3; Zhang H, 2014, SCI WORLD J, DOI 10.1155/2014/716413; Zhang J, 2019, WORLD J MICROB BIOT, V35, DOI 10.1007/s11274-019-2601-5; Zitnick-Anderson K, 2018, CAN J PLANT PATHOL, V40, P261, DOI 10.1080/07060661.2018.1429494	63	1	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0250808	10.1371/journal.pone.0250808	http://dx.doi.org/10.1371/journal.pone.0250808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898622	gold, Green Published, Green Submitted			2022-12-26	WOS:000755176200003
J	Inthaphatha, S; Louangpradith, V; Xiong, LI; Xiong, V; Ly, L; Xaitengcha, V; Phengsavanh, A; Hamajima, N; Yamamoto, E				Inthaphatha, Souphalak; Louangpradith, Viengsakhone; Xiong, Leyla Isin; Xiong, Valee; Ly, Ly; Xaitengcha, Vue; Phengsavanh, Alongkone; Hamajima, Nobuyuki; Yamamoto, Eiko			Menstrual health and factors associated with school absence among secondary school girls in Luang Prabang Province, Lao People's Democratic Republic: A cross-sectional study	PLOS ONE			English	Article							HYGIENE; SANITATION; WATER	In Lao People's Democratic Republic (Lao PDR), information on school sanitation and menstrual health among secondary school girls is limited. This study aimed to explore knowledge and practices surrounding menstrual health and to identify factors associated with school absence due to menstruation among secondary school girls in Lao PDR. The study involved 1,366 girls from grade 9 to grade 12 in six secondary schools in Luang Prabang Province. Data on socio-demographics and menstrual health of the girls and data on school toilets was collected. Logistic regression analysis was performed to identify the factors associated with school absence due to menstruation. The mean age was 15.8 years old. The average age of menarche was 12.9 years old. Of 1,366 girls, 64.6% were shocked or ashamed when they reached menarche and 31.8% had been absent from school due to menstruation in the six months before this study was conducted. Factors associated with school absence due to menstruation were age >= 16 years old (AOR = 1.79, 95% CI 1.37-2.34), higher income (AOR = 2.38, 95% CI 1.16-4.87), menstrual anxiety (AOR = 1.55, 95% CI 1.09-2.20), using painkillers (AOR = 4.79, 95% CI 2.96-7.76) and other methods (AOR = 2.82, 95% CI 1.86-4.28) for dysmenorrhea, and disposing used pads in places other than the school's waste bins (AOR = 1.34, 95% CI 1.03-1.75). Living with relatives (AOR = 0.64, 95% CI 0.43-0.95) and schools outside the city (AOR = 0.59, 95% CI 0.38-0.90) were significantly less associated with school absence. Although the association between school toilets and school absence was not examined, the results of this study suggest that school toilets should be gender-separated and equipped with waste bins in the toilet. Furthermore, menstrual education should start at elementary schools and teacher training on menstrual health should be promoted.	[Inthaphatha, Souphalak; Hamajima, Nobuyuki; Yamamoto, Eiko] Nagoya Univ, Dept Healthcare Adm, Grad Sch Med, Nagoya, Aichi, Japan; [Louangpradith, Viengsakhone] Minist Hlth, Dept Healthcare & Rehabil, Vientiane Capital, Laos; [Xiong, Leyla Isin; Xiong, Valee; Ly, Ly; Xaitengcha, Vue] Days Girls Int, Luang Prabang City, Luang Prabang P, Laos; [Phengsavanh, Alongkone] Univ Hlth Sci, Fac Med, Vientiane Capital, Laos	Nagoya University	Yamamoto, E (corresponding author), Nagoya Univ, Dept Healthcare Adm, Grad Sch Med, Nagoya, Aichi, Japan.	yamaeiko@med.nagoya-u.ac.jp		Yamamoto, Eiko/0000-0002-0517-5091	Heiwa Nakajima Foundation	Heiwa Nakajima Foundation	EY received Research Grant for Asian Region Study by Heiwa Nakajima Foundation in 2021 (http://hnf.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R., 2008, CONSTRUCTION USE ALL; Ajah LO, 2015, PATIENT PREFER ADHER, V9, P1219, DOI 10.2147/PPA.S89258; Ali TS, 2007, J HEALTH POPUL NUTR, V25, P189; Alka Malhotra, 2016, Waterlines, V35, P277, DOI 10.3362/1756-3488.2016.021; Alves L., 2021, FRUIT VEGETABLE CONS; Anand E, 2015, SEX REPROD HEALTHC, V6, P249, DOI 10.1016/j.srhc.2015.06.001; Aniebue UU, 2009, PAN AFR MED J, V2; Belayneh Z, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7973-9; Chandra-Mouli V, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0293-6; Chin L., 2014, PERIOD SHAME EFFECT; Connolly S, 2013, J WATER SANIT HYG DE, V3, P612, DOI 10.2166/washdev.2013.168; Das P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130777; Department of General Education, 2020, SCH CENS FISC YEAR 2; Femi-Agboola Damilola M, 2017, Niger Med J, V58, P143, DOI 10.4103/nmj.NMJ_47_17; Freeman MC, 2012, TROP MED INT HEALTH, V17, P380, DOI 10.1111/j.1365-3156.2011.02927.x; Goli S, 2020, CHILD YOUTH SERV REV, V117, DOI 10.1016/j.childyouth.2020.105283; Gultie T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108644; Hennegan J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012596; Jasper C, 2012, INT J ENV RES PUB HE, V9, P2772, DOI 10.3390/ijerph9082772; Lao People's Revolutionary Youth Union United Nations Population Fund, 2014, AD YOUTH SIT AN LAO; Lao Statistics Bureau, 2016, RES POP HOUS CENS 20; Lao Statistics Bureau, 2018, LAO SOC IND SURV 2 S; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; Oche M. O., 2012, Scientific Research and Essays, V7, P410; Phillips-Howard PA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013229; Research Institute for Educational Sciences, 2013, NAT SCI TXB SEC GRAD; Sami N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035828; Schuiling KD., 2017, WOMENS GYNECOLOGIC H, VThird ed; Sommer M., 2012, J CULT AFR WOMEN STU, V20, P63; Sommer M, 2009, CULT HEALTH SEX, V11, P383, DOI 10.1080/13691050902722372; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; SVN Netherlands Development Organizations, 2013, PRACT BRIEF WAT; Tegegne TK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1118; Thakre SB, 2012, INDIAN PEDIATR, V49, P733, DOI 10.1007/s13312-012-0156-8; The National Assembly, 2007, LAW ED AM 04 PROM DE; United Nation Children's Fund (UNICEF), 2004, STATE WORLDS CHILDRE; United Nations Children's Fund (UNICEF), GUID MENSTR HLTH HYG, VFirst ed; United Nations Children's Fund (UNICEF), 2019, SIT CHILDR WOM LAO P; United Nations Children's Fund (UNICEF) and World Health Organization (WHO), 2019, PROGR HOUS DRINK WAT; United Nations Educational Scientific and Cultural Organization (UNESCO), 2017, GOOD POL PRACT HLTH, V10; United Nations Population Fund (UNFPA), 2003, STAT WORLDS POP 2003; Upashe SP, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0245-7; van Eijk AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010290	43	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0261268	10.1371/journal.pone.0261268	http://dx.doi.org/10.1371/journal.pone.0261268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898645	Green Published, gold			2022-12-26	WOS:000755176200031
J	Yoon, J; Choi, Y; Jang, J; Shin, NY; Ahn, KJ; Kim, BS				Yoon, Jimin; Choi, Yangsean; Jang, Jinhee; Shin, Na-Young; Ahn, Kook-Jin; Kim, Bum-Soo			Preoperative assessment of cervical lymph node metastases in patients with papillary thyroid carcinoma: Incremental diagnostic value of dual-energy CT combined with ultrasound	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ULTRASONOGRAPHY; STATEMENT; ACCURACY; CANCER	Purpose To determine whether dual-energy CT (DECT) has incremental diagnostic value when combined with ultrasound (US) in the diagnosis of metastatic cervical lymph nodes (LNs) in patients with papillary thyroid carcinoma (PTC). Methods This was a single-center retrospective cohort study of patients diagnosed with PTC between October 2019 and August 2020. US features of LNs to include hyperechogenicity, round shape, microcalcification, cystic component, and homogeneous/peripheral vascularity were considered suggestive of metastasis. The HU of arterial phase (HUarterial) and DECT-derived CT images [contrast media (CM) and areas under the 100 keV monoenergetic curve (AUC(100keV))] were measured. Effective atomic numbers (Z(eff)), iodine concentration (mg/mL), and slope of the HU curve (lambda(HU)) were also obtained. The values for metastatic and benign LNs were compared using Student's t-test with false-discovery correction. Logistic regression with areas under the receiver operating characteristic curves (AUCs) were performed for predicting metastatic LNs. Results A total of 102 patients were included (49 metastatic and 53 benign LNs; mean age, 4615 years). Metastatic LNs showed significantly higher values for HUarterial, CM, Z(eff), lambda(HU), AUC(100keV), and iodine concentration (all, P = 0.001). In logistic regression, the HUarterial demonstrated the highest AUC (0.824; 95% confidence interval [CI], 0.751-0.897), followed by CM HU (0.762; 95% CI, 0.679-0.846). Combination of DECT parameters with US features improved the AUC from 0.890 to 0.941. Conclusion Compared to US features alone, combination with DECT-derived quantitative parameters improved diagnostic performance in predicting metastatic cervical LNs in patients with PTC.	[Yoon, Jimin; Choi, Yangsean; Jang, Jinhee; Shin, Na-Young; Ahn, Kook-Jin; Kim, Bum-Soo] Catholic Univ Korea, Coll Med, Dept Radiol, Seoul St Marys Hosp, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Choi, Y (corresponding author), Catholic Univ Korea, Coll Med, Dept Radiol, Seoul St Marys Hosp, Seoul, South Korea.	phillipchoi007@gmail.com		Kim, Bum-soo/0000-0002-3870-6813	Reyon Pharmaceuticals, Co., Ltd. (Seoul, Korea)	Reyon Pharmaceuticals, Co., Ltd. (Seoul, Korea)	This research was funded by Reyon Pharmaceuticals, Co., Ltd. (Seoul, Korea) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caron Nadine R, 2005, Curr Treat Options Oncol, V6, P311, DOI 10.1007/s11864-005-0035-9; Cho SJ, 2019, EUR RADIOL, V29, P4635, DOI 10.1007/s00330-019-06036-8; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Coruh AG, 2020, J COMPUT ASSIST TOMO, V44, P262, DOI 10.1097/RCT.0000000000001005; Goo HW, 2017, KOREAN J RADIOL, V18, P555, DOI 10.3348/kjr.2017.18.4.555; Greene FL, 2002, AJCC CANC STAGING HD; He MZ, 2019, J COMPUT ASSIST TOMO, V43, P970, DOI 10.1097/RCT.0000000000000927; Kim E, 2008, THYROID, V18, P411, DOI 10.1089/thy.2007.0269; Lesnik D, 2014, HEAD NECK-J SCI SPEC, V36, P191, DOI 10.1002/hed.23277; Li GP, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007143; Liu XW, 2015, RADIOLOGY, V275, P167, DOI 10.1148/radiol.14140481; McCollough CH, 2015, RADIOLOGY, V276, P637, DOI 10.1148/radiol.2015142631; Park JE, 2017, AM J NEURORADIOL, V38, P782, DOI 10.3174/ajnr.A5054; Pelgrim GJ, 2017, EUR RADIOL, V27, P3904, DOI 10.1007/s00330-017-4752-9; Randolph GW, 2012, THYROID, V22, P1144, DOI 10.1089/thy.2012.0043; Shin JH, 2016, KOREAN J RADIOL, V17, P370, DOI 10.3348/kjr.2016.17.3.370; Sivanandan R, 2001, BRIT J SURG, V88, P1241, DOI 10.1046/j.0007-1323.2001.01843.x; Suh CH, 2017, AM J NEURORADIOL, V38, P154, DOI 10.3174/ajnr.A4967; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Ying M, 2013, CANCER IMAGING, V13, P658, DOI 10.1102/1470-7330.2013.0056; Yoo RE, 2020, CANCERS, V12, DOI 10.3390/cancers12051190; Zhao YF, 2017, J THORAC DIS, V9, P4758, DOI 10.21037/jtd.2017.09.151	22	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0261233	10.1371/journal.pone.0261233	http://dx.doi.org/10.1371/journal.pone.0261233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898649	Green Published, gold			2022-12-26	WOS:000755176200028
J	Abu-Saad, K; Daoud, N; Kaplan, G; Ziv, A; Cohen, AD; Pollack, D; Olmer, L; Kalter-Leibovici, O				Abu-Saad, Kathleen; Daoud, Nihaya; Kaplan, Giora; Ziv, Arnona; Cohen, Arnon D.; Pollack, Daphna; Olmer, Liraz; Kalter-Leibovici, Ofra		Diabet Arab Population Israel D	A strengths-based approach to exploring diabetes management in an Indigenous minority population: A mixed methods study	PLOS ONE			English	Article							FOCUS GROUPS; HEALTH; DISEASE; ARABS; JEWS; FOOD; DETERMINANTS; PROMOTION; ISRAEL; CARE	Indigenous and other marginalized racial/ethnic minorities have poorer health status than majority populations, including higher rates of type 2 diabetes. These disparities have typically been addressed using a 'deficit-based' discourse that isolates disease management from the broader social, economic, political context and does not incorporate patient perspectives. We aimed to explore factors affecting glycemic control among Indigenous Arabs with diabetes in Israel using a strengths-based approach that centered participants' knowledge of their context, needs, resources and strengths. We conducted an exploratory sequential mixed methods study, which included 10 focus groups (5 men's, 5 women's) and 296 quantitative in-person surveys. Participants with diagnosed diabetes were randomly drawn from the patient list of the largest healthcare service organization (survey response rate: 93%). Prominent and interconnected themes emerged from focus group discussions, including: diet, physical activity, and social, economic, mental/psychological and political stress. The discussions raised the need for adapting diabetes management approaches to incorporate participants' communal, physical and psychological well-being, and socioeconomic/political realities. The connections between these factors and diabetes management were also reflected in multivariable analyses of the survey data. Women (OR: 2.03; 95% CI: 1.09-4.63), people with disabilities (OR: 2.43; 95% CI: 1.28-4.64), and unemployed people (OR: 2.64; 95% CI: 1.28-5.44) had higher odds of economic barriers to diabetes management. Furthermore, female sex (OR: 2.26; 95% CI: 1.25-4.09), unemployment (OR: 4.07; 95% CI: 1.64-10.10), and suboptimal glycemic control (OR: 1.20, 95% CI: 1.03-1.41 per 1-unit increase in HbA1c) were associated with moderate-to-severe depressive symptoms. A pro-active, team-based healthcare approach incorporating Indigenous/minority participants' knowledge, experience, and strengths has the potential to improve individuals' diabetes management. Healthcare services should be structured in ways that enable providers to listen to their patients, address their key concerns, and foster their strengths.	[Abu-Saad, Kathleen; Kaplan, Giora; Ziv, Arnona; Pollack, Daphna; Olmer, Liraz; Kalter-Leibovici, Ofra] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Ramat Gan, Israel; [Daoud, Nihaya] Ben Gurion Univ Negev, Dept Publ Hlth, Fac Hlth Sci, Beer Sheva, Israel; [Cohen, Arnon D.] Clalit Hlth Serv, Tel Aviv, Israel; [Cohen, Arnon D.] Ben Gurion Univ Negev, Siaal Res Ctr Family Med & Primary Care, Fac Hlth Sci, Beer Sheva, Israel; [Kalter-Leibovici, Ofra] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Chaim Sheba Medical Center; Ben Gurion University; Clalit Health Services; Ben Gurion University; Tel Aviv University; Sackler Faculty of Medicine	Abu-Saad, K (corresponding author), Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Ramat Gan, Israel.	kathleena@gertner.health.gov.il		Daoud, Nihaya/0000-0003-4542-8978; Kalter - Leibovici, Ofra/0000-0002-7404-7333	Israel Ministry of Health [3-4063]	Israel Ministry of Health	This study was funded by Grant number 3-4063 to OKL from the Israel Ministry of Health (https://www.health.gov.il/English/Topics/Research/Pages/default.aspx).The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-saad I, 2004, SOCIAL IDENTITIES, V10, P101, DOI DOI 10.1080/1350463042000191010; Abu-Saad K., 2013, DIET QUALITY EVIDENC, VVolume 2, P225; Abu-Saad K, 2018, ISR J HEALTH POLICY, V7, DOI 10.1186/s13584-018-0208-1; Abu-Saad K, 2012, J NUTR, V142, P2175, DOI 10.3945/jn.112.166611; Bartgis J, 2016, AM INDIAN ALASKA NAT, V23, pI, DOI 10.5820/aian.2303.2016.i; Bertran EA, 2017, PRIM CARE DIABETES, V11, P13, DOI 10.1016/j.pcd.2016.07.004; Brondani MA, 2008, QUAL HEALTH RES, V18, P1145, DOI 10.1177/1049732308320114; Caxaj CS, 2015, GLOB QUALIT NURS RES, V2, DOI 10.1177/2333393615580764; Central Bureau of Statistics, 2018, STAT ABSTRACT ISR 20; Central Bureau of Statistics, 2018, LIST LOC AUTH ISR; Condon Elizabeth., 2015, DIET QUALITY AMERICA; Daniel H, 2018, ANN INTERN MED, V168, P577, DOI 10.7326/M17-2441; Dankwa-Mullan I, 2016, AM J PUBLIC HEALTH, V106, P637, DOI 10.2105/AJPH.2016.303077; Daoud N, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01339-5; Daoud N, 2018, INT J PUBLIC HEALTH, V63, P313, DOI 10.1007/s00038-017-1065-3; Daoud N, 2012, SOC SCI MED, V74, P1163, DOI 10.1016/j.socscimed.2011.12.041; Derbarl Yerrigan Health Service (DYHS) Aboriginal Corporation, 2019, HEART HLTH PROGR 201, P35; Dickson M, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05804-3; Drawson AS, 2017, INT INDIG POLICY J, V8, DOI 10.18584/iipj.2017.8.2.5; Dubbin L, 2017, QUAL HEALTH RES, V27, P497, DOI 10.1177/1049732316645319; Dwairy M, 2002, CLIN PSYCHOL REV, V22, P343, DOI 10.1016/S0272-7358(01)00100-3; Endelweld M., 2018, POVERTY SOCIAL GAPS, DOI [10.1186/s13584-018-0238-8, DOI 10.1186/S13584-018-0238-8]; Endevelt R, 2014, PATIENT PREFER ADHER, V8, P147, DOI 10.2147/PPA.S54799; Endeweld M, 2018, ISR J HEALTH POLICY, V7, DOI 10.1186/s13584-018-0238-8; Fazelipour M, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1059-2; Fogarty W., 2018, DEFICIT DISCOURSE ST; Fogelman Y, 2016, J COMMUNITY HOSP INT, V6, DOI 10.3402/jchimp.v6.31204; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Gvion L, 2006, AGR HUM VALUES, V23, P299, DOI 10.1007/s10460-006-9003-7; Hallett J, 2017, QUAL HEALTH RES, V27, P1267, DOI 10.1177/1049732316669340; Hesketh K., 2011, INEQUALITY REPORT PA; Igal YP., 2020, ACTA SCI OPHTHALMOLO, V3, P13; Jaffe A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176661; Jernigan VBB, 2017, AM J PUBLIC HEALTH, V107, P441, DOI 10.2105/AJPH.2016.303605; Jones B, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01334-w; Kalter-Leibovici O, 2012, DIABETIC MED, V29, P748, DOI 10.1111/j.1464-5491.2011.03516.x; Kouris-Blazos A, 2000, ASIA PAC J CLIN NUTR, V9, P224, DOI 10.1046/j.1440-6047.2000.00189.x; Kremnitzer Mordechai, 2018, HAARETZ; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Krueger RA., 2001, SOCIAL ANAL SELECTED, P4, DOI DOI 10.1136/BMJ.311.7000.299; Levin-Zamir D, 2016, GLOB HEALTH PROMOT, V23, P5, DOI 10.1177/1757975914548200; Lewin-Epstein N., 1993, ISRAEL STUDIES B, V9, P3; Luque JS, 2014, J COMMUN HEALTH, V39, P181, DOI 10.1007/s10900-013-9744-3; Lustick I., 1980, ARABS JEWISH STATE I, DOI [10.1126/science.208.4447.1052, DOI 10.1126/SCIENCE.208.4447.1052]; McEwen MM, 2019, DIABETES EDUCATOR, V45, P272, DOI 10.1177/0145721719837899; Metzl JM, 2020, JAMA-J AM MED ASSOC, V324, P231, DOI 10.1001/jama.2020.9289; Ray KS, 2021, J MED HUMANIT, V42, P725, DOI 10.1007/s10912-021-09681-7; Rieger KL, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-01503-6; Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615; Simonds VW, 2013, AM J PUBLIC HEALTH, V103, P2185, DOI 10.2105/AJPH.2012.301157; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Thurber KA, 2020, SSM-POPUL HLTH, V12, DOI 10.1016/j.ssmph.2020.100637; Treister-Goltzman Y, 2015, WORLD J DIABETES, V6, P192, DOI 10.4239/wjd.v6.i1.192; Vallesi S, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071514; Victor RG, 2019, CIRCULATION, V139, P10, DOI 10.1161/CIRCULATIONAHA.118.038165; Voorhees HL, 2020, QUAL HEALTH RES, V30, P228, DOI 10.1177/1049732319868985; Wain T, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0677-2; Wilf-Miron R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-729; Zucker I, 2016, J IMMIGR MINOR HEALT, V18, P1328, DOI 10.1007/s10903-016-0341-2	60	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0261030	10.1371/journal.pone.0261030	http://dx.doi.org/10.1371/journal.pone.0261030			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890440	Green Published, gold			2022-12-26	WOS:000747293600024
J	Amico, E; Bulai, IM				Amico, Enrico; Bulai, Iulia Martina			How political choices shaped Covid connectivity: The Italian case study	PLOS ONE			English	Article								The importance of implementing new methodologies to study the ever-increasing amount of Covid-19 data is apparent. The aftermath analysis of these data could inform us on how specific political decisions influenced the dynamics of the pandemic outbreak. In this paper we use the Italian outbreak as a case study, to study six different Covid indicators collected in twenty Italian regions. We define a new object, the Covidome, to investigate the network of functional Covid interactions between regions. We analyzed the Italian Covidome over the course of 2020, and found that Covid connectivity between regions follows a sharp North-South community gradient. Furthermore, we explored the Covidome dynamics and individuated differences in regional Covid connectivity between the first and second waves of the pandemic. These differences can be associated to the two different lockdown strategies adopted for the first and the second wave from the Italian government. Finally, we explored to what extent Covid connectivity was associated with the Italian geographical network, and found that Central regions were more tied to the structural constraints than Northern or Southern regions in the spread of the virus. We hope that this approach will be useful in gaining new insights on how political choices shaped Covid dynamics across nations.	[Amico, Enrico; Bulai, Iulia Martina] EPFL Ecole Polytech, Inst Bioengn, Ctr Neuroprosthet, Inst Bioengn Fed Lausanne, Lausanne, Switzerland; [Amico, Enrico] Univ Geneva, Dept Radiol & Med Informat, Geneva, Switzerland; [Bulai, Iulia Martina] Univ Basilicata, Dept Math Comp Sci & Econ, Potenza, Italy	University of Geneva; University of Basilicata	Bulai, IM (corresponding author), EPFL Ecole Polytech, Inst Bioengn, Ctr Neuroprosthet, Inst Bioengn Fed Lausanne, Lausanne, Switzerland.; Bulai, IM (corresponding author), Univ Basilicata, Dept Math Comp Sci & Econ, Potenza, Italy.	imbulai@uniss.it			SNSF (Swiss National Science Foundation) Ambizione [PZ00P2 185716]; MUR (Ministero dell'Universita e della Ricerca) [AIM1852570-1]; Finanziamento GNCS Giovani Ricercatori 2020-2021	SNSF (Swiss National Science Foundation) Ambizione; MUR (Ministero dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)); Finanziamento GNCS Giovani Ricercatori 2020-2021	EA acknowledges financial support from the SNSF (Swiss National Science Foundation) Ambizione project Fingerprinting the brain: network science to extract features of cognition, behavior and dysfunction"(grant number PZ00P2 185716). IMB has been partially supported by MUR (Ministero dell'Universita e della Ricerca) through the grant PON-AIM Linea 1 (AIM1852570-1) and by "Finanziamento GNCS Giovani Ricercatori 2020-2021". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi A.-L., 2016, NETWORK SCI; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Carroll C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77709-4; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; DECRETO DEL., 2020, DECRETO PRESIDENTE C; Della Rossa F, 2020, NAT COMMUN, V11, DOI [10.1038/s41467-020-16343-0, 10.1038/s41467-020-18827-5]; Faes C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207560; Fokas AS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82932-8; Fornito A, 2016, FUNDAMENTALS BRAIN N; Gregori D, 2020, J EPIDEMIOL COMMUN H, V74, P858, DOI 10.1136/jech-2020-214209; Italian Department of Civil Protection, DAT COVID 19 IT; Lam ME, 2021, HUM SOC SCI COMMUN, V8, DOI 10.1057/s41599-020-00679-5; Lancichinetti A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00336; Lavezzo E, 2021, NATURE, V590, pE11, DOI 10.1038/s41586-020-2956-7; Lavezzo E, 2020, NATURE, V584, P425, DOI 10.1038/s41586-020-2488-1; Lolli S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73197-8; Marques AG, 2020, IEEE SIGNAL PROC MAG, V37, P11, DOI 10.1109/MSP.2020.3020715; Mecenas P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238339; Miljan P, 2020, IEEE SIGNAL PROC MAG, V37, P150, DOI 10.1109/MSP.2020.3018087; Mugnai G, 2020, EUR J INTERN MED, V77, P161, DOI 10.1016/j.ejim.2020.05.039; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nussbaumer-Streit B, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013574; Pepe E, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00575-2; Rawson T, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00262; Rosensteel GE., 2021, CHARACTERIZING EPIDE; Weible CM, 2020, POLICY SCI, V53, P225, DOI 10.1007/s11077-020-09381-4	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0261041	10.1371/journal.pone.0261041	http://dx.doi.org/10.1371/journal.pone.0261041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890442	Green Submitted, Green Published, gold			2022-12-26	WOS:000747293600025
J	Dida, M; Cian, C; Barraud, PA; Guerraz, M; Laboissiere, R				Dida, Merrick; Cian, Corinne; Barraud, Pierre-Alain; Guerraz, Michel; Laboissiere, Rafael			Idiosyncratic multisensory reweighting as the common cause for motion sickness susceptibility and adaptation to postural perturbation	PLOS ONE			English	Article							DYNAMICS; FREQUENCY; STABILIZATION; INTEGRATION; SHIP	Numerous empirical and modeling studies have been done to find a relationship between postural stability and the susceptibility to motion sickness (MS). However, while the demonstration of a causal relationship between postural stability and the susceptibility to MS is still lacking, recent studies suggest that motion sick individuals have genuine deficits in selecting and reweighting multimodal sensory information. Here we investigate how the adaptation to changing postural situations develops and how the dynamics in multisensory integration is modulated on an individual basis along with MS susceptibility. We used a postural task in which participants stood on a posturographic platform with either eyes open (EO) or eyes closed (EC) during three minutes. The platform was static during the first minute (baseline phase), oscillated harmonically during the second minute (perturbation phase) and returned to its steady state for the third minute (return phase). Principal component (PC) analysis was applied to the sequence of short-term power density spectra of the antero-posterior position of the center of pressure. Results showed that the less motion-sick a participant is, the more similar is his balance between high and low frequencies for EO and EC conditions (as calculated from the eigenvector of the first PC). By fitting exponential decay models to the first PC score in the return phase, we estimated, for each participant in each condition, the sluggishness to return to the baseline spectrum. We showed that the de-adaptation following platform oscillation depends on the susceptibility to MS. These results suggest that non motion-sick participants finely adjust their spectrum in the perturbation phase (i.e. reweighting) and therefore take longer to return to their initial postural control particularly with eyes closed. Thus, people have idiosyncratic ways of doing sensory reweighting for postural control, these processes being tied to MS susceptibility.	[Dida, Merrick; Cian, Corinne; Guerraz, Michel; Laboissiere, Rafael] Univ Grenoble Alpes, Univ Savoie Mt Blanc, CNRS, LPNC,UMR 5105, Grenoble, France; [Cian, Corinne] Inst Rech Biomed Armees, Bretigny Sur Orge, France; [Barraud, Pierre-Alain] Univ Grenoble Alpes, TIMC IMAG, Grenoble INP, CHU Grenoble Alpes, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Guerraz, M (corresponding author), Univ Grenoble Alpes, Univ Savoie Mt Blanc, CNRS, LPNC,UMR 5105, Grenoble, France.	michel.guerraz@univ-smb.fr	; Laboissiere, Rafael/E-9814-2013	GUERRAZ, Michel/0000-0002-4267-6995; Laboissiere, Rafael/0000-0002-2180-9250	Ministere de la Defense (France) [07co805]; Agence de l'Innovation pour la Defense	Ministere de la Defense (France); Agence de l'Innovation pour la Defense	This work was supported by grant #07co805 from Ministere de la De ' fense (France), awarded to CC and the grant from Agence de l'Innovation pour la De ' fense awarded to MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asslander L, 2014, J NEUROPHYSIOL, V111, P1852, DOI 10.1152/jn.00669.2013; Balasubramaniam R, 2000, GAIT POSTURE, V11, P12, DOI 10.1016/S0966-6362(99)00051-X; Bates DM., 2007, NONLINEAR REGRESSION, P398; Bos JE, 1998, BRAIN RES BULL, V47, P537, DOI 10.1016/S0361-9230(98)00088-4; Bos JE, 2005, AVIAT SPACE ENVIR MD, V76, P1111; Carver S, 2006, BIOL CYBERN, V95, P123, DOI 10.1007/s00422-006-0069-5; Catanzariti JF, 2016, EUR SPINE J, V25, P438, DOI 10.1007/s00586-015-4060-5; Day BL, 2002, ADV EXP MED BIOL, V508, P129; Diels C, 2013, HUM FACTORS, V55, P595, DOI 10.1177/0018720812469046; Golding JF, 2001, AVIAT SPACE ENVIR MD, V72, P188; Golding JF, 2006, AUTON NEUROSCI-BASIC, V129, P67, DOI 10.1016/j.autneu.2006.07.019; Guerraz M, 2000, EXP BRAIN RES, V131, P244, DOI 10.1007/s002219900307; Guerraz M, 2008, NEUROPHYSIOL CLIN, V38, P391, DOI 10.1016/j.neucli.2008.09.007; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Guignard John C., 1990, MOTION SPACE SICKNES, P123; Horak F, 1996, HDB PHYSIOL 12, V12, P255; Jeka JJ, 2008, EXP BRAIN RES, V191, P453, DOI 10.1007/s00221-008-1539-x; Laboissiere R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144466; Li RX, 2018, EXP BRAIN RES, V236, P1631, DOI 10.1007/s00221-018-5246-y; Mahboobin A, 2009, MED BIOL ENG COMPUT, V47, P921, DOI 10.1007/s11517-009-0477-5; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; Mayo AM, 2011, PSYCHOL SCI, V22, P118, DOI 10.1177/0956797610392927; MONEY KE, 1970, PHYSIOL REV, V50, P1, DOI 10.1152/physrev.1970.50.1.1; Nachum Z, 2004, LARYNGOSCOPE, V114, P581, DOI 10.1097/00005537-200403000-00036; NASHNER L, 1978, BRAIN RES, V150, P403, DOI 10.1016/0006-8993(78)90291-3; OHANLON JF, 1974, AEROSPACE MED, V45, P366; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Oman C M, 1982, Acta Otolaryngol Suppl, V392, P1; OMAN CM, 1990, CAN J PHYSIOL PHARM, V68, P294, DOI 10.1139/y90-044; Owen N, 1998, BRAIN RES BULL, V47, P471, DOI 10.1016/S0361-9230(98)00101-4; Palmisano S, 2018, EXP BRAIN RES, V236, P315, DOI 10.1007/s00221-017-5130-1; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Polastri PF, 2012, EXP BRAIN RES, V223, P99, DOI 10.1007/s00221-012-3244-z; Reason James T., 1975, MOTION SICKNESS, Vvii; REASON JT, 1969, INT J MAN MACH STUD, V1, P21, DOI 10.1016/S0020-7373(69)80009-X; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; RICCIO G E, 1991, Ecological Psychology, V3, P195, DOI 10.1207/s15326969eco0303_2; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; Smart LJ, 2002, HUM FACTORS, V44, P451, DOI 10.1518/0018720024497745; Stoffregen TA, 1998, BRAIN RES BULL, V47, P437, DOI 10.1016/S0361-9230(98)00102-6; Stoffregen TA, 2000, HUM MOVEMENT SCI, V19, P203, DOI 10.1016/S0167-9457(00)00009-9; Stoffregen TA, 2007, J MOTOR BEHAV, V39, P126, DOI 10.3200/JMBR.39.2.126-138; Stoffregen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066949; Tal D, 2010, NEUROSCI LETT, V479, P134, DOI 10.1016/j.neulet.2010.05.044; Van der Kooij H, 2001, BIOL CYBERN, V84, P103, DOI 10.1007/s004220000196; Varlet M, 2015, EXP BRAIN RES, V233, P1607, DOI 10.1007/s00221-015-4235-7; Weech S, 2018, J NEUROPHYSIOL, V120, P2201, DOI 10.1152/jn.00477.2018	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260863	10.1371/journal.pone.0260863	http://dx.doi.org/10.1371/journal.pone.0260863			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882734	Green Published, gold			2022-12-26	WOS:000755037200047
J	Kittel, B; Kalleitner, F; Schiestl, DW				Kittel, Bernhard; Kalleitner, Fabian; Schiestl, David W.			Peers for the fearless: Social norms facilitate preventive behaviour when individuals perceive low COVID-19 health risks	PLOS ONE			English	Article							PUBLIC TRUST; PROTECTION MOTIVATION; COOPERATION; EVOLUTION; EPIDEMIC; APPEALS; MASK	A strategy frequently adopted to contain the COVID-19 pandemic involves three non-pharmaceutical interventions that depend on high levels of compliance in society: maintaining physical distance from others, minimizing social contacts, and wearing a face mask. These measures require substantial changes in established practices of social interaction, raising the question of which factors motivate individuals to comply with these preventive behaviours. Using Austrian panel survey data from April 2020 to April 2021, we show that perceived health risks, social norms, and trust in political institutions stimulate people to engage in preventive behaviour. A moderation analysis shows that the effectiveness of social norms in facilitating preventive behaviour increases when people's perceptions of health risks decrease. No such moderation effect is observed for trust in political institutions. These results suggest that strong social norms play a crucial role in achieving high rates of preventive behaviour, especially when perceived levels of health risks are low.	[Kittel, Bernhard; Kalleitner, Fabian; Schiestl, David W.] Univ Vienna, Dept Econ Sociol, Vienna, Austria	University of Vienna	Kittel, B (corresponding author), Univ Vienna, Dept Econ Sociol, Vienna, Austria.	bernhard.kittel@univie.ac.at		Schiestl, David Wolfgang/0000-0001-6930-5900; Kittel, Bernhard/0000-0001-9799-8310; Kalleitner, Fabian/0000-0002-1196-824X	Austrian Science Fund [P33907-G]; Vienna Science and Technology Fund [EI-COV20-006]; University of Vienna; Austrian Chamber of Labour; Federation of Austrian Industries	Austrian Science Fund(Austrian Science Fund (FWF)); Vienna Science and Technology Fund; University of Vienna; Austrian Chamber of Labour; Federation of Austrian Industries	The data collection of this project has been funded by the Austrian Science Fund (Grant P33907-G) and the Vienna Science and Technology Fund (Grant EI-COV20-006). Further funding has been received from the rectorate of the University of Vienna, the Austrian Chamber of Labour and the Federation of Austrian Industries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaluck J., 2021, NORMALIZING COMMUNIT, pw28734, DOI [10.3386/w28734, DOI 10.3386/W28734]; Alwan NA, 2020, LANCET, V396, pE71, DOI 10.1016/S0140-6736(20)32153-X; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 1991, CREDIBILITY TRUST RI; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bailey M., 2020, SOCIAL NETWORKS SHAP, DOI [10.3386/w28234, DOI 10.3386/W28234]; Betsch C, 2020, P NATL ACAD SCI USA, V117, P21851, DOI 10.1073/pnas.2011674117; Blagov PS, 2021, SOC PSYCHOL PERS SCI, V12, P697, DOI 10.1177/1948550620936439; Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Carbon CC, 2021, I-PERCEPTION, V12, DOI 10.1177/20416695211021114; Caserotti M, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2021.113688; Cheng KK, 2022, LANCET, V399, pE39, DOI 10.1016/S0140-6736(20)30918-1; Cheng VCC, 2020, J INFECTION, V81, P107, DOI 10.1016/j.jinf.2020.04.024; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Cialdini R.B., 2006, SOC INFLUENCE, V1, p3, DOI [10.1080/15534510500181459, DOI 10.1080/15534510500181459]; Cialdini R.B., 1998, HDB SOCIAL PSYCHOL 4, P151; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Clark Cory, 2020, Glob Transit, V2, P76, DOI 10.1016/j.glt.2020.06.003; Czypionka T, 2021, ANN INTERN MED, V174, P511, DOI 10.7326/M20-6625; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; Devine D, 2021, POLIT STUD REV, V19, P274, DOI 10.1177/1478929920948684; Di Paolo R, 2020, EFFECT NORM BASED ME, DOI DOI 10.31234/OSF.IO/7863G; Diaz R, 2020, MORAL VALUES TRAIT P, DOI [10.31234/osf.io/5zrqx, DOI 10.31234/OSF.IO/5ZRQX]; Diekmann A, 2020, Z SOZIOL, V49, P236, DOI 10.1515/zfsoz-2020-0021; Diekmann A, 2014, AM SOCIOL REV, V79, P65, DOI 10.1177/0003122413512316; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI DOI 10.1016/j.idm.2020.04.001; Engel C., 2008, J I ECON, V4, P275, DOI 10.1017/S1744137408001094; Everett J.A., 2020, EFFECTIVENESS MORAL, DOI [10.31234/osf.io/9yqs8, DOI 10.31234/OSF.IO/9YQS8]; Fancourt D, 2020, LANCET, V396, P464, DOI 10.1016/S0140-6736(20)31690-1; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2007, ANNU REV SOCIOL, V33, P43, DOI 10.1146/annurev.soc.33.040406.131812; Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X; Ferrer RA, 2015, CURR OPIN PSYCHOL, V5, P85, DOI 10.1016/j.copsyc.2015.03.012; Gotz FM, 2021, AM PSYCHOL, V76, P39, DOI 10.1037/amp0000740; Google, 2021, COVID 19 COMM MOB RE; Grant AM, 2011, PSYCHOL SCI, V22, P1494, DOI 10.1177/0956797611419172; Greene WH., 2004, ECONOMET REV, V23, P125, DOI [10.1081/ETC-120039606, DOI 10.1081/ETC-120039606]; Greenhalgh T, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1435; Habersaat KB, 2020, NAT HUM BEHAV, V4, P677, DOI 10.1038/s41562-020-0906-x; Hainmueller J, 2019, POLIT ANAL, V27, P163, DOI 10.1017/pan.2018.46; Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5; Haug N, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-01009-0; Heffner J, 2021, PERS INDIV DIFFER, V170, DOI 10.1016/j.paid.2020.110420; Heiler G, 2020, IEEE INT CONF BIG DA, P3123, DOI 10.1109/BigData50022.2020.9378374; Henderson J, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00369; Hetherington MJ, 1998, AM POLIT SCI REV, V92, P791, DOI 10.2307/2586304; Hetherington MJ., 2007, WHY TRUST MATTERS DE; Horne C, 2007, RATION SOC, V19, P139, DOI 10.1177/1043463107077386; Ingledew D K, 1999, J Health Psychol, V4, P193, DOI 10.1177/135910539900400213; Intawan C, 2018, J POLIT, V80, P601, DOI 10.1086/694785; Jay J, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-00998-2; Jensen UlrichThy., 2020, J BEHAV PUBLIC ADM, V3, DOI [10.30636/jbpa.32.182, DOI 10.30636/JBPA.32.182]; Jordan J., 2020, DONT GET IT DONT SPR, DOI DOI 10.31234/OSF.IO/YUQ7X; Jorgensen F, 2020, PSYARXIV, DOI [10.31234/osf.io/uzwgf, DOI 10.31234/OSF.IO/UZWGF]; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Kitamura S., 2020, PSYARXIV, DOI [10.31234/osf.io/rsbmz, DOI 10.31234/OSF.IO/RSBMZ]; Kittel B., 2020, AUSSDA, DOI [10.11587/28KQNS, DOI 10.11587/28KQNS]; Kittel B, 2021, EUR POLIT SCI, V20, P318, DOI 10.1057/s41304-020-00294-7; Lapinski MK, 2017, COMMUN RES, V44, P367, DOI 10.1177/0093650215605153; Lapinski MK, 2005, COMMUN THEOR, V15, P127, DOI 10.1093/ct/15.2.127; Larsen M., 2020, J BEHAV PUBL ADM, V3, P1, DOI [10.30636/jbpa.32.164, DOI 10.30636/JBPA.32.164]; Lau JTF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-18; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Lindenberg S, 2007, J SOC ISSUES, V63, P117, DOI 10.1111/j.1540-4560.2007.00499.x; Lindenberg Siegwart, 2013, HDB RATIONAL CHOICE, P72; Ludeke SG, 2021, PERS INDIV DIFFER, V177, DOI 10.1016/j.paid.2021.110828; MADDUX JE, 1983, J EXP SOC PSYCHOL, V19, P469, DOI 10.1016/0022-1031(83)90023-9; Marien S, 2011, EUR J POLIT RES, V50, P267, DOI 10.1111/j.1475-6765.2010.01930.x; Martinez D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247454; Maughan-Brown B, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4593-0; Mitze T, 2020, P NATL ACAD SCI USA, V117, P32293, DOI 10.1073/pnas.2015954117; Moehring A., 2021, SURFACING NORMS INCR, DOI [10.31234/osf.io/srv6t, DOI 10.31234/OSF.IO/SRV6T]; Morse B, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000007; Nivette A, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113370; Opp K.-D., 2015, INT ENCY SOCIAL BEHA, V17, P5, DOI [10.1016/B978-0-08-097086-8.32103-1, DOI 10.1016/B978-0-08-097086-8.32103-1]; Opp K-D., 2017, SOCIAL DILEMMAS I, P119; Opp KD, 2013, THEOR DECIS, V74, P383, DOI 10.1007/s11238-012-9315-6; Papageorge NW, 2020, SOCIODEMOGRAPHIC FAC, DOI [10.3386/w27378, DOI 10.3386/W27378]; Papke LE, 2008, J ECONOMETRICS, V145, P121, DOI 10.1016/j.jeconom.2008.05.009; Pfattheicher S, 2020, PSYCHOL SCI, V31, P1363, DOI 10.1177/0956797620964422; Reid AE, 2011, HANDBOOK OF BEHAVIORAL MEDICINE: METHODS AND APPLICATIONS, P263, DOI 10.1007/978-0-387-09488-5_19; Rimal RN, 2005, J HEALTH COMMUN, V10, P433, DOI 10.1080/10810730591009880; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; Rothgerber H., 2020, POLITICIZING COVID 1, DOI [10.31234/osf.io/k23cv, DOI 10.31234/OSF.IO/K23CV]; Schultz PW, 2010, FRONT SOC PSYCHOL, P385; Schultz PW, 2008, SOC INFLUENCE, V3, P4, DOI 10.1080/15534510701755614; Schultz PW, 1999, BASIC APPL SOC PSYCH, V21, P25, DOI 10.1207/s15324834basp2101_3; Siegrist M, 2014, EUR PSYCHOL, V19, P23, DOI 10.1027/1016-9040/a000169; Simpson B, 2015, ANNU REV SOCIOL, V41, P43, DOI 10.1146/annurev-soc-073014-112242; Tannenbaum MB, 2015, PSYCHOL BULL, V141, P1178, DOI 10.1037/a0039729; Tyler TR, 2011, WHY PEOPLE COOPERATE: THE ROLE OF SOCIAL MOTIVATIONS, P1; Ullmann-Margalit Edna., 1977, EMERGENCE NORMS; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; van der Bles AM, 2020, P NATL ACAD SCI USA, V117, P7672, DOI 10.1073/pnas.1913678117; Wise T, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200742; Young SD, 2021, PREV MED, V145, DOI 10.1016/j.ypmed.2021.106424; Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117; Zitek EM, 2021, PERS INDIV DIFFER, V171, DOI 10.1016/j.paid.2020.110491	101	4	4	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260171	10.1371/journal.pone.0260171	http://dx.doi.org/10.1371/journal.pone.0260171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY8LQ	34882685	gold, Green Published			2022-12-26	WOS:000755037200022
J	Noble, PJM; Appleton, C; Radford, AD; Nenadic, G				Noble, Peter-John Mantyla; Appleton, Charlotte; Radford, Alan David; Nenadic, Goran			Using topic modelling for unsupervised annotation of electronic health records to identify an outbreak of disease in UK dogs	PLOS ONE			English	Article							SURVEILLANCE	A key goal of disease surveillance is to identify outbreaks of known or novel diseases in a timely manner. Such an outbreak occurred in the UK associated with acute vomiting in dogs between December 2019 and March 2020. We tracked this outbreak using the clinical free text component of anonymised electronic health records (EHRs) collected from a sentinel network of participating veterinary practices. We sourced the free text (narrative) component of each EHR supplemented with one of 10 practitioner-derived main presenting complaints (MPCs), with the 'gastroenteric' MPC identifying cases involved in the disease outbreak. Such clinician-derived annotation systems can suffer from poor compliance requiring retrospective, often manual, coding, thereby limiting real-time usability, especially where an outbreak of a novel disease might not present clinically as a currently recognised syndrome or MPC. Here, we investigate the use of an unsupervised method of EHR annotation using latent Dirichlet allocation topic-modelling to identify topics inherent within the clinical narrative component of EHRs. The model comprised 30 topics which were used to annotate EHRs spanning the natural disease outbreak and investigate whether any given topic might mirror the outbreak time-course. Narratives were annotated using the Gensim Library LdaModel module for the topic best representing the text within them. Counts for narratives labelled with one of the topics significantly matched the disease outbreak based on the practitioner-derived 'gastroenteric' MPC (Spearman correlation 0.978); no other topics showed a similar time course. Using artificially injected outbreaks, it was possible to see other topics that would match other MPCs including respiratory disease. The underlying topics were readily evaluated using simple word-cloud representations and using a freely available package (LDAVis) providing rapid insight into the clinical basis of each topic. This work clearly shows that unsupervised record annotation using topic modelling linked to simple text visualisations can provide an easily interrogable method to identify and characterise outbreaks and other anomalies of known and previously un-characterised diseases based on changes in clinical narratives.	[Noble, Peter-John Mantyla; Radford, Alan David] Univ Liverpool, Inst Infect Vet & Ecol Sci, Wirral, Merseyside, England; [Appleton, Charlotte] Univ Lancaster, Ctr Hlth Informat Comp & Stat CHICAS, Lancaster Med Sch, Lancaster, England; [Nenadic, Goran] Univ Manchester, Dept Comp Sci, Manchester, Lancs, England	University of Liverpool; Lancaster University; University of Manchester	Noble, PJM (corresponding author), Univ Liverpool, Inst Infect Vet & Ecol Sci, Wirral, Merseyside, England.	rtnorle@liverpool.ac.uk			DogsTrust [BB/N019547/1]; Biotechnology and Biological Sciences Research Council; British Small Animal Veterinary Association	DogsTrust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Small Animal Veterinary Association	ADR, PJN, GN No funder reference number, DogsTrust, https://www.dogstrust.org.uk ADR, PJN, GN BB/N019547/1, Biotechnology and Biological Sciences Research Council, https:// bbsrc.ukri.org ADR, PJN No funder reference number, British Small Animal Veterinary Association, https://www.bsava.com The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello-Casteleiro M, 2019, J BIOMED SEMANT, V10, DOI 10.1186/s13326-019-0212-6; Arsevska E, 2018, VET REC, V183, P182, DOI 10.1136/vr.k3462; Arsevska E, 2018, VET REC, V182, P369, DOI 10.1136/vr.k1426; Bisgin H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S11; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Blei DM, 2006, P 23 INT C MACH LEAR, P113; Chan KR, 2013, INT CONF DAT MIN WOR, P56, DOI 10.1109/ICDMW.2013.91; Chen LZ, 2016, DATA MIN KNOWL DISC, V30, P681, DOI 10.1007/s10618-015-0434-x; Dorea FC., 2016, VET MED RES REPORTS; ehrek R., 2010, P 2010 WORKSH NEW CH, P45, DOI DOI 10.13140/2.1.2393.1847; Ferasin L, 2019, J SMALL ANIM PRACT, V60, P139, DOI 10.1111/jsap.12976; Ghosh S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40841; Goldberg D, 2020, HAW INT C SYST SCI H; Hale AC., 2019, SCI REP-UK, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; HALL PA, 1986, J CLIN PATHOL, V39, P622, DOI 10.1136/jcp.39.6.622; Harkema H, 2009, J BIOMED INFORM, V42, P839, DOI 10.1016/j.jbi.2009.05.002; Hughes M, 2017, STUD HEALTH TECHNOL, V235, P246, DOI 10.3233/978-1-61499-753-5-246; Kagashe I, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7393; Kass PH, 2016, PEERJ, V4, DOI 10.7717/peerj.1940; Kennedy N, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0108-y; Loper, 2009, NATURAL LANGUAGE PRO; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Mimno D., 2011, OPTIMIZING SEMANTIC, DOI [10.1038/nmeth.1619 21623347, DOI 10.1038/NMETH.161921623347]; Minarro-Gimenez JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209547; Mueller A., WORDCLOUD PYTHON DOC; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Neill Dan G, 2017, Canine Genet Epidemiol, V4, P5, DOI 10.1186/s40575-017-0045-5; Park S, 2017, J BIOMED INFORM, V75, P35, DOI 10.1016/j.jbi.2017.09.003; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Perez J, 2018, COMPUT METH PROG BIO, V164, P111, DOI 10.1016/j.cmpb.2018.07.002; Radford A, 2010, VET REC, V167, P472, DOI 10.1136/vr.c5180; Radford A., 2021, EMERG INFECT DIS, V27; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Sanchez-Vizcano F, 2015, VET REC, V177, P591, DOI 10.1136/vr.h6174; Shirley K., 2014, P WORKSHOP INTERACTI, P63, DOI 10.3115/v1/W14-3110; Sidey-Gibbons JAM, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0681-4; Singleton DA, 2020, VET REC, V186, P190, DOI 10.1136/vr.m553; Smith SL, 2020, VET REC, V186, P324, DOI 10.1136/vr.m972; Valenti AP, 2019, ASSIST TECHNOL, DOI 10.1080/10400435.2019.1623342; Van Rossum G, 2009, PYTHON 3 REFERENCE M, DOI DOI 10.5555/1593511; VENOM CODING GROUP. Group TVC, 2020, VENOM VET NOM; Wang YS, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-018-0723-6; Yao L, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0781-4; Zimmerman KL, 2005, VET CLIN PATH, V34, P7, DOI 10.1111/j.1939-165X.2005.tb00002.x	44	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260402	10.1371/journal.pone.0260402	http://dx.doi.org/10.1371/journal.pone.0260402			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882714	Green Published, gold			2022-12-26	WOS:000755037200028
J	Forcada, Y; Boursnell, M; Catchpole, B; Church, DB				Forcada, Yaiza; Boursnell, Mike; Catchpole, Brian; Church, David B.			A genome-wide association study identifies novel candidate genes for susceptibility to diabetes mellitus in non-obese cats	PLOS ONE			English	Article							RISK-FACTORS; TYPE-2; OBESITY; ARCHITECTURE; PREVALENCE; RELEASE; CANINE	Diabetes mellitus (DM) is a common feline endocrinopathy, which is similar to human type 2 diabetes (T2DM) in terms of its pathophysiology. T2DM occurs due to peripheral insulin resistance and/or beta-cell dysfunction. Several studies have identified genetic and environmental factors that contribute to susceptibility to human T2DM. In cats, environmental factors such as obesity and physical inactivity have been linked with DM, although to date, the only genetic association that has been demonstrated is with a polymorphism in the feline MC4R gene. The aim of this study was to perform a genome-wide association study (GWAS) to identify polymorphisms associated with feline DM. Illumina Infinium 63k iSelect DNA arrays were used to analyse genomic DNA samples from 200 diabetic domestic shorthair cats and 399 non-diabetic control cats. Data was analysed using PLINK whole genome data analysis toolset. A linear model analysis, EMMAX, was done to test for population structure and HAPLOVIEW was used to identify haplotype blocks surrounding the significant SNPs to assist with candidate gene nomination. A total of 47,497 SNPs were available for analysis. Four SNPs were identified with genome-wide significance: chrA2.4150731 (p(raw) = 9.94 x10(-8)); chrUn17.115508 (p(raw) = 6.51 x10(-8)); chrUn17.394136 (p(raw) = 2.53 x10(-8)); chrUn17.314128 (p(raw) = 2.53 x10(-8)) as being associated with DM. The first SNP is located within chromosome A2, less than 4kb upstream of the dipeptidyl-peptidase-9 (DPP9) gene, a peptidase involved in incretin inactivation. The remaining three SNPs are located within a haplotype block towards the end of chromosome A3; within this region, genes of interest include TMEM18 and ACP1, both previously associated with T2DM. This study indicates a polygenic component to susceptibility to DM in cats and has highlighted several loci and candidate genes worthy of further investigation.	[Forcada, Yaiza; Church, David B.] Royal Vet Coll, Vet Clin Sci, N Mymms, Herts, England; [Boursnell, Mike] Anim Hlth Trust, Canine Genet, Newmarket, Suffolk, England; [Catchpole, Brian] Royal Vet Coll, Pathol & Populat Sci, N Mymms, Herts, England	University of London; University of London Royal Veterinary College; Animal Health Trust; University of London; University of London Royal Veterinary College	Forcada, Y (corresponding author), Royal Vet Coll, Vet Clin Sci, N Mymms, Herts, England.	yaizaforcada@hotmail.com		Forcada, Yaiza/0000-0003-2678-8126	Morris Animal Foundation [D12FE-512]	Morris Animal Foundation	YF received the SNP arrays as a grant from the Morris Animal Foundation. Grant title and code: D12FE-512: Genome-Wide Association Study to Identify Susceptibility Genes for Diabetes Mellitus in Cats. https://www.morrisanimalfoundation.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaddad H, 2014, MAMM GENOME, V25, P354, DOI 10.1007/s00335-014-9517-z; Alhaddad H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053537; Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS15, DOI 10.2337/dc21-S002; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Balmer L, 2020, GENES-BASEL, V11, DOI 10.3390/genes11111369; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bottini N, 2004, METABOLISM, V53, P995, DOI 10.1016/j.metabol.2004.03.006; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Deacon CF, 2008, FRONT BIOSCI-LANDMRK, V13, P1780, DOI 10.2741/2799; DeFronzo RA, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.19; Dusatkova L, 2013, FOLIA BIOL-PRAGUE, V59, P123; Eu-ahsunthornwattana J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004445; Filler S, 2012, J HERED, V103, P727, DOI 10.1093/jhered/ess039; Forcada Y, 2014, J VET INTERN MED, V28, P458, DOI 10.1111/jvim.12275; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Gandolfi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053173; Gilor C, 2016, J FELINE MED SURG, V18, P733, DOI 10.1177/1098612X16660441; Gloria-Bottini F, 2010, ACTA DIABETOL, V47, pS139, DOI 10.1007/s00592-009-0153-0; Golovko L, 2013, VIRUS RES, V175, P58, DOI 10.1016/j.virusres.2013.04.006; Han RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12348; Henson MS, 2006, ILAR J, V47, P234, DOI 10.1093/ilar.47.3.234; Himanshu D, 2020, J DIABETES METAB DIS, V19, P1959, DOI 10.1007/s40200-020-00641-x; Huan Y, 2015, J PHARMACOL TOX MET, V71, P8, DOI 10.1016/j.vascn.2014.11.002; Kalnina I, 2013, GENE, V527, P462, DOI 10.1016/j.gene.2013.06.079; Khan MAB, 2020, J EPIDEMIOL GLOB HEA, V10, P107, DOI 10.2991/jegh.k.191028.001; Kronfeld D. S., 1994, Journal of Nutrition, V124, p2683S, DOI 10.1093/jn/124.suppl_12.2683S; Laflamme D, 1997, FELINE PRACT, V25, P13; Lawlor N, 2017, TRENDS GENET, V33, P244, DOI 10.1016/j.tig.2017.01.010; Lecoutre S, 2021, WORLD J DIABETES, V12, P366, DOI 10.4239/wjd.v12.i4.366; Lederer R, 2009, VET J, V179, P254, DOI 10.1016/j.tvjl.2007.09.019; Lee P, 2013, VET J, V195, P221, DOI 10.1016/j.tvjl.2012.06.027; Lequarre AS, 2011, VET J, V189, P155, DOI 10.1016/j.tvjl.2011.06.013; McCann TM, 2007, J FELINE MED SURG, V9, P289, DOI 10.1016/j.jfms.2007.02.001; O'Neill DG, 2016, J VET INTERN MED, V30, P964, DOI 10.1111/jvim.14365; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Ohlund M, 2017, J VET INTERN MED, V31, P29, DOI 10.1111/jvim.14618; Ohlund M, 2015, J VET INTERN MED, V29, P1342, DOI 10.1111/jvim.13584; Padrutt I, 2015, RES VET SCI, V99, P23, DOI 10.1016/j.rvsc.2014.12.001; Prahl A, 2007, J FELINE MED SURG, V9, P351, DOI 10.1016/j.jfms.2007.02.004; Rand JS, 2004, J NUTR, V134, p2072S, DOI 10.1093/jn/134.8.2072S; Rand JS, 1997, AUST VET J, V75, P402, DOI 10.1111/j.1751-0813.1997.tb14340.x; Riederer A, 2016, J VET INTERN MED, V30, P92, DOI 10.1111/jvim.13817; Sallander M, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-61; Samaha G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76166-3; Sell H, 2013, DIABETES CARE, V36, P4083, DOI 10.2337/dc13-0496; Seng KC, 2008, EUR J HUM GENET, V16, P554, DOI 10.1038/ejhg.2008.12; Shu Y-H., 2009, J CLIN ENDOCRINOLOGY, V94; Slingerland LI, 2009, VET J, V179, P247, DOI 10.1016/j.tvjl.2007.08.035; Takeuchi F, 2011, DIABETOLOGIA, V54, P1350, DOI 10.1007/s00125-011-2086-8; Thomsen M., 2012, J CLIN ENDOCRINOLOGY, V97	51	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0259939	10.1371/journal.pone.0259939	http://dx.doi.org/10.1371/journal.pone.0259939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874954	gold, Green Published			2022-12-26	WOS:000753617500010
J	Nonarath, HJ; Hall, AE; SenthilKumar, G; Abroe, B; Eells, JT; Liedhegner, ES				Nonarath, Hannah J.; Hall, Alexandria E.; SenthilKumar, Gopika; Abroe, Betsy; Eells, Janis T.; Liedhegner, Elizabeth S.			670nm photobiomodulation modulates bioenergetics and oxidative stress, in rat Muller cells challenged with high glucose	PLOS ONE			English	Article							LEVEL LASER THERAPY; FACTOR-KAPPA-B; NITRIC-OXIDE; IN-VIVO; MITOCHONDRIAL DAMAGE; NM LIGHT; ACTIVATION; EXPRESSION; APOPTOSIS; HOMEOSTASIS	Diabetic retinopathy (DR), the most common complication of diabetes mellitus, is associated with oxidative stress, nuclear factor-kappa B (NF kappa B) activation, and excess production of vascular endothelial growth factor (VEGF) and intracellular adhesion molecule-1 (ICAM-1). Muller glial cells, spanning the entirety of the retina, are involved in DR inflammation. Mitigation of DR pathology currently occurs via invasive, frequently ineffective therapies which can cause adverse effects. The application of far-red to near-infrared (NIR) light (630-1000nm) reduces oxidative stress and inflammation in vitro and in vivo. Thus, we hypothesize that 670nm light treatment will diminish oxidative stress preventing downstream inflammatory mechanisms associated with DR initiated by Muller cells. In this study, we used an in vitro model system of rat Muller glial cells grown under normal (5 mM) or high (25 mM) glucose conditions and treated with a 670 nm light emitting diode array (LED) (4.5 J/cm(2)) or no light (sham) daily. We report that a single 670 nm light treatment diminished reactive oxygen species (ROS) production and preserved mitochondrial integrity in this in vitro model of early DR. Furthermore, treatment for 3 days in culture reduced NF kappa B activity to levels observed in normal glucose and prevented the subsequent increase in ICAM-1. The ability of 670nm light treatment to prevent early molecular changes in this in vitro high glucose model system suggests light treatment could mitigate early deleterious effects modulating inflammatory signaling and diminishing oxidative stress.	[Nonarath, Hannah J.; Hall, Alexandria E.; SenthilKumar, Gopika; Abroe, Betsy; Eells, Janis T.; Liedhegner, Elizabeth S.] Univ Wisconsin Milwaukee, Dept Biomed Sci, Coll Hlth Sci, Milwaukee, WI 53211 USA; [Nonarath, Hannah J.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [SenthilKumar, Gopika] Med Coll Wisconsin, Med Scientist Training Program, Milwaukee, WI 53226 USA	University of Wisconsin System; University of Wisconsin Milwaukee; Medical College of Wisconsin; Medical College of Wisconsin	Liedhegner, ES (corresponding author), Univ Wisconsin Milwaukee, Dept Biomed Sci, Coll Hlth Sci, Milwaukee, WI 53211 USA.	liedhegn@uwm.edu		SenthilKumar, Gopika/0000-0001-5781-1056	National Institutes of Health NEI SBIR Grant [1R43EY025892]; Fight for Sight Summer Research Fellowship; College of Health Sciences Research Grants, University of Wisconsin-Milwaukee	National Institutes of Health NEI SBIR Grant; Fight for Sight Summer Research Fellowship; College of Health Sciences Research Grants, University of Wisconsin-Milwaukee	This research was supported in part by funding from the National Institutes of Health NEI SBIR Grant 1R43EY025892 (https://sbir.nih.gov/). H.J.N. was awarded a Fight for Sight Summer Research Fellowship (www.fightforsight.org). H.J. N. and A.E.H were each awarded College of Health Sciences Research Grants, University of Wisconsin-Milwaukee (https://uwm.edu/healthsciences/). The authors wish to thank Quantum Devices Inc. (Barneveld, WI) for providing the LED arrays used in these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankri R, 2010, LASER SURG MED, V42, P348, DOI 10.1002/lsm.20849; Bai YY, 2009, J PATHOL, V219, P446, DOI 10.1002/path.2611; Ball KA, 2011, J PHOTOCH PHOTOBIO B, V102, P182, DOI 10.1016/j.jphotobiol.2010.12.002; Beirne K, 2017, MITOCHONDRION, V36, P85, DOI 10.1016/j.mito.2017.05.002; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Centers for Disease Control and Prevention, 2018, NATL DIABETES STAT R; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; Chen JS, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-49; Cheng Y, 2018, DIABETES, V67, P291, DOI 10.2337/db17-0803; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Tien DN, 2014, SCI REP-UK, V4, DOI 10.1038/srep05094; Devi TS, 2012, EXP DIABETES RES, DOI 10.1155/2012/438238; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Elmarakby AA, 2012, CARDIOVASC THER, V30, P49, DOI 10.1111/j.1755-5922.2010.00218.x; Fu SH, 2015, DIABETES, V64, P3554, DOI 10.2337/db15-0180; Fuma S, 2015, MOL VIS, V21, P883; Hamblin MR, 2018, PHOTOCHEM PHOTOBIOL, V94, P199, DOI 10.1111/php.12864; Kim SR, 2008, BBA-MOL CELL RES, V1783, P886, DOI 10.1016/j.bbamcr.2008.01.004; Kokkinopoulos I, 2013, NEUROBIOL AGING, V34, P602, DOI 10.1016/j.neurobiolaging.2012.04.014; Kowluru RA, 2003, FREE RADICAL RES, V37, P1169, DOI 10.1080/10715760310001604189; Kowluru RA, 2015, BBA-MOL BASIS DIS, V1852, P2474, DOI 10.1016/j.bbadis.2015.08.001; Kumar Priti, 2018, Cold Spring Harb Protoc, V2018, DOI 10.1101/pdb.prot095505; Li J, 2012, ACTA PHARMACOL SIN, V33, P1030, DOI 10.1038/aps.2012.61; Liang JG, 2012, FREE RADICAL BIO MED, V53, P1459, DOI 10.1016/j.freeradbiomed.2012.08.003; Melotti P, 2001, GENE THER, V8, P1436, DOI 10.1038/sj.gt.3301533; Mitchell S, 2016, WIRES SYST BIOL MED, V8, P227, DOI 10.1002/wsbm.1331; Moriyama Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P1351, DOI 10.1562/2005-02-28-RA-450; Moriyama Y, 2009, LASER SURG MED, V41, P227, DOI 10.1002/lsm.20745; Nagai N, 2017, TOXICOLOGY, V381, P19, DOI 10.1016/j.tox.2017.02.014; Obrosova IG, 2001, PHARMACOLOGY, V62, P172, DOI 10.1159/000056091; Poyton RO, 2011, DISCOV MED, V11, P154; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; Saliba A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139003; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Shelton MD, 2007, J BIOL CHEM, V282, P12467, DOI 10.1074/jbc.M610863200; Shen WY, 2020, DIABETOLOGIA, V63, P1900, DOI 10.1007/s00125-020-05189-2; Sivapathasuntharam C, 2017, NEUROBIOL AGING, V52, P66, DOI 10.1016/j.neurobiolaging.2017.01.001; Sorrentino FS, 2016, LIFE SCI, V162, P54, DOI 10.1016/j.lfs.2016.08.001; Stitt AW, 2016, PROG RETIN EYE RES, V51, P156, DOI 10.1016/j.preteyeres.2015.08.001; Sun Y, 2013, EYE, V27, P1299, DOI 10.1038/eye.2013.158; Tan SM, 2015, EXP EYE RES, V136, P1, DOI 10.1016/j.exer.2015.04.015; Tang J, 2014, BRIT J OPHTHALMOL, V98, P1013, DOI 10.1136/bjophthalmol-2013-304477; Tang J, 2013, INVEST OPHTH VIS SCI, V54, P3681, DOI 10.1167/iovs.12-11018; Tien T, 2017, INVEST OPHTH VIS SCI, V58, P2915, DOI 10.1167/iovs.16-21355; Toft-Kehler AK, 2017, MITOCHONDRION, V36, P43, DOI 10.1016/j.mito.2017.02.002; Trudeau K, 2011, INVEST OPHTH VIS SCI, V52, P8657, DOI 10.1167/iovs.11-7934; Tsai SR, 2015, PHOTODIAGN PHOTODYN, V12, P123, DOI 10.1016/j.pdpdt.2014.10.009; Wang J, 2016, INVEST OPHTH VIS SCI, V57, P2770, DOI 10.1167/iovs.15-18995; Wu MY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3420187; Xi X, 2005, BIOCHEM BIOPH RES CO, V326, P548, DOI 10.1016/j.bbrc.2004.11.064; Xie B, 2012, INVEST OPHTH VIS SCI, V53, P1023, DOI 10.1167/iovs.11-8695; Zhang LL, 2010, J CELL PHYSIOL, V224, P218, DOI 10.1002/jcp.22123; Zhang R, 2009, J MOL CELL CARDIOL, V46, P4, DOI 10.1016/j.yjmcc.2008.09.707; Zhang T, 2018, MOL NEUROBIOL, V55, P7025, DOI 10.1007/s12035-017-0840-8; Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009	58	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0260968	10.1371/journal.pone.0260968	http://dx.doi.org/10.1371/journal.pone.0260968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY3JJ	34860856	Green Published, gold			2022-12-26	WOS:000754686900017
J	Byun, E; Kwon, TW; Kim, H; Cho, YP; Han, Y; Ko, GY; Jeong, MJ				Byun, Eunae; Kwon, Tae-Won; Kim, Hyangkyoung; Cho, Yong Pil; Han, Youngjin; Ko, Gi Young; Jeong, Min-Jae			Quality-adjusted life year comparison at medium term follow-up of endovascular versus open surgical repair for abdominal aortic aneurysm in young patients	PLOS ONE			English	Article							COST-EFFECTIVENESS; OUTCOMES; TRIAL; EVAR	Objectives This study aimed to compare the quality of life and cost effectiveness between endovascular aneurysm repair (EVAR) and open surgical repair (OSR) in young patients with abdominal aortic aneurysm (AAA). Design This was a single-center, observational, and retrospective study. Materials and methods A retrospective analysis was conducted of patients with AAA, who were <70 years old and underwent EVAR or OSR between January 2012 and October 2016. Only patients with aortic morphology that was suitable for EVAR were enrolled. Data on the complication rates, medical expenses, and expected quality-adjusted life years (QALYs) were collected, and the cost per QALY at three years was compared. Results Among 90 patients with aortic morphology who were eligible for EVAR, 37 and 53 patients underwent EVAR and OSR, respectively. No significant differences were observed in perioperative cardiovascular events and death between the two groups. However, during the follow-up period, patients undergoing OSR showed a significantly lower complication rate (hazard ratio [HR] = 0.11; P = .021). From the three-year cost-effectiveness analysis, the total sum of costs was significantly lower in the OSR group (P < .001) than that in the EVAR group, and the number of QALYs was superior in the OSR group (P = .013). The cost per QALY at three years was significantly lower in the OSR group than that in the EVAR group (mean: $4038 vs. $10 137; respectively; P < .001) Conclusions OSR had lower complication rates and better cost-effectiveness than EVAR Among young patients with feasible aortic anatomy.	[Byun, Eunae] Dona A Univ Hosp, Dept Surg, Busan, South Korea; [Kwon, Tae-Won; Kim, Hyangkyoung; Cho, Yong Pil; Han, Youngjin] Univ Ulsan, Asan Med Ctr, Dept Surg, Div Vasc Surg,Coll Med, Seoul, South Korea; [Ko, Gi Young] Univ Ulsan, Asan Med Ctr, Dept Radiol, Div Intervent Radiol,Coll Med, Seoul, South Korea; [Jeong, Min-Jae] Univ Ulsan, Gangneung Asan Hosp, Dept Surg, Coll Med, Kangnung, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan	Kwon, TW (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Surg, Div Vasc Surg,Coll Med, Seoul, South Korea.	twkwon2@amc.seoul.kr		BYUN, EUNAE/0000-0002-0130-5549; Kwon, Tae-Won/0000-0003-3803-0013				Antoniou GA, 2020, EUR J VASC ENDOVASC, V59, P385, DOI 10.1016/j.ejvs.2019.11.030; Becquemin JP, 2009, J VASC SURG, V50, P222, DOI 10.1016/j.jvs.2009.04.074; Brown LC, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16090; Burgers LT, 2016, EUR J VASC ENDOVASC, V52, P29, DOI 10.1016/j.ejvs.2016.03.001; Canning P, 2019, J VASC SURG, V70, P485, DOI 10.1016/j.jvs.2018.11.018; Chang RW, 2013, J VASC SURG, V58, P324, DOI 10.1016/j.jvs.2013.01.051; Choi K, 2018, ANN VASC SURG, V51, P187, DOI 10.1016/j.avsg.2018.02.042; De Bruin JL, 2010, NEW ENGL J MED, V362, P1881, DOI 10.1056/NEJMoa0909499; Epstein D, 2014, BRIT J SURG, V101, P623, DOI 10.1002/bjs.9464; Gallitto E., 2019, EUR J VASC ENDOVASC, V58, pE297, DOI [10.1016/j.ejvs.2019.06.904, DOI 10.1016/J.EJVS.2019.06.904]; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1872, DOI 10.1056/NEJMoa0911056; Gwon JG, 2016, ANN SURG TREAT RES, V91, P303, DOI 10.4174/astr.2016.91.6.303; IMPROVE Trial Investigators, 2017, BMJ, V359, pj4859, DOI 10.1136/bmj.j4859; Jeong S, 2020, WORLD J SURG, V44, P2002, DOI 10.1007/s00268-020-05409-1; Kim Ji-Young, 2019, Vasc Specialist Int, V35, P129, DOI 10.5758/vsi.2019.35.3.129; KOSIS, KOSIS WEB SITE; Lederle FA, 2012, NEW ENGL J MED, V367, P1988, DOI 10.1056/NEJMoa1207481; Lederle FA, 2009, JAMA-J AM MED ASSOC, V302, P1535, DOI 10.1001/jama.2009.1426; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Lilja F, 2017, EUR J VASC ENDOVASC, V53, P811, DOI 10.1016/j.ejvs.2017.02.031; Marone EM, 2020, ANN VASC SURG, V62, P173, DOI 10.1016/j.avsg.2019.05.049; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; NICE, STENT GRAFT PLAC ABD; Noh M, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011789; OECD, EXCHANGE RATES INDIC, DOI [10.1787/037-d317-en, DOI 10.1787/037-D317-EN]; Patel R, 2016, LANCET, V388, P2366, DOI 10.1016/S0140-6736(16)31135-7; Prinssen M, 2004, EUR J VASC ENDOVASC, V27, P121, DOI 10.1016/j.ejvs.2003.11.006; Salata K, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6578; Sirignano P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7893413	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260690	10.1371/journal.pone.0260690	http://dx.doi.org/10.1371/journal.pone.0260690			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855851	Green Published, gold			2022-12-26	WOS:000735299000093
J	Esbjornsson, AC; Johansson, A; Andriesse, H; Wallander, H				Esbjornsson, Anna-Clara; Johansson, Arne; Andriesse, Hanneke; Wallander, Henrik			Epidemiology of clubfoot in Sweden from 2016 to 2019: A national register study	PLOS ONE			English	Article							TALIPES EQUINOVARUS; CONGENITAL CLUBFOOT; GENETICS	Background This study aimed to estimate the birth prevalence of children born with isolated or non-isolated clubfoot in Sweden using a national clubfoot register. Secondarily we aimed to describe the clubfoot population with respect to sex, laterality, severity of deformity, comorbidity and geographic location. Methods A national register, the Swedish Pediatric Orthopedic Quality register, was used to extract data on newborn children with clubfoot. To calculate the birth prevalence of children with isolated or non-isolated clubfoot between 1(st) of January 2016 and 31(st) of December 2019, we used official reports of the total number of Swedish live births from the Swedish Board of Statistics. The Pirani score and predefined signs of atypical clubfoot were used to classify clubfoot severity at birth. Results In total 612 children with clubfoot were identified. Of these, 564 were children with isolated clubfoot, generating a birth prevalence of 1.24/1000 live births (95% confidence interval 1.15-1.35). About 8% were children with non-isolated clubfoot, increasing the birth prevalence to 1.35/1000 live births (95% confidence interval 1.25-1.46). Of the children with isolated clubfoot, 74% were boys and 47% had bilateral involvement. The children with non-isolated clubfoot had more severe foot deformities at birth and a greater proportion of clubfeet with atypical signs compared with children with isolated clubfoot. Conclusion We have established the birth prevalence of children born with isolated or non-isolated clubfoot in Sweden based on data from a national register. Moreover, we have estimated the number of children born with atypical clubfeet in instances of both isolated and non-isolated clubfoot. These numbers may serve as a baseline for expected birth prevalence when planning clubfoot treatment and when evaluating time trends of children born with clubfoot.	[Esbjornsson, Anna-Clara; Andriesse, Hanneke] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Orthopaed, Lund, Sweden; [Johansson, Arne] Skaraborg Hosp, Dept Orthopaed, Skovde, Sweden; [Wallander, Henrik] Gavle Cent Hosp, Dept Orthoped Surg, Gavle, Sweden	Lund University; Skane University Hospital	Esbjornsson, AC (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Orthopaed, Lund, Sweden.	anna-clara.esbjornsson@med.lu.se		Esbjornsson, Anna-Clara/0000-0001-6240-4674	Region Skane; Promobilia foundation; Kockska foundation	Region Skane; Promobilia foundation; Kockska foundation	This work was supported by Region Skane (ACE), the Promobilia foundation (ACE, HA) and Kockska foundation (ACE, HA). https://www.skane.se/en/http://www.kockskastiftelsen.se https://www.promobilia.se The authors HW and AJ received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, STAT SWED; [Anonymous], 2021, SVENSKT PED ORT QUAL; Bettuzzi C, 2019, J CHILD ORTHOP, V13, P478, DOI 10.1302/1863-2548.13.190010; BOO N Y, 1990, SMJ Singapore Medical Journal, V31, P539; Cardy AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017895; Carey M, 2003, PAEDIATR PERINAT EP, V17, P187, DOI 10.1046/j.1365-3016.2003.00477.x; CHING GHS, 1969, AM J HUM GENET, V21, P566; Clubfoot SomppiE., 1984, ACTA ORTHOP, V209, P1; DANIELSSON LG, 1992, ACTA ORTHOP SCAND, V63, P424, DOI 10.3109/17453679209154759; Dobbs MB, 2012, J PEDIATR ORTHOP B, V21, P7, DOI 10.1097/BPB.0b013e328349927c; Dobbs MB, 2009, CLIN ORTHOP RELAT R, V467, P1146, DOI 10.1007/s11999-009-0734-9; Epitools (Summarise categorical or continuous data), 2021, CALC CONF LIM SAMPL; Jain S, 2017, INDIAN J ORTHOP, V51, P81, DOI 10.4103/0019-5413.197551; Kancherla V, 2010, AM J MED GENET A, V152A, P1695, DOI 10.1002/ajmg.a.33481; Krogsgaard MR, 2006, ACTA ORTHOP, V77, P839, DOI 10.1080/17453670610013114; Liu YB, 2018, ACTA ORTHOP, V89, P662, DOI 10.1080/17453674.2018.1526534; Mai CT, 2019, BIRTH DEFECTS RES, V111, P1420, DOI 10.1002/bdr2.1589; Moon DK, 2014, J BONE JOINT SURG AM, V96A, P1249, DOI 10.2106/JBJS.M.01257; Morris JK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194986; Nguyen Michelle C, 2012, Iowa Orthop J, V32, P120; Ponseti I. V., 1996, CONGENITAL CLUBFOOT, P37; Ponseti IV, 2006, CLIN ORTHOP RELAT R, P171, DOI 10.1097/01.blo.0000224062.39990.48; PONSETI IV, 1994, J ORTHOP SPORT PHYS, V20, P1; Sadler B, 2019, J CHILD ORTHOP, V13, P238, DOI 10.1302/1863-2548.13.190063; SEVERIN E, 1956, Nord Med, V55, P221; Shaheen S, 2012, J PEDIATR ORTHOP B, V21, P366, DOI 10.1097/BPB.0b013e3283514183; Smythe T, 2017, TROP MED INT HEALTH, V22, P269, DOI 10.1111/tmi.12833; Todd MRLC, 2020, J CHILD ORTHOP, V14, P281, DOI 10.1302/1863-2548.14.190172; Wallander H, 2006, ACTA ORTHOP, V77, P847, DOI 10.1080/17453670610013123; Wang H, 2019, AM J MED GENET A, V179, P595, DOI 10.1002/ajmg.a.61067	30	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260336	10.1371/journal.pone.0260336	http://dx.doi.org/10.1371/journal.pone.0260336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855788	gold, Green Published			2022-12-26	WOS:000735299000045
J	Kretz, L; Bondar-Kunze, E; Hein, T; Richter, R; Schulz-Zunkel, C; Seele-Dilbat, C; van der Plas, F; Vieweg, M; Wirth, C				Kretz, Lena; Bondar-Kunze, Elisabeth; Hein, Thomas; Richter, Ronny; Schulz-Zunkel, Christiane; Seele-Dilbat, Carolin; van der Plas, Fons; Vieweg, Michael; Wirth, Christian			Vegetation characteristics control local sediment and nutrient retention on but not underneath vegetation in floodplain meadows	PLOS ONE			English	Article							COASTAL-PLAIN RIVERS; OVERBANK SEDIMENTATION; FUNCTIONAL TRAITS; SPECIES RICHNESS; PHOSPHORUS; DEPOSITION; PLANTS; SUCCESSION; NITROGEN; DYNAMICS	Sediment and nutrient retention are essential ecosystem functions that floodplains provide and that improve river water quality. During floods, the floodplain vegetation retains sediment, which settles on plant surfaces and the soil underneath plants. Both sedimentation processes require that flow velocity is reduced, which may be caused by the topographic features and the vegetation structure of the floodplain. However, the relative importance of these two drivers and their key components have rarely been both quantified. In addition to topographic factors, we expect vegetation height and density, mean leaf size and pubescence, as well as species diversity of the floodplain vegetation to increase the floodplain's capacity for sedimentation. To test this, we measured sediment and nutrients (carbon, nitrogen and phosphorus) both on the vegetation itself and on sediment traps underneath the vegetation after a flood at 24 sites along the River Mulde (Germany). Additionally, we measured biotic and topographic predictor variables. Sedimentation on the vegetation surface was positively driven by plant biomass and the height variation of the vegetation, and decreased with the hydrological distance (total R-2 = 0.56). Sedimentation underneath the vegetation was not driven by any vegetation characteristics but decreased with hydrological distance (total R-2 = 0.42). Carbon, nitrogen and phosphorus content in the sediment on the traps increased with the total amount of sediment (total R-2 = 0.64, 0.62 and 0.84, respectively), while C, N and P on the vegetation additionally increased with hydrological distance (total R-2 = 0.80, 0.79 and 0.92, respectively). This offers the potential to promote sediment and especially nutrient retention via vegetation management, such as adapted mowing. The pronounced signal of the hydrological distance to the river emphasises the importance of a laterally connected floodplain with abandoned meanders and morphological depressions. Our study improves our understanding of the locations where floodplain management has its most significant impact on sediment and nutrient retention to increase water purification processes.	[Kretz, Lena; Richter, Ronny; Seele-Dilbat, Carolin; Wirth, Christian] Univ Leipzig, Life Sci, Systemat Bot & Funct Biodivers, Leipzig, Germany; [Kretz, Lena; Schulz-Zunkel, Christiane; Seele-Dilbat, Carolin; Vieweg, Michael] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol & Social Ecol Syst, Leipzig, Germany; [Bondar-Kunze, Elisabeth; Hein, Thomas] Univ Nat Resources & Life Sci, Inst Hydrobiol & Aquat Ecosyst Management, Vienna, Austria; [Bondar-Kunze, Elisabeth; Hein, Thomas] WasserCluster Lunz, Lunz Am See, Austria; [Richter, Ronny; Wirth, Christian] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Richter, Ronny] Univ Leipzig, Inst Geog Geoinformat & Remote Sensing, Leipzig, Germany; [van der Plas, Fons] Wageningen Univ, Plant Ecol & Nat Conservat, Wageningen, Netherlands; [Wirth, Christian] Max Planck Inst Biogeochem, Jena, Germany	Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Natural Resources & Life Sciences, Vienna; Leipzig University; Wageningen University & Research; Max Planck Society	Kretz, L (corresponding author), Univ Leipzig, Life Sci, Systemat Bot & Funct Biodivers, Leipzig, Germany.; Kretz, L (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol & Social Ecol Syst, Leipzig, Germany.	lena.kretz@uni-leipzig.de	Kretz, Lena/AAA-3302-2022	Kretz, Lena/0000-0002-8040-4421; Vieweg, Michael/0000-0003-3454-2281	German Federal Ministry of Education and Research (BMBF); German Federal Agency for Nature Conservation (BfN) [01LC1322E]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Agency for Nature Conservation (BfN)	C.W. received funding from the German Federal Ministry of Education and Research (BMBF) and the German Federal Agency for Nature Conservation (BfN) for the project: Wilde Mulde Revitalization of a wild river landscape in Central Germany (Funding label: 01LC1322E). There was no additional external funding received for this study.	Akram S, 2014, J HYDROL, V510, P472, DOI 10.1016/j.jhydrol.2014.01.001; [Anonymous], 2016, THE MATHWORKS; Antheunisse AM, 2006, RIVER RES APPL, V22, P1039, DOI 10.1002/rra.956; ASSELMAN NEM, 1995, EARTH SURF PROCESSES, V20, P481, DOI 10.1002/esp.3290200602; Aureliano AF, 2018, NATIVA, V6, P389, DOI 10.31413/nativa.v6i4.5405; Brodie CR, 2011, CHEM GEOL, V282, P67, DOI 10.1016/j.chemgeo.2011.01.007; Burylo M, 2012, PLANT SOIL, V353, P135, DOI 10.1007/s11104-011-1017-2; Campetella G, 2011, AGR ECOSYST ENVIRON, V145, P38, DOI 10.1016/j.agee.2011.06.025; Camporeale C, 2013, REV GEOPHYS, V51, P379, DOI 10.1002/rog.20014; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Conte M, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P89; Corenblit D, 2011, EARTH-SCI REV, V106, P307, DOI 10.1016/j.earscirev.2011.03.002; Corenblit D, 2009, EARTH SURF PROC LAND, V34, P1790, DOI 10.1002/esp.1876; Corenblit D, 2009, GLOBAL ECOL BIOGEOGR, V18, P507, DOI 10.1111/j.1466-8238.2009.00461.x; Dalke IV, 2018, PLANT ECOL, V219, P1295, DOI 10.1007/s11258-018-0879-2; Elliott AH, 2000, J HYDRAUL ENG-ASCE, V126, P570, DOI 10.1061/(ASCE)0733-9429(2000)126:8(570); FITTER AH, 1994, J ECOL, V82, P415, DOI 10.2307/2261309; Fox J., 2019, R COMPANION APPL REG, V.; Gurnell AM, 2012, EARTH-SCI REV, V111, P129, DOI 10.1016/j.earscirev.2011.11.005; Habersack H, 2016, SCI TOTAL ENVIRON, V543, P828, DOI 10.1016/j.scitotenv.2015.10.123; Herz K, 2017, ECOL EVOL, V7, P8958, DOI 10.1002/ece3.3393; Herz K, 2017, J VEG SCI, V28, P705, DOI 10.1111/jvs.12534; Hopkins KG, 2018, J ENVIRON MANAGE, V220, P65, DOI 10.1016/j.jenvman.2018.05.013; Hunter HM, 2008, J HYDROL, V356, P131, DOI 10.1016/j.jhydrol.2008.04.003; Hupp CR, 2000, HYDROL PROCESS, V14, P2991, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2991::AID-HYP131&gt;3.0.CO;2-H; James LA, 2018, GEOMORPHOLOGY, V317, P199, DOI 10.1016/j.geomorph.2018.05.021; Jarvela J, 2002, J HYDROL, V269, P44, DOI 10.1016/S0022-1694(02)00193-2; Jeffiries R, 2003, GEOMORPHOLOGY, V51, P61, DOI 10.1016/S0169-555X(02)00325-2; Kattge J, 2020, GLOBAL CHANGE BIOL, V26, P119, DOI 10.1111/gcb.14904; Kervroedan L, 2019, PLANT SOIL, V441, P511, DOI 10.1007/s11104-019-04142-6; Kervroedan L, 2018, ECOL ENG, V118, P143, DOI 10.1016/j.ecoleng.2018.04.024; Klaus VH, 2011, BIOL CONSERV, V144, P451, DOI 10.1016/j.biocon.2010.09.031; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Kretz L., 2021, PLOS ONE, P1; Kretz L, 2022, INT REV HYDROBIOL, V107, P108, DOI 10.1002/iroh.202002077; Kretz L, 2020, OECOLOGIA, V193, P535, DOI 10.1007/s00442-020-04664-2; Laughlin DC, 2010, FUNCT ECOL, V24, P493, DOI 10.1111/j.1365-2435.2009.01672.x; Lhotsky B., 2016, Acta Botanica Hungarica, V58, P397, DOI 10.1556/ABot.58.2016.3-4.8; Liu XM, 2008, J ENVIRON QUAL, V37, P1667, DOI 10.2134/jeq2007.0437; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Manners R, 2013, J GEOPHYS RES-EARTH, V118, P65, DOI 10.1029/2011JF002188; Middelkoop H, 1998, GEOGR ANN A, V80A, P95, DOI 10.1111/j.0435-3676.1998.00029.x; Milla R, 2011, ANN BOT-LONDON, V107, P455, DOI 10.1093/aob/mcq261; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; Natho S, 2014, AQUAT SCI, V76, P633, DOI 10.1007/s00027-014-0360-9; Natho S, 2020, FRONT ENV SCI-SWITZ, V8, DOI 10.3389/fenvs.2020.00074; Nilsson C, 2000, BIOSCIENCE, V50, P783, DOI 10.1641/0006-3568(2000)050[0783:AORECB]2.0.CO;2; Noe GB, 2005, ECOL APPL, V15, P1178, DOI 10.1890/04-1677; Noe GB, 2009, ECOSYSTEMS, V12, P728, DOI 10.1007/s10021-009-9253-5; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Ordonez JC, 2010, AM NAT, V175, P225, DOI 10.1086/649582; Ortiz AC, 2013, J GEOPHYS RES-EARTH, V118, P2585, DOI 10.1002/2013JF002858; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Paul M, 2016, COAST ENG, V117, P70, DOI 10.1016/j.coastaleng.2016.07.004; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; Proulx R, 2014, J PLANT ECOL, V7, P518, DOI 10.1093/jpe/rtt065; R Core Team, 2020, R LANG ENV STAT COMP; River M, 2018, AMBIO, V47, P124, DOI 10.1007/s13280-017-0981-z; Rodriguez M, 2019, RIVER RES APPL, V35, P1241, DOI 10.1002/rra.3510; Schulz-Zunkel C, 2021, WETLANDS, V41, DOI 10.1007/s13157-021-01458-x; Schwanghart W, 2014, EARTH SURF DYNAM, V2, P1, DOI 10.5194/esurf-2-1-2014; Scown MW, 2015, GEOMORPHOLOGY, V245, P102, DOI 10.1016/j.geomorph.2015.05.024; Sharma P, 2004, J HYDROL, V289, P190, DOI 10.1016/j.jhydrol.2003.11.023; Sival FP., 2005, RES MANAGING RIVERS, P82; Steiger J, 2005, RIVER RES APPL, V21, P719, DOI 10.1002/rra.879; Steiger J, 2003, RIVER RES APPL, V19, P335, DOI 10.1002/rra.708; Steiger J, 2003, GEOMORPHOLOGY, V49, P1, DOI 10.1016/S0169-555X(02)00144-7; Steiger J, 2001, REGUL RIVER, V17, P443, DOI 10.1002/rrr.644; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Tockner K, 1999, FRESHWATER BIOL, V41, P521, DOI 10.1046/j.1365-2427.1999.00399.x; Tockner K, 2010, FRESHWATER BIOL, V55, P135, DOI 10.1111/j.1365-2427.2009.02371.x; TURNPENNY AWH, 1980, J FISH BIOL, V17, P681, DOI 10.1111/j.1095-8649.1980.tb02802.x; Vastila K, 2016, J HYDRAUL ENG, V142, DOI 10.1061/(ASCE)HY.1943-7900.0001058; Vastila K, 2018, J SOIL SEDIMENT, V18, P3114, DOI 10.1007/s11368-017-1776-3; Venables W., 2013, MODERN APPL STAT S P, DOI DOI 10.1007/978-0-387-21706-2; Venterink HO, 2006, APPL VEG SCI, V9, P163; Venterink HO, 2003, J ENVIRON QUAL, V32, P1430, DOI 10.2134/jeq2003.1430; Wacker L, 2009, J PLANT ECOL-UK, V2, P95, DOI 10.1093/jpe/rtp010; Walling DE, 1998, GEOMORPHOLOGY, V24, P209, DOI 10.1016/S0169-555X(98)00017-8; Wohl E, 2015, BIOSCIENCE, V65, P358, DOI 10.1093/biosci/biv002; Wolf KL, 2013, J ENVIRON QUAL, V42, P1245, DOI 10.2134/jeq2012.0466; Wright IJ, 2017, SCIENCE, V357, P917, DOI 10.1126/science.aal4760	84	0	0	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0252694	10.1371/journal.pone.0252694	http://dx.doi.org/10.1371/journal.pone.0252694			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855757	Green Published, gold			2022-12-26	WOS:000735299000003
J	Kumar, D; Villarreal, DJ; Meuret, AE				Kumar, Divya; Villarreal, Dario J.; Meuret, Alicia E.			Walking on the bright side: Associations between affect, depression, and gait	PLOS ONE			English	Article							NEGATIVE AFFECT; SPEED; PATTERNS; BALANCE; AGE; DYSFUNCTION; PARAMETERS; RUMINATION; SYMPTOMS; ANXIETY	Background Psychomotor change is a core symptom of depression and one of the criteria in diagnosing depressive disorders. Research suggests depressed individuals demonstrate deviations in gait, or walking, compared to non-depressed controls. However, studies are sparse, often limited to older adults and observational gait assessment. It is also unclear if gait changes are due to dysregulation of affect, a core feature of depression. The current study addressed this gap by investigating the relation between positive and negative affect, depressive symptom severity, and gait in young adults. Methods Using three-dimensional motion capture, gait parameters (velocity, stride length, and step time) were attained from 90 young adults during a task where they walked ten meters at their own pace overground in a laboratory for ten minutes. Self-report measures of mood and affect were collected. Results On average, the study population reported high negative and low positive affect. Contrary to our hypotheses, hierarchical regressions demonstrated no significant associations between gait parameters and affective or depressive symptoms (ps>.05). Conclusions Our findings do not support a relation between affective symptoms and gait parameters. The results may indicate age-dependent gait pathology or that other symptoms of depression may influence gait more strongly than affect. They may also reflect an observational bias of gait changes in depressed young adults, one that is unsupported by objective data. Replication is warranted to further examine whether affective symptomology is embodied via gait differences in young adults.	[Kumar, Divya; Meuret, Alicia E.] Southern Methodist Univ, Dept Psychol, Dallas, TX 75205 USA; [Villarreal, Dario J.] Southern Methodist Univ, Dept Engn, Dallas, TX USA; [Villarreal, Dario J.] Toyota North Amer, Dallas, TX USA	Southern Methodist University; Southern Methodist University	Kumar, D; Meuret, AE (corresponding author), Southern Methodist Univ, Dept Psychol, Dallas, TX 75205 USA.	divyak@smu.edu; ameuret@smu.edu						American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; [Anonymous], 2017, ANN PHYS REHABIL MED, DOI [10.1016/j.rehab.2017.07.103, DOI 10.1016/J.REHAB.2017.07.103]; Barbuti M, 2019, BIPOLAR DISORD, V21, P785, DOI 10.1111/bdi.12816; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bennabi D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/158746; Brandler TC, 2012, AM J GERIAT PSYCHIAT, V20, P425, DOI 10.1097/JGP.0b013e31821181c6; Brown LA, 2002, EXP BRAIN RES, V145, P286, DOI 10.1007/s00221-002-1082-0; Callisaya ML, 2017, GEROSCIENCE, V39, P231, DOI 10.1007/s11357-017-9973-y; Cohen AS, 2016, J ABNORM PSYCHOL, V125, P299, DOI 10.1037/abn0000136; Conrad A, 2008, PSYCHOPHYSIOLOGY, V45, P366, DOI 10.1111/j.1469-8986.2007.00601.x; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Day RK, 1999, J AFFECT DISORDERS, V55, P89, DOI 10.1016/S0165-0327(99)00010-5; Delbaere K, 2009, J GERONTOL A-BIOL, V64, P237, DOI 10.1093/gerona/gln014; Demakakos P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068632; Donoghue OA, 2015, AM J GERIAT PSYCHIAT, V23, P189, DOI 10.1016/j.jagp.2014.04.005; Ellmers TJ, 2020, J GERONTOL A-BIOL, V75, P961, DOI 10.1093/gerona/glz176; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fried EI, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0325-4; Gabel NM, 2015, INT J GERIATR PSYCH, V30, P1120, DOI 10.1002/gps.4340; Hausdorff JM, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-39; Iqbal N, 2015, J AFFECT DISORDERS, V181, P18, DOI 10.1016/j.jad.2015.04.002; Jayakody O, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00419; Kessler RC, 2002, J HEALTH SOC BEHAV, V43, P171, DOI 10.2307/3090195; Lemke MR, 2000, J PSYCHIATR RES, V34, P277, DOI 10.1016/S0022-3956(00)00017-0; Michalak J, 2009, PSYCHOSOM MED, V71, P580, DOI 10.1097/PSY.0b013e3181a2515c; Murri MB, 2020, PSYCHIAT RES, V284, DOI 10.1016/j.psychres.2019.112687; Osoba MY, 2019, LARYNGOSCOPE INVEST, V4, P143, DOI 10.1002/lio2.252; Patience J, 2019, AM J GERIAT PSYCHIAT, V27, P1375, DOI 10.1016/j.jagp.2019.07.007; Perera S, 2016, J GERONTOL A-BIOL, V71, P63, DOI 10.1093/gerona/glv126; Radovanovic S, 2014, PSYCHIAT RES, V217, P39, DOI 10.1016/j.psychres.2014.02.001; Samson MM, 2001, AGING CLIN EXP RES, V13, P16, DOI 10.1007/BF03351489; Shankman Stewart A, 2020, J Psychiatr Brain Sci, V5, DOI 10.20900/jpbs.20200007; Sialino LD, 2021, BMC GERIATR, V21, DOI 10.1186/s12877-021-02279-7; SLOMAN L, 1982, AM J PSYCHIAT, V139, P94; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Taylor ME, 2017, ARCH GERONTOL GERIAT, V73, P148, DOI 10.1016/j.archger.2017.07.023; Thomsen DK, 2006, COGNITION EMOTION, V20, P1216, DOI 10.1080/02699930500473533; Virmani T, 2018, GAIT POSTURE, V65, P100, DOI 10.1016/j.gaitpost.2018.07.167; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wolfson L, 2001, NEUROSCIENTIST, V7, P178, DOI 10.1177/107385840100700212; Zimmerman M, 2001, COMPR PSYCHIAT, V42, P175, DOI 10.1053/comp.2001.23126	43	2	2	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260893	10.1371/journal.pone.0260893	http://dx.doi.org/10.1371/journal.pone.0260893			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855876	Green Published, gold			2022-12-26	WOS:000735299000150
J	Ozger, HS; Karakus, R; Kuscu, EN; Bagriacik, UE; Oruklu, N; Yaman, M; Turkoglu, M; Erbas, G; Atak, AY; Senol, E				Ozger, Hasan Selcuk; Karakus, Resul; Kuscu, Elif Nazli; Bagriacik, Umit Emin; Oruklu, Nihan; Yaman, Melek; Turkoglu, Melda; Erbas, Gonca; Atak, Aysegul Yucel; Senol, Esin			Serial measurement of cytokines strongly predict COVID-19 outcome	PLOS ONE			English	Article								Purpose Cytokines are major mediators of COVID-19 pathogenesis and several of them are already being regarded as predictive markers for the clinical course and outcome of COVID-19 cases. A major pitfall of many COVID-19 cytokine studies is the lack of a benchmark sampling timing. Since cytokines and their relative change during an infectious disease course is quite dynamic, we evaluated the predictive value of serially measured cytokines for COVID-19 cases. Methods In this single-center, prospective study, a broad spectrum of cytokines were determined by multiplex ELISA assay in samples collected at admission and at the third day of hospitalization. Appropriateness of cytokine levels in predicting mortality were assessed by receiver-operating characteristic (ROC) analyses for both sampling times in paralel to conventional biomarkers. Results At both sampling points, higher levels of IL-6, IL-7, IL-10, IL-15, IL-27 IP-10, MCP-1, and GCSF were found to be more predictive for mortality (p<0.05). Some of these cytokines, such as IL-6, IL-10, IL-7 and GCSF, had higher sensitivity and specificity in predicting mortality. AUC values of IL-6, IL-10, IL-7 and GCSF were 0.85 (0.65 to 0.92), 0.88 (0.73 to 0.96), 0.80 (0.63 to 0.91) and 0.86 (0.70 to 0.95), respectively at hospital admission. Compared to hospital admission, on the 3rd day of hospitalization serum levels of IL-6 and, IL-10 decreased significantly in the survivor group, unlike the non-survivor group (IL-6, p = 0.015, and IL-10, p = 0.016). Conclusion Our study results suggest that single-sample-based cytokine analyzes can be misleading and that cytokine levels measured serially at different sampling times provide a more precise and accurate estimate for the outcome of COVID-19 patients.	[Ozger, Hasan Selcuk; Kuscu, Elif Nazli; Senol, Esin] Gazi Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Ankara, Turkey; [Karakus, Resul; Bagriacik, Umit Emin; Oruklu, Nihan; Yaman, Melek; Atak, Aysegul Yucel] Gazi Univ, Fac Med, Dept Immunol, Ankara, Turkey; [Turkoglu, Melda] Gazi Univ, Fac Med, Dept Internal Med & Intens Care, Ankara, Turkey; [Erbas, Gonca] Gazi Univ, Fac Med, Dept Radiol, Ankara, Turkey	Gazi University; Gazi University; Gazi University; Gazi University	Ozger, HS (corresponding author), Gazi Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Ankara, Turkey.	sozger@yahoo.com	Karakus, Resul/AIC-6499-2022; Örüklü, Nihan/AID-4611-2022	Karakus, Resul/0000-0003-2654-6119; Ozger, H.Selcuk/0000-0003-3894-0092				Akbari H, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118167; Angioni R, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03151-z; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Chi Y, 2020, J INFECT DIS, V222, P746, DOI 10.1093/infdis/jiaa363; Costela-Ruiz VJ, 2020, CYTOKINE GROWTH F R, V54, P62, DOI 10.1016/j.cytogfr.2020.06.001; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]; Ghazavi A, 2021, CYTOKINE, V137, DOI 10.1016/j.cyto.2020.155323; Gousseff M, 2020, J INFECTION, V81, P821, DOI 10.1016/j.jinf.2020.06.073; Ji P, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000023315; Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763; Galvan-Roman JM, 2021, J ALLERGY CLIN IMMUN, V147, P72, DOI 10.1016/j.jaci.2020.09.018; Mojtabavi H, 2020, EUR CYTOKINE NETW, V31, P44, DOI 10.1684/ecn.2020.0448; Monastero RN, 2017, INT J INFLAMM, V2017, DOI 10.1155/2017/4309485; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Mulchandani R, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13429; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Tato Cristina M, 2008, Cell, V132, DOI 10.1016/j.cell.2008.01.001; Udomsinprasert W, 2021, J CLIN IMMUNOL, V41, P11, DOI 10.1007/s10875-020-00899-z; Wilson JG, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140289; World Health Organization (WHO), 2021, COVID 19 WEEKL EP UP; Yan W, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05847-9; Yang Y, 2020, J ALLERGY CLIN IMMUN, V146, P119, DOI 10.1016/j.jaci.2020.04.027; Zhu JY, 2021, J MED VIROL, V93, P35, DOI 10.1002/jmv.26085	24	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260623	10.1371/journal.pone.0260623	http://dx.doi.org/10.1371/journal.pone.0260623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855834	gold, Green Published			2022-12-26	WOS:000735299000078
J	Pollreis, RE; Roscoe, C; Phinney, RJ; Malesha, SS; Burns, MC; Ceniseros, A; Washington, CH; Nutting, AJ; Ball, CL				Pollreis, Rachel E.; Roscoe, Clay; Phinney, Rachel J.; Malesha, Surabhi S.; Burns, Matthew C.; Ceniseros, Aimee; Washington, Charles H.; Nutting, Andrew J.; Ball, Christopher L.			Evaluation of the Abbott BinaxNOW COVID-19 Test Ag Card for rapid detection of SARS-CoV-2 infection by a local public health district with a rural population	PLOS ONE			English	Article								SARS-CoV-2 RT-PCR, the gold standard for diagnostic testing, may not be readily available or logistically applicable for routine COVID-19 testing in many rural communities in the United States. In this validation study, we compared the BinaxNOW (TM) COVID-19 Test Ag Card with SARS-CoV-2 RT-PCR in 214 participants who sought COVID-19 testing from a local public health district in Idaho, USA. The median age of participants was 35 and 82.7% were symptomatic. Thirty-seven participants (17.3%) had positive RT-PCR results. Results between the two tests were 94.4% concordant. The sensitivity of the BinaxNOW (TM) COVID-19 Test Ag Card was 67.6% (95% CI: 50.2-81.9%), and the specificity was 100.0% (95% CI: 97.9-100.0%). The positive predictive value (PPV) for the BinaxNOW (TM) COVID-19 Test Ag Card was 100.0% (95% CI: 86.2-100.0%), and the negative predictive value (NPV) was 93.6% (95% CI: 89.1-96.6%). Although the sensitivity of BinaxNOW (TM) COVID-19 Test Ag Card was lower than RT-PCR, rapid results and high specificity support its use for early detection of COVID-19, especially in settings where SARS-CoV-2 RT-PCR testing is not readily available. Rapid antigen tests, such as the BinaxNOW (TM) COVID-19 Test Ag Card, may be a more convenient tool in quickly identifying and preventing COVID-19 transmission, especially in rural settings.	[Pollreis, Rachel E.; Roscoe, Clay; Phinney, Rachel J.; Malesha, Surabhi S.; Washington, Charles H.; Nutting, Andrew J.] Southwest Dist Hlth, Caldwell, ID 83607 USA; [Burns, Matthew C.; Ceniseros, Aimee; Ball, Christopher L.] Idaho Dept Hlth & Welf, Div Publ Hlth, Boise, ID USA		Pollreis, RE (corresponding author), Southwest Dist Hlth, Caldwell, ID 83607 USA.	Rachel.Pollreis@phd3.idaho.gov		Ceniseros, Aimee/0000-0002-4491-1282; Pollreis, Rachel/0000-0003-0359-875X				[Anonymous], 2020, BINAXNOWTM COVID 19; [Anonymous], 2020, POT FALS POS RES ANT; Dunne EM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250322; Esbin MN, 2020, RNA, V26, P771, DOI 10.1261/rna.076232.120; Freed N., SARS COV2 GENOME SEQ, V5, P2021, DOI [10.17504/protocols.io.btsrnnd6, DOI 10.17504/PROTOCOLS.IO.BTSRNND6]; Health Resources & Services Administration, DEFINING RURAL POPUL; Manabe YC, 2020, JAMA-J AM MED ASSOC, V324, P2153, DOI 10.1001/jama.2020.21694; Mina MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2025631; Pilarowski G, 2021, J INFECT DIS, V223, P1139, DOI 10.1093/infdis/jiaa802; Pollock NR, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00083-21; Pondaven-Letourmy S, 2020, EUR ANN OTORHINOLARY, V137, P325, DOI 10.1016/j.anorl.2020.06.001; Prince-Guerra JL, 2021, MMWR-MORBID MORTAL W, V70, P100, DOI 10.15585/mmwr.mm7003e3; Ra SH, 2021, THORAX, V76, P61, DOI 10.1136/thoraxjnl-2020-215042; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494	15	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260862	10.1371/journal.pone.0260862	http://dx.doi.org/10.1371/journal.pone.0260862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855887	gold, Green Published			2022-12-26	WOS:000735299000144
J	Stevanato, N; Rocco, MV; Giuliani, M; Castelletti, A; Colombo, E				Stevanato, Nicolo; Rocco, Matteo, V; Giuliani, Matteo; Castelletti, Andrea; Colombo, Emanuela			Advancing the representation of reservoir hydropower in energy systems modelling: The case of Zambesi River Basin	PLOS ONE			English	Article							REGIONAL WATER; CLIMATE-CHANGE; POWER-SYSTEMS; ELECTRICITY; NEXUS; OPTIMIZATION; COST; TOOL; REQUIREMENTS; GENERATION	In state-of-the-art energy systems modelling, reservoir hydropower is represented as any other thermal power plant: energy production is constrained by the plant's installed capacity and a capacity factor calibrated on the energy produced in previous years. Natural water resource variability across different temporal scales and the subsequent filtering effect of water storage mass balances are not accounted for, leading to biased optimal power dispatch strategies. In this work, we aim at introducing a novelty in the field by advancing the representation of reservoir hydropower generation in energy systems modelling by explicitly including the most relevant hydrological constraints, such as time-dependent water availability, hydraulic head, evaporation losses, and cascade releases. This advanced characterization is implemented in an open-source energy modelling framework. The improved model is then demonstrated on the Zambezi River Basin in the South Africa Power Pool. The basin has an estimated hydropower potential of 20,000 megawatts (MW) of which about 5,000 MW has been already developed. Results show a better alignment of electricity production with observed data, with a reduction of estimated hydropower production up to 35% with respect to the baseline Calliope implementation. These improvements are useful to support hydropower management and planning capacity expansion in countries richly endowed with water resource or that are already strongly relying on hydropower for electricity production.	[Stevanato, Nicolo; Rocco, Matteo, V; Colombo, Emanuela] Politecn Milan, Dept Energy, Milan, Italy; [Stevanato, Nicolo] Fdn Eni Enrico Mattei, Milan, Italy; [Giuliani, Matteo; Castelletti, Andrea] Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy	Polytechnic University of Milan; Fondazione Mattei; Polytechnic University of Milan	Stevanato, N (corresponding author), Politecn Milan, Dept Energy, Milan, Italy.; Stevanato, N (corresponding author), Fdn Eni Enrico Mattei, Milan, Italy.	nicolo.stevanato@polimi.it	STEVANATO, NICOLO'/AFO-7916-2022	STEVANATO, NICOLO'/0000-0002-3419-0389	DAFNEDecision Analytic Framework to explore the waterenergy-food Nexus in complex transboundary water resource systems of fast developing countries research project - Horizon 2020 programme WATER 2015 of the European Union [690268]	DAFNEDecision Analytic Framework to explore the waterenergy-food Nexus in complex transboundary water resource systems of fast developing countries research project - Horizon 2020 programme WATER 2015 of the European Union	MG and AC were supported by DAFNEDecision Analytic Framework to explore the waterenergy-food Nexus in complex transboundary water resource systems of fast developing countries research project funded by the Horizon 2020 programme WATER 2015 of the European Union, GA 690268. Data from the mentioned project were used. There was no additional external funding received for this study.	Agrawal N, 2018, APPL ENERG, V216, P558, DOI 10.1016/j.apenergy.2018.02.116; Ajila SA, 2007, J SYST SOFTWARE, V80, P1517, DOI 10.1016/j.jss.2007.01.011; Almazroui M, 2020, EARTH SYST ENVIRON, V4, P455, DOI 10.1007/s41748-020-00161-x; Amjath-Babu TS, 2019, APPL ENERG, V239, P494, DOI 10.1016/j.apenergy.2019.01.147; [Anonymous], HIDROLECTRICA CAHORA; Basheer M, 2019, J HYDROL, V578, DOI 10.1016/j.jhydrol.2019.124085; Beilfuss R., 2001, PATTERNS HYDROLOGICA, DOI [10.13140/RG.2.2.14255.12961, DOI 10.13140/RG.2.2.14255.12961]; Bertoni F, 2021, WATER RESOUR RES, V57, DOI 10.1029/2020WR028112; Bloomberg New Energy Finance, 2017, CLEAN ENERGY COUNTRY, DOI [10.1016/j.ccr.2006.09.003, DOI 10.1016/J.CCR.2006.09.003]; Botswana Power Corporation, 2017, BPC ANN REP; Brown T., 2018, J OPEN RES STW, V6, P4, DOI [10.53341jors.188, DOI 10.5334/JORS.188, 10.5334/jors.188]; Busch S., 2020, ANAL WATER POWER NEX, DOI [10.2760/920794, DOI 10.2760/920794]; Carvajal PE, 2019, ENERGY STRATEG REV, V23, P86, DOI 10.1016/j.esr.2018.12.008; Cervigni R., 2015, POWER WATER SECTORS; Charmchi AST, 2021, APPL ENERG, V281, DOI 10.1016/j.apenergy.2020.116136; Chowdhury AFMK, 2020, J WATER RES PLAN MAN, V146, DOI 10.1061/(ASCE)WR.1943-5452.0001279; Danish Hydraulic Institute. Mike 11, 2017, REFERENCE MANUAL HOR; Day R, 2016, ENERG POLICY, V93, P255, DOI 10.1016/j.enpol.2016.03.019; De Vita A., 2019, STUDY US EU INTEGRAT, DOI [10.2777/135510, DOI 10.2777/135510]; Del Pero C, 2019, I C CLEAN ELECT POW, P246, DOI 10.1109/ICCEP.2019.8890129; Ding T, 2020, ECOL MODEL, V419, DOI 10.1016/j.ecolmodel.2020.108943; Douglas-Mankin KR, 2010, T ASABE, V53, P1423; Duan CC, 2020, APPL ENERG, V257, DOI 10.1016/j.apenergy.2019.113984; Electricidade de Mocambique, 2018, EDM STRAT 2018 2028; Electricidade de Mozambique, 2015, REL AN EST; EMCON Consulting Group, 2006, DEMAND SIDE MANAGEME; Eskom, 2018, ESK INT REP 2018; Fairuz SMC, 2013, ENERG POLICY, V62, P493, DOI 10.1016/j.enpol.2013.08.005; Falchetta G, 2019, J CLEAN PROD, V231, P1399, DOI 10.1016/j.jclepro.2019.05.263; FAO, 1997, IRRIGATION POTENTIAL; Fernandez-Blanco Carramolino R., 2016, HYDRORELATED MODELLI, DOI [10.2760/386964, DOI 10.2760/386964]; FISHBONE LG, 1981, INT J ENERG RES, V5, P353, DOI 10.1002/er.4440050406; Gandolfi C, 1997, WATER RESOUR MANAG, V11, P377, DOI 10.1023/A:1007964732399; Gardumi F, 2018, ENERGY STRATEG REV, V20, P209, DOI 10.1016/j.esr.2018.03.005; Giuliani M, 2013, WATER RESOUR RES, V49, P3912, DOI 10.1002/wrcr.20287; Gonzalez JM, 2020, APPL ENERG, V269, DOI 10.1016/j.apenergy.2020.114794; Good J., 2019, STRATEGIES DAILY SEA; Hadebe Dudu, 2018, Current Sustainable/Renewable Energy Reports, V5, P224, DOI 10.1007/s40518-018-0119-3; Haydt G, 2011, RENEW ENERG, V36, P3068, DOI 10.1016/j.renene.2011.03.028; Heaps C., 2008, INTRO LEAP; Heussen K., 2010, INN SMART GRID TECHN, P1, DOI [DOI 10.1109/ISGTEUROPE.2010.5638865, 10.1109/ISGTEUROPE.2010.5638865]; Howells M, 2011, ENERG POLICY, V39, P5850, DOI 10.1016/j.enpol.2011.06.033; IEA, 2019, REPORT; IEA, 2019, AFR EN OUT 2019; IEA, 2015, TECH REP; IEA. (International Energy Agency), 2016, WORLD EN OUTL, P2016, DOI [DOI 10.1021/ES903811P, 10.1021/es903811p]; IEA (International Energy Agency), TECHN COLL PROGR; IEA-ETSAP, 2010, HYDR ETSAP EN TECHN; International Commission of Dams, WORLD REG DAMS 2020; International Energy Agency (IEA), IEA DAT STAT; IRENA, 2019, INN LANDSC BRIEF FLE; IRENA International Renewable Energy Agency, 2013, AFRICAN POWER POOL P; Khan Z, 2018, APPL ENERG, V210, P499, DOI 10.1016/j.apenergy.2017.05.003; Labordena M, 2015, ENRGY PROCED, V76, P77, DOI 10.1016/j.egypro.2015.07.850; Lombardi F, 2020, JOULE, V4, P2185, DOI 10.1016/j.joule.2020.08.002; Loulou R, 2008, COMPUT MANAG SCI, V5, P7, DOI 10.1007/s10287-007-0046-z; Matos JP., 2015, INT J HYDROPOWER DAM, P28; Ministry of Energy and Water Development, 2011, POW SYST DEV MAST PL; Morgenthaler S, 2020, APPL ENERG, V260, DOI 10.1016/j.apenergy.2019.114218; Namibia Power, POWER STATIONS; National Renewable Energy Laboratory, 2017, HYDR MOD CHALL; Niet T, 2021, ENERGY STRATEG REV, V35, DOI 10.1016/j.esr.2021.100650; Nyatsanza FF, 2015, J AM WATER RESOUR AS, V51, P1029, DOI 10.1111/jawr.12280; ONU, 2015, RESOLUTION ADOPTED G, DOI DOI 10.1007/S13398-014-0173-7.2; Ouedraogo NS, 2017, APPL ENERG, V190, P1047, DOI 10.1016/j.apenergy.2016.12.162; Pavicevic M, 2021, ENERGY, V228, DOI 10.1016/j.energy.2021.120623; Payet-Burin R, 2018, ENERGY, V155, P484, DOI 10.1016/j.energy.2018.05.043; Pereira-Cardenal SJ, 2016, ADV WATER RESOUR, V92, P200, DOI 10.1016/j.advwatres.2016.04.004; Pfenninger S, 2018, J OPEN SOURCE SOFTWA, V3, P825, DOI [10.21105/joss.00825, DOI 10.21105/JOSS.00825]; Pfenninger S, 2018, ENERGY STRATEG REV, V19, P63, DOI 10.1016/j.esr.2017.12.002; Pfenninger S, 2017, ENERG POLICY, V101, P211, DOI 10.1016/j.enpol.2016.11.046; Pfenninger S, 2016, ENERGY, V114, P1251, DOI 10.1016/j.energy.2016.08.060; Pfenninger S, 2015, APPL ENERG, V152, P83, DOI 10.1016/j.apenergy.2015.04.102; Pfenninger S, 2014, RENEW SUST ENERG REV, V33, P74, DOI 10.1016/j.rser.2014.02.003; Prina MG, 2020, RENEW SUST ENERG REV, V129, DOI 10.1016/j.rser.2020.109917; Ravn H., 2001, BAMOREL MODEL, P1; Redondo PD, 2015, ENRGY PROCED, V76, P49, DOI 10.1016/j.egypro.2015.07.843; Ringkjob HK, 2018, RENEW SUST ENERG REV, V96, P440, DOI 10.1016/j.rser.2018.08.002; SADC, 2018, SAPP ANN REP ENH REG; SADC Environment and Land Management Sector SADC Water Resources Sector, 2000, STAT ENV ZAMB BAS 20; SAPP, 2017, SAPP POOL PLAN 2017; Schlott Markus, 2020, 2020 5th International Conference on Green Technology and Sustainable Development (GTSD), P253, DOI 10.1109/GTSD50082.2020.9303096; Schrattenholzer L., 1981, ENERGY SUPPLY MODEL, V81, DOI 10.1016/0377-2217(83)90165-0; Sieber J, 2015, WEAP USER GUIDE; Staffell I., RENEWABLE NINJA; Sterl S, 2020, NAT SUSTAIN, V3, P710, DOI 10.1038/s41893-020-0539-0; Su YF, 2020, ENVIRON MODELL SOFTW, V126, DOI 10.1016/j.envsoft.2020.104667; Taliotis C, 2016, ENERGY SUSTAIN DEV, V31, P50, DOI 10.1016/j.esd.2015.12.001; Tilmant A, 2012, WATER POLICY, V14, P490, DOI 10.2166/wp.2011.189; Tomlinson JE, 2020, ENVIRON MODELL SOFTW, V126, DOI 10.1016/j.envsoft.2020.104635; Trondle T, 2020, JOULE, V4, P1929, DOI 10.1016/j.joule.2020.07.018; Trondle T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236958; UHCHR WHO., 2010, RIGHT WAT FACT SHEET, V56; United Nations, SDG 6; United Nations, SDG 7; United Nations World Water Assessment Programme (WWAP), 2014, UN WORLD WAT DEV REP; Urban Energy Support, 2015, UND EL DEM PATT S AF; van der Krogt WNM., RIVER BASIN SIMULATI, V7, P2013; Voisin N, 2016, ENERGY, V115, P1, DOI 10.1016/j.energy.2016.08.059; Wiese F, 2018, ENERGY STRATEG REV, V20, P26, DOI 10.1016/j.esr.2018.01.003; World Bank, 2010, ZAMB RIV BAS, V4, P1, DOI [DOI 10.4324/9781315282053, 10.4324/9781315282053]; World Commission on Dams, 2000, DAMS AND DEV; Zagona EA, 2001, J AM WATER RESOUR AS, V37, P913, DOI 10.1111/j.1752-1688.2001.tb05522.x; Zambia Energy Regulation Board, 2018, EN SECT REP; Zimbabwe Energy Regulatory Authority, 2017, ZERA ANN REP	105	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0259876	10.1371/journal.pone.0259876	http://dx.doi.org/10.1371/journal.pone.0259876			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855781	gold, Green Published			2022-12-26	WOS:000735299000024
J	Kim, CH; Chung, CK; Choi, Y; Lee, J; Yang, SH; Lee, CH; Park, SB; Kim, KT; Rhee, JM; Park, MS				Kim, Chi Heon; Chung, Chun Kee; Choi, Yunhee; Lee, Juhee; Yang, Seung Heon; Lee, Chang Hyun; Park, Sung Bae; Kim, Kyoung-Tae; Rhee, John M.; Park, Moon Soo			Direct medical costs after surgical or nonsurgical treatment for degenerative lumbar spinal disease: A nationwide matched cohort study with a 10-year follow-up	PLOS ONE			English	Article							LOW-BACK-PAIN; RESEARCH TRIAL SPORT; NONOPERATIVE TREATMENT; REOPERATION RATES; DISC HERNIATION; PRACTICE PATTERNS; HEALTH INSURANCE; FUSION SURGERY; OUTCOMES; SPONDYLOLISTHESIS	Objective The demand for treating degenerative lumbar spinal disease has been increasing, leading to increased utilization of medical resources. Thus, we need to understand how the budget of insurance is currently used. The objective of the present study is to overview the utilization of the National Health Insurance Service (NHIS) by providing the direct insured cost between patients receiving surgery and patients receiving nonsurgical treatment for degenerative lumbar disease. Methods The NHIS-National Sample Cohort was utilized to select patients with lumbar disc herniation, spinal stenosis, spondylolisthesis or spondylolysis. A matched cohort study design was used to show direct medical costs of surgery (n = 2,698) and nonsurgical (n = 2,698) cohorts. Non-surgical treatment included medication, physiotherapy, injection, and chiropractic. The monthly costs of the surgery cohort and nonsurgical cohort were presented at initial treatment, posttreatment 1, 3, 6, 9, and 12 months and yearly thereafter for 10 years. Results The characteristics and matching factors were well-balanced between the matched cohorts. Overall, surgery cohort spent $50.84/patient/month, while the nonsurgical cohort spent $29.34/patient/month (p<0.01). Initially, surgery treatment led to more charge to NHIS ($2,762) than nonsurgical treatment ($180.4) (p<0.01). Compared with the non-surgical cohort, the surgery cohort charged $33/month more for the first 3 months, charged less at 12 months, and charged approximately the same over the course of 10 years. Conclusion Surgical treatment initially led to more government reimbursement than nonsurgical treatment, but the charges during follow-up period were not different. The results of the present study should be interpreted in light of the costs of medical services, indirect costs, societal cost, quality of life and societal willingness to pay in each country. The monetary figures are implied to be actual economic costs but those in the reimbursement system instead reflect reimbursement charges from the government.	[Kim, Chi Heon; Chung, Chun Kee; Yang, Seung Heon; Lee, Chang Hyun; Park, Sung Bae] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea; [Kim, Chi Heon; Chung, Chun Kee; Yang, Seung Heon; Lee, Chang Hyun; Park, Sung Bae] Seoul Natl Univ, Dept Neurosurg, Coll Med, Seoul, South Korea; [Chung, Chun Kee] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Choi, Yunhee; Lee, Juhee] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Div Med Stat, Seoul, South Korea; [Park, Sung Bae] Seoul Natl Univ, Boramae Med Ctr, Dept Neurosurg, Boramae Hosp, Seoul, South Korea; [Kim, Kyoung-Tae] Kyungpook Natl Univ Hosp, Dept Neurosurg, Daegu, South Korea; [Kim, Kyoung-Tae] Kyungpook Natl Univ, Sch Med, Dept Neurosurg, Daegu, South Korea; [Rhee, John M.] Emory Univ, Dept Orthopaed Surg, Sch Med, Atlanta, GA 30322 USA; [Park, Moon Soo] Hallym Univ, Dept Orthoped, Dongtan Sacred Heart Hosp, Gyeonggi, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Emory University; Hallym University	Chung, CK (corresponding author), Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea.; Chung, CK (corresponding author), Seoul Natl Univ, Dept Neurosurg, Coll Med, Seoul, South Korea.; Chung, CK (corresponding author), Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea.	chungc@snu.ac.kr		Kim, Chi Heon/0000-0003-0497-1130	Seoul National University, Seoul, Republic of Korea; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HC15C1320]	Seoul National University, Seoul, Republic of Korea; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was financially supported by the New Faculty Startup Fund ($ 35,000) from Seoul National University (CHK), Seoul 03080, Republic of Korea. A grant ($1,300,000) from the Korea Health Technology Research & Development Project supported this study through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (HC15C1320) (CKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No authors in this study received salary or materials by funders.	Ademi Z, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14382; Alonso-Garcia M, 2020, SPINE, V45, pE1026, DOI 10.1097/BRS.0000000000003476; Alvin MD, 2016, CLIN SPINE SURG, V29, pE80, DOI 10.1097/BSD.0000000000000103; Avellanal M, 2019, NEUROSPINE, V16, P354, DOI 10.14245/ns.1836170.085; Beachler DC, 2016, J BONE JOINT SURG AM, V98, P1064, DOI 10.2106/JBJS.15.01106; Daffner SD, 2010, SPINE J, V10, P463, DOI 10.1016/j.spinee.2010.02.005; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Falavigna A, 2016, J NEUROSURG-SPINE, V24, P608, DOI 10.3171/2015.7.SPINE15441; Fayssoux R, 2010, POPUL HEALTH MANAG, V13, P9, DOI 10.1089/pop.2009.0061; Glassman SD, 2012, SPINE, V37, P769, DOI 10.1097/BRS.0b013e3181e03099; Ivanova JI, 2011, SPINE J, V11, P622, DOI 10.1016/j.spinee.2011.03.017; Jung JM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65108-8; Kim CH, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83471-y; Kim CH, 2019, SPINE, V44, P1382, DOI 10.1097/BRS.0000000000003065; Kim CH, 2018, WORLD NEUROSURG, V119, pE313, DOI 10.1016/j.wneu.2018.07.139; Kim CH, 2018, SPINE, V43, P585, DOI 10.1097/BRS.0000000000002473; Kim CH, 2015, SPINE, V40, pE1063, DOI 10.1097/BRS.0000000000001053; Kim CH, 2013, SPINE J, V13, P1230, DOI 10.1016/j.spinee.2013.06.069; Kim CH, 2013, SPINE, V38, P581, DOI 10.1097/BRS.0b013e318274f9a7; Kim KH, 2012, J KOREAN MED SCI, V27, P579, DOI 10.3346/jkms.2012.27.6.579; Kuntz KM, 2000, SPINE, V25, P1132, DOI 10.1097/00007632-200005010-00015; Lad SP, 2013, SPINE, V38, P1119, DOI 10.1097/BRS.0b013e318287f04e; Lee CH, 2020, WORLD NEUROSURG, V139, pE439, DOI 10.1016/j.wneu.2020.04.026; Lee CH, 2018, NEUROSPINE, V15, P66, DOI 10.14245/ns.1836038.019; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lee SS, 2014, VALUE HEALTH, V17, P476, DOI 10.1016/j.jval.2014.03.1719; Lee WY, 2014, INT J ENV RES PUB HE, V11, P7304, DOI 10.3390/ijerph110707304; Malter AD, 1998, SPINE, V23, P814, DOI 10.1097/00007632-199804010-00015; Martin BI, 2007, SPINE, V32, P2119, DOI 10.1097/BRS.0b013e318145a56a; Martin BI, 2007, SPINE, V32, P382, DOI 10.1097/01.brs.0000254104.55716.46; Martin BI, 2019, SPINE, V44, P369, DOI 10.1097/BRS.0000000000002822; Martin BI, 2014, SPINE J, V14, P1237, DOI 10.1016/j.spinee.2013.08.018; Martin BI, 2014, SPINE, V39, P769, DOI 10.1097/BRS.0000000000000275; Martin-Fernandez J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-287; Menger RP, 2018, NEUROSPINE, V15, P216, DOI 10.14245/ns.1836082.041; Mummaneni PV, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.3.FOCUS1450; Olafsson G, 2017, J MED ECON, V20, P1281, DOI 10.1080/13696998.2017.1372252; Parker SL, 2012, WORLD NEUROSURG, V78, DOI 10.1016/j.wneu.2011.09.013; Patel SA, 2021, JBJS REV, V9, DOI 10.2106/JBJS.RVW.20.00124; Rihn JA, 2015, J BONE JOINT SURG AM, V97A, P177, DOI 10.2106/JBJS.N.00313; Schoenfeld AJ, 2017, CLIN ORTHOP RELAT R, V475, P2838, DOI 10.1007/s11999-017-5229-5; Shin Y, 1995, World Hosp Health Serv, V31, P3; Tosteson ANA, 2008, SPINE, V33, P2108, DOI 10.1097/BRS.0b013e318182e390; Tosteson ANA, 2011, SPINE, V36, P2061, DOI 10.1097/BRS.0b013e318235457b; Tosteson ANA, 2008, ANN INTERN MED, V149, P845, DOI 10.7326/0003-4819-149-12-200812160-00003; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441	48	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260460	10.1371/journal.pone.0260460	http://dx.doi.org/10.1371/journal.pone.0260460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852015	gold, Green Submitted, Green Published			2022-12-26	WOS:000755762900036
J	Fisher-Wellman, KH; Hagen, JT; Kassai, M; Kao, LP; Nelson, MAM; McLaughlin, KL; Coalson, HS; Fox, TE; Tan, SF; Feith, DJ; Kester, M; Loughran, TP; Claxton, DF; Cabot, MC				Fisher-Wellman, Kelsey H.; Hagen, James T.; Kassai, Miki; Kao, Li-Pin; Nelson, Margaret A. M.; McLaughlin, Kelsey L.; Coalson, Hannah S.; Fox, Todd E.; Tan, Su-Fern; Feith, David J.; Kester, Mark; Loughran, Thomas P. Jr Jr; Claxton, David F.; Cabot, Myles C.			Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia	FASEB JOURNAL			English	Article						acute myeloid leukemia; chemotherapy resistance; HL-60 cells; mitochondrial bioenergetics; sphingolipids; vincristine	GLUCOSYLCERAMIDE SYNTHASE; DRUG-RESISTANCE; CANCER-CELLS; CERAMIDE METABOLISM; P-GLYCOPROTEIN; INHIBITION; APOPTOSIS; ACCUMULATION; CYTOTOXICITY; DIAGNOSTICS	Modifications in sphingolipid (SL) metabolism and mitochondrial bioenergetics are key factors implicated in cancer cell response to chemotherapy, including chemotherapy resistance. In the present work, we utilized acute myeloid leukemia (AML) cell lines, selected to be refractory to various chemotherapeutics, to explore the interplay between SL metabolism and mitochondrial biology supportive of multidrug resistance (MDR). In agreement with previous findings in cytarabine or daunorubicin resistant AML cells, relative to chemosensitive wildtype controls, HL-60 cells refractory to vincristine (HL60/VCR) presented with alterations in SL enzyme expression and lipidome composition. Such changes were typified by upregulated expression of various ceramide detoxifying enzymes, as well as corresponding shifts in ceramide, glucosylceramide, and sphingomyelin (SM) molecular species. With respect to mitochondria, despite consistent increases in both basal respiration and maximal respiratory capacity, direct interrogation of the oxidative phosphorylation (OXPHOS) system revealed intrinsic deficiencies in HL60/VCR, as well as across multiple MDR model systems. Based on the apparent requirement for augmented SL and mitochondrial flux to support the MDR phenotype, we explored a combinatorial therapeutic paradigm designed to target each pathway. Remarkably, despite minimal cytotoxicity in peripheral blood mononuclear cells (PBMC), co-targeting SL metabolism, and respiratory complex I (CI) induced synergistic cytotoxicity consistently across multiple MDR leukemia models. Together, these data underscore the intimate connection between cellular sphingolipids and mitochondrial metabolism and suggest that pharmacological intervention across both pathways may represent a novel treatment strategy against MDR.	[Fisher-Wellman, Kelsey H.; Hagen, James T.; Nelson, Margaret A. M.; McLaughlin, Kelsey L.; Coalson, Hannah S.] East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27834 USA; [Fisher-Wellman, Kelsey H.; Hagen, James T.; Kassai, Miki; Kao, Li-Pin; Nelson, Margaret A. M.; McLaughlin, Kelsey L.; Coalson, Hannah S.; Cabot, Myles C.] East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA; [Kassai, Miki; Kao, Li-Pin; Cabot, Myles C.] East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA; [Fox, Todd E.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Tan, Su-Fern; Feith, David J.; Kester, Mark; Loughran, Thomas P. Jr Jr] Univ Virginia, Sch Med, Dept Med Hematol Oncol, Charlottesville, VA 22908 USA; [Feith, David J.; Kester, Mark; Loughran, Thomas P. Jr Jr] Univ Virginia, Canc Ctr, Charlottesville, VA 22908 USA; [Claxton, David F.] Penn State Univ, Coll Med, Dept Med, Div Hematol & Oncol, Hershey, PA USA; [Claxton, David F.] Penn State Canc Inst, Hershey, PA USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of Virginia; University of Virginia; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Fisher-Wellman, KH (corresponding author), East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27834 USA.; Fisher-Wellman, KH; Cabot, MC (corresponding author), East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA.; Cabot, MC (corresponding author), East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA.	fisherwellmank17@ecu.edu; cabotm@ecu.edu		Mclaughlin, Kelsey/0000-0001-6175-7523	NIH [P01 CA171983]; Brody Brothers Foundation, Kinston, NC;  [DOD-W81XWH-19-1-0213]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brody Brothers Foundation, Kinston, NC; 	The work was supported by DOD-W81XWH-19-1-0213 (K.H.F.-W.) and NIH P01 CA171983 (M.C.C), as well as a grant from the Brody Brothers Foundation, Kinston, NC	Baran Y, 2011, J CANCER RES CLIN, V137, P1535, DOI 10.1007/s00432-011-1016-y; Barth BM, 2019, BLOOD ADV, V3, P2598, DOI 10.1182/bloodadvances.2018021295; Bartholomae S, 2016, PEDIATR BLOOD CANCER, V63, P242, DOI 10.1002/pbc.25785; Bonhoure E, 2006, LEUKEMIA, V20, P95, DOI 10.1038/sj.leu.2404023; Bridges HR, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0287-9; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Chatzakos V, 2012, BIOCHEM PHARMACOL, V84, P712, DOI 10.1016/j.bcp.2012.06.009; Chen JH, 2019, NAT MED, V25, P103, DOI 10.1038/s41591-018-0267-4; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Farge T, 2017, CANCER DISCOV, V7, P716, DOI 10.1158/2159-8290.CD-16-0441; Fisher-Wellman KH, 2021, CELL SIGNAL, V78, DOI 10.1016/j.cellsig.2020.109838; Fisher-Wellman KH, 2018, CELL REP, V24, P3593, DOI 10.1016/j.celrep.2018.08.091; Fisher-Wellman KH, 2013, FREE RADICAL BIO MED, V65, P1201, DOI 10.1016/j.freeradbiomed.2013.09.008; Giussani P, 2014, INT J MOL SCI, V15, P4356, DOI 10.3390/ijms15034356; Gottesman MM, 2016, ANNU REV PHARMACOL, V56, P85, DOI 10.1146/annurev-pharmtox-010715-103111; Gouaze V, 2004, MOL CANCER THER, V3, P633; Gouaze-Andersson V, 2007, BBA-MOL CELL BIOL L, V1771, P1407, DOI 10.1016/j.bbalip.2007.09.005; Gouaze-Andersson V, 2011, ANTI-CANCER AGENT ME, V11, P891, DOI 10.2174/187152011797655069; Gu WX, 2021, J CONTROL RELEASE, V329, P706, DOI 10.1016/j.jconrel.2020.10.005; Guieze R, 2019, CANCER CELL, V36, P369, DOI 10.1016/j.ccell.2019.08.005; Huang WC, 2011, FASEB J, V25, P3661, DOI 10.1096/fj.10-180190; Jiang WH, 2014, BBA-MOL CELL BIOL L, V1841, P783, DOI 10.1016/j.bbalip.2013.09.005; Kao LP, 2019, J LIPID RES, V60, P1590, DOI 10.1194/jlr.RA119000251; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Lee WK, 2017, CELL SIGNAL, V38, P134, DOI 10.1016/j.cellsig.2017.06.017; Lesack Kyle, 2011, J Pathol Inform, V2, P52, DOI 10.4103/2153-3539.91130; Liu YY, 2011, INT J ONCOL, V39, P425, DOI 10.3892/ijo.2011.1052; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Lucci A, 1998, ANTICANCER RES, V18, P475; Maurer BJ, 2000, JNCI-J NATL CANCER I, V92, P1897, DOI 10.1093/jnci/92.23.1897; McLaughlin KL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74718-1; McLaughlin KL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60536-y; McLaughlin KL, 2018, BIOCHEM BIOPH RES CO, V504, P742, DOI 10.1016/j.bbrc.2018.09.022; Messner MC, 2010, ADV EXP MED BIOL, V688, P156; Molina JR, 2018, NAT MED, V24, P1036, DOI 10.1038/s41591-018-0052-4; Morad SAF, 2018, ADV CANCER RES, V140, P235, DOI 10.1016/bs.acr.2018.04.013; Morad SAF, 2016, J LIPID RES, V57, P1231, DOI 10.1194/jlr.M067389; Morad SAF, 2015, BBA-MOL CELL BIOL L, V1851, P919, DOI 10.1016/j.bbalip.2015.03.001; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Nelson MAM, 2021, ELIFE, V10, DOI [10.7554/elife.63104, 10.7554/eLife.63104]; Nelson MAM, 2021, METHODS MOL BIOL, V2277, P371, DOI 10.1007/978-1-0716-1270-5_23; Neuzil J, 2013, MITOCHONDRION, V13, P199, DOI 10.1016/j.mito.2012.07.112; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ogretmen B, 2000, BIOCHEMISTRY-US, V39, P194, DOI 10.1021/bi991943f; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Okuda S, 2017, NUCLEIC ACIDS RES, V45, pD1107, DOI 10.1093/nar/gkw1080; Olshefski RS, 2001, INT J CANCER, V93, P131, DOI 10.1002/ijc.1301; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pearson JM, 2020, MOL CANCER RES, V18, P352, DOI 10.1158/1541-7786.MCR-19-0619; Sanchenkov A, 2001, JNCI-J NATL CANCER I, V93, P347, DOI 10.1093/jnci/93.5.347; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shabbits JA, 2002, MOL CANCER THER, V1, P205; Shaffer BC, 2012, DRUG RESIST UPDATE, V15, P62, DOI 10.1016/j.drup.2012.02.001; Snider JM, 2019, J LIPID RES, V60, P819, DOI 10.1194/jlr.M089714; Song MS, 2003, NEUROPHARMACOLOGY, V45, P1130, DOI 10.1016/S0028-3908(03)00284-3; Tan SF, 2019, J LIPID RES, V60, P1078, DOI 10.1194/jlr.M091876; Tan SF, 2016, ONCOTARGET, V7, P83208, DOI 10.18632/oncotarget.13079; Truman JP, 2014, BBA-MOL CELL BIOL L, V1841, P1174, DOI 10.1016/j.bbalip.2013.12.013; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Vasan K, 2020, CELL METAB, V32, P341, DOI 10.1016/j.cmet.2020.06.019; Yamane M, 2011, BIOCHIMIE, V93, P1446, DOI 10.1016/j.biochi.2011.04.016; Yang YL, 2012, CANCER SCI, V103, P1538, DOI 10.1111/j.1349-7006.2012.02335.x	64	3	3	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22094	10.1096/fj.202101194RRR	http://dx.doi.org/10.1096/fj.202101194RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34888943	Green Submitted, Green Accepted			2022-12-26	WOS:000734992000005
J	Hill, KE; Lovett, BM; Schwarzbauer, JE				Hill, Katherine E.; Lovett, Benjamin M.; Schwarzbauer, Jean E.			Heparan sulfate is necessary for the early formation of nascent fibronectin and collagen I fibrils at matrix assembly sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY MULTIPLE EXOSTOSES; BINDING DOMAIN; EXT1; EXPRESSION; INTEGRINS; PLASMA; IDENTIFICATION; BIOSYNTHESIS; TRANSPORTER; MUTATIONS	Fibronectin (FN), an essential component of the extracellular matrix (ECM), is assembled via a cell-mediated process in which integrin receptors bind secreted FN and mediate its polymerization into fibrils that extend between cells, ultimately forming an insoluble matrix. Our previous work using mutant Chinese hamster ovary (CHO) cells identified the glycosaminoglycan heparan sulfate (HS) and its binding to FN as essential for the formation of insoluble FN fibrils. In this study, we investigated the contributions of HS at an early stage of the assembly process using knockdown of exostosin-1 (EXT1), one of the glycosyltransferases required for HS chain synthesis. NIH 3T3 fibroblasts with decreased EXT1 expression exhibited a significant reduction in both FN and type I collagen in the insoluble matrix. We show that FN fibril formation is initiated at matrix assembly sites, and while these sites were formed by cells with EXT1 knockdown, their growth was stunted compared with wild-type cells. The most severe defect observed was in the polymerization of nascent FN fibrils, which was reduced 2.5-fold upon EXT1 knockdown. This defect was rescued by the addition of exogenous soluble heparin chains long enough to simultaneously bind multiple FN molecules. The activity of soluble heparin in this process indicates that nascent fibril formation depends on HS more so than on the protein component of a specific HS proteoglycan. Together, our results suggest that heparin or HS is necessary for concentrating and localizing FN molecules at sites of early fibril assembly.	[Hill, Katherine E.; Lovett, Benjamin M.; Schwarzbauer, Jean E.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Schwarzbauer, JE (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	jschwarz@princeton.edu		Schwarzbauer, Jean/0000-0003-1012-7593	National Institutes of Health [NIAMS R01 AR073236]; Sud Cook '39 Fund for the Prevention of Addiction to Alcohol and other Mind-altering Drugs; NIH [T32 GM007388]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sud Cook '39 Fund for the Prevention of Addiction to Alcohol and other Mind-altering Drugs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by grants (to J. E. S.) from the National Institutes of Health NIAMS R01 AR073236 and the Sud Cook '39 Fund for the Prevention of Addiction to Alcohol and other Mind-altering Drugs. K. E. H. and B. M. L. were supported by a NIH T32 GM007388 predoctoral training grant to the Department of Molecular Biology at Princeton University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; Beltrami G, 2016, CLIN CASES MINER BON, V13, P110, DOI 10.11138/ccmbm/2016.13.2.110; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Christopher RA, 1997, J CELL SCI, V110, P569; Chung CY, 1997, J CELL SCI, V110, P1413; Duchesne L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001361; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Galante LL, 2007, J CELL BIOL, V179, P999, DOI 10.1083/jcb.200707150; Garrison CM, 2021, MOL BIOL CELL, V32, P739, DOI 10.1091/mbc.E20-08-0533; Hameetman L, 2007, JNCI-J NATL CANCER I, V99, P396, DOI 10.1093/jnci/djk067; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Klass CM, 2000, J CELL SCI, V113, P493; Legeai-Mallet L, 2000, J BONE MINER RES, V15, P1489, DOI 10.1359/jbmr.2000.15.8.1489; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Matsumoto Y, 2010, J BIOL CHEM, V285, P19227, DOI 10.1074/jbc.M110.105338; Maurer LM, 2016, CRIT REV BIOCHEM MOL, V51, P213, DOI 10.1080/10409238.2016.1184224; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; Pace JM, 2001, HUM MUTAT, V18, P319, DOI 10.1002/humu.1193; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Reitman I, 2018, MATRIX BIOL, V67, P107, DOI 10.1016/j.matbio.2017.11.012; Roberts ISD, 2008, J AM SOC NEPHROL, V19, P450, DOI 10.1681/ASN.2007080842; Rossi A, 2001, HUM MUTAT, V17, P159, DOI 10.1002/humu.1; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Saunders JT, 2019, MOL BIOL CELL, V30, P2218, DOI 10.1091/mbc.E19-03-0140; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; Vanita V, 2009, GENET TEST MOL BIOMA, V13, P43, DOI 10.1089/gtmb.2008.0055; Vega Maria E, 2020, Matrix Biol Plus, V8, P100048, DOI 10.1016/j.mbplus.2020.100048; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Walker A, 1996, BIOCHEM J, V317, P871, DOI 10.1042/bj3170871; Wei G, 2000, J BIOL CHEM, V275, P27733; Wierzbicka-Patynowski Iwona, 2004, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1012s25; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; WILSON CL, 1992, J CELL BIOL, V119, P923, DOI 10.1083/jcb.119.4.923; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314	39	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101479	10.1016/j.jbc.2021.101479	http://dx.doi.org/10.1016/j.jbc.2021.101479			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1GJ	34890641	gold, Green Published			2022-12-26	WOS:000748376400013
J	Wear, SS; Sande, C; Ovchinnikova, OG; Preston, A; Whitfield, C				Wear, Samantha S.; Sande, Caitlin; Ovchinnikova, Olga G.; Preston, Andrew; Whitfield, Chris			Investigation of core machinery for biosynthesis of Vi antigen capsular polysaccharides in Gram-negative bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SALMONELLA-TYPHI; BORDETELLA-PARAPERTUSSIS; SYNTHASE; LIPOPOLYSACCHARIDE; DOMAIN; GLYCOSYLTRANSFERASES; CLASSIFICATION; HYALURONAN; POLYMERASE	Salmonella enterica serovar Typhi causes typhoid fever. It possesses a Vi antigen capsular polysaccharide coat that is important for virulence and is the basis of a current glyco-conjugate vaccine. Vi antigen is also produced by environmental Bordetella isolates, while mammal-adapted Bordetella species (such as Bordetella bronchiseptica) produce a capsule of undetermined structure that cross-reacts with antibodies recognizing Vi antigen. The Vi antigen backbone is composed of poly-alpha-(1 -> 4)-linked N-acetylgalactosaminuronic acid, modified with O-acetyl residues that are necessary for vaccine efficacy. Despite its biological and biotechnological importance, some central aspects of Vi antigen production are poorly understood. Here we demonstrate that TviE and TviD, two proteins encoded in the viaB (Vi antigen production) locus, interact and are the Vi antigen polymerase and O-acetyltransferase, respectively. Structural modeling and site-directed mutagenesis reveal that TviE is a GT4-family glycosyl-transferase. While TviD has no identifiable homologs beyond Vi antigen systems in other bacteria, structural modeling suggests that it belongs to the large SGNH hydrolase family, which contains other O-acetyltransferases. Although TviD possesses an atypical catalytic triad, its O-acetyltransferase function was verified by antibody reactivity and C-13 NMR data for tviD-mutant polysaccharide. The B. bronchiseptica genetic locus predicts a mode of synthesis distinct from classical S. enterica Vi antigen production, but which still involves TviD and TviE homologs that are both active in a reconstituted S. Typhi system. These findings provide new insight into Vi antigen production and foundational information for the glycoengineering of Vi antigen production in heterologous bacteria.	[Wear, Samantha S.; Sande, Caitlin; Ovchinnikova, Olga G.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Preston, Andrew] Univ Bath, Milner Ctr Evolut, Bath, Avon, England; [Preston, Andrew] Univ Bath, Dept Biol & Biochem, Bath, Avon, England	University of Guelph; University of Bath; University of Bath	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada.	cwhitfie@uoguelph.ca		Wear, Samantha/0000-0002-3894-140X; Sande, Caitlin/0000-0002-0437-366X	Canadian Institutes of Health Research (CIHR) Foundation Grant program; Canada Research Chair; CIHR Doctoral Fellowship	Canadian Institutes of Health Research (CIHR) Foundation Grant program(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); CIHR Doctoral Fellowship(Canadian Institutes of Health Research (CIHR))	This research was funded by the Canadian Institutes of Health Research (CIHR) Foundation Grant program (to C. W.). C. W. is the recipient of a Canada Research Chair and C. S. received a CIHR Doctoral Fellowship.	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Allen AG, 1998, MOL MICROBIOL, V29, P27, DOI 10.1046/j.1365-2958.1998.00878.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asler IL, 2017, ACS CHEM BIOL, V12, P1928, DOI 10.1021/acschembio.6b01140; Batt SM, 2010, J BIOL CHEM, V285, P37741, DOI 10.1074/jbc.M110.165407; Bergfeld AK, 2009, J BIOL CHEM, V284, P6, DOI 10.1074/jbc.M807518200; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHEAH E, 1993, PROTEIN ENG, V6, P575, DOI 10.1093/protein/6.6.575; Chua TK, 2008, PLANT CELL, V20, P1059, DOI 10.1105/tpc.107.051193; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Cotter PA, 2001, PRINCIPLES BACTERIAL, P619; Crawford RW, 2013, MBIO, V4, DOI 10.1128/mBio.00232-13; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; DANIELS EM, 1989, INFECT IMMUN, V57, P3159, DOI 10.1128/IAI.57.10.3159-3164.1989; Doyle L, 2019, NAT CHEM BIOL, V15, P632, DOI 10.1038/s41589-019-0276-8; Fiebig T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18464-y; Gariev IA, 2006, BIOINFORMATICS, V22, P2574, DOI 10.1093/bioinformatics/btl413; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; Gross R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-449; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; HERRMANN KW, 1962, J PHYS CHEM-US, V66, P295, DOI 10.1021/j100808a025; HEYNS K., 1967, CARBOHYD RES, V3, P340, DOI 10.1016/S0008-6215(00)82210-7; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; HONE DM, 1988, INFECT IMMUN, V56, P1326, DOI 10.1128/IAI.56.5.1326-1333.1988; Hoo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115243; Jones CS, 2020, J BIOL CHEM, V295, P8204, DOI 10.1074/jbc.RA120.013108; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kantele A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060583; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Keestra-Gounder AM, 2015, NAT REV MICROBIOL, V13, P206, DOI 10.1038/nrmicro3428; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KLUGMAN KP, 1987, LANCET, V2, P1165; Kostova Z, 2003, EUR J BIOCHEM, V270, P4507, DOI 10.1046/j.1432-1033.2003.03844.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lanz ND, 2021, BIOCHEMISTRY-US, V60, P2044, DOI 10.1021/acs.biochem.1c00088; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liston SD, 2018, P NATL ACAD SCI USA, V115, pE4870, DOI 10.1073/pnas.1801336115; Liston SD, 2016, P NATL ACAD SCI USA, V113, P6719, DOI 10.1073/pnas.1524665113; Liston SD, 2015, J BIOL CHEM, V290, P1075, DOI 10.1074/jbc.M114.622480; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Low KE, 2018, CURR OPIN STRUC BIOL, V53, P32, DOI 10.1016/j.sbi.2018.05.001; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Morgan JLW, 2016, NATURE, V531, P329, DOI 10.1038/nature16966; Neo YL, 2010, MICROBES INFECT, V12, P238, DOI 10.1016/j.micinf.2009.12.002; Ovchinnikova OG, 2016, J BIOL CHEM, V291, P21519, DOI 10.1074/jbc.M116.751115; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; QADRI A, 1990, J IMMUNOASSAY, V11, P235, DOI 10.1080/01971529008053271; Ramirez AS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02880-2; Rawat A, 2021, MICROBIOL RES, V249, DOI 10.1016/j.micres.2021.126784; Riley LM, 2013, J BIOL CHEM, V288, P22299, DOI 10.1074/jbc.M113.484931; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; SNELLINGS NJ, 1981, J BACTERIOL, V145, P1010, DOI 10.1128/JB.145.2.1010-1017.1981; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Sychantha D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02332; SZEWCZYK B, 1980, INFECT IMMUN, V29, P539; Taylor Clare M., 2005, V12, P55, DOI 10.1159/000081689; Troutman JM, 2009, BIOCHEMISTRY-US, V48, P2807, DOI 10.1021/bi802284d; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Virlogeux I, 1995, MICROBIOL-SGM, V141, P3039, DOI 10.1099/13500872-141-12-3039; Wear SS, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00625-19; Weigel PH, 2017, GLYCOBIOLOGY, V27, P536, DOI 10.1093/glycob/cwx012; Weigel PH, 2015, GLYCOBIOLOGY, V25, P632, DOI 10.1093/glycob/cwv006; Wetter M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045609; Whitfield C, 2020, ANNU REV MICROBIOL, V74, P521, DOI 10.1146/annurev-micro-011420-075607; Willis LM, 2013, P NATL ACAD SCI USA, V110, P20753, DOI 10.1073/pnas.1312637110; Willis LM, 2013, CARBOHYD RES, V378, P35, DOI 10.1016/j.carres.2013.05.007; Willis LM, 2013, P NATL ACAD SCI USA, V110, P7868, DOI 10.1073/pnas.1222317110; Wilson RP, 2011, INFECT IMMUN, V79, P830, DOI 10.1128/IAI.00961-10; Wu R, 2015, J BACTERIOL, V197, P2734, DOI 10.1128/JB.00110-15; Zhang H, 2006, BIOCHEMISTRY-US, V45, P8163, DOI 10.1021/bi060446d; Zheng Y, 2011, J BIOL CHEM, V286, P36108, DOI 10.1074/jbc.M111.275974; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	75	1	1	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101486	10.1016/j.jbc.2021.101486	http://dx.doi.org/10.1016/j.jbc.2021.101486			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1GJ	34896394	Green Published, gold			2022-12-26	WOS:000748376400001
J	Desalegn, D; Abdu, Z; Hajure, M				Desalegn, Defaru; Abdu, Zakir; Hajure, Mohammedamin			Prevalence of tobacco dependence and associated factors among patients with schizophrenia attending their treatments at southwest Ethiopia; hospital-based cross-sectional study	PLOS ONE			English	Article							NICOTINE DEPENDENCE; CIGARETTE-SMOKING; FAGERSTROM TEST; SEVERITY; BEHAVIOR	Background Tobacco smoking is the most typically employed in patients with mental disorders; among them, patients with schizophrenia are the very best users. The rate of smoking among patients with schizophrenia is between two and three times greater than the general population in western countries. However, there is a scarcity of studies on the magnitude and associated factors of tobacco dependence among patients with schizophrenia in Ethiopia. Therefore, we assessed the prevalence of tobacco dependence and associated factors among patients with schizophrenia at Mettu Karl referral, Bedelle, and Agaro hospitals, Southwest, Ethiopia. Method Hospital-based the multistage stratified cross-sectional study design was conducted among 524 patients with schizophrenia who are on treatment. Fagerstrom Test for Nicotine Dependence (FTND) was used to screen the prevalence of tobacco dependence. Analysis of data was done using SPSS version 24. Result The prevalence of tobacco dependence among study participants was 22.3% (95% CI) (18.6, 26). Concerning the severity of tobacco dependence, 3.5%, 13.8%, and 5% of the respondents report moderate, high, and very high levels of tobacco dependence respectively. The proportions of tobacco dependence among male schizophrenic patients 88 (25.8%) were higher compared to their counterparts 27 (15.5%). After controlling the effects of cofounders in the final regression analysis, male gender (AOR 2.19, 95% CI = 1.25, 3.83), being on treatment for more than 5years (AOR 4.37, 95% CI = 2.11, 9.02), having a history of admission (AOR 4.01, 95% CI = 1.99, 8.11), and family history of mental illness (AOR 1.90, 95% CI = 1.04, 3.48) were shown to have a significant positive association with tobacco dependence. Conclusion and recommendation A study show a significant proportion of tobacco dependence among people living with schizophrenia. Factors like, being male gender, being on treatment for more than 5 years, having a history of admission, and family history of mental illness was found to have a significant positive association with tobacco dependence. Hence, there is a need for coordinated and comprehensive management clinically to manage tobacco dependence along with identified risk factors in patients with schizophrenia. Also the finding call for the clinicians, managers, ministry of health and other stakeholders on the substance use prevention strategies that target personal and environmental control.	[Desalegn, Defaru; Abdu, Zakir; Hajure, Mohammedamin] Mettu Univ, Coll Hlth Sci, Dept Psychiat, Mettu, Oromia Region, Ethiopia		Desalegn, D (corresponding author), Mettu Univ, Coll Hlth Sci, Dept Psychiat, Mettu, Oromia Region, Ethiopia.	defdesalegn2007@gmail.com		Desalegn, Defaru/0000-0001-7264-9966	Mettu University	Mettu University	The study was funded by Mettu University. The university had no role in the design of the study, in the collection, analysis, and interpretation of the data; or in writing the manuscript.	An HM, 2016, NEUROSCI BULL, V32, P383, DOI 10.1007/s12264-016-0022-0; [Anonymous], 2013, AM PSYCHIAT ASS, P21; Ayano G, 2022, J PUBLIC HEALTH-HEID, V30, P1143, DOI 10.1007/s10389-020-01385-x; Bosgelmez S, 2017, DUSUNEN ADAM, V30, P233, DOI 10.5350/DAJPN2017300307; Buckley TC, 2005, ADDICT BEHAV, V30, P1029, DOI 10.1016/j.addbeh.2004.09.005; Collins Ashely, 2018, J Addict, V2018, P8102165, DOI 10.1155/2018/8102165; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; Goff DC, 2005, J CLIN PSYCHIAT, V66, P183, DOI 10.4088/JCP.v66n0205; Hagman BT, 2008, ADDICT BEHAV, V33, P582, DOI 10.1016/j.addbeh.2007.11.007; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Jamison DT., 2015, DIS CONTROL PRIORITI, DOI [10.1038/nrc4019, DOI 10.1038/NRC4019]; Jiang JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071343; Krishnadas R, 2012, BRIT J PSYCHIAT, V201, P306, DOI 10.1192/bjp.bp.111.107953; Latha SP., 2019, ARCH MENTAL HLTH, V20, P14; Li Y, 2019, GEN PSYCHIAT, V32, DOI 10.1136/gpsych-2018-100014; Lindblom EN, 2015, FOOD DRUG LAW J, V70, P55; Malone KM, 2003, AM J PSYCHIAT, V160, P773, DOI 10.1176/appi.ajp.160.4.773; Manzar MD., 2018, BMC PSYCHIATRY, V18, P1, DOI [10.1186/s12888-017-1517-6, DOI 10.1186/S12888-017-1517-6]; Mayerova M, 2018, NEUROPSYCH DIS TREAT, V14, P1535, DOI 10.2147/NDT.S163839; Meszaros ZS, 2011, AM J ADDICTION, V20, P462, DOI 10.1111/j.1521-0391.2011.00150.x; Mikami I, 1999, JPN J CANCER RES, V90, P1071, DOI 10.1111/j.1349-7006.1999.tb00679.x; Molla Z., 2017, BMC RES NOTES, V10, P1, DOI [10.1186/s13104-016-2345-3, DOI 10.1186/S13104-016-2345-3]; Mori T, 2003, PSYCHIAT RES, V120, P207, DOI 10.1016/S0165-1781(03)00191-4; Patkar AA, 2002, J NERV MENT DIS, V190, P604, DOI 10.1097/00005053-200209000-00005; Rey R, 2017, EUR ARCH PSY CLIN N, V267, P567, DOI 10.1007/s00406-017-0779-9; Rojas CG, 2003, REV MED CHILE, V131, P873; Sagud M, 2009, PSYCHIAT DANUB, V21, P371; Tatar ZB., 2018, ANN MED RES, V25, P349; World Health Organization, 2009, WHO REPORT GLOBAL TO; World Health Organization WHO Tobacco Free Initiative, WORLD NO TOB DAY 200; Xu YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088478; Yoshimasu K, 2003, J EPIDEMIOL, V13, P183, DOI 10.2188/jea.13.183; Zhang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030937; Ziaaddini Hassan, 2009, Addict Health, V1, P38	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0261154	10.1371/journal.pone.0261154	http://dx.doi.org/10.1371/journal.pone.0261154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY5KW	34910737	gold, Green Published			2022-12-26	WOS:000754828900038
J	Dal Bo, E; Gentili, C; Spoto, A; Bruno, G; Castellani, A; Tripodi, C; Fischmeister, FPS; Cecchetto, C				Dal Bo, Elisa; Gentili, Claudio; Spoto, Andrea; Bruno, Giovanni; Castellani, Andrea; Tripodi, Carmen; Fischmeister, Florian Ph. S.; Cecchetto, Cinzia			The social odor scale: Development and initial validation of a new scale for the assessment of social odor awareness	PLOS ONE			English	Article							BODY ODOR; NORMATIVE DATA; MATE CHOICE; IDENTIFICATION; RESPONSES; DISCRIMINATION; CHEMOSIGNALS; METAANALYSIS; SENSITIVITY; OLFACTION	The degree of attention individuals pay to olfactory cues (called odor awareness) influences the role of odors in everyday life. Particularly, odors produced by the human body (i.e., social odors) are able to carry a wide variety of information and to elicit a broad spectrum of emotional reactions, making them essential in interpersonal relationships. Hence, despite the assessment of awareness toward social odors is crucial, a proper tool is still lacking. Here, we designed and initially validated the Social Odor Scale (SOS), a 12-item scale designed to measure the individual differences in awareness towards different social odors. In Study 1, an exploratory factor analysis (EFA; KMO test: MSA = 0.78; Bartlett's test: chi(2)(78) = 631.34, p < 0.001; Chi-squared test: chi(2)(42) = 71.84, p = 0.003) suggests that the three factors structure was the model that best fit with the Italian version of the scale. The confirmatory factor analysis (CFA) supports a second-order model with one higher-order factor representing social odor awareness in general and three lower-order factors representing familiar, romantic partner, and stranger social odors. The final version of the scale presented a good fit (RMSEA = 0.012, SRMR = 0.069, CFI = 0.998, TLI = 0.997). In Study 2, CFA was performed in the German version of the scale confirming the validity of scale structure. Study 3 and 4 revealed that SOS total score and its subscales were positively correlated with other validated olfactory scales, but not with olfactory abilities. Moreover, SOS was found to be related to the gender of the participants: women reported to be more aware to social odors and, specifically, to familiar social odors than men. Overall, the results indicated that SOS is a valid and reliable instrument to assess awareness toward social odors in everyday life.	[Dal Bo, Elisa; Gentili, Claudio] Univ Padua, Padova Neurosci Ctr PNC, Padua, Italy; [Dal Bo, Elisa; Gentili, Claudio; Spoto, Andrea; Bruno, Giovanni; Castellani, Andrea; Tripodi, Carmen; Cecchetto, Cinzia] Univ Padua, Dept Gen Psychol, Padua, Italy; [Fischmeister, Florian Ph. S.] Karl Franzens Univ Graz, Inst Psychol, Graz, Austria; [Fischmeister, Florian Ph. S.] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria	University of Padua; University of Padua; University of Graz; Medical University of Vienna	Cecchetto, C (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	cinzia.cecchetto@unipd.it	Fischmeister, Florian Ph.S/M-5310-2013; Cecchetto, Cinzia/AAW-1113-2020; Bruno, Giovanni/AAF-1563-2021	Fischmeister, Florian Ph.S/0000-0003-4573-7666; Cecchetto, Cinzia/0000-0001-9047-9884; Spoto, Andrea/0000-0002-7580-544X; Castellani, Andrea/0000-0001-5329-3810; Bruno, Giovanni/0000-0002-2526-880X; Dal Bo, Elisa/0000-0002-8329-2584	European Commission Horizon 2020 research and innovation program [824153]; Department of General Psychology from MIUR [262]; FWF, Austrian Science Fund [KLI 639, I 418]	European Commission Horizon 2020 research and innovation program; Department of General Psychology from MIUR; FWF, Austrian Science Fund(Austrian Science Fund (FWF))	The present study is part of the POTION project that has received funding from the European Commission Horizon 2020 research and innovation program under grant agreement No. 824153, https://ec.europa.eu/programmes/ horizon2020/en. EDB Ph.D. scholarship is funded by the abovementioned grant. CC is supported by a grant of the Department of General Psychology from MIUR (Dipartimenti di Eccellenza DM 11/05/ 2017 n. 262, https://www.miur.gov.it/dipartimentidi-eccellenza). FF is supported by the FWF, Austrian Science Fund, through grant KLI 639 and I 418, https://www.fwf.ac.at/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Cecchetto C, 2016, CHEM SENSES, V41, pE39; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Croy I, 2019, PHYSIOL BEHAV, V198, P151, DOI 10.1016/j.physbeh.2018.09.014; Croy I, 2010, EUR ARCH OTO-RHINO-L, V267, P67, DOI 10.1007/s00405-009-1054-0; Cupchik GC, 2005, COGNITION EMOTION, V19, P121, DOI 10.1080/0269993044100011; Dal Bo E, 2020, CHEM SENSES, V45, P855, DOI 10.1093/chemse/bjaa067; de Groot JHB, 2017, CHEM SENSES, V42, P663, DOI 10.1093/chemse/bjx049; Dean J., 2009, JALT TESTING EVALUAT, V13, P20; Dematte ML, 2011, CHEMOSENS PERCEPT, V4, P175, DOI 10.1007/s12078-011-9103-7; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; Endevelt-Shapira Y, 2020, CHEMOSENS PERCEPT, V13, P123, DOI 10.1007/s12078-019-09273-9; Endevelt-Shapira Y, 2018, NAT NEUROSCI, V21, P111, DOI 10.1038/s41593-017-0024-x; Ferdenzi C, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0268; Ferdenzi C, 2019, PHYSIOL BEHAV, V210, DOI 10.1016/j.physbeh.2019.112561; Ferdenzi C, 2010, J CHEM ECOL, V36, P847, DOI 10.1007/s10886-010-9827-x; Ferdenzi C, 2008, CHEMOSENS PERCEPT, V1, P190, DOI 10.1007/s12078-008-9020-6; Garver-Apgar CE, 2008, EVOL HUM BEHAV, V29, P223, DOI 10.1016/j.evolhumbehav.2007.12.007; Gergely G, 1996, INT J PSYCHOANAL, V77, P1181; Gilbert A.N., 1998, J MENT IMAG, V22, P146; Granqvist P, 2019, PHYSIOL BEHAV, V198, P144, DOI 10.1016/j.physbeh.2018.08.024; Havlicek J, 2008, PERS INDIV DIFFER, V45, P565, DOI 10.1016/j.paid.2008.06.019; Havlicek J, 2017, SPRINGER HBK, P949; Havlicek J, 2009, PSYCHONEUROENDOCRINO, V34, P497, DOI 10.1016/j.psyneuen.2008.10.007; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hofer MK, 2020, PSYCHOL SCI, V31, P449, DOI 10.1177/0956797620905615; Hofer MK, 2018, J PERS SOC PSYCHOL, V114, P1, DOI 10.1037/pspa0000110; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Kline P., 2014, EASY GUIDE FACTOR AN; Kollndorfer K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167520; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lee M. D., 2013, BAYESIAN DATA ANAL C; Li CH, 2016, BEHAV RES METHODS, V48, P936, DOI 10.3758/s13428-015-0619-7; Liuzza MT, 2017, CHEM SENSES, V42, P499, DOI 10.1093/chemse/bjw107; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; Lundstrom JN, 2010, VITAM HORM, V83, P1, DOI 10.1016/S0083-6729(10)83001-8; Lundstrom JN, 2009, HUM BRAIN MAPP, V30, P2571, DOI 10.1002/hbm.20686; Lundstrom JN, 2006, BIOL PSYCHOL, V71, P244, DOI 10.1016/j.biopsycho.2005.07.001; Mahmut MK, 2019, PHYSIOL BEHAV, V207, P179, DOI 10.1016/j.physbeh.2019.05.003; McBurney DH, 2006, J APPL SOC PSYCHOL, V36, P2325, DOI 10.1111/j.0021-9029.2006.00105.x; McGann JP, 2017, SCIENCE, V356, DOI 10.1126/science.aam7263; Meade AW, 2012, PSYCHOL METHODS, V17, P437, DOI 10.1037/a0028085; Mindrila D, 2010, INT J DIGITAL SOC, V1, P60, DOI [10.20533/ijds.2040.2570.2010.0010, DOI 10.20533/IJDS.2040.2570.2010.0010]; Navarrete-Palacios E, 2003, BIOL PSYCHOL, V63, P269, DOI 10.1016/S0301-0511(03)00076-0; Novakova L, 2014, CHEMOSENS PERCEPT, V7, P56, DOI 10.1007/s12078-014-9167-2; NOVAKOVA LM, 2014, ANTHROPOL REV, V77, P331, DOI DOI 10.2478/anre-2014-0024; Olatunji BO, 2020, J BEHAV THER EXP PSY, V68, DOI 10.1016/j.jbtep.2019.101543; Oleszkiewicz A, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0265; Oleszkiewicz A, 2019, EUR ARCH OTO-RHINO-L, V276, P719, DOI 10.1007/s00405-018-5248-1; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Parma V, 2020, CHEM SENSES, V45, P609, DOI 10.1093/chemse/bjaa041; Parma V, 2017, SPRINGER HBK, P963; Parma V, 2013, BIOL PSYCHIAT, V74, P220, DOI 10.1016/j.biopsych.2013.01.010; Pause BM, 2008, INT J PSYCHOPHYSIOL, V70, P16, DOI 10.1016/j.ijpsycho.2008.04.003; Pause BM, 2012, CHEMOSENS PERCEPT, V5, P55, DOI 10.1007/s12078-011-9108-2; Pause BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010342; Pause BM, 2009, INT J PSYCHOPHYSIOL, V74, P88, DOI 10.1016/j.ijpsycho.2009.07.008; Pause BM, 1996, BIOL PSYCHOL, V44, P31, DOI 10.1016/S0301-0511(96)05207-6; Perl O, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0372; PORTER RH, 1983, PHYSIOL BEHAV, V30, P151, DOI 10.1016/0031-9384(83)90051-3; R Core Team, 2021, R LANG ENV STAT; Regenbogen C, 2017, P NATL ACAD SCI USA, V114, P6400, DOI 10.1073/pnas.1617357114; Roberts SC, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0258; Roberts SC, 2011, ARCH SEX BEHAV, V40, P1111, DOI 10.1007/s10508-011-9803-8; Schafer L, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0266; Semin GR, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9110887; Seo HS, 2011, CHEM SENSES, V36, P177, DOI 10.1093/chemse/bjq112; Shamon H, 2020, SURV RES METHODS-GER, V14, P54, DOI 10.18148/srm/2020.v14i1.7374; Silva Maren de Moraes e, 2018, Dement. neuropsychol., V12, P123, DOI 10.1590/1980-57642018dn12-020004; Singh D, 2001, P ROY SOC B-BIOL SCI, V268, P797, DOI 10.1098/rspb.2001.1589; Singh PB, 2018, CHEM SENSES, V43, P411, DOI 10.1093/chemse/bjy028; Smeets MAM, 2020, METABOLITES, V10, DOI 10.3390/metabo10030084; Smeets MAM, 2008, CHEM SENSES, V33, P725, DOI 10.1093/chemse/bjn038; Song T, 2017, J OBSTET GYNAECOL, V37, P919, DOI 10.1080/01443615.2017.1312313; Sorokowska A, 2018, CHEM SENSES, V43, P503, DOI 10.1093/chemse/bjy038; Stephenson R, 2010, MOVEMENT DISORD, V25, P2099, DOI 10.1002/mds.23234; Taalman H, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00190; Team JASP, 2020, JASP VERS 0 13 1; Ubel S, 2017, PERCEPTION, V46, P1427, DOI 10.1177/0301006617721120; Wrzesniewski A, 1999, CHEM SENSES, V24, P713, DOI 10.1093/chemse/24.6.713; Wyatt TD, 2005, CHEM SIGNAL, V10, P7, DOI 10.1007/0-387-25160-X_2; Yong AG, 2013, TUTOR QUANT METHODS, V9, P79, DOI 10.20982/tqmp.09.2.p079	83	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0260587	10.1371/journal.pone.0260587	http://dx.doi.org/10.1371/journal.pone.0260587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905551	gold, Green Published, Green Submitted			2022-12-26	WOS:000754615500007
J	Stohy, A; Abdelhakam, HT; Ali, S; Elhenawy, M; Hassan, AA; Masoud, M; Glaser, S; Rakotonirainy, A				Stohy, Ahmed; Abdelhakam, Heba-Tullah; Ali, Sayed; Elhenawy, Mohammed; Hassan, Abdallah A.; Masoud, Mahmoud; Glaser, Sebastien; Rakotonirainy, Andry			Hybrid pointer networks for traveling salesman problems optimization	PLOS ONE			English	Article								In this work, we proposed a hybrid pointer network (HPN), an end-to-end deep reinforcement learning architecture is provided to tackle the travelling salesman problem (TSP). HPN builds upon graph pointer networks, an extension of pointer networks with an additional graph embedding layer. HPN combines the graph embedding layer with the transformer's encoder to produce multiple embeddings for the feature context. We conducted extensive experimental work to compare HPN and Graph pointer network (GPN). For the sack of fairness, we used the same setting as proposed in GPN paper. The experimental results show that our network significantly outperforms the original graph pointer network for small and large-scale problems. For example, it reduced the cost for travelling salesman problems with 50 cities/nodes (TSP50) from 5.959 to 5.706 without utilizing 2opt. Moreover, we solved benchmark instances of variable sizes using HPN and GPN. The cost of the solutions and the testing times are compared using Linear mixed effect models. We found that our model yields statistically significant better solutions in terms of the total trip cost.	[Stohy, Ahmed; Abdelhakam, Heba-Tullah; Ali, Sayed; Hassan, Abdallah A.] Minya Univ, Dept Comp & Syst Engn, Al Minya, Egypt; [Elhenawy, Mohammed; Masoud, Mahmoud; Glaser, Sebastien; Rakotonirainy, Andry] Queensland Univ Technol, Ctr Accid Res & Rd Safety, Brisbane, Qld, Australia	Egyptian Knowledge Bank (EKB); Minia University; Queensland University of Technology (QUT)	Masoud, M (corresponding author), Queensland Univ Technol, Ctr Accid Res & Rd Safety, Brisbane, Qld, Australia.	Mahmoud.masoud@qut.edu.au	Masoud, Mahmoud/AAM-5976-2020; Glaser, Sebastien/O-6760-2018	Masoud, Mahmoud/0000-0002-0130-4327; Elhenawy, Mohammed/0000-0003-2634-4576; Glaser, Sebastien/0000-0003-0658-7765	Motor Accident Insurance Commission (MAIC) Queensland	Motor Accident Insurance Commission (MAIC) Queensland	This research was supported (partially or fully) by the Motor Accident Insurance Commission (MAIC) Queensland.The views expressed herein are those of the authors and are not necessarily those of the MAIC.	Applegate D. L., 2011, TRAVELING SALESMAN P; Bello I., 2017, ICLR; Bengio Y, 2021, EUR J OPER RES, V290, P405, DOI 10.1016/j.ejor.2020.07.063; Bresson X., 2021, TRANSFORMER NETWORK; Chen Mingxiang, 2020, DYNAMIC PARTIAL REMO; Christofides N., 1976, WORST CASE ANAL NEW; Dai H., 2017, LEARNING COMBINATORI; Deudon M., 2018, INT C INT CONSTR PRO; Garey M.R., 1979, COMPUTERS INTRACTABI; GOLDEN B, 1980, OPER RES, V28, P694, DOI 10.1287/opre.28.3.694; Helsgaun K, 2000, EUR J OPER RES, V126, P106, DOI 10.1016/S0377-2217(99)00284-2; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Joshi C, 2019, EFFICIENT GRAPH CONV; Kool W., 2019, DEEPRLSTRUCTPRED ICL; Kool W, 2018, ATTENTION LEARN SOLV; Lo S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01171; Ma Q., 2019, COMBINATORIAL OPTIMI; Mnih V, 2016, PR MACH LEARN RES, V48; Reinelt G., 1991, ORSA Journal on Computing, V3, P376, DOI 10.1287/ijoc.3.4.376; Rennie SJ, 2017, PROC CVPR IEEE, P1179, DOI 10.1109/CVPR.2017.131; Sutskever I., 2014, ADV NEURAL INFORM PR, DOI DOI 10.1007/S10107-014-0839-0; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Vaswani A, 2017, ADV NEUR IN, V30; Vinyals O., 2015, POINTER NETWORKS, DOI [10.3389/fcell.2015.00032, DOI 10.3389/FCELL.2015.00032]; Voudouris C, 1999, EUR J OPER RES, V113, P469, DOI 10.1016/S0377-2217(98)00099-X; WILLIAMS RJ, 1992, MACH LEARN, V8, P229, DOI 10.1007/BF00992696; Wu YX, 2022, IEEE T NEUR NET LEAR, V33, P5057, DOI [10.1109/TIA.2021.3127144, 10.1109/TNNLS.2021.3068828]	27	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0260995	10.1371/journal.pone.0260995	http://dx.doi.org/10.1371/journal.pone.0260995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905571	Green Published, gold, Green Submitted			2022-12-26	WOS:000754615500017
J	Hamada, C; Kawagoe, T; Takamura, M; Nagai, A; Yamaguchi, S; Onoda, K				Hamada, Chizuko; Kawagoe, Toshikazu; Takamura, Masahiro; Nagai, Atsushi; Yamaguchi, Shuhei; Onoda, Keiichi			Altered resting-state functional connectivity of the frontal-striatal circuit in elderly with apathy	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; LATE-LIFE DEPRESSION; PARKINSONS-DISEASE; BASAL GANGLIA; PRE-SMA; MOTOR AREA; PROJECTIONS; ORGANIZATION; IMPAIRMENTS; PARALLEL	Apathy is defined as reduction of goal-directed behaviors and a common nuisance syndrome of neurodegenerative and psychiatric disease. The underlying mechanism of apathy implicates changes of the front-striatal circuit, but its precise alteration is unclear for apathy in healthy aged people. The aim of our study is to investigate how the frontal-striatal circuit is changed in elderly with apathy using resting-state functional MRI. Eighteen subjects with apathy (7 female, 63.7 +/- 3.0 years) and eighteen subjects without apathy (10 female, 64.8 +/- 3.0 years) who underwent neuropsychological assessment and MRI measurement were recruited. We compared functional connectivity with/within the striatum between the apathy and non-apathy groups. The seed-to-voxel group analysis for functional connectivity between the striatum and other brain regions showed that the connectivity was decreased between the ventral rostral putamen and the right dorsal anterior cingulate cortex/supplementary motor area in the apathy group compared to the non-apathy group while the connectivity was increased between the dorsal caudate and the left sensorimotor area. Moreover, the ROI-to-ROI analysis within the striatum indicated reduction of functional connectivity between the ventral regions and dorsal regions of the striatum in the apathy group. Our findings suggest that the changes in functional connectivity balance among different frontal-striatum circuits contribute to apathy in elderly.	[Hamada, Chizuko] Shimane Univ, Grad Sch Med, Izumo, Shimane, Japan; [Kawagoe, Toshikazu] Tokai Univ, Liberal Arts Educ Ctr, Kyushu Campuses, Kumamoto, Japan; [Takamura, Masahiro; Nagai, Atsushi] Shimane Univ, Fac Med, Dept Neurol, Izumo, Shimane, Japan; [Yamaguchi, Shuhei] Shimane Prefectural Cent Hosp, Dept Neurol, Izumo, Shimane, Japan; [Onoda, Keiichi] Otemon Gakuin Univ, Dept Psychol, Osaka, Japan	Shimane University; Tokai University; Shimane University	Hamada, C (corresponding author), Shimane Univ, Grad Sch Med, Izumo, Shimane, Japan.	okuzihc@med.shimane-u.ac.jp	Takamura, Masahiro/AEJ-6059-2022	Takamura, Masahiro/0000-0001-9742-152X				Albertini D, 2020, PROG NEUROBIOL, V184, DOI 10.1016/j.pneurobio.2019.101699; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alexopoulos GS, 2013, J AFFECT DISORDERS, V149, P398, DOI 10.1016/j.jad.2012.11.023; Bell PT, 2015, HUM BRAIN MAPP, V36, P1278, DOI 10.1002/hbm.22701; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2016, CEREB CORTEX, V26, P807, DOI 10.1093/cercor/bhv247; Brodaty H, 2010, INT PSYCHOGERIATR, V22, P426, DOI 10.1017/S1041610209991335; Caeiro L, 2013, CEREBROVASC DIS, V35, P23, DOI 10.1159/000346076; Baggio HC, 2015, MOVEMENT DISORD, V30, P671, DOI 10.1002/mds.26137; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chang SE., 2020, FRONT PSYCHOL, P10, DOI [10.3389/fpsyg.2020.00010, DOI 10.3389/FPSYG.2020.00010]; Cummine J, 2017, BRAIN TOPOGR, V30, P579, DOI 10.1007/s10548-017-0553-3; Dan R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12457-6; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Douven E, 2017, NEUROPSYCHOL REV, V27, P202, DOI 10.1007/s11065-017-9356-2; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Ducharme S, 2018, J NEUROL NEUROSUR PS, V89, P389, DOI 10.1136/jnnp-2017-316277; Duffy J, 2000, Curr Psychiatry Rep, V2, P434, DOI 10.1007/s11920-000-0029-z; DUM RP, 1991, J NEUROSCI, V11, P667; Fan J, 2008, CEREB CORTEX, V18, P796, DOI 10.1093/cercor/bhm125; Fazio L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165301; Fettes P, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00025; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fu ZZ, 2019, NEURON, V101, P165, DOI 10.1016/j.neuron.2018.11.016; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Haber SN, 2016, DIALOGUES CLIN NEURO, V18, P7; Inase M, 1999, BRAIN RES, V833, P191, DOI 10.1016/S0006-8993(99)01531-0; Janssen RJ, 2015, NEUROIMAGE, V119, P398, DOI 10.1016/j.neuroimage.2015.06.084; Jones SA, 2019, CORTEX, V119, P100, DOI 10.1016/j.cortex.2019.04.008; Kawagoe T, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00124; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lanctot KL, 2017, ALZHEIMERS DEMENT, V13, P84, DOI 10.1016/j.jalz.2016.05.008; Le Heron C, 2019, J NEUROL NEUROSUR PS, V90, P302, DOI 10.1136/jnnp-2018-318265; Lehericy S, 2004, CEREB CORTEX, V14, P1302, DOI 10.1093/cercor/bhh091; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Liu J, 2002, J COMP NEUROL, V443, P71, DOI 10.1002/cne.10087; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; Martinez-Horta S, 2017, BRAIN IMAGING BEHAV, V11, P1334, DOI 10.1007/s11682-016-9607-5; Morris LS, 2016, CORTEX, V74, P118, DOI 10.1016/j.cortex.2015.11.004; Okada K., 1998, JPN J STROKE, V20, P318, DOI [DOI 10.3995/JSTR0KE.20.318, DOI 10.3995/JSTROKE.20.318]; Onoda K, 2015, NEUROPSYCHOLOGIA, V77, P10, DOI 10.1016/j.neuropsychologia.2015.07.030; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Pink A, 2015, NEUROLOGY, V84, P935, DOI 10.1212/WNL.0000000000001307; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Radakovic R, 2014, PSYCHIAT RES, V219, P658, DOI 10.1016/j.psychres.2014.06.010; Reijnders JSAM, 2010, MOVEMENT DISORD, V25, P2318, DOI 10.1002/mds.23268; Roth RM, 2016, J NEUROPSYCH CLIN N, V28, P191, DOI 10.1176/appi.neuropsych.15100241; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Semprini Roberta, 2012, J Aging Res, V2012, P436251, DOI 10.1155/2012/436251; Shen YT, 2018, NEUROSCI LETT, V683, P75, DOI 10.1016/j.neulet.2018.06.043; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; Starkstein SE, 2005, J NEUROL NEUROSUR PS, V76, P1070, DOI 10.1136/jnnp.2004.052795; Thobois S, 2010, BRAIN, V133, P1111, DOI 10.1093/brain/awq032; Tunnard C, 2011, INT J GERIATR PSYCH, V26, P741, DOI 10.1002/gps.2603; Vogt BA, 2016, J CHEM NEUROANAT, V74, P28, DOI 10.1016/j.jchemneu.2016.01.010; Wallis JD., 2011, FRONT NEUROSCI, V5, P1, DOI [10.3389/fnins.2011.00001, DOI 10.3389/FNINS.2011.00001]; Wigg CMD, 1999, ARQ NEURO-PSIQUIAT, V57, P547, DOI 10.1590/S0004-282X1999000400002; Yan H., 2015, FRONT HUM NEUROSCI, V9, P1, DOI [10.3389/fnhum.2015.00001, DOI 10.3389/FNHUM.2015.00001]; Yuen GS, 2014, J AFFECT DISORDERS, V166, P179, DOI 10.1016/j.jad.2014.05.008; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	60	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0261334	10.1371/journal.pone.0261334	http://dx.doi.org/10.1371/journal.pone.0261334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ0LY	34898646	Green Published, gold			2022-12-26	WOS:000755176200035
J	Yang, JZ; Wen, SW; Krewski, D; Corsi, DJ; Walker, M; Mattison, D; Moog, R; McNair, D; Huang, HP; Zhuang, GH				Yang, Jianzhou; Wen, Shi Wu; Krewski, Daniel; Corsi, Daniel J.; Walker, Mark; Mattison, Donald; Moog, Ryan; McNair, Doug; Huang, Huiping; Zhuang, Guihua			Association of treatments for acute appendicitis with pregnancy outcomes in the United States from 2000 to 2016: Results from a multi-level analysis	PLOS ONE			English	Article							LAPAROSCOPIC APPENDECTOMY; SUSPECTED APPENDICITIS; METAANALYSIS; SAFETY; WOMEN	Background Open appendectomy, laparoscopic appendectomy, and non-surgical treatment are three options to treat acute appendicitis during pregnancy. Previous studies on the association of different treatment methods for acute appendicitis with pregnancy outcomes have been limited by small sample sizes and residual confounding, especially with respect to hospital-level factors. This study aimed to investigate the association of treatment method for acute appendicitis with pregnancy outcomes using a multi-level analysis. Methods A retrospective cohort study was conducted based on a large electronic health records database in the United States during the period 2000 to 2016. All pregnancies diagnosed with acute appendicitis and treated in participating hospitals during the study period were included. We conducted multi-level hierarchical logistic regression to analyze both individual- and hospital-level factors for abortion, preterm labor, and cesarean section. Results A total of 10,271 acute appendicitis during pregnancy were identified during the study period. Of them, 5,872 (57.2%) were treated by laparoscopic appendectomy, 1,403 (13.7%) by open appendectomy, and 2,996 (29.2%) by non-surgical treatment. Compared with open appendectomy, both laparoscopic appendectomy (adjusted OR, 0.6, 95% CI, 0.4, 0.9) and non-surgical treatment (adjusted OR, 0.4; 95% CI, 0.3-0.7) showed a decreased risk of preterm labor. Other important individual-level determinants of adverse pregnancy outcomes included maternal age, gestational hypertension, and anemia during pregnancy, the hospital-level determinant included the number of beds. Conclusions Compared with open appendectomy, both laparoscopic appendectomy and non-surgical treatment may be associated with a lower risk of preterm labor, without increased risks of abortion and cesarean section.	[Yang, Jianzhou; Zhuang, Guihua] Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China; [Yang, Jianzhou] Changzhi Med Coll, Dept Publ Hlth & Prevent Med, Changzhi, Shanxi, Peoples R China; [Yang, Jianzhou; Wen, Shi Wu; Corsi, Daniel J.; Walker, Mark] Ottawa Hosp, OMNI Res Grp, Res Inst, Ottawa, ON, Canada; [Wen, Shi Wu; Krewski, Daniel; Corsi, Daniel J.; Walker, Mark] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Wen, Shi Wu; Corsi, Daniel J.; Walker, Mark] Univ Ottawa, Fac Med, Dept Obstet & Gynecol, Ottawa, ON, Canada; [Krewski, Daniel; Mattison, Donald] Univ Ottawa, Fac Med, McLaughlin Ctr Populat Hlth Risk Assessment, Ottawa, ON, Canada; [Krewski, Daniel; Mattison, Donald] Risk Sci Int, Ottawa, ON, Canada; [Mattison, Donald] Univ South Carolina, Arnold Sch Publ Hlth, Epidemiol & Biostat, Columbia, SC 29208 USA; [Moog, Ryan] Cerner Corp, Kansas City, MO USA; [McNair, Doug] Bill & Melinda Gates Fdn, Washington, DC USA; [Huang, Huiping] Xia Men Univ, Dept Infect Control, Affiliated Hosp 1, Xiamen, Fujian, Peoples R China	Xi'an Jiaotong University; Changzhi Medical College; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; University of South Carolina System; University of South Carolina Columbia; Bill & Melinda Gates Foundation; Xiamen University	Zhuang, GH (corresponding author), Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China.	zhuanggh@mail.xjtu.edu.cn	McNair, Douglas/GSJ-0611-2022	McNair, Douglas/0000-0003-0965-883X	Canadian Institutes of Health Research (CIHR) [FDN-148438]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by Canadian Institutes of Health Research (CIHR) through a grant awarded to SW (grant number FDN-148438). The funder has no role in study design, data statistics or submission of this work.	Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; [Anonymous], 2020, SURG ENDOSC, DOI DOI 10.1007/S00464-020-07911-Y; Augustin G, 2020, SURG ENDOSC, V34, P4245, DOI 10.1007/s00464-020-07674-6; Boakye EA, 2020, JAMA OTOLARYNGOL, V146, P444, DOI 10.1001/jamaoto.2020.0132; Chakraborty J, 2019, ANZ J SURG, V89, P1373, DOI 10.1111/ans.14963; Cheng HT, 2015, SURG ENDOSC, V29, P1394, DOI 10.1007/s00464-014-3810-5; Cox TC, 2016, SURG ENDOSC, V30, P593, DOI 10.1007/s00464-015-4244-4; DeShazo JP, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1025-7; Di Saverio S, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00306-3; Frountzas M, 2019, ANN ROY COLL SURG, V101, P235, DOI 10.1308/rcsann.2019.0011; Goldstein H, 2002, STAT MED, V21, P3291, DOI 10.1002/sim.1264; Il Joo J, 2017, AM J MED, V130, P1467, DOI 10.1016/j.amjmed.2017.04.046; Juhasz-Boss I, 2014, DTSCH ARZTEBL INT, V111, P465, DOI 10.3238/arztebl.2014.0465; Kirshtein B, 2009, WORLD J SURG, V33, P475, DOI 10.1007/s00268-008-9890-4; Lee SH, 2019, BMC SURG, V19, DOI 10.1186/s12893-019-0505-9; Liu JW, 2021, ASIAN J ENDOSC SURG, V14, P207, DOI 10.1111/ases.12851; Mellinger JL, 2015, CLIN GASTROENTEROL H, V13, P577, DOI 10.1016/j.cgh.2014.09.038; Orso M, 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0235714, 10.1371/journal.pone.0235714.r001, 10.1371/journal.pone.0235714.r002, 10.1371/journal.pone.0235714.r003, 10.1371/journal.pone.0235714.r004]; Prodromidou A, 2018, EUR J OBSTET GYN R B, V225, P40, DOI 10.1016/j.ejogrb.2018.04.010; Solomon N, 2020, ARCH GYNECOL OBSTET, V302, P1421, DOI 10.1007/s00404-020-05767-0; Walsh Colin A, 2008, Int J Surg, V6, P339, DOI 10.1016/j.ijsu.2008.01.006; Wen SW, 1996, J EPIDEMIOL COMMUN H, V50, P207, DOI 10.1136/jech.50.2.207; Wilasrusmee C, 2012, BRIT J SURG, V99, P1470, DOI 10.1002/bjs.8889; Winter NN, 2017, ANZ J SURG, V87, P334, DOI 10.1111/ans.13750; Yoo KC, 2016, INT J COLORECTAL DIS, V31, P1475, DOI 10.1007/s00384-016-2584-8; Yumi H, 2008, SURG ENDOSC, V22, P849, DOI 10.1007/s00464-008-9758-6	26	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0260991	10.1371/journal.pone.0260991	http://dx.doi.org/10.1371/journal.pone.0260991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898628	Green Published, gold			2022-12-26	WOS:000755176200018
J	Kaso, AW; Hareru, HE; Agero, G; Ashuro, Z				Kaso, Abdene Weya; Hareru, Habtamu Endashaw; Agero, Gebi; Ashuro, Zemachu			Assessment of practice of Covid-19 preventive measures and associated factors among residents in Southern, Ethiopia	PLOS ONE			English	Article							KNOWLEDGE; ATTITUDE	Introduction Coronavirus (Covid-19) is a respiratory disease mostly affecting old aged and those with comorbidities. Due to resource constraints in developing countries, control of Covid-19 was based on preventive measures. However, there is variation in adherence to these precautionary measures from place to place among communities. Therefore, this study assessed the practice of Covid-19 preventive measures and associated factors among residents of Southern, Ethiopia. Methods A community-based cross-sectional study was employed on residents of Southern, Ethiopia. Interviewer administered questionnaire was used to collect data from households through systematic random sampling methods. Data was entered, coded, and analyzed using STATA version 16. Logistic regression analysis was used to explore the association between outcome variables and predictor variables. Finally, the interpretation of Adjusted Odds ratio (AOR) with 95% Confidence Interval (CI) and p-value was done for statistically significant factors of Covid-19 preventive measures practice. Results The proportion of residents who had good practice of Covid-19 preventive measures was 31.3% (95% CI: 26.5, 36.1). Out of 364 residents, 264 (72.5%) used facemasks, 218 (59.9%) washed their hands frequently, 167 (45.9%) practiced social distancing, 135 (37.1%) stayed at home, 75 (18.1%) avoided handshaking and 228 (62.6%) used hand sanitizer. Following government directions (AOR = 225; 95% CI: 68.6, 738), good knowledge about Covid-19 (AOR = 3.47; 95% CI: 1.12, 10.73), having access to water supply (AOR = 2.92; 95% CI: 1.05, 8.18), belief towards protectiveness of preventive measure (AOR = 3.53; 95% CI: 1.08, 11.61) and chronic illness (AOR = 5.09; 95% CI: 1.44, 17.96) were significantly associated with practice of Covid-19 preventive measures. Conclusion In this study, the proportion of residents practicing Covid-19 preventive measures was low. Having comorbidity, following government directions, knowledge about Covid-19 and access to water supply were significantly associated with Covid-19 preventive measures practice. Therefore, government and all concerned stakeholders should increase the accessibility of infrastructure and provide continuous awareness creation campaigns regarding Covid-19 mode of transmission, sign and symptom, and protectiveness of Covid-19 preventive measures. Moreover, dissemination of teaching aids using local languages and close monitoring of community compliance to Covid-19 preventive measures is crucial.	[Kaso, Abdene Weya; Hareru, Habtamu Endashaw; Ashuro, Zemachu] Dilla Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dilla, Ethiopia; [Agero, Gebi] Arsi Univ, Coll Hlth Sci, Dept Publ Hlth, Assela, Ethiopia	Dilla University	Kaso, AW (corresponding author), Dilla Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dilla, Ethiopia.	abdannekaso@gmail.com	Agero, Gebi/ABG-0900-2022; Kaso, Abdene/AGX-6502-2022; Hareru, Habtamu Endashaw/AGL-4485-2022	Agero, Gebi/0000-0002-4610-4724; Kaso, Abdene/0000-0003-0626-3226; Hareru, Habtamu Endashaw/0000-0002-0591-0893	Dilla University College of Medicine and Health science for continuous effort	Dilla University College of Medicine and Health science for continuous effort	Our deepest gratitude goes to the Dilla University College of Medicine and Health science for continuous effort and support. Our indebtedness also goes to Wenago town Health office and Health center staff for their genuine advice and direction during data collection.	Alahdal H, 2020, J INFECT PUBLIC HEAL, V13, P1446, DOI 10.1016/j.jiph.2020.06.015; Alennu T, 2021, RISK MANAG HEALTHC P, V14, P439, DOI 10.2147/RMHP.S287600; Amsalu B, 2021, J MULTIDISCIP HEALTH, V14, P219, DOI 10.2147/JMDH.S292409; [Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2021, WEEKLY OPERATIONAL U; Apanga PA, 2021, TROP MED INT HEALTH, V26, P656, DOI 10.1111/tmi.13566; Apanga PA, 2021, AM J TROP MED HYG, V104, P526, DOI 10.4269/ajtmh.20-1301; Asemahagn MA, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00254-3; Bante A, 2021, PATIENT PREFER ADHER, V15, P237, DOI 10.2147/PPA.S293647; Cirrincione L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093603; Clark Cory, 2020, Glob Transit, V2, P76, DOI 10.1016/j.glt.2020.06.003; Defar A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248420; Ditekemena JD, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043356; Emiru TigabuDesie., 2020, J COMMUNITY MED HLTH, V1; Gutu B, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251062; Han YY, 2021, J MED INTERNET RES, V23, DOI 10.2196/23097; Kassa AM, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-044202; Kassie BA, 2020, ADV PUBLIC HLTH, V2020, DOI 10.1155/2020/7526037; Kebede Tewodros Aragie, 2020, RAPID ASSESSMENT IMP; Lee H, 2020, AFR J REPROD HEALTH, V24, P66, DOI 10.29063/ajrh2020/v24i2s.11; Mboowa G, 2021, AM J TROP MED HYG, V104, P502, DOI 10.4269/ajtmh.20-1174; Mola S, 2021, RISK MANAG HEALTHC P, V14, P253, DOI 10.2147/RMHP.S277904; Patra RC, 2020, F1000RESEARCH, V9, P718; Rahman A, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/8223; Sayedahmed AMS, 2020, SCI AFR, V10, DOI 10.1016/j.sciaf.2020.e00652; Prasetyo YT, 2020, INT J INFECT DIS, V99, P312, DOI 10.1016/j.ijid.2020.07.074; ul Haq S, 2020, J INFECT DEV COUNTR, V14, P823, DOI 10.3855/jidc.12851; Wang L, 2020, J INFECTION, V80, P639, DOI 10.1016/j.jinf.2020.03.019; WHO, 1 CAS COVID 19 CONF; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	31	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0261186	10.1371/journal.pone.0261186	http://dx.doi.org/10.1371/journal.pone.0261186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890428	gold, Green Published			2022-12-26	WOS:000747293600033
J	Siegel, EM; Ajidahun, A; Berglund, A; Guerrero, W; Eschrich, S; Putney, RM; Magliocco, A; Riggs, B; Winter, K; Simko, JP; Ajani, JA; Guha, C; Okawara, GS; Abdalla, I; Becker, MJ; Pizzolato, JF; Crane, CH; Brown, KD; Shibata, D				Siegel, Erin M.; Ajidahun, Abidemi; Berglund, Anders; Guerrero, Whitney; Eschrich, Steven; Putney, Ryan M.; Magliocco, Anthony; Riggs, Bridget; Winter, Kathryn; Simko, Jeff P.; Ajani, Jaffer A.; Guha, Chandan; Okawara, Gordon S.; Abdalla, Ibrahim; Becker, Mark J.; Pizzolato, Joseph F.; Crane, Christopher H.; Brown, Kevin D.; Shibata, David			Genome-wide host methylation profiling of anal and cervical carcinoma	PLOS ONE			English	Article							DNA METHYLATION; INTRAEPITHELIAL NEOPLASIA; NATURAL-HISTORY; CANCER; MARKERS; LESIONS; RISK; GENE; MEN; PROGRESSION	HPV infection results in changes in host gene methylation which, in turn, are thought to contribute to the neoplastic progression of HPV-associated cancers. The objective of this study was to identify joint and disease-specific genome-wide methylation changes in anal and cervical cancer as well as changes in high-grade pre-neoplastic lesions. Formalin-fixed paraffin-embedded (FFPE) anal tissues (n = 143; 99% HPV+) and fresh frozen cervical tissues (n = 28; 100% HPV+) underwent microdissection, DNA extraction, HPV genotyping, bisulfite modification, DNA restoration (FFPE) and analysis by the Illumina HumanMethylation450 Array. Differentially methylated regions (DMR; t test q < 0.01, 3 consecutive significant CpG probes and mean Delta beta methylation value > 0.3) were compared between normal and cancer specimens in partial least squares (PLS) models and then used to classify anal or cervical intraepithelial neoplasia-3 (AIN3/CIN3). In AC, an 84-gene PLS signature (355 significant probes) differentiated normal anal mucosa (NM; n = 9) from AC (n = 121) while a 36-gene PLS signature (173 significant probes) differentiated normal cervical epithelium (n = 10) from CC (n = 9). The CC progression signature was validated using three independent publicly available datasets (n = 424 cases). The AC and CC progression PLS signatures were interchangeable in segregating normal, AIN3/CIN3 and AC and CC and were found to include 17 common overlapping hypermethylated genes. Moreover, these signatures segregated AIN3/CIN3 lesions similarly into cancer-like and normal-like categories. Distinct methylation changes occur across the genome during the progression of AC and CC with overall similar profiles and add to the evidence suggesting that HPV-driven oncogenesis may result in similar non-random methylomic events. Our findings may lead to identification of potential epigenetic drivers of HPV-associated cancers and also, of potential markers to identify higher risk pre-cancerous lesions.	[Siegel, Erin M.; Riggs, Bridget] Dept Canc Epidemiol, Tampa, FL USA; [Ajidahun, Abidemi; Guerrero, Whitney; Shibata, David] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN 38163 USA; [Berglund, Anders; Eschrich, Steven; Putney, Ryan M.] Biostat & Bioinformat, Tampa, FL USA; [Magliocco, Anthony] H Lee Moffitt Canc Ctr & Res Inst, Anat Pathol, Tampa, FL USA; [Winter, Kathryn] NRG Oncol Stat & Data Management Ctr ACR, Philadelphia, PA USA; [Simko, Jeff P.] UCSF Med Ctr Mt Zion, San Francisco, CA USA; [Ajani, Jaffer A.; Crane, Christopher H.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Guha, Chandan] Montefiore Med Ctr, New York, NY USA; [Okawara, Gordon S.] Hamilton Hlth Sci, Juravinski Canc Ctr, Hamilton, ON, Canada; [Abdalla, Ibrahim] Canc Res Ozarks CCOP, Springfield, MO USA; [Becker, Mark J.] Columbus Community Clin Oncol Program, Columbus, OH USA; [Pizzolato, Joseph F.] Mt Sinai Comprehens Canc Ctr CCOP, Miami, FL USA; [Brown, Kevin D.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	University of Tennessee System; University of Tennessee Health Science Center; H Lee Moffitt Cancer Center & Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion; University of Texas System; UTMD Anderson Cancer Center; Montefiore Medical Center; McMaster University; State University System of Florida; University of Florida	Shibata, D (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN 38163 USA.	dshibata@uthsc.edu	Eschrich, Steven/K-6848-2013	Eschrich, Steven/0000-0002-9833-2788	National Cancer Institute (NCI) [R21CA185921-01A, U10CA180868, U10CA180822, UG1CA189867, U24CA196067]; American Society of Colon and Rectal Surgeons; Florida Biomedical Research Program [2BT01, 05NIR11]; Miles for Moffitt Milestone Award; Moffitt's Total Cancer Care Initiative; H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center [P30-CA076292]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society of Colon and Rectal Surgeons; Florida Biomedical Research Program; Miles for Moffitt Milestone Award; Moffitt's Total Cancer Care Initiative; H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center	This project was supported by grants R21CA185921-01A, U10CA180868 (NRG Oncology Operations), U10CA180822 (NRG Oncology SDMC), UG1CA189867 (NRG Oncology NCORP), U24CA196067 (NRG Oncology Biospecimen Bank) from the National Cancer Institute (NCI), the American Society of Colon and Rectal Surgeons (Shibata/Siegel PI), the Florida Biomedical Research Program (2BT01 and 05NIR11), and Miles for Moffitt Milestone Award (Siegel and Shibata). This project was also supported in part by Moffitt's Total Cancer Care Initiative and the Tissue Core, Molecular Genomics Core, Biostatistics and Bioinformatics Core, and the Collaborative Data Services Core at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center, under grant number P30-CA076292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2008, JAMA-J AM MED ASSOC, V299, P1914, DOI 10.1001/jama.299.16.1914; Berry JM, 2014, INT J CANCER, V134, P1147, DOI 10.1002/ijc.28431; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Boers A, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0196-3; Burgers WA, 2007, ONCOGENE, V26, P1650, DOI 10.1038/sj.onc.1209950; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386; Clarke MA, 2018, CANCER CYTOPATHOL, V126, P447, DOI 10.1002/cncy.22018; De Strooper LMA, 2014, CANCER PREV RES, V7, P1251, DOI 10.1158/1940-6207.CAPR-14-0237; Denisenko ON, 1996, J BIOL CHEM, V271, P27701, DOI 10.1074/jbc.271.44.27701; Dirks RAM, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0284-4; Eijsink JJH, 2012, INT J CANCER, V130, P1861, DOI 10.1002/ijc.26326; Farkas SA, 2013, EPIGENETICS-US, V8, P1213, DOI 10.4161/epi.26346; Hariri S, 2015, CANCER EPIDEM BIOMAR, V24, P393, DOI 10.1158/1055-9965.EPI-14-0649; Hernandez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050533; Higashi RT, 2022, AIDS CARE, V34, P220, DOI 10.1080/09540121.2021.1883512; Huang HS, 2015, J MOL NEUROSCI, V55, P684, DOI 10.1007/s12031-014-0408-2; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Konishi Y, 2015, ANAL BIOCHEM, V484, P66, DOI 10.1016/j.ab.2015.05.003; Kuo CC, 2014, CLIN CHEM LAB MED, V52, P1235, DOI 10.1515/cclm-2013-0780; Lendvai A, 2012, EPIGENETICS-US, V7, P1268, DOI 10.4161/epi.22301; Leonard SM, 2012, CARCINOGENESIS, V33, P1286, DOI 10.1093/carcin/bgs157; Li YF, 2015, EPIGENETICS-US, V10, P229, DOI 10.1080/15592294.2015.1006506; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Marongiu L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-384; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Matsusaka K, 2011, CANCER RES, V71, P7187, DOI 10.1158/0008-5472.CAN-11-1349; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Nikolaidis C, 2015, CANCER EPIDEMIOL, V39, P682, DOI 10.1016/j.canep.2015.07.008; Palefsky JM, 2012, SEX HEALTH, V9, P580, DOI 10.1071/SH12045; Park Ina U, 2010, Curr Infect Dis Rep, V12, P126, DOI 10.1007/s11908-010-0090-7; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Sahasrabudhe A, 2016, DEVELOPMENT, V143, P449, DOI 10.1242/dev.130104; Salit IE, 2010, AIDS, V24, P1307, DOI 10.1097/QAD.0b013e328339e592; Sanchez-Vega F, 2013, EPIGENETICS-US, V8, P1355, DOI 10.4161/epi.26701; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Senkomago V, 2019, MMWR-MORBID MORTAL W, V68, P724, DOI 10.15585/mmwr.mm6833a3; Shridhar R, 2015, CA-CANCER J CLIN, V65, P139, DOI 10.3322/caac.21259; Siegel EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122495; Siegel EM, 2014, CANCER EPIDEM BIOMAR, V23, P2622, DOI 10.1158/1055-9965.EPI-14-0464; Siegel EM, 2014, DIS COLON RECTUM, V57, P941, DOI 10.1097/DCR.0000000000000160; Simpson HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141906; Steenbergen RDM, 2014, NAT REV CANCER, V14, P395, DOI 10.1038/nrc3728; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; van der Zee RP, 2021, CLIN INFECT DIS, V72, P2154, DOI 10.1093/cid/ciaa397; van der Zee RP, 2021, MOL ONCOL, V15, P3024, DOI 10.1002/1878-0261.12926; van der Zee RP, 2019, CLIN INFECT DIS, V68, P1110, DOI 10.1093/cid/ciy601; Verlaat W, 2018, EPIGENETICS-US, V13, P769, DOI 10.1080/15592294.2018.1507197; Verlaat W, 2018, CLIN CANCER RES, V24, P3456, DOI 10.1158/1078-0432.CCR-17-3615; Verlaat W, 2017, CLIN CANCER RES, V23, P3813, DOI 10.1158/1078-0432.CCR-16-2641; Wisman GBA, 2006, INT J CANCER, V119, P1908, DOI 10.1002/ijc.22060; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Wong KY, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-16; Yamada K, 2013, CELL CYCLE, V12, P2348, DOI 10.4161/cc.25511; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; Yang N, 2009, CANCER EPIDEM BIOMAR, V18, P3000, DOI 10.1158/1055-9965.EPI-09-0405; Yogo K, 2012, HISTOCHEM CELL BIOL, V137, P53, DOI 10.1007/s00418-011-0887-y	58	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260857	10.1371/journal.pone.0260857	http://dx.doi.org/10.1371/journal.pone.0260857			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882728	Green Published, gold			2022-12-26	WOS:000755037200046
J	Obayemi, MJ; Akintayo, CO; Oniyide, AA; Aturamu, A; Badejogbin, OC; Atuma, CL; Saidi, AO; Mahmud, H; Olaniyi, KS				Obayemi, Mary J.; Akintayo, Christopher O.; Oniyide, Adesola A.; Aturamu, Ayodeji; Badejogbin, Olabimpe C.; Atuma, Chukwubueze L.; Saidi, Azeezat O.; Mahmud, Hadiza; Olaniyi, Kehinde S.			Protective role of melatonin against adipose-hepatic metabolic comorbidities in experimentally induced obese rat model	PLOS ONE			English	Article							INSULIN-RESISTANCE; BODY-WEIGHT; OBESTATIN; GHRELIN; SECRETION; PANCREAS; INJURY; INTERRELATIONSHIPS; INFLAMMATION; ANTIOXIDANT	Background Adipose and hepatic metabolic dysfunctions are critical comorbidities that also aggravate insulin resistance in obese individuals. Melatonin is a low-cost agent and previous studies suggest that its use may promote metabolic health. However, its effects on some comorbidities associated with obesity are unknown. Herein, we investigated the hypothesis that melatonin supplementation would attenuate adipose-hepatic metabolic dysfunction in high fat diet (HFD)-induced obesity in male Wistar rats. Materials and methods Twenty-four adult male Wistar rats (n = 6/group) were used: Control group received vehicle (normal saline), obese group received 40% high fat diet, melatonin-treated group received 4 mg/kg of melatonin, and obese plus melatonin group received 40% HFD and melatonin. The treatment lasted for 12 weeks. Results HFD caused increased food intake, body weight, insulin level, insulin resistance and plasma and liver lipid but decreased adipose lipid. In addition, HFD also increased plasma, adipose and liver malondialdehyde, IL-6, uric acid and decreased Glucose-6-phosphate dehydrogenase, glutathione, nitric oxide and circulating obestatin concentration. However, these deleterious effects except food intake were attenuated when supplemented with melatonin. Conclusion Taken together, the present results indicate that HFD exposure causes adipose-hepatic metabolic disturbance in obese animals, which are accompanied by oxidative stress and inflammation. In addition, the present results suggest that melatonin supplementation attenuates adipose-hepatic metabolic dysfunction, accompanying obesity by suppression of oxidative stress/inflammation-dependent mechanism and increasing circulating obestatin.	[Obayemi, Mary J.; Akintayo, Christopher O.; Oniyide, Adesola A.; Aturamu, Ayodeji; Atuma, Chukwubueze L.; Saidi, Azeezat O.; Mahmud, Hadiza; Olaniyi, Kehinde S.] Afe Babalola Univ, Dept Physiol, Coll Med & Hlth Sci, Ado Ekiti, Nigeria; [Badejogbin, Olabimpe C.] Babcock Univ, Benjamin Carson Sch Med, Dept Physiol, Ilishan Remo, Nigeria		Olaniyi, KS (corresponding author), Afe Babalola Univ, Dept Physiol, Coll Med & Hlth Sci, Ado Ekiti, Nigeria.	kennethnitty2010@gmail.com	Olaniyi, Kehinde/GPK-5850-2022	Olaniyi, Kehinde/0000-0002-8229-9688				Agarwal P, 2018, CRIT REV CL LAB SCI, V55, P71, DOI 10.1080/10408363.2017.1422109; Agnew A, 2011, PEPTIDES, V32, P755, DOI 10.1016/j.peptides.2010.12.005; Al-Massadi O, 2018, TRENDS PHARMACOL SCI, V39, P685, DOI 10.1016/j.tips.2018.06.004; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Aly GS, 2020, J PEDIATR ENDOCR MET, V33, P199, DOI 10.1515/jpem-2019-0286; Bahrami N, 2018, BIOMED PHARMACOTHER, V108, P515, DOI 10.1016/j.biopha.2018.09.044; Banting FG, 1922, J LAB CLIN MED, V7, P251; Briggs DI, 2011, J NEUROENDOCRINOL, V23, P620, DOI 10.1111/j.1365-2826.2011.02148.x; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Cheng M.D., 2020, ENDOCRINOLOGY DIABET; Cipolla-Neto J, 2014, J PINEAL RES, V56, P371, DOI 10.1111/jpi.12137; Cipolla-Neto J, 2018, ENDOCR REV, V39, P990, DOI 10.1210/er.2018-00084; Cowan E, 2016, BRIT J PHARMACOL, V173, P2165, DOI 10.1111/bph.13502; Crujeiras AB, 2014, J ENDOCRINOL INVEST, V37, P119, DOI 10.1007/s40618-013-0004-2; Dezaki K, 2006, DIABETES, V55, P3486, DOI 10.2337/db06-0878; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gesmundo I, 2013, IUBMB LIFE, V65, P976, DOI 10.1002/iub.1226; Granata R, 2012, FASEB J, V26, P3393, DOI 10.1096/fj.11-201343; Gurriaran-Rodriguez U, 2011, J CELL MOL MED, V15, P1927, DOI 10.1111/j.1582-4934.2010.01192.x; Hassan NE, 2018, GENES DIS, V5, P150, DOI 10.1016/j.gendis.2017.12.004; Hosseinzadeh A, 2018, LIFE SCI, V201, P17, DOI 10.1016/j.lfs.2018.03.032; Hsieh CJ, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-49; Hsing AW, 2003, J NATL CANCER I, V95, P67, DOI 10.1093/jnci/95.1.67; Kasimay O, 2006, HEPATOL RES, V36, P11, DOI 10.1016/j.hepres.2006.06.009; Koc M, 2014, PEPTIDES, V60, P23, DOI 10.1016/j.peptides.2014.07.019; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Lehr S, 2012, PROTEOM CLIN APPL, V6, P91, DOI 10.1002/prca.201100052; Lukacs A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7839-1; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Moechars D, 2006, GASTROENTEROLOGY, V131, P1131, DOI 10.1053/j.gastro.2006.07.009; Moridi H, 2018, INT J REPROD BIOMED, V16, P261; Muhlbauer E, 2007, J PINEAL RES, V42, P105, DOI 10.1111/j.1600-079X.2006.00399.x; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Olaniyi K.S., 2021, SCI REP-UK, V11, P1, DOI [10.1038/s41598-020-79139-8, DOI 10.1038/S41598-020-79139-8]; Olaniyi KS, 2020, EXP BIOL MED, V245, P667, DOI 10.1177/1535370220913847; Olaniyi KS, 2020, J ENDOCRINOL, V246, P1, DOI 10.1530/JOE-19-0582; Pamukcu O, 2013, J PEDIATR GASTR NUTR, V57, P211, DOI 10.1097/MPG.0b013e318294711e; Peschke E, 2013, INT J MOL SCI, V14, P6981, DOI 10.3390/ijms14046981; Prunet-Marcassus B, 2003, ENDOCRINOLOGY, V144, P5347, DOI 10.1210/en.2003-0693; Reiter RJ, 2016, J PINEAL RES, V61, P253, DOI 10.1111/jpi.12360; Ren AJ, 2008, BIOCHEM BIOPH RES CO, V369, P969, DOI 10.1016/j.bbrc.2008.02.146; Romagnali M, 2010, FREE RADICAL BIO MED, V49, P171, DOI 10.1016/j.freeradbiomed.2010.03.024; SAARELA S, 1994, LIFE SCI, V54, P295, DOI 10.1016/0024-3205(94)00786-1; Sartori C, 2009, ENDOCRINOLOGY, V150, P5311, DOI 10.1210/en.2009-0425; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sharp GC, 2019, DIABETOLOGIA, V62, P1802, DOI 10.1007/s00125-019-4919-9; Shirai T, 2016, NUTR RES, V36, P262, DOI 10.1016/j.nutres.2015.11.018; Stumpf I, 2008, J PINEAL RES, V45, P318, DOI 10.1111/j.1600-079X.2008.00593.x; Szewczyk-Golec K, 2015, J PINEAL RES, V59, P277, DOI 10.1111/jpi.12257; Tabassum H, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12648; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Wang WM, 2014, J INT MED RES, V42, P1202, DOI 10.1177/0300060514543040; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao CM, 2008, CELL TISSUE RES, V331, P575, DOI 10.1007/s00441-007-0514-3; Zhao YY, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/6430486	58	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260546	10.1371/journal.pone.0260546	http://dx.doi.org/10.1371/journal.pone.0260546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879109	gold, Green Published			2022-12-26	WOS:000754625200019
J	Xia, Q; Jia, J; Hu, CP; Lu, JY; Li, JJ; Xu, HY; Fang, JC; Feng, DJ; Wang, LW; Chen, Y				Xia, Qing; Jia, Jing; Hu, Chupeng; Lu, Jinying; Li, Jiajin; Xu, Haiyan; Fang, Jianchen; Feng, Dongju; Wang, Liwei; Chen, Yun			Tumor-associated macrophages promote PD-L1 expression in tumor cells by regulating PKM2 nuclear translocation in pancreatic ductal adenocarcinoma	ONCOGENE			English	Article							PYRUVATE-KINASE M2; CANCER-IMMUNOTHERAPY; CARCINOMA CELLS; PATHWAY; METABOLISM	In many types of cancer, tumor cells prefer to use glycolysis as a major energy acquisition method. Here, we found that the (18)fluoro-deoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT)-based markers were positively associated with the expression of programmed cell death ligand 1 (PD-L1), pyruvate kinase M2 (PKM2), both of which indicate poor prognosis in patients with pancreatic ductal adenocarcinoma (PDAC). However, the regulatory mechanism of PD-L1 remains elusive. In this study, we confirmed that transforming growth factor-beta1 (TGF-beta 1) secreted by tumor-associated macrophages (TAMs) was a key factor contributing to the expression of PD-L1 in PDAC cells by inducing the nuclear translocation of PKM2. Using co-immunoprecipitation and chromatin immunoprecipitation assays, we demonstrated that the interaction between PKM2 and signal transducer and activator of transcription 1 (STAT1) was enhanced by TGF-beta 1 stimulation, which facilitated the transactivation of PD-L1 by the binding of PKM2 and STAT1 to its promoter. In vivo, PKM2 knockdown decreased PD-L1 expression in PDAC cells and inhibited tumor growth partly by promoting natural killer cell activation and function, and the combination of PD-1/PD-L1 blockade with PKM2 knockdown limited tumor growth. In conclusion, PKM2 significantly contributes to TAM-induced PD-L1 overexpression and immunosuppression, providing a novel target for immunotherapies for PDAC.	[Xia, Qing] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Oncol, Shanghai 200127, Peoples R China; [Jia, Jing] Nanjing Med Univ, Med Ctr Digest Dis, Affiliated Hosp 2, Nanjing 210011, Jiangsu, Peoples R China; [Hu, Chupeng; Lu, Jinying; Chen, Yun] Nanjing Med Univ, Jiangsu Canc Hosp, Res Ctr Clin Oncol, Jiangsu Inst Canc Res,Affiliated Canc Hosp, Nanjing 210018, Jiangsu, Peoples R China; [Hu, Chupeng; Lu, Jinying; Feng, Dongju; Chen, Yun] Nanjing Med Univ, Dept Immunol, Key Lab Human Funct Genom Jiangsu Prov, Nanjing 211166, Jiangsu, Peoples R China; [Hu, Chupeng; Lu, Jinying; Chen, Yun] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 211166, Jiangsu, Peoples R China; [Li, Jiajin] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Nucl Med, Shanghai 200127, Peoples R China; [Xu, Haiyan; Wang, Liwei] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, Shanghai 200127, Peoples R China; [Fang, Jianchen] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Pathol, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, Y (corresponding author), Nanjing Med Univ, Jiangsu Canc Hosp, Res Ctr Clin Oncol, Jiangsu Inst Canc Res,Affiliated Canc Hosp, Nanjing 210018, Jiangsu, Peoples R China.; Chen, Y (corresponding author), Nanjing Med Univ, Dept Immunol, Key Lab Human Funct Genom Jiangsu Prov, Nanjing 211166, Jiangsu, Peoples R China.; Chen, Y (corresponding author), Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 211166, Jiangsu, Peoples R China.; Wang, LW (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, Shanghai 200127, Peoples R China.	liweiwang@shsmu.edu.cn; chenyun@njmu.edu.cn		chen, yun/0000-0002-4118-362X; Li, Jiajin/0000-0003-1300-6025	National Natural Science Foundation of China [82071767, 81772602, 91742105, 91942309, 82073195, 8210102291, 81874048]; Jiangsu Provincial key research development program of China [BE2018750]; Key Laboratory of Emergency and Trauma, Ministry of Education [KLET-201913]; Innovation Group Project of Shanghai Municipal Health Commission [2019CXJQ03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial key research development program of China; Key Laboratory of Emergency and Trauma, Ministry of Education; Innovation Group Project of Shanghai Municipal Health Commission	This work was supported by project grants from The National Natural Science Foundation of China (82071767, 81772602, 91742105, and 91942309 to Y.C.; 82073195 to Q.X.; 8210102291 to C.P.H., and 81874048 to L.W.W.), Jiangsu Provincial key research development program of China (BE2018750 to Y.C.), Key Laboratory of Emergency and Trauma, Ministry of Education (KLET-201913 to Y.C.), and Innovation Group Project of Shanghai Municipal Health Commission (2019CXJQ03 to L.W.W.).	Adamska A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071338; Alsaab HO, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00561; Balachandran VP, 2019, GASTROENTEROLOGY, V156, P2056, DOI 10.1053/j.gastro.2018.12.038; Brooks J, 2018, CANCER RES, V78, P475, DOI 10.1158/0008-5472.CAN-17-2415; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chen BF, 2020, BIOMATERIALS, V255, DOI 10.1016/j.biomaterials.2020.120187; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Colak S, 2017, TRENDS CANCER, V3, P56, DOI 10.1016/j.trecan.2016.11.008; Cortese N, 2020, CANCER IMMUNOL RES, V8, P493, DOI 10.1158/2326-6066.CIR-19-0403; David JM, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1349589; Deng WJ, 2018, CELL REP, V24, P366, DOI 10.1016/j.celrep.2018.06.026; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Feng MY, 2017, CANCER LETT, V407, P57, DOI 10.1016/j.canlet.2017.08.006; Gao XL, 2013, J BIOL CHEM, V288, P15971, DOI 10.1074/jbc.M112.448753; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Garrido F, 2001, ADV CANCER RES, V83, P117, DOI 10.1016/S0065-230X(01)83005-0; Giehl K, 2000, ONCOGENE, V19, P4531, DOI 10.1038/sj.onc.1203806; Gong J, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0316-z; Hsu J, 2018, J CLIN INVEST, V128, P4654, DOI 10.1172/JCI99317; Hussain SM, 2021, CELL ONCOL, V44, P673, DOI 10.1007/s13402-021-00594-0; Ijichi H, 2004, ONCOGENE, V23, P1043, DOI 10.1038/sj.onc.1207222; Jiang XJ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0928-4; Joergensen MT, 2010, PANCREAS, V39, P243, DOI 10.1097/MPA.0b013e3181bae8ab; Kumar Y, 2007, PANCREAS, V35, P114, DOI 10.1097/mpa.0b013e3180537237; Li TE, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.589997; Long L, 2020, J CANCER, V11, P4442, DOI 10.7150/jca.42610; Mohammad GH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151635; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Ohaegbulam KC, 2015, TRENDS MOL MED, V21, P24, DOI 10.1016/j.molmed.2014.10.009; Palsson-McDermott EM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01300; Pan Y, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1581529; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Roemer MGM, 2016, CANCER IMMUNOL RES, V4, P910, DOI 10.1158/2326-6066.CIR-16-0201; Ruscetti M, 2020, CELL, V181, P424, DOI 10.1016/j.cell.2020.03.008; Shifrin N, 2014, SEMIN IMMUNOL, V26, P138, DOI 10.1016/j.smim.2014.02.007; Smahel M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061331; Subramanian G, 2004, CANCER RES, V64, P5200, DOI 10.1158/0008-5472.CAN-04-0018; Van Audenaerde JRM, 2018, PHARMACOL THERAPEUT, V189, P31, DOI 10.1016/j.pharmthera.2018.04.003; Wartenberg M, 2018, CLIN CANCER RES, V24, P4444, DOI 10.1158/1078-0432.CCR-17-3401; Wong N, 2015, CANCER LETT, V356, P184, DOI 10.1016/j.canlet.2014.01.031; Yan L, 2019, CANCERS, V11, DOI 10.3390/cancers11101460; Yang S, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.607209; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhang C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01295; Zhang X, 2017, NAT COMMUN, V8, P1, DOI [10.1038/s41467-017-01968-5, 10.1038/ncomms14542, 10.1038/s41467-017-00321-0]; Zhang Z, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0317-8	47	11	12	1	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2022	41	6					865	877		10.1038/s41388-021-02133-5	http://dx.doi.org/10.1038/s41388-021-02133-5		DEC 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YT5VS	34862460	Green Published, hybrid			2022-12-26	WOS:000725939000001
J	Mwaiswelo, RO; Mmbando, BP; Chacky, F; Molteni, F; Mohamed, A; Lazaro, S; Mkalla, SF; Samuel, B; Ngasala, B				Mwaiswelo, Richard O.; Mmbando, Bruno P.; Chacky, Frank; Molteni, Fabrizio; Mohamed, Ally; Lazaro, Samwel; Mkalla, Sylvia F.; Samuel, Bushukatale; Ngasala, Billy			Malaria infection and anemia status in under-five children from Southern Tanzania where seasonal malaria chemoprevention is being implemented	PLOS ONE			English	Article							INTERVENTION; MALNUTRITION; HOUSEHOLD; IMPACT; RISK	Background Malaria and anemia remain major public health challenges in Tanzania. Household socioeconomic factors are known to influence these conditions. However, it is not clear how these factors influence malaria transmission and anemia in Masasi and Nanyumbu Districts. This study presents findings on malaria and anemia situation in under-five children and its influencing socioeconomic factors in Masasi and Nanyumbu Districts, surveyed as part of an ongoing seasonal malaria chemoprevention operational study. Methods A community-based cross-sectional survey was conducted between August and September 2020. Finger-prick blood samples collected from children aged 3-59 months were used to test for malaria infection using malaria rapid diagnostic test (mRDT), thick smears for determination of asexual and sexual parasitemia, and thin smear for parasite speciation. Hemoglobin concentration was measured using a HemoCue spectrophotometer. A structured questionnaire was used to collect household socioeconomic information from parents/caregivers of screened children. The prevalence of malaria was the primary outcome. Chi-square tests, t-tests, and logistic regression models were used appropriately. Results Overall mRDT-based malaria prevalence was 15.9% (373/2340), and was significantly higher in Nanyumbu (23.7% (167/705) than Masasi District (12.6% (206/1635), p<0.001. Location (Nanyumbu), no formal education, household number of people, household number of under-fives, not having a bed net, thatched roof, open/partially open eave, sand/soil floor, and low socioeconomic status were major risks for malaria infection. Some 53.9% (1196/2218) children had anemia, and the majority were in Nanyumbu (63.5% (458/705), p<0.001. Location (Nanyumbu), mRDT positive, not owning a bed net, not sleeping under bed net, open/partially open eave, thatched window, sex of the child, and age of the child were major risk factors for anemia. Conclusion Prevalence of malaria and anemia was high and was strongly associated with household socioeconomic factors. Improving household socioeconomic status is expected to reduce the prevalence of the conditions in the area.	[Mwaiswelo, Richard O.] Hubert Kairuki Mem Univ, Dept Microbiol Immunol & Parasitol, Dar Es Salaam, Tanzania; [Mmbando, Bruno P.] Tanga Res Ctr, Natl Inst Med Res, Tanga, Tanzania; [Chacky, Frank; Molteni, Fabrizio; Mohamed, Ally; Lazaro, Samwel] Minist Hlth Community Dev Gender Elderly & Childr, Natl Malaria Control Programme, Dodoma, Tanzania; [Mkalla, Sylvia F.] Tanzania Commiss Sci & Technol, Directorate Res Coordinat & Promot, Dar Es Salaam, Tanzania; [Samuel, Bushukatale; Ngasala, Billy] Muhimbili Univ Hlth & Allied Sci, Dept Med Parasitol & Entomol, Dar Es Salaam, Tanzania	National Institute of Medical Research; Muhimbili University of Health & Allied Sciences	Mwaiswelo, RO (corresponding author), Hubert Kairuki Mem Univ, Dept Microbiol Immunol & Parasitol, Dar Es Salaam, Tanzania.	richiemwai@yahoo.com		Mwaiswelo, Richard/0000-0002-1341-4304; Mmbando, Bruno/0000-0001-7232-8708	BN Global Fund	BN Global Fund	BN Global Fund Funders did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ayele DG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-195; Chirebvu Elijah, 2014, Malar Res Treat, V2014, P403069, DOI 10.1155/2014/403069; Coleman M, 2010, T ROY SOC TROP MED H, V104, P143, DOI 10.1016/j.trstmh.2009.07.010; Custodio E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-225; Deressa W, 2007, T ROY SOC TROP MED H, V101, P939, DOI 10.1016/j.trstmh.2007.04.018; Dobbs KR, 2016, PARASITOLOGY, V143, P129, DOI 10.1017/S0031182015001626; Duggan MB, 2010, ANN TROP PAEDIATR, V30, P1, DOI 10.1179/146532810X12637745451834; Edwards HM, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2852-5; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; EMA, 2016, GUID GOOD CLIN PRACT, V6; Gahutu JB, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-134; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Ghosh K, 2007, PARASITOL RES, V101, P1463, DOI 10.1007/s00436-007-0742-1; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Guerra M, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2354-x; Haldar Kasturi, 2009, Hematology Am Soc Hematol Educ Program, P87, DOI 10.1182/asheducation-2009.1.87; Hassan TH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005395; Kateera F, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0973-z; Khatib RA, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2446-7; Kinung'hi SM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0864-5; Klinkenberg E, 2006, TROP MED INT HEALTH, V11, P578, DOI 10.1111/j.1365-3156.2006.01609.x; Lowassa A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-129; Mazigo Humphrey D, 2010, Malar Res Treat, V2010, P794261, DOI 10.4061/2010/794261; Mazigo Humphrey D, 2011, BMC Res Notes, V4, P359, DOI 10.1186/1756-0500-4-359; Mazigo HD, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-44; Mmbando BP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-165; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; National Malaria Control Programme (NMCP), 2014, NAT MAL STRAT PLAN 2; NBS, 2017, MAL IND SURV 2017; Oladeinde BH, 2012, IRAN J PARASITOL, V7, P31; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Papaioannou I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47614-6; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; PMI, 2019, TANZ MAL OP PLAN FIS; PMI, 2014, TANZ MAL OP PLAN FIS; PMI, 2017, TANZ MAL OP PLAN 201; Rahmani S., 2015, Journal of Nutrition and Food Sciences, V5, P333; Reynaldi A, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2657-6; Ronald LA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-105; Sakwe N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218442; Salim N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003660; Siza JE, 2015, KOREAN J PARASITOL, V53, P525, DOI 10.3347/kjp.2015.53.5.525; Somi MF, 2007, AM J TROP MED HYG, V77, P1020, DOI 10.4269/ajtmh.2007.77.1020; Spitzen J, 2008, PHYSIOL ENTOMOL, V33, P116, DOI 10.1111/j.1365-3032.2008.00612.x; Sultana M, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0066-5; Tahita MC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-464; Urbaniak G.C., 2013, RES RANDOMIZER VERSI; Vajda EA, 2017, TROP MED INFECT DIS, V2, DOI 10.3390/tropicalmed2010004; Weatherall David J, 2002, Hematology Am Soc Hematol Educ Program, P35; West PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065787; White NJ, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2509-9; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2018, UN ACC COR MAL INT H; World Health Organization, 2015, WORLD MAL REP 2015; World Health Organization, 2017, DEPRESSION; World Health Organization, 2006, WHO CHILD GROWTH STA; Yadav K, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-19; Yeka A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118901	58	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260785	10.1371/journal.pone.0260785	http://dx.doi.org/10.1371/journal.pone.0260785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855878	gold, Green Published			2022-12-26	WOS:000735299000120
J	Park, YG; Lee, JH; Lim, UT				Park, Young-Gyun; Lee, Joon-Ho; Lim, Un Taek			Functional response of Amblyseius eharai (Acari: Phytoseiidae) on Tetranychus urticae (Acari: Tetranychidae)	PLOS ONE			English	Article							TEMPERATURE-DEPENDENT DEVELOPMENT; CALIFORNICUS MCGREGOR ACARI; LIFE-HISTORY TRAITS; NEOSEIULUS-CALIFORNICUS; BIOLOGICAL-CONTROL; MITES ACARI; OVIPOSITION MODEL; HOST-PLANT; WOMERSLEYI; PREFERENCE	Amblyseius eharai is a generalist predatory mite that consumes spider mites, rust mites, thrips, and pollen, with a high adaptability to various plants. To better understand ecological and behavioral aspects of this species, we investigated its functional response to different stages of two-spotted spider mite, Tetranychus urticae. Furthermore, we compared its environmental adaptability with that of other referenced phytoseiids using a temperature-dependent model of the intrinsic rate of increase. We were able to calculate the functional response parameters of both sexes of A. eharai when preying on eggs or larvae of T. urticae and, for females only, when preying on the deutonymph of T. urticae. Among the various combinations tested herein, A. eharai females preying on T. urticae larvae had the highest attack rate and shortest handling time. For eggs of T. urticae, A. eharai showed a lower attack rate; however, its handling time for eggs was significantly shorter compared to other phytoseiids. Using T. urticae larva as a prey, the attack rate of female A. eharai was higher and the handling time of both sexes of this species was shorter than those of other phytoseiid mites. Amblyseius eharai populations can show maximum performance quickly due to this species' lower optimal temperature for population growth (28.1 degrees C) compared to other phytoseiid mites. Thus, we provided evidence that this predatory mite has the potential to be a new, effective biological control agent of greenhouse pests such as T. urticae due to its high predation capacity and low optimal temperature.	[Park, Young-Gyun; Lee, Joon-Ho] Seoul Natl Univ, Dept Agr Biotechnol, Entomol Program, Seoul, South Korea; [Lee, Joon-Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Park, Young-Gyun; Lim, Un Taek] Andong Natl Univ, Dept Plant Med, Andong, South Korea; [Lee, Joon-Ho] Seoul Natl Univ, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Andong National University; Seoul National University (SNU)	Lim, UT (corresponding author), Andong Natl Univ, Dept Plant Med, Andong, South Korea.	utlim@andong.ac.kr		Park, Young-gyun/0000-0002-6519-1069; Lim, Un Taek/0000-0002-6704-0627	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [PJ013362042021]	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was carried out with the support of Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ013362042021), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JJ, 2010, J APPL ENTOMOL, V134, P98, DOI 10.1111/j.1439-0418.2009.01440.x; Amitai S., 1981, Israel Journal of Entomology, V15, P59; Attia S, 2013, J PEST SCI, V86, P361, DOI 10.1007/s10340-013-0503-0; Blackwood JS, 2001, ENVIRON ENTOMOL, V30, P1103, DOI 10.1603/0046-225X-30.6.1103; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; Chant D. A., 1959, CANADIAN ENTOMOL S12, V12; Collier T, 2004, BIOL CONTROL, V31, P245, DOI 10.1016/j.biocontrol.2004.05.001; Cuthbert RN, 2018, BIOL CONTROL, V121, P50, DOI 10.1016/j.biocontrol.2018.02.008; Dermauw W, 2013, P NATL ACAD SCI USA, V110, pE113, DOI 10.1073/pnas.1213214110; DICKE M, 1989, OECOLOGIA, V81, P302, DOI 10.1007/BF00377075; El Taj HF, 2012, EXP APPL ACAROL, V56, P247, DOI 10.1007/s10493-012-9516-2; Fathipour Y, 2020, BIOL CONTROL, V146, DOI 10.1016/j.biocontrol.2020.104266; Fathipour Y, 2018, ACAROLOGIA, V58, P31, DOI 10.24349/acarolo-gia/20184225; Fathipour Y, 2017, SYST APPL ACAROL-UK, V22, P159, DOI 10.11158/saa.22.2.1; Hajek AE, 2018, NATURAL ENEMIES INTR, V2nd, DOI DOI 10.1017/9781107280267; Ji J, 2015, SYST APPL ACAROL-UK, V20, P491, DOI 10.11158/saa.20.5.5; Juliano S.A., 2001, DESIGN ANAL ECOLOGIC, P178, DOI DOI 10.1201/9781003059813; Kakimoto Kazuki, 2004, Kyushu Byogaichu Kenkyukaiho, V50, P82; Kim DS, 2003, EXP APPL ACAROL, V31, P191, DOI 10.1023/B:APPA.0000010385.00864.28; Kim T, 2013, J APPL ENTOMOL, V137, P282, DOI 10.1111/j.1439-0418.2012.01734.x; Kim T, 2009, J APPL ENTOMOL, V133, P284, DOI 10.1111/j.1439-0418.2008.01343.x; Kwon DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139934; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; Lee HS, 2011, EXP APPL ACAROL, V53, P17, DOI 10.1007/s10493-010-9385-5; Lee MH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30018-3; Lemos F, 2010, EXP APPL ACAROL, V52, P1, DOI 10.1007/s10493-010-9344-1; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Marinosci C, 2015, ECOL EVOL, V5, P3151, DOI 10.1002/ece3.1554; McMurtry JA, 1997, ANNU REV ENTOMOL, V42, P291, DOI 10.1146/annurev.ento.42.1.291; McMurtry JA, 2015, PROG BIOL CONTROL, V19, P133, DOI 10.1007/978-3-319-15042-0_5; Mcmurtry JA, 2013, SYST APPL ACAROL-UK, V18, P297, DOI 10.11158/saa.18.4.1; Papanikolaou NE, 2020, ECOSPHERE, V11, DOI 10.1002/ecs2.3147; Park Y, 2020, THESIS SEOUL NATL U; Park YL, 2002, J ECON ENTOMOL, V95, P952, DOI 10.1603/0022-0493-95.5.952; Park YG, 2020, J ASIA-PAC ENTOMOL, V23, P869, DOI 10.1016/j.aspen.2020.07.021; Pascual-Ruiz S, 2014, EXP APPL ACAROL, V62, P337, DOI 10.1007/s10493-013-9744-0; Rahman MA, 2020, J ECON ENTOMOL, V113, P1735, DOI 10.1093/jee/toaa078; ROGERS D, 1972, J ANIM ECOL, V41, P369, DOI 10.2307/3474; Ryu Myon Ok, 1997, Korean Journal of Applied Entomology, V36, P224; Sabelis MW., 1986, LECT NOTES BIOMATHEM, P298; SAS Institute, 2013, SAS US GUID STAT VER; Schmidt RA, 2014, EXP APPL ACAROL, V62, P1, DOI 10.1007/s10493-013-9730-6; Shi PJ, 2016, ANN ENTOMOL SOC AM, V109, P211, DOI 10.1093/aesa/sav121; Song ZW, 2016, SYST APPL ACAROL-UK, V21, P936, DOI 10.11158/saa.21.7.7; Sousa VC, 2019, CURR OPIN INSECT SCI, V36, P82, DOI 10.1016/j.cois.2019.08.006; Sugawara R, 2018, BIOL CONTROL, V126, P26, DOI 10.1016/j.biocontrol.2018.07.010; Sugawara R, 2017, J ECON ENTOMOL, V110, P1533, DOI 10.1093/jee/tox177; SYSTAT Software Inc, 2002, TABLECURVE 2D AUTOMA; van den Boom CEM, 2003, J APPL ENTOMOL, V127, P177, DOI 10.1046/j.1439-0418.2003.00726.x; WAITE GK, 1994, ENTOMOPHAGA, V39, P275, DOI 10.1007/BF02373032	50	0	0	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260861	10.1371/journal.pone.0260861	http://dx.doi.org/10.1371/journal.pone.0260861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855893	gold, Green Published			2022-12-26	WOS:000735299000143
J	Rice, SJ; Belani, CP				Rice, Shawn J.; Belani, Chandra P.			Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer	PLOS ONE			English	Article							TO-LYMPHOCYTE RATIO; NSCLC PATIENTS; PROGNOSIS; INFLAMMATION; NEUTROPHIL; SURVIVAL; MARKER; ASSAYS; INDEX	Blood-based biomarkers including systemic inflammation (SI) indicators or circulating factors (cytokines, chemokines, or growth factors) are associated with a poor prognosis for lung cancer patients. Collectively these biomarkers can predict the immune state of a patient. We wanted to define and compare the immune states of small cell and non-small cell lung cancer patients, in the hopes that the information gained could lead to overall improvements in patient care and outcomes. Specimens and data from 235 patients was utilized, 49 surgically resected non-small cell lung cancer (NSCLC) patients with no evidence of disease (DF), 135 advanced non-small cell lung cancer (NSCLC), 51 small cell lung cancer (SCLC). SI markers neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte (PLR), systemic inflammation index (SII), and systemic inflammation response index (SIRI) were determined from blood counts. Forty-seven plasma cytokines were measured using a multiplex bead-based assay. Progression-free survival (PFS) and overall survival (OS) were assessed using Kaplan-Meier and Cox Proportional Hazards models. NSCLC patients had significantly high levels of SI markers than SCLC and DF patients, while NLR, PLR and SII were also higher in SCLC than DF patients. SI optimized marker values to differentiate SI value were; 6.04 (NLR), 320 (PLR), 1615 (SII), and 7.3 (SIRI). Elevated levels NLR (p<0.001), PLR (p<0.001), and SII (p = 0.018) were associated with a worse PFS and OS in NSCLC, while none of the markers were associated with PFS in SCLC patients. NSCLC patients with a poor outcome displayed heterogeneous immune states relative to systemic inflammation and circulating IL-6 markers. These groups could be distinguished based on the cytokines IL-8, TNF alpha, and IL-27. We identified heterogeneity of immune states in SCLC and NSCLC patients and in NSCLC patients with the poorest prognosis. This heterogeneity could be exploited to improve outcomes for these patients.	[Rice, Shawn J.; Belani, Chandra P.] Penn State Canc Inst, Hershey, PA 17033 USA; [Belani, Chandra P.] Milton S Hershey Med Ctr, Dept Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Belani, CP (corresponding author), Penn State Canc Inst, Hershey, PA 17033 USA.; Belani, CP (corresponding author), Milton S Hershey Med Ctr, Dept Med, Hershey, PA 17033 USA.	cbelani@psu.edu		Belani, Chandra/0000-0001-5049-5329				Akinci Ozyurek Berna, 2017, Asian Pac J Cancer Prev, V18, P1417; Alifano M, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.03.174; Bakouny Z, 2020, NAT MED, V26, P650, DOI 10.1038/s41591-020-0873-9; Bastid J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00718; Brahmer J., 2015, J CLIN ONCOL; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Bremnes RM, 2011, J THORAC ONCOL, V6, P824, DOI 10.1097/JTO.0b013e3182037b76; Cancer.Net, 2020, LUNG CANC NONSMALL C; Chang CH, 2013, INT J CANCER, V132, P1977, DOI 10.1002/ijc.27892; Chen YS, 2019, ONCOL REP, V42, P1141, DOI 10.3892/or.2019.7220; Comen EA, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00056; CRAN, COMPREHENSIVE R ARCH; David JM, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4030022; Derman BA, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3122-y; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Drpa G, 2020, RADIOL ONCOL, V54, P437, DOI 10.2478/raon-2020-0054; Dusselier M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219060; Fabbi M, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3958069; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gao YY, 2017, ONCOTARGET, V8, P27489, DOI 10.18632/oncotarget.14225; Hirsch FR, 2017, J THORAC ONCOL, V12, P208, DOI 10.1016/j.jtho.2016.11.2228; Huang J, 2020, ONCOLOGY-NY, V34, P272; Kim H, 2017, ONCOTARGET, V8, P98524, DOI 10.18632/oncotarget.21567; Li S, 2017, J CANCER RES CLIN, V143, P2455, DOI 10.1007/s00432-017-2506-3; Liu D, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3893-1; Liu JJ, 2019, J CLIN LAB ANAL, V33, DOI 10.1002/jcla.22964; Matsubara T, 2020, J THORAC DIS, V12, P1520, DOI 10.21037/jtd.2020.02.27; McLaughlin J, 2016, JAMA ONCOL, V2, P46, DOI 10.1001/jamaoncol.2015.3638; Montfort A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01818; Nakaya A, 2018, INT J CLIN ONCOL, V23, P634, DOI 10.1007/s10147-018-1250-2; Ren FP, 2019, ONCOTARGETS THER, V12, P4235, DOI 10.2147/OTT.S199176; Rice SJ, 2019, LUNG CANCER, V131, P58, DOI 10.1016/j.lungcan.2019.03.014; Schiavoni G, 2011, CANCER RES, V71, P768, DOI 10.1158/0008-5472.CAN-10-2788; Silva EM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181125; Stagg J, 2011, P NATL ACAD SCI USA, V108, P7142, DOI 10.1073/pnas.1016569108; Takeda T, 2018, THORAC CANCER, V9, P1291, DOI 10.1111/1759-7714.12838; Wang LQ, 2017, ONCOL LETT, V14, P6449, DOI 10.3892/ol.2017.7047; Wang X., PRETREATMENT NEUTROP, P1178; Zhang Y, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000013788; Zhao JJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20190297; Zhao P, 2018, ONCOL LETT, V15, P3820, DOI 10.3892/ol.2018.7735	41	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260988	10.1371/journal.pone.0260988	http://dx.doi.org/10.1371/journal.pone.0260988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855926	gold, Green Published			2022-12-26	WOS:000735299000165
J	Rohan, E; Turjanicova, JC; Liska, V				Rohan, Eduard; Turjanicova, Jana Camprova; Liska, Vaclav			Geometrical model of lobular structure and its importance for the liver perfusion analysis	PLOS ONE			English	Article							POROUS-MEDIA; BLOOD-FLOW; HOMOGENIZATION; TISSUE; MICROCIRCULATION	A convenient geometrical description of the microvascular network is necessary for computationally efficient mathematical modelling of liver perfusion, metabolic and other physiological processes. The tissue models currently used are based on the generally accepted schematic structure of the parenchyma at the lobular level, assuming its perfect regular structure and geometrical symmetries. Hepatic lobule, portal lobule, or liver acinus are considered usually as autonomous functional units on which particular physiological problems are studied. We propose a new periodic unit-the liver representative periodic cell (LRPC) and establish its geometrical parametrization. The LRPC is constituted by two portal lobulae, such that it contains the liver acinus as a substructure. As a remarkable advantage over the classical phenomenological modelling approaches, the LRPC enables for multiscale modelling based on the periodic homogenization method. Derived macroscopic equations involve so called effective medium parameters, such as the tissue permeability, which reflect the LRPC geometry. In this way, mutual influences between the macroscopic phenomena, such as inhomogeneous perfusion, and the local processes relevant to the lobular (mesoscopic) level are respected. The LRPC based model is intended for its use within a complete hierarchical model of the whole liver. Using the Double-permeability Darcy model obtained by the homogenization, we illustrate the usefulness of the LRPC based modelling to describe the blood perfusion in the parenchyma.	[Rohan, Eduard; Turjanicova, Jana Camprova] Univ West Bohemia, Fac Appl Sci, Dept Mech, Plzen, Czech Republic; [Liska, Vaclav] Charles Univ Pilsen, Fac Med, Biomed Ctr, Plzen, Czech Republic	University of West Bohemia Pilsen; Charles University Prague	Rohan, E (corresponding author), Univ West Bohemia, Fac Appl Sci, Dept Mech, Plzen, Czech Republic.	rohan@kme.zcu.cz		Rohan, Eduard/0000-0002-0300-4600	European Regional Development Fund-Project ``Application of Modern Technologies in Medicine and Industry'' [CZ.02.1.01/0.0/0.0/17 048/0007280]	European Regional Development Fund-Project ``Application of Modern Technologies in Medicine and Industry''	This research was supported by the European Regional Development Fund-Project ``Application of Modern Technologies in Medicine and Industry'', No. CZ.02.1.01/0.0/0.0/17 048/0007280. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Badejani R, 2020, COMPUT METHOD BIOMEC, V23, P987, DOI 10.1080/10255842.2020.1782389; ARBOGAST T, 1990, SIAM J MATH ANAL, V21, P823, DOI 10.1137/0521046; Bonfiglio A, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002563; Chou D., 2014, J BIOSCIENCES MED, V2, P1, DOI [10.4236/jbm.2014.22001, DOI 10.4236/JBM.2014.22001]; Christ B, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00906; Cioranescu D, 2008, SIAM J MATH ANAL, V40, P1585, DOI 10.1137/080713148; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Debbaut C, 2014, COMPUT METHOD BIOMEC, V17, P1295, DOI 10.1080/10255842.2012.744399; Debbaut C, 2014, J ANAT, V224, P509, DOI 10.1111/joa.12156; Debbaut C, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005545; Drasdo D, 2014, J HEPATOL, V61, P951, DOI 10.1016/j.jhep.2014.06.013; Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016; Fu X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198060; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Guo LW, 2020, INT J ENG SCI, V147, DOI 10.1016/j.ijengsci.2019.103204; Ho H, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.01061; Hohme S, 2007, CHEM-BIOL INTERACT, V168, P74, DOI 10.1016/j.cbi.2007.01.010; Koppl T, 2020, INT J NUMER METH BIO, V36, DOI 10.1002/cnm.3386; Kwon YJ, 2015, CLIN MOL HEPATOL, V21, P7, DOI 10.3350/cmh.2015.21.1.7; Lettmann KA, 2014, J THEOR BIOL, V348, P33, DOI 10.1016/j.jtbi.2014.01.016; Lodewick TM, 2016, HPB, V18, P764, DOI 10.1016/j.hpb.2016.06.009; Lorente S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73208-8; Lukes V., 2020, HOMOGENIZATION LARGE; Ma RF, 2019, INT J NUMER METH BIO, V35, DOI 10.1002/cnm.3229; Marrone G, 2016, J HEPATOL, V65, P608, DOI 10.1016/j.jhep.2016.04.018; Matsumoto T, 1982, Acta Pathol Jpn, V32 Suppl 2, P285; McCuskey RS, 2000, LIVER, V20, P3, DOI 10.1034/j.1600-0676.2000.020001003.x; Moreno R., 2017, COMPUTATIONAL BIOMEC, V1, P71, DOI [10.1007/978-3-319-54481-6_6, DOI 10.1007/978-3-319-54481-6_6]; Mosharaf-Dehkordi M, 2019, COMPUT METHOD BIOMEC, V22, P901, DOI 10.1080/10255842.2019.1601180; Paton RC., 2003, PRACTICE AUTONOMOUS, P411; Peyrounette M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189474; Piergiovanni M, 2017, J BIOMECH, V63, P125, DOI 10.1016/j.jbiomech.2017.08.011; Rani HP, 2006, J BIOMECH, V39, P551, DOI 10.1016/j.jbiomech.2004.11.029; RAPPAPORT AM, 1954, ANAT REC, V119, P11, DOI 10.1002/ar.1091190103; Rezania V, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0034-5; Rezania V, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-52; Ricken T, 2015, BIOMECH MODEL MECHAN, V14, P515, DOI 10.1007/s10237-014-0619-z; Ricken T, 2010, BIOMECH MODEL MECHAN, V9, P435, DOI 10.1007/s10237-009-0186-x; Rohan E, 2015, APPL MATH COMPUT, V267, P583, DOI 10.1016/j.amc.2015.01.054; Rohan E, 2012, J MECH PHYS SOLIDS, V60, P857, DOI 10.1016/j.jmps.2012.01.013; Rohan E, 2018, P 6 EUR C COMP MECH, V1, P870; Rohan E, P 15 INT C COMP PLAS; Rohan E, 2021, COMPUT STRUCT, V251, DOI 10.1016/j.compstruc.2020.106404; Rohan E, 2006, COMPUT STRUCT, V84, P1095, DOI 10.1016/j.compstruc.2006.01.008; Rohan E, 2019, COMPUT MATH APPL, V78, P3044, DOI 10.1016/j.camwa.2019.04.004; Rohan E, 2018, J MATH BIOL, V77, P421, DOI 10.1007/s00285-018-1209-y; Rohan E, 2010, INT J MULTISCALE COM, V8, P81, DOI 10.1615/IntJMultCompEng.v8.i1.70; Romanelli RG, 2016, CURR DRUG TARGETS, V17, P1804, DOI 10.2174/1389450117666160613101413; Showalter RE, 2004, J MATH ANAL APPL, V295, P191, DOI 10.1016/j.jmaa.2004.03.031; Siggers JH, 2014, BIOMECH MODEL MECHAN, V13, P363, DOI 10.1007/s10237-013-0516-x; White D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162215	51	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260068	10.1371/journal.pone.0260068	http://dx.doi.org/10.1371/journal.pone.0260068			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855778	Green Published, gold			2022-12-26	WOS:000735299000028
J	Jafari, M; Shiran, B; Rabiei, G; Ravash, R; Tabatabaei, BES; Martinez-Gomez, P				Jafari, Marjan; Shiran, Behrouz; Rabiei, Gholamreza; Ravash, Roudabeh; Tabatabaei, Badraldin Ebrahim Sayed; Martinez-Gomez, Pedro			Identification and verification of seed development related miRNAs in kernel almond by small RNA sequencing and qPCR	PLOS ONE			English	Article							TARGET GENES; STARCH; SIZE; EXPRESSION; MICRORNAS; POLLEN; FLOWER; OVEREXPRESSION; STARVATION; SUCROSE	Many studies have investigated the role of miRNAs on the yield of various plants, but so far, no report is available on the identification and role of miRNAs in fruit and seed development of almonds. In this study, preliminary analysis by high-throughput sequencing of short RNAs of kernels from the crosses between almond cultivars 'Sefid' x 'Mamaee' (with small and large kernels, respectively) and 'Sefid' x 'P. orientalis' (with small kernels) showed that the expressions of several miRNAs such as Pdu-miR395a-3p, Pdu-miR8123-5p, Pdu-miR482f, Pdu-miR6285, and Pdu-miR396a were significantly different. These miRNAs targeted genes encoding different proteins such as NYFB-3, SPX1, PGSIP3 (GUX2), GH3.9, and BEN1. The result of RT-qPCR revealed that the expression of these genes showed significant differences between the crosses and developmental stages of the seeds, suggesting that these genes might be involved in controlling kernel size because the presence of these miRNAs had a negative effect on their target genes. Pollen source can influence kernel size by affecting hormonal signaling and metabolic pathways through related miRNAs, a phenomenon known as xenia.	[Jafari, Marjan; Rabiei, Gholamreza] Shahrekord Univ, Fac Agr, Dept Hort, Shahrekord, Iran; [Shiran, Behrouz; Ravash, Roudabeh] Shahrekord Univ, Fac Agr, Dept Plant Breeding & Biotechnol, Shahrekord, Iran; [Shiran, Behrouz] Shahrekord Univ, Inst Biotechnol, Shahrekord, Iran; [Tabatabaei, Badraldin Ebrahim Sayed] Isfahan Univ Technol, Coll Agr, Dept Biotechnol, Esfahan, Iran; [Martinez-Gomez, Pedro] CEBAS CSIC, Dept Plant Breeding, Murcia, Spain	Shahrekord University; Shahrekord University; Shahrekord University; Isfahan University of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS)	Shiran, B (corresponding author), Shahrekord Univ, Fac Agr, Dept Plant Breeding & Biotechnol, Shahrekord, Iran.; Shiran, B (corresponding author), Shahrekord Univ, Inst Biotechnol, Shahrekord, Iran.	shirna@sku.ac.ir	Martinez-Gomez, Pedro/G-4217-2011	Martinez-Gomez, Pedro/0000-0003-1054-8814; Shiran, Behrouz/0000-0001-9997-4718	Shahrekord University, Iran National Science Foundation (INSF); Biotechnology and Horticultural Research Institute of Shahrekord University	Shahrekord University, Iran National Science Foundation (INSF); Biotechnology and Horticultural Research Institute of Shahrekord University	We would like to acknowledge Shahrekord University, Iran National Science Foundation (INSF) and the Biotechnology and Horticultural Research Institute of Shahrekord University that support our research on laboratory experiments. We are grateful to Dr. S. H. Nourbakhsh who provided valuable almond samples. We wish to highlight our gratitude to Dr. Hossein Fallahi and Dr. Pedro J Marti ' nez-Garci ' a for the collaboration in the data analysis.	Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Aryal R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-20; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Bagnaresi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051609; Barakat A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-481; Barakat A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-38; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Cao DY, 2016, PLANT SCI, V247, P1, DOI 10.1016/j.plantsci.2016.02.012; Carbone F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221460; Chatterjee M, 2005, PLANT SCI, V168, P501, DOI 10.1016/j.plantsci.2004.09.015; Chaudhury AM, 2001, ANNU REV CELL DEV BI, V17, P677, DOI 10.1146/annurev.cellbio.17.1.677; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cheng X, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2794040; Correa JP., 2018, FRONT PLANT SCI, V9, P1, DOI [10.3389/fpls.2018.00001, DOI 10.3389/FPLS.2018.00001]; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; CRANE JC, 1980, HORTSCIENCE, V15, P184; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dhaka N, 2021, CRIT REV BIOTECHNOL, V41, P594, DOI 10.1080/07388551.2021.1873238; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fan FH, 2022, J PLANT GROWTH REGUL, V41, P2949, DOI 10.1007/s00344-021-10486-0; Fernandez D, 2012, MOL PLANT PATHOL, V13, P17, DOI 10.1111/j.1364-3703.2011.00723.x; Figueiredo DD, 2014, BIOCHEM SOC T, V42, P358, DOI 10.1042/BST20130221; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; Ge AJ, 2013, PHYSIOL PLANTARUM, V148, P387, DOI 10.1111/j.1399-3054.2012.01713.x; Griggs WH., 1953, POLLINATION REQUIREM, P424; Hossein-Ava S., 2006, INT J HORT SCI TECH, V37, P370; Hwang H, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11030556; Jackson JF, 1996, SEX PLANT REPROD, V9, P367, DOI 10.1007/BF02441958; Jafari M, IDENTIFICATION XENIA; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; Javadi D., 2006, INT J HORT SCI TECHN, V7, P15; Jiang WB, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25928; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kang CY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2014-2; Kant S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002021; Karimi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156519; Kester D. E., 1975, Advances in fruit breeding. Temperate nuts., P387; Lakhwani D, 2020, PLANT GROWTH REGUL, V90, P223, DOI 10.1007/s10725-020-00572-w; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; Lei MG, 2011, PLANT PHYSIOL, V156, P1116, DOI 10.1104/pp.110.171736; Li S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2334-2; Lin SI, 2010, PLANT CELL PHYSIOL, V51, P2119, DOI 10.1093/pcp/pcq170; Liu F, 2010, PLANT J, V62, P508, DOI 10.1111/j.1365-313X.2010.04170.x; Liu YL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-695; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; MARTIN C, 1995, PLANT CELL, V7, P971, DOI 10.1105/tpc.7.7.971; Nithin C, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4232-2; Niu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep35675; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Parreira JR, 2021, HORTIC RES-ENGLAND, V8, DOI 10.1038/s41438-020-00448-0; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Rubio M, 2015, MOL PLANT PATHOL, V16, P164, DOI 10.1111/mpp.12169; Rubio-Pina JA, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue5-fulltext-10; Sanchez-Perez R, 2004, EUPHYTICA, V138, P263, DOI 10.1023/B:EUPH.0000047097.96271.bf; Sanchez-Perez R, 2012, SCI HORTIC-AMSTERDAM, V139, P62, DOI 10.1016/j.scienta.2012.02.028; SOCIASICOMPANY R, 1976, J AM SOC HORTIC SCI, V101, P490; Sun XD, 2010, CURR OPIN PLANT BIOL, V13, P611, DOI 10.1016/j.pbi.2010.08.009; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; VEZVAEI A, 1995, AUST J EXP AGR, V35, P109, DOI 10.1071/EA9950109; Wang C., 2020, STUDY MIRNAS MEDIATE, DOI [10.21203/rs.3.rs-101517/, DOI 10.21203/RS.3.RS-101517]; Wang C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-122; Wang Yan, 2021, Plant Cell Physiol, V62, P564, DOI 10.1093/pcp/pcab011; Wang ZY, 2009, J INTEGR PLANT BIOL, V51, P663, DOI 10.1111/j.1744-7909.2009.00834.x; Westfall CS, 2016, P NATL ACAD SCI USA, V113, P13917, DOI 10.1073/pnas.1612635113; Wu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-953; Xiao WY, 2006, PLANT PHYSIOL, V142, P1160, DOI 10.1104/pp.106.088849; Xu SM, 2012, MOL PLANT, V5, P430, DOI 10.1093/mp/ssr090; Yao JL, 2015, PLANT J, V84, P417, DOI 10.1111/tpj.13021; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zhang H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180600; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045953; Zhang YC, 2013, NAT BIOTECHNOL, V31, P848, DOI 10.1038/nbt.2646; Zheng LJ, 2019, MOL GENET GENOMICS, V294, P501, DOI 10.1007/s00438-018-1524-4	76	0	0	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260492	10.1371/journal.pone.0260492	http://dx.doi.org/10.1371/journal.pone.0260492			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851991	Green Published, gold			2022-12-26	WOS:000755762900039
J	Kinahan, SM; Silcott, DB; Silcott, BE; Silcott, RM; Silcott, PJ; Silcott, BJ; Distelhorst, SL; Herrera, VL; Rivera, DN; Crown, KK; Lucero, GA; Santarpia, JL				Kinahan, Sean M.; Silcott, David B.; Silcott, Blake E.; Silcott, Ryan M.; Silcott, Peter J.; Silcott, Braden J.; Distelhorst, Steven L.; Herrera, Vicki L.; Rivera, Danielle N.; Crown, Kevin K.; Lucero, Gabriel A.; Santarpia, Joshua L.			Aerosol tracer testing in Boeing 767 and 777 aircraft to simulate exposure potential of infectious aerosol such as SARS-CoV-2	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; CONTAMINANT TRANSPORT; EXPIRATORY AEROSOLS; TRANSMISSION; CABIN; DEPOSITION; IMPACT	The COVID-19 pandemic has reintroduced questions regarding the potential risk of SARS-CoV-2 exposure amongst passengers on an aircraft. Quantifying risk with computational fluid dynamics models or contact tracing methods alone is challenging, as experimental results for inflight biological aerosols is lacking. Using fluorescent aerosol tracers and real time optical sensors, coupled with DNA-tagged tracers for aerosol deposition, we executed ground and inflight testing on Boeing 767 and 777 airframes. Analysis here represents tracer particles released from a simulated infected passenger, in multiple rows and seats, to determine the exposure risk via penetration into breathing zones in that row and numerous rows ahead and behind the index case. We present here conclusions from 118 releases of fluorescent tracer particles, with 40+ Instantaneous Biological Analyzer and Collector sensors placed in passenger breathing zones for real-time measurement of simulated virus particle penetration. Results from both airframes showed a minimum reduction of 99.54% of 1 mu m aerosols from the index source to the breathing zone of a typical passenger seated directly next to the source. An average 99.97 to 99.98% reduction was measured for the breathing zones tested in the 767 and 777, respectively. Contamination of surfaces from aerosol sources was minimal, and DNA-tagged 3 mu m tracer aerosol collection techniques agreed with fluorescent methodologies.	[Kinahan, Sean M.; Herrera, Vicki L.; Santarpia, Joshua L.] Univ Nebraska Med Ctr, Omaha, NE 68198 USA; [Kinahan, Sean M.; Distelhorst, Steven L.; Rivera, Danielle N.; Crown, Kevin K.; Lucero, Gabriel A.; Santarpia, Joshua L.] Natl Strateg Res Ctr, Omaha, NE 68198 USA; [Silcott, David B.; Silcott, Blake E.; Silcott, Ryan M.; Silcott, Peter J.; Silcott, Braden J.] S3I LLC, Reisterstown, MD USA	University of Nebraska System; University of Nebraska Medical Center	Kinahan, SM (corresponding author), Univ Nebraska Med Ctr, Omaha, NE 68198 USA.; Kinahan, SM (corresponding author), Natl Strateg Res Ctr, Omaha, NE 68198 USA.	skinahan@nsri.nebraskaresearch.gov	Santarpia, Joshua/AAW-5199-2021		United States Transportation Command (USTRANSCOM) through an Army Research Office [W911NF-17-C-0060]	United States Transportation Command (USTRANSCOM) through an Army Research Office	These studies were sponsored by United States Transportation Command (USTRANSCOM) through an Army Research Office Contract (W911NF-17-C-0060) to Zeteo Tech Incorporated. Zeteo Tech provided project management, programmatic support, and technical expertise. Additional test plan review and expertise were provided by DARPA Biological Technologies Office (BTO) as a courtesy to USTRANSCOM. United Airlines won a competitive bid for initial testing and methods development, and then donated fuel, airplanes, and flight time for the follow-on testing presented here at no cost. Boeing answered engineering questions and provided operational feedback on ECS system performance at no cost as a courtesy to USTRANSCOM. Instruments were loaned by DHS Science and Technology Directorate via MIT Lincoln Laboratories, and the National Guard Bureau via L2 Defense. NSRI, S3I, and UNMC received subcontracting funding from Zeteo Tech to perform experiments and provide analysis and aerobiology expertise. The funder provided support in the form of salaries but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arumuru V, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0030101; Asadi S, 2020, AEROSOL SCI TECH, V54, P635, DOI 10.1080/02786826.2020.1749229; Bae SH, 2020, EMERG INFECT DIS, V26, P2705, DOI 10.3201/eid2611.203353; Bennett JS, 2013, HVAC&R RES, V19, P962, DOI 10.1080/10789669.2013.838990; Centers for Disease Control, 2020, SARS COV 2 POT AIRB; Chalmers TC, 1986, AIRL CAB ENV AIR QUA; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen WH, 2017, BUILD ENVIRON, V111, P80, DOI 10.1016/j.buildenv.2016.10.017; Burton NC, 2007, ANN OCCUP HYG, V51, P143, DOI 10.1093/annhyg/mel073; de Man P, 2021, CLIN INFECT DIS, V73, P170, DOI 10.1093/cid/ciaa1270; de Sousa NR, 2020, ANN WORK EXPOS HEAL, V64, P852, DOI 10.1093/annweh/wxaa053; DeFreez R., 2009, OPT BASED BIOL CHEM, V7484; Edwards DA, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021830118; Freedman DO, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa178; Hamner L, 2020, MMWR-MORBID MORTAL W, V69, P606, DOI 10.15585/mmwr.mm6919e6; Harding RN, 2016, AEROSOL SCI TECH, V50, P429, DOI 10.1080/02786826.2016.1162903; Hinds WC, 1999, AEROSOL TECHNOLOGY P, V2nd, P504, DOI 10.1016/0021-8502(83)90049-6; Hoehl S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18044; Lednickya JA, 2020, INT J INFECT DIS, V100, P476, DOI [10.1016/j.ijid.2020.09.025, 10.1101/2020.08.03.20167395]; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Li B, 2016, INDOOR AIR, V26, P806, DOI 10.1111/ina.12265; Li F, 2014, ATMOS ENVIRON, V85, P223, DOI 10.1016/j.atmosenv.2013.11.049; Liljegren JC, 2016, HEALTH SECUR, V14, P237, DOI 10.1089/hs.2016.0010; Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3; MacIntyre CR, 2020, INT J NURS STUD, V108, DOI 10.1016/j.ijnurstu.2020.103629; Mckinsey & Company, 2020, SURV US PEOPL SAY TH; McMahon Shannon, 2020, WASH POST; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Moses FW, 2020, EMERG INFECT DIS, V26, P2298, DOI 10.3201/eid2609.201749; Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349; Parks SR, 1996, J APPL BACTERIOL, V80, P529, DOI 10.1111/j.1365-2672.1996.tb03252.x; Santarpia JL, 2022, J EXPO SCI ENV EPID, V32, P706, DOI 10.1038/s41370-021-00376-8; Schuit M, 2020, J INFECT DIS, V222, P564, DOI 10.1093/infdis/jiaa334; Schwartz KL, 2020, CAN MED ASSOC J, V192, pE410, DOI 10.1503/cmaj.75015; Silcott D., 2020, TRANSCOM AMC COMM AI; Sun YG, 2005, ASHRAE TRAN, V111, P45; Swadi T, 2021, EMERG INFECT DIS, V27, P687, DOI 10.3201/eid2703.204714; Tang JW, 2021, J HOSP INFECT, V110, P89, DOI 10.1016/j.jhin.2020.12.022; Tang JW, 2009, J R SOC INTERFACE, V6, pS727, DOI 10.1098/rsif.2009.0295.focus; Therkorn J, 2019, INDOOR AIR, V29, P143, DOI 10.1111/ina.12506; To GNS, 2009, AEROSOL SCI TECH, V43, P466, DOI 10.1080/02786820902736658; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Wan MP, 2009, AEROSOL SCI TECH, V43, P322, DOI 10.1080/02786820802641461; You RY, 2017, BUILD ENVIRON, V111, P110, DOI 10.1016/j.buildenv.2016.10.018; You RY, 2016, J BUILD PERFORM SIMU, V9, P699, DOI 10.1080/19401493.2016.1196730; Zhang Z, 2009, BUILD ENVIRON, V44, P85, DOI 10.1016/j.buildenv.2008.01.012	47	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0246916	10.1371/journal.pone.0246916	http://dx.doi.org/10.1371/journal.pone.0246916			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851965	Green Submitted, Green Published, gold			2022-12-26	WOS:000755762900001
J	Nguyen, TT; Hoang, T; Tran, KN; Kim, H; Jang, SH; Lee, C				Thu-Thuy Nguyen; Trang Hoang; Tran, Kiet N.; Kim, Hyeonji; Jang, Sei-Heon; Lee, ChangWoo			Essential roles of buried phenylalanine in the structural stability of thioredoxin from a psychrophilic Arctic bacterium Sphingomonas sp.	PLOS ONE			English	Article							ESCHERICHIA-COLI THIOREDOXIN; HYDROPHOBIC CORE; GENOME SEQUENCE; ESTERASE; MECHANISM; RESIDUES	Thioredoxin (Trx), a small redox protein, exhibits thermal stability at high temperatures regardless of its origin, including psychrophiles. Trxs have a common structure consisting of the central beta-sheet flanked by an aliphatic cluster on one side and an aromatic cluster on the other side. Although the roles of aromatic amino acids in the folding and stability of proteins have been studied extensively, the contributions of aromatic residues to the stability and function of Trx, particularly Trxs from cold-adapted organisms, have not been fully elucidated. This study examined the roles of aromatic amino acids in the aromatic cluster of a Trx from the psychrophilic Arctic bacterium Sphingomonas sp. PAMC 26621 (SpTrx). The aromatic cluster of SpTrx was comprised of W11, F26, F69, and F80, in which F26 at the beta 2 terminus was buried inside. The substitution of tyrosine for F26 changed the SpTrx conformation substantially compared to that of F69 and F80. Further biochemical and spectroscopic investigations on F26 showed that the F26Y, F26W, and F26A mutants resulted in structural instability of SpTrx in both urea- and temperature-induced unfolding and lower insulin reduction activities. The Trx reductase (SpTR) showed lower catalytic efficiencies against F26 mutants compared to the wild-type SpTrx. These results suggest that buried F26 is essential for maintaining the active-site conformation of SpTrx as an oxidoreductase and its structural stability for interactions with SpTR at colder temperatures.	[Lee, ChangWoo] Daegu Univ, Dept Biomed Sci, Gyongsan, South Korea; Daegu Univ, Ctr Bionanomat, Gyongsan, South Korea	Daegu University; Daegu University	Lee, C (corresponding author), Daegu Univ, Dept Biomed Sci, Gyongsan, South Korea.	leec@daegu.ac.kr		Tran Ngoc, Kiet/0000-0002-2847-844X	Daegu University Research Grant	Daegu University Research Grant	This work was supported by a Daegu University Research Grant (2018) to C.L.	Aqvist J, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0051; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; ASSEMAT K, 1995, PROTEIN SCI, V4, P2510, DOI 10.1002/pro.5560041207; Balsera M, 2019, FREE RADICAL BIO MED, V140, P28, DOI 10.1016/j.freeradbiomed.2019.03.003; Boyineni J, 2014, BBA-PROTEINS PROTEOM, V1844, P1076, DOI 10.1016/j.bbapap.2014.03.009; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Collins T, 2019, APPL MICROBIOL BIOT, V103, P2857, DOI 10.1007/s00253-019-09659-5; Cotugno R, 2009, MOL BIOSYST, V5, P519, DOI 10.1039/b818467d; De Maayer P, 2014, EMBO REP, V15, P508, DOI 10.1002/embr.201338170; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; Falasca P, 2012, EXTREMOPHILES, V16, P539, DOI 10.1007/s00792-012-0453-0; VuThi H, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz218; HELLINGA HW, 1992, BIOCHEMISTRY-US, V31, P11203, DOI 10.1021/bi00160a034; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1975, P NATL ACAD SCI USA, V72, P2305, DOI 10.1073/pnas.72.6.2305; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Hong S, 2012, BIOTECHNOL LETT, V34, P1051, DOI 10.1007/s10529-012-0866-y; Ingles-Prieto A, 2013, STRUCTURE, V21, P1690, DOI 10.1016/j.str.2013.06.020; Jang SH, 2012, J BACTERIOL, V194, P3263, DOI 10.1128/JB.00517-12; Kashif A, 2017, ACS OMEGA, V2, P8760, DOI 10.1021/acsomega.7b01435; LADBURY JE, 1995, BIOCHEMISTRY-US, V34, P2148, DOI 10.1021/bi00007a007; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V26; Lee C, 2017, CATALYSTS, V7, DOI 10.3390/catal7040112; Lee H, 2012, J BACTERIOL, V194, P3030, DOI 10.1128/JB.00395-12; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Modi T, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0184; Napolitano S, 2019, J BIOL CHEM, V294, P14105, DOI 10.1074/jbc.RA119.009718; Truongvan N, 2016, EXTREMOPHILES, V20, P187, DOI 10.1007/s00792-016-0812-3; Ruggiero A, 2019, FEBS J, V286, P1752, DOI 10.1111/febs.14767; Sengupta Rajib, 2014, World J Biol Chem, V5, P68, DOI 10.4331/wjbc.v5.i1.68; Slaby I, 1996, J BIOL CHEM, V271, P3091, DOI 10.1074/jbc.271.6.3091; Starks CM, 2007, PROTEIN SCI, V16, P92, DOI 10.1110/ps.062519707; Tran KN, 2021, BBA-PROTEINS PROTEOM, V1869, DOI 10.1016/j.bbapap.2020.140543; Tzul FO, 2017, P NATL ACAD SCI USA, V114, pE1627, DOI 10.1073/pnas.1613892114	37	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0261123	10.1371/journal.pone.0261123	http://dx.doi.org/10.1371/journal.pone.0261123			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910731	Green Published, gold			2022-12-26	WOS:000754828900036
J	Mapumulo, S; Haskins, L; Luthuli, S; Horwood, C				Mapumulo, Sphindile; Haskins, Lyn; Luthuli, Silondile; Horwood, Christiane			Health workers' disrespectful and abusive behaviour towards women during labour and delivery: A qualitative study in Durban, South Africa	PLOS ONE			English	Article							CHILDBIRTH; CARE	Background A high prevalence of disrespectful and abusive behaviour by health workers towards women during labour and delivery has been widely described in health facilities, particularly in Africa, and is a worldwide public health concern. Such behaviours are barriers to care-seeking, and are associated with adverse outcomes for mothers and newborns. This paper reports experiences of disrespectful care among informal working women in three public health facilities in Durban, South Africa. Methods A qualitative longitudinal study was conducted among a cohort of informal working women recruited during pregnancy in two clinics in Durban. The study comprised a series of in-depth interviews conducted at different time points from pregnancy until mothers had returned to work, followed by focus group discussions (FGDs) with cohort participants. We present data from participatory FGDs, known as 'Journey with my Baby', conducted at the end of the study, during which women's experiences from pregnancy until returning to work were reviewed and explored. Thematic analysis was used with NVIVO v12.4. Results Three 'Journey with my Baby' FGDs were conducted with a total of 15 participants between March and October 2019. Many participants narrated experiences of disrespectful behavior from nurses during labour and childbirth, with several women becoming very distressed as a result. Women described experiencing rudeness and verbal abuse from nurses, lack of privacy and confidentiality, nurses refusing to provide care, being denied companionship and being left unattended for long periods during labour. Women described feeling anxious and unsafe while in the labour ward because of the behaviour they experienced directly and observed other patients experiencing. Such experiences created bad reputations for health facilities, so that women in the local community were reluctant to attend some facilities. Conclusion Disrespect and abuse continues to be a serious concern in public health facilities in South Africa. We challenge the health system to effectively address the underlying causes of disrespectful behavior among health workers, initiate robust monitoring to identify abusive behavior when it occurs, and take appropriate actions to ensure accountability so that women receive the high-quality maternity care they deserve.	[Mapumulo, Sphindile; Haskins, Lyn; Luthuli, Silondile; Horwood, Christiane] Univ KwaZulu Natal, Howard Coll Campus, Ctr Rural Hlth, Durban, South Africa	University of Kwazulu Natal	Mapumulo, S (corresponding author), Univ KwaZulu Natal, Howard Coll Campus, Ctr Rural Hlth, Durban, South Africa.	Mapumulos@ukzn.ac.za	Horwood, Christiane Marianne/GRF-4446-2022	Horwood, Christiane Marianne/0000-0003-4395-1423	World Health Organization;  [2018/845490]	World Health Organization(World Health Organization); 	The funding for this study was provided by the World Health Organization. The recipient was Dr Christiane Horwood (2018/845490). The funders did not participate or play a role in the design of the study, data collection, data analysis or reporting of the results.	Afulani P, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1806-1; Afulani PA, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0591-7; Afulani PA, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0381-7; Amnesty International, 2014, STRUGGL MAT HLTH BAR; [Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2020, WORLD HLTH ORG, DOI DOI 10.1080/09639284.2021.1971095; Assembly UG, 1979, CONVENTION ELIMINATI; Bandyambona E., 2013, COMMUNITY BASED COOP; Bohren MA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003766.pub6; Bohren MA, 2016, SSM-POPUL HLTH, V2, P640, DOI 10.1016/j.ssmph.2016.07.003; Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847; Chadwick RJ, 2016, SAMJ S AFR MED J, V106, P5, DOI [10.7196/SAMJ.2016.v106i5.10708, 10.7196/samj.2016.v106i5.10708]; Constitution South African, 1996, CONSTITUTION REPUBLI, P27; Das JK, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S2-S4; DESA U., 2018, WORLD URB PROSP 2018; Filippi V, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0778-7; Gqola Pumla Dineo, 2007, AFRICAN IDENTITIES, V5, P111, DOI DOI 10.1080/14725840701253894; Gruber KJ, 2013, J PERINAT EDUC, V22, P49, DOI 10.1891/1058-1243.22.1.49; Gurung G, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2034-5; Hastings-Tolsma M, 2018, WOMEN BIRTH, V31, pE42, DOI 10.1016/j.wombi.2017.06.015; Hill K., 2010, EXPLORING EVIDENCE D; Ishola F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174084; Jewkes R, 1998, SOC SCI MED, V47, P1781, DOI 10.1016/S0277-9536(98)00240-8; Keller U, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060775; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; KwaZulu-Natal Department of Health, 2019, ANN REP 2018 19 VOTE; Lambert J, 2018, MIDWIFERY, V62, P256, DOI 10.1016/j.midw.2018.04.007; Luthuli S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09917-6; Malatji R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103667; Montesinos-Segura R, 2018, INT J GYNECOL OBSTET, V140, P184, DOI 10.1002/ijgo.12353; Mukanga B., 2021, COGENT MED, V8; National Department of health RoSA, 2015, GUID MAT CAR S AFR M; Okafor II, 2015, INT J GYNECOL OBSTET, V128, P110, DOI 10.1016/j.ijgo.2014.08.015; Oosthuizen SJ, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0411-5; Pickles C, 2015, S AFR CRIME Q, P5, DOI [10.4314/sacq.v54i1.1, 10.4314/sacq.v54i 1.1]; Rosen HE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0728-4; Rosen P, 2004, J MIDWIFERY WOM HEAL, V49, P24, DOI 10.1016/j.jmwh.2003.10.013; Sadler M, 2016, REPROD HEALTH MATTER, V24, P47, DOI 10.1016/j.rhm.2016.04.002; Sando D, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1019-4; Sethi R, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0370-x; Shefer T, 2008, FEM PSYCHOL, V18, P157, DOI 10.1177/0959353507088265; Sheferaw ED, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0323-4; Shimoda K, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-017-0447-6; South African Population Census, 2011, IND DER FULL POP CEN; Warren CE, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1288-6; White Ribbon Alliance, 2011, RESPECTFUL MATERNITY; World Bank, 2018, FINANCIAL INCLUSION; World Health Organization, 2015, PREVENTION ELIMINATI; Zitha E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145035	49	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261204	10.1371/journal.pone.0261204	http://dx.doi.org/10.1371/journal.pone.0261204			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY2HZ	34905562	Green Published, gold			2022-12-26	WOS:000754615500026
J	Nouanthong, P; Hefele, L; Keokhamphue, J; Sorrasin, V; Khounvisith, V; Souksakhone, C; Jutavijittum, P; Muller, CP; Black, AP; Hubschen, JM				Nouanthong, Phonethipsavanh; Hefele, Lisa; Keokhamphue, Jerapha; Sorrasin, Vonhphet; Khounvisith, Vilaysone; Souksakhone, Chanthala; Jutavijittum, Prapan; Muller, Claude P.; Black, Antony P.; Huebschen, Judith M.			Analyses of blood donor samples from eight provinces in Lao PDR suggest considerable variation concerning HBV exposure and carriage	PLOS ONE			English	Article							B-VIRUS INFECTION; HEPATITIS-B; EPIDEMIOLOGY; SEROPREVALENCE; VACCINATION	Introduction Hepatitis B is endemic in Lao PDR and about 9% of the adult population is chronically infected. In this study, we investigated regional, occupational, age and sex-related differences in hepatitis B epidemiology in Lao blood donors. Methods 5017 voluntary blood donors from 8 different provinces were tested for hepatitis B markers by ELISA. Predictors for the prevalence of hepatitis B surface antigen (HBsAg) and antibodies against the core antigen (anti-HBc) were assessed by bivariate and multivariable analyses. Results In total, 41% of the participants were positive for anti-HBc; the HBsAg prevalence was estimated at 6.9% among all participants (9.2% among first-time donors and 3.9% among repeat donors). Among first-time donors, HBsAg positivity was associated independently with being male (p<0.001), being from the North (p<0.001) and being soldier (p<0.001). Participants were more likely to be anti-HBc positive when they were male (p<0.001), from the Northern provinces (p<0.001) and older than 20 years (p<0.01). Conclusion In conclusion, our study confirmed an overall high HBsAg and anti-HBc prevalence in Lao PDR, albeit with considerable regional variation. The identification of a sizeable number of HBsAg positives among repeat donors warrants a thorough investigation of current blood screening, record keeping, donor identification and counselling practises.	[Nouanthong, Phonethipsavanh; Khounvisith, Vilaysone; Black, Antony P.] Inst Pasteur Laos, Lao Lux Lab, Viangchan, Laos; [Hefele, Lisa; Muller, Claude P.; Huebschen, Judith M.] Luxembourg Inst Hlth, Dept Infect & Immun, Esch Sur Alzette, Luxembourg; [Keokhamphue, Jerapha; Sorrasin, Vonhphet; Souksakhone, Chanthala] Lao Red Cross, Natl Blood Transfus Ctr, Rue Phai Nam, Viangchan, Laos; [Jutavijittum, Prapan] Chiang Mai Univ, Fac Med, Dept Pathol, Chiang Mai, Thailand	Luxembourg Institute of Health; Chiang Mai University	Hubschen, JM (corresponding author), Luxembourg Inst Hlth, Dept Infect & Immun, Esch Sur Alzette, Luxembourg.	judith.huebschen@lih.lu			Ministry of Foreign and European Affairs, Luxembourg; Luxembourg Institute of Health	Ministry of Foreign and European Affairs, Luxembourg; Luxembourg Institute of Health	This work was supported by the Ministry of Foreign and European Affairs, Luxembourg (project "Luxembourg-Laos Partnership for Research and Capacity Building in Infectious Disease Surveillance II") and the Luxembourg Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, BMC INFECT DIS, V19, P1; Aragon Tomas J., 2017, **DATA OBJECT**; Black AP, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-457; Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040; Doussantousse S, 2011, CULT HEALTH SEX, V13, pS279, DOI 10.1080/13691058.2011.584633; Evdokimov K, 2017, CLIN MICROBIOL INFEC, V23, P197, DOI 10.1016/j.cmi.2016.10.007; Fox J., 2014, R COMPANION APPL REG; Franco E, 2012, WORLD J HEPATOL, V4, P74, DOI 10.4254/wjh.v4.i3.74; GAVI, 2020, LAO PDR GAV VACC ALL; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Hipgrave DB, 2003, AM J TROP MED HYG, V69, P288, DOI 10.4269/ajtmh.2003.69.288; Ishida T, 2002, J CLIN VIROL, V24, P31, DOI 10.1016/S1386-6532(01)00222-0; Jutavijittum P, 2014, VOX SANG, V106, P31, DOI 10.1111/vox.12073; Jutavijittum Prapan, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P674; Komada K, 2015, INT J INFECT DIS, V36, P21, DOI 10.1016/j.ijid.2015.04.020; Liu Chun-Jen, 2007, J Chin Med Assoc, V70, P141; Lyttleton C, 2011, CULT HEALTH SEX, V13, pS263, DOI 10.1080/13691058.2011.562307; Murhekar MV, 2008, T ROY SOC TROP MED H, V102, P729, DOI 10.1016/j.trstmh.2008.04.044; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Phoummalaysith B, 2018, VACCINE, V36, P2666, DOI 10.1016/j.vaccine.2018.03.051; R Core Team, 2020, R LANG ENV STAT COMP; Razavi-Shearer D, 2018, LANCET GASTROENTEROL, V3, P383, DOI 10.1016/S2468-1253(18)30056-6; Ruggieri A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02302; Shen YY, 2015, WORLD J GASTROENTERO, V21, P12586, DOI 10.3748/wjg.v21.i44.12586; van Lunzen J, 2014, J INFECT DIS, V209, pS79, DOI 10.1093/infdis/jiu159; Venables WN., 2002, MODERN APPL STAT S 4; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wait S, 2016, LANCET GASTROENTEROL, V1, P248, DOI 10.1016/S2468-1253(16)30031-0; Wang SS, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5984-6; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wickham H., 2017, TIDYVERSE; World Health Organization, 2020, HEP B FACTSH; World Health Organization, 2019, UN CHILDR FUND LAO P; World Health Organization, 2017, GLOBAL HEPATITIS REP; Xeuatvongsa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088829; Zeileis A., R NEWS, V2, P7	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0259814	10.1371/journal.pone.0259814	http://dx.doi.org/10.1371/journal.pone.0259814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898623	gold, Green Published			2022-12-26	WOS:000755176200008
J	Franzen, A; Wohner, F				Franzen, Axel; Woehner, Fabienne			Fatigue during the COVID-19 pandemic: Evidence of social distancing adherence from a panel study of young adults in Switzerland	PLOS ONE			English	Article							GUIDELINES; SCALE; TRUST	In this paper we analyze panel data (N = 400) to investigate the change in attitudes towards the Covid-19 measures and the change in compliance behavior between the first and second lockdowns in a sample of young adults from the University of Bern, Switzerland. We find considerable fatigue. While respondents expressed high acceptance of and compliance with the Covid-19 measures during the first lockdown, both acceptance and compliance behavior decreased substantially during the second lockdown. Moreover, we show via a structural equation model that respondents' compliance behavior is largely driven by the perception of how others behave and by the acceptance of the Covid-19 measures. All other effects scrutinized e.g., individual and social risk perception, trust in politics, and pro-social orientations affect compliance behavior via the acceptance of Covid-19 measures. We also conduct two tests of causality of the estimated relation between attitudes towards the measures and social distancing behavior. The first test incorporates the effect of compliance behavior reported during the first lockdown on attitudes during the second lockdown. The second test involves estimating a first difference panel regression model of attitudes on compliance behavior. The results of both tests suggest that the effect of Covid-19 attitudes on social distancing behavior can be interpreted causally.	[Franzen, Axel; Woehner, Fabienne] Univ Bern, Inst Sociol, Bern, Switzerland	University of Bern	Franzen, A (corresponding author), Univ Bern, Inst Sociol, Bern, Switzerland.	axel.franzen@unibe.ch						Acock AC, 2013, DISCOVERING STRUCTUR, VRev, DOI DOI 10.1080/10538712.2011.607753; Aichholzer J, 2017, EINFUHRUNG LINEARE S; Atkinson-Clement C, 2021, HUM SOC SCI COMMUN, V8, DOI 10.1057/s41599-021-00749-2; Ayalon L, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052643; Bailus BJ, 2021, AUTOPHAGY, V17, P4119, DOI 10.1080/15548627.2021.1904489; Barari S., 2020, EVALUATING COVID 19, DOI [10.1101/2020.03.27.20042820, DOI 10.1101/2020.03.27.20042820]; Bentler PM, 2000, J APPL PSYCHOL, V85, P125, DOI 10.1037/0021-9010.85.1.125; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bollen K.A., 1989, STRUCTURAL EQUATIONS, DOI [10.1002/cne.21974, DOI 10.1002/ARCO.5207]; Cai GX, 2021, J PSYCHIATR RES, V136, P296, DOI 10.1016/j.jpsychires.2021.02.008; Caplanova A, 2021, INT ADV ECON RES, V27, P47, DOI 10.1007/s11294-021-09818-3; Capraro V., SOCIAL SCI COVID 19, DOI 10.31234/osf.io/65xmg; Cato S, 2020, PUBLIC HEALTH, V188, P51, DOI 10.1016/j.puhe.2020.08.005; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; de Bruin WB, 2020, AM J PREV MED, V59, P157, DOI 10.1016/j.amepre.2020.05.001; Farjam M, 2021, ROY SOC OPEN SCI, V8, DOI 10.1098/rsos.201310; Fetzer T., 2020, HARVARD BUSINESS SCH, DOI [10.31234/osf.io/3kfmh, DOI 10.31234/OSF.IO/3KFMH]; Finney SJ, 2006, QUANT METH EDUC BEHA, P269; Franzen A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247447; Franzen A, 2019, METHODS DATA ANAL, V13, P37, DOI 10.12758/mda.2019.01; Fuady A, 2021, ASIA-PAC J PUBLIC HE, V33, P605, DOI 10.1177/10105395211015048; Hao F, 2021, HEALTH PLACE, V68, DOI 10.1016/j.healthplace.2021.102537; Hoyle R.H., 2012, HDB STRUCTURAL EQUAT; Imbriano G, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.612725; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Lee J, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9010075; Ling G.H.T., 2020, TECHNIUM SOC SCI J, V7, P312; Ludwig V., 2015, SAGE HDB REGRESSION, P327, DOI DOI 10.4135/9781446288146.N15; Nivette A, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113370; O'Connell K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244974; Pak A, 2021, RISK MANAG HEALTHC P, V14, P293, DOI 10.2147/RMHP.S278774; Ravert RD, 2021, J ADOLESCENT HEALTH, V68, P460, DOI 10.1016/j.jadohealth.2020.12.001; Rudert SC, 2022, GROUP PROCESS INTERG, V25, P1819, DOI 10.1177/13684302211023562; Satorra A., 1994, LATENT VARIABLES ANA, P399, DOI DOI 10.2307/2291370; StataCorp, 2021, STAT STRUCT EQ MOD R; Urban D., 2014, STRUKTURGLEICHUNGSMO; Welter VDE, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030933; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Wright L, 2021, PREV MED, V153, DOI 10.1016/j.ypmed.2021.106713; Yapi RB, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18094757; Yong JSC, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.646892; Yu C.-Y., 2002, THESIS	42	5	5	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0261276	10.1371/journal.pone.0261276	http://dx.doi.org/10.1371/journal.pone.0261276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YN5JA	34890414	Green Published, gold			2022-12-26	WOS:000747293600040
J	Nyabongo, L; Odongo, DO; Milton, G; Machuka, E; Vudriko, P; Pelle, R; Kanduma, EG				Nyabongo, Lionel; Odongo, David O.; Milton, Gad; Machuka, Eunice; Vudriko, Patrick; Pelle, Roger; Kanduma, Esther G.			Molecular survey of cattle ticks in Burundi: First report on the presence of the invasive Rhipicephalus microplus tick	PLOS ONE			English	Article							BOOPHILUS-MICROPLUS; GENUS RHIPICEPHALUS; THEILERIA-PARVA; BORNE DISEASES; CLIMATE-CHANGE; IXODIDAE; ACARI; DECOLORATUS; VARIEGATUM; SEQUENCES	A recent research study on prevalence of tick-borne pathogens in Burundi reported high prevalence and endemicity of Theileria parva, Anaplasma marginale and Babesia bigemina infections in cattle. Detailed information about tick species infesting animals, their distribution and genetic diversity in Burundi is outdated and limited. This study therefore assessed the prevalence and genetic diversity of tick species infesting cattle across agroecological zones (AEZs) in Burundi. A cross-sectional study on the occurrence of tick species was conducted in 24 districts of Burundi between October and December 2017. Differential identification and characterization of ticks collected was conducted using tick morphological keys and molecular tools (cox1 and 12S rRNA gene). Chi-square test was used to test for association between agroecological zones and the prevalence of tick species. Phylogenetic relationships were inferred using bayesian and maximum likelihood algorithms. A total of 483 ticks were collected from the five AEZs sampled. Six tick species comprising of Rhipicephalus appendiculatus, R. sanguineus, R. evertsi evertsi, R. microplus, R. decoloratus and Amblyomma variegatum were observed. Rhipicephalus appendiculatus were the most prevalent ticks (~45%). A total of 138 specimens (28%) were found to be Rhipicephalus microplus, suggesting an emerging threat for cattle farmers. Twelve R. appendiculatus cox1 haplotypes were obtained from 106 specimens that were sequenced. Two cox1 haplotypes of R. microplus which clustered into previously reported Clade A were observed. Rhipicephalus sanguineus and R. evertsi evertsi ticks, the vectors of numerous zoonotic pathogens, were collected from cattle, which constitute a high risk for public health. These findings reveal an overlapping distribution of tick vectors in Burundi. The design of ticks and tick-borne diseases control strategies should consider the distribution of different vectors across the AEZs particularly the presence of the highly invasive R. microplus tick in Burundi and the potential risk of introducing the pathogenic Babesia bovis.	[Nyabongo, Lionel; Odongo, David O.] Univ Nairobi UoN, Dept Biol, Fac Sci & Technol, Nairobi, Kenya; [Nyabongo, Lionel; Machuka, Eunice; Pelle, Roger] Biosci Eastern & Cent Africa Int Livestock Res In, Nairobi, Kenya; [Nyabongo, Lionel] Natl Vet Lab Bujumbura, Bujumbura, Burundi; [Milton, Gad] Int Livestock Res Inst, Tick Unit, Nairobi, Kenya; [Vudriko, Patrick] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Kampala, Uganda; [Kanduma, Esther G.] Univ Nairobi, Dept Biochem, Fac Sci & Technol, Nairobi, Kenya	University of Nairobi; CGIAR; International Livestock Research Institute (ILRI); Makerere University; University of Nairobi	Nyabongo, L (corresponding author), Univ Nairobi UoN, Dept Biol, Fac Sci & Technol, Nairobi, Kenya.; Nyabongo, L (corresponding author), Biosci Eastern & Cent Africa Int Livestock Res In, Nairobi, Kenya.; Nyabongo, L (corresponding author), Natl Vet Lab Bujumbura, Bujumbura, Burundi.	lyonnel3@yahoo.fr	Machuka, Eunice/AAG-2443-2022; Machuka, Eunice/AFK-3646-2022	Machuka, Eunice/0000-0002-1142-3442; Machuka, Eunice/0000-0002-1142-3442; Lionel, Nyabongo/0000-0003-4649-6323; Milton Owido, Gad/0000-0002-3557-6523	BecAILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program; Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; Syngenta Foundation for Sustainable Agriculture (SFSA); Bill & Melinda Gates Foundation (BMGF); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida); BMGF [OPP1075938]	BecAILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program; Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership(Australian Government); Syngenta Foundation for Sustainable Agriculture (SFSA)(Syngenta); Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida); BMGF	This work was supported by the BecAILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program. The ABCF Program is funded by the Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; the Syngenta Foundation for Sustainable Agriculture (SFSA); the Bill & Melinda Gates Foundation (BMGF); the UK Department for International Development (DFID) and the Swedish International Development Cooperation Agency (Sida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The grant number for the award received is BMGF OPP1075938.	Amzati GS, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2904-7; Araya-Anchetta A, 2015, INFECT GENET EVOL, V29, P164, DOI 10.1016/j.meegid.2014.11.008; Beati L, 2001, J PARASITOL, V87, P32, DOI 10.1645/0022-3395(2001)087[0032:AOTSRA]2.0.CO;2; Beati L, 2012, VECTOR-BORNE ZOONOT, V12, P514, DOI 10.1089/vbz.2011.0859; Burger TD, 2014, MOL PHYLOGENET EVOL, V76, P241, DOI 10.1016/j.ympev.2014.03.017; Dahmani M, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3742-y; Dantas-Torres F, 2015, INT J PARASITOL-PAR, V4, P452, DOI 10.1016/j.ijppaw.2015.07.001; Dantas-Torres F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-213; Estrada-Pena A, 2006, EXP APPL ACAROL, V38, P219, DOI 10.1007/s10493-006-0003-5; Estrada-Pena A, 2001, J PARASITOL, V87, P978, DOI 10.1645/0022-3395(2001)087[0978:CWACIH]2.0.CO;2; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gachohi J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-194; Jacquet S., 2012, E SOVE 2012 BIOL INT; KAISER MN, 1988, PREV VET MED, V6, P199, DOI 10.1016/0167-5877(88)90031-1; Kanduma EG, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04266-0; Kanduma EG, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1631-1; Kivaria FM, 2006, TROP ANIM HEALTH PRO, V38, P291, DOI 10.1007/s11250-006-4181-2; LATIF AA, 1992, INSECT SCI APPL, V13, P505, DOI 10.1017/S1742758400016088; Low VL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0956-5; Lynen G, 2008, EXP APPL ACAROL, V44, P147, DOI 10.1007/s10493-008-9134-1; Madder M, 2002, EXP APPL ACAROL, V27, P209, DOI 10.1023/A:1021694207456; Magona JW, 2011, EXP APPL ACAROL, V55, P203, DOI 10.1007/s10493-011-9456-2; Manirakiza J, 2017, ANIM GENET, V48, P544, DOI 10.1111/age.12578; Marques R, 2020, VET RES, V51, DOI 10.1186/s13567-020-00802-z; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000821; Moran M C, 1990, Parassitologia, V32, P177; Muhanguzi D, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04043-z; Murrell A, 2000, MOL PHYLOGENET EVOL, V16, P1, DOI 10.1006/mpev.2000.0762; Nene V, 2016, TICKS TICK-BORNE DIS, V7, P549, DOI 10.1016/j.ttbdis.2016.02.001; NORVAL RAI, 1994, EXP APPL ACAROL, V18, P383, DOI 10.1007/BF00051522; Nyabongo L, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-020-04531-2; Olwoch JM, 2007, ONDERSTEPOORT J VET, V74, P45, DOI 10.4102/ojvr.v74i1.139; Shyma K P, 2015, J Parasitol Res, V2015, P506586, DOI 10.1155/2015/506586; Silatsa BA, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3738-7; Silatsa BA, 2019, TICKS TICK-BORNE DIS, V10, P585, DOI 10.1016/j.ttbdis.2019.02.002; Sungirai M, 2018, VET PARASITOL REG ST, V14, P41, DOI 10.1016/j.vprsr.2018.08.006; Sungirai M, 2017, MED VET ENTOMOL, V31, P78, DOI 10.1111/mve.12215; Tonnesen MH, 2004, EXP APPL ACAROL, V32, P199, DOI 10.1023/B:APPA.0000021789.44411.b5; Vudriko P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-015-1278-3; Walker A.R., 2003, EDINBURGH SCOTLAND B, P1; Yssouf A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-38	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0261218	10.1371/journal.pone.0261218	http://dx.doi.org/10.1371/journal.pone.0261218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890445	Green Published, gold			2022-12-26	WOS:000747293600037
J	Rakshita, KN; Singh, S; Verma, VK; Sharma, BB; Saini, N; Iquebal, MA; Sharma, A; Dey, SS; Behera, TK				Rakshita, K. N.; Singh, Shrawan; Verma, Veerendra Kumar; Sharma, Brij Bihari; Saini, Navinder; Iquebal, Mir Asif; Sharma, Akanksha; Dey, Shyam Sunder; Behera, T. K.			Agro-morphological and molecular diversity in different maturity groups of Indian cauliflower (Brassica oleracea var. botrytis L.)	PLOS ONE			English	Article							MICROSATELLITE MARKERS; CURD; SEQUENCES; MODEL	The present study analysed the molecular and agro-morphological diversity in a set of 92 diverse cauliflower genotypes and two each of cabbage and broccoli. Field evaluation of the genotypes was done in randomized block design (RBD) at two locations (i.e. IARI, New Delhi and ICAR-RC-NEH Region, Barapani) during Rabi2019-20. Genotypes showed variation for all the eight observed traits at both locations and, the differences in early and snowball groups were distinct. Pusa Meghna, DC-33-8, Pusa Kartiki and CC-14 were earliest for curd initiation. Genotypes showed higher values for curd traits at Delhi. Molecular diversity was detected with 90 polymorphic simple sequence repeats (SSR). Number of alleles ranged from 1 to 9 with mean value of 2.16 and the highest polymorphic information content (PIC) value was observed for primer BoGMS0742 (0.68) with a mean value of 0.18. Cluster analysis using agro-morphological traits substantiated classification of the genotypes for maturity groups. However, SSR analysis revealed four clusters and with a composite pattern of genotype distribution. STRUCTURE analysis also supported the admixture and four subpopulations. The studyindicates for introgression of genetic fragments across the maturity groups, thereby, potential for use in further genetic improvement and heterosis breeding.	[Rakshita, K. N.; Singh, Shrawan; Sharma, Brij Bihari; Sharma, Akanksha; Dey, Shyam Sunder; Behera, T. K.] ICAR Indian Agr Res Inst, Div Vegetable Sci, New Delhi, India; [Verma, Veerendra Kumar] ICAR Res Complex, Res Complex North Eastern Hill Reg, Barapani, Meghalaya, India; [Saini, Navinder] ICAR Indian Agr Res Inst, Div Genet, New Delhi, India; [Iquebal, Mir Asif] ICAR Indian Agr Stat Res Inst, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - ICAR Research Complex for NEH Region; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute	Singh, S (corresponding author), ICAR Indian Agr Res Inst, Div Vegetable Sci, New Delhi, India.	singhshrawan@refiffmail.com	IQUEBAL, MIR ASIF/ABG-6027-2021	IQUEBAL, MIR ASIF/0000-0003-3787-5997; Singh, Shrawan/0000-0003-2060-4402	PG School, IARI for fellowship, NAPEH-CAAST; CRP Hybrid Technology (Cauliflower) project	PG School, IARI for fellowship, NAPEH-CAAST; CRP Hybrid Technology (Cauliflower) project	Main author acknowledges PG School, IARI for fellowship, NAPEH-CAAST for financial support. We thank to ICAR for financial support to the part of study in CRP Hybrid Technology (Cauliflower) project. Authors thanks Director, IARI for research facilities and Director, ICAR-NEH-Research Complex, Barapani for facilities. Head, Division of Vegetable Science, IARI for support.	Akshay Chittora, 2015, Electronic Journal of Plant Breeding, V6, P842; Astarini IA, 2004, AUST J AGR RES, V55, P117, DOI 10.1071/AR03012; Bisht NC, 2009, THEOR APPL GENET, V118, P413, DOI 10.1007/s00122-008-0907-z; Chatterjee S., 2018, BIOSCCAN 2018, V13, P459; CRISP P, 1982, EUPHYTICA, V31, P725, DOI 10.1007/BF00039211; Dey SS, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2346-0; Dey SS., 2011, INDIAN J PLANT GENET, V24, P48; El-Esawi M. A., 2012, Journal of Agricultural Science (Toronto), V4, P20; El-Esawi MA, 2016, CR BIOL, V339, P133, DOI 10.1016/j.crvi.2016.02.002; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flannery ML, 2006, THEOR APPL GENET, V113, P1221, DOI 10.1007/s00122-006-0377-0; Hale AL, 2006, J AM SOC HORTIC SCI, V131, P418, DOI 10.21273/JASHS.131.3.418; Jindal Salesh Kumar, 2005, Crop Improvement, V32, P92; Kalia P, 2018, ACTA HORTIC, V1203, P121, DOI 10.17660/ActaHortic.2018.1203.19; Kalia P., 2021, ADV PLANT BREEDING S, V10; Kumar A., 2018, J PHARMACOGN PHYTOCH, V7, P1761; Lan TH, 2000, GENETICS, V155, P1927; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li HT, 2011, MOL BREEDING, V28, P585, DOI 10.1007/s11032-010-9509-y; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Louarn S, 2007, GENET RESOUR CROP EV, V54, P1717, DOI 10.1007/s10722-006-9181-6; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nimkar S. A., 2014, International Journal of Farm Sciences, V4, P27; OPSTAT, ONL STAT SOFTW; Plieske J, 2001, THEOR APPL GENET, V102, P689, DOI 10.1007/s001220051698; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Pushpa HD, 2016, INDIAN J GENET PL BR, V76, P64, DOI 10.5958/0975-6906.2016.00009.2; Rai N., 2005, ADV VEGETABLE PRODUC; Ram H, 2016, INDIAN J AGR SCI, V86, P1299; Rohlf FJ, 1998, NTSYS PC NUMERICAL T; Saha P, 2020, EUPHYTICA, V216, DOI 10.1007/s10681-020-02696-6; Seshadri VS., 1996, VEG SCI, V23, P114; Sharma BB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152290; Sharma SR., 2005, J NEW SEEDS, V6, P151, DOI [10.1300/J153v06n02_08, DOI 10.1300/J153V06N02_08]; Shi JQ, 2014, DNA RES, V21, P53, DOI 10.1093/dnares/dst040; Singh B., 2013, SAARC Journal of Agriculture, V11, P183; Singh B. K., 2018, International Journal of Vegetable Science, V24, P58, DOI 10.1080/19315260.2017.1354242; Singh R, 2003, TXB VEGETABLES TUBER, P81; Singh S, 2012, J HORTIC SCI BIOTECH, V87, P137, DOI 10.1080/14620316.2012.11512844; Singh S, 2021, GENET RESOUR CROP EV, V68, P1603, DOI 10.1007/s10722-020-01090-4; Smith LB, 2000, MOL BREEDING, V6, P603, DOI 10.1023/A:1011370525688; SWARUP V, 1972, ECON BOT, V26, P381, DOI 10.1007/BF02860710; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Thakur AK., 2018, HEREDITAS, P155, DOI [10.16288/j.yczz.17-096, DOI 10.16288/J.YCZZ.17-096]; Thorwarth P, 2018, G3-GENES GENOM GENET, V8, P707, DOI 10.1534/g3.117.300199; Tonguc M, 2004, EUPHYTICA, V137, P193, DOI 10.1023/B:EUPH.0000041577.84388.43; Vanlalneihi B, 2019, INDIAN J HORTIC, V76, P300, DOI 10.5958/0974-0112.2019.00046.X; Verma V. K., 2017, International Journal of Vegetable Science, V23, P411, DOI 10.1080/19315260.2017.1317314; Zhu SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208551	51	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0260246	10.1371/journal.pone.0260246	http://dx.doi.org/10.1371/journal.pone.0260246			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890399	Green Published, gold			2022-12-26	WOS:000747293600009
J	Farr, ER; Johnson, MR; Nelson, MW; Hare, JA; Morrison, WE; Lettrich, MD; Vogt, B; Meaney, C; Howson, UA; Auster, PJ; Borsuk, FA; Brady, DC; Cashman, MJ; Colarusso, P; Grabowski, JH; Hawkes, JP; Mercaldo-Allen, R; Packer, DB; Stevenson, DK				Farr, Emily R.; Johnson, Michael R.; Nelson, Mark W.; Hare, Jonathan A.; Morrison, Wendy E.; Lettrich, Matthew D.; Vogt, Bruce; Meaney, Christopher; Howson, Ursula A.; Auster, Peter J.; Borsuk, Frank A.; Brady, Damian C.; Cashman, Matthew J.; Colarusso, Phil; Grabowski, Jonathan H.; Hawkes, James P.; Mercaldo-Allen, Renee; Packer, David B.; Stevenson, David K.			An assessment of marine, estuarine, and riverine habitat vulnerability to climate change in the Northeast US	PLOS ONE			English	Article							SEA-LEVEL RISE; OCEAN ACIDIFICATION; COASTAL WETLANDS; SALT MARSHES; NEW-ENGLAND; CARBON ACCUMULATION; FUTURE CHANGES; UNITED-STATES; FLOOD RISK; FISH	Climate change is impacting the function and distribution of habitats used by marine, coastal, and diadromous species. These impacts often exacerbate the anthropogenic stressors that habitats face, particularly in the coastal environment. We conducted a climate vulnerability assessment of 52 marine, estuarine, and riverine habitats in the Northeast U.S. to develop an ecosystem-scale understanding of the impact of climate change on these habitats. The trait-based assessment considers the overall vulnerability of a habitat to climate change to be a function of two main components, sensitivity and exposure, and relies on a process of expert elicitation. The climate vulnerability ranks ranged from low to very high, with living habitats identified as the most vulnerable. Over half of the habitats examined in this study are expected to be impacted negatively by climate change, while four habitats are expected to have positive effects. Coastal habitats were also identified as highly vulnerable, in part due to the influence of non-climate anthropogenic stressors. The results of this assessment provide regional managers and scientists with a tool to inform habitat conservation, restoration, and research priorities, fisheries and protected species management, and coastal and ocean planning.	[Farr, Emily R.] NOAA, Off Habitat Conservat, Natl Marine Fisheries Serv, Silver Spring, MD 20910 USA; [Johnson, Michael R.; Stevenson, David K.] NOAA, Habitat & Ecosyst Serv Div, Greater Atlantic Reg Fisheries Off, Natl Marine Fisheries Serv, Gloucester, MA USA; [Nelson, Mark W.; Lettrich, Matthew D.] NOAA, ECS, Off Sci & Technol, Natl Marine Fisheries Serv, Silver Spring, MD USA; [Hare, Jonathan A.] NOAA, Northeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Woods Hole, MA USA; [Morrison, Wendy E.] NOAA, Off Sustainable Fisheries, Natl Marine Fisheries Serv, Silver Spring, MD USA; [Vogt, Bruce] NOAA, NOAA Chesapeake Bay Off, Natl Marine Fisheries Serv, Annapolis, MD USA; [Meaney, Christopher] US Fish & Wildlife Serv, Gulf Maine Coastal Program, Falmouth, ME USA; [Howson, Ursula A.] Bur Ocean Energy Management, Off Renewable Energy Programs, Sterling, VA USA; [Auster, Peter J.] Myst Aquarium, Groton, CT USA; [Auster, Peter J.] Univ Connecticut, Groton, CT USA; [Borsuk, Frank A.] US EPA, Reg 3, Wheeling, WV USA; [Brady, Damian C.] Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA; [Cashman, Matthew J.] US Geol Survey, Maryland Delaware DC Water Sci Ctr, Baltimore, MD USA; [Colarusso, Phil] US EPA, Reg 1, Boston, MA USA; [Grabowski, Jonathan H.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA; [Hawkes, James P.] NOAA, Northeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Orono, ME USA; [Mercaldo-Allen, Renee] NOAA, Milford Lab, Northeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Milford, CT USA; [Packer, David B.] NOAA, James J Howard Marine Sci Lab, Northeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Highlands, NJ USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; US Fish & Wildlife Service; University of Connecticut; United States Environmental Protection Agency; University of Maine System; University of Maine Orono; United States Department of the Interior; United States Geological Survey; United States Environmental Protection Agency; Northeastern University; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Farr, ER (corresponding author), NOAA, Off Habitat Conservat, Natl Marine Fisheries Serv, Silver Spring, MD 20910 USA.	efarr@manomet.org		Johnson, Michael/0000-0003-0846-7978; Lettrich, Matthew/0000-0003-4749-2260; Nelson, Mark/0000-0002-2575-2183	National Oceanic and Atmospheric Administration (NOAA) NMFS Office of Habitat Conservation; NMFS Office of Science and Technology; National Marine Sanctuary Foundation [20-10-B-281]	National Oceanic and Atmospheric Administration (NOAA) NMFS Office of Habitat Conservation; NMFS Office of Science and Technology; National Marine Sanctuary Foundation	Funding for this project was provided by the National Oceanic and Atmospheric Administration (NOAA) NMFS Office of Habitat Conservation and NMFS Office of Science and Technology. ECS Federal, Inc in support of NOAA NMFS Office of Science and Technology provided salary for authors MWN and MDL. PJA was funded by Award 20-10-B-281 from the National Marine Sanctuary Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able KW, 2005, ESTUAR COAST SHELF S, V64, P5, DOI 10.1016/j.ecss.2005.02.002; Allyn AJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231595; Andersen TJ, 2011, MAR GEOL, V279, P178, DOI 10.1016/j.margeo.2010.10.025; [Anonymous], 2011, SCANNING CONSERVATIO; Arkema KK, 2013, NAT CLIM CHANGE, V3, P913, DOI 10.1038/NCLIMATE1944; Armstrong WH, 2014, HYDROLOG SCI J, V59, P1636, DOI 10.1080/02626667.2013.862339; Armstrong WH, 2012, J AM WATER RESOUR AS, V48, P306, DOI 10.1111/j.1752-1688.2011.00613.x; Auster P, 2015, IMAGING SURVEYS SELE; Auster Peter J., 2013, Biodiversity, V14, P195; Auster Peter J., 2013, Biodiversity (Ottawa), V14, P193, DOI 10.1080/14888386.2013.850446; Auster PJ, 1998, AM FISH S S, V22, P150; Auster PJ, 2005, COLD WATER CORALS EC, P643; AYVAZIAN SG, 1992, ESTUARIES, V15, P368, DOI 10.2307/1352784; Balouskus RG, 2012, ESTUAR COAST, V35, P1100, DOI 10.1007/s12237-012-9495-x; Barros VR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1133; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bell RJ, 2015, ICES J MAR SCI, V72, P1311, DOI 10.1093/icesjms/fsu217; Bjork M., 2008, Managing seagrasses for resilience to climate change; Blanchard JL, 2012, PHILOS T R SOC B, V367, P2979, DOI 10.1098/rstb.2012.0231; Blum AG, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2356; BOESCH DF, 1984, ESTUARIES, V7, P460, DOI 10.2307/1351627; Boyero L, 2012, GLOBAL ECOL BIOGEOGR, V21, P134, DOI 10.1111/j.1466-8238.2011.00673.x; Bradford MJ, 2008, CAN WATER RESOUR J, V33, P165, DOI 10.4296/cwrj3302165; Brown AC, 2002, ENVIRON CONSERV, V29, P62, DOI 10.1017/S037689290200005X; Brown CJ, 2019, FISH FISH, V20, P1, DOI 10.1111/faf.12318; Buchsbaum R., 2005, DECLINE FISHERIES RE, P1; Cahoon DR., 2009, COASTAL WETLAND SUST; Carey JC, 2017, ESTUAR COAST, V40, P626, DOI 10.1007/s12237-015-9971-1; Cherry JA, 2009, J ECOL, V97, P67, DOI 10.1111/j.1365-2745.2008.01449.x; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Colburn LL, 2016, MAR POLICY, V74, P323, DOI 10.1016/j.marpol.2016.04.030; Collins MJ, 2009, J AM WATER RESOUR AS, V45, P279, DOI 10.1111/j.1752-1688.2008.00277.x; Comer P.., 2017, ASSESSING CLIMATE CH; Cooley SR, 2009, OCEANOGRAPHY, V22, P172, DOI 10.5670/oceanog.2009.106; Cowardin L.M., 1979, CLASSIFICATION WETLA; Crosby SC, 2016, ESTUAR COAST SHELF S, V181, P93, DOI 10.1016/j.ecss.2016.08.018; Crozier LG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217711; Daley ML, 2009, J N AM BENTHOL SOC, V28, P929, DOI 10.1899/09-052.1; Deegan LA, 2005, DECLINE FISHERIES RE, P67; Demaria EMC, 2016, J HYDROL-REG STUD, V5, P309, DOI 10.1016/j.ejrh.2015.11.007; DePasquale E, 2015, MAR ECOL PROG SER, V523, P145, DOI 10.3354/meps11142; Deser C, 2012, NAT CLIM CHANGE, V2, P775, DOI 10.1038/NCLIMATE1562; DeWeber JT, 2018, GLOBAL CHANGE BIOL, V24, P2735, DOI 10.1111/gcb.14101; Dionne M, 1998, AM FISH S S, V22, P384; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Donnelly JP, 2001, P NATL ACAD SCI USA, V98, P14218, DOI 10.1073/pnas.251209298; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Dugan JE, 2018, ESTUAR COAST, V41, pS180, DOI 10.1007/s12237-017-0254-x; Eaton JG, 1996, LIMNOL OCEANOGR, V41, P1109, DOI 10.4319/lo.1996.41.5.1109; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Federal Geographic Data Committee, 1979, AD COW CART GOL LARO; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Friedland KD, 2020, FISH OCEANOGR, V29, P396, DOI 10.1111/fog.12485; Gaichas SK, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00105; Galbraith H, 2002, WATERBIRDS, V25, P173, DOI 10.1675/1524-4695(2002)025[0173:GCCASL]2.0.CO;2; Galbraith H, 2013, VULN FISH WILDL HAB; Gawarkiewicz GG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00553; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gazeau F, 2013, MAR BIOL, V160, P2207, DOI 10.1007/s00227-013-2219-3; Gedan KB, 2011, CLIMATIC CHANGE, V106, P7, DOI 10.1007/s10584-010-0003-7; Gedan KB, 2011, MAR ECOL PROG SER, V434, P229, DOI 10.3354/meps09084; Geraldi NR, 2014, BIOL INVASIONS, V16, P1819, DOI 10.1007/s10530-013-0629-2; Gittman RK, 2016, ECOL APPL, V26, P249, DOI 10.1890/14-0716; Gledhill DK, 2015, OCEANOGRAPHY, V28, P182, DOI 10.5670/oceanog.2015.41; Gobler CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083648; Goode AG, 2019, GLOBAL CHANGE BIOL, V25, P3906, DOI 10.1111/gcb.14778; Grimm NB, 2013, FRONT ECOL ENVIRON, V11, P474, DOI 10.1890/120282; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Hall CJ, 2012, BIOSCIENCE, V62, P723, DOI 10.1525/bio.2012.62.8.5; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; Hare JA, 2012, ICES J MAR SCI, V69, P1753, DOI 10.1093/icesjms/fss160; Hare JA, 2010, ECOL APPL, V20, P452, DOI 10.1890/08-1863.1; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; HECK KL, 1989, ESTUARIES, V12, P59, DOI 10.2307/1351497; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Henderson MJ., 2020, FRONT MAR SCI, V7, P1, DOI [10.3389/fmars.2020.00548, DOI 10.3389/FMARS.2020.00548]; Henson SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14682; Hodgkins GA., 2005, CHANGES MAGNITUDE AN; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00158; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Howard J, 2017, FRONT ECOL ENVIRON, V15, P42, DOI 10.1002/fee.1451; Howard J, 2013, OCEANOGR MAR BIOL, V51, P71; Hsu C.C, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [DOI 10.7275/PDZ9-TH90, 10.7275/pdz9-th90]; Johnson MR., 2008, NMFSNE2O9 NAT OC ATM; Jones MC, 2015, ICES J MAR SCI, V72, P741, DOI 10.1093/icesjms/fsu172; Karmalkar AV, 2021, NAT CLIM CHANGE, V11, P854, DOI 10.1038/s41558-021-01159-7; Kearney M.S., 2002, EOS T AM GEOPHYS UN, V83, P173, DOI [10.1029/2002EO000112, DOI 10.1029/2002EO000112]; Kennedy V.S., 2002, COASTAL MARINE ECOSY; Kennish MJ, 2014, ESTUAR COAST, V37, pS3, DOI 10.1007/s12237-014-9779-4; Khan AH, 2013, ICES J MAR SCI, V70, P915, DOI 10.1093/icesjms/fst002; Kirwan ML, 2011, BIOGEOSCIENCES, V8, P987, DOI 10.5194/bg-8-987-2011; Kirwan ML, 2012, NATURE, V489, P550, DOI 10.1038/nature11440; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Kjesbu OS, 2014, P NATL ACAD SCI USA, V111, P3478, DOI 10.1073/pnas.1316342111; Kleisner KM, 2017, PROG OCEANOGR, V153, P24, DOI 10.1016/j.pocean.2017.04.001; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Kolker AS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043874; Kortsch S, 2015, P ROY SOC B-BIOL SCI, V282, P31, DOI 10.1098/rspb.2015.1546; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Langley JA, 2009, P NATL ACAD SCI USA, V106, P6182, DOI 10.1073/pnas.0807695106; Lazzari MA, 2006, ESTUAR COAST SHELF S, V69, P591, DOI 10.1016/j.ecss.2006.04.025; Lazzari MA, 2008, FISH RES, V90, P296, DOI 10.1016/j.fishres.2007.11.020; Lellis-Dibble KA., 2008, NMFSFSPO90 US DEP CO; Letcher BH, 2016, PEERJ, V4, DOI 10.7717/peerj.1727; Lettrich MD, 2019, NOAA TECHNICAL MEMOR, P80; Lins HF, 1999, GEOPHYS RES LETT, V26, P227, DOI 10.1029/1998GL900291; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lyons MP, 2020, ECOL APPL, V30, DOI 10.1002/eap.2100; MAHAJAN V, 1976, J MARKETING RES, V13, P317, DOI 10.2307/3150755; Mattocks S, 2017, BIOSCIENCE, V67, P713, DOI 10.1093/biosci/bix069; Miller AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147627; Minello TJ, 2003, MAR ECOL PROG SER, V246, P39, DOI 10.3354/meps246039; Moller I, 2014, NAT GEOSCI, V7, P848, DOI [10.1038/ngeo2251, 10.1038/NGEO2287, 10.1038/NGEO2251]; Morato T, 2020, GLOBAL CHANGE BIOL, V26, P2181, DOI 10.1111/gcb.14996; Morley JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196127; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Morrison WE., 2015, NMFSOSF3 US DEP COMM; National Oceanic and Atmospheric Administration, 2021, NOAA TID CURR SEA LE; National Oceanic and Atmospheric Administration, 2020, STAT EC MIDATL; National Oceanic and Atmospheric Administration, 2021, STAT EC NEW ENGL DEP; National Oceanic and Atmospheric Administration, 2015, NOAA NAT HAB POL; National Research Council, 1997, STRIK BAL IMPR STEW; National Research Council, 2002, EFF TRAWL DREDG SEAF; National Research Council, 1997, STRIK BAL IMPR STEW, P177; Nelson EJ, 2013, FRONT ECOL ENVIRON, V11, P483, DOI 10.1890/120312; Neto AG, 2021, COMMUN EARTH ENVIRON, V2, DOI 10.1038/s43247-021-00143-5; Nicholls RJ, 1999, GLOBAL ENVIRON CHANG, V9, pS69, DOI 10.1016/S0959-3780(99)00019-9; Nicholls RJ, 2004, GLOBAL ENVIRON CHANG, V14, P69, DOI 10.1016/j.gloenvcha.2003.10.007; Nicholls RJ, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P315; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Nightingale B., 2001, WHITE PAPER DREDGING; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Packer DB., 2017, NMFSOHC4 NAT OC ATM; Packer DB., 2007, STATE DEEP CORAL ECO; Packer DB, 2017, DEEP SEA CORAL TAXA; Pappal A., 2010, MARINE INVASIVE SPEC; Paxton BJ., 2006, CTR CONSERVATION BIO; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Pershing AJ., 2018, OCEANS MARINE RESOUR; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; Peterson M. S., 2000, Wetlands Ecology and Management, V8, P209, DOI 10.1023/A:1008452805584; Pinsky ML, 2014, OCEANOGRAPHY, V27, P146, DOI 10.5670/oceanog.2014.93; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2016, INTEGR COMP BIOL, V56, P31, DOI 10.1093/icb/icw019; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner H-O., 2014, CONTRIBUTION WORKING; Powell EJ, 2019, J COAST CONSERV, V23, P1, DOI 10.1007/s11852-018-0632-y; Pyne MI, 2017, GLOBAL CHANGE BIOL, V23, P77, DOI 10.1111/gcb.13437; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Reguero BG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192132; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Rosenberg A, 2000, B MAR SCI, V66, P535; Saba VS, 2016, J GEOPHYS RES-OCEANS, V121, P118, DOI 10.1002/2015JC011346; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Santora JA, 2017, MAR ECOL PROG SER, V580, P205, DOI 10.3354/meps12278; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Shellenbarger Jones A., 2009, COASTAL SENSITIVITY; Short FT, 2016, AQUAT BOT, V135, P3, DOI 10.1016/j.aquabot.2016.06.006; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; Smith JAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065091; Smith SL, 2017, ENVIRON SCI POLICY, V78, P49, DOI 10.1016/j.envsci.2017.09.009; Sousa A, 2021, SCI TOTAL ENVIRON, V795, DOI 10.1016/j.scitotenv.2021.148652; Spencers PD, 2019, GLOBAL CHANGE BIOL, V25, P3954, DOI 10.1111/gcb.14763; Staudinger MD., 2012, IMPACTS CLIMATE CHAN; Staudinger MD, 2019, FISH OCEANOGR, V28, P532, DOI 10.1111/fog.12429; Staudt A, 2013, FRONT ECOL ENVIRON, V11, P494, DOI 10.1890/120275; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stock CA, 2011, PROG OCEANOGR, V88, P1, DOI 10.1016/j.pocean.2010.09.001; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Sweet W., 2017, NOAA TECHNICAL REPOR, DOI 10.7289/v5/tr-nos-coops-083; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Teck SJ, 2010, ECOL APPL, V20, P1402, DOI 10.1890/09-1173.1; Titus JG, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044008; Tyrrell MC, 2007, J EXP MAR BIOL ECOL, V342, P54, DOI 10.1016/j.jembe.2006.10.014; U.S. Environmental Protection Agency, 2016, EPA841R16007 OFF RES; U.S. Fish and Wildlife Service and National Oceanic and Atmospheric Administration, 2012, NAT FISH WILDL PLANT; Valiela I, 2004, J EXP MAR BIOL ECOL, V300, P131, DOI 10.1016/j.jembe.2003.12.023; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Von Holle B, 2019, J WILDLIFE MANAGE, V83, P694, DOI 10.1002/jwmg.21633; Waldbusser GG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128376; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Watling L, 2005, ERLANGEN EARTH C SER, P279, DOI 10.1007/3-540-27673-4_13; Watson EB, 2017, ESTUAR COAST, V40, P617, DOI [10.1007/s12237-016-0166-1, 10.1007/s12237-016-0069-1]; Wiest WA, 2016, CONDOR, V118, P274, DOI 10.1650/CONDOR-15-30.1; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Witman JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189388; Woodson CB, 2015, P NATL ACAD SCI USA, V112, P1710, DOI 10.1073/pnas.1417143112; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353; Wuebbles D. J., 2017, CLIMATE SCI SPECIAL, VI, P470, DOI [10.7930/J0J964J6, DOI 10.7930/J0J964J6]	195	1	1	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260654	10.1371/journal.pone.0260654	http://dx.doi.org/10.1371/journal.pone.0260654			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882701	gold, Green Published			2022-12-26	WOS:000755037200035
J	Glei, DA; Weinstein, M				Glei, Dana A.; Weinstein, Maxine			Disadvantaged Americans are suffering the brunt of rising pain and physical limitations	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; HEALTH RESEARCH; BACK-PAIN; TRENDS; DISABILITY; DISPARITIES; PATHWAY	Using data from three national surveys of US adults (one cohort and two cross-sectional studies, covering the period from the mid-1990s to the mid-2010s), we quantify the degree to which disparities by socioeconomic status (SES) in self-reported pain and physical limitations widened and explore whether they widened more in midlife than in later life. Unlike most prior studies that use proxy measures of SES (e.g., education), we use a multidimensional measure of SES that enables us to evaluate changes over time in each outcome for fixed percentiles of the population, thereby avoiding the problem of lagged selection bias. Results across multiple datasets demonstrate that socioeconomic disparities in pain and physical limitations consistently widened since the late 1990s, and if anything, widened even more in midlife than in late life (above 75). For those aged 50-74, the SES disparities in most outcomes widened by more than 50% and in some cases, the SES gap more than doubled. In contrast, the magnitude of SES widening was much smaller above age 75 and, in the vast majority of cases, not significant. Pain prevalence increased at all levels of SES, but disadvantaged Americans suffered the largest increases. Physical function deteriorated for those with low SES, but there was little change and perhaps improvement among the most advantaged Americans. At the 10th percentile of SES, the predicted percentage with a physical limitation at age 50 increased by 6-10 points between the late-1990s and the 2010s, whereas at the 90th percentile of SES, there was no change in two surveys and in the third survey, the corresponding percentage declined from 31% in 1996-99 to 22% in 2016-18. The worst-off Americans are being left behind in a sea of pain and physical infirmity, which may have dire consequences for their quality of life and for society as a whole (e.g., lost productivity, public costs).	[Glei, Dana A.; Weinstein, Maxine] Georgetown Univ, Ctr Populat & Hlth, Washington, DC 20057 USA	Georgetown University	Glei, DA (corresponding author), Georgetown Univ, Ctr Populat & Hlth, Washington, DC 20057 USA.	dag77@georgetown.edu		Glei, Dana/0000-0002-2865-9355	National Institute on Aging [P01 AG020166, U19AG051426]; Graduate School of Arts and Sciences, Georgetown University	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Graduate School of Arts and Sciences, Georgetown University	This work was supported by the National Institute on Aging [https://www.nia.nih.gov/, grant numbers P01 AG020166 and U19AG051426 to Carol Ryff (PI of the MIDUS project)] and the Graduate School of Arts and Sciences, Georgetown University (https://grad.georgetown.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JS, 2013, J AM GERIATR SOC, V61, P583, DOI 10.1111/jgs.12172; Azevedo LF, 2012, J PAIN, V13, P773, DOI 10.1016/j.jpain.2012.05.012; Ballantyne JC, 2003, NEW ENGL J MED, V349, P1943, DOI 10.1056/NEJMra025411; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Brim OG, 2016, TECHNICAL REPORT MET; Case A, 2020, P NATL ACAD SCI USA, V117, P24785, DOI 10.1073/pnas.2012350117; Coe C., 2016, MIDLIFE US MIDUS REF, DOI 10.3886/ICPSR36532.v2; Covinsky KE, 2009, J AM GERIATR SOC, V57, P1556, DOI 10.1111/j.1532-5415.2009.02388.x; Cutler DM, 2020, W27974 NAT BUR EC RE; Di Iorio A, 2007, SPINE, V32, pE809, DOI 10.1097/BRS.0b013e31815cd422; Dowd JB, 2014, INT J EPIDEMIOL, V43, P983, DOI 10.1093/ije/dyu120; Edmond SL, 2003, J AM GERIATR SOC, V51, P1702, DOI 10.1046/j.1532-5415.2003.51553.x; Freedman VA, 2013, DEMOGRAPHY, V50, P661, DOI 10.1007/s13524-012-0167-z; Glei DA, 2022, J AGING HEALTH, V34, P78, DOI 10.1177/08982643211028121; Glei DA, 2020, SOC SCI MED, V246, DOI 10.1016/j.socscimed.2020.112789; Glei DA, 2019, J AGING HEALTH, V31, P1067, DOI 10.1177/0898264318759378; Harris KM, 2021, JAMA-J AM MED ASSOC, V325, P2045, DOI 10.1001/jama.2021.4073; Iezzoni LI, 2014, DISABIL HEALTH J, V7, P402, DOI 10.1016/j.dhjo.2014.05.007; Institute for Social Research, 2019, HTLH RET STUD 2018 C; Institute of Medicine, 2011, REL AM BLUEPR TRANS, DOI [10.17226/13172, DOI 10.17226/13172]; Leveille SG, 2007, PAIN, V128, P69, DOI 10.1016/j.pain.2006.08.031; Li Z., 2018, R45419, P21; Ljungvall A, 2012, SOC SCI MED, V75, P109, DOI 10.1016/j.socscimed.2012.03.003; Maestas N, 2020, P NATL ACAD SCI USA, V117, P26559, DOI 10.1073/pnas.2018650117; Martin LG, 2014, DISABIL HEALTH J, V7, pS4, DOI 10.1016/j.dhjo.2013.06.007; Morden NE, 2014, MED CARE, V52, P852, DOI 10.1097/MLR.0000000000000183; National Academies of Sciences Engineering and Medicine 2021, 2021, HIGH RIS MORT RAT WO, DOI [10.17226/25976, DOI 10.17226/25976]; National Center for Health Statistics, 2018, HLTH US 2018, P65; National Center for Health Statistics, 2019, NAT HLTH INT SURV; Oakes JM, 2003, SOC SCI MED, V56, P769, DOI 10.1016/S0277-9536(02)00073-4; Oakes M., 2020, E SOURCE BEHAV SOCIA; Ogden Cynthia L, 2010, NCHS Data Brief, P1; Reid MC, 2005, J GERONTOL A-BIOL, V60, P793, DOI 10.1093/gerona/60.6.793; Schoeni RF, 2005, AM J PUBLIC HEALTH, V95, P2065, DOI 10.2105/AJPH.2004.048744; Scudds RJ, 2001, DISABIL REHABIL, V23, P654, DOI 10.1080/09638280110043942; Seeman TE, 2010, AM J PUBLIC HEALTH, V100, P100, DOI 10.2105/AJPH.2008.157388; StataCorp, 2019, STAT REL 16 STAT SOF; Stokes AC, 2020, SSM-POPUL HLTH, V12, DOI 10.1016/j.ssmph.2020.100644; University of California Berkeley (USA) and Max Planck Institute for Demographic Research (Germany), 2021, HUMAN MORTALITY DATA; Yu Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167193; Zajacova A, 2021, DEMOGRAPHY, V58, P711, DOI 10.1215/00703370-8977691; Zajacova A, 2017, BIODEMOGR SOC BIOL, V63, P21, DOI 10.1080/19485565.2016.1263150; Zimmer Z, 2020, J GERONTOL B-PSYCHOL, V75, P436, DOI 10.1093/geronb/gbx162	43	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0261375	10.1371/journal.pone.0261375	http://dx.doi.org/10.1371/journal.pone.0261375			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882731	Green Published, gold			2022-12-26	WOS:000755037200067
J	Mayseless, N; Reiss, AL				Mayseless, Naama; Reiss, Allan L.			The neurodevelopmental basis of humor appreciation: A fNIRS study of young children	PLOS ONE			English	Article							BRAIN; CONNECTIVITY; MODEL; FMRI; COMPREHENSION; HEMODYNAMICS; INCONGRUITY; MECHANISMS; MATURATION; CHILDHOOD	Humor is crucial for social development. Despite this, very few studies have examined the neurodevelopment of humor in very young children, and none to date have used functional near-infrared spectroscopy (fNIRS) to study this important cognitive construct. The main aim of the current study was to characterize the neural basis of humor processing in young children between the ages of 6-8 years. Thirty-five healthy children (6-8 years old) watched funny and neutral video clips while undergoing fNIRS imaging. We observed activation increases in left temporo-occipito-parietal junction (TOPJ), inferior-parietal lobe (IPL), dorsolateral-prefrontal cortex (DLPFC) and right inferior frontal gyrus (IFG) and superior parietal lobe (SPL) regions. Activation in left TOPJ was positively correlated with age. In addition, we found that coherence increased in humor viewing compared to neutral content, mainly between remote regions. This effect was different for boys and girls, as boys showed a more pronounced increase in coherence for funny compared to neutral videos, more so in frontoparietal networks. These results expand our understanding of the neurodevelopment of humor by highlighting the effect of age on the neural basis of humor appreciation as well as emphasizing different developmental trajectories of boys and girls.	[Mayseless, Naama; Reiss, Allan L.] Stanford Univ, Sch Med, Ctr Interdisciplinary Brain Sci Res, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Reiss, Allan L.] Stanford Univ, Dept Radiol, Sch Med, Stanford, CA 94305 USA; [Reiss, Allan L.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Mayseless, N (corresponding author), Stanford Univ, Sch Med, Ctr Interdisciplinary Brain Sci Res, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	naama27@gmail.com						Amir O, 2015, CEREB CORTEX, V25, P1405, DOI 10.1093/cercor/bht343; BAKEMAN R, 1984, CHILD DEV, V55, P1278, DOI 10.2307/1129997; Baker JM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201486; Baker JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26492; Bariaud F., 1989, J CHILDREN CONT SOC, V20, P15, DOI [10.1300/J274V20N01_03, DOI 10.1300/J274V20N01_03]; Boersma M, 2013, BRAIN CONNECT, V3, P50, DOI 10.1089/brain.2012.0106; Bozikas VP, 2007, J NERV MENT DIS, V195, P325, DOI 10.1097/01.nmd.0000243798.10242.e2; BRODZINSKY DM, 1981, SEX ROLES, V7, P561, DOI 10.1007/BF00288632; Brown I, 1993, EARLY CHILD DEV CARE, V93, P35, DOI DOI 10.1080/0030443930930103; Bruner Jerome S., 1976, PLAY ITS ROLE DEV EV; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; Caverzasi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100274; Chan YC, 2013, NEUROIMAGE, V66, P169, DOI 10.1016/j.neuroimage.2012.10.019; Chan YC, 2012, NEUROIMAGE, V61, P899, DOI 10.1016/j.neuroimage.2012.03.052; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Cui X, 2012, NEUROIMAGE, V59, P2430, DOI 10.1016/j.neuroimage.2011.09.003; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Dunn J., 1988, BEGINNINGS SOCIAL UN; Feng YJ, 2014, J NEUROLINGUIST, V32, P59, DOI 10.1016/j.jneuroling.2014.08.007; Fishburn FA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00076; Girouard A, 2010, HUM-COMPUT INT-SPRIN, P221, DOI 10.1007/978-1-84996-272-8_13; Goel V, 2001, NAT NEUROSCI, V4, P237, DOI 10.1038/85076; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Halverson CF, 2003, J PERS, V71, P995, DOI 10.1111/1467-6494.7106005; Huppert TJ, 2006, NEUROIMAGE, V29, P368, DOI 10.1016/j.neuroimage.2005.08.065; Kohn N, 2011, NEUROPSYCHOLOGIA, V49, P888, DOI 10.1016/j.neuropsychologia.2011.02.010; Kotthoff H, 2006, J PRAGMATICS, V38, P4, DOI 10.1016/j.pragma.2005.06.003; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Loizou E, 2006, EARLY CHILD EDUC J, V33, P425, DOI 10.1007/s10643-005-0053-z; Lyons V, 2004, J AUTISM DEV DISORD, V34, P521, DOI 10.1007/s10803-004-2547-8; Marinkovic K, 2011, COGN AFFECT BEHAV NE, V11, P113, DOI 10.3758/s13415-010-0017-7; Martin RA, 2007, PSYCHOLOGY OF HUMOR: AN INTEGRATIVE APPROACH, P1, DOI 10.1016/B978-012372564-6/50020-4; Mashal N, 2007, BRAIN LANG, V100, P115, DOI 10.1016/j.bandl.2005.10.005; McGhee P.E, 2013, HUMOR AGING, V27; McGhee P. E., 2014, HUMOR CHILDRENS DEV; McGhee Paul E., 1989, J CHILDREN CONT SOC, V20, P119, DOI DOI 10.1300/J274V20N; McGhee PE., 1979, HUMOR ITS ORIGIN DEV; Medvedev AV, 2014, NEUROIMAGE, V85, P400, DOI 10.1016/j.neuroimage.2013.05.092; Medvedev AV, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3533266; Mobbs D, 2005, P NATL ACAD SCI USA, V102, P16502, DOI 10.1073/pnas.0408457102; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Molavi B, 2012, PHYSIOL MEAS, V33, P259, DOI 10.1088/0967-3334/33/2/259; Neely MN, 2012, J NEUROSCI, V32, P1784, DOI 10.1523/JNEUROSCI.4172-11.2012; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; PICKERING E, 1987, LEARN DISABILITY Q, V10, P45, DOI 10.2307/1510754; Pien D., 1980, CHILDRENS HUMOUR, P1; Plichta MM, 2007, NEUROIMAGE, V35, P625, DOI 10.1016/j.neuroimage.2006.11.028; Polimeni JO, 2010, J PSYCHIATR RES, V44, P434, DOI 10.1016/j.jpsychires.2009.10.003; Racz FS, 2017, BIOMED OPT EXPRESS, V8, P3842, DOI 10.1364/BOE.8.003842; Reddy V, 2002, BRIT J PSYCHOL, V93, P219, DOI 10.1348/000712602162553; Reddy V, 1991, PLAYING OTHERSEXPECT; Rosenbaum D, 2016, NEUROBIOL AGING, V39, P57, DOI 10.1016/j.neurobiolaging.2015.11.022; Sagiv SK, 2019, P NATL ACAD SCI USA, V116, P18347, DOI 10.1073/pnas.1903940116; Samson AC, 2008, SOC NEUROSCI-UK, V3, P125, DOI 10.1080/17470910701745858; Samson AC, 2009, NEUROPSYCHOLOGIA, V47, P1023, DOI 10.1016/j.neuropsychologia.2008.10.028; Semrud-Clikeman M, 2010, J CHILD NEUROL, V25, P1248, DOI 10.1177/0883073810373144; Shultz T.R, 1976, COGNITIVE DEVELOPMEN; SHULTZ TR, 1974, CHILD DEV, V45, P100, DOI 10.1111/j.1467-8624.1974.tb00564.x; SHULTZ TR, 1972, J EXP CHILD PSYCHOL, V13, P456, DOI 10.1016/0022-0965(72)90074-4; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Suls J., 1977, ITS FUNNY THING HUMO, P41, DOI DOI 10.1016/B978-0-08-021376-7.50012-7; Suls JM., 1972, PSYCHOL HUMOR THEORE, V1, P81, DOI 10.1016/B978-0-12-288950-9.50010-9; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vartanian O, 2005, NEUROIMAGE, V27, P927, DOI 10.1016/j.neuroimage.2005.05.016; Veatch TC, 1998, HUMOR, V11, P161, DOI 10.1515/humr.1998.11.2.161; Vrticka P, 2013, NAT REV NEUROSCI, V14, P860, DOI 10.1038/nrn3566; Vrticka P, 2013, NEUROPSYCHOLOGIA, V51, P2799, DOI 10.1016/j.neuropsychologia.2013.09.028; Vrticka P, 2013, SOC NEUROSCI-UK, V8, P291, DOI 10.1080/17470919.2013.794751; Wechsler D., 2011, WECHSLER ABBREVIATED; Wu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055347; WYATT JS, 1986, LANCET, V2, P1063, DOI 10.1016/S0140-6736(86)90467-8; WYER RS, 1992, PSYCHOL REV, V99, P663, DOI 10.1037/0033-295X.99.4.663; Zhang JY, 2007, NEUROIMAGE, V38, P239, DOI 10.1016/j.neuroimage.2007.07.033	74	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0259422	10.1371/journal.pone.0259422	http://dx.doi.org/10.1371/journal.pone.0259422			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY2LS	34879055	gold, Green Published			2022-12-26	WOS:000754625200003
J	Guracho, TT; Atomssa, EM; Megersa, OA; Tolossa, T				Guracho, Tsega Tola; Atomssa, Emiru Merdassa; Megersa, Obsa Amante; Tolossa, Tadesse			Determinants of dental caries among adolescent patients attending Hospitals in West Wollega Zone, Western Ethiopia: A case-control study	PLOS ONE			English	Article							GLOBAL BURDEN; DISEASES; CHILDREN; GROWTH	Background Dental caries is a prevalent disease in both developed and developing countries and is a public health problem among adolescents. This study aimed to assess the determinants of dental caries among adolescent patients in the west Wollega Zone, Western Ethiopia. Methods A hospital-based unmatched case-control study design was conducted in West Wollega Zone, West Ethiopia. A total of 133 cases and 266 controls participated in this study. Data were collected using pre-tested questionnaires from three hospitals. Epi-info version 7 was used for data entry and was analyzed using SPSS version 20. Frequency, proportion, mean and standard deviation were computed to summarize the data. Statistics are presented using tables and bar graphs. Multivariable binary logistic regression analysis was used to identify the determinants of dental caries at P < 0.05. The adjusted odds ratio with 95% confidence interval (CI) was used to show the strength of association between the predictors and dental caries. Results A total of 399 adolescents were enrolled in this study, yielding a response rate of 100%. The study found that, daily consumption of sugared coffee (AOR = 2.91, 95% CI:1.62, 5.23), khat chewing (AOR = 2.90, 95%CI: 1.46, 3.15), daily consumption of bread (AOR = 2.65, 95%CI: 1.44, 4.89), daily consumption of sweet foods (AOR = 2.04, 95%CI:1.19, 3.48), living in urban areas (AOR = 1.86, 95%CI:1.09, 3.15), and daily tooth brushing using toothpaste or stick (AOR = 0.48;95%CI, 0.28, 0.81) were significantly associated with dental caries among adolescents. Conclusions and recommendations In this study, drinking sugared coffee, daily consumption of bread, khat chewing, sugary food consumption, living in urban areas, and daily tooth brushing using toothpaste were significantly associated with dental caries. Therefore, improving dietary and drinking habits and strengthening regular tooth brushing are important for reducing dental caries among adolescents.	[Guracho, Tsega Tola] World Vis Ethiopia, Nedjo, Oromia, Ethiopia; [Atomssa, Emiru Merdassa; Megersa, Obsa Amante; Tolossa, Tadesse] Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia		Tolossa, T (corresponding author), Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia.	yadanotolasa@gmail.com		Tolasa, Tadesse/0000-0002-7936-9024				Al-Sharafi BA, 2015, CLIN MED INSIGHTS-EN, V8, P47, DOI 10.4137/CMED.S26045; Astatkie A, 2015, EPIDEMIOL HEALTH, V37, DOI 10.4178/epih/e2015009; Ayele FA, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-7; Bagramian RA, 2009, AM J DENT, V22, P3; Balaji S M, 2018, Indian J Dent Res, V29, P820, DOI 10.4103/ijdr.IJDR_812_18; Berhane H. Y., 2014, Open Journal of Preventive Medicine, V4, P640, DOI 10.4236/ojpm.2014.48073; Bernabe E, 2020, J DENT RES, V99, P362, DOI 10.1177/0022034520908533; Borges Tássia Silvana, 2016, Rev. paul. pediatr., V34, P489, DOI [10.1016/j.rpped.2016.02.004, 10.1016/j.rppede.2016.02.013]; Burnett D, 2016, J CHILD HEALTH CARE, V20, P252, DOI 10.1177/1367493515569328; Chala S, 2016, REV STOMATOL CHIR, V117, P367, DOI 10.1016/j.revsto.2016.05.005; CHUNG CS, 1977, J DENT RES, V56, P11, DOI 10.1177/00220345770560010101; Deen JL, 1999, B WORLD HEALTH ORGAN, V77, P518; Frazão Paulo, 2012, Braz. oral res., V26, P108, DOI 10.1590/S1806-83242012000700016; Gladwell K., 2012, DENT CARIES ITS RELA; Glick M, 2021, INT DENT J, V71, P3, DOI 10.1016/j.identj.2020.12.026; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Jin LJ, 2016, ORAL DIS, V22, P609, DOI 10.1111/odi.12428; Kassebaum NJ, 2015, J DENT RES, V94, P650, DOI 10.1177/0022034515573272; Kazeminia M, 2020, HEAD FACE MED, V16, DOI 10.1186/s13005-020-00237-z; Kidd EAM, 2005, ESSENTIALS DENT CARI; Lee K, 2009, GLOB INST, P1; Teixeira AKM, 2016, CIENC SAUDE COLETIVA, V21, P3871, DOI 10.1590/1413-812320152112.12582015; Mason J., 2010, CONCEPTS DENT PUBLIC, VSecond; Freire MDM, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000093, 10.11606/s1518-8787.2018052000093]; Maxim Dana Cristiana, 2010, Rev Med Chir Soc Med Nat Iasi, V114, P866; Moynihan P, 2004, PUBLIC HEALTH NUTR, V7, P201, DOI 10.1079/PHN2003589; Mulu Wondemagegn, 2014, BMC Res Notes, V7, P949, DOI 10.1186/1756-0500-7-949; Ndagire Barbara, 2020, Braz. Dent. J., V31, P171, DOI 10.1590/0103-6440202002841; Petersen PE, 2013, ORAL HLTH SURVEYS BA, V5th; PMA2020/Ethiopia, 2020, AD YOUNG WOM HLTH BR; Poul E.P., 2003, CONTINUOUS IMPROVEME; Senait M., 2005, DETERMINANTE FACTORS, P80; Sheiham A, 2006, BRIT DENT J, V201, P625, DOI 10.1038/sj.bdj.4814259; SONNBERGER H, 1989, J APPL ECONOM, V4, P97, DOI 10.1002/jae.3950040108; Teshome A, 2016, PREVALENCE DENT CARI; Thorpe SJ, 2006, J DENT ED, V70, P8, DOI [10.1002/j.0022-0337.2006.70.11_suppl.tb04209.x, DOI 10.1002/J.0022-0337.2006.70.11_SUPPL.TB04209.X]; Touger-Decker R, 2003, AM J CLIN NUTR, V78, p881S, DOI 10.1093/ajcn/78.4.881S; van Gemert-Schriks MCM, 2011, CLIN ORAL INVEST, V15, P141, DOI 10.1007/s00784-010-0380-3; Wandera Margaret, 2003, Afr Health Sci, V3, P19; *WHO, 2017, WHONMHNHD1712; World Health Organization, 2003, DENT DIS OR HLTH GLO; Yarom N, 2010, ORAL SURG ORAL MED O, V109, pE60, DOI 10.1016/j.tripleo.2010.02.022; Yitayeh A., 2016, AGE, V12, P15; Zewdu T, 2021, ENVIRON HEALTH PREV, V26, DOI 10.1186/s12199-021-00943-3	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260427	10.1371/journal.pone.0260427	http://dx.doi.org/10.1371/journal.pone.0260427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855813	gold, Green Published			2022-12-26	WOS:000735299000056
J	Han, JW; Sung, PS; Jang, JW; Choi, JY; Yoon, SK				Han, Ji Won; Sung, Pil Soo; Jang, Jeong Won; Choi, Jong Young; Yoon, Seung Kew			Whole blood viscosity is associated with extrahepatic metastases and survival in patients with hepatocellular carcinoma	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; ASPIRIN SUPPRESSES; ALPHA-FETOPROTEIN; CANCER METASTASIS; PIVKA-II; PERFORMANCE; SORAFENIB; FORCES; MODEL; RISK	Whole blood viscosity (WBV) is increased in cancer patients and associated with the advanced stage with systemic metastases. However, relevance of WBV in hepatocellular carcinoma (HCC) remains unclear. This pilot study included a discovery cohort of 148 treatment-naive HCC patients with preserved liver function, and a validation cohort of 33 treatment-experienced HCC patients with nivolumab. Systolic and diastolic WBV was measured using an automated scanning capillary tube viscometer at diagnosis or before the nivolumab treatment. Extrahepatic metastases were observed in 15 treatment-naive patients (11.3%) at diagnosis. Portal vein tumor thrombosis (PVTT), tumor size, number of tumors, and systolic/diastolic WBV were factors associated with extrahepatic metastases. Systolic WBV and diastolic WBV were significantly increased in patients with metastases compared with patients without metastases. Multivariate logistic regression showed that high diastolic WBV > 16 cP was an independent factor associated with metastases. Notably, patients who developed extrahepatic metastases during the observation period among patients without metastases at diagnosis had higher diastolic WBV initially. Patients with high diastolic WBV had poor survival, and multivariate Cox regression analyses showed high diastolic WBV was an independent risk factor for poor survival with the Child-Pugh B7 and PVTT. High diastolic WBV also predicted poor survival in patients with low alpha-fetoprotein (AFP) and proteins induced by vitamin K antagonist-II (PIVKA-II) levels. In 33 nivolumab-treated patients, high diastolic WBV before the treatment was also tended to be associated with overall and progression-free survival. Our study is the first in which high WBV is associated with the distant metastases and survival in patients with HCC, but future prospective, large cohort studies are necessary to validate the results.	[Han, Ji Won; Sung, Pil Soo; Jang, Jeong Won; Choi, Jong Young; Yoon, Seung Kew] Catholic Univ Korea, Catholic Univ Liver Res Ctr, Coll Med, Seoul, South Korea; [Han, Ji Won; Sung, Pil Soo; Jang, Jeong Won; Choi, Jong Young; Yoon, Seung Kew] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Gastroenterol & Hepatol,Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Yoon, SK (corresponding author), Catholic Univ Korea, Catholic Univ Liver Res Ctr, Coll Med, Seoul, South Korea.; Yoon, SK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Gastroenterol & Hepatol,Dept Internal Med, Seoul, South Korea.	yoonsk@catholic.ac.kr	Sung, Pil Soo/AAD-6344-2021	Sung, Pil Soo/0000-0002-5780-9607; Yoon, Seung Kew/0000-0002-4476-4868	Young Medical Scientist Research Grant through the Daewoong Foundation [DY20201P]; Seoul St. Mary's Hospital, The Catholic University of Korea	Young Medical Scientist Research Grant through the Daewoong Foundation; Seoul St. Mary's Hospital, The Catholic University of Korea	This research was supported by Young Medical Scientist Research Grant through the Daewoong Foundation (DY20201P) (to J.W.H.). This study was also supported by the Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea (to J.W.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Anton H, 2013, DEVELOPMENT, V140, P4426, DOI 10.1242/dev.096768; Bobek V, 2004, BIOMED PHARMACOTHER, V58, P213, DOI 10.1016/j.biopha.2003.11.007; Bruix J, 2017, J HEPATOL, V67, P999, DOI 10.1016/j.jhep.2017.06.026; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Choi JY, 2013, WORLD J GASTROENTERO, V19, P339, DOI 10.3748/wjg.v19.i3.339; Dai XY, 2017, CLIN CANCER RES, V23, P6267, DOI 10.1158/1078-0432.CCR-17-0242; DINTENFASS L, 1977, Haematologia, V11, P301; DINTENFASS L, 1982, CLIN HEMORHEOL, V2, P259; Dorland YL, 2017, CELL MOL LIFE SCI, V74, P279, DOI 10.1007/s00018-016-2325-8; Duvoux C, 2012, GASTROENTEROLOGY, V143, P986, DOI 10.1053/j.gastro.2012.05.052; Elwood PC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152402; Fidler IJ, 2008, LANCET ONCOL, V9, P808, DOI 10.1016/S1470-2045(08)70201-8; Follain G, 2020, NAT REV CANCER, V20, P107, DOI 10.1038/s41568-019-0221-x; Follain G, 2018, DEV CELL, V45, P33, DOI 10.1016/j.devcel.2018.02.015; Font-Clos F, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101073; Gao J, 1990, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V12, P300; Gokturk HS, 2009, SOUTH MED J, V102, P1013, DOI 10.1097/SMJ.0b013e3181b50057; HU DE, 1988, CLIN HEMORHEOL, V8, P945; Jang B, 2016, J KOREAN MED SCI, V31, P1943, DOI 10.3346/jkms.2016.31.12.1943; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Jung JM, 2014, CLIN BIOCHEM, V47, P489, DOI 10.1016/j.clinbiochem.2014.01.021; Kato K, 2007, HEPATOL RES, V37, P444, DOI 10.1111/j.1872-034X.2007.00051.x; Kauffmann-Guerrero D, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90397-y; KHAN MM, 1995, CLIN HEMORHEOL, V15, P37; Kim DY, 2007, ONCOLOGY-BASEL, V72, P52, DOI 10.1159/000111707; Lee CH, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1315-5; Liao D, 2015, CLIN CANCER RES, V21, P5349, DOI 10.1158/1078-0432.CCR-15-0198; Liu Q, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0742-4; Marrella A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245536; Mazzaferro V, 2018, GASTROENTEROLOGY, V154, P128, DOI 10.1053/j.gastro.2017.09.025; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Nwose EU, 2010, N AM J MED SCI, V2, P353, DOI 10.4297/najms.2010.2353; Omoti CE, 2009, CLIN HEMORHEOL MICRO, V42, P279, DOI 10.3233/CH-2009-1198; Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487; Park JW, 2019, GUT LIVER, V13, P227, DOI 10.5009/gnl19024; Piscaglia F, 2013, DIGEST LIVER DIS, V45, P852, DOI 10.1016/j.dld.2013.03.002; Pressiani T, 2013, ANN ONCOL, V24, P406, DOI 10.1093/annonc/mds343; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Saha S, 2016, CANCER RES, V76, P2000, DOI 10.1158/0008-5472.CAN-15-1360; Sanghera C, 2019, LIVER INT, V39, P2008, DOI 10.1111/liv.14220; Scott JG, 2014, EUR J CANCER, V50, P3068, DOI 10.1016/j.ejca.2014.08.019; Shi J, 2011, J HEPATO-BIL-PAN SCI, V18, P74, DOI 10.1007/s00534-010-0314-0; Simon TG, 2020, NEW ENGL J MED, V382, P1018, DOI 10.1056/NEJMoa1912035; Skretteberg PT, 2010, SCAND CARDIOVASC J, V44, P107, DOI [10.3109/14017430903171248, 10.1080/14017430903171248]; Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943; Sung PS, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01043; Taco-Vasquez ED, 2019, CUREUS, V11, DOI 10.7759/cureus.3925; Tamariz LJ, 2008, AM J EPIDEMIOL, V168, P1153, DOI 10.1093/aje/kwn243; Tamer S, 2007, CLIN HEMORHEOL MICRO, V36, P247; Toyoda H, 2006, CLIN GASTROENTEROL H, V4, P1528, DOI 10.1016/j.cgh.2006.09.021; Toyoda H, 2011, CANCER SCI, V102, P1025, DOI 10.1111/j.1349-7006.2011.01875.x; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263; von Tempelhoff G-F, SEMINARS THROMBOSIS; von Tempelhoff GF, 2000, CLIN HEMORHEOL MICRO, V22, P107; Wang Kai, 2003, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V17, P280; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; Yang Yan, 2005, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V19, P61; Ying J, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-017-0198-7; Yu XY, 2016, CLIN HEMORHEOL MICRO, V62, P335, DOI 10.3233/CH-151974; Zhang YY, 2018, CANCER LETT, V429, P29, DOI 10.1016/j.canlet.2018.05.004; Zhao HY, 2015, CLIN ENDOCRINOL, V83, P806, DOI 10.1111/cen.12776; Zhao N, 2016, SCI REP-UK, V6, DOI 10.1038/srep23091	65	3	3	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260311	10.1371/journal.pone.0260311	http://dx.doi.org/10.1371/journal.pone.0260311			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855786	Green Published, gold			2022-12-26	WOS:000735299000042
J	Holmboe, K; Larkman, C; de Klerk, C; Simpson, A; Bell, MA; Patton, L; Christodoulou, C; Dvergsdal, H				Holmboe, Karla; Larkman, Charlotte; de Klerk, Carina; Simpson, Andrew; Bell, Martha Ann; Patton, Leslie; Christodoulou, Charis; Dvergsdal, Henrik			The early childhood inhibitory touchscreen task: A new measure of response inhibition in toddlerhood and across the lifespan	PLOS ONE			English	Article							STOP SIGNAL TASK; EXECUTIVE FUNCTION; DEVELOPMENTAL-CHANGES; INDIVIDUAL-DIFFERENCES; COGNITIVE CONTROL; SELF-REGULATION; YOUNG-CHILDREN; PERFORMANCE; GO; ABILITY	Research into the earliest development of inhibitory control is limited by a lack of suitable tasks. In particular, commonly used inhibitory control tasks frequently have too high language and working memory demands for children under 3 years of age. Furthermore, researchers currently tend to shift to a new set of inhibitory control tasks between infancy, toddlerhood, and early childhood, raising doubts about whether the same function is being measured. Tasks that are structurally equivalent across age could potentially help resolve this issue. In the current report, a new response inhibition task, the Early Childhood Inhibitory Touchscreen Task (ECITT), was developed. This task can be minimally modified to suit different ages, whilst remaining structurally equivalent. In the new task, participants have to overcome a tendency to respond to a frequently rewarded location on a touchscreen and instead make an alternative response. The ECITT was validated in three independent studies (with additional data, N = 166, reported in Supporting Information). In Study 1 (N = 81), cross-sectional data indicated that inhibitory performance on the task improved significantly between 24 and 30 months of age. In Study 2 (N = 38), longitudinal data indicated steady improvement in inhibitory control between 18, 21 and 24 months, with significant stability in individual performance differences between each consecutive age in terms of accuracy (but not in terms of reaction time). Finally, in Study 3 (N = 64), inhibitory performance on a faster-paced version of the same task showed a similar developmental course across the lifespan (4-84 years) to other response inhibition tasks and was significantly correlated with Stop-signal performance. The ECITT extends the assessment of response inhibition earlier than previous tasks-into early toddlerhood. Because the task is simple and structurally equivalent across age, future longitudinal studies should benefit from using the ECITT to investigate the development of inhibitory control in a consistent manner across the toddler years and beyond.	[Holmboe, Karla] Univ Bristol, Sch Psychol Sci, Bristol, Avon, England; [Holmboe, Karla] Univ Oxford, Dept Expt Psychol, Oxford, England; [Larkman, Charlotte; de Klerk, Carina; Simpson, Andrew; Christodoulou, Charis] Univ Essex, Dept Psychol, Colchester, Essex, England; [de Klerk, Carina] Ctr Brain & Cognit Dev, Dept Psychol Sci, London, England; [Bell, Martha Ann; Patton, Leslie] Virginia Tech, Dept Psychol, Blacksburg, VA USA; [Dvergsdal, Henrik] Nord Univ, Business Sch, Dept Entrepreneurship Innovat & Org, Bodo, Norway	University of Bristol; University of Oxford; University of Essex; University of London; Birkbeck University London; Virginia Polytechnic Institute & State University; Nord University	Holmboe, K (corresponding author), Univ Bristol, Sch Psychol Sci, Bristol, Avon, England.; Holmboe, K (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford, England.	karla.holmboe@bristol.ac.uk	Holmboe, Karla/ABG-6406-2021	Holmboe, Karla/0000-0003-3157-6101; Dvergsdal, Henrik/0000-0002-8515-1670	UK Medical Research Council [MR/N008626/1]; Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health [R03 HD091644]; Leverhulme Trust [RPG-2015-115]	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health; Leverhulme Trust(Leverhulme Trust)	This research was funded by: 1. The UK Medical Research Council (MR/N008626/1, PI: KH), https://www.ukri.org/councils/mrc/.2.Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (R03 HD091644, PI: MAB), https://www.nichd.nih.gov/.3.CdK was funded by a research project grant from the Leverhulme Trust (RPG-2015-115, PI: Victoria Southgate), https://www.leverhulme.ac.uk.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akshoomoff N, 2014, NEUROPSYCHOLOGY, V28, P1, DOI 10.1037/neu0000001; Archibald SJ, 1999, CHILD NEUROPSYCHOL, V5, P115, DOI 10.1076/chin.5.2.115.3167; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; BECKER MG, 1987, DEV NEUROPSYCHOL, V3, P275, DOI 10.1080/87565648709540381; Bedard AC, 2002, DEV NEUROPSYCHOL, V21, P93, DOI 10.1207/S15326942DN2101_5; BELL MA, 1992, CHILD DEV, V63, P1142, DOI 10.2307/1131523; Bell MA, 1999, INFANT BEHAV DEV, V22, P221, DOI 10.1016/S0163-6383(99)00010-7; Brock LL, 2009, EARLY CHILD RES Q, V24, P337, DOI 10.1016/j.ecresq.2009.06.001; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Camerota M, 2019, PSYCHOL ASSESSMENT, V31, P995, DOI 10.1037/pas0000725; Carlson S. M., 2016, EXECUTIVE FUNCTION P, P45, DOI [DOI 10.1037/14797-003, 10.1037/14797-003]; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Carlson SM, 2004, DEV PSYCHOL, V40, P1105, DOI 10.1037/0012-1649.40.6.1105; Carver AC, 2001, INT J NEUROSCI, V107, P43, DOI 10.3109/00207450109149756; Carver AC, 2001, INT J NEUROSCI, V111, P39, DOI 10.3109/00207450108986551; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; Cragg L, 2008, DEVELOPMENTAL SCI, V11, P819, DOI 10.1111/j.1467-7687.2008.00730.x; Cragg L, 2009, DEV PSYCHOBIOL, V51, P533, DOI 10.1002/dev.20391; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Dalley JW, 2017, NAT REV NEUROSCI, V18, P158, DOI 10.1038/nrn.2017.8; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Delacre M, 2017, INT REV SOC PSYCHOL, V30, P92, DOI 10.5334/irsp.82; Di Norcia A, 2015, J CHILD FAM STUD, V24, P909, DOI 10.1007/s10826-014-9901-z; DIAMOND A, 1985, CHILD DEV, V56, P868, DOI 10.1111/j.1467-8624.1985.tb00160.x; Diamond A, 2002, DEV PSYCHOL, V38, P352, DOI 10.1037/0012-1649.38.3.352; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Durston S, 2006, DEVELOPMENTAL SCI, V9, P1, DOI 10.1111/j.1467-7687.2005.00454.x; Durston S, 2002, DEVELOPMENTAL SCI, V5, pF9, DOI 10.1111/1467-7687.00235; Enkavi AZ, 2019, P NATL ACAD SCI USA, V116, P5472, DOI 10.1073/pnas.1818430116; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fiske A, 2019, DEV REV, V52, P42, DOI 10.1016/j.dr.2019.100866; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Friedman NP, 2011, DEV PSYCHOL, V47, P1410, DOI 10.1037/a0023750; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Garon N, 2014, CHILD NEUROPSYCHOL, V20, P713, DOI 10.1080/09297049.2013.857650; Gerardi-Caulton G, 2000, DEVELOPMENTAL SCI, V3, P397, DOI 10.1111/1467-7687.00134; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; Happaney K, 2004, BRAIN COGNITION, V55, P1, DOI 10.1016/j.bandc.2004.01.001; Hedge C, 2018, BEHAV RES METHODS, V50, P1166, DOI 10.3758/s13428-017-0935-1; Hendry A, 2022, DEVELOPMENTAL SCI, V25, DOI 10.1111/desc.13193; Holmboe K., 2021, NEURAL CORRELATES IN; Holmboe K., 2008, FRONTAL CORTEX FUNCT; Holmboe K, 2008, J EXP CHILD PSYCHOL, V100, P89, DOI 10.1016/j.jecp.2007.09.004; Holmboe K, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12690; Howard SJ, 2017, J PSYCHOEDUC ASSESS, V35, P255, DOI 10.1177/0734282916633009; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Johnstone SJ, 2007, INT J PSYCHOPHYSIOL, V63, P25, DOI 10.1016/j.ijpsycho.2006.07.001; Kim S, 2013, J ABNORM CHILD PSYCH, V41, P43, DOI 10.1007/s10802-012-9661-4; Kochanska G, 2000, DEV PSYCHOL, V36, P220, DOI 10.1037//0012-1649.36.2.220; Kovacs AM, 2009, P NATL ACAD SCI USA, V106, P6556, DOI 10.1073/pnas.0811323106; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; Lagattuta KH, 2011, DEVELOPMENTAL SCI, V14, P481, DOI 10.1111/j.1467-7687.2010.00994.x; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; Ling DS, 2016, COGNITIVE DEV, V37, P67, DOI 10.1016/j.cogdev.2015.10.003; LIVESEY DJ, 1991, AUST J PSYCHOL, V43, P133, DOI 10.1080/00049539108260137; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; Mehnert J, 2013, BRAIN DEV-JPN, V35, P894, DOI 10.1016/j.braindev.2012.11.006; Mulder H, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00733; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Petersen IT, 2016, DEV REV, V40, P25, DOI 10.1016/j.dr.2016.02.001; Rahman AA, 2017, DEV NEUROPSYCHOL, V42, P336, DOI 10.1080/87565641.2017.1355917; Rey-Mermet A, 2018, J EXP PSYCHOL LEARN, V44, P501, DOI 10.1037/xlm0000450; Rothbart MK, 2003, J PERS, V71, P1113, DOI 10.1111/1467-6494.7106009; Rouder J. N., 2019, WHY MOST STUDIES IND, DOI [10.31234/osf.io/3cjr5, DOI 10.31234/OSF.IO/3CJR5]; Savalei, 2021, 6 SOLUTIONS MORE REL; Simpson A, 2006, J EXP CHILD PSYCHOL, V94, P18, DOI 10.1016/j.jecp.2005.10.003; Simpson A, 2007, DEV PSYCHOL, V43, P417, DOI 10.1037/0012-1649.43.2.417; Simpson A, 2012, DEVELOPMENTAL SCI, V15, P62, DOI 10.1111/j.1467-7687.2011.01105.x; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Willoughby M, 2011, DEV NEUROPSYCHOL, V36, P162, DOI 10.1080/87565641.2010.549980; Zelazo PD, 2013, MONOGR SOC RES CHILD, V78, P16, DOI 10.1111/mono.12032; Zelazo PD, 2012, CHILD DEV PERSPECT, V6, P354, DOI 10.1111/j.1750-8606.2012.00246.x	74	4	4	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260695	10.1371/journal.pone.0260695	http://dx.doi.org/10.1371/journal.pone.0260695			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855865	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000735299000097
J	MacInnis, AG				MacInnis, Alexander G.			Time-to-event estimation of birth prevalence trends: A method to enable investigating the etiology of childhood disorders including autism	PLOS ONE			English	Article							COHORT EFFECTS EXPLAIN; SPECTRUM DISORDER; CHILDREN BORN; AGE; DIAGNOSIS; INCREASE; IDENTIFICATION; EPIDEMIOLOGY; HISTORY	An unbiased, widely accepted estimate of the rate of occurrence of new cases of autism over time would facilitate progress in understanding the causes of autism. The same may also apply to other disorders. While incidence is a widely used measure of occurrence, birth prevalence-the proportion of each birth year cohort with the disorder-is the appropriate measure for disorders and diseases of early childhood. Studies of autism epidemiology commonly speculate that estimates showing strong increases in rate of autism cases result from an increase in diagnosis rates rather than a true increase in cases. Unfortunately, current methods are not sufficient to provide a definitive resolution to this controversy. Prominent experts have written that it is virtually impossible to solve. This paper presents a novel method, time-to-event birth prevalence estimation (TTEPE), to provide accurate estimates of birth prevalence properly adjusted for changing diagnostic factors. It addresses the shortcomings of prior methods. TTEPE is based on well-known time-to-event (survival) analysis techniques. A discrete survival process models the rates of incident diagnoses by birth year and age. Diagnostic factors drive the probability of diagnosis as a function of the year of diagnosis. TTEPE models changes in diagnostic criteria, which can modify the effective birth prevalence when new criteria take effect. TTEPE incorporates the development of diagnosable symptoms with age. General-purpose optimization software estimates all parameters, forming a non-linear regression. The paper specifies all assumptions underlying the analysis and explores potential deviations from assumptions and optional additional analyses. A simulation study shows that TTEPE produces accurate parameter estimates, including trends in both birth prevalence and the probability of diagnosis in the presence of sampling effects from finite populations. TTEPE provides high power to resolve small differences in parameter values by utilizing all available data points.				a.macinnis@alumni.stanford.edu		MacInnis, Alexander/0000-0002-4246-4116				Al-Qabandi M, 2011, PEDIATRICS, V128, pE211, DOI 10.1542/peds.2010-1881; American Psychiatric Association, DSM HIST; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Baxter AJ, 2015, PSYCHOL MED, V45, P601, DOI 10.1017/S003329171400172X; Campbell CA, 2011, AUT CHILD PSYCHO, P25, DOI 10.1007/978-1-4419-8065-6_3; Centers for Disease Control, BIRTH DEF SURV TOOLK; Centers for Disease Control, 2018, MMWR SURVEILL SUMM, V67, P1; Centers for Disease Control, 2020, MMWR SURVEILL SUMM, V69, P1; Centers for Disease Control, 2009, MMWR SURVEILL SUMM, V58, P21; Centers for Disease Control, 2018, MMWR SURVEILL SUMM, V65, P1; COX DR, 1972, J R STAT SOC B, V34, P187; Croen LA, 2002, J AUTISM DEV DISORD, V32, P207, DOI 10.1023/A:1015453830880; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Giserman-Kiss I, 2020, J AUTISM DEV DISORD, V50, P3263, DOI 10.1007/s10803-019-04138-2; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hahn Robert, 2007, MMWR Recomm Rep, V56, P1; Hansen SN, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-016-0280-6; Hansen SN, 2015, JAMA PEDIATR, V169, P56, DOI 10.1001/jamapediatrics.2014.1893; Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Hyman SL, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-3447; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Keyes KM, 2012, INT J EPIDEMIOL, V41, P495, DOI 10.1093/ije/dyr193; King M, 2009, INT J EPIDEMIOL, V38, P1224, DOI 10.1093/ije/dyp261; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; LJUNG L, 1994, AUTOMATICA, V30, P265, DOI 10.1016/0005-1098(94)90029-9; Lord C, 2021, AM J PSYCHIAT, V178, P680, DOI 10.1176/appi.ajp.2021.21060578; MacInnis AG., 2017, THESIS STANFORD U ST; MacInnis AG, 2020, **DATA OBJECT**, DOI [10.17605/OSF.IO/WPNKU, DOI 10.17605/OSF.IO/WPNKU]; Maenner MJ, 2013, J AM ACAD CHILD PSY, V52, P401, DOI 10.1016/j.jaac.2013.01.014; McKenzie K., 2016, CURR DEV DISORD REP, V3, P104, DOI [10.1007/s40474-016-0085-7, DOI 10.1007/S40474-016-0085-7]; Morris TP, 2019, STAT MED, V38, P2074, DOI 10.1002/sim.8086; Morris-Rosendahl DJ, 2020, DIALOGUES CLIN NEURO, V22, P65, DOI 10.31887/DCNS.2020.22.1/macrocq; Myers SM, 2019, J AUTISM DEV DISORD, V49, P1455, DOI 10.1007/s10803-018-3834-0; National Birth Defects Prevention Network, 2004, GUIDELINES CONDUCTIN; Nevison C, 2018, J AUTISM DEV DISORD, V48, P4103, DOI 10.1007/s10803-018-3670-2; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; OBrien RM, 2015, CH CRC STAT SOC BEHA, P1; Ozonoff S, 2018, J AM ACAD CHILD PSY, V57, P849, DOI 10.1016/j.jaac.2018.06.022; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P12; RODGERS WL, 1982, AM SOCIOL REV, V47, P774, DOI 10.2307/2095213; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sasayama D, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.9234; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Shattuck PT, 2009, J AM ACAD CHILD PSY, V48, P474, DOI 10.1097/CHI.0b013e31819b3848; Sheldrick RC, 2017, J AM ACAD CHILD PSY, V56, P313, DOI 10.1016/j.jaac.2017.01.012; Spiers N, 2013, INT J EPIDEMIOL, V42, P1520, DOI 10.1093/ije/dyt029; Szatmari P, 2015, JAMA PSYCHIAT, V72, P276, DOI 10.1001/jamapsychiatry.2014.2463; Szklo M, 2014, EPIDEMIOLOGY BASICS; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Wolff JJ, 2021, J AM ACAD CHILD PSY, V60, P958, DOI 10.1016/j.jaac.2020.07.910; Zwaigenbaum L, 2018, BMJ-BRIT MED J, V361, DOI [10.1136/bmj.k1674, 10.1136/hmj.k1674]	55	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260738	10.1371/journal.pone.0260738	http://dx.doi.org/10.1371/journal.pone.0260738			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855847	Green Published, gold			2022-12-26	WOS:000735299000108
J	Noda-Nicolau, NM; Silva, MD; Bento, GFC; Ferreira, JSB; Novak, J; Morales, JAP; Tronco, JA; Bolpetti, AN; Pinto, GVS; Polettini, J; Marconi, C; da Silva, MG				Noda-Nicolau, Nathalia Mayumi; Silva, Mariana de Castro; Cosi Bento, Giovana Fernanda; Baptista Ferreira, Jeniffer Sena; Novak, Juliano; Pessoa Morales, Julia Andrade; Tronco, Julia Abbade; Bolpetti, Aline Nascimento; Silva Pinto, Gabriel Vitor; Polettini, Jossimara; Marconi, Camila; da Silva, Marcia Guimaraes			Cervicovaginal levels of human beta defensins during bacterial vaginosis	PLOS ONE			English	Article							HUMAN BETA-DEFENSIN-2; ANTIMICROBIAL PEPTIDES; EXPRESSION; IMMUNITY; HEALTH; LACTOBACILLI; ENVIRONMENT; CYTOKINES; INDUCE; WOMEN	Aims To compare the cervicovaginal levels of human beta defensin (hBD)-1, 2 and 3 of women according to the status of Nugent-defined bacterial vaginosis (BV). Methods A total of 634 women of reproductive age were included in the study. Participants were equally distributed in two groups: according to the classification of vaginal smears according to Nugent criteria in normal (scores 0 to 3) and BV (scores >= 7). Cervicovaginal fluid samples were used for measurements of hBDs1, 2 and 3 levels by enzyme-linked immunosorbent assay (ELISA). Levels of each hBD were compared between the two study groups using Mann-Whitney test, with p-value <0.05 considered as significant. Odds ratio (OR) and 95% confidence interval (95% CI) were calculated for sociodemographic variables and hBD1-3 levels associated with BV a multivariable analysis. Correlation between Nugent score and measured levels of hBDs1-3 were calculated using Spearman's test. Results Cervicovaginal fluids from women with BV showed lower levels of hBD-1 [median 2,400.00 pg/mL (0-27,800.00); p<0.0001], hBD-2 [5,600.00 pg/mL (0-45,800.00); p<0.0001] and hBD-3 [1,600.00 pg/mL (0-81,700.00); p = 0.012] when compared to optimal microbiota [hBD-1: [median 3,400.00 pg/mL (0-35,600.00), hBD-2: 12,300.00 pg/mL (0-95,300.00) and hBD-3: 3,000.00 pg/mL (0-64,300.00), respectively]. Multivariable analysis showed that lower levels of hBD-1 (OR: 2.05; 95% CI: 1.46-2.87), hBD-2 (OR: 1.85; 95% CI: 1.32-2.60) and hBD-3 (OR: 1.90; 95% CI: 1.37-2.64) were independently associated BV. Significant negative correlations were observed between Nugent scores and cervicovaginal levels of hBD-1 (Spearman's rho = -0.2118; p = 0.0001) and hBD-2 (*Spearman's rho = -0.2117; p = 0.0001). Conclusions Bacterial vaginosis is associated with lower cervicovaginal levels of hBDs1-3 in reproductive-aged women.	[Noda-Nicolau, Nathalia Mayumi; Silva, Mariana de Castro; Cosi Bento, Giovana Fernanda; Baptista Ferreira, Jeniffer Sena; Novak, Juliano; Pessoa Morales, Julia Andrade; Tronco, Julia Abbade; Bolpetti, Aline Nascimento; Silva Pinto, Gabriel Vitor; Marconi, Camila; da Silva, Marcia Guimaraes] Sao Paulo State Univ UNESP, Botucatu Med Sch, Dept Pathol, Sao Paulo, Brazil; [Polettini, Jossimara] Univ Fed Fronteira Sul UFFS, Med Sch, Grad Program Biomed Sci, Passo Fundo, RS, Brazil; [Marconi, Camila] Univ Fed Parana UFPR, Dept Basic Pathol, Setor Ciencias Biol, Curitiba, Parana, Brazil	Universidade Estadual Paulista; Universidade Federal da Fronteira Sul; Universidade Federal do Parana	da Silva, MG (corresponding author), Sao Paulo State Univ UNESP, Botucatu Med Sch, Dept Pathol, Sao Paulo, Brazil.	marcia.guimaraes@unesp.br	de Castro Silva, Mariana/AFN-8122-2022; Marconi, Camila/C-6936-2012; da Silva, Márcia Guimarães/M-8080-2019	de Castro Silva, Mariana/0000-0002-2251-9730; Marconi, Camila/0000-0001-7742-1186; da Silva, Márcia Guimarães/0000-0002-4663-7926; Novak, Juliano/0000-0003-4788-5734	Sao Paulo Research Foundation (FAPESP) [2012/16800-3]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Sao Paulo Research Foundation (FAPESP; Grant 2012/16800-3, https://fapesp.br), granted to Dr. Ma ' rcia Guimaraes da Silva of the Department of Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A. K., 2015, IMUNOLOGIA CELULAR M; Albanesi C, 2007, J IMMUNOL, V179, P984, DOI 10.4049/jimmunol.179.2.984; Amabebe E, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00181; Carlisle MD, 2009, J INNATE IMMUN, V1, P118, DOI 10.1159/000181015; Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007; Dunsche A, 2001, J ORAL PATHOL MED, V30, P154, DOI 10.1034/j.1600-0714.2001.300305.x; Fan SR, 2008, INT J GYNECOL OBSTET, V103, P50, DOI 10.1016/j.ijgo.2008.05.020; Fichorova RN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0224359; Fleming DC, 2003, FERTIL STERIL, V79, P856, DOI 10.1016/S0015-0282(02)04930-0; Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Haarmann H, 2015, BIOCHEM BIOPH RES CO, V467, P46, DOI 10.1016/j.bbrc.2015.09.126; Habil N, 2014, BENEF MICROBES, V5, P483, DOI 10.3920/BM2013.0061; HO BSW, 1992, J CLIN PATHOL, V45, P439, DOI 10.1136/jcp.45.5.439; James CP, 2018, EUR J HUM GENET, V26, P434, DOI 10.1038/s41431-017-0061-7; Jiang W, 2012, CURR HIV RES, V10, P504, DOI 10.2174/157016212802429848; Kenyon C, 2013, AM J OBSTET GYNECOL, V209, P505, DOI 10.1016/j.ajog.2013.05.006; King AE, 2003, J REPROD IMMUNOL, V59, P1, DOI 10.1016/S0165-0378(02)00083-9; Kobatake E, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02414; Kotani H, 2020, JPN J INFECT DIS, V73, P214, DOI 10.7883/yoken.JJID.2019.190; Kotani H, 2018, HYPERTENS RES PREGNA, V6, P68, DOI 10.14390/jsshp.HRP2018-005; Lavorato HL., 2015, OPEN J OBSTET GYNECO, V05, P600; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Marconi C, 2015, INT J GYNECOL OBSTET, V131, P137, DOI 10.1016/j.ijgo.2015.05.016; McCray PB, 1997, AM J RESP CELL MOL, V16, P343, DOI 10.1165/ajrcmb.16.3.9070620; Mitchell C, 2014, AM J REPROD IMMUNOL, V71, P555, DOI 10.1111/aji.12264; Mitchell C, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.019; Morris M, 2001, BRIT J OBSTET GYNAEC, V108, P439; Murphy K, 2016, J INFECT DIS, V214, pS29, DOI 10.1093/infdis/jiw140; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Paolillo R, 2009, INT IMMUNOPHARMACOL, V9, P1265, DOI 10.1016/j.intimp.2009.07.008; Patel MV, 2013, AM J REPROD IMMUNOL, V69, P463, DOI 10.1111/aji.12078; Pazgier M, 2007, CURR PHARM DESIGN, V13, P3096, DOI 10.2174/138161207782110381; Pivarcsi A, 2005, MICROBES INFECT, V7, P1117, DOI 10.1016/j.micinf.2005.03.016; Prado-Montes de Oca E, 2010, INT J BIOCHEM CELL B, V42, P800, DOI 10.1016/j.biocel.2010.01.021; REDONDOLOPEZ V, 1990, REV INFECT DIS, V12, P856; Schlee M, 2008, CLIN EXP IMMUNOL, V151, P528, DOI 10.1111/j.1365-2249.2007.03587.x; Schroder JM, 1999, INT J BIOCHEM CELL B, V31, P645, DOI 10.1016/S1357-2725(99)00013-8; Steubesand N, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-36; Suarez-Carmona M, 2015, CYTOKINE GROWTH F R, V26, P361, DOI 10.1016/j.cytogfr.2014.12.005; Suff N, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00106; Valore EV, 2006, INFECT IMMUN, V74, P5693, DOI 10.1128/IAI.00524-06; Valore EV, 2002, AM J OBSTET GYNECOL, V187, P561, DOI 10.1067/mob.2002.125280; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; Wehkamp K, 2006, J INVEST DERMATOL, V126, P121, DOI 10.1038/sj.jid.5700020	45	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260753	10.1371/journal.pone.0260753	http://dx.doi.org/10.1371/journal.pone.0260753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855866	Green Published, gold			2022-12-26	WOS:000735299000111
J	Weng, SF; Akyea, RK; Man, KKC; Lau, WCY; Iyen, B; Blais, JE; Chan, EW; Siu, CW; Qureshi, N; Wong, ICK; Kai, J				Weng, Stephen Franklin; Akyea, Ralph Kwame; Man, Kenneth K. C.; Lau, Wallis C. Y.; Iyen, Barbara; Blais, Joseph Edgar; Chan, Esther W.; Siu, Chung Wah; Qureshi, Nadeem; Wong, Ian C. K.; Kai, Joe			Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease	PLOS ONE			English	Article							LDL-CHOLESTEROL; EFFICACY; THERAPY; SAFETY; METAANALYSIS; EVOLOCUMAB; REDUCTION; INSIGHTS; OUTCOMES; STROKE	Background Variability in low-density lipoprotein cholesterol (LDL-C) response to statins is underappreciated. We characterised patients by their statin response (SR), baseline risk of cardiovascular disease (CVD) and 10-year CVD outcomes. Methods and results A multivariable model was developed using 183,213 United Kingdom (UK) patients without CVD to predict probability of sub-optimal SR, defined by guidelines as <40% reduction in LDL-C. We externally validated the model in a Hong Kong (HK) cohort (n = 170,904). Patients were stratified into four groups by predicted SR and 10-year CVD risk score: [SR1] optimal SR & low risk; [SR2] sub-optimal SR & low risk; [SR3] optimal SR & high risk; [SR4] sub-optimal SR & high risk; and 10-year hazard ratios (HR) determined for first major adverse cardiovascular event (MACE). Our SR model included 12 characteristics, with an area under the curve of 0.70 (95% confidence interval [CI] 0.70-0.71; UK) and 0.68 (95% CI 0.67-0.68; HK). HRs for MACE in predicted sub-optimal SR with low CVD risk groups (SR2 to SR1) were 1.39 (95% CI 1.35-1.43, p<0.001; UK) and 1.14 (95% CI 1.11-1.17, p<0.001; HK). In both cohorts, patients with predicted sub-optimal SR with high CVD risk (SR4 to SR3) had elevated risk of MACE (UK HR 1.36, 95% CI 1.32-1.40, p<0.001: HK HR 1.25, 95% CI 1.21-1.28, p<0.001). Conclusions Patients with sub-optimal response to statins experienced significantly more MACE, regardless of baseline CVD risk. To enhance cholesterol management for primary prevention, statin response should be considered alongside risk assessment.	[Weng, Stephen Franklin; Akyea, Ralph Kwame; Iyen, Barbara; Qureshi, Nadeem; Kai, Joe] Univ Nottingham, Div Primary Care, Primary Care Stratified Med PRISM, Nottingham, England; [Man, Kenneth K. C.; Lau, Wallis C. Y.; Wong, Ian C. K.] UCL Sch Pharm, Ctr Med Optimisat Res & Educ CMORE, Res Dept Practice & Policy, London, England; [Man, Kenneth K. C.; Lau, Wallis C. Y.; Blais, Joseph Edgar; Chan, Esther W.; Wong, Ian C. K.] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Safe Medicat Practice & Res, Dept Pharmacol & Pharm, Hong Kong, Peoples R China; [Siu, Chung Wah] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Cardiol Div, Hong Kong, Peoples R China	University of Nottingham; University of London; University College London; University of Hong Kong; University of Hong Kong	Akyea, RK (corresponding author), Univ Nottingham, Div Primary Care, Primary Care Stratified Med PRISM, Nottingham, England.	Ralph.Akyea1@nottingham.ac.uk	Akyea, Ralph Kwame/ABP-5358-2022; Man, Kenneth/AAD-2846-2019; Chan, Esther Wai Yin/B-3522-2012; Lau, Wallis/J-3800-2018	Akyea, Ralph Kwame/0000-0003-4529-8237; Man, Kenneth/0000-0001-8645-1942; Kai, Joe/0000-0001-9040-9384; Qureshi, Nadeem/0000-0003-4909-0644; Iyen, Barbara/0000-0001-9720-1180; Chan, Esther Wai Yin/0000-0002-7602-9470; Blais, Joseph Edgar/0000-0001-7895-198X; Lau, Wallis/0000-0003-2320-0470	AMGEN Ltd.	AMGEN Ltd.(Amgen)	Funded by scientific donation by AMGEN Ltd. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Akyea RK, 2019, HEART, V105, P975, DOI 10.1136/heartjnl-2018-314253; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bangalore S, 2016, AM J MED, V129, P384, DOI 10.1016/j.amjmed.2015.10.024; Blais JE, 2019, ATHEROSCLEROSIS, V280, P174, DOI 10.1016/j.atherosclerosis.2018.11.015; Bonaca MP, 2018, CIRCULATION, V137, P338, DOI 10.1161/CIRCULATIONAHA.117.032235; Cheung BMY, 2017, HONG KONG MED J, V23, P191, DOI 10.12809/hkmj165045; Curtis HJ, 2020, BRIT J GEN PRACT, V70, pE525, DOI 10.3399/bjgp20X710873; Giugliano RP, 2018, CIRCULATION, V137, P1571, DOI 10.1161/CIRCULATIONAHA.117.030950; Giugliano RP, 2017, LANCET, V390, P1962, DOI 10.1016/S0140-6736(17)32290-0; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Hawkes N, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3674; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Hicks KA, 2018, CIRCULATION, V137, P961, DOI 10.1161/CIRCULATIONAHA.117.033502; Ho PM, 2006, ARCH INTERN MED, V166, P1842, DOI 10.1001/archinte.166.17.1842; Hong Kong Hospital A., 2016, HOSP AUTH STAT REP 2; Karlson B, 2016, EUR HEART J-CARD PHA, V2, P212, DOI 10.1093/ehjcvp/pvw006; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Liu XH, 2012, STAT MED, V31, P2676, DOI 10.1002/sim.4509; Mann DM, 2010, ANN PHARMACOTHER, V44, P1410, DOI 10.1345/aph.1P150; Mega JL, 2009, ARTERIOSCL THROM VAS, V29, P1310, DOI 10.1161/ATVBAHA.109.188474; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; NICE, 2016, CLIN GUID CG181 CARD; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Salami JA, 2017, JAMA CARDIOL, V2, P56, DOI 10.1001/jamacardio.2016.4700; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; SHEAR CL, 1992, CIRCULATION, V85, P1293, DOI 10.1161/01.CIR.85.4.1293; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Timmis A, 2020, EUR HEART J, V41, P12, DOI 10.1093/eurheartj/ehz859; Vancheri F, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010500	29	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260839	10.1371/journal.pone.0260839	http://dx.doi.org/10.1371/journal.pone.0260839			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855879	Green Published, gold			2022-12-26	WOS:000735299000135
J	Yu, SH; Chen, W; Jiang, ZC				Yu, Sihao; Chen, Wei; Jiang, Zicheng			Platelet count/spleen volume ratio has a good predictive value for esophageal varices in patients with hepatitis B liver cirrhosis	PLOS ONE			English	Article							DIAMETER RATIO; PORTAL-HYPERTENSION; MANAGEMENT; RISK; VALIDATION; DIAGNOSIS; CONSENSUS; HEMORRHAGE; COUNT; RULE	Background & aims Platelet count/spleen longest diameter ratio (PSDR) is widely used in clinical practice due to its good performance in predicting esophageal varices (EV). We obtained spleen volume (SV) by magnetic resonance examination, the purpose of this study was to evaluate the clinical value of platelet count/spleen volume ratio (PSVR) and spleen volume in predicting EV in patients with hepatitis B cirrhosis. Methods: This study was a diagnostic accuracy experiment and retrospective, 199 patients with hepatitis B cirrhosis who met the criteria were selected as the research subjects. All patients were collected blood samples in the morning on an empty stomach within 2 days, and related indicators were tested. Within 10 days, they received electronic gastroscopy and abdominal magnetic resonance examination. According to the Child-Pugh score, the patients were divided into groups with or without EV and with or without high-risk esophageal varices (HRV), then statistical analysis of the two groups was performed. Results The area under the curve (AUC) of PSVR in predicting EV or HRV in each group (85.5%-92.6%) was higher than PSDR, SV, spleen diameter, and platelet count. The AUC of PSDR in diagnosing HRV was higher than SV, and the AUC of SV in diagnosing EV was higher than PSDR, but the difference was not significant (P>0.05). In Child-Pugh A patients, Multivariate logistic regression analysis showed PSVR could be a predictor of HRV (P<0.05), SV was a reliable predictor of EV (P<0.05). Conclusion PSVR is better than PSDR, spleen diameter, platelet count in predicting EV; in the absence of serological results, SV could be used instead of PSDR. Both can predict EV or HRV of patients with hepatitis B cirrhosis.	[Yu, Sihao; Chen, Wei] Hubei Univ Med, Xiangyang Peoples Hosp 1, Dept Gastroenterol, Xiangyang City, Hubei, Peoples R China; [Jiang, Zicheng] Hubei Univ Med, Ankang Cent Hosp, Dept Infect Dis, Ankang City, Shanxi, Peoples R China	Hubei University of Medicine; Hubei University of Medicine	Chen, W (corresponding author), Hubei Univ Med, Xiangyang Peoples Hosp 1, Dept Gastroenterol, Xiangyang City, Hubei, Peoples R China.; Jiang, ZC (corresponding author), Hubei Univ Med, Ankang Cent Hosp, Dept Infect Dis, Ankang City, Shanxi, Peoples R China.	chenweiyf@163.com; jzc1977@126.com		Sihao, Yu/0000-0001-9658-727X				ANDERSEN KE, 1978, ENDOSCOPY, V10, P180, DOI 10.1055/s-0028-1098289; Baig WW, 2008, CAN J GASTROENTEROL, V22, P825, DOI 10.1155/2008/287274; Berzigotti A, 2013, GASTROENTEROLOGY, V144, P102, DOI 10.1053/j.gastro.2012.10.001; Cardenas A, 2016, ANN HEPATOL, V15, P289, DOI 10.5604/16652681.1193729; Chen RH, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/7407506; Chow KU., 2016, RADIOLOGY, V279, DOI [10.1148/radiol.2015150887, DOI 10.1148/RADIOL.2015150887]; Colli A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008759.pub2; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907; Garcia-Tsao G, 2017, HEPATOLOGY, V65, P310, DOI 10.1002/hep.28906; Giannini E, 2003, GUT, V52, P1200, DOI 10.1136/gut.52.8.1200; Giannini EG, 2006, AM J GASTROENTEROL, V101, P2511, DOI 10.1111/j.1572-0241.2006.00874.x; Giannini EG, 2005, DIGEST LIVER DIS, V37, P779, DOI 10.1016/j.dld.2005.05.007; Kazemi F, 2006, J HEPATOL, V45, P230, DOI 10.1016/j.jhep.2006.04.006; Liu L, 2017, ALCOHOL CLIN EXP RES, V41, P291, DOI 10.1111/acer.13295; Moore KP, 2003, HEPATOLOGY, V38, P258, DOI 10.1053/jhep.2003.50315; Tripathi D, 2015, GUT, V64, P1680, DOI 10.1136/gutjnl-2015-309262; Wang HY, 2021, J HEPATOL, V74, P584, DOI 10.1016/j.jhep.2020.09.034	18	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260774	10.1371/journal.pone.0260774	http://dx.doi.org/10.1371/journal.pone.0260774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855845	Green Published, gold			2022-12-26	WOS:000735299000118
J	Gross, M; Spektor, M; Jaffe, A; Kucukkaya, AS; Iseke, S; Haider, SP; Strazzabosco, M; Chapiro, J; Onofrey, JA				Gross, Moritz; Spektor, Michael; Jaffe, Ariel; Kucukkaya, Ahmet S.; Iseke, Simon; Haider, Stefan P.; Strazzabosco, Mario; Chapiro, Julius; Onofrey, John A.			Improved performance and consistency of deep learning 3D liver segmentation with heterogeneous cancer stages in magnetic resonance imaging	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; STAGING-SYSTEM; CIRRHOSIS; REMNANT; STATISTICS; VOLUMETRY; PROGNOSIS; HEPATITIS	Purpose Accurate liver segmentation is key for volumetry assessment to guide treatment decisions. Moreover, it is an important pre-processing step for cancer detection algorithms. Liver segmentation can be especially challenging in patients with cancer-related tissue changes and shape deformation. The aim of this study was to assess the ability of state-of-the-art deep learning 3D liver segmentation algorithms to generalize across all different Barcelona Clinic Liver Cancer (BCLC) liver cancer stages. Methods This retrospective study, included patients from an institutional database that had arterial-phase T1-weighted magnetic resonance images with corresponding manual liver segmentations. The data was split into 70/15/15% for training/validation/testing each proportionally equal across BCLC stages. Two 3D convolutional neural networks were trained using identical U-net-derived architectures with equal sized training datasets: one spanning all BCLC stages ("All-Stage-Net": AS-Net), and one limited to early and intermediate BCLC stages ("Early-Intermediate-Stage-Net": EIS-Net). Segmentation accuracy was evaluated by the Dice Similarity Coefficient (DSC) on a dataset spanning all BCLC stages and a Wilcoxon signed-rank test was used for pairwise comparisons. Results 219 subjects met the inclusion criteria (170 males, 49 females, 62.89.1 years) from all BCLC stages. Both networks were trained using 129 subjects: AS-Net training comprised 19, 74, 18, 8, and 10 BCLC 0, A, B, C, and D patients, respectively; EIS-Net training comprised 21, 86, and 22 BCLC 0, A, and B patients, respectively. DSCs (mean +/- SD) were 0.954 +/- 0.018 and 0.946 +/- 0.032 for AS-Net and EIS-Net (p<0.001), respectively. The AS-Net 0.956 +/- 0.014 significantly outperformed the EIS-Net 0.941 +/- 0.038 on advanced BCLC stages (p<0.001) and yielded similarly good segmentation performance on early and intermediate stages (AS-Net: 0.952 +/- 0.021; EIS-Net: 0.949 +/- 0.027; p = 0.107). Conclusion To ensure robust segmentation performance across cancer stages that is independent of liver shape deformation and tumor burden, it is critical to train deep learning models on heterogeneous imaging data spanning all BCLC stages.	[Gross, Moritz; Spektor, Michael; Kucukkaya, Ahmet S.; Iseke, Simon; Haider, Stefan P.; Chapiro, Julius; Onofrey, John A.] Yale Univ, Sch Med, Dept Radiol & Biomed Imaging, 333 Cedar St, New Haven, CT 06510 USA; [Gross, Moritz; Kucukkaya, Ahmet S.] Charite Univ Med Berlin, Charite Ctr Diagnost & Intervent Radiol, Berlin, Germany; [Jaffe, Ariel; Strazzabosco, Mario] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Iseke, Simon] Rostock Univ, Dept Diagnost & Intervent Radiol, Pediat Radiol & Neuroradiol, Med Ctr, Rostock, Germany; [Haider, Stefan P.] Ludwig Maximilians Univ Munchen, Dept Otorhinolaryngol, Univ Hosp, Munich, Germany; [Onofrey, John A.] Yale Univ, Sch Med, Dept Urol, 333 Cedar St, New Haven, CT 06510 USA; [Onofrey, John A.] Yale Univ, Dept Biomed Engn, New Haven, CT 06510 USA	Yale University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Yale University; University of Rostock; University of Munich; Yale University; Yale University	Onofrey, JA (corresponding author), Yale Univ, Sch Med, Dept Radiol & Biomed Imaging, 333 Cedar St, New Haven, CT 06510 USA.; Onofrey, JA (corresponding author), Yale Univ, Sch Med, Dept Urol, 333 Cedar St, New Haven, CT 06510 USA.; Onofrey, JA (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06510 USA.	john.onofrey@yale.edu		Gross, Moritz/0000-0002-6831-5004; Haider, Stefan/0000-0002-7640-3645	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [P30 KD034989]; National Institutes of Health [DDRCC DK034989-36]; Rolf W. Gunther Foundation for Radiological Sciences	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rolf W. Gunther Foundation for Radiological Sciences	J.A.O. was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Number P30 KD034989 and M.S. the National Institutes of Health Grant Award Number DDRCC DK034989-36 for the Clinical Translational Core of the Yale Liver Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Nation Institutes of Health. M.G. was supported by a travel grant by the Rolf W. Gu<spacing diaeresis>nther Foundation for Radiological Sciences for travel to Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EK, 2006, ANN SURG ONCOL, V13, P1271, DOI 10.1245/s10434-006-9045-5; ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Bousabarah K, 2021, ABDOM RADIOL, V46, P216, DOI 10.1007/s00261-020-02604-5; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Castro DC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17478-w; Chernyak V, 2018, RADIOLOGY, V289, P816, DOI 10.1148/radiol.2018181494; Child C G, 1964, Major Probl Clin Surg, V1, P1; Chlebus G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217228; Deussen P., 2019, 920011 DIN SPEC; Dodd GD, 1999, AM J ROENTGENOL, V173, P1031, DOI 10.2214/ajr.173.4.10511173; Elghazy HL, 2021, 2021 IEEE WORLD AI IOT CONGRESS (AIIOT), P28, DOI [10.1109/AIIOT52608.2021.9454216, 10.1109/AIIoT52608.2021.9454216]; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gotra A, 2017, INSIGHTS IMAGING, V8, P377, DOI 10.1007/s13244-017-0558-1; Gruber N, 2019, 2019 13TH INTERNATIONAL CONFERENCE ON SAMPLING THEORY AND APPLICATIONS (SAMPTA); Guerra J., 2021, NUKLEARMED-NUCL MED, V60; Guglielmi A, 2012, DIGEST SURG, V29, P6, DOI 10.1159/000335713; Hamer OW, 2007, NAT CLIN PRACT GASTR, V4, P215, DOI 10.1038/ncpgasthep0766; He KM, 2016, LECT NOTES COMPUT SC, V9908, P630, DOI 10.1007/978-3-319-46493-0_38; Heidari Marjan, 2021, J Biomed Phys Eng, V11, P527, DOI 10.31661/jbpe.v0i0.2103-1293; Huynh HT, 2017, INT J COMPUT ASS RAD, V12, P235, DOI 10.1007/s11548-016-1498-9; Huber A, 2015, EUR J RADIOL OPEN, V2, P90, DOI 10.1016/j.ejro.2015.05.002; Isensee F, 2021, NAT METHODS, V18, P203, DOI 10.1038/s41592-020-01008-z; Jansen MJA, 2019, J MED IMAGING, V6, DOI 10.1117/1.JMI.6.4.044003; Jimenez-Pastor A, 2021, EUR RADIOL, V31, P7876, DOI 10.1007/s00330-021-07838-5; Kerfoot Eric, 2019, Statistical Atlases and Computational Models of the Heart. Atrial Segmentation and LV Quantification Challenges. 9th International Workshop, STACOM 2018. Held in Conjunction with MICCAI 2018. Revised Selected Papers: Lecture Notes in Computer Science (LNCS 11395), P371, DOI 10.1007/978-3-030-12029-0_40; King DB, 2015, ACS SYM SER, V1214, P1; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Leung TWT, 2002, CANCER, V94, P1760, DOI 10.1002/cncr.10384; Liu M, 2020, COMPUT BIOL MED, V122, DOI 10.1016/j.compbiomed.2020.103798; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Lu F, 2017, INT J COMPUT ASS RAD, V12, P171, DOI 10.1007/s11548-016-1467-3; Mayer P, 2019, BMC MED IMAGING, V19, DOI 10.1186/s12880-019-0309-5; Milletari F, 2016, INT CONF 3D VISION, P565, DOI 10.1109/3DV.2016.79; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Onofrey JA, 2019, I S BIOMED IMAGING, P348, DOI [10.1109/ISBI.2019.8759295, 10.1109/isbi.2019.8759295]; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Ribero Dario, 2008, Semin Intervent Radiol, V25, P104, DOI 10.1055/s-2008-1076681; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Subbaswamy A, 2021, PR MACH LEARN RES, V130; Taha AA, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0068-x; Takenaga T, 2019, INT J COMPUT ASS RAD, V14, P1259, DOI 10.1007/s11548-019-01935-z; Taner CB, 2008, LIVER TRANSPLANT, V14, P1174, DOI 10.1002/lt.21562; Tang XK, 2020, EUR J NUCL MED MOL I, V47, P2742, DOI 10.1007/s00259-020-04800-3; Theysohn JM, 2014, CLIN RADIOL, V69, P172, DOI 10.1016/j.crad.2013.09.009; Tonan T, 2010, MAGN RESON IMAGING C, V18, P383, DOI 10.1016/j.mric.2010.08.011; Villarini B, 2021, COMP MED SY, P166, DOI [10.1109/CBMS52027.2021.00066, 10.1109/cbms52027.2021.00066]; Vouche M, 2013, J HEPATOL, V59, P1029, DOI 10.1016/j.jhep.2013.06.015; Wang K, 2019, RADIOL-ARTIF INTELL, V1, DOI 10.1148/ryai.2019180022; White DL, 2017, GASTROENTEROLOGY, V152, P812, DOI 10.1053/j.gastro.2016.11.020; Winther H, 2020, ROFO-FORTSCHR RONTG, DOI 10.1055/a-1238-2887; Yamanaka J, 2007, WORLD J SURG, V31, P1249, DOI 10.1007/s00268-007-9020-8; Yamashita R, 2018, INSIGHTS IMAGING, V9, P611, DOI [10.1007/s13244-018-0639-9, 10.1007/978-3-319-98666-1_1]; Yau T, 2014, GASTROENTEROLOGY, V146, P1691, DOI 10.1053/j.gastro.2014.02.032; Zeng Q, 2019, LECT NOTES COMPUT SC, V11765, P246, DOI 10.1007/978-3-030-32245-8_28; Zhang X, 2011, IEEE ENG MED BIO, P6005, DOI 10.1109/IEMBS.2011.6091484	58	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260630	10.1371/journal.pone.0260630	http://dx.doi.org/10.1371/journal.pone.0260630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852007	gold, Green Published			2022-12-26	WOS:000755762900052
J	Scime, NV; Hetherington, E; Tomfohr-Madsen, L; Nettel-Aguirre, A; Chaput, KH; Tough, SC				Scime, Natalie, V; Hetherington, Erin; Tomfohr-Madsen, Lianne; Nettel-Aguirre, Alberto; Chaput, Kathleen H.; Tough, Suzanne C.			Hypertensive disorders in pregnancy and child development at 36 months in the All Our Families prospective cohort study	PLOS ONE			English	Article							GESTATIONAL HYPERTENSION; STAGES QUESTIONNAIRES; POSTNATAL DEPRESSION; RISK-FACTORS; PREECLAMPSIA; FETAL; GROWTH; PITFALLS; DISEASES; INFANTS	Hypertensive disorders in pregnancy (HDP) are associated with increased risk of offspring neurodevelopmental disorders, suggesting long-term adverse impacts on fetal brain development. However, the relationship between HDP and deficits in general child development is unclear. Our objective was to assess the association between HDP and motor and cognitive developmental delay in children at 36 months of age. We analyzed data from the All Our Families community-based cohort study (n = 1554). Diagnosis of HDP-gestational or chronic hypertension, preeclampsia, or eclampsia-was measured through medical records. Child development was measured by maternal-report on five domains of the Ages and Stages Questionnaire (ASQ-3). Standardized cut-off scores were used to operationalize binary variables for any delay, motor delay, and cognitive delay. We calculated adjusted risk ratios (aRRs) and 95% confidence intervals (CIs) using logistic regression, sequentially controlling for potential confounders followed by factors suspected to lie on the causal pathway. Overall, 8.0% of women had HDP and hypertension-exposed children had higher prevalence of delay than unexposed children. Hypertension-exposed children had elevated risk for developmental delay, but CIs crossed the null. The aRRs quantifying the fully adjusted effect of HDP on child development were 1.19 (95% CI 0.92, 1.53) for any delay, 1.18 (95% CI 0.86, 1.61) for motor delay, and 1.24 (95% CI 0.83, 1.85) for cognitive delay. We did not find a statistically significant association between HDP and developmental delay. Confidence intervals suggest that children exposed to HDP in utero have either similar or slightly elevated risk of any, motor, and cognitive delay at 36 months after controlling for maternal and obstetric characteristics. The observed direction of association aligns with evidence of biological mechanisms whereby hypertensive pathology can disrupt fetal neurodevelopment; however, more evidence is needed. Findings may have implications for early developmental monitoring and intervention following prenatal hypertension exposure.	[Scime, Natalie, V; Chaput, Kathleen H.; Tough, Suzanne C.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Hetherington, Erin; Chaput, Kathleen H.] Univ Calgary, Dept Obstet & Gynaecol, Calgary, AB, Canada; [Tomfohr-Madsen, Lianne] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Tomfohr-Madsen, Lianne; Tough, Suzanne C.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Nettel-Aguirre, Alberto] Univ Wollongong, Ctr Hlth & Social Analyt, NIASRA, Sch Math & Appl Stat, Wollongong, NSW, Australia	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Wollongong	Scime, NV (corresponding author), Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.	natalie.scime@ucalgary.ca		Nettel-Aguirre, Alberto/0000-0001-6604-0652	Alberta Innovates Health Solutions Interdisciplinary Team grant [200700595]; Alberta Children's Hospital Foundation; Canadian Institutes of Health Research Canada Graduate Scholarship Doctoral Award; Alberta Innovates Post-Doctoral Fellowship	Alberta Innovates Health Solutions Interdisciplinary Team grant; Alberta Children's Hospital Foundation; Canadian Institutes of Health Research Canada Graduate Scholarship Doctoral Award(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Post-Doctoral Fellowship	The All Our Families study was funded by Alberta Innovates Health Solutions Interdisciplinary Team grant (https://albertainnovates.ca/; #200700595) and The Alberta Children's Hospital Foundation (https://www.childrenshospital.ab.ca/).NVS is supported by a Canadian Institutes of Health Research Canada Graduate Scholarship Doctoral Award (https://cihr-irsc.gc.ca/).EH is supported by an Alberta Innovates Post-Doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adane AA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4234; Allen Victoria M, 2004, BMC Pregnancy Childbirth, V4, P17, DOI 10.1186/1471-2393-4-17; Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Ananth CV, 2017, AM J OBSTET GYNECOL, V217, P167, DOI 10.1016/j.ajog.2017.04.016; Ananth CV, 2006, AM J OBSTET GYNECOL, V195, P1557, DOI 10.1016/j.ajog.2006.05.021; Avorgbedor F, 2019, JOGNN-J OBST GYN NEO, V48, P69, DOI 10.1016/j.jogn.2018.10.003; Basso O, 2006, JAMA-J AM MED ASSOC, V296, P1357, DOI 10.1001/jama.296.11.1357; Bernard N, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2285-8; Burd I, 2012, AM J REPROD IMMUNOL, V67, P287, DOI 10.1111/j.1600-0897.2012.01110.x; Chen ZG, 2021, IEEE T CYBERNETICS, V51, P5433, DOI 10.1109/TCYB.2020.2977858; Cheng SW, 2004, EARLY HUM DEV, V76, P39, DOI 10.1016/j.earlhumdev.2003.10.004; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; De Ocampo MPG, 2016, ARCH WOMEN MENT HLTH, V19, P1051, DOI 10.1007/s00737-016-0655-z; Devarshi PP, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051107; Doyle O, 2009, ECON HUM BIOL, V7, P1, DOI 10.1016/j.ehb.2009.01.002; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Ferguson KK, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.12.174; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; Girchenko P, 2018, INT J OBESITY, V42, P995, DOI 10.1038/s41366-018-0061-x; Grace T, 2014, PREGNANCY HYPERTENS, V4, P209, DOI 10.1016/j.preghy.2014.04.003; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Heikura U, 2013, PAEDIATR PERINAT EP, V27, P188, DOI 10.1111/ppe.12028; Horsley KJ, 2019, PSYCHOSOM MED, V81, P458, DOI 10.1097/PSY.0000000000000695; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Kingston D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126929; Kramer MS, 2017, AM J EPIDEMIOL, V185, P585, DOI 10.1093/aje/kww109; Lara E, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01591; Lawson GM, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12529; Limbos MM, 2011, J DEV BEHAV PEDIATR, V32, P499, DOI 10.1097/DBP.0b013e31822552e9; Lupattelli A, 2018, J AM ACAD CHILD PSY, V57, P200, DOI 10.1016/j.jaac.2017.12.010; Maggi S, 2010, J PAEDIATR CHILD H, V46, P627, DOI 10.1111/j.1440-1754.2010.01817.x; Maher GM, 2018, JAMA PSYCHIAT, V75, P809, DOI 10.1001/jamapsychiatry.2018.0854; Mann JR, 2011, PAEDIATR PERINAT EP, V25, P100, DOI 10.1111/j.1365-3016.2010.01157.x; Many A, 2003, HYPERTENS PREGNANCY, V22, P25, DOI 10.1081/PRG-120016791; McCowan LME, 2002, AM J OBSTET GYNECOL, V186, P1069, DOI 10.1067/mob.2002.122292; McDonald SW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S2; Nalivaeva NN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00825; Norton EC, 2013, STATA J, V13, P492, DOI 10.1177/1536867X1301300304; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Prady SL, 2018, ARCH WOMEN MENT HLTH, V21, P127, DOI 10.1007/s00737-017-0780-3; Rees S, 2008, INT J DEV NEUROSCI, V26, P3, DOI 10.1016/j.ijdevneu.2007.08.020; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Roberts LM, 2017, MIDWIFERY, V46, P17, DOI 10.1016/j.midw.2017.01.004; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schlapbach LJ, 2010, ACTA PAEDIATR, V99, P1504, DOI 10.1111/j.1651-2227.2010.01861.x; Schonhaut L, 2013, PEDIATRICS, V131, pE1468, DOI 10.1542/peds.2012-3313; Sharapova SR, 2018, PAEDIATR PERINAT EP, V32, P512, DOI 10.1111/ppe.12505; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Shay M, 2020, PSYCHOL MED, V50, P2128, DOI 10.1017/S0033291720003062; Silveira RC, 2007, ACTA PAEDIATR, V96, P1738, DOI 10.1111/j.1651-2227.2007.00552.x; Squires J., 2009, ASQ 3 USERS GUIDE; Sun BZ, 2020, JAMA PSYCHIAT, V77, P823, DOI 10.1001/jamapsychiatry.2020.0306; Tangeras LH, 2015, ARTERIOSCL THROM VAS, V35, P2478, DOI 10.1161/ATVBAHA.115.305817; Velikonja T, 2017, CHILD CARE HLTH DEV, V43, P1, DOI 10.1111/cch.12397; Wadhwani N, 2014, PROSTAG LEUKOTR ESS, V91, P21, DOI 10.1016/j.plefa.2014.05.006; Warshafsky C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010884; Whitehouse AJO, 2012, PAEDIATR PERINAT EP, V26, P101, DOI 10.1111/j.1365-3016.2011.01257.x; Wilcox AJ, 2011, AM J EPIDEMIOL, V174, P1062, DOI 10.1093/aje/kwr230; Zhang J, 2003, HYPERTENS PREGNANCY, V22, P203, DOI 10.1081/PRG-120021066	60	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260590	10.1371/journal.pone.0260590	http://dx.doi.org/10.1371/journal.pone.0260590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ9AQ	34852012	gold, Green Published			2022-12-26	WOS:000755762900048
J	Ukai, Y; Okemoto, H; Seki, Y; Nakatsugawa, Y; Kawasaki, A; Shibata, T; Mito, T; Kubo, E; Sasaki, H				Ukai, Yuki; Okemoto, Hajime; Seki, Yusuke; Nakatsugawa, Yui; Kawasaki, Akane; Shibata, Teppei; Mito, Tsuyoshi; Kubo, Eri; Sasaki, Hiroshi			Quantitative assessment of photic phenomena in the presbyopia-correcting intraocular lens	PLOS ONE			English	Article							BILATERAL IMPLANTATION; CLINICAL-OUTCOMES; EXTENDED-RANGE; PERFORMANCE; CATARACT; QUALITY	This was a prospective study to evaluate the feasibility of the photic phenomena test (PPT) for quantifying glare, halo, and starburst. We compared two presbyopia-correcting intraocular lenses (IOLs), the Symfony IOL and the PanOptix IOL, as well as the monofocal Clareon IOL in 111 IOL-implanted eyes of 111 patients who underwent the PPT 1 month postoperatively. The reproducibility of photic phenomena with the PPT was assessed in 39 multifocal IOL-implanted eyes of 20 patients and among the examiners. Patients with ocular diseases, except for refractive errors, were excluded. The mean values of the groups were evaluated. Bland-Altman plots were used to analyze statistical data (Easy R version 1.37; R Foundation for Statistical Computing, Vienna, Austria). The PPT reproducibility assessment revealed no fixed bias or regressive significance. Reproducibility was confirmed. The glare size did not differ significantly between the Symfony, PanOptix, and Clareon groups. The halo size was significantly larger in the Symfony group (p < 0.01) than in the PanOptix group. The halo intensity was significantly brighter in the PanOptix group (p < 0.01) than in the Symfony group. In contrast, no halos were perceived in the Clareon group. The starburst size or intensity did not differ significantly between the Symfony, PanOptix, and Clareon groups. We identified the photic phenomenon related to various IOLs.	[Ukai, Yuki; Okemoto, Hajime; Seki, Yusuke; Nakatsugawa, Yui; Kawasaki, Akane; Shibata, Teppei; Mito, Tsuyoshi; Kubo, Eri; Sasaki, Hiroshi] Kanazawa Med Univ, Dept Ophthalmol, Kahoku, Ishikawa, Japan	Kanazawa Medical University	Sasaki, H (corresponding author), Kanazawa Med Univ, Dept Ophthalmol, Kahoku, Ishikawa, Japan.	mogu@kanzawa-med.ac.jp		Mito, Tsuyoshi/0000-0001-7672-9947				Bissen-Miyajima H, 2020, JPN J OPHTHALMOL, V64, P140, DOI 10.1007/s10384-019-00712-4; Buckhurst PJ, 2015, J CATARACT REFR SURG, V41, P2424, DOI 10.1016/j.jcrs.2015.05.041; Chang DH, 2016, CLIN OPHTHALMOL, V10, P1471, DOI 10.2147/OPTH.S108298; Cochener B, 2018, CLIN OPHTHALMOL, V12, P2305, DOI 10.2147/OPTH.S184712; Cochener B, 2014, J REFRACT SURG, V30, P762, DOI 10.3928/1081597X-20141021-08; Darian-Smith E, 2020, J CATARACT REFR SURG, V46, P179, DOI 10.1097/j.jcrs.0000000000000044; de Silva SR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003169.pub4; Kamiya K, 2014, AM J OPHTHALMOL, V158, P215, DOI 10.1016/j.ajo.2014.04.010; Li L, 2017, Zhonghua Yan Ke Za Zhi, V53, P599, DOI 10.3760/cma.j.issn.0412-4081.2017.08.008; Lubinski W, 2014, MED SCI MONITOR, V20, P1220, DOI 10.12659/MSM.890585; Marques JP, 2015, EUR J OPHTHALMOL, V25, P516, DOI 10.5301/ejo.5000638; Ribeiro FJ, 2020, J CATARACT REFR SURG, V46, P694, DOI 10.1097/j.jcrs.0000000000000118; Rosen E, 2016, J CATARACT REFR SURG, V42, P310, DOI 10.1016/j.jcrs.2016.01.014; Son HS, 2019, J REFRACT SURG, V35, P551, DOI 10.3928/1081597X-20190806-02; Song XH, 2020, J CATARACT REFR SURG, V46, P540, DOI 10.1097/j.jcrs.0000000000000088; Tan JL, 2019, CLIN OPHTHALMOL, V13, P1071, DOI 10.2147/OPTH.S202380; Yeu E, 2021, OPHTHALMOLOGY, V128, pE132, DOI 10.1016/j.ophtha.2020.08.025; Zhao Yun-e, 2008, Zhonghua Yan Ke Za Zhi, V44, P33	18	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260406	10.1371/journal.pone.0260406	http://dx.doi.org/10.1371/journal.pone.0260406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851975	gold, Green Published			2022-12-26	WOS:000755762900032
J	Choi, CS; Gwin, M; Voth, S; Kolb, C; Zhou, C; Nelson, AR; DeWeever, A; Koloteva, A; Annamdevula, NS; Murphy, JM; Wagener, BM; Pittet, JF; Lim, STS; Balczon, R; Stevens, T; Lin, MT				Choi, Chung-Sik; Gwin, Meredith; Voth, Sarah; Kolb, Claire; Zhou, Chun; Nelson, Amy R.; DeWeever, Althea; Koloteva, Anna; Annamdevula, Naga S.; Murphy, James M.; Wagener, Brant M.; Pittet, Jean-Francois; Lim, Ssang-Taek S.; Balczon, Ron; Stevens, Troy; Lin, Mike T.			Cytotoxic tau released from lung microvascular endothelial cells upon infection with Pseudomonas aeruginosa promotes neuronal tauopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERM COGNITIVE IMPAIRMENT; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; BIG-TAU; PHOSPHORYLATION; PROPAGATION; AGGREGATION; PROTEINS	Patients who recover from nosocomial pneumonia often-times exhibit long-lasting cognitive impairment comparable with what is observed in Alzheimer's disease patients. We previously hypothesized that the lung endothelium contributes to infection-related neurocognitive dysfunction, because bacteria-exposed endothelial cells release a form(s) of cytotoxic tau that is sufficient to impair long-term potentiation in the hippocampus. However, the full-length lung and endothelial tau isoform(s) have yet to be resolved and it remains unclear whether the infection-induced endothelial cytotoxic tau triggers neuronal tau aggregation. Here, we demonstrate that lung endothelial cells express a big tau isoform and three additional tau isoforms that are similar to neuronal tau, each containing four microtubule-binding repeat domains, and that tau is expressed in lung capillaries in vivo. To test whether infection elicits endothelial tau capable of causing transmissible tau aggregation, the cells were infected with Pseudomonas aeruginosa. The infection-induced tau released from endothelium into the medium-induced neuronal tau aggregation in reporter cells, including reporter cells that express either the four microtubule-binding repeat domains or the full-length tau. Infection-induced release of pathological tau variant(s) from endothelium, and the ability of the endothelial-derived tau to cause neuronal tau aggregation, was abolished in tau knockout cells. After bacterial lung infection, brain homogenates from WT mice, but not from tau knockout mice, initiated tau aggregation. Thus, we conclude that bacterial pneumonia initiates the release of lung endothelial-derived cytotoxic tau, which is capable of propagating a neuronal tauopathy.	[Choi, Chung-Sik; Gwin, Meredith; Voth, Sarah; Zhou, Chun; Nelson, Amy R.; DeWeever, Althea; Koloteva, Anna; Annamdevula, Naga S.; Stevens, Troy; Lin, Mike T.] Univ S Alabama, Dept Physiol & Cell Biol, Mobile, AL 36688 USA; [Gwin, Meredith; Voth, Sarah; Kolb, Claire; Zhou, Chun; DeWeever, Althea; Balczon, Ron; Stevens, Troy; Lin, Mike T.] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA; [Kolb, Claire; Murphy, James M.; Lim, Ssang-Taek S.; Balczon, Ron] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL USA; [Wagener, Brant M.; Pittet, Jean-Francois] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA	University of South Alabama; University of South Alabama; University of South Alabama; University of Alabama System; University of Alabama Birmingham	Lin, MT (corresponding author), Univ S Alabama, Dept Physiol & Cell Biol, Mobile, AL 36688 USA.; Lin, MT (corresponding author), Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA.	mlin@southalabama.edu	Voth, Sarah B./AGJ-8666-2022; Nelson, Amy R./HCH-3772-2022	Voth, Sarah B./0000-0003-3796-7154; Nelson, Amy R./0000-0003-2025-1408; Murphy, James/0000-0002-9690-0024; Selby Gwin, Meredith/0000-0002-3084-8032; Lim, Steve/0000-0003-0323-8607	NIH [HL140182, HL140182-S, GM127584, HL66299, HL60024]; AHA [19PRE34380166, F31 HL147512, S10RR027535]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association)	This work was funded by NIH grants HL140182 and HL140182-S (to M. T. L.), GM127584 (to B. M. W.), HL66299 (to T. S. and R. B.), HL60024 (to T. S.), AHA 19PRE34380166 (to M. G.), F31 HL147512 (to S. V.), and S10RR027535 (to University of South Alabama BioImaging Core). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexeyev M, 2020, AM J PHYSIOL-HEART C, V319, pH349, DOI 10.1152/ajpheart.00276.2020; Balczon R, 2021, FASEB J, V35, DOI 10.1096/fj.202100718R; Balczon R, 2020, FEBS OPEN BIO, V10, P2464, DOI 10.1002/2211-5463.12997; Balczon R, 2019, FASEB J, V33, P10300, DOI 10.1096/fj.201900322R; Balczon R, 2017, FASEB J, V31, P2785, DOI 10.1096/fj.201601042RR; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Blum D, 2015, HUM MOL GENET, V24, P76, DOI 10.1093/hmg/ddu421; BOYNE LJ, 1995, J COMP NEUROL, V358, P279, DOI 10.1002/cne.903580209; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Fischer I, 2020, TRENDS NEUROSCI, V43, P493, DOI 10.1016/j.tins.2020.04.007; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; GOEDERT M, 1992, P NATL ACAD SCI USA, V89, P1983, DOI 10.1073/pnas.89.5.1983; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Gu YJ, 1996, J NEUROCHEM, V67, P1235; He LQ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.160; He ZH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13787-x; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Lace G, 2009, BRAIN, V132, P1324, DOI 10.1093/brain/awp059; Laurent C, 2018, BIOMED J, V41, P21, DOI 10.1016/j.bj.2018.01.003; Lee JY, 2018, AM J PHYSIOL-LUNG C, V315, pL41, DOI 10.1152/ajplung.00446.2017; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Lin MT, 2018, AM J RESP CRIT CARE, V198, P1575, DOI 10.1164/rccm.201801-0060LE; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Morrow KA, 2016, AM J PHYSIOL-LUNG C, V310, P1337, DOI 10.1152/ajplung.00103.2015; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Ochoa CD, 2012, J BIOL CHEM, V287, P25407, DOI 10.1074/jbc.M111.301440; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Rauch JN, 2020, NATURE, V580, P381, DOI 10.1038/s41586-020-2156-5; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Scott AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66321-1; Shah FA, 2013, AM J RESP CRIT CARE, V188, P586, DOI 10.1164/rccm.201212-2154OC; Stevens TC, 2014, AM J PHYSIOL-LUNG C, V306, pL915, DOI 10.1152/ajplung.00135.2013; Tak H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081682; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Voth S, 2020, FASEB J, V34, P9156, DOI 10.1096/fj.202000051RRR; Wagener BM, 2020, TOXINS, V12, DOI 10.3390/toxins12060369; Wang Y, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-016-0143-y	49	3	3	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101482	10.1016/j.jbc.2021.101482	http://dx.doi.org/10.1016/j.jbc.2021.101482			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1GJ	34896150	Green Published, gold			2022-12-26	WOS:000748376400010
J	Mendauletova, A; Latham, JA				Mendauletova, Aigera; Latham, John A.			Biosynthesis of the redox cofactor mycofactocin is controlled by the transcriptional regulator MftR and induced by long-chain acyl-CoA species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE PROTEIN; MYCOBACTERIUM-TUBERCULOSIS; TETR FAMILY; CORYNEBACTERIUM-GLUTAMICUM; STREPTOMYCES-COELICOLOR; STRUCTURAL BASIS; MYMA OPERON; DNA-BINDING; REPRESSOR; GENE	Mycofactocin (MFT) is a ribosomally synthesized and posttranslationally-modified redox cofactor found in pathogenic mycobacteria. While MFT biosynthetic proteins have been extensively characterized, the physiological conditions under which MFT biosynthesis is required are not well understood. To gain insights into the mechanisms of regulation of MFT expression in Mycobacterium smegmatis mc(2)155, we investigated the DNA-binding and ligand-binding activities of the putative TetR-like transcription regulator, MftR. In this study, we demonstrated that MftR binds to the mft promoter region. We used DNase I footprinting to identify the 27 bp palindromic operator located 5' to mftA and found it to be highly conserved in Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium ulcerans, and Mycobacterium marinum. To determine under which conditions the mft biosynthetic gene cluster (BGC) is induced, we screened for effectors of MftR. As a result, we found that MftR binds to long-chain acylCoAs with low micromolar affinities. To demonstrate that oleoyl-CoA induces the mft BGC in vivo, we re-engineered a fluorescent protein reporter system to express an MftA- mCherry fusion protein. Using this mCherry fluorescent readout, we show that the mft BGC is upregulated in M. smegmatis mc(2)155 when oleic acid is supplemented to the media. These results suggest that MftR controls expression of the mft BGC and that MFT production is induced by longchain acyl-CoAs. Since MFT-dependent dehydrogenases are known to colocalize with acyl carrier protein/CoA-modifying enzymes, these results suggest that MFT might be critical for fatty acid metabolism or cell wall reorganization.	[Mendauletova, Aigera; Latham, John A.] Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA	University of Denver	Latham, JA (corresponding author), Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA.	john.latham@du.edu		Latham, John/0000-0002-3034-1768; Mendauletova, Aigera/0000-0002-6443-0144	National Institutes of Health [GM 124002]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant GM 124002 (to J. A. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050562; Anand S, 2012, FEBS J, V279, P3214, DOI 10.1111/j.1742-4658.2012.08707.x; Aufhammer SW, 2004, STRUCTURE, V12, P361, DOI 10.1016/j.str.2004.02.010; Ayikpoe R, 2019, APPL MICROBIOL BIOT, V103, P2903, DOI 10.1007/s00253-019-09684-4; Ayikpoe R, 2018, BIOCHEMISTRY-US, V57, P5379, DOI 10.1021/acs.biochem.8b00816; Ayikpoe RS, 2019, J AM CHEM SOC, V141, P13582, DOI 10.1021/jacs.9b06102; Bhukya H, 2017, J STRUCT BIOL, V198, P134, DOI 10.1016/j.jsb.2017.03.006; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2813, DOI 10.1021/acs.biochem.6b00355; Brune I, 2012, J BIOTECHNOL, V159, P225, DOI 10.1016/j.jbiotec.2011.12.001; Carroll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009823; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Croxatto A, 2002, J BACTERIOL, V184, P1617, DOI 10.1128/JB.184.6.1617-1629.2002; Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13; Dong WY, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2019305118; Dubey AA, 2019, BIOCHEM BIOPH RES CO, V516, P1073, DOI 10.1016/j.bbrc.2019.07.008; Grkovic S, 1998, J BIOL CHEM, V273, P18665, DOI 10.1074/jbc.273.29.18665; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Grove A, 2010, MOL BIOSYST, V6, P2133, DOI 10.1039/c0mb00086h; Gupta A, 2014, BIOCHEMISTRY-US, V53, P4368, DOI 10.1021/bi500219t; Haft DH, 2017, SCI REP-UK, V7, DOI 10.1038/srep41074; Haft DH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-21; Hetrick KJ, 2017, CURR OPIN CHEM BIOL, V38, P36, DOI 10.1016/j.cbpa.2017.02.005; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; Hirooka K, 2011, BIOSCI BIOTECH BIOCH, V75, P1325, DOI 10.1271/bbb.110098; Khaliullin B, 2017, J BIOL CHEM, V292, P13022, DOI 10.1074/jbc.M117.795682; Khaliullin B, 2016, FEBS LETT, V590, P2538, DOI 10.1002/1873-3468.12249; Krishnamoorthy G, 2021, MBIO, V12, DOI 10.1128/mBio.01665-21; Krishnamoorthy G, 2019, MBIO, V10, DOI 10.1128/mBio.00190-19; Krug A, 2005, J BIOL CHEM, V280, P585, DOI 10.1074/jbc.M408271200; Lara J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17504-x; Le TBK, 2011, NUCLEIC ACIDS RES, V39, P9433, DOI 10.1093/nar/gkr640; Matsuoka H, 2007, J BIOL CHEM, V282, P5180, DOI 10.1074/jbc.M606831200; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Minch KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6829; Montalban-Lopez M, 2021, NAT PROD REP, V38, P130, DOI 10.1039/d0np00027b; Nazarova EV, 2019, ELIFE, V8, DOI 10.7554/eLife.43621; ONAKA H, 1995, J BACTERIOL, V177, P6083, DOI 10.1128/jb.177.21.6083-6092.1995; Ortega MA, 2016, CELL CHEM BIOL, V23, P31, DOI 10.1016/j.chembiol.2015.11.012; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Palanca C, 2016, FEBS J, V283, P1039, DOI 10.1111/febs.13643; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Pena-Ortiz L, 2020, CHEM SCI, V11, P5182, DOI 10.1039/d0sc01172j; Penuelas-Urquides K, 2013, BRAZ J MICROBIOL, V44, P287, DOI 10.1590/S1517-83822013000100042; Peterson EJR, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188584; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Rodriguez-Garcia A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni086; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Singh A, 2003, FEMS MICROBIOL LETT, V227, P53, DOI 10.1016/S0378-1097(03)00648-7; Turkarslan S, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.10; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; VORHOLT J, 1995, ARCH MICROBIOL, V163, P112, DOI 10.1007/s002030050179; Wang Y, 2012, J BACTERIOL, V194, P5237, DOI 10.1128/JB.00989-12; Yang SF, 2013, J BIOL CHEM, V288, P23687, DOI 10.1074/jbc.M113.468694; Yang X, 2013, CHEM-EUR J, V19, P7662, DOI 10.1002/chem.201300401; Yao JW, 2017, BIOCHIMIE, V141, P30, DOI 10.1016/j.biochi.2017.06.015; Zhu W, 2020, CURR OPIN CHEM BIOL, V59, P93, DOI 10.1016/j.cbpa.2020.05.001	58	1	1	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101474	10.1016/j.jbc.2021.101474	http://dx.doi.org/10.1016/j.jbc.2021.101474			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1GJ	34896395	Green Published, gold			2022-12-26	WOS:000748376400008
J	Lee, JS; Goldstein, JM; Moon, JL; Herzegh, O; Jr, DAB; Oberste, MS; Hughes, H; Bedi, K; Gerard, D; Cameron, B; Benton, C; Chida, A; Ahmad, A; Jr, DJP; Tang, XL; Sulaiman, N; Teklu, D; Batra, D; Howard, D; Sheth, M; Kuhnert, W; Bialek, SR; Hutson, CL; Pohl, J; Carroll, DS				Lee, Justin S.; Goldstein, Jason M.; Moon, Jonathan L.; Herzegh, Owen; Jr, Dennis A. Bagarozzi; Oberste, M. Steven; Hughes, Heather; Bedi, Kanwar; Gerard, Dorothie; Cameron, Brenique; Benton, Christopher; Chida, Asiya; Ahmad, Ausaf; Jr, David J. Petway; Tang, Xiaoling; Sulaiman, Nicky; Teklu, Dawit; Batra, Dhwani; Howard, Dakota; Sheth, Mili; Kuhnert, Wendi; Bialek, Stephanie R.; Hutson, Christina L.; Pohl, Jan; Carroll, Darin S.			Analysis of the initial lot of the CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel	PLOS ONE			English	Article								At the start of the COVID-19 pandemic, the Centers for Disease Control and Prevention (CDC) designed, manufactured, and distributed the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel for SARS-CoV-2 detection. The diagnostic panel targeted three viral nucleocapsid gene loci (N1, N2, and N3 primers and probes) to maximize sensitivity and to provide redundancy for virus detection if mutations occurred. After the first distribution of the diagnostic panel, state public health laboratories reported fluorescent signal in the absence of viral template (false-positive reactivity) for the N3 component and to a lesser extent for N1. This report describes the findings of an internal investigation conducted by the CDC to identify the cause(s) of the N1 and N3 false-positive reactivity. For N1, results demonstrate that contamination with a synthetic template, that occurred while the "bulk" manufactured materials were located in a research lab for quality assessment, was the cause of false reactivity in the first lot. Base pairing between the 3' end of the N3 probe and the 3' end of the N3 reverse primer led to amplification of duplex and larger molecules resulting in false reactivity in the N3 assay component. We conclude that flaws in both assay design and handling of the "bulk" material, caused the problems with the first lot of the 2019-nCoV Real-Time RT-PCR Diagnostic Panel. In addition, within this study, we found that the age of the examined diagnostic panel reagents increases the frequency of false positive results for N3. We discuss these findings in the context of improvements to quality control, quality assurance, and assay validation practices that have since been improved at the CDC.	[Lee, Justin S.; Goldstein, Jason M.; Moon, Jonathan L.; Herzegh, Owen; Jr, Dennis A. Bagarozzi; Hughes, Heather; Bedi, Kanwar; Gerard, Dorothie; Cameron, Brenique; Benton, Christopher; Chida, Asiya; Ahmad, Ausaf; Jr, David J. Petway; Tang, Xiaoling; Sulaiman, Nicky; Teklu, Dawit; Batra, Dhwani; Howard, Dakota; Sheth, Mili; Pohl, Jan; Carroll, Darin S.] Ctr Dis Control & Prevent, Natl Ctr Emerging Zoonot Infect Dis, Div Sci Resources, Atlanta, GA 30329 USA; [Oberste, M. Steven; Bialek, Stephanie R.] Ctr Dis Control & Prevent, Natl Ctr Infect Resp Dis, Div Viral Dis, Atlanta, GA USA; [Kuhnert, Wendi] Ctr Dis Control & Prevent, Off Deputy Director Infect Dis, Atlanta, GA USA; [Hutson, Christina L.] Ctr Dis Control & Prevent, Natl Ctr Emerging Zoonot Infect Dis, Div High Consequence Pathogens & Pathol, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Carroll, DS (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging Zoonot Infect Dis, Div Sci Resources, Atlanta, GA 30329 USA.	dcarroll@cdc.gov	Ahmad, Ausaf/T-3014-2019	Ahmad, Ausaf/0000-0002-5029-9536; Moon, Jonathan/0000-0001-6533-507X; Goldstein, Jason/0000-0003-1558-1832				[Anonymous], 2019, GENIOUS PRIME 201911; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Food and Drug Administration, 2020, EM US AUTH CDC 2019; Jaeger LH, 2021, INT J INFECT DIS, V102, P437, DOI 10.1016/j.ijid.2020.10.079; Liu Nan, LIB PREP CUT RUN NEB, DOI [10.17504/protocols.io.bagaibse, DOI 10.17504/PROTOCOLS.IO.BAGAIBSE]; Lu XY, 2020, EMERG INFECT DIS, V26, P1654, DOI 10.3201/eid2608.201246; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Yoshimoto FK, 2020, PROTEIN J, V39, P198, DOI 10.1007/s10930-020-09901-4	8	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0260487	10.1371/journal.pone.0260487	http://dx.doi.org/10.1371/journal.pone.0260487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910739	Green Published, gold			2022-12-26	WOS:000754828900018
J	Coronel, L; Hackes, D; Schwab, K; Riege, K; Hoffmann, S; Fischer, M				Coronel, Luis; Haeckes, David; Schwab, Katjana; Riege, Konstantin; Hoffmann, Steve; Fischer, Martin			p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundance	ONCOGENE			English	Article							P53; KINASE; CELL; TARGET; AMPK; TRANSCRIPTION; METABOLISM; ACTIVATION; NETWORK; PATHWAY	In recent years the tumor suppressor p53 has been increasingly recognized as a potent regulator of the cell metabolism and for its ability to inhibit the critical pro-survival kinases AKT and mTOR. The mechanisms through which p53 controls AKT and mTOR, however, are largely unclear. Here, we demonstrate that p53 activates the metabolic regulator DDIT4 indirectly through the regulatory factor X 7 (RFX7). We provide evidence that DDIT4 is required for p53 to inhibit mTOR complex 2 (mTORC2)-dependent AKT activation. Most strikingly, we also find that the DDIT4 regulator RFX7 is required for p53-mediated inhibition of mTORC1 and AKT. Our results suggest that AMPK activation plays no role and p53-mediated AKT inhibition is not critical for p53-mediated mTORC1 inhibition. Moreover, using recently developed physiological cell culture media we uncover that basal p53 and RFX7 activity can play a critical role in restricting mTORC1 activity under physiological nutrient conditions, and we propose a nutrient-dependent model for p53-RFX7-mediated mTORC1 inhibition. These results establish RFX7 and its downstream target DDIT4 as essential effectors in metabolic control elicited by p53.	[Coronel, Luis; Haeckes, David; Schwab, Katjana; Riege, Konstantin; Hoffmann, Steve; Fischer, Martin] Fritz Lipmann Inst FLI, Leibniz Inst Aging, Computat Biol Grp, Beutenbergstr 11, D-07745 Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Hoffmann, S; Fischer, M (corresponding author), Fritz Lipmann Inst FLI, Leibniz Inst Aging, Computat Biol Grp, Beutenbergstr 11, D-07745 Jena, Germany.	Steve.Hoffmann@leibniz-fli.de; Martin.Fischer@leibniz-fli.de	Fischer, Martin/I-4825-2014	Fischer, Martin/0000-0002-3429-1876; Hackes, David/0000-0002-2177-5206; Luis Eduardo, Coronel Carrion/0000-0001-7906-0732; Schwab, Katjana/0000-0002-6916-2900	German Research Foundation (DFG) [FI 1993/2-1]; German Federal Ministry for Education and Research (BMBF) [031L016D]; Federal Government of Germany; State of Thuringia; Projekt DEAL	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Federal Government of Germany; State of Thuringia; Projekt DEAL	This work was supported by the German Research Foundation (DFG) [research grant FI 1993/2-1 to MF] and the German Federal Ministry for Education and Research (BMBF) [031L016D to SH]. The FLI is a member of the Leibniz Association and is financially supported by the Federal Government of Germany and the State of Thuringia. Open Access funding enabled and organized by Projekt DEAL.	Agarwal S, 2016, MOL CANCER RES, V14, P66, DOI 10.1158/1541-7786.MCR-15-0159; Akeno N, 2015, ONCOGENE, V34, P589, DOI 10.1038/onc.2013.589; Andrysik Z, 2017, GENOME RES, V27, P1645, DOI 10.1101/gr.220533.117; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baum N, 2009, ONCOGENE, V28, P3915, DOI 10.1038/onc.2009.248; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Bowling S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04167-y; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Cantor JR, 2017, CELL, V169, P258, DOI 10.1016/j.cell.2017.03.023; Castro W, 2018, NAT IMMUNOL, V19, P809, DOI 10.1038/s41590-018-0144-9; Coronel L, 2021, NUCLEIC ACIDS RES, V49, P7437, DOI 10.1093/nar/gkab575; Cui DR, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03185-3; Dennis MD, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005103; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Duan L, 2018, J MOL CELL BIOL, V10, P331, DOI 10.1093/jmcb/mjx051; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Fischer BA, 2020, TRENDS CANCER, V6, P6, DOI 10.1016/j.trecan.2019.11.001; Fischer M, 2021, TRENDS CANCER, V7, P12, DOI 10.1016/j.trecan.2020.08.007; Fischer M, 2019, ONCOGENE, V38, P4095, DOI 10.1038/s41388-019-0706-9; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P6070, DOI 10.1093/nar/gkw523; Grande BM, 2019, BLOOD, V133, P1313, DOI 10.1182/blood-2018-09-871418; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Horton LE, 2002, ONCOGENE, V21, P5325, DOI 10.1038/sj.onc.1205662; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Kon N, 2021, GENE DEV, V35, P59, DOI 10.1101/gad.340919.120; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Lopez C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08578-3; Luo YD, 2021, J HEPATOL, V74, P96, DOI 10.1016/j.jhep.2020.07.036; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; Miyamoto T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603204; Nicolay BN, 2015, GENE DEV, V29, P1875, DOI 10.1101/gad.264127.115; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Zheng RB, 2019, NUCLEIC ACIDS RES, V47, pD729, DOI 10.1093/nar/gky1094	40	3	3	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2022	41	7					1063	1069		10.1038/s41388-021-02147-z	http://dx.doi.org/10.1038/s41388-021-02147-z		DEC 2021	7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YX7EK	34907345	hybrid, Green Published			2022-12-26	WOS:000730070200001
J	Kalam, A; Shano, S; Khan, MA; Islam, A; Warren, N; Hassan, MM; Davis, M				Kalam, Abul; Shano, Shahanaj; Khan, Mohammad Asif; Islam, Ariful; Warren, Narelle; Hassan, Mohammad Mahmudul; Davis, Mark			Understanding the social drivers of antibiotic use during COVID-19 in Bangladesh: Implications for reduction of antimicrobial resistance	PLOS ONE			English	Article							INFECTION; STIGMA	Antimicrobial resistance (AMR) is a global public health crisis that is now impacted by the COVID-19 pandemic. Little is known how COVID-19 risks influence people to consume antibiotics, particularly in contexts like Bangladesh where these pharmaceuticals can be purchased without a prescription. This paper identifies the social drivers of antibiotics use among home-based patients who have tested positive with SARS-CoV-2 or have COVID-19-like symptoms. Using qualitative telephone interviews, the research was conducted in two Bangladesh cities with 40 participants who reported that they had tested positive for coronavirus (n = 20) or had COVID-19-like symptoms (n = 20). Our analysis identified five themes in antibiotic use narratives: antibiotics as 'big' medicine; managing anxiety; dealing with social repercussions of COVID-19 infection; lack of access to COVID-19 testing and healthcare services; and informal sources of treatment advice. Antibiotics were seen to solve physical and social aspects of COVID-19 infection, with urgent ramifications for AMR in Bangladesh and more general implications for global efforts to mitigate AMR.	[Kalam, Abul] Helen Keller Int, Bangladesh Country Off, Dhaka, Bangladesh; [Shano, Shahanaj] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh; [Shano, Shahanaj; Islam, Ariful] EcoHealth Alliance, New York, NY USA; [Khan, Mohammad Asif] Chattogram Civil Surgeon Off, Chattogram, Bangladesh; [Warren, Narelle; Davis, Mark] Monash Univ, Sch Social & Polit Sci, Melbourne, Vic, Australia; [Hassan, Mohammad Mahmudul] Chittagong Vet & Anim Sci Univ, Chattogram, Bangladesh; [Davis, Mark] Monash Univ, Ctr Impact Antimicrobial Resistance, Melbourne, Vic, Australia	Monash University; Monash University	Kalam, A (corresponding author), Helen Keller Int, Bangladesh Country Off, Dhaka, Bangladesh.	a.kalam724@gmail.com	Hassan, Mohammad Mahmudul/U-6929-2019; Hassan, Mohammad/GZA-7507-2022	Hassan, Mohammad Mahmudul/0000-0001-6495-4637; Hassan, Mohammad/0000-0002-1712-0004; Kalam, Md Abul/0000-0003-4236-8519	Bangladesh Bureau of Educational Information and Statistics (BANBEIS) [SD2019967]	Bangladesh Bureau of Educational Information and Statistics (BANBEIS)	This work is partially funded by Bangladesh Bureau of Educational Information and Statistics (BANBEIS), ID number SD2019967. Mohammad Mahmudul Hassan was supported by BANBEIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelenda-Alonso G, 2020, INFECT CONT HOSP EP, V41, P1371, DOI 10.1017/ice.2020.381; Al-Zaman MS, 2020, AM J TROP MED HYG, V103, P1357, DOI 10.4269/ajtmh.20-0826; Ancillotti M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6047-8; [Anonymous], 2020, NAT MICROBIOL, V5, P779, DOI 10.1038/s41564-020-0739-4; Ansari S, 2021, JAC-ANTIMICROB RESIS, V3, DOI 10.1093/jacamr/dlab038; Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00154; Atif M, 2019, INFECT DRUG RESIST, V12, P687, DOI 10.2147/IDR.S189114; Barrett R, 2008, J INFECT DIS, V197, pS34, DOI 10.1086/524986; Biswas M, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-15; Butler CC, 2021, LANCET, V397, P1063, DOI 10.1016/S0140-6736(21)00461-X; Chandler CIR., 2016, LONDON SCH HYG TROP, P8; Charmaz K., 2007, PRACTICAL GUIDE QUAL; Cohen D, 2001, HEALTH-LONDON, V5, P441, DOI 10.1177/136345930100500403; Davis M., 2020, J PHARM PRACT RES, V50, P463, DOI [10.1002/jppr.1701, DOI 10.1002/jppr.1701]; Davis M, 2020, SOC SCI MED, V256, DOI 10.1016/j.socscimed.2020.113032; Denyer Willis L., 2018, AMR CONTROL, V4, P114; Dixon J, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2020.113594; Faiz M. A., 2011, Regional Health Forum, V15, P1; Flowers P, 2006, PSYCHOL HEALTH, V21, P109, DOI 10.1080/14768320500286286; Hassan MM, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13090194; Hay SI, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1073-z; Hoque R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227947; Hsu J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1983; Huremovic D., 2019, PSYCHIAT PANDEMICS, DOI [10.1007/978-3-030-15346-5_2, DOI 10.1007/978-3-030-15346-5_2]; Huttner BD, 2020, CLIN MICROBIOL INFEC, V26, P808, DOI 10.1016/j.cmi.2020.04.024; Huttner B, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001239; Irawati L, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7718-9; Islam Ariful, 2021, Biosaf Health, V3, P39, DOI 10.1016/j.bsheal.2020.09.006; Joarder T., 2020, ASSESSMENT STAFFING, DOI [10.1136/bmjopen-2019-035183, DOI 10.1136/BMJOPEN-2019-035183]; Kar SK., 2020, MED VIROLOGY PATHOGE, P198; Khadka S, 2020, DRUGS THER PERSPECT, V36, P250, DOI 10.1007/s40267-020-00728-8; King LM, 2021, CLIN INFECT DIS, V73, pE652, DOI 10.1093/cid/ciaa1896; Kleinman A., 1988, ILLNESS NARRATIVES; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Laizu J, 2018, AMETICAN J PHARM, V1, P1; Lee CHJ, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7030082; Lohm D, 2020, HEALTH RISK SOC, V22, P231, DOI 10.1080/13698575.2020.1783436; Lucas PJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225270; Malaria Consortium, 2019, ON HLTH COMM ENG 2 C; McDowell A, 2017, MED ANTHROPOL Q, V31, P332, DOI 10.1111/maq.12345; Mohiuddin M, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0075-z; Mukharjee S. K., 2017, Journal of Drug Delivery and Therapeutics, V7, P34, DOI 10.22270/jddt.v7i4.1456; Murray AK, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01020; Nahar P, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05512-y; Naylor NR, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0336-y; Nichter M., 2001, CULTURAL PERSPECTIVE; Nicola M, 2020, INT J SURG, V77, P206, DOI 10.1016/j.ijsu.2020.04.001; Norris P, 2013, ANTIBIOTICS-BASEL, V2, P465, DOI 10.3390/antibiotics2040465; Norris P, 2009, J PRIM HEALTH CARE, V1, P30, DOI 10.1071/HC09030; Norris P, 2010, J IMMIGR MINOR HEALT, V12, P107, DOI 10.1007/s10903-008-9224-5; North J., 2020, CHALLENGES TACKLING, P45, DOI [10.1017/9781108864121.004, DOI 10.1017/9781108864121.004]; Nuriddin A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000410; ONeill J., 2014, REV ANTIMICROB RESIS; Our Hong Kong Foundation, 2021, HONG KONGS PARTICIPA; Pedersen A, 2010, PSYCHOSOM MED, V72, P823, DOI 10.1097/PSY.0b013e3181f1d003; Rawson TM, 2020, CLIN INFECT DIS, V71, P2459, DOI 10.1093/cid/ciaa530; Redfern J, 2020, JAC-ANTIMICROB RESIS, V2, DOI 10.1093/jacamr/dlaa012; Rezasoltani S, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.590683; Rousham EK, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028215; Shammi M, 2021, ENVIRON DEV SUSTAIN, V23, P6148, DOI 10.1007/s10668-020-00867-y; Tirodkar MA, 2011, J IMMIGR MINOR HEALT, V13, P385, DOI 10.1007/s10903-009-9304-1; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van der Geest S, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-48; Weiner BK, 2007, MED HYPOTHESES, V68, P474, DOI 10.1016/j.mehy.2006.09.015; Whittaker A, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8030135; WHO, 2020, CLIN MAN COVID 19; WHO, 2020, MORBIDITY MORTALITY; WHO, 2020, HOME CARE PATIENTS C; Whyte S., 2003, SOCIAL LIVES MED; Williams J, 2011, INFECT DIS SOCIAL ST; Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]; Yantzi R, 2019, GLOB PUBLIC HEALTH, V14, P750, DOI 10.1080/17441692.2018.1542017; Zar HJ, 2020, PAEDIATR RESPIR REV, V35, P70, DOI 10.1016/j.prrv.2020.06.016	73	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261368	10.1371/journal.pone.0261368	http://dx.doi.org/10.1371/journal.pone.0261368			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905563	gold, Green Published			2022-12-26	WOS:000754615500038
J	Phoka, T; Fule, L; Da Fonseca, JP; Cokelaer, T; Picardeau, M; Patarakul, K				Phoka, Theerapat; Fule, Lenka; Da Fonseca, Juliana Pipoli; Cokelaer, Thomas; Picardeau, Mathieu; Patarakul, Kanitha			Investigating the role of the carbon storage regulator A (CsrA) in Leptospira spp.	PLOS ONE			English	Article							ESCHERICHIA-COLI; RNA-BINDING; POSTTRANSCRIPTIONAL REGULATION; CARBOHYDRATE-METABOLISM; GLYCOGEN BIOSYNTHESIS; PATHOGENIC LEPTOSPIRA; POSITIVE REGULATION; SWARMING MOTILITY; BIOFILM FORMATION; FLHDC EXPRESSION	y Carbon Storage Regulator A (CsrA) is a well-characterized post-transcriptional global regulator that plays a critical role in response to environmental changes in many bacteria. CsrA has been reported to regulate several metabolic pathways, motility, biofilm formation, and virulence-associated genes. The role of csrA in Leptospira spp., which are able to survive in different environmental niches and infect a wide variety of reservoir hosts, has not been characterized. To investigate the role of csrA as a gene regulator in Leptospira, we generated a L. biflexa csrA deletion mutant (Delta csrA) and csrA overexpressing Leptospira strains. The Delta csrA L. biflexa displayed poor growth under starvation conditions. RNA sequencing revealed that in rich medium only a few genes, including the gene encoding the flagellar filament protein FlaB3, were differentially expressed in the Delta csrA mutant. In contrast, 575 transcripts were differentially expressed when csrA was overexpressed in L. biflexa. Electrophoretic mobility shift assay (EMSA) confirmed the RNA-seq data in the Delta csrA mutant, showing direct binding of recombinant CsrA to flaB3 mRNA. In the pathogen L. interrogans, we were not able to generate a csrA mutant. We therefore decided to overexpress csrA in L. interrogans. In contrast to the overexpressing strain of L. biflexa, the overexpressing L. interrogans strain had poor motility on soft agar. The overexpressing strain of L. interrogans also showed significant upregulation of the flagellin flaB1, flaB2, and flaB4. The interaction of L. interrogans rCsrA and flaB4 was confirmed by EMSA. Our results demonstrated that CsrA may function as a global regulator in Leptospira spp. under certain conditions that cause csrA overexpression. Interestingly, the mechanisms of action and gene targets of CsrA may be different between non-pathogenic and pathogenic Leptospira strains.	[Phoka, Theerapat] Chulalongkorn Univ, Grad Sch, Med Microbiol Interdisciplinary & Int Program, Bangkok, Thailand; [Fule, Lenka; Picardeau, Mathieu] French Natl Reference Ctr Leptospirosis, Inst Pasteur, Biol Spirochetes Unit, Paris, France; [Da Fonseca, Juliana Pipoli; Cokelaer, Thomas] Inst Pasteur, Ctr Ressources & Rech Technol C2RT, Plate Forme Technol Biom, Paris, France; [Cokelaer, Thomas] Inst Pasteur, Hub Bioinformat & Biostat, Dept Biol Computat, Paris, France; [Patarakul, Kanitha] Chulalongkorn Univ, Fac Med, Dept Microbiol, Bangkok, Thailand; [Patarakul, Kanitha] Chulalongkorn Univ, Chula Vaccine Res Ctr Chula VRC, Ctr Excellence Vaccine Res & Dev, Bangkok, Thailand	Chulalongkorn University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Chulalongkorn University; Chulalongkorn University	Patarakul, K (corresponding author), Chulalongkorn Univ, Fac Med, Dept Microbiol, Bangkok, Thailand.; Patarakul, K (corresponding author), Chulalongkorn Univ, Chula Vaccine Res Ctr Chula VRC, Ctr Excellence Vaccine Res & Dev, Bangkok, Thailand.	kanitha.pa@chula.ac.th			100th Anniversary Chulalongkorn University; 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund); Chulalongkorn University [GB-CU-61-12-30-02]; Ratchadaphiseksomphot Endowment Fund (Matching fund), Faculty of Medicine, Chulalongkorn University; ANR LEPTOMOVE [18-CE15-0027-01]; France Genomique [ANR-10-INBS-09-09]; IBISA	100th Anniversary Chulalongkorn University; 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)(Chulalongkorn University); Chulalongkorn University(Chulalongkorn University); Ratchadaphiseksomphot Endowment Fund (Matching fund), Faculty of Medicine, Chulalongkorn University; ANR LEPTOMOVE(French National Research Agency (ANR)); France Genomique; IBISA	This work is part of the PhD thesis of T. P., who received financial support from "the 100th Anniversary Chulalongkorn University for Doctoral Scholarship and the 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)". K.P. is partly supported by Chulalongkorn University GB-CU-61-12-30-02 and Ratchadaphiseksomphot Endowment Fund (Matching fund), Faculty of Medicine, Chulalongkorn University. This research was also supported by ANR LEPTOMOVE (18-CE15-0027-01) to M.P. We thank the Biomics Platform, C2RT, Institut Pasteur, Paris, France, supported by France Genomique (ANR-10-INBS-09-09) and IBISA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikarla H, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00045; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ang S, 2001, J BIOMED SCI, V8, P160, DOI 10.1159/000054028; Arnold WK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203286; Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Berndt V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36932-w; Butz HA, 2021, MBIO, V12, DOI 10.1128/mBio.03380-20; Casanovas-Massana A, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/aem.00507-18, 10.1128/AEM.00507-18]; Chatterjee A, 2010, MOL PLANT MICROBE IN, V23, P1316, DOI 10.1094/MPMI-01-10-0017; Cokelaer T., 2017, J OPEN SOURCE SOFTW, V2, P352, DOI DOI 10.21105/JOSS.00352; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Cune J, 2005, J BACTERIOL, V187, P5841, DOI 10.1128/JB.187.16.5841-5845.2005; Dubey AK, 2005, RNA, V11, P1579, DOI 10.1261/rna.2990205; Dubey AK, 2003, J BACTERIOL, V185, P4450, DOI 10.1128/JB.185.15.4450-4460.2003; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; Esquerre T, 2016, SCI REP-UK, V6, DOI 10.1038/srep25057; Fields JA, 2008, J BACTERIOL, V190, P3411, DOI 10.1128/JB.01928-07; Fontana C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152916; Gaultney RA, 2020, NUCLEIC ACIDS RES, V48, P12102, DOI 10.1093/nar/gkaa966; Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5; Hauslein I, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170149; Heroven AK, 2008, MOL MICROBIOL, V68, P1179, DOI 10.1111/j.1365-2958.2008.06218.x; Hu WL, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.02377-16, 10.1128/aem.02377-16]; Iraola G, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00042-16; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; Jonas K, 2010, ENVIRON MICROBIOL, V12, P524, DOI 10.1111/j.1462-2920.2009.02097.x; Kao CY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00483; Kao CY, 2014, HELICOBACTER, V19, P443, DOI 10.1111/hel.12148; Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12; Lawhon SD, 2003, MOL MICROBIOL, V48, P1633, DOI 10.1046/j.1365-2958.2003.03535.x; Lee JH, 2019, MOL PLANT MICROBE IN, V32, P1448, DOI 10.1094/MPMI-03-19-0077-R; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Li JQ, 2018, MICROBIOL-SGM, V164, P1308, DOI 10.1099/mic.0.000704; Liaw SJ, 2003, J MED MICROBIOL, V52, P19, DOI 10.1099/jmm.0.05024-0; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06; Lo M, 2010, INFECT IMMUN, V78, P4850, DOI 10.1128/IAI.00435-10; Louvel H., 2007, CURR PROTOC MICROBIO, DOI [10.1002/9780471729259.mc12e04s05, DOI 10.1002/9780471729259.MC12E04S05]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Martinez LC, 2011, MOL MICROBIOL, V80, P1637, DOI 10.1111/j.1365-2958.2011.07674.x; Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06; Matsunaga J, 2012, APPL ENVIRON MICROB, V78, P5699, DOI 10.1128/AEM.00713-12; Mercante J, 2006, J BIOL CHEM, V281, P31832, DOI 10.1074/jbc.M606057200; Morin M, 2017, MBIO, V8, DOI 10.1128/mBio.01628-17; Mukherjee S, 2016, P NATL ACAD SCI USA, V113, P9870, DOI 10.1073/pnas.1602455113; Mulcahy H, 2006, INFECT IMMUN, V74, P3012, DOI 10.1128/IAI.74.5.3012-3015.2006; Nally JE, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00362; Ouyang ZM, 2014, INFECT IMMUN, V82, P1511, DOI 10.1128/IAI.01555-13; Pappas CJ, 2015, APPL ENVIRON MICROB, V81, P3176, DOI 10.1128/AEM.00173-15; Patarakul K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-31; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Picardeau M, 2008, APPL ENVIRON MICROB, V74, P319, DOI 10.1128/AEM.02172-07; Picardeau M, 2015, CURR TOP MICROBIOL, V387, P43, DOI 10.1007/978-3-662-45059-8_4; Potts AH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211430; Potts AH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01613-1; Pourciau C, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.601352; Pourciau C, 2019, MBIO, V10, DOI 10.1128/mBio.01034-19; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; Romeo T, 1996, RES MICROBIOL, V147, P505, DOI 10.1016/0923-2508(96)84004-6; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; SABNIS NA, 1995, J BIOL CHEM, V270, P29096, DOI 10.1074/jbc.270.49.29096; Sahr T, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006629; Sanjuan E, 2009, INFECT IMMUN, V77, P5149, DOI 10.1128/IAI.00673-09; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; Sze CW, 2011, INFECT IMMUN, V79, P1270, DOI 10.1128/IAI.00871-10; Tan Y, 2015, MOL BIOSYST, V11, P1434, DOI 10.1039/c4mb00600c; Thibeaux R, 2020, NPJ BIOFILMS MICROBI, V6, DOI 10.1038/s41522-020-0134-1; Trueba G, 2004, INT MICROBIOL, V7, P35; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; Van Assche E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00141; Varni V, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00345-16; Wang SM, 2017, RES MICROBIOL, V168, P700, DOI 10.1016/j.resmic.2017.08.003; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Wei BD, 2000, J BACTERIOL, V182, P1632, DOI 10.1128/JB.182.6.1632-1640.2000; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; Wilf NM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-822; Wunder EA, 2016, MOL MICROBIOL, V101, P457, DOI 10.1111/mmi.13403; Yakhnin AV, 2013, MOL MICROBIOL, V87, P851, DOI 10.1111/mmi.12136; Yakhnin H, 2007, MOL MICROBIOL, V64, P1605, DOI 10.1111/j.1365-2958.2007.05765.x; Yang HH, 1996, J BACTERIOL, V178, P1012, DOI 10.1128/jb.178.4.1012-1017.1996; Zavala-Alvarado C, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008904; Zavala-Alvarado C, 2020, METHODS MOL BIOL, V2134, P41, DOI 10.1007/978-1-0716-0459-5_5; Zhang JJ, 2018, MOL MICROBIOL, V109, P63, DOI 10.1111/mmi.13967; Zuerner RL, 2015, CURR TOP MICROBIOL, V387, P223, DOI 10.1007/978-3-662-45059-8_9; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	90	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0260981	10.1371/journal.pone.0260981	http://dx.doi.org/10.1371/journal.pone.0260981			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898610	Green Published, gold			2022-12-26	WOS:000755176200017
J	Shiota, Y; Hirosawa, T; Yoshimura, Y; Tanaka, S; Hasegawa, C; Iwasaki, S; An, KM; Soma, D; Sano, M; Yokoyama, S; Kikuchi, M				Shiota, Yuka; Hirosawa, Tetsu; Yoshimura, Yuko; Tanaka, Sanae; Hasegawa, Chiaki; Iwasaki, Sumie; An, Kyung-Min; Soma, Daiki; Sano, Masuhiko; Yokoyama, Shigeru; Kikuchi, Mitsuru			A common variant of CNTNAP2 is associated with sub-threshold autistic traits and intellectual disability	PLOS ONE			English	Article							SEMANTIC PRAGMATIC DISORDER; COMMUNICATION DISORDERS; SPECTRUM DISORDERS; CHILDREN; GENE; IMPAIRMENTS; REVEALS; RISK	Y Sub-threshold autistic traits are common in the general population. Children with sub-threshold autistic traits have difficulties with social adaptation. Contactin-associated protein-like 2 (CNTNAP2) is associated with the development of Autism spectrum disorder (ASD) and the single-nucleotide polymorphism rs2710102 (G/A) of CNTNAP2 is suggested to contribute to sub-threshold social impairments and intellectual disabilities. We recruited 67 children with Autistic disorder (AD) (49 boys, 18 girls, aged 38-98 months) and 57 typically developing (TD) children (34 boys, 23 girls, aged 53-90 months). We assessed the participants' intelligence and social reciprocity using the Kaufman Assessment Battery for Children (K-ABC) and the Social Responsiveness Scale (SRS), respectively. Genomic DNA was extracted from the buccal mucosa and genotyped for rs2710102. A chi-square test revealed a significant association between genotype and group [chi(2)(2) = 6.56, p = 0.038]. When a co-dominant model was assumed, the results from linear regression models demonstrated that TD children with A-carriers (AA + AG) presented higher SRS T-scores [t(55) = 2.11, p = 0.039] and lower simultaneous processing scale scores of K-ABC [t(55) = -2.19, p = 0.032] than those with GG homozygotes. These associations were not significant in children with ASD. TD children with the rs2710102 A-allele may have more sub-threshold autistic traits than those with GG homozygotes, reflected in higher SRS scores and lower simultaneous processing scale scores. These results support the use of genetic evidence to detect sub-threshold autistic traits.	[Shiota, Yuka; Hirosawa, Tetsu; Yoshimura, Yuko; Tanaka, Sanae; An, Kyung-Min; Yokoyama, Shigeru; Kikuchi, Mitsuru] Osaka Univ, United Grad Sch Child Dev, Kanazawa, Ishikawa, Japan; [Shiota, Yuka; Hirosawa, Tetsu; Yoshimura, Yuko; Tanaka, Sanae; An, Kyung-Min; Yokoyama, Shigeru; Kikuchi, Mitsuru] Kanazawa Univ, Kanazawa, Ishikawa, Japan; [Shiota, Yuka; Hirosawa, Tetsu; Yoshimura, Yuko; Tanaka, Sanae; An, Kyung-Min; Yokoyama, Shigeru; Kikuchi, Mitsuru] Hamamatsu Univ, Sch Med, Kanazawa, Ishikawa, Japan; [Shiota, Yuka; Hirosawa, Tetsu; Yoshimura, Yuko; Tanaka, Sanae; An, Kyung-Min; Yokoyama, Shigeru; Kikuchi, Mitsuru] Chiba Univ, Kanazawa, Ishikawa, Japan; [Shiota, Yuka; Hirosawa, Tetsu; Yoshimura, Yuko; Tanaka, Sanae; An, Kyung-Min; Yokoyama, Shigeru; Kikuchi, Mitsuru] Univ Fukui, Kanazawa, Ishikawa, Japan; [Shiota, Yuka; Hirosawa, Tetsu; Tanaka, Sanae; Hasegawa, Chiaki; Iwasaki, Sumie; An, Kyung-Min; Yokoyama, Shigeru; Kikuchi, Mitsuru] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan; [Hirosawa, Tetsu; Soma, Daiki; Sano, Masuhiko; Kikuchi, Mitsuru] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan; [Yoshimura, Yuko] Kanazawa Univ, Inst Human & Social Sci, Kanazawa, Ishikawa, Japan	Osaka University; Kanazawa University; University of Fukui; Kanazawa University; Kanazawa University; Kanazawa University	Hirosawa, T (corresponding author), Osaka Univ, United Grad Sch Child Dev, Kanazawa, Ishikawa, Japan.; Hirosawa, T (corresponding author), Kanazawa Univ, Kanazawa, Ishikawa, Japan.; Hirosawa, T (corresponding author), Hamamatsu Univ, Sch Med, Kanazawa, Ishikawa, Japan.; Hirosawa, T (corresponding author), Chiba Univ, Kanazawa, Ishikawa, Japan.; Hirosawa, T (corresponding author), Univ Fukui, Kanazawa, Ishikawa, Japan.; Hirosawa, T (corresponding author), Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan.; Hirosawa, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan.	hirosawatetsu1982@yahoo.co.jp	Hasegawa, Chiaki/HHS-2658-2022; An, Kyung-min/GXG-7062-2022	An, Kyung-min/0000-0003-4093-8549	JSPS KAKENHI [20H03599, 20K16623]; Center of Innovation Program of the Japan Science and Technology Agency, JST, Japan [Collaborative Research Program of the Collaborative Research Network for Asian Children with Developmental Disorders]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Center of Innovation Program of the Japan Science and Technology Agency, JST, Japan [Collaborative Research Program of the Collaborative Research Network for Asian Children with Developmental Disorders]	This work was supported by JSPS KAKENHI grants (Grant Number 20H03599) to MK, [Grant Numbers 20K16623] to TH, and the Center of Innovation Program of the Japan Science and Technology Agency, JST, Japan [supported by a grant from the Collaborative Research Program of the Collaborative Research Network for Asian Children with Developmental Disorders]. NO Include this sentence at the end of your statement: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Association AP, 2000, DIAGNOSTIC STAT MANU, V4; Bai TJ, 2019, SOC COGN AFFECT NEUR, V14, P1297, DOI [10.1093/scan/nsaa008, 10.1093/scan.nsaa008]; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; BISHOP DVM, 1989, BRIT J DISORD COMMUN, V24, P107; Bolte S, 2008, AUTISM RES, V1, P354, DOI 10.1002/aur.49; BOGEN J E, 1969, Bulletin of the Los Angeles Neurological Societies, V34, P135; Bralten J, 2018, MOL PSYCHIATR, V23, P1205, DOI [10.1038/mp.2017.127, 10.1038/mp.2017.98]; BROOK SL, 1992, J AUTISM DEV DISORD, V22, P61, DOI 10.1007/BF01046403; Christ SE, 2010, NEUROPSYCHOLOGY, V24, P590, DOI 10.1037/a0019176; Constantino J. N., 2005, SOCIAL RESPONSIVENES; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Constantino JN., 2012, SRS2 SOCIAL RESPONSI, V2nd ed; Gazzaniga MS, 1975, UCLA ED, V17, P9; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gokcen E, 2014, BRIT J PSYCHOL, V105, P187, DOI 10.1111/bjop.12033; Gordon HW., 1983, MUSIC RIGHT HEMISPHE; Gregor A, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-106; Hirosawa T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235380; Horita N, 2015, META GENE, V5, P1, DOI 10.1016/j.mgene.2015.04.003; Jackman C, 2009, PEDIATR NEUROL, V40, P310, DOI 10.1016/j.pediatrneurol.2008.10.013; Kamio Y, 2013, ACTA PSYCHIAT SCAND, V128, P45, DOI 10.1111/acps.12034; Kaufman A. S, 2004, KAUFMAN BRIEF INTELL; KAUFMAN AS, 1987, J CHILD NEUROL, V2, P3, DOI 10.1177/088307388700200102; Kaufman AS., 1983, KAUFMAN ASSESSMENT B; Kaufman AS., 1985, NEWMARK MAJOR PSYCHO; Koeda M, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00087; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Lord C., AUTISM DIAGNOSTIC OB; Lundstrom S, 2011, PSYCHOL MED, V41, P2423, DOI 10.1017/S0033291711000377; Lundstrom S, 2012, ARCH GEN PSYCHIAT, V69, P46, DOI 10.1001/archgenpsychiatry.2011.144; Maenner MJ, 2020, MMWR SURVEILL SUMM, V69, P1, DOI 10.15585/mmwr.ss6904a1; Mazen I, 2008, HORM RES, V70, P118, DOI 10.1159/000137657; NEBES RD, 1974, PSYCHOL BULL, V81, P1, DOI 10.1037/h0035626; Newton-Cheh C, 2005, MUTAT RES-FUND MOL M, V573, P54, DOI 10.1016/j.mrfmmm.2005.01.006; Ozonoff S, 1996, BRAIN LANG, V52, P411, DOI 10.1006/brln.1996.0022; Riva V, 2018, CEREB CORTEX, V28, P2100, DOI 10.1093/cercor/bhx115; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Saito A, 2017, J AUTISM DEV DISORD, V47, P3333, DOI 10.1007/s10803-017-3245-7; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; SHIELDS J, 1991, BRIT J DISORD COMMUN, V26, P383; Steer CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012633; Stein MB, 2011, BIOL PSYCHIAT, V69, P825, DOI 10.1016/j.biopsych.2010.11.008; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Szatmari P, 1998, J AUTISM DEV DISORD, V28, P351, DOI 10.1023/A:1026096203946; Tompkins CA, 2012, ARCH PHYS MED REHAB, V93, pS61, DOI 10.1016/j.apmr.2011.10.015; Turkstra LS, 2017, DISABIL REHABIL, V39, P1872, DOI 10.1080/09638288.2016.1212113; Uddin MS, 2021, HUM CELL, V34, P1410, DOI 10.1007/s13577-021-00546-8; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Volkmar F, 2005, ANNU REV PSYCHOL, V56, P315, DOI 10.1146/annurev.psych.56.091103.070159; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Werling AM, 2016, J NEURAL TRANSM, V123, P353, DOI 10.1007/s00702-015-1458-5; Wessels JAM, 2006, ARTHRITIS RHEUM, V54, P2830, DOI 10.1002/art.22032; Whalley HC, 2011, AM J MED GENET B, V156B, P941, DOI 10.1002/ajmg.b.31241; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Whitehouse AJO, 2011, GENES BRAIN BEHAV, V10, P451, DOI 10.1111/j.1601-183X.2011.00684.x; Wiebe MJ, 1986, J SCHOOL PSYCHOL, V22, P369; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	64	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0260548	10.1371/journal.pone.0260548	http://dx.doi.org/10.1371/journal.pone.0260548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ0LY	34898614	gold, Green Published			2022-12-26	WOS:000755176200012
J	Islam, MR; Hasan, ATMK; Khatun, N; Ridi, IN; Rasheed, MMO; Islam, SMA; Karim, MN				Islam, Muhammad Rafiqul; Hasan, A. T. M. Kamrul; Khatun, Nazrina; Ridi, Ishrat Nur; Rasheed, Md. Mamun Or; Islam, Syed Mohammad Ariful; Karim, Md Nazmul			Demographic differentials of lung cancer survival in Bangladeshi patients	PLOS ONE			English	Article							EDUCATION LEVEL; EPIDEMIOLOGY; GENDER; CARE; AGE	Background Lung cancer is the leading cause of cancer-related mortality worldwide. Demographic differential has been linked with the treatment outcome and survival in recent literature, mostly from the developed world. Considering diversity in population characteristics across income strata, it's worth assessing the link in low- and middle-income population as well. Current study aimed to assess the association of demographic characteristics with lung cancer survival in Bangladeshi lung cancer patients. Methods & results All newly diagnosed primary lung cancer cases attending the national institute of cancer research & Hospital (NICRH), a tertiary cancer care center in Dhaka, Bangladesh between 2018 and 2019 were considered for the study. Demographic information and clinical data were obtained from the patients' medical records by a trained physician. Survival estimate was generated using the Kaplan-Meier method and compared across demographic and clinicopathological categories using the log-rank test. Hazard ratio and 95% CI for treatment options are generated fitting multivariable Cox proportional hazard regression. Among 1868 patients, 84.6% were males and 15.4% were females, average ( standard deviation) age at diagnosis was 59.6 +/- 10.9 years, only 10.8% had not consumed tobacco of any form. Around two-thirds of the patient had Eastern Cooperative Oncology Group (ECOG) performance score >= 2, 29.5% had at least one comorbidity and 19.4% had metastasis at the time of presentation. Higher survival was associated with institutional education (HR 0.9; 95% CI 0.77, 0.99), and receipt of combined radiotherapy and chemotherapy (HR 0.56; 95% CI 0.46, 0.65; p <0.001). In contrast, lower survival was associated with older age between 60-69 years (HR 1.3; 95% CI 1.3, 1.5;), age <greater than or equal to> 70 years (HR 1.4; 95% CI 1.1, 1.7), having any comorbidity (HR 1.1; 95% CI 1.0, 1.3), with ECOG score >= 3 (HR 1.41; 95% CI 1.01, 1.96) and receipt of radiotherapy treatments only (HR 1.6; 95% CI 1.3, 1.9). Conclusion Older age, presence of one or more comorbidity, poorer performance status, and treatment with only RT appeared as a significant predictor of poorer prognosis of lung cancer in Bangladeshi patients. In contrast, having institutional education and treatment with combined Radiotherapy and Chemotherapy appeared as a predictor of a better prognosis. The finding of this study could serve as a basis for future studies inquiring into novel approaches for certain subgroups of patients believed to be challenged in limited resources.	[Islam, Muhammad Rafiqul; Hasan, A. T. M. Kamrul; Khatun, Nazrina] Natl Inst Canc Res & Hosp, Dept Med Oncol, Dhaka, Bangladesh; [Ridi, Ishrat Nur] Dhaka Med Coll & Hosp, Dept Med, Dhaka, Bangladesh; [Rasheed, Md. Mamun Or] Bangabandhu Sheikh Mujib Med Univ, Dept Oncol, Dhaka, Bangladesh; [Islam, Syed Mohammad Ariful] Kurmitola Gen Hosp, Dept Med, Dhaka, Bangladesh; Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia	Dhaka Medical College; Bangabandhu Sheikh Mujib Medical University (BSMMU); Monash University	Islam, MR (corresponding author), Natl Inst Canc Res & Hosp, Dept Med Oncol, Dhaka, Bangladesh.	alongsinger@gmail.com		Islam, Muhammad Rafiqul/0000-0001-6839-4040				Abbasi Salah, 2011, Lung Cancer Int, V2011, P152125, DOI 10.4061/2011/152125; Ak G, 2007, LUNG, V185, P279, DOI 10.1007/s00408-007-9021-2; Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; Biswas T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177395; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brenner DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017479; CELLA DF, 1991, J CLIN ONCOL, V9, P1500, DOI 10.1200/JCO.1991.9.8.1500; Dima S, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1252897; Ebner PJ, 2020, ANN THORAC SURG, V109, P225, DOI 10.1016/j.athoracsur.2019.07.017; Ferguson MK, 2000, ANN THORAC SURG, V69, P245, DOI 10.1016/S0003-4975(99)01078-4; Franceschini JP, 2017, J BRAS PNEUMOL, V43, P431, DOI [10.1590/s1806-37562016000000298, 10.1590/S1806-37562016000000298]; Herndon JE, 2008, J CLIN ONCOL, V26, P4116, DOI 10.1200/JCO.2008.16.7460; Hong QY, 2015, CANCER-AM CANCER SOC, V121, P3080, DOI 10.1002/cncr.29584; Huq NM, 2015, IRAN J PUBLIC HEALTH, V44, P1024; Hussain SK, 2008, ANN ONCOL, V19, P156, DOI 10.1093/annonc/mdm413; Joobeur S, 2020, PAN AFR MED J, V35, DOI 10.11604/pamj.2020.35.19.21100; KIRSH MM, 1982, ANN THORAC SURG, V34, P34, DOI 10.1016/S0003-4975(10)60849-1; Liao ML., 1993, ZHONGHUA JIE HE HE H, V16, P63; Lim JH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208492; Makitaro R, 2002, EUR RESPIR J, V19, P1087, DOI 10.1183/09031936.02.00048302; Makrantonakis PD, 2004, ONCOLOGIST, V9, P556, DOI 10.1634/theoncologist.9-5-556; Mohan A, 2020, LUNG INDIA, V37, P190, DOI 10.4103/lungindia.lungindia_333_19; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Parveen R, 2018, J THORAC ONCOL, V13, pS21, DOI 10.1016/S1556-0864(18)30318-6; Radzikowska E, 2002, ANN ONCOL, V13, P1087, DOI 10.1093/annonc/mdf187; Radzikowska E, 2001, LUNG CANCER, V33, P203, DOI 10.1016/S0169-5002(01)00199-4; Raz DJ, 2008, J THORAC ONCOL, V3, P1391, DOI 10.1097/JTO.0b013e31818ddff7; SHIMIZU H, 1984, JPN J CLIN ONCOL, V14, P595; Visbal AL, 2004, ANN THORAC SURG, V78, P209, DOI 10.1016/j.athoracsur.2003.11.021; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb; Zhou KX, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.32276	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0261238	10.1371/journal.pone.0261238	http://dx.doi.org/10.1371/journal.pone.0261238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890415	Green Published, gold			2022-12-26	WOS:000747293600038
J	Chen, ZQ; Rajamanickam, L; Cao, JF; Zhao, AD; Hu, XH				Chen, Zhiqiang; Rajamanickam, Leelavathi; Cao, Jianfang; Zhao, Aidi; Hu, Xiaohui			A localization strategy combined with transfer learning for image annotation	PLOS ONE			English	Article							MODEL	This study aims to solve the overfitting problem caused by insufficient labeled images in the automatic image annotation field. We propose a transfer learning model called CNN-2L that incorporates the label localization strategy described in this study. The model consists of an InceptionV3 network pretrained on the ImageNet dataset and a label localization algorithm. First, the pretrained InceptionV3 network extracts features from the target dataset that are used to train a specific classifier and fine-tune the entire network to obtain an optimal model. Then, the obtained model is used to derive the probabilities of the predicted labels. For this purpose, we introduce a squeeze and excitation (SE) module into the network architecture that augments the useful feature information, inhibits useless feature information, and conducts feature reweighting. Next, we perform label localization to obtain the label probabilities and determine the final label set for each image. During this process, the number of labels must be determined. The optimal K value is obtained experimentally and used to determine the number of predicted labels, thereby solving the empty label set problem that occurs when the predicted label values of images are below a fixed threshold. Experiments on the Corel5k multilabel image dataset verify that CNN-2L improves the labeling precision by 18% and 15% compared with the traditional multiple-Bernoulli relevance model (MBRM) and joint equal contribution (JEC) algorithms, respectively, and it improves the recall by 6% compared with JEC. Additionally, it improves the precision by 20% and 11% compared with the deep learning methods Weight-KNN and adaptive hypergraph learning (AHL), respectively. Although CNN-2L fails to improve the recall compared with the semantic extension model (SEM), it improves the comprehensive index of the F1 value by 1%. The experimental results reveal that the proposed transfer learning model based on a label localization strategy is effective for automatic image annotation and substantially boosts the multilabel image annotation performance.	[Chen, Zhiqiang; Rajamanickam, Leelavathi] SEGi Univ, Informat Technol, Petaling Jaya, Selangor, Malaysia; [Cao, Jianfang] Xinzhou Teachers Univ, Dept Comp Sci & Technol, Xinzhou, Peoples R China; [Cao, Jianfang; Zhao, Aidi; Hu, Xiaohui] Taiyuan Univ Sci & Technol, Sch Comp Sci & Technol, Taiyuan, Peoples R China	SEGi University; Xinzhou Teachers University; Taiyuan University of Science & Technology	Chen, ZQ (corresponding author), SEGi Univ, Informat Technol, Petaling Jaya, Selangor, Malaysia.	czq_2628@163.com		, Zhiqiang/0000-0002-5640-2370				Bretschneider T, 2002, INT GEOSCI REMOTE SE, P2253, DOI 10.1109/IGARSS.2002.1026510; Chen ST., 2020, MULTIMED TOOLS APPL, V1, P1; Feng SL, 2004, PROC CVPR IEEE, P1002; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hu J, 2018, PROC CVPR IEEE, P7132, DOI [10.1109/CVPR.2018.00745, 10.1109/TPAMI.2019.2913372]; [柯逍 Ke Xiao], 2017, [模式识别与人工智能, Pattern Recognition and Artificial Intelligence], V30, P193; Krizhevsky A., 2012, ADV NEURAL INF PROCE; [李长磊 Li Changlei], 2018, [小型微型计算机系统, Journal of Chinese Computer Systems], V39, P1860; [黎健成 Li Jiancheng], 2016, [计算机科学, Computer Science], V43, P41; Lian X., 2021, NEUROCOMPUTING, V421, P115; Ma YC, 2020, NEURAL COMPUT APPL, V32, P6559, DOI 10.1007/s00521-019-04114-y; Ma YC, 2019, MULTIMED TOOLS APPL, V78, P3767, DOI 10.1007/s11042-018-6038-x; Makadia A, 2010, INT J COMPUT VISION, V90, P88, DOI 10.1007/s11263-010-0338-6; Markatopoulou F, 2019, IEEE T CIRC SYST VID, V29, P1631, DOI 10.1109/TCSVT.2018.2848458; Newsam S, 2004, APPL OPTICS, V43, P210, DOI 10.1364/AO.43.000210; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Salma T., 2020, REMOTE SENS-BASEL, V12, P3279; Scott GJ, 2011, IEEE T GEOSCI REMOTE, V49, P1603, DOI 10.1109/TGRS.2010.2088404; Shi Cai-Juan, 2015, Journal of Software, V26, P1800, DOI 10.13328/j.cnki.jos.004687; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; Tang C, 2019, IEEE T MULTIMEDIA, V21, P2837, DOI 10.1109/TMM.2019.2909860; Tian DP, 2017, J VIS COMMUN IMAGE R, V44, P50, DOI 10.1016/j.jvcir.2017.01.015; Wu Wei, 2015, Computer Engineering and Science, V37, P1338, DOI 10.3969/j.issn.1007-130X.2015.07.018; Xiang Y, 2009, PROC CVPR IEEE, P1153, DOI 10.1109/CVPRW.2009.5206518; Yuan Ying, 2012, Journal of Software, V23, P2500, DOI 10.3724/SP.J.1001.2012.04154; [张军军 Zhang Junjun], 2020, [中国图象图形学报, Journal of Image and Graphics], V25, P1501; Zhang ML, 2007, PATTERN RECOGN, V40, P2038, DOI 10.1016/j.patcog.2006.12.019; [张晴 Zhang Qing], 2020, [中国图象图形学报, Journal of Image and Graphics], V25, P1116; Zhang XC, 2015, NEUROCOMPUTING, V149, P1658, DOI 10.1016/j.neucom.2014.08.027; Zhou Y, 2015, ICMR'15: PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON MULTIMEDIA RETRIEVAL, P447, DOI 10.1145/2671188.2749288; Zhu XQ, 2017, B CNN BRANCH CONVOLU	33	0	0	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260758	10.1371/journal.pone.0260758	http://dx.doi.org/10.1371/journal.pone.0260758			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879097	Green Published, gold			2022-12-26	WOS:000754625200028
J	Lee, SW; Kim, SM; Hur, W; Kang, BY; Lee, HL; Nam, H; Yoo, SH; Sung, PS; Kwon, JH; Jang, JW; Kim, SJ; Yoon, SK				Lee, Sung Won; Kim, Sung Min; Hur, Wonhee; Kang, Byung-Yoon; Lee, Hae Lim; Nam, Heechul; Yoo, Sun Hong; Sung, Pil Soo; Kwon, Jung Hyun; Jang, Jeong Won; Kim, Seong-Jun; Yoon, Seung Kew			Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway	PLOS ONE			English	Article							GROWTH-FACTOR-I; PHOSPHATIDYLINOSITOL 3-KINASE; REGRESSION; ENTECAVIR; AUTOPHAGY; KINASE; PROGRESSION; INHIBITION; MODULATION; CROSSTALK	Background Antifibrotic agent for the treatment of liver fibrosis has not been developed so far. Long term treatment of chronic hepatitis B patients with antiviral drugs tenofovir disoproxil fumarate (TDF) and entecavir (ETV) results in the regression of liver fibrosis, but the underlying mechanism has not been clarified. Therefore, we aimed to investigate the direct impact of TDF and ETV on liver fibrosis. Methods Activated hepatic stellate cell (HSC) cell lines were used to evaluate the effects of TDF and ETV. After treatment with each antiviral agent, cell viability, morphology, apoptotic features, autophagy and antifibrosis signalling pathways were examined. Then, collagen deposition, fibrosis markers and activated HSCs were measured in liver tissues of the liver fibrosis model mice. Results After TDF treatment, the viabilities of LX2 and HSC-T6 cells were decreased, and the cells exhibited apoptotic features, but ETV did not induce these effects. Cleavage of PARP and Caspase-3 and the inhibition of the antiapoptotic gene Bcl-xl indicated activated HSC apoptosis following TDF treatment. TDF simultaneously increased autophagy, which also regulated apoptosis through crosstalk. TDF inactivated the PI3K/Akt/mTOR signalling pathway, which was associated with the activation of both apoptosis and autophagy. In the liver fibrosis mouse model, the fibrotic area and activated HSC markers were decreased by TDF but not ETV treatment. Additionally, apoptotic cells were concentrated in the periportal fibrotic area after TDF treatment, which indicated the specific antifibrotic effect of TDF. Conclusions TDF directly ameliorates liver fibrosis by downregulating the PI3K/Akt/mTOR signalling pathway, which results in the apoptosis of activated HSCs. The antifibrotic effects of TDF indicate that it may be a therapeutic agent for the treatment of liver fibrosis.	[Lee, Sung Won; Kim, Sung Min; Hur, Wonhee; Kang, Byung-Yoon; Lee, Hae Lim; Nam, Heechul; Yoo, Sun Hong; Sung, Pil Soo; Kwon, Jung Hyun; Jang, Jeong Won; Yoon, Seung Kew] Catholic Univ Korea, POSTECH Catholic Biomed Engn Inst, Catholic Univ Liver Res Ctr, Dept Biomed & Hlth Sci, Seoul, South Korea; [Lee, Sung Won; Lee, Hae Lim; Nam, Heechul; Yoo, Sun Hong; Sung, Pil Soo; Kwon, Jung Hyun; Jang, Jeong Won; Yoon, Seung Kew] Catholic Univ Korea, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Seong-Jun] Korea Res Inst Chem Technol, Daejeon, South Korea	Catholic University of Korea; Catholic University of Korea; Korea Research Institute of Chemical Technology (KRICT)	Yoon, SK (corresponding author), Catholic Univ Korea, POSTECH Catholic Biomed Engn Inst, Catholic Univ Liver Res Ctr, Dept Biomed & Hlth Sci, Seoul, South Korea.; Yoon, SK (corresponding author), Catholic Univ Korea, Dept Internal Med, Coll Med, Seoul, South Korea.	yoonsk@catholic.ac.kr	Sung, Pil Soo/AAD-6344-2021	Sung, Pil Soo/0000-0002-5780-9607				Bagnardi V, 2015, BRIT J CANCER, V112, P580, DOI 10.1038/bjc.2014.579; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Che XH, 2012, ARCH PHARM RES, V35, P2205, DOI 10.1007/s12272-012-1219-z; Chiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069114; Choi J, 2019, JAMA ONCOL, V5, P30, DOI 10.1001/jamaoncol.2018.4070; Czaja AJ, 2004, J HEPATOL, V40, P646, DOI 10.1016/j.jhep.2004.01.009; Czochra P, 2006, J HEPATOL, V45, P419, DOI 10.1016/j.jhep.2006.04.010; delPeso L, 1997, SCIENCE, V278, P687; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4; Feig JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188135; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gentilini A, 2000, J HEPATOL, V32, P227, DOI 10.1016/S0168-8278(00)80067-7; Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Kim SM, 2017, J CELL BIOCHEM, V118, P2026, DOI 10.1002/jcb.25776; Kim YO, 2017, METHODS MOL BIOL, V1559, P279, DOI 10.1007/978-1-4939-6786-5_19; Kocabayoglu P, 2015, J HEPATOL, V63, P141, DOI 10.1016/j.jhep.2015.01.036; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lee S, 2020, CLIN MOL HEPATOL, V26, P529, DOI 10.3350/cmh.2019.0056n; Lee SW, 2020, ALIMENT PHARM THER, V52, P889, DOI 10.1111/apt.15965; Lee SW, 2020, GUT, V69, P1301, DOI 10.1136/gutjnl-2019-318947; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Lei Y, 2019, CLIN RES HEPATOL GAS, V43, P575, DOI 10.1016/j.clinre.2019.02.003; Li XY, 2017, MOL THER-NUCL ACIDS, V9, P48, DOI 10.1016/j.omtn.2017.08.011; Liang LLY, 2019, CLIN MOL HEPATOL, V25, P172, DOI 10.3350/cmh.2018.0106; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marcellin P, 2019, LIVER INT, V39, P1868, DOI 10.1111/liv.14155; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Marra F, 1997, GASTROENTEROLOGY, V112, P1297, DOI 10.1016/S0016-5085(97)70144-6; Conesa-Buendia FM, 2019, J BONE MINER RES, V34, P923, DOI 10.1002/jbmr.3665; Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y; Murata K, 2020, HEPATOLOGY, V71, P1533, DOI 10.1002/hep.30956; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Papatheodoridis GV, 2020, J HEPATOL, V73, P1037, DOI 10.1016/j.jhep.2020.06.011; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Saini KS, 2013, CANCER TREAT REV, V39, P935, DOI 10.1016/j.ctrv.2013.03.009; Schuppan D, 2018, J HEPATOL, V68, P238, DOI 10.1016/j.jhep.2017.11.012; Shaker ME, 2013, BBA-MOL CELL RES, V1833, P1992, DOI 10.1016/j.bbamcr.2013.02.033; Shi LS, 2019, MOL BIOL CELL, V30, P2527, DOI 10.1091/mbc.E19-03-0136; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Wang JL, 2015, WORLD J GASTROENTERO, V21, P9598, DOI 10.3748/wjg.v21.i32.9598; Wang Y, 2010, J HEPATOL, V53, P132, DOI 10.1016/j.jhep.2010.02.027; Wong MCS, 2018, HEPATOL INT, V12, P201, DOI 10.1007/s12072-018-9865-y; Yim HJ, 2019, CLIN MOL HEPATOL, V25, P93, DOI 10.3350/cmh.2019.1002; Zhang XL, 2018, CELL PHYSIOL BIOCHEM, V51, P897, DOI 10.1159/000495390	47	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0261067	10.1371/journal.pone.0261067	http://dx.doi.org/10.1371/journal.pone.0261067			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879114	Green Published, gold			2022-12-26	WOS:000754625200047
J	Saposnik, G; Del Rio, B; Bueno-Gil, G; Sempere, AP; Lendinez-Mesa, A; Rodriguez-Antiguedad, A; Terzaghi, M; Medrano, N; Maurino, J				Saposnik, Gustavo; Del Rio, Beatriz; Bueno-Gil, Guillermo; Sempere, Angel P.; Lendinez-Mesa, Alejandro; Rodriguez-Antigueedad, Alfredo; Terzaghi, Maria; Medrano, Nicolas; Maurino, Jorge			Behavioral aspects of nurse practitioners associated with optimal multiple sclerosis care in Spain	PLOS ONE			English	Article							THERAPEUTIC INERTIA; REGRET; VALIDATION; PEOPLE; SCALE	Background Nurse practitioners (NPs) play a critical role in the multidisciplinary management of patients with multiple sclerosis (MS). Neurologists behavioral characteristics have been associated with suboptimal clinical decisions. However, limited information is available on their impact among NPs involved in MS care. The aim of this study was to assess nurses therapeutic choices to understand behavioral factors influencing their decision making process. Methods A non-interventional, cross-sectional, web-based study was conducted. NPs actively involved in the care of patients with MS were invited to participate in the study by the Spanish Society of Neurology Nursing. Participants answered questions regarding their standard practice and therapeutic management of seven simulated relapsing-remitting MS (RRMS) case scenarios. A behavioral battery was used to measure participants ' life satisfaction, mood, positive social behaviors, feeling of helpfulness, attitudes toward adoption of evidence-based innovations, occupational burnout, and healthcare-related regret. The outcome of interest was therapeutic inertia (TI), defined as the lack of treatment escalation when there is clinical and radiological evidence of disease activity. A score to quantify TI was created based on the number of simulated scenarios where treatment intensification was warranted. Results Overall, 331 NPs were invited to participate, 130 initiated the study, and 96 (29%) completed the study. The mean age (SD) was 44.6 (9.8) years and 91.7% were female. Seventy-three participants (76.0%) felt their opinions had a significant influence on neurologists ' therapeutic decisions. Sixteen NPs (16.5%) showed severe emotional exhaustion related to work and 13 (13.5%) had depressive symptoms. The mean (SD) TI score was 0.97 (1.1). Fifty-six of NPs showed TI in at least one case scenario. Higher years of nursing experience (p = 0.014), feeling of helpfulness (p = 0.014), positive attitudes toward innovations (p = 0.046), and a higher intensity of care-related regret (p = 0.021) were associated with a lower risk of TI (adjusted R-2 = 0.28). Burnout was associated with higher risk of TI (p = 0.001). Conclusions Although NPs cannot prescribe MS treatments in Spain, their behavioral characteristics may influence the management of patients with RRMS. Continuing education and specific strategies for reducing occupational burnout may lead to better management skills and improve MS care.	[Saposnik, Gustavo] Univ Toronto, St Michaels Hosp, Div Neurol, Dept Med, Toronto, ON, Canada; [Saposnik, Gustavo; Terzaghi, Maria] Univ Toronto, Li Ka Shing Inst, Decis Neurosci Unit, Toronto, ON, Canada; [Saposnik, Gustavo] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland; [Del Rio, Beatriz] Hosp Univ La Princesa, Dept Nursing, Madrid, Spain; [Bueno-Gil, Guillermo; Medrano, Nicolas; Maurino, Jorge] Roche Pharma, Dept Med, Madrid, Spain; [Sempere, Angel P.] Hosp Gen Univ Alicante, Dept Neurol, Alicante, Spain; [Lendinez-Mesa, Alejandro] Univ Alfonso X el Sabio, Sch Med, Dept Nursing, Madrid, Spain; [Lendinez-Mesa, Alejandro] Spanish Soc Neurol Nursing SEDENE, Madrid, Spain; [Rodriguez-Antigueedad, Alfredo] Hosp Univ Cruces, Dept Neurol, Bilbao, Spain	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Zurich; Hospital de La Princesa; Roche Holding; General University Hospital of Alicante; Universidad Alfonso X el Sabio (UAX); Hospital Universitario Cruces	Maurino, J (corresponding author), Roche Pharma, Dept Med, Madrid, Spain.	jorge.maurino@roche.com	Saposnik, Gustavo/M-3937-2017	Saposnik, Gustavo/0000-0002-5950-9886; RODRIGUEZ-ANTIGUEDAD, ALFRED/0000-0002-4566-2329; Maurino, Jorge/0000-0001-9858-3555; Perez-Sempere, Angel/0000-0002-0195-2834				Aarons Gregory A, 2004, Ment Health Serv Res, V6, P61, DOI 10.1023/B:MHSR.0000024351.12294.65; Almusalam N, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7093; [Anonymous], 2019, Neurology, V92, P112, DOI 10.1212/WNL.0000000000006722; Baumsteiger R, 2019, J PERS ASSESS, V101, P305, DOI 10.1080/00223891.2017.1411918; Benedict RHB, 2003, MULT SCLER J, V9, P393, DOI 10.1191/1352458503ms902oa; Burke Therese, 2011, Int J MS Care, V13, P105, DOI 10.7224/1537-2073-13.3.105; Cameron E, 2019, MULT SCLER RELAT DIS, V27, P378, DOI 10.1016/j.msard.2018.11.023; Courvoisier DS, 2013, MED CARE, V51, P285, DOI 10.1097/MLR.0b013e318280f02c; Courvoisier DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023138; Dall'Ora C, 2020, HUM RESOUR HEALTH, V18, DOI 10.1186/s12960-020-00469-9; Di Battista G, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/752318; Djulbegovic M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134038; Linker Ralf A, 2019, Neurol Res Pract, V1, P5, DOI 10.1186/s42466-019-0005-5; Maslach C., 2018, MASLACH BURNOUT INVE, V80; Matthys E, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0698-x; Meehan M, 2020, MULT SCLER RELAT DIS, V39, DOI 10.1016/j.msard.2019.101918; Montalban X, 2018, MULT SCLER J, V24, P96, DOI 10.1177/1352458517751049; Negri L, 2022, NEUROL SCI, V43, P1903, DOI 10.1007/s10072-021-05520-8; O'Connor PJ, 2005, ADV PATIENT SAFETY R, V2; Patel RS, 2018, BEHAV SCI-BASEL, V8, DOI 10.3390/bs8110098; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Peloquin S, 2021, MULT SCLER RELAT DIS, V50, DOI 10.1016/j.msard.2021.102854; Rahn AC, 2018, INT J NURS STUD, V78, P26, DOI 10.1016/j.ijnurstu.2017.08.011; Rodrigues R, 2021, MULT SCLER RELAT DIS, V55, DOI 10.1016/j.msard.2021.103176; Saposnik G, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.675520; Saposnik Gustavo, 2019, MDM Policy Pract, V4, p2381468319855642, DOI 10.1177/2381468319855642; Saposnik Gustavo, 2018, Front Neurol, V9, P174, DOI 10.3389/fneur.2018.00174; Saposnik G, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00065; Schmid F, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18126537; Sorum PC, 2004, MED DECIS MAKING, V24, P149, DOI 10.1177/0272989X04263163; Terzaghi MA, 2020, MULT SCLER RELAT DIS, V39, DOI 10.1016/j.msard.2019.101887; Wilson A, 2017, WORLD J SURG, V41, P1454, DOI 10.1007/s00268-017-3895-9	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0261050	10.1371/journal.pone.0261050	http://dx.doi.org/10.1371/journal.pone.0261050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879095	Green Published, gold			2022-12-26	WOS:000754625200045
J	Jhun, J; Na, HS; Cho, KH; Kim, J; Moon, YM; Lee, SY; Lee, JS; Lee, AR; Kim, SJ; Cho, ML; Park, SH				Jhun, JooYeon; Na, Hyun Sik; Cho, Keun-Hyung; Kim, Jiyoung; Moon, Young-Mee; Lee, Seung Yoon; Lee, Jeong Su; Lee, A. Ram; Kim, Seok Jung; Cho, Mi-La; Park, Sung-Hwan			A green-lipped mussel reduces pain behavior and chondrocyte inflammation and attenuated experimental osteoarthritis progression	PLOS ONE			English	Article							CARTILAGE; NECROPTOSIS; ACTIVATION; OXYGEN	The green-lipped mussel (GLM) contains novel omega-3 polyunsaturated fatty acids, which exhibit anti-inflammatory and joint-protecting properties. Osteoarthritis (OA) is a degenerative joint disease characterized by a progressive loss of cartilage; oxidative stress plays a role in the pathogenesis of OA. The objectives of this study were to investigate the in vivo effects of the GLM on pain severity and cartilage degeneration using an experimental rat OA model, and to explore the mode of action of GLM. OA was induced in rats by intra-articular injection of monosodium iodoacetate (MIA) into the knee. Oral GLM was initiated on the day after 3dyas of MIA injection. Limb nociception was assessed by measuring the paw withdrawal latency and threshold. Samples were analyzed both macroscopically and histologically. Immunohistochemistry was used to investigate the expression of interleukin-1 beta (IL-1 beta), IL-6, nitrotyrosine, and inducible nitric oxide synthase (iNOS) in knee joints. Also, the GLM was applied to OA chondrocyte, and the expression on catabolic marker and necroptosis factor were evaluated by real-time polymerase chain reaction. Administration of the GLM improved pain levels by preventing cartilage damage and inflammation. GLM significantly attenuated the expression levels of mRNAs encoding matrix metalloproteinase-3 (MMP-3), MMP-13, and ADAMTS5 in IL-1 beta -stimulated human OA chondrocytes. GLM decreased the expression levels of the necroptosis mediators RIPK1, RIPK3, and the mixed lineage kinase domain-like protein (MLKL) in IL-1 beta -stimulated human OA chondrocytes. Thus, GLM reduced pain and cartilage degeneration in rats with experimentally induced OA. The chondroprotective properties of GLM included suppression of oxidative damage and inhibition of catabolic factors implicated in the pathogenesis of OA cartilage damage. We suggest that GLM may usefully treat human OA.	[Jhun, JooYeon; Na, Hyun Sik; Cho, Keun-Hyung; Kim, Jiyoung; Moon, Young-Mee; Lee, Seung Yoon; Lee, Jeong Su; Lee, A. Ram; Cho, Mi-La] Catholic Univ Korea, Rheumatism Res Ctr, Catholic Res Inst Med Sci, Seoul, South Korea; [Kim, Seok Jung] Catholic Univ Korea, Coll Med, Dept Orthoped Surg, Uijeongbu St Marys Hosp, Seoul, South Korea; [Park, Sung-Hwan] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Rheumatol,Seoul St Marys Hosp, Seoul, South Korea; [Jhun, JooYeon; Na, Hyun Sik; Cho, Keun-Hyung; Lee, Seung Yoon; Lee, Jeong Su; Lee, A. Ram; Cho, Mi-La] Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea; [Cho, Mi-La] Catholic Univ Korea, Coll Med, Dept Med Lifesci, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea	Cho, ML (corresponding author), Catholic Univ Korea, Rheumatism Res Ctr, Catholic Res Inst Med Sci, Seoul, South Korea.; Park, SH (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Rheumatol,Seoul St Marys Hosp, Seoul, South Korea.; Cho, ML (corresponding author), Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea.; Cho, ML (corresponding author), Catholic Univ Korea, Coll Med, Dept Med Lifesci, Seoul, South Korea.	iammila@catholic.ac.kr; rapark@catholic.ac.kr			Food Industry Promotional Agency of Korea	Food Industry Promotional Agency of Korea	This research was supported by a grant of the Food Industry Promotional Agency of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson SB, 2006, NAT CLIN PRACT RHEUM, V2, P304, DOI 10.1038/ncprheum0193; Abramson SB, 2008, OSTEOARTHR CARTILAGE, V16, pS15, DOI 10.1016/S1063-4584(08)60008-4; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487; Cai ZY, 2016, CELL RES, V26, P886, DOI 10.1038/cr.2016.87; Cho Se Haeng, 2003, Eur Ann Allergy Clin Immunol, V35, P212; Choi MC, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070734; Cordaro M, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-2048-y; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Del Carlo M, 2003, ARTHRITIS RHEUM-US, V48, P3419, DOI 10.1002/art.11338; Demoor M, 2014, BBA-GEN SUBJECTS, V1840, P2414, DOI 10.1016/j.bbagen.2014.02.030; Di Paola R, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1189-5; Dondelinger Y, 2016, TRENDS CELL BIOL, V26, P721, DOI 10.1016/j.tcb.2016.06.004; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; Fusco R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9060511; Grootjans S, 2017, CELL DEATH DIFFER, V24, P1184, DOI 10.1038/cdd.2017.65; Gugliandolo E, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10101827; Henrotin Y, 2005, OSTEOARTHR CARTILAGE, V13, P643, DOI 10.1016/j.joca.2005.04.002; Jayaprakash R, 2020, FOODS, V9, DOI 10.3390/foods9070879; Jeon J, 2020, ANN RHEUM DIS, V79, P1635, DOI 10.1136/annrheumdis-2020-217904; Jiang LP, 2013, J ORTHOP RES, V31, P364, DOI 10.1002/jor.22250; Alcaraz MJ, 2010, BIOCHEM PHARMACOL, V80, P13, DOI 10.1016/j.bcp.2010.02.017; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kim JH, 2014, CELL, V156, P730, DOI 10.1016/j.cell.2014.01.007; Kwon JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32206-7; Lee SY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4179; Li D, 2012, AM J MED SCI, V344, P486, DOI 10.1097/MAJ.0b013e3182579dc6; Marcu KB, 2010, CURR DRUG TARGETS, V11, P599, DOI 10.2174/138945010791011938; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Perez-Lozano ML, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020265; Pinto C, 2018, BBA-MOL BASIS DIS, V1864, P1270, DOI 10.1016/j.bbadis.2017.07.024; Pollard B, 2006, NEW ZEAL VET J, V54, P114, DOI 10.1080/00480169.2006.36622; Stebbings S, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1907-9; Treschow AP, 2007, COMP BIOCHEM PHYS B, V147, P645, DOI 10.1016/j.cbpb.2007.04.004; Whitehouse M. W., 1997, Inflammopharmacology, V5, P237, DOI 10.1007/s10787-997-0002-0; Wluka A, 2004, ANN RHEUM DIS, V63, P264, DOI 10.1136/ard/2003.007666; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459; Wu GJ, 2007, J CELL BIOCHEM, V101, P1520, DOI 10.1002/jcb.21268; Zochling J, 2004, ANN RHEUM DIS, V63, P549, DOI 10.1136/ard.2003.010637	39	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0259130	10.1371/journal.pone.0259130	http://dx.doi.org/10.1371/journal.pone.0259130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855756	Green Published, gold			2022-12-26	WOS:000735299000012
J	O'Connell, JS; Li, B; Zito, A; Ahmed, A; Cadete, M; Ganji, N; Lau, E; Alganabi, M; Farhat, N; Lee, C; Eaton, S; Mitchell, R; Ray, S; De Coppi, P; Patel, K; Pierro, A				O'Connell, Joshua S.; Li, Bo; Zito, Andrea; Ahmed, Abdalla; Cadete, Marissa; Ganji, Niloofar; Lau, Ethan; Alganabi, Mashriq; Farhat, Nassim; Lee, Carol; Eaton, Simon; Mitchell, Robert; Ray, Steve; De Coppi, Paolo; Patel, Ketan; Pierro, Agostino			Treatment of necrotizing enterocolitis by conditioned medium derived from human amniotic fluid stem cells	PLOS ONE			English	Article							THERAPY; EFFICACY; INJURY; MODELS; STATE	Purpose Necrotizing enterocolitis (NEC) is one of the most distressing gastrointestinal emergencies affecting neonates. Amniotic fluid stem cells (AFSC) improve intestinal injury and survival in experimental NEC but are difficult to administer. In this study, we evaluated whether conditioned medium (CM) derived from human AFSC have protective effects. Methods Three groups of C57BL/6 mice were studied: (i) breast-fed mice as control; (ii) experimental NEC mice receiving PBS; and (iii) experimental NEC mice receiving CM. NEC was induced between post-natal days P5 through P9 via: (A) gavage feeding of hyperosmolar formula four-time a day; (B) 10 minutes hypoxia prior to feeds; and (C) lipopolysaccharide administration on P6 and P7. Intra-peritoneal injections of either PBS or CM were given on P6 and P7. All mice were sacrificed on P9 and terminal ileum were harvested for analyses. Results CM treatment increased survival and reduced intestinal damage, decreased mucosal inflammation (IL-6; TNF-alpha), neutrophil infiltration (MPO), and apoptosis (CC3), and also restored angiogenesis (VEGF) in the ileum. Additionally, CM treated mice had increased levels of epithelial proliferation (Ki67) and stem cell activity (Olfm4; Lgr5) compared to NEC+PBS mice, showing restored intestinal regeneration and recovery during NEC induction. CM proteomic analysis of CM content identified peptides that regulated immune and stem cell activity. Conclusions CM derived from human AFSC administered in experimental NEC exhibited various benefits including reduced intestinal injury and inflammation, increased enterocyte proliferation, and restored intestinal stem cell activity. This study provides the scientific basis for the use of CM derived from AFSC in neonates with NEC.	[O'Connell, Joshua S.; Li, Bo; Zito, Andrea; Ahmed, Abdalla; Cadete, Marissa; Ganji, Niloofar; Lau, Ethan; Alganabi, Mashriq; Farhat, Nassim; Lee, Carol; Pierro, Agostino] Hosp Sick Children, Div Gen & Thorac Surg, Toronto, ON, Canada; [O'Connell, Joshua S.; Li, Bo; Zito, Andrea; Ahmed, Abdalla; Cadete, Marissa; Ganji, Niloofar; Lau, Ethan; Alganabi, Mashriq; Farhat, Nassim; Lee, Carol; Pierro, Agostino] Hosp Sick Children, Translat Med Program, Toronto, ON, Canada; [Eaton, Simon; De Coppi, Paolo] NIHR BRC Great Ormond St Hosp, Stem Cells & Regenerat Med Sect, London, England; [Eaton, Simon; De Coppi, Paolo] UCL Great Ormond St Inst Child Hlth, London, England; [Mitchell, Robert; Ray, Steve; Patel, Ketan] Micregen Ltd, Thames Valley Sci Pk, Reading, Berks, England	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of London; University College London	Pierro, A (corresponding author), Hosp Sick Children, Div Gen & Thorac Surg, Toronto, ON, Canada.; Pierro, A (corresponding author), Hosp Sick Children, Translat Med Program, Toronto, ON, Canada.	agostino.pierro@sickkids.ca	Li, Bo/AAP-6556-2020	Li, Bo/0000-0002-8298-8344; O'Connell, Joshua S./0000-0002-3608-3894; Eaton, Simon/0000-0003-0892-9204	Canadian Institutes of Health Research (CIHR) Foundation [353857]; Robert M. Filler Chair of Surgery, The Hospital for Sick Children	Canadian Institutes of Health Research (CIHR) Foundation(Canadian Institutes of Health Research (CIHR)); Robert M. Filler Chair of Surgery, The Hospital for Sick Children	AP is the recipient of a Canadian Institutes of Health Research (CIHR) Foundation Grant #353857 and the Robert M. Filler Chair of Surgery, The Hospital for Sick Children. The funding institutes had no effect on study design, analysis, or interpretation of results.	De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Drucker NA, 2018, SEMIN PEDIATR SURG, V27, P57, DOI 10.1053/j.sempedsurg.2017.11.011; Eaton S, 2013, EXPERT OPIN BIOL TH, V13, P1683, DOI 10.1517/14712598.2013.849690; Eslaminejad MB, 2012, INT J FERTIL STERIL, V6, P147; Hall NJ, 2013, J PEDIATR SURG, V48, P2359, DOI 10.1016/j.jpedsurg.2013.08.006; Jun EK, 2014, INT J MOL SCI, V15, P605, DOI 10.3390/ijms15010605; Li B, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02964-2; Li B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211431; Markel TA, 2006, SHOCK, V25, P329, DOI 10.1097/01.shk.0000192126.33823.87; McCulloh CJ, 2018, J PEDIATR SURG, V53, P1215, DOI 10.1016/j.jpedsurg.2018.02.086; McCulloh CJ, 2017, J SURG RES, V214, P278, DOI 10.1016/j.jss.2017.03.026; McCulloh CJ, 2017, J PEDIATR SURG, V52, P999, DOI 10.1016/j.jpedsurg.2017.03.028; Mellows B, 2017, STEM CELLS DEV, V26, P1316, DOI 10.1089/scd.2017.0089; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Mutanen A, 2018, EUR J PEDIATR SURG, V28, P148, DOI 10.1055/s-0038-1636943; O'Connell JS, 2021, PEDIATR SURG INT, V37, P301, DOI 10.1007/s00383-020-04826-6; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Sabnis A, 2015, NEONATOLOGY, V107, P191, DOI 10.1159/000368879; Sulistyo A, 2018, INNOV SURG SCI, V3, P87, DOI 10.1515/iss-2017-0050; Weil BR, 2009, SURGERY, V146, P190, DOI 10.1016/j.surg.2009.03.031; Yang JX, 2014, METHODS MOL BIOL, V1213, P121, DOI 10.1007/978-1-4939-1453-1_11; Zani A, 2015, F1000RESEARCH, V4, pF1000, DOI DOI 10.12688/F1000RESEARCH.6888.1; Zani A, 2016, PEDIATR SURG INT, V32, P65, DOI 10.1007/s00383-015-3813-x; Zani A, 2014, GUT, V63, P300, DOI 10.1136/gutjnl-2012-303735	25	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260522	10.1371/journal.pone.0260522	http://dx.doi.org/10.1371/journal.pone.0260522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855833	gold, Green Published			2022-12-26	WOS:000735299000065
J	Tham, WW; Sojli, E; Bryant, R; McAleer, M				Tham, Wing Wah; Sojli, Elvira; Bryant, Richard; McAleer, Michael			Common Mental Disorders and Economic Uncertainty: Evidence from the COVID-19 Pandemic in the US	PLOS ONE			English	Article							SUICIDE RATES; UNITED-STATES; HEALTH; PREVALENCE	Mental health disorders represent an enormous cost to society, are related to economic outcomes, and have increased markedly since the COVID-19 outbreak. Economic activity contracted dramatically on a global scale in 2020, representing the worst crisis since the Great Depression. This study used the COVID Impact Survey to provide insights on the interactions of mental illness and economic uncertainty during COVID-19. We used a probability-based panel survey, COVID Impact Survey, conducted in the U.S. over three waves in the period April-June 2020. The survey covered individual information on employment, economic and financial uncertainty, mental and physical health, as well as other demographic information. The prevalence of moderate mental distress was measured using a Psychological Distress Scale, a 5-item scale that is scored on a 4-point scale (total range: 0-15). The mental distress effect of employment, economic, and financial uncertainty, was assessed in a logit regression analysis conditioning for demographic and health information. It is found that employment, health coverage, social security, and food provision uncertainty are additional stressors for mental health. These economic factors work in addition to demographic effects, where groups who display increased risk for psychological distress include: women, Hispanics, and those in poor physical health. A decrease in employment and increases in economic uncertainty are associated with a doubling of common mental disorders. The population-representative survey evidence presented strongly suggests that economic policies which support employment (e.g., job keeping, job search support, stimulus spending) provide not only economic security but also constitute a major health intervention. Moving forward, the economic uncertainty effect ought to be reflected in community level intervention and prevention efforts, which should include strengthening economic support to reduce financial and economic strain.	[Tham, Wing Wah; Sojli, Elvira] Univ New South Wales, UNSW Business Sch, Sydney, NSW, Australia; [Bryant, Richard] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [McAleer, Michael] Asia Univ, Coll Management, Taichung, Taiwan	University of New South Wales Sydney; University of New South Wales Sydney; Asia University Taiwan	Sojli, E (corresponding author), Univ New South Wales, UNSW Business Sch, Sydney, NSW, Australia.	e.sojli@unsw.edu.au		Sojli, Elvira/0000-0002-1567-8901	Ministry of Science and Technology Taiwan [1173921 M.M.];  [106-2410-H468-029];  [107-2410-H-468-025];  [108-2410-H-468-024]	Ministry of Science and Technology Taiwan(Ministry of Science and Technology, Taiwan); ; ; 	This work was supported by: R.B. NHMRC (https://www.nhmrc.gov.au) Investigator Grant 1173921 M.M. Ministry of Science and Technology Taiwan (https://www.most.gov.tw/folksonomy/list/da1500c5-2898-44dd-b5645b1dc17a7d2b?l=en) Grant numbers 106-2410-H468-029, 107-2410-H-468-025, 108-2410-H-468-024 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aknin LB., 2021, MENTAL HLTH 1 YEAR C, DOI [10.31234/osf.io/zw93g, DOI 10.31234/OSF.IO/ZW93G]; [Anonymous], 2002, Bull World Health Organ, V80, P983; Bloom DE, 2011, GLOBAL EC BURDEN NON; Cenat JM, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113599; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]; Hakulinen C, 2019, ACTA PSYCHIAT SCAND, V140, P371, DOI 10.1111/acps.13067; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; International Monetary Fund, 2021, WORLD EC OUTL REC PA; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Killgore WDS, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113117; Knapp M., 2019, ROUTLEDGE HDB INT DE; Knapp M, 2020, WORLD PSYCHIATRY, V19, P3, DOI 10.1002/wps.20692; Lee YC, 2017, AUST NZ J PSYCHIAT, V51, P1198, DOI 10.1177/0004867417710730; Oyesanya M, 2015, WORLD J PSYCHIATR, V5, P243, DOI 10.5498/wjp.v5.i2.243; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Reeves A, 2012, LANCET, V380, P1813, DOI 10.1016/S0140-6736(12)61910-2; Ridley M, 2020, SCIENCE, V370, P1289, DOI 10.1126/science.aay0214; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Silva M, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796018000641; Smit F, 2006, J MENT HEALTH POLICY, V9, P193; Sojli E, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01537-x; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; World Bank, 2020, GLOB EC OUTL COVID 1; Wozniak A., 2020, COVID IMPACT SURVEY	26	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260726	10.1371/journal.pone.0260726	http://dx.doi.org/10.1371/journal.pone.0260726			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855850	gold, Green Published			2022-12-26	WOS:000735299000106
J	Volkman, HR; Perez-Padilla, J; Wong, JM; Sanchez-Gonzalez, L; Acevedo-Molina, L; Lugo-Menendez, M; Garcia, CAO; Adams, LE; Frasqueri-Quintana, VM; Rodriguez-Gonzalez, R; Gonzalez-Cosme, JA; Diaz, AEC; Alvarado, LI; Rivera-Amill, V; Brown, J; Wong, KK; Bertran-Pasarell, J; Paz-Bailey, G				Volkman, Hannah R.; Perez-Padilla, Janice; Wong, Joshua M.; Sanchez-Gonzalez, Liliana; Acevedo-Molina, Lauren; Lugo-Menendez, Martin; Oliveras Garcia, Carene A.; Adams, Laura E.; Frasqueri-Quintana, Veronica M.; Rodriguez-Gonzalez, Robert; Gonzalez-Cosme, Javier A.; Calvo Diaz, Andres E.; Alvarado, Luisa, I; Rivera-Amill, Vanessa; Brown, Jessica; Wong, Karen K.; Bertran-Pasarell, Jorge; Paz-Bailey, Gabriela			Characteristics and clinical outcomes of patients hospitalized with laboratory-confirmed COVID-19-Puerto Rico, March-August 2020	PLOS ONE			English	Article							COMORBIDITIES	Hispanics are the majority ethnic population in Puerto Rico where we reviewed charts of 109 hospitalized COVID-19 patients to better understand demographic and clinical characteristics of COVID-19 and determine risk factors for poor outcomes. Eligible medical records of hospitalized patients with confirmed COVID-19 illnesses were reviewed at four participating hospitals in population centers across Puerto Rico and data were abstracted that described the clinical course, interventions, and outcomes. We found hospitalized patients had a median of 3 underlying conditions with obesity and diabetes as the most frequently reported conditions. Intensive care unit (ICU) admission occurred among 28% of patients and 18% of patients died during the hospitalization. Patients 65 or older or with immune deficiencies had a higher risk for death. Common symptoms included cough, dyspnea, and fatigue; less than half of patients in the study reported fever which was less frequent than reported elsewhere in the literature. It is important for interventions within Hispanic communities to protect high-risk groups.	[Volkman, Hannah R.; Perez-Padilla, Janice; Wong, Joshua M.; Sanchez-Gonzalez, Liliana; Adams, Laura E.; Paz-Bailey, Gabriela] US Ctr Dis Control & Prevent, San Juan, PR 00920 USA; [Acevedo-Molina, Lauren; Bertran-Pasarell, Jorge] Hosp Auxilio Mutuo, San Juan, PR USA; [Acevedo-Molina, Lauren; Bertran-Pasarell, Jorge] Adults Univ Hosp, San Juan, PR USA; [Lugo-Menendez, Martin; Oliveras Garcia, Carene A.; Frasqueri-Quintana, Veronica M.; Rodriguez-Gonzalez, Robert; Alvarado, Luisa, I; Rivera-Amill, Vanessa] Ponce Hlth Sci Univ, Ctr Med Episcopal San Lucas, Ponce Res Inst, Ponce, PR USA; [Gonzalez-Cosme, Javier A.; Calvo Diaz, Andres E.] Hosp Univ Dr Ramon Ruiz Arnau, Bayamon, PR USA; [Brown, Jessica; Wong, Karen K.] US Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Ponce Health Sciences University; Centers for Disease Control & Prevention - USA	Volkman, HR (corresponding author), US Ctr Dis Control & Prevent, San Juan, PR 00920 USA.	HVolkman@cdc.gov	Sánchez-González, Liliana/GZK-6297-2022	Sánchez-González, Liliana/0000-0001-8289-8587; Wong, Karen/0000-0002-5287-6456; Volkman, Hannah/0000-0001-7274-9641	National Center for Emerging and Zoonotic Infectious Diseases; Center for State, Tribal, Local, and Territorial Support at the Centers for Disease Control and Prevention [U01CK000437, U01CK000580]	National Center for Emerging and Zoonotic Infectious Diseases(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Center for State, Tribal, Local, and Territorial Support at the Centers for Disease Control and Prevention	This work was supported by the National Center for Emerging and Zoonotic Infectious Diseases and the Center for State, Tribal, Local, and Territorial Support at the Centers for Disease Control and Prevention [grant numbers U01CK000437 and U01CK000580 to V.R.A.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.cdc.gov/ncezid/index.html https://www.cdc.gov/publichealthgateway/about-cstlts/index.html.	Centers for Disease Control and Prevention, 2020, EV US UPD LIST UND M; Centers for Disease Control and Prevention, 2021, DENG STAT MAPS 2020; De Vito A, 2020, EUR REV MED PHARMACO, V24, P7861, DOI 10.26355/eurrev_202007_22291; Departamento de Salud-Gobierno de Puerto Rico, INF CAS COVID 19 31; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P545, DOI 10.15585/mmwr.mm6918e1; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Izzy S, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa401; Killerby ME, 2020, MMWR-MORBID MORTAL W, V69, P790, DOI 10.15585/mmwr.mm6925e1; Palaiodimos L, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154262; Pierluisi Pedro R., 2021, OE2021017 GOB PUERT; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rodriguez-Diaz CE, 2020, ANN EPIDEMIOL, V52, P46, DOI 10.1016/j.annepidem.2020.07.007; Rossen LM, 2020, MMWR-MORBID MORTAL W, V69, P1522, DOI [10.1101/2020.06.06.20120857v1.full.pdf, 10.15585/mmwr.mm6942e2]; Ryan C, 2021, AM J EMERG MED, V45, P378, DOI 10.1016/j.ajem.2020.09.017; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P993, DOI [10.15585/mmwr.mm6930e1, 10.15585/mmwr.mm6930e1externalicon]; Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1560, DOI 10.1002/hed.26269	18	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260599	10.1371/journal.pone.0260599	http://dx.doi.org/10.1371/journal.pone.0260599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855817	gold, Green Published			2022-12-26	WOS:000735299000074
J	Lim, ZW; Wang, D; Wang, PL; Chung, CH; Huang, SS; Huang, CC; Tsai, PY; Wu, WA; Wu, KH; Chien, WC				Lim, Zhu Wei; Wang, I-Duo; Wang, Panchalli; Chung, Chi-Hsiang; Huang, Song-Shan; Huang, Chien-Chu; Tsai, Pei-Yi; Wu, Gwo-Jang; Wu, Kuo-Hsiang; Chien, Wu-Chien			Obstructive sleep apnea increases risk of female infertility: A 14-year nationwide population-based study	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; EPIDEMIOLOGY; DYSFUNCTION; WOMEN	Objectives To determine the risk of having OSA in a cohort of female subjects who are infertile and the odds of being infertile in women with OSA. Patients and methods A nationwide, case-control study of female patients 20 years or older diagnosed with female infertility living in Taiwan, from January 1, 2000, through December 31, 2013 (N = 4,078). We identified women who were infertile and created a 2:1 matched control group with women who were not infertile. We used multivariable logistic regression analysis to further estimate the effects of OSA on female infertility. Results In this 14-year retrospective study, we included 4,078 patients having an initial diagnosis of female infertility. Of those women with infertility, 1.38% had a history of OSA compared with 0.63% of fertile controls (p = 0.002). The mean ages in the study groups were 32.19 +/- 6.20 years, whereas the mean ages in the control groups were 32.24 +/- 6.37years. Women with OSA had 2.101-times the risk of female infertility compared to women without OSA (p<0.001). Conclusion Our study showed that OSA is more commonly seen in infertile women and increases the odds that a woman will be infertile. More studies need to be done on the whether or not diagnosing and treating OSA can decrease the rate of infertility.	[Lim, Zhu Wei] Changhua Christian Hosp, Dept Obstet & Gynecol, Changhua, Taiwan; [Wang, I-Duo] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, Taipei, Taiwan; [Wang, Panchalli; Huang, Song-Shan] Chiayi Christian Hosp, Dept Obstet & Gynecol, Chiayi, Taiwan; [Chung, Chi-Hsiang; Chien, Wu-Chien] Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Chung, Chi-Hsiang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Huang, Chien-Chu] China Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Huang, Chien-Chu] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Tsai, Pei-Yi] Triserv Gen Hosp, Natl Def Med Ctr, Dept Radiat Oncol, Taipei, Taiwan; [Wu, Gwo-Jang] Triserv Gen Hosp, Obstet & Gynecol Dept, Taipei, Taiwan; [Wu, Gwo-Jang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Wu, Kuo-Hsiang] Triserv Gen Hosp, Natl Def Med Ctr, Dept Nursing, Taipei, Taiwan	Changhua Christian Hospital; National Defense Medical Center; Tri-Service General Hospital; Chia-Yi Christian Hospital; Tri-Service General Hospital; National Defense Medical Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Chien, WC (corresponding author), Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Wu, WA (corresponding author), Triserv Gen Hosp, Obstet & Gynecol Dept, Taipei, Taiwan.; Wu, WA (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Wu, KH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Nursing, Taipei, Taiwan.	gwojiang@yahoo.com; kamekame@mail.ndmctsgh.edu.tw; chienwu@ndmctsgh.edu.tw			Tri-Service General Hospital Research Foundation [TSGH-D-110130, TSGH-B110012]	Tri-Service General Hospital Research Foundation	This study was supported by Grant Support from Tri-Service General Hospital Research Foundation (TSGH-D-110130, TSGH-B110012). The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrao MS, 2013, INT J GYNECOL OBSTET, V123, pS18, DOI 10.1016/j.ijgo.2013.09.008; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; [Anonymous], 2019, Obstet Gynecol, V133, pe377, DOI 10.1097/AOG.0000000000003271; BROWNELL LG, 1986, AM REV RESPIR DIS, V133, P38, DOI 10.1164/arrd.1986.133.1.38; Buyse B, 2003, RESP PHYSIOL NEUROBI, V134, P13, DOI 10.1016/S1569-9048(02)00202-1; Chen SC, 2019, LANCET, V394, P1515, DOI 10.1016/S0140-6736(19)31630-7; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171; Cheng TM., 2012, 6 COUNTRIES 6 REFORM, P171; Collop NA, 2004, CLIN CHEST MED, V25, P257, DOI 10.1016/j.ccm.2004.01.002; Ferin M, 1999, J CLIN ENDOCR METAB, V84, P1768, DOI 10.1210/jc.84.6.1768; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Galvan T, 2017, MENOPAUSE, V24, P112, DOI 10.1097/GME.0000000000000737; Gilat H, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000045; Helms C, 2013, FREE RADICAL BIO MED, V61, P464, DOI 10.1016/j.freeradbiomed.2013.04.028; Hong Eun Pyo, 2012, Genomics & Informatics, V10, P117, DOI 10.5808/GI.2012.10.2.117; Hsieh CY, 2019, CLIN EPIDEMIOL, V11, P349, DOI 10.2147/CLEP.S196293; Kapsimalis FKryger M., GENDER OBSTRUCTIVE S; Kloss JD, 2015, SLEEP MED REV, V22, P78, DOI 10.1016/j.smrv.2014.10.005; Lastra AC, 2018, GEND GENOME, V2, P43, DOI DOI 10.1177/2470289718787107; Maasilta P, 2001, CHEST, V120, P1448, DOI 10.1378/chest.120.5.1448; Mahdi BM, 2011, MIDDLE EAST FERTIL S, V16, P220, DOI 10.1016/j.mefs.2011.03.002; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; McQuillan L P, 1994, Am J Physiol, V267, pH1921; Mirer AG, 2017, MENOPAUSE, V24, P157, DOI 10.1097/GME.0000000000000744; Nitsche K, 2010, BEST PRACT RES CL EN, V24, P717, DOI 10.1016/j.beem.2010.08.001; Okpalaji C., 2016, IOSR J DENT MED SCI, V15, P77; Palnitkar G, 2018, SLEEP MED REV, V42, P149, DOI 10.1016/j.smrv.2018.07.006; Pinto JA, 2016, INT ARCH OTORHINOLAR, V20, P145, DOI 10.1055/s-0036-1579546; Popovic RM, 1998, J APPL PHYSIOL, V84, P1055, DOI 10.1152/jappl.1998.84.3.1055; Potter GDM, 2016, ENDOCR REV, V37, P584, DOI 10.1210/er.2016-1083; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Sarapik A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/606459; Slatkovska L, 2006, RESP PHYSIOL NEUROBI, V154, P379, DOI 10.1016/j.resp.2006.01.011; Soukhova-O'Hare GK, 2008, AM J RESP CRIT CARE, V178, P644, DOI 10.1164/rccm.200801-190OC; Torres M, 2014, SLEEP, V37, P1758, DOI 10.5665/sleep.4166; Wang ID, 2018, SLEEP, V41, DOI 10.1093/sleep/zsx186; Wimms A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1764837; Woodward M., 2013, EPIDEMIOLOGY STUDY D; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	41	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0260842	10.1371/journal.pone.0260842	http://dx.doi.org/10.1371/journal.pone.0260842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910749	Green Published, gold			2022-12-26	WOS:000754828900029
J	Langner, F; Arenberg, JG; Buchner, A; Nogueira, W				Langner, Florian; Arenberg, Julie G.; Buchner, Andreas; Nogueira, Waldo			Assessing the relationship between neural health measures and speech performance with simultaneous electric stimulation in cochlear implant listeners	PLOS ONE			English	Article							CHANNEL INTERACTION; PARTIAL TRIPOLAR; INTERFACE; PLACEMENT; LOUDNESS; GAP; POTENTIALS; PERCEPTION; RECIPIENTS; CHILDREN	Objectives The relationship between electrode-nerve interface (ENI) estimates and inter-subject differences in speech performance with sequential and simultaneous channel stimulation in adult cochlear implant listeners were explored. We investigated the hypothesis that individuals with good ENIs would perform better with simultaneous compared to sequential channel stimulation speech processing strategies than those estimated to have poor ENIs. Methods Fourteen postlingually deaf implanted cochlear implant users participated in the study. Speech understanding was assessed with a sentence test at signal-to-noise ratios that resulted in 50% performance for each user with the baseline strategy F120 Sequential. Two simultaneous stimulation strategies with either two (Paired) or three sets of virtual channels (Triplet) were tested at the same signal-to-noise ratio. ENI measures were estimated through: (I) voltage spread with electrical field imaging, (II) behavioral detection thresholds with focused stimulation, and (III) slope (IPG slope effect) and 50%-point differences (dB offset effect) of amplitude growth functions from electrically evoked compound action potentials with two interphase gaps. Results A significant effect of strategy on speech understanding performance was found, with Triplets showing a trend towards worse speech understanding performance than sequential stimulation. Focused thresholds correlated positively with the difference required to reach most comfortable level (MCL) between Sequential and Triplet strategies, an indirect measure of channel interaction. A significant offset effect (difference in dB between 50%-point for higher eCAP growth function slopes with two IPGs) was observed. No significant correlation was observed between the slopes for the two IPGs tested. None of the measures used in this study correlated with the differences in speech understanding scores between strategies. Conclusions The ENI measure based on behavioral focused thresholds could explain some of the difference in MCLs, but none of the ENI measures could explain the decrease in speech understanding with increasing pairs of simultaneously stimulated electrodes in processing strategies.	[Langner, Florian; Buchner, Andreas; Nogueira, Waldo] Hannover Med Sch, Dept Otorhinolaryngol, Hannover, Germany; [Langner, Florian; Buchner, Andreas; Nogueira, Waldo] Cluster Excellence Hearing4all, Hannover, Germany; [Arenberg, Julie G.] Harvard Med Sch, Dept Otolaryngol Massachusetts Eye & Ear, Boston, MA 02115 USA	Hannover Medical School; Harvard University; Harvard Medical School	Langner, F (corresponding author), Hannover Med Sch, Dept Otorhinolaryngol, Hannover, Germany.; Langner, F (corresponding author), Cluster Excellence Hearing4all, Hannover, Germany.	fllg@oticon.com			Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy EXC 2177/1 [390895286]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy EXC 2177/1(German Research Foundation (DFG))	FL, AB and WN: This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy EXC 2177/1-Project ID 390895286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas PJ, 1999, EAR HEARING, V20, P45, DOI 10.1097/00003446-199902000-00005; Berenstein CK, 2010, HEARING RES, V270, P28, DOI 10.1016/j.heares.2010.10.001; Bierer JA, 2015, TRENDS HEAR, V19, DOI 10.1177/2331216515569792; Bierer JA, 2007, J ACOUST SOC AM, V121, P1642, DOI 10.1121/1.2436712; Bierer JA, 2010, TRENDS AMPLIF, V14, P84, DOI 10.1177/1084713810375249; Bierer JA, 2011, EAR HEARING, V32, P436, DOI 10.1097/AUD.0b013e3181ff33ab; Bierer JA, 2010, EAR HEARING, V31, P247, DOI 10.1097/AUD.0b013e3181c7daf4; Blamey P, 2013, AUDIOL NEURO-OTOL, V18, P36, DOI 10.1159/000343189; Brochier T, 2021, JARO-J ASSOC RES OTO, V22, P67, DOI 10.1007/s10162-020-00773-0; Brochier T, 2021, JARO-J ASSOC RES OTO, V22, P81, DOI 10.1007/s10162-020-00774-z; BROWN CJ, 1990, J ACOUST SOC AM, V88, P1385, DOI 10.1121/1.399716; Buchner A, 2005, Cochlear Implants Int, V6 Suppl 1, P35, DOI 10.1179/cim.2005.6.Supplement-1.35; Budenz CL, 2011, J AM GERIATR SOC, V59, P446, DOI 10.1111/j.1532-5415.2010.03310.x; Buechner A, 2005, OTOL NEUROTOL, V26, P941, DOI 10.1097/01.mao.0000185069.27705.f0; Carlyon RP, 2013, J ACOUST SOC AM, V134, P503, DOI 10.1121/1.4807900; Connor CM, 2006, EAR HEARING, V27, P628, DOI 10.1097/01.aud.0000240640.59205.42; Cusumano C, 2017, OTOL NEUROTOL, V38, P334, DOI 10.1097/MAO.0000000000001322; DeVries L, 2018, JARO-J ASSOC RES OTO, V19, P571, DOI 10.1007/s10162-018-0678-4; Devries L, 2016, JARO-J ASSOC RES OTO, V17, P237, DOI 10.1007/s10162-016-0557-9; DiNino M, 2019, JARO-J ASSOC RES OTO, V20, P291, DOI 10.1007/s10162-019-00716-4; Finley CC, 2008, OTOL NEUROTOL, V29, P920, DOI 10.1097/MAO.0b013e318184f492; Firszt JB, 2004, EAR HEARING, V25, P375, DOI 10.1097/01.AUD.0000134552.22205.EE; Goldwyn JH, 2010, HEARING RES, V268, P93, DOI 10.1016/j.heares.2010.05.005; HAHLBROCK K H, 1953, Arch Ohren Nasen Kehlkopfheilkd, V162, P394, DOI 10.1007/BF02105664; Hanekom JJ, 1998, J ACOUST SOC AM, V104, P2372, DOI 10.1121/1.423772; He SM, 2020, EAR HEARING, V41, P918, DOI 10.1097/AUD.0000000000000815; HochmairDesoyer I, 1997, AM J OTOL, V18, pS83; Holden LK, 2013, EAR HEARING, V34, P342, DOI 10.1097/AUD.0b013e3182741aa7; Jahn KN, 2020, EAR HEARING, V41, P948, DOI 10.1097/AUD.0000000000000827; Jahn KN, 2020, EAR HEARING, V41, P961, DOI 10.1097/AUD.0000000000000844; Jahn KN, 2019, JARO-J ASSOC RES OTO, V20, P415, DOI 10.1007/s10162-019-00718-2; Jurgens T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193842; Kreft HA, 2019, TRENDS HEAR, V23, DOI 10.1177/2331216519851306; Langner F, 2020, HEARING RES, V398, DOI 10.1016/j.heares.2020.108091; Langner F, 2017, HEARING RES, V345, P96, DOI 10.1016/j.heares.2017.01.010; Lazard DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048739; Loizou Philipos C., 2003, Ear and Hearing, V24, P12, DOI 10.1097/01.AUD.0000052900.42380.50; Long CJ, 2014, JARO-J ASSOC RES OTO, V15, P293, DOI 10.1007/s10162-013-0437-5; McKay CM, 1998, J ACOUST SOC AM, V104, P1061, DOI 10.1121/1.423316; McKay CM, 2012, J ACOUST SOC AM, V131, P2209, DOI 10.1121/1.3683248; Mesnildrey Q, 2020, JARO-J ASSOC RES OTO, V21, P89, DOI 10.1007/s10162-020-00742-7; Miura M, 2002, ANN OTO RHINOL LARYN, V111, P1059, DOI 10.1177/000348940211101201; Nogueira W., 2016, FRONT NEUROSCI, V4, P1, DOI [10.3389/fbioe.2016.00084, DOI 10.3389/FBIOE.2016.00084]; Nogueira W, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/531213; Prado-Guitierrez P, 2006, HEARING RES, V215, P47, DOI 10.1016/j.heares.2006.03.006; Ramekers D, 2014, JARO-J ASSOC RES OTO, V15, P187, DOI 10.1007/s10162-013-0440-x; Robbins AM, 2004, ARCH OTOLARYNGOL, V130, P570; Schvartz-Leyzac KC, 2018, EAR HEARING, V39, P630, DOI 10.1097/AUD.0000000000000606; Schvartz-Leyzac KC, 2016, HEARING RES, V341, P50, DOI 10.1016/j.heares.2016.08.002; Seyyedi M, 2014, OTOL NEUROTOL, V35, P1545, DOI 10.1097/MAO.0000000000000540; Tyler RS, 1997, J ACOUST SOC AM, V102, P508, DOI 10.1121/1.419724; Vanpoucke F, 2004, OTOL NEUROTOL, V25, P282, DOI 10.1097/00129492-200405000-00014; Vanpoucke FJ, 2012, IEEE T BIO-MED ENG, V59, P307, DOI 10.1109/TBME.2011.2173198; VONBEKESY G, 1947, ACTA OTO-LARYNGOL, V35, P411; Whitmal NA, 2007, J ACOUST SOC AM, V122, P2376, DOI 10.1121/1.2773993; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005; Zhang FW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084631; Zierhofer CM, 2008, IEEE T BIO-MED ENG, V55, P1907, DOI 10.1109/TBME.2008.919839; Zwicker E., 1974, FACTS MODELS HEARING, P132	59	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0261295	10.1371/journal.pone.0261295	http://dx.doi.org/10.1371/journal.pone.0261295			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898654	gold, Green Published			2022-12-26	WOS:000755176200034
J	Spartacus, V; Shojaeizadeh, M; Raffault, V; Shoults, J; Van Wieren, K; Sparrey, CJ				Spartacus, Victoria; Shojaeizadeh, Maedeh; Raffault, Vincent; Shoults, James; Van Wieren, Ken; Sparrey, Carolyn J.			In vivo soft tissue compressive properties of the human hand	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; HEEL-PAD; INTRINSIC MUSCLES; METATARSAL HEADS; MENSTRUAL-CYCLE; IMPACT FORCE; HUMAN SKIN; BODY-FAT; STIFFNESS; INDENTATION	Background/Purpose Falls onto outstretched hands are the second most common sports injury and one of the leading causes of upper extremity injury. Injury risk and severity depends on forces being transmitted through the palmar surface to the upper extremity. Although the magnitude and distribution of forces depend on the soft tissue response of the palm, the in vivo properties of palmar tissue have not been characterized. The purpose of this study was to characterize the large deformation palmar soft tissue properties. Methods In vivo dynamic indentations were conducted on 15 young adults (21- 29 years) to quantify the soft tissue characteristics of over the trapezium. The effects of loading rate, joint position, tissue thickness and sex on soft tissue responses were assessed. Results Energy absorbed by the soft tissue and peak force were affected by loading rate and joint angle. Energy absorbed was 1.7-2.8 times higher and the peak force was 2-2.75 times higher at high rate loading than quasistatic rates. Males had greater energy absorbed than females but not at all wrist positions. Damping characteristics were the highest in the group with the thickest soft tissue while damping characteristics were the lowest in group with the thinnest soft tissues. Conclusion Palmar tissue response changes with joint position, loading rate, sex, and tissue thickness. Accurately capturing these tissue responses is important for developing effective simulations of fall and injury biomechanics and assessing the effectiveness of injury prevention strategies.	[Spartacus, Victoria; Shojaeizadeh, Maedeh; Raffault, Vincent; Sparrey, Carolyn J.] Simon Fraser Univ, Mechatron Syst Engn, Surrey, BC, Canada; [Sparrey, Carolyn J.] Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Shoults, James; Van Wieren, Ken] Simon Fraser Univ, Sci Tech Ctr, Burnaby, BC, Canada	Simon Fraser University; Simon Fraser University	Spartacus, V (corresponding author), Simon Fraser Univ, Mechatron Syst Engn, Surrey, BC, Canada.	victoria.spartacus@wanadoo.fr			Natural Science and Engineering Research Council of Canada (NSERC) [RGPIN-2018-06382]	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a Discovery Grant from the Natural Science and Engineering Research Council of Canada (NSERC RGPIN-2018-06382). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Victoria Spartacus and Maedeh Shojaeizadeh salaries were supported in part by the Discovery Grant from the Natural Science and Engineering Research Council of Canada (NSERC RGPIN-2018-06382).	Abdouni A, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170321; Abellan MA, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/814025; BADER DL, 1983, BIOMATERIALS, V4, P305, DOI 10.1016/0142-9612(83)90033-9; Bancroft LW, 2013, RADIOL CLIN N AM, V51, P299, DOI 10.1016/j.rcl.2012.09.017; Banerjee A, 2017, ARCH COMPUT METHOD E, V24, P397, DOI 10.1007/s11831-016-9164-5; Barr LV, 2010, INT ORTHOP, V34, P743, DOI 10.1007/s00264-010-0953-4; Behforootan S, 2017, J MECH BEHAV BIOMED, V68, P287, DOI 10.1016/j.jmbbm.2017.02.011; BORCHERS RE, 1995, BIOMATERIALS, V16, P545, DOI 10.1016/0142-9612(95)91128-L; Boyer G, 2009, SKIN RES TECHNOL, V15, P55, DOI 10.1111/j.1600-0846.2008.00324.x; Brach RM, 1998, INT J ENG SCI, V36, P61, DOI 10.1016/S0020-7225(97)00057-8; Carmont MR, 2005, SCOT MED J, V50, P106, DOI 10.1177/003693300505000306; Chamoret D, 2016, COMPUT ASSIST SURG, V21, P22, DOI 10.1080/24699322.2016.1240294; Chatzistergos PE, 2014, J DIABETES COMPLICAT, V28, P488, DOI 10.1016/j.jdiacomp.2014.03.011; Chavan-Dafle N, 2015, IEEE INT C INT ROBOT, P6215, DOI 10.1109/IROS.2015.7354264; Chen WM, 2011, J BIOMECH, V44, P1801, DOI 10.1016/j.jbiomech.2011.03.031; Cheng SK, 2009, J BIOMECH, V42, P1360, DOI 10.1016/j.jbiomech.2009.03.023; Choi WJ, 2015, J BIOMECH, V48, P695, DOI 10.1016/j.jbiomech.2014.12.026; Choi WJ, 2011, J BIOMECH, V44, P532, DOI 10.1016/j.jbiomech.2010.09.011; Costi JJ, 2002, CLIN BIOMECH, V17, P446, DOI 10.1016/S0268-0033(02)00035-9; Creteur V.M., 2014, EUROPEAN SOC RADIOLO; Dai AN, 2019, SKIN RES TECHNOL, V25, P142, DOI 10.1111/srt.12623; de Gelidi S, 2016, INT J APPL MECH, V8, DOI 10.1142/S1758825116500666; Deemer E, 2005, MED ENG PHYS, V27, P31, DOI 10.1016/j.medengphy.2004.09.005; DeGoede KM, 2002, J BIOMECH, V35, P843, DOI 10.1016/S0021-9290(02)00011-8; Delalleau A, 2006, J BIOMECH, V39, P1603, DOI 10.1016/j.jbiomech.2005.05.001; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Elleuch K, 2006, POLYM ENG SCI, V46, P1715, DOI 10.1002/pen.20637; Erickson B, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0128-7; Fede C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223195; FITZGERALD ER, 1975, BIORHEOLOGY, V12, P397; Fleps I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201096; FOUTZ TL, 1992, AM J VET RES, V53, P788; FOWLER PA, 1990, BRIT J OBSTET GYNAEC, V97, P595, DOI 10.1111/j.1471-0528.1990.tb02546.x; Freiman A, 2004, J CUTAN MED SURG, V8, P415, DOI 10.1007/s10227-005-0020-8; FULLER NJ, 1992, CLIN PHYSIOL, V12, P253, DOI 10.1111/j.1475-097X.1992.tb00831.x; Fung Y.C., 1993, BIOMECHANICS MECH PR; Garcia Christopher A, 2008, Foot (Edinb), V18, P61, DOI 10.1016/j.foot.2007.12.002; Gilardi G, 2002, MECH MACH THEORY, V37, P1213, DOI 10.1016/S0094-114X(02)00045-9; GOODING GAW, 1986, INVEST RADIOL, V21, P45, DOI 10.1097/00004424-198601000-00008; GOTTSAUNERWOLF F, 1995, J ORTHOPAED RES, V13, P90, DOI 10.1002/jor.1100130114; Greenwald RM, 2013, P I MECH ENG P-J SPO, V227, P244, DOI 10.1177/1754337113482706; Halbertsma JPK, 1996, ARCH PHYS MED REHAB, V77, P688, DOI 10.1016/S0003-9993(96)90009-X; Harih G, 2021, INT J IND ERGONOM, V85, DOI 10.1016/j.ergon.2021.103186; Hicks A L, 2001, Exerc Sport Sci Rev, V29, P109, DOI 10.1097/00003677-200107000-00004; Hsiao ET, 1998, J BIOMECH, V31, P1, DOI 10.1016/S0021-9290(97)00114-0; Hsu CC, 2005, ULTRASOUND MED BIOL, V31, P1423, DOI 10.1016/j.ultrasmedbio.2005.05.009; Idzikowski JR, 2000, AM J SPORT MED, V28, P825, DOI 10.1177/03635465000280061001; JAN SVS, 1994, ANAT RECORD, V238, P131, DOI 10.1002/ar.1092380115; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Just M, 2007, BRIT J DERMATOL, V156, P85, DOI 10.1111/j.1365-2133.2006.07575.x; Kalanovic D, 2003, STUD HEALTH TECHNOL, V94, P137; Kalcioglu ZI, 2011, PHILOS MAG, V91, P1339, DOI 10.1080/14786435.2010.512574; Kemper AR, 2013, ACCIDENT ANAL PREV, V50, P204, DOI 10.1016/j.aap.2012.04.014; KIEFER GN, 1989, J ORTHOPAED RES, V7, P494, DOI 10.1002/jor.1100070406; Kwan RLC, 2010, CLIN BIOMECH, V25, P601, DOI 10.1016/j.clinbiomech.2010.04.003; Ledoux WR, 2007, J BIOMECH, V40, P2975, DOI 10.1016/j.jbiomech.2007.02.009; Lee JJ, 2013, J BONE JOINT SURG AM, V95A, P850, DOI 10.2106/JBJS.L.00375; Leitschuh PH, 1996, J ORTHOPAED RES, V14, P830, DOI 10.1002/jor.1100140522; LINDE F, 1993, J BIOMECH, V26, P1249, DOI 10.1016/0021-9290(93)90072-M; Liu AQ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238785; Lombardo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112169; Lynch KM, 1996, INT J ROBOT RES, V15, P533, DOI 10.1177/027836499601500602; Ma R. R., 2011, 2011 15th International Conference on Advanced Robotics, P1, DOI 10.1109/ICAR.2011.6088576; Makhsous M, 2008, J SPINAL CORD MED, V31, P88, DOI 10.1080/10790268.2008.11753987; Matsumoto K, 2002, CLIN J SPORT MED, V12, P354, DOI 10.1097/00042752-200211000-00006; MCFARLANE RM, 1962, J BONE JOINT SURG AM, V44, P1073, DOI 10.2106/00004623-196244060-00004; McNair PJ, 1996, BRIT J SPORT MED, V30, P313, DOI 10.1136/bjsm.30.4.313; Mojra A, 2011, INT J MED ROBOT COMP, V7, P282, DOI 10.1002/rcs.396; Negishi T, 2020, J MECH BEHAV BIOMED, V102, DOI 10.1016/j.jmbbm.2019.103470; Nicolle S, 2010, J MECH BEHAV BIOMED, V3, P630, DOI 10.1016/j.jmbbm.2010.07.010; Obaid N., 2021, DEV BASELINE MODEL I; ONEILL TW, 1994, ANN RHEUM DIS, V53, P773, DOI 10.1136/ard.53.11.773; Pai S, 2010, J BIOMECH, V43, P1754, DOI 10.1016/j.jbiomech.2010.02.021; Pailler-Mattei C, 2013, J MECH BEHAV BIOMED, V28, P474, DOI 10.1016/j.jmbbm.2013.04.008; Pan L, 1998, ULTRASOUND MED BIOL, V24, P995, DOI 10.1016/S0301-5629(98)00071-4; Park SK, 2009, AM J SPORT MED, V37, P588, DOI 10.1177/0363546508326713; Penitente G, 2015, J HUM KINET, V46, P59, DOI 10.1515/hukin-2015-0034; PESHKIN MA, 1988, IEEE J ROBOT AUTOM, V4, P524, DOI 10.1109/56.20437; Pieroh P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163306; Pineau JC, 2009, J ATHL TRAINING, V44, P142, DOI 10.4085/1062-6050-44.2.142; Pribis P, 2010, NUTRIENTS, V2, P1075, DOI 10.3390/nu2101075; Rajaei N., 2018, EVALUATION FORWARD F; Rajaei N, 2018, P IEEE RAS-EMBS INT, P954; Ramo NL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190137; ROBINOVITCH SN, 1991, J BIOMECH ENG-T ASME, V113, P366, DOI 10.1115/1.2895414; Robinovitch SN, 1995, J BIOMECH ENG-T ASME, V117, P409, DOI 10.1115/1.2794200; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Sasaki K, 1999, J TRAUMA, V46, P1059, DOI 10.1097/00005373-199906000-00015; Schatzmann L, 1998, Knee Surg Sports Traumatol Arthrosc, V6 Suppl 1, pS56, DOI 10.1007/s001670050224; Schmitt KU, 2012, SPORT BIOMECH, V11, P57, DOI 10.1080/14763141.2011.637127; Schulz BW, 2008, J REHABIL RES DEV, V45, P1227, DOI 10.1682/JRRD.2007.06.0092; Smith CW, 1996, J BIOMECH ENG-T ASME, V118, P56, DOI 10.1115/1.2795946; Stewart DC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177561; Stewart DE, 2000, SIAM REV, V42, P3, DOI 10.1137/S0036144599360110; Suzuki R, 2017, MED ENG PHYS, V50, P83, DOI 10.1016/j.medengphy.2017.10.010; Suzuki R, 2017, J MECH BEHAV BIOMED, V65, P753, DOI 10.1016/j.jmbbm.2016.09.027; Tarabini M, 2016, IEEE INT SYM MED MEA, P340; Teoh JC, 2016, J BIOMECH, V49, P3022, DOI 10.1016/j.jbiomech.2016.05.032; Teoh JC, 2014, J BIOMECH, V47, P3043, DOI 10.1016/j.jbiomech.2014.06.033; TURNER WD, 1988, CLIN ORTHOP RELAT R, P251; Van Ee CA, 2000, J BIOMECH ENG-T ASME, V122, P9, DOI 10.1115/1.429621; van Geemen D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149020; Viren T, 2018, INT J COSMETIC SCI, V40, P134, DOI 10.1111/ics.12444; Wach W, 2014, FORENSIC SCI INT, V244, P136, DOI 10.1016/j.forsciint.2014.08.018; WANG Y, 1992, J APPL MECH-T ASME, V59, P635, DOI 10.1115/1.2893771; Wei YY, 2020, ANN BIOMED ENG, V48, P1181, DOI 10.1007/s10439-019-02439-2; Weickenmeier J, 2018, J MECH BEHAV BIOMED, V84, P88, DOI 10.1016/j.jmbbm.2018.04.009; WOLF R, 1992, International Journal of Cosmetic Science, V14, P83, DOI 10.1111/j.1467-2494.1992.tb00042.x; WOO SLY, 1986, J BIOMECH, V19, P399, DOI 10.1016/0021-9290(86)90016-3; Wu JZ, 2007, SKIN RES TECHNOL, V13, P34, DOI 10.1111/j.1600-0846.2007.00182.x	110	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0261008	10.1371/journal.pone.0261008	http://dx.doi.org/10.1371/journal.pone.0261008			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898632	gold, Green Published			2022-12-26	WOS:000755176200020
J	Khan, A				Khan, Amjad			Prediction of quality attributes (mechanical strength, disintegration behavior and drug release) of tablets on the basis of characteristics of granules prepared by high shear wet granulation	PLOS ONE			English	Article								High shear wet granulation is commonly applied technique for commercial manufacturing of tablets. Granulation process for tablets manufacturing is generally optimized by hit and trial which involves preparation of granules under different processing parameters, compression of granules and evaluation of the resultant tablets; and adjustment is made in granulation process on the basis of characteristics of tablets. Objective of the study was to optimize the process of high shear wet granulation and prediction of characteristics of tablets on the basis of properties of granules. Atenolol granules were prepared by high shear wet granulation method, using aqueous solution of polyvinyl pyrrolidone (PVP k-30) as binder. Concentration of binder solution and granulation time were taken as process variables, both studied at three levels. Different combinations of process variables were determined by Design Expert software. Granules were evaluated for different parameters on the basis of SeDeM-ODT (Sediment Delivery Model-Oro Dispersible Tablets) expert system. Granules from all the trials were compressed using round (10.5 mm) flat faced punches at compression weight of 250 mg/tablet. Tablets were evaluated of different quality control parameters as per USP. Results showed that both the process variables had positive effect on mechanical strength of tablets and negative effect on disintegration and dissolution rate. Granule prepared with highest level of binder concentration (15%) and highest granulation time (60 sec) resulted in tablets with highest crushing strength (11.8 kg), specific crushing strength (0.328 kg/mm(2)), tensile strength (0.208 kg/mm(2)), lowest value of friability (0.19%) and highest disintegration time (10.9 min), as predicted from granules characteristics on the basis of SeDeM-ODT expert system. Drug release from Trial-13 (processed under highest level of both process parameters) was also lower than rest of the trials. It is concluded from the study that quality characteristics of tablets can be predicted from granules characteristics using SeDeM-ODT expert system. Furthermore, SeDeM-ODT expert system can also be used for optimization of the process of high shear wet granulation.	[Khan, Amjad] Kohat Univ Sci & Technol KUST, Dept Pharm, Kohat, Pakistan	Kohat University of Science & Technology	Khan, A (corresponding author), Kohat Univ Sci & Technol KUST, Dept Pharm, Kohat, Pakistan.	dr.amjad@kust.edu.pk		Khan, Dr. Amjad/0000-0002-4121-2400				[Anonymous], 2018, USP41NF36; [Anonymous], 2005, EUROPEAN PHARMACOPOE; Aguilar-Diaz JE, 2012, EUR J PHARM BIOPHARM, V80, P638, DOI 10.1016/j.ejpb.2011.12.012; Goh HP, 2018, INT J PHARMACEUT, V547, P133, DOI 10.1016/j.ijpharm.2018.05.059; Gunjal PT, 2015, INDIAN J PHARM SCI, V77, P563, DOI 10.4103/0250-474X.169036; Karttunen AP, 2019, EUR J PHARM SCI, V133, P40, DOI 10.1016/j.ejps.2019.03.001; Khan A, 2019, DRUG DEV IND PHARM, V45, P1537, DOI 10.1080/03639045.2019.1634094; Khan A, 2017, DISSOLUT TECHNOL, V24, P14, DOI 10.14227/DT240417P14; Lin CY, 2019, ADV POWDER TECHNOL, V30, P1513, DOI 10.1016/j.apt.2019.04.029; Liu B., 2020, POWDER TECHNOL; Mahdi F, 2018, CHEM ENG RES DES, V129, P403, DOI 10.1016/j.cherd.2017.10.038; Matsunami K, 2019, INT J PHARMACEUT, V559, P210, DOI 10.1016/j.ijpharm.2019.01.028; Mazumdar R., 2020, NANOSCI NANOTECHNOL, V10, P306, DOI [10.2174/2210681209666190220120053, DOI 10.2174/2210681209666190220120053]; Narang AS, 2017, J PHARM SCI-US, V106, P224, DOI 10.1016/j.xphs.2016.08.025; Olsson H, 2001, PHARMACEUT RES, V18, P203, DOI 10.1023/A:1011036603006; Raymond C. Rowe, 2009, HDB PHARM EXCIPIENTS; RUMPF H, 1974, CHEM-ING-TECH, V46, P1, DOI 10.1002/cite.330460102; Sarkar S, 2018, ASIAN J PHARM SCI, V13, P220, DOI 10.1016/j.ajps.2018.01.001; Sinka IC, 2009, POWDER TECHNOL, V189, P276, DOI 10.1016/j.powtec.2008.04.020; Steffens KE, 2020, INT J PHARMACEUT, V591, DOI 10.1016/j.ijpharm.2020.119941; Taipale-Kovalainen K, 2020, EUR J PHARM SCI, V151, DOI 10.1016/j.ejps.2020.105381; Taipale-Kovalainen K, 2019, EUR J PHARM SCI, V129, P10, DOI 10.1016/j.ejps.2018.11.030; Takeuchi Y, 2018, INT J PHARMACEUT, V547, P106, DOI 10.1016/j.ijpharm.2018.05.061; Usman S., 2014, NAT PROD CHEM RES, V2, P100125, DOI [10.4172/2329-6836.1000125, DOI 10.4172/2329-6836.1000125]	24	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0261051	10.1371/journal.pone.0261051	http://dx.doi.org/10.1371/journal.pone.0261051			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882723	gold, Green Published			2022-12-26	WOS:000755037200055
J	Kisiel, MA; Nordqvist, T; Westman, G; Svartengren, M; Malinovschi, A; Janols, H				Kisiel, Marta A.; Nordqvist, Tobias; Westman, Gabriel; Svartengren, Magnus; Malinovschi, Andrei; Janols, Helena			Patterns and predictors of sick leave among Swedish non-hospitalized healthcare and residential care workers with Covid-19 during the early phase of the pandemic	PLOS ONE			English	Article							UNITED-STATES; LONG-TERM; ABSENCE; SARS-COV-2; EMPLOYEES; APRIL; RISK	Healthcare and residential care workers represent two occupational groups that have, in particular, been at risk of Covid-19, its long-term consequences, and related sick leave. In this study, we investigated the predictors of prolonged sick leave among healthcare and residential workers due to non-hospitalized Covid-19 in the early period of the pandemic. This study is based on a patient register (n = 3209) and included non-hospitalized healthcare or residential care service workers with a positive RT-PCR for SARS-CoV-2 (n = 433) between March and August 2020. Data such as socio-demographics, clinical characteristics, and the length of sick leave because of Covid-19 and prior to the pandemic were extracted from the patient's electronic health records. Prolonged sick leave was defined as sick leave >= 3 weeks, based on the Swedish pandemic policy. A generalized linear model was used with a binary distribution, adjusted for age, gender, and comorbidity in order to predict prolonged sick leave. Of 433 (77% women) healthcare and residential care workers included in this study, 14.8% needed longer sick leave (> 3 weeks) due to Covid-19. Only 1.4% of the subjects were on sick leave because of long Covid. The risk of sick leave was increased two-fold among residential care workers (adjusted RR 2.14 [95% CI 1.31-3.51]). Depression/anxiety (adjusted RR 2.09 [95% CI 1.31-3.34]), obesity (adjusted RR 1.96 [95% CI 1.01-3.81]) and dyspnea at symptom onset (adjusted RR 2.47 [95% CI 1.55-3.92]), sick leave prior to the pandemic (3-12 weeks) (adjusted RR 2.23 [95% CI 1.21-4.10]) were associated with longer sick leave. From a public health perspective, considering occupational category, comorbidity, symptoms at onset, and sick leave prior to the pandemic as potential predictors of sick leave in healthcare may help prevent staff shortage.	[Kisiel, Marta A.; Nordqvist, Tobias; Svartengren, Magnus] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden; [Westman, Gabriel; Janols, Helena] Uppsala Univ, Dept Med Sci, Infect Dis, Uppsala, Sweden; [Malinovschi, Andrei] Uppsala Univ, Dept Med Sci, Clin Physiol, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Kisiel, MA (corresponding author), Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden.	marta.kisiel@medsci.uu.se		Kisiel, Marta Alina/0000-0002-0410-1509				Adelina Comas-Herrera, 2020, INT LONG TERM CARE P; AFA-insurance, 2020, ALLV ARB LANGV SJUKF; Agency) FSSI, 2021, RAPP EFF SOM COV 19, V1, P82; Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P49, DOI 10.1080/14034950410021853; Amiri S, 2020, PUBLIC HEALTH, V185, P235, DOI 10.1016/j.puhe.2020.05.023; Bhasin A, 2020, OBESITY, V28, P1811, DOI 10.1002/oby.22947; Boot CRL, 2017, OCCUP MED-OXFORD, V67, P176, DOI 10.1093/occmed/kqx014; Calvo-Bonacho E, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.580546; Donders NCGM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000960; Folkhalsomyndiheten: Folkhalsomyndigheten, 2020, FOR COV 19 OL YRK BE; Gohar B, 2020, WORK, V66, P755, DOI 10.3233/WOR-203222; Gohar B, 2020, OCCUP MED-OXFORD, V70, P338, DOI 10.1093/occmed/kqaa093; Gomez-Ochoa SA, 2021, AM J EPIDEMIOL, V190, P161, DOI 10.1093/aje/kwaa191; Groenewold MR, 2020, MMWR-MORBID MORTAL W, V69, P853, DOI 10.15585/mmwr.mm6927a1; Havervall S, 2021, JAMA-J AM MED ASSOC, V325, P2015, DOI 10.1001/jama.2021.5612; Jin H, 2020, J HOSP INFECT, V104, P452, DOI 10.1016/j.jhin.2020.02.005; Keramat SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233512; Kompaniyets L, 2021, MMWR-MORBID MORTAL W, V70, P355, DOI 10.15585/mmwr.mm7010e4; Lan FY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233588; Lehnert T, 2014, J OCCUP ENVIRON MED, V56, P20, DOI 10.1097/JOM.0000000000000065; Li WN, 2021, EPIDEMIOL INFECT, V149, DOI 10.1017/S0950268820003064; Lindahl Johanna F., 2020, Infection Ecology & Epidemiology, V10, P1789036, DOI 10.1080/20008686.2020.1789036; Maltezou HC, 2021, J HOSP INFECT, V114, P126, DOI 10.1016/j.jhin.2021.04.018; Mutambudzi M, 2021, OCCUP ENVIRON MED, V78, P307, DOI 10.1136/oemed-2020-106731; Nishiura C, 2017, J EPIDEMIOL, V27, P590, DOI 10.1016/j.je.2017.01.003; NORTH F, 1993, BRIT MED J, V306, P361, DOI 10.1136/bmj.306.6874.361; Notenbomer A, 2019, INT ARCH OCC ENV HEA, V92, P501, DOI 10.1007/s00420-018-1384-6; Pouwels KB, 2021, LANCET PUBLIC HEALTH, V6, pE30, DOI 10.1016/S2468-2667(20)30282-6; Ran L, 2020, CLIN INFECT DIS, V71, P2218, DOI 10.1093/cid/ciaa287; Rea Susan, 2013, AMIA Jt Summits Transl Sci Proc, V2013, P214; Rydenfalt C, 2020, HOME HEALTH CARE SER, V39, P223, DOI 10.1080/01621424.2020.1772936; Sahu AK, 2020, AM J EMERG MED, V38, P1727, DOI 10.1016/j.ajem.2020.05.113; Sakakibara S, 2019, INT J MENT HEALTH SY, V13, DOI 10.1186/s13033-019-0279-6; SeyedAlinaghi S, 2021, EUR J MED RES, V26, DOI 10.1186/s40001-021-00513-x; Vahidy FS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245556; Wang Xuan, 2020, Sleep Med X, V2, P100028, DOI 10.1016/j.sleepx.2020.100028; Westerlind E, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11013-2; Yang Q, 2021, J VASC SURG-VENOUS L, V9, P401, DOI 10.1016/j.jvsv.2020.07.006; Zhang J, 2020, J CLIN NURS, V29, P4020, DOI 10.1111/jocn.15425; Zheng XC, 2021, J MED VIROL, V93, P952, DOI 10.1002/jmv.26367	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260652	10.1371/journal.pone.0260652	http://dx.doi.org/10.1371/journal.pone.0260652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882720	Green Published, gold			2022-12-26	WOS:000755037200034
J	Sheen, GCH; Tung, HH; Wu, WC				Sheen, Greg Chih-Hsin; Tung, Hans H.; Wu, Wen-Chin			Citizen journalism reduces the credibility deficit of authoritarian government in risk communication amid COVID-19 outbreaks	PLOS ONE			English	Article							EPIDEMIC; TRUST	During the outbreak of an epidemic, the success in risk communications to make the public comply with disease preventive measures depends on the public's trust in the government. In this study, we aim to understand how media audiences update their trust in the government during the COVID-19 outbreak depending on the information they received. We conducted an online survey experiment in February 2020 in Hong Kong (n = 1,016) in which respondents were randomly provided with a government press release and an endorsement either from an official or a non-official source. This study shows that the information from a non-official source enhances the credibility of official government messages. Our findings imply that dictators can actually "borrow credibility" from their citizen journalists and even nondemocratic leaders can make themselves more trustworthy to potential dissenters through citizen journalism. Allowing information flow from non-official sources can be a practical measure for governments to address the problem of a credibility deficit during a pandemic.	[Sheen, Greg Chih-Hsin] Natl Cheng Kung Univ, Dept Polit Sci, Tainan, Taiwan; [Tung, Hans H.] Natl Taiwan Univ, Dept Polit Sci, Taipei, Taiwan; [Tung, Hans H.] Natl Taiwan Univ, Ctr Res Econometr Theory & Applicat, Taipei, Taiwan; [Wu, Wen-Chin] Acad Sinica, Inst Polit Sci, Taipei, Taiwan	National Cheng Kung University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Tung, HH (corresponding author), Natl Taiwan Univ, Dept Polit Sci, Taipei, Taiwan.; Tung, HH (corresponding author), Natl Taiwan Univ, Ctr Res Econometr Theory & Applicat, Taipei, Taiwan.	hanstung@ntu.edu.tw	Sheen, Greg Chih-Hsin/AAK-1447-2021; Tung, Hans H./AHC-3029-2022	Sheen, Greg Chih-Hsin/0000-0003-1961-7804; Tung, Hans H./0000-0001-5332-7582; Wu, Wen-Chin/0000-0002-3229-4619				[Anonymous], 2020, LANCET, V395, P755, DOI 10.1016/S0140-6736(20)30522-5; Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016; Brewer PR, 2013, SCI COMMUN, V35, P115, DOI 10.1177/1075547012441691; Burrell S, 2005, J HIST MED ALL SCI, V60, P478, DOI 10.1093/jhmas/jri061; Cappella J., 2009, DISTINCTIVE QUALITIE; Carpenter S, 2008, J MASS COMMUN Q, V85, P531, DOI 10.1177/107769900808500304; Chiang CF, 2011, REV ECON STUD, V78, P795, DOI 10.1093/restud/rdq037; Chuang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122970; Collman A., 2020, BUSINESS INSIDER; Downman Scott, 2013, AUSTR J COMMUNICATIO, V40, P153; Goh B., 2020, REUTERS; Haas N, 2020, AM J POLIT SCI, V64, P982, DOI 10.1111/ajps.12519; Harper K., 2017, FATE ROME CLIMATE DI; Hollyer J.R., 2018, INFORM DEMOCRACY AUT; Huang HF, 2018, J POLIT, V80, P1034, DOI 10.1086/696863; Huang HF, 2017, BRIT J POLIT SCI, V47, P283, DOI 10.1017/S0007123415000253; Imai K, 2008, J R STAT SOC A STAT, V171, P481, DOI 10.1111/j.1467-985X.2007.00527.x; James O, 2017, AM REV PUBLIC ADM, V47, P23, DOI 10.1177/0275074015580390; Liao QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013350; Mythen G, 2010, J RISK RES, V13, P45, DOI 10.1080/13669870903136159; Nieminen T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-613; Pease A, 2008, INT J PRESS/POLIT, V13, P386, DOI 10.1177/1940161208321948; Roberts M.E., 2018, CENSORED DISTRACTION; Sanz-Menendez L, 2019, PUBLIC UNDERST SCI, V28, P534, DOI 10.1177/0963662519840946; Siegrist M, 2000, RISK ANAL, V20, P713, DOI 10.1111/0272-4332.205064; Tchuenche JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S5; Tsai LL, 2007, AM POLIT SCI REV, V101, P355, DOI 10.1017/S0003055407070153; Valkenburg PM, 2013, INT J COMMUN-US, V7, P197; van der Weerd W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-575; Yu Verna, 2020, GUARDIAN; Zoorob MJ, 2017, DRUG ALCOHOL DEPEN, V173, P1, DOI 10.1016/j.drugalcdep.2016.12.011	31	4	4	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260961	10.1371/journal.pone.0260961	http://dx.doi.org/10.1371/journal.pone.0260961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY2LS	34879113	gold, Green Published			2022-12-26	WOS:000754625200039
J	Abdullah, ZT				Abdullah, Ziyad Tariq			Assessment of end-of-life vehicle recycling: Remanufacturing waste sheet steel into mesh sheet	PLOS ONE			English	Article							CYCLE ASSESSMENT; SYSTEM; ENERGY; ELVS	The automobile industry contributes significantly to global energy use and carbon emissions. Hence, there are significant economic and environmental benefits in recovering materials from end-of-life vehicles (ELVs). Here, the remanufacturing of waste steel sheet (WSS) from ELVs into useful mesh steel sheet (MSS) for metal forming applications was evaluated based on its technological, economic, and environmental feasibility. A remanufacturing plant with a dismantling capacity of over 30,171 ELV/year and a recovery capacity of 1000 m(2)/d of WSS was used as a case study. Remanufacturing can achieve a total reduction of similar to 3800 kg CO2/ELV and an economic benefit of similar to 775 USD/ELV compared with conventional recycling. The calculated feasibility indexes were similar to or exceeded standard feasibility thresholds, indicating that WSS remanufacturing is a viable sustainable development route and has synergistic benefits when combined with existing recycling plants, especially in developing countries as small-to-medium enterprises.	[Abdullah, Ziyad Tariq] Middle Tech Univ, Mech Tech Sch, Inst Technol Baghdad, Baghdad, Iraq	Middle Technical University	Abdullah, ZT (corresponding author), Middle Tech Univ, Mech Tech Sch, Inst Technol Baghdad, Baghdad, Iraq.	ziyad_tariq12@mtu.edu.iq	Abdullah, Ziyad/CAF-1714-2022	, Ziyad Tariq Abdullah/0000-0002-9008-2761				Abdullah ZT, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258399; Abdullah ZT, 2015, ADV SCI LETT, V21, P3610, DOI 10.1166/asl.2015.6561; Abullah ZT, 2015, IOP CONF SER-MAT SCI, V83, DOI 10.1088/1757-899X/83/1/012021; Altay MC, 2011, RENEW SUST ENERG REV, V15, P2447, DOI 10.1016/j.rser.2011.02.017; Ashby MF, 2013, MATERIALS AND THE ENVIRONMENT: ECO-INFORMED MATERIAL CHOICE, 2ND EDITION, P1; Belboom S, 2016, WASTE MANAGE, V50, P184, DOI 10.1016/j.wasman.2016.02.007; Berzi L, 2016, RESOUR CONSERV RECY, V108, P140, DOI 10.1016/j.resconrec.2016.01.013; Chen KC, 2010, WASTE MANAGE, V30, P1661, DOI 10.1016/j.wasman.2010.03.015; Du YB, 2014, J CLEAN PROD, V66, P272, DOI 10.1016/j.jclepro.2013.10.033; Du YB, 2012, J CLEAN PROD, V20, P82, DOI 10.1016/j.jclepro.2011.08.016; Golebiewski B, 2013, RESOUR CONSERV RECY, V80, P10, DOI 10.1016/j.resconrec.2013.07.005; Inghels D, 2016, TRANSPORT RES A-POL, V91, P80, DOI 10.1016/j.tra.2016.06.005; Li SH, 2017, IOP CONF SER-MAT SCI, V265, DOI 10.1088/1757-899X/265/1/012029; Li WC, 2016, J CLEAN PROD, V117, P176, DOI 10.1016/j.jclepro.2016.01.025; Ling TB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234603; Liu MZ, 2020, WASTE MANAGE, V117, P81, DOI 10.1016/j.wasman.2020.08.002; Mamat TNAR, 2016, J CLEAN PROD, V135, P1289, DOI 10.1016/j.jclepro.2016.06.183; Mohan TVK, 2021, SUSTAIN PROD CONSUMP, V25, P325, DOI 10.1016/j.spc.2020.09.001; Mohan TVK, 2020, ANN OPER RES, V290, P591, DOI 10.1007/s10479-018-2930-z; Sato FEK, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105118; Sato FEK, 2019, APPL ENERG, V237, P779, DOI 10.1016/j.apenergy.2019.01.002; Schmid A, 2013, RESOUR CONSERV RECY, V72, P118, DOI 10.1016/j.resconrec.2013.01.007; Simic V, 2016, RESOUR CONSERV RECY, V114, P1, DOI 10.1016/j.resconrec.2016.06.019; Simic V, 2015, WASTE MANAGE, V35, P265, DOI 10.1016/j.wasman.2014.09.013; Smink CK, 2007, J CLEAN PROD, V15, P1135, DOI 10.1016/j.jclepro.2006.05.028; Soo VK, 2017, PROC CIRP, V61, P269, DOI 10.1016/j.procir.2016.11.222; Tian J, 2016, WASTE MANAGE, V56, P384, DOI 10.1016/j.wasman.2016.07.046; Wong YC, 2018, J CLEAN PROD, V190, P285, DOI 10.1016/j.jclepro.2018.04.145; Yi S, 2021, WASTE MANAGE, V120, P659, DOI 10.1016/j.wasman.2020.10.033; Yue K, 2012, PROCEDIA ENVIRON SCI, V16, P44, DOI 10.1016/j.proenv.2012.10.007; Zhang CL, 2018, WASTE MANAGE, V76, P697, DOI 10.1016/j.wasman.2018.02.031; Zhu YX, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105208	32	0	0	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0261079	10.1371/journal.pone.0261079	http://dx.doi.org/10.1371/journal.pone.0261079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874959	gold, Green Published			2022-12-26	WOS:000753617500046
J	Bai, YX; Zhao, XH; Yao, XH; Yao, YH; An, LK; Li, X; Wang, Y; Gao, X; Jia, YT; Guan, LL; Li, M; Wu, KL; Wang, ZH				Bai, Yixiong; Zhao, Xiaohong; Yao, Xiaohua; Yao, Youhua; An, Likun; Li, Xin; Wang, Yong; Gao, Xin; Jia, Yatao; Guan, Lulu; Li, Man; Wu, Kunlun; Wang, Zhonghua			Genome wide association study of plant height and tiller number in hulless barley	PLOS ONE			English	Article							ARCHITECTURE; WHEAT; GIBBERELLIN; OUTGROWTH; GENES; YIELD; RICE; STRIGOLACTONES; TRANSCRIPTION; DOWNSTREAM	Hulless barley (Hordeum vulgare L. var. nudum), also called naked barley, is a unique variety of cultivated barley. The genome-wide specific length amplified fragment sequencing (SLAF-seq) method is a rapid deep sequencing technology that is used for the selection and identification of genetic loci or markers. In this study, we collected 300 hulless barley accessions and used the SLAF-seq method to identify candidate genes involved in plant height (PH) and tiller number (TN). We obtained a total of 1407 M paired-end reads, and 228,227 SLAF tags were developed. After filtering using an integrity threshold of >0.8 and a minor allele frequency of >0.05, 14,504,892 single-nucleotide polymorphisms (SNP) loci were screened out. The remaining SNPs were used for the construction of a neighbour-joining phylogenetic tree, and the three subcluster members showed no obvious differentiation among regional varieties. We used a genome wide association study approach to identify 1006 and 113 SNPs associated with TN and PH, respectively. Based on best linear unbiased predictors (BLUP), 41 and 29 SNPs associated with TN and PH, respectively. Thus, several of genes, including Hd3a and CKX5, may be useful candidates for the future genetic breeding of hulless barley. Taken together, our results provide insight into the molecular mechanisms controlling barley architecture, which is important for breeding and yield.	[Bai, Yixiong; Wang, Yong; Gao, Xin; Jia, Yatao; Guan, Lulu; Li, Man; Wang, Zhonghua] Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Bai, Yixiong; Zhao, Xiaohong; Yao, Xiaohua; Yao, Youhua; An, Likun; Li, Xin; Wu, Kunlun] Qinghai Univ, Qinghai Acad Agr & Forestry Sci, Qinghai Key Lab Hulless Barley Genet & Breeding, Xining, Qinghai, Peoples R China; [Zhao, Xiaohong] Chongqing Inst Med Plant Cultivat, Good Agr Practices Res Ctr Tradit, Chongqing, Peoples R China	Northwest A&F University - China; Qinghai University	Wang, ZH (corresponding author), Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Wu, KL (corresponding author), Qinghai Univ, Qinghai Acad Agr & Forestry Sci, Qinghai Key Lab Hulless Barley Genet & Breeding, Xining, Qinghai, Peoples R China.	wklqaaf@163.com; zhonghuawangnew@163.com			National Natural Science Foundation of China [32060483]; Key R&D Project of Qinghai Academy of Agriculture and Forestry Sciences [2019-NKY-01]; Qinghai Province Science and Technology Achievement Transformation Special Project [2020-NK-119]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key R&D Project of Qinghai Academy of Agriculture and Forestry Sciences; Qinghai Province Science and Technology Achievement Transformation Special Project	This work was supported by the National Natural Science Foundation of China (Grant no.32060483), Key R&D Project of Qinghai Academy of Agriculture and Forestry Sciences (Grant no. 2019-NKY-01), Qinghai Province Science and Technology Achievement Transformation Special Project (2020-NK-119).	Alqudah AM, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00117; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Bazhenov MS, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0407-1; Belcher AR, 2018, CROP SCI, V58, P120, DOI 10.2135/cropsci2017.03.0204; Bennett T, 2014, CURR OPIN PLANT BIOL, V22, P7, DOI 10.1016/j.pbi.2014.08.001; Chen GF, 2017, J GENET, V96, P177, DOI 10.1007/s12041-016-0731-1; Chen HY, 2021, PLANT CELL, V33, P1492, DOI 10.1093/plcell/koab051; Chen LP, 2018, NEW PHYTOL, V218, P219, DOI 10.1111/nph.14977; Chen Q, 2018, GENES GENOM, V40, P1091, DOI 10.1007/s13258-018-0716-y; Condorelli GE, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00893; Dai F, 2014, P NATL ACAD SCI USA, V111, P13403, DOI 10.1073/pnas.1414335111; Dai F, 2012, P NATL ACAD SCI USA, V109, P16969, DOI 10.1073/pnas.1215265109; Silva FMD, 2018, PLANT CELL ENVIRON, V41, P327, DOI 10.1111/pce.13084; Dockter C, 2014, PLANT PHYSIOL, V166, P1912, DOI 10.1104/pp.114.250738; Duan JB, 2019, P NATL ACAD SCI USA, V116, P14319, DOI 10.1073/pnas.1810980116; Galichet A, 2006, PLANT PHYSIOL, V142, P1412, DOI 10.1104/pp.106.088344; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Guo SY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2542; Guo T, 2019, MOL BREEDING, V39, DOI 10.1007/s11032-019-0993-4; Guo ZF, 2017, NEW PHYTOL, V214, P257, DOI 10.1111/nph.14342; Gyenis L, 2007, GENOME, V50, P714, DOI 10.1139/G07-054; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; He JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178177; Hu SL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01039; Jabbari M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204952; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Kebrom TH, 2012, PLANT PHYSIOL, V160, P308, DOI 10.1104/pp.112.197954; Kong WQ, 2014, THEOR APPL GENET, V127, P2387, DOI 10.1007/s00122-014-2384-x; Kuraparthy V, 2007, THEOR APPL GENET, V114, P285, DOI 10.1007/s00122-006-0431-y; Li YY, 2012, NEW PHYTOL, V196, P282, DOI 10.1111/j.1469-8137.2012.04243.x; Li ZY, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00638; Liang WH, 2014, GENE, V537, P1, DOI 10.1016/j.gene.2013.11.058; Liller CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140246; Liu JJ, 2018, THEOR APPL GENET, V131, P2439, DOI 10.1007/s00122-018-3164-9; Luo AD, 2006, PLANT CELL PHYSIOL, V47, P181, DOI 10.1093/pcp/pci233; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Minakuchi K, 2010, PLANT CELL PHYSIOL, V51, P1127, DOI 10.1093/pcp/pcq083; Nadolska-Orczyk A, 2017, THEOR APPL GENET, V130, P1081, DOI 10.1007/s00122-017-2880-x; Ramamoorthy R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028069; Seto Y, 2014, CURR OPIN PLANT BIOL, V21, P1, DOI 10.1016/j.pbi.2014.06.001; Singh D, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00394; Sitonik C, 2019, THEOR APPL GENET, V132, P2381, DOI 10.1007/s00122-019-03360-x; Song XG, 2017, CELL RES, V27, P1128, DOI 10.1038/cr.2017.102; Sukumaran S, 2015, CROP SCI, V55, P2609, DOI 10.2135/cropsci2015.03.0139; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tsuji H, 2015, PLANT J, V82, P256, DOI 10.1111/tpj.12811; Voss-Fels KP, 2018, MOL PLANT, V11, P226, DOI 10.1016/j.molp.2017.10.005; Waldie T, 2014, PLANT J, V79, P607, DOI 10.1111/tpj.12488; Wallace JG, 2016, CROP SCI, V56, P2365, DOI 10.2135/cropsci2015.10.0632; Wang B, 2018, ANNU REV PLANT BIOL, V69, P437, DOI 10.1146/annurev-arplant-042817-040422; Wang YJ, 2017, PLANT CELL REP, V36, P391, DOI 10.1007/s00299-017-2104-5; Wang ZQ, 2016, THEOR APPL GENET, V129, P603, DOI 10.1007/s00122-015-2652-4; Yao XH, 2018, HEREDITAS, V155, DOI 10.1186/s41065-018-0072-6; Yuan XJ, 2012, ASIAN AUSTRAL J ANIM, V25, P479, DOI 10.5713/ajas.2011.11435; Zeng XQ, 2015, P NATL ACAD SCI USA, V112, P1095, DOI 10.1073/pnas.1423628112; Zhang JP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1441-4; Zhang YX, 2014, NAT CHEM BIOL, V10, P1028, DOI 10.1038/nchembio.1660; Zhang YY, 2008, CELL RES, V18, P412, DOI 10.1038/cr.2008.28; Zhao L, 2015, PLANT J, V83, P528, DOI 10.1111/tpj.12905; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878	64	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260723	10.1371/journal.pone.0260723	http://dx.doi.org/10.1371/journal.pone.0260723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855842	gold, Green Published			2022-12-26	WOS:000735299000105
J	Bhat, B; Liu, SH; Lin, YT; Sentmanat, ML; Kwon, J; Akbulut, M				Bhat, Bhargavi; Liu, Shuhao; Lin, Yu-Ting; Sentmanat, Martin L.; Kwon, Joseph; Akbulut, Mustafa			Supramolecular dynamic binary complexes with pH and salt-responsive properties for use in unconventional reservoirs	PLOS ONE			English	Article							VISCOELASTIC SURFACTANT; FRACTURING FLUIDS; ELECTROSTATIC INTERACTIONS; SYSTEMS; TEMPERATURE; SIMULATION; SLICKWATER; MECHANISM; VESICLES; RHEOLOGY	Hydraulic fracturing of unconventional reservoirs has seen a boom in the last century, as a means to fulfill the growing energy demand in the world. The fracturing fluid used in the process plays a substantial role in determining the results. Hence, several research and development efforts have been geared towards developing more sustainable, efficient, and improved fracturing fluids. Herein, we present a dynamic binary complex (DBC) solution, with potential to be useful in the hydraulic fracturing domain. It has a supramolecular structure formed by the self-assembly of low molecular weight viscosifiers (LMWVs) oleic acid and diethylenetriamine into an elongated entangled network under alkaline conditions. With less than 2 wt% constituents dispersed in aqueous solution, a viscous gel that exhibits high viscosities even under shear was formed. Key features include responsiveness to pH and salinity, and a zero-shear viscosity that could be tuned by a factor of ~280 by changing the pH. Furthermore, its viscous properties were more pronounced in the presence of salt. Sand settling tests revealed its potential to hold up sand particles for extended periods of time. In conclusion, this DBC solution system has potential to be utilized as a smart salt-responsive, pH-switchable hydraulic fracturing fluid.	[Bhat, Bhargavi; Liu, Shuhao; Lin, Yu-Ting; Sentmanat, Martin L.; Kwon, Joseph; Akbulut, Mustafa] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA; [Kwon, Joseph; Akbulut, Mustafa] Texas A&M Energy Inst, College Stn, TX 77843 USA; [Akbulut, Mustafa] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Akbulut, M (corresponding author), Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA.; Akbulut, M (corresponding author), Texas A&M Energy Inst, College Stn, TX 77843 USA.; Akbulut, M (corresponding author), Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA.	makbulut@tamu.edu	Akbulut, Mustafa/M-6279-2013	Akbulut, Mustafa/0000-0001-7343-2187; Bhat, Bhargavi/0000-0002-7576-5687	U.S. Department of Energy, Office of Fossil Energy [DE-FE0031778]	U.S. Department of Energy, Office of Fossil Energy(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy, Office of Fossil Energy under award number DE-FE0031778 granted to M. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ameri A, 2018, J PETROL SCI ENG, V171, P23, DOI 10.1016/j.petrol.2018.07.021; Alzahabi A., 2020, P SPE ANN TECH C EXH, DOI [10.2118/201660-ms, DOI 10.2118/201660-MS]; Barrientos L, 2019, INT J QUANTUM CHEM, V119, DOI 10.1002/qua.25675; CATES ME, 1990, J PHYS-CONDENS MAT, V2, P6869, DOI 10.1088/0953-8984/2/33/001; Chang HM, 2020, SOFT MATTER, V16, P3505, DOI 10.1039/c9sm02508a; Chen IC, 2014, SPE J, V19, P1035, DOI 10.2118/169904-PA; Chun T, 2020, J PETROL SCI ENG, V184, DOI 10.1016/j.petrol.2019.106523; Dantas TNC, 2006, J PETROL SCI ENG, V50, P293, DOI 10.1016/j.petrol.2005.12.001; de Kruijf A.S., 1993, SPE PROD FACIL, V8, P165, DOI [10.2118/25206-pa, DOI 10.2118/25206-PA]; Fuller M. J., 2016, P SPE INT C EXH FORM, DOI [10.2118/178991-ms, DOI 10.2118/178991-MS, 10.2118/178991-MS]; Gallegos TJ., 2016, WATER RESOUR RES, P6621, DOI [10.1002/2015WR018491, DOI 10.1002/2015WR018491]; Gomaa A.M., 2014, SPE INT S EXH FORM D, DOI [10.2118/168113-ms, DOI 10.2118/168113-MS, 10.2118/168113-MS]; Gomaa AM., 2015, VISCOSITY IS NOT ALL, P2; Gu M, 2015, J PETROL SCI ENG, V134, P87, DOI 10.1016/j.petrol.2015.07.018; Gunawan S., 2012, P SPE ANN TECH C EXH, V3, P2201, DOI [10.2118/159396-ms, DOI 10.2118/159396-MS]; Hao L, 2018, IND ENG CHEM RES, V57, P9231, DOI 10.1021/acs.iecr.8b00984; Hao L, 2018, SOFT MATTER, V14, P432, DOI 10.1039/c7sm01592e; Hasan A.M.A., 2018, EGYPT J PET, V27, P1043, DOI [10.1016/j.ejpe.2018.03.005, DOI 10.1016/J.EJPE.2018.03.005]; Hu XD, 2018, J PETROL SCI ENG, V167, P110, DOI 10.1016/j.petrol.2018.03.081; Huang FH, 2012, CHEM SOC REV, V41, P5879, DOI 10.1039/c2cs90071h; Huang T., 2008, P SPE INT S FORM DAM, V2, P855; Huang TP, 2009, SPE PROD OPER, V24, P60, DOI 10.2118/106227-PA; Jennings AR, 1996, J PETROL TECHNOL, V48, P604, DOI 10.2118/36166-JPT; Kakati A, 2017, J PETROL SCI ENG, V157, P1106, DOI 10.1016/j.petrol.2017.08.017; Kang WL, 2020, J PETROL SCI ENG, V190, DOI 10.1016/j.petrol.2020.107107; Kanicky JR, 2002, J COLLOID INTERF SCI, V256, P201, DOI 10.1006/jcis.2001.8009; KESTER DR, 1967, LIMNOL OCEANOGR, V12, P176, DOI 10.4319/lo.1967.12.1.0176; Liang TB, 2018, J PETROL SCI ENG, V165, P81, DOI 10.1016/j.petrol.2018.02.010; Liu JR, 2019, J PETROL SCI ENG, V175, P624, DOI 10.1016/j.petrol.2019.01.003; Liu K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02372; Liu SH, 2021, RSC ADV, V11, P22517, DOI 10.1039/d1ra00257k; Loveless D., 2011, PC SPE ANN TECH C EX, V5, P3775, DOI [10.2118/147206-ms, DOI 10.2118/147206-MS]; Luo X, 2020, J PETROL SCI ENG, V192, DOI 10.1016/j.petrol.2020.107254; Maguire-Boyle SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12499-w; Mao JC, 2018, J PETROL SCI ENG, V164, P189, DOI 10.1016/j.petrol.2018.01.052; Nandwani SK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51318-2; Norman L., 1995, SPE EUR FORM DAM C P, P187, DOI [10.2523/30097-ms, DOI 10.2523/30097-MS]; Palisch TT., 2010, SOC PET ENG SPE AS P, V1, P24; Pei XM, 2011, SOFT MATTER, V7, P2953, DOI 10.1039/c0sm01071e; REHAGE H, 1991, MOL PHYS, V74, P933, DOI 10.1080/00268979100102721; Ren L, 2018, J PETROL SCI ENG, V166, P290, DOI 10.1016/j.petrol.2018.03.041; Roy B, 2014, RSC ADV, V4, P1708, DOI 10.1039/c3ra44524k; Shalit A, 2017, NAT CHEM, V9, P273, DOI [10.1038/NCHEM.2642, 10.1038/nchem.2642]; Shiozawa S, 2016, J PETROL SCI ENG, V138, P298, DOI 10.1016/j.petrol.2016.01.002; Song SS, 2012, LANGMUIR, V28, P219, DOI 10.1021/la203581m; Soontravanich S, 2008, J SURFACTANTS DETERG, V11, P251, DOI 10.1007/s11743-008-1080-8; Sun X, 2019, J PETROL SCI ENG, V183, DOI 10.1016/j.petrol.2019.106408; Tan P, 2017, J PETROL SCI ENG, V158, P766, DOI 10.1016/j.petrol.2017.09.004; Tang AM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01848; TANNICH JD, 1975, J PETROL TECHNOL, V27, P1309, DOI 10.2118/5113-PA; Temizel C., 2018, OFFSHORE TECHNOLOGY; Tielrooij KJ, 2010, SCIENCE, V328, P1006, DOI 10.1126/science.1183512; Tong SY, 2019, J PETROL SCI ENG, V182, DOI 10.1016/j.petrol.2019.106279; Wang J, 2020, J PETROL SCI ENG, V193, DOI 10.1016/j.petrol.2020.107359; Wang SB, 2014, J PETROL SCI ENG, V124, P432, DOI 10.1016/j.petrol.2014.09.016; Wanniarachchi WAM, 2019, J PETROL SCI ENG, V172, P83, DOI 10.1016/j.petrol.2018.09.032; Wanniarachchi WAM, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-017-6399-x; Xie HT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09304-z; Xing PY, 2013, RSC ADV, V3, P24776, DOI 10.1039/c3ra44569k; Xiong CM, 2020, RSC ADV, V10, P25311, DOI 10.1039/d0ra03854g; Xue P., 2016, SCI REP-UK, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Yan XZ, 2012, CHEM SOC REV, V41, P6042, DOI 10.1039/c2cs35091b; Yang F, 2018, J PETROL SCI ENG, V169, P646, DOI 10.1016/j.petrol.2018.06.015; Yang JF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75787-y; Yang J, 2016, SPE PROD OPER, V31, P318, DOI 10.2118/175762-PA; Yang S, 2019, ENERGIES, V12, DOI 10.3390/en12193751; Yang XJ, 2019, ENERG SOURCE PART A, V41, P1446, DOI 10.1080/15567036.2018.1548520; Yegin C, 2016, J PETROL SCI ENG, V145, P600, DOI 10.1016/j.petrol.2016.06.033; Yekeen N, 2018, J IND ENG CHEM, V66, P45, DOI 10.1016/j.jiec.2018.05.039; Yu W., 2018, SHALE GAS TIGHT OIL, DOI [10.1016/b978-0-12-813868-7.00002-x, DOI 10.1016/B978-0-12-813868-7.00002-X]; Yun W, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57485-x; Zang A., 2021, SCI REP-UK, P1, DOI [10.1038/s41598-020-79139-8, DOI 10.1038/S41598-020-79139-8]; Zhang PW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13501; Zhang X., IADC SPE AS PAC DRIL, DOI 10.2118/180595-MS; Zhang Y, 2019, RSC ADV, V9, P1199, DOI 10.1039/c8ra09483g; Zhang YM, 2015, RSC ADV, V5, P19135, DOI 10.1039/c4ra16772d; Zhou CC, 2014, SOFT MATTER, V10, P8023, DOI 10.1039/c4sm01204f	77	6	6	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260786	10.1371/journal.pone.0260786	http://dx.doi.org/10.1371/journal.pone.0260786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855902	gold, Green Published			2022-12-26	WOS:000735299000121
J	Derseh, HB; Goodger, JQD; Scheerlinck, JPY; Samuel, CS; Woodrow, IE; Palombo, EA; Cumming, A; Snibson, K				Derseh, Habtamu B.; Goodger, Jason Q. D.; Scheerlinck, Jean-Pierre Y.; Samuel, Chrishan S.; Woodrow, Ian E.; Palombo, Enzo A.; Cumming, Alistair; Snibson, Ken			The efficacy and safety of pinocembrin in a sheep model of bleomycin-induced pulmonary fibrosis	PLOS ONE			English	Article							INFLAMMATION; INHIBITION; SUPPRESSION	The primary flavonoid, pinocembrin, is thought to have a variety of medical uses which relate to its reported anti-oxidant, anti-inflammatory, anti-microbial and anti-cancer properties. Some studies have reported that this flavonoid has anti-fibrotic activities. In this study, we investigated whether pinocembrin would impede fibrosis, dampen inflammation and improve lung function in a large animal model of pulmonary fibrosis. Fibrosis was induced in two localized lung segments in each of the 10 sheep participating in the study. This was achieved via two infusions of bleomycin delivered bronchoscopically at a two-week interval. Another lung segment in the same sheep was left untreated, and was used as a healthy control. The animals were kept for a little over 5 weeks after the final infusion of bleomycin. Pinocembrin, isolated from Eucalyptus leaves, was administered to one of the two bleomycin damaged lung segments at a dose of 7 mg. This dose was given once-weekly over 4-weeks, starting one week after the final bleomycin infusion. Lung compliance (as a measure of stiffness) was significantly improved after four weekly administrations of pinocembrin to bleomycin-damaged lung segments. There were significantly lower numbers of neutrophils and inflammatory cells in the bronchoalveolar lavage of bleomycin-infused lung segments that were treated with pinocembrin. Compared to bleomycin damaged lung segments without drug treatment, pinocembrin administration was associated with significantly lower numbers of immuno-positive CD8(+) and CD4(+) T cells in the lung parenchyma. Histopathology scoring data showed that pinocembrin treatment was associated with significant improvement in inflammation and overall pathology scores. Hydroxy proline analysis showed that the administration of pinocembrin did not reduce the increased collagen content that was induced by bleomycin in this model. Analyses of Masson's Trichrome stained sections showed that pinocembrin treatment significantly reduced the connective tissue content in lung segments exposed to bleomycin when compared to bleomycin-infused lungs that did not receive pinocembrin. The striking anti-inflammatory and modest anti-fibrotic remodelling effects of pinocembrin administration were likely linked to the compound's ability to improve lung pathology and functional compliance in this animal model of pulmonary fibrosis.	[Derseh, Habtamu B.; Scheerlinck, Jean-Pierre Y.; Snibson, Ken] Univ Melbourne, Fac Vet & Agr Sci, Melbourne Vet Sch, Parkville, Vic, Australia; [Goodger, Jason Q. D.] Univ Melbourne, Sch Biosci, Parkville, Vic, Australia; [Samuel, Chrishan S.] Monash Univ, Monash Biomed Discovery Inst, Cardiovasc Dis Program, Clayton, Vic, Australia; [Samuel, Chrishan S.] Monash Univ, Dept Pharmacol, Clayton, Vic, Australia; [Woodrow, Ian E.] Univ Melbourne, Sch Ecosyst & Forest Sci, Parkville, Vic, Australia; [Palombo, Enzo A.] Swinburne Univ Technol, Dept Chem & Biotechnol, Hawthorn, Vic, Australia; [Cumming, Alistair] Gretals Australia Pty Ltd, Mornington, Vic, Australia	University of Melbourne; University of Melbourne; Monash University; Monash University; University of Melbourne; Swinburne University of Technology	Derseh, HB; Snibson, K (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Melbourne Vet Sch, Parkville, Vic, Australia.	habtamu.derseh@unimelb.edu.au; ksnibson@unimelb.edu.au		Palombo, Enzo/0000-0001-5889-1393; Derseh, Habtamu Biyazen/0000-0002-3415-7968	Gretals Australia Pty Ltd.	Gretals Australia Pty Ltd.	This study was funded by Gretals Australia Pty Ltd. https://www.gretals.com/AC is the CEO of Gretals Pty Ltd Australia The funder provided support in the form of salary for author AC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bahri S, 2017, BIOMED PHARMACOTHER, V93, P666, DOI 10.1016/j.biopha.2017.06.052; Cao GY, 2015, J ETHNOPHARMACOL, V168, P31, DOI 10.1016/j.jep.2015.03.041; Derseh HB, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.700902; Derseh HB, 2020, EXP LUNG RES, V46, P409, DOI 10.1080/01902148.2020.1834015; Derseh HB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56412-z; Dewage SNV, 2019, EXP LUNG RES, V45, P310, DOI 10.1080/01902148.2019.1695019; El-Demerdash AA, 2021, N-S ARCH PHARMACOL, V394, P1411, DOI 10.1007/s00210-021-02067-5; GALLOP PM, 1975, PHYSIOL REV, V55, P418, DOI 10.1152/physrev.1975.55.3.418; Gan WH, 2021, INT IMMUNOPHARMACOL, V90, DOI 10.1016/j.intimp.2020.107230; Giri SS, 2016, FISH SHELLFISH IMMUN, V56, P459, DOI 10.1016/j.fsi.2016.07.038; Goodger JQD, 2019, IND CROP PROD, V131, P166, DOI 10.1016/j.indcrop.2019.01.050; Gu XY, 2017, INT IMMUNOPHARMACOL, V53, P90, DOI 10.1016/j.intimp.2017.10.005; Kolb P, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01105-2019; Lan X, 2016, MOL NEUROBIOL, V53, P1794, DOI 10.1007/s12035-015-9125-2; Li XH, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11081240; McGrath EE, 2012, THORAX, V67, P97, DOI 10.1136/thoraxjnl-2011-201398; Organ L, 2017, AM J RESP CELL MOL, V56, P539, DOI 10.1165/rcmb.2016-0092OC; Organ L, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0071-6; Organ L, 2015, EXP LUNG RES, V41, P115, DOI 10.3109/01902148.2014.985806; Pei B, 2018, J NEUROIMMUNOL, V314, P42, DOI 10.1016/j.jneuroim.2017.11.006; Richeldi L, 2017, LANCET, V389, P1941, DOI 10.1016/S0140-6736(17)30866-8; Said MM, 2018, ANN HEPATOL, V17, P307, DOI [10.5604/01.3001.0010.8662, 10.5604/01.3001.0010.8661]; Yang X, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020041; Ye TX, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.547966; Ye TX, 2019, INT IMMUNOPHARMACOL, V77, DOI 10.1016/j.intimp.2019.105926; Zhou LT, 2015, EUR J PHARMACOL, V761, P211, DOI 10.1016/j.ejphar.2015.06.003	26	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260719	10.1371/journal.pone.0260719	http://dx.doi.org/10.1371/journal.pone.0260719			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855848	Green Published, gold			2022-12-26	WOS:000735299000103
J	Shu, Y; Zhang, JQ; Li, W; Zhao, PW; Zhang, QY; Zhou, M				Shu, Yang; Zhang, Jinqi; Li, Wei; Zhao, Pengwu; Zhang, Qiyue; Zhou, Mei			Thermogravimetric analysis of the pyrolysis and combustion kinetics of surface dead combustibles in the Daxing'an Mountains	PLOS ONE			English	Article							THERMAL-BEHAVIOR; WASTE; PARAMETERS; BIOMASS; DEGRADATION; TREE	In boreal regions, the frequency of forest fires is increasing. In this study, thermogravimetric analysis was used to analyze the pyrolysis kinetics of dead surface combustibles in different forest types within the Daxing'an Mountains, China. The results show that the combustible material load of forest types, the Larix forest (LG) is relatively high. Base on the E of kinetic parameters, the LG, and Quercus forest (QM) forest types had relatively high combustibility values and comprehensive combustibility values for 1-, 10-, and 100-h time lags. According to the obtained P values, the pyrolysis of dead surface fuels with 1-, 10-, and 100-h time lags is relatively difficult in the Larix / Betula mixed forest (L-B) and QM forest types. Therefore, mixed forests of the LG, L-B, and QM tree species can be established as fire-resistant forests to establish a fire barrier, reduce the combustibility of forest stands, and reduce the possibility of forest fires.	[Shu, Yang; Zhang, Jinqi; Li, Wei; Zhao, Pengwu; Zhang, Qiyue; Zhou, Mei] Inner Mongolia Agr Univ, Forestry Coll, Hohhot, Peoples R China; [Shu, Yang; Zhao, Pengwu; Zhou, Mei] Natl Orientat Observat & Res Stn Saihanwula Fores, Chifeng, Peoples R China	Inner Mongolia Agricultural University	Zhou, M (corresponding author), Inner Mongolia Agr Univ, Forestry Coll, Hohhot, Peoples R China.; Zhou, M (corresponding author), Natl Orientat Observat & Res Stn Saihanwula Fores, Chifeng, Peoples R China.	zhoumei@imau.edu.cn			National Natural Science Foundation of China [32001325]; Inner Mongolia Natural Science Foundation, China [2020MS03049]; Inner Mongolia Autonomous Region Talent Introduction Project [2021CG0002]; CFERN & GENE Award Funds on Ecological Paper	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Inner Mongolia Natural Science Foundation, China; Inner Mongolia Autonomous Region Talent Introduction Project; CFERN & GENE Award Funds on Ecological Paper	This work was supported by the National Natural Science Foundation of China [grant number 32001325]; the Inner Mongolia Natural Science Foundation, China [grant number 2020MS03049]; the Inner Mongolia Autonomous Region Talent Introduction Project[grant number 2021CG0002]; and the CFERN & GENE Award Funds on Ecological Paper.	Ahmad MS, 2017, J THERM ANAL CALORIM, V130, P1237, DOI 10.1007/s10973-017-6398-x; Alves JLF, 2022, BIOMASS CONVERS BIOR, V12, P741, DOI 10.1007/s13399-020-01077-2; Alves JLF, 2020, BIOENERG RES, V13, P1308, DOI 10.1007/s12155-020-10158-z; Badshah SL, 2021, RENEW ENERG, V179, DOI 10.1016/j.renene.2021.07.105; Badshah SL, 2021, J APPL PHYCOL, V33, P2511, DOI 10.1007/s10811-021-02459-3; Braga RM, 2014, J THERM ANAL CALORIM, V117, P1341, DOI 10.1007/s10973-014-3884-2; Cardoso CR, 2011, J ANAL APPL PYROL, V92, P392, DOI 10.1016/j.jaap.2011.07.013; Ceylan S, 2015, WASTE MANAGE RES, V33, P345, DOI 10.1177/0734242X15574590; Chandrasekaran A, 2017, BIORESOURCE TECHNOL, V233, P413, DOI 10.1016/j.biortech.2017.02.119; Damartzis T, 2011, BIORESOURCE TECHNOL, V102, P6230, DOI 10.1016/j.biortech.2011.02.060; Dimitrakopoulos AP, 2001, J ANAL APPL PYROL, V60, P123, DOI 10.1016/S0165-2370(00)00164-9; Maia AAD, 2016, BIORESOURCE TECHNOL, V204, P157, DOI 10.1016/j.biortech.2015.12.055; Ellis P.F., 2000, THESIS AUSTR NATL U; Alves JLF, 2020, RENEW ENERG, V155, P1328, DOI 10.1016/j.renene.2020.04.025; Haykiri-Acma H, 2003, ENERG CONVERS MANAGE, V44, P155, DOI 10.1016/S0196-8904(01)00200-X; Heo HS, 2010, BIORESOURCE TECHNOL, V101, pS91, DOI 10.1016/j.biortech.2009.06.003; Huang X, 2016, FUEL, V169, P93, DOI 10.1016/j.fuel.2015.12.011; Islam MA, 2016, BIORESOURCE TECHNOL, V200, P335, DOI 10.1016/j.biortech.2015.09.057; Jeguirim M, 2009, BIORESOURCE TECHNOL, V100, P4026, DOI 10.1016/j.biortech.2009.03.033; Laouge ZB, 2020, BIORESOURCE TECHNOL, V299, DOI 10.1016/j.biortech.2019.122602; Leoni E, 2001, J FIRE SCI, V19, P379, DOI 10.1106/QBDC-5VH2-U5X2-FUF7; Liu F., 2005, FOREST FIRE RES, P28; Mehmood MA, 2017, BIORESOURCE TECHNOL, V228, P18, DOI 10.1016/j.biortech.2016.12.096; Mishra RK, 2018, BIORESOURCE TECHNOL, V251, P63, DOI 10.1016/j.biortech.2017.12.029; Munir S, 2017, ENERG SOURCE PART A, V39, P775, DOI 10.1080/15567036.2016.1263254; Niu HC, 2014, PYROLYSIS KINETICS F; Ozsin G, 2017, WASTE MANAGE, V64, P315, DOI 10.1016/j.wasman.2017.03.020; Saikia R, 2018, BIORESOURCE TECHNOL, V253, P304, DOI 10.1016/j.biortech.2018.01.054; Shan YanLong, 2006, Journal of Northeast Forestry University, V34, P34; Shi HY., 2004, KINETIC STUDY FIRE C; Shu LF., 2000, FIRE SCI, P1; Slopiecka K, 2012, APPL ENERG, V97, P491, DOI 10.1016/j.apenergy.2011.12.056; Tahir MH, 2019, BIOMASS BIOENERG, V122, P193, DOI 10.1016/j.biombioe.2019.01.009; Wadhwani R, 2017, J THERM ANAL CALORIM, V130, P2035, DOI 10.1007/s10973-017-6512-0; [王雷 Wang Lei], 2020, [北京林业大学学报, Journal of Beijing Forestry University], V42, P87; Wang QH., 2011, FORESTRY RESOURCE MA, P48; Wang Yue, 2020, Journal of Forestry Engineering, V5, P155, DOI 10.13360/j.issn.2096-1359.201906047; Wu WX, 2015, FUEL, V156, P71, DOI 10.1016/j.fuel.2015.04.016; Wu ZhiWei, 2011, Journal of Northeast Forestry University, V39, P52; Yang SQ., 2017, RES FLAMMABILITY MAJ; Zanatta ER, 2016, J THERM ANAL CALORIM, V125, P437, DOI 10.1007/s10973-016-5378-x; [张恒 Zhang Heng], 2020, [林业科学, Scientia Silvae Sinicae], V56, P104; Zhang SP, 2016, BIORESOURCE TECHNOL, V199, P352, DOI 10.1016/j.biortech.2015.08.110; Zhou JQ., 2014, RES FOREST FUEL LOAD; Zhou M., 2002, J ARID LAND RESOURCE, P44; Zhu BiQin, 2011, Acta Agriculturae Universitatis Jiangxiensis, V33, P1149	46	2	2	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260790	10.1371/journal.pone.0260790	http://dx.doi.org/10.1371/journal.pone.0260790			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855872	gold, Green Published			2022-12-26	WOS:000735299000124
J	Szabo, E; Kulin, A; Mozner, O; Koranyi, L; Literati-Nagy, B; Vitai, M; Cserepes, J; Sarkadi, B; Varady, G				Szabo, Edit; Kulin, Anna; Mozner, Orsolya; Koranyi, Laszlo; Literati-Nagy, Botond; Vitai, Marta; Cserepes, Judit; Sarkadi, Balazs; Varady, Gyorgy			Potential role of the ABCG2-Q141K polymorphism in type 2 diabetes	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; TRANSPORTER ABCG2; GOUT; PHARMACOKINETICS; HYPERURICEMIA; ASSOCIATION; VARIANTS; LOCI; SNP	Type 2 diabetes mellitus (T2DM) is a complex metabolic disease and variations in multispecific membrane transporter functions may affect T2DM development, complications or treatment. In this work we have analyzed the potential effects of a major polymorphism, the Q141K variant of the ABCG2 transporter in T2DM. The ABCG2 protein is a multispecific xeno- and endobiotic transporter, affecting drug metabolism and playing a key role in uric acid extrusion. The ABCG2-Q141K variant, with reduced expression level and function, is present in 15-35% of individuals, depending on the genetic background of the population, and has been shown to significantly affect gout development. Several other diseases, including hypertension, chronic renal failure, and T2DM have also been reported to be associated with high serum uric acid levels, suggesting that ABCG2 may also play a role in these conditions. In this work we have compared relatively small cohorts (n = 203) of T2DM patients (n = 99) and healthy (n = 104) individuals regarding the major laboratory indicators of T2DM and determined the presence of the SNP rs2231142 (C421A), resulting the ABCG2-Q141K protein variant. We found significantly higher blood glucose and HbA1c levels in the T2DM patients carrying the ABCG2-Q141K variant. These findings may emphasize the potential metabolic role of ABCG2 in T2DM and indicate that further research should explore how prevention and treatment of this disease may be affected by the frequent polymorphism of ABCG2.	[Szabo, Edit; Kulin, Anna; Mozner, Orsolya; Sarkadi, Balazs; Varady, Gyorgy] Hungarian Acad Sci, ELKH Res Ctr Nat Sci, Inst Enzymol, Ctr Excellence, Budapest, Hungary; [Kulin, Anna; Mozner, Orsolya] Semmelweis Univ, Doctoral Sch Mol Med, Budapest, Hungary; [Koranyi, Laszlo; Literati-Nagy, Botond] Drug Res Ctr, Balatonfured, Hungary; [Vitai, Marta] Univ Pannonia, Res Inst Biomol & Chem Engn, Veszprem, Hungary; [Cserepes, Judit] CellPharma Kft, Budapest, Hungary; [Sarkadi, Balazs] Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University; University of Pannonia; Semmelweis University	Szabo, E; Varady, G (corresponding author), Hungarian Acad Sci, ELKH Res Ctr Nat Sci, Inst Enzymol, Ctr Excellence, Budapest, Hungary.	szabo.edit@ttk.hu; varady.gyorgy@ttk.hu		Gyorgy, Varady/0000-0003-2012-9680	Hungarian National Development and Innovation Office [NKFIH K-128011, FIEK_16-1-2016-0005, VEKOP-2.1.1-152016-00117]	Hungarian National Development and Innovation Office	This study has been supported by grants from Hungarian National Development and Innovation Office (NKFIH K-128011 to V.Gy.), FIEK_16-1-2016-0005 (B.S), and VEKOP-2.1.1-152016-00117. The employer of the author J.Cs. did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS14, DOI 10.2337/dc20-S002; Bartakova V, 2016, J DIABETES COMPLICAT, V30, P1300, DOI 10.1016/j.jdiacomp.2016.06.002; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Furukawa T, 2009, PHARM RES-DORDR, V26, P469, DOI 10.1007/s11095-008-9752-7; Giri AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep21440; Gong L, 2012, PHARMACOGENET GENOM, V22, P820, DOI 10.1097/FPC.0b013e3283559b22; Grun B, 2013, BRIT J CLIN PHARMACO, V76, P787, DOI 10.1111/bcp.12079; Hemauer SJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.035; Hoque KM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16525-w; Huls M, 2008, KIDNEY INT, V73, P220, DOI 10.1038/sj.ki.5002645; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Kasza I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048423; Keskitalo JE, 2009, PHARMACOGENOMICS, V10, P1617, DOI [10.2217/pgs.09.85, 10.2217/PGS.09.85]; Liang XM, 2017, J PHARM SCI-US, V106, P2245, DOI 10.1016/j.xphs.2017.04.078; Lu YH, 2020, INT J BIOL SCI, V16, P529, DOI 10.7150/ijbs.33007; Nakayama A, 2017, ANN RHEUM DIS, V76, P869, DOI 10.1136/annrheumdis-2016-209632; NIH Accelerating Medicines Partnership, 2014, TYPE 2 DIAB KNOWL PO; Safar Z, 2019, EXPERT OPIN DRUG MET, V15, P313, DOI 10.1080/17425255.2019.1591373; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Sarkadi B, 2020, FEBS LETT, V594, P4012, DOI 10.1002/1873-3468.13947; Siokas V, 2019, OPHTHALMIC RES, V61, P26, DOI 10.1159/000480241; Stiburkova B, 2017, RHEUMATOLOGY, V56, P1982, DOI 10.1093/rheumatology/kex295; Szabo E, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82417-8; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; van Herwaarden AE, 2006, TRENDS PHARMACOL SCI, V27, P10, DOI 10.1016/j.tips.2005.11.007; Wei FJ, 2015, GENET MOL RES, V14, P15471, DOI 10.4238/2015.November.30.25; Wei FJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28549; Woodward OM, 2013, P NATL ACAD SCI USA, V110, P5223, DOI 10.1073/pnas.1214530110; Zambo B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25695-z; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260957	10.1371/journal.pone.0260957	http://dx.doi.org/10.1371/journal.pone.0260957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855903	Green Published, gold			2022-12-26	WOS:000735299000155
J	Wieben, ED; Aleff, RA; Rinkoski, TA; Baratz, KH; Basu, S; Patel, SV; Maguire, LJ; Fautsch, MP				Wieben, Eric D.; Aleff, Ross A.; Rinkoski, Tommy A.; Baratz, Keith H.; Basu, Shubham; Patel, Sanjay, V; Maguire, Leo J.; Fautsch, Michael P.			Comparison of TCF4 repeat expansion length in corneal endothelium and leukocytes of patients with Fuchs endothelial corneal dystrophy	PLOS ONE			English	Article							CTG REPEAT	Expansion of CTG trinucleotide repeats (TNR) in the transcription factor 4 (TCF4) gene is highly associated with Fuchs Endothelial Corneal Dystrophy (FECD). Due to limitations in the availability of DNA from diseased corneal endothelium, sizing of CTG repeats in FECD patients has typically been determined using DNA samples isolated from peripheral blood leukocytes. However, it is non-feasible to extract enough DNA from surgically isolated FECD corneal endothelial tissue to determine repeat length based on current technology. To circumvent this issue, total RNA was isolated from FECD corneal endothelium and sequenced using long-read sequencing. Southern blotting of DNA samples isolated from primary cultures of corneal endothelium from these same affected individuals was also assessed. Both long read sequencing and Southern blot analysis showed significantly longer CTG TNR expansion (>1000 repeats) in the corneal endothelium from FECD patients than those characterized in leukocytes from the same individuals (<90 repeats). Our findings suggest that the TCF4 CTG repeat expansions in the FECD corneal endothelium are much longer than those found in leukocytes.	[Wieben, Eric D.; Aleff, Ross A.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Rinkoski, Tommy A.; Baratz, Keith H.; Patel, Sanjay, V; Maguire, Leo J.; Fautsch, Michael P.] Mayo Clin, Dept Ophthalmol, Rochester, MN 55902 USA; [Basu, Shubham] Mayo Clin, Div Biostat & Bioinformat, Rochester, MN USA; [Basu, Shubham] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Fautsch, MP (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN 55902 USA.	fautsch@mayo.edu		Fautsch, Michael/0000-0002-9115-2485	National Eye Institute [EY26490]; Robert Waller Career Development Award; Mayo Foundation	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Robert Waller Career Development Award; Mayo Foundation	This study was supported in part by National Eye Institute research grant EY26490 (MPF), Robert Waller Career Development Award (KHB), and Mayo Foundation (all authors). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVRET M, 1993, HUM MOL GENET, V2, P1397, DOI 10.1093/hmg/2.9.1397; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Cartolano M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157779; Castel AL, 2011, HUM MOL GENET, V20, P1, DOI 10.1093/hmg/ddq427; Du JT, 2015, J BIOL CHEM, V290, P5979, DOI 10.1074/jbc.M114.621607; Fautsch MP, 2021, PROG RETIN EYE RES, V81, DOI 10.1016/j.preteyeres.2020.100883; Hu JX, 2018, HUM MOL GENET, V27, P1015, DOI 10.1093/hmg/ddy018; Long A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189990; Mantere T, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00426; Nordin A, 2015, HUM MOL GENET, V24, P3133, DOI 10.1093/hmg/ddv064; Sepp M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022138; Sirp A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75437-3; Tardaguila M, 2018, GENOME RES, V28, P396, DOI 10.1101/gr.222976.117; Wieben ED, 2019, INVEST OPHTH VIS SCI, V60, P3636, DOI 10.1167/iovs.19-27689; Wieben ED, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219446; Wieben ED, 2017, INVEST OPHTH VIS SCI, V58, P343, DOI 10.1167/iovs.16-20900; Wieben ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049083; Xu TT, 2021, INVEST OPHTH VIS SCI, V62, DOI 10.1167/iovs.62.1.17; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	19	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260837	10.1371/journal.pone.0260837	http://dx.doi.org/10.1371/journal.pone.0260837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855896	gold, Green Published			2022-12-26	WOS:000735299000134
J	Butler, DC; Jorm, LR; Larkins, S; Humphreys, J; Desborough, J; Korda, KJ				Butler, D. C.; Jorm, L. R.; Larkins, S.; Humphreys, J.; Desborough, J.; Korda, K. J.			Examining area-level variation in service organisation and delivery across the breadth of primary healthcare. Usefulness of measures constructed from routine data	PLOS ONE			English	Article							PRIMARY-CARE SYSTEMS; SOCIOECONOMIC DISADVANTAGE; COUNTRIES; WORKFORCE; EUROPE	Background Australia has a universal healthcare system, yet organisation and delivery of primary healthcare (PHC) services varies across local areas. Understanding the nature and extent of this variation is essential to improve quality of care and health equity, but this has been hampered by a lack of suitable measures across the breadth of effective PHC systems. Using a suite of measures constructed at the area-level, this study explored their application in assessing area-level variation in PHC organisation and delivery. Methods Routinely collected data from New South Wales, Australia were used to construct 13 small area-level measures of PHC service organisation and delivery that best approximated access (availability, affordability, accommodation) comprehensiveness and coordination. Regression analyses and pairwise Pearson's correlations were used to examine variation by area, and by remoteness and area disadvantage. Results PHC service delivery varied geographically at the small-area level-within cities and more remote locations. Areas in major cities were more accessible (all measures), while in remote areas, services were more comprehensive and coordinated. In disadvantaged areas of major cities, there were fewer GPs (most disadvantaged quintile 0.9[SD 0.1] vs least 1.0[SD 0.2]), services were more affordable (97.4%[1.6] bulk-billed vs 75.7[11.3]), a greater proportion were after-hours (10.3%[3.0] vs 6.2[2.9]) and for chronic disease care (28%[3.4] vs 17.6[8.0]) but fewer for preventive care (50.7%[3.8] had cervical screening vs 62.5[4.9]). Patterns were similar in regional locations, other than disadvantaged areas had less after-hours care (1.3%[0.7] vs 6.1%[3.9]). Measures were positively correlated, except GP supply and affordability in major cities (-0.41, p < .01).	[Butler, D. C.; Desborough, J.; Korda, K. J.] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia; [Jorm, L. R.] Univ New South Wales, Ctr Big Data Res Hlth, Kensington, NSW, Australia; [Larkins, S.] James Cook Univ, Anton Breinl Res Ctr Hlth Syst Strengthening, Townsville, Qld, Australia; [Humphreys, J.] Monash Univ, Sch Rural Hlth, Melbourne, Vic, Australia	Australian National University; University of New South Wales Sydney; James Cook University; Monash University	Butler, DC (corresponding author), Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia.	Danielle.Butler@anu.edu.au	Desborough, Jane/ABD-6403-2020; Desborough, Jane/AFK-5743-2022; Larkins, Sarah/A-2319-2013	Desborough, Jane/0000-0003-1406-4593; Larkins, Sarah/0000-0002-7561-3202	Australian Government through the National Health and Medical Research Council Postgraduate Scholarship [GNT1038903]	Australian Government through the National Health and Medical Research Council Postgraduate Scholarship	DB. This research was supported through a grant from the Australian Government through the National Health and Medical Research Council Postgraduate Scholarship (GNT1038903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2011, REG POP GROWTH AUSTR; AIHW, 2014, CANC SERIES, V82; AIHW , 2020, DAT LINK TELL BIGG S; [Anonymous], 2011, 4364055001 ABS; [Anonymous], 2008, RUR REG REM HLTH IND; Australian Government Department of Health, 2020, PHN PROGR PERF RESP; Australian Institute of Health and Welfare, 2009, 45 HWL; Australian Institute of Health and Welfare, 2013, NATL HLTH WORKFORCE, V3; Butler DC, 2010, AUST J RURAL HEALTH, V18, P199, DOI 10.1111/j.1440-1584.2010.01154.x; Commonwealth of Australia Standing Council on Heatlh, 2013, NAT PRIM HLTH CAR ST; GRAPHC, 2020, ON LIN INT HLTH MAPP; GRAPHC Research School of Population health Australian National University, 2020, RES SCH POP HLTH; Humphreys JS, 2012, AUST J RURAL HEALTH, V20, P3, DOI 10.1111/j.1440-1584.2011.01252.x; Kringos D, 2013, BRIT J GEN PRACT, V63, pE742, DOI 10.3399/bjgp13X674422; Kringos DS, 2013, HEALTH AFFAIR, V32, P686, DOI 10.1377/hlthaff.2012.1242; Kringos DS, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-65; Levesque J., 2014, MEASURING ORG ATTRIB; Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18; Looper M., 2009, DELSAHEAWDHWP20092; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; MAGNET, 2020, MELB E MON GENERAL P; Pham M, 2015, HEALTH POLICY, V119, P447, DOI 10.1016/j.healthpol.2015.01.005; Mazumdar S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-343; McRae I, 2014, INT J HEALTH CARE FI, V14, P269, DOI 10.1007/s10754-014-9148-7; Medicinewise NPS., 2018, MEDICINEINSIGHT IMPR; National Health Performance Authority, 2013, HLTH COMM AUSTR EXP; Olde Hartman Tim C, 2021, BJGP Open, V5, DOI 10.3399/BJGPO.2020.0152; Pavlic DR, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0386-7; Pelone F, 2013, INT J QUAL HEALTH C, V25, P381, DOI 10.1093/intqhc/mzt020; PHIDU, PUBL HLTH INF DEV UN; Pink B., 2006, 20390 INFORM PAPER I; Pink B., 2016, SOCIOECONOMIC INDEXE; Schafer WLA, 2018, HEALTH SERV RES, V53, P2047, DOI 10.1111/1475-6773.12754; Schafer W., 2016, PRIMARY CARE 34 COUN; Schafer WLA, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-115; Starfield B, 2006, J HEALTH POLIT POLIC, V31, P11, DOI 10.1215/03616878-31-1-11; Starfield B, 2002, HEALTH POLICY, V60, P201, DOI 10.1016/S0168-8510(01)00208-1; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Turrell G, 2004, AUST NZ J PUBL HEAL, V28, P152, DOI 10.1111/j.1467-842X.2004.tb00929.x; Turrell G, 2003, MED J AUSTRALIA, V179, P325, DOI 10.5694/j.1326-5377.2003.tb05561.x; Van Loenen T, 2016, SCAND J PRIM HEALTH, V34, P5, DOI 10.3109/02813432.2015.1132883; Veillard J, 2017, MILBANK Q, V95, P836, DOI 10.1111/1468-0009.12301; Wilkinson David, 2003, Aust Health Rev, V26, P43; Wilkinson David, 2002, Aust Health Rev, V25, P123; Yong J, 2018, SOC SCI MED, V214, P197, DOI 10.1016/j.socscimed.2018.08.014	46	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260615	10.1371/journal.pone.0260615	http://dx.doi.org/10.1371/journal.pone.0260615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852021	gold, Green Accepted, Green Published			2022-12-26	WOS:000755762900050
J	Song, Q; Huang, YR; Lai, WH; Han, T; Xu, SY; Rong, X				Song, Qi; Huang, Yourui; Lai, Wenhao; Han, Tao; Xu, Shanyong; Rong, Xue			Multi-membrane search algorithm	PLOS ONE			English	Article							OPTIMIZATION; DESIGN; EXPLORATION/EXPLOITATION	This research proposes a new multi-membrane search algorithm (MSA) based on cell biological behavior. Cell secretion protein behavior and cell division and fusion strategy are the main inspirations for the algorithm. In order to verify the performance of the algorithm, we used 19 benchmark functions to compare the MSA test results with MVO, GWO, MFO and ALO. The number of iterations of each algorithm on each benchmark function is 100, the population number is 10, and the running is repeated 50 times, and the average and standard deviation of the results are recorded. Tests show that the MSA is competitive in unimodal benchmark functions and multi-modal benchmark functions, and the results in composite benchmark functions are all superior to MVO, MFO, ALO, and GWO algorithms. This paper also uses MSA to solve two classic engineering problems: welded beam design and pressure vessel design. The result of welded beam design is 1.7252, and the result of pressure vessel design is 5887.7052, which is better than other comparison algorithms. Statistical experiments show that MSA is a high-performance algorithm that is competitive in unimodal and multimodal functions, and its performance in compound functions is significantly better than MVO, MFO, ALO, and GWO algorithms.	[Song, Qi; Huang, Yourui; Lai, Wenhao; Han, Tao; Xu, Shanyong; Rong, Xue] Anhui Univ Sci & Technol, Sch Elect & Informat Engn, Huainan, Peoples R China; [Huang, Yourui] Anhui Sci & Technol Univ, Chuzhou, Peoples R China	Anhui University of Science & Technology; Anhui Science & Technology University	Huang, YR (corresponding author), Anhui Univ Sci & Technol, Sch Elect & Informat Engn, Huainan, Peoples R China.; Huang, YR (corresponding author), Anhui Sci & Technol Univ, Chuzhou, Peoples R China.	hyr628@163.com		song, qi/0000-0001-7595-7964	National Natural Science Foundation of China [61772033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Initials of the authors who received each award: YH Grant numbers awarded to each author: 61772033 The full name of each funder: National Natural Science Foundation of China URL of each funder website: http://www.izaiwen.cn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba E, 2005, IEEE T EVOLUT COMPUT, V9, P126, DOI 10.1109/TEVC.2005.843751; Askarzadeh A, 2016, COMPUT STRUCT, V169, P1, DOI 10.1016/j.compstruc.2016.03.001; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Braik M.A., 2021, NEURAL COMPUT APPL; Dhiman G, 2017, ADV ENG SOFTW, V114, P48, DOI 10.1016/j.advengsoft.2017.05.014; Digalakis JG, 2001, INT J COMPUT MATH, V77, P481, DOI 10.1080/00207160108805080; Gandomi AH, 2011, STUD COMPUT INTELL, V356, P259; Gheorghe Paun A., 2012, MEMBRANE COMPUTING I, V1; He S, 2004, ENG OPTIMIZ, V36, P585, DOI 10.1080/03052150410001704854; He S, 2009, IEEE T EVOLUT COMPUT, V13, P973, DOI 10.1109/TEVC.2009.2011992; Koppen M, 2001, IEEE T EVOLUT COMPUT, V5, P295, DOI 10.1109/4235.930318; Lee KS, 2005, COMPUT METHOD APPL M, V194, P3902, DOI 10.1016/j.cma.2004.09.007; Liang Huang., 2008, RES MEMBRANE COMPUTI; Liang JJ, 2005, 2005 IEEE SWARM INTELLIGENCE SYMPOSIUM, P68; Lin L, 2009, SOFT COMPUT, V13, P157, DOI 10.1007/s00500-008-0303-2; Mariusz Oszust., 2021, KNOWL-BASED SYST, P232; Mirjalili S., 2010, Proceedings of the 2010 International Conference on Computer and Information Application (ICCIA 2010), P374, DOI 10.1109/ICCIA.2010.6141614; Mirjalili S, 2017, ADV ENG SOFTW, V114, P163, DOI 10.1016/j.advengsoft.2017.07.002; Mirjalili S, 2016, NEURAL COMPUT APPL, V27, P1053, DOI 10.1007/s00521-015-1920-1; Mirjalili S, 2015, KNOWL-BASED SYST, V89, P228, DOI 10.1016/j.knosys.2015.07.006; Mirjalili S, 2016, NEURAL COMPUT APPL, V27, P495, DOI 10.1007/s00521-015-1870-7; Mirjalili S, 2014, NEURAL COMPUT APPL, V25, P663, DOI 10.1007/s00521-013-1525-5; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Mirjalili S, 2013, SWARM EVOL COMPUT, V9, P1, DOI 10.1016/j.swevo.2012.09.002; Mirjalili S, 2012, APPL MATH COMPUT, V218, P11125, DOI 10.1016/j.amc.2012.04.069; Molga M., 2005, TEST FUNCTIONS OPTIM, V101, P1; Olorunda O, 2008, IEEE C EVOL COMPUTAT, P1128, DOI 10.1109/CEC.2008.4630938; Pulgar-Rubio F, 2017, KNOWL-BASED SYST, V117, P70, DOI 10.1016/j.knosys.2016.08.021; RAGSDELL KM, 1976, J ENG IND-T ASME, V98, P1021, DOI 10.1115/1.3438995; Sharma M, 2021, IETE J RES, V67, P394, DOI 10.1080/03772063.2018.1548908; Singh T, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21124086; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Yang XS, 2009, LECT NOTES COMPUT SC, V5792, P169, DOI 10.1007/978-3-642-04944-6_14; Yang Xin-She, 2010, ENG OPTIMIZATION INT; Yao X, 1999, IEEE T EVOLUT COMPUT, V3, P82, DOI 10.1109/4235.771163; Yi LZ, 2022, J ELECTR ENG TECHNOL, V17, P381, DOI 10.1007/s42835-021-00883-6; Zhang YJ, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/529724; Zhonghe Zhai., 2007, CELL BIOL, V3, P101	38	3	3	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	12							e0260512	10.1371/journal.pone.0260512	http://dx.doi.org/10.1371/journal.pone.0260512			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1MC	34871309	gold, Green Published			2022-12-26	WOS:000728598900005
J	Cabrera, O; Ficorilli, J; Shaw, J; Echeverri, F; Schwede, F; Chepurny, OG; Leech, CA; Holz, GG				Cabrera, Over; Ficorilli, James; Shaw, Janice; Echeverri, Felipe; Schwede, Frank; Chepurny, Oleg G.; Leech, Colin A.; Holz, George G.			Intra-islet glucagon confers beta-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; PEPTIDE-1 RECEPTOR; SIGNAL-TRANSDUCTION; ALPHA-CELLS; ADENOSINE-3',5'-MONOPHOSPHATE LEVELS; INTRAVENOUS GLUCOSE; RAP1 ACTIVATION; MOUSE ISLETS; CAMP; EPAC	We report that intra-islet glucagon secreted from alpha-cells signals through beta-cell glucagon and GLP-1 receptors (GcgR and GLP-1R), thereby conferring to rat islets their competence to exhibit first-phase glucose-stimulated insulin secretion (GSIS). Thus, in islets not treated with exogenous glucagon or GLP-1, first-phase GSIS is abolished by a GcgR antagonist (LY2786890) or a GLP-1R antagonist (Ex[9-39]). Mechanistically, glucose competence in response to intra-islet glucagon is conditional on beta-cell cAMP signaling because it is blocked by the cAMP antagonist prodrug Rp-8-Br-cAMPS-pAB. In its role as a paracrine hormone, intra-islet glucagon binds with high affinity to the GcgR, while also exerting a "spillover" effect to bind with low affinity to the GLP-1R. This produces a right shift of the concentration-response relationship for the potentiation of GSIS by exogenous glucagon. Thus, 0.3 nM glucagon fails to potentiate GSIS, as expected if similar concentrations of intra-islet glucagon already occupy the GcgR. However, 10 to 30 nM glucagon effectively engages the beta-cell GLP-1R to potentiate GSIS, an action blocked by Ex[9-39] but not LY2786890. Finally, we report that the action of intra-islet glucagon to support insulin secretion requires a step-wise in-crease of glucose concentration to trigger first-phase GSIS. It is not measurable when GSIS is stimulated by a gradient of increasing glucose concentrations, as occurs during an oral glucose tolerance test in vivo. Collectively, such findings are understandable if defective intra-islet glucagon action contributes to the characteristic loss of first-phase GSIS in an intravenous glucose tolerance test that is diagnostic of type 2 diabetes in the clinical setting.	[Cabrera, Over; Ficorilli, James; Shaw, Janice] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Echeverri, Felipe] Biorep Technol, Miami Lakes, FL USA; [Schwede, Frank] Biolog Life Sci Inst GmbH & Co KG, Bremen, Germany; [Chepurny, Oleg G.; Leech, Colin A.; Holz, George G.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Holz, George G.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	Eli Lilly; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Cabrera, O (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.; Holz, GG (corresponding author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.; Holz, GG (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA.	over.cabrera@lilly.com; holzg@upstate.edu		Leech, Colin/0000-0002-5859-1304	NIH [R01DK069575, R01DK122332]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by NIH grants R01DK069575 and R01DK122332 (G. G. H.) . This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Bergman M, 2020, DIABETES RES CLIN PR, V165, DOI 10.1016/j.diabres.2020.108233; BRUNZELL JD, 1976, J CLIN ENDOCR METAB, V42, P222, DOI 10.1210/jcem-42-2-222; Campbell JE, 2021, NAT REV MOL CELL BIO, V22, P142, DOI 10.1038/s41580-020-00317-7; Campbell SA, 2020, MOL METAB, V39, DOI 10.1016/j.molmet.2020.101014; Capozzi ME, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126742; Chepurny OG, 2019, J BIOL CHEM, V294, P3514, DOI 10.1074/jbc.RA118.005682; Chepurny OG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22106-1; Chepurny OG, 2009, J BIOL CHEM, V284, P10728, DOI 10.1074/jbc.M900166200; Del Prato S, 2002, DIABETES, V51, pS109, DOI 10.2337/diabetes.51.2007.S109; Dungan KM, 2014, LANCET, V384, P1349, DOI 10.1016/S0140-6736(14)60976-4; Dzhura I, 2011, ISLETS, V3, P121, DOI 10.4161/isl.3.3.15507; Dzhura I, 2010, J PHYSIOL-LONDON, V588, P4871, DOI 10.1113/jphysiol.2010.198424; Fehse F, 2005, J CLIN ENDOCR METAB, V90, P5991, DOI 10.1210/jc.2005-1093; Finan B, 2020, DIABETES, V69, P532, DOI 10.2337/dbi19-0004; Galicia-Garcia U, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176275; Galvin SG, 2021, J PROTEOME RES, V20, P4507, DOI 10.1021/acs.jproteome.1c00463; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gerich JE, 2002, DIABETES, V51, pS117, DOI 10.2337/diabetes.51.2007.S117; Gilon P, 2020, J MOL BIOL, V432, P1367, DOI 10.1016/j.jmb.2020.01.004; GROMADA J, 1995, FEBS LETT, V373, P182, DOI 10.1016/0014-5793(95)01070-U; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Hatakeyama H, 2006, J PHYSIOL-LONDON, V570, P271, DOI 10.1113/jphysiol.2005.096560; Henquin JC, 2006, DIABETES, V55, P441, DOI 10.2337/diabetes.55.02.06.db05-1051; Henquin JC, 2021, MOL METAB, V48, DOI 10.1016/j.molmet.2021.101212; Henquin JC, 2021, AM J PHYSIOL-ENDOC M, V320, pE78, DOI 10.1152/ajpendo.00485.2020; Henquin JC, 2014, ENDOCRINOLOGY, V155, P3274, DOI 10.1210/en.2014-1247; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; HOLST JJ, 1994, J BIOL CHEM, V269, P18827; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; HOLZ GG, 1992, TRENDS BIOCHEM SCI, V17, P388, DOI 10.1016/0968-0004(92)90006-U; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; Huypens P, 2000, DIABETOLOGIA, V43, P1012, DOI 10.1007/s001250051484; Idevall-Hagren O, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003932; Jiang YW, 2001, P NATL ACAD SCI USA, V98, P10102, DOI 10.1073/pnas.131200398; Jun LS, 2015, DIABETES, V64, P819, DOI 10.2337/db14-1052; Kelley GG, 2009, ISLETS, V1, P260, DOI 10.4161/isl.1.3.9645; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Kofod H, 1996, ACTA PHYSIOL SCAND, V157, P347, DOI 10.1046/j.1365-201X.1996.39264000.x; Kuhtreiber WM, 2010, TRANSPL P, V42, P2027, DOI 10.1016/j.transproceed.2010.05.099; Lau J, 2015, J MED CHEM, V58, P7370, DOI 10.1021/acs.jmedchem.5b00726; Leech CA, 2010, VITAM HORM, V84, P279, DOI [10.1016/B978-0-12-381517-0.00010-2, 10.1016/S0083-6729(10)84008-7]; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; Marchetti P, 2012, DIABETOLOGIA, V55, P3262, DOI 10.1007/s00125-012-2716-9; Moede T, 2020, DIABETOLOGIA, V63, P2064, DOI 10.1007/s00125-020-05196-3; Moens K, 1996, DIABETES, V45, P257, DOI 10.2337/diabetes.45.2.257; Moens K, 2002, DIABETES, V51, P669, DOI 10.2337/diabetes.51.3.669; Moens K, 1998, DIABETES, V47, P66, DOI 10.2337/diabetes.47.1.66; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; Muller TD, 2017, PHYSIOL REV, V97, P721, DOI 10.1152/physrev.00025.2016; Nauck M, 2014, DIABETES CARE, V37, P2149, DOI 10.2337/dc13-2761; O'Malley TJ, 2014, DIABETES-METAB RES, V30, P661, DOI 10.1002/dmrr.2534; PIPELEERS D, 1982, P NATL ACAD SCI-BIOL, V79, P7322, DOI 10.1073/pnas.79.23.7322; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P824, DOI 10.1210/endo-117-3-824; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Rodriguez-Diaz R, 2018, CELL METAB, V27, P549, DOI 10.1016/j.cmet.2018.01.015; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Sandoval D, 2020, DIABETES, V69, P2238, DOI 10.2337/dbi19-0027; Schirra J, 1998, J CLIN INVEST, V101, P1421, DOI 10.1172/JCI1349; SCHUIT FC, 1985, ENDOCRINOLOGY, V117, P834, DOI 10.1210/endo-117-3-834; Schwede F, 2015, MOL ENDOCRINOL, V29, P988, DOI 10.1210/me.2014-1330; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Serre V, 1998, ENDOCRINOLOGY, V139, P4448, DOI 10.1210/en.139.11.4448; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Shigeto M, 2017, J MOL MED, V95, P361, DOI 10.1007/s00109-017-1508-6; Shigeto M, 2015, J CLIN INVEST, V125, P4714, DOI 10.1172/JCI81975; Shigeto M, 2008, J PHARMACOL SCI, V108, P274, DOI 10.1254/jphs.08090FP; Shuai HY, 2021, ACTA PHYSIOL, V231, DOI 10.1111/apha.13611; Song WJ, 2013, DIABETES, V62, P2796, DOI 10.2337/db12-1394; Song WJ, 2011, CELL METAB, V13, P308, DOI 10.1016/j.cmet.2011.02.002; Sorensen H, 2006, DIABETES, V55, P3463, DOI 10.2337/db06-0307; Svendsen B, 2018, CELL REP, V25, P1127, DOI 10.1016/j.celrep.2018.10.018; Tibaduiza EC, 2001, J BIOL CHEM, V276, P37787; Traub S, 2017, CELL REP, V18, P3192, DOI 10.1016/j.celrep.2017.03.005; Trujillo JM, 2021, THER ADV ENDOCRINOL, V12, DOI 10.1177/2042018821997320; Veluthakal R, 2018, DIABETES, V67, P1999, DOI 10.2337/db17-1174; Whalley NM, 2011, J ENDOCRINOL, V211, P99, DOI 10.1530/JOE-11-0094; Wideman RD, 2007, DIABETES, V56, P2744, DOI 10.2337/db07-0563; Zaccolo M, 2021, PHARMACOL REV, V73, P278, DOI 10.1124/pharmrev.120.000086; Zhang YL, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10092495; Zhu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127994	82	4	4	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101484	10.1016/j.jbc.2021.101484	http://dx.doi.org/10.1016/j.jbc.2021.101484			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1YB	34896391	gold, Green Published			2022-12-26	WOS:000761423400010
J	Henkel, S; Frohnecke, N; Maus, D; McConville, MJ; Laue, M; Blume, M; Seeber, F				Henkel, Stephanie; Frohnecke, Nora; Maus, Deborah; McConville, Malcolm J.; Laue, Michael; Blume, Martin; Seeber, Frank			Toxoplasma gondii apicoplast-resident ferredoxin is an essential electron transfer protein for the MEP isoprenoid-biosynthetic pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE PATHWAY; METHYLERYTHRITOL PHOSPHATE-PATHWAY; ESCHERICHIA-COLI; MEVALONATE PATHWAY; ALGAL ORIGIN; APICOMPLEXAN; GENE; REDUCTASE; SYNTHASE; INHIBITION	Apicomplexan parasites, such as Toxoplasma gondii, are unusual in that each cell contains a single apicoplast, a plastid-like organelle that compartmentalizes enzymes involved in the essential 2C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis. The last two enzymatic steps in this organellar pathway require electrons from a redox carrier. However, the small iron-sulfur cluster-containing protein ferredoxin, a likely candidate for this function, has not been investigated in this context. We show here that inducible knockdown of T. gondii ferredoxin results in progressive inhibition of growth and eventual parasite death. Surprisingly, this phenotype is not accompanied by ultrastructural changes in the apicoplast or overall cell morphology. The knockdown of ferredoxin was instead associated with a dramatic decrease in cellular levels of the last two metabolites in isoprenoid biosynthesis, 1-hydroxy-2-methyl-2-(E)- butenyl-4-gyro phosphate, and isomeric dimethylallyl pyrophosphate/isopentenyl pyrophosphate. Ferredoxin depletion was also observed to impair gliding motility, consistent with isoprenoid metabolites being important for dolichol biosynthesis, protein prenylation, and modification of other proteins involved in motility. Significantly, pharmacological inhibition of isoprenoid synthesis of the host cell exacerbated the impact of ferredoxin depletion on parasite replication, suggesting that the slow onset of parasite death after ferredoxin depletion is because of isoprenoid scavenging from the host cell and leading to partial compensation of the depleted parasite metabolites upon ferredoxin knockdown. Overall, these findings show that ferredoxin has an essential physiological function as an electron donor for the 2C-methyl-D-erythritol 4-phosphate pathway and is a potential drug target for apicomplexan parasites.	[Henkel, Stephanie; Frohnecke, Nora; Seeber, Frank] Robert Koch Inst, Mycot & Parasit Agents & Mycobacteria FG16, Berlin, Germany; [Maus, Deborah; Blume, Martin] Robert Koch Inst, Metab Microbial Pathogens NG2, Berlin, Germany; [McConville, Malcolm J.; Blume, Martin] Univ Melbourne, Bio21 Inst Mol Sci & Biotechnol, Dept Biochem & Pharmacol, Melbourne, Vic, Australia; [Laue, Michael] Robert Koch Inst, Adv Light & Electron Microscopy ZBS 4, Berlin, Germany; [Frohnecke, Nora] Berlin Chem AG, Berlin, Germany	Robert Koch Institute; Robert Koch Institute; University of Melbourne; Robert Koch Institute	Seeber, F (corresponding author), Robert Koch Inst, Mycot & Parasit Agents & Mycobacteria FG16, Berlin, Germany.	seeberf@rki.de		Maus, Deborah/0000-0002-9688-2663; Laue, Michael/0000-0002-6474-9139; Seeber, Frank/0000-0002-2271-3699	German Research Council (DFG); Federal Ministry of Education and Research (BMBF) [01KI1715]; Robert Koch-Institute	German Research Council (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Robert Koch-Institute	S. H. was supported by and M. B. and F. S. are members of the graduate school IRTG 2290 "Crossing boundaries -molecular interactions in malaria", supported by the German Research Council (DFG). D. M. and M. B. are funded by the Federal Ministry of Education and Research (BMBF) under project number 01KI1715 as part of the "Research Network Zoonotic Infectious Diseases". N. F., M. L., M. B. and F. S. received internal funding from the Robert Koch-Institute. M. J. M. is a NHMRC Principal Research Fellow.	Albuquerque-Wendt A, 2020, J BIOL CHEM, V295, P1066, DOI 10.1074/jbc.RA119.010590; Altincicek B, 2001, FEBS LETT, V499, P37, DOI 10.1016/S0014-5793(01)02516-9; Altincicek B, 2001, J BACTERIOL, V183, P2411, DOI 10.1128/JB.183.8.2411-2416.2001; Amberg-Johnson K, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01646-18; Baidoo EEK, 2019, METHODS MOL BIOL, V1859, P209, DOI 10.1007/978-1-4939-8757-3_11; Bandini G, 2019, PARASITOLOGY, V146, P1755, DOI 10.1017/S0031182019000040; Banerjee A, 2013, J BIOL CHEM, V288, P16926, DOI 10.1074/jbc.M113.464636; Bansal P, 2017, MBIO, V8, DOI [10.1128/mBio.01468-17, 10.1128/mbio.01468-17]; Baumeister S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019334; Bentlage B, 2016, J EUKARYOT MICROBIOL, V63, P123, DOI 10.1111/jeu.12261; Bergmiller T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002803; BIANCHI V, 1995, J BACTERIOL, V177, P4528, DOI 10.1128/jb.177.15.4528-4531.1995; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Blume Martin, 2018, F1000Res, V7, DOI 10.12688/f1000research.16021.1; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; BURG JL, 1988, J IMMUNOL, V141, P3584; Cassera MB, 2007, MEM I OSWALDO CRUZ, V102, P377, DOI 10.1590/S0074-02762007000300019; Castella B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15663; Cobbold SA, 2021, MOL SYST BIOL, V17, DOI 10.15252/msb.202010023; Daletos G, 2020, TRENDS BIOTECHNOL, V38, P811, DOI 10.1016/j.tibtech.2020.03.009; de Souza A, 2017, ANNU REV PLANT BIOL, V68, P85, DOI 10.1146/annurev-arplant-042916-041007; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Fauquenoy Sylvain, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.M111.008953; Flugge UI, 2005, PLANT BIOLOGY, V7, P91, DOI 10.1055/s-2004-830446; Fouts AE, 2007, INFECT IMMUN, V75, P634, DOI 10.1128/IAI.01228-06; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Frohnecke N, 2015, FEBS LETT, V589, P31, DOI 10.1016/j.febslet.2014.11.020; Garenaux E, 2008, BIOCHEMISTRY-US, V47, P12270, DOI 10.1021/bi801090a; Gas-Pascual E, 2019, J BIOL CHEM, V294, P1104, DOI 10.1074/jbc.RA118.006072; Gaudu P, 2000, J BACTERIOL, V182, P1788, DOI 10.1128/JB.182.7.1788-1793.2000; Georg KW, 2018, METAB ENG, V47, P60, DOI 10.1016/j.ymben.2018.03.004; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Han M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062467; Harb OS, 2004, EUKARYOT CELL, V3, P663, DOI 10.1128/EC.3.3.663-674.2004; Harding CR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005403; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Hollinshead M, 1997, J HISTOCHEM CYTOCHEM, V45, P1053, DOI 10.1177/002215549704500803; Holstein SA, 2004, LIPIDS, V39, P293, DOI 10.1007/s11745-004-1233-3; Hoshino Y, 2018, MOL BIOL EVOL, V35, P2185, DOI 10.1093/molbev/msy120; Imlay L, 2014, CURR CLIN MICROBIOL, V1, P37, DOI 10.1007/s40588-014-0006-7; Jacot D, 2020, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN-PERSPECTIVES AND METHODS, 3RD EDITION, P897, DOI 10.1016/B978-0-12-815041-2.00020-7; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Jelenska J, 2001, P NATL ACAD SCI USA, V98, P2723, DOI 10.1073/pnas.051629998; Jimenez-Ruiz E, 2014, PARASITOLOGY, V141, P1390, DOI 10.1017/S0031182014000559; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kameyama K., 2011, Journal of Protozoology Research, V21, P50; Kennedy K, 2019, TRENDS PARASITOL, V35, P747, DOI 10.1016/j.pt.2019.07.010; KIM K, 1993, SCIENCE, V262, P911, DOI 10.1126/science.8235614; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Krishnan A, 2020, CELL HOST MICROBE, V27, P290, DOI 10.1016/j.chom.2020.01.002; Leveque MF, 2015, MBIO, V6, DOI 10.1128/mBio.01446-15; Li QY, 2017, METAB ENG, V44, P13, DOI 10.1016/j.ymben.2017.08.005; Li ZH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003665; Liang XH, 2020, J BIOL CHEM, V295, P7743, DOI 10.1074/jbc.RA120.013004; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; McAteer S, 2001, J BACTERIOL, V183, P7403, DOI 10.1128/JB.183.24.7403-7407.2001; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meissner M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.22.e115; Molan A, 2019, TROP BIOMED, V36, P898; Nair SC, 2011, J EXP MED, V208, P1547, DOI 10.1084/jem.20110039; Nakayama T, 2013, GENES GENET SYST, V88, P175, DOI 10.1266/ggs.88.175; Okada K, 2005, J BIOL CHEM, V280, P20672, DOI 10.1074/jbc.M500865200; Pala ZR, 2018, TRENDS PARASITOL, V34, P800, DOI 10.1016/j.pt.2018.05.010; Pandini V, 2002, J BIOL CHEM, V277, P48463, DOI 10.1074/jbc.M209388200; Puan KJ, 2005, FEBS LETT, V579, P3802, DOI 10.1016/j.febslet.2005.05.047; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Ramakrishnan S, 2012, J BIOL CHEM, V287, P4957, DOI 10.1074/jbc.M111.310144; Rather GA, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1912-x; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Rohrich RC, 2005, FEBS LETT, V579, P6433, DOI 10.1016/j.febslet.2005.10.037; Salamun J, 2014, FASEB J, V28, P4729, DOI 10.1096/fj.14-252569; Seeber F, 2005, CURR PHARM DESIGN, V11, P3159, DOI 10.2174/1381612054864957; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Singh KS, 2021, NATURE, V589, P597, DOI 10.1038/s41586-020-03074-x; Swift RP, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008316; Tanaka N, 2016, MOL MICROBIOL, V99, P835, DOI 10.1111/mmi.13271; Tewari SG, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.02392-20; Thomsen-Zieger N, 2004, FEBS LETT, V576, P375, DOI 10.1016/j.febslet.2004.09.042; Ufermann CM, 2017, EXP PARASITOL, V180, P19, DOI 10.1016/j.exppara.2016.12.015; Venugopal K, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008106; Volke DC, 2019, MICROB CELL FACT, V18, DOI 10.1186/s12934-019-1235-5; Vollmer M, 2001, J BIOL CHEM, V276, P5483, DOI 10.1074/jbc.M009452200; Vranova E, 2013, ANNU REV PLANT BIOL, V64, P665, DOI 10.1146/annurev-arplant-050312-120116; Wang WX, 2010, P NATL ACAD SCI USA, V107, P11189, DOI 10.1073/pnas.1000264107; Wang WX, 2010, P NATL ACAD SCI USA, V107, P4522, DOI 10.1073/pnas.0911087107; Ward VCA, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny079; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; Zhou J, 2017, J BIOTECHNOL, V248, P1, DOI 10.1016/j.jbiotec.2017.03.005; Zhou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047513; Zimbres FM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70246-0; Zou RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079557	96	5	5	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101468	10.1016/j.jbc.2021.101468	http://dx.doi.org/10.1016/j.jbc.2021.101468			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP0ZE	34896149	gold, Green Published			2022-12-26	WOS:000748357700011
J	Shukla, PK; Meena, AS; Pierre, JF; Rao, R				Shukla, Pradeep K.; Meena, Avtar S.; Pierre, Joseph F.; Rao, RadhaKrishna			Central role of intestinal epithelial glucocorticoid receptor in alcohol- and corticosterone-induced gut permeability and systemic response	FASEB JOURNAL			English	Article						endotoxemia; hepatitis; hypothalamus; inflammation; tight junction	PITUITARY-ADRENAL AXIS; STRESSFUL LIFE EVENTS; TIGHT JUNCTIONS; TNF-ALPHA; LIVER-DISEASE; KUPFFER CELLS; FATTY LIVER; ENDOTOXEMIA; PHOSPHORYLATION; CONSUMPTION	Corticosterone, the stress hormone, exacerbates alcohol-associated tissue injury, but the mechanism involved is unknown. We examined the role of the glucocorticoid receptor (GR) in corticosterone-mediated potentiation of alcohol-induced gut barrier dysfunction and systemic response. Hepatocyte-specific GR-deficient (GR(Delta HC)) and intestinal epithelial-specific GR-deficient (GR(Delta IEC)) mice were fed ethanol, combined with corticosterone treatment. Intestinal epithelial tight junction integrity, mucosal barrier function, microbiota dysbiosis, endotoxemia, systemic inflammation, liver damage, and neuroinflammation were assessed. Corticosterone potentiated ethanol-induced epithelial tight junction disruption, mucosal permeability, and inflammatory response in GR(Delta HC) mouse colon; these effects of ethanol and corticosterone were absent in GR(Delta IEC) mice. Gut microbiota compositions in ethanol-fed GR(Delta HC) and GR(Delta IEC) mice were similar to each other. However, corticosterone treatment in ethanol-fed mice shifted the microbiota composition to distinctly different directions in GR(Delta HC) and GR(Delta IEC) mice. Ethanol and corticosterone synergistically elevated the abundance of Enterobacteriaceae and Escherichia coli and reduced the abundance of Lactobacillus in GR(Delta HC) mice but not in GR(Delta IEC) mice. In GR(Delta HC) mice, corticosterone potentiated ethanol-induced endotoxemia and systemic inflammation, but these effects were absent in GR(Delta IEC) mice. Interestingly, ethanol-induced liver damage and its potentiation by corticosterone were observed in GR(Delta HC) mice but not in GR(Delta IEC) mice. GR(Delta IEC) mice were also resistant to ethanol- and corticosterone-induced inflammatory response in the hypothalamus. These data indicate that the intestinal epithelial GR plays a central role in alcohol- and corticosterone-induced gut barrier dysfunction, microbiota dysbiosis, endotoxemia, systemic inflammation, liver damage, and neuroinflammation. This study identifies a novel target for potential therapeutic for alcohol-associated tissue injury.	[Shukla, Pradeep K.; Meena, Avtar S.; Rao, RadhaKrishna] Univ Tennessee, Coll Med, Dept Physiol, Hlth Sci Ctr, Memphis, TN 38163 USA; [Pierre, Joseph F.] Univ Tennessee, Coll Med, Dept Pediat, Hlth Sci Ctr, Memphis, TN 38163 USA; [Rao, RadhaKrishna] Memphis Vet Affairs Med Ctr, Memphis, TN USA; [Meena, Avtar S.] Ctr Cellular & Mol Biol, Hyderabad, Telangana, India	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Rao, R (corresponding author), Univ Tennessee, Dept Physiol, Hlth Sci Ctr, 3 N Dunlap,Suite S303, Memphis, TN 38163 USA.	rrao2@uthsc.edu	Pierre, Joseph/HCH-3993-2022		U.S. Department of Veterans Affairs (VA) [I01 BX003014]; HHS I National Institutes of Health (NTH) [R01-AA12307, R01-DK55532]	U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); HHS I National Institutes of Health (NTH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01 BX003014; HHS I National Institutes of Health (NTH), Grant/Award Number: R01-AA12307 and R01-DK55532	ALLAN CA, 1985, J STUD ALCOHOL, V46, P147, DOI 10.15288/jsa.1985.46.147; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Bengtsson-Palme J, 2018, BIOINFORMATICS, V34, P4027, DOI 10.1093/bioinformatics/bty482; Blaine SK, 2016, CAN J PSYCHIAT, V61, P145, DOI 10.1177/0706743716632512; Campbell HK, 2017, EXP CELL RES, V358, P39, DOI 10.1016/j.yexcr.2017.03.061; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chi HM, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-020-02053-3; Ciocan D, 2018, ALIMENT PHARM THER, V48, P961, DOI 10.1111/apt.14949; Ciocan D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23146-3; Coopman P, 2016, CELL MOL LIFE SCI, V73, P3535, DOI 10.1007/s00018-016-2260-8; Covelli V, 2005, CURR MED CHEM, V12, P1801, DOI 10.2174/0929867054367202; de Punder K, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00223; Debell F, 2014, SOC PSYCH PSYCH EPID, V49, P1401, DOI 10.1007/s00127-014-0855-7; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Erickson EK, 2019, PHARMACOL BIOCHEM BE, V177, P34, DOI 10.1016/j.pbb.2018.12.007; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Flynn NE, 2009, AMINO ACIDS, V37, P123, DOI 10.1007/s00726-008-0206-7; Gameiro GH, 2006, PHYSIOL BEHAV, V87, P643, DOI 10.1016/j.physbeh.2005.12.007; Gao YH, 2019, GUT, V68, P1311, DOI 10.1136/gutjnl-2018-316221; Grander C, 2018, GUT, V67, P892, DOI 10.1136/gutjnl-2016-313432; Haddad JJ, 2004, BIOCHEM BIOPH RES CO, V323, P361, DOI 10.1016/j.bbrc.2004.08.119; HENRY JP, 1993, INTEGR PHYS BEH SCI, V28, P369, DOI 10.1007/BF02690935; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Im GY, 2019, CLIN LIVER DIS, V23, P81, DOI 10.1016/j.cld.2018.09.005; KATHOL RG, 1988, PSYCHIAT CLIN N AM, V11, P335; Kumar M, 2019, J CLIN EXP HEPATOL, V9, P215, DOI 10.1016/j.jceh.2018.09.002; Kumari S, 2016, STEROIDS, V114, P68, DOI 10.1016/j.steroids.2016.03.016; Litwinowicz K, 2020, AM J DRUG ALCOHOL AB, V46, P4, DOI 10.1080/00952990.2019.1669629; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lv WJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7902874; Morris NL, 2015, ALCOHOL, V49, P1, DOI 10.1016/j.alcohol.2014.07.018; Mueller, 2020, ALCOHOLIC LIVER DIS; Mueller KM, 2012, MOL CELL ENDOCRINOL, V361, P1, DOI 10.1016/j.mce.2012.03.026; Mutlu E, 2009, ALCOHOL CLIN EXP RES, V33, P1836, DOI 10.1111/j.1530-0277.2009.01022.x; Nagy LE, 2016, GASTROENTEROLOGY, V150, P1756, DOI 10.1053/j.gastro.2016.02.035; Osna NA, 2017, ALCOHOL RES-CURR REV, V38, P147; Pervanidou P, 2018, HORM RES PAEDIAT, V89, P372, DOI 10.1159/000488468; Pierre JF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70461-9; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Rao R, 2009, ANN NY ACAD SCI, V1165, P62, DOI 10.1111/j.1749-6632.2009.04054.x; Rose AK, 2010, ALCOHOL CLIN EXP RES, V34, P2011, DOI 10.1111/j.1530-0277.2010.01298.x; Russell G, 2019, NAT REV ENDOCRINOL, V15, P525, DOI 10.1038/s41574-019-0228-0; Samak G, 2016, SCI REP-UK, V6, DOI 10.1038/srep38899; Samak G, 2015, BIOCHEM J, V465, P503, DOI 10.1042/BJ20140450; Seabra V, 1998, J LEUKOCYTE BIOL, V64, P615, DOI 10.1002/jlb.64.5.615; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sheppard KE, 2002, AM J PHYSIOL-GASTR L, V282, pG742, DOI 10.1152/ajpgi.00531.2001; Shukla PK, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80637-y; Shukla PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34263-4; Shukla PK, 2018, FASEB J, V32, P6274, DOI 10.1096/fj.201800351R; Sillaber I, 2004, ANN MED, V36, P596, DOI 10.1080/07853890410018862; Smart Laura, 2013, Curr Hepat Rep, V12, P59; Stephens MAC, 2012, ALCOHOL RES-CURR REV, V34, P468; Thomas P, 2006, J ENDOTOXIN RES, V12, P352, DOI 10.1179/096805106X118898; Tsukamoto H, 2009, SEMIN LIVER DIS, V29, P178, DOI 10.1055/s-0029-1214373; Van Itallie CM, 2014, SEMIN CELL DEV BIOL, V36, P157, DOI 10.1016/j.semcdb.2014.08.011; VANTHIEL DH, 1978, J CLIN INVEST, V61, P624, DOI 10.1172/JCI108973; VENKATESAN S, 1989, BIOCHEM SOC T, V17, P1114, DOI 10.1042/bst0171114; WAND GS, 1991, J CLIN ENDOCR METAB, V72, P1290, DOI 10.1210/jcem-72-6-1290; WEINHOLD L, 1991, BIOL CHEM H-S, V372, P829, DOI 10.1515/bchm3.1991.372.2.829; Westfall S, 2017, CELL MOL LIFE SCI, V74, P3769, DOI 10.1007/s00018-017-2550-9; Woods CP, 2015, J STEROID BIOCHEM, V154, P94, DOI 10.1016/j.jsbmb.2015.07.020; Yang XX, 2020, HISTOL HISTOPATHOL, V35, P1379, DOI 10.14670/HH-18-241; Young-Wolff KC, 2012, J STUD ALCOHOL DRUGS, V73, P559, DOI 10.15288/jsad.2012.73.559; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725	67	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22061	10.1096/fj.202101424R	http://dx.doi.org/10.1096/fj.202101424R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34861075	hybrid, Green Published			2022-12-26	WOS:000734992000058
J	Klimovich, B; Merle, N; Neumann, M; Elmshauser, S; Nist, A; Mernberger, M; Kazdal, D; Stenzinger, A; Timofeev, O; Stiewe, T				Klimovich, Boris; Merle, Nastasja; Neumann, Michelle; Elmshaeuser, Sabrina; Nist, Andrea; Mernberger, Marco; Kazdal, Daniel; Stenzinger, Albrecht; Timofeev, Oleg; Stiewe, Thorsten			p53 partial loss-of-function mutations sensitize to chemotherapy	ONCOGENE			English	Article							CELL-CYCLE ARREST; DNA-BINDING COOPERATIVITY; MUTANT P53; TUMOR SUPPRESSION; APOPTOTIC RESPONSE; CANCER; TUMORIGENESIS; ACTIVATION; MDM2; RECOGNITION	The tumor suppressive transcription factor p53 is frequently inactivated in cancer cells by missense mutations that cluster in the DNA binding domain. 30% hit mutational hotspot residues, resulting in a complete loss of transcriptional activity and mutant p53-driven chemotherapy resistance. Of the remaining 70% of non-hotspot mutants, many are partial loss-of-function (partial-LOF) mutants with residual transcriptional activity. The therapeutic consequences of a partial-LOF have remained largely elusive. Using a p53 mutation engineered to reduce DNA binding, we demonstrate that partial-LOF is sufficient to enhance oncogene-driven tumorigenesis in mouse models of lung and pancreatic ductal adenocarcinoma and acute myeloid leukemia. Interestingly, mouse and human tumors with partial-LOF mutations showed mutant p53 protein accumulation similar as known for hotspot mutants. Different from the chemotherapy resistance caused by p53-loss, the partial-LOF mutant sensitized to an apoptotic chemotherapy response and led to a survival benefit. Mechanistically, the pro-apoptotic transcriptional activity of mouse and human partial-LOF mutants was rescued at high mutant protein levels, suggesting that accumulation of partial-LOF mutants enables the observed apoptotic chemotherapy response. p53 non-hotspot mutants with partial-LOF, therefore, represent tumorigenic p53 mutations that need to be distinguished from other mutations because of their beneficial impact on survival in a therapy context.	[Klimovich, Boris; Merle, Nastasja; Neumann, Michelle; Elmshaeuser, Sabrina; Mernberger, Marco; Timofeev, Oleg; Stiewe, Thorsten] Univ Giessen & Marburg Lung Ctr UGMLC, Inst Mol Oncol, Marburg, Germany; [Klimovich, Boris; Merle, Nastasja; Neumann, Michelle; Elmshaeuser, Sabrina; Mernberger, Marco; Timofeev, Oleg; Stiewe, Thorsten] Philipps Univ, German Ctr Lung Res DZL, Marburg, Germany; [Nist, Andrea; Stiewe, Thorsten] Philipps Univ, Genom Core Facil, Marburg, Germany; [Kazdal, Daniel; Stenzinger, Albrecht] Heidelberg Univ Hosp, Translat Lung Res Ctr Heidelberg TLRC H, Inst Pathol, Heidelberg, Germany; [Kazdal, Daniel; Stenzinger, Albrecht] German Ctr Lung Res DZL, Heidelberg, Germany	Philipps University Marburg; Philipps University Marburg; Ruprecht Karls University Heidelberg	Timofeev, O; Stiewe, T (corresponding author), Univ Giessen & Marburg Lung Ctr UGMLC, Inst Mol Oncol, Marburg, Germany.; Timofeev, O; Stiewe, T (corresponding author), Philipps Univ, German Ctr Lung Res DZL, Marburg, Germany.; Stiewe, T (corresponding author), Philipps Univ, Genom Core Facil, Marburg, Germany.		Kazdal, Daniel/ABG-7629-2020	Kazdal, Daniel/0000-0001-8187-3281; Merle, Nastasja/0000-0003-4957-8463; Timofeev, Oleg/0000-0002-3114-6403; Stiewe, Thorsten/0000-0003-0134-7826	Projekt DEAL	Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL.	Abbas HA, 2010, CELL STEM CELL, V7, P606, DOI 10.1016/j.stem.2010.09.013; Andreeff M, 2016, CLIN CANCER RES, V22, P868, DOI 10.1158/1078-0432.CCR-15-0481; Blanden AR, 2020, ELIFE, V9, DOI [10.7554/eLife.61487, 10.7594/eLife.61487]; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Dehner A, 2005, ANGEW CHEM INT EDIT, V44, P5247, DOI 10.1002/anie.200501887; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Donehower LA, 2019, CELL REP, V28, P1370, DOI 10.1016/j.celrep.2019.07.001; Engeland K, 2018, CELL DEATH DIFFER, V25, P114, DOI 10.1038/cdd.2017.172; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Giacomelli AO, 2018, NAT GENET, V50, P1381, DOI 10.1038/s41588-018-0204-y; Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kim MP, 2018, CELL DEATH DIFFER, V25, P161, DOI 10.1038/cdd.2017.185; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Klein C, 2001, J BIOL CHEM, V276, P49020, DOI 10.1074/jbc.M107516200; Klimovich B, 2020, CELL CYCLE, V19, P109, DOI 10.1080/15384101.2019.1693748; Kotler E, 2018, MOL CELL, V71, P178, DOI 10.1016/j.molcel.2018.06.012; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Leroy B, 2014, HUM MUTAT, V35, P672, DOI 10.1002/humu.22552; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; Mellert H, 2013, CELL REP, V3, P1335, DOI 10.1016/j.celrep.2013.05.011; Mello SS, 2018, CURR OPIN CELL BIOL, V51, P65, DOI 10.1016/j.ceb.2017.11.005; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Menendez D, 2006, MOL CELL BIOL, V26, P2297, DOI 10.1128/MCB.26.6.2297-2308.2006; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Paek AL, 2016, CELL, V165, P631, DOI 10.1016/j.cell.2016.03.025; Post SM, 2010, ONCOGENE, V29, P1260, DOI 10.1038/onc.2009.423; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Resnick MA, 2003, P NATL ACAD SCI USA, V100, P9934, DOI 10.1073/pnas.1633803100; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Robles AI, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026294; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Sabapathy K, 2018, NAT REV CLIN ONCOL, V15, P13, DOI 10.1038/nrclinonc.2017.151; Schlereth K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003726; Schlereth K, 2010, MOL CELL, V38, P356, DOI 10.1016/j.molcel.2010.02.037; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Stiewe T, 2018, DRUG RESIST UPDATE, V38, P27, DOI 10.1016/j.drup.2018.05.001; Terzian T, 2007, MOL CELL BIOL, V27, P5479, DOI 10.1128/MCB.00555-06; Timofeev O, 2021, CANCERS, V13, DOI 10.3390/cancers13102422; Timofeev O, 2020, CANCER RES, V80, P5231, DOI 10.1158/0008-5472.CAN-20-2002; Timofeev O, 2019, EMBO J, V38, DOI 10.15252/embj.2019102096; Timofeev O, 2013, CELL REP, V3, P1512, DOI 10.1016/j.celrep.2013.04.008; Tiwari B, 2020, GENE DEV, V34, P1439, DOI 10.1101/gad.343186.120; Wang YX, 2011, J CLIN INVEST, V121, P893, DOI 10.1172/JCI44504; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	56	10	10	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2022	41	7					1011	1023		10.1038/s41388-021-02141-5	http://dx.doi.org/10.1038/s41388-021-02141-5		DEC 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YX7EK	34907344	hybrid, Green Published			2022-12-26	WOS:000730070200002
J	Cheng, WJ; Liu, CS; Hu, KC; Cheng, YF; Karhula, K; Harma, M				Cheng, Wan-Ju; Liu, Chiu-Shong; Hu, Kai-Chieh; Cheng, Yu-Fang; Karhula, Kati; Harma, Mikko			Night shift work and the risk of metabolic syndrome: Findings from an 8-year hospital cohort	PLOS ONE			English	Article							SLEEP DURATION; BLOOD-PRESSURE; CORTISOL; IMPACT	Objectives Studies concerning the risk of metabolic syndrome associated with night work have shown inconsistent findings, due to imprecise working time data and cross-sectional design. We used register-based daily working time data to examine the risk of incident metabolic syndrome associated with night shift work. Methods Working time data collected between 2010 and 2018 of 5775 Taiwanese hospital workers were used to identify night shift workers and to calculate the number of night shifts. Metabolic syndrome was identified by annual occupational health examination results, which were linked to the working time data. Logistic regression models and generalized estimating equations were used to examine the association between night shift work and metabolic syndrome and the 5 components of metabolic syndrome. Results Night shift work is associated with a higher risk of developing metabolic syndrome (adjusted OR = 1.36, 95% CI = 1.04 to 1.78) and high waist circumference (adjusted OR = 1.27, 95% CI = 1.07 to 1.78) compared to day work. Among night shift workers, increased number of night shifts was associated with high blood pressure (adjusted OR = 1.15, 95% CI = 1.01 to 1.31). Conclusions Night shift work is associated with metabolic risk factors. Long-term effects of circadian rhythm disruption on metabolic disturbances needs to be further studied.	[Cheng, Wan-Ju] China Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Cheng, Wan-Ju] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Cheng, Wan-Ju] China Med Univ, China Med Univ Hosp, Ctr Drug Abuse & Addict, Taichung, Taiwan; [Liu, Chiu-Shong] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Hu, Kai-Chieh] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Hu, Kai-Chieh] China Med Univ, Coll Med, Taichung, Taiwan; [Cheng, Yu-Fang] Chanhua Christian Hosp, Dept Endocrinol & Metab, Chanhua, Taiwan; [Karhula, Kati; Harma, Mikko] Finnish Inst Occupat Hlth, Helsinki, Finland	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Changhua Christian Hospital; Finnish Institute of Occupational Health	Cheng, WJ (corresponding author), China Med Univ Hosp, Dept Psychiat, Taichung, Taiwan.; Cheng, WJ (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.; Cheng, WJ (corresponding author), China Med Univ, China Med Univ Hosp, Ctr Drug Abuse & Addict, Taichung, Taiwan.	s871065@gmail.com		Cheng, Wan-Ju/0000-0003-4510-7584	Ministry of Science and Technology, Taiwan [MOST 107-2314-B-9 -063 -MY3]; China Medical University Hospital, Taiwan [DMR-111-129]; Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW109-TDU-B-212- T114004]; MOST Clinical Trial Consortium for Stroke [MOST 108-2321-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; NordForsk; Nordic programme on Health and Welfare [74809]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial Center; MOST Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; NordForsk; Nordic programme on Health and Welfare	This work was supported by the Ministry of Science and Technology, Taiwan [grant number: MOST 107-2314-B-9 -063 -MY3 to WJC]; China Medical University Hospital, Taiwan [grant number DMR-111-129 to WJC]; Taiwan Ministry of Health and Welfare Clinical Trial Center [grant number MOHW109-TDU-B-212- T114004 to KCH]; MOST Clinical Trial Consortium for Stroke [grant number MOST 108-2321-B-039-003- to KCH];Tseng-Lien Lin Foundation, Taichung, Taiwan; the NordForsk, and the Nordic programme on Health and Welfare [grant number 74809 to KK and MH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Allen JC, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110169; Bae S, 2017, J ALZHEIMERS DIS, V60, P913, DOI [10.3233/jad-161230, 10.3233/JAD-161230]; Bazett M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19189; Bekkers MBM, 2015, J OCCUP ENVIRON MED, V57, pE37, DOI 10.1097/JOM.0000000000000426; Canuto R, 2013, SLEEP MED REV, V17, P425, DOI 10.1016/j.smrv.2012.10.004; Feliciano EMC, 2019, JAMA PEDIATR, V173, P1049, DOI 10.1001/jamapediatrics.2019.3089; Champaneri S, 2013, OBESITY, V21, pE56, DOI 10.1002/oby.20047; Chellappa SL, 2019, TRENDS ENDOCRIN MET, V30, P767, DOI 10.1016/j.tem.2019.07.008; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; Driesen K, 2011, SCAND J WORK ENV HEA, V37, P402, DOI 10.5271/sjweh.3158; Flint AC, 2019, NEW ENGL J MED, V381, P243, DOI 10.1056/NEJMoa1803180; Guo YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120632; Hanley AJG, 2005, CIRCULATION, V112, P3713, DOI 10.1161/CIRCULATIONAHA.105.559633; Harma M, 2015, SCAND J WORK ENV HEA, V41, P268, DOI 10.5271/sjweh.3492; Itani O, 2017, SLEEP MED, V39, P87, DOI 10.1016/j.sleep.2017.07.027; Kim HJ, 2020, CHRONOBIOL INT, V37, P272, DOI 10.1080/07420528.2019.1671439; Korsiak J, 2018, OCCUP ENVIRON MED, V75, P132, DOI 10.1136/oemed-2017-104371; Kurl S, 2006, STROKE, V37, P806, DOI 10.1161/01.STR.0000204354.06965.44; Li J, 2018, J OCCUP MED TOXICOL, V13, DOI 10.1186/s12995-018-0204-y; Lim YC, 2018, OCCUP ENVIRON MED, V75, P716, DOI 10.1136/oemed-2018-105104; Lin YC, 2015, INT J OCCUP MED ENV, V28, P675, DOI 10.13075/ijomeh.1896.00335; Madeira SG, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18136738; Makarem N, 2019, CURR HYPERTENS REP, V21, DOI 10.1007/s11906-019-0938-7; Patterson PD, 2020, SLEEP HEALTH, V6, P387, DOI 10.1016/j.sleh.2020.03.006; Pietroiusti A, 2010, OCCUP ENVIRON MED, V67, P54, DOI 10.1136/oem.2009.046797; Proper Karin I, 2016, Am J Prev Med, V50, pe147, DOI 10.1016/j.amepre.2015.11.013; Puttonen S, 2012, SCAND J WORK ENV HEA, V38, P343, DOI 10.5271/sjweh.3267; Puttonen S, 2010, SCAND J WORK ENV HEA, V36, P96, DOI 10.5271/sjweh.2894; Ritonja J, 2018, CAN J CARDIOL, V34, P683, DOI 10.1016/j.cjca.2018.02.006; Rodriguez ACI, 2015, PSYCHONEUROENDOCRINO, V62, P301, DOI 10.1016/j.psyneuen.2015.08.014; Ryu H, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080878; Stevens RG, 2011, OCCUP ENVIRON MED, V68, P154, DOI 10.1136/oem.2009.053512; Torquati L, 2018, SCAND J WORK ENV HEA, V44, P229, DOI 10.5271/sjweh.3700; Tucker P, 2012, CHRONOBIOL INT, V29, P549, DOI 10.3109/07420528.2012.675259; Viitasalo K, 2015, PRIM CARE DIABETES, V9, P96, DOI 10.1016/j.pcd.2014.07.008; Violanti JM, 2009, ARCH ENVIRON OCCUP H, V64, P194, DOI 10.1080/19338240903241259; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Wang F, 2014, OBES REV, V15, P709, DOI 10.1111/obr.12194; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	40	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0261349	10.1371/journal.pone.0261349	http://dx.doi.org/10.1371/journal.pone.0261349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898652	Green Published, gold			2022-12-26	WOS:000755176200036
J	Issa, T; Babi, A; Issanov, A; Akilzhanova, A; Nurgaliyeva, K; Abugalieva, Z; Azizan, A; Khan, SA; Chan, CK; Alibekova, R; Aimagambetova, G				Issa, Torgyn; Babi, Aisha; Issanov, Alpamys; Akilzhanova, Ainur; Nurgaliyeva, Kadisha; Abugalieva, Zauresh; Azizan, Azliyati; Khan, Saleem A.; Chan, Chee Kai; Alibekova, Raushan; Aimagambetova, Gulzhanat			Knowledge and awareness of human papillomavirus infection and human papillomavirus vaccine among Kazakhstani women attending gynecological clinics	PLOS ONE			English	Article							CERVICAL-CANCER; ATTITUDE	Cervical cancer remains one of the top causes of cancer-related morbidity and mortality all over the world. Currently, however, there are no published studies to assess the knowledge of HPV and cervical cancer in Kazakhstan. This study aimed to assess the awareness of HPV, the knowledge of HPV as a cause of cervical cancer, and the awareness of HPV vaccination among Kazakhstani women visiting gynecological clinics across the country. In addition, the study aimed to identify the factors associated with the awareness of HPV and the HPV vaccine and knowledge of HPV as a major cause of cervical cancer. This was a cross-sectional survey-based study with 2,272 women aged between 18-70 years attending gynecological clinics, who were administered paper-based questionnaires. Data analysis included descriptive statistics consisting of mean values, standard deviations, and frequencies, where applicable. Differences in categorical variables between groups were analyzed using the Chi-square test with a significance value of <0.005. Crude odds ratio (OR) and adjusted odds ratio (AOR) with 95% corresponding confidence intervals were calculated in regression analysis using univariate and multivariable logistic regression models. The mean age of participants was 36.33 +/- 10.09 years. More than half (53%) of the participants had been screened for cervical cancer. Among those who were aware of HPV, 46% knew that HPV causes cervical cancer and 52% were aware of the HPV vaccine. The key factors related to outcome variables were age, ethnicity, education, family, number of deliveries, and menarche. From a subgroup analysis, results from the HPV test and Pap smear test were factors related to dependent variables such as awareness of HPV and awareness of HPV vaccination.	[Issa, Torgyn; Babi, Aisha; Azizan, Azliyati; Chan, Chee Kai; Aimagambetova, Gulzhanat] Nazarbayev Univ, Sch Med, Dept Biomed Sci, Nur Sultan, Kazakhstan; [Issanov, Alpamys; Alibekova, Raushan] Nazarbayev Univ, Sch Med, Dept Med, Nur Sultan, Kazakhstan; [Akilzhanova, Ainur] Nazarbayev Univ, Ctr Life Sci, Lab Genom & Personalized Med, Natl Lab Astana, Nur Sultan, Kazakhstan; [Nurgaliyeva, Kadisha; Abugalieva, Zauresh] Univ Med Ctr, Republican Diagnost Ctr, Nur Sultan, Kazakhstan; [Azizan, Azliyati] Touro Univ Nevada, Coll Osteopath Med, Henderson, NV USA; [Khan, Saleem A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Chan, Chee Kai] Wenzhou Kean Univ, Coll Sci & Technol, Wenzhou, Peoples R China	Nazarbayev University; Nazarbayev University; Nazarbayev University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wenzhou-Kean University	Aimagambetova, G (corresponding author), Nazarbayev Univ, Sch Med, Dept Biomed Sci, Nur Sultan, Kazakhstan.	gulzhanat.aimagambetova@nu.edu.kz	Aimagambetova, Gulzhanat/M-2731-2019; Babi, Aisha/HDO-4322-2022; Issanov, Alpamys/AAD-2792-2020	Aimagambetova, Gulzhanat/0000-0002-2868-4497; Babi, Aisha/0000-0002-2726-6955; Issanov, Alpamys/0000-0002-8968-2655	Nazarbayev University School of Medicine	Nazarbayev University School of Medicine	The author would like to acknowledge the Nazarbayev University School of Medicine for the supportive atmosphere that enabled the completion of this study.	Aimagambetova G, 2021, J MED SCREEN, V28, P48, DOI 10.1177/0969141320902482; [Anonymous], 2020, WORLD BANK COUNTRY C; Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Bekmukhambetov YZ, 2018, RUSS OPEN MED J, V7, DOI 10.15275/rusomj.2018.0408; Bekmukhambetov Yz, 2016, Asian Pac J Cancer Prev, V17, P2667; Bruni L., 2019, INF CENT HPVAND CANC; Canfell K, 2019, PAPILLOMAVIRUS RES, V8, DOI 10.1016/j.pvr.2019.100170; Chesson HW, 2014, SEX TRANSM DIS, V41, P660, DOI 10.1097/OLQ.0000000000000193; Cohen PA, 2019, LANCET, V393, P169, DOI 10.1016/S0140-6736(18)32470-X; Dany M, 2015, VACCINE, V33, P1001, DOI 10.1016/j.vaccine.2015.01.009; Djuric O, 2020, J BUON, V25, P116; Osis MJD, 2014, REV SAUDE PUBL, V48, P123, DOI 10.1590/S0034-8910.2014048005026; Kaidarova D, 2018, J GLOBAL ONCOL, DOI [10.1200/jgo.18.65600, DOI 10.1200/JGO.18.65600]; Kaidarova D., 2018, P EUR CANC SCREEN C; Li YY, 2018, CANCER CONTROL, V25, DOI 10.1177/1073274818799306; Niyazmetova L, 2017, INT J INFECT DIS, V54, P85, DOI 10.1016/j.ijid.2016.11.410; Pitts M, 2002, HEALTH EDUC RES, V17, P706, DOI 10.1093/her/17.6.706; Raychaudhuri S, 2012, ASIAN PAC J CANCER P, V13, P4221, DOI 10.7314/APJCP.2012.13.9.4221; StataCorp, 2017, STATA STAT SOFTWARE; Thompson EL, 2020, VACCINE, V38, P3143, DOI 10.1016/j.vaccine.2020.01.053; Waller J, 2003, SEX TRANSM INFECT, V79, P320, DOI 10.1136/sti.79.4.320; World Health Organization, 2020, CERV CANC FREE FUT 1; World Health Organization, 2020, HUMAN PAPILLOMAVIRUS; Yoo Jae-Ho, 2016, Korean J Pediatr, V59, P355; Zhumadilova A, 2018, OCHSNER J, V18, P46	25	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0261203	10.1371/journal.pone.0261203	http://dx.doi.org/10.1371/journal.pone.0261203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898639	gold, Green Published			2022-12-26	WOS:000755176200025
J	Yoshikawa, M; Asaba, K; Nakayama, T				Yoshikawa, Masahiro; Asaba, Kensuke; Nakayama, Tomohiro			Causal effect of atrial fibrillation/flutter on chronic kidney disease: A bidirectional two-sample Mendelian randomization study	PLOS ONE			English	Article							RISK; BIAS	Chronic kidney disease (CKD) and atrial fibrillation are both major burdens on the health care system worldwide. Several observational studies have reported clinical associations between CKD and atrial fibrillation; however, causal relationships between these conditions remain to be elucidated due to possible bias by confounders and reverse causations. Here, we conducted bidirectional two-sample Mendelian randomization analyses using publicly available summary statistics of genome-wide association studies (the CKDGen consortium and the UK Biobank) to investigate causal associations between CKD and atrial fibrillation/flutter in the European population. Our study suggested a causal effect of the risk of atrial fibrillation/flutter on the decrease in serum creatinine-based estimated glomerular filtration rate (eGFR) and revealed a causal effect of the risk of atrial fibrillation/flutter on the risk of CKD (odds ratio, 9.39 per doubling odds ratio of atrial fibrillation/flutter; 95% coefficient interval, 2.39-37.0; P = 0.001), while the causal effect of the decrease in eGFR on the risk of atrial fibrillation/flutter was unlikely. However, careful interpretation and further studies are warranted, as the underlying mechanisms remain unknown. Further, our sample size was relatively small and selection bias was possible.	[Yoshikawa, Masahiro; Nakayama, Tomohiro] Nihon Univ, Dept Pathol & Microbiol, Div Lab Med, Sch Med, Tokyo, Japan; [Asaba, Kensuke] Univ Tokyo Hosp, Dept Computat Diagnost Radiol & Prevent Med, Tokyo, Japan	Nihon University; University of Tokyo	Yoshikawa, M (corresponding author), Nihon Univ, Dept Pathol & Microbiol, Div Lab Med, Sch Med, Tokyo, Japan.	myosh-tky@umin.ac.jp	Nakayama, Tomohiro/GYU-0303-2022	YOSHIKAWA, Masahiro/0000-0002-3682-9713				Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Baber U, 2011, CIRC-ARRHYTHMIA ELEC, V4, P26, DOI 10.1161/CIRCEP.110.957100; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Burgess Stephen, 2019, Wellcome Open Res, V4, P186, DOI 10.12688/wellcomeopenres.15555.1; Burgess S, 2017, STAT METHODS MED RES, V26, P2333, DOI 10.1177/0962280215597579; Burgess S, 2018, EUR J EPIDEMIOL, V33, P947, DOI 10.1007/s10654-018-0424-6; Burgess S, 2016, GENET EPIDEMIOL, V40, P597, DOI 10.1002/gepi.21998; Carter AR, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1855; Choe WS, 2019, DIABETES RES CLIN PR, V148, P14, DOI 10.1016/j.diabres.2018.12.004; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Del Greco MF, 2015, STAT MED, V34, P2926, DOI 10.1002/sim.6522; Elsworth B., 2019, MRC IEU UK BIOBANK G, DOI DOI 10.5523/BRIS.PNOAT8CXO0U52P6YNFAEKEIGI; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; Hemani G, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007081; Higbee DH, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.03196-2020; Iguchi Y, 2008, AM J CARDIOL, V102, P1056, DOI 10.1016/j.amjcard.2008.06.018; Khouri Yazan, 2015, J Atr Fibrillation, V7, P1069, DOI 10.4022/jafib.1069; Kulkarni Nitin, 2012, J Atr Fibrillation, V5, P448, DOI 10.4022/jafib.448; Nielsen JB, 2018, NAT GENET, V50, P1234, DOI 10.1038/s41588-018-0171-3; R Core Team, 2020, R LANG ENV STAT COMP; Shim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120758; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Treur JL, 2021, ADDICT BIOL, V26, DOI 10.1111/adb.12849; Walker V., 2019, WELLCOME OPEN RES, V4, P113, DOI [10.12688/wellcomeopenres.15334.2, DOI 10.12688/wellcomeopenres.15334.2]; Wang K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87219-6; Wang K, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.608630; Watanabe H, 2009, AM HEART J, V158, P629, DOI 10.1016/j.ahj.2009.06.031; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; Wood A, 2019, AM J OPHTHALMOL, V206, P87, DOI 10.1016/j.ajo.2019.03.018; Wuttke M, 2019, NAT GENET, V51, P957, DOI 10.1038/s41588-019-0407-x; Xue HR, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009105; Yu Z, 2020, KIDNEY INT, V98, P708, DOI 10.1016/j.kint.2020.04.044; Zanetti D, 2020, HYPERTENSION, V75, P714, DOI 10.1161/HYPERTENSIONAHA.119.14028; Zhao JV, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1293-x; Zhao QY, 2019, INT J EPIDEMIOL, V48, P1478, DOI [10.1093/ije/dyz142, 10.1093/ije/]; Zheng J, 2020, J BONE MINER RES, V35, P1224, DOI 10.1002/jbmr.3989	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0261020	10.1371/journal.pone.0261020	http://dx.doi.org/10.1371/journal.pone.0261020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898631	Green Published, gold			2022-12-26	WOS:000755176200021
J	Abidi, SH; Imtiaz, K; Kanji, A; Qaiser, S; Khan, E; Iqbal, K; Veldhoen, M; Ghias, K; Simas, JP; Hasan, Z				Abidi, Syed Hani; Imtiaz, Kehkashan; Kanji, Akbar; Qaiser, Shama; Khan, Erum; Iqbal, Kiran; Veldhoen, Marc; Ghias, Kulsoom; Simas, J. Pedro; Hasan, Zahra			A rapid real-time polymerase chain reaction-based live virus microneutralization assay for detection of neutralizing antibodies against SARS-CoV-2 in blood/serum	PLOS ONE			English	Article								Background Individuals recovering from COVID-19 are known to have antibodies against the Spike and other structural proteins. Antibodies against Spike have been shown to display viral neutralization. However, not all antibodies against Spike have neutralizing ability although they may be cross-reactive. There is a need for easy-to-use SARS-CoV-2 neutralizing assays for the determination of virus-neutralizing activity in sera of individuals. Here we describe a PCR-based micro-neutralization assay that can be used to evaluate the viral neutralization titers of serum from SARS-CoV-2 infected individuals. Methods The SARS-CoV-2 strain used was isolated from a nasopharyngeal specimen of a COVID-19 case. The limiting dilution method was used to obtain a 50% tissue culture infective dose (TCID50) of Vero cells. For the micro-neutralization assay, 19 serum samples, with positive IgG titers against Spike Receptor-Binding Domain (RBD) were tested. After 24 hours, infected cells were inspected for the presence of a cytopathic effect, lysed and RNA RT-PCR conducted for SARS-CoV-2. PCR target Ct values were used to calculate percent neutralization/inhibition of SARS-CoV-2. Results Out of 19 samples, 13 samples gave 100% neutralization at all dilutions, 1 sample showed neutralization at the first dilution, 4 samples showed neutralization at lower dilutions, while one sample did not demonstrate any neutralization. The RBD ODs and neutralization potential percentages were found to be positively correlated. Conclusion We describe a rapid RT-PCR-based SARS-CoV-2 microneutralization assay for the detection of neutralizing antibodies. This can effectively be used to test the antiviral activity of serum antibodies for the investigation of both disease-driven and vaccine-induced responses.	[Abidi, Syed Hani; Ghias, Kulsoom] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan; [Imtiaz, Kehkashan; Kanji, Akbar; Qaiser, Shama; Khan, Erum; Iqbal, Kiran; Hasan, Zahra] Aga Khan Univ, Dept Pathol & Lab Med, Karachi, Pakistan; [Veldhoen, Marc; Simas, J. Pedro] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal; [Simas, J. Pedro] Catolica Biomed Res, Lisbon, Portugal; [Simas, J. Pedro] Univ Catolica Portuguesa, Catolica Med Sch, Lisbon, Portugal	Aga Khan University; Aga Khan University; Universidade de Lisboa; Universidade Catolica Portuguesa	Abidi, SH (corresponding author), Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan.	m.haniabidi@gmail.com	Veldhoen, Marc/GNP-0484-2022; Hasan, Zahra/AAF-2191-2020	Hasan, Zahra/0000-0001-7580-372X; Veldhoen, Marc/0000-0002-1478-9562; Simas, J Pedro/0000-0001-6982-9253	Provosts Academic Priorities Fund, The Aga Khan University; European Union [667824 -EXCELLtoINNOV]	Provosts Academic Priorities Fund, The Aga Khan University; European Union(European Commission)	This study received funding support through a grant from the Provosts Academic Priorities Fund, The Aga Khan University. MV was supported by the European Union H2020 ERA project (No 667824 -EXCELLtoINNOV).	Abdollahi Alireza, 2020, Iran J Pathol, V15, P313, DOI 10.30699/ijp.2020.127312.2387; Amanat Fatima, 2020, Curr Protoc Microbiol, V58, pe108, DOI 10.1002/cpmc.108; Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007; Aziz NA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22351-5; Figueiredo-Campos P, 2020, EUR J IMMUNOL, V50, P2025, DOI 10.1002/eji.202048970; Fontanet A, 2020, NAT REV IMMUNOL, V20, P583, DOI 10.1038/s41577-020-00451-5; Freire-Paspuel B, 2021, AM J TROP MED HYG, V104, P1516, DOI 10.4269/ajtmh.20-1484; Garcia-Nicolas O, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.644574; Gudbjartsson DF, 2020, NEW ENGL J MED, V383, P1724, DOI 10.1056/NEJMoa2026116; Hansen CH, 2021, LANCET, V397, P1204, DOI 10.1016/S0140-6736(21)00575-4; Higgins V, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.03149-20; Kadkhoda K, 2020, TRANSFUSION, V60, P1602, DOI 10.1111/trf.15897; Lau EHY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20247-4; Legros V, 2021, CELL MOL IMMUNOL, V18, P318, DOI 10.1038/s41423-020-00588-2; Manenti A, 2020, J MED VIROL, V92, P2096, DOI 10.1002/jmv.25986; Ng DL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18468-8; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rockstroh A, 2021, EMERG MICROBES INFEC, V10, P774, DOI 10.1080/22221751.2021.1913973; Salazar Eric, 2020, bioRxiv, DOI 10.1101/2020.06.08.138990; Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100; Thompson CP, 2020, EUROSURVEILLANCE, V25, P33, DOI 10.2807/1560-7917.ES.2020.25.42.2000685; Ungaro C, 2020, BIOMED J SCI TECH RE, V32, DOI [10.1016/j.bj.2019.07.007, DOI 10.1016/J.BJ.2019.07.007]; Yamayoshi S, 2021, ECLINICALMEDICINE, V32, DOI 10.1016/j.eclinm.2021.100734; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhou ZH, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009766	27	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0259551	10.1371/journal.pone.0259551	http://dx.doi.org/10.1371/journal.pone.0259551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890401	Green Published, Green Submitted, gold			2022-12-26	WOS:000747293600003
J	Foote, SL; Lipner, EM; Prevots, DR; Ricotta, EE				Foote, Sydney L.; Lipner, Ettie M.; Prevots, D. Rebecca; Ricotta, Emily E.			Environmental predictors of pulmonary nontuberculous mycobacteria (NTM) sputum positivity among persons with cystic fibrosis in the state of Florida	PLOS ONE			English	Article							LUNG-DISEASE	Nontuberculous mycobacteria (NTM) are opportunistic human pathogens that are commonly found in soil and water, and exposure to these organisms may cause pulmonary nontuberculous mycobacterial disease. Persons with cystic fibrosis (CF) are at high risk for developing pulmonary NTM infections, and studies have shown that prolonged exposure to certain environments can increase the risk of pulmonary NTM. It is therefore important to determine the risk associated with different geographic areas. Using annualized registry data obtained from the Cystic Fibrosis Foundation Patient Registry for 2010 through 2017, we conducted a geospatial analysis of NTM infections among persons with CF in Florida. A Bernoulli model in SaTScan was used to identify clustering of ZIP codes with higher than expected numbers of NTM culture positive individuals. Generalized linear mixed models with a binomial distribution were used to test the association of environmental variables and NTM culture positivity. We identified a significant cluster of M. abscessus and predictors of NTM sputum positivity, including annual precipitation and soil mineral levels.	[Foote, Sydney L.] NIAID, Off Data Sci & Emerging Technol, Off Sci Management & Operat, NIH, Rockville, MD USA; [Lipner, Ettie M.] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO USA; [Lipner, Ettie M.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Prevots, D. Rebecca; Ricotta, Emily E.] NIAID, Div Intramural Res, Epidemiol & Populat Studies Unit, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Jewish Health; Colorado School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ricotta, EE (corresponding author), NIAID, Div Intramural Res, Epidemiol & Populat Studies Unit, NIH, Rockville, MD 20852 USA.	emily.ricotta@nih.gov	Ricotta, Emily/AGX-9953-2022	Ricotta, Emily/0000-0001-9928-8275; Foote, Sydney/0000-0002-2351-6910	U.S. Department of Energy (DOE); NIAID; DOE [DE-SC0014664]; Cystic Fibrosis Foundation; Clinical Pilot and Feasibility Award; Division of Intramural Research, NIAID, National Institutes of Health	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DOE(United States Department of Energy (DOE)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Clinical Pilot and Feasibility Award; Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SLF was supported in part by an appointment to the National Institute of Allergy and Infectious Diseases (NIAID) Emerging Leaders in Data Science Research Participation Program. This program is administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy (DOE) and NIAID. ORISE is managed by ORAU under DOE contract number DE-SC0014664. EML was supported by the Cystic Fibrosis Foundation, Clinical Pilot and Feasibility Award. EER and DRP were supported by the Division of Intramural Research, NIAID, National Institutes of Health. All opinions expressed in this paper are the author's and do not necessarily reflect the policies and views of NIAID, DOE, or ORAU/ORISE.	Adjemian J, 2018, ANN AM THORAC SOC, V15, P817, DOI 10.1513/AnnalsATS.201709-727OC; Adjemian J, 2017, EMERG INFECT DIS, V23, P439, DOI 10.3201/eid2303.161827; Adjemian J, 2014, AM J RESP CRIT CARE, V190, P581, DOI 10.1164/rccm.201405-0884OC; Adjemian Jennifer, 2014, Ann Am Thorac Soc, V11, P9, DOI 10.1513/AnnalsATS.201304-085OC; Adjemian J, 2012, AM J RESP CRIT CARE, V186, P553, DOI 10.1164/rccm.201205-0913OC; Bivand R, 2019, RGDAL BINDINGS GEOSP, V1, P4; Bivand R.S., 2013, APPL SPATIAL DATA AN, DOI 10.1007/978-1-4614-7618-4; Cystic Fibrosis Foundation, PAT REG; Daley CL, 2020, CLIN INFECT DIS, V71, P905, DOI 10.1093/cid/ciaa1125; Falkinham JO, 2013, SEMIN RESP CRIT CARE, V34, P95, DOI 10.1055/s-0033-1333568; Gebert MJ, 2018, MBIO, V9, DOI 10.1128/mBio.01614-18; Gross JE, 2019, CURR OPIN PULM MED, V25, P646, DOI 10.1097/MCP.0000000000000621; Halstrom S, 2015, INT J MYCOBACT, V4, P81, DOI 10.1016/j.ijmyco.2015.03.002; Kuldorff M., 2018, SATSCAN SOFTWARE SPA; Lipner EM., 2017, ANN AM THORAC SOC, V14, P1, DOI [10.1513/AnnalsATS.201606-481FR, DOI 10.1513/ANNALSATS.201606-481FR]; Lipner EM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113854; Martiniano SL, 2019, THORAC SURG CLIN, V29, P95, DOI 10.1016/j.thorsurg.2018.09.008; MELO RA, 2018, PACKAGE GMAPSDISTANC; Pebesma E., 2005, R NEWS, V5, P9; Prevots D Rebecca, 2014, Ann Am Thorac Soc, V11, P1032, DOI 10.1513/AnnalsATS.201404-184OC; R Core Team, 2020, R LANG ENV STAT COMP; Thomson R, 2013, J CLIN MICROBIOL, V51, P3006, DOI 10.1128/JCM.00899-13; Thomson RM, 2020, SCI TOTAL ENVIRON, V740, DOI 10.1016/j.scitotenv.2020.139796	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0259964	10.1371/journal.pone.0259964	http://dx.doi.org/10.1371/journal.pone.0259964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882686	Green Published, gold			2022-12-26	WOS:000755037200016
J	Weibrecht, N; Rossler, M; Bicher, M; Emrich, S; Zauner, G; Popper, N				Weibrecht, Nadine; Roessler, Matthias; Bicher, Martin; Emrich, Stefan; Zauner, Gunther; Popper, Niki			How an election can be safely planned and conducted during a pandemic: Decision support based on a discrete event model	PLOS ONE			English	Article								In 2020, the ongoing COVID-19 pandemic caused major limitations for any aspect of social life and in specific for all events that require a gathering of people. While most events of this kind can be postponed or cancelled, democratic elections are key elements of any democratic regime and should be upheld if at all possible. Consequently, proper planning is required to establish the highest possible level of safety to both voters and scrutineers. In this paper, we present the novel and innovative way how the municipal council and district council elections in Vienna were planned and conducted using an discrete event simulation model. Key target of this process was to avoid queues in front of polling stations to reduce the risk of related infection clusters. In cooperation with a hygiene expert, we defined necessary precautions that should be met during the election in order to avoid the spread of COVID-19. In a next step, a simulation model was established and parametrized and validated using data from previous elections. Furthermore, the planned conditions were simulated to see whether excessive queues in front of any polling stations could form, as these could on the one hand act as an infection herd, and on the other hand, turn voters away. Our simulation identified some polling stations where long queues could emerge. However, splitting up these electoral branches resulted in a smooth election across all of Vienna. Looking back, the election did not lead to a significant increase of COVID-19 incidences. Therefore, it can be concluded that careful planning led to a safe election, despite the pandemic.	[Weibrecht, Nadine; Bicher, Martin; Popper, Niki] TU Wien, Inst Informat Syst Engn, Vienna, Austria; [Roessler, Matthias; Bicher, Martin; Emrich, Stefan; Zauner, Gunther; Popper, Niki] Dwh GmbH, Dwh Simulat Serv, Vienna, Austria; [Weibrecht, Nadine; Popper, Niki] Assoc Decis Support Hlth Policy & Planning DEXHEL, Vienna, Austria; [Zauner, Gunther] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Trnava, Slovakia	Technische Universitat Wien; University of Trnava	Weibrecht, N (corresponding author), TU Wien, Inst Informat Syst Engn, Vienna, Austria.; Weibrecht, N (corresponding author), Assoc Decis Support Hlth Policy & Planning DEXHEL, Vienna, Austria.	nadine.weibrecht@dexhelpp.at	Popper, Niki/AAL-6464-2021	Popper, Niki/0000-0003-4615-2774	Stadt Wien, Magistratsabteilung 62 ("City of Vienna, Municipal Department 62"); FFG [881665, 871798]	Stadt Wien, Magistratsabteilung 62 ("City of Vienna, Municipal Department 62"); FFG	Funding: The authors were funded by Stadt Wien, Magistratsabteilung 62 ("City of Vienna, Municipal Department 62"). The work within this paper was conducted with the research projects CIDS, funded by FFG within the Emergency-Call Coronavirus 2020 (project number: 881665) and the project ReproHealth, funded by FFG within the Call Research Partnerships (4th Call, project number: 871798). This statement is valid for all authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T., 2006, CHANCE, V19, P25, DOI [10.1080/09332480.2006.10722812, DOI 10.1080/09332480.2006.10722812]; [Anonymous], 2020, GEMEINDERATSWAHLEN; [Anonymous], 2017, WIENER ZEITUNG; Au C. H., 2018, J INFORM TECHNOLOGY, V19, P1, DOI [10.1080/15228053.2017.1433494, DOI 10.1080/15228053.2017.1433494]; Belenky AS., 2006, ORMS TODAY, V33, P30; Bicher M., 2020, HLTH POLICY, DOI [10.1101/2020.10.18.20214767, DOI 10.1101/2020.10.18.20214767]; Bicher M, 2021, MED DECIS MAKING, V41, P1017, DOI 10.1177/0272989X211013306; Bruckner M., 2012, SIMULATION NEWS EURO, V22, P95; Edelstein W. A., 2006, NEW VOTING SYSTEMS N; Glock B, 2013, 2013 8TH EUROSIM CONGRESS ON MODELLING AND SIMULATION (EUROSIM), P312, DOI 10.1109/EUROSIM.2013.63; GRANT FH, 1980, INTERFACES, V10, P19, DOI 10.1287/inte.10.5.19; Hotzendorfer H., 2004, SIMULATION NEWS EURO, P3; Miksch F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221564; Olabisi U. O, 2012, OPEN OPERATIONAL RES, V6, P9, DOI [10.2174/1874243201206010009, DOI 10.2174/1874243201206010009]; Rippinger C, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-020-05737-6; Stewart III C, 2015, MANAGING POLLING PLA; Taubock S., 2011, SIMULATION NEWS EURO, V21, P11, DOI [10.11128/sne.21.tn.10039, DOI 10.11128/SNE.21.TN.10039]; Wang XF, 2015, J OPER RES SOC, V66, P1363, DOI 10.1057/jors.2014.107; Wurzer G, 2015, IFAC PAPERSONLINE, V48, P868, DOI 10.1016/j.ifacol.2015.05.144; Yang Muer, 2009, Proceedings of the 2009 Winter Simulation Conference (WSC 2009), P3140, DOI 10.1109/WSC.2009.5429279; Yang M, 2014, PROD OPER MANAG, V23, P1083, DOI 10.1111/poms.12088; Yang ME, 2013, IIE TRANS, V45, P781, DOI 10.1080/0740817X.2012.721947; Zeitoun Jean -David, 2020, PUBLIC GLOBAL HLTH, DOI [10.1101/2020.05.14.20090100, DOI 10.1101/2020.05.14.20090100, 10.1101/2020.05.14.20090100.working]	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0261016	10.1371/journal.pone.0261016	http://dx.doi.org/10.1371/journal.pone.0261016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882707	Green Submitted, gold, Green Published			2022-12-26	WOS:000755037200051
J	Le, DH				Le, Duc-Hau			A network-based method for predicting disease-associated enhancers	PLOS ONE			English	Article							LONG NONCODING RNAS; RANDOM-WALK; EXPRESSION; PRIORITIZATION; IDENTIFICATION; RESOURCE; GENES; ANNOTATION; SIMILARITY; PATHWAYS	Background Enhancers regulate transcription of target genes, causing a change in expression level. Thus, the aberrant activity of enhancers can lead to diseases. To date, a large number of enhancers have been identified, yet a small portion of them have been found to be associated with diseases. This raises a pressing need to develop computational methods to predict associations between diseases and enhancers. Results In this study, we assumed that enhancers sharing target genes could be associated with similar diseases to predict the association. Thus, we built an enhancer functional interaction network by connecting enhancers significantly sharing target genes, then developed a network diffusion method RWDisEnh, based on a random walk with restart algorithm, on networks of diseases and enhancers to globally measure the degree of the association between diseases and enhancers. RWDisEnh performed best when the disease similarities are integrated with the enhancer functional interaction network by known disease-enhancer associations in the form of a heterogeneous network of diseases and enhancers. It was also superior to another network diffusion method, i.e., PageRank with Priors, and a neighborhood-based one, i.e., MaxLink, which simply chooses the closest neighbors of known disease-associated enhancers. Finally, we showed that RWDisEnh could predict novel enhancers, which are either directly or indirectly associated with diseases. Conclusions Taken together, RWDisEnh could be a potential method for predicting disease-enhancer associations.	[Le, Duc-Hau] Thuyloi Univ, Sch Comp Sci & Engn, Hanoi, Vietnam	Thuyloi University	Le, DH (corresponding author), Thuyloi Univ, Sch Comp Sci & Engn, Hanoi, Vietnam.	hauldhut@gmail.com		Le, Duc-Hau/0000-0002-4951-5916				Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bass JIF, 2015, CELL, V161, P661, DOI 10.1016/j.cell.2015.03.003; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bu HD, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1828-0; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen X, 2017, BRIEF BIOINFORM, V18, P558, DOI 10.1093/bib/bbw060; Chen X, 2018, BIOINFORMATICS, V34, P4256, DOI 10.1093/bioinformatics/bty503; Chen X, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004975; Chen X, 2016, MOL BIOSYST, V12, P624, DOI 10.1039/c5mb00697j; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Choi YJ, 2014, GASTRIC CANCER, V17, P247, DOI 10.1007/s10120-013-0277-3; Corradin O, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0085-3; D' Antonio M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00100-x; Dobrzycka B, 2011, FOLIA HISTOCHEM CYTO, V49, P631, DOI 10.5603/FHC.2011.0086; Le DH, 2018, J MOL BIOL, V430, P2219, DOI 10.1016/j.jmb.2018.05.006; Le DH, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1924-1; Le DH, 2017, BMC SYST BIOL, V11, P1, DOI 10.1186/s12918-017-0437-x; Le DH, 2012, COMPUT BIOL CHEM, V37, P17, DOI 10.1016/j.compbiolchem.2012.02.004; Fang WB, 2015, BREAST CANCER RES TR, V150, P309, DOI 10.1007/s10549-015-3324-4; Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Gao TS, 2016, BIOINFORMATICS, V32, P3543, DOI 10.1093/bioinformatics/btw495; Guala D, 2014, BIOINFORMATICS, V30, P2689, DOI 10.1093/bioinformatics/btu344; Guo XD, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-44; Hafez D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1316-x; Imamura M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10531; Jiang BY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-61; Jiang LM, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5273-x; Kamat MA, 2019, BIOINFORMATICS, V35, P4851, DOI 10.1093/bioinformatics/btz469; Karnuta JM, 2018, HUM MOL GENET, V27, pR219, DOI 10.1093/hmg/ddy167; Kibbe WA, 2015, NUCLEIC ACIDS RES, V43, pD1071, DOI 10.1093/nar/gku1011; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Le D., 2017, 2017 4 NAFOSTED C IN; Le D.-H., 2016, VIETNAM J COMPUT SCI, P1; Le DH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235670; Le DH, 2013, COMPUT BIOL CHEM, V44, P1, DOI 10.1016/j.compbiolchem.2013.01.001; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Ma XT, 2014, BRIEF BIOINFORM, V15, P685, DOI 10.1093/bib/bbt041; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Nelson CP, 2017, NAT GENET, V49, P1385, DOI 10.1038/ng.3913; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Nitsch D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005526; Niu YW, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2640-9; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Omura-Minamisawa M, 2001, CLIN CANCER RES, V7, P3481; Ostlund G, 2010, MOL CELL PROTEOMICS, V9, P648, DOI 10.1074/mcp.M900227-MCP200; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Peng K, 2013, NUCLEIC ACIDS RES, V41, pD553, DOI 10.1093/nar/gks1244; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Sal V, 2016, INT J GYNECOL CANCER, V26, P512, DOI 10.1097/IGC.0000000000000626; Shi HB, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-101; Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373; Sun J, 2014, MOL BIOSYST, V10, P2074, DOI 10.1039/c3mb70608g; Valdeolivas A, 2019, BIOINFORMATICS, V35, P497, DOI 10.1093/bioinformatics/bty637; van der Harst P, 2018, CIRC RES, V122, P433, DOI [10.1161/CIRCRESAHA.117.312086, 10.1161/circresaha.117.312086]; Vandin F, 2012, BIOCOMPUT-PAC SYM, P55; Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265; Wang H, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbaa409; Wang Z, 2018, NUCLEIC ACIDS RES, V46, pD113, DOI 10.1093/nar/gkx988; Wazir U, 2013, ANTICANCER RES, V33, P2179; White S., 2003, P 9 ACM SIGKDD INT C, P266, DOI [DOI 10.1145/956750.956782, 10.1145/956750.956782]; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Zhang GX, 2018, NUCLEIC ACIDS RES, V46, pD78, DOI 10.1093/nar/gkx920; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470; Zhou M, 2015, MOL BIOSYST, V11, P760, DOI 10.1039/c4mb00511b	66	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260432	10.1371/journal.pone.0260432	http://dx.doi.org/10.1371/journal.pone.0260432			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879086	gold, Green Published			2022-12-26	WOS:000754625200017
J	Svecic, A; Mansour, R; Tang, A; Kadoury, S				Svecic, Andrei; Mansour, Rihab; Tang, An; Kadoury, Samuel			Prediction of post transarterial chemoembolization MR images of hepatocellular carcinoma using spatio-temporal graph convolutional networks	PLOS ONE			English	Article								Magnetic resonance imaging (MRI) plays a critical role in the planning and monitoring of hepatocellular carcinomas (HCC) treated with locoregional therapies, in order to assess disease progression or recurrence. Dynamic contrast-enhanced (DCE)-MRI sequences offer temporal data on tumor enhancement characteristics which has strong prognostic value. Yet, predicting follow-up DCE-MR images from which tumor enhancement and viability can be measured, before treatment of HCC actually begins, remains an unsolved problem given the complexity of spatial and temporal information. We propose an approach to predict future DCE-MRI examinations following transarterial chemoembolization (TACE) by learning the spatio-temporal features related to HCC response from pre-TACE images. A novel Spatial-Temporal Discriminant Graph Neural Network (STDGNN) based on graph convolutional networks is presented. First, embeddings of viable, equivocal and non-viable HCCs are separated within a joint low-dimensional latent space, which is created using a discriminant neural network representing tumor-specific features. Spatial tumoral features from independent MRI volumes are then extracted with a structural branch, while dynamic features are extracted from the multi-phase sequence with a separate temporal branch. The model extracts spatio-temporal features by a joint minimization of the network branches. At testing, a pre-TACE diagnostic DCE-MRI is embedded on the discriminant spatio-temporal latent space, which is then translated to the follow-up domain space, thus allowing to predict the post-TACE DCE-MRI describing HCC treatment response. A dataset of 366 HCC's from liver cancer patients was used to train and test the model using DCE-MRI examinations with associated pathological outcomes, with the spatio-temporal framework yielding 93.5% classification accuracy in response identification, and generating follow-up images yielding insignificant differences in perfusion parameters compared to ground-truth post-TACE examinations.	[Svecic, Andrei; Kadoury, Samuel] Polytech Montreal, Dept Comp Engn, MedICAL, Montreal, PQ, Canada; [Mansour, Rihab; Tang, An; Kadoury, Samuel] CHUM Res Ctr, Montreal, PQ, Canada; [Tang, An] CHUM, Dept Radiol, Montreal, PQ, Canada; [Kadoury, Samuel] Polytech Montreal, Montreal, PQ, Canada	Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Polytechnique Montreal	Kadoury, S (corresponding author), Polytech Montreal, Dept Comp Engn, MedICAL, Montreal, PQ, Canada.; Kadoury, S (corresponding author), CHUM Res Ctr, Montreal, PQ, Canada.; Kadoury, S (corresponding author), Polytech Montreal, Montreal, PQ, Canada.	samuel.kadoury@polymtl.ca			Canadian Institutes of Health Research [MOP142401]; Fonds de recherche du Quebec en Sante (FRQ-S)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec en Sante (FRQ-S)	This study was funded by the Canadian Institutes of Health Research (https://cihr-irsc.gc.ca/) through a grant awarded to SK (MOP142401), and by Fonds de recherche du Quebec en Sante (FRQ-S) (https://frq.gouv.qc.ca/en/) through a research scholarship awarded to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abajian A, 2018, J VASC INTERV RADIOL, V29, P850, DOI 10.1016/j.jvir.2018.01.769; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Badic B, 2019, ACAD RADIOL, V26, P469, DOI 10.1016/j.acra.2018.06.004; Braman NM, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0846-1; Breuer FA, 2005, MAGN RESON MED, V53, P981, DOI 10.1002/mrm.20430; Chung JC, 2010, WORLD J GASTROENTERO, V16, P3161, DOI 10.3748/wjg.v16.i25.3161; Cook GJR, 2015, RADIOLOGY, V276, P883, DOI 10.1148/radiol.2015141309; Craig AJ, 2020, NAT REV GASTRO HEPAT, V17, P139, DOI 10.1038/s41575-019-0229-4; Creasy JM, 2019, EUR RADIOL, V29, P458, DOI 10.1007/s00330-018-5542-8; Gao JY, 2019, PROC CVPR IEEE, P4644, DOI 10.1109/CVPR.2019.00478; Hamilton WL, 2017, ADV NEUR IN, V30; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang WB, 2018, ADV NEUR IN, V31; Huynh BQ, 2017, PROC SPIE, V10134, DOI 10.1117/12.2255316; Lewis S, 2021, ABDOM RADIOL, V46, P111, DOI 10.1007/s00261-019-02378-5; Liu D, 2020, EUR RADIOL, V30, P2365, DOI 10.1007/s00330-019-06553-6; Liu ZY, 2019, CLIN CANCER RES, V25, P3538, DOI 10.1158/1078-0432.CCR-18-3190; Lobbes MBI, 2013, INSIGHTS IMAGING, V4, P163, DOI 10.1007/s13244-013-0219-y; Luo YW, 2019, PROC CVPR IEEE, P2502, DOI 10.1109/CVPR.2019.00261; Maaref A, 2020, J DIGIT IMAGING, V33, P937, DOI 10.1007/s10278-020-00332-2; Mandel W, 2019, INT J COMPUT ASS RAD, V14, P1565, DOI 10.1007/s11548-019-02041-w; Mannelli L, 2013, EUR J RADIOL, V82, P577, DOI 10.1016/j.ejrad.2012.11.026; Nie K, 2016, CLIN CANCER RES, V22, P5256, DOI 10.1158/1078-0432.CCR-15-2997; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13087; Peng J, 2020, EUR RADIOL, V30, P413, DOI 10.1007/s00330-019-06318-1; Prajapati HJ, 2013, ANN ONCOL, V24, P965, DOI 10.1093/annonc/mds605; Qu YH, 2020, THORAC CANCER, V11, P651, DOI 10.1111/1759-7714.13309; Shen Wei, 2015, Inf Process Med Imaging, V24, P588, DOI 10.1007/978-3-319-19992-4_46; Sun YH, 2017, IEEE ICC; Taesung Park, 2020, Computer Vision - ECCV 2020. 16th European Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12354), P319, DOI 10.1007/978-3-030-58545-7_19; Thibodeau-Antonacci A, 2019, MAGN RESON IMAGING, V62, P78, DOI 10.1016/j.mri.2019.06.017; Voizard N, 2019, INSIGHTS IMAGING, V10, DOI 10.1186/s13244-019-0801-z; Vorontsov E, 2019, ARXIV PREPRINT ARXIV, P6; Wang XL, 2018, LECT NOTES COMPUT SC, V11209, P413, DOI 10.1007/978-3-030-01228-1_25; Wasserstein G.A.N., 2017, ARXIV170107875; Yan SJ, 2018, AAAI CONF ARTIF INTE, P7444; Yang JR, 2020, PROC CVPR IEEE, P3286, DOI 10.1109/CVPR42600.2020.00335; Zhang JB, 2017, AAAI CONF ARTIF INTE, P1655; Zhou YN, 2019, IEEE INT CONF COMP V, P388, DOI 10.1109/ICCVW.2019.00050; Zhu W, 2018, PROC CVPR IEEE, P2743, DOI 10.1109/CVPR.2018.00290	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0259692	10.1371/journal.pone.0259692	http://dx.doi.org/10.1371/journal.pone.0259692			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874934	Green Published, gold			2022-12-26	WOS:000753617500008
J	Tleyjeh, IM; Saddik, B; AlSwaidan, N; AlAnazi, A; Ramakrishnan, RK; Alhazmi, D; Aloufi, A; AlSumait, F; Berbari, E; Halwani, R				Tleyjeh, Imad M.; Saddik, Basema; AlSwaidan, Nourah; AlAnazi, Ahmed; Ramakrishnan, Rakhee K.; Alhazmi, Deema; Aloufi, Ahmad; AlSumait, Fahad; Berbari, Elie; Halwani, Rabih			Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up	PLOS ONE			English	Article								Background Post-acute COVID-19 syndrome (PACS) is an emerging healthcare burden. The risk factors associated with PACS remain largely unclear. The aim of this study was to evaluate the frequency of new or persistent symptoms in COVID-19 patients post hospital discharge and identify associated risk factors. Methods Our prospective cohort comprised of PCR-confirmed COVID-19 patients admitted to King Fahad Medical City, Riyadh, Saudi Arabia between May and July 2020. The patients were interviewed through phone calls by trained physicians from 6 weeks up to 6 months post hospital discharge. Multivariate Cox proportional hazards and logistic regression models were used to examine for predictors associated with persistence of symptoms and non-return to baseline health. Results 222 COVID-19 patients responded to follow-up phone interviews after a median of 122 days post discharge. The majority of patients were men (77%) with mean age of 52.47 ( 13.95) years. 56.3% of patients complained of persistent symptoms; 66 (29.7%) experiencing them for >21 days and 64 (28.8%) reporting not having returned to their baseline health. Furthermore, 39 patients (17.6%) reported visiting an emergency room post discharge for COVID-19-related symptoms while 16 (7.2%) had required re-hospitalization. Shortness of breath (40.1%), cough (27.5%) and fatigue (29.7%) were the most frequently reported symptoms at follow-up. After multivariable adjustments, female gender, pre-existing hypertension and length of hospital stay were associated with an increased risk of new or persistent symptoms. Age, pre-existing lung disease and emergency room visits increased the likelihood of not fully recovering from acute COVID-19. Patients who were treated with interferon beta-1b based triple antiviral therapy during hospital stay were less likely to experience new or persistent symptoms and more likely to return to their baseline health. Conclusions COVID-19 survivors continued to suffer from dyspnea, cough and fatigue at 4 months post hospital discharge. Several risk factors could predict which patients are more likely to experience PACS and may benefit from individualized follow-up and rehabilitation programs.	[Tleyjeh, Imad M.] King Fahad Med City, Dept Med Specialt, Infect Dis Sect, Riyadh, Saudi Arabia; [Tleyjeh, Imad M.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia; [Tleyjeh, Imad M.; Berbari, Elie] Mayo Clin, Coll Med & Sci, Div Infect Dis, Rochester, MN USA; [Tleyjeh, Imad M.] Mayo Clin, Coll Med & Sci, Div Epidemiol, Rochester, MN USA; [Saddik, Basema; Halwani, Rabih] Univ Sharjah, Coll Med, Sharjah, U Arab Emirates; [Saddik, Basema; Ramakrishnan, Rakhee K.; Halwani, Rabih] Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates; [AlSwaidan, Nourah; AlAnazi, Ahmed; Alhazmi, Deema; Aloufi, Ahmad; AlSumait, Fahad] King Fahad Med City, Dept Med Specialt, Riyadh, Saudi Arabia; [Halwani, Rabih] King Saud Univ, Fac Med, Dept Pediat, Prince Abdullah Ben Khaled Celiac Dis Res Chair, Riyadh, Saudi Arabia	King Fahad Medical City; Alfaisal University; Mayo Clinic; Mayo Clinic; University of Sharjah; University of Sharjah; King Fahad Medical City; King Saud University	Tleyjeh, IM (corresponding author), King Fahad Med City, Dept Med Specialt, Infect Dis Sect, Riyadh, Saudi Arabia.; Tleyjeh, IM (corresponding author), Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.; Tleyjeh, IM (corresponding author), Mayo Clin, Coll Med & Sci, Div Infect Dis, Rochester, MN USA.; Tleyjeh, IM (corresponding author), Mayo Clin, Coll Med & Sci, Div Epidemiol, Rochester, MN USA.	Tleyjeh.Imad@mayo.edu	Ramakrishnan, Rakhee K/GLQ-5515-2022	Saddik, Basema/0000-0002-4682-5927; AlSwaidan, Nourah/0000-0003-4634-4952; Ramakrishnan, Rakhee/0000-0002-2991-3802				Al-Aly Z, 2021, NATURE, V594, P259, DOI 10.1038/s41586-021-03553-9; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Gautam N, 2022, CLIN INFECT DIS, V74, P301, DOI 10.1093/cid/ciab341; Greenhalgh T, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3026; Halpin SJ, 2021, J MED VIROL, V93, P1013, DOI 10.1002/jmv.26368; Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8; Huang L., 2021, LANCET INFECT DIS, DOI [10.5271/sjweh.3960, DOI 10.5271/SJWEH.3960]; Kawasuji H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243597; Logue JK, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0830; Lopez-Leon S, 2021, SCI REP-UK, V11, DOI [10.1038/s41598-021-95565-8, 10.1101/2021.01.27.21250617]; McCoy K, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040700; Meije Y, 2021, CLIN MICROBIOL INFEC, V27, P1151, DOI 10.1016/j.cmi.2021.04.002; Menges D., 2021, MEDRXIV2021022721252; Monk PD, 2021, LANCET RESP MED, V9, P196, DOI 10.1016/S2213-2600(20)30511-7; Morin L, 2021, JAMA-J AM MED ASSOC, V325, P1525, DOI 10.1001/jama.2021.3331; Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Ramakrishnan RK, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.686029; Sante HAd, 2021, COV 19 DIAGN PRENDR; Shah W, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n136; Sivan M, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4938; Sudre CH, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01292-y; Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P993, DOI [10.15585/mmwr.mm6930e1, 10.15585/mmwr.mm6930e1externalicon]; Townsend L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240784; Xiong QT, 2021, CLIN MICROBIOL INFEC, V27, P89, DOI 10.1016/j.cmi.2020.09.023; Yuan SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12060628; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhang YH, 2020, BIOMED PHARMACOTHER, V127, DOI 10.1016/j.biopha.2020.110195	31	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260568	10.1371/journal.pone.0260568	http://dx.doi.org/10.1371/journal.pone.0260568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874962	gold, Green Published			2022-12-26	WOS:000753617500031
J	Abdeta, A; Bitew, A; Fentaw, S; Tsige, E; Assefa, D; Lejisa, T; Kefyalew, Y; Tigabu, E; Evans, M				Abdeta, Abera; Bitew, Adane; Fentaw, Surafel; Tsige, Estifanos; Assefa, Dawit; Lejisa, Tadesse; Kefyalew, Yordanos; Tigabu, Eyasu; Evans, Martin			Phenotypic characterization of carbapenem non-susceptible gram-negative bacilli isolated from clinical specimens	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ENTEROBACTERIACEAE	Background Multidrug resistant, extremely drug-resistant, pan-drug resistant, carbapenem-resistant, and carbapenemase-producing gram-negative bacteria are becoming more common in health care settings and are posing a growing threat to public health. Objective The study was aimed to detect and phenotypically characterize carbapenem no- susceptible gram-negative bacilli at the Ethiopian Public Health Institute. Materials and methods A prospective cross-sectional study was conducted from June 30, 2019, to May 30, 2020, at the national reference laboratory of the Ethiopian Public Health Institute. Clinical samples were collected, inoculated, and incubated for each sample in accordance with standard protocol. Antimicrobial susceptibility testing was conducted using Kirby-Bauer disk diffusion method. Identification was done using the traditional biochemical method. Multidrug-resistant and extensively drug-resistant isolates were classified using a standardized definition established by the European Centre for Disease Prevention and Control and the United States Centers for Disease Prevention and Control. Gram-negative organisms with reduced susceptibility to carbapenem antibiotics were considered candidate carbapenemase producers and subjected to modified carbapenem inactivation and simplified carbapenem inactivation methods. Meropenem with EDTA was used to differentiate metallo-beta -lactamase (MBL) from serine carbapenemase. Meropenem (MRP)/meropenem + phenylboronic acid (MBO) were used to differentiate Klebsiella pneumoniae carbapenemase (KPC) from other serine carbapenemase producing gram-negative organisms. Results A total of 1,337 clinical specimens were analyzed, of which 429 gram-negative bacterial isolates were recovered. Out of 429 isolates, 319, 74, and 36 were Enterobacterales, Acinetobacter species, and Pseudomonas aeruginosa respectively. In our study, the prevalence of multidrug-resistant, extensively drug-resistant, carbapenemase-producing, and carbapenem nonsusceptible gram-negative bacilli were 45.2%, 7.7%, 5.4%, and 15.4% respectively. Out of 429 isolates, 66 demonstrated reduced susceptibility to the antibiotics meropenem and imipenem. These isolates were tested for carbapenemase production of which 34.8% (23/66) were carbapenemase producers. Out of 23 carbapenemase positive gram-negative bacteria, ten (10) and thirteen (13) were metallo-beta-lactamase and serine carbapenemase respectively. Three of 13 serine carbapenemase positive organisms were Klebsiella pneumoniae carbapenemase. Conclusion This study revealed an alarming level of antimicrobial resistance (AMR), with a high prevalence of multidrug-resistant (MDR) and extremely drug-resistant, carbapenemase-producing gram-negative bacteria, particularly among intensive care unit patients at the health facility level. These findings point to a scenario in which clinical management of infected patients becomes increasingly difficult and necessitates the use of "last-resort" antimicrobials likely exacerbating the magnitude of the global AMR crisis. This mandates robust AMR monitoring and an infection prevention and control program.	[Abdeta, Abera; Fentaw, Surafel; Tsige, Estifanos; Assefa, Dawit] Ethiopian Publ Hlth Inst, Natl Clin Bacteriol & Mycol Reference Lab, Addis Ababa, Ethiopia; [Bitew, Adane] Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia; [Lejisa, Tadesse] Ethiopian Publ Hlth Inst, Natl Clin Chem Reference Lab, Addis Ababa, Ethiopia; [Kefyalew, Yordanos] Adama Sci & Technol Univ, Sch Appl Nat Sci, Dept Appl Biol, Adama, Ethiopia; [Tigabu, Eyasu] Ohio State Univ, East African Reg Off, Global One Hlth Initiat, Addis Ababa, Ethiopia; [Evans, Martin] Lab Director & Microbiol Consultant, New York, NY USA	Addis Ababa University; Adama Science & Technology University	Abdeta, A (corresponding author), Ethiopian Publ Hlth Inst, Natl Clin Bacteriol & Mycol Reference Lab, Addis Ababa, Ethiopia.	aberaabdeta4@gmail.com		Abdeta, Abera/0000-0003-2252-6049				Abbas S, 2020, CUREUS, V12, DOI 10.7759/cureus.11914; Abolghait SK, 2020, INT J FOOD MICROBIOL, V328, DOI 10.1016/j.ijfoodmicro.2020.108669; Alebel M, 2021, INFECT DRUG RESIST, V14, DOI 10.2147/IDR.S292246; Alemayehu T, 2021, INFECT DRUG RESIST, V14, P369, DOI 10.2147/IDR.S289763; Algammal AM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88861-w; Algammal AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75914-9; Algammal AM, 2020, INFECT DRUG RESIST, V13, P3255, DOI 10.2147/IDR.S272733; Algammal AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72264-4; Algammal AM, 2020, AMB EXPRESS, V10, DOI 10.1186/s13568-020-01037-z; Algammal AM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030238; Aliramezani A, 2019, GERMS, V9, P148, DOI 10.18683/germs.2019.1171; Alonso B, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05534-1; Aminov RI, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00134; Belley A, 2021, J GLOB ANTIMICROB RE, V25, P93, DOI 10.1016/j.jgar.2021.02.031; Beyene D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222911; Biset S, 2020, ANN CLIN MICROB ANTI, V19, DOI 10.1186/s12941-020-00365-z; Bitew A, 2020, J TROP MED-US, V2020, DOI 10.1155/2020/6167234; Breurec S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1935-y; CLSI, 2017, PERFORMANCE STANDARD; CLSI, 2020, CLSI PERF STAND ANT, V30; CLSI, 2012, M02A11 CLSI; Eshetie S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0054-7; Gashaw M, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0431-0; Gashe F, 2018, J PHARMACEUTICS, V2018, DOI 10.1155/2018/5070742; Hemmati H, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05223-x; Jing XP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02391; Khaertynov KS, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00225; Kieffer N, 2016, ANTIMICROB AGENTS CH, V60, P6189, DOI 10.1128/AAC.01201-16; Leber AL, 2016, CLINICAL MICROBIOLOGY PROCEDURES HANDBOOK, 4TH EDITION, P1; Legese MH, 2017, INFECT DRUG RESIST, V10, P27, DOI 10.2147/IDR.S127177; Lopez-Hernandez I, 2020, EMERG INFECT DIS, V26, P2218, DOI 10.3201/eid2609.191772; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mainil J, 2013, VET IMMUNOL IMMUNOP, V152, P2, DOI 10.1016/j.vetimm.2012.09.032; Makharita RR, 2020, INFECT DRUG RESIST, V13, P3991, DOI 10.2147/IDR.S276975; Moges F, 2021, ANN CLIN MICROB ANTI, V20, DOI 10.1186/s12941-021-00422-1; Moges F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215177; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Okoche D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135745; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P890, DOI 10.1128/AAC.00693-09; Pierce VM, 2017, J CLIN MICROBIOL, V55, P2321, DOI 10.1128/JCM.00193-17; Raman G, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0370-9; Rolain JM, 2012, CLIN MICROBIOL INFEC, V18, P615, DOI 10.1111/j.1469-0691.2012.03902.x; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Siqueira Jr José F., 2007, Braz. Dent. J., V18, P267, DOI 10.1590/S0103-64402007000400001; Souza GL., 2019, INOPEN FORUM INFECT, V6; Teklu DS, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0488-4; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Use I Of C Packages THE Samples K Procedure T Results ETHE, 2015, MIC TEST STRIP TECHN, P7; van der Zwaluw K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123690; Ventola C Lee, 2015, P T, V40, P277; Walther-Rasmussen J, 2006, J ANTIMICROB CHEMOTH, V57, P373, DOI 10.1093/jac/dki482; Watkins RR, 2016, INFECT DIS CLIN N AM, V30, P313, DOI 10.1016/j.idc.2016.02.001; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; Zhou L, 2019, INFECT DRUG RESIST, V12, P481, DOI 10.2147/IDR.S191462	54	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0256556	10.1371/journal.pone.0256556	http://dx.doi.org/10.1371/journal.pone.0256556			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855767	Green Published, gold			2022-12-26	WOS:000735299000004
J	Chan, WH; Huang, NC; Lin, YW; Lin, FY; Tsai, CS; Yeh, CC				Chan, Wei-Hung; Huang, Nian-Cih; Lin, Yi-Wen; Lin, Feng-Yen; Tsai, Chien-Sung; Yeh, Chun-Chang			Intrathecal IGF2 siRNA injection provides long-lasting anti-allodynic effect in a spared nerve injury rat model of neuropathic pain	PLOS ONE			English	Article							RECEPTOR; NOCICEPTION; EXPRESSION; MANAGEMENT	Previous studies have shown an increase of insulin-like growth factor-2 (IGF2) in animal models of neuropathic pain. We aimed to examine the hypothesis that reducing the expression of IGF2 using intrathecal IGF2 small-interfering RNA (siRNA) would attenuate the development of neuropathic pain in rats after spared nerve injury (SNI). Male Wistar rats were divided into three groups: sham-operated group, in which surgery was performed to cut the muscles without injuring the nerves; SNI group, in which SNI surgery was performed to sever the nerves; and SNI + siRNA IGF2 group, in which SNI surgery was performed, and IGF2-siRNA was administered intrathecally 1 day after SNI. The rats were assessed for mechanical allodynia and cold allodynia 1 day before surgery (baseline), and at 2, 4, 6, 8, and 10 days after siRNA treatment. The rat spinal cord was collected for quantitative polymerase chain reaction and western blot analysis. Compared with the SNI group, rats that received IGF2 siRNA showed a significantly increased SNI-induced paw-withdrawal threshold to metal filament stimulation from Day 4 to Day 10 after SNI surgery. IGF2 siRNA significantly decreased the response duration from the acetone test from Day 2 to Day 10 following SNI surgery. SNI increased IGF2 mRNA expression on Day 2 and increased IGF2 protein expression on Day 8 and Day 10 in the spinal cord of the SNI rats. However, the above-mentioned effects of IGF2 mRNA and protein expression were significantly inhibited in the SNI + IGF2 siRNA group. We demonstrated that intrathecal administration of IGF2 siRNA provided significant inhibition of SNI-induced neuropathic pain via inhibition of IGF2 expression in the spinal cord. The analgesic effect lasted for 10 days. Further exploration of intrathecal IGF2 siRNA administration as a potential therapeutic strategy for neuropathic pain is warranted.	[Chan, Wei-Hung; Huang, Nian-Cih; Yeh, Chun-Chang] Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan; [Chan, Wei-Hung; Huang, Nian-Cih; Yeh, Chun-Chang] Triserv Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Lin, Yi-Wen] Natl Yang Ming Chiao Tung Univ, Inst Oral Biol, Hsinchu, Taiwan; [Lin, Feng-Yen] Taipei Med Univ, Dept Internal Med, Taipei, Taiwan; [Lin, Feng-Yen] Taipei Med Univ, Taipei Heart Inst, Taipei, Taiwan; [Lin, Feng-Yen] Taipei Med Univ Hosp, Div Cardiol, Taipei, Taiwan; [Tsai, Chien-Sung] Triserv Gen Hosp, Natl Def Med Ctr, Div Cardiovasc Surg, Taipei, Taiwan; [Tsai, Chien-Sung] Natl Def Med Ctr, Dept & Grad Inst Pharmacol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Yeh, CC (corresponding author), Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan.; Yeh, CC (corresponding author), Triserv Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.	anes2yeh@gmail.com	Yeh, Chun-Chang/AFS-9309-2022	, Yeh/0000-0002-7706-5991; Chan, Wei-Hung/0000-0001-5514-8932	Ministry of Science and Technology (MOST), R.O.C, program [MOST 108-2314-016-028]	Ministry of Science and Technology (MOST), R.O.C, program	This work was supported by the Ministry of Science and Technology (MOST), R.O.C, program grants for applied research, grant number: MOST 108-2314-016-028. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begemann M, 2015, NEW ENGL J MED, V373, P349, DOI 10.1056/NEJMoa1415227; Chang MC, 2018, PAIN PHYSICIAN, V21, pE225; CHOI Y, 1994, PAIN, V59, P369, DOI 10.1016/0304-3959(94)90023-X; Cobos EJ, 2018, CELL REP, V22, P1301, DOI 10.1016/j.celrep.2018.01.006; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Dones I, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8080138; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Dowdall T, 2005, PHARMACOL BIOCHEM BE, V80, P93, DOI 10.1016/j.pbb.2004.10.016; Hansenne I, 2006, J IMMUNOL, V176, P4651, DOI 10.4049/jimmunol.176.8.4651; Hemmings-Mieszczak M, 2003, NUCLEIC ACIDS RES, V31, P2117, DOI 10.1093/nar/gkg322; International Association for the Study of Pain, IASP TAX PAIN TERMS; Jensen TS, 2014, LANCET NEUROL, V13, P924, DOI 10.1016/S1474-4422(14)70102-4; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Ji Q, 2016, MOL MED REP, V13, P1914, DOI 10.3892/mmr.2015.4713; Jung YH, 2017, ACS CHEM NEUROSCI, V8, P1465, DOI 10.1021/acschemneuro.6b00401; Kalmar B, 2003, EXP NEUROL, V184, P636, DOI 10.1016/S0014-4886(03)00343-1; Kaur IP, 2012, BIODRUGS, V26, P401, DOI 10.2165/11634380-000000000-00000; Leroith Derek, 1992, Biological Signals, V1, P173; Lever I, 2003, EUR J NEUROSCI, V18, P1169, DOI 10.1046/j.1460-9568.2003.02848.x; Moalem G, 2004, NEUROSCIENCE, V129, P767, DOI 10.1016/j.neuroscience.2004.08.035; Myers RR, 2006, DRUG DISCOV TODAY, V11, P8, DOI 10.1016/S1359-6446(05)03637-8; Nishikawa N, 2017, J GEN FAM MED, V18, P56, DOI 10.1002/jgf2.5; Penas C, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00158; Peng HY, 2017, MOL NEUROBIOL, V54, P511, DOI 10.1007/s12035-015-9632-1; Qiao XR, 2020, BIOSCI BIOTECH BIOCH, V84, P321, DOI 10.1080/09168451.2019.1685370; Rohl T, 2006, J NEUROCHEM, V99, P371, DOI 10.1111/j.1471-4159.2006.04082.x; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; Schomberg D, 2012, ANN NEUROSCI, V19, P125, DOI 10.5214/ans.0972.7531.190309; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Stern SA, 2014, NEUROPSYCHOPHARMACOL, V39, P2179, DOI 10.1038/npp.2014.69; Suh HS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-37; Sullivan KA, 2008, ENDOCRINOLOGY, V149, P5963, DOI 10.1210/en.2008-1020; Sun J, 2017, INT J MOL MED, V39, P1338, DOI 10.3892/ijmm.2017.2962; Tai LW, 2018, PAIN PRACT, V18, P1068, DOI 10.1111/papr.12706; Tan PH, 2012, BRIT J ANAESTH, V108, P662, DOI 10.1093/bja/aer492; Tan Ping-Heng, 2009, Open Pain J, V2, P57; Wang F, 2016, INT J CLIN EXP MED, V9, P2542; Wittrup A, 2015, NAT REV GENET, V16, P543, DOI 10.1038/nrg3978; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; Wu FX, 2010, INT J MED SCI, V7, P251; Wu WT, 2013, NEUROPSYCH DIS TREAT, V9, P1023, DOI 10.2147/NDT.S47014; Xu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27512; Yeh CC, 2015, INT J MOL SCI, V16, P27156, DOI 10.3390/ijms161126013; Yeh CC, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0071-3; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	45	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260887	10.1371/journal.pone.0260887	http://dx.doi.org/10.1371/journal.pone.0260887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855889	gold, Green Published			2022-12-26	WOS:000735299000148
J	Montandon, M; Efuntoye, T; Itanyi, IU; Onoka, CA; Onwuchekwa, C; Gwamna, J; Schwitters, A; Onyenuobi, C; Ogidi, AG; Swaminathan, M; Oko, JO; Ijaodola, G; Odoh, D; Ezeanolue, EE				Montandon, Michele; Efuntoye, Timothy; Itanyi, Ijeoma U.; Onoka, Chima A.; Onwuchekwa, Chukwudi; Gwamna, Jerry; Schwitters, Amee; Onyenuobi, Chibuzor; Ogidi, Amaka G.; Swaminathan, Mahesh; Oko, John Okpanachi; Ijaodola, Gbenga; Odoh, Deborah; Ezeanolue, Echezona E.			Improving uptake of prevention of mother-to-child HIV transmission services in Benue State, Nigeria through a faith-based congregational strategy	PLOS ONE			English	Article							PREGNANT-WOMEN; BABY SHOWER; CARE; LINKAGE	Background Nigeria has low antiretroviral therapy (ART) coverage among HIV-positive pregnant women. In a previous cluster-randomized trial in Nigeria, Baby Shower events resulted in higher HIV testing coverage and linkage of pregnant women to ART; here, we assess outcomes of Baby Shower events in a non-research setting. Methods Baby Shower events, including a prayer ceremony, group education, music, gifting of a "mama pack" with safe delivery supplies, and HIV testing with ART linkage support for HIV-positive pregnant women, were conducted in eighty sites in Benue State, Nigeria. Client questionnaires (including demographics, ANC attendance, and HIV testing history), HIV test results, and reported linkage to ART were analyzed. Descriptive data on HIV testing and ART linkage data for facility-based care at ANC clinics in Benue State were also analyzed for comparison. Results Between July 2016 and October 2017, 10,056 pregnant women and 6,187 male partners participated in Baby Shower events; 61.5% of women attended with a male partner. Nearly half of female participants (n = 4515, 44.9%) were not enrolled in ANC for the current pregnancy, and 22.3% (n = 2,241) of female and 24.8% (n = 1,532) of male participants reported they had never been tested for HIV. Over 99% (n = 16,240) of participants had their HIV status ascertained, with 7.2% of females (n = 724) and 4.0% of males (n = 249) testing HIV-positive, and 2.9% of females (n = 274) and 2.3% of males (n = 138) receiving new HIV-positive diagnoses. The majority of HIV-positive pregnant women (93.0%, 673/724) were linked to ART. By comparison, at health facilities in Benue State during a similar time period, 99.7% of pregnant women had HIV status ascertained, 8.4% had a HIV-positive status, 2.1% were newly diagnosed HIV-positive, and 100% were linked to ART. Conclusion Community-based programs such as the faith-based Baby Shower intervention complement facility-based approaches and can reach individuals who would not otherwise access facility-based care. Future Baby Showers implementation should incorporate enhanced support for ART linkage and retention to maximize the impact of this intervention on vertical HIV transmission.	[Montandon, Michele] Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA; [Efuntoye, Timothy; Gwamna, Jerry; Schwitters, Amee; Onyenuobi, Chibuzor; Swaminathan, Mahesh] Ctr Dis Control & Prevent, Abuja, Federal Capital, Nigeria; [Itanyi, Ijeoma U.; Onoka, Chima A.; Ogidi, Amaka G.; Ezeanolue, Echezona E.] Univ Nigeria, Ctr Translat & Implementat Res, Nsukka, Enugu, Nigeria; [Itanyi, Ijeoma U.; Onoka, Chima A.] Univ Nigeria, Dept Community Med, Nsukka, Enugu, Nigeria; [Onwuchekwa, Chukwudi; Oko, John Okpanachi] Caritas Nigeria, Abuja, Federal Capital, Nigeria; [Ijaodola, Gbenga; Odoh, Deborah] Nigeria Fed Minist Hlth, Natl AIDS & STI Control Program, Abuja, Federal Capital, Nigeria; [Ezeanolue, Echezona E.] Hlth Sunrise Fdn, Las Vegas, NV USA; [Ezeanolue, Echezona E.] Univ Nigeria, Coll Med, Dept Pediat & Child Hlth, Nsukka, Enugu, Nigeria	Centers for Disease Control & Prevention - USA; University of Nigeria; University of Nigeria; University of Nigeria	Montandon, M (corresponding author), Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA.	nkf3@cdc.gov		Onoka, Chima/0000-0002-3328-1887; Montandon, Michele/0000-0003-0064-7237	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [5NU2GGH000934]; PEPFAR/CDC; Fogarty International Center of the US National Institutes of Health (NIH) [R21TW010252]; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH [R01HD087994, R01HD087994-S1]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); PEPFAR/CDC; Fogarty International Center of the US National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of grant number 5NU2GGH000934. PEPFAR/CDC funded Catholic Caritas Foundation of Nigeria (CCFN), Author JOO, as the implementing partner for this project. CDC Atlanta and CDC Nigeria co-authors provided technical support and participated in study design, data analysis, decision to publish, and preparation of the manuscript. The Fogarty International Center of the US National Institutes of Health (NIH) under grant no. R21TW010252; supported author EEE (URL: https://projectreporter.nih.gov/reporter_SearchResults.cfm?icde=52475683).The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH under grant nos. R01HD087994 and R01HD087994-S1; supported authors EEE and CAO (URL: https://projectreporter.nih.gov/reporter_SearchResults.cfm?icde=52475683).The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyu MH, 2016, LANCET HIV, V3, pE202, DOI 10.1016/S2352-3018(16)00018-7; Aluisio A, 2011, JAIDS-J ACQ IMM DEF, V56, P76, DOI 10.1097/QAI.0b013e3181fdb4c4; Audet CM, 2016, AIDS BEHAV, V20, P2090, DOI 10.1007/s10461-016-1341-x; Ayieko J, 2019, JAIDS-J ACQ IMM DEF, V80, P414, DOI [10.1097/QAI.0000000000001939, 10.1097/qai.0000000000001939]; Dahiru T, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.321.6527; Ezeanolue EE, 2017, AIDS BEHAV, V21, P587, DOI 10.1007/s10461-016-1626-0; Ezeanolue EE, 2015, LANCET GLOB HEALTH, V3, pE692, DOI 10.1016/S2214-109X(15)00195-3; Ezeanolue EE, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-62; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Gbadamosi SO, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211022; Government of Nigeria Federal Ministry of Health and National Agency for the Control of AIDS, 2019, NIG HIV AIDS IND IMP; Iwuji CC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002107; Jennings L, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-297; Kabanga E, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2475-4; Kim MH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17389; Marcos Y, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17394; Mbuagbaw L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010994.pub2; National Population Commission Federal Republic of Nigeria, 2019, NIG DEM HLTH SURV 20; Ndege S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144618; Nigeria Federal Ministry of Health National AIDS and STIs Control Programme, NAT GUID HIV PREV TR; PEPFAR, PEPFAR PAN MER DOWNL; Pew-Templeton Global Religious Futures Project, NIG COUNTR PROF 2018; Public Broadcasting Service, END AIDS FAR 2018; Sambah F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227576; Simpson D, 2018, AJAR-AFR J AIDS RES, V17, P175, DOI 10.2989/16085906.2018.1478313; Torpey K, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-29; Tweheyo R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-53; UNAIDS, 2020, PROGR START FREE STA	28	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260694	10.1371/journal.pone.0260694	http://dx.doi.org/10.1371/journal.pone.0260694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855849	gold, Green Published			2022-12-26	WOS:000735299000096
J	Nagai, J; Ishikawa, Y				Nagai, Junko; Ishikawa, Yoichi			Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database	PLOS ONE			English	Article							BURDEN; SCALE; SAFETY; DISPROPORTIONALITY; ASSOCIATIONS; MEDICATIONS; PEOPLE	Introduction Anticholinergic adverse effects (AEs) are a problem for elderly people. This study aimed to answer the following questions. First, is an analysis of anticholinergic AEs using spontaneous adverse drug event databases possible? Second, what is the main drug suspected of inducing anticholinergic AEs in the databases? Third, do database differences yield different results? Methods We used two databases: the US Food and Drug Administration Adverse Event Reporting System database (FAERS) and the Japanese Adverse Drug Event Report database (JADER) recorded from 2004 to 2020. We defined three types of anticholinergic AEs: central nervous system (CNS) AEs, peripheral nervous system (PNS) AEs, and a combination of these AEs. We counted the number of cases and evaluated the ratio of drug-anticholinergic AE pairs between FAERS and JADER. We computed reporting odds ratios (RORs) and assessed the drugs using Beers Criteria((R)). Results Constipation was the most reported AE in FAERS. The ratio of drug-anticholinergic AE pairs was statistically significantly larger in FAERS than JADER. Overactive bladder agents were suspected drugs common to both databases. Other drugs differed between the two databases. CNS AEs were associated with antidementia drugs in FAERS and opioids in JADER. In the assessment using Beers Criteria((R)), signals were detected for almost all drugs. Between the two databases, a significantly higher positive correlation was observed for PNS AEs (correlation coefficient 0.85, P = 0.0001). The ROR was significantly greater in JADER. Conclusions There are many methods to investigate AEs. This study shows that the analysis of anticholinergic AEs using spontaneous adverse drug event databases is possible. From this analysis, various suspected drugs were detected. In particular, FAERS had many cases. The differences in the results between the two databases may reflect differences in the reporting countries. Further study of the relationship between drugs and CNS AEs should be conducted.	[Nagai, Junko] Meiji Pharmaceut Univ, Off Inst Res, Kiyose, Tokyo, Japan; [Ishikawa, Yoichi] Meiji Pharmaceut Univ, Educ & Res Ctr Pharm, Dept Pediat Pharmaceut Sci, Div Clin Pharm, Kiyose, Tokyo, Japan	Meiji Pharmaceutical University; Meiji Pharmaceutical University	Nagai, J (corresponding author), Meiji Pharmaceut Univ, Off Inst Res, Kiyose, Tokyo, Japan.	nagai-j@my-pharm.ac.jp	Nagai, Junko/ADQ-8238-2022	Nagai, Junko/0000-0002-9069-5752	JSPS (The Japan Society for the Promotion of Science) KAKENHI [19K16424]	JSPS (The Japan Society for the Promotion of Science) KAKENHI	This work was supported by JSPS (The Japan Society for the Promotion of Science) KAKENHI for Grant-in-Aid for Early-Career Scientists Grant Number 19K16424 to J.N. https://www.jsps.go.jp/english/index.html The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almenoff JS, 2007, CLIN PHARMACOL THER, V82, P157, DOI 10.1038/sj.clpt.6100258; Ancelin ML, 2006, BMJ-BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; Astellas Pharma Global Development Inc., PHAS 3 STUD YM178 DO; Boustani M., 2008, AGING HLTH, V4, P311, DOI [10.2217/1745509x.4.3.311, DOI 10.2217/1745509X.4.3.311, 10.2217/1745509XA3.311, 10.2217/1745509X.4.3.311]; Carnahan RM, 2006, J CLIN PHARMACOL, V46, P1481, DOI 10.1177/0091270006292126; Chew ML, 2008, J AM GERIATR SOC, V56, P1333, DOI 10.1111/j.1532-5415.2008.01737.x; Collamati A, 2016, AGING CLIN EXP RES, V28, P25, DOI 10.1007/s40520-015-0359-7; Donohoe KL., 2020, PHARMACOTHERAPY PATH, VEleventh, P67; DrugBank, DRUGBANK REL VERS 5; Duran CE, 2013, EUR J CLIN PHARMACOL, V69, P1485, DOI 10.1007/s00228-013-1499-3; Ehrt U, 2010, J NEUROL NEUROSUR PS, V81, P160, DOI 10.1136/jnnp.2009.186239; FDA, QUEST ANSW FDAS ADV; FEINBERG M, 1993, DRUG AGING, V3, P335, DOI 10.2165/00002512-199303040-00004; Fick DM, 2019, J AM GERIATR SOC, V67, P674, DOI 10.1111/jgs.15767; Food and Drug Administration (FDA), DRUGS FDA DAT FIL; Fox C, 2011, AGE AGEING, V40, P730, DOI 10.1093/ageing/afr102; Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x; Hajjar ER., 2020, PHARMACOTHERAPY PATH, VEleventh, P69; Han L, 2008, J AM GERIATR SOC, V56, P2203, DOI 10.1111/j.1532-5415.2008.02009.x; Hirooka T., 2012, P SAS US GEN ASS TOK, P263; Jun K, 2019, GERIATR GERONTOL INT, V19, P628, DOI 10.1111/ggi.13680; Kaneko S, 2020, BIOL PHARM BULL, V43, P362, DOI 10.1248/bpb.b19-00929; Kersten H, 2014, BASIC CLIN PHARMACOL, V114, P151, DOI 10.1111/bcpt.12140; Kersten H, 2013, BRIT J CLIN PHARMACO, V75, P842, DOI 10.1111/j.1365-2125.2012.04411.x; Kouladjian L, 2014, CLIN INTERV AGING, V9, P1503, DOI 10.2147/CIA.S66660; Laatikainen O, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00358; Lisibach A, 2021, EUR J CLIN PHARMACOL, V77, P147, DOI 10.1007/s00228-020-02994-x; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Lozano-Ortega G, 2019, ADV THER, V36, P2247, DOI 10.1007/s12325-019-01035-z; Villalba-Moreno AM, 2016, ARCH GERONTOL GERIAT, V62, P1, DOI 10.1016/j.archger.2015.10.002; Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x; Matsuda S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126413; MedDRA Maintenance and Support Services Organization (MSSO), MED DICT REG ACT MED; Michel C, 2017, CLIN DRUG INVEST, V37, P415, DOI 10.1007/s40261-017-0503-6; Miyachi T, 2021, EUR J PAIN, V25, P1181, DOI 10.1002/ejp.1767; Nagai J, 2017, CLIN J PAIN, V33, P667, DOI 10.1097/AJP.0000000000000457; Nakham A, 2020, J AM MED DIR ASSOC, V21, P172, DOI 10.1016/j.jamda.2019.06.001; NCBI, MESH DAT ADV DRUG RE; Nomura K, 2015, DRUG DES DEV THER, V9, P3031, DOI 10.2147/DDDT.S81998; Pharmaceuticals and Medical Devices Agency, INF PROV DAT DOWNL P; Pharmaceuticals and Medical Devices Agency, 2014, GUIDELINES IMPLEMENT, P6; Pharmaceuticals and Medical Devices Agency, INF CAS REP ADV REAC; Rudolph JL, 2008, ARCH INTERN MED, V168, P508, DOI 10.1001/archinternmed.2007.106; SAS Institute Inc, 2018, CHAPT 3 DISTR JMP 14, P58; Sittironnarit G, 2011, DEMENT GERIATR COGN, V31, P173, DOI 10.1159/000325171; Taylor-Rowan M, 2021, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013540.pub2; The Japan Geriatrics Society, LIST DRUGS BE PRESCR; U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Office of Surveillance and Epidemiology (OSE), ASC NTSDOC FIL Q DAT; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668; van Puijenbroek EP, 2001, BRIT J CLIN PHARMACO, V52, P579, DOI 10.1046/j.0306-5251.2001.01501.x; Watanabe H., 2004, JPN J BIOMET, V25, P37, DOI [10.5691/jjb.25.37, DOI 10.5691/JJB.25.37]; Wawruch M, 2012, PHARMACOEPIDEM DR S, V21, P170, DOI 10.1002/pds.2169; Wilson NM, 2011, J AM GERIATR SOC, V59, P875, DOI 10.1111/j.1532-5415.2011.03386.x; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Yu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24955	55	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260980	10.1371/journal.pone.0260980	http://dx.doi.org/10.1371/journal.pone.0260980			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855908	gold, Green Published			2022-12-26	WOS:000735299000163
J	Pare, B; Rozendaal, M; Morin, S; Kaufmann, L; Simpson, SM; Poujol, R; Mostefai, F; Grenier, JC; Xing, H; Sanchez, M; Yechouron, A; Racette, R; Hussin, JG; Wolf, G; Pavlov, I; Smith, MA				Pare, Bastien; Rozendaal, Marieke; Morin, Sacha; Kaufmann, Lea; Simpson, Shawn M.; Poujol, Raphael; Mostefai, Fatima; Grenier, Jean-Christophe; Xing, Henry; Sanchez, Miguelle; Yechouron, Ariane; Racette, Ronald; Hussin, Julie G.; Wolf, Guy; Pavlov, Ivan; Smith, Martin A.			Patient health records and whole viral genomes from an early SARS-CoV-2 outbreak in a Quebec hospital reveal features associated with favorable outcomes	PLOS ONE			English	Article							NUMBER	The first confirmed case of COVID-19 in Quebec, Canada, occurred at Verdun Hospital on February 25, 2020. A month later, a localized outbreak was observed at this hospital. We performed tiled amplicon whole genome nanopore sequencing on nasopharyngeal swabs from all SARS-CoV-2 positive samples from 31 March to 17 April 2020 in 2 local hospitals to assess viral diversity (unknown at the time in Quebec) and potential associations with clinical outcomes. We report 264 viral genomes from 242 individuals-both staff and patients-with associated clinical features and outcomes, as well as longitudinal samples and technical replicates. Viral lineage assessment identified multiple subclades in both hospitals, with a predominant subclade in the Verdun outbreak, indicative of hospital-acquired transmission. Dimensionality reduction identified two subclades with mutations of clinical interest, namely in the Spike protein, that evaded supervised lineage assignment methods-including Pangolin and NextClade supervised lineage assignment tools. We also report that certain symptoms (headache, myalgia and sore throat) are significantly associated with favorable patient outcomes. Our findings demonstrate the strength of unsupervised, data-driven analyses whilst suggesting that caution should be used when employing supervised genomic workflows, particularly during the early stages of a pandemic.	[Pare, Bastien; Rozendaal, Marieke; Kaufmann, Lea; Simpson, Shawn M.; Xing, Henry; Smith, Martin A.] CHU St Justine Res Ctr, Montreal, PQ, Canada; [Pare, Bastien; Kaufmann, Lea; Mostefai, Fatima; Smith, Martin A.] Univ Montreal, Fac Med, Dept Biochem & Mol Med, Montreal, PQ, Canada; [Morin, Sacha] Univ Montreal, Dept Comp Sci & Operat Res, Montreal, PQ, Canada; [Morin, Sacha; Wolf, Guy] Mila Quebec AI Inst, Montreal, PQ, Canada; [Poujol, Raphael; Mostefai, Fatima; Grenier, Jean-Christophe; Hussin, Julie G.] Montreal Heart Inst, Montreal, PQ, Canada; [Sanchez, Miguelle; Yechouron, Ariane] Hop Verdun, Dept Microbiol & Infect Dis, Montreal, PQ, Canada; [Racette, Ronald; Pavlov, Ivan] Hop Verdun, Dept Emergency Med, Montreal, PQ, Canada; [Hussin, Julie G.] Univ Montreal, Fac Med, Dept Med, Montreal, PQ, Canada; [Wolf, Guy] Univ Montreal, Dept Math & Stat, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Smith, MA (corresponding author), CHU St Justine Res Ctr, Montreal, PQ, Canada.; Smith, MA (corresponding author), Univ Montreal, Fac Med, Dept Biochem & Mol Med, Montreal, PQ, Canada.; Pavlov, I (corresponding author), Hop Verdun, Dept Emergency Med, Montreal, PQ, Canada.	ivan.pavlov.md@gmail.com; martinalexandersmith@gmail.com	Smith, Martin A./L-5265-2019; Pavlov, Ivan/GVT-5113-2022	Smith, Martin A./0000-0003-2259-1713; Grenier, Jean-Christophe/0000-0001-7937-5160	IVADO MSc excellence scholarship; FRQNT B1X scholarship; Fonds de Reherche du Quebec en Sante Research Scholar - IVADO COVID19 Rapid Response grant [252997, CVD19-030]; Montreal Heart Institute Foundation; Canada CIFAR AI Chair; Fonds de Reherche du Quebec en Sante Junior 1 fellowship [295760]	IVADO MSc excellence scholarship; FRQNT B1X scholarship; Fonds de Reherche du Quebec en Sante Research Scholar - IVADO COVID19 Rapid Response grant; Montreal Heart Institute Foundation; Canada CIFAR AI Chair; Fonds de Reherche du Quebec en Sante Junior 1 fellowship	SM is supported by an IVADO MSc excellence scholarship and an FRQNT B1X scholarship. JGH is a Fonds de Reherche du Quebec en Sante Research Scholar (252997) funded by IVADO COVID19 Rapid Response grant (CVD19-030) and the Montreal Heart Institute Foundation. GW is supported by Canada CIFAR AI Chair. MAS is supported by a Fonds de Reherche du Quebec en Sante Junior 1 fellowship (295760).	Arowolo MO, 2021, J BIG DATA-GER, V8, DOI 10.1186/s40537-021-00441-x; Brunet-Ratnasingham E., 2021, INTEGRATED IMMUNOVIR, DOI [10.1101/2021.03.18.21253907v1.full, DOI 10.1101/2021.03.18.21253907V1.FULL]; Bull RA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20075-6; Burkhardt DB, 2021, NAT BIOTECHNOL, V39, P619, DOI 10.1038/s41587-020-00803-5; Dorrity MW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15351-4; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Frampton D, 2021, LANCET INFECT DIS, V21, P1246, DOI 10.1016/S1473-3099(21)00170-5; Gonzalez-Martinez A, 2021, EUR J NEUROL, V28, P3426, DOI 10.1111/ene.14718; Goyal M, 2021, INFECT GENET EVOL, V90, DOI 10.1016/j.meegid.2021.104730; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Hamelin DJ, 2022, CELL SYST, V13, P143, DOI 10.1016/j.cels.2021.09.013; Hourdel V, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.571328; Hufsky F, 2021, BRIEF BIOINFORM, V22, P642, DOI 10.1093/bib/bbaa232; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Knight Dacre, 2021, SN Compr Clin Med, V3, P247, DOI 10.1007/s42399-021-00746-1; Kobak D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13056-x; Kono N, 2019, DEV GROWTH DIFFER, V61, P316, DOI 10.1111/dgd.12608; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lee WS, 2020, NAT MICROBIOL, V5, P1185, DOI 10.1038/s41564-020-00789-5; Moon KR, 2019, NAT BIOTECHNOL, V37, P1482, DOI 10.1038/s41587-019-0336-3; Moore RM, 2020, PEERJ, V8, DOI 10.7717/peerj.8584; Mostefai F., 2021, DATA DRIVEN APPROACH, DOI [10.1101/2021.09.28.462270.abstract, DOI 10.1101/2021.09.28.462270.ABSTRACT]; Murall CarmenLia., 2021, GENOME MED, V13, P169, DOI [10.1186/s13073-021-00986-9, DOI 10.1186/S13073-021-00986-9]; Nakamichi K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82850-9; Puenpa J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73554-7; Qian GQ, 2020, CLIN INFECT DIS, V71, P861, DOI 10.1093/cid/ciaa316; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Sahlin K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20340-8; Shahriarirad R, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05128-x; Stawinski PM, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.15179; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tyson JR., 2020, IMPROVEMENTS ARTIC M, DOI [10.1101/2020.09.04.283077, DOI 10.1101/2020.09.04.283077]; Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786; Wei WE, 2020, MMWR-MORBID MORTAL W, V69, P411, DOI 10.15585/mmwr.mm6914e1; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Xiao MF, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00751-4; Young BE, 2021, EBIOMEDICINE, V66, DOI 10.1016/j.ebiom.2021.103319; Zeberg H, 2020, NATURE, V587, P610, DOI 10.1038/s41586-020-2818-3	40	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260714	10.1371/journal.pone.0260714	http://dx.doi.org/10.1371/journal.pone.0260714			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855869	gold, Green Published			2022-12-26	WOS:000735299000100
J	Sellers, GS; Jeffares, DC; Lawson, B; Prior, T; Lunt, DH				Sellers, Graham S.; Jeffares, Daniel C.; Lawson, Bex; Prior, Tom; Lunt, David H.			Identification of individual root-knot nematodes using low coverage long-read sequencing	PLOS ONE			English	Article							GENOME	Root-knot nematodes (RKN; genus Meloidogyne) are polyphagous plant pathogens of great economic importance to agriculturalists globally. These species are small, diverse, and can be challenging for accurate taxonomic identification. Many of the most important crop pests confound analysis with simple genetic marker loci as they are polyploids of likely hybrid origin. Here we take a low-coverage, long-read genome sequencing approach to characterisation of individual root-knot nematodes. We demonstrate library preparation for Oxford Nanopore Technologies Flongle sequencing of low input DNA from individual juveniles and immature females, multiplexing up to twelve samples per flow cell. Taxonomic identification with Kraken 2 (a k-mer-based taxonomic assignment tool) is shown to reliably identify individual nematodes to species level, even within the very closely related Meloidogyne incognita group. Our approach forms a robust, low-cost, and scalable method for accurate RKN species diagnostics.	[Sellers, Graham S.; Lunt, David H.] Univ Hull, Energy & Environm Inst, Dept Biol & Marine Sci, Kingston Upon Hull, N Humberside, England; [Jeffares, Daniel C.] Univ York, Dept Biol, York, N Yorkshire, England; [Jeffares, Daniel C.] Univ York, York Biomed Res Inst, York, N Yorkshire, England; [Lawson, Bex; Prior, Tom] Fera Sci Ltd, York, N Yorkshire, England	University of Hull; University of York - UK; University of York - UK; Food & Environment Research Agency	Sellers, GS; Lunt, DH (corresponding author), Univ Hull, Energy & Environm Inst, Dept Biol & Marine Sci, Kingston Upon Hull, N Humberside, England.	graham.s.sellers@gmail.com; dave.lunt@gmail.com	; Jeffares, Daniel/N-2632-2018	Lunt, David H/0000-0002-9000-7470; Jeffares, Daniel/0000-0001-7320-0706	University of Hull's Energy and Environment Institute as part of a strategic THYME project	University of Hull's Energy and Environment Institute as part of a strategic THYME project	This project was internally funded by the University of Hull's Energy and Environment Institute as part of a strategic THYME project.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Alvarez-Ortega S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48195-0; Asamizu E, 2020, MOL PLANT PATHOL, V21, P1088, DOI 10.1111/mpp.12961; Blanc-Mathieu R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006777; Blok VC, 2010, ROOT-KNOT NEMATODES, P98; Dalmasso A., 1983, Systematics Association Special Volume Series, P187; De Coster W, 2018, BIOINFORMATICS, V34, P2666, DOI 10.1093/bioinformatics/bty149; Eves-van den Akker S, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007160; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Karssen G., 2013, Plant nematology, P73, DOI 10.1079/9781780641515.0073; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Koutsovoulos GD, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00666-0; Lunt DH, 2014, PEERJ, V2, DOI 10.7717/peerj.356; Marti JM, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006967; Moens M, 2010, ROOT-KNOT NEMATODES, P1; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Phan NT, 2020, ECOL EVOL, V10, P11006, DOI 10.1002/ece3.6680; RCore Team, 2020, R LANG ENV STAT COMP; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Sato K, 2018, GENOME ANNOUNCEMENTS, V6, DOI [10.1128/genomeA.00519-18, 10.1128/genomea.00519-18]; Sellers Graham S., 2018, Metabarcoding and Metagenomics, V2, pe24556, DOI 10.3897/mbmg.2.24556; Somvanshi VS, 2018, J NEMATOL, V50, P111, DOI 10.21307/jofnem-2018-018; Susic N, 2020, J NEMATOL, V52, DOI 10.21307/jofnem-2020-025; Szitenberg Amir, 2017, Genome Biol Evol, V9, P2844, DOI 10.1093/gbe/evx201; Triantaphyllou A.C., 1985, ADV TREATISE MELOIDO, VI, P113; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0	27	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0253248	10.1371/journal.pone.0253248	http://dx.doi.org/10.1371/journal.pone.0253248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851967	Green Published, Green Accepted, gold			2022-12-26	WOS:000755762900002
J	Qi, Y; Qadir, MMF; Hastreiter, AA; Fock, RA; Machi, JF; Morales, AA; Wang, Y; Meng, ZP; Rodrigues, CO				Qi, Yue; Qadir, Mirza M. F.; Hastreiter, Araceli A.; Fock, Ricardo A.; Machi, Jacqueline F.; Morales, Alejo A.; Wang, Ying; Meng, Zhipeng; Rodrigues, Claudia O.			Endothelial c-Myc knockout enhances diet-induced liver inflammation and fibrosis	FASEB JOURNAL			English	Article						c-Myc; endothelial cells; fibrosis; inflammation	ACTIVATION; CELLS; CANCER; OVEREXPRESSION; PATHWAY; GENE	Endothelial cells play an essential role in inflammation through synthesis and secretion of chemoattractant cytokines and expression of adhesion molecules required for inflammatory cell attachment and infiltration. The mechanisms by which endothelial cells control the pro-inflammatory response depend on the type of inflammatory stimuli, endothelial cell origin, and tissue involved. In the present study, we investigated the role of the transcription factor c-Myc in inflammation using a conditional knockout mouse model in which Myc is specifically deleted in the endothelium. At a systemic level, circulating monocytes, the chemokine CCL7, and the extracellular-matrix protein osteopontin were significantly increased in endothelial c-Myc knockout (EC-Myc KO) mice, whereas the cytokine TNFSF11 was downregulated. Using an experimental model of steatohepatitis, we investigated the involvement of endothelial c-Myc in diet-induced inflammation. EC-Myc KO animals displayed enhanced pro-inflammatory response, characterized by increased expression of pro-inflammatory cytokines and leukocyte infiltration, and worsened liver fibrosis. Transcriptome analysis identified enhanced expression of genes associated with inflammation, fibrosis, and hepatocellular carcinoma in EC-Myc KO mice relative to control (CT) animals after short-exposure to high-fat diet. Analysis of a single-cell RNA-sequencing dataset of human cirrhotic livers indicated downregulation of MYC in endothelial cells relative to healthy controls. In summary, our results suggest a protective role of endothelial c-Myc in diet-induced liver inflammation and fibrosis. Targeting c-Myc and its downstream pathways in the endothelium may constitute a potential strategy for the treatment of inflammatory disease.	[Qi, Yue; Machi, Jacqueline F.; Morales, Alejo A.; Wang, Ying; Meng, Zhipeng; Rodrigues, Claudia O.] Univ Miami, Dept Mol & Cellular Pharmacol, Leonard M Miller Sch Med, Miami, FL USA; [Qi, Yue; Hastreiter, Araceli A.; Fock, Ricardo A.; Machi, Jacqueline F.; Morales, Alejo A.; Rodrigues, Claudia O.] Univ Miami, Interdisciplinary Stem Cell Inst, Leonard M Miller Sch Med, Miami, FL USA; [Qadir, Mirza M. F.] Tulane Univ, Sch Med, Sect Endocrinol & Metab, Deming Dept Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Wang, Ying; Meng, Zhipeng; Rodrigues, Claudia O.] Univ Miami, Sylvester Comprehens Canc Ctr, Leonard M Miller Sch Med, Miami, FL USA; [Hastreiter, Araceli A.; Fock, Ricardo A.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil	University of Miami; University of Miami; Tulane University; University of Miami; Universidade de Sao Paulo	Rodrigues, CO (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, 777 Glades Rd,BC-71,Room 224, Boca Raton, FL 33431 USA.	crodrigues@health.fau.edu	Qadir, Fahd/B-4578-2014	Qadir, Fahd/0000-0002-6764-6151; Rodrigues, Claudia/0000-0002-8416-3602; Hastreiter, Araceli/0000-0001-6226-8772	HHS \ NTH \ National Heart, Lung, and Blood Institute (NHLBI) [1R01HL128536-01A1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2017/50022-1]; Florida Ileart Research Institute	HHS \ NTH \ National Heart, Lung, and Blood Institute (NHLBI); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Florida Ileart Research Institute	HHS | NTH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: 1R01HL128536-01A1; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Grant; Award Number: 2017/50022-1; Florida Ileart Research Institute	Balakrishnan M, 2021, CLIN GASTROENTEROL H, V19, P61, DOI 10.1016/j.cgh.2020.04.067; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Borrello MG, 2008, CANCER LETT, V267, P262, DOI 10.1016/j.canlet.2008.03.060; Cai XB, 2018, J CELL MOL MED, V22, P5050, DOI 10.1111/jcmm.13787; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen L, 2015, J HEPATOL, V62, P156, DOI 10.1016/j.jhep.2014.07.035; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Florea V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073146; Geraud C, 2017, J CLIN INVEST, V127, P1099, DOI 10.1172/JCI90086; Hammoutene A, 2019, J HEPATOL, V70, P1278, DOI 10.1016/j.jhep.2019.02.012; Jambusaria A, 2020, ELIFE, V9, DOI 10.7554/eLife.51413; Jaruga B, 2003, J IMMUNOL, V171, P3233, DOI 10.4049/jimmunol.171.6.3233; Kokai E, 2009, CIRC RES, V104, P1151, DOI 10.1161/CIRCRESAHA.108.191460; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lafdil F, 2010, CELL MOL IMMUNOL, V7, P250, DOI 10.1038/cmi.2010.5; Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Lemos DR, 2018, J AM SOC NEPHROL, V29, P1690, DOI 10.1681/ASN.2017121283; Li AY, 2019, BIOMED PHARMACOTHER, V110, P733, DOI 10.1016/j.biopha.2018.12.029; Liao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080789; Liu T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/276850; Liu XR, 2018, CANCER SCI, V109, P3450, DOI 10.1111/cas.13794; Liu XR, 2014, CANCER RES, V74, P6623, DOI 10.1158/0008-5472.CAN-14-1279; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nevzorova YA, 2013, BBA-MOL BASIS DIS, V1832, P1765, DOI 10.1016/j.bbadis.2013.06.001; Osterreicher CH, 2011, P NATL ACAD SCI USA, V108, P308, DOI 10.1073/pnas.1017547108; Paquissi FC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01195; Pate M, 2010, ADV CLIN CHEM, V52, P109, DOI 10.1016/S0065-2423(10)52004-3; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; Pham BN, 2001, J HEPATOL, V34, P537, DOI 10.1016/S0168-8278(00)00057-X; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Qadir MMF, 2020, P NATL ACAD SCI USA, V117, P10876, DOI 10.1073/pnas.1918314117; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Rau M, 2016, J IMMUNOL, V196, P97, DOI 10.4049/jimmunol.1501175; Rodrigues CO, 2008, DEVELOPMENT, V135, P1903, DOI 10.1242/dev.011296; Rodrigues SF, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.978720; Sipos F, 2016, WORLD J GASTROENTERO, V22, P7938, DOI 10.3748/wjg.v22.i35.7938; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Torre D, 2018, CELL SYST, V7, P556, DOI 10.1016/j.cels.2018.10.007; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5; Winkler M, 2021, J HEPATOL, V74, DOI 10.1016/j.jhep.2020.08.033; Wohlfeil SA, 2019, CANCER RES, V79, P598, DOI 10.1158/0008-5472.CAN-18-1752; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xiao L, 2014, AM J PHYSIOL-HEART C, V306, pH317, DOI 10.1152/ajpheart.00182.2013; Yu LX, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0048-z; Zhang HW, 2020, CIRC RES, V127, P610, DOI 10.1161/CIRCRESAHA.119.316428; Zhang JY, 2019, INT J BIOCHEM CELL B, V114, DOI 10.1016/j.biocel.2019.105574	58	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22077	10.1096/fj.202101086R	http://dx.doi.org/10.1096/fj.202101086R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34878671				2022-12-26	WOS:000734992000045
J	Xu, BK; Huang, S; Liu, YH; Wan, C; Gu, YY; Wang, DL; Yu, HJ				Xu, Bingkuan; Huang, Shuai; Liu, Yinghui; Wan, Chun; Gu, Yuanyuan; Wang, Dianliang; Yu, Haijia			Manganese promotes alpha-synuclein amyloid aggregation through the induction of protein phase transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERNATIONAL TEAMS EXPERIENCES; NEUROLOGIST ASSESS WELDERS; INDUCED MOVEMENT-DISORDER; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; EXPOSURE; TOXICITY; ASSOCIATIONS; STEELWORKERS; DYSFUNCTION	alpha-Synuclein (alpha-Syn) is the major protein component of Lewy bodies, a key pathological feature of Parkinson's disease (PD). The manganese ion Mn2+ has been identified as an environmental risk factor of PD. However, it remains unclear how Mn2+ regulates alpha-Syn aggregation. Here, we discovered that Mn2+ accelerates alpha-Syn amyloid aggregation through the regulation of protein phase separation. We found that Mn2+ not only promotes a-Syn liquid-to-solid phase transition but also directly induces soluble alpha-Syn monomers to form solid-like condensates. Interestingly, the lipid membrane is integrated into condensates during Mn2+-induced alpha-Syn phase transition; however, the preformed Mn2+/alpha-syn condensates can only recruit lipids to the surface of condensates. In addition, this phase transition can largely facilitate alpha-Syn amyloid aggregation. Although the Mn2+-induced condensates do not fuse, our results demonstrated that they could recruit soluble alpha-Syn monomers into the existing condensates. Furthermore, we observed that a manganese chelator reverses Mn2+-induced alpha-Syn aggregation during the phase transition stage. However, after maturation, alpha-Syn aggregation becomes irreversible. These findings demonstrate that Mn2+ facilitates alpha-Syn phase transition to accelerate the formation of alpha-Syn aggregates and provide new insights for targeting alpha-Syn phase separation in PD treatment.	[Xu, Bingkuan; Huang, Shuai; Liu, Yinghui; Yu, Haijia] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Peoples R China; [Wan, Chun] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Gu, Yuanyuan] PLA Rocket Force Characterist Med Ctr, Med Safeguard Ctr, Beijing, Peoples R China; [Wang, Dianliang] PLA Rocket Force Characterist Med Ctr, Stem Cell & Tissue Engn Res Lab, Beijing, Peoples R China	Nanjing Normal University; University of Colorado System; University of Colorado Boulder	Liu, YH; Yu, HJ (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Peoples R China.; Wang, DL (corresponding author), PLA Rocket Force Characterist Med Ctr, Stem Cell & Tissue Engn Res Lab, Beijing, Peoples R China.	yinghuiliu@njnu.edu.cn; wangdianliang@sina.com; yuhaijia@njnu.edu.cn	Yu, Haijia/GXV-5159-2022	Yu, Haijia/0000-0002-7193-8034	National Natural Science Foundation of China (NSFC) [91854117, 31871425, 32100546]; Natural Science Foundation of Jiangsu Province [BK20200036]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Six Talent Peaks Project in Jiangsu Province; Jiangsu Distinguished Professor Funding	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Six Talent Peaks Project in Jiangsu Province; Jiangsu Distinguished Professor Funding	We thank Dr Jingshi Shen, Tao Gao for insightful discussions and Xiaojun Wang for technical assistance. This work was supported by the National Natural Science Foundation of China (NSFC) grants (Nos. 91854117, 31871425, and 32100546), Natural Science Foundation of Jiangsu Province (BK20200036), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Six Talent Peaks Project in Jiangsu Province, and Jiangsu Distinguished Professor Funding.	Agerschou ED, 2021, BIOPHYS CHEM, V269, DOI 10.1016/j.bpc.2020.106519; Al-Lozi A, 2017, AM J IND MED, V60, P181, DOI 10.1002/ajim.22675; Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Baba M, 1998, AM J PATHOL, V152, P879; Babinchak WM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19211-z; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bernal-Conde LD, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01399; Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649; Bowler RM, 2015, NEUROTOXICOLOGY, V49, P139, DOI 10.1016/j.neuro.2015.06.004; Boyko S, 2019, J BIOL CHEM, V294, P11054, DOI 10.1074/jbc.AC119.009198; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cai TJ, 2010, BRAIN RES, V1359, P201, DOI 10.1016/j.brainres.2010.08.055; Conicella AE, 2020, P NATL ACAD SCI USA, V117, P5883, DOI 10.1073/pnas.1912055117; de Carvalho CF, 2018, NEUROTOXICOLOGY, V69, P253, DOI 10.1016/j.neuro.2018.02.002; Doig AJ, 2015, CURR OPIN STRUC BIOL, V30, P50, DOI 10.1016/j.sbi.2014.12.004; Du K, 2018, NEUROSCI LETT, V665, P92, DOI 10.1016/j.neulet.2017.11.054; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fields CR, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00299; Fusco G, 2017, SCIENCE, V358, P1440, DOI 10.1126/science.aan6160; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; Gasset-Rosa F, 2019, NEURON, V102, P339, DOI 10.1016/j.neuron.2019.02.038; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; Gonzalez N, 2019, J NEUROCHEM, V150, P507, DOI 10.1111/jnc.14721; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; Guilarte TR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00023; Guiney SJ, 2020, J BIOL CHEM, V295, P17497, DOI 10.1074/jbc.RA120.013428; Han JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20320-5; Hardenberg MC, 2021, J MOL CELL BIOL, V13, P282, DOI 10.1093/jmcb/mjaa075; Harischandra DS, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau4543; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Hoffmann C, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166961; Ivanova MI, 2021, BIOPHYS CHEM, V269, DOI 10.1016/j.bpc.2020.106507; Jiang YM, 2006, J OCCUP ENVIRON MED, V48, P644, DOI 10.1097/01.jom.0000204114.01893.3e; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Kurochka AS, 2021, ACS CHEM NEUROSCI, V12, P825, DOI 10.1021/acschemneuro.0c00819; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Levone BR, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202008030; Li CH, 2020, NATURE, V586, P440, DOI 10.1038/s41586-020-2574-4; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Liu YH, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108611; Liu ZQ, 2021, FOOD CHEM TOXICOL, V152, DOI 10.1016/j.fct.2021.112213; Lucchini RG, 2009, NEUROMOL MED, V11, P311, DOI 10.1007/s12017-009-8108-8; Man WK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21027-4; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Miah MR, 2020, NEUROCHEM INT, V135, DOI 10.1016/j.neuint.2020.104688; Mortimer JA, 2012, NEUROLOGY, V79, P1174, DOI 10.1212/WNL.0b013e3182698ced; Munoz SS, 2021, BIOPHYS CHEM, V273, DOI 10.1016/j.bpc.2020.106534; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nguyen PH, 2021, CHEM REV, V121, P2545, DOI 10.1021/acs.chemrev.0c01122; Nguyen PH, 2020, BIOPHYS CHEM, V264, DOI 10.1016/j.bpc.2020.106421; Nguyen PH, 2016, J PHYS CHEM B, V120, P12111, DOI 10.1021/acs.jpcb.6b10722; Peres TV, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00364; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Pfalzer Anna C, 2017, Curr Environ Health Rep, V4, P223, DOI 10.1007/s40572-017-0136-1; Pradhan A, 2021, ACS CHEM NEUROSCI, V12, P1989, DOI 10.1021/acschemneuro.1c00098; Pujols J, 2020, TRENDS MOL MED, V26, P408, DOI 10.1016/j.molmed.2020.01.005; Pytowski L, 2020, P NATL ACAD SCI USA, V117, P12050, DOI 10.1073/pnas.1916716117; Qian TT, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100729; Racette BA, 2005, NEUROLOGY, V64, P230, DOI 10.1212/01.WNL.0000149511.19487.44; Racette BA, 2001, NEUROLOGY, V56, P8, DOI 10.1212/WNL.56.1.8; Racette BA, 2012, NEUROTOXICOLOGY, V33, P1356, DOI 10.1016/j.neuro.2012.08.011; Ray S, 2020, NAT CHEM, V12, DOI 10.1038/s41557-020-0465-9; Rutchik JS, 2012, J OCCUP ENVIRON MED, V54, P1562, DOI 10.1097/JOM.0b013e318216d01b; Rutchik JS, 2012, J OCCUP ENVIRON MED, V54, P1432, DOI 10.1097/JOM.0b013e318216d0df; Savitt D, 2019, DRUGS, V79, P797, DOI 10.1007/s40265-019-01104-1; Shahmoradian SH, 2019, NAT NEUROSCI, V22, P1099, DOI 10.1038/s41593-019-0423-2; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sun Y, 2020, TOXICOL LETT, V332, P164, DOI 10.1016/j.toxlet.2020.07.008; Tange H, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100367; Theillet FX, 2016, NATURE, V530, P45, DOI 10.1038/nature16531; Tinkov AA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094646; Verina T, 2013, TOXICOL LETT, V217, P177, DOI 10.1016/j.toxlet.2012.12.006; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Watson MD, 2021, BIOPHYS CHEM, V269, DOI 10.1016/j.bpc.2020.106528; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Wong YC, 2017, NAT MED, V23, P151, DOI 10.1038/nm.4269; Wu XD, 2019, MOL CELL, V73, P971, DOI 10.1016/j.molcel.2018.12.007; Xing YT, 2021, J PHYS CHEM LETT, V12, P368, DOI 10.1021/acs.jpclett.0c02567; Yu HJ, 2018, P NATL ACAD SCI USA, V115, pE8421, DOI 10.1073/pnas.1802645115; Yu HJ, 2015, J AM CHEM SOC, V137, P12873, DOI 10.1021/jacs.5b08306; Yu HJ, 2013, MOL BIOL CELL, V24, P1176, DOI 10.1091/mbc.E12-11-0810; Yu HJ, 2012, CHEM SCI, V3, P3145, DOI 10.1039/c2sc20372c	84	5	5	8	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101469	10.1016/j.jbc.2021.101469	http://dx.doi.org/10.1016/j.jbc.2021.101469			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1GJ	34871547	Green Published, gold			2022-12-26	WOS:000748376400017
J	Gummerson, E; Cardona, C; Anglewicz, P; Zachary, B; Guiella, G; Radloff, S				Gummerson, Elizabeth; Cardona, Carolina; Anglewicz, Philip; Zachary, Blake; Guiella, Georges; Radloff, Scott			The wealth gradient and the effect of COVID-19 restrictions on income loss, food insecurity and health care access in four sub-Saharan African geographies	PLOS ONE			English	Article								Introduction While there has been considerable analysis of the health and economic effects of COVID-19 in the Global North, representative data on the distribution and depth of social and economic impacts in Africa has been more limited. Methods We analyze household data collected prior to the COVID-19 pandemic and during the first wave of COVID in four African countries. We evaluate the short-term changes to household economic status and assess women's access to health care during the first wave of COVID-19 in nationally representative samples of women aged 15-49 in Kenya and Burkina Faso, and in sub-nationally representative samples of women aged 15-49 in Kinshasa, Democratic Republic of Congo and Lagos, Nigeria. We examine prevalence and distribution of household income loss, food insecurity, and access to health care during the COVID-19 lockdowns across residence and pre-pandemic wealth categories. We then regress pre-pandemic individual and household sociodemographic characteristics on the three outcomes. Results In three out of four samples, over 90% of women reported partial or complete loss of household income since the beginning of the coronavirus restrictions. Prevalence of food insecurity ranged from 17.0% (95% CI 13.6-20.9) to 39.8% (95% CI 36.0-43.7), and the majority of women in food insecure households reported increases in food insecurity during the COVID-19 restriction period. In contrast, we did not find significant barriers to accessing health care during COVID restrictions. Between 78.3% and 94.0% of women who needed health care were able successfully access it. When we examined pre-pandemic sociodemographic correlates of the outcomes, we found that the income shock of COVID-19 was substantial and distributed similarly across wealth groups, but food insecurity was concentrated among poorer households. Contrary to a-priori expectations, we find little evidence of women experiencing barriers to health care, but there is significant need for food support.	[Gummerson, Elizabeth; Cardona, Carolina; Anglewicz, Philip; Radloff, Scott] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Zachary, Blake] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Guiella, Georges] Univ Joseph Ki Zerbo Ouagadougou, Inst Super Sci Populat ISSP, Ouagadougou, Burkina Faso	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Gummerson, E (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.	egummerson@jhu.edu		Anglewicz, Philip/0000-0002-7967-3843; Gummerson, Elizabeth/0000-0002-5097-0588	Bill & Melinda Gates Foundation [009639]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work and all authors' work on this (EG, CC, BZ, PA, GG and SR) was supported by the Bill & Melinda Gates Foundation 009639. (gatesfoundation.org) Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. The funders of the study had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abate G. T., 2020, ESSP Working Paper - Ethiopia Strategy Support Program, DOI 10.2499/p15738coll2.133766; Adams-Prassl A, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104245; Adjognon GS, 2021, FOOD POLICY, V101, DOI 10.1016/j.foodpol.2021.102050; Africa Center for Strategic Studies, 2021, FOOD INS CRIS MOUNT; Aggarwal S., 2020, DID COVID 19 MARKET; Aizenman N., 2021, DOWNS UPS AFRICAS CU; Amare M., 2021, FOOD SECUR; Ataguba JE, 2020, APPL HEALTH ECON HEA, V18, P325, DOI 10.1007/s40258-020-00580-x; Beaubien J., 2021, LOCUST SWARMS THREAT; Bene C, 2020, FOOD SECUR, V12, P805, DOI 10.1007/s12571-020-01076-1; Blundell R, 2020, FISC STUD, V41, P291, DOI 10.1111/1475-5890.12232; Devereux S, 2020, FOOD SECUR, V12, P769, DOI 10.1007/s12571-020-01085-0; Diop BZ, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002699; Egger D, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe0997; El-Sadr WM, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2008193; Fengler W, S AFRICA COVID 19 LI; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gondwe G., 2020, ASSESSING IMPACT COV; Hodgins S, 2020, GLOB HEALTH-SCI PRAC, V8, P136, DOI 10.9745/GHSP-D-20-00217; Josephson A, 2021, NAT HUM BEHAV, V5, P557, DOI 10.1038/s41562-021-01096-7; Lawal Y, 2021, INT J INFECT DIS, V102, P118, DOI 10.1016/j.ijid.2020.10.038; Lone SA, 2020, EMERG MICROBES INFEC, V9, P1300, DOI 10.1080/22221751.2020.1775132; Madden P.., 2020, FIGURES WEEK MACROEC; Madgavkar A.., COVID 19 GENDER EQUA, V15, P2020; Maeda JM, 2021, SCIENCE, V371, P27, DOI 10.1126/science.abf8832Article; Mahmud M, 2021, WORLD DEV, V140, DOI 10.1016/j.worlddev.2020.105318; Mbow M, 2020, SCIENCE, V369, P624, DOI 10.1126/science.abd3902; Mwananyanda L, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n334; Njenga MK, 2020, AM J TROP MED HYG, V103, P564, DOI 10.4269/ajtmh.20-0474; Nordling L, 2020, SCIENCE, V369, P756, DOI 10.1126/science.369.6505.756; Ondoa P, 2020, LANCET MICROBE, V1, pE103, DOI 10.1016/S2666-5247(20)30068-9; PMA, COV SURV WEIGHTS CON; Roberton T, 2020, LANCET GLOB HEALTH, V8, pE901, DOI 10.1016/S2214-109X(20)30229-1; Swinnen J., 2020, COVID 19 GLOBAL FOOD, DOI 10.2499/p15738coll2.133762; Teachout M., 2020, INT GROWTH CTR POLIC; The World Bank, COVID 19 COR RESP AF; Thurlow J., 2020, COVID 19 LOCKDOWNS H, P23, DOI DOI 10.2499/P15738COLL2.133762_04; UNDP Regional Bureau for Africa, 2021, LONG TERM SOC IMP CO; Visagie J, 2021, AREA DEV POLICY, V6, P50, DOI 10.1080/23792949.2020.1851143; WFP (World Food Programme), 2020, COVID 19 WILL DOUBL; World Bank, 2021, SUBSAHARAN AFRICA PO; Zwedu S., 2020, AFRICA FIGHT COVID 1	42	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0260823	10.1371/journal.pone.0260823	http://dx.doi.org/10.1371/journal.pone.0260823			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY5KW	34910752	Green Published, gold			2022-12-26	WOS:000754828900028
J	Stettler, JM; Stevens, MR; Meservey, LM; Crump, WW; Grow, JD; Porter, SJ; Love, LS; Maughan, PJ; Jellen, EN				Stettler, Jason M.; Stevens, Mikel R.; Meservey, Lindsey M.; Crump, W. Wesley; Grow, Jed D.; Porter, Sydney J.; Love, L. Stephen; Maughan, Peter J.; Jellen, Eric N.			Improving phylogenetic resolution of the Lamiales using the complete plastome sequences of six Penstemon species	PLOS ONE			English	Article							APIACEAE SUBFAMILY APIOIDEAE; CHLOROPLAST GENOME SEQUENCE; DNA-SEQUENCES; NONCODING REGIONS; SSR-MARKERS; RBCL; NUCLEAR; DISINTEGRATION; ORGANIZATION; ANGIOSPERMS	The North American endemic genus Penstemon (Mitchell) has a recent geologic origin of ca. 3.6 million years ago (MYA) during the Pliocene/Pleistocene transition and has undergone a rapid adaptive evolutionary radiation with ca. 285 species of perennial forbs and sub-shrubs. Penstemon is divided into six subgenera occupying all North American habitats including the Arctic tundra, Central American tropical forests, alpine meadows, arid deserts, and temperate grasslands. Due to the rapid rate of diversification and speciation, previous phylogenetic studies using individual and concatenated chloroplast sequences have failed to resolve many polytomic clades. We investigated the efficacy of utilizing the plastid genomes (plastomes) of 29 species in the Lamiales order, including five newly sequenced Penstemon plastomes, for analyzing phylogenetic relationships and resolving problematic clades. We compared whole-plastome based phylogenies to phylogenies based on individual gene sequences (matK, ndhF, psaA, psbA, rbcL, rpoC2, and rps2) and concatenated sequences. We also We found that our whole-plastome based phylogeny had higher nodal support than all other phylogenies, which suggests that it provides greater accuracy in describing the hierarchal relationships among taxa as compared to other methods. We found that the genus Penstemon forms a monophyletic clade sister to, but separate from, the Old World taxa of the Plantaginaceae family included in our study. Our whole-plastome based phylogeny also supports the rearrangement of the Scrophulariaceae family and improves resolution of major clades and genera of the Lamiales.	[Stettler, Jason M.; Stevens, Mikel R.; Porter, Sydney J.; Maughan, Peter J.; Jellen, Eric N.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [Meservey, Lindsey M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Crump, W. Wesley] Washington State Univ, Irrigated Agr Res & Extens Ctr, Dept Hort, Prosser, WA USA; [Grow, Jed D.] North Dakota State Univ, Dept Plant Sci, Fargo, ND USA; [Love, L. Stephen] Univ Idaho, Aberdeen Res & Extens Ctr, Aberdeen, ID USA	Brigham Young University; Stanford University; Washington State University; North Dakota State University Fargo; Idaho; University of Idaho	Stettler, JM (corresponding author), Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA.	m.stesttler@gmail.com		Crump, W. Wesley/0000-0002-1187-7911; Stettler, Jason/0000-0002-0932-6782				Albach DC, 2005, AM J BOT, V92, P297, DOI 10.3732/ajb.92.2.297; Amiryousefi A, 2018, BIOINFORMATICS, V34, P3030, DOI 10.1093/bioinformatics/bty220; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Bremer B, 2002, MOL PHYLOGENET EVOL, V24, P274, DOI 10.1016/S1055-7903(02)00240-3; Broderick SR, 2011, GENOME, V54, P160, DOI 10.1139/G10-106; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; CLEGG MT, 1993, P NATL ACAD SCI USA, V90, P363, DOI 10.1073/pnas.90.2.363; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; Dierckxsens N, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw955; Dockter RB, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-66; Downie SR., MOL SYSTEMATICS PLAN, P14; Downie Stephen R., 2010, Plant Diversity and Evolution, V128, P111, DOI 10.1127/1869-6155/2010/0128-0005; Doyle J. J., 1987, PHYTOCHEM B, P11; Duvall MR, 2020, BOT J LINN SOC, V192, P9, DOI 10.1093/botlinnean/boz060; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Freeman C.C., 2019, FLORA N AM N MEXICO, V17, P82; Hassemer G, 2019, MOL PHYLOGENET EVOL, V138, P156, DOI 10.1016/j.ympev.2019.05.013; Holmgren NH., 2017, INTERMOUNTAIN FLORA, V4, P161; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Kajita T, 2001, SYST BOT, V26, P515; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Katsura Y, 2017, MOL BIOL EVOL, V34, P718, DOI 10.1093/molbev/msw272; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lohan AJ, 1998, GENETICS, V150, P425; OLMSTEAD RG, 1995, ANN MO BOT GARD, V82, P176, DOI 10.2307/2399876; Olmstead RG, 2001, AM J BOT, V88, P348, DOI 10.2307/2657024; Oxelman B, 2005, TAXON, V54, P411, DOI 10.2307/25065369; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Ponce-Toledo RI, 2017, CURR BIOL, V27, P386, DOI 10.1016/j.cub.2016.11.056; Potter D, 2000, SYST BOT, V25, P337, DOI 10.2307/2666646; Ricks NJ, 2017, MITOCHONDRIAL DNA B, V2, P768, DOI 10.1080/23802359.2017.1398620; Sanderson MJ, 2001, AM J BOT, V88, P1499, DOI 10.2307/3558458; Schaferhoff B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-352; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Sibbald SJ, 2020, GENOME BIOL EVOL, V12, P978, DOI 10.1093/gbe/evaa096; Singh H, 2010, MOL BREEDING, V25, P359, DOI 10.1007/s11032-009-9328-1; Sosa V, 2003, SYST BOT, V28, P96; Stevens MR., 2020, HEART PENSTEMON COUN; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; STRAW RM, 1966, BRITTONIA, V18, P80, DOI 10.2307/2805112; Sullivan AR, 2017, MOL BIOL EVOL, V34, P1689, DOI 10.1093/molbev/msx111; Sun Feng-Jie, 2010, Plant Diversity and Evolution, V128, P151, DOI 10.1127/1869-6155/2010/0128-0007; Sun FJ, 2004, S AFR J BOT, V70, P407, DOI 10.1016/S0254-6299(15)30223-4; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tillich M, 2017, NUCLEIC ACIDS RES, V45, pW6, DOI 10.1093/nar/gkx391; Vallone PM, 2004, INT J LEGAL MED, V118, P147, DOI 10.1007/s00414-004-0428-5; Walsh BM, 2001, INT J PLANT SCI, V162, P1409, DOI 10.1086/323273; Welsh SL., 2016, A UTAH FLORA, V5th; Wessinger CA, 2019, EVOL LETT, V3, P521, DOI 10.1002/evl3.130; Wessinger CA, 2016, AM J BOT, V103, P912, DOI 10.3732/ajb.1500519; Whittall JB, 2010, MOL ECOL, V19, P100, DOI 10.1111/j.1365-294X.2009.04474.x; Wolfe AD, 2021, BIORXIV2021042044065, DOI [10.1101/2021.04.20.440652, DOI 10.1101/2021.04.20.440652]; Wolfe AD, 2006, AM J BOT, V93, P1699, DOI 10.3732/ajb.93.11.1699; Yang YC, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00959; Zhu AD, 2016, NEW PHYTOL, V209, P1747, DOI 10.1111/nph.13743	63	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0261143	10.1371/journal.pone.0261143	http://dx.doi.org/10.1371/journal.pone.0261143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910738	gold, Green Published			2022-12-26	WOS:000754828900037
J	Sezginer, Y; Suggett, DJ; Izett, RW; Tortell, PD				Sezginer, Yayla; Suggett, David J.; Izett, Robert W.; Tortell, Philippe D.			Irradiance and nutrient-dependent effects on photosynthetic electron transport in Arctic phytoplankton: A comparison of two chlorophyll fluorescence-based approaches to derive primary photochemistry	PLOS ONE			English	Article							CARBON FIXATION; COMMUNITY STRUCTURE; LIGHT; PRODUCTIVITY; WATERS; OCEAN; IRON; PHOTOINHIBITION; METHODOLOGY; REQUIREMENT	We employed Fast Repetition Rate fluorometry for high-resolution mapping of marine phytoplankton photophysiology and primary photochemistry in the Lancaster Sound and Barrow Strait regions of the Canadian Arctic Archipelago in the summer of 2019. Continuous ship-board analysis of chlorophyll a variable fluorescence demonstrated relatively low photochemical efficiency over most of the cruise-track, with the exception of localized regions within Barrow Strait, where there was increased vertical mixing and proximity to land-based nutrient sources. Along the full transect, we observed strong non-photochemical quenching of chlorophyll fluorescence, with relaxation times longer than the 5-minute period used for dark acclimation. Such long-term quenching effects complicate continuous underway acquisition of fluorescence amplitude-based estimates of photosynthetic electron transport rates, which rely on dark acclimation of samples. As an alternative, we employed a new algorithm to derive electron transport rates based on analysis of fluorescence relaxation kinetics, which does not require dark acclimation. Direct comparison of kinetics- and amplitude-based electron transport rate measurements demonstrated that kinetic-based estimates were, on average, 2-fold higher than amplitude-based values. The magnitude of decoupling between the two electron transport rate estimates increased in association with photophysiological diagnostics of nutrient stress. Discrepancies between electron transport rate estimates likely resulted from the use of different photophysiological parameters to derive the kinetics- and amplitude-based algorithms, and choice of numerical model used to fit variable fluorescence curves and analyze fluorescence kinetics under actinic light. Our results highlight environmental and methodological influences on fluorescence-based photochemistry estimates, and prompt discussion of best-practices for future underway fluorescence-based efforts to monitor phytoplankton photosynthesis.	[Sezginer, Yayla; Izett, Robert W.; Tortell, Philippe D.] Univ British Columbia, Dept Earth Oceans & Atmospher Sci, Vancouver, BC, Canada; [Suggett, David J.] Univ Technol Sydney, Climate Change Cluster, Sydney, NSW, Australia; [Tortell, Philippe D.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia; University of Technology Sydney; University of British Columbia	Sezginer, Y (corresponding author), Univ British Columbia, Dept Earth Oceans & Atmospher Sci, Vancouver, BC, Canada.	ysezginer@eoas.ubc.ca			ArcticNet, a Network of Centres of Excellence of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)	ArcticNet, a Network of Centres of Excellence of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by ArcticNet, a Network of Centres of Excellence of Canada and by the Natural Sciences and Engineering Research Council of Canada (NSERC) grants awarded to PT (https://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Alderkamp AC, 2010, LIMNOL OCEANOGR, V55, P1248, DOI 10.4319/lo.2010.55.3.1248; ALGARRA P, 1993, PLANT CELL ENVIRON, V16, P149, DOI 10.1111/j.1365-3040.1993.tb00856.x; [Anonymous], 2019, CTD ROS DAT COLL CCG; [Anonymous], 2019, AVOS MET DAT COLL CC; [Anonymous], 2019, TSG DAT COLL CCGS AM; Ardyna M, 2011, MAR ECOL PROG SER, V442, P37, DOI 10.3354/meps09378; BATES SS, 1985, J PLANKTON RES, V7, P703, DOI 10.1093/plankt/7.5.703; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Boatman TG, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00319; Brown K.A., 2019, **DATA OBJECT**, DOI 10.1594/PANGAEA.908497; Brown KA, 2020, J GEOPHYS RES-BIOGEO, V125, DOI 10.1029/2019JG005414; Colombo M, 2020, GEOCHIM COSMOCHIM AC, V277, P150, DOI 10.1016/j.gca.2020.03.012; Coupel P, 2015, PROG OCEANOGR, V131, P113, DOI 10.1016/j.pocean.2014.12.003; Falkowski PG, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0376; FALKOWSKI PG, 1995, AUST J PLANT PHYSIOL, V22, P341, DOI 10.1071/PP9950341; Fritz M, 2017, NAT CLIM CHANGE, V7, P6, DOI 10.1038/nclimate3188; Fujiki T, 2008, MAR ECOL PROG SER, V353, P81, DOI 10.3354/meps07151; Gorbunov MY, 2021, LIMNOL OCEANOGR, V66, P1, DOI 10.1002/lno.11581; Gorbunov MY, 1999, PHOTOSYNTH RES, V62, P141, DOI 10.1023/A:1006360005033; Hannah CG, 2009, ARCTIC, V62, P83; Hughes DJ, 2018, LIMNOL OCEANOGR, V63, P1891, DOI 10.1002/lno.10814; Hughes KG, 2018, J GEOPHYS RES-OCEANS, V123, P5210, DOI 10.1029/2018JC013770; Ko E, 2020, J GEOPHYS RES-OCEANS, V125, DOI 10.1029/2020JC016501; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kromkamp JC, 2003, EUR J PHYCOL, V38, P103, DOI 10.1080/0967026031000094094; Lewis KM, 2019, LIMNOL OCEANOGR, V64, P284, DOI 10.1002/lno.11039; Li ZZ, 2021, PHOTOCHEM PHOTOBIOL, V97, P745, DOI 10.1111/php.13386; Martin J, 2010, MAR ECOL PROG SER, V412, P69, DOI 10.3354/meps08666; Mills MM, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00362; Moore CM, 2006, LIMNOL OCEANOGR, V51, P936, DOI 10.4319/lo.2006.51.2.0936; Moore CM, 2003, MAR ECOL PROG SER, V259, P29, DOI 10.3354/meps259029; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nummelin A, 2016, J GEOPHYS RES-OCEANS, V121, P617, DOI 10.1002/2015JC011156; Oxborough K, 2012, LIMNOL OCEANOGR-METH, V10, P142, DOI 10.4319/lom.2012.10.142; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; Pawlowicz R., 2020, M MAP MAPPING PACKAG; Peterson BJ, 2002, SCIENCE, V298, P2171, DOI 10.1126/science.1077445; Randelhoff A, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00150; Roncel M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01050; Saeck EA, 2016, MAR ECOL PROG SER, V552, P81, DOI 10.3354/meps11729; Salvucci ME, 2004, PLANT PHYSIOL, V134, P1460, DOI 10.1104/pp.103.038323; Schreiber U, 2012, PHOTOSYNTH RES, V113, P127, DOI 10.1007/s11120-012-9758-1; Schuback N, 2021, FRONT MAR SCI, V8, DOI 10.3389/fmars.2021.690607; Schuback N, 2019, BIOGEOSCIENCES, V16, P1381, DOI 10.5194/bg-16-1381-2019; Schuback N, 2017, LIMNOL OCEANOGR, V62, P898, DOI 10.1002/lno.10475; Schuback N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133235; Sherman J, 2020, LIMNOL OCEANOGR, V65, P2912, DOI 10.1002/lno.11562; Smyth TJ, 2004, J PLANKTON RES, V26, P1337, DOI 10.1093/plankt/fbh124; Suggett D., 2011, DEV APPL PHYCOL; Suggett DJ, 2015, NEW PHYTOL, V208, P370, DOI 10.1111/nph.13483; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Terhaar J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20470-z; Tortell PD, 2011, DEEP-SEA RES PT I, V58, P241, DOI 10.1016/j.dsr.2010.12.006; Tortell PD, 2005, LIMNOL OCEANOGR-METH, V3, P24, DOI 10.4319/lom.2005.3.24; Tremblay JE, 2006, LIMNOL OCEANOGR, V51, P900, DOI 10.4319/lo.2006.51.2.0900; Tremblay JE, 2015, PROG OCEANOGR, V139, P171, DOI 10.1016/j.pocean.2015.08.009; Tremblay JE, 2009, NATO SCI PEACE SECUR, P73, DOI 10.1007/978-1-4020-9460-6_7; Trimborn S, 2014, J EXP MAR BIOL ECOL, V451, P44, DOI 10.1016/j.jembe.2013.11.001; Viljoen JJ, 2018, DEEP-SEA RES PT I, V141, P118, DOI 10.1016/j.dsr.2018.09.006; Walter B, 2017, AQUAT ECOL, V51, P591, DOI 10.1007/s10452-017-9638-z; WEBB WL, 1974, OECOLOGIA, V17, P281, DOI 10.1007/BF00345747; Wei YQ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01164; Xie YY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01589; Young KL, 2015, HYDROL RES, V46, P533, DOI 10.2166/nh.2014.004; Zhu YL, 2017, MAR ECOL PROG SER, V580, P83, DOI 10.3354/meps12310	67	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0256410	10.1371/journal.pone.0256410	http://dx.doi.org/10.1371/journal.pone.0256410			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882695	Green Published, gold			2022-12-26	WOS:000755037200001
J	Valori, M; Jansson, L; Tienari, PJ				Valori, Miko; Jansson, Lilja; Tienari, Pentti J.			CD8+cell somatic mutations in multiple sclerosis patients and controls-Enrichment of mutations in STAT3 and other genes implicated in hematological malignancies	PLOS ONE			English	Article							T-CELLS; CLONAL HEMATOPOIESIS; MECHANISMS; RISK	Somatic mutations have a central role in cancer but their role in other diseases such as common autoimmune disorders is not clear. Previously we and others have demonstrated that especially CD8+ T cells in blood can harbor persistent somatic mutations in some patients with multiple sclerosis (MS) and rheumatoid arthritis. Here we concentrated on CD8+ cells in more detail and tested (i) how commonly somatic mutations are detectable, (ii) does the overall mutation load differ between MS patients and controls, and (iii) do the somatic mutations accumulate non-randomly in certain genes? We separated peripheral blood CD8+ cells from newly diagnosed relapsing MS patients (n = 21) as well as matched controls (n = 21) and performed next-generation sequencing of the CD8+ cells' DNA, limiting our search to a custom panel of 2524 immunity and cancer related genes, which enabled us to obtain a median sequencing depth of over 2000x. We discovered nonsynonymous somatic mutations in all MS patients' and controls' CD8+ cell DNA samples, with no significant difference in number between the groups (p = 0.60), at a median allelic fraction of 0.5% (range 0.2-8.6%). The mutations showed statistically significant clustering especially to the STAT3 gene, and also enrichment to the SMARCA2, DNMT3A, SOCS1 and PPP3CA genes. Known activating STAT3 mutations were found both in MS patients and controls and overall 1/5 of the mutations were previously described cancer mutations. The detected clustering suggests a selection advantage of the mutated CD8+ clones and calls for further research on possible phenotypic effects.	[Valori, Miko; Jansson, Lilja; Tienari, Pentti J.] Univ Helsinki, Translat Immunol Res Program, Helsinki, Finland; [Jansson, Lilja; Tienari, Pentti J.] Helsinki Univ Hosp, Dept Neurol, Neuroctr, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Valori, M (corresponding author), Univ Helsinki, Translat Immunol Res Program, Helsinki, Finland.	miko.valori@helsinki.fi			University of Helsinki; Multiple Sclerosis Foundation of Finland; Finnish Cultural Foundation; Biogen Finland; Sanofi-Genzyme; Roche; Novartis; Helsinki University Hospital	University of Helsinki; Multiple Sclerosis Foundation of Finland; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Biogen Finland; Sanofi-Genzyme(Sanofi-AventisGenzyme Corporation); Roche(Roche Holding); Novartis(Novartis); Helsinki University Hospital	This study has been financially supported by research grants from the Helsinki University Hospital, University of Helsinki, the Multiple Sclerosis Foundation of Finland, the Finnish Cultural Foundation, Biogen Finland, Sanofi-Genzyme, Roche and Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2021, NATURE, V593, P405, DOI 10.1038/s41586-021-03477-4; Abrahamyan S, 2020, J NEUROL NEUROSUR PS, V91, P681, DOI 10.1136/jnnp-2020-322941; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; ALLEGRETTA M, 1990, SCIENCE, V247, P718, DOI 10.1126/science.1689076; Andersson E, 2016, LEUKEMIA, V30, P1204, DOI 10.1038/leu.2015.263; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Baecher-Allan C, 2018, NEURON, V97, P742, DOI 10.1016/j.neuron.2018.01.021; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Beck DB, 2020, NEW ENGL J MED, V383, P2628, DOI 10.1056/NEJMoa2026834; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolkhovskaya OV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108658; Domenech E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038158; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; Ettersperger J, 2016, IMMUNITY, V45, P610, DOI 10.1016/j.immuni.2016.07.018; Faust GG, 2014, BIOINFORMATICS, V30, P2503, DOI 10.1093/bioinformatics/btu314; Freed D., 2018, TNSCOPE ACCURATE DET, V250647; Gaither JBS, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab023; Gaud G, 2018, NAT REV IMMUNOL, V18, P485, DOI 10.1038/s41577-018-0020-8; Gelfman S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00141-2; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Green MR, 2011, GENE CHROMOSOME CANC, V50, P313, DOI 10.1002/gcc.20856; Guerrero-Martinez JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20217-3; Ho AS, 2013, NAT GENET, V45, P791, DOI 10.1038/ng.2643; Holzelova E, 2004, NEW ENGL J MED, V351, P1409, DOI 10.1056/NEJMoa040036; Ilangumaran S, 2017, CURR TOP MICROBIOL, V410, P159, DOI 10.1007/82_2017_63; Jaiswal S, 2019, SCIENCE, V366, P586, DOI 10.1126/science.aan4673; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Johnson HM, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.582102; Kemppinen AK, 2014, MULT SCLER J, V20, P1564, DOI 10.1177/1352458514529613; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lodato MA, 2018, SCIENCE, V359, P555, DOI 10.1126/science.aao4426; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Medyouf H, 2007, NAT MED, V13, P736, DOI 10.1038/nm1588; Niemela JE, 2011, BLOOD, V117, P2883, DOI 10.1182/blood-2010-07-295501; Nikolaev SI, 2018, NEW ENGL J MED, V378, P250, DOI 10.1056/NEJMoa1709449; Oakes T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01267; Ochieng JK, 2020, ONCOGENE, V39, P6719, DOI 10.1038/s41388-020-01463-0; Potapov V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169774; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Salk JJ, 2018, NAT REV GENET, V19, P269, DOI 10.1038/nrg.2017.117; Salou M, 2015, ANN CLIN TRANSL NEUR, V2, P609, DOI 10.1002/acn3.199; Savola P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15869; Savola P, 2020, HAEMATOLOGICA, V105, P2757, DOI 10.3324/haematol.2019.220889; Savola P, 2018, HAEMATOLOGICA, V103, P304, DOI 10.3324/haematol.2017.175729; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SRIRAM S, 1994, NEUROLOGY, V44, P311, DOI 10.1212/WNL.44.2.311; Tedeschi A, 2013, EMBO REP, V14, P605, DOI 10.1038/embor.2013.64; Valori M, 2017, CLIN IMMUNOL, V175, P75, DOI 10.1016/j.clim.2016.11.018; Van Horebeek L, 2019, TRENDS GENET, V35, P935, DOI 10.1016/j.tig.2019.09.005; Van Horebeek L, 2019, HUM MOL GENET, V28, P1369, DOI 10.1093/hmg/ddy425; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Werner B, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006233; Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144; Zhang ZK, 2019, CANCER LETT, V449, P215, DOI 10.1016/j.canlet.2019.02.031	56	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0261002	10.1371/journal.pone.0261002	http://dx.doi.org/10.1371/journal.pone.0261002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874980	gold, Green Published			2022-12-26	WOS:000753617500042
J	Falco, P; Zaccagni, S				Falco, Paolo; Zaccagni, Sarah			Promoting social distancing in a pandemic: Beyond good intentions	PLOS ONE			English	Article							LOSS-FRAMED MESSAGES; BEHAVIOR GAP; DECISION-MAKING; INTERVENTIONS; PROMPTS; INFORMATION; ADHERENCE; REMINDERS; HABIT	Do reminders to promote social distancing achieve the desired effects on behavior? Much of the existing literature analyses impacts on people's intentions to comply. We run a randomised controlled trial in Denmark to test different versions of a reminder to stay home at the beginning of the crisis. Using a two-stage design, we follow up with recipients and analyse their subsequent self-reported behaviour. We find that the reminder increases ex-ante intentions to comply when it emphasises the consequences of non-compliance for the subjects themselves and their families, while it has no effect when the emphasis is on other people or the country as a whole. We also find, however, that impacts on intentions do not translate into equivalent impacts on actions. Only people in poor health react to the reminder by staying home significantly more. Our results shed light on important gaps between people's intentions and their actions in responding to the recommendations of health authorities.	[Falco, Paolo; Zaccagni, Sarah] Univ Copenhagen, Dept Econ, Copenhagen, Denmark; [Zaccagni, Sarah] Univ Copenhagen, Ctr Econ Behav & Inequal, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Falco, P (corresponding author), Univ Copenhagen, Dept Econ, Copenhagen, Denmark.	paolo.falco@econ.ku.dk	Zaccagni, Sarah/AFM-0610-2022	Zaccagni, Sarah/0000-0002-9360-1854; Falco, Paolo/0000-0002-0270-172X	Department of Economics of the University of Copenhagen; Department of Public Health of the University of Copenhagen; Center for Healthy Ageing; Center for Economic Behaviour and Inequality	Department of Economics of the University of Copenhagen; Department of Public Health of the University of Copenhagen; Center for Healthy Ageing; Center for Economic Behaviour and Inequality	This study was funded by the following: Department of Economics of the University of Copenhagen, Department of Public Health of the University of Copenhagen, Center for Healthy Ageing, Center for Economic Behaviour and Inequality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel M, 2021, J ECON BEHAV ORGAN, V183, P456, DOI 10.1016/j.jebo.2021.01.007; Abel M, 2019, AM ECON J-APPL ECON, V11, P284, DOI 10.1257/app.20170566; Allcott H, 2014, AM ECON REV, V104, P3003, DOI 10.1257/aer.104.10.3003; Altmann S, 2014, EUR ECON REV, V72, P19, DOI 10.1016/j.euroecorev.2014.07.007; Andersson O, 2016, MANAGE SCI, V62, P29, DOI 10.1287/mnsc.2014.2085; Armanasco AA, 2017, AM J PREV MED, V52, P391, DOI 10.1016/j.amepre.2016.10.042; Austin J, 2006, ENVIRON BEHAV, V38, P140, DOI 10.1177/0013916505276744; Barari S., 2020, EVALUATING COVID 19, DOI [10.1101/2020.03.27.20042820, DOI 10.1101/2020.03.27.20042820]; Barrafrem K, 2020, J ECON PSYCHOL, V77, DOI 10.1016/j.joep.2019.102188; Betsch C, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0056; Betsch C, 2013, HEALTH PSYCHOL, V32, P978, DOI 10.1037/a0031590; Bhargava S, 2015, AM ECON REV, V105, P3489, DOI 10.1257/aer.20121493; Blagov PS, 2021, SOC PSYCHOL PERS SCI, V12, P697, DOI 10.1177/1948550620936439; Calzolari G, 2017, MANAGE SCI, V63, P2915, DOI 10.1287/mnsc.2016.2499; Campos-Mercade P, 2021, J PUBLIC ECON, V195, DOI 10.1016/j.jpubeco.2021.104367; Cetron M., 2004, LEARNING SARS PREPAR, P71; Chen JY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45835-3; Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9; Cucciniello M, 2022, SOC SCI MED, V292, DOI 10.1016/j.socscimed.2021.114195; Damgaard MT, 2018, J PUBLIC ECON, V157, P15, DOI 10.1016/j.jpubeco.2017.11.005; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Everett J.A., 2020, EFFECTIVENESS MORAL, DOI [10.31234/osf.io/9yqs8, DOI 10.31234/OSF.IO/9YQS8]; Ferrer RA, 2012, J BEHAV MED, V35, P452, DOI 10.1007/s10865-011-9371-3; Fiedler S, 2020, GAME ECON BEHAV, V121, P232, DOI 10.1016/j.geb.2020.02.008; Gilbert B, 2014, J ECON BEHAV ORGAN, V107, P176, DOI 10.1016/j.jebo.2014.03.011; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Gollwitzer A., 2020, PSYARXIV, DOI 10.31234/osf.io/kvnwp; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Jordan J., 2020, DONT GET IT DONT SPR, DOI DOI 10.31234/OSF.IO/YUQ7X; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kleitman S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255268; Kothe EJ, 2015, J HEALTH PSYCHOL, V20, P580, DOI 10.1177/1359105315576606; Kristal AS, 2020, NAT HUM BEHAV, V4, P169, DOI 10.1038/s41562-019-0795-z; LEVIN IP, 1988, J EXP SOC PSYCHOL, V24, P520, DOI 10.1016/0022-1031(88)90050-9; Li M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159780; Lofgren A, 2020, J ECON BEHAV ORGAN, V174, P1, DOI 10.1016/j.jebo.2020.03.021; Lunn PD, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113478; Markel H, 2008, INT J INFECT DIS, V12, pE432, DOI 10.1016/j.ijid.2008.05.1263; MARTEAU TM, 1989, BRIT J SOC PSYCHOL, V28, P89, DOI 10.1111/j.2044-8309.1989.tb00849.x; Milkman KL, 2013, PREV MED, V56, P92, DOI 10.1016/j.ypmed.2012.10.021; Milkman KL, 2011, P NATL ACAD SCI USA, V108, P10415, DOI 10.1073/pnas.1103170108; Montinari N, 2013, JENA EC RES PAPERS; Muscillo A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237057; Porter S.R., 2004, NEW DIRECT INSTITUTI, V2004, P63, DOI [DOI 10.1002/IR.101, 10.1002/ir.101]; Rasul I, 2010, BE J ECON ANAL POLI, V10; Rattay P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251694; Rhodes RE, 2013, BRIT J HEALTH PSYCH, V18, P296, DOI 10.1111/bjhp.12032; Roberts D, 2021, POLARIZED SOCIAL DIS; Romanowich P, 2013, ADDICT BEHAV, V38, P2084, DOI 10.1016/j.addbeh.2013.01.007; Rothman AJ, 1999, PERS SOC PSYCHOL B, V25, P1355, DOI 10.1177/0146167299259003; Saba A, 2000, EUR J CLIN NUTR, V54, P540, DOI 10.1038/sj.ejcn.1601051; Schwerdtfeger AR, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00270; Smith LE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240399; Sniehotta FF, 2005, PSYCHOL HEALTH, V20, P143, DOI 10.1080/08870440512331317670; Sonntag A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134705; Tabernero C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238682; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Utych S.M., 2020, J BEHAV PUBLIC ADM, V3, DOI [10.30636/jbpa.31.151, DOI 10.30636/JBPA.31.151]; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Vekaria KM, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0100; Vervloet M, 2012, J AM MED INFORM ASSN, V19, P696, DOI 10.1136/amiajnl-2011-000748; Vietri JT, 2012, MED DECIS MAKING, V32, P447, DOI 10.1177/0272989X11427762; WILSON DK, 1987, SOC BEHAV, V2, P51	64	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260457	10.1371/journal.pone.0260457	http://dx.doi.org/10.1371/journal.pone.0260457			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855825	Green Published, Green Submitted, gold			2022-12-26	WOS:000735299000058
J	Sander, B; Finkelstein, Y; Lu, H; Nagamuthu, C; Graves, E; Ramsay, LC; Kwong, JC; Schuh, S				Sander, Beate; Finkelstein, Yaron; Lu, Hong; Nagamuthu, Chenthila; Graves, Erin; Ramsay, Lauren C.; Kwong, Jeffrey C.; Schuh, Suzanne			Healthcare cost attributable to bronchiolitis: A population-based cohort study	PLOS ONE			English	Article							PROSPECTIVE MULTICENTER; RISK-FACTORS; CHILDREN; HOSPITALIZATIONS; MANAGEMENT; DIAGNOSIS; INFECTIONS; PREDICTORS; GUIDELINE; DISCHARGE	Objective To determine 1-year attributable healthcare costs of bronchiolitis. Methods Using a population-based matched cohort and incidence-based cost analysis approach, we identified infants <12 months old diagnosed in an emergency department (ED) or hospitalized with bronchiolitis between April 1, 2003 and March 31, 2014. We propensity-score matched infants with and without bronchiolitis on sex, age, income quintile, rurality, co-morbidities, gestational weeks, small-for-gestational-age status and pre-index healthcare cost deciles. We calculated mean attributable 1-year costs using a generalized estimating equation model and stratified costs by age, sex, income quintile, rurality, co-morbidities and prematurity. Results We identified 58,375 infants with bronchiolitis (mean age 15495 days, 61.3% males, 4.2% with comorbidities). Total 1-year mean bronchiolitis-attributable costs were $4,313 per patient (95%CI: $4,148-4,477), with $2,847 (95%CI: $2,712-2,982) spent on hospitalizations, $610 (95%CI: $594-627) on physician services, $562 (95%CI: $556-567)] on ED visits, $259 (95%CI: $222-297) on other healthcare costs and $35 ($27-42) on drugs. Attributable bronchiolitis costs were $2,765 (95%CI: $2735-2,794) vs $111 (95%CI: $102-121) in the initial 10 days post index date, $4,695 (95%CI: $4,589-4,800) vs $910 (95%CI: $847-973) in the initial 180 days and $1,158 (95%CI: $1,104-1213) vs $639 (95%CI: $599-679) during days 181-360. Mean 1-year bronchiolitis costs were higher in infants <3 months old [$5,536 (95%CI: $5,216-5,856)], those with co-morbidities [$17,530 (95%CI: $14,683-20,377)] and with low birthweight [$5,509 (95%CI: $4,927-6,091)]. Conclusions Compared to no bronchiolitis, bronchiolitis incurs five-time and two-time higher healthcare costs within the initial and subsequent six-months, respectively. Most expenses occur in the initial 10 days and relate to hospitalization.	[Sander, Beate; Ramsay, Lauren C.; Kwong, Jeffrey C.] Univ Hlth Network, Toronto, ON, Canada; [Sander, Beate; Finkelstein, Yaron; Ramsay, Lauren C.; Kwong, Jeffrey C.; Schuh, Suzanne] Univ Toronto, Toronto, ON, Canada; [Sander, Beate; Finkelstein, Yaron; Lu, Hong; Nagamuthu, Chenthila; Graves, Erin; Kwong, Jeffrey C.] ICES, Toronto, ON, Canada; [Sander, Beate; Kwong, Jeffrey C.] Publ Hlth Ontario, Toronto, ON, Canada; [Finkelstein, Yaron; Schuh, Suzanne] Hosp Sick Children, Dept Paediat, Toronto, ON, Canada; [Finkelstein, Yaron; Schuh, Suzanne] Hosp Sick Children, Res Inst, Div Child Hlth Evaluat Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Sander, B (corresponding author), Univ Hlth Network, Toronto, ON, Canada.; Sander, B (corresponding author), Univ Toronto, Toronto, ON, Canada.; Sander, B (corresponding author), ICES, Toronto, ON, Canada.; Sander, B (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	beate.sander@uhnresearch.ca	Sander, Beate/P-7665-2018	Sander, Beate/0000-0003-2128-9133	Physicians Services Incorporated (P.S.I.) Foundation; ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC); Canada Research Chair [CRC-950-232429]	Physicians Services Incorporated (P.S.I.) Foundation; ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This study was funded by The Physicians Services Incorporated (P.S.I.) Foundation. This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). Parts of this material are based on data and information compiled and provided by the MOHLTC, Canadian Institute for Health Information and Cancer Care Ontario. We thank IMS Brogan Inc. for use of their Drug Information Database. This research was supported, in part, by a Canada Research Chair held by Beate Sander (CRC-950-232429). The analyses, conclusions, opinions and statements expressed herein are those of the authors and do not necessarily reflect those of the funding or data sources; no endorsement is intended or should be inferred. The funder had no role in the study design, data collection, analysis or interpretation of data, writing of the manuscript or the decision to submit the manuscript for publication.	Akenroye AT, 2014, PEDIATRICS, V133, pE227, DOI 10.1542/peds.2013-1991; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Barben J, 2008, THORAX, V63, P1103, DOI 10.1136/thx.2007.094706; Bryan MA, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3432; Cunningham S, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19710; Diez-Domingo J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0544-x; Ehlken B, 2005, EUR J PEDIATR, V164, P607, DOI 10.1007/s00431-005-1705-0; Evans J, 2012, PEDIATR PULM, V47, P381, DOI 10.1002/ppul.21549; Feudtner C, 2000, PEDIATRICS, V106, P205; Friedman JN, 2014, PAED CHILD HEALT-CAN, V19, P484, DOI 10.1093/pch/19.9.485; Gong C, 2019, PEDIATR EMERG CARE, V35, P323, DOI 10.1097/PEC.0000000000001145; Government of Ontario, 2017, ONT REN EARL YEARS C; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hasegawa K, 2013, PEDIATRICS, V132, P28, DOI 10.1542/peds.2012-3877; Jamal A, 2019, LANCET CHILD ADOLESC, V3, P539, DOI 10.1016/S2352-4642(19)30193-2; Kramer R, 2018, VACCINE, V36, P6591, DOI 10.1016/j.vaccine.2018.09.029; LEBEL M H, 1989, Archives of Disease in Childhood, V64, P1431; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Mansbach JM, 2005, PEDIATR EMERG CARE, V21, P242, DOI 10.1097/01.pec.0000161469.19841.86; Mansbach JM, 2012, PEDIATRICS, V130, pE492, DOI 10.1542/peds.2012-0444; Marlais M, 2011, ARCH DIS CHILD, V96, P648, DOI 10.1136/adc.2010.201079; Mecklin M, 2014, ACTA PAEDIATR, V103, P946, DOI 10.1111/apa.12671; National Institute for Health and Care Excellence, 2016, NICE TECHN APPR GUID; Norwood A, 2010, ACAD EMERG MED, V17, P376, DOI 10.1111/j.1553-2712.2010.00699.x; O'Brien S, 2019, J PAEDIATR CHILD H, V55, P42, DOI 10.1111/jpc.14104; Pelletier AJ, 2006, PEDIATRICS, V118, P2418, DOI 10.1542/peds.2006-1193; Prodhan P, 2011, AM J EMERG MED, V29, P168, DOI 10.1016/j.ajem.2009.08.020; Ralston S, 2013, J HOSP MED, V8, P25, DOI 10.1002/jhm.1982; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Ray JG, 2012, J OBSTET GYNAECOL CA, V34, P159, DOI 10.1016/S1701-2163(16)35159-3; Rodriguez-Martinez CE, 2019, J EVAL CLIN PRACT, V25, P682, DOI 10.1111/jep.13157; Schlapbach LJ, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01648-2016; Schuh S, 2018, J PEDIATR-US, V199, P217, DOI 10.1016/j.jpeds.2018.04.010; Schuh S, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0842; Scottish Intercollegiate Guidelines Network, 2006, BRONCH CHILDR NATL C; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Sumner A, 2010, PEDIATRICS, V126, P623, DOI 10.1542/peds.2009-3663; TISSING WJE, 1993, EUR J PEDIATR, V152, P125, DOI 10.1007/BF02072488; Turner T, 2008, Aust Fam Physician, V37, P6; WANG EEL, 1995, J PEDIATR-US, V126, P212, DOI 10.1016/S0022-3476(95)70547-3; Willwerth BM, 2006, ANN EMERG MED, V48, P441, DOI 10.1016/j.annemergmed.2006.03.021; Wodchis WP., 2013, GUIDELINES PERSON LE; Yorita KL, 2008, PEDIATRICS, V121, P244, DOI 10.1542/peds.2007-1392	43	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260809	10.1371/journal.pone.0260809	http://dx.doi.org/10.1371/journal.pone.0260809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855892	Green Published, gold			2022-12-26	WOS:000735299000129
J	Revittser, A; Selin, I; Negulyaev, Y; Chubinskiy-Nadezhdin, V				Revittser, Alla; Selin, Ivan; Negulyaev, Yuri; Chubinskiy-Nadezhdin, Vladislav			The analysis of F-actin structure of mesenchymal stem cells by quantification of fractal dimension	PLOS ONE			English	Article							CYTOSKELETON; MORPHOLOGY	The actin cytoskeleton is indispensable for the motility and migration of all types of cells; therefore, it plays a crucial role in the ability of the tissues to repair. Mesenchymal stem cells are intensively used in regenerative medicine, but usually relatively low percent of transplanted cells reaches the injury. To overcome this evident limitation, researchers try to enhance the motility and migration rate of the cells. As one of the approaches, co-cultivation and preconditioning of stem cells with biologically active compounds, which can cause actin cytoskeleton rearrangements followed by an increase of migratory properties of the cells, could be applied. The observed changes in F-actin structure induced by the compounds require quantitative estimation, and measurement of fluorescence intensity of the F-actin image captured by various microscopic techniques is commonly used nowadays. However, this approach could not always accurately detect the observed changes in the shape and structure of actin cytoskeleton. At this time, the image of F-actin has an irregular geometric pattern, and thus could be considered and characterized as a fractal object. To quantify the re-organization of cellular F-actin in terms of fractal geometry Minkovsky's box-counting method is suitable, but it is not widely used nowadays. We modified and improved the previously described method for fractal dimension measurement, and successfully applied it for the quantification of the F-actin structures of human mesenchymal stem cells.	[Revittser, Alla; Negulyaev, Yuri; Chubinskiy-Nadezhdin, Vladislav] Russian Acad Sci, Grp Ion Mech Cell Signaling, Inst Cytol, St Petersburg, Russia; [Selin, Ivan] Peter Great St Petersburg Polytech Univ, Inst Comp Sci & Technol, Higher Sch Software Engn, St Petersburg, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Peter the Great St. Petersburg Polytechnic University	Revittser, A (corresponding author), Russian Acad Sci, Grp Ion Mech Cell Signaling, Inst Cytol, St Petersburg, Russia.	eetytnet@gmail.com	Chubinskiy-Nadezhdin, Vladislav/AAS-6270-2020; Negulyaev, Yuri/N-6531-2015	Chubinskiy-Nadezhdin, Vladislav/0000-0002-8488-6130; Negulyaev, Yuri/0000-0002-1773-9798	Russian Science Foundation (RSF) [18-15-00106]	Russian Science Foundation (RSF)(Russian Science Foundation (RSF))	The research was supported by Russian Science Foundation (RSF, https://www.rscf.ru/en/) grant 18-15-00106 to Negulyaev Yuri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Alhussein G, 2016, CYTOSKELETON, V73, P221, DOI 10.1002/cm.21297; ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Fu XR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080784; Fuseler JW, 2007, MICROSC MICROANAL, V13, P133, DOI 10.1017/S1431927607070225; Fuseler JW, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00133; Hu CX, 2018, J CELL MOL MED, V22, P1428, DOI 10.1111/jcmm.13492; Kim YJ, 2015, ANIM CELLS SYST, V19, P161, DOI 10.1080/19768354.2015.1037347; Krylova TA., 2012, CELLANDTISSUEBIOLOGY, V6, P95, DOI [10.1134/S1990519X12020071, DOI 10.1134/S1990519X12020071]; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Mazini L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041306; Qian AR, 2012, IEEE T BIO-MED ENG, V59, P1374, DOI 10.1109/TBME.2012.2187785; Rajkovic N, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/8967902; Ristanovic D, 2014, NEUROSCI RES, V84, P64, DOI 10.1016/j.neures.2014.04.005; Selin I., 2021, FD FIBRILLAR ACTIN F, DOI [10.6084/m9.figshare.16985023.v1, DOI 10.6084/M9.FIGSHARE.16985023.V1]; Shammaa R, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00072; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Small JV, 1999, MICROSC RES TECHNIQ, V47, P3; Smith TG, 1996, J NEUROSCI METH, V69, P123, DOI 10.1016/S0165-0270(96)00080-5; Soundararajan M, 2018, J CELL PHYSIOL, V233, P9099, DOI 10.1002/jcp.26860; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Uppal SO, 2010, MICROSC MICROANAL, V16, P472, DOI 10.1017/S1431927610000358; Wang XJ, 2010, CHAOS, V20, DOI 10.1063/1.3526972; Zonderland J, 2019, METHODSX, V6, P2562, DOI 10.1016/j.mex.2019.10.018	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2021	16	11							e0260727	10.1371/journal.pone.0260727	http://dx.doi.org/10.1371/journal.pone.0260727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9KP	34847207	Green Published, gold			2022-12-26	WOS:000735928900058
J	Miyata, K; Horikami, D; Tachibana, Y; Yamamoto, T; Nakamura, T; Kobayashi, K; Murata, T				Miyata, Kana; Horikami, Daiki; Tachibana, Yuri; Yamamoto, Teruko; Nakamura, Tatsuro; Kobayashi, Koji; Murata, Takahisa			15-hydroxy eicosadienoic acid is an exacerbating factor for nasal congestion in mice	FASEB JOURNAL			English	Article						animal models; fatty acid; inflammation; oxidized lipids; vascular biology	ALLERGIC RHINITIS; POTASSIUM CHANNELS; PROSTAGLANDIN D-2; THROMBOXANE A(2); ARACHIDONIC-ACID; LINOLEIC-ACID; MAST-CELLS; RAT AORTA; HISTAMINE; INFILTRATION	Allergic rhinitis (AR) is one of the most common allergic inflammatory diseases worldwide. In AR, increased blood flow and vascular permeability in nasal mucosa cause rhinorrhea and nasal congestion. We investigated the role of an 11Z,14Z-eicosadienoic acid-derived metabolite, 15-hydroxy-11Z,13Z-eicosadienoic acid (15-HEDE), in functional changes in vasculature and nasal congestion in AR. Repeated intranasal administration of Ovalbumin (OVA) caused AR symptoms, such as sneezing and nasal congestion, in mice. OVA administration increased the level of 15-HEDE in nasal lavage fluid, which reached approximately 0.6 ng/ml after ten OVA treatments. Upon measuring vascular contraction, treatment with 0.1-3 mu M 15-HEDE did not cause contraction in mouse aortae, while it dilated aortae that were pre-contracted by thromboxane receptor stimulation. Pretreatment with the voltage-gated K+ (K-V) channel inhibitor 4-aminopyridine significantly inhibited the 15-HEDE-induced vascular relaxation. Intravital imaging showed that administration of 1 mu g 15-HEDE dilated blood vessels, and Mile's assay demonstrated that this administration also caused dye leakage, indicating vascular hyperpermeability in mouse ears. Computed tomography scanning and morphological study revealed that administration of 3 mu g 15-HEDE narrowed nasal passages and thickened nasal mucosa in mice. Finally, we confirmed that treating mice with 3 mu g 15-HEDE caused rhinitis symptoms, such as abdominal breathing, and reduced respiratory frequency, suggesting nasal congestion. 15-HEDE caused vasodilation by activating K-V channels and increased vascular permeability, which may lead to nasal congestion. Furthermore, 15-HEDE might be a new lipid mediator that exacerbates nasal congestion in AR.	[Miyata, Kana; Horikami, Daiki; Tachibana, Yuri; Yamamoto, Teruko; Nakamura, Tatsuro; Kobayashi, Koji; Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan	University of Tokyo	Murata, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amurata@mail.ecc.u-tokyo.ac.jp		Murata, Takahisa/0000-0002-3328-0796	MEXT I Japan Society for the Promotion of Science (BPS) [20H05678, 17H06252, 18K14603, 19K15975]; Shimadzu Science Foundation; Kobayashi Foundation; Takeda Science Foundation; Medical Corporation Kihokai	MEXT I Japan Society for the Promotion of Science (BPS); Shimadzu Science Foundation; Kobayashi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Medical Corporation Kihokai	MEXT I Japan Society for the Promotion of Science (BPS), Grant/Award Number: 20H05678, 17H06252, 18K14603 and 19K15975; Shimadzu Science Foundation; Kobayashi Foundation; Takeda Science Foundation; Medical Corporation Kihokai	ADAMS DR, 1983, ZBL VET MED C, V12, P109, DOI 10.1111/j.1439-0264.1983.tb01008.x; Arebro J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43568; Ashina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132367; Baldwin SN, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.598779; Bauchau V, 2004, EUR RESPIR J, V24, P758, DOI 10.1183/09031936.04.00013904; Bousquet J, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-00227-0; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Evans SJ, 2014, J PSYCHIATR RES, V57, P58, DOI 10.1016/j.jpsychires.2014.06.001; Ichimura K., 2010, Clinical and Experimental Allergy Reviews, V10, P20; Kefaloyianni E, 2011, J VASC RES, V48, P357, DOI 10.1159/000323475; Kobayashi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep32109; Kolmert J, 2018, PROSTAG OTH LIPID M, V137, P20, DOI 10.1016/j.prostaglandins.2018.05.005; Lambrou P, 2007, ANN ALLERG ASTHMA IM, V98, P567, DOI 10.1016/S1081-1206(10)60737-5; Lavinskiene S, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0065-4; Lavinskiene S, 2012, INFLAMMATION, V35, P1600, DOI 10.1007/s10753-012-9475-0; Liou YA, 2009, PROSTAG LEUKOTR ESS, V80, P201, DOI 10.1016/j.plefa.2009.02.003; Liu YJ, 2016, NEURON, V90, P521, DOI 10.1016/j.neuron.2016.04.005; Meltzer EO, 2016, ANN ALLERG ASTHMA IM, V116, P66, DOI 10.1016/j.anai.2015.10.022; Meltzer EO, 2001, J ALLERGY CLIN IMMUN, V108, pS45, DOI 10.1067/mai.2001.115566; Mita H, 1999, PROSTAG LEUKOTR ESS, V60, P175, DOI 10.1054/plef.1999.0022; Miyahara S, 2005, J ALLERGY CLIN IMMUN, V116, P1020, DOI 10.1016/j.jaci.2005.08.020; Moody CM, 2014, LAB ANIM-UK, V48, P298, DOI 10.1177/0023677214546509; Nakamura T, 2021, FASEB J, V35, DOI 10.1096/fj.202100827R; Nakamura T, 2017, J ALLERGY CLIN IMMUN, V140, P630, DOI 10.1016/j.jaci.2017.02.030; Nathan RA, 2008, ALLERGY ASTHMA PROC, V29, P600, DOI 10.2500/aap.2008.29.3179; Omori K, 2014, BRIT J PHARMACOL, V171, P4879, DOI 10.1111/bph.12815; ROTHSCHILD AM, 1970, BRIT J PHARMACOL, V38, P253, DOI 10.1111/j.1476-5381.1970.tb10354.x; Sato K, 2014, BIOL PHARM BULL, V37, P394, DOI 10.1248/bpb.b13-00746; Shieh CC, 2000, PHARMACOL REV, V52, P557; Storms William, 2008, Prim Care Respir J, V17, P7, DOI 10.3132/pcrj.2008.00001; Takahashi G, 2012, INT ARCH ALLERGY IMM, V158, P359, DOI 10.1159/000334555; Tanaka Y, 2006, PROSTAG OTH LIPID M, V80, P144, DOI 10.1016/j.prostaglandins.2006.06.003; TAYLOR SG, 1988, BRIT J PHARMACOL, V94, P853, DOI 10.1111/j.1476-5381.1988.tb11597.x; Varga EM, 1999, ALLERGY, V54, P338, DOI 10.1034/j.1398-9995.1999.00957.x; WoodBaker R, 1996, CLIN OTOLARYNGOL, V21, P348, DOI 10.1111/j.1365-2273.1996.tb01085.x; Yamasaki M, 1997, J PHARMACOL EXP THER, V280, P1471; Zhou W, 2005, AM J PHYSIOL-HEART C, V288, pH2210, DOI 10.1152/ajpheart.00704.2004	38	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22085	10.1096/fj.202101305R	http://dx.doi.org/10.1096/fj.202101305R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34888952				2022-12-26	WOS:000734992000032
J	Zhao, GH; Li, TT; Liu, XM; Zhang, TQ; Zhang, ZX; Kang, L; Song, J; Zhou, SJ; Chen, X; Wang, X; Li, JN; Huang, L; Li, CY; Bu, ZG; Zheng, J; Weng, CJ				Zhao, Gaihong; Li, Tingting; Liu, Xuemin; Zhang, Taoqing; Zhang, Zhaoxia; Kang, Li; Song, Jie; Zhou, Shijun; Chen, Xin; Wang, Xiao; Li, Jiangnan; Huang, Li; Li, Changyao; Bu, Zhigao; Zheng, Jun; Weng, Changjiang			African swine fever virus cysteine protease pS273R inhibits pyroptosis by noncanonically cleaving gasdermin D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY CASPASES; CELL-DEATH; CLEAVAGE; INFLAMMASOMES; REPLICATION; TARGETS; MEMBER	African swine fever (ASF) is a viral hemorrhagic disease that affects domestic pigs and wild boar and is caused by the African swine fever virus (ASFV). The ASFV virion contains a long double-stranded DNA genome, which encodes more than 150 proteins. However, the immune escape mechanism and pathogenesis of ASFV remain poorly understood. Here, we report that the pyroptosis execution protein gasdermin D (GSDMD) is a new binding partner of ASFV-encoded protein S273R (pS273R), which belongs to the SUMO-1 cysteine protease family. Further experiments demonstrated that ASFV pS273R-cleaved swine GSDMD in a manner dependent on its protease activity. ASFV pS273R specifically cleaved GSDMD at G107-A108 to produce a shorter N-terminal fragment of GSDMD consisting of residues 1 to 107 (GSDMD-N1-107). Interestingly, unlike the effect of GSDMD-N1-279 fragment produced by caspase-l-mediated cleavage, the assay of LDH release, cell viability, and virus replication showed that GSDMD-N1-107 did not trigger pyroptosis or inhibit ASFV replication. Our findings reveal a previously unrecognized mechanism involved in the inhibition of ASFV infection-induced pyroptosis, which highlights an important function of pS273R in inflammatory responses and ASFV replication.	[Zhao, Gaihong; Li, Tingting; Liu, Xuemin; Zhang, Taoqing; Zhang, Zhaoxia; Kang, Li; Song, Jie; Zhou, Shijun; Chen, Xin; Wang, Xiao; Li, Jiangnan; Huang, Li; Li, Changyao; Bu, Zhigao; Zheng, Jun; Weng, Changjiang] Chinese Acad Agr Sci CAAS, Div Fundamental Immunol, Harbin Vet Res Inst, Natl African Swine Fever Reference Lab,State Key, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Zheng, J; Weng, CJ (corresponding author), Chinese Acad Agr Sci CAAS, Div Fundamental Immunol, Harbin Vet Res Inst, Natl African Swine Fever Reference Lab,State Key, Harbin, Peoples R China.	zhengjun01@caas.cn; wengchangjiang@caas.cn	weng, changjiang/HHR-8479-2022		National Natural Science Foundation of China [31941002, 32172874]; National Key Research and Development Program of China [2021YFD1800100]; State Key Laboratory of Veterinary Biotechnology Program [SKLVBP202101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; State Key Laboratory of Veterinary Biotechnology Program	This study was supported by the National Natural Science Foundation of China (31941002 and 32172874), National Key Research and Development Program of China (Grant No. 2021YFD1800100), and State Key Laboratory of Veterinary Biotechnology Program (SKLVBP202101).	Alejo A, 2018, J VIROL, V92, DOI 10.1128/JVI.01293-18; Alonso C, 2001, J VIROL, V75, P9819, DOI 10.1128/JVI.75.20.9819-9827.2001; Alonso C, 2013, VIRUS RES, V173, P42, DOI 10.1016/j.virusres.2012.12.006; Andres G, 2002, J VIROL, V76, P12473, DOI 10.1128/JVI.76.24.12473-12482.2002; Andres G, 2001, J BIOL CHEM, V276, P780, DOI 10.1074/jbc.M006844200; Borca MV, 2018, VIRUS RES, V249, P116, DOI 10.1016/j.virusres.2018.03.017; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Brun A, 1996, VIROLOGY, V225, P227, DOI 10.1006/viro.1996.0592; Correia S, 2013, VIRUS RES, V173, P87, DOI 10.1016/j.virusres.2012.10.013; Dixon LK, 2019, VIRUS RES, V266, P25, DOI 10.1016/j.virusres.2019.04.002; Dixon LK, 2019, ANTIVIR RES, V165, P34, DOI 10.1016/j.antiviral.2019.02.018; Dixon LK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9090241; Dixon LK, 2013, VIRUS RES, V173, P3, DOI 10.1016/j.virusres.2012.10.020; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Henriques ES, 2011, PROTEIN SCI, V20, P247, DOI 10.1002/pro.554; Huang L, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108044; Huang L, 2017, BIOCHEM J, V474, P2051, DOI 10.1042/BCJ20161037; Huang L, 2015, J BIOL CHEM, V290, P27618, DOI 10.1074/jbc.M115.660761; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Karki R, 2021, CELL, V184, P149, DOI 10.1016/j.cell.2020.11.025; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kovacs SB, 2017, TRENDS CELL BIOL, V27, P673, DOI 10.1016/j.tcb.2017.05.005; Lei XB, 2017, J VIROL, V91, DOI 10.1128/JVI.01069-17; Li D, 2021, J IMMUNOL, V206, P1844, DOI 10.4049/jimmunol.2001110; Li GB, 2020, J VIROL, V94, DOI 10.1128/JVI.02125-19; Li JN, 2015, J IMMUNOL, V195, P5732, DOI 10.4049/jimmunol.1501606; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; MALMQUIST WA, 1960, AM J VET RES, V21, P104; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Rai A, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12080820; Ratajczak MZ, 2020, LEUKEMIA, V34, P1726, DOI 10.1038/s41375-020-0887-9; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reis AL, 2017, J VIROL, V91, DOI 10.1128/JVI.02338-16; Sanchez-Cordon PJ, 2018, VET J, V233, P41, DOI 10.1016/j.tvjl.2017.12.025; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Teklue T, 2020, TRANSBOUND EMERG DIS, V67, P529, DOI 10.1111/tbed.13364; Wang T, 2020, VET MICROBIOL, V249, DOI 10.1016/j.vetmic.2020.108832; Wang XX, 2018, BIOCHEM BIOPH RES CO, V506, P437, DOI 10.1016/j.bbrc.2018.10.103; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Xia NW, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13010021; Xia SY, 2019, METHOD ENZYMOL, V625, P95, DOI 10.1016/bs.mie.2019.04.024; Xia SY, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036400; Yamaoka Y, 2021, BIOCHEM BIOPH RES CO, V534, P666, DOI 10.1016/j.bbrc.2020.11.023; Yap JKY, 2020, J IMMUNOL, V205, P307, DOI 10.4049/jimmunol.2000513; Zhao DM, 2019, EMERG MICROBES INFEC, V8, P438, DOI 10.1080/22221751.2019.1590128; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548	51	11	13	13	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101480	10.1016/j.jbc.2021.101480	http://dx.doi.org/10.1016/j.jbc.2021.101480			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1GJ	34890644	gold, Green Published			2022-12-26	WOS:000748376400009
J	Jafarzadeh, H; Pauleen, DJ; Abedin, E; Weerasinghe, K; Taskin, N; Coskun, M				Jafarzadeh, Hamed; Pauleen, David J.; Abedin, Ehsan; Weerasinghe, Kasuni; Taskin, Nazim; Coskun, Mustafa			Making sense of COVID-19 over time in New Zealand: Assessing the public conversation using Twitter	PLOS ONE			English	Article							SOCIAL MEDIA; CRISIS MANAGEMENT	COVID-19 has ruptured routines and caused breakdowns in what had been conventional practice and custom: everything from going to work and school and shopping in the supermarket to socializing with friends and taking holidays. Nonetheless, COVID-19 does provide an opportunity to study how people make sense of radically changing circumstances over time. In this paper we demonstrate how Twitter affords this opportunity by providing data in real time, and over time. In the present research, we collect a large pool of COVID-19 related tweets posted by New Zealanders-citizens of a country successful in containing the coronavirus-from the moment COVID-19 became evident to the world in the last days of 2019 until 19 August 2020. We undertake topic modeling on the tweets to foster understanding and sensemaking of the COVID-19 tweet landscape in New Zealand and its temporal development and evolution over time. This information can be valuable for those interested in how people react to emergent events, including researchers, governments, and policy makers.	[Jafarzadeh, Hamed; Pauleen, David J.; Weerasinghe, Kasuni] Massey Univ, Sch Management, Massey Business Sch, Auckland, New Zealand; [Abedin, Ehsan] Univ Melbourne, Sch Comp & Informat Syst, Melbourne, Vic, Australia; [Taskin, Nazim] Bogazici Univ, Dept Management Informat Syst, Istanbul, Turkey; [Coskun, Mustafa] Minist Natl Educ, Informat Technol Dept, Bornova Sci & Art Ctr, Izmir, Turkey	Massey University; University of Melbourne; Bogazici University; Ministry of National Education - Turkey	Jafarzadeh, H (corresponding author), Massey Univ, Sch Management, Massey Business Sch, Auckland, New Zealand.	H.Jafarzadeh@massey.ac.nz	Taskin, Nazim/AGO-4376-2022	Jafarzadeh, Hamed/0000-0001-9880-5496				Abd-Alrazaq A, 2020, J MED INTERNET RES, V22, DOI 10.2196/19016; Abedin B, 2021, INFORM SYST MANAGE, V38, P151, DOI 10.1080/10580530.2020.1781987; Alomari E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010282; Alshalan R, 2020, J MED INTERNET RES, V22, DOI 10.2196/22609; Baker MG, 2020, NEW ZEAL MED J, V133, P10; Bian J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158450; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Boon-Itt S, 2020, JMIR PUBLIC HLTH SUR, V6, P245, DOI 10.2196/21978; Coskun M, 2018, INFORMATION, V9, DOI 10.3390/info9050102; D'Amato D, 2017, J CLEAN PROD, V168, P716, DOI 10.1016/j.jclepro.2017.09.053; David CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150190; de Melo T, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/24585; Erzurumlu SS, 2020, TECHNOL FORECAST SOC, V156, DOI 10.1016/j.techfore.2020.120041; Fischer-Pressler D, 2019, COMPUT HUM BEHAV, V100, P138, DOI 10.1016/j.chb.2019.05.012; Grover P, 2018, INT J INFORM MANAGE, V43, P85, DOI 10.1016/j.ijinfomgt.2018.07.003; Gruber DA, 2015, BUS HORIZONS, V58, P163, DOI 10.1016/j.bushor.2014.10.006; Grun B, 2011, J STAT SOFTW, V40, P1; Guo L, 2016, J MASS COMMUN Q, V93, P332, DOI 10.1177/1077699016639231; Heverin T, 2012, J AM SOC INF SCI TEC, V63, P34, DOI 10.1002/asi.21685; Jang HJ, 2021, J MED INTERNET RES, V23, DOI 10.2196/25431; Kaewkitipong L, 2016, COMPUT HUM BEHAV, V54, P653, DOI 10.1016/j.chb.2015.07.063; Kaila RP., 2020, INT J ADV RES ENG TE, V11, P128, DOI DOI 10.34218/IJARET.11.3.2020.011; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Knutas A., 2015, P 16 INT C COMP SYST, P184, DOI [10.1145/2812428.2812442, DOI 10.1145/2812428.2812442]; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Laato S, 2020, EUR J INFORM SYST, V29, P288, DOI 10.1080/0960085X.2020.1770632; Li DY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144988; Liu Q, 2020, J MED INTERNET RES, V22, DOI 10.2196/19118; Loper E., 2002, P COLING ACL INT PRE, V1, P63, DOI DOI 10.3115/1225403.1225421; Lyu JC, 2021, J MED INTERNET RES, V23, DOI 10.2196/25108; Mackey Tim, 2020, JMIR Public Health Surveill, V6, pe19509, DOI 10.2196/19509; Maitlis S, 2014, ACAD MANAG ANN, V8, P57, DOI 10.1080/19416520.2014.873177; Massaro M, 2021, J MED SYST, V45, DOI 10.1007/s10916-021-01726-7; Ministry of Health, COVID 19 EL STRAT AO; Mirbabaie M, 2020, J INF TECHNOL-UK, V35, P195, DOI 10.1177/0268396220929258; Mortenson MJ, 2016, INT J INFORM MANAGE, V36, P1248, DOI 10.1016/j.ijinfomgt.2016.07.007; Nature, RES HIGHLIGHT QUESTI; New Zealand Doctor, TIM COR COVID 19; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054; Reddick CG, 2017, GOV INFORM Q, V34, P110, DOI 10.1016/j.giq.2016.11.001; Reuter C, 2018, INT J HUM-COMPUT INT, V34, P280, DOI 10.1080/10447318.2018.1427832; Rortais A, 2021, FOOD CONTROL, V119, DOI 10.1016/j.foodcont.2020.107435; Shirley K., 2014, P WORKSHOP INTERACTI, P63, DOI 10.3115/v1/W14-3110; Shorey S, 2020, J PUBLIC HEALTH-UK, V42, P665, DOI 10.1093/pubmed/fdaa105; Son J, 2020, J ASSOC INF SCI TECH, V71, P1145, DOI 10.1002/asi.24329; Stieglitz S, 2018, J CONTING CRISIS MAN, V26, P4, DOI 10.1111/1468-5973.12193; Stokes DC, 2020, J GEN INTERN MED, V35, P2244, DOI 10.1007/s11606-020-05889-w; van Vliet L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237073; Wang JZ, 2020, J MED INTERNET RES, V22, DOI 10.2196/22152; Wicke P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240010; Wilson S, 2020, LEADERSHIP-LONDON, V16, P279, DOI 10.1177/1742715020929151; Xue J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239441	53	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0259882	10.1371/journal.pone.0259882	http://dx.doi.org/10.1371/journal.pone.0259882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY5KW	34910732	Green Published, gold			2022-12-26	WOS:000754828900010
J	Silva, SA; do Carmo, AS; Carvalho, KMB				Silva, Sara Araujo; do Carmo, Ariene Silva; Baiocchi Carvalho, Kenia Mara			Lifestyle patterns associated with common mental disorders in Brazilian adolescents: Results of the Study of Cardiovascular Risks in Adolescents (ERICA)	PLOS ONE			English	Article							ULTRA-PROCESSED FOOD; METAANALYSIS; CONSUMPTION; DEPRESSION; BEHAVIOR; ALCOHOL; TIME	The association between lifestyle factors and mental health has been evaluated in isolation; however, there has been a lack of information about lifestyle patterns and Common Mental Disorders (CMD) in adolescents. Therefore, the present study aims to assess the association between sets of lifestyle patterns and the occurrence of CMD in Brazilian adolescents evaluated in a national school-based cross-sectional survey. The outcome variable considered was presence of CMD. Lifestyle patterns were identified from the Principal Component Analysis. Consumption of foods, water and alcoholic beverages, sleep, physical activity, and smoking were used to identify patterns as explanatory variables. Sociodemographic characteristics, administrative dependence of the school and, nutritional status, were considered adjustment factors in the regression model. A total of 70,427 adolescents were evaluated. The principal component analysis identified three lifestyle patterns: high consumption of ultra-processed foods and low consumption of unprocessed or minimally processed foods (pattern 1); high consumption of alcoholic beverages and tobacco in the last 30 days (pattern 2); and high consumption of water and high level of physical activity (pattern 3). In the adjusted model, in patterns 1 and 2, the third tertile presented greater chance of CMD (OR 1.68; CI 95% 1.51-1.87 and OR 1.38; CI 95% 1.19-1.60, respectively). In pattern 3, the second (OR 0.88; CI 95% 0.80-0.96) and the third (OR 0.80; CI 95% 0.72-0.88) tertiles presented lower chances of CMD among the adolescents evaluated. Therefore, we suggest that health-promoting practices aimed at adolescents include multiple behaviors, with the objective of ensuring physical, mental, and social well-being.	[Silva, Sara Araujo; Baiocchi Carvalho, Kenia Mara] Univ Brasilia, Fac Hlth Sci, Grad Program Human Nutr, Brasilia, DF, Brazil; [Silva, Sara Araujo] Unieuro Univ Ctr, Dept Nutr, Brasilia, DF, Brazil; [Silva, Sara Araujo; do Carmo, Ariene Silva] Minist Hlth, Brasilia, DF, Brazil	Universidade de Brasilia	Silva, SA (corresponding author), Univ Brasilia, Fac Hlth Sci, Grad Program Human Nutr, Brasilia, DF, Brazil.; Silva, SA (corresponding author), Unieuro Univ Ctr, Dept Nutr, Brasilia, DF, Brazil.; Silva, SA (corresponding author), Minist Hlth, Brasilia, DF, Brazil.	silvanut@gmail.com		Silva, Sara/0000-0002-2605-378X	Department of Science and Technology of the Ministry of Health (DECIT/SCTIE/MS), Brazil; Sectoral Health Fund (CT-Saude), Brazil; Ministry of Science, Technology, and Innovation (MCTI), Brazil [FINEP 01090421, CNPq 565037/2010-2]	Department of Science and Technology of the Ministry of Health (DECIT/SCTIE/MS), Brazil; Sectoral Health Fund (CT-Saude), Brazil; Ministry of Science, Technology, and Innovation (MCTI), Brazil	ERICA received funding from the Department of Science and Technology of the Ministry of Health (DECIT/SCTIE/MS), Brazil; the Sectoral Health Fund (CT-Sau ' de), Brazil; and the Ministry of Science, Technology, and Innovation (MCTI), Brazil (protocol numbers FINEP 01090421 and CNPq 565037/2010-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjibade M, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1312-y; Alexander J, 2017, WHO TECH REP SER, V1002, P1; American Psychiatric Association, 2014, MANUAL DIAGNOSTICO E, V5; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Balogun O, 2014, J ADOLESCENT HEALTH, V54, P228, DOI 10.1016/j.jadohealth.2013.07.034; Barufaldi Laura Augusta, 2016, Rev. bras. epidemiol., V19, P464, DOI 10.1590/1980-5497201600020020; Black William C., 2009, ANALISE MULTIVARIADA, V6; Bloch KV, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1442-x; Brasil, 2014, GUIA ALIMENTAR POPUL; Cairns KE, 2014, J AFFECT DISORDERS, V169, P61, DOI 10.1016/j.jad.2014.08.006; Chen X, 2020, CONSUMPTION ULTRA PR, P1; Conway JM, 2003, AM J CLIN NUTR, V77, P1171, DOI 10.1093/ajcn/77.5.1171; da Silva SU., 2021, PLOS ONE, V16, P1; da Veiga GV, 2006, NUTR RES, V26, P517, DOI 10.1016/j.nutres.2006.09.002; Farias Júnior José Cazuza de, 2012, Rev. bras. epidemiol., V15, P198, DOI 10.1590/S1415-790X2012000100018; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Drapeau A., 2012, MENTAL ILLNESS UNDER; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME, DOI [10.1002/ceas.12013%0A, DOI 10.1002/CEAS.12013%0A]; Ferreira Vanessa Roriz, 2019, Addict Behav Rep, V9, P100147, DOI 10.1016/j.abrep.2018.100147; Gomez-Donoso C, 2020, EUR J NUTR, V59, P1093, DOI 10.1007/s00394-019-01970-1; Gorenstein C, 2016, INSTRUMENTOS AVALIAC; Harvey SB, 2010, BRIT J PSYCHIAT, V197, P357, DOI 10.1192/bjp.bp.109.075176; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hori D, 2016, ENVIRON HEALTH PREV, V21, P410, DOI 10.1007/s12199-016-0541-3; IBGE IBGE. Instituto Brasileiro de Geografia e Estatistica, 2016, PESQ NAC SAUD ESC PE; Instituto Brasileiro de Geografia e Estatistica, 2019, PESQ ORC FAM 2017 20; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2011, PESQ ORC FAM 2008 20; Jacka FN, 2017, EBIOMEDICINE, V17, P24, DOI 10.1016/j.ebiom.2017.02.020; Jones CM, 2020, MMWR-MORBID MORTAL W, V69, P38, DOI 10.15585/mmwr.su6901a5; Kandola A, 2019, NEUROSCI BIOBEHAV R, V107, P525, DOI 10.1016/j.neubiorev.2019.09.040; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; de Vasconcellos MTL, 2015, CAD SAUDE PUBLICA, V31, P921, DOI 10.1590/0102-311X00043214; Lopes CS, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S01518-8787.2016050006690, 10.1590/s01518-8787.2016050006690]; MARI JD, 1985, PSYCHOL MED, V15, P651; Molendijk M, 2018, J AFFECT DISORDERS, V226, P346, DOI 10.1016/j.jad.2017.09.022; Monteiro CA., 2016, WORLD NUTR, V7, P28; Ojio Y, 2016, SLEEP, V39, P1555, DOI 10.5665/sleep.6020; Pengpid S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122091; Rocha LL., 2021, PLOS ONE, V16, P1; Rocha LL, 2021, J ACAD NUTR DIET, V121, P1136, DOI 10.1016/j.jand.2020.12.010; Sarris J, 2015, LANCET PSYCHIAT, V2, P271, DOI 10.1016/S2215-0366(14)00051-0; Silva SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232007; Silva Thiago Luiz Nogueira da, 2016, Rev. Saúde Pública, V50, p3s, DOI 10.1590/s01518-8787.2016050006730; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Werneck AO, 2020, J AFFECT DISORDERS, V266, P135, DOI 10.1016/j.jad.2020.01.104; Whiteford HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116820; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health O, 2020, WHO GUID PHYS ACT SE, DOI DOI 10.4324/9780203795002; World Health Organization, 2017, INTEGRATED CARE OLDE, P1; Zheng LW, 2020, FRONT NUTR, V7, DOI 10.3389/fnut.2020.600449	50	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261261	10.1371/journal.pone.0261261	http://dx.doi.org/10.1371/journal.pone.0261261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY2HZ	34905559	Green Published, gold			2022-12-26	WOS:000754615500032
J	Guo, HJ; Phung, D; Chu, C				Guo, Haijun; Phung, Dung; Chu, Cordia			Sociodemographic, lifestyle, behavioral, and parental factors associated with sugar-sweetened beverage consumption in children in China	PLOS ONE			English	Article							NUTRITION TRANSITION; YOUNG-CHILDREN; ADOLESCENTS; OBESITY; HEALTH; DETERMINANTS; EDUCATION; DIET; AGE	Objective Evidence shows sugar-sweetened beverage (SSB) consumption is a risk factor for obesity and non-communicable diseases (NCDs) in children. Investigating the influential profiles, which have been examined insufficiently, will help to inform the reduction of SSB consumption. The present research examines the current trend in SSB consumption and associated factors among children in China, in order to inform policy development. Methods Secondary data was extracted from China's Health and Nutrition Survey (CHNS; 2004, 2006, 2009, and 2011), a repeated cross-sectional research, and a Chi-squared test was applied to compare SSB consumption in the last year, queried by social demographical, `environmental, behavioral, and parental factors. Multilevel mixed-effects logistic regression was employed to examine the trend and effects of the multiple factors. Results A total of 6015 Chinese children aged 6-17 years were investigated. From 2004 to 2011, the percentage of SSB consumption in children increased from 72.6% to 90.3%. The prevalence in urban areas was higher than the prevalence in rural areas, higher in high schools than primary and middle schools, higher in east coast affluent provinces than other provinces, and higher in high-income households than low-income households. Other associated factors include children's fast food and salty snacks preference, level of physical activity, sedentariness, and parental education. The strongest association with SSB consumption in children was the mother's SSB consumption (adjusted odds ratio: 5.54, 95% CI: 3.17-9.67). Conclusion Children's SSB consumption has increased significantly in China, and is associated with socio-economic, demographic, level of physical activity, food preference, and parental factors. Future strategies aimed at reducing SSB consumption among children need to consider these factors.	[Guo, Haijun; Phung, Dung; Chu, Cordia] Griffith Univ, Ctr Environm & Populat Hlth, Nathan, Qld, Australia	Griffith University	Guo, HJ (corresponding author), Griffith Univ, Ctr Environm & Populat Hlth, Nathan, Qld, Australia.	haijun.guo@griffithuni.edu.au		Phung, Dung/0000-0002-1615-3234; Chu, Cordia/0000-0002-3683-5638; Guo, Haijun/0000-0002-0298-0642				Ashdown-Franks G, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0796-3; Attard SM, 2015, J HYPERTENS, V33, P948, DOI 10.1097/HJH.0000000000000522; Bere E, 2008, PUBLIC HEALTH NUTR, V11, P49, DOI 10.1017/S1368980007000122; Blecher E, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160406; Brand-Miller JC, 2017, AM J CLIN NUTR, V105, P854, DOI 10.3945/ajcn.116.145318; Chen FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047380; Chen YJ, 2019, OBESITY, V27, P662, DOI 10.1002/oby.22423; Chung SJ, 2017, J PEDIATR NURS, V36, P44, DOI 10.1016/j.pedn.2017.04.010; Cockburn N, 2018, EUR J CLIN NUTR, V72, P401, DOI 10.1038/s41430-017-0021-x; Bibiloni MD, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070389; Saldiva SRDM, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-33; Feng YJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142543; Frank SM, 2019, J NUTR, V149, P1252, DOI 10.1093/jn/nxz040; Gebremariam MK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171537; Godin KM, 2019, PUBLIC HEALTH NUTR, V22, P1928, DOI 10.1017/S1368980018001246; Grimes CA, 2013, PEDIATRICS, V131, P14, DOI 10.1542/peds.2012-1628; Gui ZH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121302; Guo Q., 2013, CHINA MED HERALD, P128; Hafekost K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-950; Inhulsen MBMR, 2017, PUBLIC HEALTH NUTR, V20, P2124, DOI 10.1017/S1368980017001409; Irwin BR, 2019, PUBLIC HEALTH NUTR, V22, P3035, DOI 10.1017/S1368980019000715; Kelly B, 2010, AM J PUBLIC HEALTH, V100, P1730, DOI 10.2105/AJPH.2009.179267; Lee YH, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14050493; Lopez AM, 2017, SOC SCI MED, V172, P21, DOI 10.1016/j.socscimed.2016.11.001; Luke A, 2013, INT J EPIDEMIOL, V42, P1831, DOI 10.1093/ije/dyt159; Lundeen EA, 2018, AM J HEALTH PROMOT, V32, P1661, DOI 10.1177/0890117118763008; McNeal J.U., 1997, J CONSUM MARK, V14, P45, DOI https://doi.org/10.1108/07363769710155857; Paes VM, 2015, OBES REV, V16, P903, DOI 10.1111/obr.12310; Pan XB, 2020, J EPIDEMIOL, V30, P128, DOI 10.2188/jea.JE20180223; Parvanta SA, 2010, J ADOLESCENT HEALTH, V46, P339, DOI 10.1016/j.jadohealth.2009.08.002; Popkin BM, 2008, HEALTH AFFAIR, V27, P1064, DOI 10.1377/hlthaff.27.4.1064; Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Rahman AA, 2018, NUTR REV, V76, P88, DOI 10.1093/nutrit/nux061; Rippe JM, 2013, ADV NUTR, V4, P527, DOI 10.3945/an.113.004143; Sanchez-Pimienta TG, 2016, J NUTR, V146, P1888, DOI 10.3945/jn.115.220301; Sim E, 2019, INT DENT J, V69, P376, DOI 10.1111/idj.12485; Singh GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124845; Tasevska N, 2017, J ACAD NUTR DIET, V117, P1900, DOI 10.1016/j.jand.2017.03.013; The University of North Carolina at Chapel Hill, 2020, CHIN HLTH NUTR SURV; Totland TH, 2013, BRIT J NUTR, V110, P926, DOI 10.1017/S0007114512005946; van Ansem WJC, 2014, BRIT J NUTR, V112, P467, DOI 10.1017/S0007114514001007; Watts AW, 2018, EAT BEHAV, V30, P42, DOI 10.1016/j.eatbeh.2018.04.003; Watts AW, 2015, APPETITE, V95, P360, DOI 10.1016/j.appet.2015.07.022; Wolf A, 2008, OBES REV, V9, P151, DOI 10.1111/j.1467-789X.2007.00389.x; Yang LL, 2017, AM J PUBLIC HEALTH, V107, P1095, DOI 10.2105/AJPH.2017.303762; Yu P, 2016, PUBLIC HEALTH NUTR, V19, P2336, DOI 10.1017/S1368980016001373; Yu ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051949; Zahid A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080929; Zhou YJ, 2015, FOOD POLICY, V55, P92, DOI 10.1016/j.foodpol.2015.07.001	51	5	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0261199	10.1371/journal.pone.0261199	http://dx.doi.org/10.1371/journal.pone.0261199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890424	Green Published, gold			2022-12-26	WOS:000747293600034
J	Khan, AR; Wicaksono, WA; Ott, NJ; Poret-Peterson, AT; Browne, GT				Khan, Abdur R.; Wicaksono, Wisnu A.; Ott, Natalia J.; Poret-Peterson, Amisha T.; Browne, Greg T.			Characterization of soils conducive and non-conducive to Prunus replant disease	PLOS ONE			English	Article							1ST REPORT; PRIMERS; DIVERSITY; IDENTIFICATION; RHIZOSPHERE; BIOCONTROL; SEQUENCES; SELECTION; BACTERIAL; MODELS	Successive orchard plantings of almond and other Prunus species exhibit reduced growth and yield in many California soils. This phenomenon, known as Prunus replant disease (PRD), can be prevented by preplant soil fumigation or anaerobic soil disinfestation, but its etiology is poorly understood and its incidence and severity are hard to predict. We report here on relationships among physicochemical variables, microbial community structure, and PRD induction in 25 diverse replant soils from California. In a greenhouse bioassay, soil was considered to be "PRD-inducing" when growth of peach seedlings in it was significantly increased by preplant fumigation and pasteurization, compared to an untreated control. PRD was induced in 18 of the 25 soils, and PRD severity correlated positively with soil exchangeable-K, pH, %clay, total %N, and electrical conductivity. The structure of bacterial, fungal, and oomycete communities differed significantly between the PRD-inducing and non-inducing soils, based on PERMANOVA of Bray Curtis dissimilarities. Bacterial class MB-A2-108 of phylum Actinobacteria had high relative abundances among PRD-inducing soils, while Bacteroidia were relatively abundant among non-inducing soils. Among fungi, many ASVs classified only to kingdom level were relatively abundant among PRD-inducing soils whereas ASVs of Trichoderma were relatively abundant among non-inducing soils. Random forest classification effectively discriminated between PRD-inducing and non-inducing soils, revealing many bacterial ASVs with high explanatory values. Random forest regression effectively accounted for PRD severity, with soil exchangeable-K and pH having high predictive value. Our work revealed several biotic and abiotic variables worthy of further examination in PRD etiology.	[Khan, Abdur R.; Wicaksono, Wisnu A.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Ott, Natalia J.; Poret-Peterson, Amisha T.; Browne, Greg T.] USDA ARS Crops Pathol & Genet Res Unit, Davis, CA 95616 USA; [Wicaksono, Wisnu A.] Inst Environm Biotechnol, Graz, Austria	University of California System; University of California Davis	Browne, GT (corresponding author), USDA ARS Crops Pathol & Genet Res Unit, Davis, CA 95616 USA.	gregory.browne@usda.gov	Wicaksono, Wisnu Adi/ABB-4774-2020	Wicaksono, Wisnu Adi/0000-0002-1556-1981	Almond Board of California [PATH11]; California Department of Pesticide Regulation [12-PML-R003]	Almond Board of California; California Department of Pesticide Regulation	G.T. Browne received partial funding for this research from the Almond Board of California (https://www.almonds.com/), (grant number PATH11) and the California Department of Pesticide Regulation (https://www.cdpr.ca.gov/) (grant number 12-PML-R003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo-Guerrero Y, 2015, J APPL MICROBIOL, V119, P1112, DOI 10.1111/jam.12910; Albuquerque L, 2011, SYST APPL MICROBIOL, V34, P595, DOI 10.1016/j.syapm.2011.07.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Balbin-Suarez A, 2020, FEMS MICROBIOL ECOL, V96, DOI 10.1093/femsec/fiaa211; Bent E, 2009, FEMS MICROBIOL ECOL, V68, P192, DOI 10.1111/j.1574-6941.2009.00668.x; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P2519, DOI 10.1128/AEM.03870-12; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Borriss R., 2015, MICROBES SUSTAINABLE; Breiman L., 2001, MACH LEARN, V45, P5; Browne G, 2018, PLANT DIS, V102, P209, DOI 10.1094/PDIS-09-16-1392-RE; Browne G. T., 2018, Acta Horticulturae, P287, DOI 10.17660/ActaHortic.2018.1219.44; Browne GT, 2006, PLANT DIS, V90, P869, DOI 10.1094/PD-90-0869; BUCKLAND ST, 1993, J APPL ECOL, V30, P478, DOI 10.2307/2404188; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Clarke K.R., 2015, PRIMER VERSION 7 USE; Duncan Roger A, UC ANR PUB, V#3454; Evans J.S., 2019, RFUTILITIES RANDOM F; Fernandez H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110771; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gilardi G, 2018, PLANT DIS, V102, P454, DOI 10.1094/PDIS-05-17-0680-PDN; GUR A, 1989, SOIL BIOL BIOCHEM, V21, P829, DOI 10.1016/0038-0717(89)90177-6; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Holtz BA, 2004, ACTA HORTIC, P127, DOI 10.17660/ActaHortic.2004.638.15; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jackson CR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-274; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Kanfra X, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01666; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lacey MJ, 2001, J PHYTOPATHOL, V149, P679, DOI 10.1046/j.1439-0434.2001.00693.x; Leveau JHJ, 2007, EUR J PLANT PATHOL, V119, P279, DOI 10.1007/s10658-007-9186-9; Manici LM, 2010, EUR J AGRON, V33, P188, DOI 10.1016/j.eja.2010.05.005; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mbareche H, 2020, PEERJ, V8, DOI 10.7717/peerj.8523; MCKENRY MV, 1987, PLANT DIS, V71, P71, DOI 10.1094/PD-71-0071; McKenry MV, 1996, ALMOND PRODUCTION MA, P220; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Monard C, 2013, FEMS MICROBIOL ECOL, V84, P165, DOI 10.1111/1574-6941.12046; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Paulson J. N., 2017, BIORXIV, DOI [10.1101/099457, DOI 10.1101/099457]; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; PROEBSTING EL, 1950, P AM SOC HORTIC SCI, V56, P46; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reyes-Ramirez A, 2004, J FOOD SCI, V69, pM131, DOI 10.1111/j.1365-2621.2004.tb10721.x; Riit T, 2016, MYCOKEYS, P17, DOI 10.3897/mycokeys.14.9244; Rojas JA, 2017, PHYTOPATHOLOGY, V107, P293, DOI [10.1094/PHYTO-04-16-0176-R, 10.1094/phyto-04-16-0176-r]; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schmidt LS, 2013, PHYTOPATHOLOGY, V103, P128; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Steddom K, 2002, PHYTOPATHOLOGY, V92, P850, DOI 10.1094/PHYTO.2002.92.8.850; Tan WJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62919-7; Tang XJ, 2021, PLANT DIS, V105, P231, DOI 10.1094/PDIS-05-20-1075-PDN; Tilston EL, 2018, PHYTOBIOMES J, V2, P261, DOI 10.1094/PBIOMES-11-18-0050-R; Wang GS, 2018, HORTIC PLANT J, V4, P175, DOI 10.1016/j.hpj.2018.05.003; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yadav DR, 2014, MYCOBIOLOGY, V42, P401, DOI 10.5941/MYCO.2014.42.4.401; Yang JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046420; Yim B, 2020, HORTIC RES-ENGLAND, V7, DOI 10.1038/s41438-020-00365-2; Zhang T, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00005, 10.3389/fmicb.2016.01830, 10.3389/fmicb.2016.00227]; Zhang Y, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.02969-19	67	2	2	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0260394	10.1371/journal.pone.0260394	http://dx.doi.org/10.1371/journal.pone.0260394			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890412	Green Published, gold			2022-12-26	WOS:000747293600010
J	Carey, IM; Cook, DG; Harris, T; DeWilde, S; Chaudhry, UAR; Strachan, DP				Carey, Iain M.; Cook, Derek G.; Harris, Tess; DeWilde, Stephen; Chaudhry, Umar A. R.; Strachan, David P.			Risk factors for excess all-cause mortality during the first wave of the COVID-19 pandemic in England: A retrospective cohort study of primary care data	PLOS ONE			English	Article							OBSERVATIONAL COHORT; UK; INFECTION; DEATH	Background The COVID-19 pandemic's first wave in England during spring 2020 resulted in an approximate 50% increase in all-cause mortality. Previously, risk factors such as age and ethnicity, were identified by studying COVID-related deaths only, but these were under-recorded during this period. Objective To use a large electronic primary care database to estimate the impact of risk factors (RFs) on excess mortality in England during the first wave, compared with the impact on total mortality during 2015-19. Methods Medical history, ethnicity, area-based deprivation and vital status data were extracted for an average of 4.8 million patients aged 30-104 years, for each year between 18-March and 19-May over a 6-year period (2015-2020). We used Poisson regression to model total mortality adjusting for age and sex, with interactions between each RF and period (pandemic vs. 2015-19). Total mortality during the pandemic was partitioned into "usual" and "excess" components, assuming 2015-19 rates represented "usual" mortality. The association of each RF with the 2020 "excess" component was derived as the excess mortality ratio (EMR), and compared with the usual mortality ratio (UMR). Results RFs where excess mortality was greatest and notably higher than usual were age >80, non-white ethnicity (e.g., black vs. white EMR = 2.50, 95%CI 1.97-3.18; compared to UMR = 0.92, 95%CI 0.85-1.00), BMI>40, dementia, learning disability, severe mental illness, place of residence (London, care-home, most deprived). By contrast, EMRs were comparable to UMRs for sex. Although some co-morbidities such as cancer produced EMRs significantly below their UMRs, the EMRs were still >1. In contrast current smoking has an EMR below 1 (EMR = 0.80, 95%CI 0.65-0.98) compared to its UMR = 1.64. Conclusions Studying risk factors for excess mortality during the pandemic highlighted differences from studying cause-specific mortality. Our approach illustrates a novel methodology for evaluating a pandemic's impact by individual risk factor without requiring cause-specific mortality data.	[Carey, Iain M.; Cook, Derek G.; Harris, Tess; DeWilde, Stephen; Chaudhry, Umar A. R.; Strachan, David P.] St Georges Univ London, Populat Hlth Res Inst, London, England	St Georges University London	Carey, IM (corresponding author), St Georges Univ London, Populat Hlth Res Inst, London, England.	sgjd450@sgul.ac.uk	Carey, Iain/O-6973-2014	Carey, Iain/0000-0003-1099-8460; Harris, Tess/0000-0002-8671-1553				Aldridge Robert W, 2020, Wellcome Open Res, V5, P88, DOI [10.12688/wellcomeopenres.15922.1, 10.12688/wellcomeopenres.15922.2]; Appleby J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1607; Barron E, 2020, LANCET DIABETES ENDO, V8, P813, DOI 10.1016/S2213-8587(20)30272-2; Bhaskaran K, 2021, LANCET REG HEALTH-EU, V6, DOI 10.1016/j.lanepe.2021.100109; Bloom CI, 2021, LANCET RESP MED, V9, P699, DOI 10.1016/S2213-2600(21)00013-8; Burki TK, 2020, LANCET ONCOL, V21, P629, DOI 10.1016/S1470-2045(20)30217-5; Carey IM, 2013, J CLIN EPIDEMIOL, V66, P436, DOI 10.1016/j.jclinepi.2012.10.012; Carr MJ, 2021, LANCET PUBLIC HEALTH, V6, pe124, DOI 10.1016/S2468-2667(20)30288-7; Carreira H, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100656; Daly M, 2020, SOC POLICY ADMIN, V54, P985, DOI 10.1111/spol.12645; Davies B, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23935-x; Department of Health and Social Care GOV.UK, 2020, COVID 19 GUID TIER 1; Farsalinos K, 2020, THER ADV CHRONIC DIS, V11, DOI 10.1177/2040622320935765; Gallagher AM, 2019, PHARMACOEPIDEM DR S, V28, P563, DOI 10.1002/pds.4747; GOV.UK, 2021, PHE LSHTM CONTRIBUTI; Halpin DMG, 2020, LANCET RESP MED, V8, P436, DOI 10.1016/S2213-2600(20)30167-3; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Hopkinson NS, 2021, THORAX, V76, P714, DOI 10.1136/thoraxjnl-2020-216422; Huang Y, 2020, METABOLISM, V113, DOI 10.1016/j.metabol.2020.154378; Islam N, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1137; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Khunti K, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1548; Kontis V, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1112-0; Kontopantelis E, 2021, J EPIDEMIOL COMMUN H, V75, P213, DOI 10.1136/jech-2020-214764; Leung JM, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02108-2020; Mafham MM, 2020, LANCET, V396, P381, DOI 10.1016/S0140-6736(20)31356-8; Mansfield KE, 2021, LANCET DIGIT HEALTH, V3, pE217, DOI [10.1016/S2589-7500(21)00017-0, 10.1016/S2589-7500(21)00017-0ac.uk]; Marmot M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m693; Mathur R, 2021, LANCET, V397, P1711, DOI 10.1016/S0140-6736(21)00634-6; Morciano M, 2021, BMC MED, V19, DOI 10.1186/s12916-021-01945-2; NHS Digital, 2021, QUALITY OUTCOMES FRA; O'Connor RC, 2021, BRIT J PSYCHIAT, V218, P326, DOI 10.1192/bjp.2020.212; Office for National Statistics, 2021, REPORTED ROAD ACCIDE; Padmanabhan S, 2019, EUR J EPIDEMIOL, V34, P91, DOI 10.1007/s10654-018-0442-4; Prats-Uribe A, 2021, CLIN EPIDEMIOL, V13, P357, DOI 10.2147/CLEP.S300597; Ramakrishnan S, 2021, LANCET RESP MED, V9, P763, DOI 10.1016/S2213-2600(21)00160-0; Scally G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1932; Schultze A., 2021, WELLCOME OPEN RES, V6; Schultze A, 2020, LANCET RESP MED, V8, P1106, DOI 10.1016/S2213-2600(20)30415-X; Simons D, 2021, ADDICTION, V116, P1319, DOI 10.1111/add.15276; The Nuffield Trust, 2021, NHS PERF SUMM NOV DE; Truesdale M, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043658; Usman MS, 2021, BMJ EVID-BASED MED, V26, P279, DOI 10.1136/bmjebm-2020-111492; Ward H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21237-w; Williamson EJ, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1592; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wolf A, 2019, INT J EPIDEMIOL, V48, P1740, DOI 10.1093/ije/dyz034; Yu Ly-Mee, 2021, Lancet, V398, P843, DOI 10.1016/S0140-6736(21)01744-X	49	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260381	10.1371/journal.pone.0260381	http://dx.doi.org/10.1371/journal.pone.0260381			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882700	Green Accepted, Green Published, gold			2022-12-26	WOS:000755037200027
J	Cattaneo, L; Mezzetti, M; Lopreiato, V; Piccioli-Cappelli, F; Trevisi, E; Minuti, A				Cattaneo, Luca; Mezzetti, Matteo; Lopreiato, Vincenzo; Piccioli-Cappelli, Fiorenzo; Trevisi, Erminio; Minuti, Andrea			Gene network expression of whole blood leukocytes in dairy cows with different milk yield at dry-off	PLOS ONE			English	Article							MAMMARY-GLAND; OXIDATIVE STRESS; EARLY-LACTATION; INFLAMMATION; INVOLUTION; ANTIOXIDANT; NEUTROPHILS; METABOLISM; ACTIVATION; DISEASES	Dairy cows at dry-off undergo several management and physiological changes, resulting in alterations in plasma biomarkers of inflammation, oxidative stress, and immune system. High milk yield at the end of lactation exacerbates these responses. The underlying mechanism of these changes has yet to be elucidated. We hypothesized altered leukocyte gene expression after dry-off and different responses in cows with different milk yield. Thirteen Holstein dairy cows were sampled at the turn of dry-off to investigated whole blood leukocyte gene expression and were grouped according to the average milk yield during the last week of lactation: low (< 15 kg/d) and high milk yield (> 15 kg/d). Blood samples were collected in PAXgene tubes (Preanalytix, Hombrechtikon, Switzerland) at -7, 7, and 34 days from dry-off (DFD) to measure mRNA abundance of 37 genes. Normalized gene abundance data were subjected to MIXED model ANOVA (SAS Institute Inc., Cary, NC). Compared with -7 DFD, at 7 DFD RNA abundance of lipoxygenase genes (ALOX5, ALOX15) and myeloperoxidase (MPO) increased, and that of the antioxidant gene (SOD2) decreased. Meanwhile, genes related to recognition and immune mediation (CD16, MYD88, TLR2), migration and cell adhesion (CX3CR1, ITGAL, ITGB2, TLN1), and the antimicrobial gene MMP9 were downregulated at 7 or 34 DFD, whereas the antimicrobial IDO1 gene was upregulated. Compared with low-producing cows, cows with high milk yield at dry-off cows had upregulated expression of the pro-inflammatory cytokines IL8 and IL18 and a greater reduction in transcript abundance of the toll-like receptor (TLR) recognition-related gene TLR2. Overall, the dry-off confirmed to be a phase of intense changes, triggering an inflammatory response and somewhat suppressing leukocyte immune function. In cows with high milk yield during the week before dry-off, the inflammatory response was exacerbated.	[Cattaneo, Luca; Mezzetti, Matteo; Lopreiato, Vincenzo; Piccioli-Cappelli, Fiorenzo; Trevisi, Erminio; Minuti, Andrea] Univ Cattolica Sacro Cuore, Fac Sci Agr, Res Ctr Romeo & Enrica Invernizzi Sustainable Dai, Dept Anim Sci Food & Nutr DIANA, Piacenza, Italy	Catholic University of the Sacred Heart	Trevisi, E (corresponding author), Univ Cattolica Sacro Cuore, Fac Sci Agr, Res Ctr Romeo & Enrica Invernizzi Sustainable Dai, Dept Anim Sci Food & Nutr DIANA, Piacenza, Italy.	erminio.trevisi@unicatt.it	Cattaneo, Luca/AAC-7073-2021	Cattaneo, Luca/0000-0001-6027-7536; Minuti, Andrea/0000-0002-0617-6571	"Romeo ed Enrica Invernizzi foundation", Milan, Italy; Doctoral School on the Agro-Food System (Agrisystem) of the Universita Cattolica del Sacro Cuore (Italy)	"Romeo ed Enrica Invernizzi foundation", Milan, Italy; Doctoral School on the Agro-Food System (Agrisystem) of the Universita Cattolica del Sacro Cuore (Italy)	This study was supported by the "Romeo ed Enrica Invernizzi foundation", Milan, Italy, and the Doctoral School on the Agro-Food System (Agrisystem) of the Universita Cattolica del Sacro Cuore (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelo A, 2021, J DAIRY SCI, V104, P5909, DOI 10.3168/jds.2020-19782; Aitken SL, 2009, J DAIRY SCI, V92, P589, DOI 10.3168/jds.2008-1551; Aitken SL, 2011, J MAMMARY GLAND BIOL, V16, P291, DOI 10.1007/s10911-011-9230-4; Anwar Y, 2014, CURR DRUG TARGETS, V15, P410, DOI 10.2174/1389450114666131209110745; Atabai K, 2007, J MAMMARY GLAND BIOL, V12, P37, DOI 10.1007/s10911-007-9036-6; Awad F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175336; Buhler S, 2018, J ANIM PHYSIOL AN N, V102, pE87, DOI 10.1111/jpn.12705; Chen SZ, 2013, PROTEIN CELL, V4, P251, DOI 10.1007/s13238-013-2128-8; Crookenden MA, 2016, J DAIRY SCI, V99, P6470, DOI 10.3168/jds.2015-10877; Dado-Senn B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29420-8; Dieho K, 2016, J DAIRY SCI, V99, P2339, DOI 10.3168/jds.2015-9837; Dingwell R. T., 2001, NAT MAST COUNC ANN M, P69; Dixit N, 2012, J IMMUNOL, V189, P5954, DOI 10.4049/jimmunol.1201638; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; GORDON LI, 1979, J CLIN INVEST, V64, P226, DOI 10.1172/JCI109443; Gross JJ, 2019, J DAIRY SCI, V102, P2828, DOI 10.3168/jds.2018-15713; Hanthorn CJ, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0285-5; HURLEY WL, 1989, J DAIRY SCI, V72, P1637, DOI 10.3168/jds.S0022-0302(89)79276-6; Janeway CA, 2001, IMMUNOBIOLOGY; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Lahouassa H, 2008, MOL IMMUNOL, V45, P1153, DOI 10.1016/j.molimm.2007.07.011; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Lee M, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e5; Lopreiato V, 2020, J DAIRY SCI, V103, P1908, DOI 10.3168/jds.2019-17298; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mezzetti M, 2020, J ANIM SCI, V98, pS155, DOI 10.1093/jas/skaa134; Mezzetti M, 2020, ITAL J ANIM SCI, V19, P51, DOI 10.1080/1828051X.2019.1691472; Minuti A, 2020, FUNCT INTEGR GENOMIC, V20, P293, DOI 10.1007/s10142-019-00720-0; OLIVER SP, 1988, J DAIRY SCI, V71, P2584, DOI 10.3168/jds.S0022-0302(88)79847-1; Ollier S, 2013, J DAIRY SCI, V96, P335, DOI 10.3168/jds.2012-5955; OLSON NC, 1995, BRIT VET J, V151, P489, DOI 10.1016/S0007-1935(05)80023-5; Piantoni P, 2010, BIOINFORM BIOL INSIG, V4, P85; Putman AK, 2018, J DAIRY SCI, V101, P9350, DOI 10.3168/jds.2018-14591; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Salmi M, 1997, ADV IMMUNOL, V64, P139, DOI 10.1016/S0065-2776(08)60889-5; Seo J, 2013, J DAIRY SCI, V96, P7675, DOI 10.3168/jds.2013-6952; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Singh K, 2008, J DAIRY SCI, V91, P2236, DOI 10.3168/jds.2007-0900; Sordillo LM, 2014, ANIM PROD SCI, V54, P1204, DOI 10.1071/AN14503; SORDILLO LM, 1988, AM J VET RES, V49, P1112; Sordillo LM, 1997, J DAIRY SCI, V80, P1851, DOI 10.3168/jds.S0022-0302(97)76121-6; Sordillo LM, 2008, FREE RADICAL BIO MED, V44, P34, DOI 10.1016/j.freeradbiomed.2007.09.002; Sordillo LM, 2009, VET IMMUNOL IMMUNOP, V128, P104, DOI 10.1016/j.vetimm.2008.10.305; Stefanon B, 2002, J DAIRY RES, V69, P37, DOI 10.1017/S0022029901005246; Ster C, 2012, J DAIRY SCI, V95, P708, DOI 10.3168/jds.2011-4695; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Taraktsoglou M, 2011, VET IMMUNOL IMMUNOP, V140, P130, DOI 10.1016/j.vetimm.2010.12.002; Teng TS, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/9671604; Tian R, 2017, PROSTAG OTH LIPID M, V132, P77, DOI 10.1016/j.prostaglandins.2017.01.002; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Vilar MJ, 2020, VET J, V262, DOI 10.1016/j.tvjl.2020.105503; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Yu TC, 2012, VET IMMUNOL IMMUNOP, V147, P161, DOI 10.1016/j.vetimm.2012.04.011; Zhao X, 2019, J DAIRY SCI, V102, P6701, DOI 10.3168/jds.2019-16377; Zobel G, 2015, J DAIRY SCI, V98, P8263, DOI 10.3168/jds.2015-9617	56	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260745	10.1371/journal.pone.0260745	http://dx.doi.org/10.1371/journal.pone.0260745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882732	Green Published, gold			2022-12-26	WOS:000755037200039
J	Lijewski, M; Burdukiewicz, A; Stachon, A; Pietraszewska, J				Lijewski, Marcin; Burdukiewicz, Anna; Stachon, Aleksandra; Pietraszewska, Jadwiga			Differences in anthropometric variables and muscle strength in relation to competitive level in male handball players	PLOS ONE			English	Article							PHYSICAL PERFORMANCE-CHARACTERISTICS; TEAM HANDBALL; THROWING VELOCITY; PLAYING POSITION; PHYSIOLOGICAL-CHARACTERISTICS; HANDGRIP STRENGTH; ELITE; PARAMETERS; RESISTANCE; KINEMATICS	Somatic characteristics manifested in different body morphology have great importance for the selection of athletes in most sports. The aim of our study is to evaluate the differences in anthropometric variables and isometric strength of handball players presenting different levels of sports competence, and to study the discriminative power of selected morphological characteristics that do not change in the training process. The study included the results of anthropometric measurements routinely used to monitor athletes, and body proportion indices were calculated. Fat percentage was assessed using the BIA, whereas body build was assessed using the Heath-Carter method. Measurements of right and left hand grip strength and back strength were taken. The results of measurements and calculations were analyzed using statistical methods. It was shown that players presenting the highest level dominate by the overall size and massiveness of the body, characteristics ensuring an advantage in direct confrontation. The size of subcutaneous fat tissue and percentage of body fat varied poorly between athletes in each group. Muscle strength assessed under static conditions shows a gradient in magnitude across teams from higher to lower rank, but the differences are not statistically significant. The same somatotype (balanced mesomorph) was present in all groups. Athletes presenting high sports level are characterized by body proportions that determine biomechanical conditions conducive to optimizing the structure of movements important in handball. Stepwise discriminant analysis showed that throwing-related characteristics (hand length, upper arm length, upper limb span, lower limb length) account for 88% of the variance in team ranking and can be used to identify the morphological predisposition of adepts to play handball.	[Lijewski, Marcin; Burdukiewicz, Anna; Stachon, Aleksandra; Pietraszewska, Jadwiga] Univ Sch Phys Educ Wroclaw, Dept Biol & Med Fdn Sport, Wroclaw, Poland		Burdukiewicz, A (corresponding author), Univ Sch Phys Educ Wroclaw, Dept Biol & Med Fdn Sport, Wroclaw, Poland.	anna.burdukiewicz@awf.wroc.pl		, Anna/0000-0002-1397-9516; Pietraszewska, Jadwiga/0000-0002-1319-9755; Stachon, Aleksandra/0000-0003-3245-4560	University School of Physical Education in Wroclaw, Poland [PN/BK/2020/08]	University School of Physical Education in Wroclaw, Poland	This research was funded by University School of Physical Education in Wroclaw, Poland, grant number PN/BK/2020/08, AS received this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland TR, 2006, KIN 9 P 9 INT C INT, V1st, P29; Alanazi H., 2015, SJSR, V2, P18; Aouadi R, 2012, J SPORT MED PHYS FIT, V52, P11; BARCIKOWSKI RS, 1975, MULTIVAR BEHAV RES, V10, P353, DOI 10.1207/s15327906mbr1003_8; Can I, 2018, EUR J SPORT SCI, V4, P10; Carter J. E. L., 1990, SOMATOTYPING DEV APP; Chelly MS, 2010, J STRENGTH COND RES, V24, P1480, DOI 10.1519/JSC.0b013e3181d32fbf; Cronin J, 2017, J STRENGTH COND RES, V31, P3187, DOI 10.1519/JSC.0000000000002149; Duncan MJ, 2006, BRIT J SPORT MED, V40, P649, DOI 10.1136/bjsm.2005.021998; Fallahi AA, 2011, J HUM KINET, V29, P151, DOI 10.2478/v10078-011-0049-2; Ferragut C, 2011, J SPORT MED PHYS FIT, V51, P26; Fieseler G, 2017, J SPORT MED PHYS FIT, V57, P985, DOI 10.23736/S0022-4707.17.06938-9; Ghobadi H, 2013, J HUM KINET, V39, P213, DOI 10.2478/hukin-2013-0084; Gorostiaga EM, 2006, MED SCI SPORT EXER, V38, P357, DOI 10.1249/01.mss.0000184586.74398.03; Goulding M., 2002, SOMATOTYPE CALCULATI, V1st ed; Hammami M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01124; Haugen TA, 2016, J SPORT MED PHYS FIT, V56, P19; Havolli J, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10196774; Hermassi S, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11083492; Hermassi S, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00149; Hermassi S, 2019, SPORTVERLETZ SPORTSC, V33, P96, DOI 10.1055/s-0043-124496; Karcher MS., 2014, SPORTS MED J, V3, P112, DOI [10.1007/s40279-014-0164-z, DOI 10.1007/S40279-014-0164-Z]; Kruger K, 2014, J STRENGTH COND RES, V28, P117, DOI 10.1519/JSC.0b013e318291b713; Malacko J., 2009, SPORT SCI, V2, P36; Manchado C, 2017, J HUM KINET, V56, P177, DOI 10.1515/hukin-2017-0035; Martinez-Rodriguez A., 2020, ARCH MED DEPORT, V37, P52; Massuca L, 2013, APUNTS-MED ESPORT, V48, P143, DOI 10.1016/j.apunts.2013.06.004; Massuca Luis, 2015, Coll Antropol, V39, P109; Moss SL, 2015, J SPORT SCI, V33, P1780, DOI 10.1080/02640414.2015.1012099; Nikolaidis PT, 2015, J SPORT MED PHYS FIT, V55, P297; Nikolaidis P T, 2013, Indian J Physiol Pharmacol, V57, P361; NIKOLAIDIS P.T., 2012, FU PHYS ED SPORT, V10, P231; Nikolaidis PT, 2013, J HUM KINET, V38, P115, DOI 10.2478/hukin-2013-0051; NORTON K, 1996, ANTHROPOMETRICA, P287; Peña J., 2018, Rev Andal Med Deporte, V11, P30, DOI 10.1016/j.ramd.2016.03.002; Povoas SCA, 2012, J STRENGTH COND RES, V26, P3365, DOI 10.1519/JSC.0b013e318248aeee; Ramirez-Campillo R, 2013, J STRENGTH COND RES, V27, P2219, DOI 10.1519/JSC.0b013e31827e8681; Rdzanek J., 2019, ADV REHAB, P13, DOI 10.5114/areh.2019.85019; Rousanoglou EN, 2014, J SPORT MED PHYS FIT, V54, P611; Saeterbakken AH, 2011, J STRENGTH COND RES, V25, P712, DOI 10.1519/JSC.0b013e3181cc227e; Schwesig R, 2017, J SPORT MED PHYS FIT, V57, P1471, DOI 10.23736/S0022-4707.16.06413-6; Scotto di Palumbo A, 2017, J SPORT MED PHYS FIT, V57, P794, DOI 10.23736/S0022-4707.16.06358-1; Shariat A, 2017, REV BRAS MED ESPORTE, V23, P260, DOI 10.1590/1517-869220172304175654; Spieszny M, 2018, J HUM KINET, V63, P149, DOI 10.2478/hukin-2018-0015; Stankovic V, 2009, ACTA KINESIOL, V3, P90; Stewart AD, 2010, SPORTS ATHL PREP PER, P307; Tuquet J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197022; Valandro L, 2005, 9 INT SCI C 9 INT SC, V1st; van den Tillaar R, 2003, PERCEPT MOTOR SKILL, V97, P731, DOI 10.2466/pms.2003.97.3.731; Vila Suarez ME., 2019, INT J PERF ANAL SPOR, V19, P1; Visnapuu M, 2009, PERCEPT MOTOR SKILL, V108, P670, DOI 10.2466/PMS.108.3.670-676; Wagner H, 2011, J SPORT SCI MED, V10, P73	52	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0261141	10.1371/journal.pone.0261141	http://dx.doi.org/10.1371/journal.pone.0261141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882749	Green Published, gold			2022-12-26	WOS:000755037200062
J	Nyerges-Bohak, Z; Nagy, K; Rozsa, L; Poti, P; Kovacs, L				Nyerges-Bohak, Zsofia; Nagy, Krisztina; Rozsa, Laszlo; Poti, Peter; Kovacs, Levente			Heart rate variability before and after 14 weeks of training in Thoroughbred horses and Standardbred trotters with different training experience	PLOS ONE			English	Article							TREADMILL EXERCISE; RELIABILITY; PERFORMANCE; ADAPTATION; STRESS; PAIN; REST; AGE	Changes in heart rate and heart rate variabilty (HRV) were investigated in untrained (UT; starting their first racing season) and detrained (DT; with 1-3 years of race experience) racehorses before and after 14-week conventional training. HRV was measured at rest over 1 h between 9:00 and 10:00 AM on the usual rest day of the horses. The smallest worthwhile change (SWC) rate was calculated for all HRV parameters. UT horses had significantly higher heart rate compared to DT (P<0.001). There were no gender- or training-related differences in heart rate. The root-mean-square of successive differences (rMSSD) in the consecutive inter-beat-intervals obtained after the 14-week training period was lower compared to pre-training rMSSD (P<0.001). The rMSSD was not influenced by breed, age or gender. In DT horses, there was a significant decrease in the high frequency (HF) component of HRV (P <= 0.05) as the result of the 14-week training. These results may reflect saturation of high-frequency oscillations of inter-beat intervals rather than the reduction in parasympathetic influence on the heart. The HF did not differ significantly between the two measurements in UT horses; however, 16.6% of the animals showed a decrease in HF below SWC (P <= 0.05). This supports the likelihood of parasympathetic saturation. Although no significant decrease in heart rate was found for the post-training, 30.0% of DT and 58.3% of UT horses still showed a decrease in heart rate below the SWC. Also by individual examination, it was also visible that despite significant post-training decrease in rMSSD, 1 (4.6%) DT and 2 (6.7%) UT horses reached SWC increase in rMMSD. In the case of these horses, the possibility of maladaptation should be considered. The present results indicate that similar to as found in human athletes, cardiac ANS status of racehorses also changes during the physiological adaptation to training. To explore more precise links between HRV and training effectiveness in horses, a more frequent recording would be necessary. Detailed analysis of HRV parameters based on SWC will be able to highlight the importance of fitness evaluation at individual level.	[Nyerges-Bohak, Zsofia; Nagy, Krisztina; Rozsa, Laszlo; Poti, Peter; Kovacs, Levente] Hungarian Univ Agr & Life Sci, Inst Anim Sci, Kaposvar, Hungary	Hungarian University of Agriculture & Life Sciences	Kovacs, L (corresponding author), Hungarian Univ Agr & Life Sci, Inst Anim Sci, Kaposvar, Hungary.	Kovacs.Levente@uni-mate.hu			New National Excellence Program of the Ministry of Human Capacities [UNKP-17-3IV-ATE-3]; OTKA Research Scholarship of the National Research, Development and Innovation Office [K134204]	New National Excellence Program of the Ministry of Human Capacities; OTKA Research Scholarship of the National Research, Development and Innovation Office	The New National Excellence Program of the Ministry of Human Capacities supported this study in the form of funding to ZN-B [UNKP-17-3IV-ATE-3]. This study was also supported by the OTKA Research Scholarship of the National Research, Development and Innovation Office in the form of funds to LK [Budapest, Hungary; K134204]. Hylofit provided sensors for ZN-B for the HRV measurements. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Haddad H, 2011, INT J SPORTS MED, V32, P598, DOI 10.1055/s-0031-1275356; Allen KJ, 2016, EQUINE VET EDUC, V28, P89, DOI 10.1111/eve.12410; Antelmi I, 2004, AM J CARDIOL, V93, P381, DOI 10.1016/j.amjcard.2003.09.065; Bellenger CR, 2016, SPORTS MED, V46, P1461, DOI 10.1007/s40279-016-0484-2; Bohak Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201691; Borresen J, 2008, SPORTS MED, V38, P633, DOI 10.2165/00007256-200838080-00002; Bosquet L, 2008, BRIT J SPORT MED, V42, P709, DOI 10.1136/bjsm.2007.042200; Buchheit M, 2012, EUR J APPL PHYSIOL, V112, P711, DOI 10.1007/s00421-011-2014-0; Buchheit M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00073; Buchheit M, 2010, EUR J APPL PHYSIOL, V108, P1153, DOI 10.1007/s00421-009-1317-x; Camm AJ, 1996, EUR HEART J, V17, P354; Chalencon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052636; CLEMENT F, 1995, CR ACAD SCI III-VIE, V318, P867; Cottin F, 2006, Equine Vet J Suppl, P204; Duthie GM, 2006, J STRENGTH COND RES, V20, P246, DOI 10.1519/R-17084.1; Frick L, 2019, J VET INTERN MED, V33, P212, DOI 10.1111/jvim.15358; Hinchcliff K. W., 2008, Equine exercise physiology: the science of exercise in the athletic horse; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hug B, 2014, INT J SPORTS MED, V35, P676, DOI 10.1055/s-0033-1361184; Hynynen E, 2008, INT J SPORTS MED, V29, P552, DOI 10.1055/s-2007-989286; Iellamo F, 2002, CIRCULATION, V105, P2719, DOI 10.1161/01.CIR.0000018124.01299.AE; Iwasaki K, 2003, J APPL PHYSIOL, V95, P1575, DOI 10.1152/japplphysiol.00482.2003; Janczarek I, 2020, J VET BEHAV, V38, P1, DOI 10.1016/j.jveb.2020.05.005; Javaloyes A, 2020, J STRENGTH COND RES, V34, P1511, DOI 10.1519/JSC.0000000000003337; Kinnunen S, 2006, Equine Vet J Suppl, P214; Kuwahara M, 1999, Equine Vet J Suppl, P178; Lehmann M, 1998, MED SCI SPORT EXER, V30, P1140, DOI 10.1097/00005768-199807000-00019; Nagy K, 2009, APPL ANIM BEHAV SCI, V121, P140, DOI 10.1016/j.applanim.2009.09.008; Nunan D, 2009, MED SCI SPORT EXER, V41, P243, DOI 10.1249/MSS.0b013e318184a4b1; Ohmura H, 2002, AM J VET RES, V63, P1488, DOI 10.2460/ajvr.2002.63.1488; Ohmura Hajime, 2017, Journal of Equine Science, V28, P99, DOI 10.1294/jes.28.99; Physick-Sheard PW, 2000, EQUINE VET J, V32, P253, DOI 10.2746/042516400776563572; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plews DJ, 2017, INT J SPORT PHYSIOL, V12, P697, DOI 10.1123/ijspp.2016-0343; Plews DJ, 2014, INT J SPORT PHYSIOL, V9, P1026, DOI 10.1123/ijspp.2013-0497; Plews DJ, 2013, SPORTS MED, V43, P773, DOI 10.1007/s40279-013-0071-8; Plews DJ, 2012, EUR J APPL PHYSIOL, V112, P3729, DOI 10.1007/s00421-012-2354-4; R Core Team, 2020, R LANG ENV STAT COMP; Reid K, 2017, J VET BEHAV, V22, P1, DOI 10.1016/j.jveb.2017.09.002; Rietmann TR, 2004, J VET MED A, V51, P218, DOI 10.1111/j.1439-0442.2004.00627.x; Rietmann TR, 2004, APPL ANIM BEHAV SCI, V88, P121, DOI 10.1016/j.applanim.2004.02.016; Schmidt A, 2010, HORM BEHAV, V58, P628, DOI 10.1016/j.yhbeh.2010.06.011; Schmidt A, 2010, HORM BEHAV, V57, P209, DOI 10.1016/j.yhbeh.2009.11.003; Spencer M, 2006, J SCI MED SPORT, V9, P181, DOI 10.1016/j.jsams.2005.05.001; Stanley J, 2013, SPORTS MED, V43, P1259, DOI 10.1007/s40279-013-0083-4; Tarvainen MP., 2008, KUBIOS HRV VERSION 2; Thayer JF., 1997, BIOMED SCI INSTRUM, V34, P246; Uusitalo AIT, 1998, INT J SPORTS MED, V19, P532, DOI 10.1055/s-2007-971956; Uusitalo ALT, 2000, INT J SPORTS MED, V21, P45; Vesterinen V, 2013, SCAND J MED SCI SPOR, V23, P171, DOI 10.1111/j.1600-0838.2011.01365.x; Visser EK, 2002, PHYSIOL BEHAV, V76, P289, DOI 10.1016/S0031-9384(02)00698-4; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; Voss B, 2002, J VET MED A, V49, P137, DOI 10.1046/j.1439-0442.2002.00420.x; Younes M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00155; Young LE, 2005, J APPL PHYSIOL, V99, P1278, DOI 10.1152/japplphysiol.01319.2004	55	1	1	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0259933	10.1371/journal.pone.0259933	http://dx.doi.org/10.1371/journal.pone.0259933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882704	Green Published, gold			2022-12-26	WOS:000755037200015
J	Ali, BM; Ang, F; van der Fels-Klerx, HJ				Ali, Beshir M.; Ang, Frederic; van der Fels-Klerx, H. J.			Consumer willingness to pay for plant-based foods produced using microbial applications to replace synthetic chemical inputs	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; LATENT ATTITUDES; CHOICE MODELS; MOTIVES; QUALITY; PREFERENCES; FLAVONOIDS; INDICATORS; SCALE	Analysis of consumer preferences and willingness-to-pay (WTP) for sustainable foods produced using new agri-food technologies is required to enhance the uptake of innovations that accelerate the transition towards sustainable food systems. Consumers' willingness to buy new food products, with no or limited consumption experience, mainly depends on their food choice motivational orientations (promotion- vs prevention-orientation). The objective of this study was to elicit consumers' WTP for foods that are produced with microbial applications during the plant production phase with the aim to reduce the use of synthetic chemicals in crop farming, as well as to understand the associations of food choice motives, personal and socio-demographic factors with the WTP. We used contingent valuation to elicit consumers' WTP for three food products (wheat bread, consumer potatoes and tomato sauce) through online surveys. Data were collected from 291 consumers, primarily from Italy, Germany and the Netherlands. Descriptive statistics, latent variable modelling and logistic regression were used to analysis data. Results show that more than two-third of the respondents are willing to pay premiums of at least 0.11 euro per kg of food products for reductions in synthetic chemical use by at least 50% due to microbial applications. The amount of WTP increases with the level of reductions in synthetic chemical use. The majority of the respondents are promotion-oriented consumers in relation to their food involvement, and are more likely to pay premiums for the sustainably produced food products. Environmentally concerned consumers are also more likely to pay premiums, whereas health concerned consumers are not. This study contributes to understanding of consumers' attitude and perceived health risks towards foods obtained using microbial applications, and the heterogeneity of their preferences. Results provide insights for identifying potential buyers of foods produced using microbial applications, and to set prices according to the levels of consumers' WTP.	[Ali, Beshir M.; Ang, Frederic; van der Fels-Klerx, H. J.] Wageningen Univ Res, Business Econ Grp, Wageningen, Netherlands; [Ali, Beshir M.] Univ Wollongong Dubai, Fac Business, Knowledge Pk, Dubai, U Arab Emirates	Wageningen University & Research; University of Wollongong	Ali, BM (corresponding author), Wageningen Univ Res, Business Econ Grp, Wageningen, Netherlands.; Ali, BM (corresponding author), Univ Wollongong Dubai, Fac Business, Knowledge Pk, Dubai, U Arab Emirates.	beshirali@uowdubai.ac.ae	Ali, Beshir/AAA-3490-2022	Ang, Frederic/0000-0002-2323-7081; Ali, Beshir M./0000-0002-5865-8468	European Union's Horizon 2020 Research and Innovation Programme [818431]	European Union's Horizon 2020 Research and Innovation Programme	H.J. and F.A. acquired the funding that resulted in this manuscript. This research was funded by the European Union's Horizon 2020 Research and Innovation Programme under Grant agreement No. 818431 (SIMBA, Sustainable Innovation of Microbiome Applications in Food System). This output reflects only the authors' view and the Research Executive Agency (REA) cannot be held responsible for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02992; Alemu MH, 2019, J AGR ECON, V70, P241, DOI 10.1111/1477-9552.12285; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Ashok K, 2002, J MARKETING RES, V39, P31, DOI 10.1509/jmkr.39.1.31.18937; Bagozzi RP, 2012, J ACAD MARKET SCI, V40, P8, DOI 10.1007/s11747-011-0278-x; Baker GA, 1999, J AGR RESOUR ECON, V24, P80; Bechthold A, 2019, CRIT REV FOOD SCI, V59, P1071, DOI 10.1080/10408398.2017.1392288; Ben-Akiva M., 2002, PERPETUAL MOTION TRA, DOI [10.1016/B978-008044044-6/50022-X, DOI 10.1016/B978-008044044-6/50022-X]; Benavente-Garcia O, 2007, CURR CANCER DRUG TAR, V7, P795; Berg G, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix050; Bernard JC, 2010, J AGR RESOUR ECON, V35, P457; Blum WEH, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090287; Blumenschein K, 1998, SOUTHERN ECON J, V65, P169, DOI 10.2307/1061360; Boobis AR, 2008, TOXICOL LETT, V180, P137, DOI 10.1016/j.toxlet.2008.06.004; Buzby JC., 1995, J AGRIC APPL ECON, V27; Buzby JC., 1998, J AGRIC APPL ECON, V30; Cranfield JA., 2003, INT FOOD AGRIBUS MAN, V6; D'Hondt K, 2021, NAT MICROBIOL, V6, P138, DOI 10.1038/s41564-020-00857-w; Daly A, 2012, TRANSPORTATION, V39, P267, DOI 10.1007/s11116-011-9351-z; de Boer J, 2007, FOOD QUAL PREFER, V18, P985, DOI 10.1016/j.foodqual.2007.04.002; de Boer J, 2013, FOOD QUAL PREFER, V28, P32, DOI 10.1016/j.foodqual.2012.07.008; Diamantopoulos A, 2001, J MARKETING RES, V38, P269, DOI 10.1509/jmkr.38.2.269.18845; Eertmans A, 2005, FOOD QUAL PREFER, V16, P714, DOI 10.1016/j.foodqual.2005.04.007; European Commission, 2020, SPEC EUR, DOI [10.2762/621294, DOI 10.2762/621294]; European Commission, 2020, FACTSH FARM FORK OUR; Evans D., 2012, COLLEGIUM, V12, P113; FAO Food and Agriculture Organization, 2018, FEED PEOPL PROT PLAN; FAO Food and Agriculture Organization, AQUASTAT DAT FAOS GL, P2021; Florax RJGM, 2005, EUR REV AGRIC ECON, V32, P441, DOI 10.1093/erae/jbi025; Hamilton D, 2004, PESTICIDE RESIDUES F; Hamouz K, 1999, ROST VYROBA, V45, P293; Hess S, 2013, J CHOICE MODEL, V7, P1, DOI 10.1016/j.jocm.2013.03.005; Hess S, 2012, ENVIRON RESOUR ECON, V52, P109, DOI 10.1007/s10640-011-9522-6; Alarcon-Flores MI, 2014, FOOD ANAL METHOD, V7, P2095, DOI 10.1007/s12161-014-9852-4; Jimenez-Gomez A, 2017, AIMS MICROBIOL, V3, P483, DOI 10.3934/microbiol.2017.3.483; Katt F., 2020, TRENDS FOOD SCI TECH; Khalid M, 2017, BOT STUD, V58, DOI 10.1186/s40529-016-0160-8; Khan MS, 2009, ENVIRON CHEM LETT, V7, P1, DOI 10.1007/s10311-008-0155-0; Kim J, 2014, TRANSPORT RES A-POL, V69, P71, DOI 10.1016/j.tra.2014.08.016; Maher J., 2020, SUSTAINABLE MICROBES; McFadden D., 1986, MARKET SCI, V5, p275?297, DOI [10.1287/mksc.5.4.275, DOI 10.1287/MKSC.5.4.275]; Meixner O, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12187270; Menendez E, 2017, AIMS MICROBIOL, V3, P502, DOI 10.3934/microbiol.2017.3.502; Mitchell AE, 2007, J AGR FOOD CHEM, V55, P6154, DOI 10.1021/jf070344+; Prescott J, 2002, FOOD QUAL PREFER, V13, P489, DOI 10.1016/S0950-3293(02)00010-1; Reipurth MFS, 2019, FOOD QUAL PREFER, V73, P288, DOI 10.1016/j.foodqual.2018.10.012; Rodriguez-Morato J, 2015, MOLECULES, V20, P4655, DOI 10.3390/molecules20034655; Royne MB, 2011, J CONSUM AFF, V45, P329, DOI 10.1111/j.1745-6606.2011.01205.x; Shukla P.R., 2019, IPCC SPECIAL REPORT; Siegrist M, 2020, NAT FOOD, V1, P343, DOI 10.1038/s43016-020-0094-x; Singh BK, 2020, NAT REV MICROBIOL, V18, P601, DOI 10.1038/s41579-020-00446-y; Singh BK, 2017, MICROB BIOTECHNOL, V10, P50, DOI 10.1111/1751-7915.12592; Sok J, 2018, J AGR ECON, V69, P537, DOI 10.1111/1477-9552.12249; Springmann M, 2018, NATURE, V562, P519, DOI 10.1038/s41586-018-0594-0; STEPTOE A, 1995, APPETITE, V25, P267, DOI 10.1006/appe.1995.0061; Tobi RCA, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11236575; Woo SL, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01801; Wu X, 2020, J AGR ECON, V71, P184, DOI 10.1111/1477-9552.12327; Yu XH, 2014, FOOD POLICY, V45, P80, DOI 10.1016/j.foodpol.2014.01.003; Zizzo DJ., 2021, EXP ECON, V29, P1	60	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260488	10.1371/journal.pone.0260488	http://dx.doi.org/10.1371/journal.pone.0260488			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874958	Green Published, gold			2022-12-26	WOS:000753617500027
J	Ekechukwu, END; Useh, E; Nna, OL; Ekechukwu, NI; Obi, ON; Aguwa, EN; Arinze-Onyia, SU; Abaraogu, UO; Utti, VA				Ekechukwu, Echezona Nelson Dominic; Useh, Erobogha; Nna, Obumneme Linky; Ekechukwu, Nmachukwu Ifeoma; Obi, Ogbonna Nnajiobi; Aguwa, Emmanuel Nwabueze; Arinze-Onyia, Sussan Uzoamaka; Abaraogu, Ukachukwu Okaroafor; Utti, Victor Adimabua			Ergonomic assessment of work-related musculoskeletal disorder and its determinants among commercial mini bus drivers and driver assistants (mini bus conductors) in Nigeria	PLOS ONE			English	Article							LOW-BACK-PAIN; RISK-FACTORS; PREVALENCE; VIBRATION	Introduction Work-related musculoskeletal disorder (WMSD) is a leading causes of occupational injury and disability among drivers and workers in the transport industry. This study evaluated the ergonomically assessed WMSD and its determinants among Nigerian commercial mini bus drivers (BD) and mini bus conductors (BC) Method A total of 379 participants (BD = 200, BC = 179) were purposively sampled for this exploratory cross-sectional study. Participants' WMSD and work related variables were respectively assessed using the standardized Nordic questionnaire and a content-validated, Driving Work Station Assessment (DWSA) form. Data were analyzed descriptively and inferentially using chi-square and logistic regression. The level of significance was set at alpha = 0.05. Results The participants were aged between 20 and 66 years, with a mean age of 33.2610.76years (BD = 38.42 +/- 10.22years, BC = 27.50 +/- 8.13years); most of whom consumed alcohol (84.4%) and experienced severe job stress (73.4%). There was a high prevalence (95.8%; BD = 94.5%, BC = 97.8%) of WMSDs, the lower back (66.8%) and upper back (54.1%) had the highest regional prevalence of WMSD. The BC (BC vs BD) had significantly (p<0.05) higher prevalence of Neck (47.7% vs 21.5%) and upper back (80.4% vs 30.5%) WMSDs. Conversely, the BD (BD vs BC) had significantly (p<0.05) higher prevalence of low-back (85.0% vs 46.4%), knee (25.0% vs 9.5%), elbow (11.5% vs 3.9%), and wrist (10.5% vs 3.4%) WMSD. There was a significant association between WMSD and each of work duration (X-2 = 11.634, p = 0.009), work frequency (X-2 = 8.394, p = 0.039), job dissatisfaction (X2 = 10.620, p = 0.001) and job stress (X-2 = 16.879, p = 0.001). Working beyond 4days/week (OR = 10.019, p = 0.001), job dissatisfaction (OR = 1.990, p = 0.031), constrained working postures (OR = 5.324, p = 0.003) and fatigue (OR = 4.719, p = 0.002) were the predictors of WMSD. Conclusion Job stress, work duration and work frequency, posture and fatigue are important determinants of WMSDs among mini bus drivers and their assistants in Nigeria. Ergonomics training intervention for this population is recommended.	[Ekechukwu, Echezona Nelson Dominic; Useh, Erobogha; Nna, Obumneme Linky; Abaraogu, Ukachukwu Okaroafor] Univ Nigeria, Fac Hlth Sci & Technol, Dept Rehabil Med, Coll Med, Enugu, Nigeria; [Ekechukwu, Echezona Nelson Dominic; Ekechukwu, Nmachukwu Ifeoma] LANCET Physiotherapy Wellness & Res Ctr, Enugu, Nigeria; [Ekechukwu, Echezona Nelson Dominic; Aguwa, Emmanuel Nwabueze] Univ Nigeria, Inst Publ Hlth, Coll Med, Environm & Occupat Hlth Unit, Enugu, Nigeria; [Obi, Ogbonna Nnajiobi] Univ Port, Dept Physiotherapy, Harcourt Teaching Hosp, Port Harcourt, Nigeria; [Aguwa, Emmanuel Nwabueze] Univ Nigeria, Dept Community Med, Coll Med, Fac Med Sci, Enugu, Nigeria; [Arinze-Onyia, Sussan Uzoamaka] Enugu State Univ, Dept Community Med, Coll Med, Parklane, Enugu, Nigeria; [Abaraogu, Ukachukwu Okaroafor] Glasgow Caledonian Univ, Physiotherapy Dept, Glasgow, Lanark, Scotland; [Utti, Victor Adimabua] Univ Essex, Sch Sport Rehabil & Exercise Sci, Colchester, Essex, England	University of Nigeria; University of Nigeria; University of Nigeria; Glasgow Caledonian University; University of Essex	Ekechukwu, END (corresponding author), Univ Nigeria, Fac Hlth Sci & Technol, Dept Rehabil Med, Coll Med, Enugu, Nigeria.; Ekechukwu, END (corresponding author), LANCET Physiotherapy Wellness & Res Ctr, Enugu, Nigeria.; Ekechukwu, END (corresponding author), Univ Nigeria, Inst Publ Hlth, Coll Med, Environm & Occupat Hlth Unit, Enugu, Nigeria.	nelson.ekechukwu@unn.edu.ng		Obi, Ogbonna/0000-0002-2071-6319; Abaraogu, Ukachukwu/0000-0002-1967-1459; Ekechukwu, Echezona/0000-0002-0494-2869				Abdulkhaleq LA, 2018, VET WORLD, V11, P627, DOI 10.14202/vetworld.2018.627-635; Aini N.A., 2015, INT J PUB HLTH CLIN, V2, P34; Akinpelu A. O., 2011, African Journal of Biomedical Research, V14, P89; Borle A., 2012, MUSCULOSKELETAL MORB, V3, P29; Bovenzi M, 2006, J SOUND VIB, V298, P514, DOI 10.1016/j.jsv.2006.06.001; Campo M, 2008, PHYS THER, V88, P608, DOI 10.2522/ptj.20070127; Chen JC, 2005, OCCUP MED-OXFORD, V55, P535, DOI 10.1093/occmed/kqi125; Chmiel N., 2017, INTRO WORK ORG PSYCH; Ekechukwu Echezona Nelson Dominic, 2019, Proceedings of the 20th Congress of the International Ergonomics Association (IEA 2018). Volume III: Musculoskeletal Disorders. Advances in Intelligent Systems and Computing (AISC 820), P765, DOI 10.1007/978-3-319-96083-8_92; Ezeukwu AO., 2015, J HEAL SCI, V2015, P18; Gangopadhyay S, 2012, INT J OCCUP SAF ERGO, V18, P521, DOI 10.1080/10803548.2012.11076957; Guire R, 2017, COMP EXERC PHYSIOL, V13, P7, DOI 10.3920/CEP160026; Guo HR, 2004, J OCCUP HEALTH, V46, P26, DOI 10.1539/joh.46.26; IJzelenberg W, 2004, SCAND J WORK ENV HEA, V30, P56, DOI 10.5271/sjweh.765; Karmeniemi P., 2015, ERGON OPEN J, V8, P57; Kim MG, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-9; Krause N, 1998, SPINE, V23, P2507, DOI 10.1097/00007632-199812010-00005; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Leroux I, 2005, INT ARCH OCC ENV HEA, V78, P379, DOI 10.1007/s00420-004-0578-2; Lin MY, 2017, APPL ERGON, V65, P382, DOI 10.1016/j.apergo.2017.04.006; Lurie RC, 2018, APPL ERGON, V67, P246, DOI 10.1016/j.apergo.2017.10.007; Madhan Chandran SY., 2015, J ERGON, Vs3; Mozafari Abolfazl, 2015, Acta Med Iran, V53, P432; Naidoo S, 2009, AM J IND MED, V52, P202, DOI 10.1002/ajim.20662; Odole A., 2019, MUSCULOSKEL SCI PRAC, P39, DOI [10.1016/j.msksp.2018.11.007, DOI 10.1016/J.MSKSP.2018.11.007]; OHLSSON K, 1994, ERGONOMICS, V37, P891, DOI 10.1080/00140139408963698; Okunribido OO, 2008, ERGONOMICS, V51, P308, DOI 10.1080/00140130701637262; Oluka CD, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-03615-5; Onawumi AS., 2012, IJRRAS, V11, P1; Punnett L, 2004, J ELECTROMYOGR KINES, V14, P13, DOI 10.1016/j.jelekin.2003.09.015; Rugbeer N, 2016, SA J. Sports Med., V28, P55, DOI [10.17159/2078-516x/2016/v28i2a1109, 10.17159/2078-516X/2016/v28i2a1577]; Sekkay F, 2018, APPL ERGON, V72, P69, DOI 10.1016/j.apergo.2018.05.005; Szeto GPY, 2007, J OCCUP REHABIL, V17, P181, DOI 10.1007/s10926-007-9070-7; Tamrin SBM, 2014, HUM FACTOR ERGON MAN, V24, P369, DOI 10.1002/hfm.20387; Thomas J. R., 2015, RES METHODS PHYS ACT, V7th; Wallin AO, 2015, J NURS MANAGE, V23, P368, DOI 10.1111/jonm.12145	36	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260211	10.1371/journal.pone.0260211	http://dx.doi.org/10.1371/journal.pone.0260211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YW7TO	34874951	Green Published, gold			2022-12-26	WOS:000753617500017
J	Jaouimaa, FZ; Dempsey, D; Van Osch, S; Kinsella, S; Burke, K; Wyse, J; Sweeney, J				Jaouimaa, Fatima-Zahra; Dempsey, Daniel; Van Osch, Suzanne; Kinsella, Stephen; Burke, Kevin; Wyse, Jason; Sweeney, James			An age-structured SEIR model for COVID-19 incidence in Dublin, Ireland with framework for evaluating health intervention cost	PLOS ONE			English	Article								Strategies adopted globally to mitigate the threat of COVID-19 have primarily involved lockdown measures with substantial economic and social costs with varying degrees of success. Morbidity patterns of COVID-19 variants have a strong association with age, while restrictive lockdown measures have association with negative mental health outcomes in some age groups. Reduced economic prospects may also afflict some age cohorts more than others. Motivated by this, we propose a model to describe COVID-19 community spread incorporating the role of age-specific social interactions. Through a flexible parameterisation of an age-structured deterministic Susceptible Exposed Infectious Removed (SEIR) model, we provide a means for characterising different forms of lockdown which may impact specific age groups differently. Social interactions are represented through age group to age group contact matrices, which can be trained using available data and are thus locally adapted. This framework is easy to interpret and suitable for describing counterfactual scenarios, which could assist policy makers with regard to minimising morbidity balanced with the costs of prospective suppression strategies. Our work originates from an Irish context and we use disease monitoring data from February 29th 2020 to January 31st 2021 gathered by Irish governmental agencies. We demonstrate how Irish lockdown scenarios can be constructed using the proposed model formulation and show results of retrospective fitting to incidence rates and forward planning with relevant "what if / instead of" lockdown counterfactuals. Uncertainty quantification for the predictive approaches is described. Our formulation is agnostic to a specific locale, in that lockdown strategies in other regions can be straightforwardly encoded using this model.	[Burke, Kevin; Sweeney, James] Univ Limerick, Dept Math & Stat, Limerick, Ireland; [Dempsey, Daniel; Wyse, Jason] Trinity Coll Dublin, Sch Comp Sci & Stat, Dublin, Ireland; [Van Osch, Suzanne; Kinsella, Stephen] Univ Limerick, Kemmy Business Sch, Limerick, Ireland	University of Limerick; Trinity College Dublin; University of Limerick	Sweeney, J (corresponding author), Univ Limerick, Dept Math & Stat, Limerick, Ireland.	james.a.sweeney@ul.ie	Kinsella, Stephen/ABH-3066-2020	Kinsella, Stephen/0000-0002-7943-4797; Burke, Kevin/0000-0001-8724-809X; Sweeney, James/0000-0002-5649-3233	Science Foundation Ireland (SFI) [20/COV/0166]; COVID-19 Rapid Response Research and Innovation Funding Call	Science Foundation Ireland (SFI)(Science Foundation Ireland); COVID-19 Rapid Response Research and Innovation Funding Call	This research project was funded by Science Foundation Ireland (SFI) grant number 20/COV/0166 under the COVID-19 Rapid Response Research and Innovation Funding Call.	Beirne K., 2020, POTENTIAL COSTS DIST; Box G.E., 1987, EMPIRICAL MODEL BUIL, VVolume 424; Brauner JM, 2021, SCIENCE, V371, P802, DOI 10.1126/science.abd9338; Brodeur A, 2021, J ECON SURV, V35, P1007, DOI 10.1111/joes.12423; Byrne AW, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039856; Canabarro A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236310; Chang W, 2021, SHINY WEB APPL FRAME; Chowell Gerardo, 2017, Infect Dis Model, V2, P379, DOI 10.1016/j.idm.2017.08.001; Coyle Diane, 2015, GDP BRIEF AFFECTIONA; Cuevas-Maraver J, 2021, MATH BIOSCI, V336, DOI 10.1016/j.mbs.2021.108590; Darmody M, 2020, ESRI SURVEY STAT REP, DOI [10.26504/sustat94, DOI 10.26504/SUSTAT94]; Devereux MP, 2020, OXFORD REV ECON POL, V36, pS225, DOI 10.1093/oxrep/graa019; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Eichenbaum M.S., 2020, 26882 NBER, DOI [10.3386/w26882, DOI 10.3386/W26882]; Evoy DM., 2020, RELATIVE INFECTIOUSN, V07, P2020; Fitzgerald J., 2020, CHALLENGES GLOBALIZA; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Griffin J, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040263; Grimm V, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83540-2; HPSC, 2020, EP COVID 19 IR DAIL; IEMAG, 2020, POP LEV SEIR MOD COV; Kaplan G., 2020, GREAT LOCKDOWN BIG S; Kimathi M, 2021, INFECT DIS MODEL, V6, P15, DOI 10.1016/j.idm.2020.10.012; Kwong ASF, 2021, BRIT J PSYCHIAT, V218, P334, DOI 10.1192/bjp.2020.242; Lee T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249262; Li B., 2021, EPIDEMIOLOGY, DOI [10.1101/2021.07.07.21260122v2, DOI 10.1101/2021.07.07.21260122, 10.1101/2021.07.07.21260122]; McAloon C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039652; Moore S, 2021, LANCET INFECT DIS, V21, P793, DOI 10.1016/S1473-3099(21)00143-2; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Naraigh LO, 2020, MATH BIOSCI, V330, DOI 10.1016/j.mbs.2020.108496; Nash JC, 2011, J STAT SOFTW, V43, P1; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nishiura H., 2009, MATH STAT ESTIMATION, P103, DOI [DOI 10.1007/978-90-481-2313-1_5, 10.1007/978-90-481-2313-1_5]; PAWITAN Y., 2001, ALL LIKELIHOOD; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Prem K, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005697; R Core Team, 2021, R LANGUAGE ENV STAT; Sievert C, 2020, PLOTLY CREATE INTERA; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Taylor L, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n879; Teimouri A., 2020, SEIR MODEL CONTACT T, V07, P2020; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woloszko N, 2020, OECD EC DEP WORKING, V1634, DOI [10.1787/6b9c7518-en, DOI 10.1787/6B9C7518-EN]	44	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260632	10.1371/journal.pone.0260632	http://dx.doi.org/10.1371/journal.pone.0260632			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874981	Green Published, Green Submitted, gold			2022-12-26	WOS:000753617500033
J	Dato, KMG; Degbegni, MR; Atchade, MN; Tachin, MZ; Hounkonnou, MN; Omondi, BA				Dato, Keladome Maturin Geoffroy; Degbegni, Mahougnon Robinson; Atchade, Mintode Nicodeme; Tachin, Martine Zandjanakou; Hounkonnou, Mahouton Norbert; Omondi, Bonaventure Aman			Spatial parameters associated with the risk of banana bunchy top disease in smallholder systems	PLOS ONE			English	Article							VIRUS; ERA	The Banana Bunchy Top Disease (BBTD), caused by the Banana Bunchy Top Virus (BBTV) is the most important and devastating in many tropical countries. BBTD epidemiology has been little studied, mixed landscape smallholder systems. The relative risks associated with this disease vary between geographical areas and landscapes. This work analyzed the management and vegetation conditions in smallholder gardens to assess the factors linked to landscape-level BBTV transmission and management. Mapping was done in this study area which is in a BBTD-endemic region, involving farmers actively managing the disease, but with household-level decision making. A spatial scanning statistic was used to detect and identify spatial groups at the 5% significance threshold, and a Poisson regression model was used to explore propagation vectors and the effect of surrounding vegetation and crop diversity. Spatial groups with high relative risk were identified in three communities, Dangbo, Houeyogbe, and Adjarra. Significant associations emerged between the BBTD prevalence and some crop diversity, seed systems, and BBTD management linked factors. The identified factors form important candidate management options for the detailed assessment of landscape-scale BBTD management in smallholder communities.	[Dato, Keladome Maturin Geoffroy; Degbegni, Mahougnon Robinson; Atchade, Mintode Nicodeme; Hounkonnou, Mahouton Norbert] Univ Abomey Calavi, Int Chair Math Phys & Applicat ICMPA UNESCO CHAIR, Cotonou, Benin; [Atchade, Mintode Nicodeme] Natl Univ Sci Technol Engn & Math, Natl Higher Sch Math Genius & Modelizat, Abomey, Benin; [Tachin, Martine Zandjanakou] Natl Univ Agr, Doctorate Sch Agr & Water Sci, Ketou, Benin; [Omondi, Bonaventure Aman] Biovers Int Alliance Biovers Int & CIAT, Cotonou, Benin	University of Abomey Calavi	Dato, KMG (corresponding author), Univ Abomey Calavi, Int Chair Math Phys & Applicat ICMPA UNESCO CHAIR, Cotonou, Benin.	dageomark2@yahoo.fr	DATO, Kéladomé Maturin Géoffroy/AGJ-4291-2022; Atchade, Nicodème Mintodè/I-8053-2016	DATO, Kéladomé Maturin Géoffroy/0000-0003-2865-2900; Atchade, Nicodème Mintodè/0000-0002-5507-6251	Bill & Melinda Gates Foundation [INV-010652]; University of Queensland [1229]; Consortium Research Programme on Root Tubers and Bananas, BA 3.4, Banana Viral Diseases	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); University of Queensland(University of Queensland); Consortium Research Programme on Root Tubers and Bananas, BA 3.4, Banana Viral Diseases	This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [BBTV mitigation: Community management in Nigeria, and screening wild banana progenitors for resistance. Project: INV-010652 (formerly OPP1130226)]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. We also have this work was funded by the University of Queensland Grant to Bioversity International under the project: BBTV mitigation: Community management in Nigeria and screening wild banana progenitors for resistance - Remote Mapping and Detection of Banana Canopy in Mixed Landscapes (Number 1229). Community Management of BBTD was funded by the Consortium Research Programme on Root Tubers and Bananas, BA 3.4, Banana Viral Diseases. We are grateful to RTB and her donor consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RO, 2013, PLANT DIS, V97, P290, DOI 10.1094/PDIS-08-12-0745-PDN; Ajambo S, 2018, ACTA HORTIC, V1196, P219, DOI 10.17660/ActaHortic.2018.1196.27; Allen R. N., 1977, SPREAD BUNCHY TOP DI, P27; ALLEN RN, 1987, AUST J AGR RES, V38, P373, DOI 10.1071/AR9870373; ALLEN RN, 1978, AUST J AGR RES, V29, P1223, DOI 10.1071/AR9781223; Baudouin J.P., 2002, AMELIORATION PLANTES; Blomme G, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01290; Chabi MC, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-018-0280-1; Chen S., 2016, RECENT PAT ENG, V10, P160, DOI [10.2174/1872212110666160712230039, DOI 10.2174/1872212110666160712230039]; Chen Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45045-x; Chesneau C, 2015, COURSES LIGNE; DALE JL, 1987, ADV VIRUS RES, V33, P301, DOI 10.1016/S0065-3527(08)60321-8; Dhed'a Djailo B., 2019, CULTURE BANANIERS PL, V72; DWASS M, 1957, ANN MATH STAT, V28, P181, DOI 10.1214/aoms/1177707045; FAO, 2018, PREV GEST MAL BUNCH; FAOSTAT, 2019, DONN PROD BAN; Guttmann A., 2014, EVALUATION METHODES; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jacobsen K, 2019, PLANT PATHOL, V68, P207, DOI 10.1111/ppa.12958; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M., 2010, INFORM MANAGEMENT SE; Lassoudiere A, 2007, BANANIER SA CULTURE; Lepoint P., 2014, ATELIER PLANIFICATIO; Lillesand T., 2015, REMOTE SENSING IMAGE; Lokossou B., 2012, New Disease Reports, V25, P13, DOI 10.5197/j.2044-0588.2012.025.013; Messina G, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12091491; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; Mulugo L, 2020, AFR J SCI TECHNOL IN, V12, P453, DOI 10.1080/20421338.2019.1634900; Omondi BA, 2020, PLANT PATHOL, V69, P1754, DOI 10.1111/ppa.13253; Pajares G, 2015, PHOTOGRAMM ENG REM S, V81, P281, DOI 10.14358/PERS.81.4.281; Rybicki EP, 2015, ARCH VIROL, V160, P17, DOI 10.1007/s00705-014-2295-9; Rybicki EP, 1999, ADV VIRUS RES, V53, P127, DOI 10.1016/S0065-3527(08)60346-2; Selvaraj MG, 2020, ISPRS J PHOTOGRAMM, V169, P110, DOI 10.1016/j.isprsjprs.2020.08.025; Simbare A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12187467; Stainton D, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev009; Tsouros DC, 2019, INFORMATION, V10, DOI 10.3390/info10110349; Varghese Abhishek, 2020, PLoS Comput Biol, V16, pe1007878, DOI 10.1371/journal.pcbi.1007878; Viljoen A, 2017, BANANA DIS PESTS FIE; Zhang CH, 2012, PRECIS AGRIC, V13, P693, DOI 10.1007/s11119-012-9274-5	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0260976	10.1371/journal.pone.0260976	http://dx.doi.org/10.1371/journal.pone.0260976			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY3JJ	34860836	gold, Green Published			2022-12-26	WOS:000754686900018
J	Beketie, ED; Kahsay, HB; Nigussie, FG; Tafese, WT				Beketie, Eskedar Demissie; Kahsay, HaileMariam Berhe; Nigussie, Fiseha Girma; Tafese, Wubishet Tesfaye			Magnitude and associated factors of antenatal depression among mothers attending antenatal care in Arba Minch town, Ethiopia, 2018	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; COMMON MENTAL-DISORDERS; POSTNATAL-DEPRESSION; VALIDATION; SCALE; PREGNANCY; OUTCOMES	Background Depression is a common mental disorder. The burden of antenatal depression is higher in developing countries which is 20% as compared to developed ones 10% to 15%. In Ethiopia around one-fifth of pregnant mothers are depressed. Despite the severity of the problem, only a few studies have been done in Ethiopia, and there is no study done in Arba Minch on the problem. Objective To assess the magnitude and associated factors of antenatal depressive symptoms among pregnant women attending Public Health facilities in Arba Minch town Southern Nations and Nationalities Peoples Region, Ethiopia 2018. Methods Health Institution based, cross-sectional study design was used to assess the magnitude and associated factors of antenatal depression among 323 pregnant mothers who came for antenatal care follow-up in all public health facilities in Arba Minch town. The systematic random sampling technique was applied. Interviewer administered, pretested structured Questionnaire containing Edinburgh postpartum depression scale was utilized. EPI INFO was used to enter data and then the data were analyzed by logistic regression using SPSS. Variables with P-value less than 0.2 in the bivariate logistic regression were inserted in for multivariable analysis to see their independent effect and those with P-value less than 0.05 were used to determine the significant association between dependent and independent variables. Result The magnitude of antenatal depression was 35.4%. Variables that were significantly associated with antenatal depression on multivariate analysis were anxiety (AOR = 5.49, 95%CI: 2.56, 11.77), un-planned pregnancy (AOR = 2.71, 95%CI: 1.21, 6.07), and Primigravida (AOR = 2.96, 95%CI: 1.28, 6.8). Similarly, uneducated mothers and those who attend only elementary school had AOR 4.92, 95% CI 1.36,17.73 and AOR 4.04955CI 1.23, 13.39 respectively. Conclusion The magnitude of antenatal depression, intimate partner violence, and threatening life event in Arba Minch town was high. Anxiety, unplanned pregnancy, educational status, and Primigravida were significantly associated factors with depression. There should be a mechanism for routine screening and management of antenatal depression and intimate partner violence during antenatal care follow-up.	[Beketie, Eskedar Demissie; Tafese, Wubishet Tesfaye] Wolkite Univ, Coll Med & Hlth Sci, Dept Nursing, Wolkite, Ethiopia; [Kahsay, HaileMariam Berhe] Mekelle Univ, Coll Med & Hlth Sci, Sch Nursing, Mekelle, Ethiopia; [Nigussie, Fiseha Girma] Debrebirhan Univ, Coll Med & Hlth Sci, Dept Nursing, Debirebirhan, Ethiopia	Mekelle University	Beketie, ED (corresponding author), Wolkite Univ, Coll Med & Hlth Sci, Dept Nursing, Wolkite, Ethiopia.	eskedardemissie@gmail.com	Tafese, Wubishet Tesfaye/GQO-9275-2022	Tafese, Wubishet Tesfaye/0000-0003-1793-7361; Beketie, Eskedar/0000-0001-9235-1980				Adewuya AO, 2006, J PSYCHOSOM OBST GYN, V27, P267, DOI 10.1080/01674820600915478; Al-Azri Mohammed, 2016, Sultan Qaboos Univ Med J, V16, pe35, DOI 10.18295/squmj.2016.16.01.007; Alebel A, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0637-x; Ayele TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155125; Bindt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048396; Biratu A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0092-x; Bisetegn TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161108; Brittain K, 2015, PAEDIATR PERINAT EP, V29, P505, DOI 10.1111/ppe.12216; Dadi AF, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0792-y; Darkwa EO, 2017, INTEGR BLOOD PRESS C, V10, P9, DOI 10.2147/IBPC.S129106; Dibaba Y, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-135; Faisal-Cury A, 2012, REV BRAS PSIQUIATR, V34, P446, DOI 10.1016/j.rbp.2012.01.003; Fisher J., 2012, PREVALENCE DETERMINA; Gemta WA, 2015, ANN GLOB HEALTH, V81, DOI [10.1016/j.aogh.2015.01.004, DOI 10.1016/J.AOGH.2015.01.004]; Gerberding J.L., 2007, INTIMATE PARTNER VIO; Getinet Wondale, 2018, Depress Res Treat, V2018, P3649269, DOI 10.1155/2018/3649269; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; Hanlon C, 2008, J AFFECT DISORDERS, V108, P251, DOI 10.1016/j.jad.2007.10.023; Hartley M, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-9; Hay DF, 2010, CHILD DEV, V81, P149, DOI 10.1111/j.1467-8624.2009.01386.x; Hegde S.S., 2013, J PHARM BIOMED SCI, V30, P1011; Hoge EA, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7500; Jarde A, 2016, JAMA PSYCHIAT, V73, P826, DOI 10.1001/jamapsychiatry.2016.0934; Krauss Pereira Priscila, 2011, DEPRESSION PREGNANCY; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; Marcus M, 2012, WHO DEP MENTAL HLTH; Motrico E, 2013, J AFFECT DISORDERS, V150, P931, DOI 10.1016/j.jad.2013.05.017; NgoI TV., 2018, PLOS ONE, V13; Pearson RM, 2013, JAMA PSYCHIAT, V70, P1312, DOI 10.1001/jamapsychiatry.2013.2163; Rabin RF, 2009, AM J PREV MED, V36, P439, DOI 10.1016/j.amepre.2009.01.024; Reichenheim ME, 2004, J EPIDEMIOL COMMUN H, V58, P523, DOI 10.1136/jech.2003.011742; Reynolds CF, 2017, WORLD PSYCHIATRY, V16, P316, DOI 10.1002/wps.20459; Rubertsson C, 2011, NORD J PSYCHIAT, V65, P414, DOI 10.3109/08039488.2011.590606; Rwakarema M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0225-y; Sadock B.J., 2015, KAPLAN SADOCKS SYNOP, P509; Saeed A, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0184-7; Stewart RC, 2014, ARCH WOMEN MENT HLTH, V17, P145, DOI 10.1007/s00737-013-0387-2; Tesfaye M, 2010, J AFFECT DISORDERS, V122, P102, DOI 10.1016/j.jad.2009.06.020; Thompson Okechukwu, 2016, Depress Res Treat, V2016, P4518979, DOI 10.1155/2016/4518979; Trott CD, 2017, VIOLENCE AGAINST WOM, V23, P1016, DOI 10.1177/1077801216654018; van Heyningen T, 2016, J AFFECT DISORDERS, V203, P121, DOI 10.1016/j.jad.2016.05.052; Weiss Steve J, 2003, Violence Vict, V18, P131, DOI 10.1891/vivi.2003.18.2.131; World Health Organization, 2016, MAT MENT HLTH; Yusuff ASM, 2015, J MATERN-FETAL NEO M; Zeng YC, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0452-7; Zhong QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125096	46	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260691	10.1371/journal.pone.0260691	http://dx.doi.org/10.1371/journal.pone.0260691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855843	Green Published, gold			2022-12-26	WOS:000735299000094
J	Berent, I; Platt, M				Berent, Iris; Platt, Melanie			Public misconceptions about dyslexia: The role of intuitive psychology	PLOS ONE			English	Article							SEDUCTIVE ALLURE; BIOGENETIC EXPLANATIONS; NEUROSCIENCE INFORMATION; CHILDREN THINK; BRAIN IMAGES; MIND; JUDGMENTS; BODY; DIFFICULTIES; PERCEPTIONS	Despite advances in its scientific understanding, dyslexia is still associated with rampant public misconceptions. Here, we trace these misconceptions to the interaction between two intuitive psychological principles: Dualism and Essentialism. We hypothesize that people essentialize dyslexia symptoms that they anchor in the body. Experiment 1 shows that, when dyslexia is associated with visual confusions (b/d reversals)-symptoms that are naturally viewed as embodied (in the eyes), laypeople consider dyslexia as more severe, immutable, biological, and heritable, compared to when dyslexia is linked to difficulties with phonological decoding (a symptom seen as less strongly embodied). Experiments 2-3 show that the embodiment of symptoms plays a causal role in promoting essentialist thinking. Experiment 2 shows that, when participants are provided evidence that the symptoms of dyslexia are embodied (i.e., they "show up" in a brain scan), people are more likely to consider dyslexia as heritable compared to when the same symptoms are diagnosed behaviorally (without any explicit evidence for the body). Finally, Experiment 3 shows that reasoning about the severity of dyslexia symptoms can be modulated by manipulating people's attitudes about the mind/body links, generally. These results show how public attitudes towards psychological disorders arise from the very principles that make the mind tick.	[Berent, Iris; Platt, Melanie] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA	Northeastern University	Berent, I (corresponding author), Northeastern Univ, Dept Psychol, Boston, MA 02115 USA.	i.berent@northeastern.edu						Ahn W-k, 2017, OXFORD LIB PSYCHOL O, P603; Bennett Laura, 2008, J Genet Couns, V17, P550, DOI 10.1007/s10897-008-9178-8; Berent I., 2021, OXFORD STUDIES EXPT, V4; Berent I., 2020, BLIND STORYTELLER WE, DOI 10.1093/oso/9780190061920.001.0001; Berent I, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2108274118; Berent I, 2021, COGNITION, V213, DOI 10.1016/j.cognition.2021.104701; Berent I, 2021, COGNITIVE SCI, V45, DOI 10.1111/cogs.12970; Berent I, 2021, J EXP SOC PSYCHOL, V93, DOI 10.1016/j.jesp.2020.104100; Berent I, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.562666; Berent Iris, 2019, Open Mind (Camb), V3, P101, DOI 10.1162/opmi_a_00029; Berent I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044875; Bering JM, 2004, DEV PSYCHOL, V40, P217, DOI 10.1037/0012-1649.40.2.217; Bloom P, 2004, DESCARTESBABY SCI CH, Vxv; BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; Castillo A, 2018, ANN DYSLEXIA, V68, P203, DOI 10.1007/s11881-018-0163-0; Chalik L, 2017, DEV PSYCHOL, V53, P1178, DOI 10.1037/dev0000301; Chudek M, 2018, RELIG BRAIN BEHAV, V8, P354, DOI 10.1080/2153599X.2017.1377757; Cohen E, 2008, J COGN CULT, V8, P23, DOI 10.1163/156770908X289198; Cutting LE, 2013, BRAIN CONNECT, V3, P199, DOI 10.1089/brain.2012.0116; Deacon BJ, 2009, J SOC CLIN PSYCHOL, V28, P415, DOI 10.1521/jscp.2009.28.4.415; Dehaene S., 2009, READING BRAIN SCI EV; Fernandez-Duque D, 2015, J COGNITIVE NEUROSCI, V27, P926, DOI 10.1162/jocn_a_00750; Forstmann M, 2015, J EXP PSYCHOL GEN, V144, P222, DOI 10.1037/xge0000045; Forstmann M, 2012, PSYCHOL SCI, V23, P1239, DOI 10.1177/0956797612442392; Furnham A., 2013, PSYCHOLOGY, V4, P940, DOI [10.4236/psych.2013.412136, DOI 10.4236/PSYCH.2013.412136]; Gabay Y, 2020, J INT NEUROPSYCH SOC, V26, P407, DOI 10.1017/S135561771900122X; Galaburda AM, 2006, NAT NEUROSCI, V9, P1213, DOI 10.1038/nn1772; GELMAN SA, 1991, COGNITION, V38, P213, DOI 10.1016/0010-0277(91)90007-Q; Gelman SA., 2003, ESSENTIAL CHILD ORIG, Vx; Gibbs S, 2015, EUR J SPEC NEEDS EDU, V30, P323, DOI 10.1080/08856257.2015.1022999; Giofre D, 2019, DYSLEXIA, V25, P284, DOI 10.1002/dys.1629; Gottlieb S, 2018, PSYCHOL SCI, V29, P121, DOI 10.1177/0956797617722609; Haslam N, 2015, CURR DIR PSYCHOL SCI, V24, P399, DOI 10.1177/0963721415588082; Hirschfeld LA, 1997, COGNITIVE DEV, V12, P213, DOI 10.1016/S0885-2014(97)90014-9; Hood B, 2012, COGNITION, V125, P466, DOI 10.1016/j.cognition.2012.07.005; Hook CJ, 2013, J COGNITIVE NEUROSCI, V25, P1397, DOI 10.1162/jocn_a_00407; Hopkins EJ, 2016, COGNITION, V155, P67, DOI 10.1016/j.cognition.2016.06.011; Hulme C, 2016, CURR OPIN PEDIATR, V28, P731, DOI 10.1097/MOP.0000000000000411; Im SH, 2017, BRIT J EDUC PSYCHOL, V87, P518, DOI 10.1111/bjep.12162; Keil F. C., 1986, LANGUAGE LEARNING CO, P133; Kemp JJ, 2014, BEHAV RES THER, V56, P47, DOI 10.1016/j.brat.2014.02.009; Kim NS, 2016, J EXP PSYCHOL-APPL, V22, P39, DOI 10.1037/xap0000070; Kuhlmeier VA, 2004, COGNITION, V94, P95, DOI 10.1016/j.cognition.2004.02.007; Kvaale EP, 2013, SOC SCI MED, V96, P95, DOI 10.1016/j.socscimed.2013.07.017; Kvaale EP, 2013, CLIN PSYCHOL REV, V33, P782, DOI 10.1016/j.cpr.2013.06.002; Landi N, 2019, LANG LINGUIST COMPAS, V13, DOI 10.1111/lnc3.12349; Lebowitz MS, 2014, P NATL ACAD SCI USA, V111, P17786, DOI 10.1073/pnas.1414058111; Lebowitz MS, 2013, J CONSULT CLIN PSYCH, V81, P518, DOI 10.1037/a0031730; Loughman A, 2018, COGN RES, V3, DOI 10.1186/s41235-018-0136-1; Macdonald K, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01314; McCabe DP, 2008, COGNITION, V107, P343, DOI 10.1016/j.cognition.2007.07.017; MEDIN D, 1989, SIMILARITY AND ANALOGICAL REASONING, P179, DOI 10.1017/CBO9780511529863.009; Newman GE, 2008, CHILD DEV, V79, P1344, DOI 10.1111/j.1467-8624.2008.01192.x; Newman GE, 2019, MIND LANG, V34, P585, DOI 10.1111/mila.12226; Olson R., 1990, READING ITS DEV COMP, P261; Parfit DA., 1987, DIVIDED MINDS NATURE, P19; Peterson RL, 2012, LANCET, V379, P1997, DOI 10.1016/S0140-6736(12)60198-6; Racine E, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01850; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Rhodes RE, 2014, J EXP PSYCHOL LEARN, V40, P1432, DOI 10.1037/a0036844; Sandoboe G, 2021, COGN NEUROPSYCHOL, V38, P205, DOI 10.1080/02643294.2021.1976127; Schweitzer NJ, 2013, COGNITION, V129, P501, DOI 10.1016/j.cognition.2013.08.009; Setoh P, 2013, P NATL ACAD SCI USA, V110, P15937, DOI 10.1073/pnas.1314075110; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; Snowling MJ, 2012, INT J LANG COMM DIS, V47, P27, DOI 10.1111/j.1460-6984.2011.00081.x; Song S, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02904; SPRINGER K, 1991, CHILD DEV, V62, P767, DOI 10.2307/1131176; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Wang Jinjing Jenny, 2019, Open Mind (Camb), V3, P89, DOI 10.1162/opmi_a_00028; Washburn EK, 2014, DYSLEXIA, V20, P1, DOI 10.1002/dys.1459; Waxman S, 2007, DEV PSYCHOL, V43, P294, DOI 10.1037/0012-1649.43.2.294; Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20040; Weisberg DS, 2015, JUDGM DECIS MAK, V10, P429	73	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0259019	10.1371/journal.pone.0259019	http://dx.doi.org/10.1371/journal.pone.0259019			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855765	Green Published, gold			2022-12-26	WOS:000735299000011
J	Halawa, E; Ryad, L; El-Shenawy, NS; Al-Eisa, RA; El-Hak, HNG				Halawa, Ekramy; Ryad, Lamia; El-Shenawy, Nahla S.; Al-Eisa, Rasha A.; El-Hak, Heba N. Gad			Evaluation of acetamiprid and azoxystrobin residues and their hormonal disrupting effects on male rats using liquid chromatography-tandem mass spectrometry	PLOS ONE			English	Article							NEONICOTINOID INSECTICIDES; STEROID-HORMONES; MS/MS; SERUM; MILK; VALIDATION; EXTRACTION; ANDROGENS; ESTROGENS; TOXICITY	Endocrine-disrupting compounds as pesticides affect the hormonal balance, and this can result in several diseases. Therefore, the analysis of representative hormones with acetamiprid (AC) and azoxystrobin (AZ) was a good strategy for the investigation of the endocrine-disrupting activity of pesticides. Hence, a sensitive and rapid analytical method using liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed. The method was validated for the analysis of AC, AZ, estriol, estrone, progesterone, and testosterone in the serum, testis, and liver of rats. The correlation between the residues of pesticides and the disturbance of the endocrine system was evaluated. The different mass parameters, mobile phase types, analytical columns, injection volumes, and extraction solvents were compared to get the lowest limit of detection of the studied compounds. The detection limits of AC, AZ, estriol, estrone, progesterone, and testosterone were 0.05, 0.05, 1.0, 10, and 1.0 ng/ml, respectively. The method developed was applied to evaluate the changes in these hormones induced by the duration of exposure to AC and AZ in rat testis and serum. The hormones level in rat serum and testis had a significant decrease as they were oral gavage treated with different high concentrations of studied pesticides. Both pesticides were distributed in the body of rats by the multi-compartment model (liver, testis, and serum).	[Halawa, Ekramy; Ryad, Lamia] Agr Res Ctr, Cent Lab Residue Anal Pesticides & Heavy Met Food, Ismailia, Egypt; [El-Shenawy, Nahla S.; El-Hak, Heba N. Gad] Suez Canal Univ, Fac Sci, Zool Dept, Ismailia, Egypt; [Al-Eisa, Rasha A.] Taif Univ, Coll Sci, Biol Dept, At Taif, Saudi Arabia	Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Egyptian Knowledge Bank (EKB); Suez Canal University; Taif University	El-Shenawy, NS (corresponding author), Suez Canal Univ, Fac Sci, Zool Dept, Ismailia, Egypt.	elshenawy_nahla@hotmail.com	Gad EL-Hak, Heba Nageh/P-4451-2018; El-Shenawy, Nahla S./AAS-9714-2021	Gad EL-Hak, Heba Nageh/0000-0002-1967-6866; 				Barreiro R, 2015, FOODS, V4, P605, DOI 10.3390/foods4040605; Chang HS, 2009, J HAZARD MATER, V172, P1, DOI 10.1016/j.jhazmat.2009.06.135; Combarnous Y, 2019, TOXICS, V7, DOI 10.3390/toxics7010005; Combarnous Y, 2017, CR BIOL, V340, P406, DOI 10.1016/j.crvi.2017.07.009; Coppola L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093282; Domenech-Coca C, 2019, J CHROMATOGR B, V1108, P11, DOI 10.1016/j.jchromb.2019.01.002; Draskau MK, 2019, ENVIRON POLLUT, V255, DOI 10.1016/j.envpol.2019.113309; Eacker SM, 2008, MOL ENDOCRINOL, V22, P623, DOI 10.1210/me.2006-0534; European Commission (EC), 2004, SANCO13922001 EC; Evans TJ, 2018, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, 3RD EDITION, P273, DOI 10.1016/B978-0-12-811410-0.00017-9; French D, 2019, CLIN MASS SPECTROM, V11, P12, DOI 10.1016/j.clinms.2018.11.005; Gray LE, 2004, ILAR J, V45, P425, DOI 10.1093/ilar.45.4.425; Hammel YA, 2008, J CHROMATOGR A, V1177, P58, DOI 10.1016/j.chroma.2007.10.112; Harwood DT, 2009, CLIN CHIM ACTA, V409, P78, DOI 10.1016/j.cca.2009.09.003; Kamat A, 2002, TRENDS ENDOCRIN MET, V13, P122, DOI 10.1016/S1043-2760(02)00567-2; Keikotlhaile BM, 2010, FOOD CHEM TOXICOL, V48, P1, DOI 10.1016/j.fct.2009.10.031; Khalil SR, 2017, ENVIRON POLLUT, V223, P51, DOI 10.1016/j.envpol.2016.12.027; Kim KB, 2008, TOXICOL SCI, V101, P197, DOI 10.1093/toxsci/kfm277; Kong DY, 2017, BIOL REPROD, V96, P254, DOI [10.1093/biolre/iox007, 10.1095/biolreprod.116.139550]; Labadie P, 2006, CHEMOSPHERE, V64, P1274, DOI 10.1016/j.chemosphere.2005.12.065; Mario JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142172; Marta Z, 2016, J PHARMACEUT BIOMED, V129, P135, DOI 10.1016/j.jpba.2016.06.024; Martin-Pozo L., 2020, TALANTA, P208; Mosbah R, 2018, DRUG CHEM TOXICOL, V41, P206, DOI 10.1080/01480545.2017.1337127; Muller AK, 2020, ENVIRON POLLUT, V257, DOI 10.1016/j.envpol.2019.113636; Nauen R, 2005, ARCH INSECT BIOCHEM, V58, P200, DOI 10.1002/arch.20043; Novakova L, 2009, ANAL CHIM ACTA, V656, P8, DOI 10.1016/j.aca.2009.10.004; Pohanish, 2015, SITTIGS HDB PESTICID, P1; Pouech C, 2012, ANAL BIOANAL CHEM, V402, P2777, DOI 10.1007/s00216-012-5723-2; Ritskes-Hoitinga M, 2012, LABORATORY MOUSE, P567, DOI 10.1016/B978-0-12-382008-2.00024-6; Rodriguez EM, 2007, COMP BIOCHEM PHYS A, V146, P661, DOI 10.1016/j.cbpa.2006.04.030; Ronning HT, 2006, J CHROMATOGR A, V1118, P226, DOI 10.1016/j.chroma.2006.03.099; Shao B, 2005, ANAL CHIM ACTA, V548, P41, DOI 10.1016/j.aca.2005.06.003; Silveira RS, 2020, CHEMOSPHERE, V240, DOI 10.1016/j.chemosphere.2019.124951; Tochitani T, 2016, EXP TOXICOL PATHOL, V68, P125, DOI 10.1016/j.etp.2015.11.004; Tournier M, 2015, STEROIDS, V104, P252, DOI 10.1016/j.steroids.2015.10.011; Turk G, 2007, THERIOGENOLOGY, V67, P778, DOI 10.1016/j.theriogenology.2006.10.013; U.S. Environmental Protection Agency, 1997, US EPA PEST FACT SHE; U.S. Environmental Protection Agency, 1997, PEST FACT SHEET AZ; US Food and Drug Administration, 2015, AN PROC METH VAL DRU; Vial J, 1999, ANAL CHEM, V71, P2672, DOI 10.1021/ac981179n; Wang Y, 2019, TALANTA, V205, DOI 10.1016/j.talanta.2019.120144; WHO, 2002, GLOB ASS STAT OF THE; Williams M., 2013, DRUG DEVELOP RES, V74, P339, DOI DOI 10.1002/DDR.21085; Wittenberg JB, 2017, J AGR FOOD CHEM, V65, P7288, DOI 10.1021/acs.jafc.6b05263; Yamamuro T, 2014, J CHROMATOGR B, V969, P85, DOI 10.1016/j.jchromb.2014.06.008; Yang FW, 2019, FOOD CHEM TOXICOL, V133, DOI 10.1016/j.fct.2019.110759; Yeter O, 2014, J FORENSIC SCI, V59, P287, DOI 10.1111/1556-4029.12368; Yilmaz BO, 2018, CHEMOSPHERE, V212, P447, DOI 10.1016/j.chemosphere.2018.08.112; Zhang AG, 2000, J NEUROCHEM, V75, P1294, DOI 10.1046/j.1471-4159.2000.751294.x	50	0	0	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0259383	10.1371/journal.pone.0259383	http://dx.doi.org/10.1371/journal.pone.0259383			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855766	Green Published, gold			2022-12-26	WOS:000735299000015
J	Martin, C; Luteijn, M; Letton, W; Robertson, J; McDonald, S				Martin, Chris; Luteijn, Michiel; Letton, William; Robertson, Josephine; McDonald, Stuart			A model framework for projecting the prevalence and impact of Long-COVID in the UK	PLOS ONE			English	Article								The objective of this paper is to model lost Quality Adjusted Life Years (QALYs) from symptoms arising from COVID-19 disease in the UK population, including symptoms of 'long-COVID'. The scope includes QALYs lost to symptoms, but not deaths, due to acute COVID-19 and long-COVID. The prevalence of symptomatic COVID-19, encompassing acute symptoms and long-COVID symptoms, was modelled using a decay function. Permanent injury as a result of COVID-19 infection, was modelled as a fixed prevalence. Both parts were combined to calculate QALY loss due to COVID-19 symptoms. Assuming a 60% final attack rate for SARS-CoV-2 infection in the population, we modelled 299,730 QALYs lost within 1 year of infection (90% due to symptomatic COVID-19 and 10% permanent injury) and 557,764 QALYs lost within 10 years of infection (49% due to symptomatic COVID-19 and 51% due to permanent injury). The UK Government willingness-to-pay to avoid these QALY losses would be pound 17.9 billion and pound 32.2 billion, respectively. Additionally, 90,143 people were subject to permanent injury from COVID-19 (0.14% of the population). Given the ongoing development in information in this area, we present a model framework for calculating the health economic impacts of symptoms following SARS-CoV-2 infection. This model framework can aid in quantifying the adverse health impact of COVID-19, long-COVID and permanent injury following COVID-19 in society and assist the proactive management of risk posed to health. Further research is needed using standardised measures of patient reported outcomes relevant to long-COVID and applied at a population level.	[Martin, Chris] UCL Inst Hlth Informat, London, England; [Luteijn, Michiel] Hannover Re UK Life Branch, London, England; [Letton, William] Crystallise, Basildon, England; [Robertson, Josephine] Optum Int, London, England; [McDonald, Stuart] Lloyds Banking Grp, London, England	University of London; University College London; Lloyds Banking Group	Martin, C (corresponding author), UCL Inst Hlth Informat, London, England.	chris.martin@crystallise.com		Martin, Christopher/0000-0002-5914-8873; Luteijn, Michiel/0000-0002-9526-9015; Letton, William/0000-0002-6252-0963	Crystallise Ltd.	Crystallise Ltd.	This study was supported by Crystallise Ltd. in the form of salaries for CM and WL, Lloyds Banking Group in the form of a salary for SM, Hannover Re in the form of a salary for ML, and Optum International in the form of a salary for JR. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2694; Alwan NA, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3565; [Anonymous], 2020, COVID 19 RAP GUID MA; Arnold DT, 2021, THORAX, V76, P399, DOI 10.1136/thoraxjnl-2020-216086; Associated Press, 2021, ASS PRESS; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Basu A, 2021, VALUE HEALTH, V24, P632, DOI 10.1016/j.jval.2020.11.013; Briggs AH, 2021, HEALTH ECON, V30, P699, DOI 10.1002/hec.4208; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Fraser E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3001; GOV, 2020, UK COR COVID 19 UK; Halpin SJ, 2021, J MED VIROL, V93, P1013, DOI 10.1002/jmv.26368; Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; HM Treasury, 2020, GREEN BOOK CENTR GOV; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; ICNARC, 2020, ICNARC REP COVID 19; Janssen MF, 2019, EUR J HEALTH ECON, V20, P205, DOI 10.1007/s10198-018-0955-5; Kamdar BB, 2020, THORAX, V75, P17, DOI 10.1136/thoraxjnl-2019-213803; LEWIS G, 1992, J EPIDEMIOL COMMUN H, V46, P92, DOI 10.1136/jech.46.2.92; LITTLEJOHNS P, 1989, BMJ-BRIT MED J, V298, P1556, DOI 10.1136/bmj.298.6687.1556; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Marti J, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0178-8; Martin C, 2021, BMC MED INFORM DECIS, V21, DOI 10.1186/s12911-021-01504-y; Office for National Statistics, 2021, CORONAVIRUS COVID 19; Office of National Statistics, 2020, PREVALENCE LONG COVI; Ophuis RH, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1890-9; Ramasamy MN, 2020, LANCET, V396, P1979, DOI 10.1016/S0140-6736(20)32466-1; Sudre CH, 2020, ATTRIBUTES PREDICTOR, DOI [10.1101/2020.10.19.20214494, DOI 10.1101/2020.10.19.20214494, 10.19.20214494]; Zala D, 2020, VALUE HEALTH, V23, P1432, DOI 10.1016/j.jval.2020.07.001; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260843	10.1371/journal.pone.0260843	http://dx.doi.org/10.1371/journal.pone.0260843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855874	gold, Green Published, Green Submitted			2022-12-26	WOS:000735299000136
J	Canas, JAO; Alfonso, MJP; Plazas, CDN; Arbelaez, CMM; Rueda, JSP				Ocampo Canas, Jovana Alexandra; Pinilla Alfonso, Maria Janeth; Navarro Plazas, Clemencia del Pilar; Mejia Arbelaez, Carlos Mauricio; Patino Rueda, Jhon Sebastian			Experiences of women with Zika virus (ZIKV) versus the provision of health services in two cities in Colombia: A qualitative study	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; MENS INVOLVEMENT; PREGNANT-WOMEN; CARE; EPIDEMIC	Background In February 2016, the World Health Organization (WHO) declared the epidemic of the ZIKA virus (ZIKV) in Latin America to be a public health emergency. In Colombia, 11,944 pregnant women registered a ZIKV infection during the epidemic. So far, little is known about the experiences of women infected with ZIKV during their pregnancy, especially those relating to the provision of health services during the period of the epidemic. Objective To explore the experiences of pregnant women diagnosed with ZIKV infection about the provision of health services in two Colombian cities, considering the perspective of sexual and reproductive rights. Methods Qualitative study under the grounded theory approach, which uses semi-structured interviews as tools to explore the biographical experience of mothers during their gestation process and ZIKV infection, dividing the interview into two broad categories: before and during pregnancy. Results Twenty-two women were interviewed, 10 in Cali and 12 in Villavicencio. The average age at the time of pregnancy was 27.6 years. Most women were not planning at the time of pregnancy and the pregnancy was unwanted. Most campaigns focused on mosquito eradication rather than on sexual and reproductive health campaigns. The quality of health care was not sufficient, adequate, or appropriate. Also, the breakdown of the health system to deal with the pandemic was also noted. Some women were treated with disrespect by health professionals. Voluntary termination of pregnancy was inadequately advised, and women lost autonomy regarding decisions about their health. Conclusions In the health care of ZIKV epidemics, it is necessary to include the gender perspective, more specifically, sexual and reproductive rights. In addition, these epidemics must be addressed through a comprehensive, appropriate, and not fragmented health system, in which sexual and reproductive rights must be mainstreamed in all health promotion and prevention programs.	[Ocampo Canas, Jovana Alexandra; Pinilla Alfonso, Maria Janeth; Navarro Plazas, Clemencia del Pilar; Mejia Arbelaez, Carlos Mauricio; Patino Rueda, Jhon Sebastian] Univ Andes, Res Line Hlth Syst Childhood Gender Intercultural, Res Grp Publ Hlth Med Educ & Med Professionalism, Sch Med, Bogota, DC, Colombia; [Ocampo Canas, Jovana Alexandra] Univ Andes, Sch Med, Bogota, DC, Colombia	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Canas, JAO (corresponding author), Univ Andes, Res Line Hlth Syst Childhood Gender Intercultural, Res Grp Publ Hlth Med Educ & Med Professionalism, Sch Med, Bogota, DC, Colombia.; Canas, JAO (corresponding author), Univ Andes, Sch Med, Bogota, DC, Colombia.	ja.ocampo@uniandes.edu.co		Patino Rueda, Jhon Sebastian/0000-0002-5666-5349; Mejia Arbelaez, Carlos Mauricio/0000-0003-1294-7288; Ocampo Canas, Jovana Alexandra/0000-0002-5116-8255	HRP Alliance, part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP) - World Health Organization (WHO); UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR) - World Health Organization (WHO); Universidad de los Andes [2017/764695-0]; World Health Organization [2017/764695-0]	HRP Alliance, part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP) - World Health Organization (WHO); UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR) - World Health Organization (WHO); Universidad de los Andes; World Health Organization(World Health Organization)	This work was funded by HRP Alliance, part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP) and the UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR), both cosponsored programs hosted by the World Health Organization (WHO). The financing was made through the Contract Number: 2017/764695-0 signed between the Universidad de los Andes and the World Health Organization	Arenas-Monreal L, 2015, SALUD PUBLICA MEXICO, V57, P66; Bellizzi S, 2020, CONTRACEPTION, V101, P26, DOI 10.1016/j.contraception.2019.09.006; Bellizzi S, 2020, J PEDIATR ADOL GYNEC, V33, P144, DOI 10.1016/j.jpag.2019.11.004; Bustamante-Forest R, 2004, NURS CLIN N AM, V39, P301, DOI 10.1016/j.cnur.2004.02.001; Cartwright Alice F, 2019, Gates Open Res, V3, P1513, DOI 10.12688/gatesopenres.13045.2; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Di Meglio G, 2019, PAED CHILD HEALT-CAN, V24, P160, DOI 10.1093/pch/pxz033; Ebuenyi ID, 2018, PAN AFR MED J, V30, DOI 10.11604/pamj.2018.30.2.11794; Eisenberg D, 2013, J ADOLESCENT HEALTH, V52, pS59, DOI 10.1016/j.jadohealth.2013.01.012; Meireles JFF, 2017, PSYCHOL HEALTH, V32, P798, DOI 10.1080/08870446.2017.1307369; Gaete Quezada RA, 2014, REFLEXIONES BASES PR; Gomez HM, 2020, INT J GYNECOL OBSTET, V148, P29, DOI 10.1002/ijgo.13045; Instituto Nacional de Salud, 2016, B EP SEM, V52, P50; Instituto Nacional de Salud -INS, 2016, B EP SEM SEM EP NUM, V27, P1; Kerguelen C., 2008, CALIDAD SALUD COLOMB; Lin HZ, 2017, SINGAP MED J, V58, P171, DOI 10.11622/smedj.2017026; Ministerio de Salud y de Proteccion Social, 2016, LIN PROV AB CLIN GES, P35; Ministerio de Salud y de Proteccion Social, 1993, RES NUM 8430 1993; Ministerio de Salud y Proteccion Social, 2016, INFOGRAFIAS; Ministerio de salud y proteccion social; profamilia, 2015, ENCUESTA NACL DEMOGR; Canas JAO, 2020, INT J GYNECOL OBSTET, V148, P4, DOI 10.1002/ijgo.13041; Pacheco O, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMoa1604037; Pan American Health Organization, 2016, GUID SURV ZIK VIR DI; Bravo LR, 2018, REV ESP SALUD PUBLIC, V92; Simmons RG, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2018.12.022; Snyder AH, 2018, WOMEN HEALTH ISS, V28, P219, DOI 10.1016/j.whi.2018.01.005; Sternberg P, 2004, HEALTH PROMOT INT, V19, P389, DOI 10.1093/heapro/dah312; STRUTZEL E, 1968, NURS RES, V17, P364; Suárez Roberto, 2006, Antipod. Rev. Antropol. Arqueol., P123; Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113; Tirado V, 2020, INT J GYNECOL OBSTET, V148, P36, DOI 10.1002/ijgo.13046; Weldemariam KT, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-8088-z; Weldon Caroline T, 2018, PLoS Negl Trop Dis, V12, pe0006708, DOI 10.1371/journal.pntd.0006708; Wolgemuth TE, 2020, WOMEN HEALTH ISS, V30, P57, DOI 10.1016/j.whi.2019.08.005; World Health Organization, WHO STAT 1 M INT HLT; Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448	36	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260583	10.1371/journal.pone.0260583	http://dx.doi.org/10.1371/journal.pone.0260583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855811	gold, Green Published			2022-12-26	WOS:000735299000072
J	Stahl, K; Groene, O				Stahl, Katja; Groene, Oliver			ASK ME!-Routine measurement of patient experience with patient safety in ambulatory care: A mixed-mode survey	PLOS ONE			English	Article							GENERAL-PRACTICE; SATISFACTION; INCIDENTS; ERRORS; VALIDATION; OUTCOMES; EVENTS; RATES; MAIL; US	Objective Routine measurement of patient safety from the patients' perspective receives increasing attention as an important component of safety measurement systems. The aim of this study was to examine patients' experience with patient safety in ambulatory care and the results' implications for routine patient safety measurement in ambulatory care. Design Cross-sectional mixed-mode survey. Setting General practitioner and specialist practices. Participants Patients aged >18 years seeking care in ambulatory care practices between February and June 2020. Methods A 22-item-questionnaire was completed in the practice or at home either on paper or online. Multivariate logistic regression was used to analyse the influence of survey mode and patient characteristics on patient experience with patient safety. Results The overall response rate was 71.1%. Most patients completed the questionnaire on site (76.6%) and on paper (96.1%). Between 30.1% to 68.5% of the respondents report the most positive option for patient experience with the main domains of patient safety. A total of 2.9% of patients reported having experienced a patient-safety event (PSE) during the last 12 months. Patients who filled in the questionnaire off site were more likely to report negative experiences for the scales communication & information (OR 1.2, 95% CI 1.0-1.5), rapport & participation (OR 1.4, 95% CI 1.1-1.7) and access (OR 1.3, 95% CI 0.9-1.4) than those who completed it on site. Those who chose a paper questionnaire were more likely to report negative experiences for all five scales compared to web responders. Conclusion Routine measurement of patient experience with factors contributing to the occurrence of PSEs can achieve high response rates by offering flexible participation options. Results gained from mixed-mode surveys need to take mode-effects into account when interpreting and using the results. Further research is needed in how to adequately assess number and type of experienced events in routine measurements.	[Stahl, Katja; Groene, Oliver] OptiMedis AG, Dept Res & Innovat, Hamburg, Germany		Stahl, K (corresponding author), OptiMedis AG, Dept Res & Innovat, Hamburg, Germany.	k.stahl@optimedis.de		Stahl, Katja/0000-0001-5696-9513	German Federal Ministry of Health [ZMVI1-2519-PAT001]	German Federal Ministry of Health	KS OG Grant number: ZMVI1-2519-PAT001 Funder: German Federal Ministry of Health URL: https://www.bundesgesundheitsministerium.de/ The funder provided support in the form of salaries for authors [KS, OG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. KS is employed as Manager Research & Innovation at OptiMedis AG. OG is Vice-Chairman of OptiMedis AG. The authors affiliations did not have role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all practice teams and patients who participated in this study. We also thank the German Coalition for Patient Safety, the regional Association of Statutory Health Insurance Physicians (Westfalen-Lippe) for their support in the development of the questionnaire and the recruitment of the practices. Thanks are also extended to the German Agency for Quality in Medicine who supported the development process of the questionnaire with expert advice.	Anastario MP, 2010, HEALTH SERV RES, V45, P1345, DOI 10.1111/j.1475-6773.2010.01129.x; Avery AJ, 2013, BRIT J GEN PRACT, V63, pE543, DOI 10.3399/bjgp13X670679; Batbaatar E, 2017, PERSPECT PUBLIC HEAL, V137, P89, DOI 10.1177/1757913916634136; Aller MB, 2013, INT J INTEGR CARE, V13; Beattie M, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0089-0; Bjertnaes O, 2016, PATIENT PREFER ADHER, V10, P2255, DOI 10.2147/PPA.S116424; Bjertnaes O, 2015, INT J QUAL HEALTH C, V27, P26, DOI 10.1093/intqhc/mzu087; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Brogger J, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.5.e40; Bull C, 2019, HEALTH SERV RES, V54, P1023, DOI 10.1111/1475-6773.13187; Burt J., 2017, IMPROVING PATIENT EX; Cantuaria ML, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0882-x; Chaneliere M, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0803-9; Christensen AI, 2022, SCAND J PUBLIC HEALT, V50, P180, DOI 10.1177/1403494820966534; Coulter A, 2009, POINT CARE MEASURES; Crow R, 2002, Health Technol Assess, V6, P1; Daikeler J, 2020, J SURV STAT METHODOL, V8, P513, DOI 10.1093/jssam/smz008; Elwyn G, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S14; Fricker R.D., 2002, FIELD METHOD, V14, P347, DOI DOI 10.1177/152582202237725; Geraedts M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034617; Giles SJ, 2019, BMJ QUAL SAF, V28, P389, DOI 10.1136/bmjqs-2018-007988; Gleeson H, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011907; Gribble RK, 2005, MED CARE, V43, P276, DOI 10.1097/00005650-200503000-00010; Guo YM, 2016, AM J PUBLIC HEALTH, V106, P1422, DOI 10.2105/AJPH.2016.303198; Hagan TL, 2017, J PAIN SYMPTOM MANAG, V54, P368, DOI 10.1016/j.jpainsymman.2017.07.005; Haggerty JL, 2012, ANN FAM MED, V10, P443, DOI 10.1370/afm.1378; Hernan AL, 2015, BMJ QUAL SAF, V24, P583, DOI 10.1136/bmjqs-2015-004049; Hoebel J, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-46; Iversen HH, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-036533; Jensen HI, 2010, SOC SCI MED, V70, P1882, DOI 10.1016/j.socscimed.2010.02.035; Kelfve S, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-01138-0; King A, 2010, QUAL SAF HEALTH CARE, V19, P148, DOI 10.1136/qshc.2008.030114; Kistler CE, 2010, ARCH INTERN MED, V170, P1480, DOI 10.1001/archinternmed.2010.288; Lawton R, 2015, BMJ QUAL SAF, V24, P369, DOI 10.1136/bmjqs-2014-003691; Levtzion-Korach O, 2010, JT COMM J QUAL PATIE, V36, P402, DOI 10.1016/S1553-7250(10)36059-4; Lin OS, 2007, GASTROINTEST ENDOSC, V65, P775, DOI 10.1016/j.gie.2006.11.032; Makeham MAB, 2008, QUAL SAF HEALTH CARE, V17, P53, DOI 10.1136/qshc.2007.022491; Mastellos N, 2014, INT J INTEGR CARE, V14; Meyer VM, 2022, ANN SURG, V275, pE75, DOI 10.1097/SLA.0000000000004078; Mlikotic R, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5068; Nakash Rachel A, 2006, BMC Med Res Methodol, V6, P5, DOI 10.1186/1471-2288-6-5; Nelson EC, 2004, MED CARE, V42, P259, DOI 10.1097/01.mlr.0000114914.32196.c7; OECD, 2019, PUTT PEOPL CTR HLTH; Panesar SS, 2016, BMJ QUAL SAF, V25, P544, DOI 10.1136/bmjqs-2015-004178; Rhodes P, 2016, HEALTH EXPECT, V19, P253, DOI 10.1111/hex.12342; Ricci-Cabello I, 2017, BRIT J GEN PRACT, V67, pE474, DOI 10.3399/bjgp17X691085; Ricci-Cabello I, 2016, ANN FAM MED, V14, P253, DOI 10.1370/afm.1935; Ricci-Cabello I, 2015, FAM PRACT, V32, P106, DOI 10.1093/fampra/cmu052; Richards S H, 2011, Prim Health Care Res Dev, V12, P68, DOI 10.1017/S1463423610000319; Rolstad S, 2011, VALUE HEALTH, V14, P1101, DOI 10.1016/j.jval.2011.06.003; Sandager M, 2016, J PATIENT EXP, V3, P63; Schrappe M., 2018, APS WEI BUCH PATIENT; Schwappach DLB, 2010, MED CARE RES REV, V67, P119, DOI 10.1177/1077558709342254; Segal LS, 2015, J PEDIATR ORTHOPED, V35, P774, DOI 10.1097/BPO.0000000000000350; Singh H, 2014, BMJ QUAL SAF, V23, P727, DOI 10.1136/bmjqs-2013-002627; Slater M, 2016, CAN FAM PHYSICIAN, V62, pE740; Slawomirski L., 2018, FLYING BLIND, DOI [10.1002/cpt.1226, DOI 10.1002/CPT.1226]; Smyth JD, 2014, SOC SCI RES, V48, P135, DOI 10.1016/j.ssresearch.2014.06.002; Stahl K., 2020, FRAG MICH FEHLERPR V; Stocks SJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017786; Stocks SJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020952; Stoyanov S, 2012, BMJ QUAL SAF, V21, P50, DOI 10.1136/bmjqs-2012-001169; van den Hombergh P, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0519-7; van Walraven C, 2008, CAN MED ASSOC J, V179, P1013, DOI 10.1503/cmaj.080430; Vincent C, 2012, CAN MED ASSOC J, V184, P15, DOI 10.1503/cmaj.111311; Ward JK, 2012, BMJ QUAL SAF, V21, P685, DOI 10.1136/bmjqs-2011-000213; Weingart SN, 2005, J GEN INTERN MED, V20, P830, DOI 10.1111/j.1525-1497.2005.0180.x; World Health Organization, 2009, CONCEPTUAL FRAMEWORK; Zuidgeest M, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1241	69	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0259252	10.1371/journal.pone.0259252	http://dx.doi.org/10.1371/journal.pone.0259252			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851966	Green Published, gold			2022-12-26	WOS:000755762900009
J	Azad, A; Farhan, MA; Murray, CR; Suzuki, K; Eitzen, G; Touret, N; Moore, RB; Murray, AG				Azad, Abul K.; Farhan, Maikel A.; Murray, Cameron R.; Suzuki, Kunimasa; Eitzen, Gary; Touret, Nicolas; Moore, Ronald B.; Murray, Allan G.			FGD5 regulates endothelial cell PI3 kinase-beta to promote neo-angiogenesis	FASEB JOURNAL			English	Article						CXCL12; endothelial cell; neovascularization; phosphatidylinositide 3-kinase; Rac1 GTP-binding protein; signal transduction	P110-ALPHA ISOFORM; INHIBITION; GENES; AXIS; RAS	Angiogenesis is required in embryonic development and tissue repair in the adult. Vascular endothelial growth factor (VEGF) initiates angiogenesis, and VEGF or its receptor is targeted therapeutically to block pathological angiogenesis. Additional pro-angiogenic cues, such as CXCL12 acting via the CXCR4 receptor, co-operate with VEGF/VEGFR2 to cue vascular patterning. We studied the role of FGD5, an endothelial Rho GTP/GDP exchange factor (RhoGEF), to regulate CXCR4-dependent signals in the endothelial cell (EC). Patient-derived renal cell carcinomas produce a complex milieu of growth factors that stimulated sprouting angiogenesis and endothelial tip cell differentiation ex vivo that was blocked by EC FGD5 loss. In a simplified model, CXCL12 augmented sprouting and tip gene expression under conditions where VEGF was limiting. CXCL12-stimulated tip cell differentiation was dependent on PI3 kinase (PI3K)-beta activity. Knockdown of EC FGD5 abolished CXCR4 signaling to PI3K-beta and Akt. Further, inhibition of Rac1, a Rho GTPase required for PI3K-beta activity, recapitulated the signaling defects of FGD5 deficiency, suggesting that FGD5 may regulate PI3K-beta activity through Rac1. Overexpression of a RhoGEF deficient, Dbl domain-deleted FGD5 mutant reduced CXCL12-stimulated Akt phosphorylation and failed to rescue PI3K signaling in native FGD5-deficient EC, indicating that FGD5 RhoGEF activity is required for FDG5 function. Endothelial expression of mutant PI3K-beta with an inactivated Rho binding domain confirmed that CXCL12-stimulated PI3K activity in EC requires Rac1-GTP co-regulation. Together, this data identify the role of FGD5 to generate Rac1-GTP to regulate pro-angiogenic CXCR4-dependent PI3K-beta signaling in EC. Inhibition of FGD5 activity may complement current angiogenesis inhibitor drugs.	[Azad, Abul K.; Farhan, Maikel A.; Murray, Allan G.] Univ Alberta, Dept Med, Rm 275 HMRC, Edmonton, AB T6G 2S2, Canada; [Murray, Cameron R.; Touret, Nicolas] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Suzuki, Kunimasa] Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada; [Eitzen, Gary] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada; [Moore, Ronald B.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Murray, AG (corresponding author), Univ Alberta, Dept Med, Rm 275 HMRC, Edmonton, AB T6G 2S2, Canada.	allan.murray@ualberta.ca	Moore, Ronald Brian/AET-3015-2022		Departmental Translational Research Scholarship; Canadian Cancer Society [CCSRI IG 703774]	Departmental Translational Research Scholarship; Canadian Cancer Society(Canadian Cancer Society (CCS))	AKA was supported in part by a Departmental Translational Research Scholarship. Operating funding fur this project was granted to AGM from the Canadian Cancer Society CCSRI IG 703774	Azad AK, 2020, ONCOGENE, V39, P6480, DOI 10.1038/s41388-020-01444-3; Bergerot P, 2019, MOL CANCER THER, V18, P2185, DOI 10.1158/1535-7163.MCT-18-1399; Bresnick AR, 2019, ENDOCRINOLOGY, V160, P536, DOI 10.1210/en.2018-00843; Cavallero S, 2015, DEV CELL, V33, P469, DOI 10.1016/j.devcel.2015.03.018; Chen XY, 2019, CARDIOVASC RES, V115, P1343, DOI 10.1093/cvr/cvy298; Cheng C, 2012, CIRCULATION, V125, P3142, DOI 10.1161/CIRCULATIONAHA.111.064030; Das S, 2019, CELL, V176, P1128, DOI 10.1016/j.cell.2018.12.023; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Eitzen G, 2019, BIOCHEM CELL BIOL, V97, P257, DOI 10.1139/bcb-2018-0185; Farhan MA, 2017, ARTERIOSCL THROM VAS, V37, P2301, DOI 10.1161/ATVBAHA.117.309978; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Gazit R, 2014, J EXP MED, V211, P1314, DOI 10.1084/jem.20130428; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Haddad G, 2014, BLOOD, V124, P2142, DOI 10.1182/blood-2014-02-557975; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; He LJ, 2017, J CLIN INVEST, V127, P2968, DOI 10.1172/JCI93868; Ho M, 2003, PHYSIOL GENOMICS, V13, P249, DOI 10.1152/physiolgenomics.00186.2002; Houslay DM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aae0453; Hultgren NW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18633-z; Ivins S, 2015, DEV CELL, V33, P455, DOI 10.1016/j.devcel.2015.03.026; Kim BG, 2017, CARDIOVASC RES, V113, P1677, DOI 10.1093/cvr/cvx188; Kurogane Y, 2012, ARTERIOSCL THROM VAS, V32, P988, DOI 10.1161/ATVBAHA.111.244004; Lee MY, 2014, P NATL ACAD SCI USA, V111, P12865, DOI 10.1073/pnas.1408472111; Liu SL, 2018, MOL CELL, V71, P1092, DOI 10.1016/j.molcel.2018.07.035; Ma Shaolin, 2018, F1000Res, V7, P326, DOI 10.12688/f1000research.11771.1; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marin-Juez R, 2019, DEV CELL, V51, P503, DOI 10.1016/j.devcel.2019.10.019; Motzer RJ, 2020, NAT MED, V26, P1733, DOI 10.1038/s41591-020-1044-8; Mullaly SC, 2002, EUR J IMMUNOL, V32, P1493, DOI 10.1002/1521-4141(200205)32:5<1493::AID-IMMU1493>3.0.CO;2-G; Murillo MM, 2014, J CLIN INVEST, V124, P3601, DOI 10.1172/JCI74134; Nakhaei-Nejad M, 2012, ARTERIOSCL THROM VAS, V32, P2694, DOI 10.1161/ATVBAHA.112.300074; Park Sally, 2021, Small GTPases, V12, P147, DOI 10.1080/21541248.2019.1674765; Schwartz S, 2015, CANCER CELL, V27, P109, DOI 10.1016/j.ccell.2014.11.008; Soler A, 2013, J EXP MED, V210, P1937, DOI 10.1084/jem.20121571; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takabatake Y, 2009, J AM SOC NEPHROL, V20, P1714, DOI 10.1681/ASN.2008060640; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Ziegler ME, 2016, ANGIOGENESIS, V19, P359, DOI 10.1007/s10456-016-9509-6	40	0	0	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22080	10.1096/fj.202100554R	http://dx.doi.org/10.1096/fj.202100554R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34882832				2022-12-26	WOS:000734992000016
J	Izquierdo, PG; Calahorro, F; Thisainathan, T; Atkins, JH; Haszczyn, J; Lewis, CJ; Tattersall, JEH; Green, AC; Holden-Dye, L; O'Connor, V				Izquierdo, Patricia G.; Calahorro, Fernando; Thisainathan, Thibana; Atkins, James H.; Haszczyn, Johanna; Lewis, Christian J.; Tattersall, John E. H.; Green, A. Christopher; Holden-Dye, Lindy; O'Connor, Vincent			Cholinergic signaling at the body wall neuromuscular junction distally inhibits feeding behavior in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED ACETYLCHOLINE-RECEPTOR; C-ELEGANS; LEVAMISOLE RESISTANCE; FUNCTIONAL GENOMICS; WILD-TYPE; GENES; SENSITIVITY; GENETICS; ENCODES; GROWTH	Complex biological functions within organisms are frequently orchestrated by systemic communication between tissues. In the model organism Caenorhabditis elegans, the pharyngeal and body wall neuromuscular junctions are two discrete structures that control feeding and locomotion, respectively. Separate, the well-defined neuromuscular circuits control these distinct tissues. Nonetheless, the emergent behaviors, feeding and locomotion, are coordinated to guarantee the efficiency of food intake. Here, we show that pharmacological hyperactivation of cholinergic transmission at the body wall muscle reduces the rate of pumping behavior. This was evidenced by a systematic screening of the effect of the cholinesterase inhibitor aldicarb on the rate of pharyngeal pumping on food in mutant worms. The screening revealed that the key determinants of the inhibitory effect of aldicarb on pharyngeal pumping are located at the body wall neuromuscular junction. In fact, the selective stimulation of the body wall muscle receptors with the agonist levamisole inhibited pumping in a lev-1-dependent fashion. Interestingly, this response was independent of unc-38, an alpha subunit of the nicotinic receptor classically expressed with lev-1 at the body wall muscle. This implies an uncharacterized lev-1-containing receptor underpins this effect. Overall, our results reveal that body wall cholinergic transmission not only controls locomotion but simultaneously inhibits feeding behavior.	[Izquierdo, Patricia G.; Calahorro, Fernando; Thisainathan, Thibana; Atkins, James H.; Haszczyn, Johanna; Lewis, Christian J.; Holden-Dye, Lindy; O'Connor, Vincent] Univ Southampton, Fac Environm & Life Sci, Sch Biol Sci, Southampton, Hants, England; [Tattersall, John E. H.; Green, A. Christopher] Def Sci & Technol Lab, Dstl, Salisbury, Wilts, England	University of Southampton; Defence Science & Technology Laboratory	Izquierdo, PG (corresponding author), Univ Southampton, Fac Environm & Life Sci, Sch Biol Sci, Southampton, Hants, England.	P.Gonzalez@soton.ac.uk	Calahorro, Fernando/H-3294-2013	G. Izquierdo, Patricia/0000-0002-5491-0048; Holden-Dye, Lindy/0000-0002-9704-1217; O'Connor, Vincent/0000-0003-3185-5709	NIH Office of Research Infrastructure Programs [P40 OD010440]; University of Southampton (United Kingdom); Defence Science and Technology Laboratory, Porton Down, Wiltshire (United Kingdom)	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southampton (United Kingdom); Defence Science and Technology Laboratory, Porton Down, Wiltshire (United Kingdom)	Additional C. elegans strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This work was funded by the University of Southampton (United Kingdom) and the Defence Science and Technology Laboratory, Porton Down, Wiltshire (United Kingdom). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Almedom RB, 2009, EMBO J, V28, P2636, DOI 10.1038/emboj.2009.204; Argiles JM, 2018, NAT REV ENDOCRINOL, V15, P9, DOI 10.1038/s41574-018-0123-0; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; AVERY L, 1993, J EXP BIOL, V175, P283; Avery L., 1997, C ELEGANS, V2nd; Bandyopadhyay J, 2002, MOL BIOL CELL, V13, P3281, DOI 10.1091/mbc.E02-01-0005; Ben Arous J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007584; Bhattacharya R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004584; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Boulin T, 2012, NAT NEUROSCI, V15, P1374, DOI 10.1038/nn.3197; BRENNER S, 1974, GENETICS, V77, P71; Briseno-Roa L, 2014, J BIOL CHEM, V289, P10967, DOI 10.1074/jbc.C113.534677; Calahorro F, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.189423; CHALFIE M, 1985, J NEUROSCI, V5, P956; Choudhary S, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008396; Combes D, 2000, J MOL BIOL, V300, P727, DOI 10.1006/jmbi.2000.3917; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; CULOTTI JG, 1983, J NEUROSCI, V3, P359; Dalliere N, 2015, THESIS U SOUTHAMPTON; Dalliere N, 2016, FASEB J, V30, P836, DOI 10.1096/fj.15-279257; Delanoue R, 2010, DEV CELL, V18, P1012, DOI 10.1016/j.devcel.2010.05.007; Demontis F, 2009, DEVELOPMENT, V136, P983, DOI 10.1242/dev.027466; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fay David, 2006, WormBook, P1; Fleming JT, 1997, J NEUROSCI, V17, P5843; Franks CJ, 2009, INVERTEBR NEUROSCI, V9, P43, DOI 10.1007/s10158-009-0088-8; Blanco MG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0007021; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Gottschalk A, 2006, J NEUROSCI METH, V154, P68, DOI 10.1016/j.jneumeth.2005.11.016; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Hernando G, 2012, MOL PHARMACOL, V82, P550, DOI 10.1124/mol.112.079962; Holden-Dye L, 2013, PARASITOL INT, V62, P606, DOI 10.1016/j.parint.2013.03.004; Huang YC, 2019, ELIFE, V8, DOI 10.7554/eLife.45905; Hwang JM, 1999, RECEPTOR CHANNEL, V6, P415; Izquierdo PG, 2021, NEUROTOXICOLOGY, V82, P50, DOI 10.1016/j.neuro.2020.11.001; Jospin M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000265; Karsenty G, 2016, CELL, V164, P1248, DOI 10.1016/j.cell.2016.02.043; Keane J, 2003, GENETICS, V164, P153; Kudelska MM, 2018, INVERTEBR NEUROSCI, V18, DOI 10.1007/s10158-018-0219-1; Lee YS, 2000, J NEUROCHEM, V75, P1800, DOI 10.1046/j.1471-4159.2000.0751800.x; Lee YS, 1999, J NEUROCHEM, V72, P58, DOI 10.1046/j.1471-4159.1999.0720058.x; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Maryon EB, 1996, J CELL BIOL, V134, P885, DOI 10.1083/jcb.134.4.885; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miyabayashi T, 1999, DEV BIOL, V215, P314, DOI 10.1006/dbio.1999.9470; Oh KH, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2400; Pierron M, 2016, J NEUROSCI, V36, P6525, DOI 10.1523/JNEUROSCI.3733-15.2016; Putrenko I, 2005, J BIOL CHEM, V280, P6392, DOI 10.1074/jbc.M412644200; Rai M, 2016, ANNU REV PHYSIOL, V78, P85, DOI 10.1146/annurev-physiol-021115-105305; RAIZEN DM, 1995, GENETICS, V141, P1365; Rajan A, 2011, DEV CELL, V21, P29, DOI 10.1016/j.devcel.2011.06.034; Rapti G, 2011, EMBO J, V30, P706, DOI 10.1038/emboj.2010.355; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Selkirk ME, 2005, CHEM-BIOL INTERACT, V157, P263, DOI 10.1016/j.cbi.2005.10.039; Selkirk ME, 2005, PARASITOLOGY, V131, pS3; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Takahashi M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007134; Treinin M, 2021, J NEUROCHEM, V158, P1274, DOI 10.1111/jnc.15164; Trojanowski NF, 2014, J NEUROPHYSIOL, V112, P951, DOI 10.1152/jn.00150.2014; Verma S, 2017, P NATL ACAD SCI USA, V114, P5539, DOI 10.1073/pnas.1619820114	72	1	1	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101466	10.1016/j.jbc.2021.101466	http://dx.doi.org/10.1016/j.jbc.2021.101466			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP0ZE	34864060	Green Accepted, Green Published, gold			2022-12-26	WOS:000748357700009
J	Shobo, A; James, N; Dai, D; Rontgen, A; Black, C; Kwizera, JR; Hancock, MA; Bui, KH; Multhaup, G				Shobo, Adeola; James, Nicholas; Dai, Daniel; Roentgen, Alexander; Black, Corbin; Kwizera, Jean-Robert; Hancock, Mark A.; Bui, Khanh Huy; Multhaup, Gerhard			The amyloid-beta(1-42)-oligomer interacting peptide D-AIP possesses favorable biostability, pharmacokinetics, and brain region distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-AMINO-ACID; ALZHEIMERS-DISEASE; BETA; TOXICITY; OLIGOMERS; METABOLISM; MECHANISM; PATHOLOGY; SEEDS	We have previously developed a unique 8-amino acid A beta 42 oligomer-Interacting Peptide (AIP) as a novel anti-amyloid strategy for the treatment of Alzheimer's disease. Our lead candidate has successfully progressed from test tubes (i.e., in vitro characterization of protease-resistant D-AIP) to transgenic flies (i.e., in vivo rescue of human A beta 42-mediated toxicity via D-AIP-supplemented food). In the present study, we examined D-AIP in terms of its stability in multiple biological matrices (i.e., ex-vivo mouse plasma, whole blood, and liver S9 fractions) using MALDI mass spectrometry, pharmacokinetics using a rapid and sensitive LC-MS method, and blood brain barrier (BBB) penetrance in WT C57LB/6 mice. DAIP was found to be relatively stable over 3 h at 37 degrees C in all matrices tested. Finally, label-free MALDI imaging showed that orally administered D-AIP can readily penetrate the intact BBB in both male and female WT mice. Based upon the favorable stability, pharmacokinetics, and BBB penetration outcomes for orally administered D-AIP in WT mice, we then examined the effect of D-AIP on amyloid "seeding" in vitro (i.e., freshly monomerized versus preaggregated A beta 42). Complementary biophysical assays (ThT, TEM, and MALDI-TOF MS) showed that D-AIP can directly interact with synthetic A beta 42 aggregates to disrupt primary and/or secondary seeding events. Taken together, the unique mechanistic and desired therapeutic potential of our lead D-AIP candidate warrants further investigation, that is, testing of D-AIP efficacy on the altered amyloid/ tau pathology in transgenic mouse models of Alzheimer's disease.	[Shobo, Adeola; Roentgen, Alexander; Kwizera, Jean-Robert; Hancock, Mark A.; Multhaup, Gerhard] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [James, Nicholas; Multhaup, Gerhard] McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada; [Dai, Daniel; Black, Corbin; Bui, Khanh Huy] McGill Univ, Strathcona Anat Dent Bldg, Montreal, PQ, Canada; [Roentgen, Alexander] Univ Cologne, Inst Biochem, Cologne, Germany	McGill University; McGill University; McGill University; University of Cologne	Multhaup, G (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.; Multhaup, G (corresponding author), McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada.	Gerhard.multhaup@mcgill.ca	Shobo, Adeola/GLR-3962-2022	Shobo, Adeola/0000-0002-2846-323X; Black, Corbin/0000-0003-2777-6434; Rontgen, Alexander/0000-0002-0500-4815; Hancock, Mark/0000-0001-7427-7449; Bui, Khanh Huy/0000-0003-2814-9889; Dai, Daniel/0000-0002-9973-0446; James, Nicholas/0000-0002-9939-4278	Canada Foundation for Innovation (CFI) funding	Canada Foundation for Innovation (CFI) funding	G. M. holds both a Canada Research Chair Tier one in Molecular Pharmacology and Canada Foundation for Innovation (CFI) funding.	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Barucker C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15410; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; DANIELLO A, 1993, J BIOL CHEM, V268, P26941; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dobson CM, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a033878; Erickson MA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071632; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Feng Zhaoqianqi, 2016, BioMolecular Concepts, V7, P179, DOI 10.1515/bmc-2015-0035; Funke SA, 2010, ACS CHEM NEUROSCI, V1, P639, DOI 10.1021/cn100057j; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2014, J INTERN MED, V275, P296, DOI 10.1111/joim.12192; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Jack CR, 2012, ANN NEUROL, V71, P765, DOI 10.1002/ana.22628; Jagota S, 2013, MED CHEM RES, V22, P3991, DOI 10.1007/s00044-012-0386-2; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kolrep F, 2017, TOXICOL IN VITRO, V42, P161, DOI 10.1016/j.tiv.2017.04.009; KREBS HANS ADOLF, 1935, BIOCHEM JOUR, V29, P1620; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Liebsch F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10152-w; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mehrazma B, 2018, MOLECULES, V23, DOI 10.3390/molecules23092387; Ohide H, 2011, J CHROMATOGR B, V879, P3162, DOI 10.1016/j.jchromb.2011.06.028; Pignatello R, 2013, WOODH PUB SER BIOMED, P1, DOI 10.1533/9781908818348.1; Prideaux B, 2012, J PROTEOMICS, V75, P4999, DOI 10.1016/j.jprot.2012.07.028; Rompp A, 2015, ANAL BIOANAL CHEM, V407, P2023, DOI 10.1007/s00216-015-8479-7; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Scarff CA, 2018, JOVE-J VIS EXP, DOI 10.3791/57199; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shobo A, 2015, ASSAY DRUG DEV TECHN, V13, P277, DOI 10.1089/adt.2015.634; Surnar B, 2019, ACS NANO, V13, P11034, DOI 10.1021/acsnano.9b02807; Thacker D, 2020, P NATL ACAD SCI USA, V117, P25272, DOI 10.1073/pnas.2002956117; Uhlmann RE, 2020, NAT NEUROSCI, V23, P1580, DOI 10.1038/s41593-020-00737-w; Villemagne VL, 2018, NAT REV NEUROL, V14, P225, DOI 10.1038/nrneurol.2018.9; Vossel KA, 2017, LANCET NEUROL, V16, P311, DOI 10.1016/S1474-4422(17)30044-3; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X; Zhao LN, 2012, INT J MOL SCI, V13, P7303, DOI 10.3390/ijms13067303; Zhong YF, 2019, J NEUROCHEM, V150, P74, DOI 10.1111/jnc.14720	42	1	1	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101483	10.1016/j.jbc.2021.101483	http://dx.doi.org/10.1016/j.jbc.2021.101483			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1GJ	34896396	Green Published, gold			2022-12-26	WOS:000748376400005
J	Wang, ZX; Martellucci, S; Van Enoo, A; Austin, D; Gelber, C; Campana, WM				Wang, Zixuan; Martellucci, Stefano; Van Enoo, Alicia; Austin, Dana; Gelber, Cohava; Campana, Wendy M.			alpha 1-Antitrypsin derived SP16 peptide demonstrates efficacy in rodent models of acute and neuropathic pain	FASEB JOURNAL			English	Article						LRP1; neuroinflammation; neuropathic pain; nociception; peripheral nerve injury; SP16	RECEPTOR-RELATED PROTEIN; PLASMINOGEN-ACTIVATOR; SCHWANN-CELLS; FORMALIN TEST; BINDING; COMPLEXES; THROMBIN; INTERNALIZATION; INFLAMMATION; NOCICEPTION	SP16 is an innovative peptide derived from the carboxyl-terminus of alpha 1-Antitrypsin (AAT), corresponding to residues 364-380, and contains recognition sequences for the low-density lipoprotein receptor-related protein-1 (LRP1). LRP1 is an endocytic and cell-signaling receptor that regulates inflammation. Deletion of Lrp1 in Schwann cells increases neuropathic pain; however, the role of LRP1 activation in nociceptive and neuropathic pain regulation remains unknown. Herein, we show that SP16 is bioactive in sensory neurons in vitro. Neurite length and regenerative gene expression were increased by SP16. In PC12 cells, SP16 activated Akt and ERK1/2 cell-signaling in an LRP1-dependent manner. When formalin was injected into mouse hind paws, to model inflammatory pain, SP16 dose-dependently attenuated nociceptive pain behaviors in the early and late phases. In a second model of acute pain using capsaicin, SP16 significantly reduced paw licking in both male and female mice (p < .01) similarly to enzymatically inactive tissue plasminogen activator, a known LRP1 interactor. SP16 also prevented development of tactile allodynia after partial nerve ligation and this response was sustained for nine days (p < .01). Immunoblot analysis of the injured nerve revealed decreased CD11b (p < .01) and Toll-like receptor-4 (p < .005). In injured dorsal root ganglia SP16 reduced CD11b(+) cells (p < .05) and GFAP (p < .005), indicating that inflammatory cell recruitment and satellite cell activation were inhibited. In conclusion, administration of SP16 blocked pain-related responses in three distinct pain models, suggesting efficacy against acute nociceptive, inflammatory, and neuropathic pain. SP16 also attenuated innate immunity in the PNS. These studies identify SP16 as a potentially effective treatment for pain.	[Wang, Zixuan; Martellucci, Stefano; Van Enoo, Alicia; Campana, Wendy M.] Univ Calif San Diego, Sch Med, Dept Anesthesiol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Van Enoo, Alicia; Campana, Wendy M.] Univ Calif San Diego, Program Neurosci, La Jolla, CA 92093 USA; [Austin, Dana; Gelber, Cohava] Serpin Pharma, Manassas, VA USA; [Campana, Wendy M.] San Diego Vet Adm Hlth Care Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Campana, WM (corresponding author), Univ Calif San Diego, Sch Med, Dept Anesthesiol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	wcampana@health.ucsd.edu	Martellucci, Stefano/O-8129-2019	Martellucci, Stefano/0000-0002-3952-3162	NIH/NINDS [R01 NS097590]; Veterans Administration [1I01RX002484]	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Administration(US Department of Veterans Affairs)	This work was supported by a NIH/NINDS grant R01 NS097590 (to W.M.C) and by the Veterans Administration 1I01RX002484 (to W.M.C).	Abdo H, 2019, SCIENCE, V365, P695, DOI 10.1126/science.aax6452; Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Attal N, 2019, REV NEUROL-FRANCE, V175, P46, DOI 10.1016/j.neurol.2018.08.005; Avraham O, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18642-y; Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2; Bravo-Caparros I, 2020, FASEB J, V34, P5951, DOI 10.1096/fj.201901921R; Brifault C, 2019, GLIA, V67, P1210, DOI 10.1002/glia.23599; Bruno K, 2018, PAIN, V159, P1908, DOI 10.1097/j.pain.0000000000001306; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chuang TY, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0343-2; CODERRE TJ, 1992, J NEUROSCI, V12, P3665; Das L, 2021, AM J PATHOL, V191, P590, DOI 10.1016/j.ajpath.2021.01.001; Das L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224738; Demeule M, 2008, J NEUROCHEM, V106, P1534, DOI 10.1111/j.1471-4159.2008.05492.x; Donnelly S, 2006, ARTHRITIS RHEUM-US, V54, P1543, DOI 10.1002/art.21783; Flutsch A, 2016, NEUROREPORT, V27, P1305, DOI 10.1097/WNR.0000000000000691; Garcia-Fernandez P, 2021, PAIN REP, V6, DOI 10.1097/PR9.0000000000000898; Gonias SL, 2014, AM J PATHOL, V184, P18, DOI 10.1016/j.ajpath.2013.08.029; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; Hanani M, 2020, NAT REV NEUROSCI, V21, P485, DOI 10.1038/s41583-020-0333-z; Hao HN, 2009, J NEUROIMMUNOL, V212, P26, DOI 10.1016/j.jneuroim.2009.04.020; HERZ J, 1991, J BIOL CHEM, V266, P21232; HOLZER P, 1991, PHARMACOL REV, V43, P143; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; JOSLIN G, 1991, J BIOL CHEM, V266, P11282; Kalinski AL, 2020, ELIFE, V9, DOI 10.7554/eLife.60223; Kohro Y, 2020, NAT NEUROSCI, V23, P1376, DOI 10.1038/s41593-020-00713-4; Kounnas MZ, 1996, J BIOL CHEM, V271, P6523, DOI 10.1074/jbc.271.11.6523; Li Y, 2015, J NEUROSCI, V35, P13487, DOI 10.1523/JNEUROSCI.1956-15.2015; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Long GL, 2003, EUR J BIOCHEM, V270, P4059, DOI 10.1046/j.1432-1033.2003.03793.x; Luo X, 2019, J NEUROSCI, V39, P6848, DOI 10.1523/JNEUROSCI.3257-18.2019; Maekawa H, 1996, J BIOL CHEM, V271, P18604, DOI 10.1074/jbc.271.31.18604; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Mantuano E, 2017, BLOOD, V130, P1364, DOI 10.1182/blood-2017-04-780205; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Mattei V, 2020, J NEUROCHEM, V152, P468, DOI 10.1111/jnc.14891; Migliorini M, 2020, J BIOL CHEM, V295, P212, DOI 10.1074/jbc.RA119.010449; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Old EA, 2014, J CLIN INVEST, V124, P2023, DOI 10.1172/JCI71389; Orita S, 2013, J NEUROSCI, V33, P5590, DOI 10.1523/JNEUROSCI.3342-12.2013; Patel S, 2001, J GENE MED, V3, P271, DOI 10.1002/jgm.180; Poplawski G, 2018, GLIA, V66, P1577, DOI 10.1002/glia.23325; Potere N, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00051; Quinn KA, 1999, EXP CELL RES, V251, P433, DOI 10.1006/excr.1999.4590; Raoof R, 2018, RHEUMATOLOGY, V57, P429, DOI 10.1093/rheumatology/kex308; Sadri M, 2022, GLIA, V70, P256, DOI 10.1002/glia.24098; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Strickland DK, 2011, METHOD ENZYMOL, V499, P17, DOI 10.1016/B978-0-12-386471-0.00002-X; Toldo Stefano, 2017, JACC Basic Transl Sci, V2, P561, DOI 10.1016/j.jacbts.2017.05.007; van den Biggelaar M, 2015, J BIOL CHEM, V290, P16463, DOI 10.1074/jbc.M115.650911; Volkow N, 2018, ANNU REV MED, V69, P451, DOI 10.1146/annurev-med-011817-044739; Wen XJ, 2017, ONCOTARGET, V8, P69370, DOI 10.18632/oncotarget.20628; Wohlford GF, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247357; YAMAMOTO T, 1992, ANESTHESIOLOGY, V77, P757, DOI 10.1097/00000542-199210000-00021; Yoon C, 2013, J BIOL CHEM, V288, P26557, DOI 10.1074/jbc.M113.478552; Yu XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13839-2; Zhang HJ, 2009, GLIA, V57, P1588, DOI 10.1002/glia.20872	63	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22093	10.1096/fj.202101031RR	http://dx.doi.org/10.1096/fj.202101031RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34888951				2022-12-26	WOS:000734992000009
J	Islam, A; Ferdous, J; Abu Sayeed, M; Islam, S; Rahman, MK; Abedin, J; Saha, O; Hassan, MM; Shirin, T				Islam, Ariful; Ferdous, Jinnat; Abu Sayeed, Md; Islam, Shariful; Rahman, Md Kaisar; Abedin, Josefina; Saha, Otun; Hassan, Mohammad Mahmudul; Shirin, Tahmina			Spatial epidemiology and genetic diversity of SARS-CoV-2 and related coronaviruses in domestic and wild animals	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SARS-LIKE CORONAVIRUS; BAT; EMERGENCE; RESERVOIRS; ORIGIN	The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) showed susceptibility to diverse animal species. We conducted this study to understand the spatial epidemiology, genetic diversity, and statistically significant genetic similarity along with per-gene recombination events of SARS-CoV-2 and related viruses (SC2r-CoVs) in animals globally. We collected a number of different animal species infected with SARS-CoV-2 and its related viruses. Then, we retrieved genome sequences of SARS-CoV-2 and SC2r-CoVs from GISAID and NCBI GenBank for genomic and mutational analysis. Although the evolutionary origin of SARS-CoV-2 remains elusive, the diverse SC2r-CoV have been detected in multiple Rhinolophus bat species and in Malayan pangolin. To date, human-to-animal spillover events have been reported in cat, dog, tiger, lion, gorilla, leopard, ferret, puma, cougar, otter, and mink in 25 countries. Phylogeny and genetic recombination events of SC2r-CoVs showed higher similarity to the bat coronavirus RaTG13 and BANAL-103 for most of the genes and to some Malayan pangolin coronavirus (CoV) strains for the N protein from bats and pangolin showed close resemblance to SARS-CoV-2. The clustering of animal and human strains from the same geographical area has proved human-to-animal transmission of the virus. The Alpha, Delta and Mu-variant of SARS-CoV-2 was detected in dog, gorilla, lion, tiger, otter, and cat in the USA, India, Czech Republic, Belgium, and France with momentous genetic similarity with human SARS-CoV-2 sequences. The mink variant mutation (spike_Y453F) was detected in both humans and domestic cats. Moreover, the dog was affected mostly by clade O (66.7%), whereas cat and American mink were affected by clade GR (31.6 and 49.7%, respectively). The alpha-variant was detected as 2.6% in cat, 4.8% in dog, 14.3% in tiger, 66.7% in gorilla, and 77.3% in lion. The highest mutations observed in mink where the substitution of D614G in spike (95.2%) and P323L in NSP12 (95.2%) protein. In dog, cat, gorilla, lion, and tiger, Y505H and Y453F were the common mutations followed by Y145del, Y144del, and V70I in S protein. We recommend vaccine provision for pet and zoo animals to reduce the chance of transmission in animals. Besides, continuous epidemiological and genomic surveillance of coronaviruses in animal host is crucial to find out the immediate ancestor of SARS-CoV-2 and to prevent future CoVs threats to humans.	[Islam, Ariful; Ferdous, Jinnat; Abu Sayeed, Md; Islam, Shariful; Rahman, Md Kaisar; Abedin, Josefina; Saha, Otun] EcoHlth Alliance, New York, NY 10018 USA; [Islam, Ariful] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Geelong, Vic, Australia; [Islam, Ariful; Ferdous, Jinnat; Abu Sayeed, Md; Islam, Shariful; Rahman, Md Kaisar; Abedin, Josefina; Saha, Otun; Shirin, Tahmina] Inst Epidemiol Dis Control & Res IEDCR, Dhaka, Bangladesh; [Saha, Otun] Univ Dhaka, Dept Microbiol, Dhaka, Bangladesh; [Hassan, Mohammad Mahmudul] Chattogram Vet & Anim Sci Univ, Fac Vet Med, Chattogram, Bangladesh	EcoHealth Alliance; Deakin University; University of Dhaka	Islam, A (corresponding author), EcoHlth Alliance, New York, NY 10018 USA.; Islam, A (corresponding author), Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Geelong, Vic, Australia.; Islam, A (corresponding author), Inst Epidemiol Dis Control & Res IEDCR, Dhaka, Bangladesh.	arif@ecohealthalliance.org	Hassan, Mohammad/GZA-7507-2022; Hassan, Mohammad Mahmudul/U-6929-2019; Islam, Shariful/GOP-0120-2022	Hassan, Mohammad/0000-0002-1712-0004; Hassan, Mohammad Mahmudul/0000-0001-6495-4637; Islam, Shariful/0000-0003-1986-4960; SAYEED, MD ABU/0000-0002-6626-4178; Islam, Ariful/0000-0002-9210-3351; Saha, Otun/0000-0001-9159-0437; Ferdous, Jinnat/0000-0002-6071-4692	NIH, National Institute of Allergy and Infectious Diseases (NIAID) [U01AI153420]	NIH, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partially funded by NIH, National Institute of Allergy and Infectious Diseases (NIAID) Grant #U01AI153420, Ariful Islam has been supported through this grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony SJ, 2017, MBIO, V8, DOI [10.1128/mBio.00373-17, 10.1128/mbio.00373-17]; Ashour HM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030186; Barrs VR, 2020, EMERG INFECT DIS, V26, P3071, DOI [10.3201/eid2612.202786, 10.3201/eid2612.202786.]; Bayarri-Olmos R, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100536; Beer M, 2020, COVID 19 EXPT INFECT; Bergner LM, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020252; Brook CE, 2015, TRENDS MICROBIOL, V23, P172, DOI 10.1016/j.tim.2014.12.004; Cagliani R, 2020, J VIROL, V94, DOI 10.1128/JVI.00411-20; Chen LH, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau021; Cowley LA., 2021, MEDRXIV2021010521249; Cox-Witton K, 2021, ONE HEALTH-AMSTERDAM, V13, DOI 10.1016/j.onehlt.2021.100247; Delahay RJ, 2021, ONE HEALTH OUTLOOK, V3, DOI 10.1186/s42522-021-00039-6; Delong J., 2020, DUTCH MINISTER CONFI; Enserink M, 2020, SCIENCE, V368, P1169, DOI 10.1126/science.368.6496.1169; Frutos R, 2020, INFECT GENET EVOL, V84, DOI 10.1016/j.meegid.2020.104493; Garigliany M, 2020, EMERG INFECT DIS, V26, P3069, DOI 10.3201/eid2612.202223; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Geldenhuys M, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13050936; Goumenou M, 2020, MOL MED REP, V21, P2293, DOI 10.3892/mmr.2020.11037; Lam HM, 2018, MOL BIOL EVOL, V35, P247, DOI 10.1093/molbev/msx263; Hamer SA, 2022, TRANSBOUND EMERG DIS, V69, P1656, DOI 10.1111/tbed.14122; Hamer Sarah A, 2020, bioRxiv, DOI 10.1101/2020.12.08.416339; Islam AMT, 2021, ENVIRON SCI POLLUT R, V28, P34450, DOI 10.1007/s11356-021-12806-z; Islam A, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13101908; Islam A, 2021, INFECT GENET EVOL, V92, DOI 10.1016/j.meegid.2021.104884; Islam A, 2021, TRANSBOUND EMERG DIS, V68, P3643, DOI 10.1111/tbed.13973; Islam Ariful, 2021, Biosaf Health, V3, P39, DOI 10.1016/j.bsheal.2020.09.006; Islam A, 2020, ECOHEALTH, V17, P398, DOI 10.1007/s10393-020-01488-7; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Jaimes JA, 2020, J MOL BIOL, V432, P3309, DOI 10.1016/j.jmb.2020.04.009; Jo WK, 2021, TRANSBOUND EMERG DIS, V68, P1824, DOI 10.1111/tbed.13872; Kirby T, 2021, LANCET RESP MED, V9, pE20, DOI 10.1016/S2213-2600(21)00005-9; Kiros M, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01416-9; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lee J, 2020, ECOHEALTH, V17, P406, DOI 10.1007/s10393-020-01503-x; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Liu P, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008421; Logeot M, 2022, TRANSBOUND EMERG DIS, V69, P986, DOI 10.1111/tbed.14131; Lu GW, 2015, TRENDS MICROBIOL, V23, P468, DOI 10.1016/j.tim.2015.06.003; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Luo CM, 2018, J VIROL, V92, DOI 10.1128/JVI.00116-18; Makarenkov V, 2021, BMC ECOL EVOL, V21, DOI 10.1186/s12862-020-01732-2; Mallapaty S, 2021, NATURE, V597, P603, DOI 10.1038/d41586-021-02596-2; Mallapaty S, 2020, NATURE, V588, P15, DOI 10.1038/d41586-020-03217-0; Martin DP, 2021, VIRUS EVOL, V7, DOI 10.1093/ve/veaa087; McAloose D, 2020, MBIO, V11, DOI 10.1128/mBio.02220-20; Munnink BBO, 2021, SCIENCE, V371, P172, DOI 10.1126/science.abe5901; Napit R., 2021, RAPID GENOMIC SURVEI; OIE, AN DIS; OIE, 2020, COVID 19 SARS COV 2; Patterson EI, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20097-0; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Reuters, REUTERS; Ruiz-Arrondo I, 2021, TRANSBOUND EMERG DIS, V68, P973, DOI 10.1111/tbed.13803; Saha O, 2020, GENE REP, V21, DOI 10.1016/j.genrep.2020.100951; Sailleau C, 2020, TRANSBOUND EMERG DIS, V67, P2324, DOI 10.1111/tbed.13659; Sayeed M., 2020, ADV ANIM VET SCI, V8, P804, DOI [10.17582/journal.aavs/2020/8.8.804.812, DOI 10.17582/JOURNAL.AAVS/2020/8.8.804.812]; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD94, DOI 10.1093/nar/gky989; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Sit THC, 2020, NATURE, V586, P776, DOI 10.1038/s41586-020-2334-5; Skirmuntt EC, 2020, ANNU REV VIROL, V7, P103, DOI 10.1146/annurev-virology-092818-015613; Smyth D.S., 2021, MEDRXIV, V848, P157740, DOI [10.1101/2021.03.21.21253978, DOI 10.1101/2021.03.21.21253978]; Touati R, 2020, GENOMICS, V112, P4189, DOI 10.1016/j.ygeno.2020.07.003; van Aart AE, 2022, TRANSBOUND EMERG DIS, V69, P3001, DOI 10.1111/tbed.14173; Wang LF, 2007, CURR TOP MICROBIOL, V315, P325; Wilson DJ, 2006, GENETICS, V172, P1411, DOI 10.1534/genetics.105.044917; Wong G, 2020, ZOOL RES, V41, P213, DOI 10.24272/j.issn.2095-8137.2020.031; World Health Organization, MIDDLE E RESP SYNDRO; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xiao X, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91470-2; Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022; Zhang YZ, 2020, CELL, V181, P223, DOI 10.1016/j.cell.2020.03.035; Zhang ZP, 2020, J INFECTION, V80, pE28, DOI 10.1016/j.jinf.2020.03.010; Zhao J, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.580137; Zhou H, 2021, CELL, V184, P4380, DOI 10.1016/j.cell.2021.06.008; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9	77	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0260635	10.1371/journal.pone.0260635	http://dx.doi.org/10.1371/journal.pone.0260635			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910734	gold, Green Published			2022-12-26	WOS:000754828900022
J	Kayiga, H; Genevive, DA; Amuge, PM; Ssemata, AS; Nanzira, RS; Nakimuli, A				Kayiga, Herbert; Genevive, Diane Achanda; Amuge, Pauline Mary; Ssemata, Andrew Sentoogo; Nanzira, Racheal Samantha; Nakimuli, Annettee			Lived experiences of frontline healthcare providers offering maternal and newborn services amidst the novel corona virus disease 19 pandemic in Uganda: A qualitative study	PLOS ONE			English	Article								Background The COVID-19 pandemic has brought many health systems in low resource settings to their knees. The pandemic has had crippling effects on the already strained health systems in provision of maternal and newborn healthcare. With the travel restrictions, social distancing associated with the containment of theCOVID-19 pandemic, healthcare providers could be faced with challenges of accessing their work stations, and risked burnout as they offered maternal and newborn services. This study sought to understand the experiences and perceptions of healthcare providers at the frontline during the first phase of the lockdown as they offered maternal and newborn health care services in both public and private health facilities in Uganda with the aim of streamlining patient care in face of the current COVID-19 pandemic and in future disasters. Methods Between June 2020 and December 2020, 25 in-depth interviews were conducted among healthcare providers of different cadres in eight Public, Private-Not-for Profit and Private Health facilities in Kampala, Uganda. The interview guide primarily explored the lived experiences of healthcare providers as they offered maternal and newborn healthcare services during the COVID-19 pandemic. All of the in depth interviews were audio recorded and transcribed verbatim. Themes and subthemes were identified using both inductive thematic and phenomenological approaches. Results The content analysis of the in depth interviews revealed that the facilitators of maternal and newborn care service delivery among the healthcare providers during the COVID-19 pandemic included; salary bonuses, the passion to serve their patients, availability of accommodation during the pandemic, transportation to and from the health facilities by the health facilities, teamwork, fear of losing their jobs and fear of litigation if something went wrong with the mothers or their babies. The barriers to their service delivery included; lack of transport means to access their work stations, fear of contracting COVID-19 and transmitting it to their family members, salary cuts, loss of jobs especially in the private health facilities, closure of the non-essential services to combat high patient numbers, inadequate supply of Personal Protective equipment (PPE), being put in isolation or quarantine for two weeks which meant no earning, brutality from the security personnel during curfew hours and burnout from long hours of work and high patient turnovers. Conclusion The COVID-19 Pandemic has led to a decline in quality of maternal and newborn service delivery by the healthcare providers as evidenced by shorter consultation time and failure to keep appointments to attend to patients. Challenges with transport, fears of losing jobs and fear of contracting COVID-19 with the limited access to personal protective equipment affected majority of the participants. The healthcare providers in Uganda despite the limitations imposed by the COVID-19 pandemic are driven by the inherent passion to serve their patients. Availability of accommodation and transport at the health facilities, provision of PPE, bonuses and inter professional teamwork are critical motivators that needed to be tapped to drive teams during the current and future pandemics.	[Kayiga, Herbert; Nakimuli, Annettee] Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynecol, Kampala, Uganda; [Genevive, Diane Achanda; Nanzira, Racheal Samantha] Kawempe Natl Referral Hosp, Kampala, Uganda; [Amuge, Pauline Mary] Baylor Coll Med, Kampala, Uganda; [Ssemata, Andrew Sentoogo] Makerere Univ, Coll Hlth Sci, Dept Psychiat, Kampala, Uganda	Makerere University; Baylor College of Medicine; Makerere University	Kayiga, H (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynecol, Kampala, Uganda.	hkayiga@gmail.com			Government of Uganda through the Makerere University Research Innovations Fund (RIF) project of Makerere University	Government of Uganda through the Makerere University Research Innovations Fund (RIF) project of Makerere University	This project was supported by The Government of Uganda through the Makerere University Research Innovations Fund (RIF) project of Makerere University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Government of Uganda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas K, 2020, LANCET GLOB HEALTH, V8, pE1264, DOI [10.1016/S2214-109X(20)30308-9, 10.1016/52214-109X(20)30308-9]; Acup C, 2017, ACTA TROP, V165, P230, DOI 10.1016/j.actatropica.2016.05.009; [Anonymous], 2020, LAB TEST STRAT REC C; [Anonymous], 2018, RECOMMENDATIONS INTR; ATAGI, 2020, GUID PRINC MAINT IMM; Athumani Halima, 2021, VOA 0707; Athumani Halima, UGANDA CUTS COST COV; Benova L, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3546-3; Burt JF, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-006102; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2; Daily Monitor,, DAILY MONITOR; Das S, 2020, CLIN DRUG INVEST, V40, P591, DOI 10.1007/s40261-020-00927-1; Desa U., 2015, 241 ESAPWP; Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410; Gildner TE, 2020, AM J HUM BIOL, V32, DOI 10.1002/ajhb.23494; Godman B, 2020, BANGLADESH J MED SCI, V19, pS103, DOI 10.3329/bjms.v19i0.48413; Hall C, 2020, THIS ONE THING COULD; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hussein J, 2020, SEX REPROD HLTH MATT, V28, DOI 10.1080/26410397.2020.1746065; Imani B, 2019, ISSUES MENT HEALTH N, V40, P712, DOI 10.1080/01612840.2017.1395497; index Mundi, 2019, UG DEM PROF; Kayiga H., 2021, IMPACT COVID 19 PAND; Kearns AD, 2016, BJOG-INT J OBSTET GY, V123, P540, DOI 10.1111/1471-0528.13818; Kiguli J, 2009, PATIENT PREFER ADHER, V3, P77; Konde-Lule J, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-29; Lincoln Y.S., 1986, NEW DIRECTIONS PROGR, V1986, P73, DOI [https://doi.org/10.1002/ev.1427, 10.1002/ev.1427, DOI 10.1002/EV.1427]; Macro O., 2000, UG DEM HLTH SURV; Madinah N., 2016, IOSR J NURS HLTH SCI, V5, P30; Mann R, 2018, AUST NZ J OBSTET GYN, V58, P449, DOI 10.1111/ajo.12764; Mary Tusingwire Anne, 2020, COVID 19 UGANDA; Matama R, 2021, J GAMBL STUD, V37, P551, DOI 10.1007/s10899-020-09973-y; Nalumansi A, 2021, INT J INFECT DIS, V104, P282, DOI 10.1016/j.ijid.2020.10.073; Nelson R, 2020, LANCET INFECT DIS, V20, P546, DOI 10.1016/S1473-3099(20)30304-2; Nilsson M, 2016, NATURE, V534, P320, DOI 10.1038/534320a; Ogunleye OO, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01205; Okwero P, 2010, WOR BANK WORK PAPER, P1, DOI 10.1596/978-0-8213-8290-5; Olum R, 2020, INT J INFECT DIS, V96, P517, DOI 10.1016/j.ijid.2020.05.073; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Pallangyo E, 2020, MIDWIFERY, V89, DOI 10.1016/j.midw.2020.102775; Patton MQ., 2002, QUALITATIVE RES EVAL, V3rd; Purcell LN, 2020, INT J SURG, V76, P111, DOI 10.1016/j.ijsu.2020.03.002; Ridpath Alison Delano, 2017, Pan Afr Med J, V27, P24, DOI 10.11604/pamj.supp.2017.27.3.11783; Roberton T, 2020, LANCET GLOB HEALTH, V8, pE901, DOI 10.1016/S2214-109X(20)30229-1; Sabastiano Rwengabo, COVID 19 UGANDA NATL; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Speziale HS, 2011, QUALITATIVE RES NURS; Stephens I, 2009, J FAM PLAN REPROD H, V35, P215, DOI 10.1783/147118909789587150; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Uganda Bureau of Statistics , 2017, UPHIA 2016 2017 INT; Uganda Ministry of Health, COR VIR COVID 19 PAN; Wilhelm JA, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010406; World Health Organization, 2020, CONT ESS SEX REPR MA; World Health Organization, 2021, NEW DRUGS APPR WORLD; World Health Organization, 2018, MAN EP KEY FACTS MAJ; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	56	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0259835	10.1371/journal.pone.0259835	http://dx.doi.org/10.1371/journal.pone.0259835			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YN5JA	34890417	gold, Green Accepted, Green Published			2022-12-26	WOS:000747293600005
J	Bozigar, M; Lawson, AB; Pearce, JL; Svendsen, ER; Vena, JE				Bozigar, Matthew; Lawson, Andrew B.; Pearce, John L.; Svendsen, Erik R.; Vena, John E.			Using Bayesian time-stratified case-crossover models to examine associations between air pollution and "asthma seasons" in a low air pollution environment	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; COARSE PARTICULATE MATTER; HEALTH-CARE UTILIZATION; HOSPITAL ADMISSIONS; CHILDHOOD ASTHMA; GRASS-POLLEN; RACIAL DISPARITIES; RESPIRATORY VIRUS; CHILDREN; EXPOSURE	Many areas of the United States have air pollution levels typically below Environmental Protection Agency (EPA) regulatory limits. Most health effects studies of air pollution use meteorological (e.g., warm/cool) or astronomical (e.g., solstice/equinox) definitions of seasons despite evidence suggesting temporally-misaligned intra-annual periods of relative asthma burden (i.e., "asthma seasons"). We introduce asthma seasons to elucidate whether air pollutants are associated with seasonal differences in asthma emergency department (ED) visits in a low air pollution environment. Within a Bayesian time-stratified case-crossover framework, we quantify seasonal associations between highly resolved estimates of six criteria air pollutants, two weather variables, and asthma ED visits among 66,092 children ages 5-19 living in South Carolina (SC) census tracts from 2005 to 2014. Results show that coarse particulates (particulate matter <10 mu m and >2.5 mu m: PM10-2.5) and nitrogen oxides (NOx) may contribute to asthma ED visits across years, but are particularly implicated in the highest-burden fall asthma season. Fine particulate matter (<2.5 mu m: PM2.5) is only associated in the lowest-burden summer asthma season. Relatively cool and dry conditions in the summer asthma season and increased temperatures in the spring and fall asthma seasons are associated with increased ED visit odds. Few significant associations in the medium-burden winter and medium-high-burden spring asthma seasons suggest other ED visit drivers (e.g., viral infections) for each, respectively. Across rural and urban areas characterized by generally low air pollution levels, there are acute health effects associated with particulate matter, but only in the summer and fall asthma seasons and differing by PM size.	[Bozigar, Matthew; Lawson, Andrew B.; Pearce, John L.; Svendsen, Erik R.; Vena, John E.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Bozigar, Matthew] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA	Medical University of South Carolina; Boston University	Bozigar, M (corresponding author), Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.; Bozigar, M (corresponding author), Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA.	bozigar@bu.edu		Bozigar, Matthew/0000-0003-0429-0247				Akinbami LJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2354; American Lung Association, REP CARD S CAR; [Anonymous], 2010, S CAR; Appel KW, 2011, GEOSCI MODEL DEV, V4, P357, DOI 10.5194/gmd-4-357-2011; Babatunde OA, 2016, CANCER CAUSE CONTROL, V27, P503, DOI 10.1007/s10552-016-0724-7; Bi JZ, 2020, ENVIRON RES, V190, DOI 10.1016/j.envres.2020.109967; Bobb JF, 2015, BIOSTATISTICS, V16, P493, DOI 10.1093/biostatistics/kxu058; Bozigar M., 2020, INT J HEALTH GEOGR, V19, P1, DOI [10.1186/s12942-020-0197-5, DOI 10.1186/S12942-020-0197-5]; Bozigar M, 2020, HEALTH PLACE, V66, DOI 10.1016/j.healthplace.2020.102426; Brauer M, 2008, ENVIRON HEALTH PERSP, V116, P680, DOI 10.1289/ehp.10952; Bryant-Stephens T, 2009, J ALLERGY CLIN IMMUN, V123, P1199, DOI 10.1016/j.jaci.2009.04.030; Bulkhi AA, 2020, J ALLER CL IMM-PRACT, V8, P3029, DOI 10.1016/j.jaip.2020.05.022; BUSSE WW, 1972, J ALLERGY CLIN IMMUN, V50, P289, DOI 10.1016/0091-6749(72)90027-9; Carlton AG, 2010, ENVIRON SCI TECHNOL, V44, P8553, DOI 10.1021/es100636q; Carracedo-Martinez E, 2010, ENVIRON HEALTH PERSP, V118, P1173, DOI 10.1289/ehp.0901485; Castro CR, 2019, ANN ALLERG ASTHMA IM, V123, P220, DOI 10.1016/j.anai.2019.05.001; Chang HH., 2019, ENVIRON MONIT ASSESS, P191, DOI [10.1007/s10661-019-7311-9, DOI 10.1007/S10661-019-7311-9]; Claudio L, 2006, ANN EPIDEMIOL, V16, P332, DOI 10.1016/j.annepidem.2005.06.046; Cohen HA, 2014, PEDIATRICS, V133, pE923, DOI 10.1542/peds.2013-2022; Darrow LA, 2012, J ALLERGY CLIN IMMUN, V130, P630, DOI 10.1016/j.jaci.2012.06.020; de Valpine P, 2017, J COMPUT GRAPH STAT, V26, P403, DOI 10.1080/10618600.2016.1172487; Delfino RJ, 2014, EPIDEMIOLOGY, V25, P48, DOI 10.1097/EDE.0000000000000016; Delfino RJ, 2009, ANN ALLERG ASTHMA IM, V102, P138, DOI 10.1016/S1081-1206(10)60244-X; Eggleston PA, 2009, PEDIATRICS, V123, pS160, DOI 10.1542/peds.2008-2233F; Eggo RM, 2016, P NATL ACAD SCI USA, V113, P2194, DOI 10.1073/pnas.1518677113; Erbas B, 2012, CLIN EXP ALLERGY, V42, P799, DOI 10.1111/j.1365-2222.2012.03995.x; Fakhri AA, 2009, ENVIRON HEALTH PERSP, V117, P1287, DOI 10.1289/ehp.0900541; Fan JC, 2016, ENVIRON SCI POLLUT R, V23, P843, DOI 10.1007/s11356-015-5321-x; Fleming DM, 2000, THORAX, V55, P662, DOI 10.1136/thorax.55.8.662; Foley KM, 2010, GEOSCI MODEL DEV, V3, P205, DOI 10.5194/gmd-3-205-2010; Friberg MD, 2016, ENVIRON SCI TECHNOL, V50, P3695, DOI 10.1021/acs.est.5b05134; Gass K, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0044-5; Gelman A., 2018, PRIOR CHOICE RECOMME; Gleason JA, 2015, J ASTHMA, V52, P815, DOI 10.3109/02770903.2015.1033726; Gleason JA, 2014, ENVIRON RES, V132, P421, DOI 10.1016/j.envres.2014.03.035; Gong H, 2003, INHAL TOXICOL, V15, P305, DOI 10.1080/08958370390168300; Goodwin AJ, 2016, CHEST, V150, P829, DOI 10.1016/j.chest.2016.07.004; Guo YM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05509; Heguy L, 2008, ENVIRON RES, V106, P203, DOI 10.1016/j.envres.2007.10.005; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Hu YB, 2020, ENVIRON RES, V191, DOI 10.1016/j.envres.2020.110115; Janes H, 2005, STAT MED, V24, P285, DOI 10.1002/sim.1889; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Jariwala SP, 2011, J ASTHMA, V48, P442, DOI 10.3109/02770903.2011.567427; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; Kedem B., 2002, REGRESSION MODELS TI; Keet CA, 2018, AM J RESP CRIT CARE, V197, P737, DOI 10.1164/rccm.201706-1267OC; Kim H., 2009, PREV CHRONIC DIS, P6; Lawson AB, 2008, BAYESIAN DIS MAPPING, V3rd; Li S, 2013, BIOMETRICS, V69, P925, DOI 10.1111/biom.12102; Liu LJ, 2021, CHEMOSPHERE, V263, DOI 10.1016/j.chemosphere.2020.127856; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Marks GB, 2001, THORAX, V56, P468, DOI 10.1136/thorax.56.6.468; McElligott JT, 2013, J RURAL HEALTH, V29, P198, DOI 10.1111/j.1748-0361.2012.00434.x; Miranda ML, 2011, INT J ENV RES PUB HE, V8, P1755, DOI 10.3390/ijerph8061755; Mohr LB, 2008, J ASTHMA, V45, P936, DOI 10.1080/02770900802404082; Monto AS, 2004, PEDIATR INFECT DIS J, V23, pS58, DOI 10.1097/01.inf.0000108193.91607.34; NIMBLE Development Team, 2018, NIMBLE: MCMC, Particle Filtering, DOI 10.5281/zenodo.1322114; Orellano P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174050; Pearce J, 2017, AIR QUAL ATMOS HLTH, V10, P1181, DOI 10.1007/s11869-017-0503-y; Peng RD, 2008, JAMA-J AM MED ASSOC, V299, P2172, DOI 10.1001/jama.299.18.2172; Pennington AF, 2018, EPIDEMIOLOGY, V29, P22, DOI [10.1097/EDE.0000000000000754, 10.1097/ede.0000000000000754]; Perry TT, 2012, ANN ALLERG ASTHMA IM, V108, P254, DOI 10.1016/j.anai.2012.01.017; Powell H, 2015, ENVIRON HEALTH PERSP, V123, P1152, DOI 10.1289/ehp.1408720; PRISM, 2022, US; R Core Team, 2021, R LANG ENV STAT; Salciccioli JD, 2021, J ALLER CL IMM-PRACT, V9, P2896, DOI 10.1016/j.jaip.2021.04.038; Schappi GF, 1999, CLIN EXP ALLERGY, V29, P633, DOI 10.1046/j.1365-2222.1999.00567.x; Schatz M, 2013, J ALLER CL IMM-PRACT, V1, P618, DOI 10.1016/j.jaip.2013.07.009; South Carolina Department of Environmental Health and Control, 2021, AMB AIR MON NETW; SPIEKSMA FTM, 1990, CLIN EXP ALLERGY, V20, P273, DOI 10.1111/j.1365-2222.1990.tb02683.x; Strickland MJ, 2010, AM J RESP CRIT CARE, V182, P307, DOI 10.1164/rccm.200908-1201OC; Sun XZ, 2016, SCI TOTAL ENVIRON, V544, P185, DOI 10.1016/j.scitotenv.2015.11.100; Taquechel K, 2020, J ALLER CL IMM-PRACT, V8, P3378, DOI [10.1016/j.jaip.2020.057, 10.1016/j.jaip.2020.07.057]; Togias A, 2010, J ALLERGY CLIN IMMUN, V125, P540, DOI 10.1016/j.jaci.2010.01.040; United States Environmental Protection Agency, 2020, 2012 NAT AMB QUAL ST; Valet RS, 2011, ANN ALLERG ASTHMA IM, V106, P467, DOI 10.1016/j.anai.2011.02.013; van der A RJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009021; Wallace K, 2013, CANCER CAUSE CONTROL, V24, P463, DOI 10.1007/s10552-012-0133-5; WHO, 2016, AMBIENT AIR POLLUTIO; Wilson S, 2015, ENVIRON RES, V140, P562, DOI 10.1016/j.envres.2015.05.016; Winquist A, 2014, EPIDEMIOLOGY, V25, P666, DOI 10.1097/EDE.0000000000000146; Wisniewski JA, 2016, ALLERGY ASTHMA PROC, V37, P475, DOI 10.2500/aap.2016.37.3994; Witkowska A, 2016, AIR QUAL ATMOS HLTH, V9, P761, DOI 10.1007/s11869-015-0378-8; Yung JA, 2018, ANN ALLERG ASTHMA IM, V120, P488, DOI 10.1016/j.anai.2018.01.016	85	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260264	10.1371/journal.pone.0260264	http://dx.doi.org/10.1371/journal.pone.0260264			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879071	Green Published, gold			2022-12-26	WOS:000754625200011
J	Heydari, S; Konstantinoudis, G; Behsoodi, AW				Heydari, Shahram; Konstantinoudis, Garyfallos; Behsoodi, Abdul Wahid			Effect of the COVID-19 pandemic on bike-sharing demand and hire time: Evidence from Santander Cycles in London	PLOS ONE			English	Article							RANDOM PARAMETERS MODEL; NETWORK DESIGN; BICYCLE SHARE; IMPACT; USAGE; TRANSPORT; SYSTEM; HETEROGENEITY; WASHINGTON; BIKESHARE	The COVID-19 pandemic has been influencing travel behaviour in many urban areas around the world since the beginning of 2020. As a consequence, bike-sharing schemes have been affected-partly due to the change in travel demand and behaviour as well as a shift from public transit. This study estimates the varying effect of the COVID-19 pandemic on the London bike-sharing system (Santander Cycles) over the period March-December 2020. We employed a Bayesian second-order random walk time-series model to account for temporal correlation in the data. We compared the observed number of cycle hires and hire time with their respective counterfactuals (what would have been if the pandemic had not happened) to estimate the magnitude of the change caused by the pandemic. The results indicated that following a reduction in cycle hires in March and April 2020, the demand rebounded from May 2020, remaining in the expected range of what would have been if the pandemic had not occurred. This could indicate the resiliency of Santander Cycles. With respect to hire time, an important increase occurred in April, May, and June 2020, indicating that bikes were hired for longer trips, perhaps partly due to a shift from public transit.	[Heydari, Shahram; Behsoodi, Abdul Wahid] Univ Southampton, Southampton, Hants, England; [Konstantinoudis, Garyfallos] Imperial Coll London, London, England	University of Southampton; Imperial College London	Heydari, S (corresponding author), Univ Southampton, Southampton, Hants, England.	s.heydari@soton.ac.uk	; Konstantinoudis, Garyfallos/E-2808-2016	Heydari, Shahram/0000-0001-5497-4909; Konstantinoudis, Garyfallos/0000-0001-7493-9334				Blangiardo M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240286; Borkowski P, 2021, J TRANSP GEOGR, V90, DOI 10.1016/j.jtrangeo.2020.102906; Caggiani L, 2019, TRANSP RES PROC, V37, P59, DOI 10.1016/j.trpro.2018.12.166; Cervero R, 2019, TRANSPORT POLICY, V74, P153, DOI 10.1016/j.tranpol.2018.09.007; Chibwe J, 2021, SUSTAIN CITIES SOC, V69, DOI 10.1016/j.scs.2021.102871; Congdon P., 2007, BAYESIAN STAT MODELL, DOI [10.1177/1471082X0700700205, DOI 10.1177/1471082X0700700205]; de Valpine P, 2017, J COMPUT GRAPH STAT, V26, P403, DOI 10.1080/10618600.2016.1172487; El-Assi W, 2017, TRANSPORTATION, V44, P589, DOI 10.1007/s11116-015-9669-z; Eren E, 2020, SUSTAIN CITIES SOC, V54, DOI 10.1016/j.scs.2019.101882; European Transport Safety Council, 2001, COMMUNICATION; Faghih-Imani A, 2020, TRANSPORTATION, V47, P529, DOI 10.1007/s11116-018-9896-1; Faghih-Imani A, 2014, J TRANSP GEOGR, V41, P306, DOI 10.1016/j.jtrangeo.2014.01.013; Fuller D, 2012, PREV MED, V54, P74, DOI 10.1016/j.ypmed.2011.09.021; Gebhart K, 2014, TRANSPORTATION, V41, P1205, DOI 10.1007/s11116-014-9540-7; Guo YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185100; Haddon C., 2021, LIFTING LOCKDOWN 202; Heydari S, 2018, ANAL METHODS ACCID R, V20, P68, DOI 10.1016/j.amar.2018.10.001; Heydari S, 2018, ANAL METHODS ACCID R, V19, P33, DOI 10.1016/j.amar.2018.06.003; Hu SH, 2021, J TRANSP GEOGR, V91, DOI 10.1016/j.jtrangeo.2021.102997; Jobe J., 2021, TRANSPORTATION RES I, V10, DOI [10.1016/j.trip.2021.100353, DOI 10.1016/J.TRIP.2021.100353]; Kim K, 2018, J TRANSP GEOGR, V66, P309, DOI 10.1016/j.jtrangeo.2018.01.001; Kontis V, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1112-0; Kubalak S, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13126544; Lazarus J, 2020, J TRANSP GEOGR, V84, DOI 10.1016/j.jtrangeo.2019.102620; Lei YY, 2021, TRANSPORT POLICY, V110, P487, DOI 10.1016/j.tranpol.2021.07.003; Li AY, 2021, COMPUT ENVIRON URBAN, V90, DOI 10.1016/j.compenvurbsys.2021.101703; Li HJ, 2021, TRANSPORT RES A-POL, V150, P140, DOI 10.1016/j.tra.2021.06.010; Li HJ, 2019, TRANSPORT RES A-POL, V130, P398, DOI 10.1016/j.tra.2019.09.050; Li HJ, 2018, TRANSPORT RES A-POL, V111, P304, DOI 10.1016/j.tra.2018.03.020; Loaiza-Monsalve D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213106; Martin EW, 2014, J TRANSP GEOGR, V41, P315, DOI 10.1016/j.jtrangeo.2014.06.026; Mattsson LG, 2015, TRANSPORT RES A-POL, V81, P16, DOI 10.1016/j.tra.2015.06.002; Morton C, 2020, J TRANSP GEOGR, V88, DOI 10.1016/j.jtrangeo.2020.102854; Nikiforiadis A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12198215; Nikitas A, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13094620; Nikitas A, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11113206; Noland RB, 2021, J TRANSP HEALTH, V20, DOI 10.1016/j.jth.2021.101016; ONS, 2021, COR IMP UK TRAV TOUR; Padmanabhan Vyas, 2021, Transp Res Interdiscip Perspect, V9, P100282, DOI 10.1016/j.trip.2020.100282; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Pucher J, 2010, PREV MED, V50, pS106, DOI 10.1016/j.ypmed.2009.07.028; Saberi M, 2018, J TRANSP GEOGR, V66, P154, DOI 10.1016/j.jtrangeo.2017.11.018; Sears J, 2012, TRANSPORT RES REC, P105, DOI 10.3141/2314-14; Shaheen SA., 2014, PUBLIC BIKESHARING N; Shaheen SA, 2010, TRANSPORT RES REC, P159, DOI 10.3141/2143-20; Teixeira Joao Filipe, 2020, Transp Res Interdiscip Perspect, V6, P100166, DOI 10.1016/j.trip.2020.100166; Transport for London, 2020, TFL SANT CELEBR 10 Y; Vickerman R, 2021, TRANSPORT POLICY, V103, P95, DOI 10.1016/j.tranpol.2021.01.005; Wang HY, 2021, TRANSPORT POLICY, V106, P262, DOI 10.1016/j.tranpol.2021.04.004; Wang KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089405; Weinert J, 2007, TRANSPORTATION, V34, P301, DOI 10.1007/s11116-007-9118-8; Younes H, 2019, J TRANSP GEOGR, V76, P83, DOI 10.1016/j.jtrangeo.2019.03.004	52	9	9	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260969	10.1371/journal.pone.0260969	http://dx.doi.org/10.1371/journal.pone.0260969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855914	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000735299000160
J	Sato, A; Aihara, R; Karino, K				Sato, Aya; Aihara, Ryu-ichi; Karino, Kenji			Male coloration affects female gestation period and timing of fertilization in the guppy (Poecilia reticulata)	PLOS ONE			English	Article							SEQUENTIAL MATE CHOICE; COLORFUL MALE GUPPIES; MATING PREFERENCES; SPERM COMPETITION; ATTRACTIVE MALES; MALE PHENOTYPE; HERITABILITY; POPULATION; QUALITY; TRAITS	The trade-up hypothesis is a female behavioral strategy related to mating with multiple males. In this hypothesis, females can produce high-quality offspring while avoiding the risk of losing reproductive opportunities by non-selective mating with males at first mating and then re-mating with more attractive males. As an internal mechanism to realize this behavioral strategy, we predicted that females would immediately fertilize their eggs when they mated with attractive males, whereas females would delay fertilization when they mated with unattractive males to trade-up sires of offspring. The guppy (Poecilia reticulata) is an ovoviviparous fish with internal fertilization, and females show a clear mate preference based on the area of orange coloration on the bodies of males. In addition, it is known that females show a re-mating strategy consistent with the trade-up hypothesis. We tested whether the attractiveness of mated males affected the gestation period and the timing of fertilization. Females were paired with either colorful males or drab males, and the gestation periods (the number of days from mating to parturition) were compared. In addition, we dissected the abdomens of the females at intervals of several days after mating and observed whether the eggs were fertilized. The gestation period in females that were paired with attractive colorful males was significantly shorter than that in females that were paired with drab males. We found that females that mated with colorful males also had their eggs fertilized earlier than those that mated with drab males. Our findings show that differences in the timing of fertilization according to attractiveness of the mate increase the opportunity for cryptic female choice and trading up.	[Sato, Aya] Gunma Univ, Cooperat Fac Educ, Dept Sci Educ, Maebashi, Gumma, Japan; [Aihara, Ryu-ichi; Karino, Kenji] Tokyo Gakugei Univ, Dept Biol, Tokyo, Japan	Gunma University; Tokyo Gakugei University	Sato, A (corresponding author), Gunma Univ, Cooperat Fac Educ, Dept Sci Educ, Maebashi, Gumma, Japan.	satoaya@gunma-u.ac.jp						Barbosa F., 2015, CRYPTIC FEMALE CHOIC, P385, DOI [10.1007/978-3-319-17894-3_14, DOI 10.1007/978-3-319-17894-3_14]; Bateman PW, 2001, ANIM BEHAV, V61, P631, DOI 10.1006/anbe.2000.1617; Becher SA, 2004, P ROY SOC B-BIOL SCI, V271, P1009, DOI 10.1098/rspb.2004.2701; Birkhead T.R., 1998, P579, DOI 10.1016/B978-012100543-6/50039-8; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Constanz J., 1989, ECOLOGY EVOLUTION LI, V1st, P33; Dennenmoser S., 2015, CRYPTIC FEMALE CHOIC, P203, DOI 10.1007/978-3-319-17894-3_8; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; EBERHARD WG, 1995, TRENDS ECOL EVOL, V10, P493, DOI 10.1016/S0169-5347(00)89205-8; Evans JP, 2007, BEHAV ECOL SOCIOBIOL, V61, P719, DOI 10.1007/s00265-006-0302-1; Evans JP, 2010, P ROY SOC B-BIOL SCI, V277, P3195, DOI 10.1098/rspb.2010.0826; Evans JP, 2000, P NATL ACAD SCI USA, V97, P10074, DOI 10.1073/pnas.180207297; Evans JP, 2004, J FISH BIOL, V65, P1154, DOI 10.1111/j.0022-1112.2004.00502.x; Evans JP, 2004, P ROY SOC B-BIOL SCI, V271, P2035, DOI 10.1098/rspb.2004.2815; Evans JP, 2001, P ROY SOC B-BIOL SCI, V268, P719, DOI 10.1098/rspb.2000.1577; Gabor CR, 1997, BEHAV ECOL, V8, P162, DOI 10.1093/beheco/8.2.162; Grether GF, 2005, P ROY SOC B-BIOL SCI, V272, P2181, DOI 10.1098/rspb.2005.3197; Halliday T.R., 1983, P3; HAYNES JL, 1995, COPEIA, P147; HOUDE AE, 1992, HEREDITY, V69, P229, DOI 10.1038/hdy.1992.120; HOUDE AE, 1987, EVOLUTION, V41, P1, DOI 10.1111/j.1558-5646.1987.tb05766.x; Janhunen M, 2009, BIOL J LINN SOC, V98, P794, DOI 10.1111/j.1095-8312.2009.01317.x; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Karino K, 2004, ICHTHYOL RES, V51, P316, DOI 10.1007/s10228-004-0234-6; Karino K, 2005, BEHAV ECOL SOCIOBIOL, V59, P1, DOI 10.1007/s00265-005-0001-3; Karino K, 2010, J FISH BIOL, V77, P299, DOI 10.1111/j.1095-8649.2010.02688.x; Karino K, 2001, J ETHOL, V19, P33, DOI 10.1007/s101640170015; Karino K, 2009, ETHOLOGY, V115, P682, DOI 10.1111/j.1439-0310.2009.01650.x; Kelly CD, 1999, P ROY SOC B-BIOL SCI, V266, P2403, DOI 10.1098/rspb.1999.0938; Locatello L, 2006, J EVOLUTION BIOL, V19, P1595, DOI 10.1111/j.1420-9101.2006.01117.x; Magris M, 2017, ANIM BEHAV, V131, P45, DOI 10.1016/j.anbehav.2017.07.009; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Martyn U, 2006, DEV DYNAM, V235, P617, DOI 10.1002/dvdy.20664; Matthews IM, 1997, P ROY SOC B-BIOL SCI, V264, P695, DOI 10.1098/rspb.1997.0099; Mehlis M, 2013, CURR ZOOL, V59, P761, DOI 10.1093/czoolo/59.6.761; Neff BD, 2004, EVOLUTION, V58, P1846; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Peters A, 2004, J EVOLUTION BIOL, V17, P1111, DOI 10.1111/j.1420-9101.2004.00743.x; Pilastro A, 2007, ANIM BEHAV, V74, P321, DOI 10.1016/j.anbehav.2006.09.016; Pilastro A, 2002, P ROY SOC B-BIOL SCI, V269, P1325, DOI 10.1098/rspb.2002.2017; Pilastro A, 2004, EVOLUTION, V58, P665, DOI 10.1111/j.0014-3820.2004.tb01690.x; Pilastro A, 2008, BEHAV ECOL, V19, P374, DOI 10.1093/beheco/arm140; Pitcher TE, 2007, J FISH BIOL, V70, P165, DOI 10.1111/j.1095-8649.2006.01292.x; Pitcher TE, 2001, CAN J ZOOL, V79, P1891, DOI 10.1139/cjz-79-10-1891; Pitcher TE, 2003, P ROY SOC B-BIOL SCI, V270, P1623, DOI 10.1098/rspb.2002.2280; Moyano MPS, 2014, J SEA RES, V85, P300, DOI 10.1016/j.seares.2013.05.015; Simmons L. W., 2001, MG BEH ECOL; Skinner AMJ, 2007, BEHAV ECOL, V18, P47, DOI 10.1093/beheco/arl049; Thiel M, 2003, BEHAV ECOL SOCIOBIOL, V55, P113, DOI 10.1007/s00265-003-0677-1; THORNHILL R, 1983, AM NAT, V122, P765, DOI 10.1086/284170	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0261004	10.1371/journal.pone.0261004	http://dx.doi.org/10.1371/journal.pone.0261004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855912	gold, Green Published			2022-12-26	WOS:000735299000167
J	Hassen, S; Adane, M				Hassen, Seada; Adane, Metadel			Facemask-wearing behavior to prevent COVID-19 and associated factors among public and private bank workers in Ethiopia	PLOS ONE			English	Article							CHINESE	Background Given widespread vulnerability to COVID-19 infection in areas with low vaccination rates, facemask wearing is repeatedly emphasized for the general population including bank workers, who have contact with many customers each day. Over the first year of the COVID-19 pandemic, studies focused on facemask wearing among healthcare workers but not among bank workers, who are also at risk of COVID-19. To address this gap and to consider intervention measures that encourage the wearing of facemasks, this study was conducted to identify behaviors of facemask wearing and associated factors among bank workers in Dessie City, Ethiopia. Materials and methods An institution-based cross-sectional study was conducted among 413 bank workers who were selected using a simple random sampling technique from January 1(st) to 30(th), 2021 in Dessie City, Ethiopia. Data were collected using a structured questionnaire and on-the-spot observational checklist. The collected data were checked, coded and entered to EpiData version 4.6 and exported to Statistical Package for Social Sciences (SPSS) version 25.0 for data cleaning and analysis. Data were analyzed using bivariable (crude odds ratio [COR]) and multivariable (adjusted odds ratio [AOR]) logistic regression model at 95% confidence interval (CI). Variables from the bivariable analysis with a p-value <0.25 were considered for multivariable analysis. Then, variables that had a p-value <0.05 were declared as factors significantly associated with behavior of facemask wearing. Main findings In this study, the behavior of facemask wearing among bank workers was 50.4% [95%CI: 45.3-55.2%] with 21.1% always wearing a facemask, 72.4% sometimes, and 6.5% never. A majority of the bank workers 350 (84.7%) had good knowledge of COVID-19 and half of them 208 (50.4%) had a positive attitude towards taking precautions against COVID-19. Just over two-thirds of the respondents 284 (68.8%) preferred to wear a non-medical mask. Two hundred fifty-five (61.7%) said wearing a facemask interfered with communication and 259 (62.7%) felt that wearing a facemask was not comfortable. Facemask-wearing behavior was significantly associated with a high level of positive attitude towards taking precautions against COVID-19 (AOR = 3.27, 95% CI: 1.75-6.11), the perception that the consequences of getting COVID-19 could be serious (AOR = 4.87, 95% CI: 2.38-9.94), the presence of chronic illness (AOR = 2.19, 95% CI: 1.07-4.48), sex being female (AOR = 1.87, 95% CI: 1.06-3.32) and age being greater or equal to 35 years (AOR = 9.25, 95% CI: 4.79-17.88). Conclusion The main finding of the study showed that the behavior of facemask wearing among bank workers was relatively low (50.4%) compared to other types of workers as found in other studies. To increase the behavior of facemask wearing among bank workers, health decision makers need to develop updated guidance for promotion of facemask wearing to increase the practical and appropriate use of facemasks among bank workers. Bank managers and concerned government bodies should enforce mask use to change behavior of these workers.	[Hassen, Seada; Adane, Metadel] Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia	University of Gondar	Hassen, S (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia.	seah9400m@gmail.com	Hassen, Seada/GOH-0623-2022; Adane, Metadel/AFQ-9478-2022	Adane, Metadel/0000-0002-7039-4768				Aisuodionoe ME., INT J SC HEALTHC RES, V1, P70; Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217; [Anonymous], 2002, Bull World Health Organ, V80, P983; Apanga PA, 2021, AM J TROP MED HYG, V104, P526, DOI 10.4269/ajtmh.20-1301; Barasheed O, 2016, INT J INFECT DIS, V47, P105, DOI 10.1016/j.ijid.2016.03.023; Baye K., 2020, COVID 19 PREVENTION; CDC Centers for disease control and prevention, 2020, COVID 19 COR DIS COV, V19; Chen Xuyu, 2020, Int J Environ Res Public Health, V17, DOI 10.3390/ijerph17082893; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; CSA. Central Statistical Agency, 2014, POPULATION PROJECTIO, V3; Desalegn Z, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244780; Dessie City Adminstration, 2019, DESS CIT ADM OFF ANN; Ferng YH, 2011, PUBLIC HEALTH NURS, V28, P13, DOI 10.1111/j.1525-1446.2010.00918.x; Haischer MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240785; Howard G, 2020, J WATER HEALTH, V18, P613, DOI 10.2166/wh.2020.162; Huang Y, 2020, J MED INTERNET RES, V22, DOI 10.2196/18718; iek Slavoj., 2020, COVID 19 CORONAVIRUS; Ilesanmi O, 2020, PEERJ, V8, DOI 10.7717/peerj.10038; Isah MB., 2020, CORONA VIRUS DIS 201; Kalu AU., 2020, LIB INF SCI DIG, V13, P100; Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744; Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002; Lee M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092977; Maina Michuki, 2020, Wellcome Open Res, V5, P211, DOI 10.12688/wellcomeopenres.16222.1; MOH  EPHI, 2020, MIN HLTH UG UG NAT T; Muller O, 2020, DEUT MED WOCHENSCHR, V145, P670, DOI 10.1055/a-1162-1987; Muniyappa R, 2020, AM J PHYSIOL-ENDOC M, V318, pE736, DOI 10.1152/ajpendo.00124.2020; Natnael T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247954; Pereira-Avila FMV, 2020, REV LAT-AM ENFERM, V28, DOI 10.1590/1518-8345.4604.3360; Ray I, 2020, WORLD DEV, V135, DOI 10.1016/j.worlddev.2020.105086; Scheid JL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186655; Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032; Wada K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1065; WB. World bank, 2020, POL BRIEF IMP COVID, V20; WHO, 2020, CRIT PREP READ RESP, V2; WHO/UNICEF. WHO/UNICEF. Ministry of Health, 2020, GUID US MASKS; WHO. World Health Organization, COVID 19 WEEKL EP UP, P2021; Wong CL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217878; World Health Organization, 2021, COVID 19 WORLD WORK; World Health Organization, 1948, BAS DOC; Yildirim M, 2021, PSYCHOL HEALTH MED, V26, P35, DOI 10.1080/13548506.2020.1776891; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	43	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0259659	10.1371/journal.pone.0259659	http://dx.doi.org/10.1371/journal.pone.0259659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851973	gold, Green Published			2022-12-26	WOS:000755762900013
J	Xiong, HB; Chen, L; Sun, ZH; Li, ZQ; Zhou, K; Chen, ZH				Xiong, Haibin; Chen, Li; Sun, Zhaohua; Li, Zhiqing; Zhou, Kun; Chen, Zhenghao			Simulating the impact of piers on hydrodynamics and pollutant transport: A case study in the Middle Yangtze River	PLOS ONE			English	Article							PETROCHEMICAL PLANT; SONGHUA RIVER; WATER; EXPLOSION; FLOW	It is known that channel engineering, including the construction of piers, will change the river hydrodynamic characteristics, which is a significant factor affecting the transport process of pollutants. With this regard, this study uses the well-validated and tested hydrodynamic module and transport module of MIKE 21 to simulate the hydrodynamics and water quality under various pier densities in the Wuhan reach. Hydrodynamic changes around the piers show spatial differences, which are similar under different discharges. The range and amplitude of hydrodynamic spatial variations increase with the increase in pier density. However, there is a critical value of 1.25 to 2.5 units/km. When the pier density is less than this critical value, this type of cumulative effect is the most significant. Additionally, greater changes can be found in chemical oxygen demand concentrations, which also show spatial and temporal variations. The area with high chemical oxygen demand concentration upstream and downstream from the engineering area exhibits the distribution characteristics of "decrease in the downstream area and increase in the upstream area" and "increase in downstream the area and decrease in the upstream area" respectively. In the reach section of the engineering area, the area with high chemical oxygen demand concentration increases in the front area near the piers and decreases near the shoreline. Furthermore, the concentration shows attenuation actions with a longer residence time owing to the buffering effect of pier groups. These results have significant implications on shoreline planning and utilization. Moreover, they provide scientific guidelines for water management.	[Xiong, Haibin; Chen, Li; Sun, Zhaohua; Li, Zhiqing; Zhou, Kun; Chen, Zhenghao] Wuhan Univ, State Key Lab Water Resources & Hydropower Engn S, Wuhan, Peoples R China	Wuhan University	Sun, ZH (corresponding author), Wuhan Univ, State Key Lab Water Resources & Hydropower Engn S, Wuhan, Peoples R China.	Lnszh@126.com		Sun, Zhaohua/0000-0002-2410-3309	National Key Research and Development Project of China [2018YFC0407802]; National Natural Science Foundation of China [51879198]	National Key Research and Development Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	H.X, L. C and Z.S are financially supported by the National Key Research and Development Project of China Grant (No.2018YFC0407802) and the National Natural Science Foundation of China (No.51879198) (http://www.nsfc.gov.cn/english/site_1/index.html).The funders had no role in study design, data collection, and analysis decision to publish, or preparation of the manuscript.	Ali KHM, 2002, J HYDRAUL RES, V40, P161, DOI 10.1080/00221680209499859; Ban JY, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13094637; Castelle B, 2018, ESTUAR COAST SHELF S, V200, P212, DOI 10.1016/j.ecss.2017.11.005; Chai YF, 2020, HYDROL RES, V51, P470, DOI 10.2166/nh.2020.143; Chai Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41583-6; Dai YJ, 2010, ANAL SCI, V26, P519, DOI 10.2116/analsci.26.519; DHI, 2014, MIKE 21 MIKE 3 FLOW; Fu HY., 2008, YANGTZE RIVER, V39, P40; Fu WJ, 2008, ENVIRON SCI POLLUT R, V15, P178, DOI 10.1065/espr2007.11.457; Garcia-Oliva M, 2017, INT J MAR ENERGY, V19, P177, DOI 10.1016/j.ijome.2017.07.006; Han JQ, 2017, GEOMORPHOLOGY, V298, P31, DOI 10.1016/j.geomorph.2017.09.034; Huang LN, 2017, WATER-SUI, V9, DOI 10.3390/w9090708; Huang W, 2021, ENVIRON MODEL ASSESS, V26, P63, DOI 10.1007/s10666-020-09715-9; Jia H, 2018, FRONT EARTH SCI-PRC, V12, P625, DOI 10.1007/s11707-018-0688-x; Li CJ, 2019, OCEAN COAST MANAGE, V179, DOI 10.1016/j.ocecoaman.2019.104814; Long YN, 2016, WATER-SUI, V8, DOI 10.3390/w8110516; Pagliara S, 2006, J HYDRAUL ENG, V132, P545, DOI 10.1061/(ASCE)0733-9429(2006)132:6(545); Rayburg S, 2009, HYDROL RES, V40, P364, DOI 10.2166/nh.2009.110; Ren Z. J., 2017, PORT WATERWAY ENG, V10, P118; Ritter A, 2013, J HYDROL, V480, P33, DOI 10.1016/j.jhydrol.2012.12.004; Suman A, 2015, HYDROL RES, V46, P824, DOI 10.2166/nh.2014.065; Wang H.Y, 2008, PRELIMINARY STUDY SU; Wang W, 2019, WATER-SUI, V11, DOI 10.3390/w11061181; Worman A., 2005, ACTA GEOPHYS, V53, P517; Xiong HB, 2021, WATER SUPPLY, V21, P3114, DOI 10.2166/ws.2021.080; Yan T, 2019, WATER SCI ENG, V12, P136, DOI 10.1016/j.wse.2019.05.004; [张楚天 Zhang Chutian1], 2013, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V22, P1363; Zhang H, 2020, ENVIRON SCI POLLUT R, V27, P469, DOI 10.1007/s11356-019-06517-9; Zhang P, 2021, J HYDROL, V597, DOI 10.1016/j.jhydrol.2021.126153; [张细兵 ZHANG Xibing], 2011, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V20, P1138	30	0	0	7	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260527	10.1371/journal.pone.0260527	http://dx.doi.org/10.1371/journal.pone.0260527			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852009	Green Published, gold			2022-12-26	WOS:000755762900043
J	Mukai, RG; Matsumoto, HG; Akiyama, HG				Mukai, Ryo G.; Matsumoto, Hidetaka G.; Akiyama, Hideo G.			Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age-related macular degeneration	PLOS ONE			English	Article							DISEASE; SAFETY; RANIBIZUMAB; MORTALITY	PurposeTo analyze the risk factors associated with emerging intraocular inflammation (IOI) after intravitreal brolucizumab injection (IVBr) to treat age-related macular degeneration (AMD). MethodsThis study included 93 eyes of 90 patients. The incidence of emerging IOI was analyzed. The patients were classified into IOI or non-IOI groups, and background clinical characteristics in each group were compared. ResultsIOI occurred in 14 eyes of 14 cases (16%; five women, nine men [5:9]; IOI group) after IVBr; contrastingly, no IOI occurred in 76 patients (10 women, 66 men [10:66]; non-IOI group). The mean ages in IOI and non-IOI groups were 79.4 +/- 8.1 and 73.8 +/- 8.9 years old, respectively, and the average age in the IOI group was significantly higher than that in the non-IOI group (P = 0.0425). In addition, the percentages of females in the IOI and non-IOI groups were 43% and 13%, respectively, and IOI occurred predominantly in females (odds ratio: 4.95, P = 0.0076). Moreover, the prevalence of diabetes in the IOI and non-IOI groups was 64% and 32%, respectively, with a significant difference (odds ratio: 3.90, P = 0.0196). In contrast, the prevalence of hypertension in the IOI and non-IOI groups was 36% and 57%, respectively, with no significant difference (P = 0.15). ConclusionThe comparison of clinical profiles of IOI or non-IOI cases in IVBr treatment for AMD suggests that the risk factors for IOI are old age, female sex, and history of diabetes; however, IOI with vasculitis or vascular occlusion in this cohort does not seem to cause severe visual impairment. Further studies are required to investigate potential risk factors for IOI.	[Mukai, Ryo G.; Matsumoto, Hidetaka G.; Akiyama, Hideo G.] Gunma Univ, Dept Ophthalmol, Grad Sch Med, Maebashi, Gunma, Japan	Gunma University	Mukai, RG (corresponding author), Gunma Univ, Dept Ophthalmol, Grad Sch Med, Maebashi, Gunma, Japan.	rmukai@gunma-u.ac.jp		Matsumoto, Hidetaka/0000-0003-2311-0280; Mukai, Ryo/0000-0003-1796-9232				Beovu&TRADE;(brolucizumab), POSTMARKETING DAT; Berg K, 2017, ACTA OPHTHALMOL, V95, P796, DOI 10.1111/aos.13522; Dugel PU, 2021, OPHTHALMOLOGY, V128, P89, DOI [10.1016/j.opatha.2020.06.028, 10.1016/j.ophtha.2020.06.028]; Enriquez AB, 2021, JAMA OPHTHALMOL, V139, P441, DOI 10.1001/jamaophthalmol.2020.7085; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Haug Sara J, 2020, Am J Ophthalmol Case Rep, V18, P100680, DOI 10.1016/j.ajoc.2020.100680; Iyer Prashanth G, 2020, Am J Ophthalmol Case Rep, V20, P100989, DOI 10.1016/j.ajoc.2020.100989; Jain Atul, 2020, Am J Ophthalmol Case Rep, V18, P100687, DOI 10.1016/j.ajoc.2020.100687; JANKA HU, 1985, HORM METAB RES, V15, P15; Kitchens JW, 2016, OPHTHALMOLOGY, V123, P1511, DOI 10.1016/j.ophtha.2016.02.046; Krentz AJ, 2009, J VASC RES, V46, P515, DOI 10.1159/000226220; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Li JQ, 2020, BRIT J OPHTHALMOL, V104, P1077, DOI 10.1136/bjophthalmol-2019-314422; Maguire MG, 2016, OPHTHALMOLOGY, V123, P1751, DOI 10.1016/j.ophtha.2016.03.045; Maruko I, 2021, GRAEF ARCH CLIN EXP, V259, P2857, DOI 10.1007/s00417-021-05136-w; Matsumoto H, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86014-7; Mones J, 2021, OPHTHALMOLOGY, V128, P1050, DOI 10.1016/j.ophtha.2020.11.011; Noma H, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073427; Ogura Yuichiro, 2016, Nippon Ganka Gakkai Zasshi, V120, P87; Rich RM, 2006, RETINA-J RET VIT DIS, V26, P495, DOI 10.1097/01.iae.0000225766.75009.3a; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Sauerborn M, 2010, TRENDS PHARMACOL SCI, V31, P53, DOI 10.1016/j.tips.2009.11.001; Sharma A, 2021, EYE, V35, P1292, DOI 10.1038/s41433-020-01227-w; Spinelli FR, 2013, CLIN EXP RHEUMATOL, V31, P954; STOUT RW, 1979, DIABETOLOGIA, V16, P141, DOI 10.1007/BF01219790; Tolentino M, 2011, SURV OPHTHALMOL, V56, P95, DOI 10.1016/j.survophthal.2010.08.006; Uemura A, 2021, PROG RETIN EYE RES, V84, DOI 10.1016/j.preteyeres.2021.100954; Ueta T, 2014, OPHTHALMOLOGY, V121, P2193, DOI 10.1016/j.ophtha.2014.05.022; Witkin Andre J, 2020, J Vitreoretin Dis, V4, P269, DOI 10.1177/2474126420930863; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Zarbin MA, 2018, ASIA-PAC J OPHTHALMO, V7, P63, DOI 10.22608/APO.2017495	32	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	12							e0259879	10.1371/journal.pone.0259879	http://dx.doi.org/10.1371/journal.pone.0259879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM1MC	34871313	gold, Green Published			2022-12-26	WOS:000728598900004
J	Weng, CH; Butt, WWW; Brooks, MB; Clarke, C; Jenkins, HE; Holland, SD; Chiang, SS				Weng, Chien-Hsiang; Butt, Wesley Wing Wah; Brooks, Meredith B.; Clarke, Claudia; Jenkins, Helen E.; Holland, Sabina D.; Chiang, Silvia S.			Diagnostic value of symptoms for pediatric SARS-CoV-2 infection in a primary care setting	PLOS ONE			English	Article								Purpose To evaluate the diagnostic value of symptoms used by daycares and schools to screen children and adolescents for SARS-CoV-2 infection, we analyzed data from a primary care setting. Methods This cohort study included all patients <= 17 years old who were evaluated at Providence Community Health Centers (PCHC; Providence, U.S.), for COVID-19 symptoms and/or exposure, and received SARS-CoV-2 polymerase chain reaction (PCR) testing between March-June 2020. Participants were identified from PCHC electronic medical records. For three age groups-0-4, 5-11, and 12-17 years-we estimated the sensitivity, specificity, and area under the receiver operating curve (AUC) of individual symptoms and three symptom combinations: a case definition published by the Rhode Island Department of Health (RIDOH), and two novel combinations generated by different statistical approaches to maximize sensitivity, specificity, and AUC. We evaluated symptom combinations both with and without consideration of COVID-19 exposure. Myalgia, headache, sore throat, abdominal pain, nausea, anosmia, and ageusia were not assessed in 0-4 year-olds due to the lower reliability of these symptoms in this group. Results Of 555 participants, 217 (39.1%) were SARS-CoV-2-infected. Fever was more common among 0-4 years-olds (p = 0.002); older children more frequently reported fatigue (p = 0.02). In children >= 5 years old, anosmia or ageusia had 94-98% specificity. In all ages, exposure history most accurately predicted infection. With respect to individual symptoms, cough most accurately predicted infection in <5 year-olds (AUC 0.69) and 12-17 year-olds (AUC 0.62), while headache was most accurate in 5-11 year-olds (AUC 0.62). In combination with exposure history, the novel symptom combinations generated statistically to maximize test characteristics had sensitivity >95% but specificity <30%. No symptom or symptom combination had AUC >= 0.70. Conclusions Anosmia or ageusia in children >= 5 years old should raise providers' index of suspicion for COVID-19. However, our overall findings underscore the limited diagnostic value of symptoms.	[Weng, Chien-Hsiang; Butt, Wesley Wing Wah] Brown Univ, Dept Family Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Weng, Chien-Hsiang; Butt, Wesley Wing Wah; Clarke, Claudia] Providence Community Hlth Ctr, Providence, RI USA; [Brooks, Meredith B.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Jenkins, Helen E.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Holland, Sabina D.; Chiang, Silvia S.] Brown Univ, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02912 USA; [Chiang, Silvia S.] Rhode Isl Hosp, Ctr Int Hlth Res, Providence, RI 02903 USA	Brown University; Harvard University; Harvard Medical School; Boston University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Chiang, SS (corresponding author), Brown Univ, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02912 USA.; Chiang, SS (corresponding author), Rhode Isl Hosp, Ctr Int Hlth Res, Providence, RI 02903 USA.	silvia_chiang@brown.edu		Weng, Chien-Hsiang/0000-0002-0794-1263				American Academy of Pediatrics and the Children's Hospital Association, CHILDREN COVID 19 ST; Assaker R, 2020, BRIT J ANAESTH, V125, pE330, DOI 10.1016/j.bja.2020.05.026; Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4; Castagnoli R, 2020, JAMA PEDIATR, V174, P882, DOI 10.1001/jamapediatrics.2020.1467; Center of Disease Control and Prevention, CHILD TEEN BMI; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Du ZaH Y., R PACKAGE; Figueroa JF, 2020, HEALTH AFFAIR, V39, P1984, DOI 10.1377/hlthaff.2020.01040; Goyal MK, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-009951; Hoang A, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100433; Hurst JH., 2020, CLIN INFECT DIS, DOI [10.1101/2020.08.18.20166835, DOI 10.1093/cid/ciaa1693]; Johns Hopkins University School of Medicine, COVID 19 DASHBOARD C; King JA, 2021, CAN MED ASSOC J, V193, pE1, DOI 10.1503/cmaj.202065; Page KR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005953; Providence Community Health Center, FACTAND FIG; Rhode Island Department of Health, OUTBREAK RESPONSE PR; Rhode Island Department of Health, COVID19 INFORM; Shane AL., 2020, J PEDIAT INFECT DIS; Struyf T, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013665; Swann OV, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3249; Viner RM, 2021, ARCH DIS CHILD, V106, P802, DOI 10.1136/archdischild-2020-320972; Weng CH, 2021, EPIDEMIOL INFECT, V149, DOI 10.1017/S0950268821000133; Weng CH, 2020, J GEN INTERN MED, DOI 10.1007/s11606-020-06026-3; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548	24	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0249980	10.1371/journal.pone.0249980	http://dx.doi.org/10.1371/journal.pone.0249980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898635	Green Published, gold, Green Submitted			2022-12-26	WOS:000755176200002
J	Dvornyk, V; Ponomarenko, I; Belyaeva, T; Reshetnikov, E; Churnosov, M				Dvornyk, Volodymyr; Ponomarenko, Irina; Belyaeva, Tatyana; Reshetnikov, Evgeny; Churnosov, Mikhail			Filaggrin gene polymorphisms are associated with atopic dermatitis in women but not in men in the Caucasian population of Central Russia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OPEN-ANGLE GLAUCOMA; SUSCEPTIBILITY LOCI; ASTHMA; ECZEMA; DISEASE; RISK; PREVALENCE; VARIANTS; RHINITIS	Background and purpose This study aimed to analyze the gender-specific association of the filaggrin (FLG) gene polymorphisms with atopic dermatitis (AD) in Caucasians from the central region of Russia. Methods The study sample consisted of 906 female (including 474 patients with AD and 432 controls) and 406 male (such as 226 patients with AD and 180 controls) participants. Genotyping of ten polymorphisms of the FLG gene was done. The logistic regression was used to analyze the associations. A total of 125 SNPs (seven AD-associated SNPs and 118 proxy SNPs, r(2)>= 0.8) FLG gene were used for the in silico functional annotation analysis in the females. Results Significant associations were identified between seven SNPs of the FLG gene (rs12130219, rs61816761, rs558269137, rs12144049, rs3126085, rs471144, rs6661961) and AD in females: rs12144049 was associated independent individually (for allele C OR = 1.71, 95%Cl 1.19-2.46, p(perm) = 0.004 and OR = 1.76, 95%Cl 1.18-2.63, p(perm) = 0.006 according to the additive and dominant genetic models, respectively) and seven SNPs of the FLG gene within 14 haplotypes. Haplotype GGT [rs61816761-rs3126085-rs12144049] showed the strongest association (OR = 0.55, p(perm) = 0.001). No association between the analyzed SNPs and AD was determined in the male group. The subsequent bioinformatic analysis predicted the SNPs of the FLG gene that possessed epigenetic and non-synonymous effects, were involved in the control of gene expression and alternative splicing of genes that contribute to AD pathophysiology. Conclusion Polymorphisms of the FLG gene are associated with AD in females but not in males in the Caucasian population of Central Russia.	[Dvornyk, Volodymyr] Alfaisal Univ, Coll Sci & Gen Studies, Dept Life Sci, Riyadh, Saudi Arabia; [Ponomarenko, Irina; Belyaeva, Tatyana; Reshetnikov, Evgeny; Churnosov, Mikhail] Belgorod State Univ, Dept Med Biol Disciplines, Belgorod, Russia	Alfaisal University; Belgorod State University	Reshetnikov, E (corresponding author), Belgorod State Univ, Dept Med Biol Disciplines, Belgorod, Russia.	reshetnikov@bsu.edu.ru	Churnosov, Mikhail/W-1313-2017; Ponomarenko, Irina/R-3358-2017	Churnosov, Mikhail/0000-0003-1254-6134; Ponomarenko, Irina/0000-0002-5652-0166; Reshetnikov, Evgeny/0000-0002-5429-6666				Abuabara K, 2019, J ALLERGY CLIN IMMUN, V144, P710, DOI 10.1016/j.jaci.2019.05.040; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; Banihani SA, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020017; Barbarot S, 2018, ALLERGY, V73, P1284, DOI 10.1111/all.13401; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baurecht H, 2015, AM J HUM GENET, V96, P104, DOI 10.1016/j.ajhg.2014.12.004; Belyaeva T.M., 2020, RES RESULTS BIOMEDIC, V6, P160, DOI [10.18413/2658-6533-2020-6-2-0-2, DOI 10.18413/2658-6533-2020-6-2-0-2]; Belyaeva T, 2020, DATA BRIEF, V29, DOI 10.1016/j.dib.2020.105307; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Blakeway H, 2020, BRIT J DERMATOL, V183, P443, DOI 10.1111/bjd.18778; Che RL, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-9; Chen W, 2008, ALLERGY, V63, P1418, DOI 10.1111/j.1398-9995.2008.01880.x; Chidwick K, 2020, AUSTRALAS J DERMATOL, V61, pE319, DOI 10.1111/ajd.13268; Drucker AM, 2017, J INVEST DERMATOL, V137, P26, DOI 10.1016/j.jid.2016.07.012; Dvornyk V, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257060; Eliseeva N, 2021, OPHTHALMIC GENET, V42, P698, DOI 10.1080/13816810.2021.1955275; Eliseeva N, 2021, MOL VIS, V27, P262; Feldman SR, 2019, AM HEALTH DRUG BENEF, V12, P83; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Ferreira MAR, 2019, AM J HUM GENET, V104, P665, DOI 10.1016/j.ajhg.2019.02.022; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Golovchenko O, 2020, EUR J OBSTET GYN R B, V253, P52, DOI 10.1016/j.ejogrb.2020.07.045; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; Harrop J, 2007, CLIN EXP ALLERGY, V37, P526, DOI 10.1111/j.1365-2222.2007.02679.x; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; Hwang CY, 2010, ACTA DERM-VENEREOL, V90, P589, DOI 10.2340/00015555-0963; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Kage Paula, 2020, Allergol Select, V4, P86, DOI 10.5414/ALX02174E; KALOGEROMITROS D, 1995, CLIN EXP ALLERGY, V25, P461, DOI 10.1111/j.1365-2222.1995.tb01078.x; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Kim BE, 2018, ALLERGY ASTHMA IMMUN, V10, P207, DOI 10.4168/aair.2018.10.3.207; Kim J, 2019, ALLERGY ASTHMA PROC, V40, P84, DOI 10.2500/aap.2019.40.4202; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LARSEN FVS, 1985, ACTA DERM-VENEREOL, P159; Leynaert N, 2004, J ALLERGY CLIN IMMUN, V113, P86, DOI 10.1016/j.jaci.2003.10.010; Lieden A, 2009, ALLERGY, V64, P304, DOI 10.1111/j.1398-9995.2008.01856.x; Litovkina O, 2014, GENE, V546, P112, DOI 10.1016/j.gene.2014.04.020; Marenholz I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9804; Margolis DJ, 2018, J INVEST DERMATOL, V138, P1501, DOI 10.1016/j.jid.2018.01.029; Martin MJ, 2020, GENES-BASEL, V11, DOI 10.3390/genes11040442; Minyaylo O, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92527-y; Moskalenko MI, 2019, KARDIOLOGIYA, V59, P31, DOI 10.18087/cardio.2598; Moskalenko M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84645-4; Nedoszytko B, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186484; Ng YT, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100477; Olafsdottir TA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14144-8; Osman M, 2003, ARCH DIS CHILD, V88, P587, DOI 10.1136/adc.88.7.587; Osman Mustafa, 2007, Prim Care Respir J, V16, P28, DOI 10.3132/pcrj.2007.00006; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Ponomarenko I, 2021, FRONT GENET, V11, DOI 10.3389/fgene.2020.512940; Ponomarenko I, 2020, REPROD BIOMED ONLINE, V41, P943, DOI 10.1016/j.rbmo.2020.04.016; Ponomarenko I, 2020, GENE, V757, DOI 10.1016/j.gene.2020.144933; Ponomarenko I, 2019, GENE, V686, P228, DOI 10.1016/j.gene.2018.11.042; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reshetnikov E, 2017, J OBSTET GYNAECOL RE, V43, P1139, DOI 10.1111/jog.13329; Reshetnikov EA, 2015, J RENIN-ANGIO-ALDO S, V16, P623, DOI 10.1177/1470320313501217; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Saeki H, 2006, J DERMATOL, V33, P817, DOI 10.1111/j.1346-8138.2006.00187.x; Schaarschmidt H, 2015, J ALLERGY CLIN IMMUN, V136, P802, DOI 10.1016/j.jaci.2015.01.047; Starikova D, 2021, OPHTHALMIC RES, V64, P458, DOI 10.1159/000512507; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Tikunova E, 2017, INT J OPHTHALMOL-CHI, V10, P1490, DOI 10.18240/ijo.2017.10.02; Trzeciak M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030862; Trzeciak M, 2017, INT ARCH ALLERGY IMM, V172, P11, DOI 10.1159/000453452; van Beijsterveldt CEM, 2007, EUR RESPIR J, V29, P516, DOI 10.1183/09031936.00065706; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Weidinger S, 2013, HUM MOL GENET, V22, P4841, DOI 10.1093/hmg/ddt317; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; Yang G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082867; Zhu ZZ, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01507-2019	73	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0261026	10.1371/journal.pone.0261026	http://dx.doi.org/10.1371/journal.pone.0261026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882715	Green Published, gold			2022-12-26	WOS:000755037200053
J	Ma, ZW; Liu, YR; Gao, YD				Ma, Zhengwei; Liu, Yiran; Gao, Yida			Research on the impact of COVID-19 on Chinese small and medium-sized enterprises: Evidence from Beijing	PLOS ONE			English	Article							SMALL BUSINESS; FIT INDEX; COMPANIES; ADOPTION	COVID-19 leads small and medium-sized enterprises (SMEs) to survive very hard. The development difficulties of SMEs lead to weak employment and GDP growth in various countries. In the process of COVID-19's continuous spread, what is the major reason for the difficulties of SMEs? This paper hopes to answer this question by studying SMEs in Beijing. On this basis, this paper uses structural equation model (SEM) to study the relatively fast recovery of SMEs in Beijing, China, to explore the factors affecting SMEs in the pandemic. After detailed desk research and interviews with relevant entrepreneurs, this paper collects 234 valid questionnaires from SMEs in various industries in Beijing with the help of Federation of Industry and Commerce and Chamber of Commerce in Beijing. Then the data is analyzed with the SEM, which shows the relationship between cash flow from financing activities, markets, employees, costs, government policies and the impact of the pandemic. Finally, an impact model of the pandemic on SMEs is established. The result of the model indicates that the direct effect of the pandemic on the market is the most prominent, and government policies can significantly reduce the negative impact of the pandemic on SMEs indirectly. Based on this, this paper puts forward some policy suggestions, such as the targeted issuance of consumption vouchers and the reduction of administrative barriers. This will enable megacities in various countries to improve policy support for SMEs and promote the recovery and development of SMEs.	[Ma, Zhengwei; Liu, Yiran; Gao, Yida] China Univ Petr, Sch Econ & Management, Beijing, Peoples R China	China University of Petroleum	Ma, ZW (corresponding author), China Univ Petr, Sch Econ & Management, Beijing, Peoples R China.	ma_zhengwei@163.com		Ma, Zhengwei/0000-0002-3783-8435	National Fund of Philosophy and Social Science of China [18BJY251]	National Fund of Philosophy and Social Science of China	The authors received funding from the National Fund of Philosophy and Social Science of China (grant number 18BJY251 to ZM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin L, 2020, ENERG EXPLOR EXPLOIT, V38, P1810, DOI 10.1177/0144598720934007; Bartik AW, 2020, P NATL ACAD SCI USA, V117, P17656, DOI 10.1073/pnas.2006991117; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BOLLEN KA, 1989, SOCIOL METHOD RES, V17, P303, DOI 10.1177/0049124189017003004; Brown NA, 2017, INT J DISAST RISK RE, V22, P362, DOI 10.1016/j.ijdrr.2017.02.005; Brown R., 2020, J BUS VENTURING INSI, V14, pE00174, DOI DOI 10.1016/J.JBVI.2020.E00174; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Chowdhury P, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12166408; Cowling M, 2020, INT SMALL BUS J, V38, P593, DOI 10.1177/0266242620945102; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Desson Z, 2020, HEALTH POLICY TECHN, V9, P405, DOI 10.1016/j.hlpt.2020.09.003; Forsythe E, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104238; Goodell JW, 2020, FINANC RES LETT, V35, DOI 10.1016/j.frl.2020.101512; Granja J., 2020, 202052 U CHIC B FRIE, P1; Green D, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104321; Guo YM, 2021, ECON ANAL POLICY, V69, P253, DOI 10.1016/j.eap.2020.12.010; Gupta V, 2017, INFORM SOFTWARE TECH, V92, P75, DOI 10.1016/j.infsof.2017.07.010; Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128; Hao F, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102636; Harrison DA, 1997, INFORM SYST RES, V8, P171, DOI 10.1287/isre.8.2.171; HILL RJ, 1977, CONTEMP SOCIOL, V6, P244, DOI 10.2307/2065853; Hock-Doepgen M, 2021, J BUS RES, V130, P683, DOI 10.1016/j.jbusres.2019.12.001; Huang A, 2020, INT J HOSP MANAG, V91, DOI 10.1016/j.ijhm.2020.102660; Huiqin L., 2020, BUS ECON, P140; Iwamoto H, 2019, PROCEDIA MANUF, V39, P695, DOI 10.1016/j.promfg.2020.01.446; Joreskog K.G., 1985, LISREL 6 ANAL LINEAR; Jung HS, 2021, INT J HOSP MANAG, V92, DOI 10.1016/j.ijhm.2020.102703; Ketchen DJ, 2013, LONG RANGE PLANN, V46, P184, DOI 10.1016/j.lrp.2013.01.002; Kim AT, 2021, RES SOC STRAT MOBIL, V71, DOI 10.1016/j.rssm.2020.100563; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Latifi MA, 2021, TECHNOVATION, V107, DOI 10.1016/j.technovation.2021.102274; Lingli Y., 2020, J HUBEI U EC HUMANIT, V17; Lu Y, 2020, ENVIRON HAZARDS-UK, V19, P323, DOI 10.1080/17477891.2020.1763902; Ma ZW, 2019, PETROL SCI, V16, P929, DOI 10.1007/s12182-019-0339-1; Malesios C, 2020, ANN OPER RES, V294, P623, DOI 10.1007/s10479-018-3080-z; Mirza Nawazish, 2020, Q Rev Econ Finance, DOI 10.1016/j.qref.2020.09.002; Mohapatra S, 2021, REV ECON HOUSEHOLD, V19, P291, DOI 10.1007/s11150-020-09512-z; Nunally JC, 1978, PSYCHOMETRIC THEORY; Pellesova P, 2014, PROCD SOC BEHV, V110, P932, DOI 10.1016/j.sbspro.2013.12.939; Pereira DD, 2021, J AIR TRANSP MANAG, V91, DOI 10.1016/j.jairtraman.2020.101976; Qarnain SS, 2021, MATER TODAY-PROC, V45, P1264, DOI 10.1016/j.matpr.2020.04.723; Ram J, 2013, J COMPUT INFORM SYST, V54, P53, DOI 10.1080/08874417.2013.11645671; Ratnasingam J, 2020, BIORESOURCES, V15, P5951, DOI 10.15376/biores.15.3.5951-5964; Research Group of COVID-19 Epidemic Prevention and Control National Institute of Development Strategy Wuhan University, 2020, LEARNING PRACTICE, P22; Shafi M., 2020, RES GLOBAL, V2, DOI DOI 10.1016/J.RESGLO.2020.100018; Sharma Gagan Deep, 2020, Soc Sci Humanit Open, V2, P100036, DOI 10.1016/j.ssaho.2020.100036; Shehzad K, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101669; TANAKA JS, 1985, BRIT J MATH STAT PSY, V38, P197, DOI 10.1111/j.2044-8317.1985.tb00834.x; Xiaodong Q., 2020, COOPERATIVE EC TECHN, P132; Xiong H, 2020, EMERG MARK FINANC TR, V56, P2231, DOI 10.1080/1540496X.2020.1787151; Yifu L., 2001, EC RES; Zhou Xiaodong., 2019, CHINA FINANCE, P27	56	7	7	12	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0257036	10.1371/journal.pone.0257036	http://dx.doi.org/10.1371/journal.pone.0257036			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY8LQ	34882688	Green Published, gold			2022-12-26	WOS:000755037200002
J	Allingham, J; Floriano, WB				Allingham, Jessica; Floriano, Wely B.			Genetic diversity in the IZUMO1-JUNO protein-receptor pair involved in human reproduction	PLOS ONE			English	Article							VARIANT CALL FORMAT; LINKAGE DISEQUILIBRIUM; POSITIVE SELECTION; NATURAL-SELECTION; SPERM; FERTILIZATION; INFERTILITY; EVOLUTION; GENOME; INSIGHTS	Fertilization in mammals begins with the union of egg and sperm, an event that starts a cascade of cellular processes. The molecular-level understanding of these processes can guide the development of new strategies for controlling and/or promoting fertilization, and inform researchers and medical professional on the best choice of interventions. The proteins encoded by the IZUMO1 and JUNO genes form a ligand-receptor protein pair involved in the recognition of sperm and egg. Due to their role in the fertilization process, these proteins are potential targets for the development of novel anti-contraceptive, as well as infertility treatments. Here we present a comprehensive analysis of these gene sequences, with the objective of identifying evolutionary patterns that may support their relevance as targets for preventing or improving fertility among humans. JUNO and IZUMO1 gene sequences were identified within the genomes of over 2,000 humans sequenced in the 1000 Genomes Project. The human sequences were subjected to analyses of nucleotide diversity, deviation from neutrality of genetic variation, population-based differentiation (F-ST), haplotype inference, and whole chromosome scanning for signals of positive or of balancing selection. Derived alleles were determined by comparison to archaic hominin and other primate genomes. The potential effect of common non-synonymous variants on protein-protein interaction was also assessed. IZUMO1 displays higher variability among human individuals than JUNO. Genetic differentiation between continental population pairs was within whole-genome estimates for all but the JUNO gene in the African population group with respect to the other 4 population groups (American, East Asian, South Asian, and European). Tajima's D values demonstrated deviation from neutrality for both genes in comparison to a group of genes identified in the literature as under balancing or positive selection. Tajima's D for IZUMO1 aligns with values calculated for genes presumed to be under balancing selection, whereas JUNO's value aligned with genes presumed to be under positive selection. These inferences on selection are both supported by SNP density, nucleotide diversity and haplotype analysis. A JUNO haplotype carrying 3 derived alleles out of 5, one of which is a missense mutation implicated in polyspermy, was found to be significant in a population of African ancestry. Polyspermy has a disadvantageous impact on fertility and its presence in approximately 30% of the population of African ancestry may be associated to a potentially beneficial role of this haplotype. This role has not been established and may be related to a non-reproductive role of JUNO. The high degree of conservation of the JUNO sequence combined with a dominant haplotype across multiple population groups supports JUNO as a potential target for the development of contraceptive treatments. In addition to providing a detailed account of human genetic diversity across these 2 important and related genes, this study also provides a framework for large population-based studies investigating protein-protein interactions at the genome level.	[Allingham, Jessica; Floriano, Wely B.] Lakehead Univ, Dept Chem, Thunder Bay, ON, Canada	Lakehead University	Floriano, WB (corresponding author), Lakehead Univ, Dept Chem, Thunder Bay, ON, Canada.	wely.floriano@lakeheadu.ca	Floriano, Wely/GOK-1319-2022	Floriano, Wely/0000-0001-8913-0458				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Alachiotis N, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0085-8; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P63, DOI 10.1016/j.fertnstert.2012.09.023; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Andres AM, 2009, MOL BIOL EVOL, V26, P2755, DOI 10.1093/molbev/msp190; Association P, 2014, GUARDIAN; Aydin H, 2016, NATURE, V534, P562, DOI 10.1038/nature18595; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Bianchi E, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0101; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; BROWN AHD, 1975, THEOR POPUL BIOL, V8, P184, DOI 10.1016/0040-5809(75)90031-3; Bushnik T, 2012, HUM REPROD, V27, P738, DOI 10.1093/humrep/der465; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; Chandra A, 2013, INFERTILITY IMPAIRED; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clarke L, 2017, NUCLEIC ACIDS RES, V45, pD854, DOI 10.1093/nar/gkw829; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fox Edward J, 2014, Next Gener Seq Appl, V1; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Gardner AJ, 2006, REPROD FERT DEVELOP, V18, P53, DOI 10.1071/RD05122; Gerrits T, 2017, FACTS VIEWS VIS OBGY, V9, P39; Grayson P, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150296; Grayson Phil, 2012, Int J Evol Biol, V2012, P958164, DOI 10.1155/2012/958164; Han L, 2016, CURR BIOL, V26, pR100, DOI 10.1016/j.cub.2015.12.034; Hart MW, 2018, PEERJ, V6, DOI 10.7717/peerj.4259; Herrero J, 2016, DATABASE-OXFORD, DOI [10.1093/database/bav096, 10.1093/database/baw053]; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; Kato K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12198; Kinoshita T, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.190290; Knaus BJ, 2017, MOL ECOL RESOUR, V17, P44, DOI 10.1111/1755-0998.12549; Korneliussen TS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-289; Kurabayashi T, 2016, MATURITAS, V83, P33, DOI 10.1016/j.maturitas.2015.08.015; Lai YT, 2019, P NATL ACAD SCI USA, V116, P2152, DOI 10.1073/pnas.1813597116; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Moon JM, 2018, G3-GENES GENOM GENET, V8, P1315, DOI 10.1534/g3.118.200035; Mou L, 2017, J REPROD DEVELOP, V63, P1, DOI 10.1262/jrd.2016-108; Ohto U, 2016, NATURE, V534, P566, DOI 10.1038/nature18596; Okabe M, 2015, ASIAN J ANDROL, V17, P646, DOI 10.4103/1008-682X.153299; Okabe M, 2013, DEVELOPMENT, V140, P4471, DOI 10.1242/dev.090613; OLSON JM, 1994, AM J HUM GENET, V55, P574; Organization WH, REPR HLTH INF 2020; Precention CfDCa, INF 2015; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; R Core Team, 2021, R LANG ENV STAT; Renaud G, 2018, BIOINFORMATICS, V34, P1398, DOI 10.1093/bioinformatics/btx749; Risso DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25506; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Salbaum JM, 2013, BBA-MOL BASIS DIS, V1832, P1653, DOI 10.1016/j.bbadis.2013.04.028; Satouh Y, 2012, J CELL SCI, V125, P4985, DOI 10.1242/jcs.100867; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shriver Mark D, 2004, Hum Genomics, V1, P274; Siewert KM, 2020, GENOME BIOL EVOL, V12, P3873, DOI 10.1093/gbe/evaa013; SIMONSEN KL, 1995, GENETICS, V141, P413; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Subramanian S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2441-8; Sun H, 2019, AGING-US, V11, P10952, DOI 10.18632/aging.102497; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Szabo L, 2015, GENOME BIOL, V16, DOI [10.1186/s13059-015-0690-5, 10.1186/s13059-016-1123-9]; TAJIMA F, 1989, GENETICS, V123, P585; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; Turner LM, 2008, INT J DEV BIOL, V52, P769, DOI 10.1387/ijdb.082577lt; Uniprot, RAIN HUMAN; Wall JD, 2014, GENOME RES, V24, P1734, DOI 10.1101/gr.168393.113; Wassarman PM, 2014, NATURE, V508, P466, DOI 10.1038/nature13227; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649; Yanagimachi R., 1988, CURRENT TOPICS MEMBR, P3, DOI DOI 10.1016/S0070-2161(08)60129-X; Yu MR, 2018, J ASSIST REPROD GEN, V35, P539, DOI 10.1007/s10815-017-1101-5; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009; Zhang YB, 2010, J HUM GENET, V55, P350, DOI 10.1038/jhg.2010.33; Zhou Z, 2018, BJOG-INT J OBSTET GY, V125, P432, DOI 10.1111/1471-0528.14966	85	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260692	10.1371/journal.pone.0260692	http://dx.doi.org/10.1371/journal.pone.0260692			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879103	gold, Green Published, Green Submitted			2022-12-26	WOS:000754625200024
J	Crivellenti, LZ; Cintra, CA; Maia, SR; Silva, GEB; Borin-Crivellenti, S; Cianciolo, R; Adin, CA; Tinucci-Costa, M; Pennacchi, CS; Santana, AE				Crivellenti, Leandro Zuccolotto; Cintra, Cristiane Alves; Maia, Suellen Rodrigues; Barros Silva, Gyl Eanes; Borin-Crivellenti, Sofia; Cianciolo, Rachel; Adin, Christopher A.; Tinucci-Costa, Mirela; Pennacchi, Caio Santos; Santana, Aureo Evangelista			Glomerulotubular pathology in dogs with subclinical ehrlichiosis	PLOS ONE			English	Article							RENAL BIOPSY; CANINE EHRLICHIOSIS; ANTIBODIES; DIAGNOSIS; INFECTION; DISEASE	Subclinical stage of ehrlichiosis is characterized by absence of clinical or laboratory alterations; however, it could lead to silent glomerular/tubular changes and contribute significantly to renal failure in humans and animals. The aim of this study was to evaluate glomerular and tubular alterations in dogs with subclinical ehrlichiosis. We evaluated renal biopsies of 14 bitches with subclinical ehrlichiosis and 11 control dogs. Samples were obtained from the left kidney, and the tissue obtained was divided for light microscopy, immunofluorescence, and transmission electron microscopy. Abnormalities were identified by light microscopy in 92.9% of dogs with ehrlichiosis, but not in any of the dogs of the control group. Mesangial cell proliferation and synechiae (46.1%) were the most common findings, but focal segmental glomerulosclerosis and ischemic glomeruli (38.4%), focal glomerular mesangial matrix expansion (30.7%), mild to moderate interstitial fibrosis and tubular atrophy (23%), and glomerular basement membrane spikes (23%) were also frequent in dogs with ehrlichiosis. All animals with ehrlichiosis exhibited positive immunofluorescence staining for immunoglobulins. Transmission electron microscopy from dogs with ehrlichiosis revealed slight changes such as sparse surface projections and basement membrane double contour. The subclinical phase of ehrlichiosis poses a higher risk of development of kidney damage due to the deposition of immune complexes.	[Crivellenti, Leandro Zuccolotto; Borin-Crivellenti, Sofia; Pennacchi, Caio Santos] Univ Fed Uberlandia UFU, Grad Program Vet Sci PPGCV, Coll Vet Med FAMEV, Uberlandia, MG, Brazil; [Cintra, Cristiane Alves; Tinucci-Costa, Mirela; Santana, Aureo Evangelista] Univ Estadual Paulista Julio de Mesquita Filho UN, Dept Vet Clin & Surg, Fac Ciencias Agr Vet FCAV, Jaboticabal, Brazil; [Maia, Suellen Rodrigues] Univ Estadual Paulista Julio de Mesquita Filho UN, Fac Med Vet & Zootecn FMVZ, Dept Vet Clin, Botucatu, SP, Brazil; [Barros Silva, Gyl Eanes] Univ Fed Maranhao UFMA, Dept Pathol, Sao Luis, Maranhao, Brazil; [Cianciolo, Rachel] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [Adin, Christopher A.] Univ Florida, Dept Small Anim Clin Sci, Gainesville, FL 32610 USA	Universidade Federal de Uberlandia; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal do Maranhao; University System of Ohio; Ohio State University; State University System of Florida; University of Florida	Maia, SR (corresponding author), Univ Estadual Paulista Julio de Mesquita Filho UN, Fac Med Vet & Zootecn FMVZ, Dept Vet Clin, Botucatu, SP, Brazil.	suellenrmaia@gmail.com	Pennacchi, Caio/GZL-6418-2022	Santos Pennacchi, Caio/0000-0002-1043-131X; Maia, Suellen/0000-0003-4599-6641				Silva GEB, 2010, NEPHROLOGY, V15, P171, DOI 10.1111/j.1440-1797.2009.01197.x; Borin S, 2009, ARQ BRAS MED VET ZOO, V61, P566, DOI 10.1590/S0102-09352009000300007; Burton W, 2020, J AM ANIM HOSP ASSOC, V56, P159, DOI 10.5326/JAAHA-MS-7012; Cianciolo RE, 2013, J VET INTERN MED, V27, pS10, DOI 10.1111/jvim.12226; CODNER EC, 1992, AM J VET RES, V53, P2286; Crivellenti LZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164479; de Castro MB, 2004, VET PARASITOL, V119, P73, DOI 10.1016/j.vetpar.2003.10.012; do Carmo GM, 2015, COMP IMMUNOL MICROB, V43, P16, DOI 10.1016/j.cimid.2015.09.005; Goldstein RE, 2013, J VET INTERN MED, V27, pS60, DOI 10.1111/jvim.12232; Grauer GF, 2011, TOP COMPANION ANIM M, V26, P121, DOI 10.1053/j.tcam.2011.04.002; Harrus S, 2004, ANTIMICROB AGENTS CH, V48, P4488, DOI 10.1128/AAC.48.11.4488-4490.2004; Harrus S, 2002, VET MICROBIOL, V86, P361, DOI 10.1016/S0378-1135(02)00022-6; Harrus S, 1998, J CLIN MICROBIOL, V36, P73, DOI 10.1128/JCM.36.1.73-76.1998; Harrus S, 2001, VET MICROBIOL, V83, P343, DOI 10.1016/S0378-1135(01)00431-X; Harrus S, 2011, VET J, V187, P292, DOI 10.1016/j.tvjl.2010.02.001; Heiene R, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-13; Huussen J, 2004, NETH J MED, V62, P4; International Renal Interest Society (IRIS), IRIS STAG CKD; IQBAL Z, 1994, VET MICROBIOL, V42, P281, DOI 10.1016/0378-1135(94)90059-0; Lees GE, 2004, VET CLIN N AM-SMALL, V34, P867, DOI 10.1016/j.cvsm.2004.03.004; Littman MP, 2011, VET CLIN N AM-SMALL, V41, P31, DOI 10.1016/j.cvsm.2010.09.006; Luckschander N, 2003, SCHWEIZ ARCH TIERH, V145, P482, DOI 10.1024/0036-7281.145.10.482; Mai J, 2013, NEPHROLOGY, V18, P525, DOI 10.1111/nep.12093; Faria JLM, 2011, REV BRAS PARASITOL V, V20, P71, DOI 10.1590/S1984-29612011000100015; Mylonakis ME, 2004, J AM ANIM HOSP ASSOC, V40, P174, DOI 10.5326/0400174; Neer T. M., 2006, INFECT DIS DOG CAT, P203; Nicholson ML, 2000, KIDNEY INT, V58, P390, DOI 10.1046/j.1523-1755.2000.00177.x; Parmar C, 2013, TURK J VET ANIM SCI, V37, P282, DOI 10.3906/vet-1201-12; Purswell EK, 2020, J VET INTERN MED, V34, P742, DOI 10.1111/jvim.15610; Scaglia F, 1999, PEDIATR NEPHROL, V13, P600, DOI 10.1007/s004670050666; Silva GEB, 2014, INT J CLIN EXP MED, V7, P1619; Silva L. S., 2016, Brazilian Journal of Veterinary Pathology, V9, P2; Skotarczak B, 2003, ANN AGR ENV MED, V10, P137; Thomas LD, 2007, AM J TRANSPLANT, V7, P1641, DOI 10.1111/j.1600-6143.2007.01821.x; Troy GC., 1990, INFECT DIS DOG CAT, P404; Vaden SL, 2005, J VET INTERN MED, V19, P794, DOI 10.1892/0891-6640(2005)19[794:RBARSO]2.0.CO;2; Vaden SL, 2004, VET CLIN N AM-SMALL, V34, P887, DOI 10.1016/j.cvsm.2004.03.010; Vessieres F, 2019, J SMALL ANIM PRACT, V60, P683, DOI 10.1111/jsap.13065; WANER T, 1995, VET IMMUNOL IMMUNOP, V48, P177, DOI 10.1016/0165-2427(95)05420-B; Waner T., 1999, Israel Journal of Veterinary Medicine, V54, P103; Waner T, 2000, J VET DIAGN INVEST, V12, P240, DOI 10.1177/104063870001200307; Waner T, 1997, VET PARASITOL, V69, P307, DOI 10.1016/S0304-4017(96)01130-2; WOODY BJ, 1991, VET CLIN N AM-SMALL, V21, P75, DOI 10.1016/S0195-5616(91)50009-7; Zatelli A, 2005, VET RADIOL ULTRASOUN, V46, P434, DOI 10.1111/j.1740-8261.2005.00079.x	44	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260702	10.1371/journal.pone.0260702	http://dx.doi.org/10.1371/journal.pone.0260702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879085	gold, Green Published			2022-12-26	WOS:000754625200025
J	Lyu, JC; Luli, GK; Ling, PM				Lyu, Joanne Chen; Luli, Garving K.; Ling, Pamela M.			Vaping discussion in the COVID-19 pandemic: An observational study using Twitter data	PLOS ONE			English	Article							CIGARETTE; SMOKING; MEDIA	Background With the spread of COVID-19, significant concerns have been raised about the potential increased risk for electronic cigarette (e-cigarette) users for COVID-19 infection and related syndromes. Social media is an increasingly popular source for health information dissemination and discussion, and can affect health outcomes. Objective This study aims to identify the topics in the public vaping discussion in COVID-19-related Twitter posts in order to get insight into public vaping-related perceptions, attitudes and concerns, and to discern possible misinformation and misconceptions around vaping in the COVID-19 pandemic. Methods Using the tweets ID database maintained by Georgia State University's Panacea Lab, we downloaded the tweets related to COVID-19 from March 11, 2020, when the World Health Organization declared COVID-19 a pandemic, to February 12, 2021. We used R to analyze the tweets that contained a list of 79 keywords related to vaping. After removing duplicates and tweets created by faked accounts or bots, the final data set consisted of 11,337 unique tweets from 7,710 different users. We performed the latent Dirichlet allocation (LDA) algorithm for topic modeling and carried out a sentiment analysis. Results Despite fluctuations, the number of daily tweets was relatively stable (average number of daily tweets = 33.4) with a sole conspicuous spike happening on a few days after August 11, 2020 when a research team published findings that teenagers and young adults who vape face a much higher risk of COVID-19 infection than their peers who do not vape. Topic modeling generated 8 topics: linkage between vaping and risk of COVID-19 infection, vaping pneumonia and the origin of COVID-19, vaping and spread of COVID-19, vaping regulation, calling for quitting vaping, protecting youth, similarity between e-cigarette or vaping-associated lung injury (EVALI) and COVID-19, and sales information. Daily sentiment scores showed that the public sentiment was predominantly negative, but became slightly more positive over the course of the study time period. Conclusions While some content in the public discourse on vaping before the COVID-19 pandemic continued in Twitter posts during the COVID-19 time period, new topics emerged. We found a substantial amount of anti-vaping discussion and dominantly negative sentiment around vaping during COVID-19, a sharp contrast to the predominantly pro-vaping voice on social media in the pre-COVID-19 period. Continued monitoring of social media conversations around vaping is needed, and the public health community may consider using social media platforms to actively convey scientific information around vaping and vaping cessation.	[Lyu, Joanne Chen; Ling, Pamela M.] Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA; [Luli, Garving K.] Univ Calif Davis, Dept Math, Davis, CA 95616 USA	University of California System; University of California San Francisco; University of California System; University of California Davis	Lyu, JC (corresponding author), Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA.	chenjoanne.lyu@ucsf.edu		Ling, Pamela/0000-0001-6166-9347; Lyu, Chen/0000-0002-4178-6746				American Lung Association, 2020, WHAT YOU NEED KNOW S; Banda JM., 2021, [A, Zenodo], DOI 10.5281/zenodo.4484079; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Blum A, 2020, FOUNDATIONS OF DATA SCIENCE, P1, DOI 10.1017/9781108755528; Documenting the Now, 2020, HYDR COMP SOFTW; Esposito G, 2020, BRIT J PHARMACOL, V177, P4967, DOI 10.1111/bph.15157; Forsyth SR, 2010, NICOTINE TOB RES, V12, P810, DOI 10.1093/ntr/ntq101; Freeman B, 2012, TOB CONTROL, V21, P139, DOI 10.1136/tobaccocontrol-2011-050193; Gaiha SM, 2020, J ADOLESCENT HEALTH, V67, P519, DOI 10.1016/j.jadohealth.2020.07.002; Gao YK, 2021, JMIR PUBLIC HLTH SUR, V7, P124, DOI 10.2196/24859; Gilpin DF, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1206-8; Glowacki EM, 2017, CYBERPSYCH BEH SOC N, V20, P133, DOI 10.1089/cyber.2016.0409; Gotts JE, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5275; Health Matters, 2020, VAP COVID 19 CAN VAP, DOI [10.1016/j.drugalcdep.2020.108438, DOI 10.1016/J.DRUGALCDEP.2020.108438]; Healthline, 2020, SMOK VAP HER WHAT YO; Huang JD, 2014, TOB CONTROL, V23, P26, DOI 10.1136/tobaccocontrol-2014-051551; iek Slavoj., 2020, COVID 19 CORONAVIRUS; Janmohamed K, 2020, J MED INTERNET RES, V22, DOI 10.2196/21743; Jiang FS, 2021, ADV MATH, V385, DOI 10.1016/j.aim.2021.107756; Johns Hopkins Medicine, WHAT IS COR; Jun SP, 2021, TECHNOL FORECAST SOC, V166, DOI 10.1016/j.techfore.2021.120592; Kim AE, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4466; Lazard AJ, 2017, TOB CONTROL, V26, pe112, DOI 10.1136/tobaccocontrol-2016-053295; Lazard Allison J, 2016, JMIR Public Health Surveill, V2, pe171, DOI 10.2196/publichealth.6551; Lynas M., 2020, CORN ALL SCI CORN AL; Majmundar A, 2020, NICOTINE TOB RES, V22, P1667, DOI 10.1093/ntr/ntaa064; McAlinden KD, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01645-2020; McCausland K, 2019, J MED INTERNET RES, V21, DOI 10.2196/11953; Patanavanich R, 2020, NICOTINE TOB RES, V22, P1653, DOI 10.1093/ntr/ntaa082; Spano M, 2020, SENTIMENT ANAL ED R; Stanton T, 2020, 16 TYPES EMPLOYEE BE; Thorud K., 2021, CONTROVERSY ROLE SOC; Truth initiative, 2020, MAJ YOUNG VAP WORR C; Volkow ND, 2020, ANN INTERN MED, V173, P61, DOI 10.7326/M20-1212; Zhao YH, 2017, HEALTH INFO LIBR J, V34, P268, DOI 10.1111/hir.12192	35	0	0	13	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260290	10.1371/journal.pone.0260290	http://dx.doi.org/10.1371/journal.pone.0260290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY2LS	34879077	Green Published, gold			2022-12-26	WOS:000754625200012
J	Duong, HT; Massey, ZB; Churchill, V; Popova, L				Duong, Hue Trong; Massey, Zachary B.; Churchill, Victoria; Popova, Lucy			Are smokers scared by COVID-19 risk? How fear and comparative optimism influence smokers' intentions to take measures to quit smoking	PLOS ONE			English	Article							CIGARETTE WARNING LABELS; UNREALISTIC OPTIMISM; NICOTINE DEPENDENCE; HEALTH; PERCEPTIONS; CESSATION; EMOTIONS; ANXIETY; NEWS; SUSCEPTIBILITY	Research suggests that smoking may compound the risk of serious health problems to smokers who contract COVID-19. This study examines whether and how exposure to news stories reporting the severe COVID-19 risk to smokers may influence smokers' emotional responses (fear, anxiety, and sadness) and intentions to take measures to quit smoking. Current smokers in the US participated in an online experiment (N = 495) and were randomized to read smoking risk news stories or news stories reporting the combined risk of smoking and COVID-19. We found that combined risk news stories lead to participants feeling more fearful and sadder than when they viewed smoking risk news stories (M = 5.74; SD = 2.57 vs. M = 5.20; SD = 2.74; p < .05). Fear fully mediated the effect of news exposure on intentions to take measures to quit smoking (beta = .09; SE = 05; 95% CI [.010, .200]). Moreover, moderated-mediation analyses revealed that the mediating effect of fear was conditioned on the levels of comparative optimism, such that the association between fear and intentions to take measures to quit smoking was only significant among smokers whose comparative optimism was at the mean score (beta = .16; SE = 05; 95% CI [.071, .250]), and for those whose comparative optimism was high (beta = .27; SE = .06; 95% CI [.146, .395]). These results suggest that fear of the pandemic and optimism might play important roles in predicting and explaining the association between exposure to news stories and intentions to take measures to quit smoking. Messages about heightened risk of COVID-19 complications for smokers that increase fear might be an effective strategy to motivate smokers to quit. Such messages should be used to turn the adversity of COVID-19 pandemic into an intervention opportunity to reduce tobacco-related disease.	[Duong, Hue Trong] Georgia State Univ, Dept Commun, Atlanta, GA 30303 USA; [Massey, Zachary B.] Univ Missouri, Sch Journalism, Columbia, MO 65211 USA; [Churchill, Victoria; Popova, Lucy] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University of Missouri System; University of Missouri Columbia; University System of Georgia; Georgia State University	Popova, L (corresponding author), Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA.	lpopova1@gsu.edu		Churchill, Victoria/0000-0003-0393-3212	National Cancer Institute of the National Institutes of Health; Food and Drug Administration (FDA) Center for Tobacco Products [R00CA187460]	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Food and Drug Administration (FDA) Center for Tobacco Products	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health and the Food and Drug Administration (FDA) Center for Tobacco Products (R00CA187460). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the FDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimakopoulou K, 2020, HEALTH EXPECT, V23, P1502, DOI 10.1111/hex.13134; Berlin I, 2020, NICOTINE TOB RES, V22, P1650, DOI 10.1093/ntr/ntaa059; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Brodie M, 2003, J HEALTH POLIT POLIC, V28, P927, DOI 10.1215/03616878-28-5-927; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; Chambers JR, 2004, PSYCHOL BULL, V130, P813, DOI 10.1037/0033-2909.130.5.813; Chang CC, 2012, HEALTH COMMUN, V27, P111, DOI 10.1080/10410236.2011.569004; Cho HC, 2013, HEALTH COMMUN, V28, P146, DOI 10.1080/10410236.2012.664805; Cho YJ, 2018, SOC SCI MED, V197, P226, DOI 10.1016/j.socscimed.2017.10.003; Connor J, 2020, SOC SCI MED, V266, DOI 10.1016/j.socscimed.2020.113364; Dickert S, 2011, J BEHAV DECIS MAKING, V24, P361, DOI 10.1002/bdm.697; Dillard AJ, 2006, J HEALTH COMMUN, V11, P93, DOI 10.1080/10810730600637343; Dillard AJ, 2009, PERS SOC PSYCHOL B, V35, P1540, DOI 10.1177/0146167209343124; Farrelly MC, 2005, AM J PUBLIC HEALTH, V95, P425, DOI 10.2105/AJPH.2004.049692; Farsalinos K, 2020, THER ADV CHRONIC DIS, V11, DOI 10.1177/2040622320935765; Feldman C, 2013, J INFECTION, V67, P169, DOI 10.1016/j.jinf.2013.05.004; Fishbein M, 2011, PREDICTING AND CHANGING BEHAVIOR: THE REASONED ACTION APPROACH, P1; Garfin DR, 2020, HEALTH PSYCHOL, V39, P355, DOI 10.1037/hea0000875; Gray JA., NEUROPSYCHOLOGY ANXI, V2nd; Grummon AH, 2022, TOB CONTROL, V31, P402, DOI 10.1136/tobaccocontrol-2020-055956; Hall MG, 2018, TOB CONTROL, V27, pE136, DOI 10.1136/tobaccocontrol-2017-053972; Hammond D, 2004, CAN J PUBLIC HEALTH, V95, P201, DOI 10.1007/BF03403649; Han G, 2014, HEALTH COMMUN, V29, P109, DOI 10.1080/10410236.2012.723267; Han S, 2007, J CONSUM PSYCHOL, V17, P158, DOI 10.1016/S1057-7408(07)70023-2; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hefler M, 2020, TOB CONTROL, V29, P245, DOI 10.1136/tobaccocontrol-2020-055807; Hoek J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-609; Duong HT, 2019, AM J HEALTH EDUC, V50, P25, DOI 10.1080/19325037.2018.1548315; Hyland A, 2006, HEALTH EDUC RES, V21, P296, DOI 10.1093/her/cyh068; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jackson S., 1992, MESSAGE EFFECTS RES; Jiang C., 2020, TOB INDUC DIS, P18, DOI [10.18332/tid/118722, DOI 10.18332/TID/118722]; Tetik BK, 2021, J COMMUN HEALTH, V46, P471, DOI 10.1007/s10900-020-00880-2; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kim HS, 2012, J COMMUN, V62, DOI 10.1111/j.1460-2466.2012.01644.x; Klemm C, 2016, J RISK RES, V19, P1, DOI 10.1080/13669877.2014.923029; Klemperer EM, 2020, NICOTINE TOB RES, V22, P1662, DOI 10.1093/ntr/ntaa072; KOZLOWSKI LT, 1994, DRUG ALCOHOL DEPEN, V34, P211, DOI 10.1016/0376-8716(94)90158-9; Leppin A, 2009, INT J BEHAV MED, V16, P7, DOI 10.1007/s12529-008-9002-8; Lerner JS, 2000, COGNITION EMOTION, V14, P473, DOI 10.1080/026999300402763; Lerner JS, 2001, J PERS SOC PSYCHOL, V81, P146, DOI 10.1037//0022-3514.81.1.146; Li YC, 2020, TOB CONTROL, V29, P496, DOI 10.1136/tobaccocontrol-2019-055116; Liu JY, 2019, J COMPUT-MEDIAT COMM, V24, P1, DOI 10.1093/jcmc/zmy021; Liu Y., 2021, ACMTRANS INTERNET TE, V22, P1; Monzani D, 2021, PERS INDIV DIFFER, V168, DOI 10.1016/j.paid.2020.110388; Moradi P, 2007, BRIT J OPHTHALMOL, V91, P605, DOI 10.1136/bjo.2006.108191; Nabi RL, 2002, COMMUN MONOGR, V69, P204, DOI 10.1080/03637750216541; National Cancer Institute, 2008, NIH PUB, V07-6242; Nes LS, 2006, PERS SOC PSYCHOL REV, V10, P235, DOI 10.1207/s15327957pspr1003_3; Netemeyer RG, 2016, J PUBLIC POLICY MARK, V35, P124, DOI 10.1509/jppm.15.008; Newey S, WHY HAVE SO MANY COR; Niederdeppe J, 2007, COMMUN RES, V34, P382, DOI 10.1177/0093650207302784; O'Keefe DJ, 2003, COMMUN THEOR, V13, P251, DOI 10.1111/j.1468-2885.2003.tb00292.x; Park JS, 2016, HEALTH COMMUN, V31, P346, DOI 10.1080/10410236.2014.957375; Park T, 2021, RES SOC ADMIN PHARM, V17, P1859, DOI 10.1016/j.sapharm.2020.06.004; Patanavanich R, 2020, NICOTINE TOB RES, V22, P1653, DOI 10.1093/ntr/ntaa082; Peretti-Watel P, 2007, TOB CONTROL, V16, P351, DOI 10.1136/tc.2007.020362; Perkins AM, 2007, EMOTION, V7, P252, DOI 10.1037/1528-3542.7.2.252; PIERCE JP, 1990, AM J PUBLIC HEALTH, V80, P565, DOI 10.2105/AJPH.80.5.565; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Popova L, 2022, TOB CONTROL, V31, P397, DOI 10.1136/tobaccocontrol-2020-056276; Radcliffe NM, 2002, PERS SOC PSYCHOL B, V28, P836, DOI 10.1177/0146167202289012; Reddy RK, 2021, J MED VIROL, V93, P1045, DOI 10.1002/jmv.26389; Romer D, 2020, SOC SCI MED, V263, DOI 10.1016/j.socscimed.2020.113356; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Selden TM, 2020, HEALTH AFFAIR, V39, P1624, DOI 10.1377/hlthaff.2020.00897; Shepperd JA, 2002, PSYCHOL BELG, V42, P65; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Strzelak A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15051033; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trumbo C, 2011, RISK ANAL, V31, P1907, DOI 10.1111/j.1539-6924.2011.01633.x; United States Public Health Service Office of the Surgeon General National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health., 2020, SMOK CESS REP SURG G; Van't Riet J, 2013, HEALTH PSYCHOL REV, V7, pS104, DOI 10.1080/17437199.2011.606782; Veribiac J-F., 2001, PERS INDIV DIFFER, V5, P605; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Wang AL, 2015, TOB CONTROL, V24, P225, DOI 10.1136/tobaccocontrol-2014-051993; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; WEINSTEIN ND, 1987, J BEHAV MED, V10, P481, DOI 10.1007/BF00846146; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; Wong LP, 2010, PREV MED, V51, P92, DOI 10.1016/j.ypmed.2010.04.010; Wong NCH, 2009, J APPL COMMUN RES, V37, P1, DOI 10.1080/00909880802593928; Yang B, 2019, HEALTH EDUC BEHAV, V46, P471, DOI 10.1177/1090198118825236; Yang JZ, 2018, J RISK RES, V21, P834, DOI 10.1080/13669877.2016.1247378; Zhao XQ, 2009, HEALTH COMMUN, V24, P259, DOI 10.1080/10410230902805932; Zhou Z., 2016, TOB INDUC DIS, P14, DOI [10.1186/s12971-016-0079-6, DOI 10.1186/S12971-016-0079-6]	85	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260478	10.1371/journal.pone.0260478	http://dx.doi.org/10.1371/journal.pone.0260478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874964	gold, Green Published			2022-12-26	WOS:000753617500025
J	Townshend-Bulson, L; Roik, E; Barbour, Y; Bruden, DJT; Homan, CE; Espera, HGF; Stevenson, TJ; Hewitt, AM; Rhodes, W; Gove, JE; Plotnik, JN; Snowball, MM; McGilvray, J; Simons, BC; Johnston, JM; McMahon, BJ				Townshend-Bulson, Lisa; Roik, Elena; Barbour, Youssef; Bruden, Dana J. T.; Homan, Chriss E.; Espera, Hannah G. F.; Stevenson, Timothy J.; Hewitt, Annette M.; Rhodes, Wileina; Gove, James E.; Plotnik, Julia N.; Snowball, Mary M.; McGilvray, John; Simons, Brenna C.; Johnston, Janet M.; McMahon, Brian J.			The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals	PLOS ONE			English	Article							GENOTYPE 3 INFECTION; STAGE LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; VIRUS; RIBAVIRIN; EPIDEMIOLOGY; LEDIPASVIR; SAFETY; RISK; REGIMENS	Background Direct-acting antiviral (DAA) drugs have been effective in the treatment of chronic hepatitis C virus (HCV) infection. Limited data are available on safety, tolerability, and efficacy in American Indian or Alaska Native people. We aim to evaluate the treatment outcomes of sofosbuvir- based regimens for treatment of HCV in a real life setting in Alaska Native/American Indian (AN/AI) people. Methods AN/AI patients within the Alaska Tribal Health System with confirmed positive anti-HCV and HCV RNA, who were 18 years of age and older were included in the study. Pretreatment baseline patient characteristics, treatment efficacy based on sustained virologic response (SVR) 12 weeks after treatment completion, and adverse effects were assessed. The following treatments were given according to the American Association for the Study of Liver Diseases/Infectious Disease Society of America (AASLD/IDSA) HCV Guidance: ledipasvir/sofosbuvir, sofosbuvir plus weight-based ribavirin, and sofosbuvir/velpatasvir. Results We included 501 patients with a mean age of 54.3 (range 21.3-78.3) in the study. Overall SVR was achieved in 95.2% of patients who received one of the three DAA regimens. For those with cirrhosis, overall SVR was 92.8% and for those with genotype 3 91.1% achieved SVR. The most common symptom experienced during treatment was headache. Joint pain was found to decrease during treatment. One person discontinued sofosbuvir plus ribavirin due to myocardial infarction and one discontinued sofosbuvir/velpatasvir due to urticaria. Conclusions In the real-world setting, sofosbuvir-based treatment is safe, effective, and well tolerated in AN/AI patients. Sustained virologic response was high regardless of HCV genotype or cirrhosis status.	[Townshend-Bulson, Lisa; Roik, Elena; Barbour, Youssef; Homan, Chriss E.; Espera, Hannah G. F.; Hewitt, Annette M.; Rhodes, Wileina; Gove, James E.; Plotnik, Julia N.; Snowball, Mary M.; Johnston, Janet M.; McMahon, Brian J.] Alaska Nat Tribal Hlth Consortium, Liver Dis & Hepatitis Program, Anchorage, AK 99508 USA; [Bruden, Dana J. T.; Simons, Brenna C.] Ctr Dis Control & Prevent, Anchorage, AK USA; [Stevenson, Timothy J.] Alaska State Virol Lab, Anchorage, AK USA; [McGilvray, John] Southcent Fdn, Dept Pharm, Anchorage, AK USA	Alaska Native Tribal Health Consortium; Centers for Disease Control & Prevention - USA	Townshend-Bulson, L (corresponding author), Alaska Nat Tribal Hlth Consortium, Liver Dis & Hepatitis Program, Anchorage, AK 99508 USA.	ltownshend@anthc.org	Johnston, Janet/HGB-9980-2022	Roik, Elena/0000-0001-7226-2198; Johnston, Janet/0000-0001-8738-9677	Gilead Sciences [IN-US-334-1329]	Gilead Sciences(Gilead Sciences)	This study was funded in part by Gilead Sciences, Gilead IN-US-334-1329. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLD, AASLD GUID TREATM CH, DOI [10.1002/hep.28156, DOI 10.1002/HEP.28156]; Afdhal Nezam H, 2014, Gastroenterol Hepatol (N Y), V10, P815; Alonso S, 2017, J VIRAL HEPATITIS, V24, P304, DOI 10.1111/jvh.12648; American Association for the Study of Liver Diseases Infectious Diseases Society of America, HCV GUID REC TEST MA; Behrends CN, 2021, J URBAN HEALTH, V98, P563, DOI 10.1007/s11524-020-00422-0; Boucher LM, 2019, SUBST USE MISUSE, V54, P18, DOI 10.1080/10826084.2018.1485699; Bruden DJT, 2017, HEPATOLOGY, V66, P37, DOI 10.1002/hep.29115; CDC, 2019, LIV CANC FACTS; CDC, 2019, VIR HEP SURV REP US; Department of Health NYS, 2019, NEW YORK STAT HEP C; El Khoury AC, 2012, J VIRAL HEPATITIS, V19, P153, DOI 10.1111/j.1365-2893.2011.01563.x; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Esteban R, 2018, GASTROENTEROLOGY, V155, P1120, DOI 10.1053/j.gastro.2018.06.042; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Feld JJ, 2016, CLIN INFECT DIS, V63, P776, DOI 10.1093/cid/ciw387; Gayam V, 2018, EUR J GASTROEN HEPAT, V30, P1200, DOI 10.1097/MEG.0000000000001233; Gentile I, 2014, REV RECENT CLIN TRIA, V9, P1, DOI 10.2174/1574887108666131213120354; Gounder PP, 2018, EUROSURVEILLANCE, V23, P13, DOI 10.2807/1560-7917.ES.2018.23.40.1700408; Hajarizadeh B, 2020, J HEPATOL, V72, P643, DOI 10.1016/j.jhep.2019.11.012; HHS, 2017, NAT VIR HEP PLAN 201; HHS, 2011, NAT VIR HEP ACT PLAN; Hofmeister MG, 2019, HEPATOLOGY, V69, P1020, DOI 10.1002/hep.30297; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Livingston SE, 2016, INT J CIRCUMPOL HEAL, V75, DOI 10.3402/ijch.v75.30696; Lledo GM, 2018, AIDS, V32, P2347, DOI 10.1097/QAD.0000000000001966; Loggi E, 2017, J CLIN VIROL, V93, P66, DOI 10.1016/j.jcv.2017.05.021; McMahon BJ, 2004, HEPATOLOGY, V39, P325, DOI 10.1002/hep.20046; McMahon BJ., 2019, CLIN INFECT DIS; McMahon BJ, 2017, CLIN GASTROENTEROL H, V15, P431, DOI 10.1016/j.cgh.2016.10.012; McMahon BJ, 2010, GASTROENTEROLOGY, V138, P922, DOI 10.1053/j.gastro.2009.10.056; Mera J, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz128; Mizokami M, 2015, LANCET INFECT DIS, V15, P645, DOI 10.1016/S1473-3099(15)70099-X; Mohamed AA, 2015, WORLD J HEPATOL, V7, P2676, DOI 10.4254/wjh.v7.i26.2676; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Smith MA, 2015, ANN PHARMACOTHER, V49, P343, DOI 10.1177/1060028014563952; Smith-Palmer J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0748-8; State of Alaska, HEP C OV TREATM UPD; Su F, 2017, HEPATOLOGY, V65, P426, DOI 10.1002/hep.28901; Sung JC, 2020, J VIRAL HEPATITIS, V27, P350, DOI 10.1111/jvh.13234; Washington State Department of Health, 2019, HEP C FREE WASH PLAN; WHO, 2017, WHO PUBLISHES LIST B; World Health Organization, 2019, HEP C KEY FACTS; Younossi ZM, 2015, J INFECT DIS, V212, P367, DOI 10.1093/infdis/jiv005; Younossi ZM, 2015, HEPATOLOGY, V61, P1798, DOI 10.1002/hep.27724; Zeng XH, 2015, ULTRASOUND MED BIOL, V41, P1538, DOI 10.1016/j.ultrasmedbio.2015.01.011; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260970	10.1371/journal.pone.0260970	http://dx.doi.org/10.1371/journal.pone.0260970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855920	Green Published, gold, Green Submitted			2022-12-26	WOS:000735299000161
J	Xu, YY; Ye, JY; Khalofah, A; Zuan, ATK; Ullah, R; El-Shehawi, AM				Xu, Yanyun; Ye, Junyong; Khalofah, Ahlam; Zuan, Ali Tan Kee; Ullah, Rehmat; El-Shehawi, Ahmed M.			Seed germination ecology of Conyza sumatrensis populations stemming from different habitats and implications for management	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; RANGE EXPANSION; BONARIENSIS; WEED; CONSERVATION; EMERGENCE; AGRICULTURE; TEMPERATURE; CANADENSIS; TILLAGE	Conyza sumatrensis (Retz.) E. H. Walker is an obnoxious weed, emerging as an invasive species globally. Seed germination biology of four populations of the species stemming from arid, semi-arid, temperate, and humid regions was determined in this study. Seed germination was recorded under six different environmental cues (i.e., light/dark periods, constant and alternating day and night temperatures, pH, salinity, and osmotic potential levels) in separate experiment for each cue. Populations were main factor, whereas levels of each environmental cue were considered as sub-factor. The impact of seed burial depths on seedling emergence was inferred in a greenhouse pot experiment. Seed germination was recorded daily and four germination indices, i.e., seed germination percentage, mean germination time, time to reach 50% germination, and mean daily germination were computed. Tested populations and levels of different environmental cues had significant impact on various seed germination indices. Overall, seeds stemming from arid and semi-arid regions had higher seed germination potential under stressful and benign environmental conditions compared to temperate and humid populations. Seed of all populations required a definite light period for germination and 12 hours alternating light and dark period resulted in the highest seed germination. Seed germination of all populations occurred under 5-30 degrees C constant and all tested alternate day and night temperatures. However, the highest seed germination was recorded under 20 degrees C. Seeds of arid and semi-arid populations exhibited higher germination under increased temperature, salinity and osmotic potential levels indicating that maternal environment strongly affected germination traits of the tested populations. The highest seed germination of the tested populations was noted under neutral pH, while higher and lower pH than neutral had negative impact on seed germination. Arid and semi-arid populations exhibited higher seed germination under increased pH compared to temperate and humid populations. Seed burial depth had a significant effect on the seedling emergence of all tested populations. An initial increase was noted in seedling emergence percentage with increasing soil depth. However, a steep decline was recorded after 2 cm seed burial depth. These results indicate that maternal environment strongly mediates germination traits of different populations. Lower emergence from >4 cm seed burial depth warrants that deep burial of seeds and subsequent zero or minimum soil disturbance could aid the management of the species in agricultural habitats. However, management strategies should be developed for other habitats to halt the spread of the species.	[Xu, Yanyun] Lishui Univ, Coll Ecol, Lishui, Peoples R China; [Ye, Junyong] Rural Ind Dev Ctr Liandu Dist, Lishui, Peoples R China; [Khalofah, Ahlam] King Khalid Univ, Fac Sci, Dept Biol, Abha, Saudi Arabia; [Khalofah, Ahlam] King Khalid Univ, Res Ctr Adv Mat Sci RCAMS, Abha, Saudi Arabia; [Zuan, Ali Tan Kee] Univ Putra Malaysia, Fac Agr, Dept Land Management, Seri Kembangan, Selangor, Malaysia; [Ullah, Rehmat] Soil & Water Testing Lab Res, Dera Ghazi Khan, Punjab, Pakistan; [El-Shehawi, Ahmed M.] Taif Univ, Coll Sci, Dept Biotechnol, At Taif, Saudi Arabia	Lishui University; King Khalid University; King Khalid University; Universiti Putra Malaysia; Taif University	Ye, JY (corresponding author), Rural Ind Dev Ctr Liandu Dist, Lishui, Peoples R China.; Zuan, ATK (corresponding author), Univ Putra Malaysia, Fac Agr, Dept Land Management, Seri Kembangan, Selangor, Malaysia.	yhy8813@sina.com; tkz@upm.edu.my	Khalofah, Ahlam/GPP-3951-2022; Khalofah, Ahlam/GQO-8938-2022; El-Shehawi, Ahmed/F-5566-2011	Khalofah, Ahlam/0000-0002-0005-504X; Khalofah, Ahlam/0000-0002-0005-504X; El-Shehawi, Ahmed/0000-0003-4357-4904; Ali Tan, Kee Zuan/0000-0003-0473-4303	Taif University, Taif, Saudi Arabia [TURSP -2020/75]	Taif University, Taif, Saudi Arabia	The current work was funded by Taif University Researchers Supporting Project number (TURSP -2020/75), Taif University, Taif, Saudi Arabia. There was no additional external funding involved in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 1992, TREE PLANT NOTES US; Agostinetto D, 2018, CIENC RURAL, V48, DOI 10.1590/0103-8478cr20170687; AHMED M, 1990, PHYTOCHEMISTRY, V29, P2715, DOI 10.1016/0031-9422(90)85226-6; Al-Wahaibi LH, 2019, BIOCHEM SYST ECOL, V87, DOI 10.1016/j.bse.2019.103959; Ali S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244059; Awan TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090305; Bewley J.D., 2013, NONOGAKI HIROYUKI SE, V3, DOI [10.1007/978-1-4614-4693-4, DOI 10.1007/978-1-4614-4693-4]; Bukun B, 2015, INVASIVE PLANTS CATA, P254; CABI, CON SUM TALL FLEAB, P2021; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2009, WEED SCI, V57, P235, DOI 10.1614/WS-08-141.1; Chauhan BS, 2008, WEED SCI, V56, P820, DOI 10.1614/WS-08-070.1; Chauhan BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep26006; Chauhan BS, 2006, WEED SCI, V54, P471, DOI 10.1614/WS-05-176R1.1; COOLBEAR P, 1984, J EXP BOT, V35, P1609, DOI 10.1093/jxb/35.11.1609; ELLIS RH, 1981, SEED SCI TECHNOL, V9, P373; Farooq M, 2014, SOIL TILL RES, V141, P1, DOI 10.1016/j.still.2014.03.012; Farooq S, 2019, S AFR J BOT, V123, P361, DOI 10.1016/j.sajb.2019.03.031; Farooq S, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11061123; Farooq S, 2017, ACTA OECOL, V84, P23, DOI 10.1016/j.actao.2017.08.004; Fernandez-Pascual E, 2021, NEW PHYTOL, V229, P3573, DOI 10.1111/nph.17086; Forcella F, 2000, FIELD CROP RES, V67, P123, DOI 10.1016/S0378-4290(00)00088-5; Fowler R, 2001, SOIL TILL RES, V61, P93, DOI 10.1016/S0167-1987(01)00181-7; Garcia AL, 2013, WEED SCI, V61, P146, DOI 10.1614/WS-D-12-00023.1; Karlsson LM, 2007, WEED RES, V47, P433, DOI 10.1111/j.1365-3180.2007.00576.x; Kassam A., 2019, International Journal of Environmental Studies, V76, P29, DOI 10.1080/00207233.2018.1494927; Loura D, 2020, WEED SCI, V68, P411, DOI 10.1017/wsc.2020.28; Mahajan G, 2021, WEED SCI, V69, P687, DOI 10.1017/wsc.2021.56; Mahmood AH, 2016, WEED SCI, V64, P486, DOI 10.1614/WS-D-15-00184.1; Michael, 1977, P 6 AS PAC WEED SCI, P87; MICHEL BE, 1973, PLANT PHYSIOL, V51, P914, DOI 10.1104/pp.51.5.914; Nandula VK, 2006, WEED SCI, V54, P898, DOI 10.1614/WS-06-006R2.1; Nichols V, 2015, FIELD CROP RES, V183, P56, DOI 10.1016/j.fcr.2015.07.012; Onen H., 2020, Agriculture and Forestry, V66, P169, DOI 10.17707/AgricultForest.66.3.14; Onen H, 2018, WEED SCI, V66, P494, DOI 10.1017/wsc.2018.20; Onen H, 2017, WEED SCI, V65, P115, DOI 10.1614/WS-D-16-00011.1; Ottavini D, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9090533; Ozaslan C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17169-5; Ozaslan C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164369; Pittelkow CM, 2015, NATURE, V517, P365, DOI 10.1038/nature13809; Pruski JF, 2006, NOVON, V16, P96, DOI 10.3417/1055-3177(2006)16[96:CSVLCA]2.0.CO;2; Rasool N, 2016, ECOL PROCESS, V5, P1, DOI DOI 10.1186/s13717-016-0054-4; Royo-Esnal A, 2015, WEED RES, V55, P387, DOI 10.1111/wre.12154; Saeed A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241601; Shahzad M, 2016, SOIL TILL RES, V163, P71, DOI 10.1016/j.still.2016.05.012; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; STEEL R. G. D., 1960, Principles and procedures of statistics.; Trezzi MM, 2015, WEED RES, V55, P34, DOI 10.1111/wre.12125; Valencia-Gredilla F, 2020, ANN APPL BIOL, V176, P36, DOI 10.1111/aab.12556; Vidal RA, 2007, PLANTA DANINHA, V25, P309, DOI 10.1590/S0100-83582007000200010; Walker EH., 1971, J JAPANESE BOT, V47, P1; Wu H, 2007, WEED BIOL MANAG, V7, P192, DOI 10.1111/j.1445-6664.2007.00256.x; Yamashita O. M., 2016, Ambiencia, V12, P655; ZINZOLKER A, 1985, PHYTOPARASITICA, V13, P229	54	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260674	10.1371/journal.pone.0260674	http://dx.doi.org/10.1371/journal.pone.0260674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855863	gold, Green Published			2022-12-26	WOS:000735299000090
J	Witkowski, W; Kuik, L; Rucka, M; Daszkiewicz, K; Andrzejewska, A; Luczkiewicz, P				Witkowski, Wojciech; Kuik, Leszek; Rucka, Magdalena; Daszkiewicz, Karol; Andrzejewska, Angela; Luczkiewicz, Piotr			Medially positioned plate in first metatarsophalangeal joint arthrodesis	PLOS ONE			English	Article							HALLUX-VALGUS	Objective The purpose of this study was to biomechanically compare the stability of first metatarsophalangeal (MTP1) joint arthrodesis with dorsally and medially positioned plates. Methods A physical model of the MTP1 joint consists of printed synthetic bones, a titanium locking plate and screws. In the experiments, samples with dorsally and medially positioned plates were subjected to loading of ground load character in a universal testing machine. Force-displacement relations and relative displacements of bones were recorded. The obtained results were used to validate the corresponding finite element models of the MTP1 joint. Nonlinear finite element simulations of the toe-off phase of gait were performed to determine the deformation and stress state in the MTP1 joint for two positions of the plate. Results In numerical simulations, the maximum displacement in the dorsal direction was noticed at the tip of the distal phalanx and was equal to 19.6 mm for the dorsal plate and 9.63 mm for the medial plate for a resultant force of 150 N. Lower relative bone displacements and smaller plastic deformation in the plate were observed in the model with the medial plate. Stress values were also smaller in the medially positioned plate and locking screws compared to fixation with the dorsal plate. Conclusions A medially positioned locking plate provides better stability of the MTP1 joint than a dorsally positioned plate due to greater vertical bending stiffness of the medial plate. Smaller relative bone displacements observed in fixation with the medial plate may be beneficial for the bone healing process. Moreover, lower stress values may decrease the risk of complications associated with hardware failure.	[Witkowski, Wojciech; Rucka, Magdalena; Daszkiewicz, Karol; Andrzejewska, Angela] Gdansk Univ Technol, Fac Civil & Environm Engn, Dept Mech Mat & Struct, Gdansk, Poland; [Kuik, Leszek; Luczkiewicz, Piotr] Med Univ Gdansk, Clin Orthopaed & Kinet Organ Traumatol 2, Gdansk, Poland	Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk	Luczkiewicz, P (corresponding author), Med Univ Gdansk, Clin Orthopaed & Kinet Organ Traumatol 2, Gdansk, Poland.	plucz@gumed.edu.pl	Rucka, Magdalena/Q-3519-2016; Andrzejewska, Angela Jadwiga/AAH-9089-2019; Luczkiewicz, Piotr/AAC-2970-2020; Witkowski, Wojciech/E-3550-2017	Rucka, Magdalena/0000-0001-7870-281X; Andrzejewska, Angela Jadwiga/0000-0002-2458-0703; Luczkiewicz, Piotr/0000-0001-8988-1251; Witkowski, Wojciech/0000-0003-2832-7892				Abben KW, 2018, J FOOT ANKLE SURG, V57, P771, DOI 10.1053/j.jfas.2018.02.011; Akrami M, 2018, BIOMECH MODEL MECHAN, V17, P559, DOI 10.1007/s10237-017-0978-3; Bennett GL, 2009, FOOT ANKLE INT, V30, P752, DOI 10.3113/FAI.2009.0752; Berlet Gregory C, 2008, Foot Ankle Spec, V1, P24, DOI 10.1177/1938640007311920.; Calderone D R, 1993, J Foot Ankle Surg, V32, P517; Campbell B, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0525-z; Claes L, 2021, J BIOMECH, V115, DOI 10.1016/j.jbiomech.2020.110148; COUGHLIN MJ, 1990, ORTHOPEDICS, V13, P1037; Dayton P, 2001, J Foot Ankle Surg, V40, P414; Ellington JK, 2010, FOOT ANKLE INT, V31, P385, DOI 10.3113/FAI.2010.0385; Fuhrmann RA, 2011, FOOT ANKLE CLIN, V16, P1, DOI 10.1016/j.fcl.2010.12.003; Gaudin G, 2018, ORTHOP TRAUMATOL-SUR, V104, P1221, DOI 10.1016/j.otsr.2018.08.011; Hanon M.M., 2019, INT REV APPL SCI ENG, V10, P173, DOI [10.1556/1848.2019.0021, DOI 10.1556/1848.2019.0021]; Harris E, 2017, FOOT ANKLE SURG, V23, P268, DOI 10.1016/j.fas.2016.07.005; HULBERT K F, 1955, Lancet, V268, P597; Kluess D, 2009, COMPUT METH PROG BIO, V95, P23, DOI 10.1016/j.cmpb.2009.01.004; Kuik Leszek, 2021, Ortop Traumatol Rehabil, V23, P205, DOI 10.5604/01.3001.0014.9256; Ledoux WR, 2002, GAIT POSTURE, V15, P1, DOI 10.1016/S0966-6362(01)00165-5; Lienau J, 2005, J ORTHOP RES, V23, P639, DOI 10.1016/j.orthres.2004.09.006; Lienau J, 2010, TISSUE ENG PT A, V16, P191, DOI [10.1089/ten.tea.2009.0187, 10.1089/ten.TEA.2009.0187]; Lopez-Lopez D, 2022, INT WOUND J, V19, P507, DOI 10.1111/iwj.13649; Lowenberg DW, 2008, CLIN ORTHOP RELAT R, V466, P2947, DOI 10.1007/s11999-008-0515-x; MCKEEVER DC, 1952, J BONE JOINT SURG AM, V34-A, P129, DOI 10.2106/00004623-195234010-00013; Munuera PV, 2008, INT ORTHOP, V32, P489, DOI 10.1007/s00264-007-0350-9; PERREN SM, 1977, UNFALLHEILKUNDE, V80, P161; Rippstein PF, 2012, FOOT ANKLE INT, V33, P400, DOI 10.3113/FAI.2012.0400; Sanchez-Gomez R, 2020, FOOT ANKLE INT, V41, P457, DOI 10.1177/1071100719901116; Seo S, 2005, INT J IMPACT ENG, V31, P735, DOI 10.1016/j.ijimpeng.2004.04.010; Smith R W, 1992, Foot Ankle, V13, P367; Steiner JA, 2017, J ORTHOP RES, V35, P2415, DOI 10.1002/jor.23551; Steiner JA, 2016, MED ENG PHYS, V38, P417, DOI 10.1016/j.medengphy.2016.01.006; Tourne Y, 1997, FOOT ANKLE INT, V18, P195, DOI 10.1177/107110079701800402	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260572	10.1371/journal.pone.0260572	http://dx.doi.org/10.1371/journal.pone.0260572			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34852005	Green Published, gold			2022-12-26	WOS:000755762900046
J	Martinez, OE; Mahoney, BJ; Goring, AK; Yi, SW; Tran, DP; Cascio, D; Phillips, ML; Muthana, MM; Chen, X; Jung, ME; Loo, JA; Clubb, RT				Martinez, Orlando E.; Mahoney, Brendan J.; Goring, Andrew K.; Yi, Sung-Wook; Tran, Denise P.; Cascio, Duilio; Phillips, Martin L.; Muthana, Musleh M.; Chen, Xi; Jung, Michael E.; Loo, Joseph A.; Clubb, Robert T.			Insight into the molecular basis of substrate recognition by the wall teichoic acid glycosyltransferase TagA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; MEMBRANE-PROTEIN; NMR; BIOSYNTHESIS; CLASSIFICATION; REFINEMENT; ENZYMES; BINDING; GENE	Wall teichoic acid (WTA) polymers are covalently affixed to the Gram-positive bacterial cell wall and have important functions in cell elongation, cell morphology, biofilm formation, and beta-lactam antibiotic resistance. The first committed step in WTA biosynthesis is catalyzed by the TagA glycosyl-transferase (also called TarA), a peripheral membrane protein that produces the conserved linkage unit, which joins WTA to the cell wall peptidoglycan. TagA contains a conserved GT26 core domain followed by a C-terminal polypeptide tail that is important for catalysis and membrane binding. Here, we report the crystal structure of the Thermoanaerobacter italicus TagA enzyme bound to UDP-N-acetyl-D-mannosamine, revealing the molecular basis of substrate binding. Native MS experiments support the model that only monomeric TagA is enzymatically active and that it is stabilized by membrane binding. Molecular dynamics simulations and enzyme activity measurements indicate that the C-terminal polypeptide tail facilitates catalysis by encapsulating the UDP-N-acetyl-D-mannosamine substrate, presenting three highly conserved arginine residues to the active site that are important for catalysis (R214, R221, and R224). From these data, we present a mechanistic model of catalysis that ascribes functions for these residues. This work could facilitate the development of new antimicrobial compounds that disrupt WTA biosynthesis in pathogenic bacteria.	[Martinez, Orlando E.; Mahoney, Brendan J.; Goring, Andrew K.; Yi, Sung-Wook; Tran, Denise P.; Phillips, Martin L.; Jung, Michael E.; Loo, Joseph A.; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Martinez, Orlando E.; Mahoney, Brendan J.; Goring, Andrew K.; Cascio, Duilio; Loo, Joseph A.; Clubb, Robert T.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Muthana, Musleh M.; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Jung, Michael E.; Loo, Joseph A.; Clubb, Robert T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Muthana, Musleh M.] Univ Maryland, Sch Med, Inst Human Virol, Div Immunotherapy, Baltimore, MD 21201 USA; [Muthana, Musleh M.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Davis; University of California System; University of California Los Angeles; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Clubb, RT (corresponding author), Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA.; Clubb, RT (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.	rclubb@mbi.ucla.edu	Goring, Andrew/D-4261-2018	Goring, Andrew/0000-0003-4220-6472; Tran, Denise/0000-0002-4445-5600; Martinez, Orlando/0000-0002-9910-9289; Muthana, Musleh/0000-0003-1242-5631; Mahoney, Brendan/0000-0003-4323-9276	National Institutes of Health (NIH) [AI52217, GM103479]; NIH Chemistry-Biology Training Fellowship [T32GM008496]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Chemistry-Biology Training Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the National Institutes of Health (NIH) (AI52217 [to R. T. C.]; GM103479 [to J. A. L.]). O. E. M. was supported by the NIH Chemistry-Biology Training Fellowship (T32GM008496). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BECERRA SP, 1991, BIOCHEMISTRY-US, V30, P11707, DOI 10.1021/bi00114a015; Bhavsar AP, 2005, J BIOL CHEM, V280, P36691, DOI 10.1074/jbc.M507154200; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen L, 2020, MBIO, V11, DOI 10.1128/mBio.02749-19; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; D'Elia MA, 2009, J BACTERIOL, V191, P4030, DOI 10.1128/JB.00611-08; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duarte JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-334; Eletsky A, 2001, J BIOMOL NMR, V20, P177, DOI 10.1023/A:1011265430149; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDL J, 1983, ARCH MICROBIOL, V135, P215, DOI 10.1007/BF00414483; Farha MA, 2013, ACS CHEM BIOL, V8, P226, DOI 10.1021/cb300413m; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; FRIEDHOFF P, 1994, PROTEIN EXPRES PURIF, V5, P37, DOI 10.1006/prep.1994.1005; Gale RT, 2017, CELL CHEM BIOL, V24, P1537, DOI 10.1016/j.chembiol.2017.09.006; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ginsberg C, 2006, ACS CHEM BIOL, V1, P25, DOI 10.1021/cb0500041; Haft RF, 1996, MOL MICROBIOL, V19, P555, DOI 10.1046/j.1365-2958.1996.395931.x; HECKELS JE, 1977, BIOCHEM J, V162, P359, DOI 10.1042/bj1620359; Holland LM, 2011, MICROBIOL-SGM, V157, P408, DOI 10.1099/mic.0.042234-0; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kattke M. D., 2019, PROTEIN DATA BANK; Kattke MD, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007723; Keller R., 2004, COMPUTER AIDED RESON, V1; KOJIMA N, 1985, J BACTERIOL, V161, P299, DOI 10.1128/JB.161.1.299-306.1985; Kumar R, 2019, EUR J MED CHEM, V182, DOI 10.1016/j.ejmech.2019.111602; Laganowsky A, 2013, NAT PROTOC, V8, P639, DOI 10.1038/nprot.2013.024; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lee D, 2006, J MAGN RESON, V178, P72, DOI 10.1016/j.jmr.2005.08.014; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRorie D. K., 2004, SELF ASSOCIATING SYS; Misawa Y, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005061; Muthana MM, 2012, CHEM COMMUN, V48, P2728, DOI 10.1039/c2cc17577k; Naumova IB, 2001, FEMS MICROBIOL REV, V25, P269, DOI 10.1016/S0168-6445(00)00064-4; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Prive GG, 2009, CURR OPIN STRUC BIOL, V19, P379, DOI 10.1016/j.sbi.2009.07.008; Rahman A, 2001, J BACTERIOL, V183, P6509, DOI 10.1128/JB.183.22.6509-6516.2001; Robson SA, 2021, J BIOMOL NMR, V75, P293, DOI 10.1007/s10858-021-00379-5; ROSS PD, 1991, BIOCHEMISTRY-US, V30, P6269, DOI 10.1021/bi00239a027; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Schade J, 2016, FEBS LETT, V590, P3758, DOI 10.1002/1873-3468.12288; Schirner K, 2011, ACS CHEM BIOL, V6, P407, DOI 10.1021/cb100390w; Schirner K, 2009, EMBO J, V28, P830, DOI 10.1038/emboj.2009.25; Sewell EWC, 2014, J ANTIBIOT, V67, P43, DOI 10.1038/ja.2013.100; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Soldo B, 2002, MICROBIOL-SGM, V148, P2079, DOI 10.1099/00221287-148-7-2079; Soldo B, 2002, J BACTERIOL, V184, P4316, DOI 10.1128/JB.184.15.4316-4320.2002; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Wang S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005324; Wanner S, 2017, NAT MICROBIOL, V2, DOI [10.1038/nmicrobiol.2016.257, 10.1038/nmicrobiol.2017.48]; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; Xu JB, 2019, P NATL ACAD SCI USA, V116, P16856, DOI 10.1073/pnas.1821309116; YOKOYAMA K, 1986, EUR J BIOCHEM, V161, P479, DOI 10.1111/j.1432-1033.1986.tb10469.x; Zhang H., 2014, PROTEIN DATA BANK; Zhang H, 2016, J BIOL CHEM, V291, P22106, DOI 10.1074/jbc.M116.731695; Zhang H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5339; Zhang YH, 2006, BIOCHEMISTRY-US, V45, P10895, DOI 10.1021/bi060872z	77	2	2	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101464	10.1016/j.jbc.2021.101464	http://dx.doi.org/10.1016/j.jbc.2021.101464			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI2AK	34864059	gold, Green Published			2022-12-26	WOS:000761429500001
J	Liu, L; Liu, TT; Xie, GG; Zhu, XQ; Wang, Y				Liu, Lei; Liu, Ting-Ting; Xie, Guo-Guang; Zhu, Xiao-Qi; Wang, Yun			Ubiquitin ligase TRIM32 promotes dendrite arborization by mediating degradation of the epigenetic factor CDYL	FASEB JOURNAL			English	Article						CDYL; degradation; dendrite arborization; TRIM32; ubiquitylation	GIRDLE MUSCULAR-DYSTROPHY; NEURODEVELOPMENTAL DISORDERS; MOLECULAR-MECHANISMS; PROTEIN; PLASTICITY; MIGRATION	Proper dendritic morphology is fundamental to nerve signal transmission; thus, revealing the mechanism by which dendrite arborization is regulated is of great significance. Our previous studies have found that the epigenetic molecule chromodomain Y-like (CDYL) negatively regulates dendritic branching. Current research mostly focuses on the processes downstream of CDYL, whereas the upstream regulatory process has not been investigated to date. In this study, we identified an upstream regulator of CDYL, the E3 ubiquitin ligase tripartite motif-containing protein 32 (TRIM32), which promotes dendrite arborization by mediating the ubiquitylation and degradation of CDYL. By using mass spectrometry and biochemistry strategies, we proved that TRIM32 interacted with CDYL and mediated CDYL ubiquitylation modification in vivo and in vitro. Overexpressing TRIM32 decreased the protein level of CDYL, leading to an increase in the dendritic complexity of primary cultured rat neurons. In contrast, knocking down TRIM32 increased the protein level of CDYL and decreased the dendritic complexity. The truncated form of TRIM32 without E3 ligase activity (Delta RING) lost its ability to regulate dendritic complexity. Most importantly, knockdown of CDYL abolished the reduced complexity of dendrites caused by TRIM32 knockdown, indicating that the TRIM32-mediated regulation of dendritic development depends on its regulation of downstream CDYL. Hence, our findings reveal that TRIM32 could promote dendrite arborization by mediating CDYL degradation. This work initially defines a novel biological role of TRIM32 in regulating mechanisms upstream of CDYL and further presents a potential therapeutic target for the treatment of CDYL-related neurodevelopmental disorders.	[Liu, Lei; Liu, Ting-Ting; Xie, Guo-Guang; Zhu, Xiao-Qi; Wang, Yun] Peking Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China; [Liu, Lei; Liu, Ting-Ting; Xie, Guo-Guang; Zhu, Xiao-Qi; Wang, Yun] Peking Univ, Neurosci Res Inst, Key Lab Neurosci, Minist Educ China, Beijing, Peoples R China; [Liu, Lei; Liu, Ting-Ting; Xie, Guo-Guang; Zhu, Xiao-Qi; Wang, Yun] Peking Univ, Natl Hlth Commiss, Beijing, Peoples R China; [Liu, Lei; Liu, Ting-Ting; Xie, Guo-Guang; Zhu, Xiao-Qi; Wang, Yun] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China; [Wang, Yun] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing, Peoples R China	Peking University; Ministry of Education, China; Peking University; Peking University; Peking University; Peking University	Wang, Y (corresponding author), Peking Univ, Sch Basic Med Sci, Neurosci Res Inst, Dept Neurobiol, Beijing 100191, Peoples R China.	wangy66@bjmu.edu.cn	liu, ting/GZM-3326-2022		National Natural Science Foundation of China (NSFC) [31530028, 31720103908, 32030052, 81821092]; Ministry of Science and Technology of the People's Republic of China (MOST) [20171'LA0701302]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31530028, 31720103908, 32030052 and 81821092; Ministry of Science and Technology of the People's Republic of China (MOST), Grant/Award Number: 20171' LA0701302	Caron C, 2003, EMBO REP, V4, P877, DOI 10.1038/sj.embor.embor917; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Cochran JN, 2014, BRAIN RES BULL, V103, P18, DOI 10.1016/j.brainresbull.2013.12.004; Copf T, 2016, NEUROSCI BIOBEHAV R, V68, P946, DOI 10.1016/j.neubiorev.2016.04.008; Escamilla-Del-Arenal M, 2013, MOL CELL BIOL, V33, P5005, DOI 10.1128/MCB.00866-13; Forrest MP, 2018, NAT REV NEUROSCI, V19, P215, DOI 10.1038/nrn.2018.16; Franz H, 2009, J BIOL CHEM, V284, P35049, DOI 10.1074/jbc.M109.052332; FRIDELL RA, 1995, VIROLOGY, V209, P347, DOI 10.1006/viro.1995.1266; Frosk P, 2005, EUR J HUM GENET, V13, P978, DOI 10.1038/sj.ejhg.5201436; Gulyaeva NV, 2017, BIOCHEMISTRY-MOSCOW+, V82, P237, DOI 10.1134/S0006297917030014; Hillje AL, 2011, STEM CELLS, V29, P1437, DOI 10.1002/stem.687; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kano S, 2008, CANCER RES, V68, P5572, DOI 10.1158/0008-5472.CAN-07-6231; Koleske AJ, 2013, NAT REV NEUROSCI, V14, P536, DOI 10.1038/nrn3486; Kudryashova E, 2012, J CLIN INVEST, V122, P1764, DOI 10.1172/JCI59581; Lahn BT, 1999, NAT GENET, V21, P429, DOI 10.1038/7771; Lanoue V, 2019, DEV BIOL, V451, P16, DOI 10.1016/j.ydbio.2018.12.005; Liu J, 2014, CELL DEATH DIFFER, V21, P1792, DOI 10.1038/cdd.2014.121; Liu SM, 2017, MOL CELL, V67, P853, DOI 10.1016/j.molcel.2017.07.011; Liu YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00368-z; Liu YG, 2010, J INVEST DERMATOL, V130, P1384, DOI 10.1038/jid.2009.416; Martinez-Cerdeno V, 2017, DEV NEUROBIOL, V77, P393, DOI 10.1002/dneu.22417; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Mokhonova EI, 2015, HUM MOL GENET, V24, P2873, DOI 10.1093/hmg/ddv049; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Neri M, 2013, NEUROMUSCULAR DISORD, V23, P478, DOI 10.1016/j.nmd.2013.02.003; Nicklas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030445; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Qi C, 2014, J NEUROSCI, V34, P4494, DOI 10.1523/JNEUROSCI.3647-13.2014; Qin R, 2017, CELL REP, V18, P380, DOI 10.1016/j.celrep.2016.12.043; Saccone V, 2008, HUM MUTAT, V29, P240, DOI 10.1002/humu.20633; Sato T, 2011, J CELL SCI, V124, P3492, DOI 10.1242/jcs.088799; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; SHOLL DA, 1953, J ANAT, V87, P387; Tocchini C, 2015, SEMIN CELL DEV BIOL, V47-48, P52, DOI 10.1016/j.semcdb.2015.10.017; Wu H, 2009, PROTEINS, V76, P1054, DOI 10.1002/prot.22472; Yokota T, 2006, EUR J CLIN INVEST, V36, P820, DOI 10.1111/j.1365-2362.2006.01722.x; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhang Y, 2011, J BIOL CHEM, V286, P42414, DOI 10.1074/jbc.M111.271064	42	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22087	10.1096/fj.202100031RR	http://dx.doi.org/10.1096/fj.202100031RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34888944				2022-12-26	WOS:000734992000029
J	Redding, LE; Berry, AS; Indugu, N; Huang, E; Beiting, DP; Pitta, D				Redding, Laurel E.; Berry, Alexander S.; Indugu, Nagaraju; Huang, Elizabeth; Beiting, Daniel P.; Pitta, Dipti			Gut microbiota features associated with Clostridioides difficile colonization in dairy calves	PLOS ONE			English	Article							FECAL MICROBIOTA; VEAL CALVES; PREVALENCE; DYSBIOSIS; DIARRHEA; DISEASES; HEALTHY; RISK	Diarrheal disease, a major cause of morbidity and mortality in dairy calves, is strongly associated with the health and composition of the gut microbiota. Clostridioides difficile is an opportunistic pathogen that proliferates and can produce enterotoxins when the host experiences gut dysbiosis. However, even asymptomatic colonization with C. difficile can be associated with differing degrees of microbiota disruption in a range of species, including people, swine, and dogs. Little is known about the interaction between C. difficile and the gut microbiota in dairy calves. In this study, we sought to define microbial features associated with C. difficile colonization in pre-weaned dairy calves less than 2 weeks of age. We characterized the fecal microbiota of 80 calves from 23 different farms using 16S rRNA sequencing and compared the microbiota of C. difficile-positive (n = 24) and C. difficile-negative calves (n = 56). Farm appeared to be the greatest source of variability in the gut microbiota. When controlling for calf age, diet, and farm location, there was no significant difference in Shannon alpha diversity (P = 0.50) or in weighted UniFrac beta diversity (P = 0.19) between C. difficile-positive and-negative calves. However, there was a significant difference in beta diversity as assessed using Bray-Curtiss diversity (P = 0.0077), and C. difficile-positive calves had significantly increased levels of Ruminococcus (gnavus group) (Adj. P = 0.052), Lachnoclostridium (Adj. P = 0.060), Butyricicoccus (Adj. P = 0.060), and Clostridium sensu stricto 2 compared to C. difficile-negative calves. Additionally, C. difficile-positive calves had fewer microbial co-occurrences than C. difficile-negative calves, indicating reduced bacterial synergies. Thus, while C. difficile colonization alone is not associated with dysbiosis and is therefore unlikely to result in an increased likelihood of diarrhea in dairy calves, it may be associated with a more disrupted microbiota.	[Redding, Laurel E.; Indugu, Nagaraju; Huang, Elizabeth; Pitta, Dipti] Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA; [Berry, Alexander S.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Berry, Alexander S.; Beiting, Daniel P.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Redding, LE (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA.	lredding@vet.upenn.edu		Redding, Laurel/0000-0002-3414-1202	USDA National Institute of Food and Agriculture, AHDR Sec1433 Capacity program (Formula Funds)	USDA National Institute of Food and Agriculture, AHDR Sec1433 Capacity program (Formula Funds)	LER was supported by the USDA National Institute of Food and Agriculture, AHDR Sec1433 Capacity program (Formula Funds).	Alipour MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28733-y; Anis E, 2021, VET MED SCI, V7, P1536, DOI 10.1002/vms3.567; Bardenhorst SK, 2021, MSYSTEMS, V6, DOI 10.1128/mSystems.01154-20; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry ASF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215497; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Breban M, 2017, ANN RHEUM DIS, V76, P1614, DOI 10.1136/annrheumdis-2016-211064; Hang BPT, 2021, TROP ANIM HEALTH PRO, V53, DOI 10.1007/s11250-020-02535-9; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Chua HH, 2018, GASTROENTEROLOGY, V154, P154, DOI 10.1053/j.gastro.2017.09.006; Devriese S, 2017, J CROHNS COLITIS, V11, P229, DOI 10.1093/ecco-jcc/jjw142; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dill-McFarland KA, 2017, SCI REP-UK, V7, DOI 10.1038/srep40864; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eeckhaut V, 2013, GUT, V62, P1745, DOI 10.1136/gutjnl-2012-303611; Foster DM, 2009, VET CLIN N AM-FOOD A, V25, P13, DOI 10.1016/j.cvfa.2008.10.013; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gomez DE, 2017, J VET INTERN MED, V31, P928, DOI 10.1111/jvim.14695; Grimm P, 2017, ANIMAL, V11, P1136, DOI 10.1017/S1751731116002779; Grzeskowiak L, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7080218; Gulliksen SM, 2009, J DAIRY SCI, V92, P5057, DOI 10.3168/jds.2009-2080; Hagey JV, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01093; Haley BJ, 2020, FOODBORNE PATHOG DIS, V17, P494, DOI 10.1089/fpd.2019.2768; Hall AB, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0490-5; Hammitt MC, 2008, VET MICROBIOL, V127, P343, DOI 10.1016/j.vetmic.2007.09.002; Han SH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212626; Henke MT, 2019, P NATL ACAD SCI USA, V116, P12672, DOI 10.1073/pnas.1904099116; Hennessy ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238882; Houser BA, 2012, FOODBORNE PATHOG DIS, V9, P32, DOI 10.1089/fpd.2011.0955; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klein-Jobstl D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00622; Knight DR, 2013, APPL ENVIRON MICROB, V79, P2630, DOI 10.1128/AEM.03951-12; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lepage P, 2005, INFLAMM BOWEL DIS, V11, P473, DOI 10.1097/01.MIB.0000159662.62651.06; Liang JQ, 2020, GUT, V69, P1248, DOI 10.1136/gutjnl-2019-318532; Ling ZX, 2014, APPL ENVIRON MICROB, V80, P2546, DOI 10.1128/AEM.00003-14; Lourenco JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231533; Ma T, 2020, ISME J, V14, P2223, DOI 10.1038/s41396-020-0678-3; Malmuthuge N, 2017, J DAIRY SCI, V100, P5996, DOI 10.3168/jds.2016-12239; Malmuthuge N, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00036; Malmuthuge N, 2015, J DAIRY SCI, V98, P8044, DOI 10.3168/jds.2015-9607; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; McGuirk SM, 2008, VET CLIN N AM-FOOD A, V24, P139, DOI 10.1016/j.cvfa.2007.10.003; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; O'Hara E, 2020, FEMS MICROBIOL ECOL, V96, DOI 10.1093/femsec/fiz203; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Oksanen J., 2016, COMMUNITY ECOLOGY PA; Perez-Cobas AE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00335; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Redding L, 2021, ANAEROBE, V69, DOI 10.1016/j.anaerobe.2021.102353; Rousseau C, 2011, J CLIN MICROBIOL, V49, P858, DOI 10.1128/JCM.01507-10; Sartor RB, 2015, NAT REV GASTRO HEPAT, V12, P253, DOI 10.1038/nrgastro.2015.46; Schneeberg A, 2013, J MED MICROBIOL, V62, P1190, DOI 10.1099/jmm.0.056473-0; Schoster A, 2019, VET MICROBIOL, V239, DOI 10.1016/j.vetmic.2019.108433; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Tomassini L., 2015, RECTAL MICROBIOTA DY; Virtala AMK, 1996, J AM VET MED ASSOC, V208, P2043; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Youssef O, 2018, DIGEST DIS SCI, V63, P2950, DOI 10.1007/s10620-018-5190-5; Zhang LH, 2015, ANAEROBE, V34, P1, DOI 10.1016/j.anaerobe.2015.03.008; Zheng HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166026; Zhu JJ, 2018, J MED MICROBIOL, V67, P1181, DOI 10.1099/jmm.0.000766	66	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2021	16	12							e0251999	10.1371/journal.pone.0251999	http://dx.doi.org/10.1371/journal.pone.0251999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY5KW	34910727	Green Published, Green Submitted, gold			2022-12-26	WOS:000754828900003
J	Lim, HJ; Park, MY; Jung, HS; Kwon, Y; Kim, I; Kim, DK; Yu, N; Sung, N; Lee, SH; Park, JE; Yang, YJ				Lim, Ho Jae; Park, Min Young; Jung, Hye Soo; Kwon, Youngjin; Kim, Inhee; Kim, Dong Kwan; Yu, Nae; Sung, Nackmoon; Lee, Sun-Hwa; Park, Jung Eun; Yang, Yong-Jin			Development of an efficient Sanger sequencing-based assay for detecting SARS-CoV-2 spike mutations	PLOS ONE			English	Article							CORONAVIRUS; GENOMES; PCR	Novel strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) harboring nucleotide changes (mutations) in the spike gene have emerged and are spreading rapidly. These mutations are associated with SARS-CoV-2 transmissibility, virulence, or resistance to some neutralizing antibodies. Thus, the accurate detection of spike mutants is crucial for controlling SARS-CoV-2 transmission and identifying neutralizing antibody-resistance caused by amino acid changes in the receptor-binding domain. Here, we developed five SARS-CoV-2 spike gene primer pairs (5-SSG primer assay; 69S, 144S, 417S, 484S, and 570S) and verified their ability to detect nine key spike mutations (Delta H69/V70, T95I, G142D, Delta Y144, K417T/N, L452R, E484K/Q, N501Y, and H655Y) using a Sanger sequencing-based assay. The 5-SSG primer assay showed 100% specificity and a conservative limit of detection with a median tissue culture infective dose (TCID50) values of 1.4 x 10(2) TCID50/mL. The accuracy of the 5-SSG primer assay was confirmed by next generation sequencing. The results of these two approaches showed 100% consistency. Taken together, the ability of the 5-SSG primer assay to accurately detect key SARS-CoV-2 spike mutants is reliable. Thus, it is a useful tool for detecting SARS-CoV-2 spike gene mutants in a clinical setting, thereby helping to improve the management of patients with COVID-19.	[Lim, Ho Jae; Park, Min Young; Jung, Hye Soo; Kwon, Youngjin; Kim, Inhee; Kim, Dong Kwan; Yu, Nae; Lee, Sun-Hwa; Yang, Yong-Jin] Seegene Med Fdn, Dept Mol Diagnost, Seoul, South Korea; [Lim, Ho Jae; Park, Jung Eun] Chosun Univ, Dept Integrat Biol Sci, Gwangju, South Korea; [Lim, Ho Jae; Park, Jung Eun] Chosun Univ, Educ Res Grp Age Associated Disorder Control Tech, Gwangju, South Korea; [Sung, Nackmoon] Seegene Med Fdn, Clin Res Inst, Seoul, South Korea	Chosun University; Chosun University	Yang, YJ (corresponding author), Seegene Med Fdn, Dept Mol Diagnost, Seoul, South Korea.; Park, JE (corresponding author), Chosun Univ, Dept Integrat Biol Sci, Gwangju, South Korea.; Park, JE (corresponding author), Chosun Univ, Educ Res Grp Age Associated Disorder Control Tech, Gwangju, South Korea.	yjyang@mf.seegene.com; yjyang@mf.seegene.com		Lim, Ho Jae/0000-0003-0115-5170; Yang, Yong-Jin/0000-0002-6153-9646; Park, Min Young/0000-0002-5319-5644	National Culture Collection [NCCP-43330, NCCP-43331, NCCP-43342, NCCP-43343, NCCP-43344, NCCP-43345, NCCP-43381, NCCP-43382, NCCP-43383, NCCP-43384, NCCP-43385, NCCP-43386, NCCP-43387, NCCP-43389, NCCP-43390]	National Culture Collection	We would like to thank Editage for English language editing. We also thank the National Culture Collection for Pathogens for kindly providing fifteen strains of SARS-CoV-2 as resources (NCCP-43330, NCCP-43331, NCCP-43342, NCCP-43343, NCCP-43344, NCCP-43345, NCCP-43381, NCCP-43382, NCCP-43383, NCCP-43384, NCCP-43385, NCCP-43386, NCCP-43387, NCCP-43389, and NCCP-43390) in this study.	Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Aleem A, 2021, EMERGING VARIANTS SA; Ayerbe-Algaba R, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00348; Banati P, 2021, SUSTAINABLE HUMAN DEVELOPMENT ACROSS THE LIFE COURSE, P1, DOI 10.1101/2021.03.05.21252709; Charre C, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa075; Chiara M, 2021, BRIEF BIOINFORM, V22, P616, DOI 10.1093/bib/bbaa297; Control CfD Prevention, 1998, MMWR-MORBID MORTAL W, V47, pi, DOI DOI 10.1001/jamahealthforum.2021.0325; Demirci MDS, 2020, PEERJ, V8, DOI 10.7717/peerj.9369; Deng JZ, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0790-y; Ding X, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18575-6; Gisondi P, 2020, J EUR ACAD DERMATOL, V34, P2499, DOI 10.1111/jdv.16774; Hirotsu Y, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009619; Huang Y, 2020, ACTA PHARMACOL SIN, V41, P1141, DOI 10.1038/s41401-020-0485-4; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Khailany RA, 2020, GENE REP, V19, DOI 10.1016/j.genrep.2020.100682; Konings F, 2021, NAT MICROBIOL, V6, P821, DOI 10.1038/s41564-021-00932-w; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Laskar R, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000925; Lee Y, 2020, JCO PRECIS ONCOL, V4, P1098, DOI 10.1200/PO.20.00121; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Long SW, 2021, AM J PATHOL, V191, P983, DOI 10.1016/j.ajpath.2021.03.004; Matsuda K, 2017, ADV CLIN CHEM, V80, P45, DOI 10.1016/bs.acc.2016.11.002; Mengelle C, 2012, J MED VIROL, V84, P906, DOI 10.1002/jmv.23281; Ntoumi F, 2021, INT J INFECT DIS, V105, P735, DOI 10.1016/j.ijid.2021.03.036; Pillay S, 2020, GENES-BASEL, V11, DOI 10.3390/genes11080949; Public Health England, COR COVID 19 UK; Riet J, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16039796; Roy C, 2020, GENOMICS, V112, P5331, DOI 10.1016/j.ygeno.2020.11.003; WALLIS RS, 1991, J IMMUNOL METHODS, V145, P267, DOI 10.1016/0022-1759(91)90338-G; Xie XP, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01270-4, 10.1101/2021.01.27.427998]; Yamada T, 2006, NUCLEIC ACIDS RES, V34, pW665, DOI 10.1093/nar/gkl297; Yurkovetskiy L, 2020, CELL, V183, P739, DOI 10.1016/j.cell.2020.09.032; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	33	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0260850	10.1371/journal.pone.0260850	http://dx.doi.org/10.1371/journal.pone.0260850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905589	Green Published, gold			2022-12-26	WOS:000754615500015
J	Nazarshodeh, E; Marashi, SA; Gharaghani, S				Nazarshodeh, Elmira; Marashi, Sayed-Amir; Gharaghani, Sajjad			Structural systems pharmacology: A framework for integrating metabolic network and structure-based virtual screening for drug discovery against bacteria	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; TARGETS; BIOSYNTHESIS	Advances in genome-scale metabolic models (GEMs) and computational drug discovery have caused the identification of drug targets at the system-level and inhibitors to combat bacterial infection and drug resistance. Here we report a structural systems pharmacology framework that integrates the GEM and structure-based virtual screening (SBVS) method to identify drugs effective for Escherichia coli infection. The most complete genome-scale metabolic reconstruction integrated with protein structures (GEM-PRO) of E. coli, iML1515_GP, and FDA-approved drugs have been used. FBA was performed to predict drug targets in silico. The 195 essential genes were predicted in the rich medium. The subsystems in which a significant number of these genes are involved are cofactor, lipopolysaccharide (LPS) biosynthesis that are necessary for cell growth. Therefore, some proteins encoded by these genes are responsible for the biosynthesis and transport of LPS which is the first line of defense against threats. So, these proteins can be potential drug targets. The enzymes with experimental structure and cognate ligands were selected as final drug targets for performing the SBVS method. Finally, we have suggested those drugs that have good interaction with the selected proteins as drug repositioning cases. Also, the suggested molecules could be promising lead compounds. This framework may be helpful to fill the gap between genomics and drug discovery. Results show this framework suggests novel antibacterials that can be subjected to experimental testing soon and it can be suitable for other pathogens.	[Nazarshodeh, Elmira; Gharaghani, Sajjad] Univ Tehran, Inst Biochem & Biophys, Lab Bioinformat & Drug Design LBD, Tehran, Iran; [Marashi, Sayed-Amir] Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran	University of Tehran; University of Tehran	Gharaghani, S (corresponding author), Univ Tehran, Inst Biochem & Biophys, Lab Bioinformat & Drug Design LBD, Tehran, Iran.; Marashi, SA (corresponding author), Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran.	marashi@ut.ac.ir; s.gharaghani@ut.ac.ir	Marashi, Sayed-Amir/A-5384-2008; Gharaghani, Sajjad/I-1922-2019	Marashi, Sayed-Amir/0000-0001-9801-7449; Gharaghani, Sajjad/0000-0001-5468-4258				Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bajorath J., 2015, COMPUTER AIDED DRUG; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bertani Blake, 2018, EcoSal Plus, V8, DOI 10.1128/ecosalplus.ESP-0001-2018; Bintener T, 2020, BIOCHEM SOC T, V48, P955, DOI 10.1042/BST20190867; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Chang RL, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-102; Cheng TJ, 2007, J CHEM INF MODEL, V47, P2140, DOI 10.1021/ci700257y; Daum R.S., 2007, RETAPAMULIN; Davis JJ, 2020, NUCLEIC ACIDS RES, V48, pD606, DOI 10.1093/nar/gkz943; Dhar S, 2018, J MED MICROBIOL, V67, P1, DOI 10.1099/jmm.0.000636; Dhingra D, 2013, J POSTGRAD MED, V59, P127, DOI 10.4103/0022-3859.113842; Du QL, 2011, INT J BIOL SCI, V7, P41, DOI 10.7150/ijbs.7.41; Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74; Feng ZK, 2004, BIOINFORMATICS, V20, P2153, DOI 10.1093/bioinformatics/bth214; Gaulton A, 2017, NUCLEIC ACIDS RES, V45, pD945, DOI 10.1093/nar/gkw1074; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Gu CD, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1730-3; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kennedy D.M.F., 2008, INT J BIOL MACROMOL, V42, P491; Kim HU, 2012, BIOTECHNOL J, V7, P330, DOI 10.1002/biot.201100159; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Lieven C, 2020, NAT BIOTECHNOL, V38, P272, DOI 10.1038/s41587-020-0446-y; Lionta E, 2014, CURR TOP MED CHEM, V14, P1923, DOI 10.2174/1568026614666140929124445; Ma HW, 2008, DRUG DISCOV TODAY, V13, P402, DOI 10.1016/j.drudis.2008.02.002; Makhorin A., 2008, GLPK GNU LINEAR PROG; McCloskey D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.18; Mih N, 2018, BIOINFORMATICS, V34, P2155, DOI 10.1093/bioinformatics/bty077; Mobegi FM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-958; Monk JM, 2017, NAT BIOTECHNOL, V35, P904, DOI 10.1038/nbt.3956; Naclerio GA, 2020, FUTURE MED CHEM, V12, P1253, DOI 10.4155/fmc-2020-0046; Novotni M., 2003, P ACM S SOL PHYS MOD; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-8; Ogoshi RCS, 2014, ANIM SCI J, V85, P555, DOI 10.1111/asj.12166; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Paulsen JL, 2009, J CHEM INF MODEL, V49, P2813, DOI 10.1021/ci9003078; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Perumal D, 2011, J DRUG TARGET, V19, P1, DOI 10.3109/10611861003649753; Rodionova IA, 2014, MBIO, V5, DOI 10.1128/mBio.00747-13; Schuerholz T, 2012, CURR DRUG TARGETS, V13, P1131, DOI 10.2174/138945012802002438; Shin WH, 2018, METHODS MOL BIOL, V1762, P105, DOI 10.1007/978-1-4939-7756-7_7; Shin WH, 2016, J CHEM INF MODEL, V56, P1676, DOI 10.1021/acs.jcim.6b00163; Simpson BW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0029; Sompairac N, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2682-z; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Thomanek N, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03285; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Vosmeer CR, 2014, INT J MOL SCI, V15, P798, DOI 10.3390/ijms15010798; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Waskom M.L., 2021, JOSS, V6, P3021, DOI [DOI 10.21105/JOSS.03021, 10.21105/joss.03021, 10.5281/ZENODO.592845]; WHO Collaborating Centre for Drug Statistics Methodology, 2020, GUIDELINES ATC CLASS; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Zhang G, 2013, CURR OPIN MICROBIOL, V16, P779, DOI 10.1016/j.mib.2013.09.007	56	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2021	16	12							e0261267	10.1371/journal.pone.0261267	http://dx.doi.org/10.1371/journal.pone.0261267			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2HZ	34905555	Green Published, gold			2022-12-26	WOS:000754615500033
J	Duong, SQ; Zheng, L; Xia, MJ; Jin, B; Liu, MD; Li, Z; Hao, SY; Alfreds, ST; Sylvester, KG; Widen, E; Teuteberg, JJ; McElhinney, DB; Ling, XFB				Duong, Son Q.; Zheng, Le; Xia, Minjie; Jin, Bo; Liu, Modi; Li, Zhen; Hao, Shiying; Alfreds, Shaun T.; Sylvester, Karl G.; Widen, Eric; Teuteberg, Jeffery J.; McElhinney, Doff B.; Ling, Xuefeng B.			Identification of patients at risk of new onset heart failure: Utilizing a large statewide health information exchange to train and validate a risk prediction model	PLOS ONE			English	Article							ATHEROSCLEROSIS RISK; NATRIURETIC PEPTIDE; POPULATION; DIMENSIONALITY; SURVIVAL	Background New-onset heart failure (HF) is associated with poor prognosis and high healthcare utilization. Early identification of patients at increased risk incident-HF may allow for focused allocation of preventative care resources. Health information exchange (HIE) data span the entire spectrum of clinical care, but there are no HIE-based clinical decision support tools for diagnosis of incident-HF. We applied machine-learning methods to model the one-year risk of incident-HF from the Maine statewide-HIE. Methods and results We included subjects aged >= 40 years without prior HF ICD9/10 codes during a three-year period from 2015 to 2018, and incident-HF defined as assignment of two outpatient or one inpatient code in a year. A tree-boosting algorithm was used to model the probability of incident-HF in year two from data collected in year one, and then validated in year three. 5,668 of 521,347 patients (1.09%) developed incident-HF in the validation cohort. In the validation cohort, the model c-statistic was 0.824 and at a clinically predetermined risk threshold, 10% of patients identified by the model developed incident-HF and 29% of all incident-HF cases in the state of Maine were identified. Conclusions Utilizing machine learning modeling techniques on passively collected clinical HIE data, we developed and validated an incident-HF prediction tool that performs on par with other models that require proactively collected clinical data. Our algorithm could be integrated into other HIEs to leverage the EMR resources to provide individuals, systems, and payors with a risk stratification tool to allow for targeted resource allocation to reduce incident-HF disease burden on individuals and health care systems.	[Duong, Son Q.; Zheng, Le; Hao, Shiying; McElhinney, Doff B.] Lucile Packard Childrens Hosp, Clin & Translat Res Program, Betty Irene Moore Childrens Heart Ctr, Palo Alto, CA 94304 USA; [Zheng, Le; Hao, Shiying; McElhinney, Doff B.; Ling, Xuefeng B.] Stanford Univ, Dept Cardiothorac Surg, Sch Med, Stanford, CA 94305 USA; [Xia, Minjie; Jin, Bo; Liu, Modi; Widen, Eric] HBI Solut Inc, Palo Alto, CA USA; [Li, Zhen] Zhejiang Univ, Binhai Ind Technol Res Inst, Tianjin, Peoples R China; [Li, Zhen] Southeast Univ, Sch Elect Engn, Nanjing, Jiangsu, Peoples R China; [Alfreds, Shaun T.] HealthInfoNet, Portland, ME USA; [Sylvester, Karl G.; Ling, Xuefeng B.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Teuteberg, Jeffery J.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA	Lucile Packard Children's Hospital (LPCH); Stanford University; Zhejiang University; Southeast University - China; Stanford University; Stanford University	Duong, SQ (corresponding author), Lucile Packard Childrens Hosp, Clin & Translat Res Program, Betty Irene Moore Childrens Heart Ctr, Palo Alto, CA 94304 USA.; Ling, XFB (corresponding author), Stanford Univ, Dept Cardiothorac Surg, Sch Med, Stanford, CA 94305 USA.; Ling, XFB (corresponding author), Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA.	sqduong@gmail.com		Ling, Bruce/0000-0002-5386-3884; Hao, Shiying/0000-0002-7527-2460; Alfreds, Shaun T./0000-0003-1752-4823; McElhinney, Doff/0000-0001-7242-0934				Administraion USFD, 2018, PHARM CLASS; Agarwal SK, 2012, CIRC-HEART FAIL, V5, P422, DOI 10.1161/CIRCHEARTFAILURE.111.964841; Brinkley D Marshall, 2017, Curr Heart Fail Rep, V14, P410, DOI 10.1007/s11897-017-0355-7; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Choi E, 2017, J AM MED INFORM ASSN, V24, P361, DOI 10.1093/jamia/ocw112; Choi EY, 2012, CIRC-HEART FAIL, V5, P727, DOI 10.1161/CIRCHEARTFAILURE.112.968701; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Do DT., USING EXTREME GRADIE, P1089; Echouffo-Tcheugui JB, 2015, CIRC-HEART FAIL, V8, P438, DOI 10.1161/CIRCHEARTFAILURE.114.001896; Goyal A, 2010, CIRC-HEART FAIL, V3, P698, DOI 10.1161/CIRCHEARTFAILURE.110.938175; Gueyffier F, 1999, LANCET, V353, P793, DOI 10.1016/S0140-6736(98)08127-6; Hao SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140271; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Kalogeropoulos A, 2010, J AM COLL CARDIOL, V55, P2129, DOI 10.1016/j.jacc.2009.12.045; Kiarashinejad Y, 2020, NPJ COMPUT MATER, V6, DOI 10.1038/s41524-020-0276-y; Le NQK, 2020, J PERS MED, V10, DOI 10.3390/jpm10030128; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Li JQ, 2019, IEEE J BIOMED HEALTH, V23, P2138, DOI 10.1109/JBHI.2018.2877255; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Nambi V, 2013, CLIN CHEM, V59, P1802, DOI 10.1373/clinchem.2013.203638; Ng K, 2016, CIRC-CARDIOVASC QUAL, V9, P649, DOI 10.1161/CIRCOUTCOMES.116.002797; Rasmy L, 2018, J BIOMED INFORM, V84, P11, DOI 10.1016/j.jbi.2018.06.011; Sahle BW, 2017, J CARD FAIL, V23, P680, DOI 10.1016/j.cardfail.2017.03.005; Smith JG, 2010, J AM COLL CARDIOL, V56, P1713, DOI 10.1016/j.jacc.2010.05.049; Sun Jimeng, 2012, AMIA Annu Symp Proc, V2012, P901; United States Census Bureau, 2021, J WOMENS HEALTH; von Haehling S, 2019, JACC-HEART FAIL, V7, P36, DOI 10.1016/j.jchf.2018.07.015; Wang YJ, 2015, IEEE ENG MED BIO, P2530, DOI 10.1109/EMBC.2015.7318907; Wu JL, 2010, MED CARE, V48, pS106, DOI 10.1097/MLR.0b013e3181de9e17; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Ye CY, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9268	34	1	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0260885	10.1371/journal.pone.0260885	http://dx.doi.org/10.1371/journal.pone.0260885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890438	gold, Green Published			2022-12-26	WOS:000747293600021
J	Chiu, HY; Liao, NFC; Lin, Y; Huang, YH				Chiu, Hsien-Yi; Liao, Nien-Feng Chang; Lin, Yu Jr Jr; Huang, Yu-Huei			Perception of the threat, mental health burden, and healthcare-seeking behavior change among psoriasis patients during the COVID-19 pandemic	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; SECUKINUMAB TREATMENT; IMPACT; DEPRESSION; OUTBREAK; ANXIETY; STRESS; RISK; EPIDEMIOLOGY; PREVALENCE	This study aimed to investigate the perceived threat, mental health outcomes, behavior changes, and associated predictors among psoriasis patients during the COVID-19 pandemic. The COVID-19 has been known to increase the health risks of patients with psoriasis owing to patients' immune dysregulation, comorbidities, and immunosuppressive drug use. A total of 423 psoriasis patients not infected with COVID-19 was recruited from the Department of Dermatology, National Taiwan University Hospital Hsin-Chu Branch, Chang Gung Memorial Hospital, and China Medical University Hospital from May 2020 to July 2020. A self-administered questionnaire was used to evaluate the perceived threat, mental health, and psychological impact on psoriasis patients using the Perceived COVID-19-Related Risk Scale score for Psoriasis (PCRSP), depression, anxiety, insomnia, and stress-associated symptoms (DAISS) scales, and Impact of Event Scale-Revised (IES-R), respectively. Over 94% of 423 patients with psoriasis perceived threat to be >= 1 due to COVID-19; 18% of the patients experienced psychological symptoms more frequently >= 1, and 22% perceived psychological impact during the pandemic to be >= 1. Multivariable linear regression showed that the higher psoriasis severity and comorbidities were significantly associated with higher PCRSP, DAISS, and IES-R scores. The requirement for a prolonged prescription and canceling or deferring clinic visits for psoriasis treatment among patients are the two most common healthcare-seeking behavior changes during the COVID-19 pandemic. Psoriasis patients who perceived a higher COVID-19 threat were more likely to require a prolonged prescription and have their clinic visits canceled or deferred. Surveillance of the psychological consequences in psoriasis patients due to COVID-19 must be implemented to avoid psychological consequences and inappropriate treatment delays or withdrawal.	[Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Dept Med Res, Hsin Chu Branch, Hsinchu, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Dept Dermatol, Hsin Chu Branch, Hsinchu, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ, Coll Med, Dept Dermatol, Taipei, Taiwan; [Liao, Nien-Feng Chang] China Med Univ Hosp, Dept Dermatol, Taichung, Taiwan; [Lin, Yu Jr Jr] Chang Gung Univ, Res Serv Ctr Hlth Informat, Taoyuan, Taiwan; [Huang, Yu-Huei] Chang Gung Mem Hosp, Dept Dermatol, Linkou Branch, Taoyuan, Taiwan; [Huang, Yu-Huei] Chang Gung Univ, Coll Med, Sch Med, Taoyuan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Huang, YH (corresponding author), Chang Gung Mem Hosp, Dept Dermatol, Linkou Branch, Taoyuan, Taiwan.; Huang, YH (corresponding author), Chang Gung Univ, Coll Med, Sch Med, Taoyuan, Taiwan.	huangyh@adm.cgmh.org.tw		HUANG, YU-HUEI/0000-0003-0574-1839; Chiu, Hsien-Yi/0000-0002-0493-9707	National Taiwan University Hospital, HsinChu branch [110-HCH045]; Chang Gung Memorial Hospital [CMRPG1E0061, CMRPG1E0062, CMRPG1F0161, CMRPG1G0121]; Ministry of Science and Technology, Taiwan [MOST 1102314-B-002-191]	National Taiwan University Hospital, HsinChu branch; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded in part by grants from the National Taiwan University Hospital, HsinChu branch (110-HCH045; https://www.hch.gov. tw/) (received by Hsien-Yi Chiu), Chang Gung Memorial Hospital (CMRPG1E0061, CMRPG1E0062, CMRPG1F0161, CMRPG1G0121; https://www.cgmh.org.tw/tw/Services/DeptList/3) (received by Yu-Huei Huang), and Ministry of Science and Technology, Taiwan (MOST 1102314-B-002-191; https://www.most.gov.tw/) (received by Hsien-Yi Chiu). The funders had no role in study design, data collection and analysis, interpretation of findings, manuscript writing, and target journal selection.	Alsubaie S, 2019, J INFECT DEV COUNTR, V13, P920, DOI 10.3855/jidc.11753; [Anonymous], 2020, DERMATOL THER, DOI DOI 10.1111/dth.13298; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; Cheng HY, 2020, J FORMOS MED ASSOC, V119, P771, DOI 10.1016/j.jfma.2020.03.007; Cheng SKW, 2004, PSYCHOL MED, V34, P1187, DOI 10.1017/S0033291704002272; Chiu HY, 2018, DERMATOL SIN, V36, P115, DOI 10.1016/j.dsi.2018.06.001; Chiu HY, 2018, ACTA DERM-VENEREOL, V98, P829, DOI 10.2340/00015555-2989; Chiu HY, 2016, INT J DERMATOL, V55, pE600, DOI 10.1111/ijd.13346; Chiu HY, 2016, J AM ACAD DERMATOL, V75, P224, DOI 10.1016/j.jaad.2016.02.1168; Chiwaridzo Matthew, 2017, Arch Physiother, V7, P3, DOI 10.1186/s40945-017-0031-y; Chua SE, 2004, CAN J PSYCHIAT, V49, P385, DOI 10.1177/070674370404900607; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colombo Gl, 2008, Ther Clin Risk Manag, V4, P559; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Dare LO, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6623-6; Davis L.L., 1992, APPL NURS RES, V5, P194, DOI [10.1016/S0897-1897(05)80008-4, DOI 10.1016/S0897-1897(05)80008-4]; Dubertret L, 2006, BRIT J DERMATOL, V155, P729, DOI 10.1111/j.1365-2133.2006.07405.x; Gisondi P, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040728; Goldmann E, 2014, ANNU REV PUBL HEALTH, V35, P169, DOI 10.1146/annurev-publhealth-032013-182435; Haga S, 2008, P NATL ACAD SCI USA, V105, P7809, DOI 10.1073/pnas.0711241105; Hall RCW, 2008, GEN HOSP PSYCHIAT, V30, P446, DOI 10.1016/j.genhosppsych.2008.05.003; Hao FY, 2020, BRAIN BEHAV IMMUN, V87, P100, DOI 10.1016/j.bbi.2020.04.069; Hayes J, 2010, DERMATOL THER, V23, P174, DOI 10.1111/j.1529-8019.2010.01312.x; Jeon C., 2017, J PSORIASIS PSORIATI, V2, P47, DOI [10.1177/247553031700200304, DOI 10.1177/247553031700200304]; Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048; Jo SH, 2020, COMPR PSYCHIAT, V103, DOI 10.1016/j.comppsych.2020.152213; Tribo MJ, 2019, ACTA DERM-VENEREOL, V99, P417, DOI 10.2340/00015555-3114; Ko CH, 2006, PSYCHIAT CLIN NEUROS, V60, P397, DOI 10.1111/j.1440-1819.2006.01522.x; Kurd SK, 2010, ARCH DERMATOL, V146, P891, DOI 10.1001/archdermatol.2010.186; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lebwohl M, 2020, J AM ACAD DERMATOL, V82, P1217, DOI 10.1016/j.jaad.2020.03.031; Lee AM, 2007, CAN J PSYCHIAT, V52, P233, DOI 10.1177/070674370705200405; Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685; Lim GY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21243-x; LYNN MR, 1986, NURS RES, V35, P382; McAlonan GM, 2007, CAN J PSYCHIAT, V52, P241, DOI 10.1177/070674370705200406; McDonough E, 2014, J RHEUMATOL, V41, P887, DOI 10.3899/jrheum.130797; Ning LW, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09892-y; Pierce CA, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd5487; Sareen J, 2014, CAN J PSYCHIAT, V59, P460, DOI 10.1177/070674371405900902; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sobkow A, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.582720; Strippoli D, 2020, INT J DERMATOL, V59, pE266, DOI 10.1111/ijd.15002; Tee CA, 2020, OPEN ACCESS RHEUMATO, V12, P215, DOI 10.2147/OARRR.S269889; TELFER NR, 1992, ARCH DERMATOL, V128, P39, DOI 10.1001/archderm.128.1.39; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tsai TF, 2011, J DERMATOL SCI, V63, P40, DOI 10.1016/j.jdermsci.2011.03.002; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151; Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wei JCC, 2018, J RHEUMATOL, V45, P385, DOI 10.3899/jrheum.170516; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yiu ZZN, 2021, BRIT J DERMATOL, V184, P78, DOI 10.1111/bjd.19052; Zhang MWB, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.2827	54	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0259852	10.1371/journal.pone.0259852	http://dx.doi.org/10.1371/journal.pone.0259852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY8LQ	34882690	Green Published, gold			2022-12-26	WOS:000755037200013
J	Ferwana, I; Varshney, LR				Ferwana, Ibtihal; Varshney, Lav R.			Social capital dimensions are differentially associated with COVID-19 vaccinations, masks, and physical distancing	PLOS ONE			English	Article							SARS-COV-2 INFECTIONS; VACCINE; COUNTY	Background Social capital has been associated with health outcomes in communities and can explain variations in different geographic localities. Social capital has also been associated with behaviors that promote better health and reduce the impacts of diseases. During the COVID-19 pandemic, social distancing, face masking, and vaccination have all been essential in controlling contagion. These behaviors have not been uniformly adopted by communities in the United States. Using different facets of social capital to explain the differences in public behaviors among communities during pandemics is lacking. Objective This study examines the relationship among public health behavior-vaccination, face masking, and physical distancing-during COVID-19 pandemic and social capital indices in counties in the United States. Methods We used publicly available vaccination data as of June 2021, face masking data in July 2020, and mobility data from mobile phones movements from the end of March 2020. Then, correlation analysis was conducted with county-level social capital index and its subindices (family unity, community health, institutional health, and collective efficacy) that were obtained from the Social Capital Project by the United States Senate. Results We found the social capital index and its subindices differentially correlate with different public health behaviors. Vaccination is associated with institutional health: positively with fully vaccinated population and negatively with vaccination hesitancy. Also, wearing masks negatively associates with community health, whereases reduced mobility associates with better community health. Further, residential mobility positively associates with family unity. By comparing correlation coefficients, we find that social capital and its subindices have largest effect sizes on vaccination and residential mobility. Conclusion Our results show that different facets of social capital are significantly associated with adoption of protective behaviors, e.g., social distancing, face masking, and vaccination. As such, our results suggest that differential facets of social capital imply a Swiss cheese model of pandemic control planning where, e.g., institutional health and community health, provide partially overlapping behavioral benefits.	[Ferwana, Ibtihal] Univ Illinois, Dept Comp Sci, Urbana, IL USA; [Varshney, Lav R.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Ferwana, Ibtihal; Varshney, Lav R.] Univ Illinois, Coordinated Sci Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Varshney, LR (corresponding author), Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.; Varshney, LR (corresponding author), Univ Illinois, Coordinated Sci Lab, Urbana, IL 61801 USA.	varshney@illinois.edu		Ferwana, Ibtihal/0000-0002-3313-6639	NSF [ECCS2033900]; The Center for Pathogen Diagnostics through the ZJU-UIUC Dynamic Engineering Science Interdisciplinary Research Enterprise (DESIRE)	NSF(National Science Foundation (NSF)); The Center for Pathogen Diagnostics through the ZJU-UIUC Dynamic Engineering Science Interdisciplinary Research Enterprise (DESIRE)	I. F. and L. R. V. both are funded by the following: 1. NSF with grant number ECCS2033900 2. The Center for Pathogen Diagnostics through the ZJU-UIUC Dynamic Engineering Science Interdisciplinary Research Enterprise (DESIRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bartsch SM, 2020, AM J PREV MED, V59, P493, DOI 10.1016/j.amepre.2020.06.011; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Borgonovi F, 2021, SOC SCI MED, V278, DOI 10.1016/j.socscimed.2021.113948; Borgonovi F, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113501; CDC Guidelines, 2020, COVID 19 CONS WEAR M; Cheung Chau-Kiu, 2008, Soc Work Public Health, V23, P41, DOI 10.1080/19371910802053224; Chuang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122970; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; Cuebiq, MOB DAT; Daly M, 2021, JAMA-J AM MED ASSOC, V325, P2397, DOI 10.1001/jama.2021.8246; Ding W., 2020, 27393 NAT BUR EC RES; Durante R, 2021, J PUBLIC ECON, V194, DOI 10.1016/j.jpubeco.2020.104342; Ehsan A, 2019, SSM-POPUL HLTH, V8, DOI 10.1016/j.ssmph.2019.100425; Elgar FJ, 2020, SOC SCI MED, V263, DOI 10.1016/j.socscimed.2020.113365; Elgar FJ, 2011, HEALTH PLACE, V17, P1044, DOI 10.1016/j.healthplace.2011.06.010; Fisher KA, 2020, MMWR-MORBID MORTAL W, V69, P933, DOI 10.15585/mmwr.mm6928e3; Fowler JH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248849; Freimuth VS, 2014, J HEALTH COMMUN, V19, P321, DOI 10.1080/10810730.2013.811323; Friedson A. I., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts), DOI 10.3386/w26992; Google,, 2020, COVID 19 COMM MOB RE; Health and Human Services, VACC HES COVID 19 CO; Helliwell JF, 2007, SOC INDIC RES, V81, P455, DOI 10.1007/s11205-006-0022-y; Iboi EA, 2020, INFECT DIS MODEL, V5, P510, DOI 10.1016/j.idm.2020.07.006; Immunization and Information Systems, 2021, COVID 19 VACC US JUR; Kawachi I, 1999, ANN NY ACAD SCI, V896, P120, DOI 10.1111/j.1749-6632.1999.tb08110.x; Kawachi I, 2008, SOCIAL CAPITAL HLTH, DOI [10.1007/978-0-387-71311-3_1, DOI 10.1007/978-0-387-71311-3_1]; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Larouzee J, 2020, SAFETY SCI, V126, DOI 10.1016/j.ssci.2020.104660; Lee M, 2018, US C JOINT EC COMM, P1; Lee MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241468; Loomba S, 2021, NAT HUM BEHAV, V5, P337, DOI 10.1038/s41562-021-01056-1; Lynch J, 2000, J EPIDEMIOL COMMUN H, V54, P404, DOI 10.1136/jech.54.6.404; McKenzie K, 2002, BRIT J PSYCHIAT, V181, P280, DOI 10.1192/bjp.181.4.280; Payne DC, 2020, MMWR-MORBID MORTAL W, V69, P714, DOI [10.15585/mmwr.mm6923e4, 10.15585/mmwr.mm6923e4externalicon]; PUTNAM RD, 1995, J DEMOCRACY, V0006; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Robinson E, 2021, VACCINE, V39, P2024, DOI 10.1016/j.vaccine.2021.02.005; Ronnerstrand B, 2014, PUBLIC HEALTH, V128, P709, DOI 10.1016/j.puhe.2014.05.015; RUPASINGHA A, 2006, J SOCIOECONOMICS, V0035; Seabold S, 2010, P 9 PYTHON SCI C; Soares P, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030300; Szilagyi PG, 2021, JAMA-J AM MED ASSOC, V325, P396, DOI 10.1001/jama.2020.26419; The New York Times and Dynata, 2020, NEW YORK TIMES; Ueki H, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00637-20; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Varshney L.R., 2020, MEDRXIV, DOI [10.1101/2020.04.23.20077321, DOI 10.1101/2020.04.23.20077321]	48	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260818	10.1371/journal.pone.0260818	http://dx.doi.org/10.1371/journal.pone.0260818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882709	Green Published, gold, Green Submitted			2022-12-26	WOS:000755037200042
J	Heap, SPH; Koop, C; Matakos, K; Unan, A; Weber, N				Heap, Shaun P. Hargreaves; Koop, Christel; Matakos, Konstantinos; Unan, Asli; Weber, Nina			Good news reduces trust in government and its efficacy: The case of the Pfizer/BioNTech vaccine announcement	PLOS ONE			English	Article							RISK; INFERENCE; HAPPINESS	The announcement of Pfizer/BioNTech's COVID-19 vaccine success on November 9, 2020 led to a global stock market surge. But how did the general public respond to such good news? We leverage the unexpected vaccine announcement to assess the effect of good news on citizens' government evaluations, anxiety, beliefs and elicited behaviors in the US and the UK. While most outcomes were unaffected by the news, trust in government and elected politicians (and their competency) saw a significant decline in both countries. As the news did not concern the governments, and the governments did not have time to act on the news, our results suggest that the decline of trust is more likely explained by the psychological impact of good news on reasoning style. In particular, we suggest two possible styles of reasoning that might explain our results: a form of motivated reasoning and a reasoning heuristic of relative comparison.	[Heap, Shaun P. Hargreaves; Koop, Christel; Matakos, Konstantinos; Unan, Asli; Weber, Nina] Kings Coll London, Dept Polit Econ, London, England	University of London; King's College London	Matakos, K (corresponding author), Kings Coll London, Dept Polit Econ, London, England.	konstantinos.matakos@kcl.ac.uk	Unan, Aslı/AFS-7089-2022	Unan, Aslı/0000-0002-6542-5443; Matakos, Konstantinos/0000-0002-3511-197X				Aksoy Cevat, 2020, 27401 NBER, P1, DOI [10.2139/ssrn.3625190, DOI 10.3386/W27401, DOI 10.2139/SSRN.3625190]; Alempaki D, 2019, J ECON PSYCHOL, V75, DOI 10.1016/j.joep.2018.12.011; Anderson ML, 2008, J AM STAT ASSOC, V103, P1481, DOI 10.1198/016214508000000841; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bol D, 2021, EUR J POLIT RES, V60, P497, DOI 10.1111/1475-6765.12401; Capra CM, 2004, AM ECON REV, V94, P367, DOI 10.1257/0002828041301885; De Vries CE, 2021, POLIT SCI RES METH, V9, P451, DOI 10.1017/psrm.2021.6; Drichoutis AC, 2013, J SOCIO-ECON, V45, P18, DOI 10.1016/j.socec.2013.04.008; Esaiasson P, 2021, EUR J POLIT RES, V60, P748, DOI 10.1111/1475-6765.12419; Ferraz C, 2008, Q J ECON, V123, P703, DOI 10.1162/qjec.2008.123.2.703; Fetzer T, 2021, REV ECON STAT, V103, P968, DOI 10.1162/rest_a_00946; Forgas JP, 2002, PSYCHOL INQ, V13, P1, DOI 10.1207/S15327965PLI1301_01; FT reporters, 2020, FINANC TIMES; Guiso L, 2018, J FINANC ECON, V128, P403, DOI 10.1016/j.jfineco.2018.02.007; Guriev S., 2020, Q J ECON; Hainmueller J, 2012, POLIT ANAL, V20, P25, DOI 10.1093/pan/mpr025; Healy A, 2010, Q J POLIT SCI, V5, P193, DOI 10.1561/100.00009057; Kirchsteiger G, 2006, J ECON BEHAV ORGAN, V59, P155, DOI 10.1016/j.jebo.2004.07.004; Klasnja M., 2020, J EXP POLIT SCI; KUNDA Z, 1987, J PERS SOC PSYCHOL, V53, P636, DOI 10.1037/0022-3514.53.4.636; Loewenstein G, 2000, AM ECON REV, V90, P426, DOI 10.1257/aer.90.2.426; Munoz J, 2020, POLIT ANAL, V28, P186, DOI 10.1017/pan.2019.27; Office for National Statistics, CT0486 2011 CENS SEX; Peer E, 2017, J EXP SOC PSYCHOL, V70, P153, DOI 10.1016/j.jesp.2017.01.006; Perez-Duenas C, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01542; Proto E, 2019, J ECON BEHAV ORGAN, V168, P209, DOI 10.1016/j.jebo.2019.10.006; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Schraff D, 2021, EUR J POLIT RES, V60, P1007, DOI 10.1111/1475-6765.12425; Schwarz N, 2002, EMO SOC BEH, P144; Sibley CG, 2020, AM PSYCHOL, V75, P618, DOI 10.1037/amp0000662; Tan HB, 2010, J EXP SOC PSYCHOL, V46, P571, DOI 10.1016/j.jesp.2010.01.007; Taquet M, 2016, P NATL ACAD SCI USA, V113, P9769, DOI 10.1073/pnas.1519998113; Timmons JF, 2015, WORLD DEV, V70, P13, DOI 10.1016/j.worlddev.2014.12.011; United States Census Bureau, CURRENT POPULATION S; van der Weerd W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-575	36	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260216	10.1371/journal.pone.0260216	http://dx.doi.org/10.1371/journal.pone.0260216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY8LQ	34882693	gold, Green Published			2022-12-26	WOS:000755037200023
J	Lee, J; Bae, JG; Kim, YC				Lee, Jaekyoung; Bae, Jin Gon; Kim, Yu Cheol			Relationship between the sFlt-1/PlGF ratio and the optical coherence tomographic features of chorioretina in patients with preeclampsia	PLOS ONE			English	Article							CHOROIDAL THICKNESS; PREGNANT-WOMEN; GROWTH-FACTOR; RISK	This study aimed to evaluate the correlation between ophthalmologic factors and the serologic indicator soluble fms-like tyrosine kinase 1 (sFlt-1): placental growth factor (PlGF) ratio in patients with preeclampsia using optical coherence tomography (OCT) and OCT angiography (OCT-A). A total of 52 pregnant patients (104 eyes) diagnosed with preeclampsia were recruited during their hospital stay. The associations between the sFlt-1/PlGF ratio and chorioretinal measurements, including the choroidal thickness (CT), foveal avascular zone, vascular density, and ganglion cell layer+ were evaluated. Central and nasal subfield CT of the left eye (p = 0.039; p = 0.010) and nasal subfield CT of the right eye (p = 0.042) were lower in the high sFlt-1/PlGF ratio group (>= 38). Pearson's correlation test showed a negative correlation between the sFlt-1/PlGF ratio and central subfield CT; however, this was not statistically significant (p = 0.648). Linear regression analysis revealed a significant association between the sFlt-1/PlGF ratio and central subfield CT (beta coefficient, -6.66; p = 0.01) and between sFlt-1 and central subfield CT (beta coefficient, -5.65; p = 0.00). Thus, an increase in the sFlt-1/PlGF ratio resulted in a decrease in central subfield CT.	[Lee, Jaekyoung; Kim, Yu Cheol] Keimyung Univ, Dept Ophthalmol, Sch Med, Daegu, South Korea; [Bae, Jin Gon] Keimyung Univ, Dept Obstet, Sch Med, Daegu, South Korea	Keimyung University; Keimyung University	Kim, YC (corresponding author), Keimyung Univ, Dept Ophthalmol, Sch Med, Daegu, South Korea.	eyedr@dsmc.or.kr			National Research Foundation of Korea [NRF-2019R1G1A1011559]	National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by the National Research Foundation of Korea (NRF-2019R1G1A1011559). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.nrf.re.kr/index fund award: YCK.	Amaral LM, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0757-7; Atas M, 2014, HYPERTENS PREGNANCY, V33, P299, DOI 10.3109/10641955.2013.877924; Benfica CZ, 2019, INT OPHTHALMOL, V39, P2069, DOI 10.1007/s10792-018-1043-7; Celik H, 2013, J OBSTET GYNAECOL, V33, P355, DOI 10.3109/01443615.2013.769944; Ciloglu E, 2019, EYE, V33, P1946, DOI 10.1038/s41433-019-0531-y; Dadaci Z, 2015, BRIT J OPHTHALMOL, V99, P1255, DOI 10.1136/bjophthalmol-2014-306343; Duru N, 2016, ARQ BRAS OFTALMOL, V79, P143, DOI 10.5935/0004-2749.20160044; Evcimen Y, 2019, CURR EYE RES, V44, P916, DOI 10.1080/02713683.2019.1600198; Garg A, 2014, INVEST OPHTH VIS SCI, V55, P5723, DOI 10.1167/iovs.14-14143; Hamzah F, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-145; Hernandez-Diaz S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2255; Iida T, 2002, ARCH OPHTHALMOL-CHIC, V120, P1406, DOI 10.1001/archopht.120.10.1406; JAFFE G, 1987, AM J OPHTHALMOL, V103, P309; Kim JW, 2016, EYE, V30, P349, DOI 10.1038/eye.2015.215; Kwong YYY, 2006, OPHTHALMOLOGICA, V220, P140, DOI 10.1159/000090582; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lu FX, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.024; Perry H, 2020, HYPERTENSION, V75, P755, DOI 10.1161/HYPERTENSIONAHA.119.13997; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Roos NM, 2012, OBSTET GYNECOL SURV, V67, P242, DOI 10.1097/OGX.0b013e318250a457; ROYBURT M, 1991, Obstetrical and Gynecological Survey, V46, P656, DOI 10.1097/00006254-199110000-00002; Saito M, 2018, INT OPHTHALMOL, V38, P2205, DOI 10.1007/s10792-017-0705-1; Sheibani Nader, 2013, J Ophthalmic Vis Res, V8, P1; Shim KY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251933; Skjaerven R, 2002, NEW ENGL J MED, V346, P33, DOI 10.1056/NEJMoa011379; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Stern-Ascher CN, 2021, AM J PERINAT, V38, P482, DOI 10.1055/s-0039-1698832; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; Valluri S, 1996, AM J OPHTHALMOL, V122, P672, DOI 10.1016/S0002-9394(14)70485-4; Van Bergen T, 2019, PROG RETIN EYE RES, V69, P116, DOI 10.1016/j.preteyeres.2018.10.006; WEINREB RN, 1988, AM J OPHTHALMOL, V105, P258, DOI 10.1016/0002-9394(88)90006-2; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0261287	10.1371/journal.pone.0261287	http://dx.doi.org/10.1371/journal.pone.0261287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882742	Green Published, gold			2022-12-26	WOS:000755037200066
J	Yang, XQ; Tuo, YC; Yang, YJ; Wang, X; Deng, Y; Wang, HY				Yang, Xiaoqian; Tuo, Youcai; Yang, Yanjing; Wang, Xin; Deng, Yun; Wang, Haoyu			Study on the effect of front retaining walls on the thermal structure and outflow temperature of reservoirs	PLOS ONE			English	Article							MODIFYING DAM OPERATIONS; DISSOLVED-OXYGEN; WATER WITHDRAWAL; STRATIFICATION; LAKES; RELEASE; REGIME; RIVERS; ICE	The front retaining wall (FRW) is an effective facility of selective withdrawal. Previous research has not estimated the effect of FRWs on the thermal regimes of reservoirs and outflow temperature, which are crucial to reservoir ecology. For this purpose, taking the Dongqing Reservoir as a case study, a two-dimensional hydrodynamic CE-QUAL-W2 model was configured for the typical channel-type reservoir in the southwestern Guizhou Province, to better understand the influence of FRWs on the thermal structure and outflow temperature. The simulated data from January to September 2017 showed that FRWs can change the vertical temperature distribution during the stratification period, accelerate the upper warmer water release and thus decrease the strength of thermal stratification. The stratification structure changed from a single thermocline to double thermoclines in August. An FRW resulted in an average 11.8 m increase in the thickness of the hypolimnion and a 1.2 degrees C decrease in the thickness of the thermocline layer. An FRW increased the outflow temperature by 0.4 degrees C and raised the withdrawal elevation by 16 m on average. The longitudinal velocity increased compared with the non-FRW condition, while the maximum velocity position moved up. In addition, FRWs can continuously obtain surface warmer water without manual operation and have low investment and good construction conditions. This study can provide an available selective withdrawal idea for reservoirs with similar hydraulic conditions.	[Yang, Xiaoqian; Tuo, Youcai; Yang, Yanjing; Deng, Yun; Wang, Haoyu] Sichuan Univ, State Key Lab Hydraul & Mt River Engn, Chengdu, Peoples R China; [Wang, Xin] Power China Guiyang Engn Corp Ltd, Guiyang, Peoples R China	Sichuan University	Tuo, YC (corresponding author), Sichuan Univ, State Key Lab Hydraul & Mt River Engn, Chengdu, Peoples R China.	tuoyoucai@scu.edu.cn		Tuo, Youcai/0000-0002-7032-0873				Bartholow J, 2001, ENVIRON MANAGE, V27, P609, DOI 10.1007/s0026702324; Bednarek AT, 2005, ECOL APPL, V15, P997, DOI 10.1890/04-0586; Boland K. T., 2002, Lakes and Reservoirs Research and Management, V7, P125, DOI 10.1046/j.1440-169X.2002.00176.x; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Carron JC, 2001, WATER RESOUR RES, V37, P1733, DOI 10.1029/2000WR900390; Casamitjana X, 2003, HYDROBIOLOGIA, V504, P21, DOI 10.1023/B:HYDR.0000008504.61773.77; Chung SW, 2006, WATER SCI TECHNOL, V54, P29, DOI 10.2166/wst.2006.841; Cole T.M., 2013, CE QUAL W2 2 DIMENSI, DOI [10.1023/b:hydr.0000008504.61773.77, DOI 10.1023/B:HYDR.0000008504.61773.77]; DAKE JMK, 1969, WATER RESOUR RES, V5, P484, DOI 10.1029/WR005i002p00484; Deng Y, 2011, SCI CHINA TECHNOL SC, V54, P83, DOI 10.1007/s11431-011-4602-y; Elci S, 2008, LIMNOLOGY, V9, P135, DOI 10.1007/s10201-008-0240-x; Fang X, 2009, LIMNOL OCEANOGR, V54, P2359, DOI 10.4319/lo.2009.54.6_part_2.2359; Ford DE, 1990, RESERVOIR LIMNOLOGY; Freckleton DR, 2011, J HYDRAUL ENG-ASCE, V137, P644, DOI 10.1061/(ASCE)HY.1943-7900.0000348; He W, 2018, J HYDRO-ENVIRON RES, V20, P9, DOI 10.1016/j.jher.2018.04.002; Henry R, 1999, THEORETICAL RESERVOIR ECOLOGY AND ITS APPLICATIONS, P125; Jan-Tai K., 1994, WATER SCI TECHNOL, P30; Kennedy RH, 1999, THEORETICAL RESERVOIR ECOLOGY AND ITS APPLICATIONS, P1; Lee RM, 2018, WATER-SUI, V10, DOI 10.3390/w10091284; Li J., 2015, 25 CHIN SOC ENV SCI, P1652; Ma Shengwei, 2008, Lakes & Reservoirs Research and Management, V13, P51, DOI 10.1111/j.1440-1770.2007.00353.x; Mi CX, 2019, ENVIRON SCI EUR, V31, DOI 10.1186/s12302-019-0202-4; Milstein A, 2001, AQUACULT INT, V9, P81, DOI 10.1023/A:1012530409312; NURNBERG GK, 1987, WATER RES, V21, P923, DOI 10.1016/S0043-1354(87)80009-X; Olden JD, 2010, FRESHWATER BIOL, V55, P86, DOI 10.1111/j.1365-2427.2009.02179.x; Olszewski P., 1961, Verhandlungen Internationalen Vereinigung Limnologie, V14, P855; OWENS EM, 1986, WATER RESOUR BULL, V22, P219; Palancar MC, 2006, J ENVIRON MANAGE, V81, P210, DOI 10.1016/j.jenvman.2005.10.016; Peng Yang., 2011, J GUIZHOU HYDROELECT, V25, P18; Politano M, 2008, ECOL MODEL, V212, P408, DOI 10.1016/j.ecolmodel.2007.10.040; Powerchina ZhongNan Engineering Corporation Limited, 2016, DES REP TEMP CONTR C; Ren WC, 2020, WATER-SUI, V12, DOI 10.3390/w12061788; Rheinheimer DE, 2015, J WATER RES PLAN MAN, V141, DOI 10.1061/(ASCE)WR.1943-5452.0000447; Shammaa Y, 2010, J HYDRAUL ENG-ASCE, V136, P234, DOI 10.1061/(ASCE)HY.1943-7900.0000165; Shao Jie Zhang, 2010, Proceedings of the 2010 Fourth IEEE International Conference on Secure Software Integration and Reliability Improvement Companion (SSIRI-C 2010), P1, DOI 10.1109/SSIRI-C.2010.11; Shifei T., 2011, GUIZHOU WATER POWER, V4, P18; Snortheim CA, 2017, ECOL MODEL, V343, P39, DOI 10.1016/j.ecolmodel.2016.10.014; Song QL, 2020, ENVIRON SCI POLLUT R, V27, P33052, DOI 10.1007/s11356-020-09507-4; Tuo YC, 2018, COLD REG SCI TECHNOL, V146, P223, DOI 10.1016/j.coldregions.2017.08.014; Vermeyen TB, 1995, WATER RESOURCES ENGINEERING, VOLS 1 AND 2, P521; Weber M, 2017, J ENVIRON MANAGE, V197, P96, DOI 10.1016/j.jenvman.2017.03.020; Xie QK, 2017, WATER-SUI, V9, DOI 10.3390/w9080603; Yang Y., 2019, 38 IAHR WORLD C, P2382, DOI [10.3850/38WC092019-1247, DOI 10.3850/38WC092019-1247]; Zhang YL, 2015, WATER RES, V75, P249, DOI 10.1016/j.watres.2015.02.052; Zheng TG, 2017, WATER SCI TECH-W SUP, V17, P279, DOI 10.2166/ws.2016.133; Zouabi-Aloui B, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4509-3	46	0	0	7	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0260779	10.1371/journal.pone.0260779	http://dx.doi.org/10.1371/journal.pone.0260779			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882725	Green Published, gold			2022-12-26	WOS:000755037200041
J	Makai-Boloni, S; Thijssen, E; van Brummelen, EMJ; Groeneveld, GJ; Doll, RJ				Makai-Boeloeni, Soma; Thijssen, Eva; van Brummelen, Emilie M. J.; Groeneveld, Geert J.; Doll, Robert J.			Touchscreen-based finger tapping: Repeatability and configuration effects on tapping performance	PLOS ONE			English	Article							UNIFIED PARKINSONS-DISEASE; BRADYKINESIA; IMPAIRMENT; RELIABILITY; MOVEMENTS	Parkinson's disease (PD) is a progressive neurodegenerative disease that affects almost 2% of the population above the age of 65. To better quantify the effects of new medications, fast and objective methods are needed. Touchscreen-based tapping tasks are simple yet effective tools for quantifying drug effects on PD-related motor symptoms, especially bradykinesia. However, there is no consensus on the optimal task set-up. The present study compares four tapping tasks in 14 healthy participants. In alternate finger tapping (AFT), tapping occurred with the index and middle finger with 2.5 cm between targets, whereas in alternate side tapping (AST) the index finger with 20 cm between targets was used. Both configurations were tested with or without the presence of a visual cue. Moreover, for each tapping task, within- and between-day repeatability and (potential) sensitivity of the calculated parameters were assessed. Visual cueing reduced tapping speed and rhythm, and improved accuracy. This effect was most pronounced for AST. On average, AST had a lower tapping speed with impaired accuracy and improved rhythm compared to AFT. Of all parameters, the total number of taps and mean spatial error had the highest repeatability and sensitivity. The findings suggest against the use of visual cueing because it is crucial that parameters can vary freely to accurately capture medication effects. The choice for AFT or AST depends on the research question, as these tasks assess different aspects of movement. These results encourage further validation of non-cued AFT and AST in PD patients.	[Makai-Boeloeni, Soma; Thijssen, Eva; van Brummelen, Emilie M. J.; Groeneveld, Geert J.; Doll, Robert J.] Ctr Human Drug Res, Leiden, Netherlands; [Makai-Boeloeni, Soma; Thijssen, Eva; Groeneveld, Geert J.] Leiden Univ, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Doll, RJ (corresponding author), Ctr Human Drug Res, Leiden, Netherlands.	rjdoll@chdr.nl		Thijssen, Eva/0000-0003-3907-072X; Makai-Boloni, Soma/0000-0002-5971-381X				Agostino R, 2003, MOVEMENT DISORD, V18, P560, DOI 10.1002/mds.10313; Agostino R, 1998, MOVEMENT DISORD, V13, P418, DOI 10.1002/mds.870130308; [Anonymous], 2015, J STAT SOFTW, DOI [DOI 10.18637/JSS.V067.I01, DOI 10.18637/jss.v067.i01]; Arora S, 2015, PARKINSONISM RELAT D, V21, P650, DOI 10.1016/j.parkreldis.2015.02.026; Arora S, 2018, NEUROLOGY, V91, P1528, DOI 10.1212/WNL.0000000000006366; Arroyo-Gallego T, 2017, IEEE T BIO-MED ENG, V64, P1994, DOI 10.1109/TBME.2017.2664802; Au WL., 2015, EFFECTS AGE GENDER H, P2015; Azulay JP, 2006, J NEUROL SCI, V248, P192, DOI 10.1016/j.jns.2006.05.008; Castet E, 2012, SEEING PERCEIVING, V25, P449, DOI 10.1163/187847611X620955; Cohen J.E., 1988, STAT POWER ANAL BEHA; Espay AJ, 2016, MOVEMENT DISORD, V31, P1272, DOI 10.1002/mds.26642; Espay AJ, 2011, MOVEMENT DISORD, V26, P2504, DOI 10.1002/mds.23893; Giancardo L, 2016, SCI REP-UK, V6, DOI 10.1038/srep34468; Ginis P, 2018, ANN PHYS REHABIL MED, V61, P407, DOI 10.1016/j.rehab.2017.08.002; Giovannoni G, 1999, J NEUROL NEUROSUR PS, V67, P624, DOI 10.1136/jnnp.67.5.624; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Haaxma CA, 2008, MOVEMENT DISORD, V23, P1707, DOI 10.1002/mds.22197; Hasan H, 2019, MOV DISORD CLIN PRAC, V6, P462, DOI 10.1002/mdc3.12798; Hasan H, 2017, J PARKINSON DIS, V7, P65, DOI 10.3233/JPD-160878; Heldman DA, 2014, PARKINSONISM RELAT D, V20, P590, DOI 10.1016/j.parkreldis.2014.02.022; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kim JW, 2011, MED BIOL ENG COMPUT, V49, P365, DOI 10.1007/s11517-010-0697-8; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kowal SL, 2013, MOVEMENT DISORD, V28, P311, DOI 10.1002/mds.25292; Lalvay L, 2017, MOV DISORD CLIN PRAC, V4, P316, DOI 10.1002/mdc3.12410; Lee CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158852; Lenth R, 2020, PACKAGE EMMEANSR PAC, DOI [10.1080/00031305.1980.10483031, DOI 10.1080/00031305.1980.10483031]; Lipp MM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8858; Memedi M, 2013, SENSORS-BASEL, V13, P16965, DOI 10.3390/s131216965; Mitsi G, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00273; NUTT JG, 1984, NEW ENGL J MED, V310, P483, DOI 10.1056/NEJM198402233100802; Okuno Ryuhei, 2006, Conf Proc IEEE Eng Med Biol Soc, VSuppl, P6623; Peirce J, 2018, J CHEM INF MODEL; Post B, 2005, MOVEMENT DISORD, V20, P1577, DOI 10.1002/mds.20640; R Core Team, 2020, R LANG ENV STAT COMP; Stamatakis J, 2013, COMPUT INTEL NEUROSC, V2013, DOI 10.1155/2013/717853; Summa S, 2017, INT C REHAB ROBOT, P1556, DOI 10.1109/ICORR.2017.8009469; Tavares ALT, 2005, MOVEMENT DISORD, V20, P1286, DOI 10.1002/mds.20556; Tian F, 2019, CHI 2019: PROCEEDINGS OF THE 2019 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, DOI 10.1145/3290605.3300313; Titova N, 2016, PARKINSONISM RELAT D, V33, pS56, DOI 10.1016/j.parkreldis.2016.11.013; Trager MH., 2015, J CLIN MOV DISORD, V2, P1, DOI [10.1186/s40734-014-0011-2, DOI 10.1186/S40734-014-0011-2]; Van Rossum G, 2009, PYTHON 3 REFERENCE M, DOI DOI 10.5555/1593511; Vercruysse S, 2014, CEREB CORTEX, V24, P3154, DOI 10.1093/cercor/bht170; Wirth R, 2020, BEHAV RES METHODS, V52, P2394, DOI 10.3758/s13428-020-01409-0; Wissel Benjamin D, 2017, Digit Biomark, V1, P126, DOI 10.1159/000485468; Yokoe M, 2009, PARKINSONISM RELAT D, V15, P440, DOI 10.1016/j.parkreldis.2008.11.003	48	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260783	10.1371/journal.pone.0260783	http://dx.doi.org/10.1371/journal.pone.0260783			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874977	Green Published, gold			2022-12-26	WOS:000753617500035
J	Gionfriddo, MR; Duboski, V; Middernacht, A; Kern, MS; Graham, J; Wright, EA				Gionfriddo, Michael R.; Duboski, Vanessa; Middernacht, Allison; Kern, Melissa S.; Graham, Jove; Wright, Eric A.			A mixed methods evaluation of medication reconciliation in the primary care setting	PLOS ONE			English	Article							IMPLEMENTATION; DISCREPANCIES	Objectives To understand the extent to which behaviors consistent with high quality medication reconciliation occurred in primary care settings and explore barriers to high quality medication reconciliation. Design Fully mixed sequential equal status design including ethnographic observations, semi-structured interviews, and surveys. Setting Primary care practices within an integrated healthcare delivery system in the United States. Participants We conducted 170 observations of patient encounters across 15 primary care clinics, 48 semi-structured interviews with staff, and 10 semi-structured interviews with patients. We also sent out surveys to 2,541 eligible staff with 616 responses (24% response rate) and to 5,132 eligible patients with 577 responses (11% response rate). Results Inconsistency emerged as a major barrier to effective medication reconciliation. This inconsistency was present across a variety of factors such as the lack of standardized workflows for conducting medication reconciliation, a lack of knowledge about medication and the process of medication reconciliation, varying levels of importance ascribed to medication reconciliation, and inadequate integration of medication reconciliation into clinical workflows. Findings were generally consistent across all data collection methods. Conclusion We have identified several barriers which impact the process of medication reconciliation in primary care settings. Our key finding is that the process of medication reconciliation is plagued by inconsistencies which contribute to inaccurate medication lists. These inconsistencies can be broken down into several categories (standardization, knowledge, importance, and inadequate integration) which can be targets for future studies and interventions.	[Gionfriddo, Michael R.; Duboski, Vanessa; Kern, Melissa S.; Graham, Jove; Wright, Eric A.] Geisinger, Ctr Pharm Innovat & Outcomes, Danville, PA 17822 USA; [Middernacht, Allison] Wilkes Univ, Sch Pharm, Wilkes Barre, PA 18766 USA; [Gionfriddo, Michael R.] Duquesne Univ, Sch Pharm, Div Pharmaceut Adm & Social Sci, Pittsburgh, PA 15219 USA	Wilkes University; Duquesne University	Gionfriddo, MR (corresponding author), Geisinger, Ctr Pharm Innovat & Outcomes, Danville, PA 17822 USA.; Gionfriddo, MR (corresponding author), Duquesne Univ, Sch Pharm, Div Pharmaceut Adm & Social Sci, Pittsburgh, PA 15219 USA.	gionfriddom@dug.edu	Gionfriddo, Michael/S-8359-2016	Gionfriddo, Michael/0000-0003-1391-7072	Geisinger Health Plan through the Geisinger Clinic Quality Pilot Fund program	Geisinger Health Plan through the Geisinger Clinic Quality Pilot Fund program	This work was funded by the Geisinger Health Plan through the Geisinger Clinic Quality Pilot Fund program for fiscal years 2020 and 2021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LJ, 2019, AM J HEALTH-SYST PH, V76, P2028, DOI 10.1093/ajhp/zxz236; Andrus Miranda R., 2012, Pharmacy Practice (Internet), V10, P78, DOI 10.4321/s1886-36552012000200003; Bayoumi I, 2009, ANN PHARMACOTHER, V43, P1667, DOI 10.1345/aph.1M059; Boockvar KS, 2009, QUAL SAF HEALTH CARE, V18, P32, DOI 10.1136/qshc.2007.025957; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Drenth-van Maanen AC, 2011, J AM GERIATR SOC, V59, P1976, DOI 10.1111/j.1532-5415.2011.03610_11.x; Dullabh P, 2014, DEMONSTRATING EFFECT; Freeman WJ, 2006, HEALTHCARE COST UTIL; Gardiner P, 2015, PATIENT EDUC COUNS, V98, P512, DOI 10.1016/j.pec.2014.12.010; Guisado-Gil AB, 2020, RES SOC ADMIN PHARM, V16, P995, DOI 10.1016/j.sapharm.2019.10.011; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heyworth L, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2793; Johnson KL, 2018, J DENT EDUC, V82, P839, DOI 10.21815/JDE.018.078; Kongkaew C, 2008, ANN PHARMACOTHER, V42, P1017, DOI 10.1345/aph.1L037; Leech NL, 2009, QUAL QUANT, V43, P265, DOI 10.1007/s11135-007-9105-3; MARQUIS Investigators, 2014, MARQUIS IMPL MAN GUI; Najafzadeh M, 2016, AM J MANAG CARE, V22, P654; Nassaralla CL, 2009, QUAL SAF HEALTH CARE, V18, P402, DOI 10.1136/qshc.2007.024513; Nassaralla CL, 2007, QUAL SAF HEALTH CARE, V16, P90, DOI 10.1136/qshc.2006.021113; Penm J, 2019, RES SOC ADMIN PHARM, V15, P632, DOI 10.1016/j.sapharm.2018.07.020; Peyton L, 2010, J AM PHARM ASSOC, V50, P490, DOI 10.1331/JAPhA.2010.09055; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Rangachari P, 2019, QUAL MANAG HEALTH CA, V28, P84, DOI 10.1097/QMH.0000000000000208; Redmond P, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010791.pub2; Varkey P, 2007, JT COMM J QUAL PATIE, V33, P286, DOI 10.1016/S1553-7250(07)33033-X; Vogelsmeier A, 2013, RES SOC ADMIN PHARM, V9, P419, DOI 10.1016/j.sapharm.2012.08.002; World Health Organization, 2019, HIGH 5S STAND OP PRO	29	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260882	10.1371/journal.pone.0260882	http://dx.doi.org/10.1371/journal.pone.0260882			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855888	Green Published, gold			2022-12-26	WOS:000735299000146
J	Sonuch, P; Kantachuvesiri, S; Vathesatogkit, P; Lappichetpaiboon, R; Chailimpamontri, W; Thokanit, NS; Aekplakorn, W				Sonuch, Pitchaporn; Kantachuvesiri, Surasak; Vathesatogkit, Prin; Lappichetpaiboon, Raweewan; Chailimpamontri, Worawan; Thokanit, Nintita Sripaiboonkij; Aekplakorn, Wichai			Estimation of sodium consumption by novel formulas derived from random spot and 12-hour urine collection	PLOS ONE			English	Article							POTASSIUM EXCRETION; BLOOD-PRESSURE; PREVALENCE; 24-HOUR; POPULATION	The gold standard for estimating sodium intake is 24h urine sodium excretion. Several equations have been used to estimate 24h urine sodium excretion, however, a validated formula for calculating 24h urine sodium excretion from 12h urine collection has not yet been established. This study aims to develop novel equations for estimating 24h urine sodium excretion from 12h and random spot urine collection and also to validate existing spot urine equations in the Thai population. A cross-sectional survey was carried out among 209 adult hospital personnel. Participants were asked to perform a 12h daytime, 12h nighttime, and a random spot urine collection over a period of 24 hours. The mean 24h urine sodium excretion was 4,055 +/- 1,712 mg/day. Estimated urine sodium excretion from 3 different equations using random spot urine collection showed moderate correlation and agreement with actual 24h urine sodium excretion (r = 0.54, P<0.001, ICC = 0.53 for Kawasaki; r = 0.57, P<0.001, ICC = 0.44 for Tanaka; r = 0.60, P<0.001, ICC = 0.45 for INTERSALT). Novel equations for predicting 24h urine sodium excretion were then developed using variables derived from 12h daytime urine collection, 12h nighttime urine collection, random spot urine collection, 12h daytime with random spot urine collection, and 12h nighttime with random spot urine collection which showed strong correlation and agreement with actual measured values (r = 0.88, P<0.001, ICC = 0.87; r = 0.83, P<0.001, ICC = 0.81; r = 0.67, P<0.001, ICC = 0.62; r = 0.90, P<0.001, ICC = 0.90; and r = 0.83, p<0.001, ICC = 0.82 respectively). Bland-Altman plots indicated good agreement between predicted values and actual 24h urine sodium excretion using the new equations. Newly derived equations from 12h daytime and 12h nighttime urine collection with or without casual spot urine collection were able to accurately predict 24h urine sodium excretion.	[Sonuch, Pitchaporn] Mahidol Univ, Fac Med, Dept Med, Ramathibodi Hosp, Bangkok, Thailand; [Kantachuvesiri, Surasak] Mahidol Univ, Fac Med, Dept Med, Div Nephrol,Ramathibodi Hosp, Bangkok, Thailand; [Kantachuvesiri, Surasak; Lappichetpaiboon, Raweewan; Chailimpamontri, Worawan] Nephrol Soc Thailand, Thai Lowsalt Network, Bangkok, Thailand; [Vathesatogkit, Prin] Mahidol Univ, Fac Med, Dept Med, Div Cardiol,Ramathibodi Hosp, Bangkok, Thailand; [Thokanit, Nintita Sripaiboonkij] Mahidol Univ, Fac Med, Ramathibodi Comprehens Canc Ctr, Ramathibodi Hosp, Bangkok, Thailand; [Aekplakorn, Wichai] Mahidol Univ, Fac Med, Dept Community Med, Ramathibodi Hosp, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Kantachuvesiri, S (corresponding author), Mahidol Univ, Fac Med, Dept Med, Div Nephrol,Ramathibodi Hosp, Bangkok, Thailand.; Kantachuvesiri, S (corresponding author), Nephrol Soc Thailand, Thai Lowsalt Network, Bangkok, Thailand.	surasak.kan@mahidol.ac.th		SONUCH, PITCHAPORN/0000-0001-8228-5430	Thai Health Promotion Foundation	Thai Health Promotion Foundation	This study was financially supported by the Thai Health Promotion Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUER J H, 1985, Journal of Clinical Hypertension, V1, P199; Bentley B, 2006, J CARDIOVASC NURS, V21, P63, DOI 10.1097/00005082-200601000-00012; Brown IJ, 2013, AM J EPIDEMIOL, V177, P1180, DOI 10.1093/aje/kwt066; Buranakitjaroen Peera, 2013, Journal of the Medical Association of Thailand, V96, pS1; Cappuccio FP, 1997, HEART, V78, P555, DOI 10.1136/hrt.78.6.555; Chailimpamontree W, 2021, J CLIN HYPERTENS, V23, P744, DOI 10.1111/jch.14147; Cogswell ME, 2015, ANNU REV NUTR, V35, P349, DOI 10.1146/annurev-nutr-071714-034322; Conkle J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010007; Silva Amilcar Bernardo Tomé da, 2010, Braz. J. Nephrol., V32, P165, DOI 10.1590/S0101-28002010000200005; Dwivedi Girish, 2009, Expert Rev Cardiovasc Ther, V7, P955, DOI 10.1586/erc.09.88; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Graudal NA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub4; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; Idelson PI, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020279; Imai E, 2011, CLIN EXP NEPHROL, V15, P861, DOI 10.1007/s10157-011-0523-0; Jaramillo J.., 2017, STAKEHOLDER EXPERT P; Ji C, 2012, REV PANAM SALUD PUBL, V32, P307, DOI 10.1590/S1020-49892012001000010; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; LUFT FC, 1987, AM J NEPHROL, V7, P39, DOI 10.1159/000167541; Luta X, 2018, NUTR METAB CARDIOVAS, V28, P270, DOI 10.1016/j.numecd.2017.10.028; Mill JG, 2012, BRAZ J MED BIOL RES, V45, P799, DOI 10.1590/S0100-879X2012007500114; Ngamjarus C., 2016, Siriraj Medical Journal, V68, P160; Niyomchit C.., 2019, SONGKLANAGARIND J NU, V39, P103; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Sarmugam R, 2014, NUTRIENTS, V6, P5534, DOI 10.3390/nu6125534; Satheannoppakao Warapone, 2013, Journal of the Medical Association of Thailand, V96, pS161; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; Ushio-Yamana H, 2012, NEPHRON EXP NEPHROL, V122, P95, DOI 10.1159/000348660; WESSON LG, 1964, MEDICINE, V43, P547, DOI 10.1097/00005792-196409000-00002; WHO, 2012, GUID SOD INT AD CHIL; Wolz M, 2000, AM J HYPERTENS, V13, P103, DOI 10.1016/S0895-7061(99)00241-1; World Health Organization, 2012, EFF INCR POT INT BLO; World Health Organization, 2019, HYP CAR THAIL BEST P; World Health Organization, 2013, GLOB ACT PLAN PREV C	35	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260408	10.1371/journal.pone.0260408	http://dx.doi.org/10.1371/journal.pone.0260408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855776	Green Published, gold			2022-12-26	WOS:000735299000054
J	Sun, BQ; Zhao, HW				Sun, Bingqing; Zhao, Hongwen			The bioinformatics analysis of RIOX2 gene in lung adenocarcinoma and squamous cell carcinoma	PLOS ONE			English	Article							MYC TARGET GENE; DNA METHYLATION; AIR-POLLUTION; CANCER; MINA53; EXPRESSION; VALIDATION; PROTEINS; MDIG	Lung cancer is characterized by high morbidity and mortality rates, and it has become an important public health issue worldwide. The occurrence and development of tumors is a multi-gene and multi-stage complex process. As an oncogene, ribosomal oxygenase 2 (RIOX2) has been associated with a variety of cancers. In this article, we analyzed the correlation between RIOX2 expression and methylation in lung cancer based on the databases including the cancer genome atlas (TCGA) (https://portal.gdc.cancer.gov/) and the gene expression omnibus (GEO) (https://www.ncbi.nlm.nih.gov/geo/). It was found that RIOX2 is highly expressed in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) tissues, whose expression is negatively correlated with its methylation level. In this regard, methylation at cg09716038, cg14773523, cg14941179, and cg22299097 had a significant negative correlation with RIOX2 expression in LUAD, whereas in LUSC, methylation at cg09716038, cg14773523, cg14941179, cg22299097, cg05451573, cg10779801, and cg23629183 is negatively correlated with RIOX2 expression. According to the analysis based on the databases, RIOX2 gene could not be considered as the independent prognostic biomarker in lung adenocarcinoma or squamous cell lung cancer. However, the molecular mechanism of RIOX2 gene in the development of lung cancer may be helpful in improving lung cancer therapy.	[Sun, Bingqing; Zhao, Hongwen] China Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Shenyang, Liaoning, Peoples R China	China Medical University	Zhao, HW (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Shenyang, Liaoning, Peoples R China.	hwzhao2007@163.com			National Natural Science Foundation of China [81472194]; Project of Liaoning Distinguished Professor [(2013) 204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Liaoning Distinguished Professor	This study was supported by the National Natural Science Foundation of China (Grant no. 81472194) and by the Project of Liaoning Distinguished Professor [Grant no. (2013) 204] to Hongwen Zhao. The funder had a role in study design, analysis, decision to publish and preparation of the manuscript.	Alboukadel Kassambara, 2020, GGPUBR GGPLOT2 BAS P; Balduzzi S, 2019, EVID-BASED MENT HEAL, V22, P153, DOI 10.1136/ebmental-2019-300117; Baylin SB, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019505; Blanche P, 2013, STAT MED, V32, P5381, DOI 10.1002/sim.5958; Brown T, 2009, OCCUP MED-OXFORD, V59, P89, DOI 10.1093/occmed/kqn171; Bueno R, 2020, J THORAC ONCOL, V15, P1748, DOI 10.1016/j.jtho.2020.07.005; Bundred JR, 2018, CELL MOL LIFE SCI, V75, P4093, DOI 10.1007/s00018-018-2903-z; Castellano GM, 2020, TRANSL LUNG CANCER R, V9, P951, DOI 10.21037/tlcr.2020.04.05; Cho JW, 2020, EXP MOL MED, V52, P1550, DOI 10.1038/s12276-020-00493-8; Cottrell SE, 2004, CLIN BIOCHEM, V37, P595, DOI 10.1016/j.clinbiochem.2004.05.010; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Feng L, 2016, ONCOTARGET, V7, P18006, DOI 10.18632/oncotarget.7632; Fukahori S, 2007, J PEDIATR SURG, V42, P1831, DOI 10.1016/j.jpedsurg.2007.07.008; He F, 2020, CANCER MED-US, V9, P7717, DOI 10.1002/cam4.3369; Hulbert A, 2017, CLIN CANCER RES, V23, P1998, DOI 10.1158/1078-0432.CCR-16-1371; Huo Q, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.165; Kassambara A, 2021, PACKAGE SURVMINERDRA; Kerr KM, 2007, DIS MARKERS, V23, P5, DOI 10.1155/2007/985474; Komiya K, 2010, LUNG CANCER, V69, P232, DOI 10.1016/j.lungcan.2009.10.010; Komiya K, 2010, J CANCER RES CLIN, V136, P465, DOI 10.1007/s00432-009-0679-0; Kuratomi Kettaro, 2006, Kurume Medical Journal, V53, P71, DOI 10.2739/kurumemedj.53.71; Leek JJ, 2020, R PACKAGE VERSION 34; Li P, 2018, CANCER SCI, V109, P308, DOI 10.1111/cas.13456; Lissa D, 2016, TRANSL LUNG CANCER R, V5, P492, DOI 10.21037/tlcr.2016.10.03; Liu B, 2020, CLIN CANCER RES, V26, P4339, DOI 10.1158/1078-0432.CCR-19-2896; Luo RH, 2020, AGING-US, V12, P14649, DOI 10.18632/aging.103517; Perrier A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10071061; Qiao R, 2020, CANCER MANAG RES, V12, P11063, DOI 10.2147/CMAR.S275321; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Tan XP, 2012, ONCOL LETT, V3, P1037, DOI 10.3892/ol.2012.620; TANGO T, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.1289/ehp.94102s841; Teye K, 2004, AM J PATHOL, V164, P205, DOI 10.1016/S0002-9440(10)63111-2; Teye K, 2007, ONCOL REP, V18, P841; Therneau T. M., 2013, MODELING SURVIVAL DA, DOI 10.1007/978-1-4757-3294-8; Tong R, 2015, J INTERF CYTOK RES, V35, P963, DOI 10.1089/jir.2015.0061; Tsuneoka M, 2004, CLIN CANCER RES, V10, P7347, DOI 10.1158/1078-0432.CCR-03-0543; Wang XC, 2020, GENET MOL BIOL, V43, DOI [10.1590/1678-4685-GMB-2019-0164, 10.1590/1678-4685-gmb-2019-0164]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1; Xuan F, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1084-x; Yan HD, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1122-y; Yu MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087998; Zhang Q, 2020, THERANOSTICS, V10, P602, DOI 10.7150/thno.36220; Zhang Q, 2019, SEMIN CANCER BIOL, V57, P27, DOI 10.1016/j.semcancer.2019.06.013; Zhang YD, 2005, ONCOGENE, V24, P4873, DOI 10.1038/sj.onc.1208668	49	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0259447	10.1371/journal.pone.0259447	http://dx.doi.org/10.1371/journal.pone.0259447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855761	gold, Green Published			2022-12-26	WOS:000735299000016
J	Zaitoun, IS; Song, YS; Suscha, A; El Ragaby, M; Sorenson, CM; Sheibani, N				Zaitoun, Ismail S.; Song, Yong-Seok; Suscha, Andrew; El Ragaby, Mohamed; Sorenson, Christine M.; Sheibani, Nader			7, 8-Dihydroxyflavone, a TrkB receptor agonist, provides minimal protection against retinal vascular damage during oxygen-induced ischemic retinopathy	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; 7,8-DIHYDROXYFLAVONE; EXPRESSION; PREMATURITY; BDNF; NEOVASCULARIZATION; BEVACIZUMAB; PATHWAYS	Retinopathy of prematurity (ROP) is one of the main causes of blindness in children worldwide. Brain-derived neurotrophic factor (BDNF) and its receptor, tropomyosin-related kinase B (TrkB), play critical protective roles in the development and function of neurons and vasculature. Lack of BDNF expression results in increased endothelial cell apoptosis and reduced endothelial cell-cell contact. Premature babies who develop ROP tend to have lower serum BDNF levels. BDNF expression is also significantly lower in mouse retinas following exposure to hyperoxia compared to those reared in room air. Specifically, BDNF promotes angiogenic tube formation of endothelial cells (EC), and it is considered an EC survival factor required for stabilization of intramyocardial vessels. We hypothesized that the activation of TrkB receptor protects retinal vasculature in the mice during oxygen-induced ischemic retinopathy (OIR), a model of ROP. To test this hypothesis, we treated neonatal mice with 7,8-dihydroxyflavone (DHF) (5 mg/kg body weight), a TrkB receptor agonist. We examined its potential protective effects on retinal vessel obliteration and neovascularization, two hallmarks of ROP and OIR. We found that retinas from DHF treated postnatal day 8 (P8) and P12 mice have similar levels of vessel obliteration as retinas from age-matched control mice subjected to OIR. Similarly, DHF showed no significant effect on mitigation of retinal neovascularization during OIR in P17 mice. Collectively, our studies demonstrate that the TrkB receptor agonist DHF provides no significant protective effects during OIR.	[Zaitoun, Ismail S.; Song, Yong-Seok; Suscha, Andrew; El Ragaby, Mohamed; Sheibani, Nader] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Zaitoun, Ismail S.; Song, Yong-Seok; Sorenson, Christine M.; Sheibani, Nader] Univ Wisconsin, McPherson Eye Res Inst, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Sorenson, Christine M.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Sheibani, Nader] Univ Wisconsin, Dept Cell & Regenerat Biol, Sch Med & Publ Hlth, Madison, WI USA; [Sheibani, Nader] Univ Wisconsin, Dept Biomed Engn, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zaitoun, IS (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA.; Zaitoun, IS (corresponding author), Univ Wisconsin, McPherson Eye Res Inst, Sch Med & Publ Hlth, Madison, WI 53706 USA.	iszaitoun@wisc.edu		Zaitoun, ismail/0000-0001-7174-5403	Research to Prevent Blindness; Retina Research Foundation; RRF/Daniel M. Albert Chair, National Institutes of Health [P30 EY016665]; National Institutes of Health [P30 CA014520]; National Eye Institute [R01 EY026078, R01 EY030076, R01EY032543]	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Retina Research Foundation; RRF/Daniel M. Albert Chair, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work presented here supported by an unrestricted award from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences, Retina Research Foundation, RRF/Daniel M. Albert Chair, National Institutes of Health P30 EY016665, National Institutes of Health P30 CA014520, National Eye Institute R01 EY026078, National Eye Institute R01 EY030076 and National Eye Institute R01EY032543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afarid M, 2020, J OPHTHALMOL, V2020, DOI 10.1155/2020/1602739; Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; Boltaev U, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal1670; BURKE MA, 1994, EXP NEUROL, V130, P178, DOI 10.1006/exnr.1994.1197; Castello NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091453; Chavez-Valdez R, 2012, J APPL PHYSIOL, V112, P1762, DOI 10.1152/japplphysiol.01609.2011; Chen C, 2018, P NATL ACAD SCI USA, V115, P578, DOI 10.1073/pnas.1718683115; Cheng G, 2016, EYE, V30, P877, DOI 10.1038/eye.2016.43; Chitranshi N, 2015, INT J MOL SCI, V16, P21087, DOI 10.3390/ijms160921087; Choi JW, 2016, LIFE SCI, V144, P103, DOI 10.1016/j.lfs.2015.11.028; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Fang J, 2005, FASEB J, V19, P342, DOI 10.1096/fj.04-2175com; Fenner BM, 2012, CYTOKINE GROWTH F R, V23, P15, DOI 10.1016/j.cytogfr.2012.01.002; Giacobbo BL, 2019, MOL NEUROBIOL, V56, P3295, DOI 10.1007/s12035-018-1283-6; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Gupta VK, 2013, J MOL NEUROSCI, V49, P96, DOI 10.1007/s12031-012-9899-x; Hartnett ME, 2014, INVEST OPHTH VIS SCI, V55, P6194, DOI 10.1167/iovs.14-14841; Hellgren G, 2010, NEONATOLOGY, V98, P409, DOI 10.1159/000317779; Houston SK, 2013, LASER MED SCI, V28, P683, DOI 10.1007/s10103-011-1021-z; Huang Q., 2017, ANN EYE SCI, V2; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Kang JS, 2015, INT J MOL MED, V36, P501, DOI 10.3892/ijmm.2015.2256; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P1205, DOI 10.1007/s00417-009-1116-4; Lee S, 2018, KOREAN J ANESTHESIOL, V71, P353, DOI 10.4097/kja.d.18.00242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutty GA, 2011, INVEST OPHTH VIS SCI, V52, P4039, DOI 10.1167/iovs.10-6798; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; McLoone E, 2006, BRIT J OPHTHALMOL, V90, P754, DOI 10.1136/bjo.2005.068304; Micieli JA, 2009, AM J OPHTHALMOL, V148, P536, DOI 10.1016/j.ajo.2009.05.031; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Mysona BA, 2017, EXPERT REV OPHTHALMO, V12, P69, DOI 10.1080/17469899.2017.1259566; Nie SK, 2019, PARKINSONS DIS-US, V2019, DOI 10.1155/2019/9193534; PARDRIDGE WM, 1994, PHARMACEUT RES, V11, P738, DOI 10.1023/A:1018940732550; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Quinn GE, 2018, JAMA OPHTHALMOL, V136, P1383, DOI 10.1001/jamaophthalmol.2018.4290; Rantamaki T, 2019, CELL TISSUE RES, V377, P115, DOI 10.1007/s00441-018-02985-6; Rao R, 2009, PEDIATR RES, V65, P548, DOI 10.1203/PDR.0b013e31819d9ea5; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Segatto M, 2019, J CELL PHYSIOL, V234, P18297, DOI 10.1002/jcp.28462; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Suelves AM, 2016, EYE BRAIN, V8, P37, DOI 10.2147/EB.S94439; Todd D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087923; Tokunaga CC, 2014, INVEST OPHTH VIS SCI, V55, P1884, DOI 10.1167/iovs.13-13397; Usui T, 2014, ACTA PHYSIOL, V211, P385, DOI 10.1111/apha.12249; Wallace DK, 2017, JAMA OPHTHALMOL, V135, P654, DOI 10.1001/jamaophthalmol.2017.1055; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178198; Yao Q, 2005, AM J PHYSIOL-LUNG C, V289, pL307, DOI 10.1152/ajplung.00030.2005; Zaitoun IS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45915-4; Zaitoun IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139994; Zhou WT, 2015, CURR ALZHEIMER RES, V12, P47, DOI 10.2174/1567205012666141218124243	55	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260793	10.1371/journal.pone.0260793	http://dx.doi.org/10.1371/journal.pone.0260793			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855884	Green Published, gold			2022-12-26	WOS:000735299000125
J	Sathyamoorthy, AJ; Patel, U; Paul, M; Savle, Y; Manocha, D				Sathyamoorthy, Adarsh Jagan; Patel, Utsav; Paul, Moumita; Savle, Yash; Manocha, Dinesh			COVID surveillance robot: Monitoring social distancing constraints in indoor scenarios	PLOS ONE			English	Article							INFLUENZA; IMPACT	Observing social/physical distancing norms between humans has become an indispensable precaution to slow down the transmission of COVID-19. We present a novel method to automatically detect pairs of humans in a crowded scenario who are not maintaining social distancing, i.e. about 2 meters of space between them using an autonomous mobile robot and existing CCTV (Closed-Circuit TeleVision) cameras. The robot is equipped with commodity sensors, namely an RGB-D (Red Green Blue-Depth) camera and a 2-D lidar to detect social distancing breaches within their sensing range and navigate towards the location of the breach. Moreover, it discreetly alerts the relevant people to move apart by using a mounted display. In addition, we also equip the robot with a thermal camera that transmits thermal images to security/healthcare personnel who monitors COVID symptoms such as a fever. In indoor scenarios, we integrate the mobile robot setup with a static wall-mounted CCTV camera to further improve the number of social distancing breaches detected, accurately pursuing walking groups of people etc. We highlight the performance benefits of our robot + CCTV approach in different static and dynamic indoor scenarios.	[Sathyamoorthy, Adarsh Jagan; Manocha, Dinesh] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA; [Patel, Utsav; Manocha, Dinesh] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Paul, Moumita; Savle, Yash] Univ Maryland, Inst Syst Res, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Sathyamoorthy, AJ (corresponding author), Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA.	asathyam@umd.edu		Sathyamoorthy, Adarsh Jagan/0000-0002-9678-4748	Army Research Office (ARO) [W911NF1910069, W911NF1910315, W911NF2110026]; National Science Foundation (NSF) [2031901]	Army Research Office (ARO); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	Funding agencies: 1. Army Research Office (ARO) 2. National Science Foundation (NSF) Our work was funded by the following grants: ARO Grants W911NF1910069, W911NF1910315, W911NF2110026 NSF Grant 2031901 Author who received the awards: Dinesh Manocha The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Farhadi, 2018, Arxiv, DOI arXiv:1804.02767; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Everett M, 2018, IEEE INT C INT ROBOT, P3052, DOI 10.1109/IROS.2018.8593871; Fan T, 2020, AUTONOMOUS SOCIAL DI; Fox D, 1997, IEEE ROBOT AUTOM MAG, V4, P23, DOI 10.1109/100.580977; Ghodgaonkar I, 2020, ANAL WORLDWIDE SOCIA; Kumar S, 2013, AM J PUBLIC HEALTH, V103, P1406, DOI 10.2105/AJPH.2013.301269; Liang J., 2020, REALTIME COLLISION A; Long P, 2017, OPTIMALLY DECENTRALI; Mao L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-522; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; Murphy RR., 2020, APPL ROBOTS COVID 19; Nguyen C.T, 2020, ENABLING EMERGING TE; Punn N. S., 2020, ARXIV PREPRINT ARXIV; Sathyamoorthy AJ, 2020, IEEE ROBOT AUTOM LET, V5, P4352, DOI 10.1109/LRA.2020.2996593; Sathyamoorthy AJ, 2020, DENSECAVOID REAL TI; Timpka T, 2016, EPIDEMIOL INFECT, V144, P2031, DOI 10.1017/S0950268816000169; van den Berg J, 2008, IEEE INT CONF ROBOT, P1928, DOI 10.1109/ROBOT.2008.4543489; Wojke N, 2017, IEEE IMAGE PROC, P3645; Yang D., 2020, ARXIV200703578; Yu Fan Chen, 2017, 2017 IEEE International Conference on Robotics and Automation (ICRA), P285, DOI 10.1109/ICRA.2017.7989037	22	1	1	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0259713	10.1371/journal.pone.0259713	http://dx.doi.org/10.1371/journal.pone.0259713			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851982	gold, Green Published			2022-12-26	WOS:000755762900016
J	Carroll, DJ; Burns, MWN; Mottrarn, L; Propheterl, DC; Boucher, A; Lessen, GM; Kumar, A; Malaker, SA; Xing, C; Hooper, LV; Yrlid, U; Kohler, JJ				Carroll, Daniela J.; Burns, Mary W. N.; Mottrarn, Lynda; Propheterl, Daniel C.; Boucher, Andrew; Lessen, Gabrielle M.; Kumar, Ashwani; Malaker, Stacy A.; Xing, Chao; Hooper, Lora, V; Yrlid, Ulf; Kohler, Jennifer J.			Interleukin-22 regulates B3GNT7 expression to induce fucosylation of glycoproteins in intestinal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-L-FUCOSIDASES; KERATAN SULFATE; GENE-EXPRESSION; GLYCOSYLATION; FUCOSE; LINE; IDENTIFICATION; DISTINCT; PROGRAM; COMPLEX	Interleukin (IL)-22 is a cytokine that plays a critical role in intestinal epithelial homeostasis. Its downstream functions are mediated through interaction with the heterodimeric IL-22 receptor and subsequent activation of signal transducer and activator of transcription 3 (STAT3). IL-22 signaling can induce transcription of genes necessary for intestinal epithelial cell proliferation, tissue regeneration, tight junction fortifica-tion, and antimicrobial production. Recent studies have also implicated IL-22 signaling in the regulation of intestinal epithelial fucosylation in mice. However, whether IL-22 regulates intestinal fucosylation in human intestinal epithelial cells and the molecular mechanisms that govern this process are unknown. Here, in experiments performed in human cell lines and human-derived enteroids, we show that IL-22 signaling regulates expression of the B3GNT7 transcript, which encodes a beta 1-3-N-acetylglucosaminyltransferase that can participate in the synthesis of poly-N-acetyllactosamine (polyLacNAc) chains. Additionally, we find that IL-22 signaling regulates levels of the alpha 1-3-fucosylated Lewis X (Lex) blood group antigen, and that this glycan epitope is primarily displayed on O-glycosylated intestinal epithelial glycoproteins. Moreover, we show that increased expression of B3GNT7 alone is sufficient to promote increased display of Lex-decorated carbohydrate glycan structures primarily on O-glycosylated intestinal epithelial glycoproteins. Together, these data identify B3GNT7 as an intermediary in IL-22-dependent induction of fucosylation of glycoproteins and uncover a novel role for B3GNT7 in intes	[Carroll, Daniela J.; Burns, Mary W. N.; Lessen, Gabrielle M.; Kohler, Jennifer J.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Mottrarn, Lynda; Boucher, Andrew; Yrlid, Ulf] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Propheterl, Daniel C.; Hooper, Lora, V] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Kumar, Ashwani; Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Malaker, Stacy A.] Yale Univ, Dept Chem, New Haven, CT USA; [Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, Dept Bioinformat, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, Dept Populat & Data Sci, Dallas, TX 75390 USA; [Hooper, Lora, V] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Carroll, Daniela J.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Gothenburg; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University Bloomington	Kohler, JJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	Jennifer.Kohler@UTSouthwestern.edu		Burns, Mary/0000-0003-0712-237X; Xing, Chao/0000-0002-1838-0502; Malaker, Stacy/0000-0003-2382-5067	NIH [T32GM127216, R01GM090271, R01DK070855]; Welch Foundation [I-1686, I-1874]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation)	Support provided by the NIH (R01GM090271 to J. J. K. and R01DK070855 to L. V. H.) and the Welch Foundation (I-1686 to J. J. K. and I-1874 to L. V. H.) . M. W. N. B. was supported by NIH T32GM127216. L. V. H. is an investigator of the Howard Hughes Medical Institute. The content is solely the re-sponsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Remaileh M, 2015, CANCER RES, V75, P2120, DOI 10.1158/0008-5472.CAN-14-3295; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Brockhausen I., 2015, ESSENTIALS GLYCOBIOL, P113, DOI DOI 10.1101/GLYCOBIOLOGY.3E.010; Buffone A, 2013, J BIOL CHEM, V288, P1620, DOI 10.1074/jbc.M112.400929; Cailleau-Thomas A, 2000, GLYCOBIOLOGY, V10, P789, DOI 10.1093/glycob/10.8.789; Caterson B, 2018, GLYCOBIOLOGY, V28, P182, DOI 10.1093/glycob/cwy003; Co JY, 2019, CELL REP, V26, P2509, DOI 10.1016/j.celrep.2019.01.108; Cummings PSRD., 2017, ESSENTIALS GLYCOBIOL, P161, DOI DOI 10.1101/GLYCOBIOLOGY.3E.014; Devriese S, 2017, HISTOCHEM CELL BIOL, V148, P85, DOI 10.1007/s00418-017-1539-7; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Goto Y, 2016, NAT IMMUNOL, V17, P1244, DOI 10.1038/ni.3587; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Itakura Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061160; Kataoka K, 2002, BIOCHEM BIOPH RES CO, V294, P843, DOI 10.1016/S0006-291X(02)00553-3; Kitayama K, 2007, J BIOL CHEM, V282, P30085, DOI 10.1074/jbc.M703695200; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Li J, 2018, CELL CHEM BIOL, V25, P499, DOI 10.1016/j.chembiol.2018.02.005; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Littlechild SL, 2018, INVEST OPHTH VIS SCI, V59, P1641, DOI 10.1167/iovs.17-22716; Lu CH, 2014, GLYCOBIOLOGY, V24, P359, DOI 10.1093/glycob/cwu002; Malaker SA, 2019, P NATL ACAD SCI USA, V116, P7278, DOI 10.1073/pnas.1813020116; Manimala JC, 2006, ANGEW CHEM INT EDIT, V45, P3607, DOI 10.1002/anie.200600591; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nagao-Kitamoto H, 2020, NAT MED, V26, P608, DOI 10.1038/s41591-020-0764-0; Neelamegham S, 2016, CURR OPIN STRUC BIOL, V40, P145, DOI 10.1016/j.sbi.2016.09.013; Nishihara S, 2003, GLYCOBIOLOGY, V13, P445, DOI 10.1093/glycob/cwg048; NORRIS GE, 1994, STRUCTURE, V2, P1049, DOI 10.1016/S0969-2126(94)00108-1; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; PETERSON MD, 1992, J CELL SCI, V102, P581; Pham TAN, 2014, CELL HOST MICROBE, V16, P504, DOI 10.1016/j.chom.2014.08.017; Pickard JM, 2015, J IMMUNOL, V194, P5588, DOI 10.4049/jimmunol.1500395; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Propheter DC, 2017, P NATL ACAD SCI USA, V114, P11027, DOI 10.1073/pnas.1711395114; Reid L. M., 1978, P S USE ATHYMIC NUDE, P107; Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakurama H, 2012, BIOSCI BIOTECH BIOCH, V76, P1022, DOI 10.1271/bbb.111004; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Schroeder BO, 2019, GASTROENTEROL REP, V7, P3, DOI 10.1093/gastro/goy052; Seko A, 2004, FEBS LETT, V556, P216, DOI 10.1016/S0014-5793(03)01440-6; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Wang YH, 2017, SCIENCE, V357, P913, DOI 10.1126/science.aan0677; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Zachos NC, 2016, J BIOL CHEM, V291, P3759, DOI 10.1074/jbc.R114.635995	52	1	1	6	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101463	10.1016/j.jbc.2021.101463	http://dx.doi.org/10.1016/j.jbc.2021.101463			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI2AK	34864058	Green Published, gold			2022-12-26	WOS:000761429500009
J	Hu, XH; Li, ZH; Muyayalo, KP; Wang, LL; Liu, CY; Mor, G; Liao, AH				Hu, Xiao-Hui; Li, Zhi-Hui; Muyayalo, Kahindo P.; Wang, Li-Ling; Liu, Chun-Yan; Mor, Gil; Liao, Ai-Hua			A newly intervention strategy in preeclampsia: Targeting PD-1/Tim-3 signaling pathways to modulate the polarization of decidual macrophages	FASEB JOURNAL			English	Article						decidual macrophage; Gal-9; PD-1; PD-L1; preeclampsia; rat; Tim-3	CANCER-THERAPY; CELLS; BETA; PHENOTYPE; BLOCKADE; INHIBITION; TIM-3	Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) are important immune checkpoint receptors that prevent an overreacted maternal immune response to fetal antigens during pregnancy. Disruption of complex immune regulation mechanisms is associated with adverse pregnancy outcomes, including preeclampsia (PE). Our recent study showed that the Tim-3 pathway was involved in the regulation of decidual macrophage polarization. Decidual macrophages polarized to the M1 phenotype may impair uterine vessel remodeling during placentation, accounting for the occurrence of PE. Co-blockade of the PD-1/Tim-3 pathway was shown to successfully control tumor growth in preclinical cancer models. However, the effects of activating both PD-1 and Tim-3 pathways as a combined intervention strategy in PE are never reported. Herein, we observed the skew of decidual macrophage polarization toward the M1 phenotype in patients with PE and lipopolysaccharide (LPS)-induced PE-like rat model. Moreover, we found that the activation of PD-1/Tim-3 pathway by using PD-L1 and Gal-9 fusion proteins could alleviate the manifestation of the LPS-induced PE-like rats and protect their offspring. Compared with the single intervention, the combination of PD-L1and Gal-9 fusion proteins exhibited obvious advantages in the relief of PE-like symptoms, trophoblast invasion, and fetal vascular development, indicating a synergistic effect of the activated PD-1/Tim-3 pathway. The in vitro study also revealed that the combined intervention using PD-L1 and Gal-9 fusion proteins inhibited the LPS-induced M1 macrophage polarization via the synergic activation of the ERK/GSK3 beta/beta-catenin signaling pathway. Together, our findings provide the first evidence that simultaneous activation of PD-1/Tim-3 signaling pathways may have an optimal protective effect and serve as a new potential target for PE intervention.	[Hu, Xiao-Hui; Li, Zhi-Hui; Muyayalo, Kahindo P.; Wang, Li-Ling; Liu, Chun-Yan; Mor, Gil; Liao, Ai-Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Inst Reprod Hlth, 13 Hangkong Rd, Wuhan 430030, Peoples R China; [Mor, Gil] Wayne State Univ, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI USA	Huazhong University of Science & Technology; Wayne State University	Liao, AH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Inst Reprod Hlth, 13 Hangkong Rd, Wuhan 430030, Peoples R China.	aihua_liao@sina.com	Muyayalo, Kahinho Patrick/ABG-5966-2020	Muyayalo, Kahinho Patrick/0000-0001-7055-4138; Liao, Aihua/0000-0001-8533-8315; Mor, Gil/0000-0002-5499-3912	National Natural Science Foundation of China (NSFC) [81671490]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81671490	Anderson AC, 2014, CANCER IMMUNOL RES, V2, P393, DOI 10.1158/2326-6066.CIR-14-0039; Aneman I, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01864; Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; Brown MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00606; Chabtini L, 2013, J IMMUNOL, V190, P88, DOI 10.4049/jimmunol.1202176; Chen LP, 2015, J CLIN INVEST, V125, P3384, DOI 10.1172/JCI80011; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Colomb F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00267; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Gokyavuz B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39553-z; Habicht A, 2007, J IMMUNOL, V179, P5211, DOI 10.4049/jimmunol.179.8.5211; Jena MK, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10060953; Kikushige Y, 2015, CELL STEM CELL, V17, P341, DOI 10.1016/j.stem.2015.07.011; Li M, 2016, AM J PATHOL, V186, P1258, DOI 10.1016/j.ajpath.2015.12.021; Li ZH, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03142; Lively S, 2016, J NEUROPATH EXP NEUR, V75, P1058, DOI 10.1093/jnen/nlw081; Ma Y, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015080; Okada K, 2016, J LEUKOCYTE BIOL, V100, P1093, DOI 10.1189/jlb.2A0415-170RRR; Palmer JA, 2014, CELLS TISSUES ORGANS, V199, P169, DOI 10.1159/000363693; Paluch C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02306; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131; Raedler Lisa A, 2015, Am Health Drug Benefits, V8, P180; Romero D, 2016, NAT REV CLIN ONCOL, V13, DOI 10.1038/nrclinonc.2016.40; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shin DS, 2015, CURR OPIN IMMUNOL, V33, P23, DOI 10.1016/j.coi.2015.01.006; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Svensson-Arvelund J, 2015, AM J REPROD IMMUNOL, V74, P100, DOI 10.1111/aji.12357; Tang ZH, 2013, AM J REPROD IMMUNOL, V70, P104, DOI 10.1111/aji.12112; Timmerman I, 2012, MOL BIOL CELL, V23, P4212, DOI 10.1091/mbc.E12-01-0038; Tripathi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123439; Wang M, 2017, J IMMUNOL, V198, P4327, DOI 10.4049/jimmunol.1700162; Xiang DM, 2017, HEPATOLOGY, V65, P1566, DOI 10.1002/hep.28919; Yamaguchi H, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00015; Yao AH, 2014, NEUROTHERAPEUTICS, V11, P636, DOI 10.1007/s13311-013-0254-x; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zhang YH, 2019, HUM REPROD, V34, P25, DOI 10.1093/humrep/dey347; Zhao SJ, 2020, THERANOSTICS, V10, P17, DOI 10.7150/thno.36930; Zhao Z, 2014, CLIN EXP IMMUNOL, V178, P279, DOI 10.1111/cei.12401	40	6	6	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22073	10.1096/fj.202101306R	http://dx.doi.org/10.1096/fj.202101306R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34847253				2022-12-26	WOS:000734992000042
J	Wen, X; Xi, YX; Zhang, YZ; Jiao, LJ; Shi, S; Bai, SZ; Sun, FQ; Chang, GQ; Wu, R; Hao, JH; Li, HZ				Wen, Xin; Xi, Yuxin; Zhang, Yuanzhou; Jiao, Lijie; Shi, Sa; Bai, Shuzhi; Sun, Fengqi; Chang, Guiquan; Wu, Ren; Hao, Jinghui; Li, Hongzhu			DR1 activation promotes vascular smooth muscle cell apoptosis via up-regulation of CSE/H2S pathway in diabetic mice	FASEB JOURNAL			English	Article						apoptosis; diabetic mice; dopamine D1 receptors; hydrogen sulfide; VSMCs	HYDROGEN-SULFIDE; HIGH-GLUCOSE; GROWTH-FACTOR; DOPAMINE-RECEPTORS; PROLIFERATION; EXPRESSION; CALCIUM; INHIBITION; RAT; H2S	The important role of hydrogen sulfide (H2S) as a novel gasotransmitter in inhibiting proliferation and promoting apoptosis of vascular smooth muscle cells (VSMCs) has been widely recognized. The dopamine D1 receptor (DR1), a G protein coupled receptor, inhibits atherosclerosis by suppressing VSMC proliferation. However, whether DR1 contributes to VSMC apoptosis via the induction of endogenous H2S in diabetic mice is unclear. Here, we found that hyperglycemia decreased the expressions of DR1 and cystathionine-gamma-lyase (CSE, a key enzyme for endogenous H2S production) and reduced endogenous H2S generation in mouse arteries and cultured VSMCs. DR1 agonist SKF38393 increased DR1 and CSE expressions and stimulated endogenous H2S generation. Sodium hydrosulfide (NaHS, a H2S donor) increased CSE expressions and H2S generation but had no effect on DR1 expression. In addition, high glucose (HG) increased VSMC apoptosis, up-regulated IGF-1-IGF-1R and HB-EGF-EGFR, and stimulated ERK1/2 and PI3K-Akt pathways. Overexpression of DR1, the addition of SKF38393 or supply of NaHS further promoted VSMC apoptosis and down-regulated the above pathways. Knock out of CSE or the addition of the CSE inhibitor poly propylene glycol diminished the effect of SKF38393. Moreover, calmodulin (CaM) interacted with CSE in VSMCs; HG increased intracellular Ca2+ concentration and induced CaM expression, further strengthened the interaction of CaM with CSE in VSMCs, which were further enhanced by SKF38393. CaM inhibitor W-7, inositol 1,4,5-trisphosphate (IP3) inhibitor 2-APB, or ryanodine receptor inhibitor tetracaine abolished the stimulatory effect of SKF38393 on CaM expression and intracellular Ca2+ concentration. Taken together, these results suggest that DR1 up-regulates CSE/H2S signaling by inducing the Ca2+-CaM pathway followed by down-regulations of IGF-1-IGF-1R and HB-EGF-EGFR and their downstream ERK1/2 and PI3K-Akt, finally promoting the apoptosis of VSMCs in diabetic mice.	[Wen, Xin; Xi, Yuxin; Shi, Sa; Bai, Shuzhi; Sun, Fengqi; Chang, Guiquan; Wu, Ren; Hao, Jinghui; Li, Hongzhu] Harbin Med Univ, Dept Pathophysiol, Harbin, Peoples R China; [Zhang, Yuanzhou] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai, Peoples R China; [Jiao, Lijie; Li, Hongzhu] Xiamen Univ, Sch Med, Xiamen 361100, Fujian, Peoples R China	Harbin Medical University; Shanghai Jiao Tong University; Xiamen University	Li, HZ (corresponding author), Xiamen Univ, Sch Med, Xiamen 361100, Fujian, Peoples R China.	lhz2020@xmu.edu.cn	Xi, Yuxin/GWZ-8648-2022		National Natural Science Foundation of China [81770486, 81200160]; Heilongjiang Province Natural Science Foundation of China [H2018005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Natural Science Foundation of China(Natural Science Foundation of Heilongjiang Province)	This study was supported by the National Natural Science Foundation of China (No. 81770486, No. 81200160) and the Heilongjiang Province Natural Science Foundation of China (No. H2018005)	ABRAHAM JA, 1993, BIOCHEM BIOPH RES CO, V190, P125, DOI 10.1006/bbrc.1993.1020; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Bakker AD, 2016, J CELL PHYSIOL, V231, P1283, DOI 10.1002/jcp.25228; Berke JD, 2018, NAT NEUROSCI, V21, P787, DOI 10.1038/s41593-018-0152-y; Chen JT, 2016, INT J CARDIOL, V220, P681, DOI 10.1016/j.ijcard.2016.06.200; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Flamant M, 2012, NEPHROL DIAL TRANSPL, V27, P1297, DOI 10.1093/ndt/gfs030; Goldenberg JZ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4743; Hong F, 2001, LIFE SCI, V68, P1095, DOI 10.1016/S0024-3205(00)01012-2; Huang YL, 2009, CELL SIGNAL, V21, P954, DOI 10.1016/j.cellsig.2009.02.005; Jafari M, 2019, J CELL PHYSIOL, V234, P2373, DOI 10.1002/jcp.27262; Jeong IK, 2011, EXP MOL MED, V43, P684, DOI 10.3858/emm.2011.43.12.079; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Le Coz V, 2016, ONCOTARGET, V7, P82511, DOI 10.18632/oncotarget.12733; Li HZ, 2008, BASIC CLIN PHARMACOL, V102, P329, DOI 10.1111/j.1742-7843.2007.00177.x; Li HZ, 2017, AM J PHYSIOL-HEART C, V312, pH406, DOI 10.1152/ajpheart.00245.2016; Li HZ, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0035-9; Li HZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041614; Li SS, 2015, ANTIOXID REDOX SIGN, V23, P630, DOI 10.1089/ars.2014.6186; Liu N, 2017, J CELL MOL MED, V21, P3190, DOI 10.1111/jcmm.13223; LOKHANDWALA MF, 1982, J AUTON PHARMACOL, V2, P189, DOI 10.1111/j.1474-8673.1982.tb00489.x; Makam AN, 2017, CIRCULATION, V135, P180, DOI 10.1161/CIRCULATIONAHA.116.022622; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; O'Neill BT, 2019, DIABETES, V68, P556, DOI 10.2337/db18-0416; Orrenius S, 2015, BIOCHEM BIOPH RES CO, V460, P72, DOI 10.1016/j.bbrc.2015.01.137; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; RAJFER SI, 1990, CIRCULATION, V82, P97; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sahinturk V, 2020, LIFE SCI, V246, DOI 10.1016/j.lfs.2020.117416; Shi LL, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0177-4; Shuang T, 2018, BIOCHEM PHARMACOL, V149, P143, DOI 10.1016/j.bcp.2017.12.009; Sun WM, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0196-9; Sun YT, 2018, J CELL PHYSIOL, V233, P3066, DOI 10.1002/jcp.26087; Tang BL, 2006, NEUROBIOL AGING, V27, P501, DOI 10.1016/j.neurobiolaging.2005.02.001; TENNANT M, 1990, AUST NZ J SURG, V60, P747, DOI 10.1111/j.1445-2197.1990.tb07468.x; Wallace JL, 2015, ANTIOXID REDOX SIGN, V22, P398, DOI 10.1089/ars.2014.5901; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang YW, 2016, EXP CELL RES, V347, P184, DOI 10.1016/j.yexcr.2016.08.004; Wu YT, 2019, EUR J PHARMACOL, V853, P93, DOI 10.1016/j.ejphar.2019.03.021; Wu YS, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4196482; Yang BY, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12590; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420; Yang J, 2011, J AGR FOOD CHEM, V59, P11483, DOI 10.1021/jf2024819; Yao WD, 2008, BIOCHEM PHARMACOL, V75, P2055, DOI 10.1016/j.bcp.2008.01.018; Zeng CY, 2009, J HYPERTENS, V27, P1033, DOI 10.1097/HJH.0b013e3283293c7b; Zhang LX, 2021, J CELL MOL MED, V25, P8201, DOI 10.1111/jcmm.16688; Zhang M, 2012, STRUCTURE, V20, P911, DOI 10.1016/j.str.2012.03.019; Zhang YZ, 2019, AGING-US, V11, P1745, DOI 10.18632/aging.101866; Zhou DM, 2020, AGING-US, V12, P5352, DOI 10.18632/aging.102955; Zhu Q, 2015, J VASC RES, V52, P291, DOI 10.1159/000442980	60	6	6	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e22070	10.1096/fj.202101455R	http://dx.doi.org/10.1096/fj.202101455R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34859931	hybrid			2022-12-26	WOS:000734992000043
J	Abidi, SH; Aibekova, L; Davlidova, S; Amangeldiyeva, A; Foley, B; Ali, S				Abidi, Syed Hani; Aibekova, Lazzat; Davlidova, Salima; Amangeldiyeva, Aidana; Foley, Brian; Ali, Syed			Origin and evolution of HIV-1 subtype A6	PLOS ONE			English	Article							GENETIC DIVERSITY; TYPE-1 SUBTYPE; IDENTIFICATION; SEQUENCES; PHYLODYNAMICS; EPIDEMIC; RUSSIA	Background HIV outbreaks in the Former Soviet Union (FSU) countries were characterized by repeated transmission of the HIV variant AFSU, which is now classified as a distinct subtype A sub-subtype called A6. The current study used phylogenetic/phylodynamic and signature mutation analyses to determine likely evolutionary relationship between subtype A6 and other subtype A sub-subtypes. Methods For this study, an initial Maximum Likelihood phylogenetic analysis was performed using a total of 553 full-length, publicly available, reverse transcriptase sequences, from A1, A2, A3, A4, A5, and A6 sub-subtypes of subtype A. For phylogenetic clustering and signature mutation analysis, a total of 5961 and 3959 pol and env sequences, respectively, were used. Results Phylogenetic and signature mutation analysis showed that HIV-1 sub-subtype A6 likely originated from sub-subtype A1 of African origin. A6 and A1 pol and env genes shared several signature mutations that indicate genetic similarity between the two subtypes. For A6, tMRCA dated to 1975, 15 years later than that of A1. Conclusion The current study provides insights into the evolution and diversification of A6 in the backdrop of FSU countries and indicates that A6 in FSU countries evolved from A1 of African origin and is getting bridged outside the FSU region.	[Abidi, Syed Hani] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan; [Aibekova, Lazzat] Nazarbayev Univ, Sch Sci & Humanities, Dept Biol, Nur Sultan, Kazakhstan; [Davlidova, Salima; Amangeldiyeva, Aidana; Ali, Syed] Nazarbayev Univ, Sch Med, Dept Biomed Sci, Nur Sultan, Kazakhstan; [Foley, Brian] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM USA	Aga Khan University; Nazarbayev University; Nazarbayev University; United States Department of Energy (DOE); Los Alamos National Laboratory	Ali, S (corresponding author), Nazarbayev Univ, Sch Med, Dept Biomed Sci, Nur Sultan, Kazakhstan.	syed.ali@nu.edu.kz		Aibekova, Lazzat/0000-0002-5703-9219	Nazarbayev University [110119FD4516]; National Institute On Drug Abuse of the National Institutes of Health [R03DA052179]	Nazarbayev University; National Institute On Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	The study was funded by Nazarbayev University under the grant:110119FD4516, and by the National Institute On Drug Abuse of the National Institutes of Health under Award Number R03DA052179. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093415; Aibekova L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191891; Amangaldiyeva A, 2019, AIDS RES THER, V16, DOI 10.1186/s12981-019-0251-1; Aralaguppe SPG, 2016, AIDS RES HUM RETROV, V32, P503, DOI [10.1089/aid.2015.0208, 10.1089/AID.2015.0208]; Bervoets J., 2011, VESTNIK J RUSSIAN AS; Bobkov A, 2001, AIDS RES HUM RETROV, V17, P257, DOI 10.1089/088922201750063188; Bobkova M, 2013, AIDS REV, V15, P204; Desire N, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0461-y; Diez-Fuertes F, 2015, INFECT GENET EVOL, V33, P197, DOI 10.1016/j.meegid.2015.05.003; Frost SDW, 2010, PHILOS T R SOC B, V365, P1879, DOI 10.1098/rstb.2010.0060; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Jagdagsuren D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189605; Kirichenko A, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12080838; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Kousiappa I, 2009, AIDS RES HUM RETROV, V25, P23, DOI 10.1089/aid.2008.0168; Kousiappa I, 2009, AIDS RES HUM RETROV, V25, P727, DOI 10.1089/aid.2008.0239; LUKASHOV VV, 1995, AIDS, V9, P435, DOI 10.1097/00002030-199509050-00004; McCormick-Davis C, 2000, AIDS RES HUM RETROV, V16, P1089, DOI 10.1089/08892220050075363; Da Silva RKM, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13061093; Neogi U, 2012, AIDS RES HUM RETROV, V28, P952, DOI [10.1089/aid.2011.0380, 10.1089/AID.2011.0380]; Novitsky V, 2010, VIRUSES-BASEL, V2, P33, DOI 10.3390/v2010033; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Reinis M, 2001, AIDS RES HUM RETROV, V17, P1305, DOI 10.1089/088922201750461384; Riva C, 2008, AIDS RES HUM RETROV, V24, P1319, DOI 10.1089/aid.2008.0119; Salemi M, 2008, AIDS RES HUM RETROV, V24, P771, DOI 10.1089/aid.2007.0181; Shankarappa R, 2001, J VIROL, V75, P10479, DOI 10.1128/JVI.75.21.10479-10487.2001; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Thomson MM, 2007, AIDS RES HUM RETROV, V23, P1599, DOI 10.1089/aid.2007.0166; Tongo M, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey003; UNAIDS, UNAIDS DAT 2020 2020; Yilmaz G, 2006, INT J INFECT DIS, V10, P286, DOI 10.1016/j.ijid.2005.06.011	33	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0260604	10.1371/journal.pone.0260604	http://dx.doi.org/10.1371/journal.pone.0260604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898626	Green Published, gold			2022-12-26	WOS:000755176200014
J	Campbell, K; Cosenza, N; Meech, R; Buhnerkempe, M; Qin, J; Rybak, L; Fox, D				Campbell, Kathleen; Cosenza, Nicole; Meech, Robert; Buhnerkempe, Michael; Qin, Jun; Rybak, Leonard; Fox, Daniel			Preloaded D-methionine protects from steady state and impulse noise-induced hearing loss and induces long-term cochlear and endogenous antioxidant effects	PLOS ONE			English	Article							OXIDATIVE STRESS; ACOUSTIC TRAUMA; STEROID INJECTION; THRESHOLD SHIFT; GLUTATHIONE; PREVENTION; EXPOSURE; TINNITUS; DAMAGE	Objective Determine effective preloading timepoints for D-methionine (D-met) otoprotection from steady state or impulse noise and impact on cochlear and serum antioxidant measures. Design D-met started 2.0-, 2.5-, 3.0-, or 3.5- days before steady-state or impulse noise exposure with saline controls. Auditory brainstem response (ABRs) measured from 2 to 20 kHz at baseline and 21 days post-noise. Samples were then collected for serum (SOD, CAT, GR, GPx) and cochlear (GSH, GSSG) antioxidant levels. Study sample Ten Chinchillas per group. Results Preloading D-met significantly reduced ABR threshold shifts for both impulse and steady state noise exposures but with different optimal starting time points and with differences in antioxidant measures. For impulse noise exposure, the 2.0, 2.5, and 3.0 day preloading start provide significant threshold shift protection at all frequencies. Compared to the saline controls, serum GR for the 3.0 and 3.5 day preloading groups was significantly increased at 21 days with no significant increase in SOD, CAT or GPx for any impulse preloading time point. Cochlear GSH, GSSG, and GSH/GSSG ratio were not significantly different from saline controls at 21 days post noise exposure. For steady state noise exposure, significant threshold shift protection occurred at all frequencies for the 3.5, 3.0 and 2.5 day preloading start times but protection only occurred at 3 of the 6 test frequencies for the 2.0 day preloading start point. Compared to the saline controls, preloaded D-met steady-state noise groups demonstrated significantly higher serum SOD for the 2.5-3.5 day starting time points and GPx for the 2.5 day starting time but no significant increase in GR or CAT for any preloading time point. Compared to saline controls, D-met significantly increased cochlear GSH concentrations in the 2 and 2.5 day steady-state noise exposed groups but no significant differences in GSSG or the GSH/GSSG ratio were noted for any steady state noise-exposed group. Conclusions The optimal D-met preloading starting time window is earlier for steady state (3.5-2.5 days) than impulse noise (3.0-2.0). At 21 days post impulse noise, D-met increased serum GR for 2 preloading time points but not SOD, CAT, or GpX and not cochlear GSH, GSSG or the GSH/GSSG ratio. At 21 days post steady state noise D-met increased serum SOD and GPx at select preloading time points but not CAT or GR. However D-met did increase the cochlear GSH at select preloading time points but not GSSG or the GSH/GSSG ratio.	[Campbell, Kathleen; Cosenza, Nicole; Meech, Robert] Southern Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62026 USA; [Buhnerkempe, Michael] Southern Illinois Univ, Sch Med, Dept Internal Med, Stat, Springfield, IL USA; [Qin, Jun] Southern Illinois Univ, Dept Engn, Carbondale, IL USA; [Rybak, Leonard] Southern Illinois Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Springfield, IL USA; [Fox, Daniel] Springfield Clin, Dept Clin Res, Springfield, IL USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Campbell, K (corresponding author), Southern Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62026 USA.	kcampbell@siumed.edu						Alagic Z, 2011, ACTA OTO-LARYNGOL, V131, P802, DOI 10.3109/00016489.2011.564652; Alamgir H, 2016, MIL MED, V181, P301, DOI 10.7205/MILMED-D-14-00612; Alberti P. W., 1998, Noise Health, V1, P3; AXELSSON A, 1991, INT J PEDIATR OTORHI, V21, P143, DOI 10.1016/0165-5876(91)90145-2; Baker D. H., 1994, Amino acids in farm animal nutrition., P37; Blackwell DL., 2014, VITAL HLTH STT, V10; BOHNE BA, 1983, HEARING RES, V11, P41, DOI 10.1016/0378-5955(83)90044-8; Campbell K, 2011, HEARING RES, V282, P138, DOI 10.1016/j.heares.2011.08.003; Campbell Kathleen C M, 2003, J Am Acad Audiol, V14, P144; Campbell KCM, 2007, HEARING RES, V226, P92, DOI 10.1016/j.heares.2006.11.012; Chang YS, 2017, ACTA OTO-LARYNGOL, V137, P716, DOI 10.1080/00016489.2017.1280850; Cheng PW, 2008, EAR HEARING, V29, P65; Claussen AD, 2013, INT J AUDIOL, V52, P801, DOI 10.3109/14992027.2013.840933; Clifford RE, 2011, OTOLARYNG HEAD NECK, V145, P999, DOI 10.1177/0194599811414496; Fernandez-Checa JC, 1998, BIOFACTORS, V8, P7, DOI 10.1002/biof.5520080102; Grondin Y, 2013, HEARING RES, V298, P93, DOI 10.1016/j.heares.2012.12.011; Hamstra DA, 2010, CLIN CANCER RES, V16, P2666, DOI 10.1158/1078-0432.CCR-09-3318; HELLSTROM PA, 1992, BRIT J AUDIOL, V26, P267, DOI 10.3109/03005369209076646; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; HENDERSON D, 1995, OCCUP MED, V10, P513; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); Jacono AA, 1998, HEARING RES, V117, P31, DOI 10.1016/S0378-5955(97)00214-1; Kamerbeek NM, 2007, BLOOD, V109, P3560, DOI 10.1182/blood-2006-08-042531; Karkucinska-Wieckowska A, 2011, FOLIA NEUROPATHOL, V49, P56; Kopke RD, 2002, LARYNGOSCOPE, V112, P1515, DOI 10.1097/00005537-200209000-00001; Lang L., 1994, ENVIRON HEALTH PERSP, V102, DOI [10.1289/ehp.94102924, DOI 10.1289/EHP.94102924]; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837; Meredith MJ, 1998, BIOCHEM BIOPH RES CO, V248, P458, DOI 10.1006/bbrc.1998.8998; Metternich FU, 1999, LARYNGO RHINO OTOL, V78, P614; NIDCD, 2020, NAT I DEAFN COMM DIS; PRINTEN KJ, 1979, AM J CLIN NUTR, V32, P1200, DOI 10.1093/ajcn/32.6.1200; Qin J., 2014, POMA; Rabinowitz PM, 2000, AM FAM PHYSICIAN, V61, P2749; Rewerska A, 2013, EUR ARCH OTO-RHINO-L, V270, P1513, DOI 10.1007/s00405-012-2265-3; Rukmini M S, 2004, Indian J Clin Biochem, V19, P114, DOI 10.1007/BF02894268; Samson J, 2008, NEUROSCIENCE, V152, P146, DOI 10.1016/j.neuroscience.2007.11.015; Sechi G, 1996, PROG NEURO-PSYCHOPH, V20, P1159, DOI 10.1016/S0278-5846(96)00103-0; Segal S, 2003, Noise Health, V5, P13; Sha SH, 2000, HEARING RES, V142, P34, DOI 10.1016/S0378-5955(00)00003-4; Smith Andrew W., 1998, Noise Health, V1, P6; Suckfuell M, 2007, ACTA OTO-LARYNGOL, V127, P938, DOI 10.1080/00016480601110212; U.S. Department of Veterans Affairs, VET BEN ADM ANN BEN, P91; U.S. Department of Veterans Affairs Veterans Benefits Administration, 2012, ANN BEN REP FISC YEA; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Vuyyuri SB, 2008, CLIN CANCER RES, V14, P2161, DOI 10.1158/1078-0432.CCR-07-1954; Wang YR, 2019, J INT MED RES, V47, P3874, DOI 10.1177/0300060519860679; WOLGEMUTH KS, 1995, MIL MED, V160, P219, DOI 10.1093/milmed/160.5.219; Zhou YD, 2013, AUDIOL NEURO-OTOL, V18, P89, DOI 10.1159/000345208	49	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0261049	10.1371/journal.pone.0261049	http://dx.doi.org/10.1371/journal.pone.0261049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879107	Green Published, gold			2022-12-26	WOS:000754625200044
J	Fausett, S; Poullet, N; Gimond, C; Vielle, A; Bellone, M; Braendle, C				Fausett, Sarah; Poullet, Nausicaa; Gimond, Clotilde; Vielle, Anne; Bellone, Michele; Braendle, Christian			Germ cell apoptosis is critical to maintain Caenorhabditis elegans offspring viability in stressful environments	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; STEM-CELLS; C-ELEGANS; DAMAGE; ETHANOL; PATHWAY; LONGEVITY; RECEPTOR; CASPASE; OOCYTE	Maintaining reproduction in highly variable, often stressful, environments is an essential challenge for all organisms. Even transient exposure to mild environmental stress may directly damage germ cells or simply tax the physiology of an individual, making it difficult to produce quality gametes. In Caenorhabditis elegans, a large fraction of germ cells acts as nurse cells, supporting developing oocytes before eventually undergoing so-called physiological germ cell apoptosis. Although C. elegans apoptosis has been extensively studied, little is known about how germline apoptosis is influenced by ecologically relevant environmental stress. Moreover, it remains unclear to what extent germline apoptosis contributes to maintaining oocyte quality, and thus offspring viability, in such conditions. Here we show that exposure to diverse environmental stressors, likely occurring in the natural C. elegans habitat (starvation, ethanol, acid, and mild oxidative stress), increases germline apoptosis, consistent with previous reports on stress-induced apoptosis. Using loss-of-function mutant alleles of ced-3 and ced-4, we demonstrate that eliminating the core apoptotic machinery strongly reduces embryonic survival when mothers are exposed to such environmental stressors during early adult life. In contrast, mutations in ced-9 and egl-1 that primarily block apoptosis in the soma but not in the germline, did not exhibit such reduced embryonic survival under environmental stress. Therefore, C. elegans germ cell apoptosis plays an essential role in maintaining offspring fitness in adverse environments. Finally, we show that ced-3 and ced-4 mutants exhibit concomitant decreases in embryo size and changes in embryo shape when mothers are exposed to environmental stress. These observations may indicate inadequate oocyte provisioning due to the absence of germ cell apoptosis. Taken together, our results show that the central genes of the apoptosis pathway play a key role in maintaining gamete quality, and thus offspring fitness, under ecologically relevant environmental conditions.	[Fausett, Sarah; Poullet, Nausicaa; Gimond, Clotilde; Vielle, Anne; Bellone, Michele; Braendle, Christian] Univ Cote Azur, CNRS, INSERM, IBV, Nice, France; [Fausett, Sarah; Poullet, Nausicaa] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC USA; [Poullet, Nausicaa] INRAE, URZ, F-97170 Petit Bourg, Guadeloupe, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of North Carolina; University of North Carolina Wilmington; INRAE	Braendle, C (corresponding author), Univ Cote Azur, CNRS, INSERM, IBV, Nice, France.	braendle@unice.fr		Fausett, Sarah/0000-0003-2046-0226				Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Bailly A, 2013, ADV EXP MED BIOL, V757, P249, DOI 10.1007/978-1-4614-4015-4_9; BRENNER S, 1974, GENETICS, V77, P71; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Brys K, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-91; Carranza-Garcia E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218265; Chartier NT, 2021, NAT PHYS, V17, P920, DOI 10.1038/s41567-021-01235-x; Clarke E, 2017, GGBEESWARM CATEGORIC; Conradt Barbara, 2005, WormBook, P1; Dall KB, 2019, GENES NUTR, V14, DOI 10.1186/s12263-019-0650-x; Davis JR, 2008, ALCOHOL CLIN EXP RES, V32, P853, DOI 10.1111/j.1530-0277.2008.00639.x; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Frezal L, 2015, ELIFE, V4, DOI 10.7554/eLife.05849; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gartner Anton, 2008, WormBook, P1, DOI 10.1895/wormbook.1.145.1; Gimond C, 2019, GENETICS, V213, P615, DOI 10.1534/genetics.119.302462; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hartig F., 2022, DHARMA RESIDUAL DIAG; HARTMAN P, 1995, J GERONTOL A-BIOL, V50, pB322, DOI 10.1093/gerona/50A.6.B322; Heaton MB, 2002, NEUROSCI LETT, V334, P83, DOI 10.1016/S0304-3940(02)01123-0; Heidler T, 2010, BIOGERONTOLOGY, V11, P183, DOI 10.1007/s10522-009-9239-x; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Hubbard EJA, 2019, GENETICS, V213, P1145, DOI 10.1534/genetics.119.300238; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; King SD, 2019, CELL DEATH DIFFER, V26, P162, DOI 10.1038/s41418-018-0108-5; Kobara M., 2020, AGING, P11, DOI [10.1016/b978-0-12-818698-5.00002-x, DOI 10.1016/B978-0-12-818698-5.00002-X]; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lascarez-Lagunas LI, 2014, MOL CELL BIOL, V34, P2499, DOI 10.1128/MCB.01532-13; Lenth R., 2020, EMMEANS ESTIMATED MA, DOI DOI 10.1080/00031305.1980.10483031>.LICENSE; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu Y, 2011, P NATL ACAD SCI USA, V108, pE813, DOI 10.1073/pnas.1103218108; Luo SJ, 2010, CELL, V143, P299, DOI 10.1016/j.cell.2010.09.013; Mashimo K, 2006, ARCH TOXICOL, V80, P421, DOI 10.1007/s00204-006-0066-4; McArthur K, 2018, TRENDS CELL BIOL, V28, P475, DOI 10.1016/j.tcb.2018.02.003; Mishra N, 2018, GENETICS, V210, P983, DOI 10.1534/genetics.118.301500; Nadarajan S, 2009, DEVELOPMENT, V136, P2223, DOI 10.1242/dev.034603; Ow MC., 2019, 673764 BIORXIV, DOI [10.1101/673764, DOI 10.1101/673764]; Park D, 2006, DEVELOPMENT, V133, P4193, DOI 10.1242/dev.02614; Penkov S, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-0760-3; Pinan-Lucarre B, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001331; POULLET N., 2013, DEVELOPMENTAL PLASTI; Poullet N, 2015, EVOL DEV, V17, P380, DOI 10.1111/ede.12170; Putnam R.W., 2012, CELL PHYSL SOURCE BO, P303; R Core Team, 2020, R LANG ENV STAT COMP; Riddle D.L., 1997, GENETIC ENV REGULATI; Salinas LS, 2006, CELL DEATH DIFFER, V13, P2129, DOI 10.1038/sj.cdd.4401976; SCHEDL T, 1988, GENETICS, V119, P43; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Seidel HS., 2018, BIORXIV322487, DOI [10.1101/322487, DOI 10.1101/322487]; Smith SW, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0161-8; Stiernagle Theresa, 2006, WormBook, P1; Templeman NM, 2018, J CELL BIOL, V217, P93, DOI 10.1083/jcb.201707168; Tran AT, 2019, CELL DEATH DIFFER, V26, P2637, DOI 10.1038/s41418-019-0325-6; Vielle A, 2016, EVOLUTION, V70, P2485, DOI 10.1111/evo.13043; Wang JJ, 2017, TOXICOL RES-UK, V6, P412, DOI 10.1039/c7tx00046d; Weaver BP, 2020, DEV CELL, V53, P358, DOI 10.1016/j.devcel.2020.03.015; Weaver BP, 2017, DEV CELL, V41, P665, DOI 10.1016/j.devcel.2017.05.013; Weaver BP, 2014, ELIFE, V3, DOI 10.7554/eLife.04265; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolke U, 2007, DEVELOPMENT, V134, P2227, DOI 10.1242/dev.004952; Wood WB, 1988, NEMATODE CAENORHABDI; Yang KM, 2012, FEMS YEAST RES, V12, P675, DOI 10.1111/j.1567-1364.2012.00818.x; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	72	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2021	16	12							e0260573	10.1371/journal.pone.0260573	http://dx.doi.org/10.1371/journal.pone.0260573			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY2LS	34879088	gold, Green Published			2022-12-26	WOS:000754625200020
J	Burman, DD				Burman, Douglas D.			Topography of hippocampal connectivity with sensorimotor cortex revealed by optimizing smoothing kernel and voxel size	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; FUNCTIONAL CONNECTIVITY; LONG-AXIS; PSYCHOPHYSIOLOGICAL INTERACTIONS; PREFRONTAL CORTEX; RESTING-STATE; FMRI; ANTERIOR; MEMORY; ORGANIZATION	Studies of the hippocampus use smaller voxel sizes and smoothing kernels than cortical activation studies, typically using a multivoxel seed with specified radius for connectivity analysis. This study identified optimal processing parameters for evaluating hippocampal connectivity with sensorimotor cortex (SMC), comparing effectiveness by varying parameters during both activation and connectivity analysis. Using both 3mm and 4mm isovoxels, smoothing kernels of 0-10mm were evaluated on the amplitude and extent of motor activation and hippocampal connectivity with SMC. Psychophysiological interactions (PPI) identified hippocampal connectivity with SMC during volitional movements, and connectivity effects from multivoxel seeds were compared with alternate methods; a structural seed represented the mean connectivity map from all voxels within a region, whereas a functional seed represented the regional voxel with maximal SMC connectivity. With few exceptions, the same parameters were optimal for activation and connectivity. Larger isovoxels showed larger activation volumes in both SMC and the hippocampus; connectivity volumes from structural seeds were also larger, except from the posterior hippocampus. Regardless of voxel size, the 10mm smoothing kernel generated larger activation and connectivity volumes from structural seeds, as well as larger beta estimates at connectivity maxima; structural seeds also produced larger connectivity volumes than multivoxel seeds. Functional seeds showed lesser effects from voxel size and smoothing kernels. Optimal parameters revealed topography in structural seed connectivity along both the longitudinal axis and mediolateral axis of the hippocampus. These results indicate larger voxels and smoothing kernels can improve sensitivity for detecting both cortical activation and hippocampal connectivity.	[Burman, Douglas D.] NorthShore Univ Hlth Syst, Dept Radiol, Evanston, IL 60201 USA	NorthShore University Health System	Burman, DD (corresponding author), NorthShore Univ Hlth Syst, Dept Radiol, Evanston, IL 60201 USA.	DBurman2@northshore.org			Center for Advanced Imaging (CAI) at NorthShore University HealthSystem	Center for Advanced Imaging (CAI) at NorthShore University HealthSystem	The author wishes to thank the Center for Advanced Imaging (CAI) at NorthShore University HealthSystem for its administrative support.	Acton PD, 1998, EUR J NUCL MED, V25, P663; Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Ahmed-Leitao F, 2016, PSYCHIAT RES-NEUROIM, V256, P33, DOI 10.1016/j.pscychresns.2016.09.008; Alahmadi AAS, 2021, NEURORADIOLOGY, V63, P99, DOI 10.1007/s00234-020-02523-8; Ankudowich E, 2019, PSYCHOL AGING, V34, P251, DOI 10.1037/pag0000310; Beisteiner R, 2001, NEUROIMAGE, V13, P1016, DOI 10.1006/nimg.2000.0737; Blankenburg F, 2003, CEREB CORTEX, V13, P987, DOI 10.1093/cercor/13.9.987; Blankenship SL, 2017, HUM BRAIN MAPP, V38, P182, DOI 10.1002/hbm.23353; Brunec IK, 2018, CURR BIOL, V28, P2129, DOI 10.1016/j.cub.2018.05.016; Burman DD., 2018, HIPPOCAMPAL CONNECTI, DOI [10.1101/479436, DOI 10.1101/479436]; Burman DD, 2019, FUNCTIONAL MRI DATAS, DOI [10.25790/bml0cm.53, DOI 10.25790/BML0CM.53]; Burman DD, 2021, CREATING HIPPOCAMPAL, DOI [10.17504/protocols.io.byu6pwze, DOI 10.17504/PROTOCOLS.IO.BYU6PWZE]; Burman DD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222064; Burman DD, 2009, BRAIN IMAGING BEHAV, V3, P10, DOI 10.1007/s11682-008-9046-z; Chang JJ, 2019, NEUROBIOL STRESS, V11, DOI 10.1016/j.ynstr.2019.100195; Chao LL, 2014, PSYCHIAT RES-NEUROIM, V222, P119, DOI 10.1016/j.pscychresns.2014.03.005; Chen NK, 2003, NEUROIMAGE, V19, P817, DOI 10.1016/S1053-8119(03)00091-0; Chen ZK, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00015; Cohen MX., 2011, CURR BIOL, P21, DOI [10.1016/j.cub.2011.11.026, DOI 10.1016/J.CUB.2011.11.026]; Courtney SM, 1998, PHILOS T R SOC B, V353, P1819, DOI 10.1098/rstb.1998.0334; Danker JF, 2017, CEREB CORTEX, V27, P3515, DOI 10.1093/cercor/bhw146; de Lange FP, 2005, J COGNITIVE NEUROSCI, V17, P97, DOI 10.1162/0898929052880039; de Wael RV, 2018, P NATL ACAD SCI USA, V115, P10154, DOI 10.1073/pnas.1803667115; Eichenbaum H, 2017, NAT REV NEUROSCI, V18, P547, DOI 10.1038/nrn.2017.74; Erickson KI, 2012, NEUROSCIENTIST, V18, P82, DOI 10.1177/1073858410397054; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Forcato C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151381; Fotuhi M, 2012, NAT REV NEUROL, V8, P189, DOI 10.1038/nrneurol.2012.27; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Geng FJ, 2019, NEUROIMAGE, V195, P433, DOI 10.1016/j.neuroimage.2019.03.035; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Grady CL, 2003, HIPPOCAMPUS, V13, P572, DOI 10.1002/hipo.10114; Haneef Z, 2014, EPILEPSIA, V55, P137, DOI 10.1111/epi.12476; Hopfinger JB, 2000, NEUROIMAGE, V11, P326, DOI 10.1006/nimg.2000.0549; Hsieh LT, 2014, NEURON, V81, P1165, DOI 10.1016/j.neuron.2014.01.015; Kim H, 2015, HIPPOCAMPUS, V25, P500, DOI 10.1002/hipo.22387; Kleinschmidt A, 1997, EUR J NEUROSCI, V9, P2178, DOI 10.1111/j.1460-9568.1997.tb01384.x; KLEMM WR, 1982, NEUROSCI BIOBEHAV R, V6, P429, DOI 10.1016/0149-7634(82)90026-4; Kurth R, 1998, NEUROREPORT, V9, P207, DOI 10.1097/00001756-199801260-00006; Lech RK, 2014, BEHAV BRAIN RES, V268, P22, DOI 10.1016/j.bbr.2014.03.030; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Liu P, 2017, J NEUROSCI METH, V291, P1, DOI 10.1016/j.jneumeth.2017.08.003; Liu ZX, 2017, J NEUROSCI, V37, P599, DOI [10.1523/JNEUROSCI.2610-16.2017, 10.1523/JNEUROSCI.2610-16.2016]; Lotze M, 2000, NEUROIMAGE, V11, P473, DOI 10.1006/nimg.2000.0556; Malivoire BL, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1716-9; Mayes AR, 2019, HIPPOCAMPUS, V29, P46, DOI 10.1002/hipo.23031; Mikl M, 2008, MAGN RESON IMAGING, V26, P490, DOI 10.1016/j.mri.2007.08.006; Molloy EK, 2014, NEUROIMAGE, V86, P221, DOI 10.1016/j.neuroimage.2013.09.001; Murphy JE, 2020, NEUROSCI RES, V150, P51, DOI 10.1016/j.neures.2019.01.009; Nadel L, 2013, J COGNITIVE NEUROSCI, V25, P22, DOI 10.1162/jocn_a_00313; O'Reilly JX, 2012, SOC COGN AFFECT NEUR, V7, P604, DOI 10.1093/scan/nss055; Pajula J, 2014, MAGN RESON IMAGING, V32, P1114, DOI 10.1016/j.mri.2014.06.001; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; Poppenk J, 2013, TRENDS COGN SCI, V17, P230, DOI 10.1016/j.tics.2013.03.005; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Qin SZ, 2016, BRAIN STRUCT FUNCT, V221, P3237, DOI 10.1007/s00429-015-1098-4; Qin SZ, 2014, NAT NEUROSCI, V17, P1263, DOI 10.1038/nn.3788; Rigoli F, 2019, CORTEX, V115, P1, DOI 10.1016/j.cortex.2019.01.005; Robinson JL, 2015, HUM BRAIN MAPP, V36, P5018, DOI 10.1002/hbm.22987; Rombouts SARB, 2001, NEUROIMAGE, V14, P67, DOI 10.1006/nimg.2001.0799; SANES JN, 1995, SCIENCE, V268, P1775, DOI 10.1126/science.7792606; Selmeczy D, 2019, DEV COGN NEUROS-NETH, V36, DOI 10.1016/j.dcn.2018.10.003; Sheldon S, 2016, NEUROPSYCHOLOGIA, V90, P148, DOI 10.1016/j.neuropsychologia.2016.06.028; Smith APR, 2006, NEURON, V49, P631, DOI 10.1016/j.neuron.2005.12.025; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Sperling R, 2003, NEUROIMAGE, V20, P1400, DOI 10.1016/S1053-8119(03)00391-4; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Taylor WD, 2014, AM J GERIAT PSYCHIAT, V22, P1504, DOI 10.1016/j.jagp.2013.11.004; Thulborn KR, 1997, NMR BIOMED, V10, P183, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<183::AID-NBM469>3.0.CO;2-W; van Westen D, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-28; Wang L, 2010, NEUROIMAGE, V51, P910, DOI 10.1016/j.neuroimage.2010.02.046; Wang SF, 2016, NEUROBIOL LEARN MEM, V134, P123, DOI 10.1016/j.nlm.2016.01.005; Worsley KJ, 2005, NEUROIMAGE, V26, P635, DOI 10.1016/j.neuroimage.2005.02.007; Wu CWW, 2011, BRAIN CONNECT, V1, P401, DOI 10.1089/brain.2011.0018; Zartl M, 2014, BRAIN TOPOGR, V27, P228, DOI 10.1007/s10548-013-0289-7; Zeidman P, 2015, CORTEX, V73, P240, DOI 10.1016/j.cortex.2015.09.002; Zeidman P, 2015, CEREB CORTEX, V25, P3836, DOI 10.1093/cercor/bhu266	77	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260245	10.1371/journal.pone.0260245	http://dx.doi.org/10.1371/journal.pone.0260245			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874961	Green Submitted, Green Published, gold			2022-12-26	WOS:000753617500018
J	Liu, WH; Jiang, Y; Zhang, JY; Ma, ZQ				Liu, Wenhuan; Jiang, Yun; Zhang, Jingyao; Ma, Zeqi			RFARN: Retinal vessel segmentation based on reverse fusion attention residual network	PLOS ONE			English	Article							ADAPTIVE HISTOGRAM EQUALIZATION; BLOOD-VESSELS; COLOR IMAGES; NORMALIZATION; NET	Accurate segmentation of retinal vessels is critical to the mechanism, diagnosis, and treatment of many ocular pathologies. Due to the poor contrast and inhomogeneous background of fundus imaging and the complex structure of retinal fundus images, this makes accurate segmentation of blood vessels from retinal images still challenging. In this paper, we propose an effective framework for retinal vascular segmentation, which is innovative mainly in the retinal image pre-processing stage and segmentation stage. First, we perform image enhancement on three publicly available fundus datasets based on the multiscale retinex with color restoration (MSRCR) method, which effectively suppresses noise and highlights the vessel structure creating a good basis for the segmentation phase. The processed fundus images are then fed into an effective Reverse Fusion Attention Residual Network (RFARN) for training to achieve more accurate retinal vessel segmentation. In the RFARN, we use Reverse Channel Attention Module (RCAM) and Reverse Spatial Attention Module (RSAM) to highlight the shallow details of the channel and spatial dimensions. And RCAM and RSAM are used to achieve effective fusion of deep local features with shallow global features to ensure the continuity and integrity of the segmented vessels. In the experimental results for the DRIVE, STARE and CHASE datasets, the evaluation metrics were 0.9712, 0.9822 and 0.9780 for accuracy (Acc), 0.8788, 0.8874 and 0.8352 for sensitivity (Se), 0.9803, 0.9891 and 0.9890 for specificity (Sp), area under the ROC curve(AUC) was 0.9910, 0.9952 and 0.9904, and the F1-Score was 0.8453, 0.8707 and 0.8185. In comparison with existing retinal image segmentation methods, e.g. UNet, R2UNet, DUNet, HAnet, Sine-Net, FANet, etc., our method in three fundus datasets achieved better vessel segmentation performance and results.	[Liu, Wenhuan; Jiang, Yun; Zhang, Jingyao; Ma, Zeqi] Northwest Normal Univ, Coll Comp Sci & Engn, Lanzhou, Gansu, Peoples R China	Northwest Normal University - China	Liu, WH (corresponding author), Northwest Normal Univ, Coll Comp Sci & Engn, Lanzhou, Gansu, Peoples R China.	2019211769@nwnu.edu.cn		liu, wenhuan/0000-0003-4319-4506	National Natural Science Foundation of China [61962054, 61163036]; Gansu Provincial Science and Technology Program - Natural Science Foundation of China [1606RJZA047]; Northwest Normal University Major Research Project Incubation Program [nwnu-LKZD2021-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Gansu Provincial Science and Technology Program - Natural Science Foundation of China; Northwest Normal University Major Research Project Incubation Program	This work was supported in part by the National Natural Science Foundation of China (61962054), in part by the National Natural Science Foundation of China (61163036), in part by the 2016 Gansu Provincial Science and Technology Program (1606RJZA047) funded by the Natural Science Foundation of China, and in part by the 2021 Northwest Normal University Major Research Project Incubation Program (nwnu-LKZD2021-06).	Almazroa A, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/180972; Alom MZ, 2019, J MED IMAGING, V6, DOI 10.1117/1.JMI.6.1.014006; Atli I, 2021, ENG SCI TECHNOL, V24, P271, DOI 10.1016/j.jestch.2020.07.008; Azzopardi G, 2015, MED IMAGE ANAL, V19, P46, DOI 10.1016/j.media.2014.08.002; Boski M, 2017, 2017 10TH INTERNATIONAL WORKSHOP ON MULTIDIMENSIONAL (ND) SYSTEMS (NDS); Chen GN, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1263056; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; Chen SH, 2018, LECT NOTES COMPUT SC, V11213, P236, DOI 10.1007/978-3-030-01240-3_15; Dharmawan DA, 2019, IEEE ACCESS, V7, P41885, DOI 10.1109/ACCESS.2019.2906344; Feng ZW, 2017, IEEE IMAGE PROC, P1742; Franklin SW, 2014, BIOCYBERN BIOMED ENG, V34, P117, DOI 10.1016/j.bbe.2014.01.004; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P407, DOI 10.1016/j.cmpb.2012.03.009; Fu J, 2019, PROC CVPR IEEE, P3141, DOI 10.1109/CVPR.2019.00326; Hao SJ, 2020, NEUROCOMPUTING, V406, P302, DOI 10.1016/j.neucom.2019.11.118; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Hu K, 2018, NEUROCOMPUTING, V309, P179, DOI 10.1016/j.neucom.2018.05.011; Huang ZH, 2021, SCI PROGRAMMING-NETH, V2021, DOI 10.1155/2021/5520407; Ioffe S., 2015, P 32 INT C INT C MAC, P448, DOI [10.5555/3045118.3045167, DOI 10.5555/3045118.3045167]; Jain A, 2005, PATTERN RECOGN, V38, P2270, DOI 10.1016/j.patcog.2005.01.012; Jainish GR, 2020, MULTIMED TOOLS APPL, V79, P22337, DOI 10.1007/s11042-020-08958-8; Jiang Y, 2021, SYMMETRY-BASEL, V13, DOI 10.3390/sym13030365; Jin QG, 2019, KNOWL-BASED SYST, V178, P149, DOI 10.1016/j.knosys.2019.04.025; Jobson DJ, 1997, IEEE T IMAGE PROCESS, V6, P965, DOI 10.1109/83.597272; Jonas JB, 2000, INVEST OPHTH VIS SCI, V41, P1764; Khan KB, 2019, PATTERN ANAL APPL, V22, P767, DOI 10.1007/s10044-018-0754-8; Khan KB, 2017, J INF SCI ENG, V33, P1611, DOI 10.6688/JISE.2017.33.6.14; Khawaja A, 2019, IEEE ACCESS, V7, P164344, DOI 10.1109/ACCESS.2019.2953259; King DB, 2015, ACS SYM SER, V1214, P1; Kundu A, 2012, PROC INT CONF EMERG, P316, DOI 10.1109/EAIT.2012.6407935; LAND EH, 1977, SCI AM, V237, P108, DOI 10.1038/scientificamerican1277-108; Liskowski P, 2016, IEEE T MED IMAGING, V35, P2369, DOI 10.1109/TMI.2016.2546227; Long J., 2015, P IEEE C COMP VIS PA, P3431, DOI DOI 10.1109/CVPR.2015.7298965; Loshchilov I., 2017, ARXIV171105101; Miao YC, 2015, 2015 8TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND INFORMATICS (BMEI), P62, DOI 10.1109/BMEI.2015.7401474; Minhaj A., 2018, TRANSLATIONAL VISION, V7, P23, DOI [10.1167/tvst.7.2.23, DOI 10.1167/TVST.7.2.23]; Owen CG, 2009, INVEST OPHTH VIS SCI, V50, P2004, DOI 10.1167/iovs.08-3018; Palomera-Perez MA, 2010, IEEE T INF TECHNOL B, V14, P500, DOI 10.1109/TITB.2009.2036604; Pang YW, 2019, IEEE I CONF COMP VIS, P4229, DOI 10.1109/ICCV.2019.00433; Payette B., 2002, COLOR SPACE CONVERTE; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; Reza AM, 2004, J VLSI SIG PROC SYST, V38, P35, DOI 10.1023/B:VLSI.0000028532.53893.82; Ronneberger O., 2015, P MICCAI MUN GERM 5, P234, DOI DOI 10.1007/978-3-319-24574-4_28; Shahsayari S, 2020, INT J RADIAT BIOL, V96, P502, DOI 10.1080/09553002.2020.1704906; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Soomro TA, 2018, IEEE ACCESS, V6, P3524, DOI 10.1109/ACCESS.2018.2794463; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Tian C, 2020, BIOCYBERN BIOMED ENG, V40, P583, DOI 10.1016/j.bbe.2020.01.011; Tomar, 2021, ARXIV PREPRINT ARXIV; Wang DY, 2020, IEEE J BIOMED HEALTH, V24, P3384, DOI 10.1109/JBHI.2020.3002985; Xue Ke, 2020, 2020 IEEE 5th International Conference on Image, Vision and Computing (ICIVC), P59, DOI 10.1109/ICIVC50857.2020.9177454; Zhang HG, 2019, PROC CVPR IEEE, P5971, DOI 10.1109/CVPR.2019.00613; Zhuang J.T., 2018, ARXIV PREPRINT ARXIV	53	1	1	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0257256	10.1371/journal.pone.0257256	http://dx.doi.org/10.1371/journal.pone.0257256			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY3JJ	34860847	gold, Green Published			2022-12-26	WOS:000754686900002
J	Marchant, E; Todd, C; James, M; Crick, T; Dwyer, R; Brophy, S				Marchant, Emily; Todd, Charlotte; James, Michaela; Crick, Tom; Dwyer, Russell; Brophy, Sinead			Primary school staff perspectives of school closures due to COVID-19, experiences of schools reopening and recommendations for the future: A qualitative survey in Wales	PLOS ONE			English	Article							HEALTH-CARE	School closures due to the COVID-19 global pandemic are likely to have a range of negative consequences spanning the domains of child development, education and health, in addition to the widening of inequalities and inequities. Research is required to improve understanding of the impact of school closures on the education, health and wellbeing of pupils and school staff, the challenges posed during face-to-face reopening and importantly to identify how the impacts of these challenges can be addressed going forward to inform emerging policy and practice. This qualitative study aimed to reflect on the perspectives and experiences of primary school staff (pupils aged 3-11) in Wales regarding school closures and the initial face-to-face reopening of schools and to identify recommendations for the future. A total of 208 school staff completed a national online survey through the HAPPEN primary school network, consisting of questions about school closures (March to June 2020), the phased face-to-face reopening of schools (June to July 2020) and a return to face-to-face education. Thematic analysis of survey responses highlighted that primary school staff perceive that gaps in learning, health and wellbeing have increased and inequalities have widened during school closures. Findings from this study identified five recommendations; (i) prioritise the health and wellbeing of pupils and staff; (ii) focus on enabling parental engagement and support; (iii) improve digital competence amongst pupils, teachers and parents; (iv) consider opportunities for smaller class sizes and additional staffing; and (v) improve the mechanism of communication between schools and families, and between government and schools.	[Marchant, Emily; Todd, Charlotte; James, Michaela; Brophy, Sinead] Swansea Univ, Fac Med Hlth & Life Sci, Med Sch, Swansea, W Glam, Wales; [Crick, Tom] Swansea Univ, Fac Humanities & Social Sci, Dept Educ & Childhood Studies, Swansea, W Glam, Wales; [Dwyer, Russell] St Thomas Community Primary Sch, Swansea, W Glam, Wales	Swansea University; Swansea University	Marchant, E (corresponding author), Swansea Univ, Fac Med Hlth & Life Sci, Med Sch, Swansea, W Glam, Wales.	E.K.Marchant@swansea.ac.uk	Crick, Tom/C-8481-2011; Marchant, Emily/AAC-4917-2022	Crick, Tom/0000-0001-5196-9389; Marchant, Emily/0000-0002-9701-5991; Brophy, Sinead/0000-0001-7417-2858	National Centre for Population Health and Wellbeing Research; Economic and Social Research Council (ESRC) [ES/J500197/1]	National Centre for Population Health and Wellbeing Research; Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the National Centre for Population Health and Wellbeing Research (https://ncphwr.org.uk/).The Economic and Social Research Council (ESRC) funded the development of the HAPPEN network (grant number: ES/J500197/1; EM was the recipient) which this research was conducted through.	Albudaiwi D., 2017, SAGE RES METHODS, DOI [10.1016/j.ymeth.2016.12.015, DOI 10.1016/J.YMETH.2016.12.015]; [Anonymous], 1986, J THOUGHT; Armitage R, 2020, LANCET GLOB HEALTH, V8, pE644, DOI 10.1016/S2214-109X(20)30116-9; Azevedo JP., 2020, SIMULATING POTENTIAL; Baranne ML, 2018, CHILD ADOL PSYCH MEN, V12, DOI 10.1186/s13034-018-0225-4; Becker SP, 2020, J CHILD PSYCHOL PSYC, V61, P757, DOI 10.1111/jcpp.13278; Benzeval M, 2020, UNDERSTANDING SOC CO; Blasko Z., 2020, ED INEQUALITIES EURO; Blundell R., 2020, COVID 19 IN; Bonal X, 2020, INT REV EDUC, V66, P635, DOI 10.1007/s11159-020-09860-z; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Briner R, 2007, WORKLIFE SUPPORT; Brossard M, 2020, PARENTAL ENGAGEMENT; Burnard P, 1991, Nurse Educ Today, V11, P461, DOI 10.1016/0260-6917(91)90009-Y; Chapman AL, 2015, J ROY COLL PHYS EDIN, V45, P201, DOI 10.4997/JRCPE.2015.305; Children's Commissioner for Wales, 2020, COR ME; Christian D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1557-0; Chun Tie Y, 2019, SAGE OPEN MED, V7, DOI 10.1177/2050312118822927; Cohen DJ, 2008, ANN FAM MED, V6, P331, DOI 10.1370/afm.818; Collie B.., 2020, COVID 19 S IMPACT AU; Cortis D, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00202; Crick T., 2021, ITNOW, V63, P16, DOI [10.1093/itnow/bwab005, DOI 10.1093/ITNOW/BWAB005]; Crick T., 2020, COVID 19 CATALYST RE; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Department for Education, 2021, NEW ED REC PACK CHIL; Devitt A, 2020, PARENT PERSPECTIVES; Dorn E., 2020, COVID 19 STUDENT LEA; Education Endowment Foundation, 2020, BEST EV SUPP STUD LE; Feinstein L, 2006, P COP S; HAPPEN Wales, 2020, EARL FIND HAPPEN HOM; Harris A, 2020, SCH LEADERSH MANAG, V40, P243, DOI 10.1080/13632434.2020.1811479; Hoffman JA, 2020, WORLD MED HEALTH POL, V12, P300, DOI 10.1002/wmh3.365; Ilie S, 2017, BRIT EDUC RES J, V43, P253, DOI 10.1002/berj.3260; James M., 2021, IMPACT SCH CLOSURES, DOI [10.1136/bmjopen-2021-051574, DOI 10.1136/BMJOPEN-2021-051574]; Kelly Y, 2011, ARCH DIS CHILD, V96, P832, DOI 10.1136/adc.2010.195917; Lee J, 2020, LANCET CHILD ADOLESC, V4, P421, DOI 10.1016/S2352-4642(20)30109-7; Lewis SJ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n521; Loades ME, 2020, J AM ACAD CHILD PSY, V59, P1218, DOI 10.1016/j.jaac.2020.05.009; Lorenc A, 2020, BACK SCH STUDY FINAL; Lucas PJ, 2021, DATA POVERTY SCOTLAN; Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1525, DOI 10.1111/apa.15371; Marchant E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212242; Moore SA, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-00987-8; Nagata JM, 2020, OBESITY, V28, P1582, DOI 10.1002/oby.22917; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Pearcey S, 2020, REPORT 04 CHANGES CH; Reimers F.M., 2020, FRAMEWORK GUIDE ED R; Roffey S., 2012, ED CHILD PSYCHOL, V29, P8; Roland D., 2020, BMJ-BRIT MED J; Sadique MZ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-135; SAGE, 2004, SAGE ENCY SOCIAL SCI, DOI [10.4135/9781412950589.n550, DOI 10.4135/9781412950589.N550]; SAGE, 2019, THEM AN SURV RESP UN; Scottish Government, 2020, MIGR HELP SCOTL PROS; Sharp C., 2020, CAMBRIDGE HDB PERSON; Siegel Angela A., 2021, ITiCSE '21: Proceedings of the 26th Conference on Innovation and Technology in Computer Science Education, P597, DOI 10.1145/3456565.3461439; Sport England, 2020, OTH WAYS GEN FUND; Strauss A. L, 1994, HDB QUALITATIVE RES, V1st, P273, DOI DOI 10.1007/BF00988593; Sun KY, 2020, LANCET DIGIT HEALTH, V2, pE201, DOI 10.1016/S2589-7500(20)30026-1; Sundaram N, 2021, HEALTH EDUC RES, V36, P272, DOI 10.1093/her/cyab016; The Delve Initiative, 2020, 4 DELVE; Todd C, 2016, PERSPECT PUBLIC HEAL, V136, P115, DOI 10.1177/1757913916638231; UNESCO, 2020, PORTH ARTH DEP ENV W; UNESCO Chair Global Health and Education, 2020, PREV SURV SCH REOP U; UNICEF UK, 2020, RET SCH SURV; United Nations Children's Fund (UNICEF) World Health Organization International Bank for Reconstruction and Development & The World Bank, 2020, RISK COMMUNICATION E; Van Lancker W, 2020, LANCET PUBLIC HEALTH, V5, pE243, DOI 10.1016/S2468-2667(20)30084-0; Vindrola-Padros C, 2020, QUAL HEALTH RES, V30, P2192, DOI 10.1177/1049732320951526; Viner RM, 2021, JAMA PEDIATR, V175, P143, DOI 10.1001/jamapediatrics.2020.4573; Viner RM, 2021, ARCH DIS CHILD, V106, P111, DOI 10.1136/archdischild-2020-319963; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Vizard T., 2020, NHS DIGITAL; Watermeyer R, 2021, BRIT J SOCIOL EDUC, V42, P651, DOI 10.1080/01425692.2021.1937058; Watermeyer R, 2021, HIGH EDUC, V81, P623, DOI 10.1007/s10734-020-00561-y; Weale S., 2020, GUARDIAN; Welsh, 2020, ADD LEARN NEEDS TRAN; Welsh Government, 2018, BREX OUR LAND SEC FU	76	5	5	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260396	10.1371/journal.pone.0260396	http://dx.doi.org/10.1371/journal.pone.0260396			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855789	Green Published, gold			2022-12-26	WOS:000735299000052
J	Srivastava, A; Singh, GP; Srivastava, PC				Srivastava, Anjana; Singh, Gajan Pal; Srivastava, Prakash Chandra			Method validation for determination of nine pesticides in okra and their mitigation using different solutions	PLOS ONE			English	Article							RESIDUES; DECONTAMINATION; CUTICLES; REMOVAL	In this paper we optimized QuEChERS method for extraction of nine pesticides viz. acephate, acetamiprid, chlorpyrifos, cypermethrin, imidacloprid, thiamethoxam, profenofos (insecticides), carbendazim and tebuconazole (fungicides) and performed their quantitative estimation in okra crop by HPLC-UV and GC-ECD. Decontamination treatments namely washing with running tap water, soaking in lukewarm water (50-60 degrees C), soaking in solutions of 1% NaCl, 5% NaHCO3, 2% CH3COOH, 0.01% KMnO4 and three commercial formulations were also done for ten minutes every time, to calculate the extent of pesticide removal from okra. Results revealed that the proposed extraction method was efficient, inexpensive, accurate, rapid and precise and can suitably be used for the simultaneous quantitative determination of the above pesticides. The standard curve was linear over the concentration range of 0.05-5 mu g g(-1) with R-2 close to one (0.999). Soaking of okra in 2% acetic acid and then washing proved as the best decontamination treatments for all the pesticides. It showed the highest relative decontaminating capacity in comparison to the other solutions tested. Since the pesticide residues are usually present in higher amount in vegetables being consumed, it is of utmost importance to keep an eye over the use of pesticides to protect the crops.	[Srivastava, Anjana; Singh, Gajan Pal] Govind Ballabh Pant Univ Agr & Technol, Coll Basic Sci & Humanities, Dept Chem, Us Nagar, Uttarakhand, India; [Srivastava, Prakash Chandra] Govind Ballabh Pant Univ Agr & Technol, Coll Agr, Dept Soil Sci, Us Nagar, Uttarakhand, India	Govind Ballabh Pant University of Agriculture Technology; Govind Ballabh Pant University of Agriculture Technology	Srivastava, A (corresponding author), Govind Ballabh Pant Univ Agr & Technol, Coll Basic Sci & Humanities, Dept Chem, Us Nagar, Uttarakhand, India.	anj612003@gmail.com			All India Network Project (AINP) on Pesticide Residue Analysis, Indian Council of Agricultural Research, New Delhi [AINP/25]	All India Network Project (AINP) on Pesticide Residue Analysis, Indian Council of Agricultural Research, New Delhi	This study was financed by the Coordinator, All India Network Project (AINP) on Pesticide Residue Analysis, Indian Council of Agricultural Research, New Delhi vide grant no AINP/25 dated 21.5.2020 awarded to Anjana Srivastava. The funds provided for financial assistance were very limited and were only enough to conduct the studies. A letter informing these facts has already been submitted earlier. Due to lack of funds available for meeting the expenses of publication the authors request the Editor, PLOS One to kindly provide a complete waiver of publication fee for the research article.	Anastassiades M, 2003, J AOAC INT, V86, P412; Awata BG., 1984, PESTOLOGY, V8, P14; Begum A., 2016, INT J AGRON AGR RES, V9, P24; Bhilwadikar T, 2019, COMPR REV FOOD SCI F, V18, P1003, DOI 10.1111/1541-4337.12453; Chauhan SS., 2013, WUD J AGR RES, V1, P250; Craddock HA, 2019, ENVIRON HEALTH-GLOB, V18, DOI 10.1186/s12940-018-0441-7; Fatih CM, 2012, GIDA, V10, P69; Gajbhiye V., 1985, PESTOLOGY, V9, P13; Gouri Satpathy, 2012, Journal of Agricultural Science (Toronto), V4, P69; Gupta A., 1988, PEST RES J, V10, P86; HEREDIA A, 1991, BIOCHIM BIOPHYS ACTA, V1062, P239, DOI 10.1016/0005-2736(91)90398-R; Kelagiri SS., 2017, J ENTOMOL ZOOL STUD, V5, P1966; Lopez-Fernandez O, 2013, FOOD CONTROL, V34, P530, DOI 10.1016/j.foodcont.2013.05.022; Paranthaman R., 2012, American Journal of Biochemistry and Biotechnology, V8, P1, DOI 10.3844/ajbbsp.2012.1.6; Srivastava A., 2021, PESTOLOGY, V45, P36; Tang HPO, 2013, TRAC-TREND ANAL CHEM, V45, P48, DOI 10.1016/j.trac.2013.01.005; TYREE MT, 1991, PLANT PHYSIOL, V97, P273, DOI 10.1104/pp.97.1.273; Vemuri SB., 2015, SCHOLARS J AGR VET S, V2, P27; Yang TX, 2017, J AGR FOOD CHEM, V65, P9744, DOI 10.1021/acs.jafc.7b03118	19	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260851	10.1371/journal.pone.0260851	http://dx.doi.org/10.1371/journal.pone.0260851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855881	Green Published, gold			2022-12-26	WOS:000735299000139
J	Xia, Y; Zhang, XX; Jiang, MX; Zhang, HB; Wang, YF; Zhang, YY; Seviour, R; Kong, YH				Xia, Yun; Zhang, Xuxiang; Jiang, Mingxin; Zhang, Hongbo; Wang, Yinfeng; Zhang, Yuyu; Seviour, Robert; Kong, Yunhong			In vitro co-metabolism of epigallocatechin-3-gallate (EGCG) by the mucin-degrading bacterium Akkermansia muciniphila	PLOS ONE			English	Article							GUT MICROBIOTA; DIETARY POLYPHENOLS; GROWTH; FIBER; TEA; POPULATION; RESISTANCE; DYSBIOSIS; OBESITY; IMPACT	Akkermansia muciniphila is a Gram-negative bacterium that resides within the gut mucus layer, and plays an important role in promoting gut barrier integrity, modulating the immune response and inhibiting gut inflammation. Growth stimulation of A. muciniphila by polyphenols including epigallocatechin-3-gallate (EGCG) from difference sources is well-documented. However, no published in vitro culture data on utilization of polyphenols by A. muciniphila are available, and the mechanism of growth-stimulating prebiotic effect of polyphenols on it remains unclear. Here in vitro culture studies have been carried out on the metabolism of EGCG by A. muciniphila in the presence of either mucin or glucose. We found that A. muciniphila did not metabolize EGCG alone but could co-metabolize it together with both these substrates in the presence of mineral salts and amino acids for mucin and protein sources for glucose. Our metabolomic data show that A. muciniphila converts EGCG to gallic acid, epigallocatechin, and (-)-epicatechin through ester hydrolysis. The (-)-epicatechin formed is then further converted to hydroxyhydroquinone. Co-metabolism of A. muciniphila of EGCG together with either mucin or glucose promoted substantially its growth, which serves as a further demonstration of the growth-promoting effect of polyphenols on A. muciniphila and provides an important addition to the currently available proposed mechanisms of polyphenolic prebiotic effects on A. muciniphila.	[Xia, Yun; Jiang, Mingxin; Zhang, Hongbo; Wang, Yinfeng; Zhang, Yuyu] Kunming Univ, Sch Agr & Life Sci, Kunming, Yunnan, Peoples R China; [Zhang, Xuxiang] Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Seviour, Robert] La Trobe Univ, Microbiol Dept, Bundoora, Vic, Australia; [Kong, Yunhong] Kunming Univ, Dianchi Lake Environm Protect Collaborat Res Ctr, Kunming, Yunnan, Peoples R China	Kunming University; Kunming Medical University; La Trobe University; Kunming University	Xia, Y (corresponding author), Kunming Univ, Sch Agr & Life Sci, Kunming, Yunnan, Peoples R China.; Kong, YH (corresponding author), Kunming Univ, Dianchi Lake Environm Protect Collaborat Res Ctr, Kunming, Yunnan, Peoples R China.	xiayun22@hotmail.com; kongyunhong@hotmail.com		seviour, robert/0000-0002-1366-0484	National Natural Science Foundation of China [31860029, 31760178]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Yes, this study was financially supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn) (Research grants 31860029 and 31760178 to Yunhong Kong and Yun Xia respectively). Both Y. Kong and Y. Xia are key members of this project contributing to the study design, data collection and analysis, preparation of the manuscript. The founder had no role in study design, data collection and analysis, decision on publish, or preparation of the manuscript.	Anhe FF, 2016, GUT MICROBES, V7, P146, DOI 10.1080/19490976.2016.1142036; Anhe FF, 2015, CURR OBES REP, V4, P389, DOI 10.1007/s13679-015-0172-9; Anhe FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142; Becken B, 2021, MBIO, V12, DOI 10.1128/mBio.00478-21; Cani PD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01765; Chang YF, 2020, INT J BIOL MACROMOL, V159, P373, DOI 10.1016/j.ijbiomac.2020.05.055; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Crittenden R, 2002, J SCI FOOD AGR, V82, P781, DOI 10.1002/jsfa.1095; Delaney ML, 1997, J CLIN MICROBIOL, V35, P558, DOI 10.1128/JCM.35.3.558-562.1997; Derosa L, 2020, EUR UROL, V78, P195, DOI 10.1016/j.eururo.2020.04.044; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Derrien M, 2017, MICROB PATHOGENESIS, V106, P171, DOI 10.1016/j.micpath.2016.02.005; Dey P, 2020, J NUTR BIOCHEM, V84, DOI 10.1016/j.jnutbio.2020.108455; Earley H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51878-3; Edwards CA, 2017, NUTR BULL, V42, P356, DOI 10.1111/nbu.12296; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Grajeda-Iglesias C, 2021, AGING-US, V13, P6375, DOI 10.18632/aging.202739; Guo XF, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4195-3; Haug K, 2020, NUCLEIC ACIDS RES, V48, pD440, DOI 10.1093/nar/gkz1019; Isnard S, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa338; Kemperman RA, 2013, FOOD RES INT, V53, P659, DOI 10.1016/j.foodres.2013.01.034; Kirmiz N, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.02117-19; Kong YH, 2010, APPL ENVIRON MICROB, V76, P6933, DOI 10.1128/AEM.00217-10; Kosciow K, 2020, INT J BIOL MACROMOL, V149, P331, DOI 10.1016/j.ijbiomac.2020.01.246; Lattimer JM, 2010, NUTRIENTS, V2, P1266, DOI 10.3390/nu2121266; Li C, 2000, CHEM RES TOXICOL, V13, P177, DOI 10.1021/tx9901837; Liu XX, 2020, J FUNCT FOODS, V75, DOI 10.1016/j.jff.2020.104261; Loo YT, 2020, COMPR REV FOOD SCI F, V19, P1268, DOI 10.1111/1541-4337.12563; Macchione IG, 2019, EUR REV MED PHARMACO, V23, P8075, DOI 10.26355/eurrev_201909_19024; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; MILLER RS, 1981, GASTROENTEROLOGY, V81, P759; Ouyang J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00645; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Roopchand DE, 2015, DIABETES, V64, P2847, DOI 10.2337/db14-1916; Rothwell JA, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat070; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Sheng LL, 2018, FASEB J, V32, P6371, DOI 10.1096/fj.201800370R; STAMS AJM, 1993, APPL ENVIRON MICROB, V59, P1114, DOI 10.1128/AEM.59.4.1114-1119.1993; Tzounis X, 2008, BRIT J NUTR, V99, P782, DOI 10.1017/S0007114507853384; Unno K, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700294; Ushiroda C, 2019, J CLIN BIOCHEM NUTR, V65, P34, DOI 10.3164/jcbn.18-116; Van den Berg FF, 2021, BJS OPEN, V5, DOI 10.1093/bjsopen/zrab061; Van Hul M, 2019, CURR NUTR REP, V8, P307, DOI 10.1007/s13668-019-00281-5; van Passel MWJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016876; Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803; Xia Y, 2019, APPL MICROBIOL BIOT, V103, P1823, DOI 10.1007/s00253-018-09581-2; Xing LJ, 2019, J AGR FOOD CHEM, V67, P1029, DOI 10.1021/acs.jafc.8b06146; Yang QQ, 2020, CRIT REV FOOD SCI, V60, P1243, DOI 10.1080/10408398.2019.1565490; Zhang NN, 2018, MOLECULES, V23, DOI 10.3390/molecules23092188	51	1	1	12	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260757	10.1371/journal.pone.0260757	http://dx.doi.org/10.1371/journal.pone.0260757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855864	Green Published, gold			2022-12-26	WOS:000735299000113
J	DeDreu, J; Pal-Ghosh, S; Mattapallil, MJ; Caspi, RR; Stepp, MA; Menko, AS				DeDreu, JodiRae; Pal-Ghosh, Sonali; Mattapallil, Mary J.; Caspi, Rachel R.; Stepp, Mary Ann; Menko, A. Sue			Uveitis-mediated immune cell invasion through the extracellular matrix of the lens capsule	FASEB JOURNAL			English	Article						basement membrane; immune cell attachment; immune cell infiltration; immune cell migration; immune privilege; inflammation; lens; matrix; uveitic	BLOOD-RETINAL BARRIER; TRABECULAR MESHWORK; CATARACT; ANGIOGENESIS; HUMOR; EYE; COMPLICATIONS; UVEORETINITIS; RESPONSES; PROTEINS	While the eye is considered an immune privileged site, its privilege is abrogated when immune cells are recruited from the surrounding vasculature in response to trauma, infection, aging, and autoimmune diseases like uveitis. Here, we investigate whether in uveitis immune cells become associated with the lens capsule and compromise its privilege in studies of C57BL/6J mice with experimental autoimmune uveitis. These studies show that at D14, the peak of uveitis in these mice, T cells, macrophages, and Ly6G/Ly6C+ immune cells associate with the lens basement membrane capsule, burrow into the capsule matrix, and remain integrated with the capsule as immune resolution is occurring at D26. 3D surface rendering image analytics of confocal z-stacks and scanning electron microscopy imaging of the lens surface show the degradation of the lens capsule as these lens-associated immune cells integrate with and invade the lens capsule, with a subset infiltrating both epithelial and fiber cell regions of lens tissue, abrogating its immune privilege. Those immune cells that remain on the surface often become entwined with a fibrillar net-like structure. Immune cell invasion of the lens capsule in uveitis has not been described previously and may play a role in induction of lens and other eye pathologies associated with autoimmunity.	[DeDreu, JodiRae; Menko, A. Sue] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Pal-Ghosh, Sonali; Stepp, Mary Ann] George Washington Univ, Sch Med & Hlth Sci, Dept Anat & Cell Biol, Washington, DC 20052 USA; [Mattapallil, Mary J.; Caspi, Rachel R.] NEI, Lab Immunol, NIH, Bethesda, MD 20892 USA; [Stepp, Mary Ann] George Washington Univ, Sch Med & Hlth Sci, Dept Ophthalmol, Washington, DC 20052 USA; [Menko, A. Sue] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Ophthalmol, Philadelphia, PA 19107 USA	Jefferson University; George Washington University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); George Washington University; Jefferson University	Menko, AS (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 564 Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.; Menko, AS (corresponding author), Thomas Jefferson Univ, Wills Vis Res Ctr Jefferson, 564 Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.	sue.menko@jefferson.edu		Mattapallil, Mary/0000-0003-0615-7343; Menko, A. Sue/0000-0002-7514-4696; Stepp, Mary Ann/0000-0001-5623-2538	National Institute of Health, National Eye Institute [EY021784]	National Institute of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a grant from the National Institute of I lealth, National Eye Institute, EY021784 to ASM and MAS. Scanning Electron Microscopy was done at the GWU Nanofabrication and Imaging Center directed by Anastas Popratiloff.	Agarwal RK, 2004, METH MOLEC MED, V102, P395; Bajwa A, 2015, CLIN OPHTHALMOL, V9, P889, DOI 10.2147/OPTH.S80972; Bednarczyk M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041402; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; Blum-Hareuveni T, 2017, AM J OPHTHALMOL, V177, P139, DOI 10.1016/j.ajo.2017.02.023; Bos KJ, 2001, J MOL BIOL, V306, P1011, DOI 10.1006/jmbi.2000.4429; Burkholder BM, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4979; Carreon T, 2017, PROG RETIN EYE RES, V57, P108, DOI 10.1016/j.preteyeres.2016.12.004; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Caspi Rachel R, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1506s53; CHAN CC, 1990, J AUTOIMMUN, V3, P247, DOI 10.1016/0896-8411(90)90144-H; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072161; Chen L, 2008, INVEST OPHTH VIS SCI, V49, P4476, DOI 10.1167/iovs.08-1971; Chen M, 2018, AM J PATHOL, V188, P1007, DOI 10.1016/j.ajpath.2017.12.021; Chong WP, 2020, IMMUNITY, V53, P384, DOI 10.1016/j.immuni.2020.06.022; Crabtree E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56462-3; DeDreu J, 2021, MATRIX BIOL, V96, P18, DOI 10.1016/j.matbio.2020.12.005; DeDreu J, 2020, FASEB J, V34, P9316, DOI 10.1096/fj.202000289R; Demir I., 2015, VISION MODELING VISU, P65; Diacovo TG, 1996, BLOOD, V88, P146; Dick AD, 2016, OPHTHALMOLOGY, V123, P655, DOI 10.1016/j.ophtha.2015.10.028; Dustin ML, 2019, CELL, V177, P499, DOI 10.1016/j.cell.2019.03.038; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Gery I, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02304; GHOSH S, 1991, J CELL PHYSIOL, V149, P184, DOI 10.1002/jcp.1041490203; Guo TT, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01769; Harkness LM, 2017, J CELL MOL MED, V21, P3288, DOI 10.1111/jcmm.13232; Heissig B, 2010, HISTOL HISTOPATHOL, V25, P765, DOI 10.14670/HH-25.765; Jakos T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02037; Ji YH, 2015, CLIN BIOCHEM, V48, P1304, DOI 10.1016/j.clinbiochem.2015.08.006; Jones W, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.037283; Kezic JM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3697; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Lee EJ, 2016, J IMMUNOL, V196, P3148, DOI 10.4049/jimmunol.1502355; Llop SM, 2018, SEMIN OPHTHALMOL, V33, P64, DOI 10.1080/08820538.2017.1353815; Logan CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16456-5; Mattapallil MJ, 2015, INVEST OPHTH VIS SCI, V56, P5439, DOI 10.1167/iovs.15-17280; Mecham RP, 2015, MATRIX BIOL, V47, P13, DOI 10.1016/j.matbio.2015.05.003; Molzer C, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.608377; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Napier RJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18961-0; Neill T, 2021, MATRIX BIOL, V100, P118, DOI 10.1016/j.matbio.2021.04.001; Ohlmann AV, 2005, CURR EYE RES, V30, P27, DOI 10.1080/02713680490894333; Ozates S, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01373-5; Palsson S, 2017, CLIN OPHTHALMOL, V11, P1549, DOI 10.2147/OPTH.S143886; Pepple KL, 2018, INVEST OPHTH VIS SCI, V59, P2504, DOI 10.1167/iovs.18-24192; Perez VL, 2015, TRENDS IMMUNOL, V36, P354, DOI 10.1016/j.it.2015.04.003; Prieto-del-Cura M, 2020, EUR J OPHTHALMOL, V30, P1381, DOI 10.1177/1120672119899379; Richardson RB, 2020, INT J RADIAT BIOL, V96, P1339, DOI 10.1080/09553002.2020.1812759; Rosenbaum JT, 2008, OPHTHAL RES, V40, P165, DOI 10.1159/000119870; Rosenzweig HL, 2009, J LEUKOCYTE BIOL, V85, P711, DOI 10.1189/jlb.0808478; Runkle EA, 2011, METHODS MOL BIOL, V686, P133, DOI 10.1007/978-1-60761-938-3_5; Saunders AE, 2010, CELL SIGNAL, V22, P339, DOI 10.1016/j.cellsig.2009.10.003; Sharma SM, 2017, BEST PRACT RES CL RH, V31, P846, DOI 10.1016/j.berh.2018.08.002; Smigiel KS, 2017, PROG MOL BIOL TRANSL, V147, P167, DOI 10.1016/bs.pmbts.2017.01.003; Stepp MA, 2021, TRANSL RES, V236, P52, DOI 10.1016/j.trsl.2021.05.005; Streilein JW, 2003, J LEUKOCYTE BIOL, V74, P179, DOI 10.1189/jlb.1102574; Sun Y, 2020, SURV OPHTHALMOL, V65, P133, DOI 10.1016/j.survophthal.2019.10.003; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; Tsirouki T, 2018, OCUL IMMUNOL INFLAMM, V26, P2, DOI 10.1080/09273948.2016.1196713; Tu ZD, 2012, INVEST OPHTH VIS SCI, V53, P959, DOI 10.1167/iovs.11-8377; Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415; van der Wijk AE, 2019, FASEB J, V33, P5320, DOI 10.1096/fj.201801499RRR; Walia A, 2015, BBA-GEN SUBJECTS, V1850, P2422, DOI 10.1016/j.bbagen.2015.09.007; Wight TN, 2017, CELL IMMUNOL, V312, P1, DOI 10.1016/j.cellimm.2016.12.003; Wormstone IM, 2021, PROG RETIN EYE RES, V82, DOI 10.1016/j.preteyeres.2020.100905; Zhang YB, 2012, IMMUNOLOGY, V135, P268, DOI 10.1111/j.1365-2567.2011.03549.x	67	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2022	36	1							e21995	10.1096/fj.202101098R	http://dx.doi.org/10.1096/fj.202101098R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XV5OR	34874579	Green Published			2022-12-26	WOS:000734992000023
J	Alencar, J; de Mello, CF; Leite, PJ; Bastos, AQ; Silva, SOF; Serdeiro, M; Silva, JD; Muller, GA				Alencar, Jeronimo; de Mello, Cecilia Ferreira; Leite, Paulo Jose; Bastos, Amanda Queiroz; Freitas Silva, Shayenne Olsson; Serdeiro, Michele; Silva, Julia dos Santos; Muller, Gerson Azulim			Oviposition activity of Haemagogus leucocelaenus (Diptera: Culicidae) during the rainy and dry seasons, in areas with yellow fever virus circulation in the Atlantic Forest, Rio de Janeiro, Brazil	PLOS ONE			English	Article							STATE; JANTHINOMYS; ABUNDANCE; MOSQUITOS	The present study aims to analyze the effectiveness of ovitraps in the capture of Hg leucocelaenus eggs and evaluate the influence of the dry and rainy seasons on their abundance and hatching rates. The eggs were collected in the Atlantic Forest of State of Rio de Janeiro, Brazil, an area in which the yellow fever virus is known to circulate. We distributed 15 ovitraps in three sampling points, with five ovitraps per point. We distributed 15 ovitraps in three sampling points on trees within a forested area, which were sequentially numbered, monitored, and replaced every two weeks from October 2016 to April 2018. There was a high dominance of Hg. leucocelaenus eggs (98.4%) and a variation in egg hatching rates between the wet and dry seasons. These rates were 1.5 times higher in the rainy season than in the dry season. The rainy season also showed a greater abundance of eggs and higher values of ovitrap positivity and egg density indexes in the installed ovitraps. The abundances of Hg. leucocelaenus eggs were positively correlated with mean monthly temperature and air humidity but not significantly correlated with accumulated precipitation. These results, as well as their implications for the possible use of ovitraps to monitor vector mosquitoes of yellow fever in the study region, are discussed.	[Alencar, Jeronimo; de Mello, Cecilia Ferreira; Leite, Paulo Jose; Bastos, Amanda Queiroz; Freitas Silva, Shayenne Olsson; Serdeiro, Michele; Silva, Julia dos Santos] Oswaldo Cruz Inst FIOCRUZ, Diptera Lab, Rio De Janeiro, Brazil; [de Mello, Cecilia Ferreira; Bastos, Amanda Queiroz] Univ Fed Rural Rio de Janeiro, Inst Biol, Grad Program Anim Biol, Rio De Janeiro, Brazil; [Freitas Silva, Shayenne Olsson] Oswaldo Cruz Inst Fiocruz, Grad Program Trop Med, Rio De Janeiro, Brazil; [Muller, Gerson Azulim] Farroupilha Fed Inst Educ Sci & Technol, Panambi, RS, Brazil	Fundacao Oswaldo Cruz; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Fundacao Oswaldo Cruz; Instituto Federal Farroupilha	Alencar, J (corresponding author), Oswaldo Cruz Inst FIOCRUZ, Diptera Lab, Rio De Janeiro, Brazil.	jalencar@ioc.fiocruz.br		Alencar, Jeronimo/0000-0001-7863-2698	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [E-26/202.658/2018, E-26/ 010.101076/2018]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	JA - (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ; http://www. faperj.br/; grant number E-26/202.658/2018; E-26/ 010.101076/2018) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar J, 2008, J VECTOR ECOL, V33, P389, DOI 10.3376/1081-1710-33.2.389; Alencar J, 2021, TROP MED INFECT DIS, V6, DOI 10.3390/tropicalmed6020099; Alencar J, 2016, J VECTOR ECOL, V41, P18, DOI 10.1111/jvec.12189; Alencar J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122268; Alencar J, 2013, J MED ENTOMOL, V50, P791, DOI 10.1603/ME12120; Alencar J, 2011, J MED ENTOMOL, V48, P223, DOI 10.1603/ME09214; ARNELL J H, 1973, Contributions of the American Entomological Institute, V10, P1; Nascimento KLC, 2020, ENVIRON HEALTH INSIG, V14, DOI 10.1177/1178630219886570; Campos RE, 2006, MEM I OSWALDO CRUZ, V101, P47, DOI 10.1590/S0074-02762006000100009; CHADEE DD, 1995, MED VET ENTOMOL, V9, P372, DOI 10.1111/j.1365-2915.1995.tb00006.x; Consoli RAGB, 1994, LOURENCO DE OLIVEIRA, V1st; Couto-Lima D, 2020, MEM I OSWALDO CRUZ, V115, DOI 10.1590/0074-02760200218; Cunha MS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41950-3; Cunha MV, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57679-3; de Araujo WS, 2020, J MED ENTOMOL, V57, P1913, DOI 10.1093/jme/tjaa103; Evangelista E, 2021, ACTA TROP, V221, DOI 10.1016/j.actatropica.2021.106009; Farnesi LC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006063; Forattini OP, 2002, USP; Silva SOF, 2018, VECTOR-BORNE ZOONOT, V18, P214, DOI 10.1089/vbz.2017.2222; GALINDO P, 1950, AM J TROP MED, V30, P533; GALINDO PEDRO, 1955, ANN ENT SOC AMER, V48, P158; Giovanetti M, 2020, J VIROL, V94, DOI 10.1128/JVI.01623-19; Gomes A.deC., 1998, INF EPIDEMIOL GICO S, V7, P49, DOI [10.5123/s0104-16731998000300006, DOI 10.5123/S0104-16731998000300006]; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; KENKEL NC, 1989, VEGETATIO, V83, P195, DOI 10.1007/BF00031692; Kerkow A, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3368-0; Lin YS, 2008, ZOOL STUD, V47, P129; Mangudo C, 2018, B ENTOMOL RES, V108, P203, DOI 10.1017/S0007485317000700; MARCONDES CB, 2010, REV BIOMED, V21, P221; Marcuzzo FF., 2013, REV BRAS GEOGR FIS, V6, P91; Mogi Motoyoshi, 2004, P13; Prefeitura Municipal Macae, 2019, SECR AMB SUST; Reinert J.F, 2009, J EUR MOSQ CONTROL A, V27, P68; de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180; Schaeffer B, 2008, INFECT GENET EVOL, V8, P422, DOI 10.1016/j.meegid.2007.07.002; Silva-Inacio CL, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0502-2020; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Stahlhöfer Brenda Dessbesell, 2021, Rev. chil. entomol., V47, P375, DOI 10.35249/rche.47.2.21.20; Tatila-Ferreira A, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759060, 10.1590/s1678-9946201759060]; TIKASINGH ES, 1981, MOSQ NEWS, V41, P677; TRAPIDO H, 1957, AM J TROP MED HYG, V6, P114, DOI 10.4269/ajtmh.1957.6.114; Tubaki RM, 2010, NEOTROP ENTOMOL, V39, P664, DOI 10.1590/S1519-566X2010000400030; Wilk-da-Silva R, 2020, ACTA TROP, V204, DOI 10.1016/j.actatropica.2020.105385	43	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0261283	10.1371/journal.pone.0261283	http://dx.doi.org/10.1371/journal.pone.0261283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898653	gold, Green Published			2022-12-26	WOS:000755176200033
J	Kim, HJ; Kato, N; Ndathe, R; Thyssen, GN; Jones, DC; Ratnayaka, HH				Kim, Hee Jin; Kato, Naohiro; Ndathe, Ruth; Thyssen, Gregory N.; Jones, Don C.; Ratnayaka, Harish H.			Evidence for thermosensitivity of the cotton (Gossypium hirsutum L.) immature fiber (im) mutant via hypersensitive stomatal activity	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; MITOCHONDRIAL COMPLEX-I; HIGH-TEMPERATURE; ALTERNATIVE OXIDASE; SIGNAL-TRANSDUCTION; PHOTOSYSTEM-II; RNA; STRESS; PHOTOSYNTHESIS; LEAVES	Thickness of cotton fiber, referred to as fiber maturity, is a key determinant of fiber quality, lint yield, and textile performance. The cotton immature fiber (im) mutant has been used to study fiber maturity since its fiber is thinner than the wild type near isogeneic line (NIL), Texas Marker-1 (TM-1). The im phenotype is caused by a single recessive mutation of a pentatricopeptide repeat (PPR) gene that reduces the activity of mitochondrial complex I and up-regulates stress responsive genes. However, the mechanisms altering the stress responses in im mutant are not well understood. Thus, we characterized growth and gas exchange in im and TM-1 under no stress and also investigated their stress responses by comparing gas exchange and transcriptomic profiles under high temperature. Phenotypic differences were detected between the NILs in non-fiber tissues although less pronounced than the variation in fibers. At near optimum temperature (28 +/- 3 degrees C), im maintained the same photosynthetic performance as TM-1 by means of greater stomatal conductance. In contrast, under high temperature stress (>34 degrees C), im leaves reduced photosynthesis by decreasing the stomatal conductance disproportionately more than TM-1. Transcriptomic analyses showed that the genes involved in heat stress responses were differentially expressed between the NIL leaves. These results indicate that the im mutant previously reported to have low activity of mitochondrial complex I displays increased thermosensitivity by impacting stomatal conductance. They also support a notion that mitochondrial complex I activity is required for maintenance of optimal photosynthetic performance and acclimation of plants to high temperature stress. These findings may be useful in the future efforts to understand how physiological mechanisms play a role in determining cotton fiber maturity and may influence stress responses in other crops.	[Kim, Hee Jin; Thyssen, Gregory N.] USDA ARS, Southern Reg Res Ctr, Cotton Fiber Biosci Res Unit, New Orleans, LA 70124 USA; [Kato, Naohiro; Ndathe, Ruth] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Jones, Don C.] Cotton Inc, Cary, NC USA; [Ratnayaka, Harish H.] Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA	United States Department of Agriculture (USDA); Louisiana State University System; Louisiana State University; Cotton Incorporated; Xavier University of Louisiana	Kim, HJ (corresponding author), USDA ARS, Southern Reg Res Ctr, Cotton Fiber Biosci Res Unit, New Orleans, LA 70124 USA.; Ratnayaka, HH (corresponding author), Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA.	heejin.kim@usda.gov; hratnaya@xula.edu	Kim, Heejin/HII-8568-2022	Kato, Naohiro/0000-0002-4571-3456	USDA-ARS CRIS Project [6435-21000-018- 00D]; Cotton Incorporated [19858]	USDA-ARS CRIS Project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Cotton Incorporated(Cotton R&D Corp)	This research was supported by the USDA-ARS CRIS Project # 6435-21000-018- 00D and Cotton Incorporated-sponsored projects #19858. The private funder provided financial support in the form of research materials, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author in the funding organization are articulated in the `author contributions' section.	Acharya B, 2009, PLANT MOL BIOL, V69, P451, DOI 10.1007/s11103-008-9427-0; Andres-Colas N, 2017, P NATL ACAD SCI USA, V114, P8883, DOI 10.1073/pnas.1705815114; Apostolova EL., 2016, HDB PHOTOSYNTHESIS, V3rd, P301; Araujo WL, 2011, PLANT SIGNAL BEHAV, V6, P1305, DOI 10.4161/psb.6.9.16425; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Benedict CR., 1999, COTTONORIGIN HIST TE, P269; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Bradow J.M., 2000, J COTTON SCI, V4, P31; Brestic M., 2013, MOL STRESS PHYSL PLA, P87, DOI DOI 10.1007/978-81-322-0807-5_4; Burke JJ, 2010, PHYSIOLOGY OF COTTON, P123, DOI 10.1007/978-90-481-3195-2_12; Chaudhry MR., 2010, IND APPL NATURAL FIB, P219; Chen LS, 2010, ACTA PHYSIOL PLANT, V32, P253, DOI 10.1007/s11738-009-0402-4; Conaty WC, 2012, CROP SCI, V52, P1828, DOI 10.2135/cropsci2011.11.0581; Crafts-Brandner SJ, 2000, P NATL ACAD SCI USA, V97, P13430, DOI 10.1073/pnas.230451497; Dahal K, 2017, NEW PHYTOL, V213, P560, DOI 10.1111/nph.14169; Djebbar R, 2012, PLANTA, V235, P603, DOI 10.1007/s00425-011-1524-7; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dutilleul C, 2003, PLANT PHYSIOL, V131, P264, DOI 10.1104/pp.011155; Fang DD, 2018, CROP SCI, V58, P2214, DOI 10.2135/cropsci2018.03.0184; Fedoroff NV, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P485, DOI 10.1007/978-90-481-3112-9_22; French AD, 2018, COTTON FIBER PHYS CH, P13; Frydrych I., 2010, COTTON TECHNOLOGY 21, P251; Garruna-Hernandez R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111402; Guruprasad KN., 2016, HDB PHOTOSYNTHESIS; Gutierres S, 1997, P NATL ACAD SCI USA, V94, P3436, DOI 10.1073/pnas.94.7.3436; Haigler CH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00104; Haili N, 2016, PLANT PHYSIOL, V170, P354, DOI 10.1104/pp.15.01591; Hequet EF, 2006, TEXT RES J, V76, P576, DOI 10.1177/0040517506064710; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hoffmann WA, 2005, FUNCT ECOL, V19, P932, DOI 10.1111/j.1365-2435.2005.01045.x; Hsieh WY, 2015, PLANT PHYSIOL, V168, P490, DOI 10.1104/pp.15.00354; Israelsson M, 2006, CURR OPIN PLANT BIOL, V9, P654, DOI 10.1016/j.pbi.2006.09.006; Jones H. G., 1992, Plants and microclimate: a quantitative approach to environmental plant physiology.; Kelly B, 2015, AGRON MONOGR, V57, P665, DOI 10.2134/agronmonogr57.2013.0031; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim H.J., 2018, COTTON FIBER PHYS CH, P133; Kim HJ, 2019, J COTTON RES, V2, DOI 10.1186/s42397-019-0027-0; Kim HJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-889; Kim HJ, 2013, THEOR APPL GENET, V126, P23, DOI 10.1007/s00122-012-1956-x; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kmiecik P, 2016, J EXP BOT, V67, P3793, DOI 10.1093/jxb/erw136; KOHEL RJ, 1990, CROP SCI, V30, P419, DOI 10.2135/cropsci1990.0011183X003000020038x; Kohel RJ, 2002, J HERED, V93, P130, DOI 10.1093/jhered/93.2.130; KOHEL RJ, 1974, CROP SCI, V14, P471, DOI 10.2135/cropsci1974.0011183X001400030040x; Koyro H-W., 2018, PLANT METABOLITES RE, P281; Labs M, 2016, PHOTOSYNTH RES, V129, P231, DOI 10.1007/s11120-016-0217-2; Landivar J., 1996, B B, V2, P1996; Law YS, 2015, PLANT PHYSIOL, V169, P1344, DOI 10.1104/pp.15.01115; Leister D, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00387; Lord E., 1956, J TEXTILE I T, V47, pT16; Lord E., 1981, ORIGIN ASSESSMENT CO; Masoomi-Aladizgeh F, 2021, PLANT CELL ENVIRON, V44, P2150, DOI 10.1111/pce.13908; Mathur S, 2014, J PHOTOCH PHOTOBIO B, V137, P116, DOI 10.1016/j.jphotobiol.2014.01.010; Medrano H, 2002, ANN BOT-LONDON, V89, P895, DOI 10.1093/aob/mcf079; Min L, 2014, PLANT PHYSIOL, V164, P1293, DOI 10.1104/pp.113.232314; Misra AN., 2012, BIOPHYSICS, V7, P171, DOI DOI 10.5772/35111; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Mott KA, 2008, PLANT CELL ENVIRON, V31, P1299, DOI 10.1111/j.1365-3040.2008.01845.x; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Neelam Soda, 2016, Abiotic stress response in plants, P107; Noguchi K, 2008, MITOCHONDRION, V8, P87, DOI 10.1016/j.mito.2007.09.003; Pareek A, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P1, DOI 10.1007/978-90-481-3112-9; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Percy R, 2015, AGRON MONOGR, V57, P155, DOI 10.2134/agronmonogr57.2013.0042; Priault P, 2006, J EXP BOT, V57, P3195, DOI 10.1093/jxb/erl083; Priault P, 2006, J EXP BOT, V57, P2075, DOI 10.1093/jxb/erj161; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Raper TB, 2019, CROP SCI, V59, P307, DOI 10.2135/cropsci2018.04.0222; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Rock CD, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P33, DOI 10.1007/978-90-481-3112-9_3; Rungrat Tepsuda, 2016, Arabidopsis Book, V14, pe0185, DOI 10.1199/tab.0185; Sabar M, 2000, PLANT PHYSIOL, V124, P1239, DOI 10.1104/pp.124.3.1239; SCHULZE ED, 1973, PLANTA, V110, P29, DOI 10.1007/BF00386920; Singh RP, 2007, ADV AGRON, V93, P313, DOI 10.1016/S0065-2113(06)93006-5; Sinsawat V, 2004, ENVIRON EXP BOT, V52, P123, DOI 10.1016/j.envexpbot.2004.01.010; Small ID, 2020, PLANT J, V101, P1040, DOI 10.1111/tpj.14578; Snider JL, 2015, AGRON MONOGR, V57, P339, DOI 10.2134/agronmonogr57.2013.0044; Sun T, 2016, TRENDS PLANT SCI, V21, P962, DOI 10.1016/j.tplants.2016.07.005; Takahashi F, 2019, CURR OPIN PLANT BIOL, V47, P106, DOI 10.1016/j.pbi.2018.10.006; THIBODEAUX DP, 1986, TEXT RES J, V56, P130, DOI 10.1177/004051758605600211; Thyssen GN, 2016, G3-GENES GENOM GENET, V6, P1627, DOI 10.1534/g3.116.027649; Wakelyn PJ., 2010, COTTON FIBER CHEM TE; Wang B, 2020, FIELD CROP RES, V248, DOI 10.1016/j.fcr.2020.107735; Wang C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-94; Wang C, 2013, CROP SCI, V53, P27, DOI 10.2135/cropsci2012.05.0304; Wang MJ, 2019, NAT GENET, V51, P224, DOI 10.1038/s41588-018-0282-x; Wang Y, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0410; WANJURA DF, 1992, T ASAE, V35, P153, DOI 10.13031/2013.28582; Weissenberger S, 2017, PLANT MOL BIOL, V93, P355, DOI 10.1007/s11103-016-0566-4; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; Zarkovic J, 2005, PLANT MOL BIOL, V57, P871, DOI 10.1007/s11103-005-3249-0; Zhang DY, 2021, GENETICS, V217, DOI 10.1093/genetics/iyaa017; Zhu Q, 2012, PLANT J, V71, P836, DOI 10.1111/j.1365-313X.2012.05036.x	96	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2021	16	12							e0259562	10.1371/journal.pone.0259562	http://dx.doi.org/10.1371/journal.pone.0259562			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ0LY	34898615	gold, Green Published			2022-12-26	WOS:000755176200007
J	Rossouw, S; Greyling, T; Adhikari, T				Rossouw, Stephanie; Greyling, Talita; Adhikari, Tamanna			The evolution of happiness pre and peri-COVID-19: A Markov Switching Dynamic Regression Model	PLOS ONE			English	Article							TIME-SERIES	Happiness levels often fluctuate from one day to the next, and an exogenous shock such as a pandemic can likely disrupt pre-existing happiness dynamics. This paper fits a Marko Switching Dynamic Regression Model (MSDR) to better understand the dynamic patterns of happiness levels before and during a pandemic. The estimated parameters from the MSDR model include each state's mean and duration, volatility and transition probabilities. Once these parameters have been estimated, we use the one-step method to predict the unobserved states' evolution over time. This gives us unique insights into the evolution of happiness. Furthermore, as maximising happiness is a policy priority, we determine the factors that can contribute to the probability of increasing happiness levels. We empirically test these models using New Zealand's daily happiness data for May 2019 -November 2020. The results show that New Zealand seems to have two regimes, an unhappy and happy regime. In 2019 the happy regime dominated; thus, the probability of being unhappy in the next time period (day) occurred less frequently, whereas the opposite is true for 2020. The higher frequency of time periods with a probability of being unhappy in 2020 mostly correspond to pandemic events. Lastly, we find the factors positively and significantly related to the probability of being happy after lockdown to be jobseeker support payments and international travel. On the other hand, lack of mobility is significantly and negatively related to the probability of being happy.	[Rossouw, Stephanie] Auckland Univ Technol, Fac Culture & Soc, Sch Social Sci & Publ Policy, Auckland, New Zealand; [Greyling, Talita] Univ Johannesburg, Sch Econ, Johannesburg, Gauteng, South Africa; [Adhikari, Tamanna] Al Akhawayn Univ, Sch Business Adm, Ifrane, Morocco; [Adhikari, Tamanna] Univ Johannesburg, Coll Business & Econ, Sch Econ, Johannesburg, Gauteng, South Africa	Auckland University of Technology; University of Johannesburg; Al Akhawayn University; University of Johannesburg	Rossouw, S (corresponding author), Auckland Univ Technol, Fac Culture & Soc, Sch Social Sci & Publ Policy, Auckland, New Zealand.	stephanie.rossouw@aut.ac.nz	Greyling, Talita/AAC-7567-2022	Greyling, Talita/0000-0002-3777-7003; Rossouw, Stephanie/0000-0003-3538-9215	Auckland University of Technology via the Faculty of Culture and Society; University of Johannesburg	Auckland University of Technology via the Faculty of Culture and Society; University of Johannesburg	The following authors received salaries from their institutions, whom were also the funders of the research. 1. Stephanie Rossouw: Auckland University of Technology via the Faculty of Culture and Society. 2. Talita Greyling: University of Johannesburg via the University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algan Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209562; [Anonymous], 2021, EC WEEKLY; [Anonymous], 2020, COVID 19 DAT PORT; [Anonymous], 2020, GLOB BEH PERC COVID; [Anonymous], 2020, DAT COVID 19; [Anonymous], 2021, INT TRAV; Brodeur A., 2020, ARXIV PREPRINT ARXIV; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Bryson A, 2016, LABOUR ECON, V42, P151, DOI 10.1016/j.labeco.2016.09.002; Every-Palmer S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241658; Google,, 2020, COVID 19 COMM MOB RE; Granger C., 1978, STOCH PROC APPL, V8, P87, DOI 10.1016/0304-4149(78)90069-8; Granger C. W. J., 1993, MODELLING NONLINEAR; Greyling T, 2021, S AFR J ECON, V89, P25, DOI [10.1111/saje.12284, DOI 10.1111/SAJE.12284]; Greyling T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245546; Hamermesh S., IZA DISCUSSION PAPER, P13140; HAMILTON JD, 1989, ECONOMETRICA, V57, P357, DOI 10.2307/1912559; Helliwell JF, 2014, SOC INDIC RES, V116, P389, DOI 10.1007/s11205-013-0306-y; Ismail MohdTahir., 2007, J FUNDAM SCI, V3, P211, DOI 10.11113/mjfas.v3n2.30; Keller T, 2018, SOCIOL CAS, V54, P371, DOI 10.13060/00380288.2018.54.3.411; Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032; McLeod AI., 1983, J TIME SER ANAL, V4, P269, DOI [DOI 10.1111/J.1467-9892.1983.TB00373.X, 10.1111/j.1467-9892.1983.tb00373.x]; McLeod K, 2018, TREASURY ANAL PAPER, P04; Ministry of Social Development, 2020, JOBS SUPP; Omnicore, 2020, OMN AG; PHILLIPS PCB, 1988, BIOMETRIKA, V75, P335, DOI 10.1093/biomet/75.2.335; Piekalkiewicz M, 2017, ECON LABOUR RELAT RE, V28, P361, DOI 10.1177/1035304617717130; Roser M, 2020, WHY DID RENEWABLES B; Rossouw S, 2019, GROSS NATL HAPPINESS; Rossouw S, 2021, S AFR J EC MAN SCI; Rossouw S., 2020, HDB LABOR HUMAN RESO, DOI [10.1007/978-3-319-57365-6_183-1, DOI 10.1007/978-3-319-57365-6_183-1]; Sacks DW, 2010, NBER WORKING PAPERS, V16441, DOI [10.3386/w16441, DOI 10.3386/W16441]; Sibley CG, 2020, AM PSYCHOL, V75, P618, DOI 10.1037/amp0000662; Simionescu M, 2017, GLO DISCUSSION PAPER, V81; Xaba D., 2019, J EC BEHAV STUDIES, V11, P10	35	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2021	16	12							e0259579	10.1371/journal.pone.0259579	http://dx.doi.org/10.1371/journal.pone.0259579			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YN5JA	34890413	Green Published, gold			2022-12-26	WOS:000747293600004
J	Cunha, HS; Sclauser, BS; Wildemberg, PF; Fernandes, EAM; dos Santos, JA; Lage, MD; Lorenz, C; Barbosa, GL; Quintanilha, JA; Chiaravalloti-Neto, F				Cunha, Higor Souza; Sclauser, Brenda Santana; Wildemberg, Pedro Fonseca; Militao Fernandes, Eduardo Augusto; dos Santos, Jefersson Alex; Lage, Mariana de Oliveira; Lorenz, Camila; Barbosa, Gerson Laurindo; Quintanilha, Jose Alberto; Chiaravalloti-Neto, Francisco			Water tank and swimming pool detection based on remote sensing and deep learning: Relationship with socioeconomic level and applications in dengue control	PLOS ONE			English	Article							PREMISE CONDITION INDEX; SPACEBORNE IMAGING SPECTROSCOPY; AEDES-AEGYPTI DIPTERA; RISK; AREAS; CULICIDAE; ABUNDANCE; CITY; NDWI	Studies have shown that areas with lower socioeconomic standings are often more vulnerable to dengue and similar deadly diseases that can be spread through mosquitoes. This study aims to detect water tanks installed on rooftops and swimming pools in digital images to identify and classify areas based on the socioeconomic index, in order to assist public health programs in the control of diseases linked to the Aedes aegypti mosquito. This study covers four regions of Campinas, SAo Paulo, characterized by different socioeconomic contexts. With mosaics of images obtained by a 12.1 MP Canon PowerShot S100 (5.2 mm focal length) carried by unmanned aerial vehicles, we developed deep learning algorithms in the scope of computer vision for the detection of water tanks and swimming pools. An object detection model, which was initially created for areas of Belo Horizonte, Minas Gerais, was enhanced using the transfer learning technique, and allowed us to detect objects in Campinas with fewer samples and more efficiency. With the detection of objects in digital images, the proportions of objects per square kilometer for each region studied were estimated by adopting a Chi-square distribution model. Thus, we found that regions with low socioeconomic status had more exposed water tanks, while regions with high socioeconomic levels had more exposed pools. Using deep learning approaches, we created a useful tool for Ae. aegypti control programs to utilize and direct disease prevention efforts. Therefore, we concluded that it is possible to detect objects directly related to the socioeconomic level of a given region from digital images, which encourages the practicality of this approach for studies aimed towards public health.	[Cunha, Higor Souza; Sclauser, Brenda Santana] Univ Sao Paulo, Polytech Sch, Dept Elect Engn, Sao Paulo, Brazil; [Wildemberg, Pedro Fonseca; Militao Fernandes, Eduardo Augusto; dos Santos, Jefersson Alex] Univ Fed Minas Gerais, Dept Comp Sci, Belo Horizonte, MG, Brazil; [Lage, Mariana de Oliveira] Univ Sao Paulo, Inst Energy & Environm, Environm Sci Grad Program PROCAM, Sao Paulo, Brazil; [Lorenz, Camila; Chiaravalloti-Neto, Francisco] Univ Sao Paulo, Fac Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil; [Barbosa, Gerson Laurindo] State Dept Hlth, Endem Control Superintendence, Sao Paulo, Brazil; [Quintanilha, Jose Alberto] Univ Sao Paulo, Inst Energy & Environm, Sci Div Environm Management Sci & Technol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Cunha, HS (corresponding author), Univ Sao Paulo, Polytech Sch, Dept Elect Engn, Sao Paulo, Brazil.	higor.s.c@usp.br	Neto, Francisco Chiaravalloti/F-8006-2012; Lorenz, Camila/C-3635-2019; Barbosa, Gerson L/N-9403-2013	Neto, Francisco Chiaravalloti/0000-0003-2686-8740; Lorenz, Camila/0000-0003-2121-9063; Barbosa, Gerson L/0000-0002-5624-2354; Cunha, Higor/0000-0003-4368-584X	Sao Paulo Research Foundation (FAPESP) [2015/06687-3, 2017/10297-1, 2020/01596-8]; Serrapilheira Institute [R-2011-37776]; Research Pro-Rectory of the University of Sao Paulo [668/2018]; National Council for Scientific and Technological Development (CNPq) [306025/2019-1, 305188/2020-8, 311395/2018-0, 424700/2018-2]; Minas Gerais Research Foundation (FAPEMIG) [APQ00449-17]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Serrapilheira Institute; Research Pro-Rectory of the University of Sao Paulo; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais Research Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Sao Paulo Research Foundation (FAPESP - https://fapesp.br) grants 2015/06687-3 (G.L.B.), 2017/10297-1 (C.L.) and 2020/01596-8 (F.C.N.). Serrapilheira Institute (https://serrapilheira.org) grant R-2011-37776 (J.A.S.). H.S.C., B.S.S., and F. C.N. were supported by grant 668/2018 from the Research Pro-Rectory of the University of Sao Paulo (https://prp.usp.br). National Council for Scientific and Technological Development (CNPq https://www.gov.br/cnpq) grants 306025/2019-1 (F.C.N.), 305188/2020-8 (J.A.Q.), 311395/2018-0 (J.A.S.) and 424700/2018-2 (J.A.S.). P.F.W., E.A. M.F, and J.A.S. were supported by grant APQ00449-17 from the Minas Gerais Research Foundation (FAPEMIG - https://fapemig.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, TROP MED INT HEALTH, V10, P597, DOI 10.1111/j.1365-3156.2005.01428.x; Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006822; [Anonymous], 2018, AGISOFT PHOTOSCAN US; Ayush K, 2020, PROCEEDINGS OF THE TWENTY-NINTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P4410; Barbosa GL, 2020, ACTA TROP, V209, DOI 10.1016/j.actatropica.2020.105543; Brady OJ, 2015, EPIDEMICS-NETH, V11, P92, DOI 10.1016/j.epidem.2015.03.002; Braun A, 2019, JOINT URB REMOTE SEN; Carlucci M, 2022, SOC INDIC RES, V161, P937, DOI 10.1007/s11205-020-02448-y; Chiaravalloti Neto Francisco, 1997, Revista da Sociedade Brasileira de Medicina Tropical, V30, P279, DOI 10.1590/S0037-86821997000400002; Chiaravalloti-Neto F, 2015, ACTA TROP, V142, P167, DOI 10.1016/j.actatropica.2014.11.017; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; de Azevedo TS, 2018, GEOSPATIAL HEALTH, V13, P179, DOI 10.4081/gh.2018.623; Digital Camera Database, CAN POWERSHOT S100; Farinelli EC, 2018, ACTA TROP, V180, P47, DOI 10.1016/j.actatropica.2018.01.005; Feria-Arroyo T.P., 2020, SUB AGRIC ENV, V71, P12; Fernandes E., 2020, AN 16 WORKSH VIS COM, P117, DOI [10.5753/wvc.2020.13491, DOI 10.5753/WVC.2020.13491]; Ferreira MP., 2006, ESPACOS DIMENSOES PO; Ford A., 1998, COLOUR SPACE CONVERS, P1; Fouet C, 2019, TRENDS PARASITOL, V35, P85, DOI 10.1016/j.pt.2018.10.004; Galindo C., 2009, IEEE INT GEOSCIENCE, V4, P4; García Herrera Arístides Lázaro, 2017, Rev.Med.Electrón., P1; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Guanter L, 2019, SURV GEOPHYS, V40, P657, DOI 10.1007/s10712-018-9485-z; Guanter L, 2015, REMOTE SENS-BASEL, V7, P8830, DOI 10.3390/rs70708830; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kim M, 2011, PHOTOGRAMM ENG REM S, V77, P1169, DOI 10.14358/PERS.77.11.1169; Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505; Landau KI, 2012, J VECTOR ECOL, V37, P407, DOI 10.1111/j.1948-7134.2012.00245.x; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lesser Jeffrey, 2016, NACLA REPORT AM, V48, P123, DOI DOI 10.1080/10714839.2016.1201268; Li Y, 2018, WIRES DATA MIN KNOWL, V8, DOI 10.1002/widm.1264; Lorenz C, 2020, ACTA TROP, V205, DOI 10.1016/j.actatropica.2020.105398; Lorenz C, 2019, ACTA TROP, V198, DOI [10.1016/j.actatropica.2019.105093, 10.1016/j.actatropica]; Lowe B., 2015, INT J SOFT COMPUT IJ, V6, P1, DOI [10.5121/ijsc.2015.6101, DOI 10.5121/IJSC.2015.6101]; Maciel-de-Freitas R, 2008, TROP MED INT HEALTH, V13, P1488, DOI 10.1111/j.1365-3156.2008.02162.x; Manrique-Saide P, 2013, J AM MOSQUITO CONTR, V29, P337, DOI 10.2987/13-6350.1; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; McFeeters SK, 2013, REMOTE SENS-BASEL, V5, P3544, DOI 10.3390/rs5073544; Mountrakis G, 2011, ISPRS J PHOTOGRAMM, V66, P247, DOI 10.1016/j.isprsjprs.2010.11.001; Niebergall S., 2006, 1 EARSEL WORKSH SIG; Nino L, 2008, BIOMEDICA, V28, P578, DOI 10.7705/biomedica.v28i4.64; OPAS/OMS Brasil, CAS DENG NAS AM ULTR; Paszke A, 2019, ADV NEUR IN, V32; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Peres RC, 2013, J VECTOR ECOL, V38, P190, DOI 10.1111/j.1948-7134.2013.12027.x; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Rodriguez-Cuenca B, 2014, REMOTE SENS-BASEL, V6, P2628, DOI 10.3390/rs6042628; Safonova A, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21051617; Saghri JA, 2007, P SOC PHOTO-OPT INS, V6696, pB6961, DOI 10.1117/12.740236; Saini I., 2019, INT J ADV RES COMPUT, V10, P34, DOI [10.26483/ijarcs.v10i5.6466, DOI 10.26483/IJARCS.V10I5.6466]; Sanchez L, 2010, TROP MED INT HEALTH, V15, P173, DOI 10.1111/j.1365-3156.2009.02437.x; Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474; SEADE-Fundacao Sistema Estadual de Analise de Dados, 2010, IND PAUL VULN SOC; Swanson AL., 2014, United States-Patent Application, Patent No. [US 2014/0019166A1, 20140019166]; Teurlai M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004211; Tien D., 2007, P DIG IM COMP TECHN, P523, DOI [10.1109/DICTA.2007.4426841, DOI 10.1109/DICTA.2007.4426841]; TunLin W, 1995, AM J TROP MED HYG, V53, P591, DOI 10.4269/ajtmh.1995.53.591; van der Linden S, 2019, SURV GEOPHYS, V40, P471, DOI 10.1007/s10712-018-9486-y; Vezzani D, 2004, MEM I OSWALDO CRUZ, V99, P351, DOI 10.1590/S0074-02762004000400002; Wada Kentaro, LABELME IMAGE POLYGO; Wang F, 2018, J APPL REMOTE SENS, V12, DOI 10.1117/1.JRS.12.016040; Whiteman A, 2019, ECOHEALTH, V16, P210, DOI 10.1007/s10393-019-01417-3; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Zambon I, 2017, GEOGR ANN B, V99, P319, DOI 10.1080/04353684.2017.1294857	66	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2021	16	12							e0258681	10.1371/journal.pone.0258681	http://dx.doi.org/10.1371/journal.pone.0258681			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY8LQ	34882711	gold, Green Published			2022-12-26	WOS:000755037200006
J	Sanabria, NM; Gulumian, M				Sanabria, Natasha M.; Gulumian, Mary			The use of HRM shifts in qPCR to investigate a much neglected aspect of interference by intracellular nanoparticles	PLOS ONE			English	Article							GOLD NANOPARTICLES; EXPOSURE	Genetic molecular studies used to understand potential risks of engineered nanomaterials (ENMs) are incomplete. Intracellular residual ENMs present in biological samples may cause assay interference. This report applies the high-resolution melt (HRM) feature of RT-qPCR to detect shifts caused by the presence of gold nanoparticles (AuNPs). A universal RNA standard (untreated control) sample was spiked with known amounts of AuNPs and reverse transcribed, where 10 reference genes were amplified. The amplification plots, dissociation assay (melt) profiles, electrophoretic profiles and HRM difference curves were analysed and detected interference caused by AuNPs, which differed according to the amount of AuNP present (i.e. semi-quantitative). Whether or not the assay interference was specific to the reverse transcription or the PCR amplification step was tested. The study was extended to a target gene-of-interest (GOI), Caspase 7. Also, the effect on in vitro cellular samples was assessed (for reference genes and Caspase 7). This method can screen for the presence of AuNPs in RNA samples, which were isolated from biological material in contact with the nanomaterials, i.e., during exposure and risk assessment studies. This is an important quality control procedure to be implemented when quantifying the expression of a GOI from samples that have been in contact with various ENMs. It is recommended to further examine 18S, PPIA and TBP since these were the most reliable for detecting shifts in the difference curves, irrespective of the source of the RNA, or, the point at which the different AuNPs interacted with the assay.	[Sanabria, Natasha M.; Gulumian, Mary] Natl Inst Occupat Hlth, Div Natl Hlth Lab Serv, Johannesburg, South Africa; [Gulumian, Mary] Univ Witwatersrand, Sch Pathol, Haematol & Mol Med Dept, Johannesburg, South Africa; [Gulumian, Mary] North West Univ, Water Res Grp, Unit Environm Sci & Management, Potchefstroom, South Africa	National Health Laboratory Service; University of Witwatersrand; North West University - South Africa	Gulumian, M (corresponding author), Natl Inst Occupat Hlth, Div Natl Hlth Lab Serv, Johannesburg, South Africa.; Gulumian, M (corresponding author), Univ Witwatersrand, Sch Pathol, Haematol & Mol Med Dept, Johannesburg, South Africa.; Gulumian, M (corresponding author), North West Univ, Water Res Grp, Unit Environm Sci & Management, Potchefstroom, South Africa.	MaryG@nioh.ac.za		Sanabria, Natasha/0000-0002-1613-6178	Department of Science and Technology (DST) of South Africa; NIOH/NHLS Research Trust development grant [2014-2DEV29-SNT1]	Department of Science and Technology (DST) of South Africa; NIOH/NHLS Research Trust development grant	MG received funding, i,e, this work was supported by the Department of Science and Technology (DST) of South Africa. NS also received funding, i.e. this work was supported by the NIOH/NHLS Research Trust development grant (2014-2DEV29-SNT1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Zamora-Justo JA, 2019, J NANOMATER, V2019, DOI 10.1155/2019/5982047; Bai YL, 2015, ACS APPL MATER INTER, V7, P13142, DOI 10.1021/am508842v; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Falagan-Lotsch P, 2016, P NATL ACAD SCI USA, V113, P13318, DOI 10.1073/pnas.1616400113; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; Haber AL, 2008, ANAL BIOANAL CHEM, V392, P887, DOI 10.1007/s00216-008-2358-4; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Kanipandian Nagarajan, 2019, Biotechnology Reports, V23, pe00339, DOI 10.1016/j.btre.2019.e00339; Khatri M, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-42; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P21, DOI 10.1016/j.biocel.2009.09.013; Lou XH, 2013, ACS APPL MATER INTER, V5, P6276, DOI 10.1021/am4013209; Manson J, 2011, GOLD BULL, V44, P99, DOI 10.1007/s13404-011-0015-8; McComb S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau9433; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Perez-Hernandez M, 2017, PART FIBRE TOXICOL, V14, DOI 10.1186/s12989-017-0222-4; Prado M., EVALUATION EFFECT MA; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Sanabria NM, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0299-9; Sanabria NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114123; Shaat H, 2016, INT J PHARMACEUT, V504, P125, DOI 10.1016/j.ijpharm.2016.03.051; Shi YG, 2002, STRUCTURE, V10, P285, DOI 10.1016/S0969-2126(02)00732-3; Simon DF, 2013, APPL ENVIRON MICROB, V79, P4774, DOI 10.1128/AEM.00998-13; Spadavecchia J, 2016, INT J NANOMED, V11, P791, DOI 10.2147/IJN.S97476; TURKEVICH J, 1953, J PHYS CHEM-US, V57, P670, DOI 10.1021/j150508a015; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vetten M, 2019, TOXICOL APPL PHARM, V363, P131, DOI 10.1016/j.taap.2018.11.014; Vetten MA, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-50; Vossaert L, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-21; Wan WJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/32/325702; Wilhelmi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065704; Xu LM, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-16; Zhang YQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031849, 10.1371/journal.pone.0030262]	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2021	16	12							e0260207	10.1371/journal.pone.0260207	http://dx.doi.org/10.1371/journal.pone.0260207			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW7TO	34874941	Green Published, gold			2022-12-26	WOS:000753617500016
J	Seligsohn, D; Crestani, C; Gitahi, N; Flodin, EL; Chenais, E; Zadoks, RN				Seligsohn, Dinah; Crestani, Chiara; Gitahi, Nduhiu; Flodin, Emelie Lejon; Chenais, Erika; Zadoks, Ruth N.			Investigation of extramammary sources of Group B Streptococcus reveals its unusual ecology and epidemiology in camels	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; SEROTYPE IV; MASTITIS; AGALACTIAE; BOVINE; DAIRY; MILK; HERDS; DROMEDARIUS; CATTLE	Camels are vital to food production in the drylands of the Horn of Africa, with milk as their main contribution to food security. A major constraint to camel milk production is mastitis, inflammation of the mammary gland. The condition negatively impacts milk yield and quality as well as household income. A leading cause of mastitis in dairy camels is Streptococcus agalactiae, or group B Streptococcus (GBS), which is also a commensal and pathogen of humans and cattle. It has been suggested that extramammary reservoirs for this pathogen may contribute to the occurrence of mastitis in camels. We explored the molecular epidemiology of GBS in camels using a cross-sectional study design for sample collection and phenotypic, genomic and phylogenetic analysis of isolates. Among 88 adult camels and 93 calves from six herds in Laikipia County, Kenya, GBS was detected in 20% of 50 milk samples, 25% of 152 nasal swabs, 8% of 90 oral swabs and 3% of 90 rectal swabs, but not in vaginal swabs. Per camel herd, two to four sequence types (ST) were identified using Multi Locus Sequence Typing (MLST). More than half of the isolates belonged to ST617 or its single-locus variant, ST1652, with these STs found across all sample types. Capsular serotype VI was detected in 30 of 58 isolates. In three herds, identical STs were detected in milk and swab samples, suggesting that extramammary sources of GBS may contribute to the maintenance and spread of GBS within camel herds. This needs to be considered when developing prevention and control strategies for GBS mastitis. The high nasal carriage rate, low recto-vaginal carriage rate, and high prevalence of serotype VI for GBS in camels are in stark contrast to the distribution of GBS in humans and in cattle and reveal hitherto unknown ecological and molecular features of this bacterial species.	[Seligsohn, Dinah] Natl Vet Inst, Dept Anim Hlth & Antimicrobial Strategies, Uppsala, Sweden; [Seligsohn, Dinah] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Crestani, Chiara; Zadoks, Ruth N.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Gitahi, Nduhiu] Univ Nairobi, Dept Publ Hlth Pharmacol & Toxicol, Nairobi, Kenya; [Flodin, Emelie Lejon] Uppsala Small Anim Clin, Uppsala, Sweden; [Chenais, Erika] Natl Vet Inst, Dept Dis Control & Epidemiol, Uppsala, Sweden; [Zadoks, Ruth N.] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Camden, NSW, Australia	National Veterinary Institute SVA; Swedish University of Agricultural Sciences; University of Glasgow; University of Nairobi; National Veterinary Institute SVA; University of Sydney	Seligsohn, D (corresponding author), Natl Vet Inst, Dept Anim Hlth & Antimicrobial Strategies, Uppsala, Sweden.; Seligsohn, D (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden.	dinah.seligsohn@sva.se		Zadoks, Ruth/0000-0002-1164-8000	Swedish Research Council [VR2015_03583]; University of Glasgow's College of Medical, Veterinary and Life Sciences Doctoral Training Programme	Swedish Research Council(Swedish Research CouncilEuropean Commission); University of Glasgow's College of Medical, Veterinary and Life Sciences Doctoral Training Programme	This study was funded by the Swedish Research Council [grant number VR2015_03583] (https://www.vr.se/) awarded to EC. The funding body was not involved in the study design, data collection and analysis, interpretation of data, decision to publish or in preparation of the manuscript. CC was supported by the University of Glasgow's College of Medical, Veterinary and Life Sciences Doctoral Training Programme 2017-2021.	Absalon J, 2021, LANCET INFECT DIS, V21, P263, DOI 10.1016/S1473-3099(20)30478-3; Anderson DM, 2012, J EAST AFR STUD, V6, P383, DOI 10.1080/17531055.2012.696886; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bekele T, 2011, J DAIRY SCI, V94, P1310, DOI 10.3168/jds.2010-3654; Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Capurro A, 2010, J DAIRY SCI, V93, P180, DOI 10.3168/jds.2009-2471; Catley A, 2016, REV SCI TECH OIE, V35, P389, DOI 10.20506/rst.35.2.2524; Christie R. N. E. Atkins, 1944, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V22, P197; Cineros JLB., 2017, 145284 BIORXIV; Clinical and Laboratory Standards Institute (CLSI), 2017, PERFORMANCE STANDARD, V28; Cobo-Angel C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208990; Cobo-Angel CG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50225-w; Crestani C, 2021, MICROB GENOMICS, V7, DOI 10.1099/mgen.0.000648; Da Cunha V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5544; Farah Z, 2007, LIVEST SCI, V110, P187, DOI 10.1016/j.livsci.2006.12.010; Faye B., 2012, British Journal of Environment and Climate Change, V2, P227; Fischer A, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-86; Foster-Nyarko E, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0714-7; Georgiadis NJ, 2007, BIOL CONSERV, V137, P461, DOI 10.1016/j.biocon.2007.03.005; Gruet P, 2001, ADV DRUG DELIVER REV, V50, P245, DOI 10.1016/S0169-409X(01)00160-0; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Heffernan C, 2000, DELIVERY VET SERVICE; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Jorgensen HJ, 2016, VET MICROBIOL, V184, P64, DOI 10.1016/j.vetmic.2015.12.014; Kagunyu AW, 2014, PASTORALISM, V4, DOI 10.1186/s13570-014-0013-6; Kenya National Bureau of Statistics & County Government of Laikipia, 2019, COUNT STAT ABSTR LAI; KLASTRUP O, 1974, NORD VET MED, V26, P197; Kozlov AM, 2019, BIOINFORMATICS, V35, P4453, DOI 10.1093/bioinformatics/btz305; Lamuka PO, 2017, PASTORALISM, V7, DOI 10.1186/s13570-017-0095-z; Le Doare K, 2013, VACCINE, V31, pD7, DOI 10.1016/j.vaccine.2013.01.009; Lents CA, 2002, J ANIM SCI, V80, P1405; Lyhs U, 2016, EMERG INFECT DIS, V22, P2097, DOI 10.3201/eid2212.151447; Mahmmod YS, 2015, J DAIRY SCI, V98, P6913, DOI 10.3168/jds.2015-9397; Manning SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008795; Matofari JW., 2003, J TROP MICROBIOL BIO, V2, P11; Metcalf BJ, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.02.021; Mork T, 2012, VET MICROBIOL, V155, P81, DOI 10.1016/j.vetmic.2011.08.010; Mutua J M, 2017, J Vet Med, V2017, P1216283, DOI 10.1155/2017/1216283; Noor IM, 2013, PASTORALISM, V3, DOI 10.1186/2041-7136-3-28; PACKER C, 1992, ANIM BEHAV, V43, P265, DOI 10.1016/S0003-3472(05)80222-2; Richards VP, 2019, MOL BIOL EVOL, V36, P2572, DOI 10.1093/molbev/msz169; Richards VP, 2011, INFECT GENET EVOL, V11, P1263, DOI 10.1016/j.meegid.2011.04.019; SCHALM O. W., 1957, JOUR AMER VET MED ASSOC, V130, P199; Scornec H, 2017, J ANTIMICROB CHEMOTH, V72, P2722, DOI 10.1093/jac/dkx202; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Seligsohn D, 2020, J DAIRY SCI, V103, P4717, DOI 10.3168/jds.2019-17701; Seligsohn D, 2021, BMC MICROBIOL, V21, DOI 10.1186/s12866-021-02228-9; Sipka A, 2021, J DAIRY SCI, V104, P4936, DOI 10.3168/jds.2020-19166; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Sorensen UBS, 2019, VET MICROBIOL, V235, P71, DOI 10.1016/j.vetmic.2019.06.008; Sorensen UBS, 2010, MBIO, V1, DOI 10.1128/mBio.00178-10; Teatero S, 2015, J CLIN MICROBIOL, V53, P2919, DOI 10.1128/JCM.01128-15; Tinggren S., 2019, THESIS SLU UPPSALA; Volpato G, 2019, REG ENVIRON CHANGE, V19, P849, DOI 10.1007/s10113-018-1438-z; Wernery U, 2018, J CAMEL PRACT RES, V25, P311, DOI 10.5958/2277-8934.2018.00044.9; Younan M, 2007, VET REC, V160, P330, DOI 10.1136/vr.160.10.330; Younan M., 2002, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V55, P177; Younan M, 2001, PREV VET MED, V51, P307, DOI 10.1016/S0167-5877(01)00228-8; Zadoks RN, 2002, J CLIN MICROBIOL, V40, P3894, DOI 10.1128/JCM.40.11.3894-3902.2002; Zubair S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00515-13	62	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2021	16	12							e0252973	10.1371/journal.pone.0252973	http://dx.doi.org/10.1371/journal.pone.0252973			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY3JJ	34860840	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000754686900001
J	Fantozzi, MPT; Faraguna, U; Ugon, A; Ciuti, G; Pinna, A				Fantozzi, Maria Paola Tramonti; Faraguna, Ugo; Ugon, Adrien; Ciuti, Gastone; Pinna, Andrea			Automatic Cyclic Alternating Pattern (CAP) analysis: Local and multi-trace approaches	PLOS ONE			English	Article							SLEEP; COMPONENTS; ELECTROENCEPHALOGRAM; MICROSTRUCTURE	The Cyclic Alternating Pattern (CAP) is composed of cycles of two different electroencephalographic features: an activation A-phase followed by a B-phase representing the background activity. CAP is considered a physiological marker of sleep instability. Despite its informative nature, the clinical applications remain limited as CAP analysis is a time-consuming activity. In order to overcome this limit, several automatic detection methods were recently developed. In this paper, two new dimensions were investigated in the attempt to optimize novel, efficient and automatic detection algorithms: 1) many electroencephalographic leads were compared to identify the best local performance, and 2) the global contribution of the concurrent detection across several derivations to CAP identification. The developed algorithms were tested on 41 polysomnographic recordings from normal (n = 8) and pathological (n = 33) subjects. In comparison with the visual CAP analysis as the gold standard, the performance of each algorithm was evaluated. Locally, the detection on the F4-C4 derivation showed the best performance in comparison with all other leads, providing practical suggestions of electrode montage when a lean and minimally invasive approach is preferable. A further improvement in the detection was achieved by a multi-trace method, the Global Analysis-Common Events, to be applied when several recording derivations are available. Moreover, CAP time and CAP rate obtained with these algorithms positively correlated with the ones identified by the scorer. These preliminary findings support efficient automated ways for the evaluation of the sleep instability, generalizable to both normal and pathological subjects affected by different sleep disorders.	[Fantozzi, Maria Paola Tramonti; Faraguna, Ugo; Ugon, Adrien; Pinna, Andrea] Sorbonne Univ, Lab Informat Paris 6, CNRS, Paris, France; [Fantozzi, Maria Paola Tramonti; Ciuti, Gastone] Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy; [Fantozzi, Maria Paola Tramonti] Univ Pisa, Dept Translat Res & New Surg & Med Technol, Pisa, Italy; [Faraguna, Ugo] IRCCS Fdn Stella Maris, Dept Dev Neurosci, Pisa, Italy; [Ugon, Adrien] ESIEE Paris, Noisy Le Grand, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Scuola Superiore Sant'Anna; University of Pisa; IRCCS Fondazione Stella Maris; Universite Gustave-Eiffel; ESIEE Paris	Fantozzi, MPT (corresponding author), Sorbonne Univ, Lab Informat Paris 6, CNRS, Paris, France.; Fantozzi, MPT (corresponding author), Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy.; Fantozzi, MPT (corresponding author), Univ Pisa, Dept Translat Res & New Surg & Med Technol, Pisa, Italy.	mariapaola.fantozzi@gmail.com	Tramonti Fantozzi, Maria Paola/AAB-5912-2022; Faraguna, Ugo/J-6805-2012	Tramonti Fantozzi, Maria Paola/0000-0001-5146-4997; Faraguna, Ugo/0000-0002-4814-7218				Barcaro U, 2004, SLEEP MED, V5, P567, DOI 10.1016/j.sleep.2004.07.012; Chamorro R., 2013, SLEEP MED, V14, pe42, DOI [10.1016/j.sleep.2013.11.064, DOI 10.1016/J.SLEEP.2013.11.064]; De Carli F, 2004, BRAIN RES BULL, V63, P399, DOI 10.1016/j.brainresbull.2003.12.013; De Gennaro L, 2002, NEUROPSYCHOBIOLOGY, V45, P95, DOI 10.1159/000048683; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Farina B, 2003, J AFFECT DISORDERS, V77, P227, DOI 10.1016/S0165-0327(02)00147-7; Ferri R, 2005, CLIN NEUROPHYSIOL, V116, P696, DOI 10.1016/j.clinph.2004.09.021; Ferri R, 2005, SLEEP MED, V6, P29, DOI 10.1016/j.sleep.2004.06.010; Ferri R, 2012, J SLEEP RES, V21, P212, DOI 10.1111/j.1365-2869.2011.00981.x; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Halasz P, 2004, J SLEEP RES, V13, P1, DOI 10.1111/j.1365-2869.2004.00388.x; Hartmann S, 2019, IEEE T NEUR SYS REH, V27, P1695, DOI 10.1109/TNSRE.2019.2934828; Karimzadeh F, 2015, 2015 38TH INTERNATIONAL CONFERENCE ON TELECOMMUNICATIONS AND SIGNAL PROCESSING (TSP), P448, DOI 10.1109/TSP.2015.7296302; Kubicki S, 1996, J CLIN NEUROPHYSIOL, V13, P285, DOI 10.1097/00004691-199607000-00003; Largo R, 2005, 2005 IEEE INTERNATIONAL WORKSHOP ON INTELLIGENT SIGNAL PROCESSING (WISP), P44; Mariani S, 2013, CLIN NEUROPHYSIOL, V124, P1815, DOI 10.1016/j.clinph.2013.04.005; Mariani S, 2011, IEEE ENG MED BIO, P1491, DOI 10.1109/IEMBS.2011.6090364; Mariani S, 2010, IEEE ENG MED BIO, P5085, DOI 10.1109/IEMBS.2010.5626211; Mendonca F, 2022, NEURAL COMPUT APPL, V34, P11097, DOI 10.1007/s00521-018-3474-5; Navona C, 2002, CLIN NEUROPHYSIOL, V113, P1826, DOI 10.1016/S1388-2457(02)00284-5; Parrino L, 1996, J CLIN NEUROPHYSIOL, V13, P314, DOI 10.1097/00004691-199607000-00005; Parrino L, 1997, CLIN NEUROPHARMACOL, V20, P253, DOI 10.1097/00002826-199706000-00010; Parrino L, 1996, PSYCHOPHARMACOLOGY, V126, P1, DOI 10.1007/BF02246405; Parrino L, 1998, ELECTROEN CLIN NEURO, V107, P439, DOI 10.1016/S0013-4694(98)00108-4; Parrino L, 2000, NEUROLOGY, V54, P1633, DOI 10.1212/WNL.54.8.1633; Parrino L, 2012, EPILEPSIA, V53, P1178, DOI 10.1111/j.1528-1167.2012.03502.x; Parrino L, 2012, SLEEP MED REV, V16, P27, DOI 10.1016/j.smrv.2011.02.003; Parrino L, 2009, SLEEP MED, V10, P1139, DOI 10.1016/j.sleep.2008.12.014; Poryazova R, 2011, CLIN NEUROPHYSIOL, V122, P1788, DOI 10.1016/j.clinph.2011.02.028; Rosa AC, 1999, CLIN NEUROPHYSIOL, V110, P585, DOI 10.1016/S1388-2457(98)00030-3; Rosa A, 2006, ARQ NEURO-PSIQUIAT, V64, P578, DOI 10.1590/S0004-282X2006000400008; Saccomandi F, 2008, CLIN NEUROPHYSIOL, V119, P959, DOI 10.1016/j.clinph.2007.12.016; Terzano MG, 2002, SLEEP MED, V3, P187, DOI 10.1016/S1389-9457(02)00003-5; Terzano MG, 2000, SLEEP MED REV, V4, P101, DOI 10.1053/smrv.1999.0083; Terzano MG, 2003, CLIN NEUROPHYSIOL, V114, P1715, DOI 10.1016/S1388-2457(03)00136-6; Terzano MG, 2000, CLIN NEUROPHYSIOL, V111, P283, DOI 10.1016/S1388-2457(99)00245-X; TERZANO MG, 1992, SLEEP, V15, P64; Thomas RJ, 2007, SLEEP, V30, P553, DOI 10.1093/sleep/30.5.553	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260984	10.1371/journal.pone.0260984	http://dx.doi.org/10.1371/journal.pone.0260984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855925	Green Published, gold			2022-12-26	WOS:000735299000164
J	Jain, G; Walter, L; Reed, C; O'Donnell, P; Troy, J				Jain, Gagan; Walter, Lauren; Reed, Carolyn; O'Donnell, Patricia; Troy, Jeffrey			How do patients and physicians communicate about hereditary angioedema in the United States?	PLOS ONE			English	Article							QUALITY-OF-LIFE; IMPACT; MANAGEMENT; INFORMATION; OUTCOMES; BURDEN	Background Hereditary angioedema (HAE) is a rare disease that manifests as recurrent and debilitating angioedema attacks, significantly impacting patients' quality of life. Objective To assess communication dynamics between patients with HAE and treating physicians and the impact this has on the treatment of HAE in the United States. Methods This observational study used an institutional review board-approved protocol to collect four sources of patient-physician communication data from the period between January 2015 and May 2017: in-office conversations between patients aged >= 18 years with HAE and physicians, follow-up dictations with physicians, telephone interviews with patients and physicians, and publicly available social media posts from patients. Participant language was qualitatively assessed and key communication elements and communication gaps identified. Results Twenty-five in-office conversations, 14 follow-up physician dictations, and 17 telephone interviews were conducted with a total of 29 unique patients, 4 caregivers, and 14 physicians. In-office conversations were generally physician-driven and focused primarily on symptom frequency, location, and severity; lexicon from both parties centered on "episodes" and "swelling." During visits, impact on quality of life was not routinely assessed by physicians nor discussed proactively by patients; however, during telephone interviews and online, patients frequently described the multifaceted burden of HAE. Patients highlighted the difficulties they experience by using repetition, emphasis, and metaphors; they also varied the descriptors used for attacks depending on the communication goal. Physicians used intensifiers to emphasize the necessity of rescue medication access, whereas prophylactic treatments were positioned as an option for frequent or laryngeal attacks. Conclusion Vocabulary differences suggest that the full impact of HAE is not consistently communicated by patients to physicians during clinical visits, indicating the potential for misaligned understanding of disease burden. A patient-driven, rather than physician-driven approach to the discussions may elicit valuable information that could help to optimize treatment approaches.	[Jain, Gagan] Takeda Pharmaceut Co Ltd, Lexington, MA 02421 USA; [Walter, Lauren; Reed, Carolyn; O'Donnell, Patricia; Troy, Jeffrey] Verilogue, Philadelphia, PA USA; [Walter, Lauren] Real Chem, Philadelphia, PA USA; [Reed, Carolyn] Comcast, Philadelphia, PA USA		Jain, G (corresponding author), Takeda Pharmaceut Co Ltd, Lexington, MA 02421 USA.	gagan.jain@takeda.com			Shire, a Takeda company, Lexington, MA, USA; Shire, a Takeda Company	Shire, a Takeda company, Lexington, MA, USA; Shire, a Takeda Company	This study was funded by Shire, a Takeda company, Lexington, MA, USA. Shire, a Takeda Company, provided funding for Verilogue to conduct the analysis. Shire, a Takeda company, provided funding to Excel Medical Affairs for support in writing and editing this manuscript. The funder provided support in the form of salary for author GJ and although the funder had input on the study and reviewed the manuscript for accuracy, the interpretation of the data was made by the authors independently. Real Chemistry and Comcast had no involvement with this study or manuscript."(Note that "W2O Group" was recently rebranded to "Real Chemistry".)	Ainsworth-Vaughn N., 1998, CLAIMING POWER DOCTO, P147; Ainsworth-Vaughn N., 2010, HDB DISCOURSE ANAL; Aygoren-Pursun E, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-99; Banerji A, 2021, J ASTHMA ALLERGY, V14, P119, DOI 10.2147/JAA.S284029; Banerji A, 2018, ALLERGY ASTHMA PROC, V39, P212, DOI 10.2500/aap.2018.39.4123; Banerji A, 2016, ALLERGY RHINOL, V7, pE172, DOI 10.2500/ar.2016.7.0165; Bernstein JA, 2017, INT J EMERG MED, V10, DOI 10.1186/s12245-017-0141-z; Betschel S, 2019, ALLERGY ASTHMA CL IM, V15, DOI 10.1186/s13223-019-0376-8; Bientzle M, 2017, HEALTH EXPECT, V20, P845, DOI 10.1111/hex.12521; Bientzle M, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4597; Blankenship C., 2009, BIOTECHNOLOGY HEALTH, V5, P37; Boissy A, 2016, J GEN INTERN MED, V31, P755, DOI 10.1007/s11606-016-3597-2; Boxer Harriet, 2009, Fam Pract Manag, V16, P12; Britto MT, 2004, PEDIATRICS, V114, P1272, DOI 10.1542/peds.2003-1134-L; Budych K, 2012, HEALTH POLICY, V105, P154, DOI 10.1016/j.healthpol.2012.02.018; Bygum A, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00212; CLARK NM, 1995, ACAD MED, V70, P957, DOI 10.1097/00001888-199511000-00008; Davis K., 1988, POWER MICROSCOPE; Eggeling M, 2020, PSYCHOL HEALTH MED, V25, P259, DOI 10.1080/13548506.2019.1687917; Farkas Henriette, 2010, Allergy Asthma Clin Immunol, V6, P19, DOI 10.1186/1710-1492-6-19; Fissler T, 2015, JMIR CANCER, V1, DOI 10.2196/cancer.4279; Fouche AS, 2014, ANN ALLERG ASTHMA IM, V112, P371, DOI 10.1016/j.anai.2013.05.028; Goodwin M. H., 1990, HE SAID SHE SAID TAL; Hein N., 1987, TEXT INTERDISCIPLINA, V7, P37; Henao MP, 2016, THER CLIN RISK MANAG, V12, P701, DOI 10.2147/TCRM.S86293; Henzl V., 1990, DOCTOR PATIENT INTER, P77; Heritage J, 2006, STUD INTERACT SOCIO, P1, DOI 10.1017/CBO9780511607172; Hummelinck A, 2006, PATIENT EDUC COUNS, V62, P228, DOI 10.1016/j.pec.2005.07.006; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Kimmerle J, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00035; Longhurst H, 2018, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00245; Longhurst H, 2017, IMMUNOL ALLERGY CLIN, V37, P557, DOI 10.1016/j.iac.2017.04.003; Longhurst H, 2016, CLIN REV ALLERG IMMU, V51, P230, DOI 10.1007/s12016-016-8575-2; Lumry WR, 2017, IMMUNOL ALLERGY CLIN, V37, P617, DOI 10.1016/j.iac.2017.03.004; Lumry WR, 2010, ALLERGY ASTHMA PROC, V31, P407, DOI 10.2500/aap.2010.31.3394; Lusher J M, 1987, Transfus Med Rev, V1, P123, DOI 10.1016/S0887-7963(87)70012-1; Maurer M, 2018, ALLERGY, V73, P1575, DOI 10.1111/all.13384; Miller KL, 2009, HAEMOPHILIA, V15, P73, DOI 10.1111/j.1365-2516.2008.01875.x; Mishler EG., 1984, DISCOURSE MED; Nasr IH, 2016, EXPERT REV CLIN IMMU, V12, P19, DOI 10.1586/1744666X.2016.1100963; Naughton CA, 2018, PHARMACY, V6, DOI 10.3390/pharmacy6010018; Riedl MA, 2015, J ALLER CL IMM-PRACT, V3, P220, DOI 10.1016/j.jaip.2014.08.017; Riedl MA, 2013, IMMUNOL ALLERGY CLIN, V33, P471, DOI 10.1016/j.iac.2013.07.003; Rutten LJF, 2016, ADV THER, V33, P1440, DOI 10.1007/s12325-016-0369-7; Shuy R., 1983, SOCIAL ORG DOCTOR PA, P189; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; The FrankelR., 2002, LINGUISTICS LANGUAGE; Thorne S, 2006, FAM COMMUNITY HEALTH, V29, p4S, DOI 10.1097/00003727-200601001-00003; Venetis MK, 2009, PATIENT EDUC COUNS, V77, P379, DOI 10.1016/j.pec.2009.09.015; Verilogue Inc, 2019, QUERY NOV; Weijts W., 1993, PATIENT PARTICIPATIO, P39; Weller K, 2016, ALLERGY, V71, P1203, DOI 10.1111/all.12900; Weller K, 2012, ALLERGY, V67, P1289, DOI 10.1111/all.12007; Young Katharine, 1989, TEXTS IDENTITY, P152; Zanichelli A, 2016, ANN ALLERG ASTHMA IM, V117, P394, DOI 10.1016/j.anai.2016.08.014; Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc	56	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260805	10.1371/journal.pone.0260805	http://dx.doi.org/10.1371/journal.pone.0260805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW0CT	34855883	Green Published, gold			2022-12-26	WOS:000735299000128
J	Justen, L; Carlsmith, D; Paskewitz, SM; Bartholomay, LC; Bron, GM				Justen, Lennart; Carlsmith, Duncan; Paskewitz, Susan M.; Bartholomay, Lyric C.; Bron, Gebbiena M.			Identification of public submitted tick images: A neural network approach	PLOS ONE			English	Article							PACIFICUS ACARI IXODIDAE; LYME-DISEASE DIAGNOSES; UNITED-STATES; GEOGRAPHIC-DISTRIBUTION; IXODES-SCAPULARIS	Ticks and tick-borne diseases represent a growing public health threat in North America and Europe. The number of ticks, their geographical distribution, and the incidence of tick-borne diseases, like Lyme disease, are all on the rise. Accurate, real-time tick-image identification through a smartphone app or similar platform could help mitigate this threat by informing users of the risks associated with encountered ticks and by providing researchers and public health agencies with additional data on tick activity and geographic range. Here we outline the requirements for such a system, present a model that meets those requirements, and discuss remaining challenges and frontiers in automated tick identification. We compiled a user-generated dataset of more than 12,000 images of the three most common tick species found on humans in the U.S.: Amblyomma americanum, Dermacentor variabilis, and Ixodes scapularis. We used image augmentation to further increase the size of our dataset to more than 90,000 images. Here we report the development and validation of a convolutional neural network which we call "TickIDNet," that scores an 87.8% identification accuracy across all three species, outperforming the accuracy of identifications done by a member of the general public or healthcare professionals. However, the model fails to match the performance of experts with formal entomological training. We find that image quality, particularly the size of the tick in the image (measured in pixels), plays a significant role in the network's ability to correctly identify an image: images where the tick is small are less likely to be correctly identified because of the small object detection problem in deep learning. TickIDNet's performance can be increased by using confidence thresholds to introduce an "unsure" class and building image submission pipelines that encourage better quality photos. Our findings suggest that deep learning represents a promising frontier for tick identification that should be further explored and deployed as part of the toolkit for addressing the public health consequences of tick-borne diseases.	[Justen, Lennart; Carlsmith, Duncan] Univ Wisconsin, Coll Liberal Arts & Sci, Dept Phys, Madison, WI USA; [Paskewitz, Susan M.; Bron, Gebbiena M.] Univ Wisconsin, Coll Agr & Life Sci, Dept Entomol, Madison, WI 53706 USA; [Bartholomay, Lyric C.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bron, GM (corresponding author), Univ Wisconsin, Coll Agr & Life Sci, Dept Entomol, Madison, WI 53706 USA.	bieneke.bron@wur.nl	Justen, Lennart/GWZ-3765-2022	Bron, Gebbiena/0000-0002-4431-2482; Justen, Lennart/0000-0001-7250-1099	Centers for Disease Control and Prevention [U01CK000505]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	LCB and SMP received the Cooperative Agreement Number U01CK000505, funded by the Centers for Disease Control and Prevention. https://eur03.safelinks.protection.outlook.com/?url=http% 3A%2F%2Fwww.cdc.gov%2F&data=04%7C01% 7Cbieneke.bron%40wur.nl%7Cb5fa490d76514fd f4dbc08d9a90f4f65%7C27d137e5761f4dc1af88d 26430abb18f%7C0%7C0%7C63772670697681 6835%7CUnknown%7CTWFpbGZsb3d8eyJWIj oiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1 haWwiLCJXVCI6Mn0%3D%7C2000&sdata= b1fFPelOzGWiIhcUHckLIr7xzaPmfejINsLEmebm 4Os%3D&reserved=0 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention.	Abadi Martin, 2016, arXiv; Akbarian S., 2020, ABS200911931 CORR; Antonise-Kamp L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2836-4; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bron GM, 2021, J MED ENTOMOL, V58, P866, DOI 10.1093/jme/tjaa234; Burlina PM, 2020, COMPUT BIOL MED, V125, DOI 10.1016/j.compbiomed.2020.103977; Burlina PM, 2019, COMPUT BIOL MED, V105, P151, DOI 10.1016/j.compbiomed.2018.12.007; Butler AD, 2017, TICKS TICK-BORNE DIS, V8, P262, DOI 10.1016/j.ttbdis.2016.11.010; Chollet F, 2016, KERAS, DOI DOI 10.1038/NATURE083580; Couret J, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008904; De Fauw J, 2018, NAT MED, V24, P1342, DOI 10.1038/s41591-018-0107-6; Dhillon Anamika, 2020, Progress in Artificial Intelligence, V9, P85, DOI 10.1007/s13748-019-00203-0; Dodge S, 2016, 2016 EIGHTH INTERNATIONAL CONFERENCE ON QUALITY OF MULTIMEDIA EXPERIENCE (QOMEX); Eisen L, 2021, J MED ENTOMOL, V58, P1, DOI 10.1093/jme/tjaa165; Eisen RJ, 2017, ILAR J, V58, P319, DOI 10.1093/ilar/ilx005; Eisen RJ, 2018, TRENDS PARASITOL, V34, P295, DOI 10.1016/j.pt.2017.12.006; Eisen RJ, 2016, J MED ENTOMOL, V53, P349, DOI 10.1093/jme/tjv237; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Estrada-Pena A, 2017, TICKS TICK-BORNE DIS, V8, P540, DOI 10.1016/j.ttbdis.2017.03.001; Fernandez MP, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/14769; GBIF.org, 2020, OCC DOWNL, DOI [10.15468/dl.4gbcs6, DOI 10.15468/DL.4GBCS6]; GBIF.org, 2020, OCC DOWNL, DOI [10.15468/dl.sq29u5, DOI 10.15468/DL.SQ29U5]; GBIF.org, 2020, OCC DOWNL, DOI [10.15468/dl.tyybke, DOI 10.15468/DL.TYYBKE]; Girshick R, 2014, PROC CVPR IEEE, P580, DOI 10.1109/CVPR.2014.81; Hahn MB, 2016, J MED ENTOMOL, V53, P1176, DOI 10.1093/jme/tjw076; Heaven W.D, 2020, TECHNOLOGY REV; Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397; Huang R, 2018, IEEE INT CONF BIG DA, P2503, DOI 10.1109/BigData.2018.8621865; Jordan RA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211778; Kingma D. P., 2015, 3 INT C LEARNING REP; Kopsco HL, 2021, J MED ENTOMOL, V58, P837, DOI 10.1093/jme/tjaa196; Kopsco HL, 2020, J MED ENTOMOL, V57, P1955, DOI 10.1093/jme/tjaa140; Kugeler KJ, 2021, EMERG INFECT DIS, V27, P616, DOI 10.3201/eid2702.202731; Kugeler KJ, 2015, EMERG INFECT DIS, V21, P1455, DOI 10.3201/eid2108.141878; Lee SH, 2015, IEEE IMAGE PROC, P452, DOI 10.1109/ICIP.2015.7350839; Lele S.R., 2019, RESOURCESELECTION RE; Lewis J, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6010022; Lim JS, 2019, ARXIV PREPRINT ARXIV; Liu SQ, 2014, I S BIOMED IMAGING, P1015, DOI 10.1109/ISBI.2014.6868045; MacLeod N, 2010, NATURE, V467, P154, DOI 10.1038/467154a; Mader EM, 2021, J MED ENTOMOL, V58, P1503, DOI 10.1093/jme/tjaa094; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Nelson CA, 2015, EMERG INFECT DIS, V21, P1625, DOI 10.3201/eid2109.150417; Omodior O, 2021, EXP APPL ACAROL, V84, P607, DOI 10.1007/s10493-021-00639-x; Perez L, 2017, ARXIV171204621; Pfeifer LM., 2020, ARXIV201111459; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1; Salman A, 2016, LIMNOL OCEANOGR-METH, V14, P570, DOI 10.1002/lom3.10113; Schwartz AM, 2021, EMERG INFECT DIS, V27, P499, DOI 10.3201/eid2702.202728; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; Swanson A, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.26; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Tong K, 2020, IMAGE VISION COMPUT, V97, DOI 10.1016/j.imavis.2020.103910; Tsoumakas G., 2007, INT J DATA WAREHOUS, V3, P1; Viera AJ, 2005, FAM MED, V37, P360; Villon S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67573-7; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Xu Y, 2018, J ANAL TEST, V2, P249, DOI 10.1007/s41664-018-0068-2	60	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260622	10.1371/journal.pone.0260622	http://dx.doi.org/10.1371/journal.pone.0260622			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855822	Green Published, Green Submitted, gold			2022-12-26	WOS:000735299000077
J	Rahman, M; Tariqujjaman, M; Mahfuz, M; Ahmed, T; Sarma, H				Rahman, Mahfuzur; Tariqujjaman, Md; Mahfuz, Mustafa; Ahmed, Tahmeed; Sarma, Haribondhu			Caregiver perceived barriers to the use of micronutrient powder for children aged 6-59 months in Bangladesh	PLOS ONE			English	Article							NUTRITION; PREDICTORS; PROGRAMS; COVERAGE	Background The effectiveness of micronutrient powder (MNP) on the health outcome of children is yet to be proved. Although studies identified the barriers to the use of MNP the underlying factors related to the barriers to the use of MNP are still unexplored. We examined the underlying factors associated with the barriers reported by the caregivers of the children aged 6-59 months in Bangladesh. Methods We analyzed pooled data of 3, 634 caregiver-child dyads extracted from eight cross-sectional surveys. The surveys were conducted as part of an evaluation of the Maternal, Infant and Young Children Nutrition programme (phase 2) in Bangladesh. We performed univariate analysis to find the barriers reported by the caregivers of the children. We identified the underlying factors related to the reported barriers by performing multiple logistic regression analysis. Results The mostly reported barrier was perceived lack of need for MNP among the caregivers of the children (39.9%), followed by lack of awareness of the product (21.7%) and cost of the product (18.1%). Caregivers of older children (adjusted odds ratio (aOR): 1.69; 95% CI: 1.43, 2.00) and caregivers who maintained good infant and young child feeding practices (aOR: 1.32; 95% CI: 1.12, 1.57) perceived more lack of need for MNP. Caregivers of the female children (aOR: 0.79; 95% CI: 0.63, 0.98) were less likely to report that their children disliked MNP compared to the caregivers of the male children. Conclusion Programmes intended to effectively promote MNP among the caregivers of children aged 6-59 months should carefully consider the factors that could underlie the barriers to the use of MNP.	[Rahman, Mahfuzur; Tariqujjaman, Md; Mahfuz, Mustafa; Ahmed, Tahmeed] Icddr B, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Sarma, Haribondhu] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); Australian National University	Rahman, M (corresponding author), Icddr B, Nutr & Clin Serv Div, Dhaka, Bangladesh.	mahfuzur.rahman@icddrb.org	Mahfuz, Mustafa/H-5923-2017	Mahfuz, Mustafa/0000-0002-4090-785X; Sarma, Haribondhu/0000-0003-1553-8498; Rahman, Mahfuzur/0000-0002-3117-9846	Children's Investment Fund Foundation (CIFF), UK	Children's Investment Fund Foundation (CIFF), UK	Research for this article was founded by the Children's Investment Fund Foundation (CIFF), UK. The views, opinions, assumptions, or any other information set out in this article are solely those of the authors and should not be attributed to CIFF or any person connected with CIFF.	Ahmed S, 2021, PUBLIC HEALTH NUTR, V24, pS59, DOI 10.1017/S1368980020003602; Aparco Juan Pablo, 2017, Rev. perú. med. exp. salud publica, V34, P590, DOI 10.17843/rpmesp.2017.344.3164; Bahl K., 2013, NUTR BETTER TOMORROW, V110; Burchi F, 2010, ECON HUM BIOL, V8, P331, DOI 10.1016/j.ehb.2010.05.010; De-Regil LM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008959.pub2; Dewey Kathryn G., 2003, Food and Nutrition Bulletin, V24, P5; Global Alliance for Improved Nutrition, HOM FORT BANGL; Gross GJ, 2001, PUBLIC HEALTH NURS, V18, P157, DOI 10.1046/j.1525-1446.2001.00157.x; Guevarra E., 2014, Field Exchange - Emergency Nutrition Network ENN, P60; Jefferds MED, 2015, MATERN CHILD NUTR, V11, P77, DOI 10.1111/mcn.12214; Kim SS, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0164800, 10.1371/journal.pone.0147745]; Kodish S, 2015, FOOD NUTR BULL, V36, P138, DOI 10.1177/0379572115586784; Kodish S, 2011, FOOD NUTR BULL, V32, P292, DOI 10.1177/156482651103200315; Leyvraz M, 2017, J NUTR, V147, p995S, DOI 10.3945/jn.116.245407; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mirkovic KR, 2016, PUBLIC HEALTH NUTR, V19, P1768, DOI 10.1017/S1368980015003572; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; Olney DK, 2012, J NUTR, V142, p178S, DOI 10.3945/jn.110.137182; Sarma H, 2021, PUBLIC HEALTH NUTR, V24, pS7, DOI 10.1017/S1368980019004415; Sarma H, 2021, PUBLIC HEALTH NUTR, V24, pS37, DOI 10.1017/S1368980020000439; Sarma H, 2021, PUBLIC HEALTH NUTR, V24, pS48, DOI 10.1017/S1368980020000038; Sarma H, 2021, PUBLIC HEALTH NUTR, V24, pS23, DOI 10.1017/S1368980019003768; Sarma H, 2016, FOOD NUTR BULL, V37, P340, DOI 10.1177/0379572116645916; Tanner J., 1990, FETUS MAN PHYS GROWT; World Health Organization, 2001, GUID PRINC COMPL FEE; World Health Organization, 2005, GUID PRINC FEED NONB; World Health Organization, 2001, IR DEF ASS PREV CONT	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2021	16	12							e0260773	10.1371/journal.pone.0260773	http://dx.doi.org/10.1371/journal.pone.0260773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW0CT	34855857	gold, Green Published			2022-12-26	WOS:000735299000117
J	Curriero, FC; Wychgram, C; Rebman, AW; Corrigan, AE; Kvit, A; Shields, T; Aucott, JN				Curriero, Frank C.; Wychgram, Cara; Rebman, Alison W.; Corrigan, Anne E.; Kvit, Anton; Shields, Timothy; Aucott, John N.			The Lyme and Tickborne Disease Dashboard: A map-based resource to promote public health awareness and research collaboration	PLOS ONE			English	Article								With the incidence of Lyme and other tickborne diseases on the rise in the US and globally, there is a critical need for data-driven tools that communicate the magnitude of this problem and help guide public health responses. We present the Johns Hopkins Lyme and Tickborne Disease Dashboard (https://www.hopkinslymetracker.org/), a new tool that harnesses the power of geography to raise awareness and fuel research and scientific collaboration. The dashboard is unique in applying a geographic lens to tickborne diseases, aiming not only to become a global tracker of tickborne diseases but also to contextualize their complicated geography with a comprehensive set of maps and spatial data sets representing a One Health approach. We share our experience designing and implementing the dashboard, describe the main features, and discuss current limitations and future directions.	[Curriero, Frank C.; Wychgram, Cara; Corrigan, Anne E.; Kvit, Anton; Shields, Timothy] Johns Hopkins Bloomberg Sch Publ Hlth, Spatial Sci Publ Hlth Ctr, Dept Epidemiol, Baltimore, MD 21205 USA; [Rebman, Alison W.; Aucott, John N.] Johns Hopkins Univ, Sch Med, Dept Med, Lyme Dis Res Ctr,Div Rheumatol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Wychgram, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Spatial Sci Publ Hlth Ctr, Dept Epidemiol, Baltimore, MD 21205 USA.	cwychgr2@jhu.edu		Wychgram, Cara/0000-0002-2875-8812	David P. Nolan Charitable Fund	David P. Nolan Charitable Fund	The Johns Hopkins Lyme and Tickborne Disease Dashboard is funded by a gift from the David P. Nolan Charitable Fund (to FCC, no grant number). The funder provided input on the dashboard design but was not involved in data collection and analysis, decision to publish, or preparation of the manuscript.	Agriculture and Agri-Food Canada, SOILS CAN DER; Alberta Health, INT HLTH DAT APPL; [Anonymous], 2019, ESRI ARCGIS PROVERSI; [Anonymous], LYM DIS SURV AV DAT; British Columbia Centre for Disease Control, REP DIS DAT DASHB; Centers for Disease Control and Prevention, MMWR SUMM NOT INF DI; Centers for Disease Control and Prevention, TICK SURV; Centers for Disease Control and Prevention, CAS DEF REP FORMS; Environment and Climate Change Canada, CAN GRIDD TEMP PREC; Esri, EXPL DES MARK AR DMA; Government of Manitoba,, MAN HLTH SEN ACT LIV; Government of New Brunswick, NEW BRUNSW COMM DIS; Institut national de sante publique du Quebec, RES ANN SURV MAL LYM; Killilea ME, 2008, ECOHEALTH, V5, P167, DOI 10.1007/s10393-008-0171-3; Kugeler KJ, 2021, EMERG INFECT DIS, V27, P616, DOI 10.3201/eid2702.202731; National Oceanic and Atmospheric Administration National Centers for Environmental Information., US CLIM DIV DAT NCLI; Natural Resources Canada, 2015, LAND COV CAN; Natural Resources Canada, DOWNL DIR DOC; Nova Scotia Department of Health and Wellness, POP HLTH ASS SURV; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Public Health Agency of Canada, 2018, SURV LYM DIS; Public Health Ontario, INF DIS TRENDS ONT; R Core Team, 2021, R LANGUAGE ENV STAT; RStudio:, 2021, SHINY WEB APPL FRAME; Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195; Statistic Canada, CORR REPR NDVI US HI; Statistics Canada, 2016 CENS BOUND FIL; Statistics Canada, CENS PROGR; Statistics Canada, HLTH REG BOUND FIL; Stone BL, 2017, VECTOR-BORNE ZOONOT, V17, P619, DOI 10.1089/vbz.2017.2127; U.S. Census Bureau, CART BOUND FIL SHAP; U.S. Geological Survey (USGS), EARTHEXPLORER; US Department of Agriculture Natural Resources Conservation Service, WEB SOIL SURV; US Geological Survey, NLCD 2016 LAND COV C	34	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260122	10.1371/journal.pone.0260122	http://dx.doi.org/10.1371/journal.pone.0260122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851988	gold, Green Published			2022-12-26	WOS:000755762900024
J	Singer, G; Overko, R; Yilmaz, S; Crisostomi, E; Shorten, R				Singer, Gunda; Overko, Roman; Yilmaz, Serife; Crisostomi, Emanuele; Shorten, Robert			Markovian city-scale modelling and mitigation of micro-particles from tires	PLOS ONE			English	Article							PARTICULATE MATTER; AIR-POLLUTION; EMISSION	The recent uptake in popularity in vehicles with zero tailpipe emissions is a welcome development in the fight against traffic induced airborne pollutants. As vehicle fleets become electrified, and tailpipe emissions become less prevalent, non-tailpipe emissions (from tires and brake disks) will become the dominant source of traffic related emissions, and will in all likelihood become a major concern for human health. This trend is likely to be exacerbated by the heavier weight of electric vehicles, their increased power, and their increased torque capabilities, when compared with traditional vehicles. While the problem of emissions from tire wear is well-known, issues around the process of tire abrasion, its impact on the environment, and modelling and mitigation measures, remain relatively unexplored. Work on this topic has proceeded in several discrete directions including: on-vehicle collection methods; vehicle tire-wear abatement algorithms and controlling the ride characteristics of a vehicle, all with a view to abating tire emissions. Additional approaches include access control mechanisms to manage aggregate tire emissions in a geofenced area with other notable work focussing on understanding the particle size distribution of tire generated PM, the degree to which particles become airborne, and the health impacts of tire emissions. While such efforts are already underway, the problem of developing models to predict the aggregate picture of a network of vehicles at the scale of a city, has yet to be considered. Our objective in this paper is to present one such model, built using ideas from Markov chains. Applications of our modelling approach are given toward the end of this note, both to illustrate the utility of the proposed method, and to illustrate its application as part of a method to collect tire dust particles.	[Singer, Gunda] Johannes Kepler Univ Linz, Inst Design & Control Mechatron Syst, Linz, Austria; [Overko, Roman] Univ Coll Dublin, Sch Elect & Elect Engn, Dublin, Ireland; [Yilmaz, Serife] Mehmet Akif Ersoy Univ, Educ Fac, Dept Math Educ, Burdur, Turkey; [Crisostomi, Emanuele] Univ Pisa, Dept Energy Syst Terr & Construct Engn, Pisa, Italy; [Shorten, Robert] Imperial Coll London, Dyson Sch Design Engn, London, England	Johannes Kepler University Linz; University College Dublin; Mehmet Akif Ersoy University; University of Pisa; Imperial College London	Overko, R (corresponding author), Univ Coll Dublin, Sch Elect & Elect Engn, Dublin, Ireland.	roman.overko@ucdconnect.ie	; Crisostomi, Emanuele/G-8216-2015	Shorten, Robert/0000-0002-9239-2499; Crisostomi, Emanuele/0000-0002-7973-6357	Scientific and Technological Research Council of Turkey (TUBITAK) [21514107-115.99-E.181626]; Science Foundation Ireland (SFI) [16/IA/4610]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Science Foundation Ireland (SFI)(Science Foundation Ireland)	Serife Yilmaz Grant 21514107-115.99-E.181626 The Scientific and Technological Research Council of Turkey (TUBITAK) www.tubitak.gov.tr The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Roman Overko Grant 16/IA/4610 Science Foundation Ireland (SFI) https://www.sfi.ie The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato F, 2014, J HAZARD MATER, V275, P31, DOI 10.1016/j.jhazmat.2014.04.053; Baensch-Baltruschat B, 2020, SCI TOTAL ENVIRON, V733, DOI 10.1016/j.scitotenv.2020.137823; Besenczi R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246062; Buehler R, 2021, TRANSPORT REV, V41, P393, DOI 10.1080/01441647.2021.1914900; Chen H, 2017, LANCET, V389, P718, DOI 10.1016/S0140-6736(16)32399-6; Combs T, 2021, TRANSP RES INTERDISC, V9, P1, DOI DOI 10.1016/J.TRIP.2021.100322; Crisostomi E, 2011, GREEN IT: TECHNOLOGIES AND APPLICATIONS, P381; Crisostomi E, 2011, INT J CONTROL, V84, P633, DOI 10.1080/00207179.2011.568005; Crisostomi E., 2017, ELECT PLUG HYBRID VE; de Miranda RM, 2012, AIR QUAL ATMOS HLTH, V5, P63, DOI 10.1007/s11869-010-0124-1; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Donati L, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10228146; Doyle P, 2009, ARXIV PREPRINT ARXIV; European Environment Agency, 2014, AIR QUAL EUR 2014 RE, DOI 10.2800/22775; Even-Dar E, 2003, J MACH LEARN RES, V5, P1; Faizrahnemoon M, 2015, INT J CONTROL, V88, P2354, DOI 10.1080/00207179.2015.1043582; Fauser P., 1999, PARTICULATE AIR POLL; Foitzik MJ, 2018, WEAR, V394, P87, DOI 10.1016/j.wear.2017.09.023; Gehring U, 2015, EPIDEMIOLOGY, V26, P300, DOI 10.1097/EDE.0000000000000264; Grigoratos T., 2014, 26648 EUR, DOI DOI 10.2790/21481; Grigoratos T, 2018, ATMOS ENVIRON, V182, P200, DOI 10.1016/j.atmosenv.2018.03.049; Hatzopoulou M, 2010, TRANSPORT RES D-TR E, V15, P315, DOI 10.1016/j.trd.2010.03.007; Jekel M, 2019, SCI REPORT TYRE ROAD; Katsikouli P, 2020, FRONT SUSTAIN CITIES, V2, DOI 10.3389/frsc.2020.575482; Kemeny J. G., 1960, FINITE MARKOV CHAINS; Keuken M, 2010, SCI TOTAL ENVIRON, V408, P4591, DOI 10.1016/j.scitotenv.2010.06.052; Kole PJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101265; Korytov M.S., 2020, J PHYS C SERIES, V1441; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; Obereigner G., 2021, SAE TECHNICAL PAPER; Obereigner G., 2020, P IEEE INT C SYST TH; Overko Roman, 2020, IEEE T INTELL TRANSP; Polukarova M, 2020, ENVIRON INT, V135, DOI 10.1016/j.envint.2019.105337; Prenner S, 2021, ENVIRON POLLUT, V290, DOI 10.1016/j.envpol.2021.118102; Schraufnagel DE, 2020, EXP MOL MED, V52, P311, DOI 10.1038/s12276-020-0403-3; Sedgewick R, 2011, ALGORITHMS; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Timmers VRJH, 2016, ATMOS ENVIRON, V134, P10, DOI 10.1016/j.atmosenv.2016.03.017; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; Wang T, 2021, TRANSPORT RES C-EMER, V125, DOI 10.1016/j.trc.2021.103046; WHO, 2013, HLTH EFF PART MATT P	41	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2021	16	12							e0260226	10.1371/journal.pone.0260226	http://dx.doi.org/10.1371/journal.pone.0260226			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ9AQ	34851981	gold, Green Published			2022-12-26	WOS:000755762900026
J	Marsay, KS; Greaves, S; Mahabaleshwar, H; Ho, CM; Roehl, H; Monk, PN; Carney, TJ; Partridge, LJ				Marsay, Katherine S.; Greaves, Sarah; Mahabaleshwar, Harsha; Ho, Charmaine Min; Roehl, Henry; Monk, Peter N.; Carney, Tom J.; Partridge, Lynda J.			Tetraspanin Cd9b and Cxcl12a/Cxcr4b have a synergistic effect on the control of collective cell migration	PLOS ONE			English	Article							LATERAL-LINE; TISSUE MIGRATION; GENOME DUPLICATION; PROTEINS; CATENIN; CD81; ACTIVATION; MOTILITY; FUSION; SIGNAL	Collective cell migration is essential for embryonic development and homeostatic processes. During zebrafish development, the posterior lateral line primordium (pLLP) navigates along the embryo flank by collective cell migration. The chemokine receptors, Cxcr4b and Cxcr7b, as well as their cognate ligand, Cxcl12a, are essential for this process. We corroborate that knockdown of the zebrafish cd9 tetraspanin orthologue, cd9b, results in mild pLL abnormalities. Through generation of CRISPR and TALEN mutants, we show that cd9a and cd9b function partially redundantly in pLLP migration, which is delayed in the cd9b single and cd9a; cd9b double mutants. This delay led to a transient reduction in neuromast numbers. Loss of both Cd9a and Cd9b sensitized embryos to reduced Cxcr4b and Cxcl12a levels. Together these results provide evidence that Cd9 modulates collective cell migration of the pLLP during zebrafish development. One interpretation of these observations is that Cd9 contributes to more effective chemokine signalling.	[Marsay, Katherine S.; Partridge, Lynda J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield, S Yorkshire, England; [Marsay, Katherine S.; Monk, Peter N.] Univ Sheffield, Dept Infect Immun & Cardiovasc Sci, Sheffield, S Yorkshire, England; [Marsay, Katherine S.; Carney, Tom J.] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Greaves, Sarah; Roehl, Henry] Univ Sheffield, Dept Biomed Sci, Sheffield, S Yorkshire, England; [Mahabaleshwar, Harsha; Ho, Charmaine Min; Carney, Tom J.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Expt Med Bldg,Yunnan Garden Campus, Singapore, Singapore	University of Sheffield; University of Sheffield; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Sheffield; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Roehl, H (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield, S Yorkshire, England.	h.roehl@sheffield.ac.uk	Monk, Peter/C-6155-2008; Carney, Tom James/ACF-9214-2022	Monk, Peter/0000-0003-4637-3059; Carney, Tom James/0000-0003-2371-1924; Partridge, Lynda/0000-0002-2098-9747; Marsay, Katherine/0000-0002-8004-5908	MRC [MR/J001457/1]; IMCB-ASTAR Singapore; University of Sheffield	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); IMCB-ASTAR Singapore(Agency for Science Technology & Research (A*STAR)); University of Sheffield	The project was partly funded under the grant HR received from the MRC (MR/J001457/1). KM was funded by a studentship from IMCB-ASTAR Singapore and the University of Sheffield. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud MP, 2015, BLOOD, V126, P1802, DOI 10.1182/blood-2015-02-628560; Brand MM., 2002, KEEPING RAISING ZEBR, V7, P39; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Brzoska E, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0041-1; Colak-Champollion T, 2019, CURR BIOL, V29, P2570, DOI 10.1016/j.cub.2019.06.061; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Brolosy MA, 2019, NATURE, V568, P193, DOI 10.1038/s41586-019-1064-z; Gallardo VE, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-120; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Gartlan KH, 2010, J IMMUNOL, V185, P3158, DOI 10.4049/jimmunol.0902867; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hassuna N, 2009, BIODRUGS, V23, P341, DOI 10.2165/11315650-000000000-00000; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Howe DG, 2013, NUCLEIC ACIDS RES, V41, pD854, DOI 10.1093/nar/gks938; Huang CL, 2004, ONCOGENE, V23, P7475, DOI 10.1038/sj.onc.1208063; Huang SF, 2005, GENOMICS, V86, P674, DOI 10.1016/j.ygeno.2005.08.004; Huang SF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-306; Jiang X., 2020, BIOCH BIOPHYS ACTA M; Johnson JL, 2009, J CELL SCI, V122, P2263, DOI 10.1242/jcs.045997; Kaji K, 2002, DEV BIOL, V247, P327, DOI 10.1006/dbio.2002.0694; Knobeloch KP, 2000, MOL CELL BIOL, V20, P5363, DOI 10.1128/MCB.20.15.5363-5369.2000; Lee JH, 2010, GUT, V59, P907, DOI 10.1136/gut.2009.194068; Leung KT, 2011, BLOOD, V117, P1840, DOI 10.1182/blood-2010-04-281329; Lin QF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51612-z; Matsuda M, 2013, DEVELOPMENT, V140, P2387, DOI 10.1242/dev.091348; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Minina S, 2007, CURR BIOL, V17, P1164, DOI 10.1016/j.cub.2007.05.073; Mohan A, 2007, EXP EYE RES, V84, P781, DOI 10.1016/j.exer.2006.06.014; Nogare DD, 2020, SEMIN CELL DEV BIOL, V100, P186, DOI 10.1016/j.semcdb.2019.12.015; Nogare DD, 2017, MECH DEVELOP, V148, P69, DOI 10.1016/j.mod.2017.04.005; Olson HM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00083; Ovalle S, 2007, INT J CANCER, V121, P2140, DOI 10.1002/ijc.22902; Stephens B, 2013, PROG MOL BIOL TRANSL, V115, P375, DOI 10.1016/B978-0-12-394587-7.00009-9; Suarez H, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12082; Takeda Y, 2003, J CELL BIOL, V161, P945, DOI 10.1083/jcb.200212031; Takeda Y, 2008, J BIOL CHEM, V283, P26089, DOI 10.1074/jbc.M801902200; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; Thelen M, 2018, CYTOKINE, V109, P72, DOI 10.1016/j.cyto.2018.02.011; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thomas ED, 2015, WIRES DEV BIOL, V4, P1, DOI 10.1002/wdev.160; Trikic MZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019683; Valdivia LE, 2011, DEVELOPMENT, V138, P3931, DOI 10.1242/dev.062695; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Venkiteswaran G, 2013, CELL, V155, P674, DOI 10.1016/j.cell.2013.09.046; Wright MD, 2004, MOL CELL BIOL, V24, P5978, DOI 10.1128/MCB.24.13.5978-5988.2004; Xu H, 2014, DEV BIOL, V385, P316, DOI 10.1016/j.ydbio.2013.10.027; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yauch RL, 2000, BIOCHEM J, V351, P629, DOI 10.1042/0264-6021:3510629	54	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2021	16	11							e0260372	10.1371/journal.pone.0260372	http://dx.doi.org/10.1371/journal.pone.0260372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9KP	34847198	Green Published, Green Accepted, gold			2022-12-26	WOS:000735928900026
